data_2mwg_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mwg _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.517 ' O ' ' OG ' ' A' ' 6' ' ' SER . . . -156.98 169.95 23.64 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 116.65 -1.643 . . . . 0.0 110.19 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.6 p -72.9 -18.81 61.37 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 124.902 1.376 . . . . 0.0 110.808 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -70.59 -67.02 0.53 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 114.444 -1.253 . . . . 0.0 112.189 174.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -66.71 -38.58 87.01 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.517 ' OG ' ' O ' ' A' ' 2' ' ' ALA . 64.1 m -58.97 -41.63 87.97 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 120.441 -0.503 . . . . 0.0 110.306 -177.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.658 ' CE2' HD13 ' A' ' 9' ' ' ILE . 41.1 t80 82.1 86.18 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 O-C-N 123.909 0.756 . . . . 0.0 111.301 176.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.455 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -60.86 -134.78 0.01 OUTLIER Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -177.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.658 HD13 ' CE2' ' A' ' 7' ' ' PHE . 57.2 mt 78.95 108.72 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.695 0 C-N-CA 122.583 0.353 . . . . 0.0 110.775 -178.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -63.31 -22.65 72.09 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.422 1.415 . . . . 0.0 112.134 -178.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.72 -37.83 95.29 Favored Glycine 0 C--O 1.245 0.817 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.766 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.56 -39.07 91.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.359 0.6 . . . . 0.0 109.744 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 49.8 tp -62.95 -41.62 99.56 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -62.61 -39.56 94.17 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 56.2 t -60.74 -44.24 96.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 O-C-N 122.365 -0.21 . . . . 0.0 110.986 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 93.0 mt -62.62 -43.59 98.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.181 -177.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.407 ' NZ ' ' HA ' ' B' ' 6' ' ' SER . 98.9 mttt -62.4 -46.03 90.46 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 119.331 -0.948 . . . . 0.0 112.123 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.65 ' HZ3' HG12 ' B' ' 113' ' ' ILE . 98.6 mttt -60.65 -39.51 88.6 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 118.881 -1.128 . . . . 0.0 109.082 -175.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.8 -42.34 93.23 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.092 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.3 mt -63.26 -40.97 98.89 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.105 0.479 . . . . 0.0 109.879 178.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.41 -38.86 92.78 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.576 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 53.7 m170 -58.16 -39.83 79.87 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 122.27 -0.268 . . . . 0.0 111.592 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.0 p -114.69 130.23 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.522 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 35.6 ptt180 -72.04 109.32 5.77 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 122.245 1.021 . . . . 0.0 111.945 -177.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.5 p -140.21 142.9 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.555 ' O ' ' N ' ' A' ' 123' ' ' GLN . . . -98.18 93.12 1.33 Allowed Glycine 0 C--N 1.313 -0.709 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.215 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 51.6 t -125.15 129.83 73.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 175.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.1 m -136.66 158.82 37.56 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.3 mt -120.21 129.59 75.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 177.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.419 ' HB ' ' OD1' ' A' ' 37' ' ' ASN . 16.5 p -106.39 166.92 10.19 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.503 178.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.401 ' O ' ' HA ' ' A' ' 37' ' ' ASN . 45.0 t0 -131.83 104.14 14.3 Favored Pre-proline 0 C--N 1.32 -0.701 0 C-N-CA 120.491 -0.483 . . . . 0.0 110.813 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.464 ' CG ' HG22 ' A' ' 117' ' ' THR . 36.7 Cg_endo -63.93 -23.11 68.36 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.379 1.386 . . . . 0.0 111.605 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.12 -34.38 76.24 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.209 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.8 mt -87.4 165.03 15.88 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.861 177.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.701 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 43.2 tt0 -63.24 132.14 50.71 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -176.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.52 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 57.1 t0 62.32 21.19 12.35 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 177.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.419 ' OD1' ' HB ' ' A' ' 30' ' ' THR . 35.0 t-20 42.73 66.59 4.2 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.816 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.701 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 89.1 Cg_endo -70.67 156.18 61.47 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 123.664 2.909 . . . . 0.0 111.993 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.3 mt -88.05 125.16 41.5 Favored 'Isoleucine or valine' 0 C--O 1.246 0.905 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.376 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.2 m -105.65 -42.8 7.13 Favored 'Isoleucine or valine' 0 C--N 1.343 0.324 0 O-C-N 123.613 0.571 . . . . 0.0 111.998 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -96.06 123.75 39.8 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.566 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.1 p -142.67 139.83 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.338 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.545 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 57.6 p30 -97.39 165.12 12.17 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.468 ' HA ' ' OE1' ' A' ' 44' ' ' GLN . 13.2 mm100 -66.09 -38.03 87.26 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 177.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.88 -26.77 63.44 Favored Glycine 0 N--CA 1.453 -0.186 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.545 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 71.4 t80 -59.28 -47.58 84.84 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 -179.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.573 HG11 ' O ' ' A' ' 52' ' ' TYR . 69.5 t -59.38 -44.69 93.08 Favored 'Isoleucine or valine' 0 C--N 1.349 0.585 0 O-C-N 121.241 -0.912 . . . . 0.0 111.366 -173.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -63.73 -37.84 88.86 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.727 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 59.7 ttm -66.57 -43.82 83.93 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 175.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 36.4 p -91.87 -21.99 20.32 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.126 0.488 . . . . 0.0 111.315 -178.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . 77.83 19.56 75.21 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.573 ' O ' HG11 ' A' ' 47' ' ' VAL . 82.9 m-85 -112.58 139.31 48.27 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 122.868 0.467 . . . . 0.0 111.28 178.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -65.85 149.2 50.57 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.785 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.29 -32.32 73.92 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -178.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -66.36 -42.48 87.98 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 119.591 -0.843 . . . . 0.0 111.466 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -65.61 -45.1 84.44 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 119.886 -0.725 . . . . 0.0 109.427 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.412 HD13 ' CD2' ' A' ' 46' ' ' PHE . 97.0 mt -62.1 -46.7 95.87 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 C-N-CA 119.85 -0.74 . . . . 0.0 112.47 -174.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.2 mt -60.77 142.8 55.6 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.53 -3.08 87.33 Favored Glycine 0 N--CA 1.464 0.529 0 CA-C-O 119.234 -0.759 . . . . 0.0 112.877 177.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -136.19 152.08 50.4 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.275 1.537 . . . . 0.0 111.682 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.535 ' C ' ' H ' ' A' ' 63' ' ' ARG . 24.9 t-20 -80.27 151.89 29.33 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.194 0.521 . . . . 0.0 110.509 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 85.6 m -64.56 14.15 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.342 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.535 ' H ' ' C ' ' A' ' 61' ' ' ASN . 36.3 ptt-85 -61.14 -40.78 95.12 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 122.073 -0.392 . . . . 0.0 111.354 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -55.12 -22.91 18.47 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -178.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.4 mt -66.04 -36.62 83.74 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.402 0.62 . . . . 0.0 112.636 176.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -61.95 137.87 58.3 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.061 -178.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.498 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -147.63 -147.73 4.6 Favored Glycine 0 CA--C 1.543 1.801 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.096 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.411 ' HB3' ' HH ' ' A' ' 95' ' ' TYR . 88.7 tttt -62.66 -41.2 98.94 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -177.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.633 ' H ' ' HH ' ' A' ' 95' ' ' TYR . 9.3 m-70 -76.84 -7.87 56.26 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.245 -177.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.498 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 27.4 m -64.02 129.38 39.81 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.22 -0.592 . . . . 0.0 109.71 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -86.47 111.9 42.57 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.809 -177.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.6 -31.38 91.59 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 121.97 1.78 . . . . 0.0 113.206 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.12 -40.11 95.48 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.111 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.43 ' OE1' ' HB ' ' A' ' 90' ' ' VAL . 78.8 mm-40 -65.31 -43.17 91.88 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.2 t -60.38 -43.69 94.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 114.189 -1.369 . . . . 0.0 107.74 -176.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -64.42 -38.06 89.71 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.646 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -63.49 -39.7 95.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.329 0.585 . . . . 0.0 110.625 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.92 -43.94 97.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.941 177.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -62.53 -42.95 99.86 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 113.925 -1.489 . . . . 0.0 108.287 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 99.3 m -61.24 -49.83 75.53 Favored 'General case' 0 C--O 1.247 0.947 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.8 -41.66 96.06 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 118.646 -0.692 . . . . 0.0 111.598 -169.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.0 mt -63.23 -39.29 94.2 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 118.702 0.683 . . . . 0.0 111.188 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 66.7 tp60 -64.87 -34.35 78.17 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -85.28 -3.54 58.86 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.599 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.2 tttt 48.57 37.59 9.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.679 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -120.64 143.89 37.39 Favored Pre-proline 0 CA--C 1.534 0.364 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -61.8 144.2 96.71 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 121.318 1.345 . . . . 0.0 113.307 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.5 p -139.39 141.39 35.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.805 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.572 ' CG2' ' OD1' ' A' ' 107' ' ' ASN . 97.4 m -125.64 121.82 34.63 Favored 'General case' 0 C--N 1.344 0.345 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 175.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.43 ' HB ' ' OE1' ' A' ' 74' ' ' GLU . 27.0 m -139.59 158.77 27.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 120.675 0.274 . . . . 0.0 111.274 178.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -104.7 129.25 52.91 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 176.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 19.8 tt -138.55 130.46 37.57 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 CA-C-N 120.902 1.683 . . . . 0.0 112.207 178.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.445 ' OE1' ' O ' ' A' ' 69' ' ' HIS . 86.7 mt-30 -61.77 137.26 58.23 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.886 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -137.53 158.52 44.22 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.977 -178.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.633 ' HH ' ' H ' ' A' ' 69' ' ' HIS . 93.9 m-85 -117.82 136.7 53.24 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -178.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -84.94 -173.52 4.77 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.175 0.512 . . . . 0.0 111.704 -178.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.42 -43.63 98.37 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.155 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 41.1 p-10 -83.81 6.12 22.53 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -178.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.17 -0.31 83.63 Favored Glycine 0 N--CA 1.465 0.609 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.967 176.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 23.0 m -60.65 138.04 58.11 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.664 ' C ' ' SD ' ' A' ' 101' ' ' MET . 13.2 tmm? -104.09 129.03 51.76 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.878 0.37 . . . . 0.0 111.072 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.491 ' N ' ' SD ' ' A' ' 101' ' ' MET . 53.2 p90 -142.65 159.01 43.07 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 120.276 -0.57 . . . . 0.0 109.677 -178.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.832 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 23.6 m95 -90.38 144.29 25.95 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.493 HD22 ' HG2' ' A' ' 123' ' ' GLN . 54.9 t-20 -137.44 106.08 5.86 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -177.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 80.5 tt0 -72.22 134.34 45.58 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -177.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 40.5 tp -120.05 124.78 46.71 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.572 ' OD1' ' CG2' ' A' ' 89' ' ' THR . 97.8 m-20 -121.11 122.11 39.34 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 176.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 96.2 mt -119.52 129.12 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 O-C-N 123.43 0.457 . . . . 0.0 111.264 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -138.36 124.57 12.78 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.878 -0.147 . . . . 0.0 110.648 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -70.81 150.27 61.52 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 122.25 1.967 . . . . 0.0 112.54 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.5 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 67.4 mtt -121.59 153.8 37.58 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -127.48 93.96 3.86 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 177.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 96.2 mt -119.93 130.56 74.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.529 -177.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 50.01 37.54 14.32 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 118.746 0.703 . . . . 0.0 111.736 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 59.21 29.94 19.6 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.979 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -127.53 146.61 50.45 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.676 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 5.2 t -82.78 -175.38 5.76 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.279 -0.888 . . . . 0.0 109.471 -178.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.676 ' CD2' ' O ' ' A' ' 117' ' ' THR . 73.0 m-85 -168.83 156.18 7.43 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 171.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -129.14 146.31 51.1 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 174.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -135.63 136.88 50.12 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.366 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -111.25 128.48 8.71 Favored Glycine 0 CA--C 1.503 -0.683 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 178.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 96.5 mt -116.99 128.9 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.555 ' N ' ' O ' ' A' ' 26' ' ' GLY . 15.1 mp0 -120.14 116.91 26.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.101 0.477 . . . . 0.0 109.959 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -116.95 114.84 24.4 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.819 -178.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.485 ' OD1' ' OG1' ' A' ' 127' ' ' THR . 68.3 t0 -63.63 125.24 23.64 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -175.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.7 mp -89.93 1.08 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 CA-C-N 113.887 -1.506 . . . . 0.0 110.457 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.485 ' OG1' ' OD1' ' A' ' 125' ' ' ASP . 18.4 m -60.46 -42.72 96.77 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.257 -0.902 . . . . 0.0 112.716 -177.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -60.07 -43.06 95.73 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -178.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -63.28 -39.62 95.1 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.705 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.832 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.7 mttt -62.49 -40.57 97.11 Favored 'General case' 0 CA--C 1.503 -0.854 0 C-N-CA 118.486 -1.286 . . . . 0.0 110.52 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.11 -37.3 84.6 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.485 ' CE2' HD13 ' A' ' 136' ' ' LEU . 90.5 t80 -61.49 -45.26 94.98 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.43 176.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.85 -38.92 92.87 Favored 'General case' 0 C--N 1.342 0.248 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.88 -40.51 95.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.84 0.352 . . . . 0.0 110.15 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 54.5 tp -60.97 -43.6 98.55 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.485 HD13 ' CE2' ' A' ' 132' ' ' TYR . 84.9 mt -62.62 -41.53 99.07 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.196 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.34 -40.62 97.81 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.915 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -60.59 -41.84 95.52 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -177.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 63.3 m -61.33 -40.59 94.81 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.635 176.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 144' ' ' THR . 84.3 mt -63.53 -41.83 98.47 Favored 'General case' 0 C--O 1.221 -0.431 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 90.3 m -61.44 -45.97 92.05 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.295 -177.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.33 -40.14 93.3 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 95.9 mt -64.8 -43.51 96.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 113.781 -1.554 . . . . 0.0 111.281 176.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.504 ' N ' ' O ' ' A' ' 140' ' ' LEU . 90.4 m -62.24 -46.04 90.62 Favored 'General case' 0 C--N 1.344 0.361 0 C-N-CA 120.316 -0.554 . . . . 0.0 112.289 -178.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.06 -39.74 95.63 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 118.815 -1.154 . . . . 0.0 109.017 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.2 mt -63.3 -42.48 99.04 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.756 -0.657 . . . . 0.0 112.517 178.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.753 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.0 p -60.62 -39.95 90.12 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -177.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.495 ' C ' ' O ' ' A' ' 147' ' ' SER . 17.0 m -27.41 79.55 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.428 0 O-C-N 126.617 2.448 . . . . 0.0 106.733 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.753 ' N ' ' O ' ' A' ' 147' ' ' SER . 20.1 Cg_exo -62.89 145.17 94.48 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.007 1.138 . . . . 0.0 114.672 -174.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.512 ' O ' ' CG2' ' A' ' 151' ' ' VAL . 8.8 tp -120.57 135.45 60.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 103.124 -2.917 . . . . 0.0 103.124 175.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.512 ' CG2' ' O ' ' A' ' 150' ' ' ILE . 92.3 t -167.73 90.93 0.69 Allowed Pre-proline 0 CA--C 1.516 -0.355 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 178.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -61.39 137.34 69.47 Favored 'Trans proline' 0 C--N 1.3 -2.006 0 N-CA-C 109.465 -1.013 . . . . 0.0 109.465 -176.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.564 ' O ' ' HD2' ' A' ' 154' ' ' ARG . 45.6 mm -67.47 -44.43 86.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 119.746 -0.782 . . . . 0.0 111.069 179.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.581 HH12 HG21 ' B' ' 153' ' ' ILE . 0.3 OUTLIER -159.12 -154.89 0.44 Allowed 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.082 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 63.0 t-20 -87.89 104.37 16.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 122.189 0.995 . . . . 0.0 111.897 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 89.91 8.61 66.96 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 114.243 -1.344 . . . . 0.0 111.022 -177.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.7 mt -124.09 125.71 71.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 CA-C-O 121.748 0.785 . . . . 0.0 109.477 174.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.656 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 57.8 m -132.82 151.47 52.01 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.276 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -138.96 141.96 38.4 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.546 -0.721 . . . . 0.0 111.244 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 25.9 tp -133.15 80.2 60.01 Favored Pre-proline 0 N--CA 1.471 0.581 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.141 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -69.65 149.18 67.24 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.778 2.319 . . . . 0.0 113.137 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 86.6 mt -116.99 126.13 52.44 Favored 'General case' 0 C--O 1.25 1.116 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.393 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 47.3 t -123.47 131.48 73.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 115.0 169.61 16.07 Favored Glycine 0 N--CA 1.479 1.537 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.93 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.779 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 54.2 t30 -84.96 113.14 21.19 Favored 'General case' 0 C--O 1.213 -0.835 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.454 HD13 HD11 ' A' ' 174' ' ' ILE . 44.8 tp -73.66 103.48 4.26 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -177.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.533 ' H ' ' HE ' ' A' ' 170' ' ' ARG . 9.8 p -86.82 167.34 14.47 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.557 178.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.22 -33.82 76.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.411 0.624 . . . . 0.0 111.6 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.1 -43.39 92.25 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.595 178.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.779 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 88.0 mtm180 -64.66 -31.22 72.35 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.134 0.974 . . . . 0.0 112.051 177.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.42 ' CZ ' ' CD2' ' A' ' 166' ' ' LEU . 0.5 OUTLIER -55.1 -29.38 57.5 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.564 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.524 ' O ' HG21 ' A' ' 175' ' ' VAL . 92.2 m-20 -61.12 -40.46 93.86 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 119.038 -1.065 . . . . 0.0 109.679 -177.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 52.6 m -59.71 -41.02 89.88 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.443 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.454 HD11 HD13 ' A' ' 166' ' ' LEU . 66.1 mt -63.35 -44.07 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.524 HG21 ' O ' ' A' ' 172' ' ' ASN . 26.8 m -62.57 -39.81 85.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . 0.418 ' N ' HG23 ' A' ' 175' ' ' VAL . 98.5 m -62.86 -35.16 79.05 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.303 0.573 . . . . 0.0 110.416 178.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' THR . . . . . 0.474 ' O ' HG13 ' A' ' 181' ' ' ILE . 25.0 m -61.7 -19.44 62.38 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.201 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 87.8 mt -60.97 -41.43 96.36 Favored 'General case' 0 C--O 1.247 0.967 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 -177.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 19.2 m -59.63 -42.94 93.83 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . 0.587 ' O ' ' OG ' ' A' ' 183' ' ' SER . 92.1 m-20 -61.43 -37.67 84.35 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 122.588 0.355 . . . . 0.0 110.983 178.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 177' ' ' THR . 67.6 mt -58.56 -37.71 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 O-C-N 121.685 -0.634 . . . . 0.0 109.476 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 85.0 mt -60.9 -40.34 92.71 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 119.418 -0.913 . . . . 0.0 108.833 -177.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.587 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 77.8 p -62.01 -33.86 75.13 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.528 176.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 59.3 p -89.37 23.36 2.56 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 120.752 0.31 . . . . 0.0 111.66 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 78.1 p -63.0 -20.54 65.39 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.775 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.71 -37.56 82.1 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.793 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.656 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 98.7 m-20 -73.3 115.05 12.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.424 0.631 . . . . 0.0 110.902 -179.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.92 -42.56 99.84 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.045 -0.98 . . . . 0.0 113.03 -177.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -113.78 131.52 56.19 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.266 0.555 . . . . 0.0 110.779 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 38.9 tp -120.0 127.07 52.28 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 92.2 mt -114.27 127.15 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 118.658 0.663 . . . . 0.0 109.607 177.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.7 mm -112.23 126.71 69.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . 0.47 ' CG ' ' HG ' ' A' ' 195' ' ' SER . 39.0 t0 -94.66 118.27 31.45 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 122.046 0.927 . . . . 0.0 110.78 177.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 95.9 mt -98.56 -3.49 36.25 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.392 175.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' SER . . . . . 0.47 ' HG ' ' CG ' ' A' ' 193' ' ' ASP . 78.0 p -62.69 -33.7 75.62 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.629 0.604 . . . . 0.0 112.629 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.78 -43.63 98.98 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 108.491 -1.844 . . . . 0.0 108.491 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 1.161 HD23 ' O ' ' A' ' 199' ' ' GLN . 4.9 tt -70.0 129.15 38.68 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 113.104 -1.548 . . . . 0.0 108.584 -176.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.632 ' N ' HD21 ' A' ' 197' ' ' LEU . . . -60.24 -50.56 73.18 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.242 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 1.161 ' O ' HD23 ' A' ' 197' ' ' LEU . 58.4 tt0 -132.29 157.01 45.53 Favored 'General case' 0 C--O 1.204 -1.322 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -175.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.427 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 47.1 t -117.16 132.1 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 O-C-N 120.306 -1.496 . . . . 0.0 108.889 177.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -83.73 154.92 23.34 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.572 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -64.65 -39.2 93.27 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.123 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -58.26 -31.97 67.93 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 17.5 m -60.39 -41.86 94.69 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.563 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.497 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -57.22 -38.64 74.05 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -177.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -62.63 -37.01 84.61 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -64.76 -38.91 92.58 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.967 177.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 94.6 mt -63.47 -44.51 98.85 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.079 0 C-N-CA 119.598 -0.841 . . . . 0.0 108.982 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . 0.497 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 72.0 m-85 -61.53 -44.11 97.65 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.691 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.0 -41.87 98.53 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 119.347 -0.941 . . . . 0.0 109.363 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.452 ' O ' ' HG ' ' A' ' 215' ' ' LEU . 38.8 mt -62.66 -42.08 99.42 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 78.1 p -61.99 -41.6 98.21 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 119.351 -0.939 . . . . 0.0 110.151 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -65.11 -45.36 85.44 Favored 'General case' 0 C--O 1.233 0.203 0 O-C-N 121.942 -0.474 . . . . 0.0 111.713 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 50.8 tp -62.36 -44.64 96.0 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 211' ' ' LEU . 85.8 mt -63.03 -40.54 98.04 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.705 -177.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.6 -44.26 96.48 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 90.5 mt -61.99 -39.81 93.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.09 0.472 . . . . 0.0 109.749 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 68.5 p -75.94 -10.96 59.85 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.308 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.63 37.39 14.0 Favored Glycine 0 C--O 1.219 -0.808 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.906 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 96.3 m -124.73 111.15 15.22 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.714 1.257 . . . . 0.0 111.309 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -62.31 138.44 58.43 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.548 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 48.0 tp -114.14 130.58 56.59 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 122.849 0.46 . . . . 0.0 109.874 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 3.3 mp -119.04 135.04 60.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.462 HG23 HD11 ' A' ' 224' ' ' ILE . 49.7 mm -115.14 132.24 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 38.5 p -133.57 166.8 21.74 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.863 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 78.09 19.61 74.49 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.684 -0.967 . . . . 0.0 110.684 178.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 97.4 mt -81.96 129.32 37.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 114.14 -1.03 . . . . 0.0 108.879 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 56.9 tttt -75.3 139.23 71.78 Favored Pre-proline 0 CA--C 1.533 0.31 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.58 -39.66 87.47 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.134 1.223 . . . . 0.0 112.526 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -62.83 -40.31 97.0 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-O 121.88 0.848 . . . . 0.0 110.262 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 49.0 tp -63.76 -42.05 97.89 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.543 176.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.31 -37.93 89.17 Favored 'General case' 0 N--CA 1.462 0.16 0 O-C-N 121.938 -0.476 . . . . 0.0 111.273 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 94.1 mtp -63.78 -41.15 98.0 Favored 'General case' 0 C--O 1.247 0.936 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.48 -38.86 92.76 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.594 177.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 32.4 mmt -65.68 -37.4 86.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.716 178.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -60.82 -41.67 96.17 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 121.558 -0.714 . . . . 0.0 109.371 -177.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.24 -41.55 97.07 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.527 0.68 . . . . 0.0 110.58 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 54.3 tp -63.02 -41.67 99.61 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 177.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 240' ' ' ALA . 67.0 t0 -166.81 128.91 1.74 Allowed 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.417 -0.802 . . . . 0.0 112.656 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . 0.402 ' N ' ' OD1' ' A' ' 239' ' ' ASP . . . -61.19 -27.88 68.74 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.853 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . 0.422 ' O ' ' HB2' ' A' ' 244' ' ' SER . 88.2 m-20 -60.92 -28.96 69.31 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.537 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -55.98 -43.81 77.97 Favored 'General case' 0 C--N 1.316 -0.881 0 O-C-N 121.235 -0.916 . . . . 0.0 109.048 -176.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 88.4 p -63.48 -19.27 64.6 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.039 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' SER . . . . . 0.422 ' HB2' ' O ' ' A' ' 241' ' ' ASN . 43.4 m -55.31 -38.4 68.62 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.259 178.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 96.8 mt -87.8 124.72 33.91 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 119.794 -0.762 . . . . 0.0 112.687 -176.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -49.19 134.62 17.73 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.903 -176.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 95.5 m -126.61 132.01 51.36 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.215 -1.357 . . . . 0.0 111.364 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -116.07 140.98 48.73 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.331 178.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' SER . . . . . 0.448 ' O ' ' OD1' ' A' ' 250' ' ' ASN . 78.1 p -60.59 -41.94 95.73 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.448 ' OD1' ' O ' ' A' ' 249' ' ' SER . 99.2 m-20 -145.45 159.63 42.8 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.613 0.72 . . . . 0.0 111.069 -178.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 66.0 t -61.99 -44.72 99.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 114.632 -1.167 . . . . 0.0 112.085 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.31 -43.8 98.27 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -64.13 -42.4 96.83 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.216 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . 0.424 ' O ' HG21 ' A' ' 257' ' ' VAL . . . -64.96 -41.81 95.14 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.973 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . 0.615 HG13 HH11 ' B' ' 154' ' ' ARG . 73.3 t -63.08 -45.59 98.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.009 -178.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.93 -47.72 79.38 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.562 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . 0.506 ' O ' ' C ' ' A' ' 258' ' ' LEU . 27.6 m -66.75 -41.67 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 120.138 -0.625 . . . . 0.0 112.403 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.506 ' C ' ' O ' ' A' ' 257' ' ' VAL . 1.3 mt -28.37 -72.93 0.05 OUTLIER Pre-proline 0 C--N 1.346 0.452 0 CA-C-O 119.562 -0.256 . . . . 0.0 111.248 -177.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' PRO . . . . . 0.475 ' CD ' ' CB ' ' A' ' 258' ' ' LEU . 45.4 Cg_endo -64.13 140.43 71.61 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.005 1.137 . . . . 0.0 112.073 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 259' ' ' PRO . 96.8 mt -152.74 -27.12 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 178.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 N--CA 1.473 0.68 0 CA-C-O 118.159 -0.924 . . . . 0.0 110.622 -177.017 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.493 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.83 158.94 29.25 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 118.728 -0.653 . . . . 0.0 109.933 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 80.7 p -58.88 -25.08 63.01 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 124.177 0.923 . . . . 0.0 110.908 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -68.88 -63.31 1.08 Allowed 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.521 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -67.18 -38.09 84.8 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.496 178.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' SER . . . . . 0.458 ' O ' ' HB3' ' B' ' 7' ' ' PHE . 66.3 m -59.69 -42.53 93.14 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 120.442 -0.503 . . . . 0.0 109.906 -177.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . 0.667 ' CE2' HD13 ' B' ' 9' ' ' ILE . 41.7 t80 83.08 88.19 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 O-C-N 123.904 0.753 . . . . 0.0 110.293 177.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . 0.472 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -62.42 -134.98 0.01 OUTLIER Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -178.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . 0.667 HD13 ' CE2' ' B' ' 7' ' ' PHE . 56.4 mt 79.25 108.54 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.656 0 C-N-CA 122.546 0.338 . . . . 0.0 111.059 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -62.45 -24.25 75.41 Favored 'Trans proline' 0 N--CA 1.498 1.793 0 C-N-CA 121.428 1.419 . . . . 0.0 111.792 -178.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.92 -40.45 98.88 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -64.18 -38.94 92.87 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.742 0.782 . . . . 0.0 109.626 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 51.1 tp -62.25 -42.55 99.43 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 114.757 -1.11 . . . . 0.0 112.114 -177.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -64.54 -33.33 75.66 Favored 'General case' 0 CA--C 1.563 1.466 0 CA-C-O 121.628 0.727 . . . . 0.0 110.759 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 74.1 t -61.9 -46.16 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 113.094 -1.867 . . . . 0.0 111.108 176.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 94.7 mt -63.76 -43.79 98.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.07 0.462 . . . . 0.0 110.255 -178.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . 0.472 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 98.9 mttt -63.42 -42.51 98.73 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.41 -41.07 98.72 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.065 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.67 -39.1 87.16 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.689 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 89.3 mt -64.07 -42.0 97.15 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.05 0.452 . . . . 0.0 110.234 175.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.95 -39.2 93.91 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.121 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 52.4 m170 -57.61 -40.14 78.47 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 121.192 -0.203 . . . . 0.0 111.365 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 10.6 p -114.28 130.27 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.531 ' O ' ' HG3' ' B' ' 24' ' ' ARG . 35.5 ptt180 -71.57 107.15 4.31 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 122.176 0.989 . . . . 0.0 112.392 -177.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.0 p -142.04 133.61 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.497 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' B' ' 123' ' ' GLN . . . -89.45 97.03 2.28 Favored Glycine 0 N--CA 1.434 -1.451 0 C-N-CA 119.441 -1.361 . . . . 0.0 113.326 -175.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 50.0 t -125.43 129.4 72.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 174.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 27.3 m -138.11 156.48 30.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.803 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 95.5 mt -119.43 127.87 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 122.579 1.18 . . . . 0.0 111.17 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.442 ' HB ' ' OD1' ' B' ' 37' ' ' ASN . 18.3 p -111.57 157.73 20.03 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 113.07 -1.877 . . . . 0.0 108.27 -176.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -125.38 104.4 28.5 Favored Pre-proline 0 C--O 1.24 0.569 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.12 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.76 -20.56 64.97 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 121.678 1.585 . . . . 0.0 111.564 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.37 -42.68 99.6 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.048 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 96.3 mt -74.97 -175.48 2.58 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 121.833 -0.542 . . . . 0.0 111.243 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . 0.7 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 42.6 tt0 -78.9 130.93 36.16 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.46 ' O ' ' OD1' ' B' ' 36' ' ' ASP . 62.4 t0 56.37 36.26 27.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.661 177.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' ASN . . . . . 0.442 ' OD1' ' HB ' ' B' ' 30' ' ' THR . 23.1 t-20 31.89 68.68 0.83 Allowed Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.7 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 91.4 Cg_endo -72.08 155.69 56.68 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 C-N-CA 123.332 2.688 . . . . 0.0 111.569 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 96.3 mt -87.35 129.5 38.67 Favored 'Isoleucine or valine' 0 C--O 1.247 0.943 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 26.8 m -109.32 -42.31 5.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 O-C-N 123.943 0.777 . . . . 0.0 112.478 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -96.99 123.91 40.83 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.4 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 5.3 p -142.6 140.37 28.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.446 177.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . 0.577 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 57.5 p30 -100.72 160.98 13.92 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.162 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' GLN . . . . . 0.46 ' HA ' ' OE1' ' B' ' 44' ' ' GLN . 12.8 mm100 -62.98 -36.95 85.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.66 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.07 -27.04 64.27 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.577 ' HB2' ' OD1' ' B' ' 43' ' ' ASN . 65.9 t80 -60.37 -43.09 96.9 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . 0.706 HG11 ' O ' ' B' ' 52' ' ' TYR . 76.9 t -61.07 -46.16 97.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.231 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -63.31 -43.73 97.0 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 119.896 -0.721 . . . . 0.0 110.317 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 59.7 ttm -63.41 -42.48 98.75 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 35.0 p -95.15 -16.55 22.49 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.609 -178.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' B' ' 47' ' ' VAL . . . 74.45 17.19 79.79 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 178.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . 0.706 ' O ' HG11 ' B' ' 47' ' ' VAL . 83.8 m-85 -109.94 145.19 37.32 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 122.953 0.501 . . . . 0.0 110.328 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -75.24 148.34 39.55 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 121.254 0.549 . . . . 0.0 111.24 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.96 -37.21 81.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.866 -176.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.5 -39.75 95.27 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.993 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -72.1 -33.3 67.76 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 176.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . 0.434 HD13 ' CD2' ' B' ' 46' ' ' PHE . 94.9 mt -68.02 -59.36 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 95.9 mt -53.14 134.69 38.61 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -175.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.4 -8.34 74.97 Favored Glycine 0 CA--C 1.538 1.498 0 CA-C-N 116.166 -0.47 . . . . 0.0 113.032 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -133.16 149.05 52.08 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -175.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' ASN . . . . . 0.565 ' C ' ' H ' ' B' ' 63' ' ' ARG . 24.8 t-20 -78.44 150.06 33.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.517 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' CYS . . . . . . . . . . . . . 82.5 m -63.42 9.23 0.06 Allowed 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' ARG . . . . . 0.565 ' H ' ' C ' ' B' ' 61' ' ' ASN . 34.8 ptt-85 -60.54 -32.93 71.96 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.42 -176.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -58.5 -30.61 67.17 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 86.6 mt -62.02 -41.26 97.89 Favored 'General case' 0 C--O 1.238 0.463 0 O-C-N 121.757 -0.59 . . . . 0.0 109.742 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -51.71 145.31 9.53 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.851 -175.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . 0.422 ' HA3' ' CE1' ' B' ' 95' ' ' TYR . . . -157.03 -153.9 6.85 Favored Glycine 0 CA--C 1.535 1.318 0 O-C-N 124.259 0.974 . . . . 0.0 111.774 177.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.26 -41.7 89.45 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -175.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' HIS . . . . . 0.617 ' H ' ' HH ' ' B' ' 95' ' ' TYR . 8.3 m-70 -76.07 -9.84 58.94 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.139 -177.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 26.2 m -61.89 134.03 56.17 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.517 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -90.45 112.16 51.37 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.518 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.62 -37.96 90.88 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 121.185 1.257 . . . . 0.0 111.856 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.97 -40.07 92.01 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 120.42 -0.512 . . . . 0.0 109.761 -175.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' GLU . . . . . 0.436 ' OE1' ' HB ' ' B' ' 90' ' ' VAL . 78.8 mm-40 -66.76 -38.81 87.35 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.001 177.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 70.1 t -62.43 -46.06 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -62.94 -37.46 87.13 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.667 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -62.12 -41.8 98.6 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 119.315 -0.954 . . . . 0.0 108.874 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 94.1 mt -63.49 -43.7 98.48 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 CA-C-O 120.81 0.338 . . . . 0.0 110.907 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -61.38 -43.21 99.25 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 88.4 m -61.75 -45.16 95.11 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.59 0.71 . . . . 0.0 110.171 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.36 -41.83 98.92 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 86.9 mt -62.7 -42.53 99.69 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.516 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 66.8 tp60 -62.78 -34.01 76.35 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -90.78 6.86 42.52 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.414 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 30.8 tttt 42.46 37.99 1.11 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.969 176.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -121.94 141.28 33.76 Favored Pre-proline 0 N--CA 1.467 0.42 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.222 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.1 141.38 88.45 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.075 1.183 . . . . 0.0 113.754 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.5 p -139.81 136.11 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.942 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 89' ' ' THR . . . . . 0.57 ' CG2' ' OD1' ' B' ' 107' ' ' ASN . 96.5 m -121.05 122.6 40.43 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . 0.436 ' HB ' ' OE1' ' B' ' 74' ' ' GLU . 27.3 m -138.92 162.86 27.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.913 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -115.38 121.51 43.01 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.978 -0.451 . . . . 0.0 109.819 174.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 21.3 tt -129.83 132.69 65.66 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 O-C-N 124.191 0.932 . . . . 0.0 111.623 -174.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -69.78 143.33 53.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.97 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 94' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -133.2 177.31 7.77 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 121.718 0.77 . . . . 0.0 111.43 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 95' ' ' TYR . . . . . 0.617 ' HH ' ' H ' ' B' ' 69' ' ' HIS . 96.5 m-85 -127.27 146.57 50.39 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.267 -1.333 . . . . 0.0 112.293 176.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -101.11 -179.88 4.17 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.338 0.589 . . . . 0.0 110.584 177.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.87 -36.56 79.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.306 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 38.9 p-10 -87.09 -0.44 56.66 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.466 -0.771 . . . . 0.0 112.912 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.65 3.25 64.6 Favored Glycine 0 N--CA 1.467 0.714 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.528 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 25.4 m -67.16 131.01 44.94 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 101' ' ' MET . . . . . 0.597 ' SD ' ' N ' ' B' ' 102' ' ' PHE . 14.6 tmm? -90.83 141.86 28.38 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 102' ' ' PHE . . . . . 0.597 ' N ' ' SD ' ' B' ' 101' ' ' MET . 53.4 p90 -153.35 163.94 39.02 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 177.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 103' ' ' TRP . . . . . 0.853 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 23.3 m95 -96.16 140.8 30.33 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.825 0.821 . . . . 0.0 110.428 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . 0.455 HD22 ' HG2' ' B' ' 123' ' ' GLN . 63.2 t-20 -132.97 109.46 9.58 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 114.806 -1.088 . . . . 0.0 113.476 -177.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 105' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' B' ' 123' ' ' GLN . 81.0 tt0 -78.78 123.11 26.86 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.221 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 41.1 tp -112.27 126.56 55.37 Favored 'General case' 0 C--N 1.346 0.445 0 CA-C-O 120.873 0.368 . . . . 0.0 111.874 -177.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 107' ' ' ASN . . . . . 0.57 ' OD1' ' CG2' ' B' ' 89' ' ' THR . 97.8 m-20 -120.37 126.92 51.71 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 175.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 96.4 mt -121.9 133.15 69.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.53 123.3 7.61 Favored Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 178.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -69.04 151.82 73.13 Favored 'Trans proline' 0 N--CA 1.501 1.941 0 C-N-CA 122.411 2.074 . . . . 0.0 112.471 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 111' ' ' MET . . . . . 0.426 ' HB2' ' HB2' ' B' ' 118' ' ' TYR . 67.2 mtt -128.59 143.66 51.0 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -113.24 106.59 14.81 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 106.074 -1.825 . . . . 0.0 106.074 179.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . 0.65 HG12 ' HZ3' ' A' ' 18' ' ' LYS . 96.8 mt -133.15 127.06 54.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-N 118.474 0.579 . . . . 0.0 111.525 178.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 52.48 37.86 24.0 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.026 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 59.92 36.03 21.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.707 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -132.68 150.2 52.19 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 177.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 6.9 t -100.45 153.52 19.28 Favored 'General case' 0 C--O 1.217 -0.62 0 C-N-CA 120.555 -0.458 . . . . 0.0 109.908 -177.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 118' ' ' TYR . . . . . 0.426 ' HB2' ' HB2' ' B' ' 111' ' ' MET . 90.7 m-85 -148.43 146.37 28.4 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 121.071 -1.018 . . . . 0.0 111.182 -178.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -122.59 138.6 54.53 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 120.66 0.267 . . . . 0.0 111.198 -176.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.7 p -129.28 135.8 60.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -177.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -112.59 122.74 6.02 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 89.1 mt -111.71 127.31 68.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 123' ' ' GLN . . . . . 0.514 ' N ' ' O ' ' B' ' 26' ' ' GLY . 15.3 mp0 -118.61 122.96 43.83 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -119.92 123.6 43.97 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . 0.573 ' OD1' ' N ' ' B' ' 127' ' ' THR . 67.2 t0 -70.37 129.05 38.27 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.634 -178.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . 0.551 ' O ' ' HG3' ' B' ' 130' ' ' LYS . 2.7 mp -102.61 15.55 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.837 0 CA-C-O 122.052 0.93 . . . . 0.0 109.278 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 127' ' ' THR . . . . . 0.573 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 19.5 m -63.13 -44.63 95.05 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 114.225 -1.352 . . . . 0.0 113.013 175.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -61.34 -46.1 91.64 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 129' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -63.69 -35.16 79.64 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.548 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 130' ' ' LYS . . . . . 0.853 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 98.7 mttt -63.73 -40.6 97.14 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 113.865 -1.516 . . . . 0.0 110.547 174.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.41 -41.38 96.66 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 132' ' ' TYR . . . . . 0.478 ' CE2' HD13 ' B' ' 136' ' ' LEU . 90.1 t80 -60.56 -44.16 96.46 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 121.693 -0.629 . . . . 0.0 111.066 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.0 -36.73 84.94 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 120.328 -0.549 . . . . 0.0 109.548 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.2 -39.54 94.94 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.881 178.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 54.1 tp -62.59 -41.3 98.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.187 0.518 . . . . 0.0 109.741 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 136' ' ' LEU . . . . . 0.478 HD13 ' CE2' ' B' ' 132' ' ' TYR . 86.9 mt -62.9 -41.89 99.6 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.27 177.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 137' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.56 -36.78 84.79 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.466 -1.243 . . . . 0.0 110.432 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.05 -43.01 99.82 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.896 177.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 70.1 m -60.74 -44.38 96.75 Favored 'General case' 0 C--N 1.343 0.323 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' B' ' 144' ' ' THR . 84.2 mt -61.04 -40.25 92.88 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -177.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 91.3 m -61.85 -45.46 93.71 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.91 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -66.33 -42.12 88.63 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 93.7 mt -63.67 -43.17 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.714 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 144' ' ' THR . . . . . 0.443 ' N ' ' O ' ' B' ' 140' ' ' LEU . 90.2 m -61.75 -45.24 94.77 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.56 -40.59 97.38 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 119.074 -1.051 . . . . 0.0 109.412 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 86.1 mt -64.49 -41.51 96.41 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 147' ' ' SER . . . . . 0.641 ' O ' ' N ' ' B' ' 149' ' ' PRO . 78.1 p -60.89 -42.77 98.65 Favored 'General case' 0 CA--C 1.48 -1.726 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 148' ' ' THR . . . . . 0.494 ' C ' ' O ' ' B' ' 147' ' ' SER . 6.8 m -27.8 84.75 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.592 0 O-C-N 124.105 0.878 . . . . 0.0 110.158 177.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 149' ' ' PRO . . . . . 0.641 ' N ' ' O ' ' B' ' 147' ' ' SER . 23.0 Cg_exo -62.34 147.59 94.69 Favored 'Trans proline' 0 C--N 1.296 -2.213 0 C-N-CA 122.234 1.956 . . . . 0.0 115.641 -177.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 9.1 tp -127.74 120.17 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-N 114.004 -1.453 . . . . 0.0 107.867 174.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 63.8 t -150.71 92.95 3.82 Favored Pre-proline 0 C--N 1.314 -0.936 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.992 -178.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -60.77 137.16 71.06 Favored 'Trans proline' 0 N--CA 1.484 0.952 0 N-CA-C 109.175 -1.125 . . . . 0.0 109.175 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 153' ' ' ILE . . . . . 0.581 HG21 HH12 ' A' ' 154' ' ' ARG . 45.2 mm -67.66 -43.9 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.17 178.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 154' ' ' ARG . . . . . 0.615 HH11 HG13 ' A' ' 255' ' ' VAL . 0.3 OUTLIER -158.82 -154.01 0.4 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -179.618 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 62.3 t-20 -86.89 108.49 18.8 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.69 -16.38 58.75 Favored Glycine 0 C--O 1.221 -0.713 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 89.0 mt -110.13 125.59 67.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.326 0.584 . . . . 0.0 111.37 -176.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 158' ' ' SER . . . . . 0.636 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 68.3 m -134.7 148.91 50.41 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.096 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -134.45 145.45 48.86 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.226 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 30.3 tp -138.45 79.25 30.56 Favored Pre-proline 0 C--O 1.234 0.283 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 161' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -70.54 146.99 56.87 Favored 'Trans proline' 0 N--CA 1.5 1.869 0 C-N-CA 122.831 2.354 . . . . 0.0 114.4 -178.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 87.0 mt -112.51 132.97 54.82 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 54.2 t -128.55 132.79 67.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 113.23 169.1 17.17 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 120.35 -0.929 . . . . 0.0 111.266 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 165' ' ' ASN . . . . . 0.688 ' O ' ' CZ ' ' B' ' 170' ' ' ARG . 61.9 t30 -89.62 107.02 18.85 Favored 'General case' 0 C--O 1.215 -0.752 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -177.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 166' ' ' LEU . . . . . 0.452 HD13 HD11 ' B' ' 174' ' ' ILE . 46.7 tp -65.86 104.49 1.1 Allowed 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 -174.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 167' ' ' THR . . . . . 0.46 ' H ' ' HE ' ' B' ' 170' ' ' ARG . 9.8 p -85.37 169.97 13.18 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 114.271 -1.331 . . . . 0.0 110.901 177.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.84 -37.39 84.38 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.718 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.34 -41.24 89.85 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-O 123.44 1.591 . . . . 0.0 111.508 -178.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 170' ' ' ARG . . . . . 0.688 ' CZ ' ' O ' ' B' ' 165' ' ' ASN . 88.3 mtm180 -62.58 -35.28 79.01 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 112.276 -2.238 . . . . 0.0 110.653 177.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 171' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -54.9 -26.25 34.59 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -178.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 172' ' ' ASN . . . . . 0.472 ' O ' HG21 ' B' ' 175' ' ' VAL . 92.7 m-20 -62.88 -40.3 97.12 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.784 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 48.8 m -60.17 -41.77 93.57 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.051 0.453 . . . . 0.0 110.63 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 174' ' ' ILE . . . . . 0.452 HD11 HD13 ' B' ' 166' ' ' LEU . 64.8 mt -63.43 -44.29 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 175' ' ' VAL . . . . . 0.472 HG21 ' O ' ' B' ' 172' ' ' ASN . 27.3 m -62.44 -39.81 85.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 176' ' ' CYS . . . . . 0.424 ' N ' HG23 ' B' ' 175' ' ' VAL . 96.7 m -62.69 -35.58 80.14 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.344 178.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 177' ' ' THR . . . . . 0.512 ' O ' HG13 ' B' ' 181' ' ' ILE . 25.1 m -61.69 -19.42 62.34 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.499 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 178' ' ' LEU . . . . . . . . . . . . . 88.2 mt -61.23 -39.36 90.01 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -178.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 19.2 m -61.77 -44.03 97.69 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 120.74 0.305 . . . . 0.0 110.262 177.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 180' ' ' ASN . . . . . 0.588 ' O ' ' OG ' ' B' ' 183' ' ' SER . 92.6 m-20 -61.27 -40.22 93.29 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.853 0.358 . . . . 0.0 110.494 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . 0.512 HG13 ' O ' ' B' ' 177' ' ' THR . 72.7 mt -57.47 -32.0 40.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 O-C-N 122.284 -0.26 . . . . 0.0 110.753 -178.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 182' ' ' LEU . . . . . . . . . . . . . 83.9 mt -62.38 -41.99 99.07 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.096 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 183' ' ' SER . . . . . 0.588 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.4 p -63.28 -32.84 74.35 Favored 'General case' 0 C--N 1.334 -0.106 0 O-C-N 121.835 -0.54 . . . . 0.0 110.865 178.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 56.8 p -85.87 17.34 3.49 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.787 -177.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 78.8 p -61.5 -16.39 46.92 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.523 -176.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.17 -40.17 95.1 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 121.076 -0.25 . . . . 0.0 110.764 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 187' ' ' ASP . . . . . 0.636 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.6 m-20 -70.43 114.95 9.05 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.44 0.638 . . . . 0.0 110.635 -177.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -62.63 -42.6 99.68 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 114.922 -1.035 . . . . 0.0 113.112 -177.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -113.55 131.38 56.11 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.149 -177.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 190' ' ' LEU . . . . . . . . . . . . . 40.7 tp -123.29 119.37 29.93 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.089 177.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 84.5 mt -107.43 125.08 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 117.851 0.296 . . . . 0.0 110.89 -176.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 50.1 mm -113.7 118.83 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 193' ' ' ASP . . . . . 0.466 ' CG ' ' HG ' ' B' ' 195' ' ' SER . 41.5 t0 -90.29 112.17 23.62 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -176.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 194' ' ' LEU . . . . . . . . . . . . . 96.6 mt -94.71 -1.89 52.18 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 123.705 0.628 . . . . 0.0 109.782 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 195' ' ' SER . . . . . 0.466 ' HG ' ' CG ' ' B' ' 193' ' ' ASP . 77.9 p -60.83 -39.0 87.4 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.905 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.18 -35.19 90.47 Favored Glycine 0 N--CA 1.438 -1.205 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -178.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 197' ' ' LEU . . . . . 1.125 HD23 ' O ' ' B' ' 199' ' ' GLN . 5.3 tt -74.27 133.8 42.63 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 198' ' ' ALA . . . . . 0.655 ' N ' HD21 ' B' ' 197' ' ' LEU . . . -61.75 -47.38 85.44 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.322 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 199' ' ' GLN . . . . . 1.125 ' O ' HD23 ' B' ' 197' ' ' LEU . 59.2 tt0 -136.76 164.7 27.66 Favored 'General case' 0 C--O 1.209 -1.077 0 CA-C-O 122.083 0.944 . . . . 0.0 112.389 -177.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 200' ' ' VAL . . . . . 0.486 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 51.8 t -120.53 131.85 71.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 O-C-N 120.579 -1.326 . . . . 0.0 109.532 177.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -86.81 150.08 24.38 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.855 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.27 -33.17 74.1 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.253 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -63.7 -32.3 73.74 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.382 0.61 . . . . 0.0 109.481 177.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.2 m -60.81 -43.82 97.67 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.206 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 205' ' ' ALA . . . . . 0.633 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -58.26 -29.6 65.92 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -178.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -65.94 -38.35 88.39 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.431 0.634 . . . . 0.0 110.646 174.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -66.13 -38.46 88.21 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.477 178.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 95.0 mt -62.97 -45.51 98.69 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -178.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 209' ' ' PHE . . . . . 0.633 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 67.6 m-85 -61.47 -42.58 99.0 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.916 -176.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.82 -42.04 99.56 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 119.581 -0.847 . . . . 0.0 109.94 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 211' ' ' LEU . . . . . 0.453 ' O ' ' HG ' ' B' ' 215' ' ' LEU . 38.3 mt -62.49 -42.52 99.55 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.173 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 78.1 p -63.46 -37.29 86.72 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.291 -0.564 . . . . 0.0 112.105 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 213' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -66.18 -46.64 76.63 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.214 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 53.3 tp -63.92 -42.57 97.35 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.895 0.855 . . . . 0.0 109.863 177.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 215' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' B' ' 211' ' ' LEU . 86.2 mt -62.53 -43.4 98.91 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 113.274 -1.785 . . . . 0.0 111.288 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.19 -39.77 93.83 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.749 0.309 . . . . 0.0 111.438 -177.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 92.4 mt -63.24 -41.97 99.14 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.443 0.64 . . . . 0.0 111.196 176.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 218' ' ' THR . . . . . . . . . . . . . 68.3 p -74.75 -14.83 60.76 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.642 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 78.14 65.46 1.87 Allowed Glycine 0 CA--C 1.528 0.885 0 N-CA-C 107.485 -2.246 . . . . 0.0 107.485 -177.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 220' ' ' THR . . . . . . . . . . . . . 95.3 m -144.08 105.31 4.24 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 175.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -62.15 140.96 58.4 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.922 -176.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 45.3 tp -117.18 121.83 42.32 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.645 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 3.5 mp -112.35 129.77 67.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.04 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 224' ' ' ILE . . . . . . . . . . . . . 50.1 mm -110.74 127.13 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 44.0 p -134.24 156.46 48.36 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 121.957 0.884 . . . . 0.0 112.495 -178.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 90.5 16.85 54.44 Favored Glycine 0 C--N 1.316 -0.564 0 CA-C-N 113.951 -1.477 . . . . 0.0 111.303 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 95.5 mt -82.81 127.21 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 118.027 0.914 . . . . 0.0 111.284 -178.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 56.1 tttt -66.58 138.17 95.47 Favored Pre-proline 0 C--N 1.316 -0.868 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.525 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.9 -37.4 93.09 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 121.443 1.429 . . . . 0.0 112.616 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -62.66 -44.12 97.07 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 48.3 tp -61.68 -41.64 97.84 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.267 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.06 -37.41 87.1 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.931 -0.307 . . . . 0.0 111.414 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 94.6 mtp -64.16 -40.06 95.34 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-O 121.248 0.547 . . . . 0.0 109.629 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.43 -42.74 98.69 Favored 'General case' 0 CA--C 1.554 1.114 0 CA-C-O 122.443 1.116 . . . . 0.0 109.539 178.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 33.0 mmt -63.81 -35.86 82.0 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.507 -1.224 . . . . 0.0 111.89 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -62.06 -40.33 95.44 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.006 -178.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.01 -43.66 98.14 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 120.512 -0.475 . . . . 0.0 109.825 177.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 55.1 tp -62.57 -44.57 96.0 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.625 -178.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 239' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' B' ' 240' ' ' ALA . 66.8 t0 -159.27 132.5 7.11 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.35 -0.54 . . . . 0.0 112.106 -178.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 240' ' ' ALA . . . . . 0.41 ' N ' ' OD1' ' B' ' 239' ' ' ASP . . . -61.07 -46.55 90.22 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 177.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 241' ' ' ASN . . . . . 0.491 ' O ' ' HB2' ' B' ' 244' ' ' SER . 92.1 m-20 -44.06 -20.14 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.689 -175.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 242' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -60.63 -44.99 95.71 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.141 -0.624 . . . . 0.0 110.298 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 243' ' ' SER . . . . . . . . . . . . . 78.1 p -57.93 -42.87 85.78 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 178.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 244' ' ' SER . . . . . 0.491 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 20.0 m -34.61 -35.0 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -177.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 97.3 mt -88.36 132.51 34.4 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.702 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -58.28 135.41 57.13 Favored 'General case' 0 C--O 1.25 1.121 0 CA-C-O 121.906 0.86 . . . . 0.0 111.523 -178.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 247' ' ' THR . . . . . . . . . . . . . 98.1 m -127.13 128.09 45.63 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 114.525 -1.216 . . . . 0.0 112.004 178.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -112.46 143.78 43.02 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 249' ' ' SER . . . . . 0.565 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 78.2 p -62.57 -34.99 78.08 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.18 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 250' ' ' ASN . . . . . 0.565 ' OD1' ' O ' ' B' ' 249' ' ' SER . 99.0 m-20 -147.16 161.28 41.22 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 114.966 -1.015 . . . . 0.0 112.574 178.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 69.2 t -64.76 -44.93 96.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.788 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 252' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.04 -45.95 92.7 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -61.23 -43.24 99.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.57 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 254' ' ' ALA . . . . . . . . . . . . . . . -65.73 -39.49 91.21 Favored 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.062 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 255' ' ' VAL . . . . . 0.54 HG13 HH11 ' A' ' 154' ' ' ARG . 76.2 t -65.22 -45.76 92.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.875 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.548 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.0 -48.4 78.98 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 121.588 0.709 . . . . 0.0 111.263 -177.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 257' ' ' VAL . . . . . 0.477 ' O ' ' C ' ' B' ' 258' ' ' LEU . 27.1 m -65.09 -40.83 90.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.959 -1.018 . . . . 0.0 111.464 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 258' ' ' LEU . . . . . 0.482 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 1.3 mt -31.79 -72.3 0.07 OUTLIER Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.794 -178.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 259' ' ' PRO . . . . . 0.482 ' CD ' ' CB ' ' B' ' 258' ' ' LEU . 39.8 Cg_endo -63.11 140.94 81.04 Favored 'Trans proline' 0 N--CA 1.504 2.103 0 C-N-CA 121.59 1.527 . . . . 0.0 111.351 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 260' ' ' ILE . . . . . 0.468 HG13 ' O ' ' B' ' 259' ' ' PRO . 96.7 mt -158.33 -15.4 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-N 118.591 0.632 . . . . 0.0 112.573 177.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 78.0 mtm . . . . . 0 N--CA 1.466 0.339 0 CA-C-O 118.207 -0.901 . . . . 0.0 111.825 179.675 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.47 ' O ' ' OG ' ' A' ' 6' ' ' SER . . . -145.15 -175.16 4.59 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 88.5 p -85.11 -7.04 59.26 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.484 -0.76 . . . . 0.0 111.412 177.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -81.57 -63.45 1.39 Allowed 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 114.109 -1.405 . . . . 0.0 113.157 172.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -67.5 -38.79 84.84 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.557 ' O ' ' NZ ' ' B' ' 17' ' ' LYS . 66.9 m -59.44 -42.08 91.12 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.181 -177.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.493 ' CB ' ' O ' ' A' ' 6' ' ' SER . 46.9 t80 85.48 85.96 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 O-C-N 123.766 0.666 . . . . 0.0 111.03 177.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.618 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -58.78 -150.13 0.01 OUTLIER Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.618 ' HB ' ' O ' ' A' ' 8' ' ' GLY . 89.3 mt 91.4 111.85 0.02 OUTLIER Pre-proline 0 N--CA 1.471 0.598 0 C-N-CA 122.734 0.414 . . . . 0.0 110.775 -179.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.66 -22.03 64.77 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 121.431 1.421 . . . . 0.0 112.153 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.05 -38.68 96.36 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 120.953 -0.641 . . . . 0.0 111.917 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -65.09 -39.21 92.85 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.549 0.69 . . . . 0.0 109.968 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.6 tp -63.08 -41.5 99.42 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -63.21 -40.36 97.26 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.6 t -60.48 -44.18 95.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 O-C-N 122.242 -0.286 . . . . 0.0 110.953 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 92.9 mt -62.63 -43.74 98.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.646 -177.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.7 -45.89 90.68 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 119.411 -0.916 . . . . 0.0 112.09 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.788 ' HZ3' HG12 ' B' ' 113' ' ' ILE . 98.5 mttt -60.28 -39.26 86.22 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 118.578 -1.249 . . . . 0.0 109.074 -176.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.5 -40.93 93.14 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.242 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.8 mt -62.97 -40.71 98.55 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -63.26 -38.19 90.18 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.327 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 62.0 m170 -58.82 -39.38 81.02 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 122.2 -0.313 . . . . 0.0 111.271 -178.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.37 130.65 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.489 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 35.8 ptt180 -73.65 110.71 8.15 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 122.093 0.949 . . . . 0.0 111.961 -177.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.0 p -141.54 143.67 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.576 ' HA3' ' HB2' ' A' ' 123' ' ' GLN . . . -97.28 91.97 1.27 Allowed Glycine 0 C--N 1.313 -0.695 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.814 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 50.8 t -124.44 129.51 73.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.6 m -137.1 159.92 36.28 Favored 'Isoleucine or valine' 0 C--O 1.244 0.796 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.9 mt -119.88 131.29 72.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.667 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.7 p -108.11 165.88 11.15 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.555 ' C ' ' OD1' ' A' ' 37' ' ' ASN . 50.9 t0 -132.09 101.41 15.07 Favored Pre-proline 0 C--N 1.323 -0.544 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.194 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.401 ' CG ' HG22 ' A' ' 117' ' ' THR . 35.5 Cg_endo -63.53 -22.31 70.78 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.659 1.573 . . . . 0.0 111.746 -178.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.03 -36.01 82.14 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.231 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.5 mt -83.33 159.17 21.93 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.954 176.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.764 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 42.4 tt0 -58.53 135.67 57.37 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -177.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.535 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 59.8 t0 61.1 18.89 9.45 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 178.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.555 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 31.0 t-20 42.79 67.42 3.56 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.748 -176.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.764 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 92.2 Cg_endo -71.13 156.3 59.81 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 123.985 3.123 . . . . 0.0 112.336 -178.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.2 mt -87.16 125.45 40.98 Favored 'Isoleucine or valine' 0 C--O 1.245 0.833 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.6 m -104.52 -44.26 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 O-C-N 123.659 0.6 . . . . 0.0 112.335 -179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -96.35 124.68 40.44 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.838 -178.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.2 p -142.36 139.57 29.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 O-C-N 124.162 0.914 . . . . 0.0 109.333 176.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.57 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 56.6 p30 -97.04 167.56 10.99 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.45 ' HA ' ' OE1' ' A' ' 44' ' ' GLN . 14.1 mm100 -66.55 -39.08 88.37 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 176.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.69 -27.16 63.54 Favored Glycine 0 N--CA 1.452 -0.241 0 N-CA-C 110.331 -1.107 . . . . 0.0 110.331 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.57 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 58.1 t80 -59.08 -48.28 82.16 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.45 ' O ' ' N ' ' A' ' 51' ' ' GLY . 78.7 t -59.89 -44.62 94.71 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 O-C-N 121.092 -1.005 . . . . 0.0 111.708 -173.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -63.15 -38.24 90.38 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 120.496 -0.482 . . . . 0.0 112.035 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.451 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 60.2 ttm -66.85 -43.21 84.22 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 175.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 36.8 p -93.58 -21.32 19.49 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.993 0.425 . . . . 0.0 111.523 -177.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . 77.05 20.39 75.84 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -114.33 136.77 52.61 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.022 0.439 . . . . 0.0 111.137 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -63.57 147.63 50.94 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.703 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.22 -31.14 72.22 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -67.28 -42.24 84.16 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 119.615 -0.834 . . . . 0.0 111.499 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -66.55 -44.68 81.71 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.423 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.4 HG22 HD13 ' A' ' 57' ' ' ILE . 96.2 mt -62.03 -45.34 98.95 Favored 'Isoleucine or valine' 0 C--N 1.354 0.767 0 CA-C-O 118.046 -0.978 . . . . 0.0 111.348 -175.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.0 mt -64.37 141.22 58.85 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 -177.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.35 -0.06 86.93 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.615 178.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -137.16 152.45 49.95 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.502 1.651 . . . . 0.0 111.44 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.543 ' C ' ' H ' ' A' ' 63' ' ' ARG . 25.1 t-20 -81.88 152.25 26.93 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.245 0.545 . . . . 0.0 110.648 -178.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 83.4 m -64.16 15.36 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.34 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.543 ' H ' ' C ' ' A' ' 61' ' ' ASN . 35.8 ptt-85 -61.59 -42.19 98.5 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.255 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -55.21 -22.31 17.29 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 88.2 mt -66.39 -36.62 83.31 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 177.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -64.79 144.04 57.52 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.446 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.628 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -152.66 -147.98 4.74 Favored Glycine 0 CA--C 1.541 1.71 0 N-CA-C 111.649 -0.581 . . . . 0.0 111.649 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.16 -39.98 96.23 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -177.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.547 ' H ' ' HH ' ' A' ' 95' ' ' TYR . 8.8 m-70 -77.69 -6.97 55.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.672 0.272 . . . . 0.0 111.001 -178.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.628 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 27.9 m -64.0 128.8 37.41 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.126 -0.63 . . . . 0.0 109.729 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -85.5 109.87 25.11 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.242 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 70' ' ' THR . 52.9 Cg_exo -57.09 -31.7 91.07 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 121.91 1.74 . . . . 0.0 113.063 178.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.08 -40.16 95.64 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.172 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.49 ' OE1' ' HB ' ' A' ' 90' ' ' VAL . 79.3 mm-40 -65.91 -44.0 86.49 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 67.4 t -59.92 -44.02 93.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 114.448 -1.251 . . . . 0.0 107.799 -175.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -63.99 -37.77 88.62 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.89 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -63.35 -39.53 94.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.339 0.59 . . . . 0.0 110.228 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.89 -44.04 97.94 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 CA-C-N 114.946 -1.025 . . . . 0.0 112.0 178.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -62.96 -43.35 99.03 Favored 'General case' 0 C--O 1.251 1.141 0 CA-C-N 113.68 -1.6 . . . . 0.0 108.482 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 99.8 m -61.35 -50.08 74.35 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 119.729 -0.788 . . . . 0.0 108.962 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.89 -42.35 89.33 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 119.487 -0.292 . . . . 0.0 111.187 -173.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.421 HD23 ' CE1' ' A' ' 119' ' ' PHE . 89.2 mt -63.12 -39.79 95.7 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 119.09 0.859 . . . . 0.0 111.885 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -63.24 -35.32 79.94 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 177.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -89.34 -2.91 58.61 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.694 -177.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.406 ' NZ ' ' OE2' ' A' ' 112' ' ' GLU . 38.0 tttt 51.45 43.97 29.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.827 178.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -126.8 146.62 57.91 Favored Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 108' ' ' ILE . 24.2 Cg_exo -61.83 143.49 95.91 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.345 1.363 . . . . 0.0 112.822 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.7 142.3 30.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.862 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.518 ' CG2' ' OD1' ' A' ' 107' ' ' ASN . 96.6 m -126.41 122.22 34.7 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 175.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.49 ' HB ' ' OE1' ' A' ' 74' ' ' GLU . 29.3 m -139.05 159.47 29.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 121.106 -0.238 . . . . 0.0 111.308 178.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -103.61 133.99 47.7 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 105.021 -2.215 . . . . 0.0 105.021 176.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.48 ' O ' HG21 ' A' ' 92' ' ' ILE . 19.2 tt -142.4 125.23 14.14 Favored 'Isoleucine or valine' 0 C--N 1.374 1.635 0 CA-C-N 121.622 2.01 . . . . 0.0 112.341 176.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.407 HE22 ' HD1' ' A' ' 69' ' ' HIS . 85.9 mt-30 -58.87 136.55 57.86 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.377 179.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -136.07 159.96 40.09 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.161 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.547 ' HH ' ' H ' ' A' ' 69' ' ' HIS . 93.8 m-85 -117.12 134.67 54.49 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -178.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.451 ' HE2' ' O ' ' A' ' 49' ' ' MET . 98.9 mttt -83.79 -174.3 5.2 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.086 0.469 . . . . 0.0 111.908 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.35 -43.13 99.54 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.102 178.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 40.9 p-10 -83.53 6.42 20.53 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -178.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.7 -1.38 87.04 Favored Glycine 0 N--CA 1.473 1.163 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.352 176.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.0 m -59.73 137.96 57.9 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.691 ' C ' ' SD ' ' A' ' 101' ' ' MET . 13.4 tmm? -105.47 129.03 53.85 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 120.959 0.409 . . . . 0.0 110.508 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.487 ' N ' ' SD ' ' A' ' 101' ' ' MET . 50.7 p90 -142.16 156.22 45.34 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.175 -176.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.724 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 20.8 m95 -88.24 142.2 27.94 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.415 HD22 ' HG2' ' A' ' 123' ' ' GLN . 54.3 t-20 -136.97 102.35 4.83 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -177.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -67.75 136.77 54.75 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 -177.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 41.1 tp -121.5 122.57 40.03 Favored 'General case' 0 C--O 1.233 0.185 0 O-C-N 123.665 0.603 . . . . 0.0 112.593 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.518 ' OD1' ' CG2' ' A' ' 89' ' ' THR . 98.2 m-20 -118.85 123.32 44.42 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 116.724 -0.216 . . . . 0.0 110.64 177.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.404 ' O ' ' HA ' ' A' ' 87' ' ' PRO . 96.2 mt -120.03 128.77 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 O-C-N 123.468 0.48 . . . . 0.0 111.268 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -136.77 124.58 14.58 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 116.871 -0.15 . . . . 0.0 110.88 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -70.88 151.19 62.46 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.342 2.028 . . . . 0.0 112.499 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.516 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 67.2 mtt -124.03 153.13 41.78 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 179.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.406 ' OE2' ' NZ ' ' A' ' 85' ' ' LYS . 80.0 mm-40 -129.09 95.59 4.1 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 176.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 96.5 mt -121.02 131.4 73.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.621 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 50.43 37.98 17.02 Favored 'General case' 0 CA--C 1.515 -0.398 0 O-C-N 121.567 -0.708 . . . . 0.0 111.441 176.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 58.7 30.51 20.05 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.707 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -126.81 147.9 49.99 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.814 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 5.2 t -84.85 -171.26 3.54 Favored 'General case' 0 C--O 1.214 -0.793 0 CA-C-O 118.618 -0.706 . . . . 0.0 109.323 -178.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.814 ' CD2' ' O ' ' A' ' 117' ' ' THR . 76.3 m-85 -174.96 154.95 1.93 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 175.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.421 ' CE1' HD23 ' A' ' 82' ' ' LEU . 95.3 m-85 -130.71 146.2 52.12 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 174.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.7 134.86 56.14 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.461 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -106.81 127.85 9.03 Favored Glycine 0 CA--C 1.502 -0.774 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 96.6 mt -116.58 128.16 74.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 177.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.576 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . 17.3 mp0 -118.72 112.87 20.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.072 0.463 . . . . 0.0 109.875 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -115.07 112.16 22.17 Favored 'General case' 0 C--O 1.248 0.974 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.881 -178.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 126' ' ' ILE . 68.4 t0 -62.55 131.28 48.57 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -176.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.46 ' N ' ' OD1' ' A' ' 125' ' ' ASP . 3.3 mp -96.64 4.32 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 113.743 -1.571 . . . . 0.0 109.884 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 25.6 m -60.37 -42.34 95.6 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 121.081 -1.012 . . . . 0.0 113.388 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -59.63 -42.8 93.54 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -62.8 -39.73 95.16 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.702 177.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.724 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.8 mttt -62.34 -41.21 98.4 Favored 'General case' 0 CA--C 1.503 -0.834 0 C-N-CA 118.286 -1.366 . . . . 0.0 110.64 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -62.17 -37.59 85.81 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.492 ' CE2' HD13 ' A' ' 136' ' ' LEU . 87.5 t80 -61.48 -45.44 94.21 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.672 176.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.81 -38.61 91.56 Favored 'General case' 0 CA--C 1.522 -0.116 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.06 -40.83 97.1 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.068 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 54.8 tp -60.8 -43.84 97.62 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -177.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.492 HD13 ' CE2' ' A' ' 132' ' ' TYR . 85.2 mt -62.21 -41.34 98.29 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.382 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.09 -42.55 99.33 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 119.529 -0.868 . . . . 0.0 109.799 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -60.68 -42.12 96.46 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -177.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 58.3 m -61.57 -41.12 96.95 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.642 176.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 144' ' ' THR . 83.6 mt -63.5 -42.07 98.53 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 120.63 -0.428 . . . . 0.0 109.934 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 91.5 m -61.62 -45.4 94.23 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.152 -177.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -65.08 -40.21 94.31 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 95.2 mt -64.72 -43.39 96.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.115 -1.402 . . . . 0.0 111.313 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.51 ' N ' ' O ' ' A' ' 140' ' ' LEU . 99.4 m -62.65 -46.16 89.47 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 121.811 -0.556 . . . . 0.0 112.121 -177.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.455 ' O ' ' OG1' ' A' ' 148' ' ' THR . . . -63.31 -39.42 94.51 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 118.803 -1.159 . . . . 0.0 109.051 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 81.7 mt -63.38 -42.65 98.83 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.355 178.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.711 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.2 p -59.96 -39.65 86.34 Favored 'General case' 0 C--O 1.217 -0.644 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -178.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.49 ' C ' ' O ' ' A' ' 147' ' ' SER . 21.6 m -27.1 81.72 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.418 0 O-C-N 126.971 2.669 . . . . 0.0 106.133 -178.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.711 ' N ' ' O ' ' A' ' 147' ' ' SER . 21.1 Cg_exo -62.44 146.15 95.61 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 C-N-CA 121.427 1.418 . . . . 0.0 114.538 -175.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.574 ' O ' ' CG2' ' A' ' 151' ' ' VAL . 9.6 tp -124.52 136.58 60.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 102.843 -3.021 . . . . 0.0 102.843 178.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.574 ' CG2' ' O ' ' A' ' 150' ' ' ILE . 60.1 t -169.05 96.48 0.52 Allowed Pre-proline 0 N--CA 1.437 -1.083 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 178.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -64.8 133.28 35.68 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 109.785 -0.89 . . . . 0.0 109.785 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.564 ' O ' ' HD2' ' A' ' 154' ' ' ARG . 45.9 mm -69.19 -45.13 80.09 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.909 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.395 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.564 ' HD2' ' O ' ' A' ' 153' ' ' ILE . 1.1 tpt180 -156.15 -159.32 0.88 Allowed 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.41 ' ND2' ' HE3' ' B' ' 256' ' ' LYS . 58.9 t-20 -86.16 106.18 17.09 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.697 0.76 . . . . 0.0 111.289 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 88.8 10.06 67.52 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 113.98 -1.463 . . . . 0.0 110.501 -177.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.6 mt -128.11 122.82 59.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 175.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.615 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 58.0 m -131.92 151.75 51.51 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.199 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -134.06 140.11 46.43 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.206 -0.597 . . . . 0.0 111.404 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 29.7 tp -131.18 76.49 76.27 Favored Pre-proline 0 N--CA 1.468 0.469 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.206 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -68.89 149.11 72.02 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 122.791 2.327 . . . . 0.0 113.085 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 90.0 mt -117.38 128.63 55.22 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.179 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 45.8 t -123.48 131.56 72.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 115.58 167.55 15.18 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 120.89 -0.671 . . . . 0.0 111.92 178.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.888 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 60.0 t30 -84.19 115.64 22.53 Favored 'General case' 0 C--O 1.207 -1.151 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -178.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.478 ' CD2' ' CZ ' ' A' ' 171' ' ' PHE . 43.5 tp -75.76 105.57 6.87 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 -177.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.566 ' H ' ' HE ' ' A' ' 170' ' ' ARG . 11.4 p -88.53 167.61 13.28 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.909 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.51 -34.19 77.68 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.983 0.42 . . . . 0.0 111.945 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.76 -42.11 91.3 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.805 0.812 . . . . 0.0 110.986 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.888 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 88.2 mtm180 -64.75 -34.26 77.91 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.791 177.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.478 ' CZ ' ' CD2' ' A' ' 166' ' ' LEU . 0.4 OUTLIER -55.07 -28.3 51.29 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 119.025 -0.512 . . . . 0.0 111.727 -177.084 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.755 ' O ' HG21 ' A' ' 175' ' ' VAL . 91.0 m-20 -60.35 -40.6 91.31 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 118.718 -1.193 . . . . 0.0 110.02 -177.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 50.3 m -59.25 -40.78 87.03 Favored 'General case' 0 C--N 1.315 -0.923 0 O-C-N 121.569 -0.707 . . . . 0.0 110.538 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.402 HG23 HD12 ' A' ' 174' ' ' ILE . 66.8 mt -62.9 -43.96 99.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.755 HG21 ' O ' ' A' ' 172' ' ' ASN . 23.0 m -62.32 -39.91 85.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -178.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 98.3 m -62.38 -34.61 77.04 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.274 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' THR . . . . . 0.564 ' O ' HG13 ' A' ' 181' ' ' ILE . 25.1 m -61.86 -19.71 62.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.905 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 91.3 mt -60.99 -41.18 95.98 Favored 'General case' 0 C--O 1.248 0.99 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -177.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 19.1 m -59.75 -43.58 94.21 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . 0.594 ' O ' ' OG ' ' A' ' 183' ' ' SER . 92.0 m-20 -61.47 -35.4 77.52 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.775 0.43 . . . . 0.0 110.683 178.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . 0.564 HG13 ' O ' ' A' ' 177' ' ' THR . 67.5 mt -60.32 -41.46 87.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 84.9 mt -60.3 -40.4 90.38 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 119.342 -0.943 . . . . 0.0 108.981 -176.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.594 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 78.1 p -61.45 -33.7 74.19 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.607 176.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 58.8 p -89.39 23.71 2.46 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.79 0.329 . . . . 0.0 111.446 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 78.1 p -64.48 -20.04 65.94 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.973 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -60.56 -37.43 81.23 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.921 -178.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.615 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 98.8 m-20 -73.57 114.98 12.43 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.383 0.611 . . . . 0.0 110.582 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -62.91 -42.62 99.85 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.123 -0.944 . . . . 0.0 113.027 -177.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -111.61 132.06 54.83 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.783 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 40.0 tp -120.62 128.36 52.95 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 95.7 mt -116.94 127.32 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 118.35 0.523 . . . . 0.0 109.599 177.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.9 mm -112.84 127.05 70.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . 0.517 ' OD2' ' OG ' ' A' ' 195' ' ' SER . 40.0 t0 -94.23 118.02 30.96 Favored 'General case' 0 CA--C 1.552 1.053 0 O-C-N 121.796 -0.565 . . . . 0.0 110.824 177.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 96.0 mt -96.51 -5.07 40.28 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.825 175.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' SER . . . . . 0.517 ' OG ' ' OD2' ' A' ' 193' ' ' ASP . 78.1 p -62.87 -33.81 76.06 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -62.28 -42.0 99.72 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 118.808 -1.663 . . . . 0.0 109.025 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 1.04 HD23 ' O ' ' A' ' 199' ' ' GLN . 4.7 tt -72.09 127.89 33.97 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 112.2 -2.0 . . . . 0.0 108.159 -177.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.731 ' N ' HD21 ' A' ' 197' ' ' LEU . . . -60.8 -47.21 87.38 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.956 0.408 . . . . 0.0 111.062 -178.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 1.04 ' O ' HD23 ' A' ' 197' ' ' LEU . 58.5 tt0 -133.63 155.93 48.79 Favored 'General case' 0 C--O 1.2 -1.547 0 CA-C-N 114.609 -1.178 . . . . 0.0 114.052 -174.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.41 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 46.9 t -117.97 132.51 67.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 O-C-N 120.17 -1.582 . . . . 0.0 108.707 178.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -90.44 155.46 18.91 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.642 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -64.44 -39.34 93.63 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 120.254 -0.578 . . . . 0.0 109.915 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -57.81 -32.66 67.79 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-O 122.099 0.952 . . . . 0.0 108.944 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.9 m -61.14 -42.57 98.78 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.222 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.512 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -57.96 -39.42 78.1 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -177.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -62.26 -36.71 82.87 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -65.48 -39.11 91.56 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.113 177.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 93.5 mt -63.16 -44.2 99.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . 0.512 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 68.9 m-85 -61.82 -43.83 98.07 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.648 -178.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.64 -42.62 99.7 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 119.295 -0.962 . . . . 0.0 109.221 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.433 ' O ' ' HG ' ' A' ' 215' ' ' LEU . 37.7 mt -62.21 -41.87 98.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.644 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' SER . . . . . 0.505 ' HG ' ' N ' ' A' ' 213' ' ' HIS . 78.4 p -61.44 -41.46 97.23 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.266 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' HIS . . . . . 0.505 ' N ' ' HG ' ' A' ' 212' ' ' SER . 57.8 t-80 -64.97 -45.52 85.34 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 122.018 -0.427 . . . . 0.0 111.528 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 48.0 tp -62.12 -46.52 88.65 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 118.893 -1.123 . . . . 0.0 108.003 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 211' ' ' LEU . 90.2 mt -61.98 -40.43 95.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.588 -177.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.34 -43.47 96.4 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.442 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 84.6 mt -61.95 -39.96 93.91 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 69.2 p -76.43 -11.35 59.87 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.365 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 83.17 35.31 18.37 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-O 119.133 -0.815 . . . . 0.0 112.844 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 96.2 m -123.44 110.97 15.78 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 118.863 1.331 . . . . 0.0 111.713 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -61.63 138.46 58.31 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.81 178.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 50.0 tp -113.61 131.05 56.26 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 177.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 2.7 mp -118.37 135.14 59.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 50.1 mm -116.48 131.63 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -178.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 34.5 p -133.71 167.53 20.35 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 78.63 21.42 69.16 Favored Glycine 0 C--N 1.334 0.469 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 97.6 mt -84.68 128.15 39.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 113.924 -1.138 . . . . 0.0 108.427 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 54.3 tttt -74.02 140.56 77.24 Favored Pre-proline 0 CA--C 1.535 0.377 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.32 -39.72 89.46 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 120.942 1.095 . . . . 0.0 112.489 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -64.78 -37.38 87.4 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.507 0.67 . . . . 0.0 110.28 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 52.7 tp -63.79 -42.31 97.76 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.468 177.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -65.17 -37.12 86.36 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.042 0.449 . . . . 0.0 110.873 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 94.1 mtp -63.29 -40.97 98.85 Favored 'General case' 0 C--O 1.248 0.985 0 C-N-CA 120.074 -0.65 . . . . 0.0 109.536 -178.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -64.02 -39.9 95.14 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.462 177.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 35.1 mmt -66.76 -36.73 83.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.554 177.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -60.84 -41.87 96.66 Favored 'General case' 0 CA--C 1.513 -0.479 0 O-C-N 121.432 -0.793 . . . . 0.0 109.479 -176.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.86 -39.88 90.8 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.506 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 59.0 tp -63.44 -41.05 98.65 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 240' ' ' ALA . 67.0 t0 -167.6 129.47 1.55 Allowed 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 121.487 0.661 . . . . 0.0 112.148 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . 0.408 ' N ' ' OD1' ' A' ' 239' ' ' ASP . . . -61.04 -26.8 67.88 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.618 178.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . 0.493 ' O ' ' HB2' ' A' ' 244' ' ' SER . 90.8 m-20 -61.24 -32.68 72.48 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.326 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -55.59 -44.38 76.89 Favored 'General case' 0 C--N 1.312 -1.065 0 O-C-N 121.214 -0.929 . . . . 0.0 109.089 -175.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 94.2 p -62.82 -20.04 64.66 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.937 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' SER . . . . . 0.493 ' HB2' ' O ' ' A' ' 241' ' ' ASN . 49.7 m -56.4 -37.76 70.59 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 122.517 0.327 . . . . 0.0 111.854 177.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 92.5 mt -83.24 130.94 35.12 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 177.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -55.29 135.08 50.18 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 114.104 -1.407 . . . . 0.0 109.626 -177.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 98.0 m -126.79 132.14 51.1 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.836 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -118.09 140.54 49.61 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.401 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' SER . . . . . 0.418 ' O ' ' OD1' ' A' ' 250' ' ' ASN . 78.1 p -61.39 -42.35 98.58 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -178.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 249' ' ' SER . 98.4 m-20 -144.03 160.5 40.75 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.72 0.772 . . . . 0.0 111.43 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 77.0 t -62.38 -44.74 99.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 114.641 -1.163 . . . . 0.0 112.044 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.73 -43.78 97.47 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.329 -0.549 . . . . 0.0 109.581 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.43 -42.68 98.71 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.164 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . 0.478 ' O ' HG21 ' A' ' 257' ' ' VAL . . . -64.92 -41.88 95.18 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.729 0.776 . . . . 0.0 109.942 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 61.1 t -63.5 -45.89 96.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 114.225 -1.352 . . . . 0.0 111.304 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -63.89 -47.45 80.56 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.509 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . 0.483 ' O ' ' C ' ' A' ' 258' ' ' LEU . 33.4 m -66.89 -40.96 86.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 C-N-CA 119.908 -0.717 . . . . 0.0 112.481 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.483 ' C ' ' O ' ' A' ' 257' ' ' VAL . 0.9 OUTLIER -30.11 -73.42 0.05 OUTLIER Pre-proline 0 CA--C 1.533 0.293 0 O-C-N 123.166 0.291 . . . . 0.0 111.614 -176.847 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' PRO . . . . . 0.478 ' CD ' ' CB ' ' A' ' 258' ' ' LEU . 43.6 Cg_endo -63.87 140.24 72.35 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 120.847 1.032 . . . . 0.0 111.857 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 259' ' ' PRO . 96.1 mt -152.91 -31.18 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 O-C-N 123.453 0.47 . . . . 0.0 112.16 178.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 77.3 mtm . . . . . 0 C--O 1.217 -0.617 0 CA-C-O 118.133 -0.937 . . . . 0.0 111.143 -177.213 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.521 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.62 175.32 11.65 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 100.0 p -72.09 -11.59 60.82 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.717 -0.219 . . . . 0.0 111.19 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -83.04 -60.94 2.0 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.063 0.458 . . . . 0.0 110.661 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -67.05 -39.16 86.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.253 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' SER . . . . . 0.513 ' O ' ' HB3' ' B' ' 7' ' ' PHE . 68.4 m -59.48 -43.28 93.33 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 120.249 -0.58 . . . . 0.0 109.6 -177.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . 0.513 ' HB3' ' O ' ' B' ' 6' ' ' SER . 48.3 t80 86.94 86.97 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.891 0.744 . . . . 0.0 110.71 177.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . 0.621 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -59.99 -149.72 0.01 OUTLIER Glycine 0 C--N 1.336 0.559 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . 0.621 ' HB ' ' O ' ' B' ' 8' ' ' GLY . 88.5 mt 91.3 111.78 0.02 OUTLIER Pre-proline 0 N--CA 1.472 0.635 0 O-C-N 123.948 0.44 . . . . 0.0 110.761 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -63.86 -23.63 68.46 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 121.408 1.405 . . . . 0.0 111.788 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.58 -41.1 99.51 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -64.69 -39.33 93.47 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.843 0.83 . . . . 0.0 109.775 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 48.5 tp -61.76 -42.36 98.88 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 114.907 -1.042 . . . . 0.0 112.116 -177.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -65.15 -33.31 75.71 Favored 'General case' 0 CA--C 1.561 1.39 0 CA-C-O 121.681 0.753 . . . . 0.0 110.805 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 79.4 t -62.23 -46.46 96.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-N 112.927 -1.942 . . . . 0.0 110.912 177.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.94 -44.09 97.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.674 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . 0.557 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 98.9 mttt -63.53 -41.99 98.46 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.34 -41.21 98.87 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 119.028 -1.069 . . . . 0.0 110.254 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.61 -38.39 84.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.743 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 84.3 mt -63.77 -41.91 97.88 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.223 0.535 . . . . 0.0 110.255 175.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -62.87 -38.54 91.27 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.95 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 61.2 m170 -57.83 -39.86 78.67 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 121.19 -0.204 . . . . 0.0 111.156 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 14.1 p -115.28 130.74 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.505 ' O ' ' HG3' ' B' ' 24' ' ' ARG . 35.4 ptt180 -73.54 108.58 6.48 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 121.85 0.833 . . . . 0.0 112.316 -176.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.7 p -143.09 133.76 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.667 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.544 177.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . 0.579 ' O ' ' N ' ' B' ' 123' ' ' GLN . . . -86.78 96.21 2.13 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 119.629 -1.272 . . . . 0.0 113.488 -176.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 47.0 t -125.58 128.81 72.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 175.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 29.5 m -138.8 157.29 29.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.587 179.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 96.5 mt -118.91 129.3 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-O 121.676 0.751 . . . . 0.0 111.567 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.474 ' OG1' ' O ' ' B' ' 119' ' ' PHE . 9.9 p -111.85 154.49 25.07 Favored 'General case' 0 CA--C 1.502 -0.886 0 CA-C-N 113.073 -1.876 . . . . 0.0 108.819 -175.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.518 ' C ' ' OD1' ' B' ' 37' ' ' ASN . 51.0 t0 -122.77 102.3 38.55 Favored Pre-proline 0 C--O 1.237 0.415 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -177.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.52 -20.65 65.98 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 121.786 1.657 . . . . 0.0 111.27 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.19 -42.38 99.23 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 120.629 -0.429 . . . . 0.0 110.002 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 96.8 mt -73.15 179.79 3.68 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 121.778 -0.576 . . . . 0.0 111.097 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . 0.692 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 42.0 tt0 -75.58 132.88 40.96 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -178.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.488 ' O ' ' C ' ' B' ' 37' ' ' ASN . 66.0 t0 55.86 38.78 30.44 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.709 178.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' ASN . . . . . 0.518 ' OD1' ' C ' ' B' ' 31' ' ' ASP . 17.6 t-20 26.91 71.37 0.42 Allowed Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.692 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 92.6 Cg_endo -72.93 154.62 53.29 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 123.554 2.836 . . . . 0.0 111.944 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 95.9 mt -85.75 130.25 36.69 Favored 'Isoleucine or valine' 0 C--O 1.246 0.889 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 17.1 m -108.39 -44.06 6.5 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 O-C-N 123.884 0.74 . . . . 0.0 112.709 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -97.07 124.93 41.21 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.529 -178.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 6.5 p -142.34 140.53 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 O-C-N 124.195 0.934 . . . . 0.0 109.348 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . 0.607 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 55.4 p30 -101.18 162.62 12.76 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.144 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' GLN . . . . . 0.434 ' HA ' ' OE1' ' B' ' 44' ' ' GLN . 13.7 mm100 -62.86 -37.81 88.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.693 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.75 -27.53 64.24 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.607 ' HB2' ' OD1' ' B' ' 43' ' ' ASN . 53.3 t80 -60.36 -43.72 96.27 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . 0.545 HG11 ' O ' ' B' ' 52' ' ' TYR . 77.6 t -61.78 -45.99 97.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.25 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -62.98 -44.31 96.39 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.394 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' MET . . . . . 0.453 ' O ' ' HE2' ' B' ' 96' ' ' LYS . 60.2 ttm -63.48 -42.02 98.57 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 34.6 p -96.22 -16.1 21.63 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.931 -177.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' B' ' 47' ' ' VAL . . . 72.69 18.73 78.87 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.379 -1.089 . . . . 0.0 110.379 178.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . 0.545 ' O ' HG11 ' B' ' 47' ' ' VAL . 85.7 m-85 -111.28 144.03 41.11 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 122.893 0.477 . . . . 0.0 109.999 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -73.82 147.72 43.1 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.561 0.696 . . . . 0.0 111.228 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.42 -36.01 79.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.867 -177.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.48 -40.09 96.18 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 120.131 -0.628 . . . . 0.0 111.884 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -73.15 -33.69 65.64 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 176.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 97.2 mt -64.57 -53.95 36.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 118.204 -1.398 . . . . 0.0 109.475 177.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 88.6 mt -61.77 132.35 52.84 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.004 -170.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.55 -4.36 69.38 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 121.034 -0.603 . . . . 0.0 113.382 -177.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -133.22 149.25 52.02 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -177.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' ASN . . . . . 0.55 ' C ' ' H ' ' B' ' 63' ' ' ARG . 24.4 t-20 -78.86 151.79 31.62 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.565 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' CYS . . . . . . . . . . . . . 82.7 m -64.28 8.96 0.09 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.341 -178.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' ARG . . . . . 0.55 ' H ' ' C ' ' B' ' 61' ' ' ASN . 34.4 ptt-85 -59.4 -32.46 70.19 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.395 -177.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -60.95 -30.66 70.37 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 178.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 83.9 mt -61.66 -41.95 98.23 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 121.63 -0.669 . . . . 0.0 110.114 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -51.75 150.58 3.89 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.024 -177.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -161.13 -153.94 7.21 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.33 177.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -58.98 -40.55 85.18 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -175.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' HIS . . . . . 0.565 ' H ' ' HH ' ' B' ' 95' ' ' TYR . 7.7 m-70 -76.92 -9.43 58.68 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.307 -178.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 26.9 m -61.19 133.81 56.35 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -90.5 110.1 38.65 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.485 -178.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.17 -38.15 87.71 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 120.979 1.12 . . . . 0.0 111.677 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.83 -40.42 92.75 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 120.459 -0.496 . . . . 0.0 109.8 -176.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' GLU . . . . . 0.487 ' OE1' ' HB ' ' B' ' 90' ' ' VAL . 79.0 mm-40 -67.23 -39.44 86.21 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.789 177.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 73.9 t -61.96 -45.95 97.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -63.29 -37.05 85.75 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.655 -178.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -62.33 -41.47 98.58 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 119.393 -0.923 . . . . 0.0 108.698 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 94.2 mt -63.28 -43.76 98.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-O 120.928 0.394 . . . . 0.0 110.427 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -62.31 -42.78 99.66 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 85.1 m -61.57 -45.4 94.29 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.027 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.28 -41.15 98.24 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.411 HD23 ' CE1' ' B' ' 119' ' ' PHE . 85.9 mt -62.98 -42.14 99.76 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -62.48 -36.63 83.1 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -91.64 7.4 41.72 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.5 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 32.3 tttt 43.1 45.79 4.74 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.414 -0.515 . . . . 0.0 112.195 175.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -128.15 143.72 49.01 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.274 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.31 140.51 83.19 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 120.933 1.089 . . . . 0.0 113.289 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -140.82 137.16 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.361 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 89' ' ' THR . . . . . 0.528 ' CG2' ' OD1' ' B' ' 107' ' ' ASN . 95.7 m -121.47 123.81 42.94 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . 0.487 ' HB ' ' OE1' ' B' ' 74' ' ' GLU . 26.9 m -138.27 163.13 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.955 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -114.62 120.42 40.09 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 174.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 20.9 tt -128.3 131.79 68.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.256 -176.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -71.44 143.46 50.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.419 177.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 94' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -132.92 -178.89 5.16 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 121.268 0.556 . . . . 0.0 111.176 -177.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 95' ' ' TYR . . . . . 0.565 ' HH ' ' H ' ' B' ' 69' ' ' HIS . 96.8 m-85 -131.19 145.61 52.01 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 114.567 -1.197 . . . . 0.0 111.711 178.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . 0.453 ' HE2' ' O ' ' B' ' 49' ' ' MET . 98.6 mttt -103.01 177.09 4.93 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.317 0.58 . . . . 0.0 111.209 177.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.15 -35.43 75.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.716 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 38.4 p-10 -87.11 -1.78 58.14 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.168 0.895 . . . . 0.0 112.486 178.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.28 3.18 63.46 Favored Glycine 0 C--N 1.335 0.528 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.449 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 25.5 m -67.01 128.99 38.44 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 101' ' ' MET . . . . . 0.603 ' SD ' ' N ' ' B' ' 102' ' ' PHE . 15.1 tmm? -87.75 142.23 27.98 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 102' ' ' PHE . . . . . 0.603 ' N ' ' SD ' ' B' ' 101' ' ' MET . 52.8 p90 -153.9 162.09 41.49 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 103' ' ' TRP . . . . . 0.757 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 20.9 m95 -95.16 138.68 32.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.404 0.621 . . . . 0.0 110.785 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . 0.409 HD22 ' HG2' ' B' ' 123' ' ' GLN . 62.8 t-20 -132.66 107.19 8.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.78 -1.1 . . . . 0.0 113.567 -177.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -76.14 123.7 26.25 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.413 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 39.0 tp -111.39 125.59 54.03 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.989 0.423 . . . . 0.0 112.012 -177.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 107' ' ' ASN . . . . . 0.528 ' OD1' ' CG2' ' B' ' 89' ' ' THR . 98.3 m-20 -119.08 128.6 54.48 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 96.5 mt -123.61 133.06 70.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -142.85 122.96 7.95 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -69.89 152.29 68.61 Favored 'Trans proline' 0 N--CA 1.499 1.85 0 C-N-CA 122.381 2.054 . . . . 0.0 112.642 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 111' ' ' MET . . . . . 0.43 ' HB2' ' HB2' ' B' ' 118' ' ' TYR . 67.3 mtt -130.22 141.85 50.61 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -113.34 108.43 17.23 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . 0.788 HG12 ' HZ3' ' A' ' 18' ' ' LYS . 96.7 mt -134.52 127.93 50.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 118.279 0.491 . . . . 0.0 112.04 177.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 52.49 38.33 25.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.93 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 60.09 37.07 21.21 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.441 -178.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -132.41 153.1 51.15 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 9.7 t -104.95 151.85 23.4 Favored 'General case' 0 C--O 1.214 -0.766 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -178.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 118' ' ' TYR . . . . . 0.43 ' HB2' ' HB2' ' B' ' 111' ' ' MET . 96.2 m-85 -149.29 147.03 27.88 Favored 'General case' 0 C--O 1.239 0.541 0 O-C-N 121.066 -1.021 . . . . 0.0 110.889 -177.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 119' ' ' PHE . . . . . 0.474 ' O ' ' OG1' ' B' ' 30' ' ' THR . 90.9 m-85 -123.03 139.25 54.28 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 123.523 0.514 . . . . 0.0 110.846 -176.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -128.0 133.63 66.83 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.03 122.1 6.79 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 122' ' ' ILE . . . . . 0.428 ' HB ' ' HB2' ' B' ' 107' ' ' ASN . 91.2 mt -111.33 127.22 68.62 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.44 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 123' ' ' GLN . . . . . 0.579 ' N ' ' O ' ' B' ' 26' ' ' GLY . 17.0 mp0 -117.97 118.96 33.39 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -118.09 121.16 39.87 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . 0.588 ' OD1' ' N ' ' B' ' 127' ' ' THR . 68.0 t0 -69.36 133.56 47.97 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.043 -0.981 . . . . 0.0 112.261 -178.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . 0.494 ' O ' ' HG3' ' B' ' 130' ' ' LYS . 3.2 mp -107.24 17.89 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.77 0 CA-C-O 122.397 1.094 . . . . 0.0 108.918 177.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 127' ' ' THR . . . . . 0.588 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 97.0 m -63.76 -44.21 94.13 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 113.59 -1.641 . . . . 0.0 112.403 175.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 59.2 tptt -60.91 -45.66 93.74 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -178.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 129' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -63.34 -35.17 79.5 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.687 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 130' ' ' LYS . . . . . 0.757 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 98.7 mttt -63.1 -41.41 99.38 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 113.253 -1.794 . . . . 0.0 110.691 174.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.67 -42.1 95.62 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 132' ' ' TYR . . . . . 0.475 ' CE2' HD13 ' B' ' 136' ' ' LEU . 87.9 t80 -59.92 -44.4 94.34 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 121.878 -0.514 . . . . 0.0 111.388 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . 0.401 ' O ' ' HG3' ' B' ' 137' ' ' GLU . 97.4 mt-10 -64.94 -36.53 84.68 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.724 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 134' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' B' ' 130' ' ' LYS . 98.8 mttt -63.11 -39.31 94.33 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.756 178.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 54.4 tp -62.78 -41.25 99.16 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.401 0.62 . . . . 0.0 109.83 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 136' ' ' LEU . . . . . 0.475 HD13 ' CE2' ' B' ' 132' ' ' TYR . 87.0 mt -63.34 -41.48 98.88 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.494 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 137' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' B' ' 133' ' ' GLU . 97.2 mt-10 -64.61 -37.98 89.43 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.511 -178.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.58 -43.68 96.26 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.824 176.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 61.4 m -60.96 -44.41 97.34 Favored 'General case' 0 C--N 1.344 0.352 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' B' ' 144' ' ' THR . 84.5 mt -61.64 -40.36 94.6 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -177.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 99.3 m -61.9 -45.13 95.09 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.728 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -65.97 -42.33 90.0 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 93.9 mt -63.81 -43.2 97.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 114.515 -1.22 . . . . 0.0 110.493 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 144' ' ' THR . . . . . 0.445 ' N ' ' O ' ' B' ' 140' ' ' LEU . 99.8 m -61.7 -45.76 92.6 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.42 -40.5 97.35 Favored 'General case' 0 C--O 1.228 -0.071 0 C-N-CA 119.071 -1.052 . . . . 0.0 109.161 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 83.4 mt -64.38 -40.96 96.84 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 147' ' ' SER . . . . . 0.617 ' O ' ' N ' ' B' ' 149' ' ' PRO . 78.1 p -61.86 -41.44 97.85 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 148' ' ' THR . . . . . 0.504 ' C ' ' O ' ' B' ' 147' ' ' SER . 8.9 m -27.06 85.66 0.04 OUTLIER Pre-proline 0 N--CA 1.473 0.716 0 O-C-N 124.035 0.834 . . . . 0.0 109.999 177.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 149' ' ' PRO . . . . . 0.617 ' N ' ' O ' ' B' ' 147' ' ' SER . 24.3 Cg_exo -61.27 146.25 97.58 Favored 'Trans proline' 0 C--N 1.299 -2.036 0 C-N-CA 122.008 1.805 . . . . 0.0 115.211 -177.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 9.5 tp -127.91 123.36 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 174.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 29.9 t -152.78 96.71 2.93 Favored Pre-proline 0 C--N 1.304 -1.39 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.127 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -63.43 132.34 35.45 Favored 'Trans proline' 0 N--CA 1.486 1.062 0 CA-C-N 119.626 0.902 . . . . 0.0 109.776 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 153' ' ' ILE . . . . . 0.569 ' O ' ' HD2' ' B' ' 154' ' ' ARG . 45.8 mm -68.97 -44.33 81.48 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.437 0 C-N-CA 119.738 -0.785 . . . . 0.0 110.88 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 154' ' ' ARG . . . . . 0.569 ' HD2' ' O ' ' B' ' 153' ' ' ILE . 1.0 OUTLIER -154.96 -157.18 0.73 Allowed 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 178.678 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -86.35 110.55 19.76 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.02 -20.36 50.89 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 -177.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 88.1 mt -108.6 123.89 64.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.76 0.314 . . . . 0.0 111.738 -176.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 158' ' ' SER . . . . . 0.569 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 59.6 m -134.45 150.29 50.82 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.857 178.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -130.89 146.23 52.25 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 38.4 tp -139.61 74.58 33.28 Favored Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 161' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -69.43 148.09 66.44 Favored 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 122.754 2.303 . . . . 0.0 114.318 -177.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 92.9 mt -114.1 134.36 54.93 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 52.2 t -129.01 132.64 67.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 113.5 168.32 16.77 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 120.419 -0.896 . . . . 0.0 111.441 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 165' ' ' ASN . . . . . 0.705 ' O ' ' CZ ' ' B' ' 170' ' ' ARG . 56.2 t30 -89.09 107.79 19.24 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -179.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 166' ' ' LEU . . . . . 0.459 ' CD2' ' CZ ' ' B' ' 171' ' ' PHE . 43.5 tp -66.34 104.34 1.2 Allowed 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -174.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 167' ' ' THR . . . . . 0.472 ' H ' ' HE ' ' B' ' 170' ' ' ARG . 10.5 p -84.51 171.16 12.76 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 113.733 -1.576 . . . . 0.0 111.091 177.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -67.18 -38.46 85.42 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.766 177.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -66.55 -40.13 88.9 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-O 123.122 1.439 . . . . 0.0 111.773 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 170' ' ' ARG . . . . . 0.705 ' CZ ' ' O ' ' B' ' 165' ' ' ASN . 88.2 mtm180 -63.31 -36.83 85.0 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 112.241 -2.254 . . . . 0.0 111.109 178.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 171' ' ' PHE . . . . . 0.459 ' CZ ' ' CD2' ' B' ' 166' ' ' LEU . 0.4 OUTLIER -53.92 -25.16 19.01 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 113.607 0.965 . . . . 0.0 113.607 -178.472 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 172' ' ' ASN . . . . . 0.702 ' O ' HG21 ' B' ' 175' ' ' VAL . 90.1 m-20 -62.73 -40.2 96.47 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.872 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 49.3 m -60.41 -41.09 93.18 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.23 0.538 . . . . 0.0 110.802 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 66.5 mt -63.56 -43.95 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 175' ' ' VAL . . . . . 0.702 HG21 ' O ' ' B' ' 172' ' ' ASN . 23.8 m -62.6 -39.86 86.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 176' ' ' CYS . . . . . . . . . . . . . 98.7 m -62.49 -35.09 78.25 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.241 177.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 177' ' ' THR . . . . . 0.592 ' O ' HG13 ' B' ' 181' ' ' ILE . 25.0 m -61.41 -19.81 62.35 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.243 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 178' ' ' LEU . . . . . . . . . . . . . 93.3 mt -61.15 -39.6 90.71 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.397 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 19.6 m -61.5 -44.22 97.46 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 176.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 180' ' ' ASN . . . . . 0.598 ' O ' ' OG ' ' B' ' 183' ' ' SER . 92.0 m-20 -61.52 -40.05 93.23 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.296 0.57 . . . . 0.0 110.29 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . 0.592 HG13 ' O ' ' B' ' 177' ' ' THR . 70.4 mt -56.56 -35.94 46.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 O-C-N 121.978 -0.452 . . . . 0.0 110.582 -178.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 182' ' ' LEU . . . . . . . . . . . . . 84.1 mt -61.82 -41.79 98.22 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 119.839 -0.744 . . . . 0.0 109.187 178.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 183' ' ' SER . . . . . 0.598 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.2 p -62.97 -33.08 74.63 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 121.897 -0.502 . . . . 0.0 110.779 177.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 54.3 p -85.88 16.15 4.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.823 0.344 . . . . 0.0 111.753 -177.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 78.5 p -60.64 -16.68 41.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.782 -176.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -61.5 -40.5 94.83 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.882 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 187' ' ' ASP . . . . . 0.569 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.8 m-20 -70.44 115.27 9.42 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.528 0.68 . . . . 0.0 110.401 -178.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.88 -42.29 99.71 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 114.895 -1.048 . . . . 0.0 113.305 -177.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -111.46 131.67 55.05 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.674 -0.411 . . . . 0.0 111.135 -177.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 190' ' ' LEU . . . . . . . . . . . . . 42.1 tp -123.8 118.81 28.01 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.056 177.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 84.8 mt -107.87 126.66 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.049 -177.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 50.0 mm -115.25 117.62 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 193' ' ' ASP . . . . . 0.541 ' OD2' ' OG ' ' B' ' 195' ' ' SER . 42.6 t0 -87.64 112.19 22.07 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.938 -177.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 194' ' ' LEU . . . . . . . . . . . . . 96.1 mt -92.5 -2.78 55.98 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 176.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 195' ' ' SER . . . . . 0.541 ' OG ' ' OD2' ' B' ' 193' ' ' ASP . 78.2 p -61.14 -38.27 85.8 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.819 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.74 -34.1 87.48 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 197' ' ' LEU . . . . . 0.989 HD23 ' O ' ' B' ' 199' ' ' GLN . 4.9 tt -77.2 132.73 38.9 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 198' ' ' ALA . . . . . 0.764 ' N ' HD21 ' B' ' 197' ' ' LEU . . . -63.78 -41.8 97.88 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.854 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 199' ' ' GLN . . . . . 0.989 ' O ' HD23 ' B' ' 197' ' ' LEU . 58.9 tt0 -138.08 163.43 31.65 Favored 'General case' 0 C--O 1.203 -1.345 0 CA-C-O 122.096 0.951 . . . . 0.0 113.008 -178.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 200' ' ' VAL . . . . . 0.443 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 50.3 t -121.46 132.77 69.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 O-C-N 120.229 -1.544 . . . . 0.0 109.349 178.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -94.06 148.65 21.96 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.918 0.866 . . . . 0.0 111.359 -177.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -59.9 -33.12 71.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.857 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -63.87 -33.58 76.01 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.4 m -61.09 -44.45 97.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.096 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 205' ' ' ALA . . . . . 0.641 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -57.95 -31.66 67.07 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.835 -178.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -65.43 -38.16 89.06 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.216 0.531 . . . . 0.0 109.884 176.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -66.32 -38.96 88.89 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.586 178.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.7 -43.13 97.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.589 0.709 . . . . 0.0 110.463 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 209' ' ' PHE . . . . . 0.641 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 65.3 m-85 -61.93 -43.34 99.04 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 113.828 -1.533 . . . . 0.0 112.384 178.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.92 -42.4 97.39 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.836 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 211' ' ' LEU . . . . . 0.459 ' O ' ' HG ' ' B' ' 215' ' ' LEU . 37.7 mt -62.42 -42.49 99.48 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.078 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 212' ' ' SER . . . . . 0.506 ' HG ' ' N ' ' B' ' 213' ' ' HIS . 78.2 p -62.8 -36.13 82.12 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.836 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 213' ' ' HIS . . . . . 0.506 ' N ' ' HG ' ' B' ' 212' ' ' SER . 58.7 t-80 -67.08 -46.68 73.53 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 115.296 -0.866 . . . . 0.0 112.261 178.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 51.1 tp -63.79 -43.21 97.01 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 121.776 0.798 . . . . 0.0 109.487 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 215' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' B' ' 211' ' ' LEU . 90.9 mt -62.87 -43.89 97.59 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 113.607 -1.633 . . . . 0.0 111.253 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.55 -39.12 89.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.917 -177.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 85.7 mt -63.02 -42.79 99.88 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.314 176.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 218' ' ' THR . . . . . . . . . . . . . 66.7 p -74.24 -16.54 60.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.806 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 80.45 61.21 2.23 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 107.307 -2.317 . . . . 0.0 107.307 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 220' ' ' THR . . . . . . . . . . . . . 94.9 m -141.3 106.84 5.06 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 174.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -63.57 140.2 58.85 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.689 -174.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 44.5 tp -116.03 120.89 40.56 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.557 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 3.0 mp -109.97 129.57 64.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.758 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 224' ' ' ILE . . . . . . . . . . . . . 50.8 mm -111.0 127.11 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 43.5 p -134.34 157.76 45.54 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.924 0.869 . . . . 0.0 112.688 -178.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 90.23 18.84 48.35 Favored Glycine 0 CA--C 1.5 -0.871 0 CA-C-N 113.815 -1.539 . . . . 0.0 111.182 -177.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 95.0 mt -85.29 125.44 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 118.292 1.046 . . . . 0.0 111.556 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 49.5 tttt -62.87 139.97 97.36 Favored Pre-proline 0 C--N 1.313 -0.98 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.08 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.1 -37.93 93.78 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 121.373 1.382 . . . . 0.0 112.799 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -64.7 -41.67 95.84 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -178.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 50.7 tp -61.61 -41.87 98.07 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.014 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.34 -36.65 84.82 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.742 0.306 . . . . 0.0 111.123 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 94.3 mtp -63.73 -40.98 98.07 Favored 'General case' 0 C--O 1.25 1.094 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.793 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.51 -44.4 96.47 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 122.291 1.043 . . . . 0.0 109.332 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 35.6 mmt -64.25 -35.64 81.48 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.634 -1.167 . . . . 0.0 111.716 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -61.39 -40.33 93.98 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -177.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.06 -43.2 99.26 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.202 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 55.8 tp -61.58 -44.92 96.13 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 120.257 -0.577 . . . . 0.0 112.33 -178.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 239' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' B' ' 240' ' ' ALA . 66.8 t0 -158.09 134.69 9.65 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.355 -0.538 . . . . 0.0 112.141 -179.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 240' ' ' ALA . . . . . 0.421 ' N ' ' OD1' ' B' ' 239' ' ' ASP . . . -61.76 -46.69 88.49 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 176.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 241' ' ' ASN . . . . . 0.517 ' O ' ' HB2' ' B' ' 244' ' ' SER . 91.9 m-20 -43.21 -21.85 0.03 OUTLIER 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.361 -176.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 242' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -61.29 -45.36 94.8 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.523 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 243' ' ' SER . . . . . . . . . . . . . 77.4 p -58.18 -44.62 88.12 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 244' ' ' SER . . . . . 0.517 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 19.7 m -32.59 -37.82 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 94.9 mt -83.39 134.47 34.89 Favored 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.27 175.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -63.61 136.56 57.61 Favored 'General case' 0 C--O 1.241 0.655 0 O-C-N 121.368 -0.833 . . . . 0.0 111.645 -176.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 247' ' ' THR . . . . . . . . . . . . . 98.3 m -125.43 127.54 46.7 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.537 -1.211 . . . . 0.0 112.083 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -112.44 143.42 43.6 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 249' ' ' SER . . . . . 0.599 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 78.3 p -62.85 -33.31 74.99 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.144 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 250' ' ' ASN . . . . . 0.599 ' OD1' ' O ' ' B' ' 249' ' ' SER . 98.9 m-20 -148.43 160.19 43.29 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.189 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 73.6 t -64.66 -44.55 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.077 177.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 252' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.96 -46.09 92.1 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -60.67 -43.37 97.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.188 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 254' ' ' ALA . . . . . 0.465 ' O ' HG21 ' B' ' 257' ' ' VAL . . . -65.42 -40.47 93.4 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 120.091 -0.644 . . . . 0.0 111.332 178.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 255' ' ' VAL . . . . . . . . . . . . . 62.2 t -64.82 -45.52 94.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.656 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 256' ' ' LYS . . . . . 0.41 ' HE3' ' ND2' ' A' ' 155' ' ' ASN . 88.7 tttt -63.36 -48.65 77.06 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.485 -178.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 257' ' ' VAL . . . . . 0.465 HG21 ' O ' ' B' ' 254' ' ' ALA . 33.0 m -64.69 -41.13 91.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.623 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 258' ' ' LEU . . . . . 0.505 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 0.9 OUTLIER -33.09 -72.87 0.06 OUTLIER Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.947 -177.948 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 259' ' ' PRO . . . . . 0.544 ' O ' HG13 ' B' ' 260' ' ' ILE . 38.4 Cg_endo -62.54 141.78 87.64 Favored 'Trans proline' 0 N--CA 1.506 2.236 0 C-N-CA 121.855 1.703 . . . . 0.0 111.243 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 260' ' ' ILE . . . . . 0.544 HG13 ' O ' ' B' ' 259' ' ' PRO . 96.6 mt -160.61 -18.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 77.2 mtm . . . . . 0 C--O 1.219 -0.547 0 CA-C-O 117.919 -1.038 . . . . 0.0 111.786 -179.738 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.234 0 N-CA-C 109.054 -1.619 . . . . 0.0 109.054 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.474 ' O ' ' OG ' ' A' ' 6' ' ' SER . . . -152.54 165.47 35.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 119.173 -0.442 . . . . 0.0 110.111 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.9 p -70.9 -16.54 62.69 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 121.5 0.667 . . . . 0.0 111.356 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -72.1 -65.71 0.74 Allowed 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 114.275 -1.329 . . . . 0.0 112.151 174.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -67.07 -38.21 85.36 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.55 ' O ' ' NZ ' ' B' ' 17' ' ' LYS . 60.9 m -59.4 -42.45 91.76 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.152 -177.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.496 ' HB3' ' O ' ' A' ' 6' ' ' SER . 44.6 t80 84.6 84.04 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 O-C-N 123.69 0.618 . . . . 0.0 111.801 176.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.604 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -58.99 -141.72 0.01 OUTLIER Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -177.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.604 ' HB ' ' O ' ' A' ' 8' ' ' GLY . 86.3 mt 84.64 109.92 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.626 0 C-N-CA 122.39 0.276 . . . . 0.0 110.682 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.27 -22.37 72.23 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.49 1.46 . . . . 0.0 111.994 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.41 -37.29 94.27 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.844 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.1 -39.9 93.79 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.51 0.671 . . . . 0.0 109.847 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 52.8 tp -63.23 -41.19 99.06 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.947 -0.569 . . . . 0.0 112.215 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -63.03 -41.33 99.49 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.1 t -60.36 -44.06 95.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 O-C-N 122.339 -0.226 . . . . 0.0 110.705 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 92.3 mt -62.58 -43.48 98.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.452 -177.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.419 ' NZ ' ' HA ' ' B' ' 6' ' ' SER . 98.9 mttt -62.53 -45.38 93.25 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 119.458 -0.897 . . . . 0.0 111.879 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.642 ' HZ3' HG12 ' B' ' 113' ' ' ILE . 98.4 mttt -60.44 -39.53 87.84 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 118.555 -1.258 . . . . 0.0 109.051 -176.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.85 -41.56 91.67 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.059 -0.656 . . . . 0.0 110.262 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.6 mt -63.07 -41.24 99.39 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.61 -38.79 92.45 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.383 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 62.6 m170 -58.69 -39.98 82.27 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 122.2 -0.312 . . . . 0.0 111.243 -178.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.9 p -114.61 129.3 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.475 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 34.6 ptt180 -71.11 108.71 4.77 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 122.098 0.951 . . . . 0.0 112.081 -177.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.0 p -140.07 142.59 31.49 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 178.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -97.84 93.48 1.4 Allowed Glycine 0 C--N 1.312 -0.783 0 C-N-CA 120.776 -0.726 . . . . 0.0 113.058 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.9 t -124.41 130.0 73.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 175.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.3 m -136.34 159.22 38.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.6 mt -121.28 128.99 76.05 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.4 p -103.65 167.68 9.64 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.541 ' C ' ' OD1' ' A' ' 37' ' ' ASN . 45.6 t0 -133.37 101.23 13.45 Favored Pre-proline 0 C--N 1.32 -0.684 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.659 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.04 -22.58 73.66 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.411 1.407 . . . . 0.0 111.534 -179.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.4 -35.73 80.11 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.774 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 91.9 mt -85.85 161.0 19.29 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.656 177.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.733 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 43.1 tt0 -59.67 135.42 57.67 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -177.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.537 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 60.2 t0 60.65 22.37 12.23 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.877 178.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.541 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 22.5 t-20 40.9 67.82 2.72 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.877 -178.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.733 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 91.3 Cg_endo -71.23 156.88 58.47 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 C-N-CA 123.816 3.011 . . . . 0.0 112.493 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.4 mt -90.08 125.34 42.98 Favored 'Isoleucine or valine' 0 C--O 1.245 0.862 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.41 HG21 ' N ' ' A' ' 41' ' ' TYR . 35.3 m -105.54 -43.57 7.63 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 O-C-N 123.585 0.553 . . . . 0.0 112.102 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.41 ' N ' HG21 ' A' ' 40' ' ' VAL . 46.8 t80 -95.28 124.58 39.39 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.736 -178.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.9 p -142.58 139.55 28.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.347 177.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.569 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 56.7 p30 -96.73 166.6 11.57 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.522 ' HA ' ' OE1' ' A' ' 44' ' ' GLN . 12.6 mm100 -67.19 -37.98 84.6 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 120.961 0.41 . . . . 0.0 111.855 177.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.03 -27.51 64.9 Favored Glycine 0 C--N 1.331 0.283 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.569 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 71.0 t80 -59.13 -48.43 81.64 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.606 HG11 ' O ' ' A' ' 52' ' ' TYR . 54.9 t -59.58 -44.9 94.26 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.585 0 O-C-N 121.297 -0.877 . . . . 0.0 111.442 -173.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -63.64 -37.61 87.98 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 120.415 -0.514 . . . . 0.0 112.027 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' MET . . . . . 0.402 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 58.8 ttm -67.3 -43.59 81.35 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 175.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 39.8 p -90.06 -23.79 21.34 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.155 0.502 . . . . 0.0 111.634 -178.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . 78.78 20.44 70.9 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.606 ' O ' HG11 ' A' ' 47' ' ' VAL . 90.4 m-85 -115.02 141.89 47.38 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.003 0.521 . . . . 0.0 111.539 178.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -65.96 149.52 50.1 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.848 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.7 -33.09 75.07 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.27 -43.71 85.67 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 119.535 -0.866 . . . . 0.0 111.286 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -64.76 -44.67 89.32 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.393 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.436 HG22 HD13 ' A' ' 57' ' ' ILE . 93.5 mt -61.81 -49.98 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -174.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 84.1 mt -55.94 148.67 16.73 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 176.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.01 -4.54 61.53 Favored Glycine 0 CA--C 1.52 0.377 0 CA-C-O 119.379 -0.678 . . . . 0.0 113.305 177.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -136.98 149.37 47.48 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.041 1.42 . . . . 0.0 111.711 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.575 ' C ' ' H ' ' A' ' 63' ' ' ARG . 25.8 t-20 -80.89 152.09 28.29 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.189 0.519 . . . . 0.0 110.687 -178.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 82.0 m -62.2 15.12 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.291 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.575 ' H ' ' C ' ' A' ' 61' ' ' ASN . 34.4 ptt-85 -61.93 -41.6 98.14 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.979 -0.45 . . . . 0.0 111.376 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -56.17 -21.84 25.3 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 93.0 mt -67.25 -35.64 79.98 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.757 0.789 . . . . 0.0 113.063 177.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -63.05 142.87 58.22 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.225 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.499 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -152.8 -148.79 4.97 Favored Glycine 0 CA--C 1.54 1.638 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.685 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.485 ' HB3' ' HH ' ' A' ' 95' ' ' TYR . 88.8 tttt -62.85 -40.69 98.23 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -177.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.487 ' HD1' HE22 ' A' ' 93' ' ' GLN . 8.8 m-70 -76.5 -9.04 58.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.715 0.293 . . . . 0.0 111.101 -178.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.499 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 30.6 m -62.87 129.94 42.62 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.204 -0.598 . . . . 0.0 109.786 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -87.7 110.52 35.33 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.997 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.29 -32.16 92.92 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.993 1.795 . . . . 0.0 113.117 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.76 -39.6 94.67 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.979 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.48 ' OE1' ' HB ' ' A' ' 90' ' ' VAL . 79.4 mm-40 -65.09 -43.85 90.79 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.7 t -59.88 -43.94 93.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 114.273 -1.331 . . . . 0.0 107.817 -176.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.83 -37.8 88.73 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.724 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -63.26 -39.8 95.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.235 0.541 . . . . 0.0 110.295 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 95.1 mt -63.85 -44.07 98.02 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.996 178.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -62.83 -43.07 99.79 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 113.655 -1.611 . . . . 0.0 108.371 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 98.5 m -61.34 -48.76 79.82 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.57 -41.87 91.16 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.589 -172.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 90.6 mt -63.24 -40.08 96.43 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 118.831 0.741 . . . . 0.0 111.414 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 66.9 tp60 -64.49 -32.94 74.78 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -90.3 -2.36 58.0 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.533 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.2 tttt 49.35 39.17 15.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.955 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -121.89 144.06 40.08 Favored Pre-proline 0 CA--C 1.533 0.321 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.422 ' HB3' ' OD1' ' A' ' 109' ' ' ASP . 24.7 Cg_exo -61.46 143.32 97.33 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 121.402 1.402 . . . . 0.0 113.236 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.8 p -139.79 142.45 32.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.819 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.527 ' CG2' ' OD1' ' A' ' 107' ' ' ASN . 99.0 m -126.33 121.25 32.04 Favored 'General case' 0 C--N 1.344 0.336 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 175.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.48 ' HB ' ' OE1' ' A' ' 74' ' ' GLU . 29.9 m -138.85 158.72 30.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.323 177.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -102.87 133.58 47.72 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 176.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.0 tt -140.41 129.97 27.36 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.213 0 CA-C-N 121.067 1.758 . . . . 0.0 112.438 177.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.487 HE22 ' HD1' ' A' ' 69' ' ' HIS . 86.1 mt-30 -63.37 132.19 50.69 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.75 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -131.9 155.92 47.03 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.542 -178.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.485 ' HH ' ' HB3' ' A' ' 68' ' ' LYS . 94.1 m-85 -114.84 134.52 55.07 Favored 'General case' 0 C--N 1.346 0.444 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.402 ' HE2' ' O ' ' A' ' 49' ' ' MET . 99.0 mttt -83.61 -174.18 5.14 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.139 0.495 . . . . 0.0 111.532 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -62.44 -41.52 98.79 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.041 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 40.9 p-10 -83.95 5.17 26.52 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 111.892 0.331 . . . . 0.0 111.892 -177.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.01 -1.77 85.12 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.004 176.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 25.0 m -60.39 137.46 58.14 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 178.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.66 ' C ' ' SD ' ' A' ' 101' ' ' MET . 14.7 tmm? -104.44 127.83 52.22 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.628 0.252 . . . . 0.0 110.711 178.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -140.7 157.01 46.06 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.244 -0.582 . . . . 0.0 109.803 -177.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.786 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 20.8 m95 -88.12 141.96 28.15 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.486 HD22 ' HG2' ' A' ' 123' ' ' GLN . 56.9 t-20 -137.38 102.92 4.93 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -177.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 80.8 tt0 -67.75 136.64 54.54 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -176.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 41.8 tp -121.74 124.22 43.71 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.527 ' OD1' ' CG2' ' A' ' 89' ' ' THR . 98.0 m-20 -122.43 124.49 43.76 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.671 177.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 87' ' ' PRO . 96.4 mt -120.57 129.28 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 O-C-N 123.436 0.46 . . . . 0.0 111.597 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.422 ' OD1' ' HB3' ' A' ' 87' ' ' PRO . 2.4 m-20 -137.81 121.6 11.68 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 110.581 -0.155 . . . . 0.0 110.581 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -69.6 150.86 69.75 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 122.432 2.088 . . . . 0.0 112.713 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.615 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 66.6 mtt -121.94 153.12 38.91 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -127.81 94.19 3.88 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 176.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 96.5 mt -119.05 130.97 73.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.876 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 51.95 36.51 18.62 Favored 'General case' 0 CA--C 1.517 -0.292 0 O-C-N 121.406 -0.809 . . . . 0.0 111.468 176.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 59.42 30.31 19.98 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.758 -178.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -127.47 146.12 50.6 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 177.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.724 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 5.0 t -82.04 -173.2 4.36 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.578 -0.701 . . . . 0.0 109.77 -178.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.724 ' CD2' ' O ' ' A' ' 117' ' ' THR . 64.0 m-85 -171.11 157.44 5.16 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 173.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -131.32 146.21 52.19 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 174.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.5 p -133.15 135.68 56.29 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 177.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -109.17 127.41 8.51 Favored Glycine 0 CA--C 1.501 -0.795 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 178.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 96.2 mt -118.99 130.1 74.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.486 ' HG2' HD22 ' A' ' 104' ' ' ASN . 16.4 mp0 -120.39 117.74 28.53 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 123.563 0.539 . . . . 0.0 109.975 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -117.83 113.59 22.0 Favored 'General case' 0 C--O 1.248 0.995 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.032 -178.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 126' ' ' ILE . 68.1 t0 -64.02 132.41 50.51 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -174.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.463 ' N ' ' OD1' ' A' ' 125' ' ' ASP . 2.6 mp -97.5 2.58 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 113.765 -1.561 . . . . 0.0 110.398 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 19.3 m -60.61 -43.0 97.96 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.211 -0.931 . . . . 0.0 113.397 -178.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -59.76 -42.46 93.3 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -63.06 -39.05 93.59 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.723 177.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.786 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.7 mttt -62.41 -40.69 97.34 Favored 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 118.467 -1.293 . . . . 0.0 110.631 -178.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -62.53 -36.98 84.3 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -178.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.432 ' CE2' HD13 ' A' ' 136' ' ' LEU . 89.8 t80 -61.56 -45.96 91.93 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.597 176.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.62 -38.47 91.11 Favored 'General case' 0 C--O 1.225 -0.213 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.89 -40.91 97.07 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 51.5 tp -60.91 -43.6 98.33 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 -178.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.432 HD13 ' CE2' ' A' ' 132' ' ' TYR . 87.7 mt -62.7 -41.25 99.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.168 179.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.16 -41.1 99.19 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.766 -178.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -60.99 -41.84 97.27 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 -177.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 66.9 m -61.85 -41.0 97.29 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.661 176.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 144' ' ' THR . 90.2 mt -63.15 -41.9 99.35 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 92.8 m -61.86 -45.46 93.7 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.151 -178.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -65.41 -41.07 93.99 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 94.9 mt -64.55 -43.47 96.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 113.968 -1.469 . . . . 0.0 111.383 177.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.424 ' N ' ' O ' ' A' ' 140' ' ' LEU . 99.1 m -62.25 -46.08 90.42 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 120.432 -0.507 . . . . 0.0 112.167 -178.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.02 -41.28 97.92 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 118.789 -1.164 . . . . 0.0 108.931 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.3 mt -63.88 -42.62 97.44 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 177.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.681 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.0 p -60.56 -37.28 80.75 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -178.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.454 ' C ' ' O ' ' A' ' 147' ' ' SER . 55.5 m -31.14 83.91 0.03 OUTLIER Pre-proline 0 C--N 1.344 0.359 0 O-C-N 126.79 2.556 . . . . 0.0 106.211 -178.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.681 ' N ' ' O ' ' A' ' 147' ' ' SER . 21.7 Cg_exo -62.74 145.31 94.91 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 120.849 1.033 . . . . 0.0 114.604 -175.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.63 ' O ' ' CG2' ' A' ' 151' ' ' VAL . 8.7 tp -121.78 136.94 57.04 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.933 0 N-CA-C 102.891 -3.003 . . . . 0.0 102.891 176.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.63 ' CG2' ' O ' ' A' ' 150' ' ' ILE . 60.1 t -170.23 94.74 0.48 Allowed Pre-proline 0 N--CA 1.445 -0.685 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 177.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -63.41 143.8 89.37 Favored 'Trans proline' 0 C--N 1.298 -2.092 0 N-CA-C 109.78 -0.892 . . . . 0.0 109.78 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.577 ' O ' HG12 ' B' ' 255' ' ' VAL . 44.2 mm -77.04 -60.27 2.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.03 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.619 ' NH2' ' HD3' ' B' ' 154' ' ' ARG . 1.6 mpt_? -140.41 -157.56 0.78 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.0 t-20 -86.45 105.23 16.62 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.804 0.812 . . . . 0.0 111.5 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.11 8.55 66.6 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 114.032 -1.44 . . . . 0.0 110.615 -177.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 97.1 mt -123.93 125.57 71.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 175.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.716 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 58.5 m -132.3 151.47 51.82 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.222 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -139.34 142.84 37.6 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.575 -0.703 . . . . 0.0 111.08 177.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 16.8 tp -133.96 80.83 53.45 Favored Pre-proline 0 N--CA 1.469 0.517 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.355 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -69.25 149.89 70.7 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.788 2.325 . . . . 0.0 112.938 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 88.7 mt -119.0 128.09 54.07 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.502 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 47.7 t -124.17 131.27 73.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 116.78 169.62 15.22 Favored Glycine 0 N--CA 1.48 1.62 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.174 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.874 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 56.4 t30 -87.08 113.28 22.69 Favored 'General case' 0 C--O 1.221 -0.431 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -178.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.512 HD13 HD11 ' A' ' 174' ' ' ILE . 46.7 tp -72.39 104.19 3.68 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -178.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.651 ' H ' ' HE ' ' A' ' 170' ' ' ARG . 11.4 p -85.63 167.42 15.36 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.571 178.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.49 -34.85 79.24 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.937 0.398 . . . . 0.0 111.6 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.2 -41.97 94.01 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.757 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.874 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 88.0 mtm180 -64.08 -33.18 75.18 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.993 0.917 . . . . 0.0 112.368 178.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.475 ' CZ ' HD22 ' A' ' 166' ' ' LEU . 0.5 OUTLIER -53.68 -28.24 32.39 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 118.887 -0.578 . . . . 0.0 112.472 -178.766 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.603 ' O ' HG21 ' A' ' 175' ' ' VAL . 91.1 m-20 -61.0 -40.64 94.29 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 118.942 -1.103 . . . . 0.0 109.774 -178.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 54.7 m -59.47 -41.25 89.33 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.604 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.512 HD11 HD13 ' A' ' 166' ' ' LEU . 66.9 mt -63.69 -44.35 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 -179.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.603 HG21 ' O ' ' A' ' 172' ' ' ASN . 33.5 m -62.79 -40.39 88.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 99.3 m -62.77 -34.7 77.79 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.304 0.573 . . . . 0.0 110.34 178.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' THR . . . . . 0.495 ' O ' HG13 ' A' ' 181' ' ' ILE . 24.6 m -62.11 -19.49 63.06 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.197 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 90.5 mt -60.93 -41.17 95.66 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 18.3 m -59.48 -42.96 93.3 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . 0.628 ' O ' ' OG ' ' A' ' 183' ' ' SER . 91.0 m-20 -61.34 -36.63 80.72 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 122.668 0.387 . . . . 0.0 110.837 178.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . 0.495 HG13 ' O ' ' A' ' 177' ' ' THR . 67.0 mt -59.02 -39.92 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 O-C-N 121.558 -0.714 . . . . 0.0 109.086 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 86.3 mt -60.71 -40.61 92.88 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -177.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.628 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 77.9 p -61.65 -33.49 74.05 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.501 176.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.421 ' OG1' ' HA ' ' A' ' 181' ' ' ILE . 66.1 p -89.69 23.37 2.69 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.581 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 78.3 p -63.46 -19.93 65.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.188 0.518 . . . . 0.0 110.752 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.49 -37.29 83.14 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.916 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.716 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 98.2 m-20 -74.18 112.93 10.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.563 0.696 . . . . 0.0 110.839 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -62.74 -42.42 99.66 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 114.967 -1.015 . . . . 0.0 113.063 -177.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -110.48 130.91 55.45 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.562 -178.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 39.2 tp -120.21 128.61 53.53 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 177.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 96.7 mt -116.1 127.53 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-N 118.59 0.632 . . . . 0.0 109.689 177.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.2 mm -113.36 126.93 70.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 178.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . 0.423 ' CG ' ' HG ' ' A' ' 195' ' ' SER . 41.3 t0 -94.67 117.89 30.84 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-O 121.379 0.609 . . . . 0.0 110.667 176.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 97.9 mt -98.59 -4.81 33.23 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.882 175.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' SER . . . . . 0.423 ' HG ' ' CG ' ' A' ' 193' ' ' ASP . 78.2 p -62.31 -33.31 74.42 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.81 -42.68 99.77 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 118.553 -1.784 . . . . 0.0 109.081 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 1.087 HD23 ' O ' ' A' ' 199' ' ' GLN . 5.0 tt -70.59 128.69 36.98 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 112.891 -1.655 . . . . 0.0 107.516 -174.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.572 ' N ' HD21 ' A' ' 197' ' ' LEU . . . -60.26 -45.3 93.77 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.745 -176.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 1.087 ' O ' HD23 ' A' ' 197' ' ' LEU . 58.8 tt0 -138.81 157.31 46.31 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 114.466 -1.243 . . . . 0.0 112.847 -174.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.456 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 47.4 t -118.23 131.71 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -87.66 156.01 19.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.543 -178.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -64.35 -38.89 92.65 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.211 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -58.68 -32.35 69.05 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -178.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.6 m -61.21 -42.32 98.38 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.481 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.476 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -57.52 -39.01 75.6 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -177.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -61.64 -37.11 82.79 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.54 -39.12 91.39 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.892 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 94.8 mt -63.18 -44.23 99.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -178.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . 0.476 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 71.8 m-85 -62.21 -43.58 98.5 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.743 -178.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.34 -42.04 99.07 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 119.316 -0.954 . . . . 0.0 109.231 -178.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.419 ' O ' ' HG ' ' A' ' 215' ' ' LEU . 38.2 mt -62.08 -41.81 98.55 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 77.9 p -61.57 -41.14 96.96 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.07 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -64.49 -45.86 85.49 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.378 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 48.6 tp -62.31 -46.14 90.06 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 119.1 -1.04 . . . . 0.0 108.492 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.454 ' HA ' ' HG1' ' A' ' 218' ' ' THR . 91.2 mt -62.2 -40.8 97.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.504 -177.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.27 -44.41 95.36 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.44 -178.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 87.5 mt -61.65 -39.68 92.23 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.454 ' HG1' ' HA ' ' A' ' 215' ' ' LEU . 69.8 p -75.77 -10.79 59.73 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.244 179.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.07 33.59 26.1 Favored Glycine 0 C--N 1.343 0.925 0 C-N-CA 120.501 -0.857 . . . . 0.0 113.205 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 97.3 m -119.36 113.27 20.56 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.073 1.436 . . . . 0.0 111.512 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -64.98 138.03 58.11 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.752 178.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 45.6 tp -113.8 130.82 56.41 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 3.0 mp -117.85 133.33 64.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.445 HG23 HD11 ' A' ' 224' ' ' ILE . 49.3 mm -115.48 131.81 66.73 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 44.4 p -133.72 166.13 23.34 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 120.531 -0.467 . . . . 0.0 111.997 -178.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 80.04 19.76 69.19 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 97.1 mt -81.9 128.45 38.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 114.059 -1.07 . . . . 0.0 108.506 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 58.6 tttt -75.68 140.72 71.61 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.6 -39.22 89.63 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 121.069 1.179 . . . . 0.0 112.672 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -64.36 -39.67 94.35 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.686 0.755 . . . . 0.0 110.188 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 52.0 tp -63.91 -42.44 97.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.688 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.84 -37.9 89.1 Favored 'General case' 0 N--CA 1.461 0.103 0 O-C-N 121.952 -0.468 . . . . 0.0 110.973 -179.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 94.2 mtp -63.61 -40.89 98.05 Favored 'General case' 0 C--O 1.248 1.026 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.468 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.88 -38.62 91.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.437 177.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 35.0 mmt -65.59 -38.27 89.01 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.63 178.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -61.29 -41.82 97.61 Favored 'General case' 0 CA--C 1.515 -0.402 0 O-C-N 121.52 -0.738 . . . . 0.0 109.525 -177.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.16 -40.99 95.95 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.549 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 56.0 tp -63.52 -41.48 98.5 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 177.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -166.94 127.39 1.55 Allowed 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -60.45 -26.41 66.73 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.66 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . 0.432 ' O ' ' HB2' ' A' ' 244' ' ' SER . 91.3 m-20 -61.39 -33.84 74.36 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.523 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -55.22 -44.27 75.25 Favored 'General case' 0 C--N 1.311 -1.088 0 O-C-N 121.551 -0.718 . . . . 0.0 109.422 -175.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 97.9 p -61.92 -20.12 63.44 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.865 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 241' ' ' ASN . 40.6 m -56.03 -39.24 71.65 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.697 178.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 98.7 mt -84.03 122.82 29.31 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -43.38 135.42 3.52 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.895 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 97.9 m -127.25 132.53 50.36 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.844 177.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -118.01 139.83 50.63 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.29 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' SER . . . . . 0.469 ' HG ' ' N ' ' A' ' 250' ' ' ASN . 78.3 p -61.16 -42.87 99.34 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 119.277 -0.969 . . . . 0.0 108.589 -178.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.469 ' N ' ' HG ' ' A' ' 249' ' ' SER . 99.0 m-20 -143.83 160.56 40.55 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.699 0.762 . . . . 0.0 111.434 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 54.9 t -63.09 -44.42 99.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.933 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.76 -44.96 96.08 Favored 'General case' 0 CA--C 1.513 -0.475 0 C-N-CA 120.215 -0.594 . . . . 0.0 109.668 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -64.22 -41.36 97.06 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.361 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . 0.443 ' O ' HG21 ' A' ' 257' ' ' VAL . . . -64.83 -42.25 95.1 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.858 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . 0.498 HG13 HH11 ' B' ' 154' ' ' ARG . 68.3 t -64.03 -45.73 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-N 114.111 -1.404 . . . . 0.0 110.974 -178.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.62 -47.67 80.42 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.489 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . 0.5 ' O ' ' C ' ' A' ' 258' ' ' LEU . 24.7 m -66.58 -40.45 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 120.118 -0.633 . . . . 0.0 112.206 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.5 ' C ' ' O ' ' A' ' 257' ' ' VAL . 0.9 OUTLIER -29.36 -74.9 0.04 OUTLIER Pre-proline 0 CA--C 1.533 0.313 0 CA-C-O 119.472 -0.299 . . . . 0.0 111.253 -177.106 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' PRO . . . . . 0.496 ' CD ' ' CB ' ' A' ' 258' ' ' LEU . 40.3 Cg_endo -62.84 139.61 75.33 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 120.73 0.953 . . . . 0.0 111.884 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 96.5 mt -151.36 -23.55 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 O-C-N 123.327 0.392 . . . . 0.0 111.97 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 78.4 mtm . . . . . 0 C--O 1.218 -0.566 0 CA-C-O 118.125 -0.94 . . . . 0.0 110.637 -177.545 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.451 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.51 157.36 35.3 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 78.5 p -59.86 -22.13 61.89 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 123.339 0.399 . . . . 0.0 110.948 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -70.83 -61.58 1.71 Allowed 'General case' 0 N--CA 1.426 -1.633 0 O-C-N 121.946 -0.472 . . . . 0.0 111.133 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -67.54 -37.97 83.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.349 -0.842 . . . . 0.0 112.114 178.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' SER . . . . . 0.505 ' O ' ' HB3' ' B' ' 7' ' ' PHE . 63.9 m -59.63 -42.87 93.7 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.009 -177.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . 0.505 ' HB3' ' O ' ' B' ' 6' ' ' SER . 44.8 t80 85.13 86.82 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.754 0.659 . . . . 0.0 110.431 177.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . 0.613 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -61.0 -140.72 0.01 OUTLIER Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 -178.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . 0.613 ' HB ' ' O ' ' B' ' 8' ' ' GLY . 86.0 mt 83.62 109.81 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 122.438 0.295 . . . . 0.0 110.975 -178.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -62.3 -24.53 76.0 Favored 'Trans proline' 0 N--CA 1.499 1.852 0 C-N-CA 121.431 1.42 . . . . 0.0 111.714 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.62 -39.67 97.7 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -64.33 -40.03 95.07 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.66 0.743 . . . . 0.0 109.693 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 52.3 tp -62.28 -42.27 99.2 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.026 -178.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -64.64 -33.34 75.72 Favored 'General case' 0 CA--C 1.56 1.333 0 CA-C-O 121.585 0.707 . . . . 0.0 110.614 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 79.3 t -62.92 -46.24 96.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 113.136 -1.847 . . . . 0.0 111.08 177.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 95.5 mt -63.83 -43.96 98.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.422 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . 0.55 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 98.9 mttt -63.45 -41.99 98.65 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.94 -40.91 99.09 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 118.983 -1.087 . . . . 0.0 110.177 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.92 -38.39 85.6 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.82 -178.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 86.0 mt -64.0 -42.15 97.25 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.098 0.475 . . . . 0.0 110.222 176.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.27 -39.15 93.8 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.16 -179.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -58.04 -40.0 79.79 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 121.106 -0.237 . . . . 0.0 111.102 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 8.2 p -114.7 129.44 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.482 ' O ' ' HG3' ' B' ' 24' ' ' ARG . 34.5 ptt180 -70.94 106.65 3.72 Favored 'General case' 0 CA--C 1.527 0.079 0 CA-C-O 121.87 0.843 . . . . 0.0 112.527 -177.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.5 p -142.11 133.3 25.76 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.703 177.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . 0.453 ' O ' ' N ' ' B' ' 123' ' ' GLN . . . -88.45 97.79 2.35 Favored Glycine 0 N--CA 1.439 -1.135 0 C-N-CA 119.506 -1.33 . . . . 0.0 113.153 -176.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 45.9 t -125.3 129.08 73.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 174.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 27.5 m -138.11 155.96 30.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.821 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 94.8 mt -119.89 127.06 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 122.124 0.964 . . . . 0.0 111.181 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 23.7 p -106.71 157.99 17.3 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-N 112.654 -2.066 . . . . 0.0 108.628 -176.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.534 ' C ' ' OD1' ' B' ' 37' ' ' ASN . 46.1 t0 -126.78 101.36 26.77 Favored Pre-proline 0 C--O 1.239 0.515 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 -177.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.08 -20.7 67.81 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 121.714 1.609 . . . . 0.0 111.448 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.47 -43.29 99.12 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 120.575 -0.45 . . . . 0.0 109.865 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 91.8 mt -75.16 179.55 4.99 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.715 -0.616 . . . . 0.0 111.149 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . 0.656 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 42.5 tt0 -75.48 132.94 41.13 Favored 'General case' 0 C--N 1.342 0.245 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -178.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.5 ' O ' ' OD1' ' B' ' 36' ' ' ASP . 65.9 t0 56.21 37.11 28.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.757 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' ASN . . . . . 0.534 ' OD1' ' C ' ' B' ' 31' ' ' ASP . 13.2 t-20 30.11 70.48 0.59 Allowed Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.656 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 92.8 Cg_endo -72.82 156.26 52.99 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 123.401 2.734 . . . . 0.0 111.89 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 96.1 mt -89.28 129.48 40.19 Favored 'Isoleucine or valine' 0 C--O 1.246 0.881 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 35.1 m -108.63 -43.44 6.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 O-C-N 123.936 0.773 . . . . 0.0 112.585 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -96.05 124.86 40.23 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.45 -178.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 6.2 p -142.53 140.97 28.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.438 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . 0.605 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 56.4 p30 -101.32 160.98 13.95 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.111 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' GLN . . . . . 0.512 ' HA ' ' OE1' ' B' ' 44' ' ' GLN . 12.1 mm100 -63.0 -36.78 84.68 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.215 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.13 -27.75 65.51 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.605 ' HB2' ' OD1' ' B' ' 43' ' ' ASN . 66.8 t80 -60.32 -43.76 96.09 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.29 0.567 . . . . 0.0 109.601 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . 0.689 HG11 ' O ' ' B' ' 52' ' ' TYR . 53.6 t -61.42 -46.4 96.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.336 -178.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -63.4 -44.25 95.2 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.21 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 59.0 ttm -63.34 -42.51 98.93 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 36.1 p -93.33 -18.62 22.22 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 120.327 -0.549 . . . . 0.0 111.875 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' B' ' 47' ' ' VAL . . . 74.98 18.93 80.17 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 178.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . 0.689 ' O ' HG11 ' B' ' 47' ' ' VAL . 89.8 m-85 -112.59 146.04 39.29 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.149 0.58 . . . . 0.0 110.528 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -73.4 148.44 43.33 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.474 0.654 . . . . 0.0 111.316 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.82 -37.34 84.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.699 -177.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.81 -40.34 96.4 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.235 -0.586 . . . . 0.0 111.722 -178.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -71.62 -32.54 68.08 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 176.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 91.2 mt -66.63 -66.75 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . 0.25 97.0 mt -45.29 134.07 6.73 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.53 -9.95 73.4 Favored Glycine 0 CA--C 1.536 1.352 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.916 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -134.16 148.18 50.89 Favored 'General case' 0 C--N 1.342 0.263 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -174.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' ASN . . . . . 0.578 ' C ' ' H ' ' B' ' 63' ' ' ARG . 25.5 t-20 -79.39 151.18 31.09 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.446 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' CYS . . . . . . . . . . . . . 83.0 m -62.52 9.11 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.251 -178.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' ARG . . . . . 0.578 ' H ' ' C ' ' B' ' 61' ' ' ASN . 33.2 ptt-85 -59.89 -32.8 71.08 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.432 -177.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -60.14 -30.03 69.03 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 178.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 87.8 mt -62.2 -41.53 98.45 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 121.779 -0.575 . . . . 0.0 109.982 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -51.28 149.28 4.09 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.914 -176.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -159.84 -152.84 6.65 Favored Glycine 0 CA--C 1.537 1.426 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.944 177.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' LYS . . . . . 0.402 ' HB3' ' HH ' ' B' ' 95' ' ' TYR . 88.8 tttt -60.73 -41.75 95.93 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -175.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -74.94 -10.57 59.61 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.259 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 28.7 m -61.26 134.58 57.13 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 120.391 -0.524 . . . . 0.0 109.625 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -92.21 110.47 44.63 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.443 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.28 -38.35 88.52 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 121.023 1.149 . . . . 0.0 111.835 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.63 -39.73 89.32 Favored 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 120.451 -0.5 . . . . 0.0 109.697 -176.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' GLU . . . . . 0.472 ' OE1' ' HB ' ' B' ' 90' ' ' VAL . 79.1 mm-40 -66.52 -39.18 88.5 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.888 177.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -62.29 -45.58 98.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -63.12 -36.99 85.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.693 -177.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -62.43 -41.77 98.96 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 119.368 -0.933 . . . . 0.0 108.679 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 94.1 mt -63.47 -43.7 98.5 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-O 120.767 0.318 . . . . 0.0 110.508 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -61.96 -42.63 99.34 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 91.7 m -61.47 -45.14 95.51 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.966 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.82 -41.25 97.54 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -177.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 87.1 mt -62.98 -42.19 99.77 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.597 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 66.7 tp60 -62.85 -35.1 78.85 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . 0.416 ' O ' ' HG2' ' B' ' 86' ' ' GLU . 98.2 m-20 -92.1 6.35 46.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.594 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 30.2 tttt 42.99 40.19 2.1 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.414 -0.515 . . . . 0.0 111.823 175.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 86' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' B' ' 84' ' ' ASN . 54.6 mm-40 -122.46 141.59 35.23 Favored Pre-proline 0 N--CA 1.467 0.424 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.29 178.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 87' ' ' PRO . . . . . 0.436 ' HB3' ' OD1' ' B' ' 109' ' ' ASP . 25.6 Cg_exo -61.94 140.95 87.65 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.03 1.154 . . . . 0.0 113.716 -178.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.92 137.67 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.66 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 89' ' ' THR . . . . . 0.53 ' CG2' ' OD1' ' B' ' 107' ' ' ASN . 96.4 m -121.76 122.72 40.16 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . 0.472 ' HB ' ' OE1' ' B' ' 74' ' ' GLU . 31.1 m -138.87 162.81 28.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.892 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -114.15 121.59 44.24 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 175.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 20.6 tt -127.47 131.46 70.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.07 -175.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -70.13 139.95 52.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.763 177.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 94' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -129.44 178.86 6.15 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.626 0.727 . . . . 0.0 111.385 -177.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 95' ' ' TYR . . . . . 0.402 ' HH ' ' HB3' ' B' ' 68' ' ' LYS . 96.2 m-85 -130.43 142.42 50.5 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 114.335 -1.302 . . . . 0.0 112.173 178.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -100.47 177.68 4.96 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.129 0.49 . . . . 0.0 110.958 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.71 -35.09 75.44 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.777 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -85.95 -1.64 57.51 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 118.872 0.76 . . . . 0.0 112.709 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.42 3.23 65.06 Favored Glycine 0 N--CA 1.47 0.96 0 C-N-CA 121.15 -0.547 . . . . 0.0 112.495 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 27.3 m -67.44 129.21 39.19 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.665 178.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 101' ' ' MET . . . . . 0.514 ' C ' ' SD ' ' B' ' 101' ' ' MET . 16.9 tmm? -89.22 140.58 29.34 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 102' ' ' PHE . . . . . 0.481 ' N ' ' SD ' ' B' ' 101' ' ' MET . 52.8 p90 -151.66 161.89 41.92 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 103' ' ' TRP . . . . . 0.806 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 21.2 m95 -93.69 137.99 32.37 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.529 0.68 . . . . 0.0 110.813 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . 0.484 HD22 ' HG2' ' B' ' 123' ' ' GLN . 64.1 t-20 -133.0 106.97 7.97 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 114.74 -1.118 . . . . 0.0 113.461 -176.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 105' ' ' GLU . . . . . 0.441 ' O ' ' HA ' ' B' ' 123' ' ' GLN . 81.2 tt0 -75.09 125.04 28.09 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.75 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 40.0 tp -113.5 125.54 54.32 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.073 0.463 . . . . 0.0 112.072 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 107' ' ' ASN . . . . . 0.53 ' OD1' ' CG2' ' B' ' 89' ' ' THR . 98.0 m-20 -121.08 130.01 53.57 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.431 -0.804 . . . . 0.0 108.88 176.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 96.6 mt -123.8 132.81 70.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.699 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . 0.436 ' OD1' ' HB3' ' B' ' 87' ' ' PRO . 2.9 m-20 -142.77 120.18 7.07 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 178.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -67.97 152.05 77.26 Favored 'Trans proline' 0 N--CA 1.503 2.079 0 C-N-CA 122.632 2.221 . . . . 0.0 112.739 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 111' ' ' MET . . . . . 0.519 ' HB2' ' HB2' ' B' ' 118' ' ' TYR . 66.9 mtt -128.4 144.33 51.12 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -114.88 106.95 14.77 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . 0.642 HG12 ' HZ3' ' A' ' 18' ' ' LYS . 96.8 mt -132.88 128.18 56.51 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-N 118.428 0.558 . . . . 0.0 111.77 178.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 53.51 36.68 23.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.946 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 61.32 35.85 17.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.628 -178.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -132.85 149.99 52.2 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 7.1 t -99.83 153.2 19.33 Favored 'General case' 0 C--O 1.214 -0.766 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -177.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 118' ' ' TYR . . . . . 0.519 ' HB2' ' HB2' ' B' ' 111' ' ' MET . 89.9 m-85 -148.29 148.9 30.96 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 121.189 -0.945 . . . . 0.0 111.349 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -124.96 139.68 53.6 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 120.881 0.372 . . . . 0.0 111.181 -177.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -128.54 133.95 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -176.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.54 123.78 7.16 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.186 -0.765 . . . . 0.0 111.186 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 95.2 mt -116.38 127.66 73.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 123' ' ' GLN . . . . . 0.484 ' HG2' HD22 ' B' ' 104' ' ' ASN . 16.4 mp0 -118.47 123.9 46.29 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -121.53 119.56 32.33 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . 0.554 ' OD1' ' N ' ' B' ' 127' ' ' THR . 67.9 t0 -67.42 136.18 54.31 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.426 -178.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . 0.508 ' O ' ' HG3' ' B' ' 130' ' ' LYS . 2.7 mp -109.78 15.07 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.937 0 CA-C-O 122.174 0.988 . . . . 0.0 109.132 178.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 127' ' ' THR . . . . . 0.554 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 97.6 m -63.05 -43.8 97.61 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 113.827 -1.533 . . . . 0.0 112.347 176.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 59.8 tptt -61.26 -45.92 92.53 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -177.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 129' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -63.51 -33.92 76.63 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.47 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 130' ' ' LYS . . . . . 0.806 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 98.8 mttt -63.53 -41.35 98.47 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 113.589 -1.641 . . . . 0.0 110.856 174.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -64.44 -41.48 96.54 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 132' ' ' TYR . . . . . 0.435 ' CE2' HD13 ' B' ' 136' ' ' LEU . 90.8 t80 -60.17 -44.96 94.61 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 121.801 -0.562 . . . . 0.0 111.358 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' B' ' 137' ' ' GLU . 97.4 mt-10 -64.58 -36.25 83.63 Favored 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 134' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' B' ' 130' ' ' LYS . 98.7 mttt -63.21 -39.81 95.7 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.68 177.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 52.8 tp -62.84 -41.57 99.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.332 0.587 . . . . 0.0 109.743 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 136' ' ' LEU . . . . . 0.435 HD13 ' CE2' ' B' ' 132' ' ' TYR . 89.9 mt -62.86 -41.85 99.53 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.269 177.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 137' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' B' ' 133' ' ' GLU . 97.3 mt-10 -65.16 -37.25 86.8 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.302 -1.317 . . . . 0.0 110.441 -178.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -63.22 -43.48 97.99 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.899 176.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 69.7 m -60.8 -44.14 97.25 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 89.7 mt -61.64 -40.32 94.46 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -176.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 94.5 m -62.11 -45.26 94.27 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.827 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -66.09 -42.8 88.83 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 92.5 mt -63.8 -43.24 97.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.688 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 144' ' ' THR . . . . . . . . . . . . . 99.6 m -61.68 -45.04 95.69 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 -178.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . 0.444 ' O ' ' HB ' ' B' ' 148' ' ' THR . . . -63.27 -41.72 99.06 Favored 'General case' 0 C--O 1.227 -0.093 0 C-N-CA 118.952 -1.099 . . . . 0.0 109.346 178.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 86.1 mt -64.83 -41.18 95.94 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 176.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 147' ' ' SER . . . . . 0.595 ' O ' ' N ' ' B' ' 149' ' ' PRO . 78.2 p -62.06 -41.34 98.04 Favored 'General case' 0 CA--C 1.479 -1.769 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 148' ' ' THR . . . . . 0.482 ' C ' ' O ' ' B' ' 147' ' ' SER . 26.3 m -28.61 87.19 0.04 OUTLIER Pre-proline 0 N--CA 1.474 0.76 0 O-C-N 124.1 0.875 . . . . 0.0 109.874 176.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 149' ' ' PRO . . . . . 0.595 ' N ' ' O ' ' B' ' 147' ' ' SER . 23.8 Cg_exo -61.67 147.04 96.26 Favored 'Trans proline' 0 C--N 1.301 -1.95 0 C-N-CA 121.952 1.768 . . . . 0.0 114.942 -178.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 9.0 tp -127.73 121.98 57.89 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.533 0 CA-C-N 113.571 -1.65 . . . . 0.0 107.63 174.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 38.7 t -154.01 95.97 2.75 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.699 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -62.35 142.95 92.91 Favored 'Trans proline' 0 C--N 1.318 -1.046 0 N-CA-C 109.61 -0.958 . . . . 0.0 109.61 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 153' ' ' ILE . . . . . 0.424 ' O ' ' HD2' ' B' ' 154' ' ' ARG . 44.5 mm -77.21 -57.46 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.387 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 154' ' ' ARG . . . . . 0.619 ' HD3' ' NH2' ' A' ' 154' ' ' ARG . 1.2 tpt180 -141.53 -156.07 0.65 Allowed 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 61.0 t-20 -86.05 109.6 18.93 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.29 -16.72 59.59 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -178.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 86.7 mt -108.75 125.56 65.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-O 120.86 0.362 . . . . 0.0 110.994 -176.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 158' ' ' SER . . . . . 0.697 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 61.5 m -134.45 149.28 50.73 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.132 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -135.4 147.34 48.99 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.157 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 17.1 tp -140.09 79.55 21.95 Favored Pre-proline 0 CA--C 1.531 0.228 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 161' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -70.05 147.96 62.14 Favored 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 122.839 2.359 . . . . 0.0 114.099 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 91.6 mt -115.29 133.87 55.64 Favored 'General case' 0 C--N 1.342 0.239 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 53.9 t -128.17 132.94 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 114.79 169.71 16.26 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.56 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 165' ' ' ASN . . . . . 0.723 ' O ' ' CZ ' ' B' ' 170' ' ' ARG . 60.9 t30 -91.62 107.11 18.97 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -178.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 166' ' ' LEU . . . . . 0.505 HD13 HD11 ' B' ' 174' ' ' ILE . 47.7 tp -65.49 104.73 1.04 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -174.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 167' ' ' THR . . . . . 0.561 ' H ' ' HE ' ' B' ' 170' ' ' ARG . 11.2 p -83.88 169.92 14.6 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 114.103 -1.408 . . . . 0.0 110.797 177.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -66.32 -38.51 87.86 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.97 177.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.09 -40.0 90.45 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 123.427 1.584 . . . . 0.0 111.828 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 170' ' ' ARG . . . . . 0.723 ' CZ ' ' O ' ' B' ' 165' ' ' ASN . 88.2 mtm180 -62.3 -36.24 81.51 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 111.914 -2.403 . . . . 0.0 111.05 178.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 171' ' ' PHE . . . . . 0.442 ' CZ ' ' CD2' ' B' ' 166' ' ' LEU . 0.5 OUTLIER -53.82 -25.16 18.12 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -179.439 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 172' ' ' ASN . . . . . 0.554 ' O ' HG21 ' B' ' 175' ' ' VAL . 91.4 m-20 -62.68 -40.23 96.43 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.845 178.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 49.2 m -60.46 -41.82 94.9 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.729 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 174' ' ' ILE . . . . . 0.505 HD11 HD13 ' B' ' 166' ' ' LEU . 66.7 mt -63.92 -44.39 97.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 175' ' ' VAL . . . . . 0.554 HG21 ' O ' ' B' ' 172' ' ' ASN . 33.6 m -63.12 -40.59 89.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 176' ' ' CYS . . . . . . . . . . . . . 97.1 m -62.58 -35.05 78.29 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.344 178.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 177' ' ' THR . . . . . 0.514 ' O ' HG13 ' B' ' 181' ' ' ILE . 25.3 m -61.9 -19.54 62.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.24 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 178' ' ' LEU . . . . . . . . . . . . . 91.1 mt -61.16 -39.51 90.38 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.278 -177.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 19.3 m -61.04 -43.95 98.11 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.185 177.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 180' ' ' ASN . . . . . 0.616 ' O ' ' OG ' ' B' ' 183' ' ' SER . 91.4 m-20 -61.45 -39.94 92.65 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.9 0.381 . . . . 0.0 110.416 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . 0.514 HG13 ' O ' ' B' ' 177' ' ' THR . 71.8 mt -56.96 -34.44 44.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 O-C-N 122.221 -0.3 . . . . 0.0 110.626 -178.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 182' ' ' LEU . . . . . . . . . . . . . 85.3 mt -62.08 -41.59 98.34 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.11 178.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 183' ' ' SER . . . . . 0.616 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.1 p -63.3 -32.96 74.51 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 121.853 -0.53 . . . . 0.0 110.827 177.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 64.8 p -86.16 17.29 3.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.679 -177.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 78.1 p -61.27 -16.68 47.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.654 -177.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -61.79 -39.82 93.04 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.756 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 187' ' ' ASP . . . . . 0.697 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.1 m-20 -72.11 113.35 9.05 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.504 0.669 . . . . 0.0 110.496 -177.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -62.8 -42.22 99.62 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 114.83 -1.077 . . . . 0.0 113.119 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -110.47 130.52 55.54 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.034 -177.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 190' ' ' LEU . . . . . . . . . . . . . 41.1 tp -123.46 119.33 29.69 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.139 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 87.2 mt -107.44 126.86 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 117.796 0.271 . . . . 0.0 111.15 -176.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 49.2 mm -116.29 117.31 55.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 193' ' ' ASP . . . . . 0.449 ' CG ' ' HG ' ' B' ' 195' ' ' SER . 43.3 t0 -88.38 111.33 21.63 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -177.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 194' ' ' LEU . . . . . . . . . . . . . 98.1 mt -93.98 -2.74 52.66 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 176.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 195' ' ' SER . . . . . 0.449 ' HG ' ' CG ' ' B' ' 193' ' ' ASP . 78.2 p -61.35 -37.32 82.89 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.872 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.98 -34.01 87.49 Favored Glycine 0 N--CA 1.436 -1.312 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 197' ' ' LEU . . . . . 1.062 HD23 ' O ' ' B' ' 199' ' ' GLN . 5.2 tt -76.23 133.25 40.17 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -177.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 198' ' ' ALA . . . . . 0.614 ' N ' HD21 ' B' ' 197' ' ' LEU . . . -63.56 -41.26 98.42 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 119.979 -0.688 . . . . 0.0 111.935 -177.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 199' ' ' GLN . . . . . 1.062 ' O ' HD23 ' B' ' 197' ' ' LEU . 59.4 tt0 -140.96 164.23 30.82 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.446 0.641 . . . . 0.0 111.864 -179.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 200' ' ' VAL . . . . . 0.472 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 49.9 t -120.98 131.73 72.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 177.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -91.13 150.03 21.55 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.875 -177.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -60.5 -33.13 72.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.28 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -63.77 -33.81 76.49 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.465 0.65 . . . . 0.0 109.388 178.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.5 m -60.79 -43.93 97.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.246 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 205' ' ' ALA . . . . . 0.64 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -58.26 -30.44 66.57 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 111.79 0.292 . . . . 0.0 111.79 -177.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -65.42 -38.27 89.42 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.307 0.575 . . . . 0.0 109.932 176.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -66.39 -39.11 88.86 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.694 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.82 -43.26 97.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-O 121.688 0.756 . . . . 0.0 110.299 -178.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 209' ' ' PHE . . . . . 0.64 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 69.1 m-85 -61.95 -43.53 98.65 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 113.888 -1.505 . . . . 0.0 112.527 177.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.17 -41.77 99.28 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 119.584 -0.846 . . . . 0.0 110.046 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 211' ' ' LEU . . . . . 0.447 ' O ' ' HG ' ' B' ' 215' ' ' LEU . 37.8 mt -62.3 -42.07 99.05 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.221 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 78.2 p -63.52 -35.58 80.94 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.893 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 213' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -66.78 -46.95 73.67 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.362 -0.836 . . . . 0.0 112.141 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 52.8 tp -63.89 -42.9 97.36 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.864 0.84 . . . . 0.0 110.032 177.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 215' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' B' ' 211' ' ' LEU . 92.6 mt -63.08 -43.42 98.58 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 113.389 -1.732 . . . . 0.0 111.701 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.18 -39.41 92.57 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.913 -177.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.45 -42.3 98.64 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.322 0.582 . . . . 0.0 111.483 175.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 218' ' ' THR . . . . . . . . . . . . . 77.9 p -73.69 -15.92 61.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.716 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 78.91 63.88 2.02 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 107.051 -2.419 . . . . 0.0 107.051 -177.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 220' ' ' THR . . . . . . . . . . . . . 95.8 m -141.3 103.11 4.36 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 176.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -61.47 138.7 58.28 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.054 0.454 . . . . 0.0 110.952 -176.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 44.4 tp -115.67 121.85 43.79 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.679 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 3.2 mp -110.45 128.91 66.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.883 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 224' ' ' ILE . . . . . 0.41 HG23 HD11 ' B' ' 224' ' ' ILE . 49.6 mm -111.3 127.15 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 49.8 p -133.62 158.76 42.38 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.871 0.843 . . . . 0.0 112.709 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 89.47 16.4 57.07 Favored Glycine 0 CA--C 1.5 -0.896 0 CA-C-N 113.818 -1.537 . . . . 0.0 111.639 -177.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 95.5 mt -81.15 126.27 39.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 117.815 0.808 . . . . 0.0 111.498 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 55.4 tttt -66.19 141.2 97.24 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.341 -178.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.45 -37.56 94.75 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 121.491 1.461 . . . . 0.0 112.614 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -63.94 -43.55 95.5 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -178.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 51.8 tp -62.05 -41.58 98.28 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.159 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.72 -37.01 85.76 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.749 0.309 . . . . 0.0 111.362 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 94.5 mtp -64.01 -40.89 97.35 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.805 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.7 -42.55 99.69 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-O 122.422 1.106 . . . . 0.0 109.467 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 35.2 mmt -63.98 -36.61 84.53 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 114.322 -1.308 . . . . 0.0 111.862 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -61.96 -40.46 95.64 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.002 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.28 -43.91 96.59 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 120.679 -0.409 . . . . 0.0 110.057 177.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.29 -44.42 96.55 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.71 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 239' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' B' ' 240' ' ' ALA . 67.0 t0 -159.1 133.08 7.57 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.324 -0.551 . . . . 0.0 112.104 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 240' ' ' ALA . . . . . 0.418 ' N ' ' OD1' ' B' ' 239' ' ' ASP . . . -62.51 -44.75 95.6 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 176.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 241' ' ' ASN . . . . . 0.497 ' O ' ' HB2' ' B' ' 244' ' ' SER . 92.1 m-20 -45.52 -22.61 0.16 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.046 -175.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 242' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -60.81 -45.43 94.46 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 119.888 -0.725 . . . . 0.0 110.39 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 243' ' ' SER . . . . . . . . . . . . . 77.5 p -57.89 -42.21 84.15 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 244' ' ' SER . . . . . 0.497 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 19.7 m -35.1 -34.46 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 -178.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 96.6 mt -87.74 134.2 33.71 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.567 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -58.85 135.53 57.55 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-O 121.427 0.632 . . . . 0.0 110.75 -177.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 247' ' ' THR . . . . . . . . . . . . . 95.8 m -125.91 127.51 46.12 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.722 177.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -113.8 142.56 45.91 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 249' ' ' SER . . . . . 0.604 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 78.4 p -63.12 -34.08 76.84 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.339 -178.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 250' ' ' ASN . . . . . 0.604 ' OD1' ' O ' ' B' ' 249' ' ' SER . 99.2 m-20 -147.94 159.55 43.75 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.199 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 58.0 t -64.23 -44.39 97.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.885 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 252' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.94 -46.74 89.5 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -177.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -61.74 -43.11 99.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.654 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 254' ' ' ALA . . . . . 0.43 ' O ' HG21 ' B' ' 257' ' ' VAL . . . -64.87 -40.57 95.33 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.18 178.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 255' ' ' VAL . . . . . 0.577 HG12 ' O ' ' A' ' 153' ' ' ILE . 67.8 t -64.69 -45.72 94.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.506 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -63.26 -48.21 79.14 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.226 -178.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 257' ' ' VAL . . . . . 0.48 ' O ' ' C ' ' B' ' 258' ' ' LEU . 22.6 m -65.2 -40.31 88.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.594 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 258' ' ' LEU . . . . . 0.515 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 0.9 OUTLIER -31.8 -73.96 0.05 OUTLIER Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.592 -178.359 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 259' ' ' PRO . . . . . 0.515 ' CD ' ' CB ' ' B' ' 258' ' ' LEU . 35.5 Cg_endo -61.75 141.31 90.05 Favored 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 121.51 1.474 . . . . 0.0 111.196 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 260' ' ' ILE . . . . . 0.489 HG13 ' O ' ' B' ' 259' ' ' PRO . 96.8 mt -158.44 -12.57 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-N 118.591 0.632 . . . . 0.0 112.121 177.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 78.3 mtm . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 117.99 -1.005 . . . . 0.0 111.583 179.921 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.427 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.76 179.25 8.68 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-O 121.57 0.7 . . . . 0.0 109.518 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 97.2 p -82.62 -2.18 53.11 Favored 'General case' 0 C--N 1.39 2.337 0 O-C-N 118.151 -2.843 . . . . 0.0 112.853 176.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -87.35 -64.15 1.19 Allowed 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.141 -1.391 . . . . 0.0 112.32 175.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -68.73 -39.23 80.49 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 178.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.497 ' O ' ' CB ' ' A' ' 7' ' ' PHE . 57.0 m -58.94 -42.13 89.04 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.923 -177.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.497 ' CB ' ' O ' ' A' ' 6' ' ' SER . 33.0 t80 86.38 87.59 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 O-C-N 123.816 0.697 . . . . 0.0 111.567 176.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.526 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -60.59 -143.21 0.01 OUTLIER Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.526 ' HB ' ' O ' ' A' ' 8' ' ' GLY . 65.3 mt 84.22 110.46 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.65 0 C-N-CA 122.881 0.472 . . . . 0.0 110.584 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.94 -22.44 68.47 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 121.354 1.369 . . . . 0.0 112.18 -179.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.88 -37.29 94.44 Favored Glycine 0 C--O 1.247 0.921 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.07 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -65.04 -39.04 92.77 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.349 0.595 . . . . 0.0 109.745 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.8 tp -63.29 -41.95 99.02 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -62.32 -39.54 93.37 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 68.5 t -61.08 -43.97 97.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 O-C-N 122.02 -0.425 . . . . 0.0 111.066 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 95.4 mt -62.21 -43.28 97.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.213 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.96 -45.03 94.39 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 119.394 -0.923 . . . . 0.0 111.877 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.792 ' HZ3' HG12 ' B' ' 113' ' ' ILE . 98.5 mttt -61.05 -39.42 89.77 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 118.666 -1.214 . . . . 0.0 108.612 -175.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.35 -42.88 92.6 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 119.941 -0.703 . . . . 0.0 110.262 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.0 mt -63.1 -40.77 98.62 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -62.86 -38.9 92.7 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.491 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 57.5 m170 -58.88 -39.5 81.58 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 122.16 -0.337 . . . . 0.0 111.501 -178.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.3 p -114.82 130.36 69.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.438 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 31.6 ptt180 -72.9 110.15 6.99 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 121.939 0.876 . . . . 0.0 112.178 -177.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.5 p -140.96 143.3 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 177.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 123' ' ' GLN . . . -97.81 92.56 1.29 Allowed Glycine 0 C--N 1.312 -0.758 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.777 -178.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 52.0 t -124.79 129.98 73.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 175.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.8 m -136.92 159.24 37.01 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.5 mt -119.46 128.89 75.86 Favored 'Isoleucine or valine' 0 C--O 1.245 0.855 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 176.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.413 ' OG1' ' HB2' ' A' ' 119' ' ' PHE . 24.3 p -101.83 167.22 10.22 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 177.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.401 ' C ' ' OD1' ' A' ' 37' ' ' ASN . 53.1 t0 -133.82 101.86 12.64 Favored Pre-proline 0 C--O 1.222 -0.37 0 C-N-CA 120.314 -0.554 . . . . 0.0 109.872 178.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.57 -21.04 65.99 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 121.431 1.421 . . . . 0.0 111.501 -178.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.67 -29.72 70.85 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.316 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 91.4 mt -89.79 -178.87 5.61 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.865 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.632 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 42.1 tt0 -76.3 130.25 37.85 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -177.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.515 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 58.3 t0 63.11 22.04 13.2 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 177.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.401 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 29.7 t-20 42.3 68.03 2.99 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.996 -177.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.632 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 89.6 Cg_endo -71.36 157.17 57.38 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 124.085 3.19 . . . . 0.0 112.042 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 95.9 mt -89.84 123.61 42.12 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.453 HG21 ' N ' ' A' ' 41' ' ' TYR . 28.5 m -103.95 -43.14 8.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.1 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.453 ' N ' HG21 ' A' ' 40' ' ' VAL . 46.3 t80 -96.34 123.61 40.04 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.733 -178.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.5 p -142.87 140.29 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 O-C-N 124.356 1.035 . . . . 0.0 109.229 177.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.579 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 57.7 p30 -96.49 166.13 11.84 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.46 ' HA ' ' OE1' ' A' ' 44' ' ' GLN . 14.0 mm100 -66.15 -39.84 90.11 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 177.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.98 -25.44 61.87 Favored Glycine 0 C--O 1.237 0.294 0 N-CA-C 110.389 -1.085 . . . . 0.0 110.389 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.579 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 67.4 t80 -59.0 -47.51 84.93 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 105.863 -1.902 . . . . 0.0 105.863 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.463 ' O ' ' N ' ' A' ' 51' ' ' GLY . 53.6 t -60.04 -44.38 94.7 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 O-C-N 121.161 -0.962 . . . . 0.0 111.498 -174.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -62.44 -37.56 86.35 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 120.488 -0.485 . . . . 0.0 112.264 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 59.4 ttm -66.97 -43.64 82.55 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 176.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 34.8 p -93.48 -20.82 19.92 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.138 0.494 . . . . 0.0 111.287 -177.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . 77.82 19.44 75.47 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.462 ' O ' HG11 ' A' ' 47' ' ' VAL . 78.0 m-85 -111.79 138.79 47.9 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 122.579 0.351 . . . . 0.0 110.984 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -64.64 149.14 49.52 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.491 0.662 . . . . 0.0 109.495 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.85 -32.44 73.95 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.43 -42.34 83.33 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 119.381 -0.928 . . . . 0.0 111.382 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -64.65 -44.65 89.76 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.429 HG22 HD13 ' A' ' 57' ' ' ILE . 95.3 mt -63.76 -45.9 95.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -174.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 83.8 mt -61.09 144.7 53.05 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.14 -5.99 73.83 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.353 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -134.49 151.28 51.03 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 119.222 1.511 . . . . 0.0 112.011 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.561 ' C ' ' H ' ' A' ' 63' ' ' ARG . 25.0 t-20 -81.45 152.2 27.5 Favored 'General case' 0 N--CA 1.453 -0.316 0 O-C-N 121.882 -0.511 . . . . 0.0 110.509 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 86.0 m -63.16 15.78 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.353 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.561 ' H ' ' C ' ' A' ' 61' ' ' ASN . 35.2 ptt-85 -61.12 -42.02 97.78 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.077 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -55.65 -21.74 19.45 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -178.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.6 mt -67.44 -35.48 79.32 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 122.241 1.02 . . . . 0.0 112.864 176.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -65.65 133.3 50.83 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.753 -176.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.533 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -143.69 -148.57 4.92 Favored Glycine 0 CA--C 1.543 1.832 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -178.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.58 ' HB3' ' HH ' ' A' ' 95' ' ' TYR . 88.6 tttt -62.86 -41.11 99.25 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -177.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.444 ' O ' ' OE1' ' A' ' 93' ' ' GLN . 17.2 m-70 -75.93 -9.79 58.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.834 0.349 . . . . 0.0 110.852 -177.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.533 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 28.5 m -60.93 130.12 44.87 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.603 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -87.54 111.09 39.36 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.713 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -57.55 -31.68 92.27 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.018 1.812 . . . . 0.0 112.99 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.7 -40.26 96.34 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.951 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.415 ' OE1' ' HB ' ' A' ' 90' ' ' VAL . 79.2 mm-40 -65.6 -43.61 89.12 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.3 t -60.4 -43.13 93.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -63.67 -37.96 89.33 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 124.07 0.856 . . . . 0.0 112.007 178.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -63.31 -39.69 95.25 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.37 0.605 . . . . 0.0 110.544 178.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.1 mt -64.1 -43.79 97.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.367 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -62.65 -43.07 99.74 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 113.653 -1.612 . . . . 0.0 108.473 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 93.8 m -60.82 -49.11 78.8 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.25 -42.46 95.34 Favored 'General case' 0 C--N 1.363 1.189 0 O-C-N 123.754 0.659 . . . . 0.0 110.782 -171.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 87.4 mt -63.01 -40.94 99.26 Favored 'General case' 0 CA--C 1.514 -0.409 0 O-C-N 120.184 -1.573 . . . . 0.0 111.692 -178.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -63.42 -41.07 98.69 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -70.55 -23.35 62.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.197 177.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 49.5 tttt 63.34 46.53 4.38 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.614 -176.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -130.71 148.32 69.65 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -62.08 142.94 94.12 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 121.441 1.427 . . . . 0.0 113.493 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.09 141.43 33.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.325 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.498 ' CG2' ' OD1' ' A' ' 107' ' ' ASN . 96.6 m -126.7 119.17 26.3 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 175.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.415 ' HB ' ' OE1' ' A' ' 74' ' ' GLU . 30.1 m -138.59 157.17 30.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 121.203 -0.199 . . . . 0.0 111.413 178.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -103.8 127.3 51.3 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 177.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.8 tt -135.74 131.45 50.45 Favored 'Isoleucine or valine' 0 C--N 1.372 1.567 0 CA-C-N 121.716 2.053 . . . . 0.0 112.606 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.444 ' OE1' ' O ' ' A' ' 69' ' ' HIS . 87.5 mt-30 -63.69 135.87 57.05 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.952 -179.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -137.97 162.25 34.56 Favored 'General case' 0 C--N 1.349 0.55 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.923 -177.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.58 ' HH ' ' HB3' ' A' ' 68' ' ' LYS . 92.3 m-85 -121.38 138.3 54.32 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -178.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.425 ' HG3' ' CE1' ' A' ' 102' ' ' PHE . 99.2 mttt -86.71 -171.06 3.35 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.078 0.466 . . . . 0.0 111.525 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.69 -42.05 99.43 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.396 178.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 39.7 p-10 -85.49 7.61 22.23 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -177.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.48 -1.18 88.45 Favored Glycine 0 N--CA 1.471 0.983 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.146 177.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 23.4 m -60.06 137.63 58.05 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.678 ' C ' ' SD ' ' A' ' 101' ' ' MET . 14.1 tmm? -104.98 129.39 53.42 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 120.746 0.308 . . . . 0.0 111.231 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.472 ' N ' ' SD ' ' A' ' 101' ' ' MET . 53.5 p90 -141.12 158.97 43.19 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.927 -177.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.837 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 21.0 m95 -90.54 143.97 26.23 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -138.46 103.54 4.91 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -176.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -70.56 135.12 48.26 Favored 'General case' 0 N--CA 1.436 -1.15 0 O-C-N 120.974 -1.079 . . . . 0.0 108.16 -176.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 38.8 tp -120.16 123.61 43.73 Favored 'General case' 0 C--O 1.234 0.285 0 O-C-N 124.07 0.856 . . . . 0.0 112.662 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.498 ' OD1' ' CG2' ' A' ' 89' ' ' THR . 98.1 m-20 -119.55 123.0 42.87 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.96 177.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 96.4 mt -120.9 128.46 76.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 O-C-N 123.575 0.547 . . . . 0.0 111.496 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -137.33 126.81 15.32 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.819 -0.173 . . . . 0.0 111.003 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -70.73 151.45 63.57 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.162 1.908 . . . . 0.0 112.413 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.576 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 67.2 mtt -123.36 151.5 42.46 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -126.86 96.96 4.8 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 176.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.418 HD11 HG22 ' A' ' 113' ' ' ILE . 96.2 mt -121.02 131.56 72.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.035 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 50.27 37.46 15.1 Favored 'General case' 0 CA--C 1.515 -0.375 0 O-C-N 121.105 -0.997 . . . . 0.0 111.365 176.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 59.93 31.82 20.88 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 123.939 0.774 . . . . 0.0 110.994 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -128.71 147.95 50.8 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.705 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 3.6 t -84.3 -175.51 5.83 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-O 118.769 -0.634 . . . . 0.0 109.434 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.705 ' CD2' ' O ' ' A' ' 117' ' ' THR . 70.1 m-85 -169.1 156.04 6.94 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 173.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.413 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 86.0 m-85 -129.32 147.83 51.19 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 173.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.7 p -137.33 137.31 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -111.97 130.29 9.56 Favored Glycine 0 CA--C 1.504 -0.644 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 178.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 97.0 mt -117.65 129.54 73.93 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 177.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.52 ' N ' ' O ' ' A' ' 26' ' ' GLY . 17.9 mp0 -118.81 117.0 27.7 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.223 0.535 . . . . 0.0 109.833 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -117.99 114.97 23.96 Favored 'General case' 0 C--O 1.254 1.329 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.813 -178.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.477 ' OD1' ' OG1' ' A' ' 127' ' ' THR . 67.4 t0 -67.72 121.97 17.09 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -175.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 3.6 mp -85.4 1.07 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 113.778 -1.556 . . . . 0.0 110.299 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.477 ' OG1' ' OD1' ' A' ' 125' ' ' ASP . 27.5 m -59.43 -42.58 92.21 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.186 -0.946 . . . . 0.0 112.937 -177.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -58.87 -42.31 89.13 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 -178.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -63.23 -39.47 94.7 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.445 177.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.837 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.8 mttt -62.41 -40.76 97.58 Favored 'General case' 0 C--O 1.214 -0.771 0 O-C-N 120.504 -1.372 . . . . 0.0 110.084 -178.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.72 -37.41 86.41 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.752 0.658 . . . . 0.0 109.49 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.472 ' CE2' HD13 ' A' ' 136' ' ' LEU . 88.2 t80 -61.45 -45.9 92.33 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.408 176.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.34 -38.45 91.07 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.67 -40.31 96.66 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 52.2 tp -60.97 -43.35 98.91 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -177.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.472 HD13 ' CE2' ' A' ' 132' ' ' TYR . 85.3 mt -62.8 -41.27 99.21 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.827 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.97 -41.87 98.5 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 119.668 -0.813 . . . . 0.0 109.691 -178.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -60.14 -43.06 96.0 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -177.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 54.7 m -61.61 -41.41 97.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.731 176.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.457 ' O ' ' N ' ' A' ' 144' ' ' THR . 85.8 mt -63.07 -41.69 99.5 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 121.933 -0.48 . . . . 0.0 109.963 178.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 78.6 m -61.61 -45.42 94.17 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.514 -177.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -65.13 -39.99 93.83 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 95.2 mt -64.59 -43.18 96.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 113.873 -1.512 . . . . 0.0 111.232 176.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.457 ' N ' ' O ' ' A' ' 140' ' ' LEU . 89.3 m -62.18 -46.07 90.59 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 120.37 -0.532 . . . . 0.0 112.285 -178.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.34 -40.62 96.98 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 118.851 -1.14 . . . . 0.0 109.064 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.7 mt -63.44 -42.63 98.66 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.491 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.715 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.4 p -60.7 -36.42 78.75 Favored 'General case' 0 C--O 1.214 -0.803 0 C-N-CA 119.332 -0.947 . . . . 0.0 109.294 -177.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.438 ' C ' ' O ' ' A' ' 147' ' ' SER . 41.9 m -31.67 81.57 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.507 0 O-C-N 127.041 2.713 . . . . 0.0 105.823 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.715 ' N ' ' O ' ' A' ' 147' ' ' SER . 19.4 Cg_exo -62.51 142.07 88.84 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 CA-C-O 123.088 1.203 . . . . 0.0 114.601 -174.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.526 ' O ' ' CG2' ' A' ' 151' ' ' VAL . 9.0 tp -115.91 136.3 53.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 102.603 -3.11 . . . . 0.0 102.603 175.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' A' ' 150' ' ' ILE . 82.2 t -168.46 90.5 0.64 Allowed Pre-proline 0 CA--C 1.505 -0.771 0 N-CA-C 106.001 -1.851 . . . . 0.0 106.001 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.2 135.58 55.3 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 N-CA-C 109.678 -0.931 . . . . 0.0 109.678 -177.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.563 ' O ' ' HD2' ' A' ' 154' ' ' ARG . 44.5 mm -67.45 -44.76 86.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 119.682 -0.807 . . . . 0.0 111.109 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.657 HH11 HG13 ' B' ' 255' ' ' VAL . 0.4 OUTLIER -157.31 -156.29 0.58 Allowed 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.864 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -86.51 104.89 16.39 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.469 0.652 . . . . 0.0 111.619 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 88.56 7.96 71.22 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 114.121 -1.4 . . . . 0.0 110.245 -178.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.1 mt -123.52 123.71 67.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 174.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.612 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 69.4 m -132.38 152.57 51.4 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -137.51 143.4 41.66 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.492 177.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 16.3 tp -133.68 78.33 61.81 Favored Pre-proline 0 N--CA 1.465 0.295 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.328 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -69.2 150.19 71.33 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.68 2.253 . . . . 0.0 113.227 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 90.4 mt -118.48 125.99 51.07 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.12 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 51.4 t -122.95 131.57 73.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 117.29 168.63 14.72 Favored Glycine 0 N--CA 1.481 1.683 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.347 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.864 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 56.1 t30 -85.32 114.13 22.16 Favored 'General case' 0 C--O 1.201 -1.48 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -178.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.535 ' CD2' ' CZ ' ' A' ' 171' ' ' PHE . 48.2 tp -73.92 102.45 4.11 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -177.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.585 ' H ' ' HE ' ' A' ' 170' ' ' ARG . 10.5 p -85.49 167.69 15.23 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.446 178.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.91 -34.93 79.27 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.955 0.407 . . . . 0.0 111.894 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.15 -46.66 86.15 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.499 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.864 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 87.6 mtm180 -61.6 -31.74 71.82 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.796 177.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.535 ' CZ ' ' CD2' ' A' ' 166' ' ' LEU . 0.4 OUTLIER -54.97 -28.28 50.41 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -177.53 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.529 ' O ' HG21 ' A' ' 175' ' ' VAL . 92.6 m-20 -60.8 -40.45 92.74 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 119.045 -1.062 . . . . 0.0 110.01 -178.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 58.7 m -59.42 -40.56 87.09 Favored 'General case' 0 C--N 1.322 -0.611 0 O-C-N 121.762 -0.586 . . . . 0.0 110.638 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 67.9 mt -63.66 -44.14 98.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.529 HG21 ' O ' ' A' ' 172' ' ' ASN . 35.2 m -62.29 -40.05 86.38 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . 0.486 ' N ' HG23 ' A' ' 175' ' ' VAL . 96.6 m -62.05 -35.24 78.02 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.318 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' THR . . . . . 0.504 ' O ' HG13 ' A' ' 181' ' ' ILE . 24.9 m -61.48 -19.84 62.48 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.283 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 87.6 mt -60.82 -40.82 94.16 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -177.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 18.5 m -59.48 -43.75 93.19 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.594 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . 0.636 ' O ' ' OG ' ' A' ' 183' ' ' SER . 93.2 m-20 -61.1 -37.5 82.97 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.053 0.454 . . . . 0.0 111.059 178.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 177' ' ' THR . 66.8 mt -57.51 -39.01 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 O-C-N 121.401 -0.812 . . . . 0.0 109.165 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 87.3 mt -60.81 -40.47 92.82 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 119.439 -0.904 . . . . 0.0 108.625 -177.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.636 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 78.0 p -61.48 -34.0 74.72 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.727 176.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 53.0 p -90.45 23.58 2.93 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 122.226 -0.296 . . . . 0.0 111.514 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 78.2 p -63.04 -20.15 65.06 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.644 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.07 -36.2 79.0 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.865 -178.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.612 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 98.7 m-20 -72.55 114.0 10.2 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.568 0.699 . . . . 0.0 110.963 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -62.8 -42.48 99.73 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.919 -177.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -113.26 132.17 55.64 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.104 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 38.1 tp -120.6 128.93 53.5 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 96.4 mt -116.24 127.05 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 O-C-N 121.751 -0.593 . . . . 0.0 109.459 177.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.9 mm -113.08 126.35 70.48 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . 0.565 ' CG ' ' HG ' ' A' ' 195' ' ' SER . 40.2 t0 -95.25 120.34 35.32 Favored 'General case' 0 CA--C 1.551 1.017 0 O-C-N 121.662 -0.648 . . . . 0.0 110.48 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 96.2 mt -101.01 -2.8 30.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.891 176.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' SER . . . . . 0.565 ' HG ' ' CG ' ' A' ' 193' ' ' ASP . 78.3 p -63.31 -32.32 73.71 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.85 -47.15 92.02 Favored Glycine 0 CA--C 1.54 1.61 0 N-CA-C 108.171 -1.972 . . . . 0.0 108.171 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 1.089 HD23 ' O ' ' A' ' 199' ' ' GLN . 4.9 tt -66.02 129.82 41.12 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 112.873 -1.664 . . . . 0.0 108.755 -177.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.621 ' N ' HD21 ' A' ' 197' ' ' LEU . . . -60.79 -50.98 71.26 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-O 121.417 0.627 . . . . 0.0 110.931 -179.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 1.089 ' O ' HD23 ' A' ' 197' ' ' LEU . 58.6 tt0 -132.76 156.78 46.46 Favored 'General case' 0 C--O 1.21 -1.017 0 CA-C-N 114.728 -1.124 . . . . 0.0 114.016 -174.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.459 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 46.1 t -117.83 130.69 72.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 O-C-N 120.424 -1.423 . . . . 0.0 108.425 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -83.76 155.86 22.84 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.237 -178.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -64.79 -39.48 93.67 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.988 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -57.24 -31.4 65.5 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 -178.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.8 m -61.42 -42.74 99.22 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.709 178.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.449 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -56.44 -39.06 72.47 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -177.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -61.26 -38.09 85.46 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 121.776 -0.578 . . . . 0.0 110.087 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -64.57 -38.87 92.52 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.916 177.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.02 -44.88 99.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . 0.449 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 67.2 m-85 -61.04 -43.82 98.31 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.009 -177.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.97 -41.59 98.18 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 118.998 -1.081 . . . . 0.0 109.202 -178.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.42 ' O ' ' HG ' ' A' ' 215' ' ' LEU . 38.8 mt -62.39 -42.18 99.23 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' SER . . . . . 0.448 ' HG ' ' N ' ' A' ' 213' ' ' HIS . 78.0 p -61.04 -42.45 98.5 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.463 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' HIS . . . . . 0.448 ' N ' ' HG ' ' A' ' 212' ' ' SER . 58.5 t-80 -64.93 -45.72 84.64 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 122.034 -0.416 . . . . 0.0 111.728 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 50.3 tp -62.41 -45.93 90.88 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 119.021 -1.071 . . . . 0.0 108.15 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 211' ' ' LEU . 89.4 mt -62.84 -41.19 99.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.401 -177.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.03 -44.44 94.63 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.601 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 82.6 mt -61.93 -40.54 95.85 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 68.9 p -75.44 -11.72 60.1 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.241 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.96 40.17 9.6 Favored Glycine 0 C--O 1.217 -0.913 0 C-N-CA 120.617 -0.801 . . . . 0.0 113.863 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 99.9 m -125.99 115.03 19.26 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 119.104 1.452 . . . . 0.0 112.36 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -66.4 136.11 55.28 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.147 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 41.7 tp -111.97 128.69 56.24 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 2.8 mp -116.35 132.61 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.447 HG23 HD11 ' A' ' 224' ' ' ILE . 49.7 mm -114.35 131.39 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 39.7 p -133.38 165.75 24.12 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 120.766 -0.373 . . . . 0.0 111.583 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 79.35 20.35 69.62 Favored Glycine 0 C--O 1.224 -0.508 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 178.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 97.3 mt -81.83 128.83 38.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 113.692 -1.254 . . . . 0.0 108.124 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 66.0 tttt -75.89 139.96 70.21 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.47 -38.23 89.79 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 121.108 1.205 . . . . 0.0 112.453 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -64.94 -39.23 93.19 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-O 121.29 0.566 . . . . 0.0 110.268 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 53.3 tp -63.57 -43.11 97.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.915 -1.039 . . . . 0.0 112.753 177.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.66 -37.66 88.19 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 121.96 -0.463 . . . . 0.0 111.175 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 93.7 mtp -63.2 -40.47 97.6 Favored 'General case' 0 C--O 1.251 1.16 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.704 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -64.32 -39.29 93.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.758 176.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 30.1 mmt -65.45 -37.72 87.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.746 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -60.8 -41.02 94.81 Favored 'General case' 0 CA--C 1.513 -0.447 0 O-C-N 121.48 -0.763 . . . . 0.0 109.491 -176.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.71 -39.9 93.14 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.355 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 52.7 tp -63.18 -42.05 99.3 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 176.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -168.89 128.19 1.08 Allowed 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 121.404 0.621 . . . . 0.0 112.559 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -60.22 -28.02 67.67 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.821 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -61.16 -27.56 68.49 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.674 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -56.42 -43.73 79.66 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -176.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 96.6 p -63.2 -20.84 65.79 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 124.108 0.88 . . . . 0.0 111.298 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 41.7 m -55.25 -34.25 63.85 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 122.056 -0.403 . . . . 0.0 111.763 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 94.3 mt -89.76 121.6 32.07 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -46.1 134.77 8.12 Favored 'General case' 0 C--O 1.248 0.986 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.615 -177.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 97.8 m -126.48 132.8 51.35 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 114.605 -1.18 . . . . 0.0 110.968 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -117.51 139.49 50.86 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.788 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' SER . . . . . 0.462 ' HG ' ' N ' ' A' ' 250' ' ' ASN . 78.3 p -60.68 -42.58 97.38 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -178.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.462 ' N ' ' HG ' ' A' ' 249' ' ' SER . 98.9 m-20 -143.74 160.75 40.17 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.606 0.717 . . . . 0.0 111.651 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.02 -44.79 99.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 114.725 -1.125 . . . . 0.0 112.301 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.89 -44.67 96.78 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -178.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -62.75 -44.38 96.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.599 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -63.59 -42.45 98.28 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.975 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . 0.597 HG13 HH11 ' B' ' 154' ' ' ARG . 66.8 t -63.86 -45.41 97.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-N 114.051 -1.431 . . . . 0.0 110.798 -178.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.77 -47.09 82.36 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.846 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . 0.498 ' O ' ' C ' ' A' ' 258' ' ' LEU . 22.5 m -67.51 -41.09 85.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 O-C-N 121.453 -0.779 . . . . 0.0 112.034 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.498 ' C ' ' O ' ' A' ' 257' ' ' VAL . 1.1 mt -28.17 -74.84 0.04 OUTLIER Pre-proline 0 C--O 1.234 0.265 0 CA-C-O 119.518 -0.277 . . . . 0.0 111.542 -177.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 258' ' ' LEU . 39.9 Cg_endo -62.85 139.84 76.55 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 120.833 1.022 . . . . 0.0 111.934 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 96.6 mt -151.8 -27.17 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 O-C-N 123.779 0.675 . . . . 0.0 111.981 178.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 C--O 1.216 -0.683 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.782 -177.262 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.58 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -165.18 170.26 15.11 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 84.2 p -66.82 -16.71 64.46 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -79.85 -64.21 1.24 Allowed 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.103 -177.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -66.4 -39.81 89.24 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.302 -0.863 . . . . 0.0 113.073 178.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' SER . . . . . 0.495 ' O ' ' CB ' ' B' ' 7' ' ' PHE . 58.9 m -59.25 -42.44 91.14 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 -178.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . 0.495 ' CB ' ' O ' ' B' ' 6' ' ' SER . 32.8 t80 87.01 90.96 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.742 0.651 . . . . 0.0 110.697 177.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . 0.524 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -63.27 -142.77 0.01 OUTLIER Glycine 0 C--N 1.339 0.727 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . 0.524 ' HB ' ' O ' ' B' ' 8' ' ' GLY . 64.7 mt 83.88 110.38 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 122.773 0.429 . . . . 0.0 110.784 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -63.15 -23.61 73.08 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 C-N-CA 121.249 1.299 . . . . 0.0 111.812 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.24 -38.81 96.82 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -64.99 -39.07 92.92 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.473 0.654 . . . . 0.0 109.551 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 49.8 tp -61.95 -43.0 99.74 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.507 -177.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -64.45 -31.78 73.14 Favored 'General case' 0 CA--C 1.559 1.317 0 CA-C-O 121.358 0.599 . . . . 0.0 110.614 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 74.6 t -63.27 -46.19 96.31 Favored 'Isoleucine or valine' 0 C--O 1.249 1.053 0 CA-C-N 113.179 -1.828 . . . . 0.0 111.198 177.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.82 -43.69 97.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.795 -178.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . 0.423 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 98.9 mttt -63.31 -42.53 99.04 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.88 -40.54 97.83 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 118.991 -1.084 . . . . 0.0 109.964 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.87 -39.62 89.86 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.018 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 87.6 mt -63.81 -41.93 97.78 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.276 0.56 . . . . 0.0 110.33 175.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -62.87 -39.01 93.12 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.798 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 56.4 m170 -58.2 -39.68 79.62 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 121.086 -0.246 . . . . 0.0 111.521 -178.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 13.6 p -114.71 130.11 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.454 ' O ' ' HG3' ' B' ' 24' ' ' ARG . 31.6 ptt180 -72.43 108.17 5.38 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.687 0.755 . . . . 0.0 112.582 -177.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.0 p -142.6 134.22 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.731 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . 0.569 ' O ' ' N ' ' B' ' 123' ' ' GLN . . . -88.25 96.99 2.25 Favored Glycine 0 C--N 1.31 -0.913 0 C-N-CA 119.655 -1.26 . . . . 0.0 113.43 -176.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 48.5 t -125.74 129.19 72.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 174.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 30.2 m -138.33 156.19 29.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.473 178.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 96.1 mt -118.0 124.71 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.247 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 25.9 p -102.31 159.34 15.49 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 113.146 -1.843 . . . . 0.0 108.603 -178.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -127.43 101.74 24.25 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.3 -18.58 60.98 Favored 'Trans proline' 0 N--CA 1.49 1.309 0 C-N-CA 121.683 1.589 . . . . 0.0 111.477 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.09 -39.9 94.03 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.576 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 93.8 mt -77.16 -164.71 0.48 Allowed 'General case' 0 N--CA 1.475 0.8 0 O-C-N 122.106 -0.371 . . . . 0.0 111.057 -178.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . 0.666 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 42.4 tt0 -87.56 129.87 34.95 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.45 ' O ' ' OD1' ' B' ' 36' ' ' ASP . 62.8 t0 57.47 35.42 25.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.751 177.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' ASN . . . . . 0.424 ' C ' ' O ' ' B' ' 36' ' ' ASP . 20.0 t-20 33.04 68.95 0.92 Allowed Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.666 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 89.3 Cg_endo -72.09 155.76 56.54 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 123.745 2.963 . . . . 0.0 111.865 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 95.6 mt -88.21 127.99 40.85 Favored 'Isoleucine or valine' 0 C--O 1.246 0.908 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.438 HG21 ' N ' ' B' ' 41' ' ' TYR . 27.7 m -107.73 -43.03 6.31 Favored 'Isoleucine or valine' 0 C--N 1.343 0.3 0 O-C-N 123.892 0.745 . . . . 0.0 112.603 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' TYR . . . . . 0.438 ' N ' HG21 ' B' ' 40' ' ' VAL . 48.3 t80 -97.01 123.9 40.85 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.366 -178.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 5.7 p -142.94 140.92 27.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 124.212 0.945 . . . . 0.0 109.293 177.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . 0.609 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 57.2 p30 -100.34 161.6 13.5 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.035 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' GLN . . . . . 0.438 ' HA ' ' OE1' ' B' ' 44' ' ' GLN . 13.8 mm100 -63.4 -38.02 89.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.569 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.37 -25.6 63.0 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.609 ' HB2' ' OD1' ' B' ' 43' ' ' ASN . 62.6 t80 -59.96 -43.86 94.79 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . 0.629 HG11 ' O ' ' B' ' 52' ' ' TYR . 63.3 t -61.3 -45.69 98.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.153 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -62.87 -44.19 96.77 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.057 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 59.4 ttm -62.81 -42.83 99.88 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 34.5 p -95.62 -15.89 22.45 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.72 -178.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' B' ' 47' ' ' VAL . . . 73.46 19.22 79.64 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.336 -1.105 . . . . 0.0 110.336 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . 0.629 ' O ' HG11 ' B' ' 47' ' ' VAL . 78.4 m-85 -110.75 145.19 38.53 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 115.27 -0.465 . . . . 0.0 110.1 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -74.18 149.02 41.15 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 121.817 0.818 . . . . 0.0 110.874 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.99 -37.7 85.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.084 -177.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.03 -39.09 93.32 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 120.085 -0.646 . . . . 0.0 112.196 -178.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -72.59 -31.51 65.26 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 177.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 92.1 mt -69.91 -61.73 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 97.0 mt -49.49 133.86 19.93 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 123.966 0.791 . . . . 0.0 109.984 -178.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.98 -10.19 72.21 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.712 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -131.48 149.34 52.56 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -176.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' ASN . . . . . 0.577 ' C ' ' H ' ' B' ' 63' ' ' ARG . 25.2 t-20 -79.62 151.49 30.56 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.619 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' CYS . . . . . . . . . . . . . 83.5 m -63.28 9.9 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.256 -178.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' ARG . . . . . 0.577 ' H ' ' C ' ' B' ' 61' ' ' ASN . 33.5 ptt-85 -60.06 -32.31 70.81 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.585 -177.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -60.5 -30.89 70.0 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 85.6 mt -62.21 -41.86 98.77 Favored 'General case' 0 C--O 1.238 0.462 0 O-C-N 121.601 -0.687 . . . . 0.0 109.758 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -50.12 143.81 7.79 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -177.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . 0.498 ' HA3' ' CE1' ' B' ' 95' ' ' TYR . . . -155.08 -152.86 6.3 Favored Glycine 0 C--N 1.353 1.473 0 CA-C-N 115.967 -0.561 . . . . 0.0 112.156 176.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' LYS . . . . . 0.504 ' HB3' ' HH ' ' B' ' 95' ' ' TYR . 88.8 tttt -60.25 -42.43 95.27 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -175.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -74.77 -9.92 59.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.069 -178.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 27.4 m -60.64 133.5 56.16 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -90.55 110.92 44.56 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.39 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.64 -38.09 90.97 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 120.978 1.119 . . . . 0.0 111.63 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.16 -40.6 90.43 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -176.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' GLU . . . . . 0.405 ' OE1' ' HB ' ' B' ' 90' ' ' VAL . 79.5 mm-40 -67.0 -38.29 85.73 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.963 177.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 70.2 t -63.42 -44.76 99.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.091 0.472 . . . . 0.0 109.819 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -63.18 -37.3 86.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.7 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -62.44 -42.03 99.16 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 119.276 -0.97 . . . . 0.0 108.955 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 92.6 mt -63.51 -43.72 98.44 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 CA-C-O 120.894 0.378 . . . . 0.0 110.924 -178.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -61.37 -42.54 98.87 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 83.0 m -61.33 -44.93 96.37 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.884 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.99 -42.58 99.3 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -177.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.36 -42.49 99.44 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -62.91 -39.88 95.87 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -81.61 -4.02 54.98 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.803 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 36.7 tttt 50.08 48.52 21.88 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 121.825 -0.547 . . . . 0.0 111.649 177.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -132.93 144.58 53.44 Favored Pre-proline 0 N--CA 1.472 0.673 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.334 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.43 139.62 77.7 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 120.765 0.977 . . . . 0.0 114.045 -177.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -139.98 135.55 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.592 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 89' ' ' THR . . . . . 0.499 ' CG2' ' OD1' ' B' ' 107' ' ' ASN . 98.9 m -119.9 120.72 37.24 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . 0.405 ' HB ' ' OE1' ' B' ' 74' ' ' GLU . 30.7 m -138.33 161.95 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.594 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -114.42 121.21 42.88 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 175.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 20.8 tt -128.43 132.65 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.798 -175.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . 0.423 ' O ' ' ND2' ' B' ' 94' ' ' ASN . 85.7 mt-30 -71.21 141.67 50.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.076 178.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 94' ' ' ASN . . . . . 0.423 ' ND2' ' O ' ' B' ' 93' ' ' GLN . 8.9 m120 -134.92 179.95 5.99 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 121.247 0.546 . . . . 0.0 111.107 -177.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 95' ' ' TYR . . . . . 0.504 ' HH ' ' HB3' ' B' ' 68' ' ' LYS . 95.6 m-85 -130.23 149.68 51.81 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 114.524 -1.216 . . . . 0.0 111.855 177.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . 0.419 ' HG3' ' CE1' ' B' ' 102' ' ' PHE . 99.0 mttt -103.41 -177.07 3.26 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.269 0.557 . . . . 0.0 110.716 176.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.4 -35.07 76.48 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.647 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 36.6 p-10 -88.17 -0.33 56.96 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.271 -0.893 . . . . 0.0 113.042 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.38 3.73 66.83 Favored Glycine 0 N--CA 1.465 0.574 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.109 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 25.5 m -67.66 130.49 43.17 Favored 'General case' 0 N--CA 1.443 -0.801 0 O-C-N 122.159 -0.612 . . . . 0.0 109.39 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 101' ' ' MET . . . . . 0.57 ' SD ' ' N ' ' B' ' 102' ' ' PHE . 15.8 tmm? -90.15 142.47 27.69 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 102' ' ' PHE . . . . . 0.57 ' N ' ' SD ' ' B' ' 101' ' ' MET . 53.9 p90 -152.72 163.72 39.15 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 177.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 103' ' ' TRP . . . . . 0.839 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 22.1 m95 -95.65 140.16 30.87 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.342 178.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 62.6 t-20 -133.94 106.47 7.28 Favored 'General case' 0 C--O 1.217 -0.631 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -75.03 123.88 25.97 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 125.193 1.558 . . . . 0.0 109.262 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 38.9 tp -112.81 125.71 54.64 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 123.58 0.55 . . . . 0.0 111.608 -177.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 107' ' ' ASN . . . . . 0.499 ' OD1' ' CG2' ' B' ' 89' ' ' THR . 98.1 m-20 -118.96 127.7 53.72 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 176.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 96.5 mt -123.12 132.97 70.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -143.33 125.03 8.4 Favored Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -70.19 152.0 66.88 Favored 'Trans proline' 0 N--CA 1.5 1.878 0 C-N-CA 122.254 1.969 . . . . 0.0 112.624 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 111' ' ' MET . . . . . 0.492 ' HB2' ' HB2' ' B' ' 118' ' ' TYR . 67.2 mtt -128.69 142.17 51.1 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -113.67 109.86 19.28 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . 0.792 HG12 ' HZ3' ' A' ' 18' ' ' LYS . 96.7 mt -136.11 127.92 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 O-C-N 121.352 -0.842 . . . . 0.0 111.709 178.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 52.49 37.33 22.6 Favored 'General case' 0 C--O 1.236 0.375 0 O-C-N 123.819 0.7 . . . . 0.0 109.63 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 61.71 35.74 16.78 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.519 0.676 . . . . 0.0 110.248 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -132.21 151.36 51.85 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 177.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 5.1 t -101.02 154.21 18.9 Favored 'General case' 0 C--O 1.215 -0.748 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 118' ' ' TYR . . . . . 0.492 ' HB2' ' HB2' ' B' ' 111' ' ' MET . 90.7 m-85 -149.16 145.32 27.11 Favored 'General case' 0 C--N 1.318 -0.791 0 O-C-N 121.09 -1.006 . . . . 0.0 111.152 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -120.02 139.25 52.79 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 120.812 0.339 . . . . 0.0 111.821 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -128.92 137.35 57.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -177.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -113.54 126.21 7.3 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 94.9 mt -114.29 127.92 71.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 123' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' B' ' 26' ' ' GLY . 17.6 mp0 -117.87 123.42 45.83 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -121.56 124.19 43.77 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . 0.583 ' OD1' ' N ' ' B' ' 127' ' ' THR . 67.5 t0 -74.94 126.06 30.2 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.556 -177.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . 0.564 ' O ' ' HG3' ' B' ' 130' ' ' LYS . 3.5 mp -98.98 18.85 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.424 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 127' ' ' THR . . . . . 0.583 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 98.1 m -64.55 -44.75 89.79 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 114.326 -1.306 . . . . 0.0 112.781 175.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -59.96 -45.19 93.44 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 -177.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 129' ' ' GLN . . . . . 0.437 ' OE1' HG21 ' B' ' 126' ' ' ILE . 88.5 mt-30 -63.6 -35.02 79.14 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.441 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 130' ' ' LYS . . . . . 0.839 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 99.0 mttt -63.27 -42.0 99.09 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-N 113.232 -1.803 . . . . 0.0 110.822 174.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.99 -41.69 97.44 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 132' ' ' TYR . . . . . 0.451 ' CE2' HD13 ' B' ' 136' ' ' LEU . 89.0 t80 -60.43 -45.3 94.13 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.948 -0.47 . . . . 0.0 111.341 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.23 -37.05 86.09 Favored 'General case' 0 C--O 1.218 -0.586 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.438 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 134' ' ' LYS . . . . . 0.435 ' HG3' ' O ' ' B' ' 130' ' ' LYS . 99.0 mttt -62.63 -39.71 94.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.89 177.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 53.2 tp -62.68 -41.12 98.92 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 136' ' ' LEU . . . . . 0.451 HD13 ' CE2' ' B' ' 132' ' ' TYR . 87.7 mt -62.83 -41.78 99.46 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 114.858 -1.064 . . . . 0.0 111.566 177.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 137' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.69 -36.93 85.87 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.484 -178.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -63.28 -44.07 96.15 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.873 177.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 63.2 m -61.04 -44.05 97.98 Favored 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 85.6 mt -61.98 -40.23 94.91 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -177.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 86.1 m -61.88 -45.52 93.39 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.173 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -65.66 -41.64 92.29 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 93.0 mt -63.8 -43.12 97.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 114.458 -1.247 . . . . 0.0 110.559 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 144' ' ' THR . . . . . . . . . . . . . 89.0 m -61.69 -45.09 95.47 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -178.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . 0.41 ' O ' ' HB ' ' B' ' 148' ' ' THR . . . -63.8 -40.92 97.81 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 118.958 -1.097 . . . . 0.0 109.278 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 87.3 mt -64.53 -41.59 96.28 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 147' ' ' SER . . . . . 0.628 ' O ' ' N ' ' B' ' 149' ' ' PRO . 77.9 p -60.89 -42.1 97.34 Favored 'General case' 0 CA--C 1.481 -1.676 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 -178.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 148' ' ' THR . . . . . 0.469 ' C ' ' O ' ' B' ' 147' ' ' SER . 23.2 m -29.42 84.91 0.03 OUTLIER Pre-proline 0 N--CA 1.482 1.169 0 O-C-N 123.959 0.787 . . . . 0.0 110.182 178.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 149' ' ' PRO . . . . . 0.628 ' N ' ' O ' ' B' ' 147' ' ' SER . 22.0 Cg_exo -61.46 148.24 93.46 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.865 1.71 . . . . 0.0 115.849 -176.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 9.6 tp -125.91 117.43 48.99 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.156 0 CA-C-N 114.273 -1.33 . . . . 0.0 107.805 173.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 40.1 t -146.99 92.94 4.85 Favored Pre-proline 0 C--N 1.314 -0.946 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.592 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -60.81 136.39 65.96 Favored 'Trans proline' 0 C--N 1.316 -1.154 0 CA-C-N 120.321 1.15 . . . . 0.0 109.219 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 153' ' ' ILE . . . . . 0.629 HG21 HH12 ' A' ' 154' ' ' ARG . 44.6 mm -68.4 -44.35 83.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.956 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 154' ' ' ARG . . . . . 0.636 ' HD3' ' NH2' ' A' ' 154' ' ' ARG . 0.4 OUTLIER -156.56 -154.55 0.48 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.464 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 59.3 t-20 -87.02 108.03 18.68 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 121.024 0.44 . . . . 0.0 110.156 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.79 -17.31 58.47 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 -178.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 85.3 mt -109.38 124.07 65.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.275 0.56 . . . . 0.0 111.002 -176.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 158' ' ' SER . . . . . 0.584 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 74.5 m -134.74 149.75 50.49 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.738 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 159' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' B' ' 191' ' ' ILE . . . -132.25 147.27 52.4 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 18.0 tp -138.96 77.72 31.12 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 161' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -70.79 146.82 54.83 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 122.867 2.378 . . . . 0.0 114.095 -178.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 92.0 mt -113.03 133.85 54.79 Favored 'General case' 0 C--N 1.345 0.37 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 56.1 t -129.29 132.98 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 177.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 114.86 168.47 15.81 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.012 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 165' ' ' ASN . . . . . 0.768 ' O ' ' CZ ' ' B' ' 170' ' ' ARG . 61.4 t30 -90.03 106.65 18.62 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -177.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 166' ' ' LEU . . . . . 0.511 ' CD2' ' CZ ' ' B' ' 171' ' ' PHE . 42.3 tp -64.3 104.23 0.73 Allowed 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -174.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 167' ' ' THR . . . . . 0.571 ' CG2' HH21 ' B' ' 170' ' ' ARG . 9.6 p -85.73 168.6 14.2 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 113.806 -1.543 . . . . 0.0 111.094 177.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.05 -38.68 91.64 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.607 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -65.85 -41.68 91.38 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 122.402 1.096 . . . . 0.0 111.778 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 170' ' ' ARG . . . . . 0.768 ' CZ ' ' O ' ' B' ' 165' ' ' ASN . 87.8 mtm180 -61.53 -34.72 76.03 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 112.558 -2.11 . . . . 0.0 110.952 178.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 171' ' ' PHE . . . . . 0.511 ' CZ ' ' CD2' ' B' ' 166' ' ' LEU . 0.5 OUTLIER -54.89 -25.9 32.16 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -178.782 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 172' ' ' ASN . . . . . 0.494 ' O ' HG21 ' B' ' 175' ' ' VAL . 92.4 m-20 -62.74 -40.33 96.88 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.834 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 55.3 m -59.85 -41.41 91.36 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.013 0.435 . . . . 0.0 110.598 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 68.2 mt -63.87 -44.15 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 175' ' ' VAL . . . . . 0.494 HG21 ' O ' ' B' ' 172' ' ' ASN . 35.6 m -62.45 -40.01 86.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 176' ' ' CYS . . . . . 0.493 ' N ' HG23 ' B' ' 175' ' ' VAL . 98.1 m -61.95 -35.3 78.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.329 179.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 177' ' ' THR . . . . . 0.544 ' O ' HG13 ' B' ' 181' ' ' ILE . 25.0 m -61.84 -19.67 62.85 Favored 'General case' 0 C--O 1.22 -0.494 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.38 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 178' ' ' LEU . . . . . . . . . . . . . 89.6 mt -60.83 -39.24 88.29 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.238 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 18.9 m -61.74 -44.29 97.21 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.547 177.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 180' ' ' ASN . . . . . 0.612 ' O ' ' OG ' ' B' ' 183' ' ' SER . 92.3 m-20 -61.74 -39.99 93.53 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.161 0.505 . . . . 0.0 110.537 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . 0.544 HG13 ' O ' ' B' ' 177' ' ' THR . 73.0 mt -55.99 -33.48 35.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 O-C-N 122.143 -0.348 . . . . 0.0 110.465 -178.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 182' ' ' LEU . . . . . . . . . . . . . 86.7 mt -62.38 -41.74 98.87 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.163 178.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 183' ' ' SER . . . . . 0.612 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.1 p -63.33 -32.89 74.43 Favored 'General case' 0 C--O 1.225 -0.221 0 O-C-N 121.905 -0.497 . . . . 0.0 110.768 177.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 45.9 p -86.96 17.04 4.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.907 0.384 . . . . 0.0 111.769 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 78.6 p -60.6 -16.51 38.98 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.966 -177.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.64 -40.3 94.41 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 122.075 -0.39 . . . . 0.0 110.811 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 187' ' ' ASP . . . . . 0.584 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.3 m-20 -68.52 114.41 6.9 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.576 0.703 . . . . 0.0 110.793 -178.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.88 -42.23 99.69 Favored 'General case' 0 C--O 1.25 1.109 0 CA-C-N 114.997 -1.001 . . . . 0.0 113.242 -178.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -113.0 131.77 55.63 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 120.711 -0.395 . . . . 0.0 111.386 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 190' ' ' LEU . . . . . . . . . . . . . 40.8 tp -123.97 118.96 28.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.372 177.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 191' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' B' ' 159' ' ' ALA . 85.6 mt -106.38 125.71 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 121.128 -0.229 . . . . 0.0 111.444 -178.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 48.7 mm -115.16 117.01 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 193' ' ' ASP . . . . . 0.598 ' CG ' ' HG ' ' B' ' 195' ' ' SER . 43.0 t0 -89.42 113.09 24.38 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -176.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 194' ' ' LEU . . . . . . . . . . . . . 96.2 mt -95.45 -1.1 51.55 Favored 'General case' 0 C--O 1.239 0.509 0 O-C-N 122.265 -0.272 . . . . 0.0 110.691 177.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 195' ' ' SER . . . . . 0.598 ' HG ' ' CG ' ' B' ' 193' ' ' ASP . 78.1 p -61.17 -36.7 80.54 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.0 -178.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.42 -37.37 94.0 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 197' ' ' LEU . . . . . 1.039 HD23 ' O ' ' B' ' 199' ' ' GLN . 5.2 tt -72.34 133.63 45.07 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -178.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 198' ' ' ALA . . . . . 0.654 ' N ' HD21 ' B' ' 197' ' ' LEU . . . -61.81 -49.19 77.32 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 119.556 -0.858 . . . . 0.0 111.137 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 199' ' ' GLN . . . . . 1.039 ' O ' HD23 ' B' ' 197' ' ' LEU . 58.3 tt0 -134.5 164.55 27.22 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-O 121.783 0.802 . . . . 0.0 113.04 -178.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 200' ' ' VAL . . . . . 0.477 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 50.1 t -120.19 130.72 74.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 O-C-N 120.368 -1.458 . . . . 0.0 109.502 176.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -86.15 151.56 23.56 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.658 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -62.64 -33.12 74.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.439 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -63.46 -31.93 73.23 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.6 m -60.92 -43.78 98.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.186 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 205' ' ' ALA . . . . . 0.641 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -58.73 -30.06 67.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 119.26 -0.4 . . . . 0.0 111.848 -178.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -64.61 -39.08 93.08 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 123.79 0.681 . . . . 0.0 110.191 175.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -66.33 -38.69 88.24 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.694 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 96.3 mt -63.14 -43.92 99.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -178.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 209' ' ' PHE . . . . . 0.641 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 64.0 m-85 -61.56 -43.57 98.62 Favored 'General case' 0 C--O 1.242 0.692 0 O-C-N 124.682 1.239 . . . . 0.0 111.856 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -62.9 -41.48 99.45 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.25 -0.98 . . . . 0.0 109.727 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 211' ' ' LEU . . . . . 0.449 ' O ' ' HG ' ' B' ' 215' ' ' LEU . 37.8 mt -62.45 -42.43 99.46 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.189 -179.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 212' ' ' SER . . . . . 0.448 ' HG ' ' N ' ' B' ' 213' ' ' HIS . 78.2 p -62.74 -37.58 87.14 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.283 -0.567 . . . . 0.0 112.141 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 213' ' ' HIS . . . . . 0.448 ' N ' ' HG ' ' B' ' 212' ' ' SER . 58.8 t-80 -66.31 -47.21 74.27 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.34 178.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 53.4 tp -63.79 -43.44 96.32 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.616 0.722 . . . . 0.0 109.532 178.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 215' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' B' ' 211' ' ' LEU . 90.7 mt -63.09 -43.18 99.23 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 113.466 -1.697 . . . . 0.0 111.214 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.85 -39.46 94.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.727 -0.215 . . . . 0.0 110.933 -177.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 85.7 mt -63.25 -42.46 99.18 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.203 0.525 . . . . 0.0 111.39 176.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 218' ' ' THR . . . . . . . . . . . . . 71.9 p -75.3 -14.15 60.48 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.683 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 77.79 72.66 1.13 Allowed Glycine 0 CA--C 1.528 0.877 0 N-CA-C 107.141 -2.384 . . . . 0.0 107.141 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 220' ' ' THR . . . . . . . . . . . . . 81.7 m -151.72 100.8 2.72 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 177.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -58.59 140.09 54.88 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 121.849 -0.532 . . . . 0.0 111.103 -177.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 42.0 tp -117.49 120.72 38.97 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.171 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 2.9 mp -109.92 128.91 65.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.166 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 224' ' ' ILE . . . . . . . . . . . . . 50.4 mm -110.68 127.47 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 O-C-N 123.572 0.545 . . . . 0.0 109.532 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 43.7 p -134.42 157.57 46.11 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 90.78 16.17 55.17 Favored Glycine 0 N--CA 1.442 -0.967 0 CA-C-N 113.949 -1.478 . . . . 0.0 111.228 -177.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 95.9 mt -81.74 126.63 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 CA-C-N 117.889 0.845 . . . . 0.0 111.686 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 61.2 tttt -67.01 139.28 95.43 Favored Pre-proline 0 C--N 1.316 -0.854 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.521 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.85 -37.04 92.78 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 121.354 1.37 . . . . 0.0 112.483 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -63.08 -43.48 98.4 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 53.1 tp -62.42 -41.98 99.1 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.679 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -62.95 -36.99 85.29 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.892 0.377 . . . . 0.0 111.367 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 94.6 mtp -63.75 -41.15 98.06 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.758 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.3 -43.33 99.07 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 121.995 0.902 . . . . 0.0 109.366 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 30.2 mmt -64.33 -35.85 82.22 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.896 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -61.08 -40.62 94.38 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.987 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.77 -43.05 99.82 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.287 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 52.7 tp -62.68 -44.25 96.73 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 121.883 -0.51 . . . . 0.0 112.27 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 239' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' B' ' 240' ' ' ALA . 66.7 t0 -159.28 133.42 7.62 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 120.149 -0.62 . . . . 0.0 111.982 -178.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 240' ' ' ALA . . . . . 0.4 ' N ' ' OD1' ' B' ' 239' ' ' ASP . . . -60.98 -47.76 84.95 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 241' ' ' ASN . . . . . 0.478 ' O ' ' HB2' ' B' ' 244' ' ' SER . 90.2 m-20 -43.23 -19.37 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.475 -175.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 242' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -60.34 -45.03 94.9 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.172 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 243' ' ' SER . . . . . . . . . . . . . 78.1 p -58.77 -42.03 88.01 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 244' ' ' SER . . . . . 0.478 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 25.2 m -35.25 -32.53 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -177.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 98.9 mt -90.41 131.54 36.12 Favored 'General case' 0 CA--C 1.513 -0.452 0 O-C-N 121.1 -1.0 . . . . 0.0 110.061 178.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -59.47 134.89 57.42 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 121.421 0.629 . . . . 0.0 110.376 -176.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 247' ' ' THR . . . . . . . . . . . . . 97.3 m -125.62 127.99 47.19 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.484 -1.235 . . . . 0.0 111.861 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -113.3 144.15 43.22 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 249' ' ' SER . . . . . 0.563 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 78.6 p -64.57 -33.66 76.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.476 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 250' ' ' ASN . . . . . 0.563 ' OD1' ' O ' ' B' ' 249' ' ' SER . 99.0 m-20 -147.2 160.11 42.85 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.971 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 61.7 t -64.21 -44.69 97.49 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.254 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.293 177.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 252' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.24 -45.4 94.68 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -177.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -61.51 -44.24 97.42 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.75 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 254' ' ' ALA . . . . . . . . . . . . . . . -65.44 -40.65 93.52 Favored 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.893 178.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 255' ' ' VAL . . . . . 0.657 HG13 HH11 ' A' ' 154' ' ' ARG . 74.2 t -64.66 -45.48 95.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.3 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -63.04 -48.46 78.62 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 120.132 -0.627 . . . . 0.0 111.118 -178.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 257' ' ' VAL . . . . . 0.486 ' O ' ' C ' ' B' ' 258' ' ' LEU . 20.1 m -65.55 -40.79 89.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.662 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 258' ' ' LEU . . . . . 0.508 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 1.0 OUTLIER -31.58 -73.67 0.05 OUTLIER Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 119.499 -0.286 . . . . 0.0 111.664 -178.009 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 259' ' ' PRO . . . . . 0.508 ' CD ' ' CB ' ' B' ' 258' ' ' LEU . 36.6 Cg_endo -61.81 139.99 83.17 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 121.531 1.487 . . . . 0.0 111.575 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 260' ' ' ILE . . . . . 0.445 HG13 ' O ' ' B' ' 259' ' ' PRO . 96.6 mt -157.47 -14.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 118.665 0.666 . . . . 0.0 112.054 177.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 78.3 mtm . . . . . 0 C--O 1.214 -0.801 0 CA-C-O 117.761 -1.114 . . . . 0.0 111.573 -179.588 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.406 ' O ' ' OG ' ' A' ' 6' ' ' SER . . . -153.14 171.81 17.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 118.968 -0.539 . . . . 0.0 110.226 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.5 p -71.3 -14.89 62.36 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.332 0.653 . . . . 0.0 110.757 177.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -75.53 -66.3 0.79 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.615 175.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -67.28 -39.3 85.99 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.969 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.511 ' O ' ' HB3' ' A' ' 7' ' ' PHE . 63.1 m -59.44 -42.56 92.19 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.114 -176.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.511 ' HB3' ' O ' ' A' ' 6' ' ' SER . 44.3 t80 85.52 85.69 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 O-C-N 123.707 0.63 . . . . 0.0 112.495 177.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.645 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -62.21 -152.15 0.03 OUTLIER Glycine 0 CA--C 1.529 0.967 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -177.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.645 ' HB ' ' O ' ' A' ' 8' ' ' GLY . 66.9 mt 93.63 108.89 0.02 OUTLIER Pre-proline 0 N--CA 1.472 0.66 0 C-N-CA 122.371 0.269 . . . . 0.0 110.579 -178.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.48 -22.77 71.12 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 121.539 1.493 . . . . 0.0 112.181 -178.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.43 -38.3 96.15 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.112 -0.566 . . . . 0.0 111.726 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -65.52 -38.7 90.43 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.654 0.74 . . . . 0.0 109.706 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 52.5 tp -62.71 -41.39 99.12 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.412 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -64.25 -39.04 93.14 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.5 t -60.51 -44.16 95.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 O-C-N 122.186 -0.321 . . . . 0.0 110.434 -178.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 92.4 mt -62.71 -43.64 98.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 C-N-CA 119.756 -0.777 . . . . 0.0 109.3 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.413 ' NZ ' ' HA ' ' B' ' 6' ' ' SER . 98.9 mttt -62.12 -45.37 93.76 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 119.365 -0.934 . . . . 0.0 112.221 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.648 ' NZ ' HG12 ' B' ' 113' ' ' ILE . 98.7 mttt -60.1 -40.21 88.84 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 118.672 -1.211 . . . . 0.0 109.124 -176.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.34 -42.68 96.21 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.157 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.7 mt -62.95 -41.18 99.43 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.118 0.485 . . . . 0.0 109.926 178.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -63.49 -37.99 89.41 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.499 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 57.6 m170 -58.92 -39.8 82.63 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 122.179 -0.326 . . . . 0.0 111.254 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.2 p -113.82 130.44 67.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.481 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 34.6 ptt180 -72.51 110.25 6.76 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.99 0.9 . . . . 0.0 112.08 -177.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.3 p -140.98 143.14 28.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.164 178.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.472 ' O ' ' N ' ' A' ' 123' ' ' GLN . . . -97.91 91.76 1.2 Allowed Glycine 0 C--N 1.312 -0.768 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.76 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.4 t -124.84 130.25 73.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 175.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.4 m -137.17 159.99 36.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.6 mt -119.85 131.14 73.13 Favored 'Isoleucine or valine' 0 C--O 1.247 0.965 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 176.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.476 HG21 HG12 ' A' ' 39' ' ' ILE . 72.6 p -108.04 165.98 11.06 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.415 ' C ' ' OD1' ' A' ' 37' ' ' ASN . 56.1 t0 -130.8 103.29 15.94 Favored Pre-proline 0 C--N 1.319 -0.719 0 C-N-CA 121.087 -0.245 . . . . 0.0 110.538 178.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -62.69 -23.61 74.63 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 121.365 1.376 . . . . 0.0 111.701 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.78 -36.38 83.68 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.729 -178.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.6 mt -83.74 156.12 22.73 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.641 177.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.743 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 43.0 tt0 -58.1 138.06 56.4 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -176.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.548 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 60.0 t0 59.29 20.47 8.64 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.767 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.415 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 46.5 t-20 40.29 68.58 2.2 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.072 -177.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.743 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 91.2 Cg_endo -70.69 155.31 63.11 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 124.06 3.173 . . . . 0.0 112.649 -178.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.476 HG12 HG21 ' A' ' 30' ' ' THR . 95.8 mt -87.68 123.85 40.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.47 HG21 ' N ' ' A' ' 41' ' ' TYR . 28.0 m -104.21 -43.41 8.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.883 -178.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.47 ' N ' HG21 ' A' ' 40' ' ' VAL . 43.5 t80 -94.84 124.31 38.81 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.552 -177.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.7 p -143.35 141.1 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 O-C-N 124.314 1.009 . . . . 0.0 109.345 177.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.653 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 56.8 p30 -98.45 166.76 11.21 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.517 ' HA ' ' OE1' ' A' ' 44' ' ' GLN . 13.5 mm100 -66.7 -39.04 87.9 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 120.887 0.375 . . . . 0.0 111.868 177.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.17 -25.98 63.04 Favored Glycine 0 C--N 1.332 0.346 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.653 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 62.9 t80 -59.22 -48.42 81.67 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 -178.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.477 HG11 ' O ' ' A' ' 52' ' ' TYR . 53.7 t -58.88 -44.9 91.72 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.542 0 O-C-N 121.274 -0.891 . . . . 0.0 111.074 -173.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -63.26 -37.71 88.31 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.768 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 59.7 ttm -67.17 -44.14 80.48 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 176.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 37.9 p -90.26 -23.2 21.27 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.146 0.498 . . . . 0.0 111.845 -178.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . 77.74 19.34 75.86 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.477 ' O ' HG11 ' A' ' 47' ' ' VAL . 77.4 m-85 -112.71 138.09 50.03 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.1 0.56 . . . . 0.0 111.606 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -63.75 148.2 49.78 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.535 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.54 -32.41 73.98 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.02 -43.43 87.66 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.434 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -64.73 -44.23 90.84 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.621 178.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 88.3 mt -61.49 -51.3 74.46 Favored 'Isoleucine or valine' 0 C--N 1.347 0.489 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -174.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 86.0 mt -56.83 146.03 27.62 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 177.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.17 -6.63 74.88 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-O 119.339 -0.7 . . . . 0.0 112.829 176.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -135.0 150.52 50.34 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.832 1.316 . . . . 0.0 111.882 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.565 ' C ' ' H ' ' A' ' 63' ' ' ARG . 24.9 t-20 -80.17 150.75 30.06 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.241 0.543 . . . . 0.0 110.771 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 76.8 m -63.14 15.86 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.502 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.565 ' H ' ' C ' ' A' ' 61' ' ' ASN . 35.8 ptt-85 -61.67 -41.36 97.44 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.262 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -56.41 -20.49 19.89 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -178.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.8 mt -68.23 -34.3 75.99 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.546 0.689 . . . . 0.0 112.506 177.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -64.53 137.83 58.07 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.439 -0.8 . . . . 0.0 112.374 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.567 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -146.54 -147.06 4.49 Favored Glycine 0 CA--C 1.544 1.898 0 C-N-CA 120.825 -0.703 . . . . 0.0 111.892 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.525 ' HB3' ' HH ' ' A' ' 95' ' ' TYR . 88.7 tttt -63.01 -40.29 97.32 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -177.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.498 ' HD1' HE22 ' A' ' 93' ' ' GLN . 12.6 m-70 -76.77 -7.85 56.19 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.035 -178.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.567 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 28.9 m -63.56 128.82 37.55 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.379 -0.528 . . . . 0.0 109.807 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -84.91 109.3 19.54 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.708 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' A' ' 70' ' ' THR . 51.5 Cg_exo -56.83 -32.97 93.56 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.042 1.828 . . . . 0.0 113.11 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.46 -39.54 94.0 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.207 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -64.88 -42.31 94.93 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 77.8 t -60.38 -43.65 94.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 114.242 -1.344 . . . . 0.0 107.679 -175.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -63.47 -37.72 88.4 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.928 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -63.77 -40.08 95.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.253 0.549 . . . . 0.0 110.443 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.75 -44.08 98.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-O 122.156 0.979 . . . . 0.0 111.99 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -63.25 -42.92 99.23 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 113.522 -1.672 . . . . 0.0 108.183 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 96.6 m -61.45 -49.92 74.88 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 120.061 -0.655 . . . . 0.0 109.776 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.66 -42.14 87.75 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-O 119.183 -0.437 . . . . 0.0 111.297 -174.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.402 HD23 ' CE1' ' A' ' 119' ' ' PHE . 84.2 mt -63.12 -39.52 94.93 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 119.386 0.994 . . . . 0.0 111.439 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -65.29 -33.22 75.47 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -88.75 -2.13 58.43 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.543 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.8 tttt 50.08 41.65 23.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.752 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -126.06 144.0 47.41 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -61.61 143.55 96.86 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 121.303 1.335 . . . . 0.0 113.595 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -139.51 141.62 34.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.721 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 91.2 m -125.47 122.42 36.6 Favored 'General case' 0 C--N 1.342 0.271 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 175.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 29.7 m -138.93 157.97 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.675 176.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -102.41 134.33 45.91 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 176.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.7 tt -141.89 130.65 22.63 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.181 0 CA-C-N 120.5 1.5 . . . . 0.0 112.977 177.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.498 HE22 ' HD1' ' A' ' 69' ' ' HIS . 86.0 mt-30 -64.75 132.7 50.32 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.871 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -134.09 156.19 48.7 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.46 -178.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.525 ' HH ' ' HB3' ' A' ' 68' ' ' LYS . 93.9 m-85 -115.89 134.07 55.37 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -83.03 -173.66 4.84 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.166 0.508 . . . . 0.0 111.52 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.52 -43.11 99.61 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.65 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.457 ' CG ' ' HG1' ' A' ' 100' ' ' THR . 40.8 p-10 -82.65 5.54 20.79 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -178.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.39 -0.3 86.99 Favored Glycine 0 N--CA 1.466 0.641 0 C-N-CA 120.879 -0.676 . . . . 0.0 112.225 176.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.457 ' HG1' ' CG ' ' A' ' 98' ' ' ASP . 26.7 m -59.18 137.74 57.85 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.657 ' C ' ' SD ' ' A' ' 101' ' ' MET . 13.4 tmm? -102.36 127.89 49.17 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.724 0.297 . . . . 0.0 110.95 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.474 ' N ' ' SD ' ' A' ' 101' ' ' MET . 53.2 p90 -140.88 159.66 41.74 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.236 -0.586 . . . . 0.0 109.762 -177.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.888 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 26.1 m95 -92.55 141.12 28.85 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.473 HD22 ' HG2' ' A' ' 123' ' ' GLN . 53.9 t-20 -137.0 104.39 5.44 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -176.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 81.2 tt0 -69.25 137.38 53.08 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -177.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 44.1 tp -121.56 123.97 43.25 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -119.67 123.38 43.68 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.522 177.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 96.2 mt -121.02 128.72 76.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 O-C-N 123.345 0.403 . . . . 0.0 111.225 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -140.61 122.96 9.68 Favored Pre-proline 0 CA--C 1.541 0.596 0 CA-C-O 119.912 -0.089 . . . . 0.0 110.785 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -70.71 150.28 62.16 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 122.593 2.195 . . . . 0.0 112.912 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.547 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 66.9 mtt -122.81 153.86 38.99 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 -179.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -125.0 98.8 5.84 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.596 1.089 . . . . 0.0 108.478 176.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.404 HD11 HG22 ' A' ' 113' ' ' ILE . 95.7 mt -121.24 131.19 73.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.875 -178.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 47.63 39.57 10.15 Favored 'General case' 0 CA--C 1.516 -0.349 0 O-C-N 121.599 -0.688 . . . . 0.0 111.613 177.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 59.31 30.64 20.4 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.906 -178.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -127.81 148.54 50.45 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.754 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 5.1 t -86.01 -172.4 4.06 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 121.506 -0.746 . . . . 0.0 109.68 -178.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.754 ' CD2' ' O ' ' A' ' 117' ' ' THR . 69.7 m-85 -171.03 157.32 5.18 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 174.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.437 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 97.2 m-85 -130.27 145.18 51.73 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 173.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -132.95 133.32 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.28 128.22 9.13 Favored Glycine 0 CA--C 1.504 -0.636 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 178.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 96.1 mt -118.09 129.6 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 178.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.473 ' HG2' HD22 ' A' ' 104' ' ' ASN . 16.3 mp0 -119.54 115.84 24.84 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.172 0.511 . . . . 0.0 109.756 179.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -117.72 115.22 24.59 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.13 -177.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 126' ' ' ILE . 68.0 t0 -64.14 129.76 41.26 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -174.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.404 ' N ' ' OD1' ' A' ' 125' ' ' ASP . 2.6 mp -95.14 2.05 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 113.576 -1.647 . . . . 0.0 110.02 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 20.1 m -60.79 -42.39 97.49 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -178.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -60.35 -42.07 94.95 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -177.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -62.94 -39.25 94.04 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.855 177.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.888 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.6 mttt -62.22 -40.71 97.04 Favored 'General case' 0 CA--C 1.5 -0.979 0 C-N-CA 118.397 -1.321 . . . . 0.0 110.643 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -62.32 -37.4 85.46 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -178.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -61.75 -46.33 90.06 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.912 176.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.69 -38.9 92.56 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 130' ' ' LYS . 98.7 mttt -62.04 -40.45 95.77 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 53.1 tp -60.73 -43.53 97.78 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -177.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 86.5 mt -62.66 -41.36 99.02 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.495 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.27 -40.91 98.72 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 119.637 -0.825 . . . . 0.0 109.531 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -60.95 -41.45 96.34 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -177.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.1 m -61.99 -39.96 93.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.896 176.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.523 ' O ' ' N ' ' A' ' 144' ' ' THR . 87.7 mt -63.39 -42.03 98.78 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 99.6 m -61.85 -45.61 93.04 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.975 -177.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -64.54 -41.0 96.62 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 96.1 mt -64.7 -43.46 96.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 113.965 -1.47 . . . . 0.0 111.53 175.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.523 ' N ' ' O ' ' A' ' 140' ' ' LEU . 97.2 m -62.71 -46.07 89.82 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 120.283 -0.567 . . . . 0.0 112.358 -177.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.88 -39.84 95.7 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 118.813 -1.155 . . . . 0.0 109.138 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 87.6 mt -63.76 -42.48 97.8 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.644 178.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.679 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.1 p -60.19 -40.19 89.16 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -177.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.498 ' C ' ' O ' ' A' ' 147' ' ' SER . 93.5 m -26.64 83.57 0.03 OUTLIER Pre-proline 0 C--N 1.343 0.305 0 O-C-N 126.417 2.323 . . . . 0.0 106.814 -178.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.679 ' N ' ' O ' ' A' ' 147' ' ' SER . 22.0 Cg_exo -62.69 145.1 95.0 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 CA-C-O 122.428 0.928 . . . . 0.0 113.949 -175.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.61 ' O ' ' CG2' ' A' ' 151' ' ' VAL . 9.5 tp -120.25 135.98 58.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 102.378 -3.193 . . . . 0.0 102.378 175.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.61 ' CG2' ' O ' ' A' ' 150' ' ' ILE . 70.7 t -169.6 95.48 0.51 Allowed Pre-proline 0 N--CA 1.446 -0.64 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 176.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -61.83 135.71 57.51 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 N-CA-C 109.565 -0.975 . . . . 0.0 109.565 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.479 ' O ' ' HD2' ' A' ' 154' ' ' ARG . 46.1 mm -68.0 -44.28 84.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.104 179.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.511 HH12 HG21 ' B' ' 153' ' ' ILE . 0.3 OUTLIER -156.62 -157.65 0.72 Allowed 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 61.8 t-20 -86.94 105.88 17.41 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.871 0.843 . . . . 0.0 111.631 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 89.29 7.65 69.49 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 113.957 -1.474 . . . . 0.0 110.832 -177.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.427 HG12 ' HB2' ' A' ' 189' ' ' TYR . 96.2 mt -124.42 126.19 71.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 174.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.671 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 66.7 m -132.12 152.5 51.21 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 122.494 0.317 . . . . 0.0 110.36 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -137.91 142.02 40.62 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.612 -0.68 . . . . 0.0 111.338 177.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 15.9 tp -133.8 79.38 58.4 Favored Pre-proline 0 N--CA 1.472 0.662 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.525 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -69.65 150.76 69.32 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.782 2.322 . . . . 0.0 113.165 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 84.8 mt -116.63 125.51 51.9 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.61 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 43.2 t -122.16 130.97 74.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 115.74 169.48 15.67 Favored Glycine 0 N--CA 1.484 1.857 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.061 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.864 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 53.9 t30 -86.51 113.23 22.26 Favored 'General case' 0 C--N 1.347 0.47 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.482 ' CD2' ' CZ ' ' A' ' 171' ' ' PHE . 46.7 tp -71.32 104.39 3.15 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 -177.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.651 ' H ' ' HE ' ' A' ' 170' ' ' ARG . 10.4 p -86.46 166.98 15.08 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.414 178.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -66.01 -34.22 77.59 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.023 0.44 . . . . 0.0 111.551 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.55 -41.83 96.09 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.36 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.864 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 87.6 mtm180 -65.41 -33.98 77.22 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.328 1.051 . . . . 0.0 112.192 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.482 ' CZ ' ' CD2' ' A' ' 166' ' ' LEU . 0.4 OUTLIER -54.45 -27.94 40.85 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 118.946 -0.55 . . . . 0.0 112.239 -178.695 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.639 ' O ' HG21 ' A' ' 175' ' ' VAL . 91.6 m-20 -61.06 -40.37 93.41 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 119.652 1.114 . . . . 0.0 109.702 -178.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 41.4 m -59.77 -40.47 88.33 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.801 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 68.0 mt -63.21 -44.21 99.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.639 HG21 ' O ' ' A' ' 172' ' ' ASN . 27.1 m -62.82 -39.74 86.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 98.7 m -62.5 -34.6 77.19 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.313 0.578 . . . . 0.0 110.388 178.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' THR . . . . . 0.571 ' O ' HG13 ' A' ' 181' ' ' ILE . 24.9 m -62.63 -20.39 64.73 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.285 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 86.3 mt -61.17 -41.32 96.58 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -177.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 18.7 m -60.2 -43.27 96.06 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . 0.622 ' O ' ' OG ' ' A' ' 183' ' ' SER . 93.2 m-20 -62.25 -37.26 84.74 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 122.552 0.341 . . . . 0.0 110.963 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . 0.571 HG13 ' O ' ' A' ' 177' ' ' THR . 69.6 mt -57.9 -37.63 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 O-C-N 121.536 -0.728 . . . . 0.0 109.473 -178.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 83.1 mt -61.1 -40.7 94.74 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -177.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.622 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 78.2 p -61.05 -33.0 72.61 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.228 176.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.467 ' OG1' ' HA ' ' A' ' 181' ' ' ILE . 22.6 p -89.09 23.18 2.5 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.592 0.234 . . . . 0.0 111.542 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 78.1 p -63.52 -20.84 65.95 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.216 0.531 . . . . 0.0 110.558 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.64 -37.46 81.56 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.802 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.671 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 98.8 m-20 -74.1 113.48 11.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.388 0.613 . . . . 0.0 110.615 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -63.03 -42.17 99.71 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.999 -1.001 . . . . 0.0 112.91 -177.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . 0.427 ' HB2' HG12 ' A' ' 157' ' ' ILE . 98.2 m-85 -112.12 131.72 55.28 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.619 -178.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 39.4 tp -119.72 127.59 52.99 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 93.9 mt -114.72 126.63 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 O-C-N 121.637 -0.664 . . . . 0.0 110.027 177.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.8 mm -113.09 127.19 70.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . 0.562 ' OD2' ' OG ' ' A' ' 195' ' ' SER . 38.7 t0 -95.79 119.99 35.27 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 121.79 -0.569 . . . . 0.0 110.629 176.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 96.6 mt -97.17 -3.38 41.1 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.156 174.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' SER . . . . . 0.562 ' OG ' ' OD2' ' A' ' 193' ' ' ASP . 78.2 p -62.9 -33.26 74.94 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -62.02 -43.12 99.6 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 108.477 -1.849 . . . . 0.0 108.477 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 1.233 HD23 ' O ' ' A' ' 199' ' ' GLN . 5.2 tt -70.47 127.87 34.2 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 113.037 -1.582 . . . . 0.0 109.074 -176.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.681 ' N ' HD21 ' A' ' 197' ' ' LEU . . . -61.02 -48.69 80.62 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 119.764 -0.774 . . . . 0.0 110.772 -177.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 1.233 ' O ' HD23 ' A' ' 197' ' ' LEU . 58.3 tt0 -132.59 156.52 46.74 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 114.77 -1.105 . . . . 0.0 112.183 -174.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.426 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 45.7 t -118.14 133.25 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -91.25 153.98 19.6 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.571 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.8 -38.06 89.67 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.239 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -59.42 -31.74 69.55 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -178.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 19.1 m -60.91 -42.65 98.51 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.475 177.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.449 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -58.06 -38.24 75.94 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -177.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -61.32 -37.99 85.26 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -65.59 -38.51 89.69 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.961 177.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 94.9 mt -62.94 -43.98 99.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.027 -178.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . 0.449 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 71.0 m-85 -62.01 -42.68 99.42 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.635 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -61.96 -41.8 98.41 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.173 -178.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 39.8 mt -61.82 -42.23 98.77 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' SER . . . . . 0.435 ' HG ' ' N ' ' A' ' 213' ' ' HIS . 78.0 p -61.72 -42.09 98.49 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 119.232 -0.987 . . . . 0.0 109.734 -178.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' HIS . . . . . 0.435 ' N ' ' HG ' ' A' ' 212' ' ' SER . 59.0 t-80 -64.6 -46.25 83.49 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.723 -178.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 52.5 tp -62.39 -46.25 89.45 Favored 'General case' 0 C--N 1.344 0.354 0 C-N-CA 119.029 -1.068 . . . . 0.0 108.416 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 85.1 mt -61.72 -40.59 95.59 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.472 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.25 -44.72 95.01 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 85.2 mt -61.65 -39.57 91.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.07 0.462 . . . . 0.0 109.822 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 67.0 p -75.53 -11.58 60.05 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.481 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.88 35.39 18.95 Favored Glycine 0 C--O 1.217 -0.939 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.935 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 95.2 m -121.86 113.83 20.19 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.227 1.514 . . . . 0.0 111.148 -178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -65.78 137.24 57.11 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.206 177.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 43.5 tp -113.21 130.63 56.16 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 3.3 mp -117.41 133.74 63.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 122.857 0.463 . . . . 0.0 109.883 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 49.5 mm -114.93 132.22 64.81 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 43.9 p -134.08 166.63 22.29 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 120.392 -0.523 . . . . 0.0 112.058 -178.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 78.82 20.32 71.08 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 178.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 97.3 mt -81.56 128.61 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 CA-C-N 114.042 -1.079 . . . . 0.0 108.818 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 63.5 tttt -76.04 140.26 69.92 Favored Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.06 -38.92 87.3 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.187 1.258 . . . . 0.0 112.324 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -64.7 -39.39 93.57 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-O 121.619 0.723 . . . . 0.0 110.083 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 48.7 tp -63.55 -42.6 98.38 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.987 -1.006 . . . . 0.0 113.104 176.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.86 -38.05 89.65 Favored 'General case' 0 CA--C 1.521 -0.141 0 O-C-N 121.916 -0.49 . . . . 0.0 111.101 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 94.1 mtp -63.84 -41.48 97.82 Favored 'General case' 0 C--O 1.251 1.135 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.561 -178.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -64.15 -40.02 95.25 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.484 177.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 33.4 mmt -65.68 -38.35 89.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.625 177.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -61.61 -41.55 97.62 Favored 'General case' 0 CA--C 1.516 -0.35 0 O-C-N 121.406 -0.808 . . . . 0.0 109.188 -177.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.43 -41.24 93.61 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.458 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 55.9 tp -63.76 -41.84 97.93 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.229 0.825 . . . . 0.0 113.229 177.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -165.51 126.24 1.88 Allowed 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.604 -0.685 . . . . 0.0 112.684 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -60.05 -26.57 66.23 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.951 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -61.78 -29.97 70.49 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.192 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -55.82 -44.73 78.16 Favored 'General case' 0 C--N 1.312 -1.023 0 O-C-N 121.484 -0.76 . . . . 0.0 109.352 -176.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 95.5 p -62.31 -20.07 63.95 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.23 178.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 19.1 m -55.22 -38.18 68.1 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.511 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 97.2 mt -86.3 123.84 31.99 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -178.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -48.37 135.21 14.11 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 114.7 -1.137 . . . . 0.0 109.707 -176.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 98.0 m -127.87 132.29 49.37 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 114.528 -1.215 . . . . 0.0 111.333 178.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -116.33 139.64 50.18 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.093 178.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 78.1 p -59.67 -43.07 94.14 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 119.152 -1.019 . . . . 0.0 108.304 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -142.68 159.63 41.86 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.726 0.774 . . . . 0.0 111.312 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 75.4 t -62.61 -45.0 99.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 114.607 -1.179 . . . . 0.0 111.796 -179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.92 -43.98 97.85 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.247 -0.581 . . . . 0.0 109.519 -178.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -63.59 -41.95 98.3 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.973 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -64.9 -41.7 95.38 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.037 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . 0.4 HG13 HH11 ' B' ' 154' ' ' ARG . 77.0 t -64.02 -45.56 96.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 114.021 -1.445 . . . . 0.0 110.925 -177.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.99 -47.15 81.49 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.763 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . 0.515 ' O ' ' C ' ' A' ' 258' ' ' LEU . 28.6 m -66.34 -40.6 87.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 120.058 -0.657 . . . . 0.0 112.429 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.515 ' C ' ' O ' ' A' ' 257' ' ' VAL . 1.4 mt -28.36 -75.44 0.04 OUTLIER Pre-proline 0 C--N 1.344 0.355 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.318 -177.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' PRO . . . . . 0.507 ' CD ' ' CB ' ' A' ' 258' ' ' LEU . 42.0 Cg_endo -63.46 139.7 72.12 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 CA-C-N 119.561 0.879 . . . . 0.0 111.761 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 96.7 mt -151.38 -26.57 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.694 177.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 78.1 mtm . . . . . 0 N--CA 1.472 0.663 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.562 -177.013 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.459 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.1 163.71 38.67 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 80.4 p -59.85 -20.82 59.32 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 123.37 0.419 . . . . 0.0 111.27 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -74.2 -63.63 1.19 Allowed 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.091 0.472 . . . . 0.0 111.303 -178.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -67.03 -38.85 86.63 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.877 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' SER . . . . . 0.526 ' O ' ' HB3' ' B' ' 7' ' ' PHE . 65.7 m -60.05 -43.14 95.58 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 119.979 -0.688 . . . . 0.0 109.928 -176.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . 0.526 ' HB3' ' O ' ' B' ' 6' ' ' SER . 46.2 t80 86.39 88.91 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 O-C-N 123.751 0.657 . . . . 0.0 110.745 177.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . 0.676 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -64.23 -151.73 0.07 OUTLIER Glycine 0 CA--C 1.53 0.99 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . 0.676 ' HB ' ' O ' ' B' ' 8' ' ' GLY . 67.3 mt 92.98 108.81 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 122.387 0.275 . . . . 0.0 110.87 -178.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -62.53 -24.94 75.47 Favored 'Trans proline' 0 N--CA 1.5 1.855 0 C-N-CA 121.375 1.383 . . . . 0.0 111.847 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.7 -40.5 98.13 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 110.689 -0.965 . . . . 0.0 110.689 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -64.89 -38.62 91.57 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.726 0.774 . . . . 0.0 109.506 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 52.4 tp -61.75 -42.53 99.09 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.848 -178.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -65.68 -32.81 74.58 Favored 'General case' 0 CA--C 1.562 1.442 0 CA-C-O 121.344 0.593 . . . . 0.0 110.534 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 63.2 t -61.57 -46.28 96.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 113.097 -1.865 . . . . 0.0 110.664 177.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 92.9 mt -63.65 -43.91 98.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.259 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . 0.506 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 98.9 mttt -63.36 -41.61 98.84 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.98 -41.37 99.53 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 119.069 -1.053 . . . . 0.0 110.312 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.96 -38.8 89.91 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.656 -178.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . 0.417 ' O ' ' O ' ' B' ' 23' ' ' VAL . 85.5 mt -64.31 -41.97 96.58 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.286 0.565 . . . . 0.0 110.295 175.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -63.15 -38.34 90.79 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.34 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 56.9 m170 -58.47 -39.64 80.49 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 121.236 -0.185 . . . . 0.0 111.087 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.417 ' O ' ' O ' ' B' ' 20' ' ' LEU . 10.0 p -113.96 130.54 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.489 ' O ' ' HG3' ' B' ' 24' ' ' ARG . 34.7 ptt180 -71.79 108.42 5.09 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 121.865 0.84 . . . . 0.0 112.446 -177.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 7.1 p -143.14 134.33 23.31 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.501 177.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . 0.508 ' O ' ' N ' ' B' ' 123' ' ' GLN . . . -89.59 95.76 2.13 Favored Glycine 0 N--CA 1.436 -1.332 0 C-N-CA 119.093 -1.527 . . . . 0.0 112.748 -175.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 45.9 t -124.86 129.42 73.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 174.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 27.2 m -138.6 157.25 30.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.722 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 95.9 mt -118.84 129.82 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-O 122.377 1.084 . . . . 0.0 111.167 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.478 HG21 HG12 ' B' ' 39' ' ' ILE . 44.7 p -112.0 152.81 27.69 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 112.474 -2.148 . . . . 0.0 108.475 -175.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -121.87 103.6 39.9 Favored Pre-proline 0 C--O 1.239 0.506 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -177.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.78 -22.61 69.4 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 121.907 1.738 . . . . 0.0 111.519 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.6 -42.86 99.46 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 96.0 mt -75.41 171.08 14.87 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.507 -0.745 . . . . 0.0 111.121 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . 0.62 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 42.3 tt0 -69.85 133.56 47.51 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -176.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.522 ' O ' ' OD1' ' B' ' 36' ' ' ASP . 66.1 t0 56.59 35.51 26.18 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.701 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' ASN . . . . . 0.454 ' C ' ' O ' ' B' ' 36' ' ' ASP . 40.3 t-20 28.75 71.24 0.49 Allowed Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.62 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 91.8 Cg_endo -71.85 154.76 58.56 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 123.736 2.957 . . . . 0.0 112.191 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.478 HG12 HG21 ' B' ' 30' ' ' THR . 95.6 mt -86.85 129.17 38.88 Favored 'Isoleucine or valine' 0 C--O 1.245 0.86 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.474 HG21 ' N ' ' B' ' 41' ' ' TYR . 29.8 m -109.04 -42.89 5.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 O-C-N 123.65 0.594 . . . . 0.0 112.373 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' TYR . . . . . 0.474 ' N ' HG21 ' B' ' 40' ' ' VAL . 46.2 t80 -95.61 124.76 39.78 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 119.85 -0.74 . . . . 0.0 111.183 -178.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 5.8 p -143.55 141.86 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 O-C-N 124.102 0.876 . . . . 0.0 109.545 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . 0.675 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 56.0 p30 -102.12 162.07 13.2 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.226 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' GLN . . . . . 0.51 ' HA ' ' OE1' ' B' ' 44' ' ' GLN . 12.9 mm100 -63.1 -37.89 88.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.303 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.48 -26.48 64.44 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.675 ' HB2' ' OD1' ' B' ' 43' ' ' ASN . 59.5 t80 -60.46 -43.3 97.02 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . 0.593 HG11 ' O ' ' B' ' 52' ' ' TYR . 58.5 t -61.16 -46.33 96.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.032 -178.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -62.92 -44.23 96.64 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.341 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 59.7 ttm -63.22 -42.68 99.29 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 39.5 p -94.11 -17.29 22.95 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.934 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' B' ' 47' ' ' VAL . . . 73.67 17.74 79.26 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 178.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . 0.593 ' O ' HG11 ' B' ' 47' ' ' VAL . 77.3 m-85 -110.39 142.89 41.46 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.231 0.612 . . . . 0.0 110.565 178.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -71.91 147.67 46.82 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.388 0.613 . . . . 0.0 111.289 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.62 -36.55 83.14 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.523 -176.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.2 -39.88 95.91 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.344 -178.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -72.72 -32.67 65.89 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 176.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 92.5 mt -64.96 -74.94 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 176.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 94.9 mt -36.42 132.82 0.56 Allowed 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.766 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.28 -13.56 66.59 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-N 115.874 -0.603 . . . . 0.0 113.252 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -132.72 149.07 52.33 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 117.572 0.686 . . . . 0.0 112.315 -173.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' ASN . . . . . 0.563 ' C ' ' H ' ' B' ' 63' ' ' ARG . 24.3 t-20 -78.6 149.73 32.89 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.437 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' CYS . . . . . . . . . . . . . 86.2 m -63.11 9.57 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.327 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' ARG . . . . . 0.563 ' H ' ' C ' ' B' ' 61' ' ' ASN . 34.5 ptt-85 -59.41 -33.16 70.89 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.449 -177.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -59.73 -28.79 67.65 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 83.4 mt -61.69 -41.98 98.32 Favored 'General case' 0 C--N 1.32 -0.7 0 O-C-N 121.938 -0.477 . . . . 0.0 109.751 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -53.23 145.99 12.7 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.624 -176.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -155.69 -153.22 6.48 Favored Glycine 0 CA--C 1.538 1.5 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.983 177.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' LYS . . . . . 0.433 ' HB3' ' HH ' ' B' ' 95' ' ' TYR . 88.8 tttt -59.38 -41.47 89.45 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -176.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' HIS . . . . . 0.423 ' HD1' HE22 ' B' ' 93' ' ' GLN . 11.4 m-70 -75.44 -10.0 59.06 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 123.188 0.305 . . . . 0.0 111.171 -178.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 27.0 m -61.63 133.36 55.53 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 121.875 -0.516 . . . . 0.0 109.812 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -89.17 109.87 34.18 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.335 -178.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.16 -38.67 87.8 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 121.046 1.164 . . . . 0.0 111.811 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.13 -39.38 92.39 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 120.424 -0.511 . . . . 0.0 109.871 -175.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -66.57 -38.01 86.16 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.998 177.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 93.5 t -61.73 -45.53 98.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -63.03 -37.3 86.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.697 -178.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -62.75 -41.84 99.4 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 119.254 -0.978 . . . . 0.0 108.707 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.4 -43.73 98.62 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-O 120.781 0.324 . . . . 0.0 110.623 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -62.53 -42.47 99.55 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 99.5 m -61.45 -45.67 93.32 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.224 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.05 -40.82 97.05 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -177.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.41 HD23 ' CE1' ' B' ' 119' ' ' PHE . 81.4 mt -62.72 -42.34 99.61 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 67.1 tp60 -63.48 -34.6 78.12 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -91.96 8.12 38.98 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.413 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 31.0 tttt 42.81 43.03 3.26 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.356 175.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -127.33 141.51 41.06 Favored Pre-proline 0 N--CA 1.469 0.508 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.556 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -62.09 141.01 87.13 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 120.806 1.004 . . . . 0.0 114.077 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.92 137.13 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 98.7 m -121.11 123.59 42.69 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.897 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 30.2 m -138.41 161.72 30.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.105 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -113.75 120.66 41.56 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 120.41 -0.516 . . . . 0.0 109.645 174.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 20.8 tt -127.79 132.21 69.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.317 -174.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . 0.423 HE22 ' HD1' ' B' ' 69' ' ' HIS . 84.6 mt-30 -70.35 140.39 52.17 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.261 177.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 94' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -131.25 177.61 7.34 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 121.516 0.674 . . . . 0.0 110.911 -178.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 95' ' ' TYR . . . . . 0.433 ' HH ' ' HB3' ' B' ' 68' ' ' LYS . 96.4 m-85 -128.83 143.66 50.97 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 114.447 -1.251 . . . . 0.0 111.954 177.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -100.09 179.25 4.55 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.283 0.563 . . . . 0.0 110.553 178.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.93 -36.64 79.86 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.843 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 38.5 p-10 -84.79 -1.74 56.75 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 121.426 -0.796 . . . . 0.0 112.912 177.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.06 5.59 65.81 Favored Glycine 0 N--CA 1.467 0.726 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.685 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 29.1 m -68.06 129.95 41.48 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 101' ' ' MET . . . . . 0.551 ' SD ' ' N ' ' B' ' 102' ' ' PHE . 15.3 tmm? -87.56 140.48 29.48 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 102' ' ' PHE . . . . . 0.551 ' N ' ' SD ' ' B' ' 101' ' ' MET . 53.7 p90 -151.72 163.01 40.07 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 103' ' ' TRP . . . . . 0.901 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 26.3 m95 -96.35 138.51 33.83 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.589 0.709 . . . . 0.0 110.72 178.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . 0.442 HD22 ' HG2' ' B' ' 123' ' ' GLN . 62.8 t-20 -133.55 109.6 9.35 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 114.669 -1.15 . . . . 0.0 113.467 -176.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 105' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' B' ' 123' ' ' GLN . 81.6 tt0 -79.16 125.56 29.59 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.768 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 40.0 tp -112.62 125.37 54.21 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -176.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 107' ' ' ASN . . . . . 0.412 ' HB2' ' HB ' ' B' ' 122' ' ' ILE . 98.2 m-20 -118.57 128.59 54.71 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 176.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 96.5 mt -123.75 132.68 70.96 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.467 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -145.93 121.9 5.76 Favored Pre-proline 0 CA--C 1.542 0.665 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -69.23 152.14 72.04 Favored 'Trans proline' 0 N--CA 1.504 2.093 0 C-N-CA 122.893 2.395 . . . . 0.0 112.942 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 111' ' ' MET . . . . . 0.443 ' HB2' ' HB2' ' B' ' 118' ' ' TYR . 67.0 mtt -129.99 143.26 50.7 Favored 'General case' 0 C--O 1.245 0.831 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 179.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -110.3 109.47 19.92 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . 0.648 HG12 ' NZ ' ' A' ' 18' ' ' LYS . 96.3 mt -132.46 128.01 57.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 177.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 50.61 38.53 19.13 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.999 178.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 61.46 37.07 16.88 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.51 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -134.21 151.26 51.22 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 177.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 6.9 t -102.47 154.41 19.12 Favored 'General case' 0 C--O 1.214 -0.785 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -177.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 118' ' ' TYR . . . . . 0.443 ' HB2' ' HB2' ' B' ' 111' ' ' MET . 96.7 m-85 -148.76 147.85 29.3 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 120.828 -1.17 . . . . 0.0 111.445 -178.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 119' ' ' PHE . . . . . 0.436 ' HB2' ' OG1' ' B' ' 30' ' ' THR . 96.3 m-85 -123.2 137.42 54.89 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 123.318 0.387 . . . . 0.0 110.758 -177.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -127.26 132.02 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -177.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.39 124.09 7.48 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 122' ' ' ILE . . . . . 0.412 ' HB ' ' HB2' ' B' ' 107' ' ' ASN . 94.4 mt -114.94 127.6 72.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -178.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 123' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' B' ' 26' ' ' GLY . 16.1 mp0 -118.67 120.47 37.53 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -119.91 120.93 37.84 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . 0.569 ' OD1' ' N ' ' B' ' 127' ' ' THR . 68.0 t0 -67.31 134.79 52.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.331 -0.849 . . . . 0.0 112.704 -177.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . 0.461 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 2.6 mp -108.4 14.48 8.21 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.856 0 CA-C-O 122.054 0.93 . . . . 0.0 108.858 178.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 127' ' ' THR . . . . . 0.569 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 98.5 m -62.72 -44.15 96.97 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 113.754 -1.566 . . . . 0.0 112.47 176.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -61.7 -45.66 93.01 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -177.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 129' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -62.84 -34.65 77.78 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.316 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 130' ' ' LYS . . . . . 0.901 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 98.7 mttt -63.06 -41.58 99.5 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-N 113.47 -1.696 . . . . 0.0 111.022 174.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.69 -42.31 98.01 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -60.12 -45.44 93.0 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 121.733 -0.604 . . . . 0.0 111.494 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.87 -36.6 84.86 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 120.233 -0.587 . . . . 0.0 109.601 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 134' ' ' LYS . . . . . 0.451 ' HG3' ' O ' ' B' ' 130' ' ' LYS . 98.8 mttt -62.86 -39.15 93.52 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.66 177.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 54.7 tp -62.9 -41.58 99.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.163 0.506 . . . . 0.0 109.819 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 90.3 mt -62.67 -42.11 99.44 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.253 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 137' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.39 -36.97 85.57 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.116 -1.402 . . . . 0.0 110.299 -178.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -63.11 -43.21 99.1 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.173 175.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 62.1 m -60.8 -43.93 97.49 Favored 'General case' 0 C--N 1.344 0.354 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' B' ' 144' ' ' THR . 88.1 mt -61.1 -40.42 93.68 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -176.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 98.6 m -61.88 -45.25 94.57 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.84 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -65.49 -42.78 91.78 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.96 -43.66 97.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.695 178.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 144' ' ' THR . . . . . 0.46 ' N ' ' O ' ' B' ' 140' ' ' LEU . 99.4 m -61.35 -45.69 93.34 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -177.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . 0.41 ' O ' ' HB ' ' B' ' 148' ' ' THR . . . -63.81 -40.81 97.51 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 119.041 -1.064 . . . . 0.0 109.581 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 90.0 mt -64.55 -40.64 95.95 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 177.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 147' ' ' SER . . . . . 0.587 ' O ' ' N ' ' B' ' 149' ' ' PRO . 77.4 p -61.36 -43.31 99.09 Favored 'General case' 0 CA--C 1.477 -1.831 0 C-N-CA 119.074 -1.05 . . . . 0.0 108.23 -178.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 148' ' ' THR . . . . . 0.511 ' C ' ' O ' ' B' ' 147' ' ' SER . 43.0 m -24.48 85.66 0.04 OUTLIER Pre-proline 0 N--CA 1.478 0.929 0 O-C-N 124.051 0.844 . . . . 0.0 110.364 176.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 149' ' ' PRO . . . . . 0.587 ' N ' ' O ' ' B' ' 147' ' ' SER . 24.2 Cg_exo -61.67 147.53 95.12 Favored 'Trans proline' 0 C--N 1.299 -2.04 0 C-N-CA 120.898 1.065 . . . . 0.0 113.197 -177.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 8.8 tp -126.7 124.18 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 172.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 43.0 t -155.13 95.13 2.58 Favored Pre-proline 0 C--N 1.314 -0.963 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.103 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -60.46 136.48 67.89 Favored 'Trans proline' 0 N--CA 1.484 0.931 0 N-CA-C 109.438 -1.024 . . . . 0.0 109.438 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 153' ' ' ILE . . . . . 0.511 HG21 HH12 ' A' ' 154' ' ' ARG . 45.6 mm -69.22 -43.44 81.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.09 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 154' ' ' ARG . . . . . 0.505 ' HD3' ' NH2' ' A' ' 154' ' ' ARG . 0.2 OUTLIER -155.9 -156.01 0.6 Allowed 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.923 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -86.62 110.58 19.93 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 97.54 -15.89 61.36 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 87.9 mt -111.35 126.15 68.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 120.651 0.262 . . . . 0.0 110.666 -176.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 158' ' ' SER . . . . . 0.659 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 71.4 m -134.22 150.45 51.05 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.13 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -133.6 147.2 51.48 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.203 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 17.1 tp -140.65 78.31 21.3 Favored Pre-proline 0 CA--C 1.532 0.254 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 161' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -70.7 148.69 59.5 Favored 'Trans proline' 0 N--CA 1.499 1.848 0 C-N-CA 122.791 2.327 . . . . 0.0 114.302 -178.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 86.0 mt -112.24 134.97 53.47 Favored 'General case' 0 C--N 1.343 0.326 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 55.7 t -129.19 131.71 67.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 112.79 169.6 17.67 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 120.436 -0.888 . . . . 0.0 111.149 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 165' ' ' ASN . . . . . 0.737 ' O ' ' CZ ' ' B' ' 170' ' ' ARG . 60.2 t30 -91.25 107.36 19.15 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -177.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 166' ' ' LEU . . . . . 0.461 ' CD2' ' CZ ' ' B' ' 171' ' ' PHE . 47.7 tp -64.79 104.5 0.84 Allowed 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -173.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 167' ' ' THR . . . . . 0.554 ' H ' ' HE ' ' B' ' 170' ' ' ARG . 10.5 p -84.0 169.79 14.62 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 114.117 -1.401 . . . . 0.0 110.925 176.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.57 -37.61 85.31 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.769 177.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.41 -40.08 89.36 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 123.176 1.465 . . . . 0.0 111.539 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 170' ' ' ARG . . . . . 0.737 ' CZ ' ' O ' ' B' ' 165' ' ' ASN . 88.0 mtm180 -62.19 -37.63 86.0 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 112.084 -2.325 . . . . 0.0 111.152 178.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 171' ' ' PHE . . . . . 0.461 ' CZ ' ' CD2' ' B' ' 166' ' ' LEU . 0.4 OUTLIER -53.81 -25.37 19.03 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -179.249 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 172' ' ' ASN . . . . . 0.595 ' O ' HG21 ' B' ' 175' ' ' VAL . 92.1 m-20 -62.57 -40.37 96.64 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.024 -0.671 . . . . 0.0 110.773 178.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 36.4 m -60.57 -41.13 93.97 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.974 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 67.5 mt -63.69 -44.09 98.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 175' ' ' VAL . . . . . 0.595 HG21 ' O ' ' B' ' 172' ' ' ASN . 28.8 m -62.96 -39.84 86.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 176' ' ' CYS . . . . . . . . . . . . . 98.8 m -62.31 -35.54 79.38 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.494 178.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 177' ' ' THR . . . . . 0.595 ' O ' HG13 ' B' ' 181' ' ' ILE . 24.9 m -61.67 -20.81 63.83 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.502 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 178' ' ' LEU . . . . . . . . . . . . . 88.2 mt -61.29 -39.91 92.2 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.241 -177.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 19.0 m -61.07 -44.69 96.99 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.523 176.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 180' ' ' ASN . . . . . 0.625 ' O ' ' OG ' ' B' ' 183' ' ' SER . 92.7 m-20 -61.94 -40.65 96.27 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.846 0.355 . . . . 0.0 110.585 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . 0.595 HG13 ' O ' ' B' ' 177' ' ' THR . 73.9 mt -56.31 -31.78 33.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 O-C-N 122.262 -0.274 . . . . 0.0 111.022 -177.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 182' ' ' LEU . . . . . . . . . . . . . 82.4 mt -62.29 -41.86 98.86 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.333 177.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 183' ' ' SER . . . . . 0.625 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.2 p -62.45 -32.48 73.36 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 121.756 -0.59 . . . . 0.0 110.891 177.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 184' ' ' THR . . . . . 0.443 ' OG1' ' HA ' ' B' ' 181' ' ' ILE . 22.6 p -85.39 16.89 3.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.745 -178.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 78.5 p -61.29 -16.86 49.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.466 -176.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.0 -40.51 95.88 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 121.051 -0.259 . . . . 0.0 110.468 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 187' ' ' ASP . . . . . 0.659 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.6 m-20 -71.07 113.78 8.45 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.294 0.568 . . . . 0.0 110.378 -177.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -62.94 -42.27 99.75 Favored 'General case' 0 C--O 1.247 0.936 0 CA-C-N 114.904 -1.044 . . . . 0.0 113.149 -177.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -111.58 131.57 55.16 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.956 -178.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 190' ' ' LEU . . . . . . . . . . . . . 44.3 tp -123.61 119.03 28.66 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.176 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 84.6 mt -107.09 125.11 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-N 117.8 0.273 . . . . 0.0 111.303 -176.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 49.0 mm -115.63 118.4 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 193' ' ' ASP . . . . . 0.561 ' OD2' ' OG ' ' B' ' 195' ' ' SER . 40.6 t0 -91.19 113.29 25.52 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -176.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 194' ' ' LEU . . . . . . . . . . . . . 96.3 mt -92.34 -2.23 56.52 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 123.325 0.391 . . . . 0.0 110.223 176.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 195' ' ' SER . . . . . 0.561 ' OG ' ' OD2' ' B' ' 193' ' ' ASP . 78.3 p -61.7 -37.69 85.09 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.704 -178.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.6 -34.37 88.24 Favored Glycine 0 N--CA 1.435 -1.375 0 C-N-CA 119.416 -1.373 . . . . 0.0 109.731 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 197' ' ' LEU . . . . . 1.22 HD23 ' O ' ' B' ' 199' ' ' GLN . 5.6 tt -76.78 132.97 39.53 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -177.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 198' ' ' ALA . . . . . 0.706 ' N ' HD21 ' B' ' 197' ' ' LEU . . . -64.48 -42.03 96.13 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 119.773 -0.771 . . . . 0.0 111.947 -178.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 199' ' ' GLN . . . . . 1.22 ' O ' HD23 ' B' ' 197' ' ' LEU . 59.0 tt0 -137.57 165.41 26.39 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.215 0.531 . . . . 0.0 111.425 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 200' ' ' VAL . . . . . 0.47 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 49.4 t -122.65 132.53 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -93.72 148.83 21.75 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.768 -177.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -60.99 -32.92 72.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.289 -178.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -63.91 -32.59 74.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.367 0.603 . . . . 0.0 109.482 177.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.3 m -60.71 -44.19 96.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.268 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 205' ' ' ALA . . . . . 0.617 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -59.45 -29.33 67.71 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 111.755 0.279 . . . . 0.0 111.755 -177.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -64.95 -38.98 92.76 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.878 175.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -66.86 -37.8 85.15 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.885 178.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.41 -43.17 98.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-O 122.009 0.909 . . . . 0.0 110.101 -178.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 209' ' ' PHE . . . . . 0.617 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 68.3 m-85 -62.28 -42.59 99.47 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 113.92 -1.491 . . . . 0.0 112.686 177.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.26 -41.58 99.06 Favored 'General case' 0 C--O 1.232 0.135 0 O-C-N 121.402 -0.811 . . . . 0.0 109.901 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 211' ' ' LEU . . . . . 0.415 ' O ' ' HG ' ' B' ' 215' ' ' LEU . 38.8 mt -62.29 -42.21 99.16 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.317 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 212' ' ' SER . . . . . 0.434 ' HG ' ' N ' ' B' ' 213' ' ' HIS . 78.0 p -63.84 -36.51 84.16 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.53 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 213' ' ' HIS . . . . . 0.434 ' N ' ' HG ' ' B' ' 212' ' ' SER . 59.4 t-80 -67.01 -47.29 71.91 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.176 178.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 54.2 tp -64.07 -42.6 96.93 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 121.956 0.884 . . . . 0.0 110.546 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 215' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' B' ' 211' ' ' LEU . 85.7 mt -62.83 -43.45 98.76 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 113.343 -1.753 . . . . 0.0 111.555 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.44 -40.04 93.0 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 -176.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 86.3 mt -63.39 -42.03 98.79 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 121.371 0.605 . . . . 0.0 111.374 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 218' ' ' THR . . . . . . . . . . . . . 69.9 p -73.88 -16.63 61.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.176 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 79.55 66.13 1.71 Allowed Glycine 0 CA--C 1.528 0.892 0 N-CA-C 106.831 -2.508 . . . . 0.0 106.831 -178.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 220' ' ' THR . . . . . . . . . . . . . 96.4 m -145.15 104.07 3.92 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 176.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -62.29 139.21 58.52 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.182 0.515 . . . . 0.0 110.954 -176.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 42.7 tp -115.87 121.84 43.56 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.532 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 3.5 mp -110.61 129.5 65.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.016 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 224' ' ' ILE . . . . . . . . . . . . . 50.0 mm -111.11 126.99 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 50.5 p -133.97 157.97 44.69 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-O 122.077 0.942 . . . . 0.0 112.72 -178.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 89.1 17.86 55.0 Favored Glycine 0 CA--C 1.502 -0.77 0 CA-C-N 113.683 -1.598 . . . . 0.0 111.588 -177.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 96.1 mt -81.17 126.26 39.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 121.808 -0.819 . . . . 0.0 111.371 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 59.4 tttt -66.57 140.53 96.54 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.298 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.75 -37.24 91.98 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 121.518 1.479 . . . . 0.0 112.363 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -64.18 -42.27 96.77 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -178.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 50.9 tp -62.52 -41.73 99.04 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.751 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.24 -37.2 86.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.784 0.326 . . . . 0.0 111.224 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 94.6 mtp -64.31 -41.0 97.04 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.663 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.78 -43.87 95.07 Favored 'General case' 0 CA--C 1.553 1.065 0 CA-C-O 122.632 1.206 . . . . 0.0 109.382 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 34.3 mmt -63.76 -36.29 83.4 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.167 -1.379 . . . . 0.0 111.894 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -63.32 -39.64 95.11 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.927 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -63.12 -44.45 95.59 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 56.1 tp -61.87 -44.72 96.25 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 120.358 -0.537 . . . . 0.0 112.027 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -157.14 132.59 9.18 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.972 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 240' ' ' ALA . . . . . . . . . . . . . . . -62.0 -45.34 94.05 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 177.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 241' ' ' ASN . . . . . 0.48 ' O ' ' HB2' ' B' ' 244' ' ' SER . 89.3 m-20 -45.45 -19.68 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.111 -175.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 242' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -61.7 -45.79 92.48 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.904 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 243' ' ' SER . . . . . . . . . . . . . 77.5 p -57.77 -44.14 85.98 Favored 'General case' 0 C--N 1.343 0.32 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 244' ' ' SER . . . . . 0.48 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 15.4 m -30.88 -36.14 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 95.3 mt -88.04 131.61 34.59 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.196 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -57.63 134.74 56.43 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.346 0.593 . . . . 0.0 110.918 -177.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 247' ' ' THR . . . . . . . . . . . . . 99.4 m -127.35 129.19 47.15 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.865 178.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -113.83 143.31 44.87 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 249' ' ' SER . . . . . 0.565 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 78.0 p -62.9 -34.32 77.17 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.275 -178.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 250' ' ' ASN . . . . . 0.565 ' OD1' ' O ' ' B' ' 249' ' ' SER . 99.0 m-20 -146.26 159.14 43.74 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.19 -0.913 . . . . 0.0 112.2 178.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 75.2 t -63.96 -44.83 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.889 178.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 252' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.05 -45.79 93.33 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -61.09 -43.28 99.13 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.378 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 254' ' ' ALA . . . . . . . . . . . . . . . -65.7 -39.99 91.81 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.319 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 255' ' ' VAL . . . . . . . . . . . . . 77.4 t -64.38 -45.88 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.584 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -63.17 -48.03 80.15 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.36 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 257' ' ' VAL . . . . . 0.493 ' O ' ' C ' ' B' ' 258' ' ' LEU . 26.5 m -64.66 -40.33 88.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.776 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 258' ' ' LEU . . . . . 0.519 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 1.3 mt -31.17 -74.97 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.597 -178.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 259' ' ' PRO . . . . . 0.519 ' CD ' ' CB ' ' B' ' 258' ' ' LEU . 36.7 Cg_endo -62.07 142.08 91.1 Favored 'Trans proline' 0 N--CA 1.501 1.928 0 C-N-CA 121.04 1.16 . . . . 0.0 110.983 -178.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 260' ' ' ILE . . . . . 0.476 HG13 ' O ' ' B' ' 259' ' ' PRO . 96.8 mt -158.84 -14.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-N 118.72 0.691 . . . . 0.0 112.054 176.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 78.1 mtm . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 117.921 -1.037 . . . . 0.0 111.905 -179.637 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.041 -1.623 . . . . 0.0 109.041 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.406 ' O ' ' OG ' ' A' ' 6' ' ' SER . . . -150.81 168.49 24.27 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 116.429 -1.748 . . . . 0.0 110.18 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.2 p -70.68 -19.4 62.79 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 124.633 1.208 . . . . 0.0 110.814 178.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -70.61 -68.4 0.43 Allowed 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.531 -1.213 . . . . 0.0 112.39 175.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.22 -38.67 88.51 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.594 ' O ' ' NZ ' ' B' ' 17' ' ' LYS . 69.2 m -59.63 -41.09 89.65 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.22 -178.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.468 ' CB ' ' O ' ' A' ' 6' ' ' SER . 36.3 t80 83.49 89.8 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 O-C-N 123.765 0.666 . . . . 0.0 111.556 176.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.557 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -64.79 -141.18 0.02 OUTLIER Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 -177.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.557 ' HB ' ' O ' ' A' ' 8' ' ' GLY . 78.4 mt 83.53 110.74 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 122.584 0.354 . . . . 0.0 110.726 -178.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.79 -22.38 63.73 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 121.485 1.456 . . . . 0.0 112.294 -178.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.23 -37.49 94.61 Favored Glycine 0 C--O 1.245 0.843 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.94 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -64.82 -39.37 93.47 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.366 0.603 . . . . 0.0 109.8 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.0 tp -63.57 -41.12 98.41 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -63.68 -40.8 97.71 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.5 t -60.26 -44.19 95.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 O-C-N 122.317 -0.239 . . . . 0.0 110.868 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 92.8 mt -62.49 -43.91 98.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -177.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.414 ' NZ ' ' O ' ' B' ' 6' ' ' SER . 98.9 mttt -62.26 -45.84 91.47 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 119.441 -0.904 . . . . 0.0 111.987 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.756 ' HZ3' HG12 ' B' ' 113' ' ' ILE . 98.9 mttt -60.66 -39.34 88.0 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 118.756 -1.178 . . . . 0.0 108.871 -175.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.86 -41.79 92.22 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.137 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.5 mt -62.85 -40.93 98.97 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.57 -38.27 90.49 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.484 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 57.0 m170 -58.52 -39.84 81.26 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 122.328 -0.232 . . . . 0.0 111.422 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.5 p -113.98 129.09 70.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.516 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 35.4 ptt180 -72.03 107.71 4.88 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 122.094 0.95 . . . . 0.0 111.93 -176.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.6 p -139.22 144.44 29.2 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 178.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.446 ' HA3' ' HB2' ' A' ' 123' ' ' GLN . . . -98.87 93.73 1.35 Allowed Glycine 0 C--O 1.221 -0.706 0 C-N-CA 120.749 -0.738 . . . . 0.0 113.015 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 50.5 t -125.14 129.69 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 176.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.1 m -137.04 159.1 36.7 Favored 'Isoleucine or valine' 0 C--O 1.246 0.881 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.5 mt -120.25 129.37 75.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 176.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 26.9 p -103.11 169.03 8.8 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 177.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -133.77 101.98 12.65 Favored Pre-proline 0 C--N 1.321 -0.663 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.739 178.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.442 ' HG3' HG22 ' A' ' 117' ' ' THR . 35.2 Cg_endo -63.26 -22.37 72.32 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 121.422 1.414 . . . . 0.0 111.408 -179.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.46 -33.9 74.54 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.155 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.1 mt -87.87 172.8 9.35 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.734 177.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.707 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 42.0 tt0 -68.86 132.11 46.23 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -176.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.509 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 56.7 t0 61.7 22.25 12.81 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.37 0.605 . . . . 0.0 112.564 177.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 36.6 t-20 43.22 67.13 3.9 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.968 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.707 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 95.4 Cg_endo -70.79 154.62 63.58 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 123.79 2.993 . . . . 0.0 111.979 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.5 mt -87.34 123.54 40.16 Favored 'Isoleucine or valine' 0 C--O 1.246 0.919 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.334 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.503 HG21 ' N ' ' A' ' 41' ' ' TYR . 30.0 m -103.99 -45.14 9.53 Favored 'Isoleucine or valine' 0 C--N 1.343 0.323 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.204 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.503 ' N ' HG21 ' A' ' 40' ' ' VAL . 45.3 t80 -93.4 123.64 36.84 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.636 -178.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.1 p -142.28 140.12 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 O-C-N 124.237 0.96 . . . . 0.0 109.348 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.572 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 57.3 p30 -97.3 166.01 11.76 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.457 ' HA ' ' OE1' ' A' ' 44' ' ' GLN . 13.6 mm100 -66.41 -38.92 88.55 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 176.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.7 -26.48 62.62 Favored Glycine 0 C--N 1.33 0.201 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.572 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 66.7 t80 -58.86 -47.82 83.54 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.592 HG11 ' O ' ' A' ' 52' ' ' TYR . 78.5 t -59.97 -44.74 95.26 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 O-C-N 121.171 -0.956 . . . . 0.0 111.558 -173.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -63.2 -38.45 91.22 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.653 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 57.7 ttm -66.48 -44.07 83.68 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 175.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.48 ' HG1' ' HB2' ' A' ' 52' ' ' TYR . 41.5 p -90.11 -23.02 21.5 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.084 0.469 . . . . 0.0 111.416 -178.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . 78.05 18.97 75.83 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 -178.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.592 ' O ' HG11 ' A' ' 47' ' ' VAL . 70.4 m-85 -113.29 138.38 50.11 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 122.857 0.463 . . . . 0.0 111.28 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -63.18 148.25 48.6 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.808 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.97 -32.44 73.93 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -178.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.01 -42.03 85.66 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 119.706 -0.797 . . . . 0.0 111.483 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -64.69 -46.75 81.03 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.224 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.427 HD13 ' CD2' ' A' ' 46' ' ' PHE . 97.7 mt -60.41 -50.49 80.11 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -175.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 86.9 mt -55.84 145.3 24.99 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.25 -4.37 81.36 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.024 176.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -136.31 152.79 51.06 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.181 1.491 . . . . 0.0 111.846 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.567 ' C ' ' H ' ' A' ' 63' ' ' ARG . 25.8 t-20 -81.19 150.8 28.5 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.232 0.539 . . . . 0.0 110.453 -178.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 80.1 m -63.11 15.21 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.365 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.567 ' H ' ' C ' ' A' ' 61' ' ' ASN . 34.5 ptt-85 -61.55 -41.63 97.66 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 122.09 -0.382 . . . . 0.0 111.31 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -55.28 -22.1 17.17 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -177.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 93.4 mt -65.89 -37.1 85.25 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.538 0.685 . . . . 0.0 112.639 177.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -62.17 138.1 58.36 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.121 -178.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.474 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -147.2 -148.07 4.68 Favored Glycine 0 CA--C 1.542 1.762 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.089 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.402 ' HB3' ' HH ' ' A' ' 95' ' ' TYR . 88.8 tttt -63.14 -40.4 97.49 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -177.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -76.61 -9.22 58.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.608 0.242 . . . . 0.0 111.008 -177.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.474 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 30.0 m -64.36 128.54 36.24 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.142 -0.623 . . . . 0.0 109.59 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -86.43 112.39 45.96 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.039 -178.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -57.48 -30.6 88.81 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 121.974 1.782 . . . . 0.0 113.09 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.75 -39.98 95.6 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.054 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -65.8 -43.61 88.18 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 177.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.9 t -60.2 -44.02 94.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 114.2 -1.364 . . . . 0.0 107.476 -176.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -64.63 -37.59 88.11 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.7 179.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -63.33 -40.03 96.18 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.391 0.615 . . . . 0.0 110.784 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.84 -44.1 98.03 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 CA-C-N 114.857 -1.065 . . . . 0.0 112.055 178.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -61.83 -42.72 99.38 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 113.91 -1.495 . . . . 0.0 108.333 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 92.3 m -60.13 -49.94 75.67 Favored 'General case' 0 C--O 1.246 0.896 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.32 -40.45 94.25 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.228 -170.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 84.8 mt -62.99 -40.33 97.43 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 118.723 0.692 . . . . 0.0 111.511 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -64.09 -40.39 96.12 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -72.06 -22.26 61.4 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.475 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.9 tttt 61.22 43.8 10.56 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.452 -176.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -126.7 149.09 67.37 Favored Pre-proline 0 N--CA 1.467 0.397 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -61.81 143.44 95.97 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 121.316 1.344 . . . . 0.0 113.368 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.04 141.72 33.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.809 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.45 ' CG2' ' OD1' ' A' ' 107' ' ' ASN . 96.6 m -126.31 122.18 34.73 Favored 'General case' 0 C--N 1.343 0.315 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 175.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 27.7 m -139.55 158.08 27.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.202 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -104.51 130.06 52.48 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 175.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.2 tt -139.89 128.01 25.88 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.087 0 CA-C-N 120.958 1.708 . . . . 0.0 112.369 178.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.71 136.66 58.13 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 114.495 -1.229 . . . . 0.0 109.899 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -137.06 159.69 41.14 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.671 -179.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.402 ' HH ' ' HB3' ' A' ' 68' ' ' LYS . 95.1 m-85 -118.65 136.67 53.78 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -177.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.473 ' HA ' ' HE1' ' A' ' 52' ' ' TYR . 99.2 mttt -87.03 -172.92 4.2 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.036 0.446 . . . . 0.0 111.621 -177.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.31 -43.85 97.88 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.384 178.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 41.1 p-10 -82.23 5.1 21.01 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.61 0.0 84.53 Favored Glycine 0 N--CA 1.467 0.758 0 C-N-CA 120.825 -0.703 . . . . 0.0 111.911 176.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 18.2 m -61.15 138.66 58.21 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 178.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.689 ' C ' ' SD ' ' A' ' 101' ' ' MET . 13.6 tmm? -104.66 129.85 52.77 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.88 0.372 . . . . 0.0 110.891 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.489 ' N ' ' SD ' ' A' ' 101' ' ' MET . 54.3 p90 -141.76 158.91 43.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.666 -177.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.804 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 25.0 m95 -90.34 143.54 26.67 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.425 HD22 ' HG2' ' A' ' 123' ' ' GLN . 59.4 t-20 -138.2 101.7 4.47 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -177.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 80.4 tt0 -66.91 136.18 54.98 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -176.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 38.3 tp -120.35 123.74 43.84 Favored 'General case' 0 C--O 1.233 0.185 0 O-C-N 123.739 0.649 . . . . 0.0 112.424 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.45 ' OD1' ' CG2' ' A' ' 89' ' ' THR . 98.5 m-20 -121.38 122.67 40.33 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.598 177.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 95.5 mt -120.04 128.23 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 O-C-N 123.523 0.514 . . . . 0.0 111.215 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -136.33 122.99 14.04 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 116.942 -0.117 . . . . 0.0 110.716 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -71.78 150.81 56.63 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.281 1.988 . . . . 0.0 112.602 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.424 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 66.7 mtt -124.17 154.62 39.82 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -128.0 94.41 3.92 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 176.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 96.4 mt -119.69 130.84 73.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.563 -178.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 50.15 37.61 15.04 Favored 'General case' 0 CA--C 1.518 -0.252 0 O-C-N 121.661 -0.649 . . . . 0.0 111.476 176.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 58.77 29.3 18.52 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.884 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -125.89 147.56 49.44 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.751 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 8.4 t -83.79 -173.38 4.68 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.431 -0.793 . . . . 0.0 109.517 -178.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.751 ' CD2' ' O ' ' A' ' 117' ' ' THR . 83.5 m-85 -171.02 154.06 4.0 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 173.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -128.87 145.15 51.29 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 174.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.5 p -134.41 135.17 54.31 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 177.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.91 129.32 9.56 Favored Glycine 0 CA--C 1.505 -0.565 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 178.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.434 ' HB ' ' HB2' ' A' ' 107' ' ' ASN . 96.9 mt -117.77 128.82 74.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.452 ' HA ' ' O ' ' A' ' 105' ' ' GLU . 17.4 mp0 -119.13 116.63 26.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.145 0.498 . . . . 0.0 109.929 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -116.09 113.38 23.07 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.112 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 126' ' ' ILE . 68.2 t0 -63.8 128.74 37.16 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -176.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.414 ' N ' ' OD1' ' A' ' 125' ' ' ASP . 2.7 mp -96.29 3.88 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 113.951 -1.477 . . . . 0.0 110.398 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.5 m -60.05 -42.64 94.9 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.335 -0.853 . . . . 0.0 113.234 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -59.87 -42.32 93.46 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -63.69 -40.13 96.05 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.521 177.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.804 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.5 mttt -62.92 -41.42 99.46 Favored 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 118.393 -1.323 . . . . 0.0 110.359 -178.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -61.68 -36.69 81.58 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.424 ' CE2' HD13 ' A' ' 136' ' ' LEU . 85.8 t80 -61.82 -44.74 96.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.369 176.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.74 -38.74 92.0 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.97 -40.91 97.2 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 54.8 tp -61.26 -43.85 98.2 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.424 HD13 ' CE2' ' A' ' 132' ' ' TYR . 86.6 mt -62.54 -41.06 98.64 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.242 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.91 -41.02 97.44 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.915 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -60.82 -42.17 97.17 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -178.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 58.3 m -61.54 -41.55 97.52 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.677 177.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.464 ' O ' ' N ' ' A' ' 144' ' ' THR . 86.9 mt -64.08 -41.88 97.15 Favored 'General case' 0 C--O 1.224 -0.274 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 91.8 m -61.22 -46.03 92.11 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.38 -177.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -64.79 -40.24 94.91 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 95.7 mt -64.47 -43.49 96.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 113.939 -1.482 . . . . 0.0 111.219 177.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.464 ' N ' ' O ' ' A' ' 140' ' ' LEU . 92.7 m -62.71 -45.95 90.39 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.773 -0.579 . . . . 0.0 112.332 -178.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.4 -40.16 96.46 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 118.853 -1.139 . . . . 0.0 108.991 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 85.2 mt -63.5 -42.57 98.5 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.472 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.746 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.1 p -60.87 -38.78 86.75 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 -178.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.491 ' C ' ' O ' ' A' ' 147' ' ' SER . 31.9 m -27.22 79.85 0.02 OUTLIER Pre-proline 0 N--CA 1.467 0.415 0 O-C-N 126.531 2.394 . . . . 0.0 106.591 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.746 ' N ' ' O ' ' A' ' 147' ' ' SER . 20.9 Cg_exo -62.53 144.46 94.56 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 120.947 1.098 . . . . 0.0 114.666 -173.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.507 ' O ' ' CG2' ' A' ' 151' ' ' VAL . 9.5 tp -121.44 135.2 62.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 102.928 -2.99 . . . . 0.0 102.928 176.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.507 ' CG2' ' O ' ' A' ' 150' ' ' ILE . 99.6 t -167.55 91.81 0.69 Allowed Pre-proline 0 CA--C 1.513 -0.46 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 178.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -61.49 136.26 62.26 Favored 'Trans proline' 0 C--N 1.3 -2.011 0 N-CA-C 109.323 -1.068 . . . . 0.0 109.323 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.491 ' O ' ' HD2' ' A' ' 154' ' ' ARG . 45.5 mm -67.83 -44.34 85.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 119.932 -0.707 . . . . 0.0 110.795 179.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.491 ' HD2' ' O ' ' A' ' 153' ' ' ILE . 0.2 OUTLIER -156.89 -156.39 0.61 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.437 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.455 ' ND2' ' HE3' ' B' ' 256' ' ' LYS . 63.7 t-20 -87.51 105.14 17.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 122.08 0.943 . . . . 0.0 112.008 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 88.98 9.19 68.12 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.758 -177.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.0 mt -126.19 125.36 67.62 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 CA-C-O 121.546 0.689 . . . . 0.0 109.231 174.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.575 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 42.5 m -133.26 152.22 51.93 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.061 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -137.67 141.95 41.13 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.753 -0.592 . . . . 0.0 111.286 177.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 18.0 tp -133.93 78.33 60.33 Favored Pre-proline 0 N--CA 1.47 0.564 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.243 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -70.21 151.63 66.57 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.82 2.347 . . . . 0.0 113.096 -179.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 88.3 mt -117.47 128.76 55.31 Favored 'General case' 0 C--O 1.25 1.089 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.388 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 49.3 t -123.82 130.9 73.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 115.05 170.08 16.22 Favored Glycine 0 N--CA 1.479 1.539 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.042 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.939 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 55.9 t30 -85.05 115.29 22.78 Favored 'General case' 0 C--O 1.213 -0.841 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.419 ' CD2' ' CZ ' ' A' ' 171' ' ' PHE . 41.8 tp -73.67 105.34 4.95 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -177.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.636 ' H ' ' HE ' ' A' ' 170' ' ' ARG . 16.6 p -87.55 165.87 15.16 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.01 178.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -66.72 -33.51 75.8 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.506 0.669 . . . . 0.0 111.455 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.7 -41.36 92.43 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.686 178.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.939 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 87.6 mtm180 -64.71 -33.16 75.31 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 124.173 0.989 . . . . 0.0 112.233 176.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.419 ' CZ ' ' CD2' ' A' ' 166' ' ' LEU . 0.6 OUTLIER -54.33 -28.76 44.87 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.11 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.499 ' O ' HG21 ' A' ' 175' ' ' VAL . 92.6 m-20 -60.53 -41.19 93.94 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 119.003 -1.079 . . . . 0.0 109.857 -178.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 67.3 m -59.57 -41.15 89.54 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.692 -178.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 66.6 mt -63.33 -44.05 98.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.499 HG21 ' O ' ' A' ' 172' ' ' ASN . 30.5 m -62.72 -39.67 85.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . 0.444 ' N ' HG23 ' A' ' 175' ' ' VAL . 98.8 m -61.8 -34.5 76.02 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.262 0.553 . . . . 0.0 110.294 178.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' THR . . . . . 0.53 ' O ' HG13 ' A' ' 181' ' ' ILE . 25.3 m -62.22 -20.4 64.17 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.131 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 89.9 mt -61.12 -41.54 96.9 Favored 'General case' 0 C--O 1.246 0.887 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 16.9 m -58.87 -43.34 90.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.532 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . 0.593 ' O ' ' OG ' ' A' ' 183' ' ' SER . 92.2 m-20 -61.98 -37.98 86.85 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 122.558 0.343 . . . . 0.0 110.954 178.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 177' ' ' THR . 70.3 mt -58.62 -37.9 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 86.0 mt -60.65 -40.82 93.42 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.015 -177.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.593 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 78.1 p -61.98 -33.32 74.09 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.486 176.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.472 ' OG1' ' HA ' ' A' ' 181' ' ' ILE . 19.2 p -89.67 24.69 2.25 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.561 0.219 . . . . 0.0 111.267 -178.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 78.0 p -63.62 -20.29 65.55 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.198 0.523 . . . . 0.0 110.746 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.17 -37.19 79.42 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.825 -178.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.575 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 99.0 m-20 -74.88 113.88 12.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.457 0.646 . . . . 0.0 110.972 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.83 -42.44 99.73 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.056 -0.975 . . . . 0.0 112.885 -177.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -112.03 131.02 55.67 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.202 0.525 . . . . 0.0 110.912 -178.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 38.6 tp -120.25 128.89 53.76 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 96.2 mt -117.05 126.59 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 118.587 0.63 . . . . 0.0 109.582 177.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.6 mm -112.66 126.43 70.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . 0.502 ' OD2' ' OG ' ' A' ' 195' ' ' SER . 39.5 t0 -94.82 118.57 31.98 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 121.949 0.881 . . . . 0.0 110.46 177.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 95.7 mt -96.93 -3.79 41.17 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.257 175.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' SER . . . . . 0.502 ' OG ' ' OD2' ' A' ' 193' ' ' ASP . 78.2 p -61.72 -32.72 72.96 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.82 -42.51 99.75 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 108.766 -1.734 . . . . 0.0 108.766 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 1.18 HD23 ' O ' ' A' ' 199' ' ' GLN . 5.1 tt -72.57 128.59 36.03 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 112.975 -1.612 . . . . 0.0 108.862 -176.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.687 ' N ' HD21 ' A' ' 197' ' ' LEU . . . -60.94 -49.01 79.17 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.203 -178.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 1.18 ' O ' HD23 ' A' ' 197' ' ' LEU . 57.7 tt0 -132.79 155.53 48.76 Favored 'General case' 0 C--O 1.206 -1.219 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -175.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.401 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 53.1 t -117.13 132.43 66.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 O-C-N 120.133 -1.605 . . . . 0.0 108.875 178.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -86.16 156.16 20.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.662 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.3 -38.5 90.43 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.181 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -58.37 -31.7 67.88 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -178.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 17.6 m -60.86 -42.48 97.95 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.659 177.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.523 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -57.05 -38.74 73.67 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -177.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -62.12 -37.39 84.95 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -178.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -64.94 -39.42 93.48 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.103 177.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.29 -44.64 99.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 C-N-CA 119.525 -0.87 . . . . 0.0 108.941 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . 0.523 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 69.1 m-85 -61.65 -43.56 98.63 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.413 -178.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.0 -42.35 99.06 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 119.313 -0.955 . . . . 0.0 109.103 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.427 ' O ' ' HG ' ' A' ' 215' ' ' LEU . 40.1 mt -61.65 -42.27 98.67 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 78.1 p -61.89 -41.66 98.15 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 119.351 -0.939 . . . . 0.0 110.116 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -64.06 -45.91 86.69 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.787 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 53.9 tp -62.12 -46.14 90.37 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 211' ' ' LEU . 84.2 mt -62.56 -40.56 97.22 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.627 -176.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -61.59 -43.1 99.49 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -178.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 85.9 mt -61.8 -39.63 92.4 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 74.8 p -76.68 -11.59 59.87 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.242 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 81.26 38.63 14.45 Favored Glycine 0 C--O 1.217 -0.909 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.329 -178.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 94.7 m -123.95 112.85 17.71 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.024 1.412 . . . . 0.0 111.658 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -63.07 136.63 57.91 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.2 178.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 44.2 tp -114.43 130.63 56.72 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 3.4 mp -118.21 135.36 58.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 122.867 0.467 . . . . 0.0 109.849 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.455 HG23 HD11 ' A' ' 224' ' ' ILE . 49.0 mm -114.85 131.74 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 43.8 p -132.89 167.35 20.38 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 120.854 -0.338 . . . . 0.0 111.876 -178.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 77.31 20.47 74.98 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 97.5 mt -81.79 128.6 38.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 114.043 -1.078 . . . . 0.0 108.77 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 66.9 tttt -75.43 140.82 72.59 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.09 -39.28 86.34 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 121.138 1.225 . . . . 0.0 112.496 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -64.04 -39.31 93.8 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-O 121.829 0.823 . . . . 0.0 110.318 -178.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 49.6 tp -64.18 -42.23 96.77 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.845 -1.071 . . . . 0.0 112.721 177.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.74 -37.27 87.01 Favored 'General case' 0 CA--C 1.521 -0.154 0 O-C-N 121.753 -0.592 . . . . 0.0 111.198 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 94.5 mtp -63.7 -41.35 98.13 Favored 'General case' 0 C--O 1.247 0.959 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -178.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -63.7 -40.33 96.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.668 177.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 37.7 mmt -65.33 -37.13 86.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.823 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -60.51 -41.54 94.57 Favored 'General case' 0 CA--C 1.515 -0.385 0 O-C-N 121.544 -0.723 . . . . 0.0 109.408 -177.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.59 -40.74 92.88 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.238 0.542 . . . . 0.0 110.505 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 52.2 tp -62.89 -40.96 99.15 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 177.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 240' ' ' ALA . 67.1 t0 -169.53 130.26 1.07 Allowed 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.5 -0.75 . . . . 0.0 112.486 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . 0.416 ' N ' ' OD1' ' A' ' 239' ' ' ASP . . . -60.93 -26.89 67.82 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.811 178.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . 0.504 ' O ' ' HB2' ' A' ' 244' ' ' SER . 87.6 m-20 -60.68 -30.42 69.91 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.691 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -55.83 -43.34 76.91 Favored 'General case' 0 C--N 1.311 -1.086 0 O-C-N 121.399 -0.813 . . . . 0.0 109.056 -176.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 94.7 p -63.15 -19.12 64.18 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.043 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' SER . . . . . 0.504 ' HB2' ' O ' ' A' ' 241' ' ' ASN . 70.9 m -54.94 -37.04 65.93 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.405 177.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 95.0 mt -89.19 119.26 29.52 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 119.732 -0.787 . . . . 0.0 112.93 -177.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -42.65 135.55 2.82 Favored 'General case' 0 C--O 1.244 0.773 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.68 -178.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 97.7 m -126.52 132.72 51.32 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.198 -1.364 . . . . 0.0 111.043 178.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -117.54 141.18 48.66 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.978 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' SER . . . . . 0.467 ' O ' ' OD1' ' A' ' 250' ' ' ASN . 77.3 p -62.2 -41.03 97.98 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -178.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.467 ' OD1' ' O ' ' A' ' 249' ' ' SER . 98.9 m-20 -146.15 160.58 41.75 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.63 0.729 . . . . 0.0 111.155 -178.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 70.2 t -62.8 -45.13 99.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.142 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.04 -44.51 97.29 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.633 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -63.74 -42.32 97.89 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.343 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . 0.44 ' O ' HG21 ' A' ' 257' ' ' VAL . . . -65.19 -41.93 94.08 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.829 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 57.3 t -63.73 -45.61 96.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.927 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.81 -47.83 79.28 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.513 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . 0.487 ' O ' ' C ' ' A' ' 258' ' ' LEU . 21.7 m -66.36 -40.11 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 120.048 -0.661 . . . . 0.0 112.314 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.487 ' C ' ' O ' ' A' ' 257' ' ' VAL . 1.0 OUTLIER -30.18 -73.41 0.05 OUTLIER Pre-proline 0 C--N 1.345 0.41 0 C-N-CA 121.041 -0.264 . . . . 0.0 111.347 -176.892 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' A' ' 258' ' ' LEU . 41.0 Cg_endo -63.6 139.85 72.05 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 120.891 1.061 . . . . 0.0 112.117 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 259' ' ' PRO . 96.7 mt -152.12 -28.23 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 116.154 -0.476 . . . . 0.0 112.248 178.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.658 -177.151 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.558 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.7 159.58 40.81 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 118.974 -0.536 . . . . 0.0 109.994 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 79.7 p -59.59 -21.49 60.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 122.101 0.953 . . . . 0.0 110.877 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -73.66 -64.95 0.89 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.042 -177.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -66.39 -38.67 88.04 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.931 177.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' SER . . . . . 0.474 ' O ' ' CB ' ' B' ' 7' ' ' PHE . 68.5 m -59.87 -41.7 92.11 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 120.425 -0.51 . . . . 0.0 109.904 -178.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . 0.474 ' CB ' ' O ' ' B' ' 6' ' ' SER . 37.7 t80 84.54 92.98 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 O-C-N 123.844 0.715 . . . . 0.0 110.268 177.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . 0.568 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -67.06 -140.75 0.05 OUTLIER Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -178.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . 0.568 ' HB ' ' O ' ' B' ' 8' ' ' GLY . 75.9 mt 82.98 110.81 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.69 0 C-N-CA 122.519 0.328 . . . . 0.0 111.045 -178.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.14 -23.65 66.65 Favored 'Trans proline' 0 N--CA 1.499 1.806 0 C-N-CA 121.369 1.379 . . . . 0.0 111.936 -178.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.08 -39.7 97.96 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -64.53 -39.7 94.26 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.587 0.708 . . . . 0.0 109.652 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 50.7 tp -61.71 -42.66 99.25 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.21 -177.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -65.3 -33.59 76.35 Favored 'General case' 0 CA--C 1.562 1.418 0 CA-C-O 121.514 0.673 . . . . 0.0 110.523 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 76.0 t -62.83 -45.75 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 113.135 -1.848 . . . . 0.0 111.086 177.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 95.0 mt -64.11 -43.79 97.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.177 -178.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . 0.594 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 98.9 mttt -63.41 -42.13 98.74 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.38 -41.13 98.78 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.973 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.45 -38.81 85.32 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.522 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . 0.406 ' O ' ' O ' ' B' ' 23' ' ' VAL . 83.4 mt -63.61 -42.34 98.21 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.154 0.502 . . . . 0.0 110.152 175.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -62.84 -38.61 91.45 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.128 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 55.9 m170 -57.79 -39.91 78.65 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 121.153 -0.219 . . . . 0.0 111.38 -178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . 0.406 ' O ' ' O ' ' B' ' 20' ' ' LEU . 10.6 p -114.19 129.36 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.52 ' O ' ' HG3' ' B' ' 24' ' ' ARG . 35.1 ptt180 -71.84 105.9 3.97 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 121.971 0.891 . . . . 0.0 112.421 -176.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.0 p -141.77 134.45 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.471 178.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . 0.476 ' O ' ' N ' ' B' ' 123' ' ' GLN . . . -89.33 98.22 2.42 Favored Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 119.525 -1.321 . . . . 0.0 113.054 -175.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 48.6 t -126.03 129.01 72.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 174.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 26.9 m -138.82 156.59 28.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.857 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.402 HG21 HD13 ' B' ' 29' ' ' ILE . 96.0 mt -119.81 125.04 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 122.753 1.263 . . . . 0.0 111.595 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.422 ' HB ' ' OD1' ' B' ' 37' ' ' ASN . 37.4 p -104.17 159.45 15.68 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 113.266 -1.788 . . . . 0.0 108.844 -178.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -126.59 103.26 25.1 Favored Pre-proline 0 C--O 1.238 0.462 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.58 -19.59 65.01 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 121.88 1.72 . . . . 0.0 111.355 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.59 -41.63 97.71 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.677 -0.409 . . . . 0.0 109.922 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 94.9 mt -77.08 -172.7 2.47 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.823 -0.548 . . . . 0.0 111.209 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . 0.709 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 42.0 tt0 -79.69 130.94 35.79 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.446 ' O ' ' C ' ' B' ' 37' ' ' ASN . 61.9 t0 55.21 39.61 31.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.672 177.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' ASN . . . . . 0.446 ' C ' ' O ' ' B' ' 36' ' ' ASP . 23.1 t-20 29.8 69.73 0.61 Allowed Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.709 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 92.8 Cg_endo -72.08 153.91 57.42 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 123.449 2.766 . . . . 0.0 111.696 178.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 96.3 mt -86.58 128.33 39.62 Favored 'Isoleucine or valine' 0 C--O 1.246 0.901 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.487 HG21 ' N ' ' B' ' 41' ' ' TYR . 30.1 m -108.15 -44.77 6.94 Favored 'Isoleucine or valine' 0 C--N 1.341 0.214 0 O-C-N 123.933 0.77 . . . . 0.0 112.631 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' TYR . . . . . 0.487 ' N ' HG21 ' B' ' 40' ' ' VAL . 47.6 t80 -94.38 123.77 37.99 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.27 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 6.3 p -142.14 140.91 29.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 O-C-N 124.033 0.833 . . . . 0.0 109.414 178.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . 0.602 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 56.8 p30 -101.21 161.4 13.64 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.128 178.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' GLN . . . . . 0.454 ' HA ' ' OE1' ' B' ' 44' ' ' GLN . 13.1 mm100 -63.11 -37.77 88.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.624 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.89 -26.69 63.35 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.602 ' HB2' ' OD1' ' B' ' 43' ' ' ASN . 61.9 t80 -60.19 -43.54 95.82 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . 0.758 HG11 ' O ' ' B' ' 52' ' ' TYR . 75.3 t -61.46 -45.95 97.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.276 -179.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -62.96 -44.69 95.35 Favored 'General case' 0 C--N 1.323 -0.543 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.251 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 57.9 ttm -63.11 -42.55 99.59 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' THR . . . . . 0.425 ' HG1' ' HB2' ' B' ' 52' ' ' TYR . 40.9 p -93.53 -17.28 23.56 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.776 -177.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' B' ' 47' ' ' VAL . . . 73.44 17.71 79.08 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . 0.758 ' O ' HG11 ' B' ' 47' ' ' VAL . 70.0 m-85 -111.12 146.01 37.58 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 122.944 0.497 . . . . 0.0 110.349 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -74.4 147.16 42.33 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.45 0.643 . . . . 0.0 111.302 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.36 -38.65 84.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.05 -177.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.23 -39.17 93.86 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 120.103 -0.639 . . . . 0.0 111.81 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -72.3 -31.66 65.9 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 176.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . 0.437 HD13 ' CD2' ' B' ' 46' ' ' PHE . 91.8 mt -68.61 -71.67 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 176.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 96.8 mt -37.25 133.3 0.69 Allowed 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.813 178.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.1 -11.01 71.31 Favored Glycine 0 CA--C 1.537 1.418 0 CA-C-N 116.059 -0.519 . . . . 0.0 113.001 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -133.9 150.19 51.33 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -174.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' ASN . . . . . 0.584 ' C ' ' H ' ' B' ' 63' ' ' ARG . 25.9 t-20 -79.53 149.41 31.45 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.41 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' CYS . . . . . . . . . . . . . 81.8 m -62.74 10.08 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.372 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' ARG . . . . . 0.584 ' H ' ' C ' ' B' ' 61' ' ' ASN . 33.3 ptt-85 -60.61 -33.54 72.91 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.323 -177.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -58.92 -29.88 67.41 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 178.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 87.3 mt -62.2 -41.31 98.25 Favored 'General case' 0 C--O 1.238 0.466 0 O-C-N 121.573 -0.705 . . . . 0.0 109.686 -178.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -51.82 146.25 8.44 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.857 -176.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -156.71 -153.29 6.58 Favored Glycine 0 CA--C 1.534 1.242 0 O-C-N 123.886 0.741 . . . . 0.0 111.831 177.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.31 -41.21 93.0 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -176.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -75.95 -11.1 59.9 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.945 -178.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 28.5 m -62.02 133.7 55.68 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 120.229 -0.589 . . . . 0.0 109.427 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -91.02 112.61 54.6 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.639 -179.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.38 -37.56 89.17 Favored 'Trans proline' 0 N--CA 1.489 1.219 0 C-N-CA 121.074 1.183 . . . . 0.0 111.734 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.99 -40.51 89.41 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.793 -176.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -66.84 -39.39 87.6 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.078 177.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 75.2 t -61.82 -46.43 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -63.15 -36.99 85.45 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.76 -178.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -62.27 -42.11 99.05 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 119.371 -0.932 . . . . 0.0 109.0 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 95.5 mt -63.57 -43.44 98.25 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 CA-C-O 120.751 0.31 . . . . 0.0 110.841 -178.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -61.16 -42.39 98.47 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 76.5 m -61.15 -45.06 96.21 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.352 0.596 . . . . 0.0 110.017 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.12 -40.34 97.32 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -177.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 81.8 mt -62.65 -42.81 99.81 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.034 -0.666 . . . . 0.0 109.38 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 67.6 tp60 -63.21 -38.95 93.19 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -81.99 -4.36 56.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.92 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 45.7 tttt 50.33 43.72 26.62 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.548 176.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -127.95 146.42 59.03 Favored Pre-proline 0 N--CA 1.466 0.349 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.421 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -62.41 140.41 82.11 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 120.973 1.115 . . . . 0.0 113.893 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.58 135.9 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.725 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 89' ' ' THR . . . . . 0.467 ' CG2' ' OD1' ' B' ' 107' ' ' ASN . 93.7 m -121.01 123.45 42.44 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 29.4 m -138.64 162.74 28.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.76 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -115.91 119.8 37.12 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.931 -0.48 . . . . 0.0 109.78 174.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 20.6 tt -127.99 132.44 68.64 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.807 -174.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -70.98 144.42 50.5 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.899 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 94' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -133.62 -179.41 5.51 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-O 121.435 0.636 . . . . 0.0 111.489 -178.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 95' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -131.46 145.95 52.02 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.146 177.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . 0.449 ' HA ' ' HE1' ' B' ' 52' ' ' TYR . 98.8 mttt -103.45 -180.0 4.11 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.402 0.62 . . . . 0.0 110.658 178.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.46 -35.9 76.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.502 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 38.4 p-10 -86.82 -1.44 57.78 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.42 -0.8 . . . . 0.0 112.928 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.89 3.7 63.85 Favored Glycine 0 N--CA 1.466 0.695 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.464 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 21.7 m -68.48 129.41 39.84 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.274 -0.57 . . . . 0.0 109.478 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 101' ' ' MET . . . . . 0.594 ' SD ' ' N ' ' B' ' 102' ' ' PHE . 15.0 tmm? -88.3 143.44 27.02 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 102' ' ' PHE . . . . . 0.594 ' N ' ' SD ' ' B' ' 101' ' ' MET . 54.4 p90 -153.28 163.5 39.79 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 178.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 103' ' ' TRP . . . . . 0.826 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 25.3 m95 -95.71 139.72 31.55 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.614 0.721 . . . . 0.0 110.468 178.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . 0.411 HD22 ' HG2' ' B' ' 123' ' ' GLN . 64.8 t-20 -133.66 105.85 7.06 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 114.804 -1.089 . . . . 0.0 113.783 -177.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 105' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' B' ' 123' ' ' GLN . 81.1 tt0 -73.87 124.24 25.75 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.999 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 37.3 tp -112.04 125.42 54.07 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-O 120.936 0.398 . . . . 0.0 111.631 -177.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 107' ' ' ASN . . . . . 0.479 ' HB2' ' HB ' ' B' ' 122' ' ' ILE . 98.3 m-20 -120.15 127.87 52.89 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 176.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 95.8 mt -122.66 132.59 70.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -141.79 121.55 8.2 Favored Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -70.32 151.88 66.11 Favored 'Trans proline' 0 N--CA 1.501 1.924 0 C-N-CA 122.434 2.09 . . . . 0.0 112.505 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 66.6 mtt -130.87 143.12 50.5 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -112.12 107.4 16.31 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 178.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . 0.756 HG12 ' HZ3' ' A' ' 18' ' ' LYS . 96.8 mt -133.32 127.54 54.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-N 118.521 0.6 . . . . 0.0 111.596 177.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 52.54 38.18 25.0 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.88 178.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 58.86 37.04 24.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.53 -178.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -132.82 150.68 52.13 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 9.4 t -101.4 152.46 20.7 Favored 'General case' 0 C--O 1.217 -0.628 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -177.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -147.39 146.48 29.63 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 120.791 -1.193 . . . . 0.0 111.189 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -123.07 137.75 54.85 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.765 -177.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -128.86 133.36 66.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 -177.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.57 123.17 6.9 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 122' ' ' ILE . . . . . 0.479 ' HB ' ' HB2' ' B' ' 107' ' ' ASN . 92.4 mt -112.33 127.43 69.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 123' ' ' GLN . . . . . 0.476 ' N ' ' O ' ' B' ' 26' ' ' GLY . 17.5 mp0 -117.93 123.58 46.16 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -120.13 121.16 38.19 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' B' ' 127' ' ' THR . 68.2 t0 -69.39 131.72 45.25 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.588 -179.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . 0.51 ' O ' ' HG3' ' B' ' 130' ' ' LYS . 2.7 mp -107.51 17.82 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.807 0 CA-C-O 122.097 0.951 . . . . 0.0 109.095 178.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 127' ' ' THR . . . . . 0.548 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 99.3 m -63.85 -44.04 94.32 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.24 -1.345 . . . . 0.0 112.501 175.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 59.9 tptt -60.88 -46.15 91.76 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 129' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -63.21 -36.19 82.81 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.146 -0.933 . . . . 0.0 111.499 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 130' ' ' LYS . . . . . 0.826 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 98.5 mttt -63.57 -41.42 98.39 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-N 113.779 -1.555 . . . . 0.0 110.511 175.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.99 -41.46 97.51 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 132' ' ' TYR . . . . . 0.409 ' CE2' HD13 ' B' ' 136' ' ' LEU . 86.2 t80 -59.78 -44.11 94.07 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 121.663 -0.648 . . . . 0.0 111.156 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . 0.402 ' O ' ' HG3' ' B' ' 137' ' ' GLU . 97.6 mt-10 -64.61 -36.96 85.93 Favored 'General case' 0 C--O 1.224 -0.254 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.563 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 134' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' B' ' 130' ' ' LYS . 99.0 mttt -62.94 -39.57 95.01 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.676 178.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 54.5 tp -63.01 -41.56 99.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.32 0.581 . . . . 0.0 109.811 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 136' ' ' LEU . . . . . 0.409 HD13 ' CE2' ' B' ' 132' ' ' TYR . 89.2 mt -63.01 -41.28 99.53 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.404 177.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 137' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' B' ' 133' ' ' GLU . 97.2 mt-10 -64.37 -36.54 84.47 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.357 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.77 -43.47 96.31 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.915 176.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 62.3 m -60.87 -45.76 93.29 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 88.5 mt -60.87 -40.33 92.53 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 99.7 m -61.86 -45.44 93.79 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.97 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -66.3 -42.1 88.8 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 94.9 mt -63.11 -43.62 99.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.642 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 144' ' ' THR . . . . . 0.427 ' HA ' ' HG ' ' B' ' 147' ' ' SER . 93.4 m -61.78 -45.66 92.93 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.25 -41.31 99.04 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 119.021 -1.072 . . . . 0.0 109.369 178.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 87.5 mt -64.58 -41.12 96.47 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 177.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 147' ' ' SER . . . . . 0.64 ' O ' ' N ' ' B' ' 149' ' ' PRO . 78.2 p -61.76 -40.84 96.56 Favored 'General case' 0 CA--C 1.479 -1.779 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 148' ' ' THR . . . . . 0.486 ' C ' ' O ' ' B' ' 147' ' ' SER . 20.6 m -27.92 84.24 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.657 0 O-C-N 124.128 0.892 . . . . 0.0 110.143 177.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 149' ' ' PRO . . . . . 0.64 ' N ' ' O ' ' B' ' 147' ' ' SER . 22.8 Cg_exo -61.69 147.13 96.04 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 C-N-CA 122.044 1.829 . . . . 0.0 115.802 -176.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 9.6 tp -128.47 121.24 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-N 114.258 -1.337 . . . . 0.0 107.771 174.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 58.1 t -151.68 92.83 3.59 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.946 -178.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -60.59 136.05 64.6 Favored 'Trans proline' 0 C--N 1.32 -0.932 0 N-CA-C 109.029 -1.181 . . . . 0.0 109.029 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 153' ' ' ILE . . . . . 0.483 ' O ' ' HD2' ' B' ' 154' ' ' ARG . 45.0 mm -67.74 -43.72 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.876 178.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 154' ' ' ARG . . . . . 0.483 ' HD2' ' O ' ' B' ' 153' ' ' ILE . 0.2 OUTLIER -156.7 -155.5 0.54 Allowed 'General case' 0 C--N 1.347 0.469 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -179.718 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 62.9 t-20 -86.86 108.27 18.69 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.57 -17.42 57.64 Favored Glycine 0 C--N 1.34 0.803 0 N-CA-C 110.069 -1.213 . . . . 0.0 110.069 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 85.6 mt -110.25 125.64 67.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.144 0.497 . . . . 0.0 111.348 -176.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 158' ' ' SER . . . . . 0.563 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 47.4 m -135.1 149.6 50.07 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.87 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -132.96 145.89 51.29 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.29 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 18.0 tp -139.44 77.76 28.47 Favored Pre-proline 0 CA--C 1.531 0.227 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 161' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -71.56 150.23 56.96 Favored 'Trans proline' 0 N--CA 1.499 1.849 0 C-N-CA 122.835 2.357 . . . . 0.0 114.362 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 92.6 mt -113.83 134.93 54.49 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 55.9 t -128.46 132.93 67.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 112.8 170.61 17.97 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.198 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 165' ' ' ASN . . . . . 0.743 ' O ' ' NH1' ' B' ' 170' ' ' ARG . 61.1 t30 -90.52 107.29 19.07 Favored 'General case' 0 C--O 1.216 -0.673 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -178.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 166' ' ' LEU . . . . . 0.411 ' CD2' ' CZ ' ' B' ' 171' ' ' PHE . 40.3 tp -63.92 106.16 0.97 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -174.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 167' ' ' THR . . . . . 0.653 ' HG1' ' NE ' ' B' ' 170' ' ' ARG . 34.5 p -86.79 169.45 12.59 Favored 'General case' 0 C--N 1.353 0.729 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.285 177.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -67.61 -37.33 82.38 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.928 176.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.91 -39.55 90.69 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 123.345 1.545 . . . . 0.0 111.486 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 170' ' ' ARG . . . . . 0.743 ' NH1' ' O ' ' B' ' 165' ' ' ASN . 87.9 mtm180 -63.25 -36.36 83.42 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 112.408 -2.178 . . . . 0.0 110.842 177.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 171' ' ' PHE . . . . . 0.411 ' CZ ' ' CD2' ' B' ' 166' ' ' LEU . 0.5 OUTLIER -53.76 -25.29 18.18 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -179.009 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 172' ' ' ASN . . . . . 0.461 ' O ' HG21 ' B' ' 175' ' ' VAL . 93.4 m-20 -62.95 -40.57 98.09 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.01 178.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 57.2 m -60.49 -41.72 94.85 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.776 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 174' ' ' ILE . . . . . 0.403 HD11 HD13 ' B' ' 166' ' ' LEU . 66.4 mt -63.52 -44.45 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -178.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 175' ' ' VAL . . . . . 0.461 HG21 ' O ' ' B' ' 172' ' ' ASN . 30.5 m -62.59 -39.92 86.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -179.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 176' ' ' CYS . . . . . 0.431 ' N ' HG23 ' B' ' 175' ' ' VAL . 97.2 m -61.53 -34.82 76.19 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.226 178.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 177' ' ' THR . . . . . 0.568 ' O ' HG13 ' B' ' 181' ' ' ILE . 25.0 m -62.27 -20.4 64.23 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.25 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 178' ' ' LEU . . . . . . . . . . . . . 91.5 mt -61.27 -38.93 88.54 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.269 -178.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 18.3 m -61.95 -44.09 97.49 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 176.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 180' ' ' ASN . . . . . 0.593 ' O ' ' OG ' ' B' ' 183' ' ' SER . 93.3 m-20 -61.8 -40.89 96.78 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.956 0.408 . . . . 0.0 110.554 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . 0.568 HG13 ' O ' ' B' ' 177' ' ' THR . 75.0 mt -57.35 -31.64 38.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.776 -177.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 182' ' ' LEU . . . . . . . . . . . . . 84.5 mt -62.85 -41.68 99.45 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 119.693 -0.803 . . . . 0.0 109.202 177.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 183' ' ' SER . . . . . 0.593 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.2 p -63.54 -32.8 74.37 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 121.845 -0.534 . . . . 0.0 110.817 177.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 184' ' ' THR . . . . . 0.466 ' OG1' ' HA ' ' B' ' 181' ' ' ILE . 17.4 p -86.2 17.94 3.39 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.367 -176.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 80.3 p -61.12 -15.61 35.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.665 -177.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.45 -40.21 95.86 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 121.029 -0.268 . . . . 0.0 110.729 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 187' ' ' ASP . . . . . 0.563 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.4 m-20 -71.42 114.14 9.18 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.433 0.635 . . . . 0.0 110.831 -177.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.38 -42.43 99.41 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 114.803 -1.09 . . . . 0.0 113.09 -178.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -111.82 130.97 55.64 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.221 -178.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 190' ' ' LEU . . . . . . . . . . . . . 41.9 tp -124.1 118.24 26.47 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.926 177.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 87.0 mt -106.93 125.91 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-N 117.759 0.254 . . . . 0.0 111.216 -177.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 49.8 mm -115.41 118.54 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 193' ' ' ASP . . . . . 0.51 ' OD2' ' OG ' ' B' ' 195' ' ' SER . 41.7 t0 -90.47 111.67 23.02 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -176.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 194' ' ' LEU . . . . . . . . . . . . . 96.2 mt -92.45 -1.61 56.87 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 123.624 0.577 . . . . 0.0 109.627 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 195' ' ' SER . . . . . 0.51 ' OG ' ' OD2' ' B' ' 193' ' ' ASP . 77.8 p -60.88 -36.81 80.17 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.794 -178.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.46 -34.72 89.36 Favored Glycine 0 N--CA 1.439 -1.105 0 N-CA-C 109.919 -1.273 . . . . 0.0 109.919 -178.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 197' ' ' LEU . . . . . 1.176 HD23 ' O ' ' B' ' 199' ' ' GLN . 5.4 tt -77.22 134.01 38.73 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 198' ' ' ALA . . . . . 0.731 ' N ' HD21 ' B' ' 197' ' ' LEU . . . -63.75 -44.96 91.92 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 119.954 -0.698 . . . . 0.0 111.572 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 199' ' ' GLN . . . . . 1.176 ' O ' HD23 ' B' ' 197' ' ' LEU . 58.4 tt0 -136.83 163.25 31.07 Favored 'General case' 0 C--O 1.212 -0.921 0 CA-C-O 122.202 1.001 . . . . 0.0 112.602 -177.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 200' ' ' VAL . . . . . 0.439 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 55.8 t -120.65 132.17 70.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 O-C-N 120.382 -1.449 . . . . 0.0 109.583 177.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -89.7 150.24 22.41 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.79 -178.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -61.38 -33.24 73.33 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.325 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -63.15 -32.99 74.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.435 0.636 . . . . 0.0 109.357 177.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.7 m -60.65 -44.24 96.65 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.291 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 205' ' ' ALA . . . . . 0.676 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -58.15 -29.64 65.73 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -178.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -65.63 -38.77 90.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.502 0.668 . . . . 0.0 110.519 174.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -66.2 -39.0 89.33 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.752 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 95.4 mt -62.86 -45.72 98.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -178.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 209' ' ' PHE . . . . . 0.676 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 66.1 m-85 -61.22 -42.22 98.21 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.781 -176.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.0 -42.07 99.75 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.61 -0.836 . . . . 0.0 109.607 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 211' ' ' LEU . . . . . 0.443 ' O ' ' HG ' ' B' ' 215' ' ' LEU . 39.4 mt -62.18 -42.3 99.14 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.106 -178.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 78.2 p -63.97 -35.74 81.68 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.385 -0.526 . . . . 0.0 112.0 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 213' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -66.92 -46.87 73.48 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.106 177.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 56.5 tp -63.96 -43.08 96.87 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.598 0.713 . . . . 0.0 109.88 177.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 215' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' B' ' 211' ' ' LEU . 84.9 mt -63.07 -44.46 95.74 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 113.544 -1.662 . . . . 0.0 111.368 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -61.69 -39.08 90.19 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.258 -177.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 86.2 mt -62.86 -41.62 99.44 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.309 0.576 . . . . 0.0 111.023 176.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 218' ' ' THR . . . . . . . . . . . . . 67.3 p -76.06 -16.26 59.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.641 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 78.81 68.13 1.53 Allowed Glycine 0 CA--C 1.528 0.864 0 N-CA-C 107.573 -2.211 . . . . 0.0 107.573 -177.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 220' ' ' THR . . . . . . . . . . . . . 81.0 m -146.51 105.84 3.91 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 176.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -63.16 139.93 58.82 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.879 -175.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 40.6 tp -118.13 122.18 42.42 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.414 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 3.6 mp -112.25 129.19 68.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.249 -178.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 224' ' ' ILE . . . . . . . . . . . . . 49.5 mm -109.51 126.17 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 50.4 p -133.29 156.08 48.23 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.697 0.761 . . . . 0.0 112.559 -177.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 91.0 16.27 54.57 Favored Glycine 0 CA--C 1.504 -0.598 0 CA-C-N 114.018 -1.446 . . . . 0.0 111.319 -177.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 96.1 mt -81.48 126.48 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 118.046 0.923 . . . . 0.0 111.27 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 64.3 tttt -66.24 140.23 96.74 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.392 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.71 -36.78 91.09 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.378 1.385 . . . . 0.0 112.554 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -64.0 -43.88 94.35 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -178.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 50.1 tp -61.64 -41.8 98.01 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.526 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.82 -37.1 86.12 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.881 -0.328 . . . . 0.0 111.314 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 94.7 mtp -63.83 -41.06 97.93 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.276 -0.57 . . . . 0.0 109.777 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.11 -43.71 97.68 Favored 'General case' 0 CA--C 1.553 1.082 0 CA-C-O 122.305 1.05 . . . . 0.0 109.589 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 37.9 mmt -63.96 -35.21 79.95 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.878 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -61.71 -39.99 93.45 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.989 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.7 -43.24 99.3 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 177.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 51.4 tp -61.83 -43.79 98.14 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.636 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 239' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' B' ' 240' ' ' ALA . 66.8 t0 -162.23 135.01 5.88 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.96 -178.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 240' ' ' ALA . . . . . 0.439 ' N ' ' OD1' ' B' ' 239' ' ' ASP . . . -62.09 -44.3 96.95 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 177.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 241' ' ' ASN . . . . . 0.633 ' O ' ' HB2' ' B' ' 244' ' ' SER . 89.3 m-20 -45.83 -20.2 0.08 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.289 -174.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 242' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -61.24 -45.66 93.62 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 120.083 -0.647 . . . . 0.0 110.402 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 243' ' ' SER . . . . . . . . . . . . . 77.7 p -55.96 -43.46 77.52 Favored 'General case' 0 C--O 1.225 -0.191 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 244' ' ' SER . . . . . 0.633 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 70.9 m -34.07 -33.22 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 -177.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 97.1 mt -89.96 132.56 35.27 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.667 178.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -58.69 136.78 57.77 Favored 'General case' 0 C--O 1.251 1.176 0 CA-C-O 121.833 0.825 . . . . 0.0 111.261 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 247' ' ' THR . . . . . . . . . . . . . 97.4 m -125.97 128.01 46.84 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.74 178.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -113.64 143.46 44.54 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 249' ' ' SER . . . . . 0.564 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 78.1 p -63.11 -35.8 81.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.855 0.36 . . . . 0.0 111.295 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 250' ' ' ASN . . . . . 0.564 ' OD1' ' O ' ' B' ' 249' ' ' SER . 98.6 m-20 -146.67 162.08 39.21 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.321 178.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 73.0 t -65.0 -44.74 95.99 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.175 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.924 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 252' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.38 -46.04 91.84 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -177.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . 0.406 ' O ' HG13 ' B' ' 257' ' ' VAL . 94.7 m-20 -61.43 -43.21 99.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.763 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 254' ' ' ALA . . . . . 0.41 ' O ' HG21 ' B' ' 257' ' ' VAL . . . -65.3 -40.35 93.71 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.468 0.652 . . . . 0.0 111.08 178.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 255' ' ' VAL . . . . . . . . . . . . . 53.6 t -65.39 -45.35 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.277 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 256' ' ' LYS . . . . . 0.455 ' HE3' ' ND2' ' A' ' 155' ' ' ASN . 88.5 tttt -63.37 -48.33 78.39 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.113 -178.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 257' ' ' VAL . . . . . 0.473 ' O ' ' C ' ' B' ' 258' ' ' LEU . 21.1 m -65.14 -40.22 88.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.519 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 258' ' ' LEU . . . . . 0.492 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 1.0 OUTLIER -31.9 -73.33 0.05 OUTLIER Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.826 -178.926 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 259' ' ' PRO . . . . . 0.495 ' O ' HG13 ' B' ' 260' ' ' ILE . 37.5 Cg_endo -62.25 141.47 87.98 Favored 'Trans proline' 0 N--CA 1.504 2.092 0 C-N-CA 121.572 1.515 . . . . 0.0 111.498 -178.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 260' ' ' ILE . . . . . 0.495 HG13 ' O ' ' B' ' 259' ' ' PRO . 96.9 mt -159.35 -16.48 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 118.587 0.63 . . . . 0.0 112.411 177.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 118.083 -0.96 . . . . 0.0 111.73 179.856 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.221 -1.551 . . . . 0.0 109.221 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.36 174.84 13.82 Favored 'General case' 0 CA--C 1.483 -1.624 0 CA-C-O 123.219 1.485 . . . . 0.0 109.746 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 93.9 p -80.12 -3.81 50.31 Favored 'General case' 0 CA--C 1.572 1.795 0 O-C-N 117.817 -3.052 . . . . 0.0 112.766 177.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -85.29 -64.64 1.12 Allowed 'General case' 0 C--N 1.267 -3.017 0 O-C-N 127.09 2.744 . . . . 0.0 112.304 174.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -70.06 -38.82 75.88 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.089 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.508 ' O ' ' NZ ' ' B' ' 17' ' ' LYS . 65.6 m -59.15 -41.76 89.07 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.862 -177.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.493 ' CB ' ' O ' ' A' ' 6' ' ' SER . 36.2 t80 85.14 87.33 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.364 0.602 . . . . 0.0 111.771 176.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.549 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -60.5 -142.76 0.01 OUTLIER Glycine 0 C--N 1.337 0.628 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.549 ' HB ' ' O ' ' A' ' 8' ' ' GLY . 78.0 mt 84.96 111.76 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.629 0 O-C-N 124.075 0.515 . . . . 0.0 110.655 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.68 -22.25 64.46 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.195 1.263 . . . . 0.0 112.219 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.41 -38.54 95.94 Favored Glycine 0 N--CA 1.465 0.578 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.228 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -64.86 -39.17 93.14 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 51.9 tp -63.06 -41.66 99.51 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -63.29 -40.31 97.0 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.6 t -60.76 -44.04 96.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 O-C-N 122.014 -0.429 . . . . 0.0 111.025 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 92.9 mt -62.32 -43.49 98.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 119.508 -0.877 . . . . 0.0 109.12 -177.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.43 ' NZ ' ' HA ' ' B' ' 6' ' ' SER . 98.8 mttt -62.54 -46.22 89.36 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 119.331 -0.948 . . . . 0.0 112.036 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.788 ' HZ3' HG12 ' B' ' 113' ' ' ILE . 98.6 mttt -60.23 -39.46 86.74 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 118.72 -1.192 . . . . 0.0 108.83 -176.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.35 -42.14 90.86 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 120.034 -0.666 . . . . 0.0 110.156 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.0 mt -62.99 -40.93 99.24 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -63.08 -38.85 92.83 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.949 -0.568 . . . . 0.0 112.525 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 54.4 m170 -58.44 -40.06 81.53 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 122.168 -0.332 . . . . 0.0 111.48 -178.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.0 p -114.85 130.52 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.462 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 33.3 ptt180 -72.09 111.63 7.48 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 122.126 0.965 . . . . 0.0 112.207 -177.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.6 p -141.31 143.1 28.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.499 ' HA3' ' HB2' ' A' ' 123' ' ' GLN . . . -97.81 90.65 1.09 Allowed Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.767 -178.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 54.4 t -124.38 129.81 73.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 176.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.3 m -137.38 159.77 35.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.6 mt -120.09 129.92 74.91 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.64 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 176.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.405 ' OG1' ' HB2' ' A' ' 119' ' ' PHE . 17.5 p -106.16 166.08 10.77 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.427 ' C ' ' OD1' ' A' ' 37' ' ' ASN . 44.3 t0 -132.78 101.7 13.98 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.45 ' HG3' HG22 ' A' ' 117' ' ' THR . 37.6 Cg_endo -64.64 -21.2 65.56 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.576 1.517 . . . . 0.0 111.572 -178.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.54 -33.61 75.28 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.399 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 88.9 mt -86.83 172.22 10.27 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.272 178.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.645 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 42.2 tt0 -67.58 133.06 48.74 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -178.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.567 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 62.8 t0 61.44 20.85 11.53 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 177.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.427 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 40.4 t-20 43.1 68.68 2.74 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.727 -177.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.645 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 88.1 Cg_endo -71.4 155.63 59.73 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 123.9 3.067 . . . . 0.0 112.39 -178.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.3 mt -87.91 124.35 41.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 O-C-N 124.047 0.842 . . . . 0.0 108.977 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.405 HG21 ' N ' ' A' ' 41' ' ' TYR . 27.6 m -105.18 -42.43 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 O-C-N 123.609 0.568 . . . . 0.0 112.332 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.405 ' N ' HG21 ' A' ' 40' ' ' VAL . 46.7 t80 -97.13 123.2 40.82 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 120.289 -0.564 . . . . 0.0 111.968 -178.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.6 p -142.56 139.73 28.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.918 177.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.652 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 55.7 p30 -95.78 165.96 12.04 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.47 ' HA ' ' OE1' ' A' ' 44' ' ' GLN . 14.0 mm100 -66.63 -39.82 88.45 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 177.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.57 -25.0 62.63 Favored Glycine 0 C--O 1.236 0.247 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.652 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 64.5 t80 -59.39 -48.48 81.47 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 105.221 -2.14 . . . . 0.0 105.221 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.491 HG11 ' O ' ' A' ' 52' ' ' TYR . 54.4 t -58.78 -44.7 90.83 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.554 0 O-C-N 121.088 -1.008 . . . . 0.0 111.623 -174.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -63.15 -35.81 81.52 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 120.441 -0.504 . . . . 0.0 112.278 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 60.9 ttm -68.08 -42.66 80.07 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 177.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.402 ' HG1' ' H ' ' A' ' 52' ' ' TYR . 43.6 p -95.58 -20.59 18.86 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.358 0.599 . . . . 0.0 111.255 -177.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . 77.94 19.41 75.25 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.491 ' O ' HG11 ' A' ' 47' ' ' VAL . 75.0 m-85 -112.37 137.74 50.09 Favored 'General case' 0 C--O 1.222 -0.366 0 C-N-CA 122.569 0.348 . . . . 0.0 110.881 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -63.22 147.94 49.54 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.829 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.2 -33.79 76.84 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.61 -43.15 85.54 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.959 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -64.23 -45.12 89.6 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.354 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.422 HG22 HD13 ' A' ' 57' ' ' ILE . 96.1 mt -62.85 -48.37 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 -175.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.2 mt -57.49 144.99 34.72 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.03 -2.96 82.51 Favored Glycine 0 C--O 1.237 0.329 0 C-N-CA 121.062 -0.589 . . . . 0.0 113.534 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -134.78 151.47 50.99 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.916 1.358 . . . . 0.0 112.308 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.581 ' C ' ' H ' ' A' ' 63' ' ' ARG . 25.5 t-20 -81.57 149.38 28.66 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.343 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 71.4 m -61.96 16.15 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.515 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.581 ' H ' ' C ' ' A' ' 61' ' ' ASN . 36.5 ptt-85 -61.35 -41.52 97.19 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.973 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -55.91 -20.31 15.37 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.5 mt -68.77 -35.94 77.7 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.951 0.881 . . . . 0.0 112.064 177.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -64.92 136.85 57.3 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.877 -176.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.568 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -147.28 -149.09 4.89 Favored Glycine 0 CA--C 1.537 1.415 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -178.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.497 ' HB3' ' HH ' ' A' ' 95' ' ' TYR . 88.7 tttt -62.83 -40.03 96.14 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -177.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.419 ' HD1' HE22 ' A' ' 93' ' ' GLN . 7.3 m-70 -76.32 -9.58 58.74 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.952 0.406 . . . . 0.0 111.003 -178.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.568 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 27.0 m -61.4 129.65 42.24 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.567 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -86.49 112.1 44.02 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.791 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -57.45 -31.12 90.44 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 121.966 1.777 . . . . 0.0 113.283 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.49 -40.67 96.1 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 120.499 -0.481 . . . . 0.0 110.815 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.408 ' OE1' ' HB ' ' A' ' 90' ' ' VAL . 79.2 mm-40 -65.53 -45.03 85.02 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.4 t -59.09 -43.62 89.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -177.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -63.87 -37.74 88.52 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.042 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -63.47 -39.79 95.39 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.497 0.665 . . . . 0.0 110.128 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.22 -44.04 97.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.96 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -62.66 -43.19 99.44 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 113.771 -1.558 . . . . 0.0 108.231 -179.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 99.3 m -61.16 -48.54 81.13 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.37 -41.34 96.94 Favored 'General case' 0 C--N 1.361 1.081 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.186 -172.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 90.2 mt -63.05 -40.08 96.65 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.632 -1.293 . . . . 0.0 111.582 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -63.03 -40.78 98.77 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -70.11 -25.19 63.39 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.457 177.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 51.5 tttt 65.23 42.81 3.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.413 -176.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -125.96 148.57 63.26 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -61.64 143.82 96.99 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.334 1.356 . . . . 0.0 112.928 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.93 141.34 31.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.457 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.567 ' CG2' ' OD1' ' A' ' 107' ' ' ASN . 99.6 m -128.1 120.33 27.17 Favored 'General case' 0 C--N 1.345 0.386 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 176.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.408 ' HB ' ' OE1' ' A' ' 74' ' ' GLU . 29.0 m -138.82 158.31 29.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.82 -0.173 . . . . 0.0 111.453 178.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -102.96 128.75 49.65 Favored 'General case' 0 C--O 1.247 0.931 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.3 tt -137.55 129.45 41.0 Favored 'Isoleucine or valine' 0 C--N 1.378 1.837 0 CA-C-N 121.917 2.144 . . . . 0.0 112.363 177.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.419 HE22 ' HD1' ' A' ' 69' ' ' HIS . 86.7 mt-30 -61.5 134.29 56.69 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.107 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -135.43 159.82 40.38 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.102 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.497 ' HH ' ' HB3' ' A' ' 68' ' ' LYS . 93.0 m-85 -118.46 137.22 53.32 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.425 ' HG3' ' CE1' ' A' ' 102' ' ' PHE . 99.2 mttt -85.97 -171.77 3.75 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.394 0.616 . . . . 0.0 111.754 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -62.99 -42.08 99.75 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.295 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.486 ' CG ' ' HG1' ' A' ' 100' ' ' THR . 41.1 p-10 -84.8 8.12 18.39 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -178.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.84 -3.41 87.17 Favored Glycine 0 N--CA 1.473 1.108 0 C-N-CA 120.571 -0.824 . . . . 0.0 111.916 177.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.486 ' HG1' ' CG ' ' A' ' 98' ' ' ASP . 22.7 m -59.3 137.89 57.82 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 106.255 -1.758 . . . . 0.0 106.255 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.687 ' C ' ' SD ' ' A' ' 101' ' ' MET . 13.4 tmm? -107.01 129.29 54.82 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 122.184 -0.323 . . . . 0.0 111.032 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.439 ' N ' ' SD ' ' A' ' 101' ' ' MET . 52.9 p90 -140.61 158.62 43.71 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.404 -177.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.842 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 22.8 m95 -89.03 144.87 25.85 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.48 HD22 ' HG2' ' A' ' 123' ' ' GLN . 56.4 t-20 -139.0 102.06 4.44 Favored 'General case' 0 C--O 1.245 0.862 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -176.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.42 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 80.8 tt0 -67.27 136.43 54.91 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -177.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 40.2 tp -121.43 123.76 42.85 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -179.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.567 ' OD1' ' CG2' ' A' ' 89' ' ' THR . 98.1 m-20 -120.58 122.64 41.01 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 123.237 0.336 . . . . 0.0 110.742 177.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.403 HD11 HG21 ' A' ' 108' ' ' ILE . 96.3 mt -120.71 128.33 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 O-C-N 123.536 0.523 . . . . 0.0 111.505 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -138.24 125.14 13.26 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.17 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -71.56 152.12 59.36 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.399 2.066 . . . . 0.0 112.313 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.579 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 66.6 mtt -124.47 152.73 42.99 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -127.41 96.19 4.49 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 177.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 96.4 mt -120.34 131.28 73.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.184 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 51.13 38.33 20.6 Favored 'General case' 0 CA--C 1.511 -0.538 0 O-C-N 121.355 -0.84 . . . . 0.0 111.51 175.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 59.39 31.49 21.13 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 123.777 0.673 . . . . 0.0 111.049 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -129.55 148.73 51.48 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.76 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 7.4 t -86.58 -173.33 4.45 Favored 'General case' 0 C--O 1.209 -1.034 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -178.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.76 ' CD2' ' O ' ' A' ' 117' ' ' THR . 77.2 m-85 -170.5 155.71 5.16 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 175.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.405 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 83.7 m-85 -129.44 146.38 51.3 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 175.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -136.43 135.54 49.27 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 177.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -111.12 130.28 9.69 Favored Glycine 0 CA--C 1.5 -0.89 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 178.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 96.2 mt -119.01 129.69 74.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.499 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . 15.7 mp0 -119.67 115.27 23.59 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -116.46 113.07 22.32 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.647 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.464 ' OD1' ' N ' ' A' ' 126' ' ' ILE . 68.3 t0 -63.75 131.15 46.97 Favored 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -176.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.464 ' N ' ' OD1' ' A' ' 125' ' ' ASP . 2.6 mp -96.01 4.29 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 113.53 -1.668 . . . . 0.0 110.136 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 29.5 m -60.92 -42.45 98.14 Favored 'General case' 0 C--N 1.364 1.237 0 O-C-N 120.595 -1.316 . . . . 0.0 113.528 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -59.49 -43.06 93.41 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -63.0 -40.07 96.66 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.792 177.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.842 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.6 mttt -62.95 -40.81 98.79 Favored 'General case' 0 CA--C 1.504 -0.814 0 C-N-CA 118.277 -1.369 . . . . 0.0 110.187 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -61.43 -38.52 87.47 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.013 -178.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.519 ' CE2' HD13 ' A' ' 136' ' ' LEU . 86.6 t80 -61.76 -45.85 92.11 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.307 176.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.82 -38.29 90.53 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -62.44 -40.21 95.85 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.391 -0.524 . . . . 0.0 109.74 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 52.9 tp -61.05 -43.59 98.65 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -178.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.519 HD13 ' CE2' ' A' ' 132' ' ' TYR . 85.7 mt -62.72 -41.24 99.05 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.002 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -62.93 -41.5 99.49 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 119.337 -0.945 . . . . 0.0 109.672 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -60.14 -42.24 94.42 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -177.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 55.4 m -61.68 -41.36 97.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.851 176.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 144' ' ' THR . 84.6 mt -63.23 -41.41 99.11 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 178.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 88.3 m -61.54 -45.63 93.34 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.102 -177.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -65.19 -40.52 94.34 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 94.5 mt -64.7 -43.17 96.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 113.9 -1.5 . . . . 0.0 111.331 176.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.502 ' N ' ' O ' ' A' ' 140' ' ' LEU . 96.4 m -62.11 -46.01 90.96 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 120.372 -0.531 . . . . 0.0 112.371 -178.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.47 ' O ' ' OG1' ' A' ' 148' ' ' THR . . . -62.93 -39.77 95.6 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 118.95 -1.1 . . . . 0.0 109.451 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.4 mt -63.32 -42.71 99.0 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.719 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.0 p -59.6 -40.22 86.78 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -177.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.47 ' C ' ' O ' ' A' ' 147' ' ' SER . 12.6 m -26.72 80.64 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.524 0 O-C-N 127.54 3.025 . . . . 0.0 106.195 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.719 ' N ' ' O ' ' A' ' 147' ' ' SER . 19.3 Cg_exo -62.19 143.66 94.65 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 121.08 1.187 . . . . 0.0 113.651 -175.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.583 ' O ' ' CG2' ' A' ' 151' ' ' VAL . 8.9 tp -118.69 136.07 57.07 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 175.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.583 ' CG2' ' O ' ' A' ' 150' ' ' ILE . 89.1 t -169.25 92.59 0.55 Allowed Pre-proline 0 CA--C 1.508 -0.673 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 178.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -61.89 136.47 61.79 Favored 'Trans proline' 0 N--CA 1.487 1.105 0 CA-C-N 119.598 0.892 . . . . 0.0 110.086 -177.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.607 ' O ' ' HD2' ' A' ' 154' ' ' ARG . 45.4 mm -67.34 -45.25 86.29 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.526 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.381 178.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.607 ' HD2' ' O ' ' A' ' 153' ' ' ILE . 0.7 OUTLIER -157.71 -156.4 0.58 Allowed 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.422 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 63.1 t-20 -86.93 104.78 16.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.48 0.657 . . . . 0.0 110.971 -178.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.21 7.97 67.08 Favored Glycine 0 C--O 1.224 -0.494 0 CA-C-N 114.077 -1.42 . . . . 0.0 110.015 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.6 mt -123.92 123.66 67.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 175.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.716 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 57.6 m -132.74 151.69 51.92 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -139.84 142.44 36.6 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.333 0.587 . . . . 0.0 111.309 178.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 20.7 tp -131.34 81.19 66.01 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.322 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -69.29 150.01 70.56 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.712 2.274 . . . . 0.0 113.117 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 90.6 mt -119.62 126.72 51.85 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.792 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 55.4 t -124.11 131.6 72.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 117.68 167.8 14.34 Favored Glycine 0 N--CA 1.476 1.326 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.241 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.903 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 56.2 t30 -85.11 115.02 22.67 Favored 'General case' 0 C--O 1.204 -1.305 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.501 ' CD2' ' CZ ' ' A' ' 171' ' ' PHE . 47.8 tp -75.12 103.42 5.29 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -177.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.577 ' H ' ' HE ' ' A' ' 170' ' ' ARG . 10.7 p -85.29 167.95 15.15 Favored 'General case' 0 C--O 1.226 -0.14 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.637 178.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.75 -33.59 76.21 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.33 -45.17 89.04 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.149 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.903 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 87.4 mtm180 -63.27 -33.37 75.36 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.219 -0.9 . . . . 0.0 112.267 178.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.501 ' CZ ' ' CD2' ' A' ' 166' ' ' LEU . 0.4 OUTLIER -54.5 -28.2 43.36 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 119.086 -0.483 . . . . 0.0 111.897 -177.586 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.655 ' O ' HG21 ' A' ' 175' ' ' VAL . 91.5 m-20 -60.97 -39.81 90.99 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 118.866 -1.134 . . . . 0.0 109.842 -177.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 66.9 m -59.4 -40.92 88.14 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 121.787 -0.571 . . . . 0.0 110.484 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 67.0 mt -63.63 -44.01 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.655 HG21 ' O ' ' A' ' 172' ' ' ASN . 33.7 m -62.53 -40.89 89.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -178.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 96.5 m -62.33 -34.53 76.81 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.312 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' THR . . . . . 0.547 ' O ' HG13 ' A' ' 181' ' ' ILE . 25.4 m -61.91 -19.59 62.85 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.931 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 84.9 mt -60.87 -41.58 96.23 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -177.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 19.5 m -59.53 -43.43 93.48 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . 0.622 ' O ' ' OG ' ' A' ' 183' ' ' SER . 92.5 m-20 -61.85 -37.24 83.75 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-O 121.016 0.436 . . . . 0.0 110.719 178.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . 0.547 HG13 ' O ' ' A' ' 177' ' ' THR . 66.0 mt -58.21 -38.68 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 O-C-N 121.296 -0.877 . . . . 0.0 109.437 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 87.0 mt -60.89 -40.6 93.67 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -177.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.622 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 77.1 p -61.53 -34.02 74.83 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.526 177.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 49.4 p -89.26 25.17 1.96 Allowed 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.634 0.254 . . . . 0.0 111.304 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 78.5 p -63.6 -21.51 66.4 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.846 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -59.76 -36.96 77.71 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.14 -178.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.716 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 98.8 m-20 -72.03 112.97 8.57 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.593 0.711 . . . . 0.0 110.853 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.88 -42.78 99.89 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 114.959 -1.018 . . . . 0.0 112.802 -177.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -113.37 131.61 55.92 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.802 -178.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 38.3 tp -121.08 128.49 52.65 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 96.1 mt -116.39 127.14 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 177.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.3 mm -112.68 126.98 70.14 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . 0.43 ' CG ' ' HG ' ' A' ' 195' ' ' SER . 40.1 t0 -95.13 119.56 33.84 Favored 'General case' 0 CA--C 1.56 1.352 0 CA-C-O 119.638 -0.22 . . . . 0.0 110.913 178.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 95.8 mt -99.64 -4.03 31.82 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 125.022 1.451 . . . . 0.0 111.06 176.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' SER . . . . . 0.43 ' HG ' ' CG ' ' A' ' 193' ' ' ASP . 78.4 p -63.12 -32.24 73.57 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -62.08 -44.38 97.84 Favored Glycine 0 CA--C 1.544 1.851 0 N-CA-C 108.103 -1.999 . . . . 0.0 108.103 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 1.266 HD23 ' O ' ' A' ' 199' ' ' GLN . 6.7 tt -67.37 128.76 37.62 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 112.536 -1.832 . . . . 0.0 109.284 -178.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.408 ' N ' HD21 ' A' ' 197' ' ' LEU . . . -60.53 -50.38 73.79 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-O 121.402 0.62 . . . . 0.0 110.476 -178.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 1.266 ' O ' HD23 ' A' ' 197' ' ' LEU . 59.1 tt0 -133.55 156.5 47.7 Favored 'General case' 0 C--O 1.209 -1.034 0 CA-C-N 114.445 -1.252 . . . . 0.0 114.328 -175.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.465 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 44.9 t -116.07 131.08 69.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 O-C-N 120.321 -1.487 . . . . 0.0 108.619 178.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -84.21 155.74 22.36 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.759 -179.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.59 -39.47 93.79 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.045 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -57.16 -31.98 65.95 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.3 m -61.52 -42.38 98.72 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.546 178.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.454 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -56.39 -39.7 73.39 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -177.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -61.19 -37.41 82.84 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.634 -0.427 . . . . 0.0 109.882 -178.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.0 -38.96 92.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.835 177.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.92 -44.63 99.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 C-N-CA 119.469 -0.893 . . . . 0.0 108.734 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . 0.454 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 68.9 m-85 -62.35 -43.59 98.46 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.001 -177.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.13 -42.01 98.81 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 118.882 -1.127 . . . . 0.0 109.181 -178.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 41.1 mt -62.11 -41.66 98.44 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' SER . . . . . 0.476 ' HG ' ' N ' ' A' ' 213' ' ' HIS . 78.3 p -61.28 -42.19 98.22 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 118.936 -1.106 . . . . 0.0 110.351 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' HIS . . . . . 0.476 ' N ' ' HG ' ' A' ' 212' ' ' SER . 59.0 t-80 -63.42 -46.02 88.28 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.76 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 52.8 tp -62.49 -46.76 87.0 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 88.4 mt -62.02 -40.53 95.99 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.902 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.46 -44.5 95.8 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.292 -178.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 84.0 mt -61.76 -40.18 94.23 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 75.2 p -75.81 -11.66 60.02 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.239 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 83.1 37.05 13.21 Favored Glycine 0 C--N 1.343 0.939 0 C-N-CA 120.723 -0.751 . . . . 0.0 114.027 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 99.8 m -123.2 114.68 20.6 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.046 1.423 . . . . 0.0 112.022 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -65.65 138.08 57.76 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.268 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 42.9 tp -112.37 130.01 56.11 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 3.2 mp -117.61 132.56 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.459 HG23 HD11 ' A' ' 224' ' ' ILE . 49.4 mm -115.33 131.43 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 42.6 p -134.01 167.67 20.2 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 78.15 19.14 75.28 Favored Glycine 0 C--O 1.223 -0.537 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 97.4 mt -81.53 128.35 38.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 113.611 -1.294 . . . . 0.0 108.112 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -74.01 140.2 76.97 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.29 -38.92 88.7 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 120.99 1.127 . . . . 0.0 112.627 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -64.83 -38.7 91.86 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 121.351 0.596 . . . . 0.0 109.948 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 51.2 tp -63.64 -42.76 98.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.832 177.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.48 -37.99 89.46 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.73 -178.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 94.1 mtp -63.31 -40.4 97.23 Favored 'General case' 0 C--O 1.247 0.923 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.834 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -64.04 -39.38 93.96 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.755 177.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 33.1 mmt -65.94 -36.63 83.88 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.623 178.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -61.11 -41.48 96.76 Favored 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 121.367 -0.833 . . . . 0.0 109.413 -176.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.71 -40.68 93.14 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.618 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 54.5 tp -63.61 -41.55 98.3 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 176.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -168.18 124.63 1.05 Allowed 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.254 0.55 . . . . 0.0 112.454 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.66 -27.1 66.09 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.764 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -62.49 -26.42 68.52 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.789 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -56.23 -44.21 79.38 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -176.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 99.4 p -61.78 -20.59 63.75 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 123.766 0.666 . . . . 0.0 111.283 179.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 50.1 m -57.11 -33.77 67.68 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 94.7 mt -87.79 121.79 30.65 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 119.458 -0.897 . . . . 0.0 113.261 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -46.03 135.84 7.12 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.712 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 97.8 m -127.46 132.92 49.95 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.673 179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -118.13 139.18 51.63 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.12 178.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 78.0 p -60.47 -41.76 94.83 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -178.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -144.46 160.78 40.52 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.824 0.821 . . . . 0.0 111.604 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 72.3 t -63.23 -44.43 99.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 114.586 -1.188 . . . . 0.0 112.25 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.57 -44.54 96.08 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.036 -0.665 . . . . 0.0 109.466 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -63.83 -42.51 97.62 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.487 -178.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . 0.487 ' O ' HG21 ' A' ' 257' ' ' VAL . . . -63.88 -42.8 97.41 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 122.035 0.921 . . . . 0.0 109.791 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . 0.444 HG13 HH11 ' B' ' 154' ' ' ARG . 66.3 t -63.6 -45.71 96.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.157 -1.383 . . . . 0.0 111.143 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.84 -47.66 79.88 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.267 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . 0.506 ' O ' ' C ' ' A' ' 258' ' ' LEU . 33.3 m -66.48 -40.54 86.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 O-C-N 121.373 -0.829 . . . . 0.0 112.285 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.506 ' C ' ' O ' ' A' ' 257' ' ' VAL . 1.7 mt -28.64 -75.48 0.04 OUTLIER Pre-proline 0 N--CA 1.467 0.375 0 O-C-N 123.17 0.294 . . . . 0.0 111.607 -177.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' PRO . . . . . 0.494 ' CD ' ' CB ' ' A' ' 258' ' ' LEU . 42.7 Cg_endo -63.25 139.3 71.25 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 120.754 0.969 . . . . 0.0 111.943 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . 0.406 HD11 HG23 ' A' ' 260' ' ' ILE . 96.7 mt -151.74 -27.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 O-C-N 124.049 0.843 . . . . 0.0 111.962 178.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 78.0 mtm . . . . . 0 N--CA 1.475 0.789 0 CA-C-O 118.094 -0.955 . . . . 0.0 110.754 -177.425 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.49 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.13 165.32 36.33 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 79.4 p -66.96 -13.59 61.98 Favored 'General case' 0 CA--C 1.568 1.669 0 O-C-N 121.724 -0.61 . . . . 0.0 112.398 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -80.04 -63.25 1.45 Allowed 'General case' 0 C--N 1.311 -1.108 0 O-C-N 124.532 1.145 . . . . 0.0 109.379 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -67.05 -39.19 86.87 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.445 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' SER . . . . . 0.486 ' O ' ' CB ' ' B' ' 7' ' ' PHE . 66.6 m -59.68 -42.08 92.12 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.782 -177.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . 0.486 ' CB ' ' O ' ' B' ' 6' ' ' SER . 36.8 t80 85.85 90.96 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.573 177.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . 0.555 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -63.58 -141.85 0.02 OUTLIER Glycine 0 C--N 1.34 0.754 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . 0.555 ' HB ' ' O ' ' B' ' 8' ' ' GLY . 78.5 mt 84.49 111.86 0.03 OUTLIER Pre-proline 0 CA--C 1.545 0.776 0 O-C-N 124.086 0.521 . . . . 0.0 110.796 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.79 -24.31 68.56 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 121.109 1.206 . . . . 0.0 111.783 -178.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.71 -40.43 98.76 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.604 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -64.87 -39.44 93.55 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.557 0.694 . . . . 0.0 109.234 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 50.3 tp -62.05 -42.28 99.02 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.454 -177.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -65.14 -31.15 72.19 Favored 'General case' 0 CA--C 1.562 1.439 0 CA-C-O 121.643 0.735 . . . . 0.0 110.805 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 78.3 t -63.81 -46.27 94.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 113.119 -1.855 . . . . 0.0 111.276 177.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 95.0 mt -64.24 -43.71 97.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.761 -178.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . 0.508 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 98.9 mttt -63.35 -42.64 98.93 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.03 -40.91 99.15 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 119.105 -1.038 . . . . 0.0 109.726 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.32 -39.16 86.04 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.816 -178.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 84.2 mt -64.12 -42.02 97.0 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.383 0.611 . . . . 0.0 110.278 175.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -63.07 -39.08 93.65 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.831 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 53.0 m170 -57.63 -40.16 78.58 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 119.547 -0.263 . . . . 0.0 111.488 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 14.8 p -114.93 130.26 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.477 ' O ' ' HG3' ' B' ' 24' ' ' ARG . 33.2 ptt180 -71.7 109.97 5.95 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.888 0.851 . . . . 0.0 112.343 -177.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.2 p -143.19 133.53 22.16 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.8 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.514 177.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . 0.568 ' O ' ' N ' ' B' ' 123' ' ' GLN . . . -87.25 95.32 2.06 Favored Glycine 0 C--N 1.31 -0.87 0 C-N-CA 119.354 -1.403 . . . . 0.0 113.538 -177.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 49.7 t -125.54 129.11 72.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 174.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 27.6 m -139.01 156.49 27.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.58 0.229 . . . . 0.0 110.478 178.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 96.1 mt -117.98 126.88 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.61 177.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' B' ' 119' ' ' PHE . 24.1 p -106.65 157.42 17.71 Favored 'General case' 0 CA--C 1.505 -0.786 0 O-C-N 126.003 2.064 . . . . 0.0 108.688 -178.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -124.76 102.47 32.06 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.54 -18.3 59.07 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 121.697 1.598 . . . . 0.0 111.473 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.24 -40.26 96.93 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.741 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 90.4 mt -76.47 -170.47 1.52 Allowed 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.823 -0.548 . . . . 0.0 111.234 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . 0.64 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 42.4 tt0 -82.04 131.25 35.24 Favored 'General case' 0 C--N 1.342 0.26 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.502 ' O ' ' OD1' ' B' ' 36' ' ' ASP . 66.3 t0 56.22 35.27 25.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.063 177.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' ASN . . . . . 0.444 ' C ' ' O ' ' B' ' 36' ' ' ASP . 28.3 t-20 33.3 70.34 0.81 Allowed Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.64 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 89.2 Cg_endo -72.66 154.19 54.47 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 123.434 2.756 . . . . 0.0 111.994 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 96.1 mt -86.47 128.81 39.17 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 29.3 m -109.15 -42.82 5.6 Favored 'Isoleucine or valine' 0 C--N 1.341 0.231 0 O-C-N 123.681 0.613 . . . . 0.0 112.446 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -97.44 123.57 41.34 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.654 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 5.8 p -142.65 140.65 28.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.017 177.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . 0.688 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 57.4 p30 -99.98 160.73 14.09 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.289 179.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' GLN . . . . . 0.471 ' HA ' ' OE1' ' B' ' 44' ' ' GLN . 13.4 mm100 -62.94 -38.27 90.4 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.418 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.57 -25.63 63.48 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.688 ' HB2' ' OD1' ' B' ' 43' ' ' ASN . 60.5 t80 -60.03 -43.66 95.15 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . 0.683 HG11 ' O ' ' B' ' 52' ' ' TYR . 53.7 t -61.07 -46.33 96.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.066 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -63.36 -43.55 97.36 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.244 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 60.8 ttm -63.06 -41.92 99.56 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 41.5 p -96.75 -16.11 21.03 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.729 -178.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' B' ' 47' ' ' VAL . . . 73.08 19.69 79.7 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 178.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . 0.683 ' O ' HG11 ' B' ' 47' ' ' VAL . 74.8 m-85 -111.25 145.1 39.34 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -73.78 147.48 43.41 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.897 0.856 . . . . 0.0 111.061 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.79 -37.57 84.87 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.198 -177.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.04 -39.52 94.26 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 124.075 0.859 . . . . 0.0 111.322 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -72.86 -32.42 65.42 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 177.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 93.1 mt -67.32 -69.55 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 95.6 mt -39.36 132.36 1.48 Allowed 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.368 178.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.85 -7.45 76.88 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.516 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -132.4 149.1 52.41 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -176.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' ASN . . . . . 0.559 ' C ' ' H ' ' B' ' 63' ' ' ARG . 25.5 t-20 -79.17 150.07 31.8 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 114.572 -1.195 . . . . 0.0 110.843 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' CYS . . . . . . . . . . . . . 71.7 m -62.94 9.22 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.674 -178.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' ARG . . . . . 0.559 ' H ' ' C ' ' B' ' 61' ' ' ASN . 34.6 ptt-85 -59.4 -31.2 69.03 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.495 -178.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -61.54 -31.25 71.27 Favored 'General case' 0 C--O 1.239 0.531 0 O-C-N 121.878 -0.514 . . . . 0.0 111.922 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 92.4 mt -61.24 -44.28 97.51 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -178.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -46.59 144.11 2.38 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.424 0.631 . . . . 0.0 109.938 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . 0.455 ' HA3' ' CE1' ' B' ' 95' ' ' TYR . . . -155.39 -152.98 6.36 Favored Glycine 0 CA--C 1.543 1.817 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.656 176.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' LYS . . . . . 0.424 ' HB3' ' HH ' ' B' ' 95' ' ' TYR . 88.9 tttt -60.97 -40.99 95.51 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.447 -0.376 . . . . 0.0 111.172 -175.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -75.6 -9.93 59.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.175 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 25.0 m -60.66 133.52 56.18 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -90.55 111.72 49.1 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.453 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.39 -38.38 89.27 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 121.099 1.199 . . . . 0.0 111.882 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.99 -40.9 90.77 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.821 -176.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' GLU . . . . . 0.413 ' OE1' ' HB ' ' B' ' 90' ' ' VAL . 79.2 mm-40 -66.78 -39.35 87.78 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.835 178.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 71.0 t -62.59 -45.66 98.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -62.85 -37.28 86.23 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.748 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -62.48 -42.06 99.23 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.938 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.33 -43.79 98.77 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 CA-C-O 120.86 0.362 . . . . 0.0 110.735 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -61.58 -42.67 99.18 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 87.2 m -60.93 -46.58 90.12 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.79 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.86 -41.72 96.44 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -178.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 87.8 mt -62.13 -42.29 99.09 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -62.56 -39.89 95.09 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -80.2 -4.2 52.15 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.105 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 37.5 tttt 50.67 44.77 27.52 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.222 -0.591 . . . . 0.0 112.134 178.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -128.88 145.43 56.39 Favored Pre-proline 0 N--CA 1.467 0.383 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.15 140.1 81.87 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 120.905 1.07 . . . . 0.0 113.642 -178.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -140.12 136.59 37.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.909 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 89' ' ' THR . . . . . 0.591 ' CG2' ' OD1' ' B' ' 107' ' ' ASN . 97.4 m -122.24 122.68 39.69 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 178.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . 0.413 ' HB ' ' OE1' ' B' ' 74' ' ' GLU . 30.7 m -139.4 162.82 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.854 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -113.63 120.82 42.23 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 176.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 20.6 tt -128.43 131.79 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.68 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -70.46 141.6 52.03 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.857 178.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 94' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -133.75 -179.75 5.73 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.261 0.553 . . . . 0.0 111.174 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 95' ' ' TYR . . . . . 0.455 ' CE1' ' HA3' ' B' ' 67' ' ' GLY . 96.3 m-85 -131.11 148.25 52.71 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.485 178.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . 0.434 ' HG3' ' CE1' ' B' ' 102' ' ' PHE . 98.7 mttt -104.35 -179.08 3.84 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.052 0.453 . . . . 0.0 110.693 177.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.72 -35.52 76.54 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.493 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . 0.42 ' CG ' ' HG1' ' B' ' 100' ' ' THR . 37.0 p-10 -87.37 -0.33 56.61 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.053 0.842 . . . . 0.0 112.954 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.02 3.23 65.8 Favored Glycine 0 N--CA 1.465 0.601 0 C-N-CA 121.152 -0.546 . . . . 0.0 111.892 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 100' ' ' THR . . . . . 0.42 ' HG1' ' CG ' ' B' ' 98' ' ' ASP . 24.7 m -68.16 129.56 40.3 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 101' ' ' MET . . . . . 0.569 ' SD ' ' N ' ' B' ' 102' ' ' PHE . 15.2 tmm? -90.46 142.99 27.18 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 102' ' ' PHE . . . . . 0.569 ' N ' ' SD ' ' B' ' 101' ' ' MET . 53.9 p90 -153.6 163.62 39.67 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 103' ' ' TRP . . . . . 0.851 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 23.6 m95 -95.25 140.19 30.5 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.018 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . 0.455 HD22 ' HG2' ' B' ' 123' ' ' GLN . 62.8 t-20 -133.71 105.63 6.93 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -176.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 105' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' B' ' 123' ' ' GLN . 81.4 tt0 -73.02 126.84 30.91 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.635 1.209 . . . . 0.0 109.02 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 39.4 tp -114.18 125.91 54.47 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 107' ' ' ASN . . . . . 0.591 ' OD1' ' CG2' ' B' ' 89' ' ' THR . 98.0 m-20 -119.92 127.86 53.08 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 176.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 96.2 mt -123.69 132.83 70.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -144.51 123.12 6.86 Favored Pre-proline 0 CA--C 1.538 0.483 0 O-C-N 123.482 0.488 . . . . 0.0 109.931 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -70.74 152.71 64.45 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 122.366 2.044 . . . . 0.0 112.618 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 111' ' ' MET . . . . . 0.44 ' HB2' ' HB2' ' B' ' 118' ' ' TYR . 66.4 mtt -129.18 144.09 51.09 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -113.58 111.21 21.5 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . 0.788 HG12 ' HZ3' ' A' ' 18' ' ' LYS . 96.8 mt -137.92 127.72 35.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 O-C-N 121.534 -0.729 . . . . 0.0 111.81 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 52.25 38.33 24.43 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 123.997 0.811 . . . . 0.0 109.626 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 61.54 36.15 17.08 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.538 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -133.8 151.66 51.64 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 8.8 t -102.76 154.08 19.52 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.262 -178.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 118' ' ' TYR . . . . . 0.44 ' HB2' ' HB2' ' B' ' 111' ' ' MET . 96.8 m-85 -148.12 145.34 28.34 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.529 -0.732 . . . . 0.0 110.917 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 119' ' ' PHE . . . . . 0.431 ' O ' ' OG1' ' B' ' 30' ' ' THR . 86.4 m-85 -118.12 138.91 51.95 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.384 0.427 . . . . 0.0 111.347 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.5 p -128.22 136.15 60.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -178.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -112.2 127.88 8.27 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 95.4 mt -117.63 128.62 74.82 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 123' ' ' GLN . . . . . 0.568 ' N ' ' O ' ' B' ' 26' ' ' GLY . 15.3 mp0 -119.12 121.54 40.02 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -120.31 121.18 38.07 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . 0.58 ' OD1' ' N ' ' B' ' 127' ' ' THR . 68.3 t0 -69.12 134.16 48.97 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.083 -177.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . 0.495 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 2.5 mp -107.3 17.16 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.493 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 127' ' ' THR . . . . . 0.58 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 98.2 m -63.36 -45.23 92.15 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 114.138 -1.392 . . . . 0.0 112.647 175.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 59.7 tptt -60.53 -45.6 93.27 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 129' ' ' GLN . . . . . 0.404 ' OE1' HG21 ' B' ' 126' ' ' ILE . 88.5 mt-30 -62.53 -36.57 83.04 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.484 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 130' ' ' LYS . . . . . 0.851 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 98.9 mttt -62.64 -41.7 99.19 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 112.737 -2.028 . . . . 0.0 111.115 174.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.5 -42.08 96.06 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 132' ' ' TYR . . . . . 0.505 ' CE2' HD13 ' B' ' 136' ' ' LEU . 88.1 t80 -60.76 -44.95 96.08 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.972 -0.455 . . . . 0.0 111.785 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . 0.427 ' O ' ' HG3' ' B' ' 137' ' ' GLU . 97.3 mt-10 -63.8 -36.49 84.06 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 119.932 -0.707 . . . . 0.0 109.367 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 134' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' B' ' 130' ' ' LYS . 98.9 mttt -62.41 -39.62 93.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.801 177.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 53.8 tp -62.28 -41.76 98.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.75 0.786 . . . . 0.0 109.451 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 136' ' ' LEU . . . . . 0.505 HD13 ' CE2' ' B' ' 132' ' ' TYR . 87.6 mt -63.02 -41.82 99.65 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.921 177.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 137' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' B' ' 133' ' ' GLU . 97.3 mt-10 -65.27 -36.45 84.13 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.508 -1.678 . . . . 0.0 110.276 -178.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -63.83 -43.79 95.16 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.106 -0.638 . . . . 0.0 109.649 177.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 68.2 m -61.14 -44.1 97.85 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . 0.418 ' O ' ' N ' ' B' ' 144' ' ' THR . 86.1 mt -61.74 -40.06 93.77 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -177.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 97.2 m -61.32 -45.58 93.85 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.059 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -66.39 -42.39 87.95 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 93.1 mt -63.52 -43.19 98.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 114.517 -1.219 . . . . 0.0 110.598 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 144' ' ' THR . . . . . 0.418 ' N ' ' O ' ' B' ' 140' ' ' LEU . 92.1 m -61.31 -45.12 95.76 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.13 -40.8 96.95 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 119.299 -0.96 . . . . 0.0 109.332 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 87.1 mt -64.55 -41.17 96.5 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 177.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 147' ' ' SER . . . . . 0.626 ' O ' ' N ' ' B' ' 149' ' ' PRO . 78.4 p -61.91 -40.91 97.08 Favored 'General case' 0 CA--C 1.476 -1.895 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 -178.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 148' ' ' THR . . . . . 0.491 ' C ' ' O ' ' B' ' 147' ' ' SER . 7.3 m -28.9 85.16 0.03 OUTLIER Pre-proline 0 C--N 1.353 0.738 0 O-C-N 123.745 0.653 . . . . 0.0 110.351 176.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 149' ' ' PRO . . . . . 0.626 ' N ' ' O ' ' B' ' 147' ' ' SER . 23.4 Cg_exo -61.89 146.71 96.29 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 C-N-CA 122.393 2.062 . . . . 0.0 115.57 -176.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 9.0 tp -126.67 119.81 54.47 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.21 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.036 174.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 59.3 t -151.26 93.41 3.61 Favored Pre-proline 0 C--N 1.295 -1.764 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.809 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -60.23 137.35 74.4 Favored 'Trans proline' 0 N--CA 1.489 1.238 0 CA-C-N 119.852 0.983 . . . . 0.0 109.569 -178.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 153' ' ' ILE . . . . . 0.625 ' O ' ' HD2' ' B' ' 154' ' ' ARG . 45.2 mm -68.7 -43.55 82.98 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.579 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 154' ' ' ARG . . . . . 0.625 ' HD2' ' O ' ' B' ' 153' ' ' ILE . 0.7 OUTLIER -157.16 -154.61 0.47 Allowed 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.449 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 62.0 t-20 -87.32 107.99 18.76 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.1 -18.39 55.73 Favored Glycine 0 CA--C 1.534 1.23 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 157' ' ' ILE . . . . . 0.435 HG23 ' HB ' ' B' ' 153' ' ' ILE . 85.1 mt -108.04 124.45 64.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.287 0.565 . . . . 0.0 111.16 -177.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 158' ' ' SER . . . . . 0.668 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 69.1 m -135.0 148.72 50.04 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.517 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -134.62 146.92 50.03 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 24.4 tp -137.61 80.73 31.29 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 161' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -70.63 147.73 57.9 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.666 2.244 . . . . 0.0 114.077 -178.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 90.5 mt -114.55 133.85 55.48 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 109.074 -0.714 . . . . 0.0 109.074 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 54.6 t -130.51 132.73 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 114.3 168.61 16.25 Favored Glycine 0 N--CA 1.471 0.984 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.512 178.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 165' ' ' ASN . . . . . 0.813 ' O ' ' CZ ' ' B' ' 170' ' ' ARG . 60.5 t30 -89.92 107.16 18.95 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -178.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 166' ' ' LEU . . . . . 0.482 ' CD2' ' CZ ' ' B' ' 171' ' ' PHE . 42.1 tp -65.02 104.73 0.91 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -174.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 167' ' ' THR . . . . . 0.548 ' CG2' HH21 ' B' ' 170' ' ' ARG . 10.0 p -85.38 169.57 13.57 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 113.828 -1.533 . . . . 0.0 110.83 177.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.57 -37.52 85.1 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.307 177.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.63 -39.9 88.49 Favored 'General case' 0 CA--C 1.553 1.09 0 CA-C-O 121.682 0.753 . . . . 0.0 111.798 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 170' ' ' ARG . . . . . 0.813 ' CZ ' ' O ' ' B' ' 165' ' ' ASN . 87.9 mtm180 -63.67 -36.04 82.51 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 113.193 -1.821 . . . . 0.0 110.475 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 171' ' ' PHE . . . . . 0.482 ' CZ ' ' CD2' ' B' ' 166' ' ' LEU . 0.4 OUTLIER -54.1 -25.55 22.52 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -178.194 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 172' ' ' ASN . . . . . 0.582 ' O ' HG21 ' B' ' 175' ' ' VAL . 92.9 m-20 -62.48 -40.53 96.96 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.672 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 59.7 m -60.12 -41.76 93.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.27 0.557 . . . . 0.0 110.51 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 67.4 mt -63.9 -44.21 97.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -179.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 175' ' ' VAL . . . . . 0.582 HG21 ' O ' ' B' ' 172' ' ' ASN . 29.8 m -62.61 -40.81 89.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -178.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 176' ' ' CYS . . . . . . . . . . . . . 98.2 m -62.26 -35.44 78.97 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.291 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 177' ' ' THR . . . . . 0.578 ' O ' HG13 ' B' ' 181' ' ' ILE . 25.3 m -61.3 -19.45 61.78 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 178' ' ' LEU . . . . . . . . . . . . . 87.4 mt -60.97 -39.47 89.69 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.479 -178.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 18.2 m -62.03 -44.44 96.7 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.414 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 180' ' ' ASN . . . . . 0.604 ' O ' ' OG ' ' B' ' 183' ' ' SER . 92.1 m-20 -61.97 -40.3 95.12 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.121 0.486 . . . . 0.0 110.435 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . 0.578 HG13 ' O ' ' B' ' 177' ' ' THR . 73.3 mt -56.35 -32.37 35.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 O-C-N 122.074 -0.391 . . . . 0.0 110.74 -178.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 182' ' ' LEU . . . . . . . . . . . . . 86.4 mt -62.66 -41.5 99.1 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 183' ' ' SER . . . . . 0.604 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.7 p -63.98 -32.91 74.61 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 122.129 -0.357 . . . . 0.0 110.593 177.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 44.6 p -85.88 17.96 3.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.766 0.317 . . . . 0.0 111.684 -178.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 78.6 p -60.59 -16.44 38.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.274 -177.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.82 -40.86 96.76 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.966 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 187' ' ' ASP . . . . . 0.668 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.3 m-20 -67.98 113.32 5.58 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.699 0.761 . . . . 0.0 110.776 -178.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.8 -42.39 99.69 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 114.697 -1.138 . . . . 0.0 113.102 -178.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -113.29 130.98 56.11 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.212 -178.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 190' ' ' LEU . . . . . . . . . . . . . 40.5 tp -123.72 118.16 26.59 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.908 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 84.2 mt -106.15 125.95 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-O 120.812 0.339 . . . . 0.0 111.303 -178.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 49.7 mm -114.51 117.58 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 193' ' ' ASP . . . . . 0.438 ' CG ' ' HG ' ' B' ' 195' ' ' SER . 41.9 t0 -88.43 114.62 25.23 Favored 'General case' 0 C--O 1.246 0.873 0 CA-C-O 121.65 0.738 . . . . 0.0 111.352 -177.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 194' ' ' LEU . . . . . . . . . . . . . 96.2 mt -97.1 -1.34 45.44 Favored 'General case' 0 C--N 1.356 0.858 0 O-C-N 120.39 -1.444 . . . . 0.0 110.067 176.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 195' ' ' SER . . . . . 0.438 ' HG ' ' CG ' ' B' ' 193' ' ' ASP . 78.4 p -61.19 -36.24 79.33 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 121.169 -0.213 . . . . 0.0 110.803 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.87 -35.42 91.29 Favored Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 197' ' ' LEU . . . . . 1.295 HD23 ' O ' ' B' ' 199' ' ' GLN . 7.0 tt -74.75 132.61 41.76 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 121.847 -0.796 . . . . 0.0 109.589 -178.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 198' ' ' ALA . . . . . 0.423 ' N ' HD21 ' B' ' 197' ' ' LEU . . . -61.33 -48.9 79.23 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 119.309 -0.957 . . . . 0.0 110.143 -178.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 199' ' ' GLN . . . . . 1.295 ' O ' HD23 ' B' ' 197' ' ' LEU . 57.1 tt0 -135.06 164.62 27.24 Favored 'General case' 0 C--O 1.21 -1.02 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -178.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 200' ' ' VAL . . . . . 0.508 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 48.3 t -119.44 130.95 73.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 119.506 -1.996 . . . . 0.0 109.403 177.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -87.26 150.84 23.62 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.122 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -61.49 -32.61 72.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.59 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -64.11 -32.78 74.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.2 m -60.89 -43.36 98.61 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.573 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 205' ' ' ALA . . . . . 0.687 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -58.63 -29.53 66.59 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 119.212 -0.423 . . . . 0.0 111.792 -178.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -65.75 -38.74 89.93 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 123.649 0.593 . . . . 0.0 109.68 176.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -66.57 -38.04 86.23 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.752 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 93.5 mt -63.68 -44.36 98.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -178.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 209' ' ' PHE . . . . . 0.687 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 66.9 m-85 -61.35 -43.56 98.66 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.618 179.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.39 -41.54 98.78 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.102 -1.039 . . . . 0.0 109.532 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 39.9 mt -62.23 -41.94 98.86 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.316 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 212' ' ' SER . . . . . 0.455 ' HG ' ' N ' ' B' ' 213' ' ' HIS . 78.3 p -63.3 -35.78 81.51 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 121.686 -0.634 . . . . 0.0 112.159 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 213' ' ' HIS . . . . . 0.455 ' N ' ' HG ' ' B' ' 212' ' ' SER . 58.8 t-80 -67.18 -46.83 72.77 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.839 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 54.1 tp -64.23 -43.06 96.13 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 122.069 0.938 . . . . 0.0 109.406 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.09 -43.74 97.66 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 113.617 -1.629 . . . . 0.0 111.379 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.12 -39.32 92.15 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.005 -177.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 85.4 mt -63.7 -42.69 97.95 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.238 0.542 . . . . 0.0 111.51 176.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 218' ' ' THR . . . . . . . . . . . . . 75.9 p -74.11 -16.03 61.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.911 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 79.29 72.56 1.18 Allowed Glycine 0 CA--C 1.528 0.862 0 N-CA-C 106.517 -2.633 . . . . 0.0 106.517 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 220' ' ' THR . . . . . . . . . . . . . 93.2 m -151.85 98.2 2.44 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 177.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -56.13 139.76 46.29 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.204 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 43.1 tp -116.64 120.58 39.1 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.184 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 3.5 mp -109.13 129.23 64.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.241 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 224' ' ' ILE . . . . . . . . . . . . . 49.7 mm -111.7 126.94 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.57 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 44.5 p -134.78 157.77 45.88 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 91.07 17.55 50.57 Favored Glycine 0 CA--C 1.498 -1.027 0 CA-C-N 113.949 -1.478 . . . . 0.0 110.534 -177.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 95.7 mt -83.59 125.77 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 O-C-N 121.363 -1.08 . . . . 0.0 111.355 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 56.2 tttt -63.93 139.67 97.7 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.368 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.77 -37.17 92.1 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 121.297 1.331 . . . . 0.0 112.539 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -63.83 -43.32 96.54 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 52.0 tp -61.87 -41.78 98.27 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.913 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.03 -36.51 84.24 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.801 0.334 . . . . 0.0 111.139 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 94.5 mtp -64.47 -40.64 96.07 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.78 -43.93 97.51 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 122.107 0.956 . . . . 0.0 109.004 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 33.5 mmt -63.82 -34.96 79.09 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.989 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -61.81 -40.21 94.44 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.774 -178.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.27 -43.85 96.79 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.156 178.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 52.5 tp -62.92 -44.75 95.24 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 120.137 -0.625 . . . . 0.0 112.039 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -156.51 132.32 9.62 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 120.551 -0.46 . . . . 0.0 112.001 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 240' ' ' ALA . . . . . 0.4 ' O ' ' N ' ' B' ' 242' ' ' PHE . . . -61.93 -47.94 82.66 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 176.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 241' ' ' ASN . . . . . 0.465 ' O ' ' HB2' ' B' ' 244' ' ' SER . 92.7 m-20 -42.69 -18.28 0.01 OUTLIER 'General case' 0 C--O 1.217 -0.615 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.556 -176.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 242' ' ' PHE . . . . . 0.4 ' N ' ' O ' ' B' ' 240' ' ' ALA . 89.1 t80 -60.81 -44.58 96.69 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 119.801 -0.759 . . . . 0.0 109.906 178.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 243' ' ' SER . . . . . . . . . . . . . 78.4 p -58.85 -42.42 89.31 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 -178.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 244' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 20.5 m -33.84 -33.04 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 99.1 mt -91.69 130.37 37.5 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 121.458 -0.776 . . . . 0.0 111.889 177.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -57.59 134.76 56.42 Favored 'General case' 0 CA--C 1.502 -0.881 0 O-C-N 121.317 -0.864 . . . . 0.0 111.726 -175.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 247' ' ' THR . . . . . . . . . . . . . 96.3 m -125.25 127.66 47.08 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.917 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -112.98 144.26 42.86 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 177.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 249' ' ' SER . . . . . 0.595 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 79.4 p -64.23 -33.46 75.86 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.218 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 250' ' ' ASN . . . . . 0.595 ' OD1' ' O ' ' B' ' 249' ' ' SER . 98.8 m-20 -147.94 159.61 43.69 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 124.509 1.13 . . . . 0.0 111.937 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 77.7 t -64.34 -44.15 97.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.443 -0.798 . . . . 0.0 112.293 178.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 252' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -60.78 -46.15 91.61 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -177.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -61.37 -43.05 99.53 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.924 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 254' ' ' ALA . . . . . 0.451 ' O ' HG21 ' B' ' 257' ' ' VAL . . . -65.85 -40.25 91.54 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.913 178.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 255' ' ' VAL . . . . . 0.532 HG13 HH11 ' A' ' 154' ' ' ARG . 67.3 t -65.14 -45.71 93.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.043 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.56 -48.55 78.98 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 120.204 -0.598 . . . . 0.0 111.614 -178.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 257' ' ' VAL . . . . . 0.483 ' O ' ' C ' ' B' ' 258' ' ' LEU . 32.6 m -65.22 -40.63 89.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.678 -1.146 . . . . 0.0 111.302 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 258' ' ' LEU . . . . . 0.523 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 1.6 mt -32.25 -73.76 0.05 OUTLIER Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.589 -177.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 259' ' ' PRO . . . . . 0.523 ' CD ' ' CB ' ' B' ' 258' ' ' LEU . 36.3 Cg_endo -61.76 140.76 87.62 Favored 'Trans proline' 0 N--CA 1.505 2.155 0 C-N-CA 121.49 1.46 . . . . 0.0 111.133 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 260' ' ' ILE . . . . . 0.446 HG13 ' O ' ' B' ' 259' ' ' PRO . 96.7 mt -159.11 -13.82 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 O-C-N 121.33 -0.856 . . . . 0.0 112.204 177.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 C--O 1.216 -0.71 0 CA-C-O 117.792 -1.099 . . . . 0.0 111.353 -179.381 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.026 -1.629 . . . . 0.0 109.026 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.471 ' O ' ' OG ' ' A' ' 6' ' ' SER . . . -152.2 165.07 35.99 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.373 0.606 . . . . 0.0 110.201 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 80.8 p -70.53 -18.28 62.94 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.084 -1.01 . . . . 0.0 112.112 177.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -71.75 -65.07 0.81 Allowed 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 114.18 -1.373 . . . . 0.0 112.574 174.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -68.1 -37.77 81.55 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.99 0.424 . . . . 0.0 112.089 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.493 ' O ' ' HB3' ' A' ' 7' ' ' PHE . 70.9 m -59.44 -42.17 91.31 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -177.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.493 ' HB3' ' O ' ' A' ' 6' ' ' SER . 42.5 t80 83.95 86.93 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.134 0.493 . . . . 0.0 111.865 176.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.583 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -62.49 -142.92 0.01 OUTLIER Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 -178.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.583 ' HB ' ' O ' ' A' ' 8' ' ' GLY . 74.5 mt 85.64 110.27 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 122.701 0.4 . . . . 0.0 110.538 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.7 -22.35 69.82 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 121.389 1.393 . . . . 0.0 112.175 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.83 -38.22 95.82 Favored Glycine 0 N--CA 1.467 0.706 0 C-N-CA 121.138 -0.553 . . . . 0.0 111.919 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -65.18 -39.27 92.66 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.41 0.624 . . . . 0.0 109.614 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.2 tp -63.44 -41.15 98.67 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -63.73 -40.31 96.44 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 56.3 t -60.31 -44.36 95.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 O-C-N 122.199 -0.313 . . . . 0.0 110.892 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 92.2 mt -62.78 -43.61 98.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.407 -178.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.27 -46.04 90.58 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 119.491 -0.883 . . . . 0.0 112.119 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.611 ' HZ3' HG12 ' B' ' 113' ' ' ILE . 98.4 mttt -60.39 -39.86 88.83 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 118.51 -1.276 . . . . 0.0 109.187 -176.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.84 -42.1 92.83 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.286 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.8 mt -62.83 -40.95 99.0 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 178.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -63.92 -37.65 88.19 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.505 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 60.0 m170 -58.55 -40.15 82.2 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 122.221 -0.299 . . . . 0.0 111.417 -178.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.3 p -114.4 130.01 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.501 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 36.2 ptt180 -71.85 110.46 6.38 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-O 122.016 0.912 . . . . 0.0 112.229 -177.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.9 p -141.31 144.13 26.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 123' ' ' GLN . . . -97.55 90.99 1.14 Allowed Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.786 -178.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 51.4 t -124.23 129.26 74.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 176.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.7 m -137.49 159.78 34.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.7 mt -121.71 130.36 74.67 Favored 'Isoleucine or valine' 0 C--O 1.245 0.868 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 177.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.4 p -106.35 167.85 9.55 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.448 ' C ' ' OD1' ' A' ' 37' ' ' ASN . 44.0 t0 -134.5 102.42 11.62 Favored Pre-proline 0 C--N 1.32 -0.716 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.389 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.424 ' HG3' HG22 ' A' ' 117' ' ' THR . 36.4 Cg_endo -63.17 -23.08 73.07 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 121.453 1.436 . . . . 0.0 111.503 -178.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.97 -35.88 81.63 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.66 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.2 mt -84.31 157.35 21.54 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.498 177.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.697 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 43.3 tt0 -58.37 136.01 57.33 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -176.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.566 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 62.4 t0 60.29 22.8 12.25 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.448 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 42.4 t-20 38.16 70.06 1.35 Allowed Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.244 -176.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.697 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 92.7 Cg_endo -71.13 156.3 59.8 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 123.948 3.099 . . . . 0.0 112.121 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.6 mt -88.1 125.22 41.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.474 HG21 ' N ' ' A' ' 41' ' ' TYR . 33.9 m -104.8 -42.59 7.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.025 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.474 ' N ' HG21 ' A' ' 40' ' ' VAL . 48.9 t80 -97.68 123.76 41.73 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.809 -177.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.9 p -143.06 140.85 26.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 124.303 1.002 . . . . 0.0 109.215 177.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.573 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 57.3 p30 -98.41 166.99 11.11 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.517 ' HA ' ' OE1' ' A' ' 44' ' ' GLN . 13.2 mm100 -66.4 -38.81 88.33 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 120.988 0.423 . . . . 0.0 111.933 177.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.27 -26.86 64.47 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.573 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 66.3 t80 -59.03 -48.43 81.63 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.502 HG11 ' O ' ' A' ' 52' ' ' TYR . 61.3 t -59.41 -45.09 93.82 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 O-C-N 121.312 -0.868 . . . . 0.0 111.573 -174.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -63.64 -37.73 88.44 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 120.412 -0.515 . . . . 0.0 112.383 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 60.4 ttm -66.65 -43.01 85.76 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 114.258 1.206 . . . . 0.0 114.258 176.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 34.9 p -93.75 -20.4 20.15 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.272 0.558 . . . . 0.0 111.453 -177.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.28 21.6 72.75 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.502 ' O ' HG11 ' A' ' 47' ' ' VAL . 81.1 m-85 -115.9 138.21 51.38 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 122.909 0.484 . . . . 0.0 111.213 179.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -63.65 148.24 49.51 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.662 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.57 -32.36 73.9 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -66.21 -45.01 82.25 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 119.351 -0.94 . . . . 0.0 111.359 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -63.47 -45.44 90.8 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 119.939 -0.704 . . . . 0.0 109.749 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.4 HD13 HG22 ' A' ' 57' ' ' ILE . 90.6 mt -62.1 -48.99 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -175.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 79.0 mt -57.11 146.04 29.01 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 176.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.96 -3.91 82.27 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.875 -0.679 . . . . 0.0 113.121 177.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -137.47 151.7 48.75 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.879 1.34 . . . . 0.0 111.9 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.561 ' C ' ' H ' ' A' ' 63' ' ' ARG . 25.6 t-20 -81.23 151.92 27.91 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.701 -178.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 83.6 m -63.67 16.44 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.276 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.561 ' H ' ' C ' ' A' ' 61' ' ' ASN . 36.4 ptt-85 -62.47 -40.81 97.85 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 122.054 -0.404 . . . . 0.0 111.282 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -56.03 -21.53 22.12 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 84.0 mt -68.22 -35.24 77.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 122.003 0.906 . . . . 0.0 113.011 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -65.12 143.05 58.14 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.904 -1.044 . . . . 0.0 112.238 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.606 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -154.2 -147.57 4.7 Favored Glycine 0 CA--C 1.538 1.484 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 -177.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.54 ' HB3' ' HH ' ' A' ' 95' ' ' TYR . 88.5 tttt -63.21 -41.1 99.1 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -177.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.446 ' O ' ' OE1' ' A' ' 93' ' ' GLN . 10.8 m-70 -77.1 -8.56 57.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.955 0.407 . . . . 0.0 111.086 -177.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.606 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 26.6 m -63.04 130.28 44.01 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.657 -178.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -85.4 109.55 22.4 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.8 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.92 -32.08 91.44 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.023 1.815 . . . . 0.0 113.19 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.59 -39.64 94.1 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.975 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.475 ' OE1' ' HB ' ' A' ' 90' ' ' VAL . 78.9 mm-40 -65.84 -43.54 88.21 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.8 t -59.45 -43.83 91.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -176.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -63.88 -37.97 89.35 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.027 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -63.63 -39.67 94.95 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.243 0.544 . . . . 0.0 110.156 178.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.77 -44.47 98.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.154 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -63.01 -42.71 99.9 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 113.831 -1.531 . . . . 0.0 108.36 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 96.4 m -61.64 -48.85 78.99 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.04 -41.69 92.83 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.185 -172.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 83.0 mt -63.0 -39.55 95.11 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.025 -1.047 . . . . 0.0 111.319 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -64.17 -32.59 74.22 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 177.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -90.22 0.59 57.13 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.302 -178.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.2 tttt 45.46 35.94 2.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.55 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -119.13 143.8 34.79 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -61.39 143.39 97.66 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.62 1.546 . . . . 0.0 113.674 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -140.12 143.25 30.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.697 -177.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.488 ' CG2' ' OD1' ' A' ' 107' ' ' ASN . 99.9 m -128.46 120.59 27.14 Favored 'General case' 0 C--N 1.345 0.394 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 176.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.475 ' HB ' ' OE1' ' A' ' 74' ' ' GLU . 27.8 m -138.75 157.61 29.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.73 -0.214 . . . . 0.0 111.461 177.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -101.93 133.76 46.21 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 177.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 19.0 tt -141.18 131.9 27.06 Favored 'Isoleucine or valine' 0 C--N 1.378 1.833 0 CA-C-N 121.61 2.005 . . . . 0.0 112.417 176.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.446 ' OE1' ' O ' ' A' ' 69' ' ' HIS . 85.7 mt-30 -64.6 133.74 52.9 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.884 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -134.85 158.57 43.87 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.8 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.54 ' HH ' ' HB3' ' A' ' 68' ' ' LYS . 89.8 m-85 -116.5 134.7 54.54 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.455 ' HG3' ' CE1' ' A' ' 102' ' ' PHE . 99.1 mttt -83.7 -171.76 3.77 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.184 0.516 . . . . 0.0 111.76 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.46 -43.48 98.71 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.941 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 42.5 p-10 -84.31 7.17 20.22 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.08 -0.4 87.5 Favored Glycine 0 N--CA 1.471 0.97 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.185 176.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 23.5 m -58.93 139.15 56.99 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.622 ' C ' ' SD ' ' A' ' 101' ' ' MET . 13.8 tmm? -105.06 127.28 52.81 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.593 0.235 . . . . 0.0 110.506 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.455 ' CE1' ' HG3' ' A' ' 96' ' ' LYS . 52.7 p90 -141.68 156.12 45.65 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.958 -177.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.721 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 24.4 m95 -88.66 143.98 26.58 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.485 HD22 ' HG2' ' A' ' 123' ' ' GLN . 56.4 t-20 -138.1 100.82 4.25 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -177.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 80.6 tt0 -66.32 136.57 56.0 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -177.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 40.3 tp -122.23 122.94 40.31 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.488 ' OD1' ' CG2' ' A' ' 89' ' ' THR . 97.8 m-20 -118.67 122.61 42.93 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.71 177.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 96.4 mt -120.31 128.64 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 O-C-N 123.535 0.522 . . . . 0.0 111.635 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -139.85 123.03 10.42 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 116.714 -0.221 . . . . 0.0 110.933 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -70.98 152.13 62.75 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 122.451 2.101 . . . . 0.0 112.368 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.611 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 66.8 mtt -122.82 154.32 38.38 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -128.74 94.12 3.78 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 176.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 96.1 mt -118.51 130.78 72.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.19 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 52.5 38.51 25.76 Favored 'General case' 0 CA--C 1.512 -0.501 0 O-C-N 121.414 -0.804 . . . . 0.0 111.774 176.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 58.27 30.22 19.18 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 123.844 0.715 . . . . 0.0 110.833 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -128.2 149.09 50.6 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.173 -0.676 . . . . 0.0 109.173 177.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.756 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 5.2 t -86.1 -172.25 3.98 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 118.538 0.608 . . . . 0.0 109.514 -177.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.756 ' CD2' ' O ' ' A' ' 117' ' ' THR . 65.1 m-85 -171.69 156.26 4.26 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 175.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -131.34 146.49 52.31 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 174.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -134.94 135.18 53.17 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 177.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.75 129.2 9.42 Favored Glycine 0 CA--C 1.499 -0.908 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 178.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 96.6 mt -118.41 129.57 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.485 ' HG2' HD22 ' A' ' 104' ' ' ASN . 13.9 mp0 -121.05 113.3 19.85 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.641 0.588 . . . . 0.0 109.609 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -113.57 112.79 24.12 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.959 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -62.39 128.22 35.01 Favored 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -175.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 3.0 mt -93.53 2.29 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 113.511 -1.677 . . . . 0.0 110.199 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 20.1 m -60.56 -42.38 96.49 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.979 -1.076 . . . . 0.0 113.671 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -59.96 -42.34 93.87 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -178.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -63.01 -39.56 95.12 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.927 177.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.721 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.7 mttt -62.85 -40.79 98.54 Favored 'General case' 0 CA--C 1.502 -0.877 0 C-N-CA 118.292 -1.363 . . . . 0.0 110.621 -178.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.69 -37.93 85.92 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -178.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.483 ' CE2' HD13 ' A' ' 136' ' ' LEU . 90.7 t80 -61.67 -45.96 91.76 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.668 175.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.23 -38.93 92.81 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 120.167 -0.613 . . . . 0.0 109.539 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.07 -40.21 95.02 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 52.7 tp -60.65 -43.86 97.1 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -176.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.483 HD13 ' CE2' ' A' ' 132' ' ' TYR . 84.9 mt -62.26 -40.87 97.63 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -61.84 -41.73 98.16 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 119.398 -0.921 . . . . 0.0 109.852 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -60.81 -41.96 96.7 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -177.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.0 m -61.94 -41.14 97.63 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.877 176.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 144' ' ' THR . 87.9 mt -63.49 -41.8 98.56 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.431 -0.508 . . . . 0.0 109.884 178.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 79.9 m -61.72 -45.59 93.3 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.271 -177.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -65.3 -39.67 92.83 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 94.7 mt -64.44 -43.57 96.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 113.991 -1.458 . . . . 0.0 111.365 176.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.454 ' N ' ' O ' ' A' ' 140' ' ' LEU . 99.3 m -62.49 -46.3 89.11 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.396 -0.522 . . . . 0.0 112.25 -178.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.401 ' O ' ' OG1' ' A' ' 148' ' ' THR . . . -62.45 -40.07 95.43 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 118.875 -1.13 . . . . 0.0 109.117 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 90.1 mt -63.61 -42.8 98.19 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.689 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.1 p -60.57 -37.17 80.43 Favored 'General case' 0 C--O 1.218 -0.564 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -178.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.453 ' C ' ' O ' ' A' ' 147' ' ' SER . 27.5 m -30.06 82.82 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.41 0 O-C-N 127.003 2.689 . . . . 0.0 106.123 -176.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.689 ' N ' ' O ' ' A' ' 147' ' ' SER . 21.8 Cg_exo -62.29 144.62 95.56 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 CA-C-O 122.749 1.062 . . . . 0.0 114.432 -174.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.62 ' O ' ' CG2' ' A' ' 151' ' ' VAL . 8.9 tp -121.26 135.33 61.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 102.575 -3.12 . . . . 0.0 102.575 176.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.62 ' CG2' ' O ' ' A' ' 150' ' ' ILE . 65.5 t -169.74 94.35 0.51 Allowed Pre-proline 0 CA--C 1.507 -0.703 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 176.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -62.56 137.71 65.94 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 N-CA-C 109.843 -0.868 . . . . 0.0 109.843 -178.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.569 ' O ' ' HD2' ' A' ' 154' ' ' ARG . 45.5 mm -68.28 -44.57 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 119.991 -0.683 . . . . 0.0 110.151 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.569 ' HD2' ' O ' ' A' ' 153' ' ' ILE . 0.7 OUTLIER -156.76 -157.55 0.7 Allowed 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -86.74 104.91 16.57 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.559 0.695 . . . . 0.0 111.521 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.65 8.65 65.39 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 114.069 -1.423 . . . . 0.0 110.063 -177.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.405 HG12 ' HB2' ' A' ' 189' ' ' TYR . 96.5 mt -125.96 124.17 65.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 175.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.666 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 42.2 m -131.95 152.14 51.28 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -137.52 140.66 41.24 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.494 177.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 19.9 tp -131.21 78.49 72.49 Favored Pre-proline 0 N--CA 1.469 0.512 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.358 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -69.83 150.57 67.98 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.719 2.279 . . . . 0.0 113.033 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 92.3 mt -119.36 126.27 51.01 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.241 178.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 49.0 t -122.37 130.74 74.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 117.24 169.12 14.88 Favored Glycine 0 N--CA 1.48 1.619 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.3 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.876 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 53.6 t30 -86.19 114.7 23.23 Favored 'General case' 0 C--O 1.214 -0.803 0 CA-C-N 116.972 0.386 . . . . 0.0 110.109 -178.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.502 ' CD2' ' CZ ' ' A' ' 171' ' ' PHE . 47.1 tp -74.31 105.29 5.41 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -177.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.557 ' H ' ' HE ' ' A' ' 170' ' ' ARG . 11.4 p -87.8 167.41 13.83 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.146 0.498 . . . . 0.0 110.489 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.88 -33.96 77.26 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.92 0.39 . . . . 0.0 111.862 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.58 -42.72 95.42 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.484 178.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.876 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 87.3 mtm180 -64.93 -33.65 76.52 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 124.169 0.988 . . . . 0.0 112.884 178.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.502 ' CZ ' ' CD2' ' A' ' 166' ' ' LEU . 0.4 OUTLIER -54.73 -28.32 47.29 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 118.913 -0.565 . . . . 0.0 112.39 -178.128 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.731 ' O ' HG21 ' A' ' 175' ' ' VAL . 90.2 m-20 -61.07 -40.69 94.64 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 118.892 -1.123 . . . . 0.0 109.939 -178.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 70.2 m -59.15 -41.41 88.25 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.71 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 67.3 mt -63.67 -44.01 98.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.731 HG21 ' O ' ' A' ' 172' ' ' ASN . 33.9 m -62.56 -40.63 89.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 97.7 m -62.27 -34.2 76.1 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.131 0.491 . . . . 0.0 110.435 177.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' THR . . . . . 0.486 ' O ' HG13 ' A' ' 181' ' ' ILE . 25.1 m -61.96 -19.74 63.09 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.026 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 85.6 mt -61.04 -40.89 95.32 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -177.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 18.9 m -59.11 -43.28 91.88 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . 0.587 ' O ' ' OG ' ' A' ' 183' ' ' SER . 90.8 m-20 -61.92 -37.6 85.29 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 120.773 0.32 . . . . 0.0 110.829 178.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 177' ' ' THR . 70.3 mt -56.77 -37.17 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 121.515 -0.741 . . . . 0.0 109.765 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 85.9 mt -61.28 -40.74 95.26 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -177.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.587 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 78.1 p -62.22 -35.38 78.71 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.406 177.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 39.2 p -88.63 25.11 1.8 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.65 0.262 . . . . 0.0 111.456 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 78.1 p -65.36 -20.01 66.2 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.732 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.37 -37.46 80.8 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.986 -178.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.666 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 99.0 m-20 -72.73 114.26 10.68 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.489 0.662 . . . . 0.0 110.924 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . 0.423 ' O ' HG21 ' A' ' 220' ' ' THR . 99.8 m-20 -63.13 -42.05 99.42 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.926 -177.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . 0.405 ' HB2' HG12 ' A' ' 157' ' ' ILE . 97.1 m-85 -112.02 131.23 55.54 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.873 -178.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 38.0 tp -121.14 128.37 52.46 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 96.7 mt -117.33 128.4 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.9 mm -114.22 128.33 71.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . 0.485 ' OD2' ' OG ' ' A' ' 195' ' ' SER . 40.1 t0 -96.09 119.54 34.77 Favored 'General case' 0 CA--C 1.552 1.037 0 O-C-N 121.873 -0.517 . . . . 0.0 110.474 177.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 99.0 mt -98.38 -4.56 34.55 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.593 175.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' SER . . . . . 0.485 ' OG ' ' OD2' ' A' ' 193' ' ' ASP . 78.1 p -62.35 -33.46 74.76 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -62.42 -44.09 98.12 Favored Glycine 0 CA--C 1.534 1.243 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 1.042 HD23 ' O ' ' A' ' 199' ' ' GLN . 4.8 tt -68.96 128.51 36.96 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 112.788 -1.706 . . . . 0.0 108.495 -177.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.697 ' N ' HD21 ' A' ' 197' ' ' LEU . . . -59.68 -48.96 79.62 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 121.196 0.522 . . . . 0.0 110.703 -177.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 1.042 ' O ' HD23 ' A' ' 197' ' ' LEU . 57.9 tt0 -136.22 158.51 44.23 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 114.444 -1.253 . . . . 0.0 113.506 -173.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.445 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 46.9 t -118.72 132.28 69.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -89.53 156.79 18.39 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.296 -178.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.27 -39.94 94.97 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.104 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -57.59 -32.62 67.37 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.9 m -61.64 -42.24 98.62 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.609 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.448 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -57.5 -39.03 75.59 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -176.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -61.06 -36.35 79.38 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -64.81 -39.08 93.01 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.998 177.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 95.3 mt -63.29 -44.49 99.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -178.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . 0.448 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 75.1 m-85 -62.32 -43.36 98.99 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.6 -177.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.52 -41.93 99.18 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 119.07 -1.052 . . . . 0.0 109.105 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.432 ' O ' ' HG ' ' A' ' 215' ' ' LEU . 38.3 mt -62.25 -41.5 98.5 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' SER . . . . . 0.451 ' HG ' ' N ' ' A' ' 213' ' ' HIS . 78.2 p -61.36 -42.25 98.39 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.084 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' HIS . . . . . 0.451 ' N ' ' HG ' ' A' ' 212' ' ' SER . 57.7 t-80 -64.55 -45.66 86.14 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 120.626 -0.43 . . . . 0.0 111.372 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 47.8 tp -62.5 -45.76 91.51 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 118.909 -1.116 . . . . 0.0 108.379 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 211' ' ' LEU . 90.4 mt -62.74 -40.76 98.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.141 -177.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.62 -44.54 96.22 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.751 -178.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 84.5 mt -61.91 -39.88 93.54 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 66.8 p -74.95 -11.65 60.17 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.508 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.32 36.32 17.84 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 120.6 -0.809 . . . . 0.0 113.715 -178.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' THR . . . . . 0.423 HG21 ' O ' ' A' ' 188' ' ' ASP . 97.0 m -123.21 117.29 24.98 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 119.174 1.487 . . . . 0.0 111.708 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -68.21 137.2 54.62 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.42 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 43.6 tp -111.81 130.86 55.67 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 2.8 mp -117.83 134.29 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.468 HG23 HD11 ' A' ' 224' ' ' ILE . 49.5 mm -115.67 131.31 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -178.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 44.2 p -134.3 165.57 24.81 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.916 -177.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 78.66 21.78 68.31 Favored Glycine 0 N--CA 1.464 0.528 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 97.7 mt -83.83 128.22 39.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 113.87 -1.165 . . . . 0.0 108.291 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -77.4 141.07 65.44 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.33 -39.77 85.63 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 120.984 1.122 . . . . 0.0 112.629 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -63.04 -39.71 95.56 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.356 0.598 . . . . 0.0 110.16 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 52.4 tp -63.67 -42.64 98.02 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.904 177.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.45 -37.8 88.79 Favored 'General case' 0 CA--C 1.522 -0.109 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.991 -178.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 94.0 mtp -63.22 -41.3 99.11 Favored 'General case' 0 C--O 1.248 0.989 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.917 -178.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.96 -38.45 91.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.519 176.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 31.9 mmt -65.79 -37.61 86.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.576 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -61.11 -42.33 98.32 Favored 'General case' 0 CA--C 1.516 -0.33 0 O-C-N 121.55 -0.719 . . . . 0.0 109.401 -176.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.66 -41.59 95.34 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.524 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 54.5 tp -63.3 -41.5 98.96 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 177.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -167.58 124.26 1.14 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.299 0.571 . . . . 0.0 112.507 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.36 -26.6 65.21 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.55 -1.205 . . . . 0.0 110.625 178.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -62.37 -28.93 70.11 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.729 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -56.69 -44.51 81.56 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -176.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 95.2 p -60.93 -20.07 61.63 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 123.8 0.688 . . . . 0.0 111.15 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 31.1 m -55.79 -40.21 72.35 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 97.1 mt -81.4 122.44 27.49 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -43.1 133.51 3.83 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.028 177.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 93.8 m -127.48 133.83 49.86 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.89 177.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -119.02 139.65 51.35 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.173 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' SER . . . . . 0.507 ' HG ' ' N ' ' A' ' 250' ' ' ASN . 78.0 p -61.86 -42.63 99.29 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -178.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.507 ' N ' ' HG ' ' A' ' 249' ' ' SER . 98.8 m-20 -141.83 158.73 43.44 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.776 0.798 . . . . 0.0 111.641 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 63.3 t -62.39 -44.69 99.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 114.668 -1.151 . . . . 0.0 112.22 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.82 -44.18 97.25 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.207 -0.597 . . . . 0.0 109.434 -178.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -63.87 -41.02 97.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.375 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . 0.44 ' O ' HG21 ' A' ' 257' ' ' VAL . . . -64.2 -44.64 91.34 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.895 0.855 . . . . 0.0 109.832 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 76.6 t -63.18 -45.84 97.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 113.944 -1.48 . . . . 0.0 110.912 -178.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.33 -46.55 86.1 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.141 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . 0.498 ' O ' ' C ' ' A' ' 258' ' ' LEU . 32.1 m -68.11 -40.72 83.43 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 O-C-N 121.489 -0.757 . . . . 0.0 111.923 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.498 ' C ' ' O ' ' A' ' 257' ' ' VAL . 1.5 mt -29.49 -74.46 0.04 OUTLIER Pre-proline 0 C--O 1.234 0.237 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.538 -177.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' PRO . . . . . 0.476 ' CD ' ' CB ' ' A' ' 258' ' ' LEU . 43.6 Cg_endo -63.57 140.34 74.79 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 120.778 0.986 . . . . 0.0 111.96 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 259' ' ' PRO . 96.6 mt -153.15 -29.5 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 123.914 0.759 . . . . 0.0 111.883 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 78.0 mtm . . . . . 0 N--CA 1.474 0.751 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.567 -176.831 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.434 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.11 155.45 34.05 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 81.0 p -57.98 -27.58 63.59 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.784 176.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -65.54 -63.58 1.06 Allowed 'General case' 0 N--CA 1.437 -1.114 0 CA-C-O 121.004 0.43 . . . . 0.0 111.7 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -66.72 -38.06 85.94 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.323 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' SER . . . . . 0.501 ' O ' ' HB3' ' B' ' 7' ' ' PHE . 69.4 m -59.8 -42.53 93.63 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.877 -177.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . 0.501 ' HB3' ' O ' ' B' ' 6' ' ' SER . 43.7 t80 84.83 90.85 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.387 177.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . 0.584 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -65.45 -142.6 0.04 OUTLIER Glycine 0 C--N 1.339 0.703 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . 0.584 ' HB ' ' O ' ' B' ' 8' ' ' GLY . 74.1 mt 85.33 110.49 0.03 OUTLIER Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 122.634 0.374 . . . . 0.0 110.88 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -62.9 -24.42 74.24 Favored 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 121.314 1.343 . . . . 0.0 111.864 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.14 -40.75 98.98 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -64.21 -39.84 94.82 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.676 0.75 . . . . 0.0 109.292 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 49.2 tp -61.9 -42.38 99.01 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.419 -177.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -65.24 -32.82 74.68 Favored 'General case' 0 CA--C 1.562 1.413 0 CA-C-O 121.489 0.661 . . . . 0.0 110.624 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 72.7 t -62.24 -46.48 96.34 Favored 'Isoleucine or valine' 0 C--O 1.244 0.774 0 CA-C-N 113.189 -1.823 . . . . 0.0 110.851 177.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 93.1 mt -64.08 -43.76 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.069 -178.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . 0.473 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 99.0 mttt -63.46 -42.07 98.63 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.52 -41.43 98.5 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 118.838 -1.145 . . . . 0.0 110.142 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.52 -39.01 86.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.891 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 87.9 mt -63.9 -42.25 97.48 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.369 0.604 . . . . 0.0 110.345 175.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -63.15 -38.47 91.28 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.019 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 57.7 m170 -57.43 -40.27 78.0 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 119.54 -0.267 . . . . 0.0 111.467 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 10.0 p -114.45 129.72 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.52 ' O ' ' HG3' ' B' ' 24' ' ' ARG . 36.0 ptt180 -71.43 108.59 4.93 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.736 0.779 . . . . 0.0 112.538 -177.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.9 p -143.11 134.16 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.857 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.602 177.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' B' ' 123' ' ' GLN . . . -86.5 95.89 2.09 Favored Glycine 0 C--N 1.313 -0.742 0 C-N-CA 119.555 -1.307 . . . . 0.0 113.393 -177.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 47.0 t -125.34 128.62 72.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 174.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 34.6 m -139.09 157.23 28.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.48 178.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . 0.418 HG21 HD13 ' B' ' 29' ' ' ILE . 96.1 mt -120.54 128.58 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 O-C-N 123.721 0.638 . . . . 0.0 111.787 178.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 23.2 p -108.69 157.24 18.72 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-N 112.819 -1.991 . . . . 0.0 108.602 -176.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.435 ' C ' ' OD1' ' B' ' 37' ' ' ASN . 43.3 t0 -125.46 102.97 29.2 Favored Pre-proline 0 CA--C 1.531 0.222 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -178.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.14 -22.12 67.51 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 121.694 1.596 . . . . 0.0 111.431 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.84 -45.69 93.52 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.229 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 98.7 mt -70.64 176.88 3.82 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.786 -0.571 . . . . 0.0 111.404 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . 0.54 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 42.1 tt0 -78.23 131.37 37.1 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -175.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.516 ' O ' ' OD1' ' B' ' 36' ' ' ASP . 66.7 t0 58.2 36.91 26.12 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.582 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' ASN . . . . . 0.467 ' C ' ' O ' ' B' ' 36' ' ' ASP . 32.7 t-20 28.09 73.1 0.41 Allowed Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.54 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 91.9 Cg_endo -72.98 155.33 52.94 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 123.578 2.852 . . . . 0.0 111.732 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 96.3 mt -86.54 130.02 37.39 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.47 HG21 ' N ' ' B' ' 41' ' ' TYR . 34.5 m -109.39 -42.12 5.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 O-C-N 123.708 0.63 . . . . 0.0 112.378 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' TYR . . . . . 0.47 ' N ' HG21 ' B' ' 40' ' ' VAL . 51.2 t80 -98.73 124.1 43.36 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.485 -178.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 5.1 p -143.08 142.13 26.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 O-C-N 124.046 0.841 . . . . 0.0 109.279 177.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . 0.615 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 57.0 p30 -102.64 162.08 13.21 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.212 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' GLN . . . . . 0.509 ' HA ' ' OE1' ' B' ' 44' ' ' GLN . 12.7 mm100 -62.8 -37.42 86.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.373 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.41 -27.43 65.69 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.615 ' HB2' ' OD1' ' B' ' 43' ' ' ASN . 62.4 t80 -59.91 -43.52 94.83 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . 0.675 HG11 ' O ' ' B' ' 52' ' ' TYR . 66.1 t -61.71 -46.61 96.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.218 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -63.67 -44.36 93.97 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.439 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 60.6 ttm -62.86 -41.99 99.59 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 32.2 p -96.04 -14.86 22.62 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.35 -0.54 . . . . 0.0 112.017 -177.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' B' ' 47' ' ' VAL . . . 72.54 19.96 79.27 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 177.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . 0.675 ' O ' HG11 ' B' ' 47' ' ' VAL . 81.9 m-85 -112.99 144.94 41.71 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 122.897 0.479 . . . . 0.0 110.128 178.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -73.62 148.58 42.74 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 121.884 0.85 . . . . 0.0 111.013 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.15 -35.63 80.94 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.127 -177.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.41 -40.79 96.46 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.568 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -72.43 -32.73 66.56 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 177.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . 0.403 ' O ' ' C ' ' B' ' 58' ' ' LEU . 93.5 mt -66.1 -73.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' B' ' 57' ' ' ILE . 94.6 mt -35.27 132.51 0.38 Allowed 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.362 174.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.85 -9.16 73.43 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.831 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -136.71 149.14 47.73 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -174.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' ASN . . . . . 0.519 ' C ' ' H ' ' B' ' 63' ' ' ARG . 25.9 t-20 -78.72 152.09 31.75 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.889 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' CYS . . . . . . . . . . . . . 82.8 m -64.53 8.67 0.1 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.342 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' ARG . . . . . 0.519 ' H ' ' C ' ' B' ' 61' ' ' ASN . 34.6 ptt-85 -58.85 -30.95 68.08 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.487 -178.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -61.55 -30.78 70.86 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 81.0 mt -61.76 -42.77 99.41 Favored 'General case' 0 C--O 1.24 0.589 0 O-C-N 122.005 -0.435 . . . . 0.0 109.87 -178.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -49.99 148.93 2.96 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 123.7 0.625 . . . . 0.0 109.846 -177.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -160.57 -151.36 6.18 Favored Glycine 0 CA--C 1.54 1.656 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.339 175.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' LYS . . . . . 0.445 ' HB3' ' HH ' ' B' ' 95' ' ' TYR . 88.8 tttt -60.4 -41.88 94.8 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 122.659 -0.318 . . . . 0.0 111.738 -175.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -75.81 -9.56 58.7 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 123.169 0.293 . . . . 0.0 111.406 -178.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 24.5 m -61.35 135.79 57.82 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -91.08 109.28 34.25 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.283 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.96 -38.69 86.51 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 120.884 1.056 . . . . 0.0 111.888 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.52 -40.38 91.23 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 120.527 -0.469 . . . . 0.0 109.798 -176.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' GLU . . . . . 0.459 ' OE1' ' HB ' ' B' ' 90' ' ' VAL . 78.8 mm-40 -66.87 -38.6 86.63 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.667 177.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 85.3 t -61.74 -46.01 97.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -62.91 -37.34 86.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.738 -178.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -62.57 -41.96 99.26 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 119.359 -0.936 . . . . 0.0 108.672 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.47 -43.79 98.54 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.859 -178.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -62.48 -43.01 99.86 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 83.6 m -61.11 -45.29 95.3 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.965 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.53 -40.98 96.64 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -177.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 80.2 mt -63.18 -41.79 99.27 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -62.22 -35.42 78.86 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . 0.424 ' O ' ' C ' ' B' ' 85' ' ' LYS . 98.5 m-20 -91.16 10.25 27.79 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.604 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' B' ' 84' ' ' ASN . 30.7 tttt 38.08 37.82 0.17 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 120.509 -0.477 . . . . 0.0 112.037 176.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -120.66 140.69 30.94 Favored Pre-proline 0 N--CA 1.469 0.487 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.96 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -61.63 140.29 85.75 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 121.006 1.137 . . . . 0.0 114.011 -177.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -140.94 137.44 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -177.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 89' ' ' THR . . . . . 0.504 ' CG2' ' OD1' ' B' ' 107' ' ' ASN . 97.0 m -121.65 122.78 40.37 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . 0.459 ' HB ' ' OE1' ' B' ' 74' ' ' GLU . 28.2 m -139.04 163.2 27.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.859 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -114.71 122.4 46.31 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.189 0.519 . . . . 0.0 109.638 175.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 20.5 tt -128.9 132.58 67.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 114.999 -1.0 . . . . 0.0 112.038 -175.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . 0.439 ' O ' ' ND2' ' B' ' 94' ' ' ASN . 84.0 mt-30 -71.9 144.01 49.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.613 177.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 94' ' ' ASN . . . . . 0.439 ' ND2' ' O ' ' B' ' 93' ' ' GLN . 8.2 m120 -135.48 -178.69 5.23 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.353 0.596 . . . . 0.0 110.989 -176.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 95' ' ' TYR . . . . . 0.445 ' HH ' ' HB3' ' B' ' 68' ' ' LYS . 95.8 m-85 -132.42 145.12 50.97 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.634 -1.167 . . . . 0.0 111.829 178.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . 0.454 ' HG3' ' CE1' ' B' ' 102' ' ' PHE . 98.7 mttt -102.47 179.59 4.26 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.0 0.429 . . . . 0.0 110.917 178.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.82 -35.49 74.84 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.17 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 38.4 p-10 -88.08 -0.67 57.33 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 119.0 0.818 . . . . 0.0 112.738 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.47 5.89 64.77 Favored Glycine 0 N--CA 1.465 0.607 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.209 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 25.7 m -67.68 129.63 40.49 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.508 177.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 101' ' ' MET . . . . . 0.571 ' SD ' ' N ' ' B' ' 102' ' ' PHE . 14.9 tmm? -87.98 141.82 28.27 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 102' ' ' PHE . . . . . 0.571 ' N ' ' SD ' ' B' ' 101' ' ' MET . 53.2 p90 -154.81 162.08 41.24 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 103' ' ' TRP . . . . . 0.743 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 24.7 m95 -96.36 138.76 33.47 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.324 -0.551 . . . . 0.0 111.093 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . 0.451 HD22 ' HG2' ' B' ' 123' ' ' GLN . 64.0 t-20 -132.55 106.37 7.79 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 114.737 -1.119 . . . . 0.0 113.807 -177.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -75.49 123.92 26.28 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 124.286 0.992 . . . . 0.0 109.346 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 37.9 tp -111.61 126.02 54.56 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.075 0.464 . . . . 0.0 111.989 -177.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 107' ' ' ASN . . . . . 0.504 ' OD1' ' CG2' ' B' ' 89' ' ' THR . 97.6 m-20 -118.79 127.91 53.97 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 176.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 96.7 mt -123.79 133.11 70.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -146.6 120.9 5.23 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -69.48 153.34 70.35 Favored 'Trans proline' 0 N--CA 1.504 2.096 0 C-N-CA 122.581 2.187 . . . . 0.0 112.629 -178.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 111' ' ' MET . . . . . 0.496 ' HB2' ' HB2' ' B' ' 118' ' ' TYR . 66.5 mtt -128.74 144.02 51.07 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -113.49 108.68 17.51 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 178.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . 0.611 HG12 ' HZ3' ' A' ' 18' ' ' LYS . 96.7 mt -134.6 128.3 50.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 O-C-N 121.64 -0.663 . . . . 0.0 111.736 177.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 52.89 38.66 27.46 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 123.974 0.796 . . . . 0.0 109.695 178.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 60.55 35.94 20.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.53 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -134.55 152.03 51.5 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 9.5 t -102.62 152.92 20.62 Favored 'General case' 0 C--O 1.214 -0.812 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.298 -177.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 118' ' ' TYR . . . . . 0.496 ' HB2' ' HB2' ' B' ' 111' ' ' MET . 95.2 m-85 -147.46 147.17 29.92 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 121.349 -0.844 . . . . 0.0 111.465 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -122.89 139.2 54.29 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 120.975 0.416 . . . . 0.0 111.57 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -128.85 134.33 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -176.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -109.87 125.14 7.45 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 122' ' ' ILE . . . . . 0.402 ' HB ' ' HB2' ' B' ' 107' ' ' ASN . 95.5 mt -114.84 127.75 72.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 123' ' ' GLN . . . . . 0.451 ' HG2' HD22 ' B' ' 104' ' ' ASN . 13.8 mp0 -119.8 118.5 30.99 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -116.75 120.28 38.07 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' B' ' 127' ' ' THR . 68.0 t0 -67.65 133.8 49.99 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.465 -178.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . 0.478 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 3.3 mt -107.49 16.16 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.626 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 127' ' ' THR . . . . . 0.55 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 97.8 m -63.45 -44.08 95.54 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 114.254 -1.339 . . . . 0.0 112.672 176.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 59.7 tptt -61.38 -45.79 92.87 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -177.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 129' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -62.75 -35.42 79.73 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.474 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 130' ' ' LYS . . . . . 0.743 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 98.8 mttt -63.13 -41.4 99.31 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 112.91 -1.95 . . . . 0.0 111.073 175.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.41 -41.89 96.38 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 132' ' ' TYR . . . . . 0.459 ' CE2' HD13 ' B' ' 136' ' ' LEU . 90.9 t80 -60.83 -44.76 96.51 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.941 -0.474 . . . . 0.0 111.644 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.28 -36.56 84.49 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 119.966 -0.693 . . . . 0.0 109.75 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 134' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' B' ' 130' ' ' LYS . 98.9 mttt -63.29 -38.92 93.03 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.846 177.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 52.7 tp -62.55 -41.44 98.89 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.46 0.647 . . . . 0.0 109.385 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 136' ' ' LEU . . . . . 0.459 HD13 ' CE2' ' B' ' 132' ' ' TYR . 85.2 mt -63.03 -41.58 99.56 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.405 178.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 137' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.95 -37.74 88.52 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 113.89 -1.505 . . . . 0.0 110.237 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -63.19 -43.66 97.58 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 120.029 -0.668 . . . . 0.0 109.952 176.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 53.4 m -61.04 -44.63 97.12 Favored 'General case' 0 C--N 1.346 0.43 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 88.3 mt -61.55 -40.44 94.69 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -177.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 81.8 m -61.6 -45.37 94.38 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.961 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -66.16 -41.49 90.3 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 92.5 mt -63.69 -43.56 98.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.63 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 144' ' ' THR . . . . . . . . . . . . . 99.1 m -61.55 -45.18 95.24 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -178.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.12 -40.7 96.75 Favored 'General case' 0 C--O 1.227 -0.121 0 C-N-CA 119.192 -1.003 . . . . 0.0 109.331 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 91.5 mt -64.18 -41.39 97.14 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 147' ' ' SER . . . . . 0.61 ' O ' ' N ' ' B' ' 149' ' ' PRO . 78.1 p -62.78 -42.25 99.62 Favored 'General case' 0 CA--C 1.477 -1.854 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 148' ' ' THR . . . . . 0.508 ' C ' ' O ' ' B' ' 147' ' ' SER . 12.3 m -25.52 85.33 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.793 0 O-C-N 124.12 0.887 . . . . 0.0 110.165 176.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 149' ' ' PRO . . . . . 0.61 ' N ' ' O ' ' B' ' 147' ' ' SER . 23.8 Cg_exo -60.83 146.48 97.42 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.112 1.874 . . . . 0.0 115.897 -177.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 9.7 tp -128.36 119.33 50.24 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.148 0 CA-C-N 114.015 -1.448 . . . . 0.0 108.029 174.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 41.6 t -153.02 93.34 3.19 Favored Pre-proline 0 C--N 1.308 -1.197 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.931 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -60.18 137.27 74.18 Favored 'Trans proline' 0 N--CA 1.488 1.181 0 CA-C-N 119.728 0.939 . . . . 0.0 109.727 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 153' ' ' ILE . . . . . 0.595 ' O ' ' HD2' ' B' ' 154' ' ' ARG . 44.5 mm -68.41 -43.3 84.18 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.499 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.351 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 154' ' ' ARG . . . . . 0.595 ' HD2' ' O ' ' B' ' 153' ' ' ILE . 0.8 OUTLIER -155.96 -155.92 0.59 Allowed 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.683 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 61.8 t-20 -86.84 109.73 19.49 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.87 -18.71 56.46 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -177.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 88.0 mt -108.91 125.69 65.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.098 0.475 . . . . 0.0 111.036 -176.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 158' ' ' SER . . . . . 0.649 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 57.9 m -134.96 149.77 50.27 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.933 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -132.91 146.96 52.26 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 24.3 tp -139.5 77.07 29.51 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 161' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -70.83 147.54 56.21 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.689 2.259 . . . . 0.0 114.083 -178.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 95.1 mt -113.97 133.99 55.13 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 54.7 t -128.79 132.13 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 115.03 169.43 15.99 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 120.508 -0.854 . . . . 0.0 111.276 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 165' ' ' ASN . . . . . 0.688 ' O ' ' CZ ' ' B' ' 170' ' ' ARG . 59.2 t30 -91.5 106.55 18.57 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -177.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 166' ' ' LEU . . . . . 0.489 ' CD2' ' CZ ' ' B' ' 171' ' ' PHE . 47.5 tp -65.25 104.83 0.99 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -174.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 167' ' ' THR . . . . . 0.459 ' H ' ' HE ' ' B' ' 170' ' ' ARG . 10.7 p -84.76 171.24 12.47 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 114.088 -1.414 . . . . 0.0 110.904 176.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -66.77 -37.69 85.1 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.671 177.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.51 -40.92 89.45 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 122.456 1.122 . . . . 0.0 111.962 -178.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 170' ' ' ARG . . . . . 0.688 ' CZ ' ' O ' ' B' ' 165' ' ' ASN . 87.6 mtm180 -62.07 -36.54 81.99 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 112.367 -2.197 . . . . 0.0 111.405 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 171' ' ' PHE . . . . . 0.489 ' CZ ' ' CD2' ' B' ' 166' ' ' LEU . 0.3 OUTLIER -54.08 -26.25 26.04 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -178.92 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 172' ' ' ASN . . . . . 0.661 ' O ' HG21 ' B' ' 175' ' ' VAL . 90.3 m-20 -62.58 -40.2 96.11 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.967 178.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 67.9 m -60.46 -41.7 94.69 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.095 0.474 . . . . 0.0 110.708 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 67.8 mt -64.17 -44.12 97.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 175' ' ' VAL . . . . . 0.661 HG21 ' O ' ' B' ' 172' ' ' ASN . 34.0 m -62.9 -40.59 89.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 176' ' ' CYS . . . . . . . . . . . . . 99.5 m -62.27 -34.71 77.08 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.415 177.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 177' ' ' THR . . . . . 0.518 ' O ' HG13 ' B' ' 181' ' ' ILE . 25.2 m -61.53 -19.82 62.54 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-O 121.001 0.429 . . . . 0.0 110.213 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 178' ' ' LEU . . . . . . . . . . . . . 86.8 mt -61.1 -39.02 88.38 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.255 -178.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 19.2 m -60.94 -44.31 97.43 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.357 177.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 180' ' ' ASN . . . . . 0.576 ' O ' ' OG ' ' B' ' 183' ' ' SER . 91.2 m-20 -62.16 -40.38 95.79 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.682 0.277 . . . . 0.0 110.538 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . 0.518 HG13 ' O ' ' B' ' 177' ' ' THR . 76.3 mt -55.45 -31.77 28.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.729 -177.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 182' ' ' LEU . . . . . . . . . . . . . 84.4 mt -62.42 -42.27 99.32 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.249 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 183' ' ' SER . . . . . 0.576 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.0 p -63.53 -33.81 76.4 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 121.876 -0.515 . . . . 0.0 110.999 178.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 33.1 p -85.23 15.77 4.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.866 0.365 . . . . 0.0 111.899 -177.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 78.7 p -59.83 -16.42 28.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.977 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.38 -40.59 94.89 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.946 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 187' ' ' ASP . . . . . 0.649 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.5 m-20 -69.97 114.37 8.07 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.535 0.684 . . . . 0.0 110.711 -178.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.9 -41.99 99.63 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-N 114.9 -1.046 . . . . 0.0 113.161 -177.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -111.45 130.7 55.63 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.197 -178.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 190' ' ' LEU . . . . . . . . . . . . . 40.5 tp -124.26 118.65 27.28 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.059 177.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 88.3 mt -107.81 127.71 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 120.613 0.244 . . . . 0.0 111.552 -177.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 49.2 mm -116.68 119.13 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 193' ' ' ASP . . . . . 0.52 ' OD2' ' OG ' ' B' ' 195' ' ' SER . 40.8 t0 -89.89 111.64 22.75 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 120.919 0.39 . . . . 0.0 111.739 -177.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 194' ' ' LEU . . . . . . . . . . . . . 98.4 mt -92.14 -2.42 56.59 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.32 175.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 195' ' ' SER . . . . . 0.52 ' OG ' ' OD2' ' B' ' 193' ' ' ASP . 78.3 p -61.25 -37.34 82.75 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.865 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -62.18 -33.89 87.36 Favored Glycine 0 N--CA 1.438 -1.195 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 197' ' ' LEU . . . . . 0.989 HD23 ' O ' ' B' ' 199' ' ' GLN . 4.7 tt -77.97 133.32 38.05 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 121.962 -0.728 . . . . 0.0 109.323 -176.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 198' ' ' ALA . . . . . 0.793 ' N ' HD21 ' B' ' 197' ' ' LEU . . . -64.55 -42.23 95.82 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.361 -176.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 199' ' ' GLN . . . . . 0.989 ' O ' HD23 ' B' ' 197' ' ' LEU . 58.8 tt0 -140.48 165.02 28.57 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.623 0.725 . . . . 0.0 112.648 -178.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 200' ' ' VAL . . . . . 0.445 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 51.0 t -120.93 132.91 69.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 O-C-N 121.037 -1.04 . . . . 0.0 109.526 177.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -93.8 148.95 21.65 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.151 0.5 . . . . 0.0 110.822 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -58.07 -33.71 69.34 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.308 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -64.93 -33.39 75.91 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.4 m -61.19 -44.59 97.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.555 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 205' ' ' ALA . . . . . 0.656 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -57.71 -29.42 64.69 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.666 -177.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -65.66 -37.46 86.58 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.312 0.577 . . . . 0.0 109.603 176.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -66.12 -38.69 88.82 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.586 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.83 -43.3 97.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.079 -178.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 209' ' ' PHE . . . . . 0.656 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 73.6 m-85 -62.47 -43.14 99.54 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 114.16 -1.382 . . . . 0.0 112.733 177.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.4 -41.64 98.75 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.379 -0.929 . . . . 0.0 109.701 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 211' ' ' LEU . . . . . 0.437 ' O ' ' HG ' ' B' ' 215' ' ' LEU . 39.4 mt -62.44 -42.29 99.35 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.314 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 212' ' ' SER . . . . . 0.455 ' HG ' ' N ' ' B' ' 213' ' ' HIS . 78.3 p -62.33 -36.57 82.59 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.908 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 213' ' ' HIS . . . . . 0.455 ' N ' ' HG ' ' B' ' 212' ' ' SER . 58.1 t-80 -67.26 -46.77 72.67 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.012 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 51.0 tp -63.97 -43.35 96.02 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.81 0.815 . . . . 0.0 109.83 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 215' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' B' ' 211' ' ' LEU . 91.8 mt -62.95 -43.97 97.35 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 113.502 -1.681 . . . . 0.0 111.588 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.83 -39.5 92.01 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.82 -177.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 85.6 mt -63.56 -42.02 98.39 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.362 0.601 . . . . 0.0 111.652 176.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 218' ' ' THR . . . . . . . . . . . . . 74.2 p -74.17 -17.21 60.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.987 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 81.08 66.42 1.62 Allowed Glycine 0 CA--C 1.527 0.784 0 N-CA-C 106.696 -2.562 . . . . 0.0 106.696 -178.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 220' ' ' THR . . . . . . . . . . . . . 94.2 m -147.11 104.56 3.69 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 114.652 1.352 . . . . 0.0 114.652 176.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -61.92 140.45 58.3 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.022 -175.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 44.8 tp -116.69 121.79 42.65 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.37 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 3.0 mp -110.26 128.83 66.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.916 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 224' ' ' ILE . . . . . 0.445 HG23 HD11 ' B' ' 224' ' ' ILE . 50.7 mm -109.39 126.58 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.552 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 49.4 p -133.44 157.62 45.12 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 90.1 16.95 55.03 Favored Glycine 0 CA--C 1.499 -0.918 0 CA-C-N 113.898 -1.501 . . . . 0.0 111.117 -177.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 94.8 mt -81.72 125.64 39.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 O-C-N 121.942 -0.74 . . . . 0.0 111.851 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 65.9 tttt -66.73 141.68 97.04 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.406 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.11 -37.47 94.05 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 121.364 1.376 . . . . 0.0 112.609 178.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -64.04 -43.03 96.8 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -177.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 51.3 tp -61.89 -41.34 97.78 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.527 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.15 -36.83 85.31 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.504 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 94.7 mtp -64.08 -40.83 97.11 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.73 -42.84 97.83 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 122.195 0.997 . . . . 0.0 109.238 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 32.4 mmt -63.89 -35.92 82.22 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.782 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -61.66 -40.39 94.78 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -178.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.67 -44.43 93.79 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.07 178.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 51.0 tp -62.45 -45.41 93.17 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.924 -178.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -156.68 131.78 9.12 Favored 'General case' 0 CA--C 1.511 -0.555 0 C-N-CA 120.301 -0.559 . . . . 0.0 111.956 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 240' ' ' ALA . . . . . 0.4 ' C ' ' H ' ' B' ' 242' ' ' PHE . . . -62.13 -47.28 85.25 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 176.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 241' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' B' ' 244' ' ' SER . 93.7 m-20 -42.52 -19.16 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.484 -176.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 242' ' ' PHE . . . . . 0.4 ' H ' ' C ' ' B' ' 240' ' ' ALA . 91.8 t80 -62.6 -44.82 95.33 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.138 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 243' ' ' SER . . . . . . . . . . . . . 78.0 p -57.63 -44.02 85.24 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 244' ' ' SER . . . . . 0.477 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 19.8 m -29.81 -40.61 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 96.4 mt -84.25 141.67 30.81 Favored 'General case' 0 C--N 1.313 -1.013 0 O-C-N 121.561 -0.712 . . . . 0.0 110.993 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -69.06 133.55 48.23 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 120.923 0.392 . . . . 0.0 110.285 -174.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 247' ' ' THR . . . . . . . . . . . . . 97.8 m -124.1 125.86 45.22 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.861 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -111.71 142.85 43.52 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 249' ' ' SER . . . . . 0.571 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 78.4 p -62.86 -33.04 74.43 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.058 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 250' ' ' ASN . . . . . 0.571 ' OD1' ' O ' ' B' ' 249' ' ' SER . 99.3 m-20 -147.31 157.75 43.71 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.122 -0.945 . . . . 0.0 112.004 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 69.3 t -64.9 -44.75 96.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.263 178.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 252' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.74 -46.06 91.89 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -178.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -60.94 -42.88 99.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.651 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 254' ' ' ALA . . . . . 0.401 ' O ' HG21 ' B' ' 257' ' ' VAL . . . -65.57 -41.14 93.26 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.15 178.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 255' ' ' VAL . . . . . 0.416 ' O ' ' HD2' ' B' ' 259' ' ' PRO . 76.2 t -65.02 -45.36 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.067 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.07 -47.96 80.68 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.491 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 257' ' ' VAL . . . . . 0.48 ' O ' ' C ' ' B' ' 258' ' ' LEU . 27.2 m -65.46 -40.58 88.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.577 179.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 258' ' ' LEU . . . . . 0.507 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 1.3 mt -32.74 -73.29 0.06 OUTLIER Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.507 -177.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 259' ' ' PRO . . . . . 0.52 ' O ' HG13 ' B' ' 260' ' ' ILE . 37.1 Cg_endo -61.84 141.36 89.78 Favored 'Trans proline' 0 N--CA 1.504 2.103 0 C-N-CA 121.459 1.439 . . . . 0.0 111.308 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 260' ' ' ILE . . . . . 0.52 HG13 ' O ' ' B' ' 259' ' ' PRO . 96.7 mt -159.54 -16.43 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 CA-C-N 118.692 0.678 . . . . 0.0 112.3 177.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 78.3 mtm . . . . . 0 C--O 1.216 -0.703 0 CA-C-O 117.785 -1.102 . . . . 0.0 111.434 -178.848 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.16 172.39 18.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.144 0.497 . . . . 0.0 110.272 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 85.4 p -73.27 -10.23 59.54 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.6 -0.688 . . . . 0.0 111.17 177.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -83.33 -62.97 1.45 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 114.713 -1.131 . . . . 0.0 112.434 176.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -69.33 -39.71 78.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.782 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.611 ' O ' ' NZ ' ' B' ' 17' ' ' LYS . 57.8 m -59.62 -41.66 90.92 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -177.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.486 ' CE2' HD13 ' A' ' 9' ' ' ILE . 32.2 t80 83.18 89.64 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.179 0.514 . . . . 0.0 112.213 177.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.517 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -63.49 -140.27 0.01 OUTLIER Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -177.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.517 ' HB ' ' O ' ' A' ' 8' ' ' GLY . 67.7 mt 82.11 108.34 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 122.686 0.394 . . . . 0.0 110.523 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.93 -21.75 68.69 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.466 1.444 . . . . 0.0 112.141 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.2 -38.39 95.86 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 121.08 -0.581 . . . . 0.0 111.896 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -65.05 -39.64 93.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.512 0.672 . . . . 0.0 109.486 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 52.9 tp -62.81 -41.41 99.29 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -62.21 -40.68 96.92 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 75.0 t -60.12 -44.36 94.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 O-C-N 122.146 -0.346 . . . . 0.0 110.91 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 91.9 mt -62.51 -43.65 98.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.468 -178.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.51 -46.52 88.05 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 119.269 -0.973 . . . . 0.0 112.306 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.677 ' HZ3' ' CG1' ' B' ' 113' ' ' ILE . 98.4 mttt -59.3 -39.77 84.05 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 118.608 -1.237 . . . . 0.0 109.02 -176.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.34 -41.89 90.22 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.306 -178.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.4 mt -62.93 -40.91 99.07 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -63.43 -38.2 90.22 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 57.9 m170 -58.62 -39.86 81.68 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 122.339 -0.226 . . . . 0.0 111.329 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.6 p -113.88 129.95 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.491 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 34.8 ptt180 -72.36 108.27 5.38 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-O 122.072 0.939 . . . . 0.0 112.161 -177.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.0 p -140.47 142.96 30.06 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 123' ' ' GLN . . . -97.45 92.77 1.34 Allowed Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.674 -178.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 53.3 t -125.44 130.17 72.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.6 m -137.4 159.54 35.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.417 HG21 HD13 ' A' ' 29' ' ' ILE . 96.6 mt -121.12 129.76 75.35 Favored 'Isoleucine or valine' 0 C--O 1.247 0.952 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 177.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 19.6 p -106.32 168.47 9.13 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.518 ' C ' ' OD1' ' A' ' 37' ' ' ASN . 62.7 t0 -133.88 102.85 12.14 Favored Pre-proline 0 C--N 1.318 -0.781 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.117 178.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . 0.492 ' HG3' HG22 ' A' ' 117' ' ' THR . 36.9 Cg_endo -63.83 -22.88 69.07 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 121.495 1.463 . . . . 0.0 111.647 -178.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.02 -35.19 79.4 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.955 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.4 mt -86.39 159.81 19.25 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.375 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.817 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 42.9 tt0 -57.43 134.35 55.98 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -176.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.514 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 56.8 t0 59.76 23.49 12.39 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 178.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.518 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 39.8 t-20 38.82 65.89 2.97 Favored Pre-proline 0 CA--C 1.542 0.65 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.129 -178.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.817 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 91.3 Cg_endo -68.55 155.18 69.85 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 124.007 3.138 . . . . 0.0 112.129 -178.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.4 mt -86.53 125.0 40.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.427 HG21 ' N ' ' A' ' 41' ' ' TYR . 19.0 m -104.66 -41.78 6.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 116.136 -0.483 . . . . 0.0 112.086 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.427 ' N ' HG21 ' A' ' 40' ' ' VAL . 45.8 t80 -96.07 123.57 39.73 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.859 -178.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.5 p -142.62 139.53 28.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 O-C-N 124.295 0.997 . . . . 0.0 109.133 177.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.59 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 58.0 p30 -98.3 167.01 11.12 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.509 ' HA ' ' OE1' ' A' ' 44' ' ' GLN . 14.4 mm100 -66.43 -39.41 88.89 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 178.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.19 -26.14 63.31 Favored Glycine 0 C--N 1.33 0.208 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.59 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 60.5 t80 -59.18 -49.3 78.39 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 -179.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.418 ' O ' ' N ' ' A' ' 51' ' ' GLY . 53.5 t -58.45 -44.9 89.88 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 O-C-N 121.423 -0.798 . . . . 0.0 111.464 -174.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -62.99 -37.16 86.07 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 120.511 -0.476 . . . . 0.0 112.116 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 59.6 ttm -68.65 -43.62 75.89 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 177.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.459 ' HG1' ' H ' ' A' ' 52' ' ' TYR . 35.4 p -90.48 -23.2 21.04 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.34 0.59 . . . . 0.0 111.48 -178.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . 78.01 21.08 71.8 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 -179.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.459 ' H ' ' HG1' ' A' ' 50' ' ' THR . 70.3 m-85 -114.46 138.87 50.04 Favored 'General case' 0 C--O 1.221 -0.42 0 C-N-CA 122.936 0.494 . . . . 0.0 111.162 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -64.21 150.14 46.45 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.646 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.78 -33.55 76.12 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.26 -44.19 84.35 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.659 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -64.62 -45.49 86.65 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.585 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 92.0 mt -61.58 -50.26 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -174.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 80.6 mt -57.26 145.48 31.72 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 176.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.3 -6.68 78.89 Favored Glycine 0 N--CA 1.46 0.235 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.208 177.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -135.6 152.73 51.54 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.685 1.243 . . . . 0.0 111.903 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.559 ' C ' ' H ' ' A' ' 63' ' ' ARG . 25.2 t-20 -81.36 152.44 27.5 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.474 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 80.3 m -63.2 16.3 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.444 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.559 ' H ' ' C ' ' A' ' 61' ' ' ASN . 35.4 ptt-85 -61.88 -41.62 98.08 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.16 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -55.44 -20.55 12.78 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -178.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.7 mt -71.23 -32.17 68.45 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.611 0.719 . . . . 0.0 112.505 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -65.95 141.41 58.22 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.178 -178.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.59 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -151.08 -148.5 4.81 Favored Glycine 0 CA--C 1.539 1.553 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -178.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.538 ' HB3' ' HH ' ' A' ' 95' ' ' TYR . 88.5 tttt -62.79 -39.57 94.64 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -177.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -77.83 -8.72 58.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.902 0.382 . . . . 0.0 111.114 -178.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.59 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 28.6 m -62.27 128.69 37.26 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.55 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -85.89 111.06 35.17 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.859 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -57.44 -31.87 92.5 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.959 1.773 . . . . 0.0 113.247 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.42 -40.1 95.11 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.951 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.425 ' OE1' ' HB ' ' A' ' 90' ' ' VAL . 78.9 mm-40 -65.5 -43.99 88.39 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 71.9 t -59.3 -43.86 90.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -176.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -64.35 -37.54 87.87 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.144 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -63.28 -39.89 95.85 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.304 0.573 . . . . 0.0 110.068 178.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 93.6 mt -64.01 -44.16 97.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.933 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -62.61 -43.13 99.58 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 113.633 -1.622 . . . . 0.0 108.229 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 97.0 m -61.55 -49.44 76.65 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.4 -42.57 92.03 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.381 -172.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 89.3 mt -62.77 -39.98 95.88 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 121.473 -0.767 . . . . 0.0 111.177 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 66.9 tp60 -65.07 -31.44 72.66 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -89.62 -1.33 57.99 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.22 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 46.7 tttt 47.32 39.45 8.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.529 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -122.48 143.9 40.82 Favored Pre-proline 0 CA--C 1.532 0.287 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.424 ' HA ' ' O ' ' A' ' 108' ' ' ILE . 24.8 Cg_exo -61.63 144.37 97.45 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.559 1.506 . . . . 0.0 113.569 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -139.09 142.41 33.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.563 -178.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.504 ' CG2' ' OD1' ' A' ' 107' ' ' ASN . 97.7 m -127.57 118.21 23.5 Favored 'General case' 0 C--N 1.345 0.377 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 176.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.425 ' HB ' ' OE1' ' A' ' 74' ' ' GLU . 28.3 m -138.47 157.49 30.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.675 -0.238 . . . . 0.0 111.496 178.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -100.67 133.52 45.0 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 176.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 17.1 tt -141.28 128.21 20.88 Favored 'Isoleucine or valine' 0 C--N 1.377 1.777 0 CA-C-N 121.374 1.897 . . . . 0.0 112.711 177.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -62.61 135.69 57.51 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.254 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -138.16 161.36 37.0 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.699 -179.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.538 ' HH ' ' HB3' ' A' ' 68' ' ' LYS . 89.4 m-85 -118.14 136.23 53.74 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.435 ' HE3' ' CD1' ' A' ' 102' ' ' PHE . 99.2 mttt -85.77 -171.45 3.6 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.239 0.543 . . . . 0.0 111.921 -179.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -62.51 -44.09 97.21 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.919 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 42.9 p-10 -83.42 7.36 17.05 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.84 -1.1 89.09 Favored Glycine 0 N--CA 1.471 0.99 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.258 176.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.8 m -58.31 137.89 56.83 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.679 ' C ' ' SD ' ' A' ' 101' ' ' MET . 12.5 tmm? -104.97 129.78 53.31 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.556 0.217 . . . . 0.0 110.443 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.548 ' N ' ' SD ' ' A' ' 101' ' ' MET . 53.4 p90 -142.33 158.43 43.72 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.007 -177.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.915 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 23.3 m95 -89.8 141.26 28.8 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.487 HD22 ' HG2' ' A' ' 123' ' ' GLN . 54.3 t-20 -136.58 105.0 5.74 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -176.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.411 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 80.8 tt0 -70.18 135.99 49.63 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 -177.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 41.6 tp -120.9 122.77 40.95 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.504 ' OD1' ' CG2' ' A' ' 89' ' ' THR . 98.1 m-20 -120.31 121.65 39.09 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.773 177.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 87' ' ' PRO . 96.2 mt -119.68 128.57 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 O-C-N 123.493 0.496 . . . . 0.0 111.421 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -136.31 125.76 15.84 Favored Pre-proline 0 CA--C 1.541 0.617 0 O-C-N 123.079 0.237 . . . . 0.0 110.903 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -71.31 151.75 60.46 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.666 2.244 . . . . 0.0 112.363 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.638 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 67.0 mtt -123.89 153.17 41.51 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -128.48 91.14 3.18 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 96.2 mt -117.34 131.37 70.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.429 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 49.38 39.07 15.45 Favored 'General case' 0 CA--C 1.512 -0.499 0 O-C-N 121.496 -0.752 . . . . 0.0 111.68 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 58.7 30.42 19.93 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.954 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -127.59 146.35 50.56 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.785 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 7.7 t -85.38 -170.41 3.11 Favored 'General case' 0 C--O 1.214 -0.772 0 O-C-N 121.687 -0.633 . . . . 0.0 109.334 -178.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.785 ' CD2' ' O ' ' A' ' 117' ' ' THR . 66.0 m-85 -174.0 155.38 2.51 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 177.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -131.11 145.57 52.03 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 174.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -134.33 134.1 55.04 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.8 127.08 8.56 Favored Glycine 0 CA--C 1.501 -0.832 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 96.8 mt -116.6 128.93 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.487 ' HG2' HD22 ' A' ' 104' ' ' ASN . 17.7 mp0 -119.08 115.64 24.71 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.579 0.549 . . . . 0.0 109.63 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -117.64 111.78 19.64 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.838 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 126' ' ' ILE . 67.9 t0 -62.88 131.77 49.87 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -175.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.453 ' N ' ' OD1' ' A' ' 125' ' ' ASP . 2.9 mp -95.48 3.56 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 113.542 -1.663 . . . . 0.0 109.637 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.408 ' OG1' ' OD1' ' A' ' 125' ' ' ASP . 20.0 m -60.04 -42.98 95.58 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.007 -1.058 . . . . 0.0 113.62 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -60.57 -41.69 95.11 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -177.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -63.51 -39.79 95.36 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.003 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.915 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.6 mttt -62.81 -41.06 99.14 Favored 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 118.157 -1.417 . . . . 0.0 110.535 -178.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.1 -37.66 83.54 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.653 -178.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -61.77 -45.3 94.51 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.543 176.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.73 -38.69 91.85 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.02 -40.93 97.37 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 52.8 tp -60.64 -43.36 97.66 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -177.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 83.6 mt -62.28 -40.91 97.82 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.094 178.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.56 -41.83 98.39 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 119.355 -0.938 . . . . 0.0 109.837 -178.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -60.27 -41.55 93.5 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -177.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 48.8 m -61.66 -41.09 97.06 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.071 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 144' ' ' THR . 84.4 mt -63.69 -41.72 98.11 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.449 -0.5 . . . . 0.0 109.758 177.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 96.9 m -61.39 -46.0 92.01 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.268 -177.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -65.21 -40.48 94.19 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 95.5 mt -64.78 -43.47 96.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 113.967 -1.469 . . . . 0.0 111.523 176.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.515 ' N ' ' O ' ' A' ' 140' ' ' LEU . 92.1 m -62.53 -46.48 88.18 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.478 ' O ' ' OG1' ' A' ' 148' ' ' THR . . . -62.58 -40.57 97.29 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 118.875 -1.13 . . . . 0.0 109.251 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 85.3 mt -63.8 -42.73 97.64 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.675 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.1 p -60.93 -37.67 83.12 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -178.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.478 ' OG1' ' O ' ' A' ' 145' ' ' ALA . 18.8 m -29.09 83.73 0.03 OUTLIER Pre-proline 0 C--N 1.347 0.492 0 O-C-N 126.592 2.432 . . . . 0.0 106.613 -178.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.675 ' N ' ' O ' ' A' ' 147' ' ' SER . 22.4 Cg_exo -61.94 144.04 96.07 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 CA-C-O 122.753 1.064 . . . . 0.0 113.906 -174.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.572 ' O ' ' CG2' ' A' ' 151' ' ' VAL . 9.3 tp -120.49 135.1 61.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 102.057 -3.312 . . . . 0.0 102.057 175.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.572 ' CG2' ' O ' ' A' ' 150' ' ' ILE . 95.4 t -167.89 95.11 0.62 Allowed Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 177.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -64.12 143.69 84.96 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 N-CA-C 109.822 -0.876 . . . . 0.0 109.822 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.543 ' O ' HG12 ' B' ' 255' ' ' VAL . 43.4 mm -75.84 -68.61 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.463 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.672 ' NH2' ' HD3' ' B' ' 154' ' ' ARG . 4.8 mpt_? -132.02 -160.34 1.04 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 63.3 t-20 -83.63 104.57 13.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.799 0.809 . . . . 0.0 111.415 -178.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.16 9.2 60.84 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 113.991 -1.458 . . . . 0.0 110.115 -177.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.6 mt -126.1 123.48 63.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 175.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.684 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 74.5 m -133.16 151.72 51.96 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -138.15 141.03 40.12 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.625 177.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 21.7 tp -130.51 80.48 70.13 Favored Pre-proline 0 N--CA 1.47 0.571 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.454 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -70.34 152.47 66.31 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.758 2.305 . . . . 0.0 113.229 -178.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 90.1 mt -120.88 126.39 49.92 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.175 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 48.4 t -123.28 131.2 73.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 117.41 169.32 14.89 Favored Glycine 0 N--CA 1.477 1.423 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.238 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.78 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 57.1 t30 -85.25 115.28 22.93 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 117.16 0.48 . . . . 0.0 110.07 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.539 ' CD2' ' CZ ' ' A' ' 171' ' ' PHE . 47.1 tp -73.7 104.05 4.48 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -177.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.671 HG21 ' NE ' ' A' ' 170' ' ' ARG . 10.6 p -85.92 166.85 15.63 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.588 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.85 -34.16 77.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.166 0.507 . . . . 0.0 111.779 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.45 -42.44 95.95 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.102 178.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.78 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 87.5 mtm180 -65.37 -33.75 76.7 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 124.316 1.047 . . . . 0.0 112.462 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.539 ' CZ ' ' CD2' ' A' ' 166' ' ' LEU . 0.5 OUTLIER -54.21 -28.49 41.25 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 118.986 -0.531 . . . . 0.0 112.381 -178.778 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.506 ' O ' HG21 ' A' ' 175' ' ' VAL . 91.2 m-20 -60.55 -40.71 92.57 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 118.975 -1.09 . . . . 0.0 109.7 -178.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 52.0 m -59.22 -41.31 88.34 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 121.685 -0.635 . . . . 0.0 110.777 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 66.2 mt -63.25 -44.08 99.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.506 HG21 ' O ' ' A' ' 172' ' ' ASN . 35.4 m -62.08 -40.35 87.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . 0.478 ' N ' HG23 ' A' ' 175' ' ' VAL . 98.3 m -62.21 -33.97 75.59 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.396 178.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' THR . . . . . 0.51 ' O ' HG13 ' A' ' 181' ' ' ILE . 25.3 m -62.45 -19.85 63.93 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.135 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 86.2 mt -61.1 -41.87 97.47 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 -177.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 18.4 m -59.27 -43.28 92.51 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . 0.611 ' O ' ' OG ' ' A' ' 183' ' ' SER . 93.1 m-20 -61.78 -37.68 85.22 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 120.759 0.314 . . . . 0.0 110.661 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . 0.51 HG13 ' O ' ' A' ' 177' ' ' THR . 68.7 mt -57.15 -37.18 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 O-C-N 121.384 -0.822 . . . . 0.0 109.918 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 85.9 mt -61.16 -40.69 94.81 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -177.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.611 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 78.0 p -61.62 -33.15 73.42 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.464 177.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.437 ' OG1' ' HA ' ' A' ' 181' ' ' ILE . 21.9 p -89.88 23.32 2.79 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.672 0.272 . . . . 0.0 111.433 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 78.1 p -63.41 -21.49 66.32 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.63 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.29 -37.2 79.77 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.953 -179.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.684 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 98.6 m-20 -72.58 113.21 9.36 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.53 0.681 . . . . 0.0 110.706 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.95 -42.09 99.71 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.914 -177.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -112.88 130.89 55.94 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.862 -178.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 38.5 tp -120.82 128.81 53.2 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 96.5 mt -117.08 127.54 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.8 mm -113.17 127.4 70.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . 0.604 ' CG ' ' HG ' ' A' ' 195' ' ' SER . 40.5 t0 -95.15 117.99 31.18 Favored 'General case' 0 CA--C 1.549 0.93 0 O-C-N 121.871 -0.518 . . . . 0.0 110.538 177.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 96.1 mt -97.38 -4.93 37.48 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.661 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' SER . . . . . 0.604 ' HG ' ' CG ' ' A' ' 193' ' ' ASP . 78.1 p -62.99 -32.51 73.88 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.63 -44.39 98.01 Favored Glycine 0 CA--C 1.533 1.17 0 N-CA-C 108.332 -1.907 . . . . 0.0 108.332 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 1.148 HD23 ' O ' ' A' ' 199' ' ' GLN . 4.7 tt -68.34 127.76 34.12 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 112.871 -1.664 . . . . 0.0 109.289 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.659 ' N ' HD21 ' A' ' 197' ' ' LEU . . . -59.4 -50.08 75.35 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 120.179 -0.608 . . . . 0.0 110.562 -178.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 1.148 ' O ' HD23 ' A' ' 197' ' ' LEU . 58.1 tt0 -132.82 157.89 43.88 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 114.757 -1.11 . . . . 0.0 113.443 -175.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.449 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 44.1 t -117.69 132.71 66.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -88.56 155.45 19.63 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.642 -178.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.4 -39.49 93.95 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 120.135 -0.626 . . . . 0.0 109.987 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -57.85 -31.48 66.71 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -178.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.5 m -61.18 -42.3 98.32 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.413 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.495 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -57.65 -37.85 74.06 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -177.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -60.83 -37.79 83.22 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.516 -0.473 . . . . 0.0 109.749 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -66.02 -38.58 88.79 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.108 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 94.6 mt -63.11 -44.54 99.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -178.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . 0.495 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 73.3 m-85 -62.18 -43.38 98.96 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.427 -178.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -62.06 -41.95 98.68 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 119.125 -1.03 . . . . 0.0 109.072 -178.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.428 ' O ' ' HG ' ' A' ' 215' ' ' LEU . 39.4 mt -62.34 -41.78 98.85 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' SER . . . . . 0.477 ' HG ' ' N ' ' A' ' 213' ' ' HIS . 78.2 p -61.74 -43.15 99.41 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 118.993 -1.083 . . . . 0.0 110.14 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' HIS . . . . . 0.477 ' N ' ' HG ' ' A' ' 212' ' ' SER . 58.6 t-80 -64.14 -45.28 89.22 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.602 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 49.8 tp -62.19 -45.93 91.2 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 118.843 -1.143 . . . . 0.0 108.247 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 211' ' ' LEU . 88.0 mt -62.15 -41.03 97.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.423 -178.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -60.84 -44.78 96.52 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -177.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 85.3 mt -61.4 -40.04 92.93 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 67.4 p -75.55 -12.11 60.16 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.596 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.62 37.63 13.61 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 120.626 -0.797 . . . . 0.0 113.57 -178.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 91.9 m -123.92 114.64 20.09 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 119.02 1.41 . . . . 0.0 111.544 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -66.15 138.11 57.49 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.83 178.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 42.1 tp -114.02 130.11 56.57 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 4.0 mp -116.29 134.41 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 122.886 0.475 . . . . 0.0 109.741 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 49.0 mm -116.53 131.57 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -178.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 37.8 p -133.81 165.41 25.05 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -177.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 78.35 22.64 67.26 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . 0.409 HG21 HD13 ' A' ' 227' ' ' ILE . 97.8 mt -83.96 128.55 38.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 113.947 -1.127 . . . . 0.0 108.439 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 43.1 tttt -76.31 138.39 67.94 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.25 -39.5 86.32 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 121.044 1.162 . . . . 0.0 112.595 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -63.55 -40.0 95.88 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 121.416 0.627 . . . . 0.0 109.967 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 48.8 tp -63.66 -42.6 98.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.88 177.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.27 -37.42 87.41 Favored 'General case' 0 C--O 1.227 -0.12 0 C-N-CA 120.596 -0.441 . . . . 0.0 110.89 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 94.2 mtp -63.03 -41.13 99.45 Favored 'General case' 0 C--O 1.247 0.953 0 C-N-CA 120.004 -0.679 . . . . 0.0 109.742 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.38 -38.4 91.0 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.523 177.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 30.2 mmt -65.88 -37.5 86.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.688 178.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -61.18 -41.86 97.55 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.616 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -60.66 -40.65 92.84 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.573 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 55.6 tp -63.72 -41.03 98.15 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 177.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -169.19 125.95 0.93 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.369 0.604 . . . . 0.0 112.404 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.58 -27.36 66.2 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.893 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -61.45 -28.87 69.58 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.288 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -55.73 -44.48 77.58 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -177.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 96.8 p -61.43 -21.03 63.75 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 123.779 0.674 . . . . 0.0 111.287 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 40.6 m -55.04 -38.76 68.39 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 122.313 -0.242 . . . . 0.0 111.617 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 96.3 mt -84.19 120.36 26.11 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -44.63 134.73 5.27 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.047 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 96.8 m -128.61 133.83 48.41 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.905 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -117.7 140.05 50.19 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 114.953 -1.022 . . . . 0.0 110.959 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 78.0 p -60.23 -43.89 95.66 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -178.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -142.27 161.36 38.22 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.725 0.774 . . . . 0.0 111.79 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 77.4 t -62.46 -45.0 99.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 114.614 -1.175 . . . . 0.0 112.053 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -60.48 -44.31 96.04 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.193 -0.603 . . . . 0.0 109.561 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -62.99 -43.72 98.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.668 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . 0.44 ' O ' HG21 ' A' ' 257' ' ' VAL . . . -63.76 -43.25 96.98 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.94 0.876 . . . . 0.0 109.767 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . 0.481 HG13 HH11 ' B' ' 154' ' ' ARG . 56.9 t -63.37 -45.77 97.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 114.003 -1.453 . . . . 0.0 111.129 -177.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.46 -46.95 83.9 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 120.649 -0.421 . . . . 0.0 111.301 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . 0.494 ' O ' ' C ' ' A' ' 258' ' ' LEU . 21.2 m -66.45 -41.1 88.11 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 O-C-N 121.539 -0.726 . . . . 0.0 112.005 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.494 ' C ' ' O ' ' A' ' 257' ' ' VAL . 1.9 mt -29.85 -72.85 0.05 OUTLIER Pre-proline 0 N--CA 1.466 0.328 0 CA-C-O 119.497 -0.287 . . . . 0.0 111.51 -177.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' PRO . . . . . 0.453 ' CD ' ' CB ' ' A' ' 258' ' ' LEU . 44.7 Cg_endo -64.12 139.28 65.94 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 CA-C-N 119.635 0.905 . . . . 0.0 111.764 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 259' ' ' PRO . 96.5 mt -153.74 -25.03 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 O-C-N 123.638 0.586 . . . . 0.0 111.764 178.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 N--CA 1.475 0.811 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.68 -177.66 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.424 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.26 162.5 33.67 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 79.5 p -59.61 -21.8 60.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.779 177.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -74.67 -62.02 1.68 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 120.948 0.404 . . . . 0.0 111.361 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.72 -39.98 88.23 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.092 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' SER . . . . . 0.482 ' O ' ' HB3' ' B' ' 7' ' ' PHE . 61.0 m -60.33 -42.59 95.95 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 119.98 -0.688 . . . . 0.0 109.833 -177.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . 0.486 ' CE2' HD13 ' B' ' 9' ' ' ILE . 36.7 t80 84.79 92.86 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.339 177.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . 0.538 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -65.46 -139.87 0.03 OUTLIER Glycine 0 C--N 1.338 0.678 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . 0.538 ' HB ' ' O ' ' B' ' 8' ' ' GLY . 68.0 mt 81.61 108.35 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 122.567 0.347 . . . . 0.0 110.912 -178.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -62.94 -24.23 74.13 Favored 'Trans proline' 0 N--CA 1.499 1.814 0 C-N-CA 121.338 1.359 . . . . 0.0 111.711 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.95 -40.64 98.69 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -64.67 -39.35 93.53 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.763 0.792 . . . . 0.0 109.131 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 54.1 tp -62.41 -42.24 99.29 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.476 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -63.91 -32.39 73.91 Favored 'General case' 0 CA--C 1.562 1.431 0 CA-C-O 121.535 0.683 . . . . 0.0 110.525 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . 0.405 HG11 ' SD ' ' A' ' 111' ' ' MET . 70.0 t -62.83 -46.22 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 113.237 -1.801 . . . . 0.0 111.007 176.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 93.3 mt -64.16 -43.96 97.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.007 -178.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . 0.611 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 99.0 mttt -63.55 -41.8 98.42 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -179.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.22 -41.22 99.09 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 119.01 -1.076 . . . . 0.0 109.973 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.37 -38.73 84.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.966 -178.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 86.0 mt -63.91 -41.97 97.55 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 121.359 0.6 . . . . 0.0 110.263 175.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -63.07 -38.73 92.35 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.192 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 56.5 m170 -57.83 -39.85 78.65 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 119.557 -0.259 . . . . 0.0 111.323 -178.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 12.3 p -114.04 129.94 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.505 ' O ' ' HG3' ' B' ' 24' ' ' ARG . 35.0 ptt180 -72.0 106.21 4.19 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.711 0.767 . . . . 0.0 112.447 -177.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.6 p -142.01 133.68 26.69 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.86 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.816 177.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . 0.498 ' O ' ' N ' ' B' ' 123' ' ' GLN . . . -87.31 97.53 2.28 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 119.422 -1.37 . . . . 0.0 113.202 -176.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 49.4 t -126.41 129.07 71.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 174.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 30.0 m -138.44 156.23 29.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 121.014 -0.274 . . . . 0.0 110.429 178.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 95.8 mt -119.01 127.41 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.237 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 33.2 p -107.54 158.13 17.47 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-N 113.002 -1.908 . . . . 0.0 108.694 -177.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . 0.49 ' C ' ' OD1' ' B' ' 37' ' ' ASN . 64.1 t0 -125.18 103.07 30.09 Favored Pre-proline 0 C--O 1.236 0.381 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -178.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' PRO . . . . . 0.431 ' HG3' HG22 ' B' ' 117' ' ' THR . 37.1 Cg_endo -64.39 -21.76 66.37 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.723 1.616 . . . . 0.0 111.496 -178.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.02 -45.39 93.79 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.539 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 90.9 mt -71.23 179.45 2.85 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.913 -0.492 . . . . 0.0 111.676 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . 0.681 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 41.4 tt0 -77.13 129.67 36.31 Favored 'General case' 0 C--N 1.344 0.327 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -174.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.47 ' O ' ' C ' ' B' ' 37' ' ' ASN . 65.2 t0 58.01 38.14 26.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.461 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' ASN . . . . . 0.49 ' OD1' ' C ' ' B' ' 31' ' ' ASP . 24.3 t-20 27.69 69.73 0.49 Allowed Pre-proline 0 C--N 1.327 -0.413 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.681 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 92.1 Cg_endo -70.72 153.39 64.56 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 123.676 2.917 . . . . 0.0 111.635 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 96.0 mt -84.46 129.93 36.84 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.411 HG21 ' N ' ' B' ' 41' ' ' TYR . 18.0 m -109.55 -41.61 4.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 O-C-N 123.592 0.557 . . . . 0.0 112.339 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' TYR . . . . . 0.411 ' N ' HG21 ' B' ' 40' ' ' VAL . 48.0 t80 -96.81 123.62 40.56 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.506 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 5.8 p -142.38 140.61 28.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.222 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . 0.624 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 56.7 p30 -102.13 162.1 13.17 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.177 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' GLN . . . . . 0.489 ' HA ' ' OE1' ' B' ' 44' ' ' GLN . 13.8 mm100 -62.55 -38.12 88.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.379 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.35 -26.71 64.48 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.624 ' HB2' ' OD1' ' B' ' 43' ' ' ASN . 58.0 t80 -60.04 -43.61 95.23 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . 0.561 HG11 ' O ' ' B' ' 52' ' ' TYR . 53.3 t -61.63 -46.4 96.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.091 -178.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -63.09 -45.02 94.05 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.262 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 60.3 ttm -62.75 -42.6 99.75 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' THR . . . . . 0.44 ' HG1' ' H ' ' B' ' 52' ' ' TYR . 34.3 p -93.77 -17.63 22.93 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.968 -178.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' B' ' 47' ' ' VAL . . . 73.59 19.83 79.75 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 178.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . 0.561 ' O ' HG11 ' B' ' 47' ' ' VAL . 70.8 m-85 -112.08 145.64 39.38 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.244 -0.478 . . . . 0.0 110.172 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -74.39 148.96 40.73 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.684 0.754 . . . . 0.0 111.173 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.05 -38.15 87.65 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.698 -177.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.83 -39.94 95.89 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 120.238 -0.585 . . . . 0.0 111.854 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -73.76 -32.89 64.04 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 93.4 mt -66.2 -72.12 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 95.6 mt -37.19 131.82 0.79 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.71 175.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.28 -12.22 66.77 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.957 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -133.98 149.92 51.24 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.358 0.599 . . . . 0.0 112.595 -174.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' ASN . . . . . 0.522 ' C ' ' H ' ' B' ' 63' ' ' ARG . 25.9 t-20 -77.66 153.31 33.23 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.8 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' CYS . . . . . . . . . . . . . 84.6 m -64.91 9.12 0.1 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.524 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' ARG . . . . . 0.522 ' H ' ' C ' ' B' ' 61' ' ' ASN . 33.5 ptt-85 -58.72 -32.04 68.83 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.719 -178.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -60.33 -31.06 69.94 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 85.4 mt -61.82 -42.53 99.14 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -178.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -50.0 146.01 5.16 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 123.624 0.577 . . . . 0.0 109.764 -178.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -156.19 -152.24 6.19 Favored Glycine 0 CA--C 1.54 1.656 0 CA-C-N 115.1 -0.955 . . . . 0.0 112.773 175.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' LYS . . . . . 0.46 ' HB3' ' HH ' ' B' ' 95' ' ' TYR . 88.9 tttt -60.19 -40.76 91.17 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.576 -0.312 . . . . 0.0 111.64 -175.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -76.36 -9.27 58.52 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 123.092 0.245 . . . . 0.0 111.434 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 26.5 m -61.25 134.3 56.84 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -91.78 110.84 46.33 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.162 -178.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.43 -39.02 89.5 Favored 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 121.035 1.157 . . . . 0.0 111.917 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.74 -41.12 90.23 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 120.508 -0.477 . . . . 0.0 109.871 -176.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' GLU . . . . . 0.428 ' OE1' ' HB ' ' B' ' 90' ' ' VAL . 79.0 mm-40 -66.36 -38.96 88.78 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.752 177.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 85.9 t -61.88 -46.26 96.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -63.21 -36.84 84.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.751 -178.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -62.24 -42.12 99.03 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 119.168 -1.013 . . . . 0.0 108.642 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . 0.406 HD13 HG21 ' B' ' 78' ' ' ILE . 95.0 mt -63.53 -43.49 98.33 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 CA-C-O 120.751 0.31 . . . . 0.0 110.574 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -62.1 -42.54 99.32 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 94.9 m -61.65 -45.79 92.52 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.137 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.49 -41.49 97.34 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -177.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 86.0 mt -62.95 -42.57 99.86 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -178.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 66.8 tp60 -62.84 -33.86 76.12 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -91.39 8.28 36.99 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.498 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 37.9 tttt 40.05 41.6 0.95 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.403 -0.519 . . . . 0.0 111.946 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -124.45 140.91 36.27 Favored Pre-proline 0 N--CA 1.47 0.57 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.171 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -61.99 141.11 88.07 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 120.99 1.127 . . . . 0.0 113.827 -178.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -139.78 136.14 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.325 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 89' ' ' THR . . . . . 0.514 ' CG2' ' OD1' ' B' ' 107' ' ' ASN . 92.6 m -120.12 121.26 38.42 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.831 178.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . 0.428 ' HB ' ' OE1' ' B' ' 74' ' ' GLU . 29.2 m -139.09 162.99 27.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.978 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -113.49 119.58 38.06 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.153 0.502 . . . . 0.0 109.694 175.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 20.8 tt -126.42 131.99 70.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.144 -175.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . 0.488 ' O ' ' ND2' ' B' ' 94' ' ' ASN . 85.5 mt-30 -72.56 145.57 47.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.194 177.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 94' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' B' ' 93' ' ' GLN . 8.7 m120 -138.54 -179.67 5.94 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 121.359 0.6 . . . . 0.0 110.61 -177.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 95' ' ' TYR . . . . . 0.46 ' HH ' ' HB3' ' B' ' 68' ' ' LYS . 93.5 m-85 -129.62 148.26 51.5 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.525 177.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . 0.42 ' HG3' ' CE1' ' B' ' 102' ' ' PHE . 98.8 mttt -104.71 -179.08 3.84 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.02 0.438 . . . . 0.0 110.59 178.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.31 -36.25 77.48 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.211 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 37.6 p-10 -87.45 -1.29 57.82 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.931 0.787 . . . . 0.0 112.832 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.99 5.07 64.45 Favored Glycine 0 N--CA 1.466 0.69 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.249 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 26.5 m -67.32 128.38 36.18 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.305 177.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 101' ' ' MET . . . . . 0.663 ' SD ' ' N ' ' B' ' 102' ' ' PHE . 13.9 tmm? -87.5 143.5 27.19 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 102' ' ' PHE . . . . . 0.663 ' N ' ' SD ' ' B' ' 101' ' ' MET . 53.2 p90 -154.86 163.86 39.66 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 103' ' ' TRP . . . . . 0.934 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 24.5 m95 -96.72 137.4 35.86 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.944 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . 0.436 HD22 ' HG2' ' B' ' 123' ' ' GLN . 62.7 t-20 -132.17 110.84 10.95 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 114.904 -1.043 . . . . 0.0 113.686 -176.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -80.4 124.52 28.96 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 123.842 0.713 . . . . 0.0 109.185 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 39.8 tp -111.25 125.29 53.66 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.002 0.429 . . . . 0.0 111.824 -177.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 107' ' ' ASN . . . . . 0.514 ' OD1' ' CG2' ' B' ' 89' ' ' THR . 97.9 m-20 -120.05 126.73 51.51 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 176.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . 0.4 HD11 HG21 ' B' ' 108' ' ' ILE . 96.4 mt -122.79 133.33 69.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -143.23 123.39 7.85 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -70.0 151.92 67.88 Favored 'Trans proline' 0 N--CA 1.504 2.119 0 C-N-CA 122.657 2.238 . . . . 0.0 112.582 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 111' ' ' MET . . . . . 0.487 ' HB2' ' HB2' ' B' ' 118' ' ' TYR . 67.1 mtt -128.28 143.76 51.06 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -113.79 107.28 15.52 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . 0.677 ' CG1' ' HZ3' ' A' ' 18' ' ' LYS . 96.6 mt -134.62 127.77 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 O-C-N 121.811 -0.556 . . . . 0.0 112.071 178.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 51.15 38.5 21.14 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 123.834 0.709 . . . . 0.0 109.814 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 61.21 35.42 18.36 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.526 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -132.58 149.07 52.37 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 117' ' ' THR . . . . . 0.431 HG22 ' HG3' ' B' ' 32' ' ' PRO . 10.0 t -101.64 153.62 19.6 Favored 'General case' 0 C--O 1.214 -0.775 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -178.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 118' ' ' TYR . . . . . 0.487 ' HB2' ' HB2' ' B' ' 111' ' ' MET . 96.9 m-85 -148.13 147.55 29.61 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 121.317 -0.864 . . . . 0.0 111.497 -178.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -122.27 137.93 54.67 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 123.626 0.579 . . . . 0.0 110.9 -177.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -127.32 133.99 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -177.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.94 122.87 6.72 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 94.6 mt -113.52 127.45 70.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 123' ' ' GLN . . . . . 0.498 ' N ' ' O ' ' B' ' 26' ' ' GLY . 17.8 mp0 -118.45 121.6 40.71 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -121.42 119.34 31.8 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' B' ' 127' ' ' THR . 67.9 t0 -68.31 135.54 52.05 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.57 -177.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . 0.528 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 2.8 mp -107.41 17.72 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.512 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 127' ' ' THR . . . . . 0.553 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 97.5 m -63.95 -44.15 93.68 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 114.439 -1.255 . . . . 0.0 112.687 177.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -62.18 -45.85 91.55 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -177.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 129' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -62.58 -35.1 78.42 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.43 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 130' ' ' LYS . . . . . 0.934 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 98.6 mttt -63.64 -41.33 98.25 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-N 112.817 -1.992 . . . . 0.0 110.728 175.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.71 -41.64 95.85 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -60.47 -44.57 95.75 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.831 -0.543 . . . . 0.0 111.566 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . 0.404 ' O ' ' HG3' ' B' ' 137' ' ' GLU . 97.0 mt-10 -64.47 -36.35 83.9 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.55 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.27 -39.16 93.82 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.833 177.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.76 -41.24 99.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.565 0.698 . . . . 0.0 109.378 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 84.5 mt -63.0 -41.67 99.65 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.453 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 137' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' B' ' 133' ' ' GLU . 97.1 mt-10 -65.28 -37.51 87.41 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 113.523 -1.672 . . . . 0.0 110.229 -178.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -63.43 -43.36 97.66 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.055 176.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 65.6 m -60.64 -44.57 96.23 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' B' ' 144' ' ' THR . 86.1 mt -61.5 -40.13 93.5 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -177.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 95.4 m -61.67 -45.65 93.09 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.994 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -66.38 -42.6 87.69 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 93.8 mt -63.58 -43.5 98.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 114.438 -1.256 . . . . 0.0 110.591 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 144' ' ' THR . . . . . 0.417 ' N ' ' O ' ' B' ' 140' ' ' LEU . 91.0 m -61.76 -45.07 95.47 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.65 -41.08 96.36 Favored 'General case' 0 C--O 1.226 -0.149 0 C-N-CA 119.161 -1.016 . . . . 0.0 109.435 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.87 -41.18 95.86 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 176.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 147' ' ' SER . . . . . 0.575 ' O ' ' N ' ' B' ' 149' ' ' PRO . 78.3 p -62.44 -41.82 99.01 Favored 'General case' 0 CA--C 1.478 -1.79 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 148' ' ' THR . . . . . 0.488 ' C ' ' O ' ' B' ' 147' ' ' SER . 7.1 m -26.1 86.45 0.04 OUTLIER Pre-proline 0 N--CA 1.482 1.148 0 O-C-N 124.196 0.935 . . . . 0.0 110.425 176.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 149' ' ' PRO . . . . . 0.575 ' N ' ' O ' ' B' ' 147' ' ' SER . 24.1 Cg_exo -60.8 145.96 98.16 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 121.613 1.542 . . . . 0.0 115.342 -176.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 150' ' ' ILE . . . . . 0.414 HG23 ' O ' ' B' ' 150' ' ' ILE . 9.4 tp -127.68 119.83 52.78 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.828 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 172.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 61.0 t -150.25 94.88 3.65 Favored Pre-proline 0 C--N 1.303 -1.418 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.064 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -62.28 143.03 93.43 Favored 'Trans proline' 0 N--CA 1.485 0.983 0 N-CA-C 109.512 -0.995 . . . . 0.0 109.512 -179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 153' ' ' ILE . . . . . 0.501 ' CG2' HH12 ' A' ' 154' ' ' ARG . 44.1 mm -76.19 -66.52 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 154' ' ' ARG . . . . . 0.672 ' HD3' ' NH2' ' A' ' 154' ' ' ARG . 4.4 mpt_? -132.06 -157.92 0.85 Allowed 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 62.5 t-20 -83.98 110.39 18.39 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.06 -18.23 55.98 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -178.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 86.4 mt -108.34 124.61 64.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.993 0.425 . . . . 0.0 111.068 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 158' ' ' SER . . . . . 0.625 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 67.0 m -135.98 149.65 48.94 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.74 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -133.83 145.67 49.94 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 22.7 tp -137.28 80.22 34.64 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 161' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -72.19 149.63 52.12 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.623 2.215 . . . . 0.0 114.048 -177.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 92.1 mt -115.29 134.52 55.05 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 55.5 t -129.98 132.66 65.4 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 113.98 169.59 16.79 Favored Glycine 0 N--CA 1.47 0.911 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.48 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 165' ' ' ASN . . . . . 0.683 ' O ' ' CZ ' ' B' ' 170' ' ' ARG . 62.9 t30 -89.97 107.39 19.09 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -177.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 166' ' ' LEU . . . . . 0.523 ' CD2' ' CZ ' ' B' ' 171' ' ' PHE . 44.0 tp -64.55 104.49 0.8 Allowed 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -175.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 167' ' ' THR . . . . . 0.633 HG21 ' NE ' ' B' ' 170' ' ' ARG . 10.5 p -84.19 169.74 14.49 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-N 114.116 -1.402 . . . . 0.0 110.894 177.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -66.92 -37.42 84.29 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.637 177.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.86 -40.39 87.85 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-O 122.119 0.961 . . . . 0.0 111.554 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 170' ' ' ARG . . . . . 0.683 ' CZ ' ' O ' ' B' ' 165' ' ' ASN . 88.0 mtm180 -62.48 -35.98 81.04 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 112.762 -2.017 . . . . 0.0 111.248 178.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 171' ' ' PHE . . . . . 0.523 ' CZ ' ' CD2' ' B' ' 166' ' ' LEU . 0.5 OUTLIER -54.82 -25.64 29.78 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -178.686 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 172' ' ' ASN . . . . . 0.452 ' O ' HG21 ' B' ' 175' ' ' VAL . 91.9 m-20 -62.67 -40.26 96.52 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.804 178.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 49.2 m -60.52 -41.48 94.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.145 0.498 . . . . 0.0 110.801 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 65.9 mt -63.86 -44.03 97.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 175' ' ' VAL . . . . . 0.468 HG23 ' N ' ' B' ' 176' ' ' CYS . 33.3 m -62.54 -40.21 87.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 176' ' ' CYS . . . . . 0.468 ' N ' HG23 ' B' ' 175' ' ' VAL . 99.9 m -62.02 -35.23 77.94 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.381 178.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 177' ' ' THR . . . . . 0.545 ' O ' HG13 ' B' ' 181' ' ' ILE . 24.7 m -61.32 -20.27 62.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.938 0.399 . . . . 0.0 110.184 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 178' ' ' LEU . . . . . . . . . . . . . 87.8 mt -61.1 -39.47 90.08 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.281 -177.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 19.0 m -61.85 -44.4 96.91 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.322 177.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 180' ' ' ASN . . . . . 0.606 ' O ' ' OG ' ' B' ' 183' ' ' SER . 92.9 m-20 -61.88 -40.73 96.4 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.802 0.334 . . . . 0.0 110.411 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . 0.545 HG13 ' O ' ' B' ' 177' ' ' THR . 75.1 mt -55.69 -31.2 28.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 C-N-CA 120.916 -0.314 . . . . 0.0 110.897 -178.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 182' ' ' LEU . . . . . . . . . . . . . 85.1 mt -62.8 -42.08 99.56 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.328 177.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 183' ' ' SER . . . . . 0.606 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.2 p -62.91 -32.85 74.22 Favored 'General case' 0 N--CA 1.455 -0.183 0 O-C-N 122.004 -0.435 . . . . 0.0 110.89 177.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 184' ' ' THR . . . . . 0.438 ' OG1' ' HA ' ' B' ' 181' ' ' ILE . 21.0 p -85.49 16.09 4.05 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.77 0.319 . . . . 0.0 111.775 -178.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 79.2 p -59.68 -17.52 34.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.034 -177.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.78 -40.52 95.49 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.683 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 187' ' ' ASP . . . . . 0.625 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.2 m-20 -69.31 113.34 6.55 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.519 0.676 . . . . 0.0 110.632 -178.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -62.7 -41.96 99.39 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-N 114.807 -1.088 . . . . 0.0 113.154 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -112.49 130.45 55.99 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.2 -178.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 190' ' ' LEU . . . . . . . . . . . . . 41.1 tp -124.07 118.73 27.61 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.025 177.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 86.6 mt -107.12 126.82 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-O 120.608 0.242 . . . . 0.0 111.416 -177.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 49.2 mm -115.66 117.53 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 193' ' ' ASP . . . . . 0.645 ' CG ' ' HG ' ' B' ' 195' ' ' SER . 41.2 t0 -88.49 109.74 20.29 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.04 0.448 . . . . 0.0 112.11 -177.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 194' ' ' LEU . . . . . . . . . . . . . 96.3 mt -90.34 -3.53 57.68 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.517 176.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 195' ' ' SER . . . . . 0.645 ' HG ' ' CG ' ' B' ' 193' ' ' ASP . 78.1 p -61.46 -36.68 81.12 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.896 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.04 -33.24 83.26 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 197' ' ' LEU . . . . . 1.1 HD23 ' O ' ' B' ' 199' ' ' GLN . 4.8 tt -78.38 132.83 37.53 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 122.163 -0.61 . . . . 0.0 109.489 -177.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 198' ' ' ALA . . . . . 0.74 ' N ' HD21 ' B' ' 197' ' ' LEU . . . -63.15 -44.21 96.15 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 119.454 -0.899 . . . . 0.0 110.765 -177.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 199' ' ' GLN . . . . . 1.1 ' O ' HD23 ' B' ' 197' ' ' LEU . 58.0 tt0 -137.58 165.99 25.0 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.778 0.799 . . . . 0.0 112.947 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 200' ' ' VAL . . . . . 0.495 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 47.3 t -121.46 132.07 71.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 O-C-N 120.716 -1.24 . . . . 0.0 109.384 177.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -91.09 149.26 21.89 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.15 0.5 . . . . 0.0 110.979 -178.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.22 -32.92 71.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.414 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -64.79 -32.26 73.87 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.4 m -60.3 -44.33 95.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.572 178.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 205' ' ' ALA . . . . . 0.706 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -58.51 -28.31 65.3 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -65.42 -38.68 90.64 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.224 0.535 . . . . 0.0 109.874 176.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -67.52 -38.08 83.74 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.934 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 96.3 mt -63.61 -43.42 98.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.208 0.527 . . . . 0.0 109.866 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 209' ' ' PHE . . . . . 0.706 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 71.7 m-85 -62.19 -42.99 99.8 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.275 -1.33 . . . . 0.0 112.859 177.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -63.52 -41.35 98.5 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 119.492 -0.883 . . . . 0.0 109.545 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 211' ' ' LEU . . . . . 0.451 ' O ' ' HG ' ' B' ' 215' ' ' LEU . 40.2 mt -62.54 -42.37 99.49 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.33 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 212' ' ' SER . . . . . 0.464 ' HG ' ' N ' ' B' ' 213' ' ' HIS . 78.2 p -63.14 -36.66 84.36 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.224 -0.59 . . . . 0.0 111.873 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 213' ' ' HIS . . . . . 0.464 ' N ' ' HG ' ' B' ' 212' ' ' SER . 58.8 t-80 -67.58 -46.36 72.89 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 115.362 -0.836 . . . . 0.0 112.204 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 52.8 tp -63.77 -42.73 97.74 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.963 0.887 . . . . 0.0 109.994 177.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 215' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' B' ' 211' ' ' LEU . 89.6 mt -62.94 -44.06 97.1 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 113.454 -1.703 . . . . 0.0 111.708 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.33 -39.47 93.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.743 -176.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 86.1 mt -63.79 -42.11 97.79 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.349 0.595 . . . . 0.0 111.434 176.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 218' ' ' THR . . . . . . . . . . . . . 68.6 p -74.42 -17.58 60.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.063 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 80.61 69.42 1.4 Allowed Glycine 0 CA--C 1.528 0.87 0 N-CA-C 106.424 -2.67 . . . . 0.0 106.424 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 220' ' ' THR . . . . . . . . . . . . . 96.7 m -149.02 101.4 3.16 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 177.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -59.59 140.08 56.64 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.907 0.384 . . . . 0.0 111.055 -176.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 42.7 tp -117.54 121.62 41.46 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.313 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 4.3 mp -109.09 128.72 64.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.155 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 224' ' ' ILE . . . . . 0.422 HG23 HD11 ' B' ' 224' ' ' ILE . 49.8 mm -109.86 127.3 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.573 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 43.3 p -133.16 158.15 43.54 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.574 0.702 . . . . 0.0 112.684 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 88.44 19.98 50.2 Favored Glycine 0 CA--C 1.499 -0.943 0 CA-C-N 113.762 -1.563 . . . . 0.0 111.175 -178.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 95.9 mt -83.84 125.69 40.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 O-C-N 122.12 -0.635 . . . . 0.0 111.464 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 37.4 tttt -65.51 138.67 96.95 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.494 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.2 -37.02 94.56 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 121.424 1.416 . . . . 0.0 112.538 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -64.16 -43.34 95.46 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 50.5 tp -61.92 -41.61 98.13 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.826 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.13 -36.19 83.23 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.735 0.302 . . . . 0.0 111.286 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 94.7 mtp -64.15 -40.53 96.34 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.26 -42.41 99.15 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 122.085 0.945 . . . . 0.0 109.219 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 30.4 mmt -64.06 -35.42 80.66 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 114.625 -1.171 . . . . 0.0 112.102 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -62.26 -40.24 95.55 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.891 -177.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.07 -44.11 96.69 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.09 178.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.08 -44.95 95.56 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 120.383 -0.527 . . . . 0.0 112.303 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -158.88 133.82 8.26 Favored 'General case' 0 CA--C 1.51 -0.577 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.888 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 240' ' ' ALA . . . . . . . . . . . . . . . -62.61 -47.43 83.79 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 177.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 241' ' ' ASN . . . . . 0.482 ' O ' ' HB2' ' B' ' 244' ' ' SER . 90.2 m-20 -41.65 -19.71 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.477 -176.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 242' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -61.9 -44.87 95.89 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.816 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 243' ' ' SER . . . . . 0.432 ' O ' ' N ' ' B' ' 245' ' ' LEU . 78.1 p -57.87 -44.68 86.79 Favored 'General case' 0 C--N 1.345 0.377 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 244' ' ' SER . . . . . 0.482 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 18.0 m -29.43 -36.36 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . 0.432 ' N ' ' O ' ' B' ' 243' ' ' SER . 96.4 mt -89.18 133.37 34.44 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.369 -178.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -61.48 134.48 56.92 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 121.155 0.502 . . . . 0.0 110.474 -176.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 247' ' ' THR . . . . . . . . . . . . . 95.0 m -126.34 128.52 47.21 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.047 -0.978 . . . . 0.0 111.923 178.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -112.89 144.96 41.57 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 249' ' ' SER . . . . . 0.59 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 78.2 p -63.76 -33.54 75.89 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.818 -178.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 250' ' ' ASN . . . . . 0.59 ' OD1' ' O ' ' B' ' 249' ' ' SER . 99.3 m-20 -148.45 160.36 43.13 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.049 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 79.2 t -64.63 -44.21 96.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.046 178.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 252' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -61.29 -46.11 91.7 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . 0.434 ' O ' HG13 ' B' ' 257' ' ' VAL . 92.9 m-20 -61.07 -43.75 98.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.835 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 254' ' ' ALA . . . . . . . . . . . . . . . -65.77 -40.5 92.06 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 120.069 -0.652 . . . . 0.0 111.299 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 255' ' ' VAL . . . . . 0.543 HG12 ' O ' ' A' ' 153' ' ' ILE . 56.9 t -64.72 -45.75 94.27 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.07 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -63.01 -47.72 81.9 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 119.906 -0.718 . . . . 0.0 111.487 -178.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 257' ' ' VAL . . . . . 0.441 ' O ' ' C ' ' B' ' 258' ' ' LEU . 18.8 m -64.73 -40.41 88.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.533 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 258' ' ' LEU . . . . . 0.485 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 1.7 mt -33.79 -71.33 0.1 Allowed Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.479 -177.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 259' ' ' PRO . . . . . 0.524 ' O ' HG13 ' B' ' 260' ' ' ILE . 37.6 Cg_endo -62.39 139.91 79.49 Favored 'Trans proline' 0 N--CA 1.501 1.965 0 C-N-CA 121.418 1.412 . . . . 0.0 111.193 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 260' ' ' ILE . . . . . 0.524 HG13 ' O ' ' B' ' 259' ' ' PRO . 96.6 mt -159.62 -13.48 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 CA-C-N 118.713 0.688 . . . . 0.0 112.361 176.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 C--O 1.216 -0.686 0 CA-C-O 117.859 -1.067 . . . . 0.0 111.436 -179.983 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.433 ' O ' ' OG ' ' A' ' 6' ' ' SER . . . -160.13 170.76 20.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.144 0.497 . . . . 0.0 110.196 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 80.1 p -72.66 -14.71 61.65 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.36 -0.837 . . . . 0.0 111.788 177.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -76.32 -66.59 0.78 Allowed 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 114.326 -1.306 . . . . 0.0 112.966 174.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -66.94 -39.64 87.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.908 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.562 ' O ' ' NZ ' ' B' ' 17' ' ' LYS . 49.8 m -59.25 -41.37 88.63 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -177.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.547 ' CE2' HD13 ' A' ' 9' ' ' ILE . 36.1 t80 84.37 88.23 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.127 0.489 . . . . 0.0 112.034 177.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.45 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -62.19 -137.74 0.01 OUTLIER Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 -177.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.547 HD13 ' CE2' ' A' ' 7' ' ' PHE . 55.8 mt 79.02 109.81 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 122.679 0.392 . . . . 0.0 110.637 -178.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.59 -22.06 70.43 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 121.438 1.425 . . . . 0.0 112.138 -178.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.28 -37.46 94.9 Favored Glycine 0 N--CA 1.468 0.83 0 C-N-CA 121.045 -0.598 . . . . 0.0 111.862 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -66.14 -39.31 89.75 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.514 0.673 . . . . 0.0 109.519 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.1 tp -63.33 -41.46 98.89 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -63.65 -39.9 95.49 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 67.9 t -60.03 -44.19 94.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 O-C-N 122.174 -0.329 . . . . 0.0 110.938 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 93.0 mt -62.49 -43.57 98.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 119.589 -0.844 . . . . 0.0 109.321 -178.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.436 ' NZ ' ' HA ' ' B' ' 6' ' ' SER . 98.9 mttt -62.28 -46.19 89.88 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 119.361 -0.936 . . . . 0.0 112.022 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.538 ' NZ ' HG12 ' B' ' 113' ' ' ILE . 98.4 mttt -60.46 -39.54 87.96 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 118.642 -1.223 . . . . 0.0 109.079 -176.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.58 -42.2 91.94 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.144 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.2 mt -62.95 -40.15 96.8 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 177.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.19 -39.39 94.51 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.479 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 60.7 m170 -59.29 -39.42 82.92 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 122.226 -0.297 . . . . 0.0 111.606 -178.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.8 p -113.76 130.64 67.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.474 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 34.6 ptt180 -73.41 109.99 7.35 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-O 122.062 0.934 . . . . 0.0 112.187 -177.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.9 p -141.29 143.75 27.37 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.579 ' O ' ' N ' ' A' ' 123' ' ' GLN . . . -98.91 91.2 1.07 Allowed Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.908 -178.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 52.6 t -124.55 130.45 73.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 175.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.8 m -136.62 159.73 37.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.4 mt -120.43 129.55 75.43 Favored 'Isoleucine or valine' 0 C--O 1.244 0.797 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.4 p -106.56 167.48 9.82 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.425 ' C ' ' OD1' ' A' ' 37' ' ' ASN . 58.6 t0 -133.15 104.13 12.6 Favored Pre-proline 0 C--N 1.321 -0.66 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.251 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -63.4 -24.59 71.15 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.414 1.409 . . . . 0.0 111.501 -178.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.95 -35.75 81.17 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.17 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.4 mt -84.13 157.47 21.69 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.849 178.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.696 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 43.4 tt0 -57.46 134.59 56.2 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 113.361 0.875 . . . . 0.0 113.361 -176.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.526 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 59.2 t0 60.54 23.67 13.36 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.425 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 40.6 t-20 39.23 69.2 1.73 Allowed Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.181 -176.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.696 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 93.3 Cg_endo -70.19 155.31 64.83 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 123.95 3.1 . . . . 0.0 112.123 -178.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.0 mt -88.95 122.07 39.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.524 HG21 ' N ' ' A' ' 41' ' ' TYR . 30.3 m -102.01 -45.97 11.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.243 -178.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.524 ' N ' HG21 ' A' ' 40' ' ' VAL . 48.9 t80 -93.72 124.36 37.67 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 120.185 -0.606 . . . . 0.0 111.949 -178.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.7 p -143.09 140.27 27.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.226 0.953 . . . . 0.0 109.217 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.588 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 56.9 p30 -96.49 166.43 11.69 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.474 ' HA ' ' OE1' ' A' ' 44' ' ' GLN . 14.9 mm100 -66.55 -39.82 88.72 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 177.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.89 -24.25 60.12 Favored Glycine 0 N--CA 1.453 -0.209 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.588 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 65.5 t80 -59.61 -47.86 83.92 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 -179.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.432 ' O ' ' N ' ' A' ' 51' ' ' GLY . 71.4 t -58.96 -44.54 91.24 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.646 0 O-C-N 121.301 -0.875 . . . . 0.0 111.745 -174.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -63.25 -37.29 86.68 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 120.399 -0.52 . . . . 0.0 112.301 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 59.2 ttm -66.79 -43.38 84.1 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 176.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 36.3 p -93.51 -21.18 19.62 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.346 0.593 . . . . 0.0 111.541 -177.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . 76.44 20.46 76.88 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -179.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -113.25 137.08 52.01 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 122.783 0.433 . . . . 0.0 111.12 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -62.62 146.99 50.65 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.558 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.84 -32.9 74.82 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -66.69 -43.1 85.31 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.516 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -64.67 -45.65 85.77 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.073 -0.651 . . . . 0.0 109.252 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.423 HD13 HG22 ' A' ' 57' ' ' ILE . 89.1 mt -61.26 -49.84 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -175.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.1 mt -55.53 148.27 16.02 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 176.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.28 -3.44 77.38 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.873 -0.679 . . . . 0.0 113.062 177.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -137.15 151.41 48.78 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 118.705 1.252 . . . . 0.0 112.037 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.58 ' C ' ' H ' ' A' ' 63' ' ' ARG . 25.1 t-20 -81.77 151.71 27.31 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.553 -178.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 79.2 m -62.09 15.39 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.373 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.58 ' H ' ' C ' ' A' ' 61' ' ' ASN . 35.2 ptt-85 -62.21 -41.41 98.34 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.139 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -56.04 -21.99 24.81 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.2 mt -67.33 -35.73 80.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 122.066 0.936 . . . . 0.0 112.916 177.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -63.21 146.38 53.51 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.847 -1.069 . . . . 0.0 112.263 -178.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.539 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -156.54 -150.93 5.8 Favored Glycine 0 CA--C 1.538 1.519 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -177.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.535 ' HB3' ' HH ' ' A' ' 95' ' ' TYR . 88.7 tttt -62.75 -41.29 99.14 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.432 ' O ' ' OE1' ' A' ' 93' ' ' GLN . 11.1 m-70 -76.21 -9.08 58.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.847 0.356 . . . . 0.0 110.916 -178.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.539 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 32.9 m -62.62 128.69 37.14 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.595 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -84.75 110.99 31.8 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.825 -179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -57.29 -31.09 89.88 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 121.997 1.798 . . . . 0.0 113.207 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.5 -39.31 93.54 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.888 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.556 ' OE1' ' HB ' ' A' ' 90' ' ' VAL . 79.1 mm-40 -65.45 -44.43 87.28 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.0 t -59.31 -44.1 91.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -176.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -63.97 -38.19 90.17 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.004 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -63.68 -39.6 94.73 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.403 0.621 . . . . 0.0 110.24 178.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 94.1 mt -63.71 -44.12 98.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.053 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -62.88 -42.52 99.8 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 113.814 -1.539 . . . . 0.0 108.309 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 97.6 m -61.24 -49.37 77.37 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.65 -42.46 92.87 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.189 -172.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.436 HD23 ' CE1' ' A' ' 119' ' ' PHE . 91.5 mt -63.45 -39.56 94.79 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.007 -1.058 . . . . 0.0 111.492 -178.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -64.06 -33.16 75.12 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -89.08 -2.63 58.64 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.381 -178.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.2 tttt 49.22 40.78 18.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.59 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -122.69 144.26 42.11 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -61.32 142.88 97.37 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 121.473 1.448 . . . . 0.0 113.543 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -139.75 141.63 34.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.589 -178.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.518 ' CG2' ' OD1' ' A' ' 107' ' ' ASN . 98.8 m -128.12 120.05 26.57 Favored 'General case' 0 C--N 1.344 0.332 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 175.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.556 ' HB ' ' OE1' ' A' ' 74' ' ' GLU . 28.4 m -138.85 158.7 30.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.465 178.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -101.76 132.39 47.51 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 177.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.404 HG23 HD11 ' A' ' 92' ' ' ILE . 19.2 tt -139.99 129.44 28.29 Favored 'Isoleucine or valine' 0 C--N 1.377 1.789 0 CA-C-N 121.557 1.98 . . . . 0.0 112.527 176.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.432 ' OE1' ' O ' ' A' ' 69' ' ' HIS . 86.1 mt-30 -62.98 133.45 54.63 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.55 -1.205 . . . . 0.0 109.948 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -134.48 158.33 44.19 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.758 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.535 ' HH ' ' HB3' ' A' ' 68' ' ' LYS . 92.7 m-85 -116.16 135.13 54.2 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -179.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -83.69 -172.51 4.19 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.161 0.505 . . . . 0.0 111.618 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.05 -42.26 99.66 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.158 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.507 ' CG ' ' HG1' ' A' ' 100' ' ' THR . 41.0 p-10 -83.31 5.84 21.84 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -178.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.51 -0.65 88.39 Favored Glycine 0 N--CA 1.47 0.925 0 O-C-N 121.547 -0.721 . . . . 0.0 112.126 176.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.507 ' HG1' ' CG ' ' A' ' 98' ' ' ASP . 24.1 m -59.83 138.32 57.83 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.649 ' C ' ' SD ' ' A' ' 101' ' ' MET . 14.9 tmm? -104.45 128.75 52.42 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.561 0.22 . . . . 0.0 110.782 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -141.44 158.55 43.72 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.888 -176.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.649 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 20.7 m95 -90.81 141.29 28.96 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.506 HD22 ' HG2' ' A' ' 123' ' ' GLN . 53.1 t-20 -136.41 106.8 6.44 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -177.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 80.5 tt0 -72.37 134.9 45.7 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 -177.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 43.9 tp -120.78 123.07 41.76 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASN . . . . . 0.518 ' OD1' ' CG2' ' A' ' 89' ' ' THR . 98.0 m-20 -118.68 123.86 45.96 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.866 177.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 96.3 mt -120.21 128.45 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 O-C-N 123.525 0.516 . . . . 0.0 111.57 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -137.96 123.09 12.35 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 116.764 -0.198 . . . . 0.0 110.925 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -70.26 150.85 65.76 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.454 2.103 . . . . 0.0 112.578 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' MET . . . . . 0.58 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 66.3 mtt -122.67 152.63 40.34 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -127.23 91.51 3.33 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 177.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.416 HG22 HD11 ' A' ' 113' ' ' ILE . 96.7 mt -117.81 130.57 72.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.275 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 53.31 36.56 23.13 Favored 'General case' 0 CA--C 1.513 -0.472 0 O-C-N 121.461 -0.774 . . . . 0.0 111.648 176.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 59.21 30.62 20.41 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 123.853 0.721 . . . . 0.0 110.813 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -127.52 149.55 50.08 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.782 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 9.9 t -85.79 -173.11 4.45 Favored 'General case' 0 C--O 1.219 -0.504 0 O-C-N 121.687 -0.633 . . . . 0.0 109.489 -178.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' TYR . . . . . 0.782 ' CD2' ' O ' ' A' ' 117' ' ' THR . 69.0 m-85 -171.9 155.71 3.92 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 174.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.436 ' CE1' HD23 ' A' ' 82' ' ' LEU . 92.0 m-85 -131.51 146.34 52.18 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 174.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.87 135.1 55.57 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 177.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -106.9 127.27 8.78 Favored Glycine 0 CA--C 1.502 -0.765 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 177.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 96.3 mt -117.89 129.27 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.579 ' N ' ' O ' ' A' ' 26' ' ' GLY . 15.9 mp0 -120.18 115.74 24.24 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 123.69 0.619 . . . . 0.0 109.793 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -115.35 113.14 23.4 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.817 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.445 ' OD1' ' OG1' ' A' ' 127' ' ' THR . 68.4 t0 -65.77 123.23 19.2 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -175.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.454 ' O ' HG22 ' A' ' 126' ' ' ILE . 3.0 mp -87.0 2.89 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 113.666 -1.606 . . . . 0.0 110.194 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.445 ' OG1' ' OD1' ' A' ' 125' ' ' ASP . 31.6 m -60.13 -42.47 94.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.042 -1.036 . . . . 0.0 113.393 -178.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -59.66 -42.6 93.2 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -178.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -62.38 -39.19 92.36 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.855 176.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.649 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.8 mttt -62.53 -40.71 97.64 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 118.31 -1.356 . . . . 0.0 110.494 -178.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.53 -37.27 85.44 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.357 -0.537 . . . . 0.0 109.657 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.539 ' CE2' HD13 ' A' ' 136' ' ' LEU . 90.6 t80 -61.74 -45.7 92.8 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.244 176.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.33 -39.44 93.91 Favored 'General case' 0 C--O 1.226 -0.179 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.48 -41.23 96.95 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 50.6 tp -61.09 -43.76 98.39 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 -177.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.539 HD13 ' CE2' ' A' ' 132' ' ' TYR . 88.5 mt -62.22 -41.08 98.06 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.882 178.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -62.76 -41.36 99.18 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 119.453 -0.899 . . . . 0.0 109.762 -178.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -60.99 -42.01 97.58 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -177.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 53.7 m -61.67 -41.34 97.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.71 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 144' ' ' THR . 87.5 mt -63.39 -41.89 98.78 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.785 178.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 87.3 m -61.65 -45.33 94.49 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.381 -177.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -65.05 -41.3 95.27 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 96.4 mt -64.45 -43.6 96.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.005 -1.452 . . . . 0.0 111.235 175.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.518 ' N ' ' O ' ' A' ' 140' ' ' LEU . 95.6 m -62.29 -46.32 89.28 Favored 'General case' 0 C--N 1.345 0.411 0 C-N-CA 120.364 -0.534 . . . . 0.0 112.185 -178.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.22 -41.21 99.08 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 118.882 -1.127 . . . . 0.0 109.15 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.6 mt -63.93 -42.67 97.3 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 178.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.702 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.2 p -59.6 -38.38 81.1 Favored 'General case' 0 C--O 1.218 -0.598 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -178.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.465 ' C ' ' O ' ' A' ' 147' ' ' SER . 86.1 m -28.97 82.37 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.32 0 O-C-N 126.944 2.653 . . . . 0.0 106.101 -178.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.702 ' N ' ' O ' ' A' ' 147' ' ' SER . 23.2 Cg_exo -61.85 145.0 97.32 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 CA-C-O 122.788 1.078 . . . . 0.0 114.301 -174.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.532 ' O ' ' CG2' ' A' ' 151' ' ' VAL . 9.5 tp -120.44 136.49 57.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 102.502 -3.147 . . . . 0.0 102.502 176.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 150' ' ' ILE . 96.3 t -167.9 93.83 0.64 Allowed Pre-proline 0 CA--C 1.506 -0.725 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 178.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -63.82 143.71 86.74 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 N-CA-C 109.901 -0.846 . . . . 0.0 109.901 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.742 ' O ' HG12 ' B' ' 255' ' ' VAL . 44.3 mm -77.03 -68.71 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.659 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ARG . . . . . 0.614 HH12 ' CG2' ' B' ' 153' ' ' ILE . 3.1 mpt_? -132.99 -161.41 1.14 Allowed 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -83.34 104.99 13.93 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.849 0.833 . . . . 0.0 111.291 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.8 10.06 60.49 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 113.904 -1.498 . . . . 0.0 110.2 -177.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.5 mt -126.98 125.67 66.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.735 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 58.7 m -132.25 152.46 51.34 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -138.37 142.28 39.64 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.481 177.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 27.4 tp -135.45 80.58 45.03 Favored Pre-proline 0 N--CA 1.468 0.454 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.386 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -70.98 151.54 62.22 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.638 2.225 . . . . 0.0 113.005 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 88.6 mt -117.65 126.79 53.14 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.184 177.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 47.7 t -122.95 130.13 74.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 116.57 167.49 14.69 Favored Glycine 0 N--CA 1.479 1.558 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.179 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.841 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 57.6 t30 -84.16 115.83 22.61 Favored 'General case' 0 C--O 1.222 -0.358 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -178.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.479 ' CD2' ' CZ ' ' A' ' 171' ' ' PHE . 45.3 tp -74.28 104.83 5.19 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 -177.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.51 ' H ' ' HE ' ' A' ' 170' ' ' ARG . 10.8 p -87.04 166.74 14.81 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.269 0.557 . . . . 0.0 110.485 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.97 -33.75 76.54 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.086 0.47 . . . . 0.0 111.773 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.12 -43.76 90.94 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.519 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ARG . . . . . 0.841 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 87.1 mtm180 -64.99 -29.38 70.3 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 178.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.479 ' CZ ' ' CD2' ' A' ' 166' ' ' LEU . 0.5 OUTLIER -54.6 -28.98 50.28 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.502 ' O ' HG21 ' A' ' 175' ' ' VAL . 92.1 m-20 -60.89 -41.12 95.43 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 119.102 -1.039 . . . . 0.0 109.679 -177.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 60.0 m -59.45 -40.81 88.03 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.687 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.419 HD12 HG23 ' A' ' 174' ' ' ILE . 67.6 mt -63.25 -44.13 99.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.502 HG21 ' O ' ' A' ' 172' ' ' ASN . 34.5 m -63.0 -39.95 87.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' CYS . . . . . 0.489 ' N ' HG23 ' A' ' 175' ' ' VAL . 98.1 m -62.08 -34.66 76.71 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.431 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' THR . . . . . 0.484 ' O ' HG13 ' A' ' 181' ' ' ILE . 25.0 m -61.92 -19.27 62.52 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.097 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 88.2 mt -61.0 -41.02 95.72 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -177.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 17.4 m -58.97 -43.2 91.31 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ASN . . . . . 0.674 ' O ' ' OG ' ' A' ' 183' ' ' SER . 93.1 m-20 -61.76 -35.98 79.69 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 122.507 0.323 . . . . 0.0 110.748 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 177' ' ' THR . 65.2 mt -58.99 -40.54 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 121.441 -0.787 . . . . 0.0 109.538 -178.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 85.6 mt -60.53 -40.18 90.59 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -177.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' SER . . . . . 0.674 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 78.2 p -61.09 -33.5 73.44 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.419 175.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.409 ' OG1' ' HA ' ' A' ' 181' ' ' ILE . 60.0 p -91.71 23.59 3.51 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.7 0.286 . . . . 0.0 111.402 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 77.8 p -63.49 -20.86 65.95 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.674 -178.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.76 -37.65 82.58 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.929 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . 0.735 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 98.5 m-20 -71.38 113.75 8.74 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.617 0.722 . . . . 0.0 110.928 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -62.95 -42.73 99.91 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.86 -177.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -112.06 131.36 55.48 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.981 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 39.5 tp -120.01 127.94 53.07 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 177.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 96.2 mt -115.73 125.94 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.6 mm -112.62 126.57 70.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 178.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' ASP . . . . . 0.561 ' CG ' ' HG ' ' A' ' 195' ' ' SER . 38.7 t0 -95.58 118.09 31.64 Favored 'General case' 0 CA--C 1.551 1.007 0 O-C-N 121.88 -0.512 . . . . 0.0 110.443 177.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 96.9 mt -97.67 -3.35 39.47 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.848 175.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' SER . . . . . 0.561 ' HG ' ' CG ' ' A' ' 193' ' ' ASP . 78.0 p -62.24 -33.42 74.55 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.86 -44.68 97.52 Favored Glycine 0 CA--C 1.535 1.288 0 N-CA-C 108.39 -1.884 . . . . 0.0 108.39 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 1.104 HD23 ' O ' ' A' ' 199' ' ' GLN . 4.7 tt -69.22 128.03 35.17 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 112.792 -1.704 . . . . 0.0 108.902 -177.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ALA . . . . . 0.651 ' N ' HD21 ' A' ' 197' ' ' LEU . . . -60.8 -47.0 88.3 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-O 121.253 0.549 . . . . 0.0 110.48 -177.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . 1.104 ' O ' HD23 ' A' ' 197' ' ' LEU . 58.4 tt0 -135.83 156.86 48.14 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-N 114.623 -1.171 . . . . 0.0 113.851 -173.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.428 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 45.3 t -118.73 132.03 69.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 O-C-N 120.924 -1.11 . . . . 0.0 108.298 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -86.95 156.01 19.97 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.582 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.11 -39.06 93.22 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 120.144 -0.623 . . . . 0.0 109.975 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -57.45 -31.98 66.46 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -178.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.4 m -61.32 -42.08 98.07 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.445 178.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.433 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -58.32 -38.42 77.07 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -176.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -61.81 -37.14 83.3 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -178.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -65.92 -38.18 88.02 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.979 177.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 94.7 mt -62.84 -44.35 99.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -178.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . 0.433 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 68.4 m-85 -62.74 -43.06 99.78 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.491 -177.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.27 -42.09 99.04 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 118.961 -1.096 . . . . 0.0 109.168 -178.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 39.8 mt -62.17 -41.87 98.72 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 78.2 p -61.52 -42.36 98.7 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 119.117 -1.033 . . . . 0.0 110.26 -179.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -63.92 -45.43 89.3 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.755 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 47.8 tp -62.45 -45.87 91.1 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.18 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 87.7 mt -62.67 -40.36 96.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.366 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.42 -44.97 95.23 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.507 -177.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 86.2 mt -61.68 -40.29 94.46 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 82.6 p -75.38 -11.41 60.04 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.501 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.88 35.14 19.75 Favored Glycine 0 C--N 1.341 0.832 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.697 -178.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 96.7 m -120.47 113.84 20.9 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 119.051 1.426 . . . . 0.0 111.772 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -66.57 136.5 55.71 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.574 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 45.0 tp -112.63 129.44 56.38 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 3.0 mp -116.3 134.58 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.445 HG23 HD11 ' A' ' 224' ' ' ILE . 49.8 mm -115.41 130.74 69.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 44.8 p -133.49 165.04 25.8 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.881 -177.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 78.53 20.46 71.57 Favored Glycine 0 C--O 1.225 -0.462 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 98.1 mt -82.32 128.04 39.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 113.767 -1.217 . . . . 0.0 108.248 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -75.67 140.44 71.42 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.09 -39.62 84.92 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 121.018 1.145 . . . . 0.0 112.483 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -63.72 -38.93 92.95 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.418 0.628 . . . . 0.0 110.198 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 52.9 tp -64.23 -42.24 96.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.791 177.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.84 -37.69 88.46 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.09 -178.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 94.0 mtp -63.33 -41.06 98.86 Favored 'General case' 0 C--O 1.249 1.041 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.82 -178.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.87 -38.89 92.78 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.468 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 36.4 mmt -66.21 -37.63 86.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.514 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -61.18 -42.74 99.12 Favored 'General case' 0 CA--C 1.514 -0.405 0 O-C-N 121.58 -0.7 . . . . 0.0 109.617 -176.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.18 -40.09 88.76 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.713 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 56.7 tp -63.3 -41.09 98.93 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -168.15 127.55 1.24 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.33 0.586 . . . . 0.0 112.532 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.47 -26.59 65.37 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.801 178.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . 0.422 ' O ' ' HB2' ' A' ' 244' ' ' SER . 89.4 m-20 -62.67 -29.41 70.62 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.534 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -55.92 -45.64 78.67 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -175.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 98.4 p -60.99 -21.02 63.14 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 123.918 0.761 . . . . 0.0 111.44 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' SER . . . . . 0.422 ' HB2' ' O ' ' A' ' 241' ' ' ASN . 43.1 m -54.39 -40.47 68.22 Favored 'General case' 0 C--N 1.32 -0.713 0 O-C-N 122.342 -0.224 . . . . 0.0 111.553 178.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 95.0 mt -83.18 119.68 24.84 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -41.52 134.64 2.3 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.103 178.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 98.1 m -127.75 134.44 49.52 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.936 177.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -118.41 139.59 51.16 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.851 179.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' SER . . . . . 0.449 ' HG ' ' N ' ' A' ' 250' ' ' ASN . 78.0 p -61.38 -42.74 99.21 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -178.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' ASN . . . . . 0.449 ' N ' ' HG ' ' A' ' 249' ' ' SER . 99.3 m-20 -143.73 159.57 42.26 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.685 0.755 . . . . 0.0 111.599 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 75.9 t -62.53 -44.76 99.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 114.711 -1.132 . . . . 0.0 111.953 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.84 -44.28 97.16 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -64.14 -42.03 96.95 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.455 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . 0.492 ' O ' HG21 ' A' ' 257' ' ' VAL . . . -64.65 -42.47 95.4 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.868 0.842 . . . . 0.0 109.829 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' VAL . . . . . 0.431 HG12 ' O ' ' B' ' 153' ' ' ILE . 54.8 t -63.41 -46.04 96.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 113.946 -1.479 . . . . 0.0 111.173 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.7 -46.21 86.52 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 120.589 -0.445 . . . . 0.0 111.459 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . 0.495 ' O ' ' C ' ' A' ' 258' ' ' LEU . 32.9 m -66.71 -40.81 86.96 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 O-C-N 121.468 -0.77 . . . . 0.0 112.073 179.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.495 ' C ' ' O ' ' A' ' 257' ' ' VAL . 2.1 mt -29.48 -75.47 0.04 OUTLIER Pre-proline 0 C--O 1.234 0.262 0 O-C-N 123.099 0.25 . . . . 0.0 111.522 -177.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 258' ' ' LEU . 42.5 Cg_endo -63.33 139.96 74.34 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 120.789 0.992 . . . . 0.0 111.825 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 96.7 mt -151.85 -27.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 O-C-N 123.953 0.783 . . . . 0.0 111.973 178.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 78.1 mtm . . . . . 0 N--CA 1.473 0.708 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.736 -177.174 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.475 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.91 161.14 22.79 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 79.2 p -59.87 -21.7 61.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.871 177.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -74.21 -64.05 1.1 Allowed 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.969 0.414 . . . . 0.0 111.123 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -65.63 -39.43 91.45 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.281 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' SER . . . . . 0.484 ' O ' ' HB3' ' B' ' 7' ' ' PHE . 49.5 m -59.97 -41.88 92.94 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.094 -0.642 . . . . 0.0 109.792 -177.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . 0.545 ' CE2' HD13 ' B' ' 9' ' ' ILE . 37.8 t80 85.48 92.22 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.352 177.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' GLY . . . . . 0.469 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -65.02 -137.18 0.02 OUTLIER Glycine 0 C--N 1.338 0.687 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -178.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' ILE . . . . . 0.545 HD13 ' CE2' ' B' ' 7' ' ' PHE . 55.3 mt 78.62 109.48 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 122.613 0.365 . . . . 0.0 111.162 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -62.24 -23.87 75.68 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 121.304 1.336 . . . . 0.0 111.806 -178.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.3 -40.29 98.4 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -64.5 -39.81 94.48 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.733 0.778 . . . . 0.0 109.267 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 52.7 tp -61.88 -42.55 99.2 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.439 -177.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -65.12 -32.17 73.74 Favored 'General case' 0 CA--C 1.561 1.37 0 CA-C-O 121.479 0.657 . . . . 0.0 110.705 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 75.4 t -62.6 -46.03 97.37 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 CA-C-N 113.101 -1.863 . . . . 0.0 110.926 177.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 92.6 mt -64.04 -43.81 97.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.871 -178.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . 0.562 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 98.9 mttt -63.3 -42.44 99.04 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.21 -41.23 99.12 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 118.998 -1.081 . . . . 0.0 110.026 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.19 -38.85 84.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.867 -178.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 89.0 mt -64.31 -41.7 96.7 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 121.289 0.566 . . . . 0.0 110.122 174.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.29 -39.89 94.46 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.021 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 59.4 m170 -58.46 -39.58 80.31 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 121.121 -0.231 . . . . 0.0 111.601 -178.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 13.3 p -113.97 130.42 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.487 ' O ' ' HG3' ' B' ' 24' ' ' ARG . 34.6 ptt180 -73.15 108.04 5.82 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-O 121.726 0.774 . . . . 0.0 112.577 -177.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.6 p -143.3 133.8 22.21 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.885 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.687 177.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' GLY . . . . . 0.546 ' O ' ' N ' ' B' ' 123' ' ' GLN . . . -88.43 95.88 2.14 Favored Glycine 0 C--N 1.315 -0.626 0 C-N-CA 119.364 -1.398 . . . . 0.0 113.403 -176.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 47.7 t -125.23 129.54 73.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 174.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 31.8 m -137.97 157.29 32.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.53 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 95.8 mt -119.27 127.42 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.666 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 31.3 p -109.01 157.04 19.05 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-N 112.795 -2.002 . . . . 0.0 108.567 -177.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -124.86 104.26 30.31 Favored Pre-proline 0 C--O 1.235 0.294 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.54 -22.51 65.08 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.639 1.559 . . . . 0.0 111.59 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.13 -43.76 98.13 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.423 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 99.4 mt -73.02 174.67 7.55 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.951 -0.468 . . . . 0.0 111.378 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . 0.596 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 42.7 tt0 -73.16 131.25 41.8 Favored 'General case' 0 C--N 1.345 0.381 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -176.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.476 ' O ' ' OD1' ' B' ' 36' ' ' ASP . 66.0 t0 57.54 38.19 27.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.625 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' ASN . . . . . 0.465 ' C ' ' O ' ' B' ' 36' ' ' ASP . 29.7 t-20 28.63 71.86 0.47 Allowed Pre-proline 0 CA--C 1.535 0.368 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -178.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.596 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 92.1 Cg_endo -71.77 154.18 59.0 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 123.551 2.834 . . . . 0.0 111.84 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 95.6 mt -87.5 127.91 40.44 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.51 HG21 ' N ' ' B' ' 41' ' ' TYR . 26.7 m -108.03 -45.44 7.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 O-C-N 123.777 0.673 . . . . 0.0 112.437 -178.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' TYR . . . . . 0.51 ' N ' HG21 ' B' ' 40' ' ' VAL . 51.6 t80 -94.73 124.51 38.81 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.552 -178.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 6.0 p -142.97 140.96 27.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.311 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' ASN . . . . . 0.618 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 57.2 p30 -100.34 161.46 13.59 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.086 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' GLN . . . . . 0.453 ' HA ' ' OE1' ' B' ' 44' ' ' GLN . 14.4 mm100 -63.16 -37.98 89.37 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.502 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.17 -25.01 61.72 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.291 -0.723 . . . . 0.0 111.291 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' PHE . . . . . 0.618 ' HB2' ' OD1' ' B' ' 43' ' ' ASN . 61.3 t80 -60.33 -43.3 96.54 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' VAL . . . . . 0.459 ' O ' ' N ' ' B' ' 51' ' ' GLY . 69.4 t -61.16 -46.35 96.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.252 -178.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -62.67 -44.22 96.81 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.213 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 59.3 ttm -62.98 -42.06 99.73 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 33.8 p -96.11 -16.1 21.75 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.231 -0.588 . . . . 0.0 111.969 -178.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' B' ' 47' ' ' VAL . . . 73.08 18.3 79.11 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 178.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' TYR . . . . . 0.438 ' O ' HG11 ' B' ' 47' ' ' VAL . 82.6 m-85 -110.62 143.17 41.46 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.294 -0.453 . . . . 0.0 110.038 178.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -71.79 146.9 47.75 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-O 121.904 0.859 . . . . 0.0 110.994 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.63 -36.8 81.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.065 -177.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.37 -39.59 94.18 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.015 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -72.51 -32.04 65.83 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 177.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 95.8 mt -66.68 -71.29 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 178.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 94.2 mt -36.61 130.97 0.71 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.38 175.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.24 -8.23 69.54 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.617 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -136.08 149.14 48.6 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -174.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' ASN . . . . . 0.538 ' C ' ' H ' ' B' ' 63' ' ' ARG . 25.7 t-20 -79.55 151.6 30.6 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.798 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' CYS . . . . . . . . . . . . . 78.3 m -62.83 7.91 0.07 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.375 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' ARG . . . . . 0.538 ' H ' ' C ' ' B' ' 61' ' ' ASN . 33.5 ptt-85 -58.79 -31.89 68.82 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.54 -0.755 . . . . 0.0 112.497 -178.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -60.93 -31.2 70.74 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 178.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 81.5 mt -61.94 -42.36 99.02 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -177.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -48.02 151.67 0.92 Allowed 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.155 0.503 . . . . 0.0 109.888 -178.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -162.26 -152.93 6.92 Favored Glycine 0 CA--C 1.54 1.649 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.184 175.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' LYS . . . . . 0.448 ' HB3' ' HH ' ' B' ' 95' ' ' TYR . 88.8 tttt -60.87 -42.23 97.5 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 122.634 -0.333 . . . . 0.0 111.823 -175.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -74.93 -9.98 59.05 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.161 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 31.5 m -61.29 134.72 57.27 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -90.94 110.26 40.74 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.25 -178.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.84 -38.14 85.47 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 120.965 1.11 . . . . 0.0 111.828 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.38 -40.03 89.4 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 120.568 -0.453 . . . . 0.0 109.787 -176.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' GLU . . . . . 0.549 ' OE1' ' HB ' ' B' ' 90' ' ' VAL . 79.2 mm-40 -66.16 -39.65 89.95 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.889 177.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 72.1 t -61.92 -46.24 96.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -62.88 -37.45 86.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.885 -178.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -62.84 -41.53 99.38 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 119.312 -0.955 . . . . 0.0 108.79 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 95.0 mt -63.34 -43.73 98.72 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 CA-C-O 120.761 0.315 . . . . 0.0 110.714 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -62.27 -42.44 99.34 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 81.7 m -60.81 -45.75 93.19 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.994 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.5 -41.81 97.84 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -177.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.466 HD23 ' CE1' ' B' ' 119' ' ' PHE . 87.9 mt -63.57 -41.79 98.36 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -178.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 67.4 tp60 -62.21 -35.33 78.57 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -91.61 8.41 36.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.682 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 26.9 tttt 41.51 42.29 1.89 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.3 -0.56 . . . . 0.0 112.045 176.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -124.31 141.3 37.1 Favored Pre-proline 0 N--CA 1.471 0.58 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.096 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -61.73 140.12 84.29 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 120.875 1.05 . . . . 0.0 114.029 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.87 135.9 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -177.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 89' ' ' THR . . . . . 0.529 ' CG2' ' OD1' ' B' ' 107' ' ' ASN . 96.2 m -121.85 122.06 38.58 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 90' ' ' VAL . . . . . 0.549 ' HB ' ' OE1' ' B' ' 74' ' ' GLU . 26.9 m -139.31 163.28 26.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.753 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -113.6 121.47 44.27 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.131 0.491 . . . . 0.0 109.881 175.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 21.2 tt -127.87 131.47 69.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.034 -175.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -71.94 142.05 49.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.938 177.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 94' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -132.9 -178.47 4.97 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.407 0.623 . . . . 0.0 111.04 -176.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 95' ' ' TYR . . . . . 0.448 ' HH ' ' HB3' ' B' ' 68' ' ' LYS . 96.2 m-85 -132.2 146.03 51.74 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.813 178.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -102.93 179.29 4.32 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.056 0.455 . . . . 0.0 110.702 177.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.53 -35.16 75.31 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.243 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . 0.43 ' CG ' ' HG1' ' B' ' 100' ' ' THR . 37.0 p-10 -86.49 -1.95 58.04 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.038 0.836 . . . . 0.0 112.785 177.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.59 4.62 65.62 Favored Glycine 0 N--CA 1.465 0.612 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.165 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 100' ' ' THR . . . . . 0.43 ' HG1' ' CG ' ' B' ' 98' ' ' ASP . 25.8 m -67.65 128.98 38.46 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.331 178.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 101' ' ' MET . . . . . 0.531 ' SD ' ' N ' ' B' ' 102' ' ' PHE . 16.8 tmm? -87.25 143.37 27.31 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 102' ' ' PHE . . . . . 0.531 ' N ' ' SD ' ' B' ' 101' ' ' MET . 52.1 p90 -154.74 163.86 39.64 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 103' ' ' TRP . . . . . 0.677 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 22.0 m95 -97.51 137.57 36.26 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.276 -0.57 . . . . 0.0 111.086 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . 0.478 HD22 ' HG2' ' B' ' 123' ' ' GLN . 63.8 t-20 -131.9 113.4 13.4 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 114.707 -1.133 . . . . 0.0 113.957 -177.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -83.51 121.41 27.17 Favored 'General case' 0 C--N 1.318 -0.788 0 O-C-N 124.441 1.088 . . . . 0.0 109.015 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 41.2 tp -109.52 125.66 52.73 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.066 0.46 . . . . 0.0 111.95 -177.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 107' ' ' ASN . . . . . 0.529 ' OD1' ' CG2' ' B' ' 89' ' ' THR . 98.2 m-20 -118.34 129.6 55.53 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 176.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 96.7 mt -124.07 132.75 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -144.37 121.3 6.43 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -69.27 152.18 71.85 Favored 'Trans proline' 0 N--CA 1.503 2.043 0 C-N-CA 122.424 2.083 . . . . 0.0 112.576 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 111' ' ' MET . . . . . 0.449 ' HB2' ' HB2' ' B' ' 118' ' ' TYR . 66.1 mtt -128.75 142.26 51.06 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -112.51 105.27 13.45 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . 0.538 HG12 ' NZ ' ' A' ' 18' ' ' LYS . 96.8 mt -132.9 127.93 56.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 O-C-N 121.697 -0.627 . . . . 0.0 111.695 177.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 53.94 37.19 26.13 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 123.913 0.758 . . . . 0.0 109.713 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 60.58 36.28 19.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.266 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -132.63 153.23 51.27 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 177.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 11.3 t -103.23 152.31 21.64 Favored 'General case' 0 C--O 1.213 -0.82 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.16 -178.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 118' ' ' TYR . . . . . 0.449 ' HB2' ' HB2' ' B' ' 111' ' ' MET . 96.5 m-85 -148.04 146.95 29.09 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 121.222 -0.924 . . . . 0.0 111.278 -179.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 119' ' ' PHE . . . . . 0.466 ' CE1' HD23 ' B' ' 82' ' ' LEU . 96.7 m-85 -123.54 138.98 54.45 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 120.971 0.415 . . . . 0.0 111.512 -178.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -128.01 133.67 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -176.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.93 121.98 6.58 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 91.9 mt -113.36 127.14 70.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 123' ' ' GLN . . . . . 0.546 ' N ' ' O ' ' B' ' 26' ' ' GLY . 15.8 mp0 -118.55 122.58 42.99 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -119.68 121.21 38.74 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' B' ' 127' ' ' THR . 68.3 t0 -72.23 128.04 34.41 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.604 -177.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 126' ' ' ILE . . . . . 0.486 ' O ' ' HG3' ' B' ' 130' ' ' LYS . 2.9 mp -100.93 17.42 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.58 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 127' ' ' THR . . . . . 0.552 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 98.1 m -62.57 -44.14 97.07 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 114.197 -1.365 . . . . 0.0 112.846 176.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 59.9 tptt -61.67 -45.05 95.65 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -177.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 129' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -63.39 -35.04 79.1 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.683 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 130' ' ' LYS . . . . . 0.677 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 98.9 mttt -62.95 -41.63 99.57 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-N 112.833 -1.985 . . . . 0.0 110.835 174.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -64.3 -42.23 96.47 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 132' ' ' TYR . . . . . 0.533 ' CE2' HD13 ' B' ' 136' ' ' LEU . 91.6 t80 -60.13 -44.09 95.18 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 121.903 -0.498 . . . . 0.0 111.384 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 133' ' ' GLU . . . . . 0.457 ' O ' ' HG3' ' B' ' 137' ' ' GLU . 97.5 mt-10 -64.87 -36.55 84.7 Favored 'General case' 0 C--O 1.22 -0.453 0 C-N-CA 119.989 -0.684 . . . . 0.0 109.384 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 134' ' ' LYS . . . . . 0.413 ' HG3' ' O ' ' B' ' 130' ' ' LYS . 98.7 mttt -63.52 -39.8 95.36 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.604 177.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 49.6 tp -62.91 -41.4 99.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.349 0.595 . . . . 0.0 109.441 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 136' ' ' LEU . . . . . 0.533 HD13 ' CE2' ' B' ' 132' ' ' TYR . 88.8 mt -62.99 -41.47 99.59 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.426 177.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 137' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' B' ' 133' ' ' GLU . 97.1 mt-10 -65.06 -37.18 86.73 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 113.806 -1.543 . . . . 0.0 110.268 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.48 -43.75 96.38 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.995 177.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 67.3 m -60.94 -44.39 97.31 Favored 'General case' 0 C--N 1.346 0.449 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' B' ' 144' ' ' THR . 88.4 mt -61.73 -40.33 94.7 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -177.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 92.6 m -61.78 -45.44 93.89 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.026 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -65.66 -42.81 90.95 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 94.3 mt -63.87 -43.41 97.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.574 178.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 144' ' ' THR . . . . . 0.433 ' N ' ' O ' ' B' ' 140' ' ' LEU . 95.3 m -61.59 -45.51 93.82 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . 0.437 ' O ' ' HB ' ' B' ' 148' ' ' THR . . . -64.52 -41.73 96.21 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 119.117 -1.033 . . . . 0.0 109.295 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 86.2 mt -64.99 -40.85 95.57 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 176.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 147' ' ' SER . . . . . 0.613 ' O ' ' N ' ' B' ' 149' ' ' PRO . 78.2 p -62.06 -41.86 98.6 Favored 'General case' 0 CA--C 1.477 -1.84 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -178.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 148' ' ' THR . . . . . 0.497 ' C ' ' O ' ' B' ' 147' ' ' SER . 40.5 m -26.51 85.36 0.03 OUTLIER Pre-proline 0 N--CA 1.478 0.947 0 O-C-N 123.958 0.786 . . . . 0.0 110.188 176.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 149' ' ' PRO . . . . . 0.613 ' N ' ' O ' ' B' ' 147' ' ' SER . 24.1 Cg_exo -60.52 145.18 99.23 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.051 1.834 . . . . 0.0 115.6 -177.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 9.9 tp -125.29 119.44 55.48 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.168 0 CA-C-N 114.036 -1.438 . . . . 0.0 108.197 174.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 59.5 t -148.89 94.2 4.1 Favored Pre-proline 0 C--N 1.307 -1.274 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.806 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.04 142.88 94.1 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 CA-C-N 119.909 1.003 . . . . 0.0 109.623 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 153' ' ' ILE . . . . . 0.614 ' CG2' HH12 ' A' ' 154' ' ' ARG . 43.8 mm -77.1 -66.89 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 154' ' ' ARG . . . . . 0.608 ' HD3' ' NH2' ' A' ' 154' ' ' ARG . 2.7 mpt_? -132.96 -158.84 0.92 Allowed 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 177.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -84.2 109.49 17.79 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 101.02 -17.34 56.32 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -177.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 89.3 mt -109.78 126.43 66.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.859 0.362 . . . . 0.0 111.282 -177.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 158' ' ' SER . . . . . 0.702 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 60.7 m -135.29 149.05 49.71 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.718 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -132.46 149.33 52.35 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 29.8 tp -144.23 78.75 13.38 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 161' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -71.82 149.89 54.78 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.725 2.283 . . . . 0.0 114.108 -177.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 91.6 mt -113.68 133.3 55.41 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 55.9 t -128.38 132.38 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 113.49 167.45 16.55 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.184 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 165' ' ' ASN . . . . . 0.634 ' O ' ' NH1' ' B' ' 170' ' ' ARG . 52.9 t30 -88.55 107.53 18.94 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -178.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 166' ' ' LEU . . . . . 0.451 ' CD2' ' CZ ' ' B' ' 171' ' ' PHE . 48.2 tp -64.78 105.35 0.98 Allowed 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -174.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 167' ' ' THR . . . . . 0.453 ' CG2' HH21 ' B' ' 170' ' ' ARG . 10.9 p -84.94 169.74 13.74 Favored 'General case' 0 C--N 1.348 0.502 0 CA-C-N 114.019 -1.446 . . . . 0.0 110.79 177.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.2 -37.87 84.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.704 176.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.3 -40.97 90.37 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-O 122.455 1.121 . . . . 0.0 111.894 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 170' ' ' ARG . . . . . 0.634 ' NH1' ' O ' ' B' ' 165' ' ' ASN . 87.7 mtm180 -61.83 -34.81 76.63 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 112.376 -2.193 . . . . 0.0 111.178 177.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 171' ' ' PHE . . . . . 0.451 ' CZ ' ' CD2' ' B' ' 166' ' ' LEU . 0.5 OUTLIER -53.95 -26.25 24.67 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -178.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 172' ' ' ASN . . . . . 0.449 ' O ' HG21 ' B' ' 175' ' ' VAL . 92.8 m-20 -62.86 -40.56 97.86 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.875 179.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 57.1 m -60.7 -41.07 94.44 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.098 0.475 . . . . 0.0 110.747 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 174' ' ' ILE . . . . . 0.418 HD12 HG23 ' B' ' 174' ' ' ILE . 67.3 mt -63.92 -44.1 97.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 175' ' ' VAL . . . . . 0.498 HG23 ' N ' ' B' ' 176' ' ' CYS . 34.5 m -63.15 -40.22 88.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 176' ' ' CYS . . . . . 0.498 ' N ' HG23 ' B' ' 175' ' ' VAL . 99.1 m -61.88 -35.03 77.11 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.432 178.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 177' ' ' THR . . . . . 0.501 ' O ' HG13 ' B' ' 181' ' ' ILE . 25.1 m -61.74 -19.24 62.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.28 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 178' ' ' LEU . . . . . . . . . . . . . 89.4 mt -61.42 -39.01 89.19 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.328 -177.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 18.2 m -61.0 -43.81 98.35 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.259 177.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 180' ' ' ASN . . . . . 0.657 ' O ' ' OG ' ' B' ' 183' ' ' SER . 92.4 m-20 -62.13 -40.0 94.46 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.878 0.371 . . . . 0.0 110.481 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . 0.501 HG13 ' O ' ' B' ' 177' ' ' THR . 72.2 mt -56.11 -35.0 40.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 O-C-N 122.157 -0.339 . . . . 0.0 110.902 -178.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 182' ' ' LEU . . . . . . . . . . . . . 84.6 mt -61.78 -41.52 97.83 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 119.799 -0.761 . . . . 0.0 109.11 177.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 183' ' ' SER . . . . . 0.657 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.3 p -62.89 -32.6 73.9 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 121.8 -0.562 . . . . 0.0 110.915 176.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 184' ' ' THR . . . . . 0.411 ' OG1' ' HA ' ' B' ' 181' ' ' ILE . 50.9 p -87.52 15.73 6.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.835 0.35 . . . . 0.0 111.831 -178.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 79.5 p -59.35 -17.13 27.0 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.031 -177.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.02 -40.59 96.22 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.704 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 187' ' ' ASP . . . . . 0.702 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.2 m-20 -68.75 113.93 6.65 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.653 0.74 . . . . 0.0 110.622 -177.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.65 -42.36 99.57 Favored 'General case' 0 C--O 1.247 0.922 0 CA-C-N 114.772 -1.104 . . . . 0.0 113.118 -177.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -112.02 130.86 55.73 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 120.621 -0.431 . . . . 0.0 111.317 -178.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 190' ' ' LEU . . . . . . . . . . . . . 41.4 tp -123.13 117.64 25.86 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.901 178.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 83.9 mt -105.62 125.1 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 121.064 -0.254 . . . . 0.0 111.418 -178.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 49.7 mm -114.88 117.4 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 178.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 193' ' ' ASP . . . . . 0.575 ' CG ' ' HG ' ' B' ' 195' ' ' SER . 40.0 t0 -89.47 111.07 21.87 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.731 -176.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 194' ' ' LEU . . . . . . . . . . . . . 97.2 mt -92.24 -1.24 57.23 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.323 175.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 195' ' ' SER . . . . . 0.575 ' HG ' ' CG ' ' B' ' 193' ' ' ASP . 78.1 p -61.35 -37.16 82.34 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.698 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.42 -34.13 87.18 Favored Glycine 0 N--CA 1.439 -1.102 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 197' ' ' LEU . . . . . 1.049 HD23 ' O ' ' B' ' 199' ' ' GLN . 4.8 tt -78.19 132.71 37.71 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -176.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 198' ' ' ALA . . . . . 0.69 ' N ' HD21 ' B' ' 197' ' ' LEU . . . -64.5 -41.64 96.33 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.496 -178.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 199' ' ' GLN . . . . . 1.049 ' O ' HD23 ' B' ' 197' ' ' LEU . 58.9 tt0 -138.91 164.14 30.46 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 200' ' ' VAL . . . . . 0.438 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 50.2 t -121.36 132.51 70.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 O-C-N 120.688 -1.258 . . . . 0.0 109.433 176.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -90.46 149.42 22.23 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.926 -178.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.44 -32.45 70.22 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.295 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -64.6 -32.65 74.39 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.4 m -60.79 -44.32 96.98 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.274 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 205' ' ' ALA . . . . . 0.623 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -58.69 -29.56 66.73 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -177.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -65.44 -38.59 90.31 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.257 0.551 . . . . 0.0 109.672 176.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -66.89 -37.94 85.33 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.694 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.55 -43.46 98.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 120.528 -0.469 . . . . 0.0 109.808 -178.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 209' ' ' PHE . . . . . 0.623 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 65.3 m-85 -62.17 -43.02 99.75 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 114.195 -1.366 . . . . 0.0 112.767 177.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.42 -41.8 98.71 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.288 -0.965 . . . . 0.0 109.763 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 211' ' ' LEU . . . . . 0.405 ' O ' ' HG ' ' B' ' 215' ' ' LEU . 39.7 mt -62.27 -42.46 99.36 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.418 -179.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 78.0 p -63.15 -36.06 82.36 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.291 -0.564 . . . . 0.0 112.11 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 213' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -66.89 -46.72 74.06 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.146 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 52.0 tp -63.89 -43.17 96.83 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.765 0.793 . . . . 0.0 109.827 177.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 215' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' B' ' 211' ' ' LEU . 88.9 mt -63.2 -43.76 97.25 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 113.485 -1.689 . . . . 0.0 111.599 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.33 -39.69 91.46 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.879 -176.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 87.1 mt -63.75 -42.05 97.9 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.389 0.614 . . . . 0.0 111.587 176.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 218' ' ' THR . . . . . . . . . . . . . 75.6 p -75.13 -16.41 60.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.106 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 80.85 64.65 1.78 Allowed Glycine 0 CA--C 1.528 0.848 0 N-CA-C 106.577 -2.609 . . . . 0.0 106.577 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 220' ' ' THR . . . . . 0.4 ' O ' ' HB3' ' B' ' 215' ' ' LEU . 98.1 m -142.46 103.23 4.22 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 175.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -61.92 139.36 58.39 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.92 -176.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 42.6 tp -116.3 121.4 41.88 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.231 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 3.2 mp -110.01 128.58 66.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.223 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 224' ' ' ILE . . . . . . . . . . . . . 50.7 mm -108.86 126.05 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.735 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 51.8 p -133.0 157.16 45.89 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.511 0.672 . . . . 0.0 112.714 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 89.16 18.04 54.44 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 113.894 -1.503 . . . . 0.0 110.981 -177.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 95.5 mt -82.54 125.69 39.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 121.908 -0.76 . . . . 0.0 111.586 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -65.86 140.31 97.17 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.604 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.78 -37.01 92.28 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 121.358 1.372 . . . . 0.0 112.446 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -64.39 -43.1 95.49 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 51.3 tp -61.62 -41.55 97.63 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.701 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.12 -37.07 86.13 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.756 0.312 . . . . 0.0 111.359 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 93.9 mtp -64.08 -41.17 97.42 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.442 -0.503 . . . . 0.0 109.659 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.79 -43.67 98.19 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 122.204 1.002 . . . . 0.0 109.202 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 37.3 mmt -63.76 -35.73 81.54 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.951 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -61.88 -40.52 95.68 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -178.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.31 -43.45 97.79 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.043 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 51.8 tp -61.68 -45.52 93.66 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 120.26 -0.576 . . . . 0.0 112.228 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 239' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' B' ' 240' ' ' ALA . 66.8 t0 -156.83 135.13 11.31 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 120.39 -0.524 . . . . 0.0 112.034 -179.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 240' ' ' ALA . . . . . 0.435 ' N ' ' OD1' ' B' ' 239' ' ' ASP . . . -62.59 -46.56 87.76 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 176.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 241' ' ' ASN . . . . . 0.534 ' O ' ' HB2' ' B' ' 244' ' ' SER . 92.5 m-20 -43.74 -18.96 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.421 -175.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 242' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -61.91 -45.88 91.77 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.236 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 243' ' ' SER . . . . . 0.41 ' O ' ' N ' ' B' ' 245' ' ' LEU . 77.7 p -57.95 -45.62 86.35 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 244' ' ' SER . . . . . 0.534 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 21.0 m -28.08 -38.47 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' B' ' 243' ' ' SER . 96.9 mt -87.73 138.54 31.38 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 121.521 -0.737 . . . . 0.0 110.489 178.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -66.75 134.93 53.18 Favored 'General case' 0 C--O 1.242 0.662 0 O-C-N 121.82 -0.55 . . . . 0.0 110.742 -174.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 247' ' ' THR . . . . . . . . . . . . . 97.3 m -124.6 126.81 46.4 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.919 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -111.6 143.14 42.97 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 177.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 249' ' ' SER . . . . . 0.553 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 77.9 p -62.97 -34.75 78.19 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.107 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 250' ' ' ASN . . . . . 0.553 ' OD1' ' O ' ' B' ' 249' ' ' SER . 99.3 m-20 -146.85 159.2 43.82 Favored 'General case' 0 N--CA 1.461 0.121 0 O-C-N 124.243 0.964 . . . . 0.0 112.033 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 79.7 t -64.02 -44.6 97.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.919 178.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 252' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.23 -46.01 92.16 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -178.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -61.25 -43.75 98.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.821 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 254' ' ' ALA . . . . . 0.444 ' O ' HG21 ' B' ' 257' ' ' VAL . . . -64.9 -40.24 94.78 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.133 178.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 255' ' ' VAL . . . . . 0.742 HG12 ' O ' ' A' ' 153' ' ' ILE . 55.4 t -65.12 -45.54 93.85 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.298 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.7 -47.0 85.54 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 120.286 -0.566 . . . . 0.0 111.335 -178.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 257' ' ' VAL . . . . . 0.452 ' O ' ' C ' ' B' ' 258' ' ' LEU . 28.3 m -65.95 -40.0 86.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.758 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 258' ' ' LEU . . . . . 0.519 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 1.9 mt -33.34 -74.04 0.05 OUTLIER Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.566 -178.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 259' ' ' PRO . . . . . 0.519 ' CD ' ' CB ' ' B' ' 258' ' ' LEU . 37.3 Cg_endo -61.93 141.23 88.79 Favored 'Trans proline' 0 N--CA 1.504 2.122 0 C-N-CA 121.605 1.537 . . . . 0.0 111.463 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 260' ' ' ILE . . . . . 0.492 HG13 ' O ' ' B' ' 259' ' ' PRO . 96.9 mt -159.22 -15.02 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-N 118.73 0.696 . . . . 0.0 112.311 177.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 C--O 1.216 -0.706 0 CA-C-O 117.885 -1.055 . . . . 0.0 111.553 -179.741 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.517 ' O ' ' OG ' ' A' ' 6' ' ' SER . . . -156.98 169.95 23.64 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 116.65 -1.643 . . . . 0.0 110.19 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.6 p -72.9 -18.81 61.37 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 124.902 1.376 . . . . 0.0 110.808 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -70.59 -67.02 0.53 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 114.444 -1.253 . . . . 0.0 112.189 174.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -66.71 -38.58 87.01 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.517 ' OG ' ' O ' ' A' ' 2' ' ' ALA . 64.1 m -58.97 -41.63 87.97 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 120.441 -0.503 . . . . 0.0 110.306 -177.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.658 ' CE2' HD13 ' A' ' 9' ' ' ILE . 41.1 t80 82.1 86.18 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 O-C-N 123.909 0.756 . . . . 0.0 111.301 176.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.455 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -60.86 -134.78 0.01 OUTLIER Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -177.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.658 HD13 ' CE2' ' A' ' 7' ' ' PHE . 57.2 mt 78.95 108.72 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.695 0 C-N-CA 122.583 0.353 . . . . 0.0 110.775 -178.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -63.31 -22.65 72.09 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.422 1.415 . . . . 0.0 112.134 -178.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.72 -37.83 95.29 Favored Glycine 0 C--O 1.245 0.817 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.766 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.56 -39.07 91.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.359 0.6 . . . . 0.0 109.744 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 49.8 tp -62.95 -41.62 99.56 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -62.61 -39.56 94.17 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 56.2 t -60.74 -44.24 96.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 O-C-N 122.365 -0.21 . . . . 0.0 110.986 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 93.0 mt -62.62 -43.59 98.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.181 -177.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.407 ' NZ ' ' HA ' ' B' ' 6' ' ' SER . 98.9 mttt -62.4 -46.03 90.46 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 119.331 -0.948 . . . . 0.0 112.123 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.65 ' HZ3' HG12 ' B' ' 113' ' ' ILE . 98.6 mttt -60.65 -39.51 88.6 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 118.881 -1.128 . . . . 0.0 109.082 -175.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.8 -42.34 93.23 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.092 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.3 mt -63.26 -40.97 98.89 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.105 0.479 . . . . 0.0 109.879 178.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.41 -38.86 92.78 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.576 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 53.7 m170 -58.16 -39.83 79.87 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 122.27 -0.268 . . . . 0.0 111.592 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.0 p -114.69 130.23 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.522 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 35.6 ptt180 -72.04 109.32 5.77 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 122.245 1.021 . . . . 0.0 111.945 -177.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.5 p -140.21 142.9 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.555 ' O ' ' N ' ' A' ' 123' ' ' GLN . . . -98.18 93.12 1.33 Allowed Glycine 0 C--N 1.313 -0.709 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.215 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 51.6 t -125.15 129.83 73.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 175.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.1 m -136.66 158.82 37.56 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.3 mt -120.21 129.59 75.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 177.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.419 ' HB ' ' OD1' ' A' ' 37' ' ' ASN . 16.5 p -106.39 166.92 10.19 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.503 178.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.401 ' O ' ' HA ' ' A' ' 37' ' ' ASN . 45.0 t0 -131.83 104.14 14.3 Favored Pre-proline 0 C--N 1.32 -0.701 0 C-N-CA 120.491 -0.483 . . . . 0.0 110.813 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.464 ' CG ' HG22 ' A' ' 117' ' ' THR . 36.7 Cg_endo -63.93 -23.11 68.36 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.379 1.386 . . . . 0.0 111.605 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.12 -34.38 76.24 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.209 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.8 mt -87.4 165.03 15.88 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.861 177.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.701 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 43.2 tt0 -63.24 132.14 50.71 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -176.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.52 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 57.1 t0 62.32 21.19 12.35 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 177.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.419 ' OD1' ' HB ' ' A' ' 30' ' ' THR . 35.0 t-20 42.73 66.59 4.2 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.816 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.701 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 89.1 Cg_endo -70.67 156.18 61.47 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 123.664 2.909 . . . . 0.0 111.993 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.3 mt -88.05 125.16 41.5 Favored 'Isoleucine or valine' 0 C--O 1.246 0.905 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.376 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.2 m -105.65 -42.8 7.13 Favored 'Isoleucine or valine' 0 C--N 1.343 0.324 0 O-C-N 123.613 0.571 . . . . 0.0 111.998 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -96.06 123.75 39.8 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.566 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.1 p -142.67 139.83 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.338 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.545 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 57.6 p30 -97.39 165.12 12.17 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.468 ' HA ' ' OE1' ' A' ' 44' ' ' GLN . 13.2 mm100 -66.09 -38.03 87.26 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 177.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.88 -26.77 63.44 Favored Glycine 0 N--CA 1.453 -0.186 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.545 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 71.4 t80 -59.28 -47.58 84.84 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 -179.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.573 HG11 ' O ' ' A' ' 52' ' ' TYR . 69.5 t -59.38 -44.69 93.08 Favored 'Isoleucine or valine' 0 C--N 1.349 0.585 0 O-C-N 121.241 -0.912 . . . . 0.0 111.366 -173.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -63.73 -37.84 88.86 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.727 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 59.7 ttm -66.57 -43.82 83.93 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 175.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 36.4 p -91.87 -21.99 20.32 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.126 0.488 . . . . 0.0 111.315 -178.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . 77.83 19.56 75.21 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.573 ' O ' HG11 ' A' ' 47' ' ' VAL . 82.9 m-85 -112.58 139.31 48.27 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 122.868 0.467 . . . . 0.0 111.28 178.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -65.85 149.2 50.57 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.785 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.29 -32.32 73.92 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -178.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -66.36 -42.48 87.98 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 119.591 -0.843 . . . . 0.0 111.466 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -65.61 -45.1 84.44 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 119.886 -0.725 . . . . 0.0 109.427 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.412 HD13 ' CD2' ' A' ' 46' ' ' PHE . 97.0 mt -62.1 -46.7 95.87 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 C-N-CA 119.85 -0.74 . . . . 0.0 112.47 -174.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.2 mt -60.77 142.8 55.6 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.53 -3.08 87.33 Favored Glycine 0 N--CA 1.464 0.529 0 CA-C-O 119.234 -0.759 . . . . 0.0 112.877 177.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -136.19 152.08 50.4 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.275 1.537 . . . . 0.0 111.682 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.535 ' C ' ' H ' ' A' ' 63' ' ' ARG . 24.9 t-20 -80.27 151.89 29.33 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.194 0.521 . . . . 0.0 110.509 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 85.6 m -64.56 14.15 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.342 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.535 ' H ' ' C ' ' A' ' 61' ' ' ASN . 36.3 ptt-85 -61.14 -40.78 95.12 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 122.073 -0.392 . . . . 0.0 111.354 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -55.12 -22.91 18.47 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -178.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.4 mt -66.04 -36.62 83.74 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.402 0.62 . . . . 0.0 112.636 176.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.682 HE22 HO4' ' A' ' 900' ' ' FMN . 88.2 mt-30 -61.95 137.87 58.3 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.061 -178.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.498 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -147.63 -147.73 4.6 Favored Glycine 0 CA--C 1.543 1.801 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.096 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.411 ' HB3' ' HH ' ' A' ' 95' ' ' TYR . 88.7 tttt -62.66 -41.2 98.94 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -177.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.633 ' H ' ' HH ' ' A' ' 95' ' ' TYR . 9.3 m-70 -76.84 -7.87 56.26 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.245 -177.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.498 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 27.4 m -64.02 129.38 39.81 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.22 -0.592 . . . . 0.0 109.71 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -86.47 111.9 42.57 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.809 -177.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.6 -31.38 91.59 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 121.97 1.78 . . . . 0.0 113.206 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.12 -40.11 95.48 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.111 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.43 ' OE1' ' HB ' ' A' ' 90' ' ' VAL . 78.8 mm-40 -65.31 -43.17 91.88 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.2 t -60.38 -43.69 94.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 114.189 -1.369 . . . . 0.0 107.74 -176.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -64.42 -38.06 89.71 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.646 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -63.49 -39.7 95.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.329 0.585 . . . . 0.0 110.625 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.92 -43.94 97.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.941 177.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -62.53 -42.95 99.86 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 113.925 -1.489 . . . . 0.0 108.287 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 99.3 m -61.24 -49.83 75.53 Favored 'General case' 0 C--O 1.247 0.947 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.8 -41.66 96.06 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 118.646 -0.692 . . . . 0.0 111.598 -169.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.0 mt -63.23 -39.29 94.2 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 118.702 0.683 . . . . 0.0 111.188 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 66.7 tp60 -64.87 -34.35 78.17 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -85.28 -3.54 58.86 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.599 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.2 tttt 48.57 37.59 9.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.679 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -120.64 143.89 37.39 Favored Pre-proline 0 CA--C 1.534 0.364 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -61.8 144.2 96.71 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 121.318 1.345 . . . . 0.0 113.307 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.5 p -139.39 141.39 35.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.805 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.572 ' CG2' ' OD1' ' A' ' 107' ' ' ASN . 97.4 m -125.64 121.82 34.63 Favored 'General case' 0 C--N 1.344 0.345 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 175.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.43 ' HB ' ' OE1' ' A' ' 74' ' ' GLU . 27.0 m -139.59 158.77 27.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 120.675 0.274 . . . . 0.0 111.274 178.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -104.7 129.25 52.91 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 176.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 19.8 tt -138.55 130.46 37.57 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 CA-C-N 120.902 1.683 . . . . 0.0 112.207 178.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.445 ' OE1' ' O ' ' A' ' 69' ' ' HIS . 86.7 mt-30 -61.77 137.26 58.23 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.886 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -137.53 158.52 44.22 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.977 -178.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.633 ' HH ' ' H ' ' A' ' 69' ' ' HIS . 93.9 m-85 -117.82 136.7 53.24 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -178.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -84.94 -173.52 4.77 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.175 0.512 . . . . 0.0 111.704 -178.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.42 -43.63 98.37 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.155 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 41.1 p-10 -83.81 6.12 22.53 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -178.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.17 -0.31 83.63 Favored Glycine 0 N--CA 1.465 0.609 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.967 176.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 23.0 m -60.65 138.04 58.11 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.664 ' C ' ' SD ' ' A' ' 101' ' ' MET . 13.2 tmm? -104.09 129.03 51.76 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.878 0.37 . . . . 0.0 111.072 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.491 ' N ' ' SD ' ' A' ' 101' ' ' MET . 53.2 p90 -142.65 159.01 43.07 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 120.276 -0.57 . . . . 0.0 109.677 -178.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.832 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 23.6 m95 -90.38 144.29 25.95 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.493 HD22 ' HG2' ' A' ' 123' ' ' GLN . 54.9 t-20 -137.44 106.08 5.86 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -177.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 80.5 tt0 -72.22 134.34 45.58 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -177.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 40.5 tp -120.05 124.78 46.71 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.572 ' OD1' ' CG2' ' A' ' 89' ' ' THR . 97.8 m-20 -121.11 122.11 39.34 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 176.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 96.2 mt -119.52 129.12 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 O-C-N 123.43 0.457 . . . . 0.0 111.264 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -138.36 124.57 12.78 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.878 -0.147 . . . . 0.0 110.648 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -70.81 150.27 61.52 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 122.25 1.967 . . . . 0.0 112.54 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.5 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 67.4 mtt -121.59 153.8 37.58 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -127.48 93.96 3.86 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 177.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 96.2 mt -119.93 130.56 74.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.529 -177.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 50.01 37.54 14.32 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 118.746 0.703 . . . . 0.0 111.736 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 59.21 29.94 19.6 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.979 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -127.53 146.61 50.45 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.676 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 5.2 t -82.78 -175.38 5.76 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.279 -0.888 . . . . 0.0 109.471 -178.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.676 ' CD2' ' O ' ' A' ' 117' ' ' THR . 73.0 m-85 -168.83 156.18 7.43 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 171.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -129.14 146.31 51.1 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 174.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -135.63 136.88 50.12 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.366 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -111.25 128.48 8.71 Favored Glycine 0 CA--C 1.503 -0.683 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 178.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 96.5 mt -116.99 128.9 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.555 ' N ' ' O ' ' A' ' 26' ' ' GLY . 15.1 mp0 -120.14 116.91 26.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.101 0.477 . . . . 0.0 109.959 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -116.95 114.84 24.4 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.819 -178.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.485 ' OD1' ' OG1' ' A' ' 127' ' ' THR . 68.3 t0 -63.63 125.24 23.64 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -175.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.7 mp -89.93 1.08 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 CA-C-N 113.887 -1.506 . . . . 0.0 110.457 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.485 ' OG1' ' OD1' ' A' ' 125' ' ' ASP . 18.4 m -60.46 -42.72 96.77 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.257 -0.902 . . . . 0.0 112.716 -177.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -60.07 -43.06 95.73 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -178.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -63.28 -39.62 95.1 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.705 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.832 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.7 mttt -62.49 -40.57 97.11 Favored 'General case' 0 CA--C 1.503 -0.854 0 C-N-CA 118.486 -1.286 . . . . 0.0 110.52 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.11 -37.3 84.6 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.485 ' CE2' HD13 ' A' ' 136' ' ' LEU . 90.5 t80 -61.49 -45.26 94.98 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.43 176.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.85 -38.92 92.87 Favored 'General case' 0 C--N 1.342 0.248 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.88 -40.51 95.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.84 0.352 . . . . 0.0 110.15 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 54.5 tp -60.97 -43.6 98.55 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.485 HD13 ' CE2' ' A' ' 132' ' ' TYR . 84.9 mt -62.62 -41.53 99.07 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.196 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.34 -40.62 97.81 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.915 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -60.59 -41.84 95.52 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -177.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 63.3 m -61.33 -40.59 94.81 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.635 176.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 144' ' ' THR . 84.3 mt -63.53 -41.83 98.47 Favored 'General case' 0 C--O 1.221 -0.431 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 90.3 m -61.44 -45.97 92.05 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.295 -177.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.33 -40.14 93.3 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 95.9 mt -64.8 -43.51 96.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 113.781 -1.554 . . . . 0.0 111.281 176.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.504 ' N ' ' O ' ' A' ' 140' ' ' LEU . 90.4 m -62.24 -46.04 90.62 Favored 'General case' 0 C--N 1.344 0.361 0 C-N-CA 120.316 -0.554 . . . . 0.0 112.289 -178.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.06 -39.74 95.63 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 118.815 -1.154 . . . . 0.0 109.017 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.2 mt -63.3 -42.48 99.04 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.756 -0.657 . . . . 0.0 112.517 178.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.753 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.0 p -60.62 -39.95 90.12 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -177.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.495 ' C ' ' O ' ' A' ' 147' ' ' SER . 17.0 m -27.41 79.55 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.428 0 O-C-N 126.617 2.448 . . . . 0.0 106.733 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.753 ' N ' ' O ' ' A' ' 147' ' ' SER . 20.1 Cg_exo -62.89 145.17 94.48 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.007 1.138 . . . . 0.0 114.672 -174.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.512 ' O ' ' CG2' ' A' ' 151' ' ' VAL . 8.8 tp -120.57 135.45 60.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 103.124 -2.917 . . . . 0.0 103.124 175.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.512 ' CG2' ' O ' ' A' ' 150' ' ' ILE . 92.3 t -167.73 90.93 0.69 Allowed Pre-proline 0 CA--C 1.516 -0.355 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 178.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -61.39 137.34 69.47 Favored 'Trans proline' 0 C--N 1.3 -2.006 0 N-CA-C 109.465 -1.013 . . . . 0.0 109.465 -176.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.564 ' O ' ' HD2' ' A' ' 154' ' ' ARG . 45.6 mm -67.47 -44.43 86.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 119.746 -0.782 . . . . 0.0 111.069 179.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.581 HH12 HG21 ' B' ' 153' ' ' ILE . 0.3 OUTLIER -159.12 -154.89 0.44 Allowed 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.082 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 63.0 t-20 -87.89 104.37 16.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 122.189 0.995 . . . . 0.0 111.897 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 89.91 8.61 66.96 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 114.243 -1.344 . . . . 0.0 111.022 -177.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.7 mt -124.09 125.71 71.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 CA-C-O 121.748 0.785 . . . . 0.0 109.477 174.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.656 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 57.8 m -132.82 151.47 52.01 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.276 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -138.96 141.96 38.4 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.546 -0.721 . . . . 0.0 111.244 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 25.9 tp -133.15 80.2 60.01 Favored Pre-proline 0 N--CA 1.471 0.581 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.141 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -69.65 149.18 67.24 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.778 2.319 . . . . 0.0 113.137 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 86.6 mt -116.99 126.13 52.44 Favored 'General case' 0 C--O 1.25 1.116 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.393 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 47.3 t -123.47 131.48 73.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 115.0 169.61 16.07 Favored Glycine 0 N--CA 1.479 1.537 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.93 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.779 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 54.2 t30 -84.96 113.14 21.19 Favored 'General case' 0 C--O 1.213 -0.835 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.454 HD13 HD11 ' A' ' 174' ' ' ILE . 44.8 tp -73.66 103.48 4.26 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -177.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.533 ' H ' ' HE ' ' A' ' 170' ' ' ARG . 9.8 p -86.82 167.34 14.47 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.557 178.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.22 -33.82 76.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.411 0.624 . . . . 0.0 111.6 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.1 -43.39 92.25 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.595 178.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.779 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 88.0 mtm180 -64.66 -31.22 72.35 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.134 0.974 . . . . 0.0 112.051 177.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.42 ' CZ ' ' CD2' ' A' ' 166' ' ' LEU . 0.5 OUTLIER -55.1 -29.38 57.5 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.564 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.524 ' O ' HG21 ' A' ' 175' ' ' VAL . 92.2 m-20 -61.12 -40.46 93.86 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 119.038 -1.065 . . . . 0.0 109.679 -177.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 52.6 m -59.71 -41.02 89.88 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.443 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.454 HD11 HD13 ' A' ' 166' ' ' LEU . 66.1 mt -63.35 -44.07 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.524 HG21 ' O ' ' A' ' 172' ' ' ASN . 26.8 m -62.57 -39.81 85.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . 0.418 ' N ' HG23 ' A' ' 175' ' ' VAL . 98.5 m -62.86 -35.16 79.05 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.303 0.573 . . . . 0.0 110.416 178.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' THR . . . . . 0.474 ' O ' HG13 ' A' ' 181' ' ' ILE . 25.0 m -61.7 -19.44 62.38 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.201 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 87.8 mt -60.97 -41.43 96.36 Favored 'General case' 0 C--O 1.247 0.967 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 -177.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 19.2 m -59.63 -42.94 93.83 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.587 ' O ' ' OG ' ' A' ' 183' ' ' SER . 92.1 m-20 -61.43 -37.67 84.35 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 122.588 0.355 . . . . 0.0 110.983 178.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 177' ' ' THR . 67.6 mt -58.56 -37.71 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 O-C-N 121.685 -0.634 . . . . 0.0 109.476 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 85.0 mt -60.9 -40.34 92.71 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 119.418 -0.913 . . . . 0.0 108.833 -177.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.587 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 77.8 p -62.01 -33.86 75.13 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.528 176.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 59.3 p -89.37 23.36 2.56 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 120.752 0.31 . . . . 0.0 111.66 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 78.1 p -63.0 -20.54 65.39 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.775 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.71 -37.56 82.1 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.793 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.656 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 98.7 m-20 -73.3 115.05 12.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.424 0.631 . . . . 0.0 110.902 -179.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.92 -42.56 99.84 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.045 -0.98 . . . . 0.0 113.03 -177.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -113.78 131.52 56.19 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.266 0.555 . . . . 0.0 110.779 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 38.9 tp -120.0 127.07 52.28 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 92.2 mt -114.27 127.15 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 118.658 0.663 . . . . 0.0 109.607 177.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.7 mm -112.23 126.71 69.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . 0.47 ' CG ' ' HG ' ' A' ' 195' ' ' SER . 39.0 t0 -94.66 118.27 31.45 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 122.046 0.927 . . . . 0.0 110.78 177.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 95.9 mt -98.56 -3.49 36.25 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.392 175.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.47 ' HG ' ' CG ' ' A' ' 193' ' ' ASP . 78.0 p -62.69 -33.7 75.62 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.629 0.604 . . . . 0.0 112.629 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.78 -43.63 98.98 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 108.491 -1.844 . . . . 0.0 108.491 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 1.161 HD23 ' O ' ' A' ' 199' ' ' GLN . 4.9 tt -70.0 129.15 38.68 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 113.104 -1.548 . . . . 0.0 108.584 -176.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.632 ' N ' HD21 ' A' ' 197' ' ' LEU . . . -60.24 -50.56 73.18 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.242 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 1.161 ' O ' HD23 ' A' ' 197' ' ' LEU . 58.4 tt0 -132.29 157.01 45.53 Favored 'General case' 0 C--O 1.204 -1.322 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -175.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.427 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 47.1 t -117.16 132.1 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 O-C-N 120.306 -1.496 . . . . 0.0 108.889 177.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -83.73 154.92 23.34 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.572 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -64.65 -39.2 93.27 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.123 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -58.26 -31.97 67.93 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 17.5 m -60.39 -41.86 94.69 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.563 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.497 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -57.22 -38.64 74.05 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -177.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -62.63 -37.01 84.61 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -64.76 -38.91 92.58 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.967 177.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 94.6 mt -63.47 -44.51 98.85 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.079 0 C-N-CA 119.598 -0.841 . . . . 0.0 108.982 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . 0.497 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 72.0 m-85 -61.53 -44.11 97.65 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.691 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.0 -41.87 98.53 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 119.347 -0.941 . . . . 0.0 109.363 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.452 ' O ' ' HG ' ' A' ' 215' ' ' LEU . 38.8 mt -62.66 -42.08 99.42 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 78.1 p -61.99 -41.6 98.21 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 119.351 -0.939 . . . . 0.0 110.151 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -65.11 -45.36 85.44 Favored 'General case' 0 C--O 1.233 0.203 0 O-C-N 121.942 -0.474 . . . . 0.0 111.713 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 50.8 tp -62.36 -44.64 96.0 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 211' ' ' LEU . 85.8 mt -63.03 -40.54 98.04 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.705 -177.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.6 -44.26 96.48 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 90.5 mt -61.99 -39.81 93.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.09 0.472 . . . . 0.0 109.749 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 68.5 p -75.94 -10.96 59.85 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.308 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.63 37.39 14.0 Favored Glycine 0 C--O 1.219 -0.808 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.906 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 96.3 m -124.73 111.15 15.22 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.714 1.257 . . . . 0.0 111.309 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -62.31 138.44 58.43 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.548 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 48.0 tp -114.14 130.58 56.59 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 122.849 0.46 . . . . 0.0 109.874 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 3.3 mp -119.04 135.04 60.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.462 HG23 HD11 ' A' ' 224' ' ' ILE . 49.7 mm -115.14 132.24 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 38.5 p -133.57 166.8 21.74 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.863 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 78.09 19.61 74.49 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.684 -0.967 . . . . 0.0 110.684 178.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 97.4 mt -81.96 129.32 37.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 114.14 -1.03 . . . . 0.0 108.879 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 56.9 tttt -75.3 139.23 71.78 Favored Pre-proline 0 CA--C 1.533 0.31 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.58 -39.66 87.47 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.134 1.223 . . . . 0.0 112.526 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -62.83 -40.31 97.0 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-O 121.88 0.848 . . . . 0.0 110.262 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 49.0 tp -63.76 -42.05 97.89 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.543 176.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.31 -37.93 89.17 Favored 'General case' 0 N--CA 1.462 0.16 0 O-C-N 121.938 -0.476 . . . . 0.0 111.273 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 94.1 mtp -63.78 -41.15 98.0 Favored 'General case' 0 C--O 1.247 0.936 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.48 -38.86 92.76 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.594 177.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 32.4 mmt -65.68 -37.4 86.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.716 178.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -60.82 -41.67 96.17 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 121.558 -0.714 . . . . 0.0 109.371 -177.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.24 -41.55 97.07 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.527 0.68 . . . . 0.0 110.58 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 54.3 tp -63.02 -41.67 99.61 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 177.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 240' ' ' ALA . 67.0 t0 -166.81 128.91 1.74 Allowed 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.417 -0.802 . . . . 0.0 112.656 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.402 ' N ' ' OD1' ' A' ' 239' ' ' ASP . . . -61.19 -27.88 68.74 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.853 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.422 ' O ' ' HB2' ' A' ' 244' ' ' SER . 88.2 m-20 -60.92 -28.96 69.31 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.537 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -55.98 -43.81 77.97 Favored 'General case' 0 C--N 1.316 -0.881 0 O-C-N 121.235 -0.916 . . . . 0.0 109.048 -176.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 88.4 p -63.48 -19.27 64.6 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.039 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' SER . . . . . 0.422 ' HB2' ' O ' ' A' ' 241' ' ' ASN . 43.4 m -55.31 -38.4 68.62 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.259 178.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 96.8 mt -87.8 124.72 33.91 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 119.794 -0.762 . . . . 0.0 112.687 -176.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -49.19 134.62 17.73 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.903 -176.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 95.5 m -126.61 132.01 51.36 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.215 -1.357 . . . . 0.0 111.364 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -116.07 140.98 48.73 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.331 178.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' SER . . . . . 0.448 ' O ' ' OD1' ' A' ' 250' ' ' ASN . 78.1 p -60.59 -41.94 95.73 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.448 ' OD1' ' O ' ' A' ' 249' ' ' SER . 99.2 m-20 -145.45 159.63 42.8 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.613 0.72 . . . . 0.0 111.069 -178.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 66.0 t -61.99 -44.72 99.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 114.632 -1.167 . . . . 0.0 112.085 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.31 -43.8 98.27 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -64.13 -42.4 96.83 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.216 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . 0.424 ' O ' HG21 ' A' ' 257' ' ' VAL . . . -64.96 -41.81 95.14 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.973 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . 0.615 HG13 HH11 ' B' ' 154' ' ' ARG . 73.3 t -63.08 -45.59 98.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.009 -178.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.93 -47.72 79.38 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.562 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . 0.506 ' O ' ' C ' ' A' ' 258' ' ' LEU . 27.6 m -66.75 -41.67 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 120.138 -0.625 . . . . 0.0 112.403 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.506 ' C ' ' O ' ' A' ' 257' ' ' VAL . 1.3 mt -28.37 -72.93 0.05 OUTLIER Pre-proline 0 C--N 1.346 0.452 0 CA-C-O 119.562 -0.256 . . . . 0.0 111.248 -177.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' PRO . . . . . 0.475 ' CD ' ' CB ' ' A' ' 258' ' ' LEU . 45.4 Cg_endo -64.13 140.43 71.61 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.005 1.137 . . . . 0.0 112.073 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 259' ' ' PRO . 96.8 mt -152.74 -27.12 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 178.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 N--CA 1.473 0.68 0 CA-C-O 118.159 -0.924 . . . . 0.0 110.622 -177.017 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.493 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.83 158.94 29.25 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 118.728 -0.653 . . . . 0.0 109.933 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 80.7 p -58.88 -25.08 63.01 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 124.177 0.923 . . . . 0.0 110.908 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -68.88 -63.31 1.08 Allowed 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.521 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -67.18 -38.09 84.8 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.496 178.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.458 ' O ' ' HB3' ' B' ' 7' ' ' PHE . 66.3 m -59.69 -42.53 93.14 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 120.442 -0.503 . . . . 0.0 109.906 -177.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . 0.667 ' CE2' HD13 ' B' ' 9' ' ' ILE . 41.7 t80 83.08 88.19 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 O-C-N 123.904 0.753 . . . . 0.0 110.293 177.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . 0.472 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -62.42 -134.98 0.01 OUTLIER Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -178.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . 0.667 HD13 ' CE2' ' B' ' 7' ' ' PHE . 56.4 mt 79.25 108.54 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.656 0 C-N-CA 122.546 0.338 . . . . 0.0 111.059 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -62.45 -24.25 75.41 Favored 'Trans proline' 0 N--CA 1.498 1.793 0 C-N-CA 121.428 1.419 . . . . 0.0 111.792 -178.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.92 -40.45 98.88 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -64.18 -38.94 92.87 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.742 0.782 . . . . 0.0 109.626 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 51.1 tp -62.25 -42.55 99.43 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 114.757 -1.11 . . . . 0.0 112.114 -177.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -64.54 -33.33 75.66 Favored 'General case' 0 CA--C 1.563 1.466 0 CA-C-O 121.628 0.727 . . . . 0.0 110.759 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 74.1 t -61.9 -46.16 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 113.094 -1.867 . . . . 0.0 111.108 176.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 94.7 mt -63.76 -43.79 98.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.07 0.462 . . . . 0.0 110.255 -178.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . 0.472 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 98.9 mttt -63.42 -42.51 98.73 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.41 -41.07 98.72 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.065 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.67 -39.1 87.16 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.689 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 89.3 mt -64.07 -42.0 97.15 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.05 0.452 . . . . 0.0 110.234 175.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.95 -39.2 93.91 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.121 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 52.4 m170 -57.61 -40.14 78.47 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 121.192 -0.203 . . . . 0.0 111.365 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 10.6 p -114.28 130.27 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.531 ' O ' ' HG3' ' B' ' 24' ' ' ARG . 35.5 ptt180 -71.57 107.15 4.31 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 122.176 0.989 . . . . 0.0 112.392 -177.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.0 p -142.04 133.61 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.497 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' B' ' 123' ' ' GLN . . . -89.45 97.03 2.28 Favored Glycine 0 N--CA 1.434 -1.451 0 C-N-CA 119.441 -1.361 . . . . 0.0 113.326 -175.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 50.0 t -125.43 129.4 72.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 174.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 27.3 m -138.11 156.48 30.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.803 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 95.5 mt -119.43 127.87 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 122.579 1.18 . . . . 0.0 111.17 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.442 ' HB ' ' OD1' ' B' ' 37' ' ' ASN . 18.3 p -111.57 157.73 20.03 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 113.07 -1.877 . . . . 0.0 108.27 -176.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -125.38 104.4 28.5 Favored Pre-proline 0 C--O 1.24 0.569 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.12 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.76 -20.56 64.97 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 121.678 1.585 . . . . 0.0 111.564 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.37 -42.68 99.6 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.048 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 96.3 mt -74.97 -175.48 2.58 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 121.833 -0.542 . . . . 0.0 111.243 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . 0.7 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 42.6 tt0 -78.9 130.93 36.16 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.46 ' O ' ' OD1' ' B' ' 36' ' ' ASP . 62.4 t0 56.37 36.26 27.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.661 177.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' ASN . . . . . 0.442 ' OD1' ' HB ' ' B' ' 30' ' ' THR . 23.1 t-20 31.89 68.68 0.83 Allowed Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.7 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 91.4 Cg_endo -72.08 155.69 56.68 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 C-N-CA 123.332 2.688 . . . . 0.0 111.569 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 96.3 mt -87.35 129.5 38.67 Favored 'Isoleucine or valine' 0 C--O 1.247 0.943 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 26.8 m -109.32 -42.31 5.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 O-C-N 123.943 0.777 . . . . 0.0 112.478 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -96.99 123.91 40.83 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.4 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 5.3 p -142.6 140.37 28.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.446 177.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . 0.577 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 57.5 p30 -100.72 160.98 13.92 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.162 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' GLN . . . . . 0.46 ' HA ' ' OE1' ' B' ' 44' ' ' GLN . 12.8 mm100 -62.98 -36.95 85.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.66 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.07 -27.04 64.27 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.577 ' HB2' ' OD1' ' B' ' 43' ' ' ASN . 65.9 t80 -60.37 -43.09 96.9 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . 0.706 HG11 ' O ' ' B' ' 52' ' ' TYR . 76.9 t -61.07 -46.16 97.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.231 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -63.31 -43.73 97.0 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 119.896 -0.721 . . . . 0.0 110.317 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 59.7 ttm -63.41 -42.48 98.75 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 35.0 p -95.15 -16.55 22.49 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.609 -178.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' B' ' 47' ' ' VAL . . . 74.45 17.19 79.79 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 178.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . 0.706 ' O ' HG11 ' B' ' 47' ' ' VAL . 83.8 m-85 -109.94 145.19 37.32 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 122.953 0.501 . . . . 0.0 110.328 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -75.24 148.34 39.55 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 121.254 0.549 . . . . 0.0 111.24 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.96 -37.21 81.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.866 -176.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.5 -39.75 95.27 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.993 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -72.1 -33.3 67.76 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 176.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . 0.434 HD13 ' CD2' ' B' ' 46' ' ' PHE . 94.9 mt -68.02 -59.36 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 95.9 mt -53.14 134.69 38.61 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -175.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.4 -8.34 74.97 Favored Glycine 0 CA--C 1.538 1.498 0 CA-C-N 116.166 -0.47 . . . . 0.0 113.032 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -133.16 149.05 52.08 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -175.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' ASN . . . . . 0.565 ' C ' ' H ' ' B' ' 63' ' ' ARG . 24.8 t-20 -78.44 150.06 33.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.517 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' CYS . . . . . . . . . . . . . 82.5 m -63.42 9.23 0.06 Allowed 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . 0.565 ' H ' ' C ' ' B' ' 61' ' ' ASN . 34.8 ptt-85 -60.54 -32.93 71.96 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.42 -176.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -58.5 -30.61 67.17 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 86.6 mt -62.02 -41.26 97.89 Favored 'General case' 0 C--O 1.238 0.463 0 O-C-N 121.757 -0.59 . . . . 0.0 109.742 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . 0.668 HE22 HO4' ' B' ' 900' ' ' FMN . 88.6 mt-30 -51.71 145.31 9.53 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.851 -175.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . 0.422 ' HA3' ' CE1' ' B' ' 95' ' ' TYR . . . -157.03 -153.9 6.85 Favored Glycine 0 CA--C 1.535 1.318 0 O-C-N 124.259 0.974 . . . . 0.0 111.774 177.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.26 -41.7 89.45 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -175.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . 0.617 ' H ' ' HH ' ' B' ' 95' ' ' TYR . 8.3 m-70 -76.07 -9.84 58.94 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.139 -177.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 26.2 m -61.89 134.03 56.17 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.517 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -90.45 112.16 51.37 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.518 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.62 -37.96 90.88 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 121.185 1.257 . . . . 0.0 111.856 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.97 -40.07 92.01 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 120.42 -0.512 . . . . 0.0 109.761 -175.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' GLU . . . . . 0.436 ' OE1' ' HB ' ' B' ' 90' ' ' VAL . 78.8 mm-40 -66.76 -38.81 87.35 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.001 177.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 70.1 t -62.43 -46.06 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -62.94 -37.46 87.13 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.667 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -62.12 -41.8 98.6 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 119.315 -0.954 . . . . 0.0 108.874 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 94.1 mt -63.49 -43.7 98.48 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 CA-C-O 120.81 0.338 . . . . 0.0 110.907 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -61.38 -43.21 99.25 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 88.4 m -61.75 -45.16 95.11 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.59 0.71 . . . . 0.0 110.171 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.36 -41.83 98.92 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 86.9 mt -62.7 -42.53 99.69 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.516 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 66.8 tp60 -62.78 -34.01 76.35 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -90.78 6.86 42.52 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.414 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 30.8 tttt 42.46 37.99 1.11 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.969 176.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -121.94 141.28 33.76 Favored Pre-proline 0 N--CA 1.467 0.42 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.222 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.1 141.38 88.45 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.075 1.183 . . . . 0.0 113.754 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.5 p -139.81 136.11 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.942 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' THR . . . . . 0.57 ' CG2' ' OD1' ' B' ' 107' ' ' ASN . 96.5 m -121.05 122.6 40.43 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . 0.436 ' HB ' ' OE1' ' B' ' 74' ' ' GLU . 27.3 m -138.92 162.86 27.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.913 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -115.38 121.51 43.01 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.978 -0.451 . . . . 0.0 109.819 174.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 21.3 tt -129.83 132.69 65.66 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 O-C-N 124.191 0.932 . . . . 0.0 111.623 -174.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -69.78 143.33 53.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.97 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -133.2 177.31 7.77 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 121.718 0.77 . . . . 0.0 111.43 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' TYR . . . . . 0.617 ' HH ' ' H ' ' B' ' 69' ' ' HIS . 96.5 m-85 -127.27 146.57 50.39 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.267 -1.333 . . . . 0.0 112.293 176.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -101.11 -179.88 4.17 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.338 0.589 . . . . 0.0 110.584 177.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.87 -36.56 79.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.306 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 38.9 p-10 -87.09 -0.44 56.66 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.466 -0.771 . . . . 0.0 112.912 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.65 3.25 64.6 Favored Glycine 0 N--CA 1.467 0.714 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.528 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 25.4 m -67.16 131.01 44.94 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' MET . . . . . 0.597 ' SD ' ' N ' ' B' ' 102' ' ' PHE . 14.6 tmm? -90.83 141.86 28.38 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' PHE . . . . . 0.597 ' N ' ' SD ' ' B' ' 101' ' ' MET . 53.4 p90 -153.35 163.94 39.02 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 177.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' TRP . . . . . 0.853 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 23.3 m95 -96.16 140.8 30.33 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.825 0.821 . . . . 0.0 110.428 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . 0.455 HD22 ' HG2' ' B' ' 123' ' ' GLN . 63.2 t-20 -132.97 109.46 9.58 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 114.806 -1.088 . . . . 0.0 113.476 -177.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' B' ' 123' ' ' GLN . 81.0 tt0 -78.78 123.11 26.86 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.221 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 41.1 tp -112.27 126.56 55.37 Favored 'General case' 0 C--N 1.346 0.445 0 CA-C-O 120.873 0.368 . . . . 0.0 111.874 -177.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' ASN . . . . . 0.57 ' OD1' ' CG2' ' B' ' 89' ' ' THR . 97.8 m-20 -120.37 126.92 51.71 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 175.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 96.4 mt -121.9 133.15 69.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.53 123.3 7.61 Favored Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 178.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -69.04 151.82 73.13 Favored 'Trans proline' 0 N--CA 1.501 1.941 0 C-N-CA 122.411 2.074 . . . . 0.0 112.471 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' MET . . . . . 0.426 ' HB2' ' HB2' ' B' ' 118' ' ' TYR . 67.2 mtt -128.59 143.66 51.0 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -113.24 106.59 14.81 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 106.074 -1.825 . . . . 0.0 106.074 179.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . 0.65 HG12 ' HZ3' ' A' ' 18' ' ' LYS . 96.8 mt -133.15 127.06 54.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-N 118.474 0.579 . . . . 0.0 111.525 178.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 52.48 37.86 24.0 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.026 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 59.92 36.03 21.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.707 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -132.68 150.2 52.19 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 177.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 6.9 t -100.45 153.52 19.28 Favored 'General case' 0 C--O 1.217 -0.62 0 C-N-CA 120.555 -0.458 . . . . 0.0 109.908 -177.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' TYR . . . . . 0.426 ' HB2' ' HB2' ' B' ' 111' ' ' MET . 90.7 m-85 -148.43 146.37 28.4 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 121.071 -1.018 . . . . 0.0 111.182 -178.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -122.59 138.6 54.53 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 120.66 0.267 . . . . 0.0 111.198 -176.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.7 p -129.28 135.8 60.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -177.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -112.59 122.74 6.02 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 89.1 mt -111.71 127.31 68.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 123' ' ' GLN . . . . . 0.514 ' N ' ' O ' ' B' ' 26' ' ' GLY . 15.3 mp0 -118.61 122.96 43.83 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -119.92 123.6 43.97 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . 0.573 ' OD1' ' N ' ' B' ' 127' ' ' THR . 67.2 t0 -70.37 129.05 38.27 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.634 -178.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . 0.551 ' O ' ' HG3' ' B' ' 130' ' ' LYS . 2.7 mp -102.61 15.55 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.837 0 CA-C-O 122.052 0.93 . . . . 0.0 109.278 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 127' ' ' THR . . . . . 0.573 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 19.5 m -63.13 -44.63 95.05 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 114.225 -1.352 . . . . 0.0 113.013 175.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -61.34 -46.1 91.64 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 129' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -63.69 -35.16 79.64 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.548 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 130' ' ' LYS . . . . . 0.853 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 98.7 mttt -63.73 -40.6 97.14 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 113.865 -1.516 . . . . 0.0 110.547 174.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.41 -41.38 96.66 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 132' ' ' TYR . . . . . 0.478 ' CE2' HD13 ' B' ' 136' ' ' LEU . 90.1 t80 -60.56 -44.16 96.46 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 121.693 -0.629 . . . . 0.0 111.066 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.0 -36.73 84.94 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 120.328 -0.549 . . . . 0.0 109.548 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.2 -39.54 94.94 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.881 178.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 54.1 tp -62.59 -41.3 98.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.187 0.518 . . . . 0.0 109.741 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . 0.478 HD13 ' CE2' ' B' ' 132' ' ' TYR . 86.9 mt -62.9 -41.89 99.6 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.27 177.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 137' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.56 -36.78 84.79 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.466 -1.243 . . . . 0.0 110.432 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.05 -43.01 99.82 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.896 177.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 70.1 m -60.74 -44.38 96.75 Favored 'General case' 0 C--N 1.343 0.323 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' B' ' 144' ' ' THR . 84.2 mt -61.04 -40.25 92.88 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -177.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 91.3 m -61.85 -45.46 93.71 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.91 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -66.33 -42.12 88.63 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 93.7 mt -63.67 -43.17 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.714 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 144' ' ' THR . . . . . 0.443 ' N ' ' O ' ' B' ' 140' ' ' LEU . 90.2 m -61.75 -45.24 94.77 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.56 -40.59 97.38 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 119.074 -1.051 . . . . 0.0 109.412 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 86.1 mt -64.49 -41.51 96.41 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 147' ' ' SER . . . . . 0.641 ' O ' ' N ' ' B' ' 149' ' ' PRO . 78.1 p -60.89 -42.77 98.65 Favored 'General case' 0 CA--C 1.48 -1.726 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 148' ' ' THR . . . . . 0.494 ' C ' ' O ' ' B' ' 147' ' ' SER . 6.8 m -27.8 84.75 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.592 0 O-C-N 124.105 0.878 . . . . 0.0 110.158 177.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 149' ' ' PRO . . . . . 0.641 ' N ' ' O ' ' B' ' 147' ' ' SER . 23.0 Cg_exo -62.34 147.59 94.69 Favored 'Trans proline' 0 C--N 1.296 -2.213 0 C-N-CA 122.234 1.956 . . . . 0.0 115.641 -177.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 9.1 tp -127.74 120.17 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-N 114.004 -1.453 . . . . 0.0 107.867 174.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 63.8 t -150.71 92.95 3.82 Favored Pre-proline 0 C--N 1.314 -0.936 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.992 -178.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -60.77 137.16 71.06 Favored 'Trans proline' 0 N--CA 1.484 0.952 0 N-CA-C 109.175 -1.125 . . . . 0.0 109.175 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 153' ' ' ILE . . . . . 0.581 HG21 HH12 ' A' ' 154' ' ' ARG . 45.2 mm -67.66 -43.9 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.17 178.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . 0.615 HH11 HG13 ' A' ' 255' ' ' VAL . 0.3 OUTLIER -158.82 -154.01 0.4 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -179.618 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 62.3 t-20 -86.89 108.49 18.8 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.69 -16.38 58.75 Favored Glycine 0 C--O 1.221 -0.713 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 89.0 mt -110.13 125.59 67.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.326 0.584 . . . . 0.0 111.37 -176.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 158' ' ' SER . . . . . 0.636 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 68.3 m -134.7 148.91 50.41 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.096 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -134.45 145.45 48.86 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.226 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 30.3 tp -138.45 79.25 30.56 Favored Pre-proline 0 C--O 1.234 0.283 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 161' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -70.54 146.99 56.87 Favored 'Trans proline' 0 N--CA 1.5 1.869 0 C-N-CA 122.831 2.354 . . . . 0.0 114.4 -178.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 87.0 mt -112.51 132.97 54.82 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 54.2 t -128.55 132.79 67.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 113.23 169.1 17.17 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 120.35 -0.929 . . . . 0.0 111.266 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 165' ' ' ASN . . . . . 0.688 ' O ' ' CZ ' ' B' ' 170' ' ' ARG . 61.9 t30 -89.62 107.02 18.85 Favored 'General case' 0 C--O 1.215 -0.752 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -177.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . 0.452 HD13 HD11 ' B' ' 174' ' ' ILE . 46.7 tp -65.86 104.49 1.1 Allowed 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 -174.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 167' ' ' THR . . . . . 0.46 ' H ' ' HE ' ' B' ' 170' ' ' ARG . 9.8 p -85.37 169.97 13.18 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 114.271 -1.331 . . . . 0.0 110.901 177.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.84 -37.39 84.38 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.718 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.34 -41.24 89.85 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-O 123.44 1.591 . . . . 0.0 111.508 -178.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 170' ' ' ARG . . . . . 0.688 ' CZ ' ' O ' ' B' ' 165' ' ' ASN . 88.3 mtm180 -62.58 -35.28 79.01 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 112.276 -2.238 . . . . 0.0 110.653 177.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 171' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -54.9 -26.25 34.59 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -178.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 172' ' ' ASN . . . . . 0.472 ' O ' HG21 ' B' ' 175' ' ' VAL . 92.7 m-20 -62.88 -40.3 97.12 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.784 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 48.8 m -60.17 -41.77 93.57 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.051 0.453 . . . . 0.0 110.63 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 174' ' ' ILE . . . . . 0.452 HD11 HD13 ' B' ' 166' ' ' LEU . 64.8 mt -63.43 -44.29 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 175' ' ' VAL . . . . . 0.472 HG21 ' O ' ' B' ' 172' ' ' ASN . 27.3 m -62.44 -39.81 85.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 176' ' ' CYS . . . . . 0.424 ' N ' HG23 ' B' ' 175' ' ' VAL . 96.7 m -62.69 -35.58 80.14 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.344 178.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 177' ' ' THR . . . . . 0.512 ' O ' HG13 ' B' ' 181' ' ' ILE . 25.1 m -61.69 -19.42 62.34 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.499 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 178' ' ' LEU . . . . . . . . . . . . . 88.2 mt -61.23 -39.36 90.01 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -178.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 19.2 m -61.77 -44.03 97.69 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 120.74 0.305 . . . . 0.0 110.262 177.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 180' ' ' ASN . . . . . 0.588 ' O ' ' OG ' ' B' ' 183' ' ' SER . 92.6 m-20 -61.27 -40.22 93.29 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.853 0.358 . . . . 0.0 110.494 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . 0.512 HG13 ' O ' ' B' ' 177' ' ' THR . 72.7 mt -57.47 -32.0 40.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 O-C-N 122.284 -0.26 . . . . 0.0 110.753 -178.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 182' ' ' LEU . . . . . . . . . . . . . 83.9 mt -62.38 -41.99 99.07 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.096 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 183' ' ' SER . . . . . 0.588 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.4 p -63.28 -32.84 74.35 Favored 'General case' 0 C--N 1.334 -0.106 0 O-C-N 121.835 -0.54 . . . . 0.0 110.865 178.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 56.8 p -85.87 17.34 3.49 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.787 -177.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 78.8 p -61.5 -16.39 46.92 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.523 -176.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.17 -40.17 95.1 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 121.076 -0.25 . . . . 0.0 110.764 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 187' ' ' ASP . . . . . 0.636 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.6 m-20 -70.43 114.95 9.05 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.44 0.638 . . . . 0.0 110.635 -177.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -62.63 -42.6 99.68 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 114.922 -1.035 . . . . 0.0 113.112 -177.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -113.55 131.38 56.11 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.149 -177.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 190' ' ' LEU . . . . . . . . . . . . . 40.7 tp -123.29 119.37 29.93 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.089 177.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 84.5 mt -107.43 125.08 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 117.851 0.296 . . . . 0.0 110.89 -176.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 50.1 mm -113.7 118.83 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 193' ' ' ASP . . . . . 0.466 ' CG ' ' HG ' ' B' ' 195' ' ' SER . 41.5 t0 -90.29 112.17 23.62 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -176.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 194' ' ' LEU . . . . . . . . . . . . . 96.6 mt -94.71 -1.89 52.18 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 123.705 0.628 . . . . 0.0 109.782 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 195' ' ' SER . . . . . 0.466 ' HG ' ' CG ' ' B' ' 193' ' ' ASP . 77.9 p -60.83 -39.0 87.4 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.905 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.18 -35.19 90.47 Favored Glycine 0 N--CA 1.438 -1.205 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -178.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 197' ' ' LEU . . . . . 1.125 HD23 ' O ' ' B' ' 199' ' ' GLN . 5.3 tt -74.27 133.8 42.63 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 198' ' ' ALA . . . . . 0.655 ' N ' HD21 ' B' ' 197' ' ' LEU . . . -61.75 -47.38 85.44 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.322 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 199' ' ' GLN . . . . . 1.125 ' O ' HD23 ' B' ' 197' ' ' LEU . 59.2 tt0 -136.76 164.7 27.66 Favored 'General case' 0 C--O 1.209 -1.077 0 CA-C-O 122.083 0.944 . . . . 0.0 112.389 -177.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 200' ' ' VAL . . . . . 0.486 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 51.8 t -120.53 131.85 71.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 O-C-N 120.579 -1.326 . . . . 0.0 109.532 177.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -86.81 150.08 24.38 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.855 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.27 -33.17 74.1 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.253 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -63.7 -32.3 73.74 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.382 0.61 . . . . 0.0 109.481 177.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.2 m -60.81 -43.82 97.67 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.206 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 205' ' ' ALA . . . . . 0.633 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -58.26 -29.6 65.92 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -178.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -65.94 -38.35 88.39 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.431 0.634 . . . . 0.0 110.646 174.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -66.13 -38.46 88.21 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.477 178.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 95.0 mt -62.97 -45.51 98.69 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -178.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 209' ' ' PHE . . . . . 0.633 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 67.6 m-85 -61.47 -42.58 99.0 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.916 -176.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.82 -42.04 99.56 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 119.581 -0.847 . . . . 0.0 109.94 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . 0.453 ' O ' ' HG ' ' B' ' 215' ' ' LEU . 38.3 mt -62.49 -42.52 99.55 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.173 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 78.1 p -63.46 -37.29 86.72 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.291 -0.564 . . . . 0.0 112.105 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 213' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -66.18 -46.64 76.63 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.214 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 53.3 tp -63.92 -42.57 97.35 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.895 0.855 . . . . 0.0 109.863 177.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 215' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' B' ' 211' ' ' LEU . 86.2 mt -62.53 -43.4 98.91 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 113.274 -1.785 . . . . 0.0 111.288 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.19 -39.77 93.83 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.749 0.309 . . . . 0.0 111.438 -177.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 92.4 mt -63.24 -41.97 99.14 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.443 0.64 . . . . 0.0 111.196 176.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 218' ' ' THR . . . . . . . . . . . . . 68.3 p -74.75 -14.83 60.76 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.642 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 78.14 65.46 1.87 Allowed Glycine 0 CA--C 1.528 0.885 0 N-CA-C 107.485 -2.246 . . . . 0.0 107.485 -177.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 220' ' ' THR . . . . . . . . . . . . . 95.3 m -144.08 105.31 4.24 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 175.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -62.15 140.96 58.4 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.922 -176.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 45.3 tp -117.18 121.83 42.32 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.645 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 3.5 mp -112.35 129.77 67.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.04 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 224' ' ' ILE . . . . . . . . . . . . . 50.1 mm -110.74 127.13 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 44.0 p -134.24 156.46 48.36 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 121.957 0.884 . . . . 0.0 112.495 -178.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 90.5 16.85 54.44 Favored Glycine 0 C--N 1.316 -0.564 0 CA-C-N 113.951 -1.477 . . . . 0.0 111.303 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 95.5 mt -82.81 127.21 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 118.027 0.914 . . . . 0.0 111.284 -178.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 56.1 tttt -66.58 138.17 95.47 Favored Pre-proline 0 C--N 1.316 -0.868 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.525 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.9 -37.4 93.09 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 121.443 1.429 . . . . 0.0 112.616 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -62.66 -44.12 97.07 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 48.3 tp -61.68 -41.64 97.84 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.267 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.06 -37.41 87.1 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.931 -0.307 . . . . 0.0 111.414 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 94.6 mtp -64.16 -40.06 95.34 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-O 121.248 0.547 . . . . 0.0 109.629 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.43 -42.74 98.69 Favored 'General case' 0 CA--C 1.554 1.114 0 CA-C-O 122.443 1.116 . . . . 0.0 109.539 178.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 33.0 mmt -63.81 -35.86 82.0 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.507 -1.224 . . . . 0.0 111.89 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -62.06 -40.33 95.44 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.006 -178.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.01 -43.66 98.14 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 120.512 -0.475 . . . . 0.0 109.825 177.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 55.1 tp -62.57 -44.57 96.0 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.625 -178.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 239' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' B' ' 240' ' ' ALA . 66.8 t0 -159.27 132.5 7.11 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.35 -0.54 . . . . 0.0 112.106 -178.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 240' ' ' ALA . . . . . 0.41 ' N ' ' OD1' ' B' ' 239' ' ' ASP . . . -61.07 -46.55 90.22 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 177.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 241' ' ' ASN . . . . . 0.491 ' O ' ' HB2' ' B' ' 244' ' ' SER . 92.1 m-20 -44.06 -20.14 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.689 -175.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 242' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -60.63 -44.99 95.71 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.141 -0.624 . . . . 0.0 110.298 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 243' ' ' SER . . . . . . . . . . . . . 78.1 p -57.93 -42.87 85.78 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 178.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 244' ' ' SER . . . . . 0.491 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 20.0 m -34.61 -35.0 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -177.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 97.3 mt -88.36 132.51 34.4 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.702 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -58.28 135.41 57.13 Favored 'General case' 0 C--O 1.25 1.121 0 CA-C-O 121.906 0.86 . . . . 0.0 111.523 -178.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 247' ' ' THR . . . . . . . . . . . . . 98.1 m -127.13 128.09 45.63 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 114.525 -1.216 . . . . 0.0 112.004 178.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -112.46 143.78 43.02 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 249' ' ' SER . . . . . 0.565 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 78.2 p -62.57 -34.99 78.08 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.18 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 250' ' ' ASN . . . . . 0.565 ' OD1' ' O ' ' B' ' 249' ' ' SER . 99.0 m-20 -147.16 161.28 41.22 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 114.966 -1.015 . . . . 0.0 112.574 178.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 69.2 t -64.76 -44.93 96.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.788 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 252' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.04 -45.95 92.7 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -61.23 -43.24 99.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.57 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 254' ' ' ALA . . . . . . . . . . . . . . . -65.73 -39.49 91.21 Favored 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.062 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 255' ' ' VAL . . . . . 0.54 HG13 HH11 ' A' ' 154' ' ' ARG . 76.2 t -65.22 -45.76 92.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.875 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.548 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.0 -48.4 78.98 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 121.588 0.709 . . . . 0.0 111.263 -177.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 257' ' ' VAL . . . . . 0.477 ' O ' ' C ' ' B' ' 258' ' ' LEU . 27.1 m -65.09 -40.83 90.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.959 -1.018 . . . . 0.0 111.464 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 258' ' ' LEU . . . . . 0.482 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 1.3 mt -31.79 -72.3 0.07 OUTLIER Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.794 -178.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 259' ' ' PRO . . . . . 0.482 ' CD ' ' CB ' ' B' ' 258' ' ' LEU . 39.8 Cg_endo -63.11 140.94 81.04 Favored 'Trans proline' 0 N--CA 1.504 2.103 0 C-N-CA 121.59 1.527 . . . . 0.0 111.351 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 260' ' ' ILE . . . . . 0.468 HG13 ' O ' ' B' ' 259' ' ' PRO . 96.7 mt -158.33 -15.4 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-N 118.591 0.632 . . . . 0.0 112.573 177.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 78.0 mtm . . . . . 0 N--CA 1.466 0.339 0 CA-C-O 118.207 -0.901 . . . . 0.0 111.825 179.675 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 900' ' ' FMN . . . . . 0.682 HO4' HE22 ' A' ' 66' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 900' ' ' FMN . . . . . 0.668 HO4' HE22 ' B' ' 66' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.47 ' O ' ' OG ' ' A' ' 6' ' ' SER . . . -145.15 -175.16 4.59 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 88.5 p -85.11 -7.04 59.26 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.484 -0.76 . . . . 0.0 111.412 177.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -81.57 -63.45 1.39 Allowed 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 114.109 -1.405 . . . . 0.0 113.157 172.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -67.5 -38.79 84.84 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.557 ' O ' ' NZ ' ' B' ' 17' ' ' LYS . 66.9 m -59.44 -42.08 91.12 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.181 -177.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.493 ' CB ' ' O ' ' A' ' 6' ' ' SER . 46.9 t80 85.48 85.96 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 O-C-N 123.766 0.666 . . . . 0.0 111.03 177.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.618 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -58.78 -150.13 0.01 OUTLIER Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.618 ' HB ' ' O ' ' A' ' 8' ' ' GLY . 89.3 mt 91.4 111.85 0.02 OUTLIER Pre-proline 0 N--CA 1.471 0.598 0 C-N-CA 122.734 0.414 . . . . 0.0 110.775 -179.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.66 -22.03 64.77 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 121.431 1.421 . . . . 0.0 112.153 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.05 -38.68 96.36 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 120.953 -0.641 . . . . 0.0 111.917 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -65.09 -39.21 92.85 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.549 0.69 . . . . 0.0 109.968 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.6 tp -63.08 -41.5 99.42 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -63.21 -40.36 97.26 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.6 t -60.48 -44.18 95.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 O-C-N 122.242 -0.286 . . . . 0.0 110.953 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 92.9 mt -62.63 -43.74 98.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.646 -177.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.7 -45.89 90.68 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 119.411 -0.916 . . . . 0.0 112.09 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.788 ' HZ3' HG12 ' B' ' 113' ' ' ILE . 98.5 mttt -60.28 -39.26 86.22 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 118.578 -1.249 . . . . 0.0 109.074 -176.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.5 -40.93 93.14 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.242 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.8 mt -62.97 -40.71 98.55 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -63.26 -38.19 90.18 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.327 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 62.0 m170 -58.82 -39.38 81.02 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 122.2 -0.313 . . . . 0.0 111.271 -178.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.37 130.65 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.489 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 35.8 ptt180 -73.65 110.71 8.15 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 122.093 0.949 . . . . 0.0 111.961 -177.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.0 p -141.54 143.67 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.576 ' HA3' ' HB2' ' A' ' 123' ' ' GLN . . . -97.28 91.97 1.27 Allowed Glycine 0 C--N 1.313 -0.695 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.814 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 50.8 t -124.44 129.51 73.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.6 m -137.1 159.92 36.28 Favored 'Isoleucine or valine' 0 C--O 1.244 0.796 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.9 mt -119.88 131.29 72.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.667 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.7 p -108.11 165.88 11.15 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.555 ' C ' ' OD1' ' A' ' 37' ' ' ASN . 50.9 t0 -132.09 101.41 15.07 Favored Pre-proline 0 C--N 1.323 -0.544 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.194 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.401 ' CG ' HG22 ' A' ' 117' ' ' THR . 35.5 Cg_endo -63.53 -22.31 70.78 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.659 1.573 . . . . 0.0 111.746 -178.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.03 -36.01 82.14 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.231 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.5 mt -83.33 159.17 21.93 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.954 176.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.764 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 42.4 tt0 -58.53 135.67 57.37 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -177.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.535 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 59.8 t0 61.1 18.89 9.45 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 178.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.555 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 31.0 t-20 42.79 67.42 3.56 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.748 -176.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.764 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 92.2 Cg_endo -71.13 156.3 59.81 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 123.985 3.123 . . . . 0.0 112.336 -178.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.2 mt -87.16 125.45 40.98 Favored 'Isoleucine or valine' 0 C--O 1.245 0.833 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.6 m -104.52 -44.26 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 O-C-N 123.659 0.6 . . . . 0.0 112.335 -179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -96.35 124.68 40.44 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.838 -178.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.2 p -142.36 139.57 29.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 O-C-N 124.162 0.914 . . . . 0.0 109.333 176.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.57 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 56.6 p30 -97.04 167.56 10.99 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.45 ' HA ' ' OE1' ' A' ' 44' ' ' GLN . 14.1 mm100 -66.55 -39.08 88.37 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 176.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.69 -27.16 63.54 Favored Glycine 0 N--CA 1.452 -0.241 0 N-CA-C 110.331 -1.107 . . . . 0.0 110.331 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.57 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 58.1 t80 -59.08 -48.28 82.16 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.45 ' O ' ' N ' ' A' ' 51' ' ' GLY . 78.7 t -59.89 -44.62 94.71 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 O-C-N 121.092 -1.005 . . . . 0.0 111.708 -173.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -63.15 -38.24 90.38 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 120.496 -0.482 . . . . 0.0 112.035 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.451 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 60.2 ttm -66.85 -43.21 84.22 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 175.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 36.8 p -93.58 -21.32 19.49 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.993 0.425 . . . . 0.0 111.523 -177.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . 77.05 20.39 75.84 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -114.33 136.77 52.61 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.022 0.439 . . . . 0.0 111.137 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -63.57 147.63 50.94 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.703 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.22 -31.14 72.22 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -67.28 -42.24 84.16 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 119.615 -0.834 . . . . 0.0 111.499 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -66.55 -44.68 81.71 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.423 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.4 HG22 HD13 ' A' ' 57' ' ' ILE . 96.2 mt -62.03 -45.34 98.95 Favored 'Isoleucine or valine' 0 C--N 1.354 0.767 0 CA-C-O 118.046 -0.978 . . . . 0.0 111.348 -175.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.0 mt -64.37 141.22 58.85 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 -177.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.35 -0.06 86.93 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.615 178.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -137.16 152.45 49.95 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.502 1.651 . . . . 0.0 111.44 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.543 ' C ' ' H ' ' A' ' 63' ' ' ARG . 25.1 t-20 -81.88 152.25 26.93 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.245 0.545 . . . . 0.0 110.648 -178.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 83.4 m -64.16 15.36 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.34 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.543 ' H ' ' C ' ' A' ' 61' ' ' ASN . 35.8 ptt-85 -61.59 -42.19 98.5 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.255 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -55.21 -22.31 17.29 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 88.2 mt -66.39 -36.62 83.31 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 177.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.532 HE22 HO4' ' A' ' 900' ' ' FMN . 87.7 mt-30 -64.79 144.04 57.52 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.446 -178.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.628 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -152.66 -147.98 4.74 Favored Glycine 0 CA--C 1.541 1.71 0 N-CA-C 111.649 -0.581 . . . . 0.0 111.649 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.16 -39.98 96.23 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -177.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.547 ' H ' ' HH ' ' A' ' 95' ' ' TYR . 8.8 m-70 -77.69 -6.97 55.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.672 0.272 . . . . 0.0 111.001 -178.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.628 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 27.9 m -64.0 128.8 37.41 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.126 -0.63 . . . . 0.0 109.729 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -85.5 109.87 25.11 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.242 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 70' ' ' THR . 52.9 Cg_exo -57.09 -31.7 91.07 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 121.91 1.74 . . . . 0.0 113.063 178.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.08 -40.16 95.64 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.172 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.49 ' OE1' ' HB ' ' A' ' 90' ' ' VAL . 79.3 mm-40 -65.91 -44.0 86.49 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 67.4 t -59.92 -44.02 93.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 114.448 -1.251 . . . . 0.0 107.799 -175.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -63.99 -37.77 88.62 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.89 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -63.35 -39.53 94.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.339 0.59 . . . . 0.0 110.228 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.89 -44.04 97.94 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 CA-C-N 114.946 -1.025 . . . . 0.0 112.0 178.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -62.96 -43.35 99.03 Favored 'General case' 0 C--O 1.251 1.141 0 CA-C-N 113.68 -1.6 . . . . 0.0 108.482 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 99.8 m -61.35 -50.08 74.35 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 119.729 -0.788 . . . . 0.0 108.962 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.89 -42.35 89.33 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 119.487 -0.292 . . . . 0.0 111.187 -173.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.421 HD23 ' CE1' ' A' ' 119' ' ' PHE . 89.2 mt -63.12 -39.79 95.7 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 119.09 0.859 . . . . 0.0 111.885 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -63.24 -35.32 79.94 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 177.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -89.34 -2.91 58.61 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.694 -177.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.406 ' NZ ' ' OE2' ' A' ' 112' ' ' GLU . 38.0 tttt 51.45 43.97 29.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.827 178.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -126.8 146.62 57.91 Favored Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' A' ' 108' ' ' ILE . 24.2 Cg_exo -61.83 143.49 95.91 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.345 1.363 . . . . 0.0 112.822 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.7 142.3 30.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.862 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.518 ' CG2' ' OD1' ' A' ' 107' ' ' ASN . 96.6 m -126.41 122.22 34.7 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 175.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.49 ' HB ' ' OE1' ' A' ' 74' ' ' GLU . 29.3 m -139.05 159.47 29.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 121.106 -0.238 . . . . 0.0 111.308 178.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -103.61 133.99 47.7 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 105.021 -2.215 . . . . 0.0 105.021 176.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.48 ' O ' HG21 ' A' ' 92' ' ' ILE . 19.2 tt -142.4 125.23 14.14 Favored 'Isoleucine or valine' 0 C--N 1.374 1.635 0 CA-C-N 121.622 2.01 . . . . 0.0 112.341 176.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.407 HE22 ' HD1' ' A' ' 69' ' ' HIS . 85.9 mt-30 -58.87 136.55 57.86 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.377 179.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -136.07 159.96 40.09 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.161 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.547 ' HH ' ' H ' ' A' ' 69' ' ' HIS . 93.8 m-85 -117.12 134.67 54.49 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -178.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.451 ' HE2' ' O ' ' A' ' 49' ' ' MET . 98.9 mttt -83.79 -174.3 5.2 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.086 0.469 . . . . 0.0 111.908 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.35 -43.13 99.54 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.102 178.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 40.9 p-10 -83.53 6.42 20.53 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -178.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.7 -1.38 87.04 Favored Glycine 0 N--CA 1.473 1.163 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.352 176.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.0 m -59.73 137.96 57.9 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.691 ' C ' ' SD ' ' A' ' 101' ' ' MET . 13.4 tmm? -105.47 129.03 53.85 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 120.959 0.409 . . . . 0.0 110.508 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.487 ' N ' ' SD ' ' A' ' 101' ' ' MET . 50.7 p90 -142.16 156.22 45.34 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.175 -176.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.724 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 20.8 m95 -88.24 142.2 27.94 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.415 HD22 ' HG2' ' A' ' 123' ' ' GLN . 54.3 t-20 -136.97 102.35 4.83 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -177.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -67.75 136.77 54.75 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 -177.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 41.1 tp -121.5 122.57 40.03 Favored 'General case' 0 C--O 1.233 0.185 0 O-C-N 123.665 0.603 . . . . 0.0 112.593 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.518 ' OD1' ' CG2' ' A' ' 89' ' ' THR . 98.2 m-20 -118.85 123.32 44.42 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 116.724 -0.216 . . . . 0.0 110.64 177.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.404 ' O ' ' HA ' ' A' ' 87' ' ' PRO . 96.2 mt -120.03 128.77 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 O-C-N 123.468 0.48 . . . . 0.0 111.268 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -136.77 124.58 14.58 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 116.871 -0.15 . . . . 0.0 110.88 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -70.88 151.19 62.46 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.342 2.028 . . . . 0.0 112.499 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.516 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 67.2 mtt -124.03 153.13 41.78 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 179.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.406 ' OE2' ' NZ ' ' A' ' 85' ' ' LYS . 80.0 mm-40 -129.09 95.59 4.1 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 176.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 96.5 mt -121.02 131.4 73.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.621 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 50.43 37.98 17.02 Favored 'General case' 0 CA--C 1.515 -0.398 0 O-C-N 121.567 -0.708 . . . . 0.0 111.441 176.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 58.7 30.51 20.05 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.707 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -126.81 147.9 49.99 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.814 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 5.2 t -84.85 -171.26 3.54 Favored 'General case' 0 C--O 1.214 -0.793 0 CA-C-O 118.618 -0.706 . . . . 0.0 109.323 -178.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.814 ' CD2' ' O ' ' A' ' 117' ' ' THR . 76.3 m-85 -174.96 154.95 1.93 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 175.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.421 ' CE1' HD23 ' A' ' 82' ' ' LEU . 95.3 m-85 -130.71 146.2 52.12 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 174.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.7 134.86 56.14 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.461 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -106.81 127.85 9.03 Favored Glycine 0 CA--C 1.502 -0.774 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 96.6 mt -116.58 128.16 74.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 177.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.576 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . 17.3 mp0 -118.72 112.87 20.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.072 0.463 . . . . 0.0 109.875 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -115.07 112.16 22.17 Favored 'General case' 0 C--O 1.248 0.974 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.881 -178.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 126' ' ' ILE . 68.4 t0 -62.55 131.28 48.57 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -176.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.46 ' N ' ' OD1' ' A' ' 125' ' ' ASP . 3.3 mp -96.64 4.32 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 113.743 -1.571 . . . . 0.0 109.884 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 25.6 m -60.37 -42.34 95.6 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 121.081 -1.012 . . . . 0.0 113.388 -178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -59.63 -42.8 93.54 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -62.8 -39.73 95.16 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.702 177.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.724 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.8 mttt -62.34 -41.21 98.4 Favored 'General case' 0 CA--C 1.503 -0.834 0 C-N-CA 118.286 -1.366 . . . . 0.0 110.64 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -62.17 -37.59 85.81 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.492 ' CE2' HD13 ' A' ' 136' ' ' LEU . 87.5 t80 -61.48 -45.44 94.21 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.672 176.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.81 -38.61 91.56 Favored 'General case' 0 CA--C 1.522 -0.116 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.06 -40.83 97.1 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.068 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 54.8 tp -60.8 -43.84 97.62 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -177.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.492 HD13 ' CE2' ' A' ' 132' ' ' TYR . 85.2 mt -62.21 -41.34 98.29 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.382 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.09 -42.55 99.33 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 119.529 -0.868 . . . . 0.0 109.799 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -60.68 -42.12 96.46 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -177.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 58.3 m -61.57 -41.12 96.95 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.642 176.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 144' ' ' THR . 83.6 mt -63.5 -42.07 98.53 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 120.63 -0.428 . . . . 0.0 109.934 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 91.5 m -61.62 -45.4 94.23 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.152 -177.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -65.08 -40.21 94.31 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 95.2 mt -64.72 -43.39 96.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.115 -1.402 . . . . 0.0 111.313 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.51 ' N ' ' O ' ' A' ' 140' ' ' LEU . 99.4 m -62.65 -46.16 89.47 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 121.811 -0.556 . . . . 0.0 112.121 -177.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.455 ' O ' ' OG1' ' A' ' 148' ' ' THR . . . -63.31 -39.42 94.51 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 118.803 -1.159 . . . . 0.0 109.051 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 81.7 mt -63.38 -42.65 98.83 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.355 178.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.711 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.2 p -59.96 -39.65 86.34 Favored 'General case' 0 C--O 1.217 -0.644 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -178.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.49 ' C ' ' O ' ' A' ' 147' ' ' SER . 21.6 m -27.1 81.72 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.418 0 O-C-N 126.971 2.669 . . . . 0.0 106.133 -178.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.711 ' N ' ' O ' ' A' ' 147' ' ' SER . 21.1 Cg_exo -62.44 146.15 95.61 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 C-N-CA 121.427 1.418 . . . . 0.0 114.538 -175.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.574 ' O ' ' CG2' ' A' ' 151' ' ' VAL . 9.6 tp -124.52 136.58 60.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 102.843 -3.021 . . . . 0.0 102.843 178.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.574 ' CG2' ' O ' ' A' ' 150' ' ' ILE . 60.1 t -169.05 96.48 0.52 Allowed Pre-proline 0 N--CA 1.437 -1.083 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 178.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -64.8 133.28 35.68 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 109.785 -0.89 . . . . 0.0 109.785 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.564 ' O ' ' HD2' ' A' ' 154' ' ' ARG . 45.9 mm -69.19 -45.13 80.09 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.909 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.395 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.564 ' HD2' ' O ' ' A' ' 153' ' ' ILE . 1.1 tpt180 -156.15 -159.32 0.88 Allowed 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.41 ' ND2' ' HE3' ' B' ' 256' ' ' LYS . 58.9 t-20 -86.16 106.18 17.09 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.697 0.76 . . . . 0.0 111.289 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 88.8 10.06 67.52 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 113.98 -1.463 . . . . 0.0 110.501 -177.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.6 mt -128.11 122.82 59.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 175.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.615 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 58.0 m -131.92 151.75 51.51 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.199 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -134.06 140.11 46.43 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.206 -0.597 . . . . 0.0 111.404 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 29.7 tp -131.18 76.49 76.27 Favored Pre-proline 0 N--CA 1.468 0.469 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.206 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -68.89 149.11 72.02 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 122.791 2.327 . . . . 0.0 113.085 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 90.0 mt -117.38 128.63 55.22 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.179 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 45.8 t -123.48 131.56 72.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 115.58 167.55 15.18 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 120.89 -0.671 . . . . 0.0 111.92 178.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.888 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 60.0 t30 -84.19 115.64 22.53 Favored 'General case' 0 C--O 1.207 -1.151 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -178.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.478 ' CD2' ' CZ ' ' A' ' 171' ' ' PHE . 43.5 tp -75.76 105.57 6.87 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 -177.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.566 ' H ' ' HE ' ' A' ' 170' ' ' ARG . 11.4 p -88.53 167.61 13.28 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.909 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.51 -34.19 77.68 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.983 0.42 . . . . 0.0 111.945 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.76 -42.11 91.3 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.805 0.812 . . . . 0.0 110.986 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.888 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 88.2 mtm180 -64.75 -34.26 77.91 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.791 177.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.478 ' CZ ' ' CD2' ' A' ' 166' ' ' LEU . 0.4 OUTLIER -55.07 -28.3 51.29 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 119.025 -0.512 . . . . 0.0 111.727 -177.084 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.755 ' O ' HG21 ' A' ' 175' ' ' VAL . 91.0 m-20 -60.35 -40.6 91.31 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 118.718 -1.193 . . . . 0.0 110.02 -177.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 50.3 m -59.25 -40.78 87.03 Favored 'General case' 0 C--N 1.315 -0.923 0 O-C-N 121.569 -0.707 . . . . 0.0 110.538 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.402 HG23 HD12 ' A' ' 174' ' ' ILE . 66.8 mt -62.9 -43.96 99.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.755 HG21 ' O ' ' A' ' 172' ' ' ASN . 23.0 m -62.32 -39.91 85.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -178.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 98.3 m -62.38 -34.61 77.04 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.274 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' THR . . . . . 0.564 ' O ' HG13 ' A' ' 181' ' ' ILE . 25.1 m -61.86 -19.71 62.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.905 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 91.3 mt -60.99 -41.18 95.98 Favored 'General case' 0 C--O 1.248 0.99 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -177.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 19.1 m -59.75 -43.58 94.21 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.594 ' O ' ' OG ' ' A' ' 183' ' ' SER . 92.0 m-20 -61.47 -35.4 77.52 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.775 0.43 . . . . 0.0 110.683 178.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . 0.564 HG13 ' O ' ' A' ' 177' ' ' THR . 67.5 mt -60.32 -41.46 87.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 84.9 mt -60.3 -40.4 90.38 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 119.342 -0.943 . . . . 0.0 108.981 -176.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.594 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 78.1 p -61.45 -33.7 74.19 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.607 176.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 58.8 p -89.39 23.71 2.46 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.79 0.329 . . . . 0.0 111.446 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 78.1 p -64.48 -20.04 65.94 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.973 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -60.56 -37.43 81.23 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.921 -178.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.615 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 98.8 m-20 -73.57 114.98 12.43 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.383 0.611 . . . . 0.0 110.582 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -62.91 -42.62 99.85 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.123 -0.944 . . . . 0.0 113.027 -177.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -111.61 132.06 54.83 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.783 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 40.0 tp -120.62 128.36 52.95 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 95.7 mt -116.94 127.32 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 118.35 0.523 . . . . 0.0 109.599 177.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.9 mm -112.84 127.05 70.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . 0.517 ' OD2' ' OG ' ' A' ' 195' ' ' SER . 40.0 t0 -94.23 118.02 30.96 Favored 'General case' 0 CA--C 1.552 1.053 0 O-C-N 121.796 -0.565 . . . . 0.0 110.824 177.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 96.0 mt -96.51 -5.07 40.28 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.825 175.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.517 ' OG ' ' OD2' ' A' ' 193' ' ' ASP . 78.1 p -62.87 -33.81 76.06 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -62.28 -42.0 99.72 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 118.808 -1.663 . . . . 0.0 109.025 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 1.04 HD23 ' O ' ' A' ' 199' ' ' GLN . 4.7 tt -72.09 127.89 33.97 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 112.2 -2.0 . . . . 0.0 108.159 -177.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.731 ' N ' HD21 ' A' ' 197' ' ' LEU . . . -60.8 -47.21 87.38 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.956 0.408 . . . . 0.0 111.062 -178.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 1.04 ' O ' HD23 ' A' ' 197' ' ' LEU . 58.5 tt0 -133.63 155.93 48.79 Favored 'General case' 0 C--O 1.2 -1.547 0 CA-C-N 114.609 -1.178 . . . . 0.0 114.052 -174.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.41 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 46.9 t -117.97 132.51 67.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 O-C-N 120.17 -1.582 . . . . 0.0 108.707 178.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -90.44 155.46 18.91 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.642 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -64.44 -39.34 93.63 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 120.254 -0.578 . . . . 0.0 109.915 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -57.81 -32.66 67.79 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-O 122.099 0.952 . . . . 0.0 108.944 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.9 m -61.14 -42.57 98.78 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.222 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.512 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -57.96 -39.42 78.1 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -177.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -62.26 -36.71 82.87 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -65.48 -39.11 91.56 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.113 177.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 93.5 mt -63.16 -44.2 99.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . 0.512 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 68.9 m-85 -61.82 -43.83 98.07 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.648 -178.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.64 -42.62 99.7 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 119.295 -0.962 . . . . 0.0 109.221 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.433 ' O ' ' HG ' ' A' ' 215' ' ' LEU . 37.7 mt -62.21 -41.87 98.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.644 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' SER . . . . . 0.505 ' HG ' ' N ' ' A' ' 213' ' ' HIS . 78.4 p -61.44 -41.46 97.23 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.266 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' HIS . . . . . 0.505 ' N ' ' HG ' ' A' ' 212' ' ' SER . 57.8 t-80 -64.97 -45.52 85.34 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 122.018 -0.427 . . . . 0.0 111.528 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 48.0 tp -62.12 -46.52 88.65 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 118.893 -1.123 . . . . 0.0 108.003 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 211' ' ' LEU . 90.2 mt -61.98 -40.43 95.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.588 -177.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.34 -43.47 96.4 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.442 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 84.6 mt -61.95 -39.96 93.91 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 69.2 p -76.43 -11.35 59.87 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.365 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 83.17 35.31 18.37 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-O 119.133 -0.815 . . . . 0.0 112.844 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 96.2 m -123.44 110.97 15.78 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 118.863 1.331 . . . . 0.0 111.713 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -61.63 138.46 58.31 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.81 178.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 50.0 tp -113.61 131.05 56.26 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 177.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 2.7 mp -118.37 135.14 59.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 50.1 mm -116.48 131.63 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -178.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 34.5 p -133.71 167.53 20.35 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 78.63 21.42 69.16 Favored Glycine 0 C--N 1.334 0.469 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 97.6 mt -84.68 128.15 39.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 113.924 -1.138 . . . . 0.0 108.427 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 54.3 tttt -74.02 140.56 77.24 Favored Pre-proline 0 CA--C 1.535 0.377 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.32 -39.72 89.46 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 120.942 1.095 . . . . 0.0 112.489 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -64.78 -37.38 87.4 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.507 0.67 . . . . 0.0 110.28 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 52.7 tp -63.79 -42.31 97.76 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.468 177.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -65.17 -37.12 86.36 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.042 0.449 . . . . 0.0 110.873 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 94.1 mtp -63.29 -40.97 98.85 Favored 'General case' 0 C--O 1.248 0.985 0 C-N-CA 120.074 -0.65 . . . . 0.0 109.536 -178.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -64.02 -39.9 95.14 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.462 177.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 35.1 mmt -66.76 -36.73 83.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.554 177.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -60.84 -41.87 96.66 Favored 'General case' 0 CA--C 1.513 -0.479 0 O-C-N 121.432 -0.793 . . . . 0.0 109.479 -176.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.86 -39.88 90.8 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.506 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 59.0 tp -63.44 -41.05 98.65 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 240' ' ' ALA . 67.0 t0 -167.6 129.47 1.55 Allowed 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 121.487 0.661 . . . . 0.0 112.148 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.408 ' N ' ' OD1' ' A' ' 239' ' ' ASP . . . -61.04 -26.8 67.88 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.618 178.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.493 ' O ' ' HB2' ' A' ' 244' ' ' SER . 90.8 m-20 -61.24 -32.68 72.48 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.326 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -55.59 -44.38 76.89 Favored 'General case' 0 C--N 1.312 -1.065 0 O-C-N 121.214 -0.929 . . . . 0.0 109.089 -175.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 94.2 p -62.82 -20.04 64.66 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.937 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' SER . . . . . 0.493 ' HB2' ' O ' ' A' ' 241' ' ' ASN . 49.7 m -56.4 -37.76 70.59 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 122.517 0.327 . . . . 0.0 111.854 177.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 92.5 mt -83.24 130.94 35.12 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 177.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -55.29 135.08 50.18 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 114.104 -1.407 . . . . 0.0 109.626 -177.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 98.0 m -126.79 132.14 51.1 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.836 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -118.09 140.54 49.61 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.401 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' SER . . . . . 0.418 ' O ' ' OD1' ' A' ' 250' ' ' ASN . 78.1 p -61.39 -42.35 98.58 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -178.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 249' ' ' SER . 98.4 m-20 -144.03 160.5 40.75 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.72 0.772 . . . . 0.0 111.43 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 77.0 t -62.38 -44.74 99.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 114.641 -1.163 . . . . 0.0 112.044 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.73 -43.78 97.47 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.329 -0.549 . . . . 0.0 109.581 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.43 -42.68 98.71 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.164 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . 0.478 ' O ' HG21 ' A' ' 257' ' ' VAL . . . -64.92 -41.88 95.18 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.729 0.776 . . . . 0.0 109.942 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 61.1 t -63.5 -45.89 96.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 114.225 -1.352 . . . . 0.0 111.304 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -63.89 -47.45 80.56 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.509 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . 0.483 ' O ' ' C ' ' A' ' 258' ' ' LEU . 33.4 m -66.89 -40.96 86.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 C-N-CA 119.908 -0.717 . . . . 0.0 112.481 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.483 ' C ' ' O ' ' A' ' 257' ' ' VAL . 0.9 OUTLIER -30.11 -73.42 0.05 OUTLIER Pre-proline 0 CA--C 1.533 0.293 0 O-C-N 123.166 0.291 . . . . 0.0 111.614 -176.847 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' PRO . . . . . 0.478 ' CD ' ' CB ' ' A' ' 258' ' ' LEU . 43.6 Cg_endo -63.87 140.24 72.35 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 120.847 1.032 . . . . 0.0 111.857 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 259' ' ' PRO . 96.1 mt -152.91 -31.18 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 O-C-N 123.453 0.47 . . . . 0.0 112.16 178.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 77.3 mtm . . . . . 0 C--O 1.217 -0.617 0 CA-C-O 118.133 -0.937 . . . . 0.0 111.143 -177.213 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.521 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.62 175.32 11.65 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 100.0 p -72.09 -11.59 60.82 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.717 -0.219 . . . . 0.0 111.19 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -83.04 -60.94 2.0 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.063 0.458 . . . . 0.0 110.661 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -67.05 -39.16 86.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.253 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.513 ' O ' ' HB3' ' B' ' 7' ' ' PHE . 68.4 m -59.48 -43.28 93.33 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 120.249 -0.58 . . . . 0.0 109.6 -177.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . 0.513 ' HB3' ' O ' ' B' ' 6' ' ' SER . 48.3 t80 86.94 86.97 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.891 0.744 . . . . 0.0 110.71 177.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . 0.621 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -59.99 -149.72 0.01 OUTLIER Glycine 0 C--N 1.336 0.559 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . 0.621 ' HB ' ' O ' ' B' ' 8' ' ' GLY . 88.5 mt 91.3 111.78 0.02 OUTLIER Pre-proline 0 N--CA 1.472 0.635 0 O-C-N 123.948 0.44 . . . . 0.0 110.761 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -63.86 -23.63 68.46 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 121.408 1.405 . . . . 0.0 111.788 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.58 -41.1 99.51 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -64.69 -39.33 93.47 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.843 0.83 . . . . 0.0 109.775 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 48.5 tp -61.76 -42.36 98.88 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 114.907 -1.042 . . . . 0.0 112.116 -177.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -65.15 -33.31 75.71 Favored 'General case' 0 CA--C 1.561 1.39 0 CA-C-O 121.681 0.753 . . . . 0.0 110.805 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 79.4 t -62.23 -46.46 96.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-N 112.927 -1.942 . . . . 0.0 110.912 177.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.94 -44.09 97.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.674 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . 0.557 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 98.9 mttt -63.53 -41.99 98.46 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.34 -41.21 98.87 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 119.028 -1.069 . . . . 0.0 110.254 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.61 -38.39 84.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.743 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 84.3 mt -63.77 -41.91 97.88 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.223 0.535 . . . . 0.0 110.255 175.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -62.87 -38.54 91.27 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.95 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 61.2 m170 -57.83 -39.86 78.67 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 121.19 -0.204 . . . . 0.0 111.156 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 14.1 p -115.28 130.74 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.505 ' O ' ' HG3' ' B' ' 24' ' ' ARG . 35.4 ptt180 -73.54 108.58 6.48 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 121.85 0.833 . . . . 0.0 112.316 -176.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.7 p -143.09 133.76 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.667 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.544 177.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . 0.579 ' O ' ' N ' ' B' ' 123' ' ' GLN . . . -86.78 96.21 2.13 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 119.629 -1.272 . . . . 0.0 113.488 -176.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 47.0 t -125.58 128.81 72.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 175.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 29.5 m -138.8 157.29 29.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.587 179.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 96.5 mt -118.91 129.3 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-O 121.676 0.751 . . . . 0.0 111.567 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.474 ' OG1' ' O ' ' B' ' 119' ' ' PHE . 9.9 p -111.85 154.49 25.07 Favored 'General case' 0 CA--C 1.502 -0.886 0 CA-C-N 113.073 -1.876 . . . . 0.0 108.819 -175.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.518 ' C ' ' OD1' ' B' ' 37' ' ' ASN . 51.0 t0 -122.77 102.3 38.55 Favored Pre-proline 0 C--O 1.237 0.415 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -177.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.52 -20.65 65.98 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 121.786 1.657 . . . . 0.0 111.27 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.19 -42.38 99.23 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 120.629 -0.429 . . . . 0.0 110.002 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 96.8 mt -73.15 179.79 3.68 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 121.778 -0.576 . . . . 0.0 111.097 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . 0.692 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 42.0 tt0 -75.58 132.88 40.96 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -178.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.488 ' O ' ' C ' ' B' ' 37' ' ' ASN . 66.0 t0 55.86 38.78 30.44 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.709 178.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' ASN . . . . . 0.518 ' OD1' ' C ' ' B' ' 31' ' ' ASP . 17.6 t-20 26.91 71.37 0.42 Allowed Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.692 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 92.6 Cg_endo -72.93 154.62 53.29 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 123.554 2.836 . . . . 0.0 111.944 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 95.9 mt -85.75 130.25 36.69 Favored 'Isoleucine or valine' 0 C--O 1.246 0.889 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 17.1 m -108.39 -44.06 6.5 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 O-C-N 123.884 0.74 . . . . 0.0 112.709 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -97.07 124.93 41.21 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.529 -178.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 6.5 p -142.34 140.53 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 O-C-N 124.195 0.934 . . . . 0.0 109.348 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . 0.607 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 55.4 p30 -101.18 162.62 12.76 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.144 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' GLN . . . . . 0.434 ' HA ' ' OE1' ' B' ' 44' ' ' GLN . 13.7 mm100 -62.86 -37.81 88.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.693 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.75 -27.53 64.24 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.607 ' HB2' ' OD1' ' B' ' 43' ' ' ASN . 53.3 t80 -60.36 -43.72 96.27 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . 0.545 HG11 ' O ' ' B' ' 52' ' ' TYR . 77.6 t -61.78 -45.99 97.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.25 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -62.98 -44.31 96.39 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.394 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' MET . . . . . 0.453 ' O ' ' HE2' ' B' ' 96' ' ' LYS . 60.2 ttm -63.48 -42.02 98.57 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 34.6 p -96.22 -16.1 21.63 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.931 -177.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' B' ' 47' ' ' VAL . . . 72.69 18.73 78.87 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.379 -1.089 . . . . 0.0 110.379 178.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . 0.545 ' O ' HG11 ' B' ' 47' ' ' VAL . 85.7 m-85 -111.28 144.03 41.11 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 122.893 0.477 . . . . 0.0 109.999 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -73.82 147.72 43.1 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.561 0.696 . . . . 0.0 111.228 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.42 -36.01 79.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.867 -177.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.48 -40.09 96.18 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 120.131 -0.628 . . . . 0.0 111.884 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -73.15 -33.69 65.64 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 176.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 97.2 mt -64.57 -53.95 36.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 118.204 -1.398 . . . . 0.0 109.475 177.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 88.6 mt -61.77 132.35 52.84 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.004 -170.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.55 -4.36 69.38 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 121.034 -0.603 . . . . 0.0 113.382 -177.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -133.22 149.25 52.02 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -177.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' ASN . . . . . 0.55 ' C ' ' H ' ' B' ' 63' ' ' ARG . 24.4 t-20 -78.86 151.79 31.62 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.565 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' CYS . . . . . . . . . . . . . 82.7 m -64.28 8.96 0.09 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.341 -178.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . 0.55 ' H ' ' C ' ' B' ' 61' ' ' ASN . 34.4 ptt-85 -59.4 -32.46 70.19 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.395 -177.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -60.95 -30.66 70.37 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 178.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 83.9 mt -61.66 -41.95 98.23 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 121.63 -0.669 . . . . 0.0 110.114 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . 0.648 HE22 HO4' ' B' ' 900' ' ' FMN . 87.9 mt-30 -51.75 150.58 3.89 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.024 -177.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -161.13 -153.94 7.21 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.33 177.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -58.98 -40.55 85.18 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -175.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . 0.565 ' H ' ' HH ' ' B' ' 95' ' ' TYR . 7.7 m-70 -76.92 -9.43 58.68 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.307 -178.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 26.9 m -61.19 133.81 56.35 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -90.5 110.1 38.65 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.485 -178.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.17 -38.15 87.71 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 120.979 1.12 . . . . 0.0 111.677 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.83 -40.42 92.75 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 120.459 -0.496 . . . . 0.0 109.8 -176.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' GLU . . . . . 0.487 ' OE1' ' HB ' ' B' ' 90' ' ' VAL . 79.0 mm-40 -67.23 -39.44 86.21 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.789 177.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 73.9 t -61.96 -45.95 97.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -63.29 -37.05 85.75 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.655 -178.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -62.33 -41.47 98.58 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 119.393 -0.923 . . . . 0.0 108.698 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 94.2 mt -63.28 -43.76 98.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-O 120.928 0.394 . . . . 0.0 110.427 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -62.31 -42.78 99.66 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 85.1 m -61.57 -45.4 94.29 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.027 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.28 -41.15 98.24 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.411 HD23 ' CE1' ' B' ' 119' ' ' PHE . 85.9 mt -62.98 -42.14 99.76 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -62.48 -36.63 83.1 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -91.64 7.4 41.72 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.5 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 32.3 tttt 43.1 45.79 4.74 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.414 -0.515 . . . . 0.0 112.195 175.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -128.15 143.72 49.01 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.274 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.31 140.51 83.19 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 120.933 1.089 . . . . 0.0 113.289 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -140.82 137.16 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.361 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' THR . . . . . 0.528 ' CG2' ' OD1' ' B' ' 107' ' ' ASN . 95.7 m -121.47 123.81 42.94 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . 0.487 ' HB ' ' OE1' ' B' ' 74' ' ' GLU . 26.9 m -138.27 163.13 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.955 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -114.62 120.42 40.09 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 174.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 20.9 tt -128.3 131.79 68.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.256 -176.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -71.44 143.46 50.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.419 177.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -132.92 -178.89 5.16 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 121.268 0.556 . . . . 0.0 111.176 -177.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' TYR . . . . . 0.565 ' HH ' ' H ' ' B' ' 69' ' ' HIS . 96.8 m-85 -131.19 145.61 52.01 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 114.567 -1.197 . . . . 0.0 111.711 178.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . 0.453 ' HE2' ' O ' ' B' ' 49' ' ' MET . 98.6 mttt -103.01 177.09 4.93 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.317 0.58 . . . . 0.0 111.209 177.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.15 -35.43 75.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.716 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 38.4 p-10 -87.11 -1.78 58.14 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.168 0.895 . . . . 0.0 112.486 178.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.28 3.18 63.46 Favored Glycine 0 C--N 1.335 0.528 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.449 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 25.5 m -67.01 128.99 38.44 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' MET . . . . . 0.603 ' SD ' ' N ' ' B' ' 102' ' ' PHE . 15.1 tmm? -87.75 142.23 27.98 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' PHE . . . . . 0.603 ' N ' ' SD ' ' B' ' 101' ' ' MET . 52.8 p90 -153.9 162.09 41.49 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' TRP . . . . . 0.757 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 20.9 m95 -95.16 138.68 32.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.404 0.621 . . . . 0.0 110.785 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . 0.409 HD22 ' HG2' ' B' ' 123' ' ' GLN . 62.8 t-20 -132.66 107.19 8.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.78 -1.1 . . . . 0.0 113.567 -177.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -76.14 123.7 26.25 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.413 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 39.0 tp -111.39 125.59 54.03 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.989 0.423 . . . . 0.0 112.012 -177.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' ASN . . . . . 0.528 ' OD1' ' CG2' ' B' ' 89' ' ' THR . 98.3 m-20 -119.08 128.6 54.48 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 96.5 mt -123.61 133.06 70.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -142.85 122.96 7.95 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -69.89 152.29 68.61 Favored 'Trans proline' 0 N--CA 1.499 1.85 0 C-N-CA 122.381 2.054 . . . . 0.0 112.642 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' MET . . . . . 0.43 ' HB2' ' HB2' ' B' ' 118' ' ' TYR . 67.3 mtt -130.22 141.85 50.61 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -113.34 108.43 17.23 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . 0.788 HG12 ' HZ3' ' A' ' 18' ' ' LYS . 96.7 mt -134.52 127.93 50.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 118.279 0.491 . . . . 0.0 112.04 177.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 52.49 38.33 25.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.93 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 60.09 37.07 21.21 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.441 -178.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -132.41 153.1 51.15 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 9.7 t -104.95 151.85 23.4 Favored 'General case' 0 C--O 1.214 -0.766 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -178.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' TYR . . . . . 0.43 ' HB2' ' HB2' ' B' ' 111' ' ' MET . 96.2 m-85 -149.29 147.03 27.88 Favored 'General case' 0 C--O 1.239 0.541 0 O-C-N 121.066 -1.021 . . . . 0.0 110.889 -177.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 119' ' ' PHE . . . . . 0.474 ' O ' ' OG1' ' B' ' 30' ' ' THR . 90.9 m-85 -123.03 139.25 54.28 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 123.523 0.514 . . . . 0.0 110.846 -176.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -128.0 133.63 66.83 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . 0.479 ' HA3' ' H6 ' ' B' ' 900' ' ' FMN . . . -107.03 122.1 6.79 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 122' ' ' ILE . . . . . 0.428 ' HB ' ' HB2' ' B' ' 107' ' ' ASN . 91.2 mt -111.33 127.22 68.62 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.44 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 123' ' ' GLN . . . . . 0.579 ' N ' ' O ' ' B' ' 26' ' ' GLY . 17.0 mp0 -117.97 118.96 33.39 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -118.09 121.16 39.87 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . 0.588 ' OD1' ' N ' ' B' ' 127' ' ' THR . 68.0 t0 -69.36 133.56 47.97 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.043 -0.981 . . . . 0.0 112.261 -178.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . 0.494 ' O ' ' HG3' ' B' ' 130' ' ' LYS . 3.2 mp -107.24 17.89 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.77 0 CA-C-O 122.397 1.094 . . . . 0.0 108.918 177.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 127' ' ' THR . . . . . 0.588 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 97.0 m -63.76 -44.21 94.13 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 113.59 -1.641 . . . . 0.0 112.403 175.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 59.2 tptt -60.91 -45.66 93.74 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -178.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 129' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -63.34 -35.17 79.5 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.687 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 130' ' ' LYS . . . . . 0.757 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 98.7 mttt -63.1 -41.41 99.38 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 113.253 -1.794 . . . . 0.0 110.691 174.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.67 -42.1 95.62 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 132' ' ' TYR . . . . . 0.475 ' CE2' HD13 ' B' ' 136' ' ' LEU . 87.9 t80 -59.92 -44.4 94.34 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 121.878 -0.514 . . . . 0.0 111.388 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . 0.401 ' O ' ' HG3' ' B' ' 137' ' ' GLU . 97.4 mt-10 -64.94 -36.53 84.68 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.724 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 134' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' B' ' 130' ' ' LYS . 98.8 mttt -63.11 -39.31 94.33 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.756 178.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 54.4 tp -62.78 -41.25 99.16 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.401 0.62 . . . . 0.0 109.83 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . 0.475 HD13 ' CE2' ' B' ' 132' ' ' TYR . 87.0 mt -63.34 -41.48 98.88 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.494 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 137' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' B' ' 133' ' ' GLU . 97.2 mt-10 -64.61 -37.98 89.43 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.511 -178.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.58 -43.68 96.26 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.824 176.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 61.4 m -60.96 -44.41 97.34 Favored 'General case' 0 C--N 1.344 0.352 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' B' ' 144' ' ' THR . 84.5 mt -61.64 -40.36 94.6 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -177.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 99.3 m -61.9 -45.13 95.09 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.728 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -65.97 -42.33 90.0 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 93.9 mt -63.81 -43.2 97.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 114.515 -1.22 . . . . 0.0 110.493 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 144' ' ' THR . . . . . 0.445 ' N ' ' O ' ' B' ' 140' ' ' LEU . 99.8 m -61.7 -45.76 92.6 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.42 -40.5 97.35 Favored 'General case' 0 C--O 1.228 -0.071 0 C-N-CA 119.071 -1.052 . . . . 0.0 109.161 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 83.4 mt -64.38 -40.96 96.84 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 147' ' ' SER . . . . . 0.617 ' O ' ' N ' ' B' ' 149' ' ' PRO . 78.1 p -61.86 -41.44 97.85 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 148' ' ' THR . . . . . 0.504 ' C ' ' O ' ' B' ' 147' ' ' SER . 8.9 m -27.06 85.66 0.04 OUTLIER Pre-proline 0 N--CA 1.473 0.716 0 O-C-N 124.035 0.834 . . . . 0.0 109.999 177.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 149' ' ' PRO . . . . . 0.617 ' N ' ' O ' ' B' ' 147' ' ' SER . 24.3 Cg_exo -61.27 146.25 97.58 Favored 'Trans proline' 0 C--N 1.299 -2.036 0 C-N-CA 122.008 1.805 . . . . 0.0 115.211 -177.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 9.5 tp -127.91 123.36 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 174.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 29.9 t -152.78 96.71 2.93 Favored Pre-proline 0 C--N 1.304 -1.39 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.127 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -63.43 132.34 35.45 Favored 'Trans proline' 0 N--CA 1.486 1.062 0 CA-C-N 119.626 0.902 . . . . 0.0 109.776 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 153' ' ' ILE . . . . . 0.569 ' O ' ' HD2' ' B' ' 154' ' ' ARG . 45.8 mm -68.97 -44.33 81.48 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.437 0 C-N-CA 119.738 -0.785 . . . . 0.0 110.88 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . 0.569 ' HD2' ' O ' ' B' ' 153' ' ' ILE . 1.0 OUTLIER -154.96 -157.18 0.73 Allowed 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 178.678 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -86.35 110.55 19.76 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.02 -20.36 50.89 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 -177.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 88.1 mt -108.6 123.89 64.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.76 0.314 . . . . 0.0 111.738 -176.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 158' ' ' SER . . . . . 0.569 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 59.6 m -134.45 150.29 50.82 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.857 178.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -130.89 146.23 52.25 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 38.4 tp -139.61 74.58 33.28 Favored Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 161' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -69.43 148.09 66.44 Favored 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 122.754 2.303 . . . . 0.0 114.318 -177.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 92.9 mt -114.1 134.36 54.93 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 52.2 t -129.01 132.64 67.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 113.5 168.32 16.77 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 120.419 -0.896 . . . . 0.0 111.441 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 165' ' ' ASN . . . . . 0.705 ' O ' ' CZ ' ' B' ' 170' ' ' ARG . 56.2 t30 -89.09 107.79 19.24 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -179.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . 0.459 ' CD2' ' CZ ' ' B' ' 171' ' ' PHE . 43.5 tp -66.34 104.34 1.2 Allowed 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -174.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 167' ' ' THR . . . . . 0.472 ' H ' ' HE ' ' B' ' 170' ' ' ARG . 10.5 p -84.51 171.16 12.76 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 113.733 -1.576 . . . . 0.0 111.091 177.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -67.18 -38.46 85.42 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.766 177.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -66.55 -40.13 88.9 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-O 123.122 1.439 . . . . 0.0 111.773 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 170' ' ' ARG . . . . . 0.705 ' CZ ' ' O ' ' B' ' 165' ' ' ASN . 88.2 mtm180 -63.31 -36.83 85.0 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 112.241 -2.254 . . . . 0.0 111.109 178.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 171' ' ' PHE . . . . . 0.459 ' CZ ' ' CD2' ' B' ' 166' ' ' LEU . 0.4 OUTLIER -53.92 -25.16 19.01 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 113.607 0.965 . . . . 0.0 113.607 -178.472 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 172' ' ' ASN . . . . . 0.702 ' O ' HG21 ' B' ' 175' ' ' VAL . 90.1 m-20 -62.73 -40.2 96.47 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.872 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 49.3 m -60.41 -41.09 93.18 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.23 0.538 . . . . 0.0 110.802 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 66.5 mt -63.56 -43.95 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 175' ' ' VAL . . . . . 0.702 HG21 ' O ' ' B' ' 172' ' ' ASN . 23.8 m -62.6 -39.86 86.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 176' ' ' CYS . . . . . . . . . . . . . 98.7 m -62.49 -35.09 78.25 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.241 177.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 177' ' ' THR . . . . . 0.592 ' O ' HG13 ' B' ' 181' ' ' ILE . 25.0 m -61.41 -19.81 62.35 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.243 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 178' ' ' LEU . . . . . . . . . . . . . 93.3 mt -61.15 -39.6 90.71 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.397 -178.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 19.6 m -61.5 -44.22 97.46 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 176.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 180' ' ' ASN . . . . . 0.598 ' O ' ' OG ' ' B' ' 183' ' ' SER . 92.0 m-20 -61.52 -40.05 93.23 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.296 0.57 . . . . 0.0 110.29 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . 0.592 HG13 ' O ' ' B' ' 177' ' ' THR . 70.4 mt -56.56 -35.94 46.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 O-C-N 121.978 -0.452 . . . . 0.0 110.582 -178.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 182' ' ' LEU . . . . . . . . . . . . . 84.1 mt -61.82 -41.79 98.22 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 119.839 -0.744 . . . . 0.0 109.187 178.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 183' ' ' SER . . . . . 0.598 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.2 p -62.97 -33.08 74.63 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 121.897 -0.502 . . . . 0.0 110.779 177.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 54.3 p -85.88 16.15 4.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.823 0.344 . . . . 0.0 111.753 -177.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 78.5 p -60.64 -16.68 41.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.782 -176.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -61.5 -40.5 94.83 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.882 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 187' ' ' ASP . . . . . 0.569 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.8 m-20 -70.44 115.27 9.42 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.528 0.68 . . . . 0.0 110.401 -178.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.88 -42.29 99.71 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 114.895 -1.048 . . . . 0.0 113.305 -177.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -111.46 131.67 55.05 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.674 -0.411 . . . . 0.0 111.135 -177.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 190' ' ' LEU . . . . . . . . . . . . . 42.1 tp -123.8 118.81 28.01 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.056 177.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 84.8 mt -107.87 126.66 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.049 -177.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 50.0 mm -115.25 117.62 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 193' ' ' ASP . . . . . 0.541 ' OD2' ' OG ' ' B' ' 195' ' ' SER . 42.6 t0 -87.64 112.19 22.07 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.938 -177.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 194' ' ' LEU . . . . . . . . . . . . . 96.1 mt -92.5 -2.78 55.98 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 176.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 195' ' ' SER . . . . . 0.541 ' OG ' ' OD2' ' B' ' 193' ' ' ASP . 78.2 p -61.14 -38.27 85.8 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.819 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.74 -34.1 87.48 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 197' ' ' LEU . . . . . 0.989 HD23 ' O ' ' B' ' 199' ' ' GLN . 4.9 tt -77.2 132.73 38.9 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 198' ' ' ALA . . . . . 0.764 ' N ' HD21 ' B' ' 197' ' ' LEU . . . -63.78 -41.8 97.88 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.854 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 199' ' ' GLN . . . . . 0.989 ' O ' HD23 ' B' ' 197' ' ' LEU . 58.9 tt0 -138.08 163.43 31.65 Favored 'General case' 0 C--O 1.203 -1.345 0 CA-C-O 122.096 0.951 . . . . 0.0 113.008 -178.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 200' ' ' VAL . . . . . 0.443 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 50.3 t -121.46 132.77 69.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 O-C-N 120.229 -1.544 . . . . 0.0 109.349 178.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -94.06 148.65 21.96 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.918 0.866 . . . . 0.0 111.359 -177.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -59.9 -33.12 71.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.857 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -63.87 -33.58 76.01 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.4 m -61.09 -44.45 97.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.096 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 205' ' ' ALA . . . . . 0.641 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -57.95 -31.66 67.07 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.835 -178.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -65.43 -38.16 89.06 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.216 0.531 . . . . 0.0 109.884 176.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -66.32 -38.96 88.89 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.586 178.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.7 -43.13 97.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.589 0.709 . . . . 0.0 110.463 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 209' ' ' PHE . . . . . 0.641 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 65.3 m-85 -61.93 -43.34 99.04 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 113.828 -1.533 . . . . 0.0 112.384 178.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.92 -42.4 97.39 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.836 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . 0.459 ' O ' ' HG ' ' B' ' 215' ' ' LEU . 37.7 mt -62.42 -42.49 99.48 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.078 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 212' ' ' SER . . . . . 0.506 ' HG ' ' N ' ' B' ' 213' ' ' HIS . 78.2 p -62.8 -36.13 82.12 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.836 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 213' ' ' HIS . . . . . 0.506 ' N ' ' HG ' ' B' ' 212' ' ' SER . 58.7 t-80 -67.08 -46.68 73.53 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 115.296 -0.866 . . . . 0.0 112.261 178.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 51.1 tp -63.79 -43.21 97.01 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 121.776 0.798 . . . . 0.0 109.487 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 215' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' B' ' 211' ' ' LEU . 90.9 mt -62.87 -43.89 97.59 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 113.607 -1.633 . . . . 0.0 111.253 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.55 -39.12 89.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.917 -177.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 85.7 mt -63.02 -42.79 99.88 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.314 176.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 218' ' ' THR . . . . . . . . . . . . . 66.7 p -74.24 -16.54 60.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.806 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 80.45 61.21 2.23 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 107.307 -2.317 . . . . 0.0 107.307 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 220' ' ' THR . . . . . . . . . . . . . 94.9 m -141.3 106.84 5.06 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 174.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -63.57 140.2 58.85 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.689 -174.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 44.5 tp -116.03 120.89 40.56 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.557 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 3.0 mp -109.97 129.57 64.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.758 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 224' ' ' ILE . . . . . . . . . . . . . 50.8 mm -111.0 127.11 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 43.5 p -134.34 157.76 45.54 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.924 0.869 . . . . 0.0 112.688 -178.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 90.23 18.84 48.35 Favored Glycine 0 CA--C 1.5 -0.871 0 CA-C-N 113.815 -1.539 . . . . 0.0 111.182 -177.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 95.0 mt -85.29 125.44 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 118.292 1.046 . . . . 0.0 111.556 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 49.5 tttt -62.87 139.97 97.36 Favored Pre-proline 0 C--N 1.313 -0.98 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.08 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.1 -37.93 93.78 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 121.373 1.382 . . . . 0.0 112.799 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -64.7 -41.67 95.84 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -178.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 50.7 tp -61.61 -41.87 98.07 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.014 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.34 -36.65 84.82 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.742 0.306 . . . . 0.0 111.123 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 94.3 mtp -63.73 -40.98 98.07 Favored 'General case' 0 C--O 1.25 1.094 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.793 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.51 -44.4 96.47 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 122.291 1.043 . . . . 0.0 109.332 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 35.6 mmt -64.25 -35.64 81.48 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.634 -1.167 . . . . 0.0 111.716 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -61.39 -40.33 93.98 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -177.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.06 -43.2 99.26 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.202 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 55.8 tp -61.58 -44.92 96.13 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 120.257 -0.577 . . . . 0.0 112.33 -178.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 239' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' B' ' 240' ' ' ALA . 66.8 t0 -158.09 134.69 9.65 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.355 -0.538 . . . . 0.0 112.141 -179.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 240' ' ' ALA . . . . . 0.421 ' N ' ' OD1' ' B' ' 239' ' ' ASP . . . -61.76 -46.69 88.49 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 176.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 241' ' ' ASN . . . . . 0.517 ' O ' ' HB2' ' B' ' 244' ' ' SER . 91.9 m-20 -43.21 -21.85 0.03 OUTLIER 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.361 -176.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 242' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -61.29 -45.36 94.8 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.523 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 243' ' ' SER . . . . . . . . . . . . . 77.4 p -58.18 -44.62 88.12 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 244' ' ' SER . . . . . 0.517 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 19.7 m -32.59 -37.82 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 94.9 mt -83.39 134.47 34.89 Favored 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.27 175.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -63.61 136.56 57.61 Favored 'General case' 0 C--O 1.241 0.655 0 O-C-N 121.368 -0.833 . . . . 0.0 111.645 -176.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 247' ' ' THR . . . . . . . . . . . . . 98.3 m -125.43 127.54 46.7 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.537 -1.211 . . . . 0.0 112.083 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -112.44 143.42 43.6 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 249' ' ' SER . . . . . 0.599 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 78.3 p -62.85 -33.31 74.99 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.144 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 250' ' ' ASN . . . . . 0.599 ' OD1' ' O ' ' B' ' 249' ' ' SER . 98.9 m-20 -148.43 160.19 43.29 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.189 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 73.6 t -64.66 -44.55 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.077 177.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 252' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.96 -46.09 92.1 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -60.67 -43.37 97.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.188 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 254' ' ' ALA . . . . . 0.465 ' O ' HG21 ' B' ' 257' ' ' VAL . . . -65.42 -40.47 93.4 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 120.091 -0.644 . . . . 0.0 111.332 178.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 255' ' ' VAL . . . . . . . . . . . . . 62.2 t -64.82 -45.52 94.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.656 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 256' ' ' LYS . . . . . 0.41 ' HE3' ' ND2' ' A' ' 155' ' ' ASN . 88.7 tttt -63.36 -48.65 77.06 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.485 -178.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 257' ' ' VAL . . . . . 0.465 HG21 ' O ' ' B' ' 254' ' ' ALA . 33.0 m -64.69 -41.13 91.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.623 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 258' ' ' LEU . . . . . 0.505 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 0.9 OUTLIER -33.09 -72.87 0.06 OUTLIER Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.947 -177.948 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 259' ' ' PRO . . . . . 0.544 ' O ' HG13 ' B' ' 260' ' ' ILE . 38.4 Cg_endo -62.54 141.78 87.64 Favored 'Trans proline' 0 N--CA 1.506 2.236 0 C-N-CA 121.855 1.703 . . . . 0.0 111.243 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 260' ' ' ILE . . . . . 0.544 HG13 ' O ' ' B' ' 259' ' ' PRO . 96.6 mt -160.61 -18.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 77.2 mtm . . . . . 0 C--O 1.219 -0.547 0 CA-C-O 117.919 -1.038 . . . . 0.0 111.786 -179.738 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 900' ' ' FMN . . . . . 0.532 HO4' HE22 ' A' ' 66' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 900' ' ' FMN . . . . . 0.648 HO4' HE22 ' B' ' 66' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.234 0 N-CA-C 109.054 -1.619 . . . . 0.0 109.054 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.474 ' O ' ' OG ' ' A' ' 6' ' ' SER . . . -152.54 165.47 35.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 119.173 -0.442 . . . . 0.0 110.111 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.9 p -70.9 -16.54 62.69 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 121.5 0.667 . . . . 0.0 111.356 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -72.1 -65.71 0.74 Allowed 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 114.275 -1.329 . . . . 0.0 112.151 174.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -67.07 -38.21 85.36 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.55 ' O ' ' NZ ' ' B' ' 17' ' ' LYS . 60.9 m -59.4 -42.45 91.76 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.152 -177.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.496 ' HB3' ' O ' ' A' ' 6' ' ' SER . 44.6 t80 84.6 84.04 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 O-C-N 123.69 0.618 . . . . 0.0 111.801 176.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.604 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -58.99 -141.72 0.01 OUTLIER Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -177.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.604 ' HB ' ' O ' ' A' ' 8' ' ' GLY . 86.3 mt 84.64 109.92 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.626 0 C-N-CA 122.39 0.276 . . . . 0.0 110.682 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.27 -22.37 72.23 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.49 1.46 . . . . 0.0 111.994 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.41 -37.29 94.27 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.844 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.1 -39.9 93.79 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.51 0.671 . . . . 0.0 109.847 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 52.8 tp -63.23 -41.19 99.06 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.947 -0.569 . . . . 0.0 112.215 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -63.03 -41.33 99.49 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.1 t -60.36 -44.06 95.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 O-C-N 122.339 -0.226 . . . . 0.0 110.705 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 92.3 mt -62.58 -43.48 98.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.452 -177.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.419 ' NZ ' ' HA ' ' B' ' 6' ' ' SER . 98.9 mttt -62.53 -45.38 93.25 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 119.458 -0.897 . . . . 0.0 111.879 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.642 ' HZ3' HG12 ' B' ' 113' ' ' ILE . 98.4 mttt -60.44 -39.53 87.84 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 118.555 -1.258 . . . . 0.0 109.051 -176.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.85 -41.56 91.67 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.059 -0.656 . . . . 0.0 110.262 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.6 mt -63.07 -41.24 99.39 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.61 -38.79 92.45 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.383 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 62.6 m170 -58.69 -39.98 82.27 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 122.2 -0.312 . . . . 0.0 111.243 -178.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.9 p -114.61 129.3 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.475 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 34.6 ptt180 -71.11 108.71 4.77 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 122.098 0.951 . . . . 0.0 112.081 -177.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.0 p -140.07 142.59 31.49 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 178.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -97.84 93.48 1.4 Allowed Glycine 0 C--N 1.312 -0.783 0 C-N-CA 120.776 -0.726 . . . . 0.0 113.058 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.9 t -124.41 130.0 73.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 175.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.3 m -136.34 159.22 38.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.6 mt -121.28 128.99 76.05 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.4 p -103.65 167.68 9.64 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.541 ' C ' ' OD1' ' A' ' 37' ' ' ASN . 45.6 t0 -133.37 101.23 13.45 Favored Pre-proline 0 C--N 1.32 -0.684 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.659 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.04 -22.58 73.66 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.411 1.407 . . . . 0.0 111.534 -179.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.4 -35.73 80.11 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.774 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 91.9 mt -85.85 161.0 19.29 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.656 177.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.733 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 43.1 tt0 -59.67 135.42 57.67 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -177.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.537 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 60.2 t0 60.65 22.37 12.23 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.877 178.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.541 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 22.5 t-20 40.9 67.82 2.72 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.877 -178.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.733 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 91.3 Cg_endo -71.23 156.88 58.47 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 C-N-CA 123.816 3.011 . . . . 0.0 112.493 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.4 mt -90.08 125.34 42.98 Favored 'Isoleucine or valine' 0 C--O 1.245 0.862 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.41 HG21 ' N ' ' A' ' 41' ' ' TYR . 35.3 m -105.54 -43.57 7.63 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 O-C-N 123.585 0.553 . . . . 0.0 112.102 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.41 ' N ' HG21 ' A' ' 40' ' ' VAL . 46.8 t80 -95.28 124.58 39.39 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.736 -178.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.9 p -142.58 139.55 28.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.347 177.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.569 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 56.7 p30 -96.73 166.6 11.57 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.522 ' HA ' ' OE1' ' A' ' 44' ' ' GLN . 12.6 mm100 -67.19 -37.98 84.6 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 120.961 0.41 . . . . 0.0 111.855 177.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.03 -27.51 64.9 Favored Glycine 0 C--N 1.331 0.283 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.569 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 71.0 t80 -59.13 -48.43 81.64 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.606 HG11 ' O ' ' A' ' 52' ' ' TYR . 54.9 t -59.58 -44.9 94.26 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.585 0 O-C-N 121.297 -0.877 . . . . 0.0 111.442 -173.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -63.64 -37.61 87.98 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 120.415 -0.514 . . . . 0.0 112.027 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' MET . . . . . 0.402 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 58.8 ttm -67.3 -43.59 81.35 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 175.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 39.8 p -90.06 -23.79 21.34 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.155 0.502 . . . . 0.0 111.634 -178.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . 78.78 20.44 70.9 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.606 ' O ' HG11 ' A' ' 47' ' ' VAL . 90.4 m-85 -115.02 141.89 47.38 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.003 0.521 . . . . 0.0 111.539 178.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -65.96 149.52 50.1 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.848 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.7 -33.09 75.07 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.27 -43.71 85.67 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 119.535 -0.866 . . . . 0.0 111.286 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -64.76 -44.67 89.32 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.393 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.436 HG22 HD13 ' A' ' 57' ' ' ILE . 93.5 mt -61.81 -49.98 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -174.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 84.1 mt -55.94 148.67 16.73 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 176.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.01 -4.54 61.53 Favored Glycine 0 CA--C 1.52 0.377 0 CA-C-O 119.379 -0.678 . . . . 0.0 113.305 177.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -136.98 149.37 47.48 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.041 1.42 . . . . 0.0 111.711 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.575 ' C ' ' H ' ' A' ' 63' ' ' ARG . 25.8 t-20 -80.89 152.09 28.29 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.189 0.519 . . . . 0.0 110.687 -178.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 82.0 m -62.2 15.12 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.291 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.575 ' H ' ' C ' ' A' ' 61' ' ' ASN . 34.4 ptt-85 -61.93 -41.6 98.14 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.979 -0.45 . . . . 0.0 111.376 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -56.17 -21.84 25.3 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 93.0 mt -67.25 -35.64 79.98 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.757 0.789 . . . . 0.0 113.063 177.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.473 HE22 HO4' ' A' ' 900' ' ' FMN . 88.7 mt-30 -63.05 142.87 58.22 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.225 -178.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.499 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -152.8 -148.79 4.97 Favored Glycine 0 CA--C 1.54 1.638 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.685 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.485 ' HB3' ' HH ' ' A' ' 95' ' ' TYR . 88.8 tttt -62.85 -40.69 98.23 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -177.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.487 ' HD1' HE22 ' A' ' 93' ' ' GLN . 8.8 m-70 -76.5 -9.04 58.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.715 0.293 . . . . 0.0 111.101 -178.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.499 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 30.6 m -62.87 129.94 42.62 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.204 -0.598 . . . . 0.0 109.786 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -87.7 110.52 35.33 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.997 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.29 -32.16 92.92 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.993 1.795 . . . . 0.0 113.117 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.76 -39.6 94.67 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.979 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.48 ' OE1' ' HB ' ' A' ' 90' ' ' VAL . 79.4 mm-40 -65.09 -43.85 90.79 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.7 t -59.88 -43.94 93.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 114.273 -1.331 . . . . 0.0 107.817 -176.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.83 -37.8 88.73 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.724 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -63.26 -39.8 95.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.235 0.541 . . . . 0.0 110.295 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 95.1 mt -63.85 -44.07 98.02 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.996 178.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -62.83 -43.07 99.79 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 113.655 -1.611 . . . . 0.0 108.371 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 98.5 m -61.34 -48.76 79.82 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.57 -41.87 91.16 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.589 -172.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 90.6 mt -63.24 -40.08 96.43 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 118.831 0.741 . . . . 0.0 111.414 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 66.9 tp60 -64.49 -32.94 74.78 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -90.3 -2.36 58.0 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.533 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.2 tttt 49.35 39.17 15.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.955 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -121.89 144.06 40.08 Favored Pre-proline 0 CA--C 1.533 0.321 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.422 ' HB3' ' OD1' ' A' ' 109' ' ' ASP . 24.7 Cg_exo -61.46 143.32 97.33 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 121.402 1.402 . . . . 0.0 113.236 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.8 p -139.79 142.45 32.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.819 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.527 ' CG2' ' OD1' ' A' ' 107' ' ' ASN . 99.0 m -126.33 121.25 32.04 Favored 'General case' 0 C--N 1.344 0.336 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 175.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.48 ' HB ' ' OE1' ' A' ' 74' ' ' GLU . 29.9 m -138.85 158.72 30.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.323 177.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -102.87 133.58 47.72 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 176.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.0 tt -140.41 129.97 27.36 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.213 0 CA-C-N 121.067 1.758 . . . . 0.0 112.438 177.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.487 HE22 ' HD1' ' A' ' 69' ' ' HIS . 86.1 mt-30 -63.37 132.19 50.69 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.75 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -131.9 155.92 47.03 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.542 -178.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.485 ' HH ' ' HB3' ' A' ' 68' ' ' LYS . 94.1 m-85 -114.84 134.52 55.07 Favored 'General case' 0 C--N 1.346 0.444 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.402 ' HE2' ' O ' ' A' ' 49' ' ' MET . 99.0 mttt -83.61 -174.18 5.14 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.139 0.495 . . . . 0.0 111.532 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -62.44 -41.52 98.79 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.041 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 40.9 p-10 -83.95 5.17 26.52 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 111.892 0.331 . . . . 0.0 111.892 -177.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.01 -1.77 85.12 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.004 176.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 25.0 m -60.39 137.46 58.14 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 178.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.66 ' C ' ' SD ' ' A' ' 101' ' ' MET . 14.7 tmm? -104.44 127.83 52.22 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.628 0.252 . . . . 0.0 110.711 178.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -140.7 157.01 46.06 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.244 -0.582 . . . . 0.0 109.803 -177.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.786 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 20.8 m95 -88.12 141.96 28.15 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.486 HD22 ' HG2' ' A' ' 123' ' ' GLN . 56.9 t-20 -137.38 102.92 4.93 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -177.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 80.8 tt0 -67.75 136.64 54.54 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -176.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 41.8 tp -121.74 124.22 43.71 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.527 ' OD1' ' CG2' ' A' ' 89' ' ' THR . 98.0 m-20 -122.43 124.49 43.76 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.671 177.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 87' ' ' PRO . 96.4 mt -120.57 129.28 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 O-C-N 123.436 0.46 . . . . 0.0 111.597 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.422 ' OD1' ' HB3' ' A' ' 87' ' ' PRO . 2.4 m-20 -137.81 121.6 11.68 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 110.581 -0.155 . . . . 0.0 110.581 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -69.6 150.86 69.75 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 122.432 2.088 . . . . 0.0 112.713 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.615 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 66.6 mtt -121.94 153.12 38.91 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -127.81 94.19 3.88 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 176.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 96.5 mt -119.05 130.97 73.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.876 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 51.95 36.51 18.62 Favored 'General case' 0 CA--C 1.517 -0.292 0 O-C-N 121.406 -0.809 . . . . 0.0 111.468 176.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 59.42 30.31 19.98 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.758 -178.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -127.47 146.12 50.6 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 177.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.724 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 5.0 t -82.04 -173.2 4.36 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.578 -0.701 . . . . 0.0 109.77 -178.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.724 ' CD2' ' O ' ' A' ' 117' ' ' THR . 64.0 m-85 -171.11 157.44 5.16 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 173.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -131.32 146.21 52.19 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 174.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.5 p -133.15 135.68 56.29 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 177.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -109.17 127.41 8.51 Favored Glycine 0 CA--C 1.501 -0.795 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 178.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 96.2 mt -118.99 130.1 74.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.486 ' HG2' HD22 ' A' ' 104' ' ' ASN . 16.4 mp0 -120.39 117.74 28.53 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 123.563 0.539 . . . . 0.0 109.975 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -117.83 113.59 22.0 Favored 'General case' 0 C--O 1.248 0.995 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.032 -178.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 126' ' ' ILE . 68.1 t0 -64.02 132.41 50.51 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -174.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.463 ' N ' ' OD1' ' A' ' 125' ' ' ASP . 2.6 mp -97.5 2.58 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 113.765 -1.561 . . . . 0.0 110.398 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 19.3 m -60.61 -43.0 97.96 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.211 -0.931 . . . . 0.0 113.397 -178.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -59.76 -42.46 93.3 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -63.06 -39.05 93.59 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.723 177.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.786 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.7 mttt -62.41 -40.69 97.34 Favored 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 118.467 -1.293 . . . . 0.0 110.631 -178.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -62.53 -36.98 84.3 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -178.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.432 ' CE2' HD13 ' A' ' 136' ' ' LEU . 89.8 t80 -61.56 -45.96 91.93 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.597 176.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.62 -38.47 91.11 Favored 'General case' 0 C--O 1.225 -0.213 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.89 -40.91 97.07 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 51.5 tp -60.91 -43.6 98.33 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 -178.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.432 HD13 ' CE2' ' A' ' 132' ' ' TYR . 87.7 mt -62.7 -41.25 99.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.168 179.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.16 -41.1 99.19 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.766 -178.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -60.99 -41.84 97.27 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 -177.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 66.9 m -61.85 -41.0 97.29 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.661 176.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 144' ' ' THR . 90.2 mt -63.15 -41.9 99.35 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 92.8 m -61.86 -45.46 93.7 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.151 -178.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -65.41 -41.07 93.99 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 94.9 mt -64.55 -43.47 96.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 113.968 -1.469 . . . . 0.0 111.383 177.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.424 ' N ' ' O ' ' A' ' 140' ' ' LEU . 99.1 m -62.25 -46.08 90.42 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 120.432 -0.507 . . . . 0.0 112.167 -178.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.02 -41.28 97.92 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 118.789 -1.164 . . . . 0.0 108.931 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.3 mt -63.88 -42.62 97.44 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 177.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.681 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.0 p -60.56 -37.28 80.75 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -178.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.454 ' C ' ' O ' ' A' ' 147' ' ' SER . 55.5 m -31.14 83.91 0.03 OUTLIER Pre-proline 0 C--N 1.344 0.359 0 O-C-N 126.79 2.556 . . . . 0.0 106.211 -178.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.681 ' N ' ' O ' ' A' ' 147' ' ' SER . 21.7 Cg_exo -62.74 145.31 94.91 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 120.849 1.033 . . . . 0.0 114.604 -175.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.63 ' O ' ' CG2' ' A' ' 151' ' ' VAL . 8.7 tp -121.78 136.94 57.04 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.933 0 N-CA-C 102.891 -3.003 . . . . 0.0 102.891 176.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.63 ' CG2' ' O ' ' A' ' 150' ' ' ILE . 60.1 t -170.23 94.74 0.48 Allowed Pre-proline 0 N--CA 1.445 -0.685 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 177.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -63.41 143.8 89.37 Favored 'Trans proline' 0 C--N 1.298 -2.092 0 N-CA-C 109.78 -0.892 . . . . 0.0 109.78 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.577 ' O ' HG12 ' B' ' 255' ' ' VAL . 44.2 mm -77.04 -60.27 2.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.03 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.619 ' NH2' ' HD3' ' B' ' 154' ' ' ARG . 1.6 mpt_? -140.41 -157.56 0.78 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.0 t-20 -86.45 105.23 16.62 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.804 0.812 . . . . 0.0 111.5 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.11 8.55 66.6 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 114.032 -1.44 . . . . 0.0 110.615 -177.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 97.1 mt -123.93 125.57 71.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 175.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.716 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 58.5 m -132.3 151.47 51.82 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.222 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -139.34 142.84 37.6 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.575 -0.703 . . . . 0.0 111.08 177.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 16.8 tp -133.96 80.83 53.45 Favored Pre-proline 0 N--CA 1.469 0.517 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.355 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -69.25 149.89 70.7 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.788 2.325 . . . . 0.0 112.938 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 88.7 mt -119.0 128.09 54.07 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.502 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 47.7 t -124.17 131.27 73.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 116.78 169.62 15.22 Favored Glycine 0 N--CA 1.48 1.62 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.174 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.874 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 56.4 t30 -87.08 113.28 22.69 Favored 'General case' 0 C--O 1.221 -0.431 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -178.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.512 HD13 HD11 ' A' ' 174' ' ' ILE . 46.7 tp -72.39 104.19 3.68 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -178.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.651 ' H ' ' HE ' ' A' ' 170' ' ' ARG . 11.4 p -85.63 167.42 15.36 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.571 178.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.49 -34.85 79.24 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.937 0.398 . . . . 0.0 111.6 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.2 -41.97 94.01 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.757 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.874 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 88.0 mtm180 -64.08 -33.18 75.18 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.993 0.917 . . . . 0.0 112.368 178.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.475 ' CZ ' HD22 ' A' ' 166' ' ' LEU . 0.5 OUTLIER -53.68 -28.24 32.39 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 118.887 -0.578 . . . . 0.0 112.472 -178.766 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.603 ' O ' HG21 ' A' ' 175' ' ' VAL . 91.1 m-20 -61.0 -40.64 94.29 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 118.942 -1.103 . . . . 0.0 109.774 -178.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 54.7 m -59.47 -41.25 89.33 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.604 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.512 HD11 HD13 ' A' ' 166' ' ' LEU . 66.9 mt -63.69 -44.35 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 -179.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.603 HG21 ' O ' ' A' ' 172' ' ' ASN . 33.5 m -62.79 -40.39 88.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 99.3 m -62.77 -34.7 77.79 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.304 0.573 . . . . 0.0 110.34 178.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' THR . . . . . 0.495 ' O ' HG13 ' A' ' 181' ' ' ILE . 24.6 m -62.11 -19.49 63.06 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.197 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 90.5 mt -60.93 -41.17 95.66 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 18.3 m -59.48 -42.96 93.3 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.628 ' O ' ' OG ' ' A' ' 183' ' ' SER . 91.0 m-20 -61.34 -36.63 80.72 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 122.668 0.387 . . . . 0.0 110.837 178.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . 0.495 HG13 ' O ' ' A' ' 177' ' ' THR . 67.0 mt -59.02 -39.92 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 O-C-N 121.558 -0.714 . . . . 0.0 109.086 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 86.3 mt -60.71 -40.61 92.88 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -177.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.628 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 77.9 p -61.65 -33.49 74.05 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.501 176.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.421 ' OG1' ' HA ' ' A' ' 181' ' ' ILE . 66.1 p -89.69 23.37 2.69 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.581 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 78.3 p -63.46 -19.93 65.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.188 0.518 . . . . 0.0 110.752 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.49 -37.29 83.14 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.916 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.716 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 98.2 m-20 -74.18 112.93 10.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.563 0.696 . . . . 0.0 110.839 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -62.74 -42.42 99.66 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 114.967 -1.015 . . . . 0.0 113.063 -177.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -110.48 130.91 55.45 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.562 -178.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 39.2 tp -120.21 128.61 53.53 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 177.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 96.7 mt -116.1 127.53 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-N 118.59 0.632 . . . . 0.0 109.689 177.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.2 mm -113.36 126.93 70.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 178.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . 0.423 ' CG ' ' HG ' ' A' ' 195' ' ' SER . 41.3 t0 -94.67 117.89 30.84 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-O 121.379 0.609 . . . . 0.0 110.667 176.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 97.9 mt -98.59 -4.81 33.23 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.882 175.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.423 ' HG ' ' CG ' ' A' ' 193' ' ' ASP . 78.2 p -62.31 -33.31 74.42 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.81 -42.68 99.77 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 118.553 -1.784 . . . . 0.0 109.081 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 1.087 HD23 ' O ' ' A' ' 199' ' ' GLN . 5.0 tt -70.59 128.69 36.98 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 112.891 -1.655 . . . . 0.0 107.516 -174.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.572 ' N ' HD21 ' A' ' 197' ' ' LEU . . . -60.26 -45.3 93.77 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.745 -176.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 1.087 ' O ' HD23 ' A' ' 197' ' ' LEU . 58.8 tt0 -138.81 157.31 46.31 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 114.466 -1.243 . . . . 0.0 112.847 -174.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.456 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 47.4 t -118.23 131.71 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -87.66 156.01 19.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.543 -178.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -64.35 -38.89 92.65 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.211 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -58.68 -32.35 69.05 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -178.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.6 m -61.21 -42.32 98.38 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.481 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.476 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -57.52 -39.01 75.6 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -177.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -61.64 -37.11 82.79 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.54 -39.12 91.39 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.892 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 94.8 mt -63.18 -44.23 99.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -178.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . 0.476 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 71.8 m-85 -62.21 -43.58 98.5 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.743 -178.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.34 -42.04 99.07 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 119.316 -0.954 . . . . 0.0 109.231 -178.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.419 ' O ' ' HG ' ' A' ' 215' ' ' LEU . 38.2 mt -62.08 -41.81 98.55 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 77.9 p -61.57 -41.14 96.96 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.07 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -64.49 -45.86 85.49 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.378 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 48.6 tp -62.31 -46.14 90.06 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 119.1 -1.04 . . . . 0.0 108.492 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.454 ' HA ' ' HG1' ' A' ' 218' ' ' THR . 91.2 mt -62.2 -40.8 97.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.504 -177.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.27 -44.41 95.36 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.44 -178.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 87.5 mt -61.65 -39.68 92.23 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.454 ' HG1' ' HA ' ' A' ' 215' ' ' LEU . 69.8 p -75.77 -10.79 59.73 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.244 179.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.07 33.59 26.1 Favored Glycine 0 C--N 1.343 0.925 0 C-N-CA 120.501 -0.857 . . . . 0.0 113.205 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 97.3 m -119.36 113.27 20.56 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.073 1.436 . . . . 0.0 111.512 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -64.98 138.03 58.11 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.752 178.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 45.6 tp -113.8 130.82 56.41 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 3.0 mp -117.85 133.33 64.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.445 HG23 HD11 ' A' ' 224' ' ' ILE . 49.3 mm -115.48 131.81 66.73 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 44.4 p -133.72 166.13 23.34 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 120.531 -0.467 . . . . 0.0 111.997 -178.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 80.04 19.76 69.19 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 97.1 mt -81.9 128.45 38.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 114.059 -1.07 . . . . 0.0 108.506 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 58.6 tttt -75.68 140.72 71.61 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.6 -39.22 89.63 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 121.069 1.179 . . . . 0.0 112.672 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -64.36 -39.67 94.35 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.686 0.755 . . . . 0.0 110.188 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 52.0 tp -63.91 -42.44 97.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.688 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.84 -37.9 89.1 Favored 'General case' 0 N--CA 1.461 0.103 0 O-C-N 121.952 -0.468 . . . . 0.0 110.973 -179.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 94.2 mtp -63.61 -40.89 98.05 Favored 'General case' 0 C--O 1.248 1.026 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.468 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.88 -38.62 91.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.437 177.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 35.0 mmt -65.59 -38.27 89.01 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.63 178.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -61.29 -41.82 97.61 Favored 'General case' 0 CA--C 1.515 -0.402 0 O-C-N 121.52 -0.738 . . . . 0.0 109.525 -177.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.16 -40.99 95.95 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.549 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 56.0 tp -63.52 -41.48 98.5 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 177.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -166.94 127.39 1.55 Allowed 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -60.45 -26.41 66.73 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.66 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.432 ' O ' ' HB2' ' A' ' 244' ' ' SER . 91.3 m-20 -61.39 -33.84 74.36 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.523 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -55.22 -44.27 75.25 Favored 'General case' 0 C--N 1.311 -1.088 0 O-C-N 121.551 -0.718 . . . . 0.0 109.422 -175.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 97.9 p -61.92 -20.12 63.44 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.865 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 241' ' ' ASN . 40.6 m -56.03 -39.24 71.65 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.697 178.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 98.7 mt -84.03 122.82 29.31 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -43.38 135.42 3.52 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.895 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 97.9 m -127.25 132.53 50.36 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.844 177.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -118.01 139.83 50.63 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.29 178.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' SER . . . . . 0.469 ' HG ' ' N ' ' A' ' 250' ' ' ASN . 78.3 p -61.16 -42.87 99.34 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 119.277 -0.969 . . . . 0.0 108.589 -178.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.469 ' N ' ' HG ' ' A' ' 249' ' ' SER . 99.0 m-20 -143.83 160.56 40.55 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.699 0.762 . . . . 0.0 111.434 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 54.9 t -63.09 -44.42 99.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.933 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.76 -44.96 96.08 Favored 'General case' 0 CA--C 1.513 -0.475 0 C-N-CA 120.215 -0.594 . . . . 0.0 109.668 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -64.22 -41.36 97.06 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.361 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . 0.443 ' O ' HG21 ' A' ' 257' ' ' VAL . . . -64.83 -42.25 95.1 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.858 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . 0.498 HG13 HH11 ' B' ' 154' ' ' ARG . 68.3 t -64.03 -45.73 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-N 114.111 -1.404 . . . . 0.0 110.974 -178.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.62 -47.67 80.42 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.489 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . 0.5 ' O ' ' C ' ' A' ' 258' ' ' LEU . 24.7 m -66.58 -40.45 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 120.118 -0.633 . . . . 0.0 112.206 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.5 ' C ' ' O ' ' A' ' 257' ' ' VAL . 0.9 OUTLIER -29.36 -74.9 0.04 OUTLIER Pre-proline 0 CA--C 1.533 0.313 0 CA-C-O 119.472 -0.299 . . . . 0.0 111.253 -177.106 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' PRO . . . . . 0.496 ' CD ' ' CB ' ' A' ' 258' ' ' LEU . 40.3 Cg_endo -62.84 139.61 75.33 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 120.73 0.953 . . . . 0.0 111.884 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 96.5 mt -151.36 -23.55 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 O-C-N 123.327 0.392 . . . . 0.0 111.97 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 78.4 mtm . . . . . 0 C--O 1.218 -0.566 0 CA-C-O 118.125 -0.94 . . . . 0.0 110.637 -177.545 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.451 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.51 157.36 35.3 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 78.5 p -59.86 -22.13 61.89 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 123.339 0.399 . . . . 0.0 110.948 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -70.83 -61.58 1.71 Allowed 'General case' 0 N--CA 1.426 -1.633 0 O-C-N 121.946 -0.472 . . . . 0.0 111.133 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -67.54 -37.97 83.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.349 -0.842 . . . . 0.0 112.114 178.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.505 ' O ' ' HB3' ' B' ' 7' ' ' PHE . 63.9 m -59.63 -42.87 93.7 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.009 -177.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . 0.505 ' HB3' ' O ' ' B' ' 6' ' ' SER . 44.8 t80 85.13 86.82 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.754 0.659 . . . . 0.0 110.431 177.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . 0.613 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -61.0 -140.72 0.01 OUTLIER Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 -178.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . 0.613 ' HB ' ' O ' ' B' ' 8' ' ' GLY . 86.0 mt 83.62 109.81 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 122.438 0.295 . . . . 0.0 110.975 -178.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -62.3 -24.53 76.0 Favored 'Trans proline' 0 N--CA 1.499 1.852 0 C-N-CA 121.431 1.42 . . . . 0.0 111.714 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.62 -39.67 97.7 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -64.33 -40.03 95.07 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.66 0.743 . . . . 0.0 109.693 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 52.3 tp -62.28 -42.27 99.2 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.026 -178.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -64.64 -33.34 75.72 Favored 'General case' 0 CA--C 1.56 1.333 0 CA-C-O 121.585 0.707 . . . . 0.0 110.614 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 79.3 t -62.92 -46.24 96.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 113.136 -1.847 . . . . 0.0 111.08 177.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 95.5 mt -63.83 -43.96 98.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.422 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . 0.55 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 98.9 mttt -63.45 -41.99 98.65 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.94 -40.91 99.09 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 118.983 -1.087 . . . . 0.0 110.177 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.92 -38.39 85.6 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.82 -178.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 86.0 mt -64.0 -42.15 97.25 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.098 0.475 . . . . 0.0 110.222 176.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.27 -39.15 93.8 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.16 -179.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -58.04 -40.0 79.79 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 121.106 -0.237 . . . . 0.0 111.102 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 8.2 p -114.7 129.44 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.482 ' O ' ' HG3' ' B' ' 24' ' ' ARG . 34.5 ptt180 -70.94 106.65 3.72 Favored 'General case' 0 CA--C 1.527 0.079 0 CA-C-O 121.87 0.843 . . . . 0.0 112.527 -177.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.5 p -142.11 133.3 25.76 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.703 177.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . 0.453 ' O ' ' N ' ' B' ' 123' ' ' GLN . . . -88.45 97.79 2.35 Favored Glycine 0 N--CA 1.439 -1.135 0 C-N-CA 119.506 -1.33 . . . . 0.0 113.153 -176.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 45.9 t -125.3 129.08 73.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 174.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 27.5 m -138.11 155.96 30.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.821 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 94.8 mt -119.89 127.06 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 122.124 0.964 . . . . 0.0 111.181 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 23.7 p -106.71 157.99 17.3 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-N 112.654 -2.066 . . . . 0.0 108.628 -176.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.534 ' C ' ' OD1' ' B' ' 37' ' ' ASN . 46.1 t0 -126.78 101.36 26.77 Favored Pre-proline 0 C--O 1.239 0.515 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 -177.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.08 -20.7 67.81 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 121.714 1.609 . . . . 0.0 111.448 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.47 -43.29 99.12 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 120.575 -0.45 . . . . 0.0 109.865 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 91.8 mt -75.16 179.55 4.99 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.715 -0.616 . . . . 0.0 111.149 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . 0.656 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 42.5 tt0 -75.48 132.94 41.13 Favored 'General case' 0 C--N 1.342 0.245 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -178.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.5 ' O ' ' OD1' ' B' ' 36' ' ' ASP . 65.9 t0 56.21 37.11 28.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.757 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' ASN . . . . . 0.534 ' OD1' ' C ' ' B' ' 31' ' ' ASP . 13.2 t-20 30.11 70.48 0.59 Allowed Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.656 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 92.8 Cg_endo -72.82 156.26 52.99 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 123.401 2.734 . . . . 0.0 111.89 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 96.1 mt -89.28 129.48 40.19 Favored 'Isoleucine or valine' 0 C--O 1.246 0.881 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 35.1 m -108.63 -43.44 6.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 O-C-N 123.936 0.773 . . . . 0.0 112.585 179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -96.05 124.86 40.23 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.45 -178.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 6.2 p -142.53 140.97 28.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.438 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . 0.605 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 56.4 p30 -101.32 160.98 13.95 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.111 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' GLN . . . . . 0.512 ' HA ' ' OE1' ' B' ' 44' ' ' GLN . 12.1 mm100 -63.0 -36.78 84.68 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.215 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.13 -27.75 65.51 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.605 ' HB2' ' OD1' ' B' ' 43' ' ' ASN . 66.8 t80 -60.32 -43.76 96.09 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.29 0.567 . . . . 0.0 109.601 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . 0.689 HG11 ' O ' ' B' ' 52' ' ' TYR . 53.6 t -61.42 -46.4 96.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.336 -178.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -63.4 -44.25 95.2 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.21 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 59.0 ttm -63.34 -42.51 98.93 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 36.1 p -93.33 -18.62 22.22 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 120.327 -0.549 . . . . 0.0 111.875 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' B' ' 47' ' ' VAL . . . 74.98 18.93 80.17 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 178.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . 0.689 ' O ' HG11 ' B' ' 47' ' ' VAL . 89.8 m-85 -112.59 146.04 39.29 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.149 0.58 . . . . 0.0 110.528 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -73.4 148.44 43.33 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.474 0.654 . . . . 0.0 111.316 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -61.82 -37.34 84.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.699 -177.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.81 -40.34 96.4 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.235 -0.586 . . . . 0.0 111.722 -178.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -71.62 -32.54 68.08 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 176.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 91.2 mt -66.63 -66.75 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . 0.25 97.0 mt -45.29 134.07 6.73 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.53 -9.95 73.4 Favored Glycine 0 CA--C 1.536 1.352 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.916 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -134.16 148.18 50.89 Favored 'General case' 0 C--N 1.342 0.263 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -174.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' ASN . . . . . 0.578 ' C ' ' H ' ' B' ' 63' ' ' ARG . 25.5 t-20 -79.39 151.18 31.09 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.446 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' CYS . . . . . . . . . . . . . 83.0 m -62.52 9.11 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.251 -178.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . 0.578 ' H ' ' C ' ' B' ' 61' ' ' ASN . 33.2 ptt-85 -59.89 -32.8 71.08 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.432 -177.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -60.14 -30.03 69.03 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 178.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 87.8 mt -62.2 -41.53 98.45 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 121.779 -0.575 . . . . 0.0 109.982 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . 0.493 HE22 HO4' ' B' ' 900' ' ' FMN . 89.0 mt-30 -51.28 149.28 4.09 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.914 -176.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -159.84 -152.84 6.65 Favored Glycine 0 CA--C 1.537 1.426 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.944 177.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . 0.402 ' HB3' ' HH ' ' B' ' 95' ' ' TYR . 88.8 tttt -60.73 -41.75 95.93 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -175.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -74.94 -10.57 59.61 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.259 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 28.7 m -61.26 134.58 57.13 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 120.391 -0.524 . . . . 0.0 109.625 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -92.21 110.47 44.63 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.443 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.28 -38.35 88.52 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 121.023 1.149 . . . . 0.0 111.835 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.63 -39.73 89.32 Favored 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 120.451 -0.5 . . . . 0.0 109.697 -176.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' GLU . . . . . 0.472 ' OE1' ' HB ' ' B' ' 90' ' ' VAL . 79.1 mm-40 -66.52 -39.18 88.5 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.888 177.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -62.29 -45.58 98.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -63.12 -36.99 85.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.693 -177.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -62.43 -41.77 98.96 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 119.368 -0.933 . . . . 0.0 108.679 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 94.1 mt -63.47 -43.7 98.5 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-O 120.767 0.318 . . . . 0.0 110.508 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -61.96 -42.63 99.34 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 91.7 m -61.47 -45.14 95.51 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.966 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.82 -41.25 97.54 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -177.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 87.1 mt -62.98 -42.19 99.77 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.597 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 66.7 tp60 -62.85 -35.1 78.85 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . 0.416 ' O ' ' HG2' ' B' ' 86' ' ' GLU . 98.2 m-20 -92.1 6.35 46.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.594 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 30.2 tttt 42.99 40.19 2.1 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.414 -0.515 . . . . 0.0 111.823 175.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' B' ' 84' ' ' ASN . 54.6 mm-40 -122.46 141.59 35.23 Favored Pre-proline 0 N--CA 1.467 0.424 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.29 178.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' PRO . . . . . 0.436 ' HB3' ' OD1' ' B' ' 109' ' ' ASP . 25.6 Cg_exo -61.94 140.95 87.65 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.03 1.154 . . . . 0.0 113.716 -178.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.92 137.67 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.66 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' THR . . . . . 0.53 ' CG2' ' OD1' ' B' ' 107' ' ' ASN . 96.4 m -121.76 122.72 40.16 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . 0.472 ' HB ' ' OE1' ' B' ' 74' ' ' GLU . 31.1 m -138.87 162.81 28.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.892 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -114.15 121.59 44.24 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 175.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 20.6 tt -127.47 131.46 70.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.07 -175.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -70.13 139.95 52.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.763 177.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -129.44 178.86 6.15 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.626 0.727 . . . . 0.0 111.385 -177.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' TYR . . . . . 0.402 ' HH ' ' HB3' ' B' ' 68' ' ' LYS . 96.2 m-85 -130.43 142.42 50.5 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 114.335 -1.302 . . . . 0.0 112.173 178.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -100.47 177.68 4.96 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.129 0.49 . . . . 0.0 110.958 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.71 -35.09 75.44 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.777 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -85.95 -1.64 57.51 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 118.872 0.76 . . . . 0.0 112.709 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.42 3.23 65.06 Favored Glycine 0 N--CA 1.47 0.96 0 C-N-CA 121.15 -0.547 . . . . 0.0 112.495 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 27.3 m -67.44 129.21 39.19 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.665 178.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' MET . . . . . 0.514 ' C ' ' SD ' ' B' ' 101' ' ' MET . 16.9 tmm? -89.22 140.58 29.34 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' PHE . . . . . 0.481 ' N ' ' SD ' ' B' ' 101' ' ' MET . 52.8 p90 -151.66 161.89 41.92 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' TRP . . . . . 0.806 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 21.2 m95 -93.69 137.99 32.37 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.529 0.68 . . . . 0.0 110.813 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . 0.484 HD22 ' HG2' ' B' ' 123' ' ' GLN . 64.1 t-20 -133.0 106.97 7.97 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 114.74 -1.118 . . . . 0.0 113.461 -176.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' GLU . . . . . 0.441 ' O ' ' HA ' ' B' ' 123' ' ' GLN . 81.2 tt0 -75.09 125.04 28.09 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.75 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 40.0 tp -113.5 125.54 54.32 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.073 0.463 . . . . 0.0 112.072 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' ASN . . . . . 0.53 ' OD1' ' CG2' ' B' ' 89' ' ' THR . 98.0 m-20 -121.08 130.01 53.57 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.431 -0.804 . . . . 0.0 108.88 176.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 96.6 mt -123.8 132.81 70.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.699 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . 0.436 ' OD1' ' HB3' ' B' ' 87' ' ' PRO . 2.9 m-20 -142.77 120.18 7.07 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 178.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -67.97 152.05 77.26 Favored 'Trans proline' 0 N--CA 1.503 2.079 0 C-N-CA 122.632 2.221 . . . . 0.0 112.739 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' MET . . . . . 0.519 ' HB2' ' HB2' ' B' ' 118' ' ' TYR . 66.9 mtt -128.4 144.33 51.12 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -114.88 106.95 14.77 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . 0.642 HG12 ' HZ3' ' A' ' 18' ' ' LYS . 96.8 mt -132.88 128.18 56.51 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-N 118.428 0.558 . . . . 0.0 111.77 178.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 53.51 36.68 23.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.946 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 61.32 35.85 17.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.628 -178.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -132.85 149.99 52.2 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 7.1 t -99.83 153.2 19.33 Favored 'General case' 0 C--O 1.214 -0.766 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -177.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' TYR . . . . . 0.519 ' HB2' ' HB2' ' B' ' 111' ' ' MET . 89.9 m-85 -148.29 148.9 30.96 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 121.189 -0.945 . . . . 0.0 111.349 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -124.96 139.68 53.6 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 120.881 0.372 . . . . 0.0 111.181 -177.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -128.54 133.95 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -176.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.54 123.78 7.16 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.186 -0.765 . . . . 0.0 111.186 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 95.2 mt -116.38 127.66 73.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 123' ' ' GLN . . . . . 0.484 ' HG2' HD22 ' B' ' 104' ' ' ASN . 16.4 mp0 -118.47 123.9 46.29 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -121.53 119.56 32.33 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . 0.554 ' OD1' ' N ' ' B' ' 127' ' ' THR . 67.9 t0 -67.42 136.18 54.31 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.426 -178.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . 0.508 ' O ' ' HG3' ' B' ' 130' ' ' LYS . 2.7 mp -109.78 15.07 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.937 0 CA-C-O 122.174 0.988 . . . . 0.0 109.132 178.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 127' ' ' THR . . . . . 0.554 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 97.6 m -63.05 -43.8 97.61 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 113.827 -1.533 . . . . 0.0 112.347 176.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 59.8 tptt -61.26 -45.92 92.53 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -177.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 129' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -63.51 -33.92 76.63 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.47 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 130' ' ' LYS . . . . . 0.806 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 98.8 mttt -63.53 -41.35 98.47 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 113.589 -1.641 . . . . 0.0 110.856 174.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -64.44 -41.48 96.54 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 132' ' ' TYR . . . . . 0.435 ' CE2' HD13 ' B' ' 136' ' ' LEU . 90.8 t80 -60.17 -44.96 94.61 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 121.801 -0.562 . . . . 0.0 111.358 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' B' ' 137' ' ' GLU . 97.4 mt-10 -64.58 -36.25 83.63 Favored 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 134' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' B' ' 130' ' ' LYS . 98.7 mttt -63.21 -39.81 95.7 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.68 177.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 52.8 tp -62.84 -41.57 99.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.332 0.587 . . . . 0.0 109.743 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . 0.435 HD13 ' CE2' ' B' ' 132' ' ' TYR . 89.9 mt -62.86 -41.85 99.53 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.269 177.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 137' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' B' ' 133' ' ' GLU . 97.3 mt-10 -65.16 -37.25 86.8 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.302 -1.317 . . . . 0.0 110.441 -178.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -63.22 -43.48 97.99 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.899 176.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 69.7 m -60.8 -44.14 97.25 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 89.7 mt -61.64 -40.32 94.46 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -176.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 94.5 m -62.11 -45.26 94.27 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.827 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -66.09 -42.8 88.83 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 92.5 mt -63.8 -43.24 97.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.688 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 144' ' ' THR . . . . . . . . . . . . . 99.6 m -61.68 -45.04 95.69 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 -178.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . 0.444 ' O ' ' HB ' ' B' ' 148' ' ' THR . . . -63.27 -41.72 99.06 Favored 'General case' 0 C--O 1.227 -0.093 0 C-N-CA 118.952 -1.099 . . . . 0.0 109.346 178.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 86.1 mt -64.83 -41.18 95.94 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 176.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 147' ' ' SER . . . . . 0.595 ' O ' ' N ' ' B' ' 149' ' ' PRO . 78.2 p -62.06 -41.34 98.04 Favored 'General case' 0 CA--C 1.479 -1.769 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 148' ' ' THR . . . . . 0.482 ' C ' ' O ' ' B' ' 147' ' ' SER . 26.3 m -28.61 87.19 0.04 OUTLIER Pre-proline 0 N--CA 1.474 0.76 0 O-C-N 124.1 0.875 . . . . 0.0 109.874 176.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 149' ' ' PRO . . . . . 0.595 ' N ' ' O ' ' B' ' 147' ' ' SER . 23.8 Cg_exo -61.67 147.04 96.26 Favored 'Trans proline' 0 C--N 1.301 -1.95 0 C-N-CA 121.952 1.768 . . . . 0.0 114.942 -178.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 9.0 tp -127.73 121.98 57.89 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.533 0 CA-C-N 113.571 -1.65 . . . . 0.0 107.63 174.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 38.7 t -154.01 95.97 2.75 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.699 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -62.35 142.95 92.91 Favored 'Trans proline' 0 C--N 1.318 -1.046 0 N-CA-C 109.61 -0.958 . . . . 0.0 109.61 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 153' ' ' ILE . . . . . 0.424 ' O ' ' HD2' ' B' ' 154' ' ' ARG . 44.5 mm -77.21 -57.46 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.387 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . 0.619 ' HD3' ' NH2' ' A' ' 154' ' ' ARG . 1.2 tpt180 -141.53 -156.07 0.65 Allowed 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 61.0 t-20 -86.05 109.6 18.93 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.29 -16.72 59.59 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -178.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 86.7 mt -108.75 125.56 65.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-O 120.86 0.362 . . . . 0.0 110.994 -176.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 158' ' ' SER . . . . . 0.697 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 61.5 m -134.45 149.28 50.73 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.132 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -135.4 147.34 48.99 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.157 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 17.1 tp -140.09 79.55 21.95 Favored Pre-proline 0 CA--C 1.531 0.228 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 161' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -70.05 147.96 62.14 Favored 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 122.839 2.359 . . . . 0.0 114.099 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 91.6 mt -115.29 133.87 55.64 Favored 'General case' 0 C--N 1.342 0.239 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 53.9 t -128.17 132.94 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 114.79 169.71 16.26 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.56 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 165' ' ' ASN . . . . . 0.723 ' O ' ' CZ ' ' B' ' 170' ' ' ARG . 60.9 t30 -91.62 107.11 18.97 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -178.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . 0.505 HD13 HD11 ' B' ' 174' ' ' ILE . 47.7 tp -65.49 104.73 1.04 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -174.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 167' ' ' THR . . . . . 0.561 ' H ' ' HE ' ' B' ' 170' ' ' ARG . 11.2 p -83.88 169.92 14.6 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 114.103 -1.408 . . . . 0.0 110.797 177.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -66.32 -38.51 87.86 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.97 177.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.09 -40.0 90.45 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 123.427 1.584 . . . . 0.0 111.828 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 170' ' ' ARG . . . . . 0.723 ' CZ ' ' O ' ' B' ' 165' ' ' ASN . 88.2 mtm180 -62.3 -36.24 81.51 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 111.914 -2.403 . . . . 0.0 111.05 178.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 171' ' ' PHE . . . . . 0.442 ' CZ ' ' CD2' ' B' ' 166' ' ' LEU . 0.5 OUTLIER -53.82 -25.16 18.12 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -179.439 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 172' ' ' ASN . . . . . 0.554 ' O ' HG21 ' B' ' 175' ' ' VAL . 91.4 m-20 -62.68 -40.23 96.43 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.845 178.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 49.2 m -60.46 -41.82 94.9 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.729 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 174' ' ' ILE . . . . . 0.505 HD11 HD13 ' B' ' 166' ' ' LEU . 66.7 mt -63.92 -44.39 97.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 175' ' ' VAL . . . . . 0.554 HG21 ' O ' ' B' ' 172' ' ' ASN . 33.6 m -63.12 -40.59 89.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 176' ' ' CYS . . . . . . . . . . . . . 97.1 m -62.58 -35.05 78.29 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.344 178.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 177' ' ' THR . . . . . 0.514 ' O ' HG13 ' B' ' 181' ' ' ILE . 25.3 m -61.9 -19.54 62.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.24 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 178' ' ' LEU . . . . . . . . . . . . . 91.1 mt -61.16 -39.51 90.38 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.278 -177.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 19.3 m -61.04 -43.95 98.11 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.185 177.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 180' ' ' ASN . . . . . 0.616 ' O ' ' OG ' ' B' ' 183' ' ' SER . 91.4 m-20 -61.45 -39.94 92.65 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.9 0.381 . . . . 0.0 110.416 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . 0.514 HG13 ' O ' ' B' ' 177' ' ' THR . 71.8 mt -56.96 -34.44 44.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 O-C-N 122.221 -0.3 . . . . 0.0 110.626 -178.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 182' ' ' LEU . . . . . . . . . . . . . 85.3 mt -62.08 -41.59 98.34 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.11 178.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 183' ' ' SER . . . . . 0.616 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.1 p -63.3 -32.96 74.51 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 121.853 -0.53 . . . . 0.0 110.827 177.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 64.8 p -86.16 17.29 3.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.679 -177.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 78.1 p -61.27 -16.68 47.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.654 -177.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -61.79 -39.82 93.04 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.756 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 187' ' ' ASP . . . . . 0.697 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.1 m-20 -72.11 113.35 9.05 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.504 0.669 . . . . 0.0 110.496 -177.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -62.8 -42.22 99.62 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 114.83 -1.077 . . . . 0.0 113.119 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -110.47 130.52 55.54 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.034 -177.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 190' ' ' LEU . . . . . . . . . . . . . 41.1 tp -123.46 119.33 29.69 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.139 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 87.2 mt -107.44 126.86 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 117.796 0.271 . . . . 0.0 111.15 -176.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 49.2 mm -116.29 117.31 55.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 193' ' ' ASP . . . . . 0.449 ' CG ' ' HG ' ' B' ' 195' ' ' SER . 43.3 t0 -88.38 111.33 21.63 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -177.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 194' ' ' LEU . . . . . . . . . . . . . 98.1 mt -93.98 -2.74 52.66 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 176.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 195' ' ' SER . . . . . 0.449 ' HG ' ' CG ' ' B' ' 193' ' ' ASP . 78.2 p -61.35 -37.32 82.89 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.872 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.98 -34.01 87.49 Favored Glycine 0 N--CA 1.436 -1.312 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 197' ' ' LEU . . . . . 1.062 HD23 ' O ' ' B' ' 199' ' ' GLN . 5.2 tt -76.23 133.25 40.17 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -177.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 198' ' ' ALA . . . . . 0.614 ' N ' HD21 ' B' ' 197' ' ' LEU . . . -63.56 -41.26 98.42 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 119.979 -0.688 . . . . 0.0 111.935 -177.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 199' ' ' GLN . . . . . 1.062 ' O ' HD23 ' B' ' 197' ' ' LEU . 59.4 tt0 -140.96 164.23 30.82 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.446 0.641 . . . . 0.0 111.864 -179.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 200' ' ' VAL . . . . . 0.472 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 49.9 t -120.98 131.73 72.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 177.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -91.13 150.03 21.55 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.875 -177.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -60.5 -33.13 72.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.28 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -63.77 -33.81 76.49 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.465 0.65 . . . . 0.0 109.388 178.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.5 m -60.79 -43.93 97.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.246 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 205' ' ' ALA . . . . . 0.64 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -58.26 -30.44 66.57 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 111.79 0.292 . . . . 0.0 111.79 -177.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -65.42 -38.27 89.42 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.307 0.575 . . . . 0.0 109.932 176.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -66.39 -39.11 88.86 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.694 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.82 -43.26 97.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-O 121.688 0.756 . . . . 0.0 110.299 -178.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 209' ' ' PHE . . . . . 0.64 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 69.1 m-85 -61.95 -43.53 98.65 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 113.888 -1.505 . . . . 0.0 112.527 177.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.17 -41.77 99.28 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 119.584 -0.846 . . . . 0.0 110.046 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . 0.447 ' O ' ' HG ' ' B' ' 215' ' ' LEU . 37.8 mt -62.3 -42.07 99.05 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.221 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 78.2 p -63.52 -35.58 80.94 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.893 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 213' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -66.78 -46.95 73.67 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.362 -0.836 . . . . 0.0 112.141 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 52.8 tp -63.89 -42.9 97.36 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.864 0.84 . . . . 0.0 110.032 177.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 215' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' B' ' 211' ' ' LEU . 92.6 mt -63.08 -43.42 98.58 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 113.389 -1.732 . . . . 0.0 111.701 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.18 -39.41 92.57 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.913 -177.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.45 -42.3 98.64 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.322 0.582 . . . . 0.0 111.483 175.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 218' ' ' THR . . . . . . . . . . . . . 77.9 p -73.69 -15.92 61.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.716 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 78.91 63.88 2.02 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 107.051 -2.419 . . . . 0.0 107.051 -177.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 220' ' ' THR . . . . . . . . . . . . . 95.8 m -141.3 103.11 4.36 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 176.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -61.47 138.7 58.28 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.054 0.454 . . . . 0.0 110.952 -176.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 44.4 tp -115.67 121.85 43.79 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.679 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 3.2 mp -110.45 128.91 66.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.883 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 224' ' ' ILE . . . . . 0.41 HG23 HD11 ' B' ' 224' ' ' ILE . 49.6 mm -111.3 127.15 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 49.8 p -133.62 158.76 42.38 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.871 0.843 . . . . 0.0 112.709 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 89.47 16.4 57.07 Favored Glycine 0 CA--C 1.5 -0.896 0 CA-C-N 113.818 -1.537 . . . . 0.0 111.639 -177.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 95.5 mt -81.15 126.27 39.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 117.815 0.808 . . . . 0.0 111.498 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 55.4 tttt -66.19 141.2 97.24 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.341 -178.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.45 -37.56 94.75 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 121.491 1.461 . . . . 0.0 112.614 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -63.94 -43.55 95.5 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -178.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 51.8 tp -62.05 -41.58 98.28 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.159 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.72 -37.01 85.76 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.749 0.309 . . . . 0.0 111.362 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 94.5 mtp -64.01 -40.89 97.35 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.805 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.7 -42.55 99.69 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-O 122.422 1.106 . . . . 0.0 109.467 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 35.2 mmt -63.98 -36.61 84.53 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 114.322 -1.308 . . . . 0.0 111.862 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -61.96 -40.46 95.64 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.002 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.28 -43.91 96.59 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 120.679 -0.409 . . . . 0.0 110.057 177.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.29 -44.42 96.55 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.71 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 239' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' B' ' 240' ' ' ALA . 67.0 t0 -159.1 133.08 7.57 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.324 -0.551 . . . . 0.0 112.104 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 240' ' ' ALA . . . . . 0.418 ' N ' ' OD1' ' B' ' 239' ' ' ASP . . . -62.51 -44.75 95.6 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 176.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 241' ' ' ASN . . . . . 0.497 ' O ' ' HB2' ' B' ' 244' ' ' SER . 92.1 m-20 -45.52 -22.61 0.16 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.046 -175.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 242' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -60.81 -45.43 94.46 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 119.888 -0.725 . . . . 0.0 110.39 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 243' ' ' SER . . . . . . . . . . . . . 77.5 p -57.89 -42.21 84.15 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 244' ' ' SER . . . . . 0.497 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 19.7 m -35.1 -34.46 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 -178.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 96.6 mt -87.74 134.2 33.71 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.567 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -58.85 135.53 57.55 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-O 121.427 0.632 . . . . 0.0 110.75 -177.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 247' ' ' THR . . . . . . . . . . . . . 95.8 m -125.91 127.51 46.12 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.722 177.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -113.8 142.56 45.91 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 249' ' ' SER . . . . . 0.604 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 78.4 p -63.12 -34.08 76.84 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.339 -178.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 250' ' ' ASN . . . . . 0.604 ' OD1' ' O ' ' B' ' 249' ' ' SER . 99.2 m-20 -147.94 159.55 43.75 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.199 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 58.0 t -64.23 -44.39 97.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.885 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 252' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.94 -46.74 89.5 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -177.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -61.74 -43.11 99.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.654 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 254' ' ' ALA . . . . . 0.43 ' O ' HG21 ' B' ' 257' ' ' VAL . . . -64.87 -40.57 95.33 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.18 178.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 255' ' ' VAL . . . . . 0.577 HG12 ' O ' ' A' ' 153' ' ' ILE . 67.8 t -64.69 -45.72 94.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.506 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -63.26 -48.21 79.14 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.226 -178.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 257' ' ' VAL . . . . . 0.48 ' O ' ' C ' ' B' ' 258' ' ' LEU . 22.6 m -65.2 -40.31 88.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.594 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 258' ' ' LEU . . . . . 0.515 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 0.9 OUTLIER -31.8 -73.96 0.05 OUTLIER Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.592 -178.359 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 259' ' ' PRO . . . . . 0.515 ' CD ' ' CB ' ' B' ' 258' ' ' LEU . 35.5 Cg_endo -61.75 141.31 90.05 Favored 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 121.51 1.474 . . . . 0.0 111.196 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 260' ' ' ILE . . . . . 0.489 HG13 ' O ' ' B' ' 259' ' ' PRO . 96.8 mt -158.44 -12.57 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-N 118.591 0.632 . . . . 0.0 112.121 177.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 78.3 mtm . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 117.99 -1.005 . . . . 0.0 111.583 179.921 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 900' ' ' FMN . . . . . 0.53 HO2' ' C9 ' ' A' ' 900' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 900' ' ' FMN . . . . . 0.522 HO2' ' C9 ' ' B' ' 900' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.427 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.76 179.25 8.68 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-O 121.57 0.7 . . . . 0.0 109.518 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 97.2 p -82.62 -2.18 53.11 Favored 'General case' 0 C--N 1.39 2.337 0 O-C-N 118.151 -2.843 . . . . 0.0 112.853 176.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -87.35 -64.15 1.19 Allowed 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.141 -1.391 . . . . 0.0 112.32 175.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -68.73 -39.23 80.49 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 178.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.497 ' O ' ' CB ' ' A' ' 7' ' ' PHE . 57.0 m -58.94 -42.13 89.04 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.923 -177.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.497 ' CB ' ' O ' ' A' ' 6' ' ' SER . 33.0 t80 86.38 87.59 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 O-C-N 123.816 0.697 . . . . 0.0 111.567 176.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.526 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -60.59 -143.21 0.01 OUTLIER Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.526 ' HB ' ' O ' ' A' ' 8' ' ' GLY . 65.3 mt 84.22 110.46 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.65 0 C-N-CA 122.881 0.472 . . . . 0.0 110.584 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.94 -22.44 68.47 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 121.354 1.369 . . . . 0.0 112.18 -179.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.88 -37.29 94.44 Favored Glycine 0 C--O 1.247 0.921 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.07 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -65.04 -39.04 92.77 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.349 0.595 . . . . 0.0 109.745 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.8 tp -63.29 -41.95 99.02 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -62.32 -39.54 93.37 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 68.5 t -61.08 -43.97 97.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 O-C-N 122.02 -0.425 . . . . 0.0 111.066 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 95.4 mt -62.21 -43.28 97.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.213 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.96 -45.03 94.39 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 119.394 -0.923 . . . . 0.0 111.877 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.792 ' HZ3' HG12 ' B' ' 113' ' ' ILE . 98.5 mttt -61.05 -39.42 89.77 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 118.666 -1.214 . . . . 0.0 108.612 -175.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.35 -42.88 92.6 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 119.941 -0.703 . . . . 0.0 110.262 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.0 mt -63.1 -40.77 98.62 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -62.86 -38.9 92.7 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.491 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 57.5 m170 -58.88 -39.5 81.58 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 122.16 -0.337 . . . . 0.0 111.501 -178.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.3 p -114.82 130.36 69.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.438 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 31.6 ptt180 -72.9 110.15 6.99 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 121.939 0.876 . . . . 0.0 112.178 -177.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.5 p -140.96 143.3 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 177.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 123' ' ' GLN . . . -97.81 92.56 1.29 Allowed Glycine 0 C--N 1.312 -0.758 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.777 -178.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 52.0 t -124.79 129.98 73.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 175.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.8 m -136.92 159.24 37.01 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.5 mt -119.46 128.89 75.86 Favored 'Isoleucine or valine' 0 C--O 1.245 0.855 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 176.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.413 ' OG1' ' HB2' ' A' ' 119' ' ' PHE . 24.3 p -101.83 167.22 10.22 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 177.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.401 ' C ' ' OD1' ' A' ' 37' ' ' ASN . 53.1 t0 -133.82 101.86 12.64 Favored Pre-proline 0 C--O 1.222 -0.37 0 C-N-CA 120.314 -0.554 . . . . 0.0 109.872 178.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.57 -21.04 65.99 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 121.431 1.421 . . . . 0.0 111.501 -178.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.67 -29.72 70.85 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.316 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 91.4 mt -89.79 -178.87 5.61 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.865 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.632 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 42.1 tt0 -76.3 130.25 37.85 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -177.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.515 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 58.3 t0 63.11 22.04 13.2 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 177.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.401 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 29.7 t-20 42.3 68.03 2.99 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.996 -177.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.632 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 89.6 Cg_endo -71.36 157.17 57.38 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 124.085 3.19 . . . . 0.0 112.042 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 95.9 mt -89.84 123.61 42.12 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.453 HG21 ' N ' ' A' ' 41' ' ' TYR . 28.5 m -103.95 -43.14 8.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.1 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.453 ' N ' HG21 ' A' ' 40' ' ' VAL . 46.3 t80 -96.34 123.61 40.04 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.733 -178.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.5 p -142.87 140.29 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 O-C-N 124.356 1.035 . . . . 0.0 109.229 177.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.579 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 57.7 p30 -96.49 166.13 11.84 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.46 ' HA ' ' OE1' ' A' ' 44' ' ' GLN . 14.0 mm100 -66.15 -39.84 90.11 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 177.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.98 -25.44 61.87 Favored Glycine 0 C--O 1.237 0.294 0 N-CA-C 110.389 -1.085 . . . . 0.0 110.389 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.579 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 67.4 t80 -59.0 -47.51 84.93 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 105.863 -1.902 . . . . 0.0 105.863 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.463 ' O ' ' N ' ' A' ' 51' ' ' GLY . 53.6 t -60.04 -44.38 94.7 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 O-C-N 121.161 -0.962 . . . . 0.0 111.498 -174.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -62.44 -37.56 86.35 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 120.488 -0.485 . . . . 0.0 112.264 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 59.4 ttm -66.97 -43.64 82.55 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 176.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 34.8 p -93.48 -20.82 19.92 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.138 0.494 . . . . 0.0 111.287 -177.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . 77.82 19.44 75.47 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.462 ' O ' HG11 ' A' ' 47' ' ' VAL . 78.0 m-85 -111.79 138.79 47.9 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 122.579 0.351 . . . . 0.0 110.984 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -64.64 149.14 49.52 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.491 0.662 . . . . 0.0 109.495 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.85 -32.44 73.95 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.43 -42.34 83.33 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 119.381 -0.928 . . . . 0.0 111.382 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -64.65 -44.65 89.76 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.429 HG22 HD13 ' A' ' 57' ' ' ILE . 95.3 mt -63.76 -45.9 95.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -174.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 83.8 mt -61.09 144.7 53.05 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.14 -5.99 73.83 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.353 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -134.49 151.28 51.03 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 119.222 1.511 . . . . 0.0 112.011 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.561 ' C ' ' H ' ' A' ' 63' ' ' ARG . 25.0 t-20 -81.45 152.2 27.5 Favored 'General case' 0 N--CA 1.453 -0.316 0 O-C-N 121.882 -0.511 . . . . 0.0 110.509 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 86.0 m -63.16 15.78 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.353 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.561 ' H ' ' C ' ' A' ' 61' ' ' ASN . 35.2 ptt-85 -61.12 -42.02 97.78 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.077 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -55.65 -21.74 19.45 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -178.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.6 mt -67.44 -35.48 79.32 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 122.241 1.02 . . . . 0.0 112.864 176.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.528 HE22 HO4' ' A' ' 900' ' ' FMN . 88.3 mt-30 -65.65 133.3 50.83 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.753 -176.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.533 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -143.69 -148.57 4.92 Favored Glycine 0 CA--C 1.543 1.832 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -178.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.58 ' HB3' ' HH ' ' A' ' 95' ' ' TYR . 88.6 tttt -62.86 -41.11 99.25 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -177.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.444 ' O ' ' OE1' ' A' ' 93' ' ' GLN . 17.2 m-70 -75.93 -9.79 58.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.834 0.349 . . . . 0.0 110.852 -177.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.533 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 28.5 m -60.93 130.12 44.87 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.603 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -87.54 111.09 39.36 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.713 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -57.55 -31.68 92.27 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.018 1.812 . . . . 0.0 112.99 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.7 -40.26 96.34 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.951 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.415 ' OE1' ' HB ' ' A' ' 90' ' ' VAL . 79.2 mm-40 -65.6 -43.61 89.12 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.3 t -60.4 -43.13 93.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -63.67 -37.96 89.33 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 124.07 0.856 . . . . 0.0 112.007 178.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -63.31 -39.69 95.25 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.37 0.605 . . . . 0.0 110.544 178.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.1 mt -64.1 -43.79 97.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.367 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -62.65 -43.07 99.74 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 113.653 -1.612 . . . . 0.0 108.473 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 93.8 m -60.82 -49.11 78.8 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.25 -42.46 95.34 Favored 'General case' 0 C--N 1.363 1.189 0 O-C-N 123.754 0.659 . . . . 0.0 110.782 -171.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 87.4 mt -63.01 -40.94 99.26 Favored 'General case' 0 CA--C 1.514 -0.409 0 O-C-N 120.184 -1.573 . . . . 0.0 111.692 -178.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -63.42 -41.07 98.69 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -70.55 -23.35 62.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.197 177.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 49.5 tttt 63.34 46.53 4.38 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.614 -176.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -130.71 148.32 69.65 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -62.08 142.94 94.12 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 121.441 1.427 . . . . 0.0 113.493 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.09 141.43 33.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.325 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.498 ' CG2' ' OD1' ' A' ' 107' ' ' ASN . 96.6 m -126.7 119.17 26.3 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 175.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.415 ' HB ' ' OE1' ' A' ' 74' ' ' GLU . 30.1 m -138.59 157.17 30.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 121.203 -0.199 . . . . 0.0 111.413 178.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -103.8 127.3 51.3 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 177.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.8 tt -135.74 131.45 50.45 Favored 'Isoleucine or valine' 0 C--N 1.372 1.567 0 CA-C-N 121.716 2.053 . . . . 0.0 112.606 177.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.444 ' OE1' ' O ' ' A' ' 69' ' ' HIS . 87.5 mt-30 -63.69 135.87 57.05 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.952 -179.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -137.97 162.25 34.56 Favored 'General case' 0 C--N 1.349 0.55 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.923 -177.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.58 ' HH ' ' HB3' ' A' ' 68' ' ' LYS . 92.3 m-85 -121.38 138.3 54.32 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -178.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.425 ' HG3' ' CE1' ' A' ' 102' ' ' PHE . 99.2 mttt -86.71 -171.06 3.35 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.078 0.466 . . . . 0.0 111.525 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.69 -42.05 99.43 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.396 178.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 39.7 p-10 -85.49 7.61 22.23 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -177.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.48 -1.18 88.45 Favored Glycine 0 N--CA 1.471 0.983 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.146 177.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 23.4 m -60.06 137.63 58.05 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.678 ' C ' ' SD ' ' A' ' 101' ' ' MET . 14.1 tmm? -104.98 129.39 53.42 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 120.746 0.308 . . . . 0.0 111.231 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.472 ' N ' ' SD ' ' A' ' 101' ' ' MET . 53.5 p90 -141.12 158.97 43.19 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.927 -177.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.837 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 21.0 m95 -90.54 143.97 26.23 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -138.46 103.54 4.91 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -176.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -70.56 135.12 48.26 Favored 'General case' 0 N--CA 1.436 -1.15 0 O-C-N 120.974 -1.079 . . . . 0.0 108.16 -176.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 38.8 tp -120.16 123.61 43.73 Favored 'General case' 0 C--O 1.234 0.285 0 O-C-N 124.07 0.856 . . . . 0.0 112.662 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.498 ' OD1' ' CG2' ' A' ' 89' ' ' THR . 98.1 m-20 -119.55 123.0 42.87 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.96 177.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 96.4 mt -120.9 128.46 76.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 O-C-N 123.575 0.547 . . . . 0.0 111.496 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -137.33 126.81 15.32 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.819 -0.173 . . . . 0.0 111.003 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -70.73 151.45 63.57 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.162 1.908 . . . . 0.0 112.413 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.576 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 67.2 mtt -123.36 151.5 42.46 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -126.86 96.96 4.8 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 176.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.418 HD11 HG22 ' A' ' 113' ' ' ILE . 96.2 mt -121.02 131.56 72.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.035 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 50.27 37.46 15.1 Favored 'General case' 0 CA--C 1.515 -0.375 0 O-C-N 121.105 -0.997 . . . . 0.0 111.365 176.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 59.93 31.82 20.88 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 123.939 0.774 . . . . 0.0 110.994 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -128.71 147.95 50.8 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.705 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 3.6 t -84.3 -175.51 5.83 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-O 118.769 -0.634 . . . . 0.0 109.434 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.705 ' CD2' ' O ' ' A' ' 117' ' ' THR . 70.1 m-85 -169.1 156.04 6.94 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 173.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.413 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 86.0 m-85 -129.32 147.83 51.19 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 173.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.7 p -137.33 137.31 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -111.97 130.29 9.56 Favored Glycine 0 CA--C 1.504 -0.644 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 178.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 97.0 mt -117.65 129.54 73.93 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 177.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.52 ' N ' ' O ' ' A' ' 26' ' ' GLY . 17.9 mp0 -118.81 117.0 27.7 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.223 0.535 . . . . 0.0 109.833 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -117.99 114.97 23.96 Favored 'General case' 0 C--O 1.254 1.329 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.813 -178.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.477 ' OD1' ' OG1' ' A' ' 127' ' ' THR . 67.4 t0 -67.72 121.97 17.09 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -175.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 3.6 mp -85.4 1.07 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 113.778 -1.556 . . . . 0.0 110.299 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.477 ' OG1' ' OD1' ' A' ' 125' ' ' ASP . 27.5 m -59.43 -42.58 92.21 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.186 -0.946 . . . . 0.0 112.937 -177.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -58.87 -42.31 89.13 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 -178.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -63.23 -39.47 94.7 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.445 177.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.837 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.8 mttt -62.41 -40.76 97.58 Favored 'General case' 0 C--O 1.214 -0.771 0 O-C-N 120.504 -1.372 . . . . 0.0 110.084 -178.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.72 -37.41 86.41 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.752 0.658 . . . . 0.0 109.49 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.472 ' CE2' HD13 ' A' ' 136' ' ' LEU . 88.2 t80 -61.45 -45.9 92.33 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.408 176.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.34 -38.45 91.07 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.67 -40.31 96.66 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 52.2 tp -60.97 -43.35 98.91 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -177.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.472 HD13 ' CE2' ' A' ' 132' ' ' TYR . 85.3 mt -62.8 -41.27 99.21 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.827 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.97 -41.87 98.5 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 119.668 -0.813 . . . . 0.0 109.691 -178.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -60.14 -43.06 96.0 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -177.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 54.7 m -61.61 -41.41 97.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.731 176.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.457 ' O ' ' N ' ' A' ' 144' ' ' THR . 85.8 mt -63.07 -41.69 99.5 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 121.933 -0.48 . . . . 0.0 109.963 178.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 78.6 m -61.61 -45.42 94.17 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.514 -177.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -65.13 -39.99 93.83 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 95.2 mt -64.59 -43.18 96.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 113.873 -1.512 . . . . 0.0 111.232 176.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.457 ' N ' ' O ' ' A' ' 140' ' ' LEU . 89.3 m -62.18 -46.07 90.59 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 120.37 -0.532 . . . . 0.0 112.285 -178.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.34 -40.62 96.98 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 118.851 -1.14 . . . . 0.0 109.064 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.7 mt -63.44 -42.63 98.66 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.491 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.715 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.4 p -60.7 -36.42 78.75 Favored 'General case' 0 C--O 1.214 -0.803 0 C-N-CA 119.332 -0.947 . . . . 0.0 109.294 -177.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.438 ' C ' ' O ' ' A' ' 147' ' ' SER . 41.9 m -31.67 81.57 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.507 0 O-C-N 127.041 2.713 . . . . 0.0 105.823 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.715 ' N ' ' O ' ' A' ' 147' ' ' SER . 19.4 Cg_exo -62.51 142.07 88.84 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 CA-C-O 123.088 1.203 . . . . 0.0 114.601 -174.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.526 ' O ' ' CG2' ' A' ' 151' ' ' VAL . 9.0 tp -115.91 136.3 53.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 102.603 -3.11 . . . . 0.0 102.603 175.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' A' ' 150' ' ' ILE . 82.2 t -168.46 90.5 0.64 Allowed Pre-proline 0 CA--C 1.505 -0.771 0 N-CA-C 106.001 -1.851 . . . . 0.0 106.001 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.2 135.58 55.3 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 N-CA-C 109.678 -0.931 . . . . 0.0 109.678 -177.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.563 ' O ' ' HD2' ' A' ' 154' ' ' ARG . 44.5 mm -67.45 -44.76 86.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 119.682 -0.807 . . . . 0.0 111.109 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.657 HH11 HG13 ' B' ' 255' ' ' VAL . 0.4 OUTLIER -157.31 -156.29 0.58 Allowed 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.864 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -86.51 104.89 16.39 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.469 0.652 . . . . 0.0 111.619 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 88.56 7.96 71.22 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 114.121 -1.4 . . . . 0.0 110.245 -178.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.1 mt -123.52 123.71 67.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 174.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.612 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 69.4 m -132.38 152.57 51.4 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -137.51 143.4 41.66 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.492 177.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 16.3 tp -133.68 78.33 61.81 Favored Pre-proline 0 N--CA 1.465 0.295 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.328 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -69.2 150.19 71.33 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.68 2.253 . . . . 0.0 113.227 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 90.4 mt -118.48 125.99 51.07 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.12 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 51.4 t -122.95 131.57 73.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 117.29 168.63 14.72 Favored Glycine 0 N--CA 1.481 1.683 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.347 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.864 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 56.1 t30 -85.32 114.13 22.16 Favored 'General case' 0 C--O 1.201 -1.48 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -178.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.535 ' CD2' ' CZ ' ' A' ' 171' ' ' PHE . 48.2 tp -73.92 102.45 4.11 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -177.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.585 ' H ' ' HE ' ' A' ' 170' ' ' ARG . 10.5 p -85.49 167.69 15.23 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.446 178.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.91 -34.93 79.27 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.955 0.407 . . . . 0.0 111.894 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.15 -46.66 86.15 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.499 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.864 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 87.6 mtm180 -61.6 -31.74 71.82 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.796 177.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.535 ' CZ ' ' CD2' ' A' ' 166' ' ' LEU . 0.4 OUTLIER -54.97 -28.28 50.41 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -177.53 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.529 ' O ' HG21 ' A' ' 175' ' ' VAL . 92.6 m-20 -60.8 -40.45 92.74 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 119.045 -1.062 . . . . 0.0 110.01 -178.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 58.7 m -59.42 -40.56 87.09 Favored 'General case' 0 C--N 1.322 -0.611 0 O-C-N 121.762 -0.586 . . . . 0.0 110.638 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 67.9 mt -63.66 -44.14 98.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.529 HG21 ' O ' ' A' ' 172' ' ' ASN . 35.2 m -62.29 -40.05 86.38 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . 0.486 ' N ' HG23 ' A' ' 175' ' ' VAL . 96.6 m -62.05 -35.24 78.02 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.318 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' THR . . . . . 0.504 ' O ' HG13 ' A' ' 181' ' ' ILE . 24.9 m -61.48 -19.84 62.48 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.283 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 87.6 mt -60.82 -40.82 94.16 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -177.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 18.5 m -59.48 -43.75 93.19 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.594 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.636 ' O ' ' OG ' ' A' ' 183' ' ' SER . 93.2 m-20 -61.1 -37.5 82.97 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.053 0.454 . . . . 0.0 111.059 178.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 177' ' ' THR . 66.8 mt -57.51 -39.01 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 O-C-N 121.401 -0.812 . . . . 0.0 109.165 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 87.3 mt -60.81 -40.47 92.82 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 119.439 -0.904 . . . . 0.0 108.625 -177.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.636 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 78.0 p -61.48 -34.0 74.72 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.727 176.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 53.0 p -90.45 23.58 2.93 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 122.226 -0.296 . . . . 0.0 111.514 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 78.2 p -63.04 -20.15 65.06 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.644 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.07 -36.2 79.0 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.865 -178.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.612 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 98.7 m-20 -72.55 114.0 10.2 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.568 0.699 . . . . 0.0 110.963 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -62.8 -42.48 99.73 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.919 -177.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -113.26 132.17 55.64 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.104 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 38.1 tp -120.6 128.93 53.5 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 96.4 mt -116.24 127.05 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 O-C-N 121.751 -0.593 . . . . 0.0 109.459 177.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.9 mm -113.08 126.35 70.48 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . 0.565 ' CG ' ' HG ' ' A' ' 195' ' ' SER . 40.2 t0 -95.25 120.34 35.32 Favored 'General case' 0 CA--C 1.551 1.017 0 O-C-N 121.662 -0.648 . . . . 0.0 110.48 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 96.2 mt -101.01 -2.8 30.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.891 176.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.565 ' HG ' ' CG ' ' A' ' 193' ' ' ASP . 78.3 p -63.31 -32.32 73.71 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.85 -47.15 92.02 Favored Glycine 0 CA--C 1.54 1.61 0 N-CA-C 108.171 -1.972 . . . . 0.0 108.171 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 1.089 HD23 ' O ' ' A' ' 199' ' ' GLN . 4.9 tt -66.02 129.82 41.12 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 112.873 -1.664 . . . . 0.0 108.755 -177.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.621 ' N ' HD21 ' A' ' 197' ' ' LEU . . . -60.79 -50.98 71.26 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-O 121.417 0.627 . . . . 0.0 110.931 -179.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 1.089 ' O ' HD23 ' A' ' 197' ' ' LEU . 58.6 tt0 -132.76 156.78 46.46 Favored 'General case' 0 C--O 1.21 -1.017 0 CA-C-N 114.728 -1.124 . . . . 0.0 114.016 -174.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.459 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 46.1 t -117.83 130.69 72.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 O-C-N 120.424 -1.423 . . . . 0.0 108.425 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -83.76 155.86 22.84 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.237 -178.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -64.79 -39.48 93.67 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.988 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -57.24 -31.4 65.5 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 -178.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.8 m -61.42 -42.74 99.22 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.709 178.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.449 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -56.44 -39.06 72.47 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -177.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -61.26 -38.09 85.46 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 121.776 -0.578 . . . . 0.0 110.087 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -64.57 -38.87 92.52 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.916 177.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.02 -44.88 99.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . 0.449 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 67.2 m-85 -61.04 -43.82 98.31 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.009 -177.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.97 -41.59 98.18 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 118.998 -1.081 . . . . 0.0 109.202 -178.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.42 ' O ' ' HG ' ' A' ' 215' ' ' LEU . 38.8 mt -62.39 -42.18 99.23 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' SER . . . . . 0.448 ' HG ' ' N ' ' A' ' 213' ' ' HIS . 78.0 p -61.04 -42.45 98.5 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.463 -178.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' HIS . . . . . 0.448 ' N ' ' HG ' ' A' ' 212' ' ' SER . 58.5 t-80 -64.93 -45.72 84.64 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 122.034 -0.416 . . . . 0.0 111.728 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 50.3 tp -62.41 -45.93 90.88 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 119.021 -1.071 . . . . 0.0 108.15 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 211' ' ' LEU . 89.4 mt -62.84 -41.19 99.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.401 -177.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.03 -44.44 94.63 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.601 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 82.6 mt -61.93 -40.54 95.85 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 68.9 p -75.44 -11.72 60.1 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.241 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.96 40.17 9.6 Favored Glycine 0 C--O 1.217 -0.913 0 C-N-CA 120.617 -0.801 . . . . 0.0 113.863 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 99.9 m -125.99 115.03 19.26 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 119.104 1.452 . . . . 0.0 112.36 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -66.4 136.11 55.28 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.147 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 41.7 tp -111.97 128.69 56.24 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 2.8 mp -116.35 132.61 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.447 HG23 HD11 ' A' ' 224' ' ' ILE . 49.7 mm -114.35 131.39 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 39.7 p -133.38 165.75 24.12 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 120.766 -0.373 . . . . 0.0 111.583 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 79.35 20.35 69.62 Favored Glycine 0 C--O 1.224 -0.508 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 178.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 97.3 mt -81.83 128.83 38.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 113.692 -1.254 . . . . 0.0 108.124 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 66.0 tttt -75.89 139.96 70.21 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.47 -38.23 89.79 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 121.108 1.205 . . . . 0.0 112.453 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -64.94 -39.23 93.19 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-O 121.29 0.566 . . . . 0.0 110.268 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 53.3 tp -63.57 -43.11 97.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.915 -1.039 . . . . 0.0 112.753 177.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.66 -37.66 88.19 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 121.96 -0.463 . . . . 0.0 111.175 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 93.7 mtp -63.2 -40.47 97.6 Favored 'General case' 0 C--O 1.251 1.16 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.704 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -64.32 -39.29 93.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.758 176.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 30.1 mmt -65.45 -37.72 87.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.746 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -60.8 -41.02 94.81 Favored 'General case' 0 CA--C 1.513 -0.447 0 O-C-N 121.48 -0.763 . . . . 0.0 109.491 -176.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.71 -39.9 93.14 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.355 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 52.7 tp -63.18 -42.05 99.3 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 176.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -168.89 128.19 1.08 Allowed 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 121.404 0.621 . . . . 0.0 112.559 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -60.22 -28.02 67.67 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.821 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -61.16 -27.56 68.49 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.674 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -56.42 -43.73 79.66 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -176.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 96.6 p -63.2 -20.84 65.79 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 124.108 0.88 . . . . 0.0 111.298 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 41.7 m -55.25 -34.25 63.85 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 122.056 -0.403 . . . . 0.0 111.763 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 94.3 mt -89.76 121.6 32.07 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -46.1 134.77 8.12 Favored 'General case' 0 C--O 1.248 0.986 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.615 -177.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 97.8 m -126.48 132.8 51.35 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 114.605 -1.18 . . . . 0.0 110.968 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -117.51 139.49 50.86 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.788 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' SER . . . . . 0.462 ' HG ' ' N ' ' A' ' 250' ' ' ASN . 78.3 p -60.68 -42.58 97.38 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -178.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.462 ' N ' ' HG ' ' A' ' 249' ' ' SER . 98.9 m-20 -143.74 160.75 40.17 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.606 0.717 . . . . 0.0 111.651 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.02 -44.79 99.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 114.725 -1.125 . . . . 0.0 112.301 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.89 -44.67 96.78 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -178.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -62.75 -44.38 96.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.599 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -63.59 -42.45 98.28 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.975 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . 0.597 HG13 HH11 ' B' ' 154' ' ' ARG . 66.8 t -63.86 -45.41 97.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-N 114.051 -1.431 . . . . 0.0 110.798 -178.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.77 -47.09 82.36 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.846 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . 0.498 ' O ' ' C ' ' A' ' 258' ' ' LEU . 22.5 m -67.51 -41.09 85.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 O-C-N 121.453 -0.779 . . . . 0.0 112.034 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.498 ' C ' ' O ' ' A' ' 257' ' ' VAL . 1.1 mt -28.17 -74.84 0.04 OUTLIER Pre-proline 0 C--O 1.234 0.265 0 CA-C-O 119.518 -0.277 . . . . 0.0 111.542 -177.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 258' ' ' LEU . 39.9 Cg_endo -62.85 139.84 76.55 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 120.833 1.022 . . . . 0.0 111.934 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 96.6 mt -151.8 -27.17 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 O-C-N 123.779 0.675 . . . . 0.0 111.981 178.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 C--O 1.216 -0.683 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.782 -177.262 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.58 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -165.18 170.26 15.11 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 84.2 p -66.82 -16.71 64.46 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -79.85 -64.21 1.24 Allowed 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.103 -177.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -66.4 -39.81 89.24 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.302 -0.863 . . . . 0.0 113.073 178.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.495 ' O ' ' CB ' ' B' ' 7' ' ' PHE . 58.9 m -59.25 -42.44 91.14 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 -178.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . 0.495 ' CB ' ' O ' ' B' ' 6' ' ' SER . 32.8 t80 87.01 90.96 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.742 0.651 . . . . 0.0 110.697 177.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . 0.524 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -63.27 -142.77 0.01 OUTLIER Glycine 0 C--N 1.339 0.727 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . 0.524 ' HB ' ' O ' ' B' ' 8' ' ' GLY . 64.7 mt 83.88 110.38 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 122.773 0.429 . . . . 0.0 110.784 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -63.15 -23.61 73.08 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 C-N-CA 121.249 1.299 . . . . 0.0 111.812 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.24 -38.81 96.82 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -64.99 -39.07 92.92 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.473 0.654 . . . . 0.0 109.551 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 49.8 tp -61.95 -43.0 99.74 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.507 -177.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -64.45 -31.78 73.14 Favored 'General case' 0 CA--C 1.559 1.317 0 CA-C-O 121.358 0.599 . . . . 0.0 110.614 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 74.6 t -63.27 -46.19 96.31 Favored 'Isoleucine or valine' 0 C--O 1.249 1.053 0 CA-C-N 113.179 -1.828 . . . . 0.0 111.198 177.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.82 -43.69 97.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.795 -178.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . 0.423 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 98.9 mttt -63.31 -42.53 99.04 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.88 -40.54 97.83 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 118.991 -1.084 . . . . 0.0 109.964 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.87 -39.62 89.86 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.018 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 87.6 mt -63.81 -41.93 97.78 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.276 0.56 . . . . 0.0 110.33 175.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -62.87 -39.01 93.12 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.798 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 56.4 m170 -58.2 -39.68 79.62 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 121.086 -0.246 . . . . 0.0 111.521 -178.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 13.6 p -114.71 130.11 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.454 ' O ' ' HG3' ' B' ' 24' ' ' ARG . 31.6 ptt180 -72.43 108.17 5.38 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.687 0.755 . . . . 0.0 112.582 -177.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.0 p -142.6 134.22 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.731 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . 0.569 ' O ' ' N ' ' B' ' 123' ' ' GLN . . . -88.25 96.99 2.25 Favored Glycine 0 C--N 1.31 -0.913 0 C-N-CA 119.655 -1.26 . . . . 0.0 113.43 -176.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 48.5 t -125.74 129.19 72.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 174.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 30.2 m -138.33 156.19 29.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.473 178.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 96.1 mt -118.0 124.71 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.247 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 25.9 p -102.31 159.34 15.49 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 113.146 -1.843 . . . . 0.0 108.603 -178.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -127.43 101.74 24.25 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.3 -18.58 60.98 Favored 'Trans proline' 0 N--CA 1.49 1.309 0 C-N-CA 121.683 1.589 . . . . 0.0 111.477 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.09 -39.9 94.03 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.576 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 93.8 mt -77.16 -164.71 0.48 Allowed 'General case' 0 N--CA 1.475 0.8 0 O-C-N 122.106 -0.371 . . . . 0.0 111.057 -178.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . 0.666 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 42.4 tt0 -87.56 129.87 34.95 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.45 ' O ' ' OD1' ' B' ' 36' ' ' ASP . 62.8 t0 57.47 35.42 25.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.751 177.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' ASN . . . . . 0.424 ' C ' ' O ' ' B' ' 36' ' ' ASP . 20.0 t-20 33.04 68.95 0.92 Allowed Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.666 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 89.3 Cg_endo -72.09 155.76 56.54 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 123.745 2.963 . . . . 0.0 111.865 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 95.6 mt -88.21 127.99 40.85 Favored 'Isoleucine or valine' 0 C--O 1.246 0.908 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.438 HG21 ' N ' ' B' ' 41' ' ' TYR . 27.7 m -107.73 -43.03 6.31 Favored 'Isoleucine or valine' 0 C--N 1.343 0.3 0 O-C-N 123.892 0.745 . . . . 0.0 112.603 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' TYR . . . . . 0.438 ' N ' HG21 ' B' ' 40' ' ' VAL . 48.3 t80 -97.01 123.9 40.85 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.366 -178.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 5.7 p -142.94 140.92 27.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 124.212 0.945 . . . . 0.0 109.293 177.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . 0.609 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 57.2 p30 -100.34 161.6 13.5 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.035 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' GLN . . . . . 0.438 ' HA ' ' OE1' ' B' ' 44' ' ' GLN . 13.8 mm100 -63.4 -38.02 89.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.569 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.37 -25.6 63.0 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.609 ' HB2' ' OD1' ' B' ' 43' ' ' ASN . 62.6 t80 -59.96 -43.86 94.79 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . 0.629 HG11 ' O ' ' B' ' 52' ' ' TYR . 63.3 t -61.3 -45.69 98.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.153 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -62.87 -44.19 96.77 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.057 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 59.4 ttm -62.81 -42.83 99.88 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 34.5 p -95.62 -15.89 22.45 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.72 -178.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' B' ' 47' ' ' VAL . . . 73.46 19.22 79.64 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.336 -1.105 . . . . 0.0 110.336 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . 0.629 ' O ' HG11 ' B' ' 47' ' ' VAL . 78.4 m-85 -110.75 145.19 38.53 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 115.27 -0.465 . . . . 0.0 110.1 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -74.18 149.02 41.15 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 121.817 0.818 . . . . 0.0 110.874 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.99 -37.7 85.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.084 -177.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.03 -39.09 93.32 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 120.085 -0.646 . . . . 0.0 112.196 -178.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -72.59 -31.51 65.26 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 177.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 92.1 mt -69.91 -61.73 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 97.0 mt -49.49 133.86 19.93 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 123.966 0.791 . . . . 0.0 109.984 -178.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.98 -10.19 72.21 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.712 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -131.48 149.34 52.56 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -176.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' ASN . . . . . 0.577 ' C ' ' H ' ' B' ' 63' ' ' ARG . 25.2 t-20 -79.62 151.49 30.56 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.619 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' CYS . . . . . . . . . . . . . 83.5 m -63.28 9.9 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.256 -178.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . 0.577 ' H ' ' C ' ' B' ' 61' ' ' ASN . 33.5 ptt-85 -60.06 -32.31 70.81 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.585 -177.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -60.5 -30.89 70.0 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 85.6 mt -62.21 -41.86 98.77 Favored 'General case' 0 C--O 1.238 0.462 0 O-C-N 121.601 -0.687 . . . . 0.0 109.758 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . 0.489 HE22 HO4' ' B' ' 900' ' ' FMN . 88.5 mt-30 -50.12 143.81 7.79 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -177.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . 0.498 ' HA3' ' CE1' ' B' ' 95' ' ' TYR . . . -155.08 -152.86 6.3 Favored Glycine 0 C--N 1.353 1.473 0 CA-C-N 115.967 -0.561 . . . . 0.0 112.156 176.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . 0.504 ' HB3' ' HH ' ' B' ' 95' ' ' TYR . 88.8 tttt -60.25 -42.43 95.27 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -175.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -74.77 -9.92 59.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.069 -178.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 27.4 m -60.64 133.5 56.16 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -90.55 110.92 44.56 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.39 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.64 -38.09 90.97 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 120.978 1.119 . . . . 0.0 111.63 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.16 -40.6 90.43 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -176.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' GLU . . . . . 0.405 ' OE1' ' HB ' ' B' ' 90' ' ' VAL . 79.5 mm-40 -67.0 -38.29 85.73 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.963 177.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 70.2 t -63.42 -44.76 99.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.091 0.472 . . . . 0.0 109.819 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -63.18 -37.3 86.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.7 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -62.44 -42.03 99.16 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 119.276 -0.97 . . . . 0.0 108.955 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 92.6 mt -63.51 -43.72 98.44 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 CA-C-O 120.894 0.378 . . . . 0.0 110.924 -178.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -61.37 -42.54 98.87 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 83.0 m -61.33 -44.93 96.37 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.884 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.99 -42.58 99.3 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -177.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.36 -42.49 99.44 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -62.91 -39.88 95.87 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -81.61 -4.02 54.98 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.803 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 36.7 tttt 50.08 48.52 21.88 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 121.825 -0.547 . . . . 0.0 111.649 177.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -132.93 144.58 53.44 Favored Pre-proline 0 N--CA 1.472 0.673 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.334 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.43 139.62 77.7 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 120.765 0.977 . . . . 0.0 114.045 -177.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -139.98 135.55 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.592 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' THR . . . . . 0.499 ' CG2' ' OD1' ' B' ' 107' ' ' ASN . 98.9 m -119.9 120.72 37.24 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . 0.405 ' HB ' ' OE1' ' B' ' 74' ' ' GLU . 30.7 m -138.33 161.95 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.594 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -114.42 121.21 42.88 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 175.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 20.8 tt -128.43 132.65 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.798 -175.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . 0.423 ' O ' ' ND2' ' B' ' 94' ' ' ASN . 85.7 mt-30 -71.21 141.67 50.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.076 178.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' ASN . . . . . 0.423 ' ND2' ' O ' ' B' ' 93' ' ' GLN . 8.9 m120 -134.92 179.95 5.99 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 121.247 0.546 . . . . 0.0 111.107 -177.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' TYR . . . . . 0.504 ' HH ' ' HB3' ' B' ' 68' ' ' LYS . 95.6 m-85 -130.23 149.68 51.81 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 114.524 -1.216 . . . . 0.0 111.855 177.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . 0.419 ' HG3' ' CE1' ' B' ' 102' ' ' PHE . 99.0 mttt -103.41 -177.07 3.26 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.269 0.557 . . . . 0.0 110.716 176.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.4 -35.07 76.48 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.647 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 36.6 p-10 -88.17 -0.33 56.96 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.271 -0.893 . . . . 0.0 113.042 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.38 3.73 66.83 Favored Glycine 0 N--CA 1.465 0.574 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.109 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 25.5 m -67.66 130.49 43.17 Favored 'General case' 0 N--CA 1.443 -0.801 0 O-C-N 122.159 -0.612 . . . . 0.0 109.39 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' MET . . . . . 0.57 ' SD ' ' N ' ' B' ' 102' ' ' PHE . 15.8 tmm? -90.15 142.47 27.69 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' PHE . . . . . 0.57 ' N ' ' SD ' ' B' ' 101' ' ' MET . 53.9 p90 -152.72 163.72 39.15 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 177.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' TRP . . . . . 0.839 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 22.1 m95 -95.65 140.16 30.87 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.342 178.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 62.6 t-20 -133.94 106.47 7.28 Favored 'General case' 0 C--O 1.217 -0.631 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -75.03 123.88 25.97 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 125.193 1.558 . . . . 0.0 109.262 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 38.9 tp -112.81 125.71 54.64 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 123.58 0.55 . . . . 0.0 111.608 -177.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' ASN . . . . . 0.499 ' OD1' ' CG2' ' B' ' 89' ' ' THR . 98.1 m-20 -118.96 127.7 53.72 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 176.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 96.5 mt -123.12 132.97 70.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -143.33 125.03 8.4 Favored Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -70.19 152.0 66.88 Favored 'Trans proline' 0 N--CA 1.5 1.878 0 C-N-CA 122.254 1.969 . . . . 0.0 112.624 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' MET . . . . . 0.492 ' HB2' ' HB2' ' B' ' 118' ' ' TYR . 67.2 mtt -128.69 142.17 51.1 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -113.67 109.86 19.28 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . 0.792 HG12 ' HZ3' ' A' ' 18' ' ' LYS . 96.7 mt -136.11 127.92 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 O-C-N 121.352 -0.842 . . . . 0.0 111.709 178.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 52.49 37.33 22.6 Favored 'General case' 0 C--O 1.236 0.375 0 O-C-N 123.819 0.7 . . . . 0.0 109.63 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 61.71 35.74 16.78 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.519 0.676 . . . . 0.0 110.248 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -132.21 151.36 51.85 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 177.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 5.1 t -101.02 154.21 18.9 Favored 'General case' 0 C--O 1.215 -0.748 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' TYR . . . . . 0.492 ' HB2' ' HB2' ' B' ' 111' ' ' MET . 90.7 m-85 -149.16 145.32 27.11 Favored 'General case' 0 C--N 1.318 -0.791 0 O-C-N 121.09 -1.006 . . . . 0.0 111.152 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -120.02 139.25 52.79 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 120.812 0.339 . . . . 0.0 111.821 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -128.92 137.35 57.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -177.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -113.54 126.21 7.3 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 94.9 mt -114.29 127.92 71.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 123' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' B' ' 26' ' ' GLY . 17.6 mp0 -117.87 123.42 45.83 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -121.56 124.19 43.77 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . 0.583 ' OD1' ' N ' ' B' ' 127' ' ' THR . 67.5 t0 -74.94 126.06 30.2 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.556 -177.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . 0.564 ' O ' ' HG3' ' B' ' 130' ' ' LYS . 3.5 mp -98.98 18.85 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.424 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 127' ' ' THR . . . . . 0.583 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 98.1 m -64.55 -44.75 89.79 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 114.326 -1.306 . . . . 0.0 112.781 175.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -59.96 -45.19 93.44 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 -177.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 129' ' ' GLN . . . . . 0.437 ' OE1' HG21 ' B' ' 126' ' ' ILE . 88.5 mt-30 -63.6 -35.02 79.14 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.441 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 130' ' ' LYS . . . . . 0.839 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 99.0 mttt -63.27 -42.0 99.09 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-N 113.232 -1.803 . . . . 0.0 110.822 174.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.99 -41.69 97.44 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 132' ' ' TYR . . . . . 0.451 ' CE2' HD13 ' B' ' 136' ' ' LEU . 89.0 t80 -60.43 -45.3 94.13 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.948 -0.47 . . . . 0.0 111.341 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.23 -37.05 86.09 Favored 'General case' 0 C--O 1.218 -0.586 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.438 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 134' ' ' LYS . . . . . 0.435 ' HG3' ' O ' ' B' ' 130' ' ' LYS . 99.0 mttt -62.63 -39.71 94.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.89 177.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 53.2 tp -62.68 -41.12 98.92 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . 0.451 HD13 ' CE2' ' B' ' 132' ' ' TYR . 87.7 mt -62.83 -41.78 99.46 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 114.858 -1.064 . . . . 0.0 111.566 177.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 137' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.69 -36.93 85.87 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.484 -178.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -63.28 -44.07 96.15 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.873 177.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 63.2 m -61.04 -44.05 97.98 Favored 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 85.6 mt -61.98 -40.23 94.91 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -177.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 86.1 m -61.88 -45.52 93.39 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.173 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -65.66 -41.64 92.29 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 93.0 mt -63.8 -43.12 97.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 114.458 -1.247 . . . . 0.0 110.559 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 144' ' ' THR . . . . . . . . . . . . . 89.0 m -61.69 -45.09 95.47 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -178.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . 0.41 ' O ' ' HB ' ' B' ' 148' ' ' THR . . . -63.8 -40.92 97.81 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 118.958 -1.097 . . . . 0.0 109.278 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 87.3 mt -64.53 -41.59 96.28 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 147' ' ' SER . . . . . 0.628 ' O ' ' N ' ' B' ' 149' ' ' PRO . 77.9 p -60.89 -42.1 97.34 Favored 'General case' 0 CA--C 1.481 -1.676 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 -178.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 148' ' ' THR . . . . . 0.469 ' C ' ' O ' ' B' ' 147' ' ' SER . 23.2 m -29.42 84.91 0.03 OUTLIER Pre-proline 0 N--CA 1.482 1.169 0 O-C-N 123.959 0.787 . . . . 0.0 110.182 178.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 149' ' ' PRO . . . . . 0.628 ' N ' ' O ' ' B' ' 147' ' ' SER . 22.0 Cg_exo -61.46 148.24 93.46 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.865 1.71 . . . . 0.0 115.849 -176.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 9.6 tp -125.91 117.43 48.99 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.156 0 CA-C-N 114.273 -1.33 . . . . 0.0 107.805 173.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 40.1 t -146.99 92.94 4.85 Favored Pre-proline 0 C--N 1.314 -0.946 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.592 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -60.81 136.39 65.96 Favored 'Trans proline' 0 C--N 1.316 -1.154 0 CA-C-N 120.321 1.15 . . . . 0.0 109.219 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 153' ' ' ILE . . . . . 0.629 HG21 HH12 ' A' ' 154' ' ' ARG . 44.6 mm -68.4 -44.35 83.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.956 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . 0.636 ' HD3' ' NH2' ' A' ' 154' ' ' ARG . 0.4 OUTLIER -156.56 -154.55 0.48 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.464 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 59.3 t-20 -87.02 108.03 18.68 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 121.024 0.44 . . . . 0.0 110.156 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.79 -17.31 58.47 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 -178.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 85.3 mt -109.38 124.07 65.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.275 0.56 . . . . 0.0 111.002 -176.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 158' ' ' SER . . . . . 0.584 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 74.5 m -134.74 149.75 50.49 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.738 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' B' ' 191' ' ' ILE . . . -132.25 147.27 52.4 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 18.0 tp -138.96 77.72 31.12 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 161' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -70.79 146.82 54.83 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 122.867 2.378 . . . . 0.0 114.095 -178.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 92.0 mt -113.03 133.85 54.79 Favored 'General case' 0 C--N 1.345 0.37 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 56.1 t -129.29 132.98 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 177.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 114.86 168.47 15.81 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.012 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 165' ' ' ASN . . . . . 0.768 ' O ' ' CZ ' ' B' ' 170' ' ' ARG . 61.4 t30 -90.03 106.65 18.62 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -177.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . 0.511 ' CD2' ' CZ ' ' B' ' 171' ' ' PHE . 42.3 tp -64.3 104.23 0.73 Allowed 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -174.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 167' ' ' THR . . . . . 0.571 ' CG2' HH21 ' B' ' 170' ' ' ARG . 9.6 p -85.73 168.6 14.2 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 113.806 -1.543 . . . . 0.0 111.094 177.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.05 -38.68 91.64 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.607 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -65.85 -41.68 91.38 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 122.402 1.096 . . . . 0.0 111.778 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 170' ' ' ARG . . . . . 0.768 ' CZ ' ' O ' ' B' ' 165' ' ' ASN . 87.8 mtm180 -61.53 -34.72 76.03 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 112.558 -2.11 . . . . 0.0 110.952 178.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 171' ' ' PHE . . . . . 0.511 ' CZ ' ' CD2' ' B' ' 166' ' ' LEU . 0.5 OUTLIER -54.89 -25.9 32.16 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -178.782 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 172' ' ' ASN . . . . . 0.494 ' O ' HG21 ' B' ' 175' ' ' VAL . 92.4 m-20 -62.74 -40.33 96.88 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.834 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 55.3 m -59.85 -41.41 91.36 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.013 0.435 . . . . 0.0 110.598 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 68.2 mt -63.87 -44.15 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 175' ' ' VAL . . . . . 0.494 HG21 ' O ' ' B' ' 172' ' ' ASN . 35.6 m -62.45 -40.01 86.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 176' ' ' CYS . . . . . 0.493 ' N ' HG23 ' B' ' 175' ' ' VAL . 98.1 m -61.95 -35.3 78.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.329 179.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 177' ' ' THR . . . . . 0.544 ' O ' HG13 ' B' ' 181' ' ' ILE . 25.0 m -61.84 -19.67 62.85 Favored 'General case' 0 C--O 1.22 -0.494 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.38 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 178' ' ' LEU . . . . . . . . . . . . . 89.6 mt -60.83 -39.24 88.29 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.238 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 18.9 m -61.74 -44.29 97.21 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.547 177.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 180' ' ' ASN . . . . . 0.612 ' O ' ' OG ' ' B' ' 183' ' ' SER . 92.3 m-20 -61.74 -39.99 93.53 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.161 0.505 . . . . 0.0 110.537 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . 0.544 HG13 ' O ' ' B' ' 177' ' ' THR . 73.0 mt -55.99 -33.48 35.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 O-C-N 122.143 -0.348 . . . . 0.0 110.465 -178.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 182' ' ' LEU . . . . . . . . . . . . . 86.7 mt -62.38 -41.74 98.87 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.163 178.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 183' ' ' SER . . . . . 0.612 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.1 p -63.33 -32.89 74.43 Favored 'General case' 0 C--O 1.225 -0.221 0 O-C-N 121.905 -0.497 . . . . 0.0 110.768 177.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 45.9 p -86.96 17.04 4.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.907 0.384 . . . . 0.0 111.769 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 78.6 p -60.6 -16.51 38.98 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.966 -177.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.64 -40.3 94.41 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 122.075 -0.39 . . . . 0.0 110.811 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 187' ' ' ASP . . . . . 0.584 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.3 m-20 -68.52 114.41 6.9 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.576 0.703 . . . . 0.0 110.793 -178.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.88 -42.23 99.69 Favored 'General case' 0 C--O 1.25 1.109 0 CA-C-N 114.997 -1.001 . . . . 0.0 113.242 -178.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -113.0 131.77 55.63 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 120.711 -0.395 . . . . 0.0 111.386 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 190' ' ' LEU . . . . . . . . . . . . . 40.8 tp -123.97 118.96 28.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.372 177.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 191' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' B' ' 159' ' ' ALA . 85.6 mt -106.38 125.71 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 121.128 -0.229 . . . . 0.0 111.444 -178.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 48.7 mm -115.16 117.01 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 193' ' ' ASP . . . . . 0.598 ' CG ' ' HG ' ' B' ' 195' ' ' SER . 43.0 t0 -89.42 113.09 24.38 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -176.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 194' ' ' LEU . . . . . . . . . . . . . 96.2 mt -95.45 -1.1 51.55 Favored 'General case' 0 C--O 1.239 0.509 0 O-C-N 122.265 -0.272 . . . . 0.0 110.691 177.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 195' ' ' SER . . . . . 0.598 ' HG ' ' CG ' ' B' ' 193' ' ' ASP . 78.1 p -61.17 -36.7 80.54 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.0 -178.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.42 -37.37 94.0 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 197' ' ' LEU . . . . . 1.039 HD23 ' O ' ' B' ' 199' ' ' GLN . 5.2 tt -72.34 133.63 45.07 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -178.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 198' ' ' ALA . . . . . 0.654 ' N ' HD21 ' B' ' 197' ' ' LEU . . . -61.81 -49.19 77.32 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 119.556 -0.858 . . . . 0.0 111.137 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 199' ' ' GLN . . . . . 1.039 ' O ' HD23 ' B' ' 197' ' ' LEU . 58.3 tt0 -134.5 164.55 27.22 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-O 121.783 0.802 . . . . 0.0 113.04 -178.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 200' ' ' VAL . . . . . 0.477 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 50.1 t -120.19 130.72 74.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 O-C-N 120.368 -1.458 . . . . 0.0 109.502 176.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -86.15 151.56 23.56 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.658 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -62.64 -33.12 74.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.439 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -63.46 -31.93 73.23 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.6 m -60.92 -43.78 98.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.186 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 205' ' ' ALA . . . . . 0.641 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -58.73 -30.06 67.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 119.26 -0.4 . . . . 0.0 111.848 -178.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -64.61 -39.08 93.08 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 123.79 0.681 . . . . 0.0 110.191 175.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -66.33 -38.69 88.24 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.694 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 96.3 mt -63.14 -43.92 99.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -178.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 209' ' ' PHE . . . . . 0.641 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 64.0 m-85 -61.56 -43.57 98.62 Favored 'General case' 0 C--O 1.242 0.692 0 O-C-N 124.682 1.239 . . . . 0.0 111.856 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -62.9 -41.48 99.45 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.25 -0.98 . . . . 0.0 109.727 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . 0.449 ' O ' ' HG ' ' B' ' 215' ' ' LEU . 37.8 mt -62.45 -42.43 99.46 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.189 -179.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 212' ' ' SER . . . . . 0.448 ' HG ' ' N ' ' B' ' 213' ' ' HIS . 78.2 p -62.74 -37.58 87.14 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.283 -0.567 . . . . 0.0 112.141 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 213' ' ' HIS . . . . . 0.448 ' N ' ' HG ' ' B' ' 212' ' ' SER . 58.8 t-80 -66.31 -47.21 74.27 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.34 178.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 53.4 tp -63.79 -43.44 96.32 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.616 0.722 . . . . 0.0 109.532 178.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 215' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' B' ' 211' ' ' LEU . 90.7 mt -63.09 -43.18 99.23 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 113.466 -1.697 . . . . 0.0 111.214 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.85 -39.46 94.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.727 -0.215 . . . . 0.0 110.933 -177.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 85.7 mt -63.25 -42.46 99.18 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.203 0.525 . . . . 0.0 111.39 176.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 218' ' ' THR . . . . . . . . . . . . . 71.9 p -75.3 -14.15 60.48 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.683 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 77.79 72.66 1.13 Allowed Glycine 0 CA--C 1.528 0.877 0 N-CA-C 107.141 -2.384 . . . . 0.0 107.141 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 220' ' ' THR . . . . . . . . . . . . . 81.7 m -151.72 100.8 2.72 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 177.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -58.59 140.09 54.88 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 121.849 -0.532 . . . . 0.0 111.103 -177.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 42.0 tp -117.49 120.72 38.97 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.171 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 2.9 mp -109.92 128.91 65.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.166 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 224' ' ' ILE . . . . . . . . . . . . . 50.4 mm -110.68 127.47 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 O-C-N 123.572 0.545 . . . . 0.0 109.532 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 43.7 p -134.42 157.57 46.11 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 90.78 16.17 55.17 Favored Glycine 0 N--CA 1.442 -0.967 0 CA-C-N 113.949 -1.478 . . . . 0.0 111.228 -177.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 95.9 mt -81.74 126.63 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 CA-C-N 117.889 0.845 . . . . 0.0 111.686 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 61.2 tttt -67.01 139.28 95.43 Favored Pre-proline 0 C--N 1.316 -0.854 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.521 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.85 -37.04 92.78 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 121.354 1.37 . . . . 0.0 112.483 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -63.08 -43.48 98.4 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 53.1 tp -62.42 -41.98 99.1 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.679 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -62.95 -36.99 85.29 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.892 0.377 . . . . 0.0 111.367 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 94.6 mtp -63.75 -41.15 98.06 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.758 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.3 -43.33 99.07 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 121.995 0.902 . . . . 0.0 109.366 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 30.2 mmt -64.33 -35.85 82.22 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.896 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -61.08 -40.62 94.38 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.987 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.77 -43.05 99.82 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.287 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 52.7 tp -62.68 -44.25 96.73 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 121.883 -0.51 . . . . 0.0 112.27 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 239' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' B' ' 240' ' ' ALA . 66.7 t0 -159.28 133.42 7.62 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 120.149 -0.62 . . . . 0.0 111.982 -178.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 240' ' ' ALA . . . . . 0.4 ' N ' ' OD1' ' B' ' 239' ' ' ASP . . . -60.98 -47.76 84.95 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 241' ' ' ASN . . . . . 0.478 ' O ' ' HB2' ' B' ' 244' ' ' SER . 90.2 m-20 -43.23 -19.37 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.475 -175.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 242' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -60.34 -45.03 94.9 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.172 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 243' ' ' SER . . . . . . . . . . . . . 78.1 p -58.77 -42.03 88.01 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 244' ' ' SER . . . . . 0.478 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 25.2 m -35.25 -32.53 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -177.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 98.9 mt -90.41 131.54 36.12 Favored 'General case' 0 CA--C 1.513 -0.452 0 O-C-N 121.1 -1.0 . . . . 0.0 110.061 178.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -59.47 134.89 57.42 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 121.421 0.629 . . . . 0.0 110.376 -176.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 247' ' ' THR . . . . . . . . . . . . . 97.3 m -125.62 127.99 47.19 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.484 -1.235 . . . . 0.0 111.861 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -113.3 144.15 43.22 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 249' ' ' SER . . . . . 0.563 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 78.6 p -64.57 -33.66 76.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.476 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 250' ' ' ASN . . . . . 0.563 ' OD1' ' O ' ' B' ' 249' ' ' SER . 99.0 m-20 -147.2 160.11 42.85 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.971 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 61.7 t -64.21 -44.69 97.49 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.254 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.293 177.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 252' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.24 -45.4 94.68 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -177.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -61.51 -44.24 97.42 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.75 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 254' ' ' ALA . . . . . . . . . . . . . . . -65.44 -40.65 93.52 Favored 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.893 178.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 255' ' ' VAL . . . . . 0.657 HG13 HH11 ' A' ' 154' ' ' ARG . 74.2 t -64.66 -45.48 95.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.3 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -63.04 -48.46 78.62 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 120.132 -0.627 . . . . 0.0 111.118 -178.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 257' ' ' VAL . . . . . 0.486 ' O ' ' C ' ' B' ' 258' ' ' LEU . 20.1 m -65.55 -40.79 89.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.662 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 258' ' ' LEU . . . . . 0.508 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 1.0 OUTLIER -31.58 -73.67 0.05 OUTLIER Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 119.499 -0.286 . . . . 0.0 111.664 -178.009 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 259' ' ' PRO . . . . . 0.508 ' CD ' ' CB ' ' B' ' 258' ' ' LEU . 36.6 Cg_endo -61.81 139.99 83.17 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 121.531 1.487 . . . . 0.0 111.575 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 260' ' ' ILE . . . . . 0.445 HG13 ' O ' ' B' ' 259' ' ' PRO . 96.6 mt -157.47 -14.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 118.665 0.666 . . . . 0.0 112.054 177.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 78.3 mtm . . . . . 0 C--O 1.214 -0.801 0 CA-C-O 117.761 -1.114 . . . . 0.0 111.573 -179.588 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 900' ' ' FMN . . . . . 0.553 HO2' HD22 ' A' ' 61' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 900' ' ' FMN . . . . . 0.577 " C2'" ' OD1' ' B' ' 61' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.406 ' O ' ' OG ' ' A' ' 6' ' ' SER . . . -153.14 171.81 17.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 118.968 -0.539 . . . . 0.0 110.226 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.5 p -71.3 -14.89 62.36 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.332 0.653 . . . . 0.0 110.757 177.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -75.53 -66.3 0.79 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.615 175.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -67.28 -39.3 85.99 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.969 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.511 ' O ' ' HB3' ' A' ' 7' ' ' PHE . 63.1 m -59.44 -42.56 92.19 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.114 -176.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.511 ' HB3' ' O ' ' A' ' 6' ' ' SER . 44.3 t80 85.52 85.69 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 O-C-N 123.707 0.63 . . . . 0.0 112.495 177.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.645 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -62.21 -152.15 0.03 OUTLIER Glycine 0 CA--C 1.529 0.967 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -177.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.645 ' HB ' ' O ' ' A' ' 8' ' ' GLY . 66.9 mt 93.63 108.89 0.02 OUTLIER Pre-proline 0 N--CA 1.472 0.66 0 C-N-CA 122.371 0.269 . . . . 0.0 110.579 -178.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.48 -22.77 71.12 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 121.539 1.493 . . . . 0.0 112.181 -178.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.43 -38.3 96.15 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.112 -0.566 . . . . 0.0 111.726 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -65.52 -38.7 90.43 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.654 0.74 . . . . 0.0 109.706 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 52.5 tp -62.71 -41.39 99.12 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.412 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -64.25 -39.04 93.14 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.5 t -60.51 -44.16 95.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 O-C-N 122.186 -0.321 . . . . 0.0 110.434 -178.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 92.4 mt -62.71 -43.64 98.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 C-N-CA 119.756 -0.777 . . . . 0.0 109.3 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.413 ' NZ ' ' HA ' ' B' ' 6' ' ' SER . 98.9 mttt -62.12 -45.37 93.76 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 119.365 -0.934 . . . . 0.0 112.221 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.648 ' NZ ' HG12 ' B' ' 113' ' ' ILE . 98.7 mttt -60.1 -40.21 88.84 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 118.672 -1.211 . . . . 0.0 109.124 -176.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.34 -42.68 96.21 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.157 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.7 mt -62.95 -41.18 99.43 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.118 0.485 . . . . 0.0 109.926 178.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -63.49 -37.99 89.41 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.499 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 57.6 m170 -58.92 -39.8 82.63 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 122.179 -0.326 . . . . 0.0 111.254 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.2 p -113.82 130.44 67.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.481 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 34.6 ptt180 -72.51 110.25 6.76 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.99 0.9 . . . . 0.0 112.08 -177.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.3 p -140.98 143.14 28.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.164 178.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.472 ' O ' ' N ' ' A' ' 123' ' ' GLN . . . -97.91 91.76 1.2 Allowed Glycine 0 C--N 1.312 -0.768 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.76 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.4 t -124.84 130.25 73.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 175.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.4 m -137.17 159.99 36.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.6 mt -119.85 131.14 73.13 Favored 'Isoleucine or valine' 0 C--O 1.247 0.965 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 176.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.476 HG21 HG12 ' A' ' 39' ' ' ILE . 72.6 p -108.04 165.98 11.06 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.415 ' C ' ' OD1' ' A' ' 37' ' ' ASN . 56.1 t0 -130.8 103.29 15.94 Favored Pre-proline 0 C--N 1.319 -0.719 0 C-N-CA 121.087 -0.245 . . . . 0.0 110.538 178.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -62.69 -23.61 74.63 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 121.365 1.376 . . . . 0.0 111.701 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.78 -36.38 83.68 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.729 -178.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.6 mt -83.74 156.12 22.73 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.641 177.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.743 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 43.0 tt0 -58.1 138.06 56.4 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -176.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.548 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 60.0 t0 59.29 20.47 8.64 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.767 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.415 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 46.5 t-20 40.29 68.58 2.2 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.072 -177.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.743 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 91.2 Cg_endo -70.69 155.31 63.11 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 124.06 3.173 . . . . 0.0 112.649 -178.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.476 HG12 HG21 ' A' ' 30' ' ' THR . 95.8 mt -87.68 123.85 40.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.47 HG21 ' N ' ' A' ' 41' ' ' TYR . 28.0 m -104.21 -43.41 8.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.883 -178.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.47 ' N ' HG21 ' A' ' 40' ' ' VAL . 43.5 t80 -94.84 124.31 38.81 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.552 -177.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.7 p -143.35 141.1 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 O-C-N 124.314 1.009 . . . . 0.0 109.345 177.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.653 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 56.8 p30 -98.45 166.76 11.21 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.517 ' HA ' ' OE1' ' A' ' 44' ' ' GLN . 13.5 mm100 -66.7 -39.04 87.9 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 120.887 0.375 . . . . 0.0 111.868 177.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.17 -25.98 63.04 Favored Glycine 0 C--N 1.332 0.346 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.653 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 62.9 t80 -59.22 -48.42 81.67 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 -178.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.477 HG11 ' O ' ' A' ' 52' ' ' TYR . 53.7 t -58.88 -44.9 91.72 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.542 0 O-C-N 121.274 -0.891 . . . . 0.0 111.074 -173.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -63.26 -37.71 88.31 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.768 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 59.7 ttm -67.17 -44.14 80.48 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 176.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 37.9 p -90.26 -23.2 21.27 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.146 0.498 . . . . 0.0 111.845 -178.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . 77.74 19.34 75.86 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.477 ' O ' HG11 ' A' ' 47' ' ' VAL . 77.4 m-85 -112.71 138.09 50.03 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.1 0.56 . . . . 0.0 111.606 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -63.75 148.2 49.78 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.535 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.54 -32.41 73.98 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.02 -43.43 87.66 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.434 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -64.73 -44.23 90.84 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.621 178.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 88.3 mt -61.49 -51.3 74.46 Favored 'Isoleucine or valine' 0 C--N 1.347 0.489 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -174.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 86.0 mt -56.83 146.03 27.62 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 177.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.17 -6.63 74.88 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-O 119.339 -0.7 . . . . 0.0 112.829 176.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -135.0 150.52 50.34 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.832 1.316 . . . . 0.0 111.882 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.638 HD22 HO2' ' A' ' 900' ' ' FMN . 24.9 t-20 -80.17 150.75 30.06 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.241 0.543 . . . . 0.0 110.771 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 76.8 m -63.14 15.86 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.502 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.565 ' H ' ' C ' ' A' ' 61' ' ' ASN . 35.8 ptt-85 -61.67 -41.36 97.44 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.262 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -56.41 -20.49 19.89 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -178.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.8 mt -68.23 -34.3 75.99 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.546 0.689 . . . . 0.0 112.506 177.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.502 HE22 HO4' ' A' ' 900' ' ' FMN . 88.1 mt-30 -64.53 137.83 58.07 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.439 -0.8 . . . . 0.0 112.374 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.567 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -146.54 -147.06 4.49 Favored Glycine 0 CA--C 1.544 1.898 0 C-N-CA 120.825 -0.703 . . . . 0.0 111.892 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.525 ' HB3' ' HH ' ' A' ' 95' ' ' TYR . 88.7 tttt -63.01 -40.29 97.32 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -177.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.498 ' HD1' HE22 ' A' ' 93' ' ' GLN . 12.6 m-70 -76.77 -7.85 56.19 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.035 -178.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.567 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 28.9 m -63.56 128.82 37.55 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.379 -0.528 . . . . 0.0 109.807 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -84.91 109.3 19.54 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.708 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' A' ' 70' ' ' THR . 51.5 Cg_exo -56.83 -32.97 93.56 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.042 1.828 . . . . 0.0 113.11 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.46 -39.54 94.0 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.207 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -64.88 -42.31 94.93 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 77.8 t -60.38 -43.65 94.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 114.242 -1.344 . . . . 0.0 107.679 -175.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -63.47 -37.72 88.4 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.928 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -63.77 -40.08 95.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.253 0.549 . . . . 0.0 110.443 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.75 -44.08 98.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-O 122.156 0.979 . . . . 0.0 111.99 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -63.25 -42.92 99.23 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 113.522 -1.672 . . . . 0.0 108.183 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 96.6 m -61.45 -49.92 74.88 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 120.061 -0.655 . . . . 0.0 109.776 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.66 -42.14 87.75 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-O 119.183 -0.437 . . . . 0.0 111.297 -174.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.402 HD23 ' CE1' ' A' ' 119' ' ' PHE . 84.2 mt -63.12 -39.52 94.93 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 119.386 0.994 . . . . 0.0 111.439 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -65.29 -33.22 75.47 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -88.75 -2.13 58.43 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.543 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.8 tttt 50.08 41.65 23.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.752 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -126.06 144.0 47.41 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -61.61 143.55 96.86 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 121.303 1.335 . . . . 0.0 113.595 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -139.51 141.62 34.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.721 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 91.2 m -125.47 122.42 36.6 Favored 'General case' 0 C--N 1.342 0.271 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 175.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 29.7 m -138.93 157.97 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.675 176.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -102.41 134.33 45.91 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 176.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.7 tt -141.89 130.65 22.63 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.181 0 CA-C-N 120.5 1.5 . . . . 0.0 112.977 177.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.498 HE22 ' HD1' ' A' ' 69' ' ' HIS . 86.0 mt-30 -64.75 132.7 50.32 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.871 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -134.09 156.19 48.7 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.46 -178.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.525 ' HH ' ' HB3' ' A' ' 68' ' ' LYS . 93.9 m-85 -115.89 134.07 55.37 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -83.03 -173.66 4.84 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.166 0.508 . . . . 0.0 111.52 -178.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.52 -43.11 99.61 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.65 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.457 ' CG ' ' HG1' ' A' ' 100' ' ' THR . 40.8 p-10 -82.65 5.54 20.79 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -178.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.39 -0.3 86.99 Favored Glycine 0 N--CA 1.466 0.641 0 C-N-CA 120.879 -0.676 . . . . 0.0 112.225 176.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.457 ' HG1' ' CG ' ' A' ' 98' ' ' ASP . 26.7 m -59.18 137.74 57.85 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.657 ' C ' ' SD ' ' A' ' 101' ' ' MET . 13.4 tmm? -102.36 127.89 49.17 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.724 0.297 . . . . 0.0 110.95 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.474 ' N ' ' SD ' ' A' ' 101' ' ' MET . 53.2 p90 -140.88 159.66 41.74 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.236 -0.586 . . . . 0.0 109.762 -177.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.888 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 26.1 m95 -92.55 141.12 28.85 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.473 HD22 ' HG2' ' A' ' 123' ' ' GLN . 53.9 t-20 -137.0 104.39 5.44 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -176.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 81.2 tt0 -69.25 137.38 53.08 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -177.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 44.1 tp -121.56 123.97 43.25 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -119.67 123.38 43.68 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.522 177.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 96.2 mt -121.02 128.72 76.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 O-C-N 123.345 0.403 . . . . 0.0 111.225 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -140.61 122.96 9.68 Favored Pre-proline 0 CA--C 1.541 0.596 0 CA-C-O 119.912 -0.089 . . . . 0.0 110.785 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -70.71 150.28 62.16 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 122.593 2.195 . . . . 0.0 112.912 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.547 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 66.9 mtt -122.81 153.86 38.99 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 -179.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -125.0 98.8 5.84 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.596 1.089 . . . . 0.0 108.478 176.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.404 HD11 HG22 ' A' ' 113' ' ' ILE . 95.7 mt -121.24 131.19 73.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.875 -178.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 47.63 39.57 10.15 Favored 'General case' 0 CA--C 1.516 -0.349 0 O-C-N 121.599 -0.688 . . . . 0.0 111.613 177.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 59.31 30.64 20.4 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.906 -178.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -127.81 148.54 50.45 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.754 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 5.1 t -86.01 -172.4 4.06 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 121.506 -0.746 . . . . 0.0 109.68 -178.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.754 ' CD2' ' O ' ' A' ' 117' ' ' THR . 69.7 m-85 -171.03 157.32 5.18 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 174.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.437 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 97.2 m-85 -130.27 145.18 51.73 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 173.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -132.95 133.32 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.28 128.22 9.13 Favored Glycine 0 CA--C 1.504 -0.636 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 178.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 96.1 mt -118.09 129.6 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 178.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.473 ' HG2' HD22 ' A' ' 104' ' ' ASN . 16.3 mp0 -119.54 115.84 24.84 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.172 0.511 . . . . 0.0 109.756 179.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -117.72 115.22 24.59 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.13 -177.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 126' ' ' ILE . 68.0 t0 -64.14 129.76 41.26 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -174.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.404 ' N ' ' OD1' ' A' ' 125' ' ' ASP . 2.6 mp -95.14 2.05 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 113.576 -1.647 . . . . 0.0 110.02 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 20.1 m -60.79 -42.39 97.49 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -178.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -60.35 -42.07 94.95 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -177.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -62.94 -39.25 94.04 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.855 177.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.888 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.6 mttt -62.22 -40.71 97.04 Favored 'General case' 0 CA--C 1.5 -0.979 0 C-N-CA 118.397 -1.321 . . . . 0.0 110.643 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -62.32 -37.4 85.46 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -178.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -61.75 -46.33 90.06 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.912 176.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.69 -38.9 92.56 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 130' ' ' LYS . 98.7 mttt -62.04 -40.45 95.77 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 53.1 tp -60.73 -43.53 97.78 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -177.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 86.5 mt -62.66 -41.36 99.02 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.495 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.27 -40.91 98.72 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 119.637 -0.825 . . . . 0.0 109.531 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -60.95 -41.45 96.34 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -177.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.1 m -61.99 -39.96 93.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.896 176.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.523 ' O ' ' N ' ' A' ' 144' ' ' THR . 87.7 mt -63.39 -42.03 98.78 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 99.6 m -61.85 -45.61 93.04 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.975 -177.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -64.54 -41.0 96.62 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 96.1 mt -64.7 -43.46 96.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 113.965 -1.47 . . . . 0.0 111.53 175.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.523 ' N ' ' O ' ' A' ' 140' ' ' LEU . 97.2 m -62.71 -46.07 89.82 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 120.283 -0.567 . . . . 0.0 112.358 -177.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.88 -39.84 95.7 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 118.813 -1.155 . . . . 0.0 109.138 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 87.6 mt -63.76 -42.48 97.8 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.644 178.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.679 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.1 p -60.19 -40.19 89.16 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -177.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.498 ' C ' ' O ' ' A' ' 147' ' ' SER . 93.5 m -26.64 83.57 0.03 OUTLIER Pre-proline 0 C--N 1.343 0.305 0 O-C-N 126.417 2.323 . . . . 0.0 106.814 -178.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.679 ' N ' ' O ' ' A' ' 147' ' ' SER . 22.0 Cg_exo -62.69 145.1 95.0 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 CA-C-O 122.428 0.928 . . . . 0.0 113.949 -175.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.61 ' O ' ' CG2' ' A' ' 151' ' ' VAL . 9.5 tp -120.25 135.98 58.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 102.378 -3.193 . . . . 0.0 102.378 175.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.61 ' CG2' ' O ' ' A' ' 150' ' ' ILE . 70.7 t -169.6 95.48 0.51 Allowed Pre-proline 0 N--CA 1.446 -0.64 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 176.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -61.83 135.71 57.51 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 N-CA-C 109.565 -0.975 . . . . 0.0 109.565 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.479 ' O ' ' HD2' ' A' ' 154' ' ' ARG . 46.1 mm -68.0 -44.28 84.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.104 179.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.511 HH12 HG21 ' B' ' 153' ' ' ILE . 0.3 OUTLIER -156.62 -157.65 0.72 Allowed 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 61.8 t-20 -86.94 105.88 17.41 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.871 0.843 . . . . 0.0 111.631 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 89.29 7.65 69.49 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 113.957 -1.474 . . . . 0.0 110.832 -177.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.427 HG12 ' HB2' ' A' ' 189' ' ' TYR . 96.2 mt -124.42 126.19 71.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 174.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.671 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 66.7 m -132.12 152.5 51.21 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 122.494 0.317 . . . . 0.0 110.36 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -137.91 142.02 40.62 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.612 -0.68 . . . . 0.0 111.338 177.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 15.9 tp -133.8 79.38 58.4 Favored Pre-proline 0 N--CA 1.472 0.662 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.525 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -69.65 150.76 69.32 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.782 2.322 . . . . 0.0 113.165 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 84.8 mt -116.63 125.51 51.9 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.61 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 43.2 t -122.16 130.97 74.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 115.74 169.48 15.67 Favored Glycine 0 N--CA 1.484 1.857 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.061 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.864 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 53.9 t30 -86.51 113.23 22.26 Favored 'General case' 0 C--N 1.347 0.47 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.482 ' CD2' ' CZ ' ' A' ' 171' ' ' PHE . 46.7 tp -71.32 104.39 3.15 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 -177.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.651 ' H ' ' HE ' ' A' ' 170' ' ' ARG . 10.4 p -86.46 166.98 15.08 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.414 178.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -66.01 -34.22 77.59 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.023 0.44 . . . . 0.0 111.551 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.55 -41.83 96.09 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.36 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.864 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 87.6 mtm180 -65.41 -33.98 77.22 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.328 1.051 . . . . 0.0 112.192 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.482 ' CZ ' ' CD2' ' A' ' 166' ' ' LEU . 0.4 OUTLIER -54.45 -27.94 40.85 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 118.946 -0.55 . . . . 0.0 112.239 -178.695 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.639 ' O ' HG21 ' A' ' 175' ' ' VAL . 91.6 m-20 -61.06 -40.37 93.41 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 119.652 1.114 . . . . 0.0 109.702 -178.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 41.4 m -59.77 -40.47 88.33 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.801 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 68.0 mt -63.21 -44.21 99.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.639 HG21 ' O ' ' A' ' 172' ' ' ASN . 27.1 m -62.82 -39.74 86.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 98.7 m -62.5 -34.6 77.19 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.313 0.578 . . . . 0.0 110.388 178.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' THR . . . . . 0.571 ' O ' HG13 ' A' ' 181' ' ' ILE . 24.9 m -62.63 -20.39 64.73 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.285 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 86.3 mt -61.17 -41.32 96.58 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -177.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 18.7 m -60.2 -43.27 96.06 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.622 ' O ' ' OG ' ' A' ' 183' ' ' SER . 93.2 m-20 -62.25 -37.26 84.74 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 122.552 0.341 . . . . 0.0 110.963 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . 0.571 HG13 ' O ' ' A' ' 177' ' ' THR . 69.6 mt -57.9 -37.63 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 O-C-N 121.536 -0.728 . . . . 0.0 109.473 -178.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 83.1 mt -61.1 -40.7 94.74 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -177.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.622 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 78.2 p -61.05 -33.0 72.61 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.228 176.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.467 ' OG1' ' HA ' ' A' ' 181' ' ' ILE . 22.6 p -89.09 23.18 2.5 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.592 0.234 . . . . 0.0 111.542 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 78.1 p -63.52 -20.84 65.95 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.216 0.531 . . . . 0.0 110.558 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.64 -37.46 81.56 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.802 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.671 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 98.8 m-20 -74.1 113.48 11.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.388 0.613 . . . . 0.0 110.615 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -63.03 -42.17 99.71 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.999 -1.001 . . . . 0.0 112.91 -177.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . 0.427 ' HB2' HG12 ' A' ' 157' ' ' ILE . 98.2 m-85 -112.12 131.72 55.28 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.619 -178.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 39.4 tp -119.72 127.59 52.99 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 93.9 mt -114.72 126.63 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 O-C-N 121.637 -0.664 . . . . 0.0 110.027 177.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.8 mm -113.09 127.19 70.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . 0.562 ' OD2' ' OG ' ' A' ' 195' ' ' SER . 38.7 t0 -95.79 119.99 35.27 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 121.79 -0.569 . . . . 0.0 110.629 176.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 96.6 mt -97.17 -3.38 41.1 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.156 174.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.562 ' OG ' ' OD2' ' A' ' 193' ' ' ASP . 78.2 p -62.9 -33.26 74.94 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -62.02 -43.12 99.6 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 108.477 -1.849 . . . . 0.0 108.477 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 1.233 HD23 ' O ' ' A' ' 199' ' ' GLN . 5.2 tt -70.47 127.87 34.2 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 113.037 -1.582 . . . . 0.0 109.074 -176.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.681 ' N ' HD21 ' A' ' 197' ' ' LEU . . . -61.02 -48.69 80.62 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 119.764 -0.774 . . . . 0.0 110.772 -177.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 1.233 ' O ' HD23 ' A' ' 197' ' ' LEU . 58.3 tt0 -132.59 156.52 46.74 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 114.77 -1.105 . . . . 0.0 112.183 -174.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.426 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 45.7 t -118.14 133.25 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -91.25 153.98 19.6 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.571 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.8 -38.06 89.67 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.239 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -59.42 -31.74 69.55 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -178.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 19.1 m -60.91 -42.65 98.51 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.475 177.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.449 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -58.06 -38.24 75.94 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -177.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -61.32 -37.99 85.26 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -65.59 -38.51 89.69 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.961 177.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 94.9 mt -62.94 -43.98 99.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.027 -178.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . 0.449 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 71.0 m-85 -62.01 -42.68 99.42 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.635 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -61.96 -41.8 98.41 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.173 -178.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 39.8 mt -61.82 -42.23 98.77 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' SER . . . . . 0.435 ' HG ' ' N ' ' A' ' 213' ' ' HIS . 78.0 p -61.72 -42.09 98.49 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 119.232 -0.987 . . . . 0.0 109.734 -178.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' HIS . . . . . 0.435 ' N ' ' HG ' ' A' ' 212' ' ' SER . 59.0 t-80 -64.6 -46.25 83.49 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.723 -178.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 52.5 tp -62.39 -46.25 89.45 Favored 'General case' 0 C--N 1.344 0.354 0 C-N-CA 119.029 -1.068 . . . . 0.0 108.416 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 85.1 mt -61.72 -40.59 95.59 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.472 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.25 -44.72 95.01 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 85.2 mt -61.65 -39.57 91.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.07 0.462 . . . . 0.0 109.822 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 67.0 p -75.53 -11.58 60.05 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.481 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.88 35.39 18.95 Favored Glycine 0 C--O 1.217 -0.939 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.935 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 95.2 m -121.86 113.83 20.19 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.227 1.514 . . . . 0.0 111.148 -178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -65.78 137.24 57.11 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.206 177.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 43.5 tp -113.21 130.63 56.16 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 3.3 mp -117.41 133.74 63.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 122.857 0.463 . . . . 0.0 109.883 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 49.5 mm -114.93 132.22 64.81 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 43.9 p -134.08 166.63 22.29 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 120.392 -0.523 . . . . 0.0 112.058 -178.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 78.82 20.32 71.08 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 178.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 97.3 mt -81.56 128.61 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 CA-C-N 114.042 -1.079 . . . . 0.0 108.818 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 63.5 tttt -76.04 140.26 69.92 Favored Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.06 -38.92 87.3 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.187 1.258 . . . . 0.0 112.324 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -64.7 -39.39 93.57 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-O 121.619 0.723 . . . . 0.0 110.083 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 48.7 tp -63.55 -42.6 98.38 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.987 -1.006 . . . . 0.0 113.104 176.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.86 -38.05 89.65 Favored 'General case' 0 CA--C 1.521 -0.141 0 O-C-N 121.916 -0.49 . . . . 0.0 111.101 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 94.1 mtp -63.84 -41.48 97.82 Favored 'General case' 0 C--O 1.251 1.135 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.561 -178.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -64.15 -40.02 95.25 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.484 177.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 33.4 mmt -65.68 -38.35 89.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.625 177.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -61.61 -41.55 97.62 Favored 'General case' 0 CA--C 1.516 -0.35 0 O-C-N 121.406 -0.808 . . . . 0.0 109.188 -177.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.43 -41.24 93.61 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.458 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 55.9 tp -63.76 -41.84 97.93 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.229 0.825 . . . . 0.0 113.229 177.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -165.51 126.24 1.88 Allowed 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.604 -0.685 . . . . 0.0 112.684 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -60.05 -26.57 66.23 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.951 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -61.78 -29.97 70.49 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.192 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -55.82 -44.73 78.16 Favored 'General case' 0 C--N 1.312 -1.023 0 O-C-N 121.484 -0.76 . . . . 0.0 109.352 -176.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 95.5 p -62.31 -20.07 63.95 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.23 178.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 19.1 m -55.22 -38.18 68.1 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.511 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 97.2 mt -86.3 123.84 31.99 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -178.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -48.37 135.21 14.11 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 114.7 -1.137 . . . . 0.0 109.707 -176.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 98.0 m -127.87 132.29 49.37 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 114.528 -1.215 . . . . 0.0 111.333 178.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -116.33 139.64 50.18 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.093 178.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 78.1 p -59.67 -43.07 94.14 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 119.152 -1.019 . . . . 0.0 108.304 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -142.68 159.63 41.86 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.726 0.774 . . . . 0.0 111.312 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 75.4 t -62.61 -45.0 99.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 114.607 -1.179 . . . . 0.0 111.796 -179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.92 -43.98 97.85 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.247 -0.581 . . . . 0.0 109.519 -178.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -63.59 -41.95 98.3 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.973 -178.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -64.9 -41.7 95.38 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.037 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . 0.4 HG13 HH11 ' B' ' 154' ' ' ARG . 77.0 t -64.02 -45.56 96.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 114.021 -1.445 . . . . 0.0 110.925 -177.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.99 -47.15 81.49 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.763 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . 0.515 ' O ' ' C ' ' A' ' 258' ' ' LEU . 28.6 m -66.34 -40.6 87.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 120.058 -0.657 . . . . 0.0 112.429 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.515 ' C ' ' O ' ' A' ' 257' ' ' VAL . 1.4 mt -28.36 -75.44 0.04 OUTLIER Pre-proline 0 C--N 1.344 0.355 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.318 -177.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' PRO . . . . . 0.507 ' CD ' ' CB ' ' A' ' 258' ' ' LEU . 42.0 Cg_endo -63.46 139.7 72.12 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 CA-C-N 119.561 0.879 . . . . 0.0 111.761 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 96.7 mt -151.38 -26.57 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.694 177.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 78.1 mtm . . . . . 0 N--CA 1.472 0.663 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.562 -177.013 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.459 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.1 163.71 38.67 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 80.4 p -59.85 -20.82 59.32 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 123.37 0.419 . . . . 0.0 111.27 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -74.2 -63.63 1.19 Allowed 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.091 0.472 . . . . 0.0 111.303 -178.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -67.03 -38.85 86.63 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.877 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.526 ' O ' ' HB3' ' B' ' 7' ' ' PHE . 65.7 m -60.05 -43.14 95.58 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 119.979 -0.688 . . . . 0.0 109.928 -176.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . 0.526 ' HB3' ' O ' ' B' ' 6' ' ' SER . 46.2 t80 86.39 88.91 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 O-C-N 123.751 0.657 . . . . 0.0 110.745 177.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . 0.676 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -64.23 -151.73 0.07 OUTLIER Glycine 0 CA--C 1.53 0.99 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . 0.676 ' HB ' ' O ' ' B' ' 8' ' ' GLY . 67.3 mt 92.98 108.81 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 122.387 0.275 . . . . 0.0 110.87 -178.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -62.53 -24.94 75.47 Favored 'Trans proline' 0 N--CA 1.5 1.855 0 C-N-CA 121.375 1.383 . . . . 0.0 111.847 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.7 -40.5 98.13 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 110.689 -0.965 . . . . 0.0 110.689 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -64.89 -38.62 91.57 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.726 0.774 . . . . 0.0 109.506 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 52.4 tp -61.75 -42.53 99.09 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.848 -178.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -65.68 -32.81 74.58 Favored 'General case' 0 CA--C 1.562 1.442 0 CA-C-O 121.344 0.593 . . . . 0.0 110.534 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 63.2 t -61.57 -46.28 96.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 113.097 -1.865 . . . . 0.0 110.664 177.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 92.9 mt -63.65 -43.91 98.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.259 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . 0.506 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 98.9 mttt -63.36 -41.61 98.84 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.98 -41.37 99.53 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 119.069 -1.053 . . . . 0.0 110.312 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.96 -38.8 89.91 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.656 -178.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . 0.417 ' O ' ' O ' ' B' ' 23' ' ' VAL . 85.5 mt -64.31 -41.97 96.58 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.286 0.565 . . . . 0.0 110.295 175.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -63.15 -38.34 90.79 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.34 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 56.9 m170 -58.47 -39.64 80.49 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 121.236 -0.185 . . . . 0.0 111.087 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.417 ' O ' ' O ' ' B' ' 20' ' ' LEU . 10.0 p -113.96 130.54 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.489 ' O ' ' HG3' ' B' ' 24' ' ' ARG . 34.7 ptt180 -71.79 108.42 5.09 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 121.865 0.84 . . . . 0.0 112.446 -177.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 7.1 p -143.14 134.33 23.31 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.501 177.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . 0.508 ' O ' ' N ' ' B' ' 123' ' ' GLN . . . -89.59 95.76 2.13 Favored Glycine 0 N--CA 1.436 -1.332 0 C-N-CA 119.093 -1.527 . . . . 0.0 112.748 -175.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 45.9 t -124.86 129.42 73.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 174.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 27.2 m -138.6 157.25 30.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.722 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 95.9 mt -118.84 129.82 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-O 122.377 1.084 . . . . 0.0 111.167 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.478 HG21 HG12 ' B' ' 39' ' ' ILE . 44.7 p -112.0 152.81 27.69 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 112.474 -2.148 . . . . 0.0 108.475 -175.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -121.87 103.6 39.9 Favored Pre-proline 0 C--O 1.239 0.506 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -177.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.78 -22.61 69.4 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 121.907 1.738 . . . . 0.0 111.519 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.6 -42.86 99.46 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 96.0 mt -75.41 171.08 14.87 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.507 -0.745 . . . . 0.0 111.121 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . 0.62 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 42.3 tt0 -69.85 133.56 47.51 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -176.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.522 ' O ' ' OD1' ' B' ' 36' ' ' ASP . 66.1 t0 56.59 35.51 26.18 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.701 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' ASN . . . . . 0.454 ' C ' ' O ' ' B' ' 36' ' ' ASP . 40.3 t-20 28.75 71.24 0.49 Allowed Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.62 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 91.8 Cg_endo -71.85 154.76 58.56 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 123.736 2.957 . . . . 0.0 112.191 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.478 HG12 HG21 ' B' ' 30' ' ' THR . 95.6 mt -86.85 129.17 38.88 Favored 'Isoleucine or valine' 0 C--O 1.245 0.86 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.474 HG21 ' N ' ' B' ' 41' ' ' TYR . 29.8 m -109.04 -42.89 5.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 O-C-N 123.65 0.594 . . . . 0.0 112.373 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' TYR . . . . . 0.474 ' N ' HG21 ' B' ' 40' ' ' VAL . 46.2 t80 -95.61 124.76 39.78 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 119.85 -0.74 . . . . 0.0 111.183 -178.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 5.8 p -143.55 141.86 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 O-C-N 124.102 0.876 . . . . 0.0 109.545 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . 0.675 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 56.0 p30 -102.12 162.07 13.2 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.226 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' GLN . . . . . 0.51 ' HA ' ' OE1' ' B' ' 44' ' ' GLN . 12.9 mm100 -63.1 -37.89 88.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.303 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.48 -26.48 64.44 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.675 ' HB2' ' OD1' ' B' ' 43' ' ' ASN . 59.5 t80 -60.46 -43.3 97.02 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . 0.593 HG11 ' O ' ' B' ' 52' ' ' TYR . 58.5 t -61.16 -46.33 96.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.032 -178.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -62.92 -44.23 96.64 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.341 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 59.7 ttm -63.22 -42.68 99.29 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 39.5 p -94.11 -17.29 22.95 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.934 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' B' ' 47' ' ' VAL . . . 73.67 17.74 79.26 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 178.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . 0.593 ' O ' HG11 ' B' ' 47' ' ' VAL . 77.3 m-85 -110.39 142.89 41.46 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.231 0.612 . . . . 0.0 110.565 178.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -71.91 147.67 46.82 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.388 0.613 . . . . 0.0 111.289 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.62 -36.55 83.14 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.523 -176.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.2 -39.88 95.91 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.344 -178.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -72.72 -32.67 65.89 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 176.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 92.5 mt -64.96 -74.94 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 176.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 94.9 mt -36.42 132.82 0.56 Allowed 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.766 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.28 -13.56 66.59 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-N 115.874 -0.603 . . . . 0.0 113.252 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -132.72 149.07 52.33 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 117.572 0.686 . . . . 0.0 112.315 -173.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' ASN . . . . . 0.646 HD22 HO2' ' B' ' 900' ' ' FMN . 24.3 t-20 -78.6 149.73 32.89 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.437 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' CYS . . . . . . . . . . . . . 86.2 m -63.11 9.57 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.327 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . 0.563 ' H ' ' C ' ' B' ' 61' ' ' ASN . 34.5 ptt-85 -59.41 -33.16 70.89 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.449 -177.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -59.73 -28.79 67.65 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 83.4 mt -61.69 -41.98 98.32 Favored 'General case' 0 C--N 1.32 -0.7 0 O-C-N 121.938 -0.477 . . . . 0.0 109.751 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . 0.512 HE22 HO4' ' B' ' 900' ' ' FMN . 88.6 mt-30 -53.23 145.99 12.7 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.624 -176.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -155.69 -153.22 6.48 Favored Glycine 0 CA--C 1.538 1.5 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.983 177.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . 0.433 ' HB3' ' HH ' ' B' ' 95' ' ' TYR . 88.8 tttt -59.38 -41.47 89.45 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -176.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . 0.423 ' HD1' HE22 ' B' ' 93' ' ' GLN . 11.4 m-70 -75.44 -10.0 59.06 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 123.188 0.305 . . . . 0.0 111.171 -178.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 27.0 m -61.63 133.36 55.53 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 121.875 -0.516 . . . . 0.0 109.812 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -89.17 109.87 34.18 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.335 -178.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.16 -38.67 87.8 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 121.046 1.164 . . . . 0.0 111.811 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.13 -39.38 92.39 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 120.424 -0.511 . . . . 0.0 109.871 -175.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -66.57 -38.01 86.16 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.998 177.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 93.5 t -61.73 -45.53 98.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -63.03 -37.3 86.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.697 -178.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -62.75 -41.84 99.4 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 119.254 -0.978 . . . . 0.0 108.707 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.4 -43.73 98.62 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-O 120.781 0.324 . . . . 0.0 110.623 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -62.53 -42.47 99.55 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 99.5 m -61.45 -45.67 93.32 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.224 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.05 -40.82 97.05 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -177.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.41 HD23 ' CE1' ' B' ' 119' ' ' PHE . 81.4 mt -62.72 -42.34 99.61 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 67.1 tp60 -63.48 -34.6 78.12 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -91.96 8.12 38.98 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.413 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 31.0 tttt 42.81 43.03 3.26 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.356 175.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -127.33 141.51 41.06 Favored Pre-proline 0 N--CA 1.469 0.508 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.556 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -62.09 141.01 87.13 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 120.806 1.004 . . . . 0.0 114.077 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.92 137.13 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' THR . . . . . . . . . . . . . 98.7 m -121.11 123.59 42.69 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.897 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 30.2 m -138.41 161.72 30.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.105 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -113.75 120.66 41.56 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 120.41 -0.516 . . . . 0.0 109.645 174.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 20.8 tt -127.79 132.21 69.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.317 -174.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . 0.423 HE22 ' HD1' ' B' ' 69' ' ' HIS . 84.6 mt-30 -70.35 140.39 52.17 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.261 177.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -131.25 177.61 7.34 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 121.516 0.674 . . . . 0.0 110.911 -178.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' TYR . . . . . 0.433 ' HH ' ' HB3' ' B' ' 68' ' ' LYS . 96.4 m-85 -128.83 143.66 50.97 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 114.447 -1.251 . . . . 0.0 111.954 177.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -100.09 179.25 4.55 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.283 0.563 . . . . 0.0 110.553 178.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.93 -36.64 79.86 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.843 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 38.5 p-10 -84.79 -1.74 56.75 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 121.426 -0.796 . . . . 0.0 112.912 177.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.06 5.59 65.81 Favored Glycine 0 N--CA 1.467 0.726 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.685 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 29.1 m -68.06 129.95 41.48 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' MET . . . . . 0.551 ' SD ' ' N ' ' B' ' 102' ' ' PHE . 15.3 tmm? -87.56 140.48 29.48 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' PHE . . . . . 0.551 ' N ' ' SD ' ' B' ' 101' ' ' MET . 53.7 p90 -151.72 163.01 40.07 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' TRP . . . . . 0.901 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 26.3 m95 -96.35 138.51 33.83 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.589 0.709 . . . . 0.0 110.72 178.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . 0.442 HD22 ' HG2' ' B' ' 123' ' ' GLN . 62.8 t-20 -133.55 109.6 9.35 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 114.669 -1.15 . . . . 0.0 113.467 -176.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' B' ' 123' ' ' GLN . 81.6 tt0 -79.16 125.56 29.59 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.768 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 40.0 tp -112.62 125.37 54.21 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -176.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' ASN . . . . . 0.412 ' HB2' ' HB ' ' B' ' 122' ' ' ILE . 98.2 m-20 -118.57 128.59 54.71 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 176.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 96.5 mt -123.75 132.68 70.96 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.467 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -145.93 121.9 5.76 Favored Pre-proline 0 CA--C 1.542 0.665 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -69.23 152.14 72.04 Favored 'Trans proline' 0 N--CA 1.504 2.093 0 C-N-CA 122.893 2.395 . . . . 0.0 112.942 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' MET . . . . . 0.443 ' HB2' ' HB2' ' B' ' 118' ' ' TYR . 67.0 mtt -129.99 143.26 50.7 Favored 'General case' 0 C--O 1.245 0.831 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 179.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -110.3 109.47 19.92 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . 0.648 HG12 ' NZ ' ' A' ' 18' ' ' LYS . 96.3 mt -132.46 128.01 57.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 177.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 50.61 38.53 19.13 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.999 178.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 61.46 37.07 16.88 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.51 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -134.21 151.26 51.22 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 177.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 6.9 t -102.47 154.41 19.12 Favored 'General case' 0 C--O 1.214 -0.785 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -177.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' TYR . . . . . 0.443 ' HB2' ' HB2' ' B' ' 111' ' ' MET . 96.7 m-85 -148.76 147.85 29.3 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 120.828 -1.17 . . . . 0.0 111.445 -178.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 119' ' ' PHE . . . . . 0.436 ' HB2' ' OG1' ' B' ' 30' ' ' THR . 96.3 m-85 -123.2 137.42 54.89 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 123.318 0.387 . . . . 0.0 110.758 -177.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -127.26 132.02 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -177.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.39 124.09 7.48 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 122' ' ' ILE . . . . . 0.412 ' HB ' ' HB2' ' B' ' 107' ' ' ASN . 94.4 mt -114.94 127.6 72.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -178.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 123' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' B' ' 26' ' ' GLY . 16.1 mp0 -118.67 120.47 37.53 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -119.91 120.93 37.84 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . 0.569 ' OD1' ' N ' ' B' ' 127' ' ' THR . 68.0 t0 -67.31 134.79 52.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.331 -0.849 . . . . 0.0 112.704 -177.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . 0.461 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 2.6 mp -108.4 14.48 8.21 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.856 0 CA-C-O 122.054 0.93 . . . . 0.0 108.858 178.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 127' ' ' THR . . . . . 0.569 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 98.5 m -62.72 -44.15 96.97 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 113.754 -1.566 . . . . 0.0 112.47 176.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -61.7 -45.66 93.01 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -177.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 129' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -62.84 -34.65 77.78 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.316 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 130' ' ' LYS . . . . . 0.901 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 98.7 mttt -63.06 -41.58 99.5 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-N 113.47 -1.696 . . . . 0.0 111.022 174.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.69 -42.31 98.01 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -60.12 -45.44 93.0 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 121.733 -0.604 . . . . 0.0 111.494 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.87 -36.6 84.86 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 120.233 -0.587 . . . . 0.0 109.601 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 134' ' ' LYS . . . . . 0.451 ' HG3' ' O ' ' B' ' 130' ' ' LYS . 98.8 mttt -62.86 -39.15 93.52 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.66 177.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 54.7 tp -62.9 -41.58 99.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.163 0.506 . . . . 0.0 109.819 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 90.3 mt -62.67 -42.11 99.44 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.253 177.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 137' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.39 -36.97 85.57 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.116 -1.402 . . . . 0.0 110.299 -178.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -63.11 -43.21 99.1 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.173 175.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 62.1 m -60.8 -43.93 97.49 Favored 'General case' 0 C--N 1.344 0.354 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' B' ' 144' ' ' THR . 88.1 mt -61.1 -40.42 93.68 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -176.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 98.6 m -61.88 -45.25 94.57 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.84 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -65.49 -42.78 91.78 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.96 -43.66 97.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.695 178.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 144' ' ' THR . . . . . 0.46 ' N ' ' O ' ' B' ' 140' ' ' LEU . 99.4 m -61.35 -45.69 93.34 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -177.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . 0.41 ' O ' ' HB ' ' B' ' 148' ' ' THR . . . -63.81 -40.81 97.51 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 119.041 -1.064 . . . . 0.0 109.581 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 90.0 mt -64.55 -40.64 95.95 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 177.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 147' ' ' SER . . . . . 0.587 ' O ' ' N ' ' B' ' 149' ' ' PRO . 77.4 p -61.36 -43.31 99.09 Favored 'General case' 0 CA--C 1.477 -1.831 0 C-N-CA 119.074 -1.05 . . . . 0.0 108.23 -178.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 148' ' ' THR . . . . . 0.511 ' C ' ' O ' ' B' ' 147' ' ' SER . 43.0 m -24.48 85.66 0.04 OUTLIER Pre-proline 0 N--CA 1.478 0.929 0 O-C-N 124.051 0.844 . . . . 0.0 110.364 176.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 149' ' ' PRO . . . . . 0.587 ' N ' ' O ' ' B' ' 147' ' ' SER . 24.2 Cg_exo -61.67 147.53 95.12 Favored 'Trans proline' 0 C--N 1.299 -2.04 0 C-N-CA 120.898 1.065 . . . . 0.0 113.197 -177.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 8.8 tp -126.7 124.18 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 172.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 43.0 t -155.13 95.13 2.58 Favored Pre-proline 0 C--N 1.314 -0.963 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.103 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -60.46 136.48 67.89 Favored 'Trans proline' 0 N--CA 1.484 0.931 0 N-CA-C 109.438 -1.024 . . . . 0.0 109.438 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 153' ' ' ILE . . . . . 0.511 HG21 HH12 ' A' ' 154' ' ' ARG . 45.6 mm -69.22 -43.44 81.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.09 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . 0.505 ' HD3' ' NH2' ' A' ' 154' ' ' ARG . 0.2 OUTLIER -155.9 -156.01 0.6 Allowed 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.923 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -86.62 110.58 19.93 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 97.54 -15.89 61.36 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 87.9 mt -111.35 126.15 68.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 120.651 0.262 . . . . 0.0 110.666 -176.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 158' ' ' SER . . . . . 0.659 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 71.4 m -134.22 150.45 51.05 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.13 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -133.6 147.2 51.48 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.203 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 17.1 tp -140.65 78.31 21.3 Favored Pre-proline 0 CA--C 1.532 0.254 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 161' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -70.7 148.69 59.5 Favored 'Trans proline' 0 N--CA 1.499 1.848 0 C-N-CA 122.791 2.327 . . . . 0.0 114.302 -178.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 86.0 mt -112.24 134.97 53.47 Favored 'General case' 0 C--N 1.343 0.326 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 55.7 t -129.19 131.71 67.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 112.79 169.6 17.67 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 120.436 -0.888 . . . . 0.0 111.149 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 165' ' ' ASN . . . . . 0.737 ' O ' ' CZ ' ' B' ' 170' ' ' ARG . 60.2 t30 -91.25 107.36 19.15 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -177.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . 0.461 ' CD2' ' CZ ' ' B' ' 171' ' ' PHE . 47.7 tp -64.79 104.5 0.84 Allowed 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -173.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 167' ' ' THR . . . . . 0.554 ' H ' ' HE ' ' B' ' 170' ' ' ARG . 10.5 p -84.0 169.79 14.62 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 114.117 -1.401 . . . . 0.0 110.925 176.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.57 -37.61 85.31 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.769 177.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.41 -40.08 89.36 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 123.176 1.465 . . . . 0.0 111.539 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 170' ' ' ARG . . . . . 0.737 ' CZ ' ' O ' ' B' ' 165' ' ' ASN . 88.0 mtm180 -62.19 -37.63 86.0 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 112.084 -2.325 . . . . 0.0 111.152 178.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 171' ' ' PHE . . . . . 0.461 ' CZ ' ' CD2' ' B' ' 166' ' ' LEU . 0.4 OUTLIER -53.81 -25.37 19.03 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -179.249 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 172' ' ' ASN . . . . . 0.595 ' O ' HG21 ' B' ' 175' ' ' VAL . 92.1 m-20 -62.57 -40.37 96.64 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.024 -0.671 . . . . 0.0 110.773 178.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 36.4 m -60.57 -41.13 93.97 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.974 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 67.5 mt -63.69 -44.09 98.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 175' ' ' VAL . . . . . 0.595 HG21 ' O ' ' B' ' 172' ' ' ASN . 28.8 m -62.96 -39.84 86.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 176' ' ' CYS . . . . . . . . . . . . . 98.8 m -62.31 -35.54 79.38 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.494 178.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 177' ' ' THR . . . . . 0.595 ' O ' HG13 ' B' ' 181' ' ' ILE . 24.9 m -61.67 -20.81 63.83 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.502 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 178' ' ' LEU . . . . . . . . . . . . . 88.2 mt -61.29 -39.91 92.2 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.241 -177.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 19.0 m -61.07 -44.69 96.99 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.523 176.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 180' ' ' ASN . . . . . 0.625 ' O ' ' OG ' ' B' ' 183' ' ' SER . 92.7 m-20 -61.94 -40.65 96.27 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.846 0.355 . . . . 0.0 110.585 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . 0.595 HG13 ' O ' ' B' ' 177' ' ' THR . 73.9 mt -56.31 -31.78 33.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 O-C-N 122.262 -0.274 . . . . 0.0 111.022 -177.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 182' ' ' LEU . . . . . . . . . . . . . 82.4 mt -62.29 -41.86 98.86 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.333 177.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 183' ' ' SER . . . . . 0.625 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.2 p -62.45 -32.48 73.36 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 121.756 -0.59 . . . . 0.0 110.891 177.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 184' ' ' THR . . . . . 0.443 ' OG1' ' HA ' ' B' ' 181' ' ' ILE . 22.6 p -85.39 16.89 3.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.745 -178.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 78.5 p -61.29 -16.86 49.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.466 -176.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.0 -40.51 95.88 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 121.051 -0.259 . . . . 0.0 110.468 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 187' ' ' ASP . . . . . 0.659 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.6 m-20 -71.07 113.78 8.45 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.294 0.568 . . . . 0.0 110.378 -177.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -62.94 -42.27 99.75 Favored 'General case' 0 C--O 1.247 0.936 0 CA-C-N 114.904 -1.044 . . . . 0.0 113.149 -177.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -111.58 131.57 55.16 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.956 -178.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 190' ' ' LEU . . . . . . . . . . . . . 44.3 tp -123.61 119.03 28.66 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.176 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 84.6 mt -107.09 125.11 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-N 117.8 0.273 . . . . 0.0 111.303 -176.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 49.0 mm -115.63 118.4 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 193' ' ' ASP . . . . . 0.561 ' OD2' ' OG ' ' B' ' 195' ' ' SER . 40.6 t0 -91.19 113.29 25.52 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -176.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 194' ' ' LEU . . . . . . . . . . . . . 96.3 mt -92.34 -2.23 56.52 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 123.325 0.391 . . . . 0.0 110.223 176.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 195' ' ' SER . . . . . 0.561 ' OG ' ' OD2' ' B' ' 193' ' ' ASP . 78.3 p -61.7 -37.69 85.09 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.704 -178.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.6 -34.37 88.24 Favored Glycine 0 N--CA 1.435 -1.375 0 C-N-CA 119.416 -1.373 . . . . 0.0 109.731 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 197' ' ' LEU . . . . . 1.22 HD23 ' O ' ' B' ' 199' ' ' GLN . 5.6 tt -76.78 132.97 39.53 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -177.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 198' ' ' ALA . . . . . 0.706 ' N ' HD21 ' B' ' 197' ' ' LEU . . . -64.48 -42.03 96.13 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 119.773 -0.771 . . . . 0.0 111.947 -178.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 199' ' ' GLN . . . . . 1.22 ' O ' HD23 ' B' ' 197' ' ' LEU . 59.0 tt0 -137.57 165.41 26.39 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.215 0.531 . . . . 0.0 111.425 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 200' ' ' VAL . . . . . 0.47 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 49.4 t -122.65 132.53 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -93.72 148.83 21.75 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.768 -177.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -60.99 -32.92 72.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.289 -178.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -63.91 -32.59 74.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.367 0.603 . . . . 0.0 109.482 177.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.3 m -60.71 -44.19 96.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.268 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 205' ' ' ALA . . . . . 0.617 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -59.45 -29.33 67.71 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 111.755 0.279 . . . . 0.0 111.755 -177.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -64.95 -38.98 92.76 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.878 175.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -66.86 -37.8 85.15 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.885 178.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.41 -43.17 98.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-O 122.009 0.909 . . . . 0.0 110.101 -178.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 209' ' ' PHE . . . . . 0.617 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 68.3 m-85 -62.28 -42.59 99.47 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 113.92 -1.491 . . . . 0.0 112.686 177.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.26 -41.58 99.06 Favored 'General case' 0 C--O 1.232 0.135 0 O-C-N 121.402 -0.811 . . . . 0.0 109.901 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . 0.415 ' O ' ' HG ' ' B' ' 215' ' ' LEU . 38.8 mt -62.29 -42.21 99.16 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.317 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 212' ' ' SER . . . . . 0.434 ' HG ' ' N ' ' B' ' 213' ' ' HIS . 78.0 p -63.84 -36.51 84.16 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.53 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 213' ' ' HIS . . . . . 0.434 ' N ' ' HG ' ' B' ' 212' ' ' SER . 59.4 t-80 -67.01 -47.29 71.91 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.176 178.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 54.2 tp -64.07 -42.6 96.93 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 121.956 0.884 . . . . 0.0 110.546 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 215' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' B' ' 211' ' ' LEU . 85.7 mt -62.83 -43.45 98.76 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 113.343 -1.753 . . . . 0.0 111.555 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.44 -40.04 93.0 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 -176.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 86.3 mt -63.39 -42.03 98.79 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 121.371 0.605 . . . . 0.0 111.374 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 218' ' ' THR . . . . . . . . . . . . . 69.9 p -73.88 -16.63 61.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.176 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 79.55 66.13 1.71 Allowed Glycine 0 CA--C 1.528 0.892 0 N-CA-C 106.831 -2.508 . . . . 0.0 106.831 -178.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 220' ' ' THR . . . . . . . . . . . . . 96.4 m -145.15 104.07 3.92 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 176.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -62.29 139.21 58.52 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.182 0.515 . . . . 0.0 110.954 -176.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 42.7 tp -115.87 121.84 43.56 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.532 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 3.5 mp -110.61 129.5 65.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.016 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 224' ' ' ILE . . . . . . . . . . . . . 50.0 mm -111.11 126.99 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 50.5 p -133.97 157.97 44.69 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-O 122.077 0.942 . . . . 0.0 112.72 -178.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 89.1 17.86 55.0 Favored Glycine 0 CA--C 1.502 -0.77 0 CA-C-N 113.683 -1.598 . . . . 0.0 111.588 -177.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 96.1 mt -81.17 126.26 39.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 121.808 -0.819 . . . . 0.0 111.371 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 59.4 tttt -66.57 140.53 96.54 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.298 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.75 -37.24 91.98 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 121.518 1.479 . . . . 0.0 112.363 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -64.18 -42.27 96.77 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -178.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 50.9 tp -62.52 -41.73 99.04 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.751 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.24 -37.2 86.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.784 0.326 . . . . 0.0 111.224 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 94.6 mtp -64.31 -41.0 97.04 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.663 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.78 -43.87 95.07 Favored 'General case' 0 CA--C 1.553 1.065 0 CA-C-O 122.632 1.206 . . . . 0.0 109.382 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 34.3 mmt -63.76 -36.29 83.4 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.167 -1.379 . . . . 0.0 111.894 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -63.32 -39.64 95.11 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.927 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -63.12 -44.45 95.59 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 56.1 tp -61.87 -44.72 96.25 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 120.358 -0.537 . . . . 0.0 112.027 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -157.14 132.59 9.18 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.972 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 240' ' ' ALA . . . . . . . . . . . . . . . -62.0 -45.34 94.05 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 177.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 241' ' ' ASN . . . . . 0.48 ' O ' ' HB2' ' B' ' 244' ' ' SER . 89.3 m-20 -45.45 -19.68 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.111 -175.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 242' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -61.7 -45.79 92.48 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.904 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 243' ' ' SER . . . . . . . . . . . . . 77.5 p -57.77 -44.14 85.98 Favored 'General case' 0 C--N 1.343 0.32 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 244' ' ' SER . . . . . 0.48 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 15.4 m -30.88 -36.14 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 95.3 mt -88.04 131.61 34.59 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.196 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -57.63 134.74 56.43 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.346 0.593 . . . . 0.0 110.918 -177.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 247' ' ' THR . . . . . . . . . . . . . 99.4 m -127.35 129.19 47.15 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.865 178.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -113.83 143.31 44.87 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 249' ' ' SER . . . . . 0.565 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 78.0 p -62.9 -34.32 77.17 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.275 -178.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 250' ' ' ASN . . . . . 0.565 ' OD1' ' O ' ' B' ' 249' ' ' SER . 99.0 m-20 -146.26 159.14 43.74 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.19 -0.913 . . . . 0.0 112.2 178.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 75.2 t -63.96 -44.83 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.889 178.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 252' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.05 -45.79 93.33 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -61.09 -43.28 99.13 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.378 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 254' ' ' ALA . . . . . . . . . . . . . . . -65.7 -39.99 91.81 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.319 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 255' ' ' VAL . . . . . . . . . . . . . 77.4 t -64.38 -45.88 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.584 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -63.17 -48.03 80.15 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.36 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 257' ' ' VAL . . . . . 0.493 ' O ' ' C ' ' B' ' 258' ' ' LEU . 26.5 m -64.66 -40.33 88.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.776 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 258' ' ' LEU . . . . . 0.519 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 1.3 mt -31.17 -74.97 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.597 -178.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 259' ' ' PRO . . . . . 0.519 ' CD ' ' CB ' ' B' ' 258' ' ' LEU . 36.7 Cg_endo -62.07 142.08 91.1 Favored 'Trans proline' 0 N--CA 1.501 1.928 0 C-N-CA 121.04 1.16 . . . . 0.0 110.983 -178.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 260' ' ' ILE . . . . . 0.476 HG13 ' O ' ' B' ' 259' ' ' PRO . 96.8 mt -158.84 -14.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-N 118.72 0.691 . . . . 0.0 112.054 176.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 78.1 mtm . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 117.921 -1.037 . . . . 0.0 111.905 -179.637 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 900' ' ' FMN . . . . . 0.638 HO2' HD22 ' A' ' 61' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 900' ' ' FMN . . . . . 0.646 HO2' HD22 ' B' ' 61' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.041 -1.623 . . . . 0.0 109.041 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.406 ' O ' ' OG ' ' A' ' 6' ' ' SER . . . -150.81 168.49 24.27 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 116.429 -1.748 . . . . 0.0 110.18 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.2 p -70.68 -19.4 62.79 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 124.633 1.208 . . . . 0.0 110.814 178.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -70.61 -68.4 0.43 Allowed 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.531 -1.213 . . . . 0.0 112.39 175.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.22 -38.67 88.51 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.594 ' O ' ' NZ ' ' B' ' 17' ' ' LYS . 69.2 m -59.63 -41.09 89.65 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.22 -178.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.468 ' CB ' ' O ' ' A' ' 6' ' ' SER . 36.3 t80 83.49 89.8 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 O-C-N 123.765 0.666 . . . . 0.0 111.556 176.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.557 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -64.79 -141.18 0.02 OUTLIER Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 -177.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.557 ' HB ' ' O ' ' A' ' 8' ' ' GLY . 78.4 mt 83.53 110.74 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 122.584 0.354 . . . . 0.0 110.726 -178.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.79 -22.38 63.73 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 121.485 1.456 . . . . 0.0 112.294 -178.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.23 -37.49 94.61 Favored Glycine 0 C--O 1.245 0.843 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.94 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -64.82 -39.37 93.47 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.366 0.603 . . . . 0.0 109.8 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.0 tp -63.57 -41.12 98.41 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -63.68 -40.8 97.71 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.5 t -60.26 -44.19 95.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 O-C-N 122.317 -0.239 . . . . 0.0 110.868 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 92.8 mt -62.49 -43.91 98.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -177.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.414 ' NZ ' ' O ' ' B' ' 6' ' ' SER . 98.9 mttt -62.26 -45.84 91.47 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 119.441 -0.904 . . . . 0.0 111.987 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.756 ' HZ3' HG12 ' B' ' 113' ' ' ILE . 98.9 mttt -60.66 -39.34 88.0 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 118.756 -1.178 . . . . 0.0 108.871 -175.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.86 -41.79 92.22 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.137 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.5 mt -62.85 -40.93 98.97 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.57 -38.27 90.49 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.484 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 57.0 m170 -58.52 -39.84 81.26 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 122.328 -0.232 . . . . 0.0 111.422 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.5 p -113.98 129.09 70.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.516 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 35.4 ptt180 -72.03 107.71 4.88 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 122.094 0.95 . . . . 0.0 111.93 -176.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.6 p -139.22 144.44 29.2 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 178.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.446 ' HA3' ' HB2' ' A' ' 123' ' ' GLN . . . -98.87 93.73 1.35 Allowed Glycine 0 C--O 1.221 -0.706 0 C-N-CA 120.749 -0.738 . . . . 0.0 113.015 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 50.5 t -125.14 129.69 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 176.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.1 m -137.04 159.1 36.7 Favored 'Isoleucine or valine' 0 C--O 1.246 0.881 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.5 mt -120.25 129.37 75.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 176.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 26.9 p -103.11 169.03 8.8 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 177.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -133.77 101.98 12.65 Favored Pre-proline 0 C--N 1.321 -0.663 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.739 178.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.442 ' HG3' HG22 ' A' ' 117' ' ' THR . 35.2 Cg_endo -63.26 -22.37 72.32 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 121.422 1.414 . . . . 0.0 111.408 -179.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.46 -33.9 74.54 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.155 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.1 mt -87.87 172.8 9.35 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.734 177.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.707 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 42.0 tt0 -68.86 132.11 46.23 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -176.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.509 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 56.7 t0 61.7 22.25 12.81 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.37 0.605 . . . . 0.0 112.564 177.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 36.6 t-20 43.22 67.13 3.9 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.968 -178.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.707 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 95.4 Cg_endo -70.79 154.62 63.58 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 123.79 2.993 . . . . 0.0 111.979 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.5 mt -87.34 123.54 40.16 Favored 'Isoleucine or valine' 0 C--O 1.246 0.919 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.334 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.503 HG21 ' N ' ' A' ' 41' ' ' TYR . 30.0 m -103.99 -45.14 9.53 Favored 'Isoleucine or valine' 0 C--N 1.343 0.323 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.204 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.503 ' N ' HG21 ' A' ' 40' ' ' VAL . 45.3 t80 -93.4 123.64 36.84 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.636 -178.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.1 p -142.28 140.12 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 O-C-N 124.237 0.96 . . . . 0.0 109.348 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.572 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 57.3 p30 -97.3 166.01 11.76 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.457 ' HA ' ' OE1' ' A' ' 44' ' ' GLN . 13.6 mm100 -66.41 -38.92 88.55 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 176.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.7 -26.48 62.62 Favored Glycine 0 C--N 1.33 0.201 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.572 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 66.7 t80 -58.86 -47.82 83.54 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.592 HG11 ' O ' ' A' ' 52' ' ' TYR . 78.5 t -59.97 -44.74 95.26 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 O-C-N 121.171 -0.956 . . . . 0.0 111.558 -173.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -63.2 -38.45 91.22 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.653 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 57.7 ttm -66.48 -44.07 83.68 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 175.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.48 ' HG1' ' HB2' ' A' ' 52' ' ' TYR . 41.5 p -90.11 -23.02 21.5 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.084 0.469 . . . . 0.0 111.416 -178.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . 78.05 18.97 75.83 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 -178.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.592 ' O ' HG11 ' A' ' 47' ' ' VAL . 70.4 m-85 -113.29 138.38 50.11 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 122.857 0.463 . . . . 0.0 111.28 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -63.18 148.25 48.6 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.808 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.97 -32.44 73.93 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -178.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.01 -42.03 85.66 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 119.706 -0.797 . . . . 0.0 111.483 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -64.69 -46.75 81.03 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.224 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.427 HD13 ' CD2' ' A' ' 46' ' ' PHE . 97.7 mt -60.41 -50.49 80.11 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -175.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 86.9 mt -55.84 145.3 24.99 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.25 -4.37 81.36 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.024 176.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -136.31 152.79 51.06 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.181 1.491 . . . . 0.0 111.846 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.567 ' C ' ' H ' ' A' ' 63' ' ' ARG . 25.8 t-20 -81.19 150.8 28.5 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.232 0.539 . . . . 0.0 110.453 -178.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 80.1 m -63.11 15.21 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.365 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.567 ' H ' ' C ' ' A' ' 61' ' ' ASN . 34.5 ptt-85 -61.55 -41.63 97.66 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 122.09 -0.382 . . . . 0.0 111.31 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -55.28 -22.1 17.17 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -177.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 93.4 mt -65.89 -37.1 85.25 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.538 0.685 . . . . 0.0 112.639 177.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.563 HE22 HO4' ' A' ' 900' ' ' FMN . 87.6 mt-30 -62.17 138.1 58.36 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.121 -178.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.474 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -147.2 -148.07 4.68 Favored Glycine 0 CA--C 1.542 1.762 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.089 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.402 ' HB3' ' HH ' ' A' ' 95' ' ' TYR . 88.8 tttt -63.14 -40.4 97.49 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -177.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -76.61 -9.22 58.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.608 0.242 . . . . 0.0 111.008 -177.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.474 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 30.0 m -64.36 128.54 36.24 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.142 -0.623 . . . . 0.0 109.59 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -86.43 112.39 45.96 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.039 -178.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -57.48 -30.6 88.81 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 121.974 1.782 . . . . 0.0 113.09 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.75 -39.98 95.6 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.054 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -65.8 -43.61 88.18 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 177.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.9 t -60.2 -44.02 94.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 114.2 -1.364 . . . . 0.0 107.476 -176.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -64.63 -37.59 88.11 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.7 179.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -63.33 -40.03 96.18 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.391 0.615 . . . . 0.0 110.784 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.84 -44.1 98.03 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 CA-C-N 114.857 -1.065 . . . . 0.0 112.055 178.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -61.83 -42.72 99.38 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 113.91 -1.495 . . . . 0.0 108.333 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 92.3 m -60.13 -49.94 75.67 Favored 'General case' 0 C--O 1.246 0.896 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.32 -40.45 94.25 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.228 -170.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 84.8 mt -62.99 -40.33 97.43 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 118.723 0.692 . . . . 0.0 111.511 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -64.09 -40.39 96.12 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -72.06 -22.26 61.4 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.475 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.9 tttt 61.22 43.8 10.56 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.452 -176.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -126.7 149.09 67.37 Favored Pre-proline 0 N--CA 1.467 0.397 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -61.81 143.44 95.97 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 121.316 1.344 . . . . 0.0 113.368 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.04 141.72 33.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.809 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.45 ' CG2' ' OD1' ' A' ' 107' ' ' ASN . 96.6 m -126.31 122.18 34.73 Favored 'General case' 0 C--N 1.343 0.315 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 175.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 27.7 m -139.55 158.08 27.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.202 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -104.51 130.06 52.48 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 175.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.2 tt -139.89 128.01 25.88 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.087 0 CA-C-N 120.958 1.708 . . . . 0.0 112.369 178.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.71 136.66 58.13 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 114.495 -1.229 . . . . 0.0 109.899 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -137.06 159.69 41.14 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.671 -179.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.402 ' HH ' ' HB3' ' A' ' 68' ' ' LYS . 95.1 m-85 -118.65 136.67 53.78 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -177.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.473 ' HA ' ' HE1' ' A' ' 52' ' ' TYR . 99.2 mttt -87.03 -172.92 4.2 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.036 0.446 . . . . 0.0 111.621 -177.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.31 -43.85 97.88 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.384 178.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 41.1 p-10 -82.23 5.1 21.01 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.61 0.0 84.53 Favored Glycine 0 N--CA 1.467 0.758 0 C-N-CA 120.825 -0.703 . . . . 0.0 111.911 176.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 18.2 m -61.15 138.66 58.21 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 178.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.689 ' C ' ' SD ' ' A' ' 101' ' ' MET . 13.6 tmm? -104.66 129.85 52.77 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.88 0.372 . . . . 0.0 110.891 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.489 ' N ' ' SD ' ' A' ' 101' ' ' MET . 54.3 p90 -141.76 158.91 43.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.666 -177.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.804 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 25.0 m95 -90.34 143.54 26.67 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.425 HD22 ' HG2' ' A' ' 123' ' ' GLN . 59.4 t-20 -138.2 101.7 4.47 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -177.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 80.4 tt0 -66.91 136.18 54.98 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -176.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 38.3 tp -120.35 123.74 43.84 Favored 'General case' 0 C--O 1.233 0.185 0 O-C-N 123.739 0.649 . . . . 0.0 112.424 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.45 ' OD1' ' CG2' ' A' ' 89' ' ' THR . 98.5 m-20 -121.38 122.67 40.33 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.598 177.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 95.5 mt -120.04 128.23 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 O-C-N 123.523 0.514 . . . . 0.0 111.215 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -136.33 122.99 14.04 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 116.942 -0.117 . . . . 0.0 110.716 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -71.78 150.81 56.63 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.281 1.988 . . . . 0.0 112.602 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.424 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 66.7 mtt -124.17 154.62 39.82 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -128.0 94.41 3.92 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 176.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 96.4 mt -119.69 130.84 73.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.563 -178.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 50.15 37.61 15.04 Favored 'General case' 0 CA--C 1.518 -0.252 0 O-C-N 121.661 -0.649 . . . . 0.0 111.476 176.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 58.77 29.3 18.52 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.884 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -125.89 147.56 49.44 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.751 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 8.4 t -83.79 -173.38 4.68 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.431 -0.793 . . . . 0.0 109.517 -178.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.751 ' CD2' ' O ' ' A' ' 117' ' ' THR . 83.5 m-85 -171.02 154.06 4.0 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 173.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -128.87 145.15 51.29 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 174.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.5 p -134.41 135.17 54.31 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 177.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.91 129.32 9.56 Favored Glycine 0 CA--C 1.505 -0.565 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 178.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.434 ' HB ' ' HB2' ' A' ' 107' ' ' ASN . 96.9 mt -117.77 128.82 74.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.452 ' HA ' ' O ' ' A' ' 105' ' ' GLU . 17.4 mp0 -119.13 116.63 26.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.145 0.498 . . . . 0.0 109.929 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -116.09 113.38 23.07 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.112 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 126' ' ' ILE . 68.2 t0 -63.8 128.74 37.16 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -176.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.414 ' N ' ' OD1' ' A' ' 125' ' ' ASP . 2.7 mp -96.29 3.88 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 113.951 -1.477 . . . . 0.0 110.398 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.5 m -60.05 -42.64 94.9 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.335 -0.853 . . . . 0.0 113.234 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -59.87 -42.32 93.46 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -63.69 -40.13 96.05 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.521 177.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.804 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.5 mttt -62.92 -41.42 99.46 Favored 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 118.393 -1.323 . . . . 0.0 110.359 -178.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -61.68 -36.69 81.58 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.424 ' CE2' HD13 ' A' ' 136' ' ' LEU . 85.8 t80 -61.82 -44.74 96.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.369 176.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.74 -38.74 92.0 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.97 -40.91 97.2 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 54.8 tp -61.26 -43.85 98.2 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.424 HD13 ' CE2' ' A' ' 132' ' ' TYR . 86.6 mt -62.54 -41.06 98.64 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.242 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.91 -41.02 97.44 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.915 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -60.82 -42.17 97.17 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -178.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 58.3 m -61.54 -41.55 97.52 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.677 177.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.464 ' O ' ' N ' ' A' ' 144' ' ' THR . 86.9 mt -64.08 -41.88 97.15 Favored 'General case' 0 C--O 1.224 -0.274 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 91.8 m -61.22 -46.03 92.11 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.38 -177.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -64.79 -40.24 94.91 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 95.7 mt -64.47 -43.49 96.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 113.939 -1.482 . . . . 0.0 111.219 177.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.464 ' N ' ' O ' ' A' ' 140' ' ' LEU . 92.7 m -62.71 -45.95 90.39 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.773 -0.579 . . . . 0.0 112.332 -178.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.4 -40.16 96.46 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 118.853 -1.139 . . . . 0.0 108.991 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 85.2 mt -63.5 -42.57 98.5 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.472 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.746 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.1 p -60.87 -38.78 86.75 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 -178.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.491 ' C ' ' O ' ' A' ' 147' ' ' SER . 31.9 m -27.22 79.85 0.02 OUTLIER Pre-proline 0 N--CA 1.467 0.415 0 O-C-N 126.531 2.394 . . . . 0.0 106.591 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.746 ' N ' ' O ' ' A' ' 147' ' ' SER . 20.9 Cg_exo -62.53 144.46 94.56 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 120.947 1.098 . . . . 0.0 114.666 -173.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.507 ' O ' ' CG2' ' A' ' 151' ' ' VAL . 9.5 tp -121.44 135.2 62.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 102.928 -2.99 . . . . 0.0 102.928 176.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.507 ' CG2' ' O ' ' A' ' 150' ' ' ILE . 99.6 t -167.55 91.81 0.69 Allowed Pre-proline 0 CA--C 1.513 -0.46 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 178.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -61.49 136.26 62.26 Favored 'Trans proline' 0 C--N 1.3 -2.011 0 N-CA-C 109.323 -1.068 . . . . 0.0 109.323 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.491 ' O ' ' HD2' ' A' ' 154' ' ' ARG . 45.5 mm -67.83 -44.34 85.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 119.932 -0.707 . . . . 0.0 110.795 179.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.491 ' HD2' ' O ' ' A' ' 153' ' ' ILE . 0.2 OUTLIER -156.89 -156.39 0.61 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.437 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.455 ' ND2' ' HE3' ' B' ' 256' ' ' LYS . 63.7 t-20 -87.51 105.14 17.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 122.08 0.943 . . . . 0.0 112.008 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 88.98 9.19 68.12 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.758 -177.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.0 mt -126.19 125.36 67.62 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 CA-C-O 121.546 0.689 . . . . 0.0 109.231 174.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.575 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 42.5 m -133.26 152.22 51.93 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.061 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -137.67 141.95 41.13 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.753 -0.592 . . . . 0.0 111.286 177.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 18.0 tp -133.93 78.33 60.33 Favored Pre-proline 0 N--CA 1.47 0.564 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.243 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -70.21 151.63 66.57 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.82 2.347 . . . . 0.0 113.096 -179.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 88.3 mt -117.47 128.76 55.31 Favored 'General case' 0 C--O 1.25 1.089 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.388 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 49.3 t -123.82 130.9 73.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 115.05 170.08 16.22 Favored Glycine 0 N--CA 1.479 1.539 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.042 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.939 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 55.9 t30 -85.05 115.29 22.78 Favored 'General case' 0 C--O 1.213 -0.841 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.419 ' CD2' ' CZ ' ' A' ' 171' ' ' PHE . 41.8 tp -73.67 105.34 4.95 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -177.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.636 ' H ' ' HE ' ' A' ' 170' ' ' ARG . 16.6 p -87.55 165.87 15.16 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.01 178.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -66.72 -33.51 75.8 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.506 0.669 . . . . 0.0 111.455 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.7 -41.36 92.43 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.686 178.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.939 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 87.6 mtm180 -64.71 -33.16 75.31 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 124.173 0.989 . . . . 0.0 112.233 176.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.419 ' CZ ' ' CD2' ' A' ' 166' ' ' LEU . 0.6 OUTLIER -54.33 -28.76 44.87 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.11 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.499 ' O ' HG21 ' A' ' 175' ' ' VAL . 92.6 m-20 -60.53 -41.19 93.94 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 119.003 -1.079 . . . . 0.0 109.857 -178.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 67.3 m -59.57 -41.15 89.54 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.692 -178.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 66.6 mt -63.33 -44.05 98.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.499 HG21 ' O ' ' A' ' 172' ' ' ASN . 30.5 m -62.72 -39.67 85.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . 0.444 ' N ' HG23 ' A' ' 175' ' ' VAL . 98.8 m -61.8 -34.5 76.02 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.262 0.553 . . . . 0.0 110.294 178.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' THR . . . . . 0.53 ' O ' HG13 ' A' ' 181' ' ' ILE . 25.3 m -62.22 -20.4 64.17 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.131 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 89.9 mt -61.12 -41.54 96.9 Favored 'General case' 0 C--O 1.246 0.887 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -178.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 16.9 m -58.87 -43.34 90.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.532 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.593 ' O ' ' OG ' ' A' ' 183' ' ' SER . 92.2 m-20 -61.98 -37.98 86.85 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 122.558 0.343 . . . . 0.0 110.954 178.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 177' ' ' THR . 70.3 mt -58.62 -37.9 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 86.0 mt -60.65 -40.82 93.42 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.015 -177.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.593 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 78.1 p -61.98 -33.32 74.09 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.486 176.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.472 ' OG1' ' HA ' ' A' ' 181' ' ' ILE . 19.2 p -89.67 24.69 2.25 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.561 0.219 . . . . 0.0 111.267 -178.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 78.0 p -63.62 -20.29 65.55 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.198 0.523 . . . . 0.0 110.746 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.17 -37.19 79.42 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.825 -178.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.575 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 99.0 m-20 -74.88 113.88 12.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.457 0.646 . . . . 0.0 110.972 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.83 -42.44 99.73 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.056 -0.975 . . . . 0.0 112.885 -177.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -112.03 131.02 55.67 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.202 0.525 . . . . 0.0 110.912 -178.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 38.6 tp -120.25 128.89 53.76 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 96.2 mt -117.05 126.59 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 118.587 0.63 . . . . 0.0 109.582 177.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.6 mm -112.66 126.43 70.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . 0.502 ' OD2' ' OG ' ' A' ' 195' ' ' SER . 39.5 t0 -94.82 118.57 31.98 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 121.949 0.881 . . . . 0.0 110.46 177.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 95.7 mt -96.93 -3.79 41.17 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.257 175.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.502 ' OG ' ' OD2' ' A' ' 193' ' ' ASP . 78.2 p -61.72 -32.72 72.96 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.82 -42.51 99.75 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 108.766 -1.734 . . . . 0.0 108.766 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 1.18 HD23 ' O ' ' A' ' 199' ' ' GLN . 5.1 tt -72.57 128.59 36.03 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 112.975 -1.612 . . . . 0.0 108.862 -176.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.687 ' N ' HD21 ' A' ' 197' ' ' LEU . . . -60.94 -49.01 79.17 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.203 -178.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 1.18 ' O ' HD23 ' A' ' 197' ' ' LEU . 57.7 tt0 -132.79 155.53 48.76 Favored 'General case' 0 C--O 1.206 -1.219 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -175.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.401 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 53.1 t -117.13 132.43 66.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 O-C-N 120.133 -1.605 . . . . 0.0 108.875 178.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -86.16 156.16 20.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.662 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.3 -38.5 90.43 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.181 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -58.37 -31.7 67.88 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -178.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 17.6 m -60.86 -42.48 97.95 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.659 177.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.523 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -57.05 -38.74 73.67 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -177.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -62.12 -37.39 84.95 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -178.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -64.94 -39.42 93.48 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.103 177.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.29 -44.64 99.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 C-N-CA 119.525 -0.87 . . . . 0.0 108.941 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . 0.523 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 69.1 m-85 -61.65 -43.56 98.63 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.413 -178.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.0 -42.35 99.06 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 119.313 -0.955 . . . . 0.0 109.103 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.427 ' O ' ' HG ' ' A' ' 215' ' ' LEU . 40.1 mt -61.65 -42.27 98.67 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 78.1 p -61.89 -41.66 98.15 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 119.351 -0.939 . . . . 0.0 110.116 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -64.06 -45.91 86.69 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.787 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 53.9 tp -62.12 -46.14 90.37 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 211' ' ' LEU . 84.2 mt -62.56 -40.56 97.22 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.627 -176.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -61.59 -43.1 99.49 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -178.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 85.9 mt -61.8 -39.63 92.4 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 74.8 p -76.68 -11.59 59.87 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.242 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 81.26 38.63 14.45 Favored Glycine 0 C--O 1.217 -0.909 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.329 -178.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 94.7 m -123.95 112.85 17.71 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.024 1.412 . . . . 0.0 111.658 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -63.07 136.63 57.91 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.2 178.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 44.2 tp -114.43 130.63 56.72 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 3.4 mp -118.21 135.36 58.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 122.867 0.467 . . . . 0.0 109.849 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.455 HG23 HD11 ' A' ' 224' ' ' ILE . 49.0 mm -114.85 131.74 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 43.8 p -132.89 167.35 20.38 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 120.854 -0.338 . . . . 0.0 111.876 -178.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 77.31 20.47 74.98 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 97.5 mt -81.79 128.6 38.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 114.043 -1.078 . . . . 0.0 108.77 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 66.9 tttt -75.43 140.82 72.59 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.09 -39.28 86.34 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 121.138 1.225 . . . . 0.0 112.496 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -64.04 -39.31 93.8 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-O 121.829 0.823 . . . . 0.0 110.318 -178.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 49.6 tp -64.18 -42.23 96.77 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.845 -1.071 . . . . 0.0 112.721 177.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.74 -37.27 87.01 Favored 'General case' 0 CA--C 1.521 -0.154 0 O-C-N 121.753 -0.592 . . . . 0.0 111.198 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 94.5 mtp -63.7 -41.35 98.13 Favored 'General case' 0 C--O 1.247 0.959 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -178.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -63.7 -40.33 96.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.668 177.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 37.7 mmt -65.33 -37.13 86.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.823 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -60.51 -41.54 94.57 Favored 'General case' 0 CA--C 1.515 -0.385 0 O-C-N 121.544 -0.723 . . . . 0.0 109.408 -177.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.59 -40.74 92.88 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.238 0.542 . . . . 0.0 110.505 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 52.2 tp -62.89 -40.96 99.15 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 177.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 240' ' ' ALA . 67.1 t0 -169.53 130.26 1.07 Allowed 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.5 -0.75 . . . . 0.0 112.486 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.416 ' N ' ' OD1' ' A' ' 239' ' ' ASP . . . -60.93 -26.89 67.82 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.811 178.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.504 ' O ' ' HB2' ' A' ' 244' ' ' SER . 87.6 m-20 -60.68 -30.42 69.91 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.691 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -55.83 -43.34 76.91 Favored 'General case' 0 C--N 1.311 -1.086 0 O-C-N 121.399 -0.813 . . . . 0.0 109.056 -176.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 94.7 p -63.15 -19.12 64.18 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.043 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' SER . . . . . 0.504 ' HB2' ' O ' ' A' ' 241' ' ' ASN . 70.9 m -54.94 -37.04 65.93 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.405 177.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 95.0 mt -89.19 119.26 29.52 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 119.732 -0.787 . . . . 0.0 112.93 -177.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -42.65 135.55 2.82 Favored 'General case' 0 C--O 1.244 0.773 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.68 -178.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 97.7 m -126.52 132.72 51.32 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.198 -1.364 . . . . 0.0 111.043 178.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -117.54 141.18 48.66 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.978 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' SER . . . . . 0.467 ' O ' ' OD1' ' A' ' 250' ' ' ASN . 77.3 p -62.2 -41.03 97.98 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -178.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.467 ' OD1' ' O ' ' A' ' 249' ' ' SER . 98.9 m-20 -146.15 160.58 41.75 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.63 0.729 . . . . 0.0 111.155 -178.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 70.2 t -62.8 -45.13 99.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.142 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.04 -44.51 97.29 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.633 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -63.74 -42.32 97.89 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.343 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . 0.44 ' O ' HG21 ' A' ' 257' ' ' VAL . . . -65.19 -41.93 94.08 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.829 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 57.3 t -63.73 -45.61 96.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.927 -178.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.81 -47.83 79.28 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.513 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . 0.487 ' O ' ' C ' ' A' ' 258' ' ' LEU . 21.7 m -66.36 -40.11 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 120.048 -0.661 . . . . 0.0 112.314 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.487 ' C ' ' O ' ' A' ' 257' ' ' VAL . 1.0 OUTLIER -30.18 -73.41 0.05 OUTLIER Pre-proline 0 C--N 1.345 0.41 0 C-N-CA 121.041 -0.264 . . . . 0.0 111.347 -176.892 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' A' ' 258' ' ' LEU . 41.0 Cg_endo -63.6 139.85 72.05 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 120.891 1.061 . . . . 0.0 112.117 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 259' ' ' PRO . 96.7 mt -152.12 -28.23 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 116.154 -0.476 . . . . 0.0 112.248 178.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.658 -177.151 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.558 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.7 159.58 40.81 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 118.974 -0.536 . . . . 0.0 109.994 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 79.7 p -59.59 -21.49 60.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 122.101 0.953 . . . . 0.0 110.877 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -73.66 -64.95 0.89 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.042 -177.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -66.39 -38.67 88.04 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.931 177.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.474 ' O ' ' CB ' ' B' ' 7' ' ' PHE . 68.5 m -59.87 -41.7 92.11 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 120.425 -0.51 . . . . 0.0 109.904 -178.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . 0.474 ' CB ' ' O ' ' B' ' 6' ' ' SER . 37.7 t80 84.54 92.98 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 O-C-N 123.844 0.715 . . . . 0.0 110.268 177.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . 0.568 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -67.06 -140.75 0.05 OUTLIER Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -178.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . 0.568 ' HB ' ' O ' ' B' ' 8' ' ' GLY . 75.9 mt 82.98 110.81 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.69 0 C-N-CA 122.519 0.328 . . . . 0.0 111.045 -178.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.14 -23.65 66.65 Favored 'Trans proline' 0 N--CA 1.499 1.806 0 C-N-CA 121.369 1.379 . . . . 0.0 111.936 -178.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.08 -39.7 97.96 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -64.53 -39.7 94.26 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.587 0.708 . . . . 0.0 109.652 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 50.7 tp -61.71 -42.66 99.25 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.21 -177.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -65.3 -33.59 76.35 Favored 'General case' 0 CA--C 1.562 1.418 0 CA-C-O 121.514 0.673 . . . . 0.0 110.523 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 76.0 t -62.83 -45.75 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 113.135 -1.848 . . . . 0.0 111.086 177.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 95.0 mt -64.11 -43.79 97.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.177 -178.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . 0.594 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 98.9 mttt -63.41 -42.13 98.74 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.38 -41.13 98.78 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.973 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.45 -38.81 85.32 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.522 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . 0.406 ' O ' ' O ' ' B' ' 23' ' ' VAL . 83.4 mt -63.61 -42.34 98.21 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.154 0.502 . . . . 0.0 110.152 175.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -62.84 -38.61 91.45 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.128 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 55.9 m170 -57.79 -39.91 78.65 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 121.153 -0.219 . . . . 0.0 111.38 -178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . 0.406 ' O ' ' O ' ' B' ' 20' ' ' LEU . 10.6 p -114.19 129.36 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.52 ' O ' ' HG3' ' B' ' 24' ' ' ARG . 35.1 ptt180 -71.84 105.9 3.97 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 121.971 0.891 . . . . 0.0 112.421 -176.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.0 p -141.77 134.45 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.471 178.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . 0.476 ' O ' ' N ' ' B' ' 123' ' ' GLN . . . -89.33 98.22 2.42 Favored Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 119.525 -1.321 . . . . 0.0 113.054 -175.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 48.6 t -126.03 129.01 72.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 174.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 26.9 m -138.82 156.59 28.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.857 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.402 HG21 HD13 ' B' ' 29' ' ' ILE . 96.0 mt -119.81 125.04 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 122.753 1.263 . . . . 0.0 111.595 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.422 ' HB ' ' OD1' ' B' ' 37' ' ' ASN . 37.4 p -104.17 159.45 15.68 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 113.266 -1.788 . . . . 0.0 108.844 -178.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -126.59 103.26 25.1 Favored Pre-proline 0 C--O 1.238 0.462 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.58 -19.59 65.01 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 121.88 1.72 . . . . 0.0 111.355 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.59 -41.63 97.71 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.677 -0.409 . . . . 0.0 109.922 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 94.9 mt -77.08 -172.7 2.47 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.823 -0.548 . . . . 0.0 111.209 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . 0.709 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 42.0 tt0 -79.69 130.94 35.79 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.446 ' O ' ' C ' ' B' ' 37' ' ' ASN . 61.9 t0 55.21 39.61 31.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.672 177.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' ASN . . . . . 0.446 ' C ' ' O ' ' B' ' 36' ' ' ASP . 23.1 t-20 29.8 69.73 0.61 Allowed Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.709 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 92.8 Cg_endo -72.08 153.91 57.42 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 123.449 2.766 . . . . 0.0 111.696 178.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 96.3 mt -86.58 128.33 39.62 Favored 'Isoleucine or valine' 0 C--O 1.246 0.901 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.487 HG21 ' N ' ' B' ' 41' ' ' TYR . 30.1 m -108.15 -44.77 6.94 Favored 'Isoleucine or valine' 0 C--N 1.341 0.214 0 O-C-N 123.933 0.77 . . . . 0.0 112.631 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' TYR . . . . . 0.487 ' N ' HG21 ' B' ' 40' ' ' VAL . 47.6 t80 -94.38 123.77 37.99 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.27 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 6.3 p -142.14 140.91 29.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 O-C-N 124.033 0.833 . . . . 0.0 109.414 178.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . 0.602 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 56.8 p30 -101.21 161.4 13.64 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.128 178.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' GLN . . . . . 0.454 ' HA ' ' OE1' ' B' ' 44' ' ' GLN . 13.1 mm100 -63.11 -37.77 88.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.624 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.89 -26.69 63.35 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.602 ' HB2' ' OD1' ' B' ' 43' ' ' ASN . 61.9 t80 -60.19 -43.54 95.82 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . 0.758 HG11 ' O ' ' B' ' 52' ' ' TYR . 75.3 t -61.46 -45.95 97.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.276 -179.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -62.96 -44.69 95.35 Favored 'General case' 0 C--N 1.323 -0.543 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.251 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 57.9 ttm -63.11 -42.55 99.59 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' THR . . . . . 0.425 ' HG1' ' HB2' ' B' ' 52' ' ' TYR . 40.9 p -93.53 -17.28 23.56 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.776 -177.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' B' ' 47' ' ' VAL . . . 73.44 17.71 79.08 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . 0.758 ' O ' HG11 ' B' ' 47' ' ' VAL . 70.0 m-85 -111.12 146.01 37.58 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 122.944 0.497 . . . . 0.0 110.349 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -74.4 147.16 42.33 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.45 0.643 . . . . 0.0 111.302 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.36 -38.65 84.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.05 -177.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.23 -39.17 93.86 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 120.103 -0.639 . . . . 0.0 111.81 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -72.3 -31.66 65.9 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 176.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . 0.437 HD13 ' CD2' ' B' ' 46' ' ' PHE . 91.8 mt -68.61 -71.67 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 176.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 96.8 mt -37.25 133.3 0.69 Allowed 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.813 178.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.1 -11.01 71.31 Favored Glycine 0 CA--C 1.537 1.418 0 CA-C-N 116.059 -0.519 . . . . 0.0 113.001 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -133.9 150.19 51.33 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -174.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' ASN . . . . . 0.584 ' C ' ' H ' ' B' ' 63' ' ' ARG . 25.9 t-20 -79.53 149.41 31.45 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.41 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' CYS . . . . . . . . . . . . . 81.8 m -62.74 10.08 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.372 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . 0.584 ' H ' ' C ' ' B' ' 61' ' ' ASN . 33.3 ptt-85 -60.61 -33.54 72.91 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.323 -177.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -58.92 -29.88 67.41 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 178.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 87.3 mt -62.2 -41.31 98.25 Favored 'General case' 0 C--O 1.238 0.466 0 O-C-N 121.573 -0.705 . . . . 0.0 109.686 -178.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . 0.608 HE22 HO4' ' B' ' 900' ' ' FMN . 88.4 mt-30 -51.82 146.25 8.44 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.857 -176.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -156.71 -153.29 6.58 Favored Glycine 0 CA--C 1.534 1.242 0 O-C-N 123.886 0.741 . . . . 0.0 111.831 177.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.31 -41.21 93.0 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -176.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -75.95 -11.1 59.9 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.945 -178.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 28.5 m -62.02 133.7 55.68 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 120.229 -0.589 . . . . 0.0 109.427 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -91.02 112.61 54.6 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.639 -179.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.38 -37.56 89.17 Favored 'Trans proline' 0 N--CA 1.489 1.219 0 C-N-CA 121.074 1.183 . . . . 0.0 111.734 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.99 -40.51 89.41 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.793 -176.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -66.84 -39.39 87.6 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.078 177.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 75.2 t -61.82 -46.43 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -63.15 -36.99 85.45 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.76 -178.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -62.27 -42.11 99.05 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 119.371 -0.932 . . . . 0.0 109.0 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 95.5 mt -63.57 -43.44 98.25 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 CA-C-O 120.751 0.31 . . . . 0.0 110.841 -178.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -61.16 -42.39 98.47 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 76.5 m -61.15 -45.06 96.21 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.352 0.596 . . . . 0.0 110.017 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.12 -40.34 97.32 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -177.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 81.8 mt -62.65 -42.81 99.81 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.034 -0.666 . . . . 0.0 109.38 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 67.6 tp60 -63.21 -38.95 93.19 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -81.99 -4.36 56.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.92 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 45.7 tttt 50.33 43.72 26.62 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.548 176.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -127.95 146.42 59.03 Favored Pre-proline 0 N--CA 1.466 0.349 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.421 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -62.41 140.41 82.11 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 120.973 1.115 . . . . 0.0 113.893 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.58 135.9 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.725 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' THR . . . . . 0.467 ' CG2' ' OD1' ' B' ' 107' ' ' ASN . 93.7 m -121.01 123.45 42.44 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 29.4 m -138.64 162.74 28.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.76 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -115.91 119.8 37.12 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.931 -0.48 . . . . 0.0 109.78 174.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 20.6 tt -127.99 132.44 68.64 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.807 -174.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -70.98 144.42 50.5 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.899 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -133.62 -179.41 5.51 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-O 121.435 0.636 . . . . 0.0 111.489 -178.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -131.46 145.95 52.02 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.146 177.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . 0.449 ' HA ' ' HE1' ' B' ' 52' ' ' TYR . 98.8 mttt -103.45 -180.0 4.11 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.402 0.62 . . . . 0.0 110.658 178.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.46 -35.9 76.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.502 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 38.4 p-10 -86.82 -1.44 57.78 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.42 -0.8 . . . . 0.0 112.928 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.89 3.7 63.85 Favored Glycine 0 N--CA 1.466 0.695 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.464 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 21.7 m -68.48 129.41 39.84 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.274 -0.57 . . . . 0.0 109.478 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' MET . . . . . 0.594 ' SD ' ' N ' ' B' ' 102' ' ' PHE . 15.0 tmm? -88.3 143.44 27.02 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' PHE . . . . . 0.594 ' N ' ' SD ' ' B' ' 101' ' ' MET . 54.4 p90 -153.28 163.5 39.79 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 178.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' TRP . . . . . 0.826 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 25.3 m95 -95.71 139.72 31.55 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.614 0.721 . . . . 0.0 110.468 178.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . 0.411 HD22 ' HG2' ' B' ' 123' ' ' GLN . 64.8 t-20 -133.66 105.85 7.06 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 114.804 -1.089 . . . . 0.0 113.783 -177.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' B' ' 123' ' ' GLN . 81.1 tt0 -73.87 124.24 25.75 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.999 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 37.3 tp -112.04 125.42 54.07 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-O 120.936 0.398 . . . . 0.0 111.631 -177.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' ASN . . . . . 0.479 ' HB2' ' HB ' ' B' ' 122' ' ' ILE . 98.3 m-20 -120.15 127.87 52.89 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 176.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 95.8 mt -122.66 132.59 70.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -141.79 121.55 8.2 Favored Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -70.32 151.88 66.11 Favored 'Trans proline' 0 N--CA 1.501 1.924 0 C-N-CA 122.434 2.09 . . . . 0.0 112.505 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 66.6 mtt -130.87 143.12 50.5 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -112.12 107.4 16.31 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 178.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . 0.756 HG12 ' HZ3' ' A' ' 18' ' ' LYS . 96.8 mt -133.32 127.54 54.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-N 118.521 0.6 . . . . 0.0 111.596 177.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 52.54 38.18 25.0 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.88 178.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 58.86 37.04 24.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.53 -178.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -132.82 150.68 52.13 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 9.4 t -101.4 152.46 20.7 Favored 'General case' 0 C--O 1.217 -0.628 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -177.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -147.39 146.48 29.63 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 120.791 -1.193 . . . . 0.0 111.189 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -123.07 137.75 54.85 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.765 -177.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -128.86 133.36 66.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 -177.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.57 123.17 6.9 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 122' ' ' ILE . . . . . 0.479 ' HB ' ' HB2' ' B' ' 107' ' ' ASN . 92.4 mt -112.33 127.43 69.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 123' ' ' GLN . . . . . 0.476 ' N ' ' O ' ' B' ' 26' ' ' GLY . 17.5 mp0 -117.93 123.58 46.16 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -120.13 121.16 38.19 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' B' ' 127' ' ' THR . 68.2 t0 -69.39 131.72 45.25 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.588 -179.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . 0.51 ' O ' ' HG3' ' B' ' 130' ' ' LYS . 2.7 mp -107.51 17.82 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.807 0 CA-C-O 122.097 0.951 . . . . 0.0 109.095 178.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 127' ' ' THR . . . . . 0.548 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 99.3 m -63.85 -44.04 94.32 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.24 -1.345 . . . . 0.0 112.501 175.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 59.9 tptt -60.88 -46.15 91.76 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 129' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -63.21 -36.19 82.81 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.146 -0.933 . . . . 0.0 111.499 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 130' ' ' LYS . . . . . 0.826 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 98.5 mttt -63.57 -41.42 98.39 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-N 113.779 -1.555 . . . . 0.0 110.511 175.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.99 -41.46 97.51 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 132' ' ' TYR . . . . . 0.409 ' CE2' HD13 ' B' ' 136' ' ' LEU . 86.2 t80 -59.78 -44.11 94.07 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 121.663 -0.648 . . . . 0.0 111.156 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . 0.402 ' O ' ' HG3' ' B' ' 137' ' ' GLU . 97.6 mt-10 -64.61 -36.96 85.93 Favored 'General case' 0 C--O 1.224 -0.254 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.563 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 134' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' B' ' 130' ' ' LYS . 99.0 mttt -62.94 -39.57 95.01 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.676 178.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 54.5 tp -63.01 -41.56 99.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.32 0.581 . . . . 0.0 109.811 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . 0.409 HD13 ' CE2' ' B' ' 132' ' ' TYR . 89.2 mt -63.01 -41.28 99.53 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.404 177.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 137' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' B' ' 133' ' ' GLU . 97.2 mt-10 -64.37 -36.54 84.47 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.357 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.77 -43.47 96.31 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.915 176.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 62.3 m -60.87 -45.76 93.29 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 88.5 mt -60.87 -40.33 92.53 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 99.7 m -61.86 -45.44 93.79 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.97 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -66.3 -42.1 88.8 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 94.9 mt -63.11 -43.62 99.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.642 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 144' ' ' THR . . . . . 0.427 ' HA ' ' HG ' ' B' ' 147' ' ' SER . 93.4 m -61.78 -45.66 92.93 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.25 -41.31 99.04 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 119.021 -1.072 . . . . 0.0 109.369 178.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 87.5 mt -64.58 -41.12 96.47 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 177.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 147' ' ' SER . . . . . 0.64 ' O ' ' N ' ' B' ' 149' ' ' PRO . 78.2 p -61.76 -40.84 96.56 Favored 'General case' 0 CA--C 1.479 -1.779 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 148' ' ' THR . . . . . 0.486 ' C ' ' O ' ' B' ' 147' ' ' SER . 20.6 m -27.92 84.24 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.657 0 O-C-N 124.128 0.892 . . . . 0.0 110.143 177.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 149' ' ' PRO . . . . . 0.64 ' N ' ' O ' ' B' ' 147' ' ' SER . 22.8 Cg_exo -61.69 147.13 96.04 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 C-N-CA 122.044 1.829 . . . . 0.0 115.802 -176.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 9.6 tp -128.47 121.24 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-N 114.258 -1.337 . . . . 0.0 107.771 174.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 58.1 t -151.68 92.83 3.59 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.946 -178.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -60.59 136.05 64.6 Favored 'Trans proline' 0 C--N 1.32 -0.932 0 N-CA-C 109.029 -1.181 . . . . 0.0 109.029 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 153' ' ' ILE . . . . . 0.483 ' O ' ' HD2' ' B' ' 154' ' ' ARG . 45.0 mm -67.74 -43.72 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.876 178.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . 0.483 ' HD2' ' O ' ' B' ' 153' ' ' ILE . 0.2 OUTLIER -156.7 -155.5 0.54 Allowed 'General case' 0 C--N 1.347 0.469 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -179.718 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 62.9 t-20 -86.86 108.27 18.69 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.57 -17.42 57.64 Favored Glycine 0 C--N 1.34 0.803 0 N-CA-C 110.069 -1.213 . . . . 0.0 110.069 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 85.6 mt -110.25 125.64 67.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.144 0.497 . . . . 0.0 111.348 -176.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 158' ' ' SER . . . . . 0.563 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 47.4 m -135.1 149.6 50.07 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.87 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -132.96 145.89 51.29 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.29 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 18.0 tp -139.44 77.76 28.47 Favored Pre-proline 0 CA--C 1.531 0.227 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 161' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -71.56 150.23 56.96 Favored 'Trans proline' 0 N--CA 1.499 1.849 0 C-N-CA 122.835 2.357 . . . . 0.0 114.362 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 92.6 mt -113.83 134.93 54.49 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 55.9 t -128.46 132.93 67.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 112.8 170.61 17.97 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.198 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 165' ' ' ASN . . . . . 0.743 ' O ' ' NH1' ' B' ' 170' ' ' ARG . 61.1 t30 -90.52 107.29 19.07 Favored 'General case' 0 C--O 1.216 -0.673 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -178.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . 0.411 ' CD2' ' CZ ' ' B' ' 171' ' ' PHE . 40.3 tp -63.92 106.16 0.97 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -174.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 167' ' ' THR . . . . . 0.653 ' HG1' ' NE ' ' B' ' 170' ' ' ARG . 34.5 p -86.79 169.45 12.59 Favored 'General case' 0 C--N 1.353 0.729 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.285 177.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -67.61 -37.33 82.38 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.928 176.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.91 -39.55 90.69 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 123.345 1.545 . . . . 0.0 111.486 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 170' ' ' ARG . . . . . 0.743 ' NH1' ' O ' ' B' ' 165' ' ' ASN . 87.9 mtm180 -63.25 -36.36 83.42 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 112.408 -2.178 . . . . 0.0 110.842 177.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 171' ' ' PHE . . . . . 0.411 ' CZ ' ' CD2' ' B' ' 166' ' ' LEU . 0.5 OUTLIER -53.76 -25.29 18.18 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -179.009 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 172' ' ' ASN . . . . . 0.461 ' O ' HG21 ' B' ' 175' ' ' VAL . 93.4 m-20 -62.95 -40.57 98.09 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.01 178.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 57.2 m -60.49 -41.72 94.85 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.776 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 174' ' ' ILE . . . . . 0.403 HD11 HD13 ' B' ' 166' ' ' LEU . 66.4 mt -63.52 -44.45 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -178.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 175' ' ' VAL . . . . . 0.461 HG21 ' O ' ' B' ' 172' ' ' ASN . 30.5 m -62.59 -39.92 86.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -179.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 176' ' ' CYS . . . . . 0.431 ' N ' HG23 ' B' ' 175' ' ' VAL . 97.2 m -61.53 -34.82 76.19 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.226 178.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 177' ' ' THR . . . . . 0.568 ' O ' HG13 ' B' ' 181' ' ' ILE . 25.0 m -62.27 -20.4 64.23 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.25 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 178' ' ' LEU . . . . . . . . . . . . . 91.5 mt -61.27 -38.93 88.54 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.269 -178.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 18.3 m -61.95 -44.09 97.49 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 176.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 180' ' ' ASN . . . . . 0.593 ' O ' ' OG ' ' B' ' 183' ' ' SER . 93.3 m-20 -61.8 -40.89 96.78 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.956 0.408 . . . . 0.0 110.554 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . 0.568 HG13 ' O ' ' B' ' 177' ' ' THR . 75.0 mt -57.35 -31.64 38.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.776 -177.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 182' ' ' LEU . . . . . . . . . . . . . 84.5 mt -62.85 -41.68 99.45 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 119.693 -0.803 . . . . 0.0 109.202 177.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 183' ' ' SER . . . . . 0.593 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.2 p -63.54 -32.8 74.37 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 121.845 -0.534 . . . . 0.0 110.817 177.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 184' ' ' THR . . . . . 0.466 ' OG1' ' HA ' ' B' ' 181' ' ' ILE . 17.4 p -86.2 17.94 3.39 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.367 -176.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 80.3 p -61.12 -15.61 35.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.665 -177.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.45 -40.21 95.86 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 121.029 -0.268 . . . . 0.0 110.729 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 187' ' ' ASP . . . . . 0.563 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.4 m-20 -71.42 114.14 9.18 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.433 0.635 . . . . 0.0 110.831 -177.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.38 -42.43 99.41 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 114.803 -1.09 . . . . 0.0 113.09 -178.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -111.82 130.97 55.64 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.221 -178.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 190' ' ' LEU . . . . . . . . . . . . . 41.9 tp -124.1 118.24 26.47 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.926 177.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 87.0 mt -106.93 125.91 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-N 117.759 0.254 . . . . 0.0 111.216 -177.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 49.8 mm -115.41 118.54 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 193' ' ' ASP . . . . . 0.51 ' OD2' ' OG ' ' B' ' 195' ' ' SER . 41.7 t0 -90.47 111.67 23.02 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -176.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 194' ' ' LEU . . . . . . . . . . . . . 96.2 mt -92.45 -1.61 56.87 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 123.624 0.577 . . . . 0.0 109.627 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 195' ' ' SER . . . . . 0.51 ' OG ' ' OD2' ' B' ' 193' ' ' ASP . 77.8 p -60.88 -36.81 80.17 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.794 -178.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.46 -34.72 89.36 Favored Glycine 0 N--CA 1.439 -1.105 0 N-CA-C 109.919 -1.273 . . . . 0.0 109.919 -178.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 197' ' ' LEU . . . . . 1.176 HD23 ' O ' ' B' ' 199' ' ' GLN . 5.4 tt -77.22 134.01 38.73 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 198' ' ' ALA . . . . . 0.731 ' N ' HD21 ' B' ' 197' ' ' LEU . . . -63.75 -44.96 91.92 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 119.954 -0.698 . . . . 0.0 111.572 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 199' ' ' GLN . . . . . 1.176 ' O ' HD23 ' B' ' 197' ' ' LEU . 58.4 tt0 -136.83 163.25 31.07 Favored 'General case' 0 C--O 1.212 -0.921 0 CA-C-O 122.202 1.001 . . . . 0.0 112.602 -177.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 200' ' ' VAL . . . . . 0.439 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 55.8 t -120.65 132.17 70.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 O-C-N 120.382 -1.449 . . . . 0.0 109.583 177.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -89.7 150.24 22.41 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.79 -178.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -61.38 -33.24 73.33 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.325 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -63.15 -32.99 74.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.435 0.636 . . . . 0.0 109.357 177.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.7 m -60.65 -44.24 96.65 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.291 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 205' ' ' ALA . . . . . 0.676 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -58.15 -29.64 65.73 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -178.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -65.63 -38.77 90.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.502 0.668 . . . . 0.0 110.519 174.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -66.2 -39.0 89.33 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.752 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 95.4 mt -62.86 -45.72 98.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -178.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 209' ' ' PHE . . . . . 0.676 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 66.1 m-85 -61.22 -42.22 98.21 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.781 -176.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.0 -42.07 99.75 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.61 -0.836 . . . . 0.0 109.607 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . 0.443 ' O ' ' HG ' ' B' ' 215' ' ' LEU . 39.4 mt -62.18 -42.3 99.14 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.106 -178.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 78.2 p -63.97 -35.74 81.68 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.385 -0.526 . . . . 0.0 112.0 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 213' ' ' HIS . . . . . . . . . . . . . 56.3 t-80 -66.92 -46.87 73.48 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.106 177.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 56.5 tp -63.96 -43.08 96.87 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.598 0.713 . . . . 0.0 109.88 177.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 215' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' B' ' 211' ' ' LEU . 84.9 mt -63.07 -44.46 95.74 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 113.544 -1.662 . . . . 0.0 111.368 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -61.69 -39.08 90.19 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.258 -177.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 86.2 mt -62.86 -41.62 99.44 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.309 0.576 . . . . 0.0 111.023 176.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 218' ' ' THR . . . . . . . . . . . . . 67.3 p -76.06 -16.26 59.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.641 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 78.81 68.13 1.53 Allowed Glycine 0 CA--C 1.528 0.864 0 N-CA-C 107.573 -2.211 . . . . 0.0 107.573 -177.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 220' ' ' THR . . . . . . . . . . . . . 81.0 m -146.51 105.84 3.91 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 176.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -63.16 139.93 58.82 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.879 -175.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 40.6 tp -118.13 122.18 42.42 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.414 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 3.6 mp -112.25 129.19 68.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.249 -178.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 224' ' ' ILE . . . . . . . . . . . . . 49.5 mm -109.51 126.17 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 50.4 p -133.29 156.08 48.23 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.697 0.761 . . . . 0.0 112.559 -177.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 91.0 16.27 54.57 Favored Glycine 0 CA--C 1.504 -0.598 0 CA-C-N 114.018 -1.446 . . . . 0.0 111.319 -177.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 96.1 mt -81.48 126.48 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 118.046 0.923 . . . . 0.0 111.27 -178.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 64.3 tttt -66.24 140.23 96.74 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.392 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.71 -36.78 91.09 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.378 1.385 . . . . 0.0 112.554 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -64.0 -43.88 94.35 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -178.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 50.1 tp -61.64 -41.8 98.01 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.526 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.82 -37.1 86.12 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.881 -0.328 . . . . 0.0 111.314 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 94.7 mtp -63.83 -41.06 97.93 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.276 -0.57 . . . . 0.0 109.777 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.11 -43.71 97.68 Favored 'General case' 0 CA--C 1.553 1.082 0 CA-C-O 122.305 1.05 . . . . 0.0 109.589 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 37.9 mmt -63.96 -35.21 79.95 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.878 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -61.71 -39.99 93.45 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.989 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.7 -43.24 99.3 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 177.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 51.4 tp -61.83 -43.79 98.14 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.636 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 239' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' B' ' 240' ' ' ALA . 66.8 t0 -162.23 135.01 5.88 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.96 -178.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 240' ' ' ALA . . . . . 0.439 ' N ' ' OD1' ' B' ' 239' ' ' ASP . . . -62.09 -44.3 96.95 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 177.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 241' ' ' ASN . . . . . 0.633 ' O ' ' HB2' ' B' ' 244' ' ' SER . 89.3 m-20 -45.83 -20.2 0.08 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.289 -174.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 242' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -61.24 -45.66 93.62 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 120.083 -0.647 . . . . 0.0 110.402 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 243' ' ' SER . . . . . . . . . . . . . 77.7 p -55.96 -43.46 77.52 Favored 'General case' 0 C--O 1.225 -0.191 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 244' ' ' SER . . . . . 0.633 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 70.9 m -34.07 -33.22 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 -177.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 97.1 mt -89.96 132.56 35.27 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.667 178.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -58.69 136.78 57.77 Favored 'General case' 0 C--O 1.251 1.176 0 CA-C-O 121.833 0.825 . . . . 0.0 111.261 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 247' ' ' THR . . . . . . . . . . . . . 97.4 m -125.97 128.01 46.84 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.74 178.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -113.64 143.46 44.54 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 249' ' ' SER . . . . . 0.564 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 78.1 p -63.11 -35.8 81.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.855 0.36 . . . . 0.0 111.295 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 250' ' ' ASN . . . . . 0.564 ' OD1' ' O ' ' B' ' 249' ' ' SER . 98.6 m-20 -146.67 162.08 39.21 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.321 178.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 73.0 t -65.0 -44.74 95.99 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.175 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.924 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 252' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.38 -46.04 91.84 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -177.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . 0.406 ' O ' HG13 ' B' ' 257' ' ' VAL . 94.7 m-20 -61.43 -43.21 99.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.763 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 254' ' ' ALA . . . . . 0.41 ' O ' HG21 ' B' ' 257' ' ' VAL . . . -65.3 -40.35 93.71 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.468 0.652 . . . . 0.0 111.08 178.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 255' ' ' VAL . . . . . . . . . . . . . 53.6 t -65.39 -45.35 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.277 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 256' ' ' LYS . . . . . 0.455 ' HE3' ' ND2' ' A' ' 155' ' ' ASN . 88.5 tttt -63.37 -48.33 78.39 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.113 -178.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 257' ' ' VAL . . . . . 0.473 ' O ' ' C ' ' B' ' 258' ' ' LEU . 21.1 m -65.14 -40.22 88.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.519 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 258' ' ' LEU . . . . . 0.492 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 1.0 OUTLIER -31.9 -73.33 0.05 OUTLIER Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.826 -178.926 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 259' ' ' PRO . . . . . 0.495 ' O ' HG13 ' B' ' 260' ' ' ILE . 37.5 Cg_endo -62.25 141.47 87.98 Favored 'Trans proline' 0 N--CA 1.504 2.092 0 C-N-CA 121.572 1.515 . . . . 0.0 111.498 -178.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 260' ' ' ILE . . . . . 0.495 HG13 ' O ' ' B' ' 259' ' ' PRO . 96.9 mt -159.35 -16.48 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 118.587 0.63 . . . . 0.0 112.411 177.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 118.083 -0.96 . . . . 0.0 111.73 179.856 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 900' ' ' FMN . . . . . 0.563 HO4' HE22 ' A' ' 66' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 900' ' ' FMN . . . . . 0.608 HO4' HE22 ' B' ' 66' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.221 -1.551 . . . . 0.0 109.221 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.36 174.84 13.82 Favored 'General case' 0 CA--C 1.483 -1.624 0 CA-C-O 123.219 1.485 . . . . 0.0 109.746 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 93.9 p -80.12 -3.81 50.31 Favored 'General case' 0 CA--C 1.572 1.795 0 O-C-N 117.817 -3.052 . . . . 0.0 112.766 177.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -85.29 -64.64 1.12 Allowed 'General case' 0 C--N 1.267 -3.017 0 O-C-N 127.09 2.744 . . . . 0.0 112.304 174.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -70.06 -38.82 75.88 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.089 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.508 ' O ' ' NZ ' ' B' ' 17' ' ' LYS . 65.6 m -59.15 -41.76 89.07 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.862 -177.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.493 ' CB ' ' O ' ' A' ' 6' ' ' SER . 36.2 t80 85.14 87.33 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.364 0.602 . . . . 0.0 111.771 176.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.549 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -60.5 -142.76 0.01 OUTLIER Glycine 0 C--N 1.337 0.628 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.549 ' HB ' ' O ' ' A' ' 8' ' ' GLY . 78.0 mt 84.96 111.76 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.629 0 O-C-N 124.075 0.515 . . . . 0.0 110.655 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.68 -22.25 64.46 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.195 1.263 . . . . 0.0 112.219 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.41 -38.54 95.94 Favored Glycine 0 N--CA 1.465 0.578 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.228 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -64.86 -39.17 93.14 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 51.9 tp -63.06 -41.66 99.51 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -63.29 -40.31 97.0 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.6 t -60.76 -44.04 96.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 O-C-N 122.014 -0.429 . . . . 0.0 111.025 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 92.9 mt -62.32 -43.49 98.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 119.508 -0.877 . . . . 0.0 109.12 -177.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.43 ' NZ ' ' HA ' ' B' ' 6' ' ' SER . 98.8 mttt -62.54 -46.22 89.36 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 119.331 -0.948 . . . . 0.0 112.036 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.788 ' HZ3' HG12 ' B' ' 113' ' ' ILE . 98.6 mttt -60.23 -39.46 86.74 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 118.72 -1.192 . . . . 0.0 108.83 -176.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.35 -42.14 90.86 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 120.034 -0.666 . . . . 0.0 110.156 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.0 mt -62.99 -40.93 99.24 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -63.08 -38.85 92.83 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.949 -0.568 . . . . 0.0 112.525 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 54.4 m170 -58.44 -40.06 81.53 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 122.168 -0.332 . . . . 0.0 111.48 -178.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.0 p -114.85 130.52 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.462 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 33.3 ptt180 -72.09 111.63 7.48 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 122.126 0.965 . . . . 0.0 112.207 -177.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.6 p -141.31 143.1 28.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.499 ' HA3' ' HB2' ' A' ' 123' ' ' GLN . . . -97.81 90.65 1.09 Allowed Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.767 -178.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 54.4 t -124.38 129.81 73.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 176.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.3 m -137.38 159.77 35.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.6 mt -120.09 129.92 74.91 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.64 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 176.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.405 ' OG1' ' HB2' ' A' ' 119' ' ' PHE . 17.5 p -106.16 166.08 10.77 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.427 ' C ' ' OD1' ' A' ' 37' ' ' ASN . 44.3 t0 -132.78 101.7 13.98 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.45 ' HG3' HG22 ' A' ' 117' ' ' THR . 37.6 Cg_endo -64.64 -21.2 65.56 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.576 1.517 . . . . 0.0 111.572 -178.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.54 -33.61 75.28 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.399 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 88.9 mt -86.83 172.22 10.27 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.272 178.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.645 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 42.2 tt0 -67.58 133.06 48.74 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -178.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.567 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 62.8 t0 61.44 20.85 11.53 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 177.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.427 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 40.4 t-20 43.1 68.68 2.74 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.727 -177.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.645 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 88.1 Cg_endo -71.4 155.63 59.73 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 123.9 3.067 . . . . 0.0 112.39 -178.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.3 mt -87.91 124.35 41.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 O-C-N 124.047 0.842 . . . . 0.0 108.977 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.405 HG21 ' N ' ' A' ' 41' ' ' TYR . 27.6 m -105.18 -42.43 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 O-C-N 123.609 0.568 . . . . 0.0 112.332 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.405 ' N ' HG21 ' A' ' 40' ' ' VAL . 46.7 t80 -97.13 123.2 40.82 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 120.289 -0.564 . . . . 0.0 111.968 -178.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.6 p -142.56 139.73 28.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.918 177.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.652 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 55.7 p30 -95.78 165.96 12.04 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.47 ' HA ' ' OE1' ' A' ' 44' ' ' GLN . 14.0 mm100 -66.63 -39.82 88.45 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 177.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.57 -25.0 62.63 Favored Glycine 0 C--O 1.236 0.247 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.652 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 64.5 t80 -59.39 -48.48 81.47 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 105.221 -2.14 . . . . 0.0 105.221 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.491 HG11 ' O ' ' A' ' 52' ' ' TYR . 54.4 t -58.78 -44.7 90.83 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.554 0 O-C-N 121.088 -1.008 . . . . 0.0 111.623 -174.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -63.15 -35.81 81.52 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 120.441 -0.504 . . . . 0.0 112.278 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 60.9 ttm -68.08 -42.66 80.07 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 177.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.402 ' HG1' ' H ' ' A' ' 52' ' ' TYR . 43.6 p -95.58 -20.59 18.86 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.358 0.599 . . . . 0.0 111.255 -177.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . 77.94 19.41 75.25 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.491 ' O ' HG11 ' A' ' 47' ' ' VAL . 75.0 m-85 -112.37 137.74 50.09 Favored 'General case' 0 C--O 1.222 -0.366 0 C-N-CA 122.569 0.348 . . . . 0.0 110.881 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -63.22 147.94 49.54 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.829 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.2 -33.79 76.84 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.61 -43.15 85.54 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.959 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -64.23 -45.12 89.6 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.354 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.422 HG22 HD13 ' A' ' 57' ' ' ILE . 96.1 mt -62.85 -48.37 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 -175.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.2 mt -57.49 144.99 34.72 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.03 -2.96 82.51 Favored Glycine 0 C--O 1.237 0.329 0 C-N-CA 121.062 -0.589 . . . . 0.0 113.534 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -134.78 151.47 50.99 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.916 1.358 . . . . 0.0 112.308 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.663 HD22 HO2' ' A' ' 900' ' ' FMN . 25.5 t-20 -81.57 149.38 28.66 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.343 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 71.4 m -61.96 16.15 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.515 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.581 ' H ' ' C ' ' A' ' 61' ' ' ASN . 36.5 ptt-85 -61.35 -41.52 97.19 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.973 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -55.91 -20.31 15.37 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.5 mt -68.77 -35.94 77.7 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.951 0.881 . . . . 0.0 112.064 177.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.547 HE22 HO4' ' A' ' 900' ' ' FMN . 88.1 mt-30 -64.92 136.85 57.3 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.877 -176.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.568 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -147.28 -149.09 4.89 Favored Glycine 0 CA--C 1.537 1.415 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -178.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.497 ' HB3' ' HH ' ' A' ' 95' ' ' TYR . 88.7 tttt -62.83 -40.03 96.14 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -177.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.419 ' HD1' HE22 ' A' ' 93' ' ' GLN . 7.3 m-70 -76.32 -9.58 58.74 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.952 0.406 . . . . 0.0 111.003 -178.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.568 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 27.0 m -61.4 129.65 42.24 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.567 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -86.49 112.1 44.02 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.791 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -57.45 -31.12 90.44 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 121.966 1.777 . . . . 0.0 113.283 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.49 -40.67 96.1 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 120.499 -0.481 . . . . 0.0 110.815 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.408 ' OE1' ' HB ' ' A' ' 90' ' ' VAL . 79.2 mm-40 -65.53 -45.03 85.02 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.4 t -59.09 -43.62 89.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -177.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -63.87 -37.74 88.52 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.042 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -63.47 -39.79 95.39 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.497 0.665 . . . . 0.0 110.128 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.22 -44.04 97.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.96 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -62.66 -43.19 99.44 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 113.771 -1.558 . . . . 0.0 108.231 -179.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 99.3 m -61.16 -48.54 81.13 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.37 -41.34 96.94 Favored 'General case' 0 C--N 1.361 1.081 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.186 -172.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 90.2 mt -63.05 -40.08 96.65 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.632 -1.293 . . . . 0.0 111.582 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -63.03 -40.78 98.77 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -70.11 -25.19 63.39 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.457 177.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 51.5 tttt 65.23 42.81 3.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.413 -176.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -125.96 148.57 63.26 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -61.64 143.82 96.99 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.334 1.356 . . . . 0.0 112.928 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.93 141.34 31.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.457 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.567 ' CG2' ' OD1' ' A' ' 107' ' ' ASN . 99.6 m -128.1 120.33 27.17 Favored 'General case' 0 C--N 1.345 0.386 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 176.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.408 ' HB ' ' OE1' ' A' ' 74' ' ' GLU . 29.0 m -138.82 158.31 29.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.82 -0.173 . . . . 0.0 111.453 178.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -102.96 128.75 49.65 Favored 'General case' 0 C--O 1.247 0.931 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.3 tt -137.55 129.45 41.0 Favored 'Isoleucine or valine' 0 C--N 1.378 1.837 0 CA-C-N 121.917 2.144 . . . . 0.0 112.363 177.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.419 HE22 ' HD1' ' A' ' 69' ' ' HIS . 86.7 mt-30 -61.5 134.29 56.69 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.107 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -135.43 159.82 40.38 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.102 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.497 ' HH ' ' HB3' ' A' ' 68' ' ' LYS . 93.0 m-85 -118.46 137.22 53.32 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.425 ' HG3' ' CE1' ' A' ' 102' ' ' PHE . 99.2 mttt -85.97 -171.77 3.75 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.394 0.616 . . . . 0.0 111.754 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -62.99 -42.08 99.75 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.295 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.486 ' CG ' ' HG1' ' A' ' 100' ' ' THR . 41.1 p-10 -84.8 8.12 18.39 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -178.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.84 -3.41 87.17 Favored Glycine 0 N--CA 1.473 1.108 0 C-N-CA 120.571 -0.824 . . . . 0.0 111.916 177.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.486 ' HG1' ' CG ' ' A' ' 98' ' ' ASP . 22.7 m -59.3 137.89 57.82 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 106.255 -1.758 . . . . 0.0 106.255 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.687 ' C ' ' SD ' ' A' ' 101' ' ' MET . 13.4 tmm? -107.01 129.29 54.82 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 122.184 -0.323 . . . . 0.0 111.032 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.439 ' N ' ' SD ' ' A' ' 101' ' ' MET . 52.9 p90 -140.61 158.62 43.71 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.404 -177.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.842 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 22.8 m95 -89.03 144.87 25.85 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.48 HD22 ' HG2' ' A' ' 123' ' ' GLN . 56.4 t-20 -139.0 102.06 4.44 Favored 'General case' 0 C--O 1.245 0.862 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -176.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.42 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 80.8 tt0 -67.27 136.43 54.91 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -177.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 40.2 tp -121.43 123.76 42.85 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -179.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.567 ' OD1' ' CG2' ' A' ' 89' ' ' THR . 98.1 m-20 -120.58 122.64 41.01 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 123.237 0.336 . . . . 0.0 110.742 177.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.403 HD11 HG21 ' A' ' 108' ' ' ILE . 96.3 mt -120.71 128.33 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 O-C-N 123.536 0.523 . . . . 0.0 111.505 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -138.24 125.14 13.26 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.17 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -71.56 152.12 59.36 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.399 2.066 . . . . 0.0 112.313 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.579 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 66.6 mtt -124.47 152.73 42.99 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -127.41 96.19 4.49 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 177.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 96.4 mt -120.34 131.28 73.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.184 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 51.13 38.33 20.6 Favored 'General case' 0 CA--C 1.511 -0.538 0 O-C-N 121.355 -0.84 . . . . 0.0 111.51 175.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 59.39 31.49 21.13 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 123.777 0.673 . . . . 0.0 111.049 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -129.55 148.73 51.48 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.76 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 7.4 t -86.58 -173.33 4.45 Favored 'General case' 0 C--O 1.209 -1.034 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -178.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.76 ' CD2' ' O ' ' A' ' 117' ' ' THR . 77.2 m-85 -170.5 155.71 5.16 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 175.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.405 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 83.7 m-85 -129.44 146.38 51.3 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 175.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -136.43 135.54 49.27 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 177.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -111.12 130.28 9.69 Favored Glycine 0 CA--C 1.5 -0.89 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 178.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 96.2 mt -119.01 129.69 74.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.499 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . 15.7 mp0 -119.67 115.27 23.59 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -116.46 113.07 22.32 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.647 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.464 ' OD1' ' N ' ' A' ' 126' ' ' ILE . 68.3 t0 -63.75 131.15 46.97 Favored 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -176.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.464 ' N ' ' OD1' ' A' ' 125' ' ' ASP . 2.6 mp -96.01 4.29 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 113.53 -1.668 . . . . 0.0 110.136 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 29.5 m -60.92 -42.45 98.14 Favored 'General case' 0 C--N 1.364 1.237 0 O-C-N 120.595 -1.316 . . . . 0.0 113.528 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -59.49 -43.06 93.41 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -63.0 -40.07 96.66 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.792 177.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.842 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.6 mttt -62.95 -40.81 98.79 Favored 'General case' 0 CA--C 1.504 -0.814 0 C-N-CA 118.277 -1.369 . . . . 0.0 110.187 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -61.43 -38.52 87.47 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.013 -178.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.519 ' CE2' HD13 ' A' ' 136' ' ' LEU . 86.6 t80 -61.76 -45.85 92.11 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.307 176.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.82 -38.29 90.53 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -62.44 -40.21 95.85 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.391 -0.524 . . . . 0.0 109.74 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 52.9 tp -61.05 -43.59 98.65 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -178.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.519 HD13 ' CE2' ' A' ' 132' ' ' TYR . 85.7 mt -62.72 -41.24 99.05 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.002 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -62.93 -41.5 99.49 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 119.337 -0.945 . . . . 0.0 109.672 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -60.14 -42.24 94.42 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -177.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 55.4 m -61.68 -41.36 97.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.851 176.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 144' ' ' THR . 84.6 mt -63.23 -41.41 99.11 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 178.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 88.3 m -61.54 -45.63 93.34 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.102 -177.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -65.19 -40.52 94.34 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 94.5 mt -64.7 -43.17 96.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 113.9 -1.5 . . . . 0.0 111.331 176.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.502 ' N ' ' O ' ' A' ' 140' ' ' LEU . 96.4 m -62.11 -46.01 90.96 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 120.372 -0.531 . . . . 0.0 112.371 -178.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.47 ' O ' ' OG1' ' A' ' 148' ' ' THR . . . -62.93 -39.77 95.6 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 118.95 -1.1 . . . . 0.0 109.451 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.4 mt -63.32 -42.71 99.0 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.719 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.0 p -59.6 -40.22 86.78 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -177.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.47 ' C ' ' O ' ' A' ' 147' ' ' SER . 12.6 m -26.72 80.64 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.524 0 O-C-N 127.54 3.025 . . . . 0.0 106.195 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.719 ' N ' ' O ' ' A' ' 147' ' ' SER . 19.3 Cg_exo -62.19 143.66 94.65 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 121.08 1.187 . . . . 0.0 113.651 -175.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.583 ' O ' ' CG2' ' A' ' 151' ' ' VAL . 8.9 tp -118.69 136.07 57.07 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 175.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.583 ' CG2' ' O ' ' A' ' 150' ' ' ILE . 89.1 t -169.25 92.59 0.55 Allowed Pre-proline 0 CA--C 1.508 -0.673 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 178.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -61.89 136.47 61.79 Favored 'Trans proline' 0 N--CA 1.487 1.105 0 CA-C-N 119.598 0.892 . . . . 0.0 110.086 -177.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.607 ' O ' ' HD2' ' A' ' 154' ' ' ARG . 45.4 mm -67.34 -45.25 86.29 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.526 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.381 178.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.607 ' HD2' ' O ' ' A' ' 153' ' ' ILE . 0.7 OUTLIER -157.71 -156.4 0.58 Allowed 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.422 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 63.1 t-20 -86.93 104.78 16.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.48 0.657 . . . . 0.0 110.971 -178.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.21 7.97 67.08 Favored Glycine 0 C--O 1.224 -0.494 0 CA-C-N 114.077 -1.42 . . . . 0.0 110.015 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.6 mt -123.92 123.66 67.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 175.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.716 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 57.6 m -132.74 151.69 51.92 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -139.84 142.44 36.6 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.333 0.587 . . . . 0.0 111.309 178.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 20.7 tp -131.34 81.19 66.01 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.322 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -69.29 150.01 70.56 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.712 2.274 . . . . 0.0 113.117 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 90.6 mt -119.62 126.72 51.85 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.792 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 55.4 t -124.11 131.6 72.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 117.68 167.8 14.34 Favored Glycine 0 N--CA 1.476 1.326 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.241 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.903 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 56.2 t30 -85.11 115.02 22.67 Favored 'General case' 0 C--O 1.204 -1.305 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.501 ' CD2' ' CZ ' ' A' ' 171' ' ' PHE . 47.8 tp -75.12 103.42 5.29 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -177.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.577 ' H ' ' HE ' ' A' ' 170' ' ' ARG . 10.7 p -85.29 167.95 15.15 Favored 'General case' 0 C--O 1.226 -0.14 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.637 178.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.75 -33.59 76.21 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.33 -45.17 89.04 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.149 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.903 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 87.4 mtm180 -63.27 -33.37 75.36 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.219 -0.9 . . . . 0.0 112.267 178.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.501 ' CZ ' ' CD2' ' A' ' 166' ' ' LEU . 0.4 OUTLIER -54.5 -28.2 43.36 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 119.086 -0.483 . . . . 0.0 111.897 -177.586 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.655 ' O ' HG21 ' A' ' 175' ' ' VAL . 91.5 m-20 -60.97 -39.81 90.99 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 118.866 -1.134 . . . . 0.0 109.842 -177.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 66.9 m -59.4 -40.92 88.14 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 121.787 -0.571 . . . . 0.0 110.484 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 67.0 mt -63.63 -44.01 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.655 HG21 ' O ' ' A' ' 172' ' ' ASN . 33.7 m -62.53 -40.89 89.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -178.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 96.5 m -62.33 -34.53 76.81 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.312 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' THR . . . . . 0.547 ' O ' HG13 ' A' ' 181' ' ' ILE . 25.4 m -61.91 -19.59 62.85 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.931 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 84.9 mt -60.87 -41.58 96.23 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -177.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 19.5 m -59.53 -43.43 93.48 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.622 ' O ' ' OG ' ' A' ' 183' ' ' SER . 92.5 m-20 -61.85 -37.24 83.75 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-O 121.016 0.436 . . . . 0.0 110.719 178.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . 0.547 HG13 ' O ' ' A' ' 177' ' ' THR . 66.0 mt -58.21 -38.68 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 O-C-N 121.296 -0.877 . . . . 0.0 109.437 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 87.0 mt -60.89 -40.6 93.67 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -177.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.622 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 77.1 p -61.53 -34.02 74.83 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.526 177.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 49.4 p -89.26 25.17 1.96 Allowed 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.634 0.254 . . . . 0.0 111.304 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 78.5 p -63.6 -21.51 66.4 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.846 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -59.76 -36.96 77.71 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.14 -178.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.716 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 98.8 m-20 -72.03 112.97 8.57 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.593 0.711 . . . . 0.0 110.853 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.88 -42.78 99.89 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 114.959 -1.018 . . . . 0.0 112.802 -177.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -113.37 131.61 55.92 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.802 -178.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 38.3 tp -121.08 128.49 52.65 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 96.1 mt -116.39 127.14 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 177.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.3 mm -112.68 126.98 70.14 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . 0.43 ' CG ' ' HG ' ' A' ' 195' ' ' SER . 40.1 t0 -95.13 119.56 33.84 Favored 'General case' 0 CA--C 1.56 1.352 0 CA-C-O 119.638 -0.22 . . . . 0.0 110.913 178.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 95.8 mt -99.64 -4.03 31.82 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 125.022 1.451 . . . . 0.0 111.06 176.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.43 ' HG ' ' CG ' ' A' ' 193' ' ' ASP . 78.4 p -63.12 -32.24 73.57 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -62.08 -44.38 97.84 Favored Glycine 0 CA--C 1.544 1.851 0 N-CA-C 108.103 -1.999 . . . . 0.0 108.103 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 1.266 HD23 ' O ' ' A' ' 199' ' ' GLN . 6.7 tt -67.37 128.76 37.62 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 112.536 -1.832 . . . . 0.0 109.284 -178.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.408 ' N ' HD21 ' A' ' 197' ' ' LEU . . . -60.53 -50.38 73.79 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-O 121.402 0.62 . . . . 0.0 110.476 -178.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 1.266 ' O ' HD23 ' A' ' 197' ' ' LEU . 59.1 tt0 -133.55 156.5 47.7 Favored 'General case' 0 C--O 1.209 -1.034 0 CA-C-N 114.445 -1.252 . . . . 0.0 114.328 -175.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.465 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 44.9 t -116.07 131.08 69.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 O-C-N 120.321 -1.487 . . . . 0.0 108.619 178.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -84.21 155.74 22.36 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.759 -179.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.59 -39.47 93.79 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.045 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -57.16 -31.98 65.95 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.3 m -61.52 -42.38 98.72 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.546 178.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.454 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -56.39 -39.7 73.39 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -177.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -61.19 -37.41 82.84 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.634 -0.427 . . . . 0.0 109.882 -178.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.0 -38.96 92.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.835 177.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.92 -44.63 99.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 C-N-CA 119.469 -0.893 . . . . 0.0 108.734 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . 0.454 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 68.9 m-85 -62.35 -43.59 98.46 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.001 -177.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.13 -42.01 98.81 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 118.882 -1.127 . . . . 0.0 109.181 -178.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 41.1 mt -62.11 -41.66 98.44 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' SER . . . . . 0.476 ' HG ' ' N ' ' A' ' 213' ' ' HIS . 78.3 p -61.28 -42.19 98.22 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 118.936 -1.106 . . . . 0.0 110.351 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' HIS . . . . . 0.476 ' N ' ' HG ' ' A' ' 212' ' ' SER . 59.0 t-80 -63.42 -46.02 88.28 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.76 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 52.8 tp -62.49 -46.76 87.0 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 88.4 mt -62.02 -40.53 95.99 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.902 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.46 -44.5 95.8 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.292 -178.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 84.0 mt -61.76 -40.18 94.23 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 75.2 p -75.81 -11.66 60.02 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.239 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 83.1 37.05 13.21 Favored Glycine 0 C--N 1.343 0.939 0 C-N-CA 120.723 -0.751 . . . . 0.0 114.027 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 99.8 m -123.2 114.68 20.6 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.046 1.423 . . . . 0.0 112.022 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -65.65 138.08 57.76 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.268 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 42.9 tp -112.37 130.01 56.11 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 3.2 mp -117.61 132.56 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.459 HG23 HD11 ' A' ' 224' ' ' ILE . 49.4 mm -115.33 131.43 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 42.6 p -134.01 167.67 20.2 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 78.15 19.14 75.28 Favored Glycine 0 C--O 1.223 -0.537 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 97.4 mt -81.53 128.35 38.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 113.611 -1.294 . . . . 0.0 108.112 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -74.01 140.2 76.97 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.29 -38.92 88.7 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 120.99 1.127 . . . . 0.0 112.627 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -64.83 -38.7 91.86 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 121.351 0.596 . . . . 0.0 109.948 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 51.2 tp -63.64 -42.76 98.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.832 177.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.48 -37.99 89.46 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.73 -178.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 94.1 mtp -63.31 -40.4 97.23 Favored 'General case' 0 C--O 1.247 0.923 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.834 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -64.04 -39.38 93.96 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.755 177.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 33.1 mmt -65.94 -36.63 83.88 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.623 178.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -61.11 -41.48 96.76 Favored 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 121.367 -0.833 . . . . 0.0 109.413 -176.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.71 -40.68 93.14 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.618 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 54.5 tp -63.61 -41.55 98.3 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 176.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -168.18 124.63 1.05 Allowed 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.254 0.55 . . . . 0.0 112.454 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.66 -27.1 66.09 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.764 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -62.49 -26.42 68.52 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.789 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -56.23 -44.21 79.38 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -176.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 99.4 p -61.78 -20.59 63.75 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 123.766 0.666 . . . . 0.0 111.283 179.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 50.1 m -57.11 -33.77 67.68 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 94.7 mt -87.79 121.79 30.65 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 119.458 -0.897 . . . . 0.0 113.261 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -46.03 135.84 7.12 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.712 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 97.8 m -127.46 132.92 49.95 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.673 179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -118.13 139.18 51.63 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.12 178.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 78.0 p -60.47 -41.76 94.83 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -178.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -144.46 160.78 40.52 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.824 0.821 . . . . 0.0 111.604 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 72.3 t -63.23 -44.43 99.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 114.586 -1.188 . . . . 0.0 112.25 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.57 -44.54 96.08 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.036 -0.665 . . . . 0.0 109.466 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -63.83 -42.51 97.62 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.487 -178.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . 0.487 ' O ' HG21 ' A' ' 257' ' ' VAL . . . -63.88 -42.8 97.41 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 122.035 0.921 . . . . 0.0 109.791 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . 0.444 HG13 HH11 ' B' ' 154' ' ' ARG . 66.3 t -63.6 -45.71 96.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.157 -1.383 . . . . 0.0 111.143 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.84 -47.66 79.88 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.267 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . 0.506 ' O ' ' C ' ' A' ' 258' ' ' LEU . 33.3 m -66.48 -40.54 86.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 O-C-N 121.373 -0.829 . . . . 0.0 112.285 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.506 ' C ' ' O ' ' A' ' 257' ' ' VAL . 1.7 mt -28.64 -75.48 0.04 OUTLIER Pre-proline 0 N--CA 1.467 0.375 0 O-C-N 123.17 0.294 . . . . 0.0 111.607 -177.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' PRO . . . . . 0.494 ' CD ' ' CB ' ' A' ' 258' ' ' LEU . 42.7 Cg_endo -63.25 139.3 71.25 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 120.754 0.969 . . . . 0.0 111.943 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . 0.406 HD11 HG23 ' A' ' 260' ' ' ILE . 96.7 mt -151.74 -27.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 O-C-N 124.049 0.843 . . . . 0.0 111.962 178.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 78.0 mtm . . . . . 0 N--CA 1.475 0.789 0 CA-C-O 118.094 -0.955 . . . . 0.0 110.754 -177.425 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.49 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.13 165.32 36.33 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 79.4 p -66.96 -13.59 61.98 Favored 'General case' 0 CA--C 1.568 1.669 0 O-C-N 121.724 -0.61 . . . . 0.0 112.398 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -80.04 -63.25 1.45 Allowed 'General case' 0 C--N 1.311 -1.108 0 O-C-N 124.532 1.145 . . . . 0.0 109.379 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -67.05 -39.19 86.87 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.445 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.486 ' O ' ' CB ' ' B' ' 7' ' ' PHE . 66.6 m -59.68 -42.08 92.12 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.782 -177.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . 0.486 ' CB ' ' O ' ' B' ' 6' ' ' SER . 36.8 t80 85.85 90.96 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.573 177.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . 0.555 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -63.58 -141.85 0.02 OUTLIER Glycine 0 C--N 1.34 0.754 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . 0.555 ' HB ' ' O ' ' B' ' 8' ' ' GLY . 78.5 mt 84.49 111.86 0.03 OUTLIER Pre-proline 0 CA--C 1.545 0.776 0 O-C-N 124.086 0.521 . . . . 0.0 110.796 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.79 -24.31 68.56 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 121.109 1.206 . . . . 0.0 111.783 -178.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.71 -40.43 98.76 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.604 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -64.87 -39.44 93.55 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.557 0.694 . . . . 0.0 109.234 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 50.3 tp -62.05 -42.28 99.02 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.454 -177.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -65.14 -31.15 72.19 Favored 'General case' 0 CA--C 1.562 1.439 0 CA-C-O 121.643 0.735 . . . . 0.0 110.805 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 78.3 t -63.81 -46.27 94.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 113.119 -1.855 . . . . 0.0 111.276 177.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 95.0 mt -64.24 -43.71 97.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.761 -178.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . 0.508 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 98.9 mttt -63.35 -42.64 98.93 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.03 -40.91 99.15 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 119.105 -1.038 . . . . 0.0 109.726 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.32 -39.16 86.04 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.816 -178.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 84.2 mt -64.12 -42.02 97.0 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.383 0.611 . . . . 0.0 110.278 175.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -63.07 -39.08 93.65 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.831 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 53.0 m170 -57.63 -40.16 78.58 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 119.547 -0.263 . . . . 0.0 111.488 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 14.8 p -114.93 130.26 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.477 ' O ' ' HG3' ' B' ' 24' ' ' ARG . 33.2 ptt180 -71.7 109.97 5.95 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.888 0.851 . . . . 0.0 112.343 -177.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.2 p -143.19 133.53 22.16 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.8 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.514 177.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . 0.568 ' O ' ' N ' ' B' ' 123' ' ' GLN . . . -87.25 95.32 2.06 Favored Glycine 0 C--N 1.31 -0.87 0 C-N-CA 119.354 -1.403 . . . . 0.0 113.538 -177.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 49.7 t -125.54 129.11 72.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 174.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 27.6 m -139.01 156.49 27.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.58 0.229 . . . . 0.0 110.478 178.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 96.1 mt -117.98 126.88 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.61 177.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' B' ' 119' ' ' PHE . 24.1 p -106.65 157.42 17.71 Favored 'General case' 0 CA--C 1.505 -0.786 0 O-C-N 126.003 2.064 . . . . 0.0 108.688 -178.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -124.76 102.47 32.06 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.54 -18.3 59.07 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 121.697 1.598 . . . . 0.0 111.473 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.24 -40.26 96.93 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.741 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 90.4 mt -76.47 -170.47 1.52 Allowed 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.823 -0.548 . . . . 0.0 111.234 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . 0.64 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 42.4 tt0 -82.04 131.25 35.24 Favored 'General case' 0 C--N 1.342 0.26 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.502 ' O ' ' OD1' ' B' ' 36' ' ' ASP . 66.3 t0 56.22 35.27 25.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.063 177.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' ASN . . . . . 0.444 ' C ' ' O ' ' B' ' 36' ' ' ASP . 28.3 t-20 33.3 70.34 0.81 Allowed Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.64 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 89.2 Cg_endo -72.66 154.19 54.47 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 123.434 2.756 . . . . 0.0 111.994 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 96.1 mt -86.47 128.81 39.17 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 29.3 m -109.15 -42.82 5.6 Favored 'Isoleucine or valine' 0 C--N 1.341 0.231 0 O-C-N 123.681 0.613 . . . . 0.0 112.446 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -97.44 123.57 41.34 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.654 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 5.8 p -142.65 140.65 28.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.017 177.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . 0.688 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 57.4 p30 -99.98 160.73 14.09 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.289 179.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' GLN . . . . . 0.471 ' HA ' ' OE1' ' B' ' 44' ' ' GLN . 13.4 mm100 -62.94 -38.27 90.4 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.418 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.57 -25.63 63.48 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.688 ' HB2' ' OD1' ' B' ' 43' ' ' ASN . 60.5 t80 -60.03 -43.66 95.15 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . 0.683 HG11 ' O ' ' B' ' 52' ' ' TYR . 53.7 t -61.07 -46.33 96.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.066 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -63.36 -43.55 97.36 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.244 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 60.8 ttm -63.06 -41.92 99.56 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 41.5 p -96.75 -16.11 21.03 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.729 -178.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' B' ' 47' ' ' VAL . . . 73.08 19.69 79.7 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 178.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . 0.683 ' O ' HG11 ' B' ' 47' ' ' VAL . 74.8 m-85 -111.25 145.1 39.34 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -73.78 147.48 43.41 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.897 0.856 . . . . 0.0 111.061 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.79 -37.57 84.87 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.198 -177.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.04 -39.52 94.26 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 124.075 0.859 . . . . 0.0 111.322 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -72.86 -32.42 65.42 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 177.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 93.1 mt -67.32 -69.55 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 95.6 mt -39.36 132.36 1.48 Allowed 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.368 178.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.85 -7.45 76.88 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.516 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -132.4 149.1 52.41 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -176.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' ASN . . . . . 0.628 HD22 HO2' ' B' ' 900' ' ' FMN . 25.5 t-20 -79.17 150.07 31.8 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 114.572 -1.195 . . . . 0.0 110.843 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' CYS . . . . . . . . . . . . . 71.7 m -62.94 9.22 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.674 -178.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . 0.559 ' H ' ' C ' ' B' ' 61' ' ' ASN . 34.6 ptt-85 -59.4 -31.2 69.03 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.495 -178.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -61.54 -31.25 71.27 Favored 'General case' 0 C--O 1.239 0.531 0 O-C-N 121.878 -0.514 . . . . 0.0 111.922 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 92.4 mt -61.24 -44.28 97.51 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -178.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . 0.612 HE22 HO4' ' B' ' 900' ' ' FMN . 87.4 mt-30 -46.59 144.11 2.38 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.424 0.631 . . . . 0.0 109.938 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . 0.455 ' HA3' ' CE1' ' B' ' 95' ' ' TYR . . . -155.39 -152.98 6.36 Favored Glycine 0 CA--C 1.543 1.817 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.656 176.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . 0.424 ' HB3' ' HH ' ' B' ' 95' ' ' TYR . 88.9 tttt -60.97 -40.99 95.51 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.447 -0.376 . . . . 0.0 111.172 -175.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -75.6 -9.93 59.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.175 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 25.0 m -60.66 133.52 56.18 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -90.55 111.72 49.1 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.453 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.39 -38.38 89.27 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 121.099 1.199 . . . . 0.0 111.882 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.99 -40.9 90.77 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.821 -176.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' GLU . . . . . 0.413 ' OE1' ' HB ' ' B' ' 90' ' ' VAL . 79.2 mm-40 -66.78 -39.35 87.78 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.835 178.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 71.0 t -62.59 -45.66 98.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -62.85 -37.28 86.23 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.748 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -62.48 -42.06 99.23 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.938 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.33 -43.79 98.77 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 CA-C-O 120.86 0.362 . . . . 0.0 110.735 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -61.58 -42.67 99.18 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 87.2 m -60.93 -46.58 90.12 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.79 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.86 -41.72 96.44 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -178.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 87.8 mt -62.13 -42.29 99.09 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -62.56 -39.89 95.09 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -80.2 -4.2 52.15 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.105 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 37.5 tttt 50.67 44.77 27.52 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.222 -0.591 . . . . 0.0 112.134 178.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -128.88 145.43 56.39 Favored Pre-proline 0 N--CA 1.467 0.383 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.15 140.1 81.87 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 120.905 1.07 . . . . 0.0 113.642 -178.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -140.12 136.59 37.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.909 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' THR . . . . . 0.591 ' CG2' ' OD1' ' B' ' 107' ' ' ASN . 97.4 m -122.24 122.68 39.69 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 178.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . 0.413 ' HB ' ' OE1' ' B' ' 74' ' ' GLU . 30.7 m -139.4 162.82 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.854 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -113.63 120.82 42.23 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 176.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 20.6 tt -128.43 131.79 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.68 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -70.46 141.6 52.03 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.857 178.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -133.75 -179.75 5.73 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.261 0.553 . . . . 0.0 111.174 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' TYR . . . . . 0.455 ' CE1' ' HA3' ' B' ' 67' ' ' GLY . 96.3 m-85 -131.11 148.25 52.71 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.485 178.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . 0.434 ' HG3' ' CE1' ' B' ' 102' ' ' PHE . 98.7 mttt -104.35 -179.08 3.84 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.052 0.453 . . . . 0.0 110.693 177.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.72 -35.52 76.54 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.493 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . 0.42 ' CG ' ' HG1' ' B' ' 100' ' ' THR . 37.0 p-10 -87.37 -0.33 56.61 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.053 0.842 . . . . 0.0 112.954 179.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.02 3.23 65.8 Favored Glycine 0 N--CA 1.465 0.601 0 C-N-CA 121.152 -0.546 . . . . 0.0 111.892 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 100' ' ' THR . . . . . 0.42 ' HG1' ' CG ' ' B' ' 98' ' ' ASP . 24.7 m -68.16 129.56 40.3 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' MET . . . . . 0.569 ' SD ' ' N ' ' B' ' 102' ' ' PHE . 15.2 tmm? -90.46 142.99 27.18 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' PHE . . . . . 0.569 ' N ' ' SD ' ' B' ' 101' ' ' MET . 53.9 p90 -153.6 163.62 39.67 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' TRP . . . . . 0.851 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 23.6 m95 -95.25 140.19 30.5 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.018 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . 0.455 HD22 ' HG2' ' B' ' 123' ' ' GLN . 62.8 t-20 -133.71 105.63 6.93 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -176.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' B' ' 123' ' ' GLN . 81.4 tt0 -73.02 126.84 30.91 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.635 1.209 . . . . 0.0 109.02 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 39.4 tp -114.18 125.91 54.47 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' ASN . . . . . 0.591 ' OD1' ' CG2' ' B' ' 89' ' ' THR . 98.0 m-20 -119.92 127.86 53.08 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 176.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 96.2 mt -123.69 132.83 70.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -144.51 123.12 6.86 Favored Pre-proline 0 CA--C 1.538 0.483 0 O-C-N 123.482 0.488 . . . . 0.0 109.931 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -70.74 152.71 64.45 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 122.366 2.044 . . . . 0.0 112.618 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' MET . . . . . 0.44 ' HB2' ' HB2' ' B' ' 118' ' ' TYR . 66.4 mtt -129.18 144.09 51.09 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -113.58 111.21 21.5 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . 0.788 HG12 ' HZ3' ' A' ' 18' ' ' LYS . 96.8 mt -137.92 127.72 35.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 O-C-N 121.534 -0.729 . . . . 0.0 111.81 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 52.25 38.33 24.43 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 123.997 0.811 . . . . 0.0 109.626 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 61.54 36.15 17.08 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.538 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -133.8 151.66 51.64 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 8.8 t -102.76 154.08 19.52 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.262 -178.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' TYR . . . . . 0.44 ' HB2' ' HB2' ' B' ' 111' ' ' MET . 96.8 m-85 -148.12 145.34 28.34 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.529 -0.732 . . . . 0.0 110.917 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 119' ' ' PHE . . . . . 0.431 ' O ' ' OG1' ' B' ' 30' ' ' THR . 86.4 m-85 -118.12 138.91 51.95 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.384 0.427 . . . . 0.0 111.347 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.5 p -128.22 136.15 60.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -178.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -112.2 127.88 8.27 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 95.4 mt -117.63 128.62 74.82 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 123' ' ' GLN . . . . . 0.568 ' N ' ' O ' ' B' ' 26' ' ' GLY . 15.3 mp0 -119.12 121.54 40.02 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -120.31 121.18 38.07 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . 0.58 ' OD1' ' N ' ' B' ' 127' ' ' THR . 68.3 t0 -69.12 134.16 48.97 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.083 -177.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . 0.495 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 2.5 mp -107.3 17.16 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.493 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 127' ' ' THR . . . . . 0.58 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 98.2 m -63.36 -45.23 92.15 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 114.138 -1.392 . . . . 0.0 112.647 175.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 59.7 tptt -60.53 -45.6 93.27 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 129' ' ' GLN . . . . . 0.404 ' OE1' HG21 ' B' ' 126' ' ' ILE . 88.5 mt-30 -62.53 -36.57 83.04 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.484 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 130' ' ' LYS . . . . . 0.851 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 98.9 mttt -62.64 -41.7 99.19 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 112.737 -2.028 . . . . 0.0 111.115 174.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.5 -42.08 96.06 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 132' ' ' TYR . . . . . 0.505 ' CE2' HD13 ' B' ' 136' ' ' LEU . 88.1 t80 -60.76 -44.95 96.08 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.972 -0.455 . . . . 0.0 111.785 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . 0.427 ' O ' ' HG3' ' B' ' 137' ' ' GLU . 97.3 mt-10 -63.8 -36.49 84.06 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 119.932 -0.707 . . . . 0.0 109.367 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 134' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' B' ' 130' ' ' LYS . 98.9 mttt -62.41 -39.62 93.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.801 177.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 53.8 tp -62.28 -41.76 98.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.75 0.786 . . . . 0.0 109.451 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . 0.505 HD13 ' CE2' ' B' ' 132' ' ' TYR . 87.6 mt -63.02 -41.82 99.65 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.921 177.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 137' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' B' ' 133' ' ' GLU . 97.3 mt-10 -65.27 -36.45 84.13 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.508 -1.678 . . . . 0.0 110.276 -178.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -63.83 -43.79 95.16 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.106 -0.638 . . . . 0.0 109.649 177.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 68.2 m -61.14 -44.1 97.85 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . 0.418 ' O ' ' N ' ' B' ' 144' ' ' THR . 86.1 mt -61.74 -40.06 93.77 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -177.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 97.2 m -61.32 -45.58 93.85 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.059 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -66.39 -42.39 87.95 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 93.1 mt -63.52 -43.19 98.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 114.517 -1.219 . . . . 0.0 110.598 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 144' ' ' THR . . . . . 0.418 ' N ' ' O ' ' B' ' 140' ' ' LEU . 92.1 m -61.31 -45.12 95.76 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.13 -40.8 96.95 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 119.299 -0.96 . . . . 0.0 109.332 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 87.1 mt -64.55 -41.17 96.5 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 177.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 147' ' ' SER . . . . . 0.626 ' O ' ' N ' ' B' ' 149' ' ' PRO . 78.4 p -61.91 -40.91 97.08 Favored 'General case' 0 CA--C 1.476 -1.895 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 -178.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 148' ' ' THR . . . . . 0.491 ' C ' ' O ' ' B' ' 147' ' ' SER . 7.3 m -28.9 85.16 0.03 OUTLIER Pre-proline 0 C--N 1.353 0.738 0 O-C-N 123.745 0.653 . . . . 0.0 110.351 176.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 149' ' ' PRO . . . . . 0.626 ' N ' ' O ' ' B' ' 147' ' ' SER . 23.4 Cg_exo -61.89 146.71 96.29 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 C-N-CA 122.393 2.062 . . . . 0.0 115.57 -176.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 9.0 tp -126.67 119.81 54.47 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.21 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.036 174.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 59.3 t -151.26 93.41 3.61 Favored Pre-proline 0 C--N 1.295 -1.764 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.809 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -60.23 137.35 74.4 Favored 'Trans proline' 0 N--CA 1.489 1.238 0 CA-C-N 119.852 0.983 . . . . 0.0 109.569 -178.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 153' ' ' ILE . . . . . 0.625 ' O ' ' HD2' ' B' ' 154' ' ' ARG . 45.2 mm -68.7 -43.55 82.98 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.579 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . 0.625 ' HD2' ' O ' ' B' ' 153' ' ' ILE . 0.7 OUTLIER -157.16 -154.61 0.47 Allowed 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.449 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 62.0 t-20 -87.32 107.99 18.76 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.1 -18.39 55.73 Favored Glycine 0 CA--C 1.534 1.23 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 157' ' ' ILE . . . . . 0.435 HG23 ' HB ' ' B' ' 153' ' ' ILE . 85.1 mt -108.04 124.45 64.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.287 0.565 . . . . 0.0 111.16 -177.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 158' ' ' SER . . . . . 0.668 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 69.1 m -135.0 148.72 50.04 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.517 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -134.62 146.92 50.03 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 24.4 tp -137.61 80.73 31.29 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 161' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -70.63 147.73 57.9 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.666 2.244 . . . . 0.0 114.077 -178.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 90.5 mt -114.55 133.85 55.48 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 109.074 -0.714 . . . . 0.0 109.074 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 54.6 t -130.51 132.73 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 114.3 168.61 16.25 Favored Glycine 0 N--CA 1.471 0.984 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.512 178.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 165' ' ' ASN . . . . . 0.813 ' O ' ' CZ ' ' B' ' 170' ' ' ARG . 60.5 t30 -89.92 107.16 18.95 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -178.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . 0.482 ' CD2' ' CZ ' ' B' ' 171' ' ' PHE . 42.1 tp -65.02 104.73 0.91 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -174.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 167' ' ' THR . . . . . 0.548 ' CG2' HH21 ' B' ' 170' ' ' ARG . 10.0 p -85.38 169.57 13.57 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 113.828 -1.533 . . . . 0.0 110.83 177.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.57 -37.52 85.1 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.307 177.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.63 -39.9 88.49 Favored 'General case' 0 CA--C 1.553 1.09 0 CA-C-O 121.682 0.753 . . . . 0.0 111.798 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 170' ' ' ARG . . . . . 0.813 ' CZ ' ' O ' ' B' ' 165' ' ' ASN . 87.9 mtm180 -63.67 -36.04 82.51 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 113.193 -1.821 . . . . 0.0 110.475 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 171' ' ' PHE . . . . . 0.482 ' CZ ' ' CD2' ' B' ' 166' ' ' LEU . 0.4 OUTLIER -54.1 -25.55 22.52 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -178.194 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 172' ' ' ASN . . . . . 0.582 ' O ' HG21 ' B' ' 175' ' ' VAL . 92.9 m-20 -62.48 -40.53 96.96 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.672 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 59.7 m -60.12 -41.76 93.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.27 0.557 . . . . 0.0 110.51 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 67.4 mt -63.9 -44.21 97.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -179.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 175' ' ' VAL . . . . . 0.582 HG21 ' O ' ' B' ' 172' ' ' ASN . 29.8 m -62.61 -40.81 89.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -178.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 176' ' ' CYS . . . . . . . . . . . . . 98.2 m -62.26 -35.44 78.97 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.291 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 177' ' ' THR . . . . . 0.578 ' O ' HG13 ' B' ' 181' ' ' ILE . 25.3 m -61.3 -19.45 61.78 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 178' ' ' LEU . . . . . . . . . . . . . 87.4 mt -60.97 -39.47 89.69 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.479 -178.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 18.2 m -62.03 -44.44 96.7 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.414 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 180' ' ' ASN . . . . . 0.604 ' O ' ' OG ' ' B' ' 183' ' ' SER . 92.1 m-20 -61.97 -40.3 95.12 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.121 0.486 . . . . 0.0 110.435 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . 0.578 HG13 ' O ' ' B' ' 177' ' ' THR . 73.3 mt -56.35 -32.37 35.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 O-C-N 122.074 -0.391 . . . . 0.0 110.74 -178.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 182' ' ' LEU . . . . . . . . . . . . . 86.4 mt -62.66 -41.5 99.1 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 183' ' ' SER . . . . . 0.604 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.7 p -63.98 -32.91 74.61 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 122.129 -0.357 . . . . 0.0 110.593 177.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 44.6 p -85.88 17.96 3.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.766 0.317 . . . . 0.0 111.684 -178.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 78.6 p -60.59 -16.44 38.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.274 -177.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.82 -40.86 96.76 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.966 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 187' ' ' ASP . . . . . 0.668 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.3 m-20 -67.98 113.32 5.58 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.699 0.761 . . . . 0.0 110.776 -178.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.8 -42.39 99.69 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 114.697 -1.138 . . . . 0.0 113.102 -178.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -113.29 130.98 56.11 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.212 -178.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 190' ' ' LEU . . . . . . . . . . . . . 40.5 tp -123.72 118.16 26.59 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.908 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 84.2 mt -106.15 125.95 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-O 120.812 0.339 . . . . 0.0 111.303 -178.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 49.7 mm -114.51 117.58 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 193' ' ' ASP . . . . . 0.438 ' CG ' ' HG ' ' B' ' 195' ' ' SER . 41.9 t0 -88.43 114.62 25.23 Favored 'General case' 0 C--O 1.246 0.873 0 CA-C-O 121.65 0.738 . . . . 0.0 111.352 -177.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 194' ' ' LEU . . . . . . . . . . . . . 96.2 mt -97.1 -1.34 45.44 Favored 'General case' 0 C--N 1.356 0.858 0 O-C-N 120.39 -1.444 . . . . 0.0 110.067 176.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 195' ' ' SER . . . . . 0.438 ' HG ' ' CG ' ' B' ' 193' ' ' ASP . 78.4 p -61.19 -36.24 79.33 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 121.169 -0.213 . . . . 0.0 110.803 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.87 -35.42 91.29 Favored Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 197' ' ' LEU . . . . . 1.295 HD23 ' O ' ' B' ' 199' ' ' GLN . 7.0 tt -74.75 132.61 41.76 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 121.847 -0.796 . . . . 0.0 109.589 -178.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 198' ' ' ALA . . . . . 0.423 ' N ' HD21 ' B' ' 197' ' ' LEU . . . -61.33 -48.9 79.23 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 119.309 -0.957 . . . . 0.0 110.143 -178.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 199' ' ' GLN . . . . . 1.295 ' O ' HD23 ' B' ' 197' ' ' LEU . 57.1 tt0 -135.06 164.62 27.24 Favored 'General case' 0 C--O 1.21 -1.02 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -178.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 200' ' ' VAL . . . . . 0.508 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 48.3 t -119.44 130.95 73.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 119.506 -1.996 . . . . 0.0 109.403 177.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -87.26 150.84 23.62 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.122 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -61.49 -32.61 72.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.59 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -64.11 -32.78 74.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.2 m -60.89 -43.36 98.61 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.573 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 205' ' ' ALA . . . . . 0.687 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -58.63 -29.53 66.59 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 119.212 -0.423 . . . . 0.0 111.792 -178.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -65.75 -38.74 89.93 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 123.649 0.593 . . . . 0.0 109.68 176.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -66.57 -38.04 86.23 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.752 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 93.5 mt -63.68 -44.36 98.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -178.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 209' ' ' PHE . . . . . 0.687 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 66.9 m-85 -61.35 -43.56 98.66 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.618 179.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.39 -41.54 98.78 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.102 -1.039 . . . . 0.0 109.532 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 39.9 mt -62.23 -41.94 98.86 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.316 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 212' ' ' SER . . . . . 0.455 ' HG ' ' N ' ' B' ' 213' ' ' HIS . 78.3 p -63.3 -35.78 81.51 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 121.686 -0.634 . . . . 0.0 112.159 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 213' ' ' HIS . . . . . 0.455 ' N ' ' HG ' ' B' ' 212' ' ' SER . 58.8 t-80 -67.18 -46.83 72.77 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.839 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 54.1 tp -64.23 -43.06 96.13 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 122.069 0.938 . . . . 0.0 109.406 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.09 -43.74 97.66 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 113.617 -1.629 . . . . 0.0 111.379 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.12 -39.32 92.15 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.005 -177.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 85.4 mt -63.7 -42.69 97.95 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.238 0.542 . . . . 0.0 111.51 176.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 218' ' ' THR . . . . . . . . . . . . . 75.9 p -74.11 -16.03 61.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.911 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 79.29 72.56 1.18 Allowed Glycine 0 CA--C 1.528 0.862 0 N-CA-C 106.517 -2.633 . . . . 0.0 106.517 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 220' ' ' THR . . . . . . . . . . . . . 93.2 m -151.85 98.2 2.44 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 177.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -56.13 139.76 46.29 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.204 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 43.1 tp -116.64 120.58 39.1 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.184 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 3.5 mp -109.13 129.23 64.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.241 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 224' ' ' ILE . . . . . . . . . . . . . 49.7 mm -111.7 126.94 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.57 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 44.5 p -134.78 157.77 45.88 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 91.07 17.55 50.57 Favored Glycine 0 CA--C 1.498 -1.027 0 CA-C-N 113.949 -1.478 . . . . 0.0 110.534 -177.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 95.7 mt -83.59 125.77 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 O-C-N 121.363 -1.08 . . . . 0.0 111.355 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 56.2 tttt -63.93 139.67 97.7 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.368 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.77 -37.17 92.1 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 121.297 1.331 . . . . 0.0 112.539 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -63.83 -43.32 96.54 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 52.0 tp -61.87 -41.78 98.27 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.913 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.03 -36.51 84.24 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.801 0.334 . . . . 0.0 111.139 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 94.5 mtp -64.47 -40.64 96.07 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.78 -43.93 97.51 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 122.107 0.956 . . . . 0.0 109.004 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 33.5 mmt -63.82 -34.96 79.09 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.989 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -61.81 -40.21 94.44 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.774 -178.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.27 -43.85 96.79 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.156 178.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 52.5 tp -62.92 -44.75 95.24 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 120.137 -0.625 . . . . 0.0 112.039 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -156.51 132.32 9.62 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 120.551 -0.46 . . . . 0.0 112.001 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 240' ' ' ALA . . . . . 0.4 ' O ' ' N ' ' B' ' 242' ' ' PHE . . . -61.93 -47.94 82.66 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 176.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 241' ' ' ASN . . . . . 0.465 ' O ' ' HB2' ' B' ' 244' ' ' SER . 92.7 m-20 -42.69 -18.28 0.01 OUTLIER 'General case' 0 C--O 1.217 -0.615 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.556 -176.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 242' ' ' PHE . . . . . 0.4 ' N ' ' O ' ' B' ' 240' ' ' ALA . 89.1 t80 -60.81 -44.58 96.69 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 119.801 -0.759 . . . . 0.0 109.906 178.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 243' ' ' SER . . . . . . . . . . . . . 78.4 p -58.85 -42.42 89.31 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 -178.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 244' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 20.5 m -33.84 -33.04 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 99.1 mt -91.69 130.37 37.5 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 121.458 -0.776 . . . . 0.0 111.889 177.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -57.59 134.76 56.42 Favored 'General case' 0 CA--C 1.502 -0.881 0 O-C-N 121.317 -0.864 . . . . 0.0 111.726 -175.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 247' ' ' THR . . . . . . . . . . . . . 96.3 m -125.25 127.66 47.08 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.917 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -112.98 144.26 42.86 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 177.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 249' ' ' SER . . . . . 0.595 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 79.4 p -64.23 -33.46 75.86 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.218 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 250' ' ' ASN . . . . . 0.595 ' OD1' ' O ' ' B' ' 249' ' ' SER . 98.8 m-20 -147.94 159.61 43.69 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 124.509 1.13 . . . . 0.0 111.937 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 77.7 t -64.34 -44.15 97.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.443 -0.798 . . . . 0.0 112.293 178.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 252' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -60.78 -46.15 91.61 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -177.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -61.37 -43.05 99.53 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.924 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 254' ' ' ALA . . . . . 0.451 ' O ' HG21 ' B' ' 257' ' ' VAL . . . -65.85 -40.25 91.54 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.913 178.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 255' ' ' VAL . . . . . 0.532 HG13 HH11 ' A' ' 154' ' ' ARG . 67.3 t -65.14 -45.71 93.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.043 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.56 -48.55 78.98 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 120.204 -0.598 . . . . 0.0 111.614 -178.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 257' ' ' VAL . . . . . 0.483 ' O ' ' C ' ' B' ' 258' ' ' LEU . 32.6 m -65.22 -40.63 89.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.678 -1.146 . . . . 0.0 111.302 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 258' ' ' LEU . . . . . 0.523 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 1.6 mt -32.25 -73.76 0.05 OUTLIER Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.589 -177.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 259' ' ' PRO . . . . . 0.523 ' CD ' ' CB ' ' B' ' 258' ' ' LEU . 36.3 Cg_endo -61.76 140.76 87.62 Favored 'Trans proline' 0 N--CA 1.505 2.155 0 C-N-CA 121.49 1.46 . . . . 0.0 111.133 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 260' ' ' ILE . . . . . 0.446 HG13 ' O ' ' B' ' 259' ' ' PRO . 96.7 mt -159.11 -13.82 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 O-C-N 121.33 -0.856 . . . . 0.0 112.204 177.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 C--O 1.216 -0.71 0 CA-C-O 117.792 -1.099 . . . . 0.0 111.353 -179.381 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 900' ' ' FMN . . . . . 0.663 HO2' HD22 ' A' ' 61' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 900' ' ' FMN . . . . . 0.628 HO2' HD22 ' B' ' 61' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.026 -1.629 . . . . 0.0 109.026 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.471 ' O ' ' OG ' ' A' ' 6' ' ' SER . . . -152.2 165.07 35.99 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.373 0.606 . . . . 0.0 110.201 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 80.8 p -70.53 -18.28 62.94 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.084 -1.01 . . . . 0.0 112.112 177.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -71.75 -65.07 0.81 Allowed 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 114.18 -1.373 . . . . 0.0 112.574 174.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -68.1 -37.77 81.55 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.99 0.424 . . . . 0.0 112.089 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.493 ' O ' ' HB3' ' A' ' 7' ' ' PHE . 70.9 m -59.44 -42.17 91.31 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -177.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.493 ' HB3' ' O ' ' A' ' 6' ' ' SER . 42.5 t80 83.95 86.93 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.134 0.493 . . . . 0.0 111.865 176.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.583 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -62.49 -142.92 0.01 OUTLIER Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 -178.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.583 ' HB ' ' O ' ' A' ' 8' ' ' GLY . 74.5 mt 85.64 110.27 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 122.701 0.4 . . . . 0.0 110.538 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.7 -22.35 69.82 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 121.389 1.393 . . . . 0.0 112.175 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.83 -38.22 95.82 Favored Glycine 0 N--CA 1.467 0.706 0 C-N-CA 121.138 -0.553 . . . . 0.0 111.919 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -65.18 -39.27 92.66 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.41 0.624 . . . . 0.0 109.614 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.2 tp -63.44 -41.15 98.67 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -63.73 -40.31 96.44 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 56.3 t -60.31 -44.36 95.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 O-C-N 122.199 -0.313 . . . . 0.0 110.892 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 92.2 mt -62.78 -43.61 98.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.407 -178.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.27 -46.04 90.58 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 119.491 -0.883 . . . . 0.0 112.119 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.611 ' HZ3' HG12 ' B' ' 113' ' ' ILE . 98.4 mttt -60.39 -39.86 88.83 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 118.51 -1.276 . . . . 0.0 109.187 -176.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.84 -42.1 92.83 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.286 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.8 mt -62.83 -40.95 99.0 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 178.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -63.92 -37.65 88.19 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.505 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 60.0 m170 -58.55 -40.15 82.2 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 122.221 -0.299 . . . . 0.0 111.417 -178.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.3 p -114.4 130.01 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.501 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 36.2 ptt180 -71.85 110.46 6.38 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-O 122.016 0.912 . . . . 0.0 112.229 -177.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.9 p -141.31 144.13 26.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 123' ' ' GLN . . . -97.55 90.99 1.14 Allowed Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.786 -178.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 51.4 t -124.23 129.26 74.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 176.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.7 m -137.49 159.78 34.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.7 mt -121.71 130.36 74.67 Favored 'Isoleucine or valine' 0 C--O 1.245 0.868 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 177.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.4 p -106.35 167.85 9.55 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.448 ' C ' ' OD1' ' A' ' 37' ' ' ASN . 44.0 t0 -134.5 102.42 11.62 Favored Pre-proline 0 C--N 1.32 -0.716 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.389 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.424 ' HG3' HG22 ' A' ' 117' ' ' THR . 36.4 Cg_endo -63.17 -23.08 73.07 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 121.453 1.436 . . . . 0.0 111.503 -178.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.97 -35.88 81.63 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.66 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.2 mt -84.31 157.35 21.54 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.498 177.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.697 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 43.3 tt0 -58.37 136.01 57.33 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -176.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.566 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 62.4 t0 60.29 22.8 12.25 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.448 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 42.4 t-20 38.16 70.06 1.35 Allowed Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.244 -176.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.697 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 92.7 Cg_endo -71.13 156.3 59.8 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 123.948 3.099 . . . . 0.0 112.121 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.6 mt -88.1 125.22 41.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.474 HG21 ' N ' ' A' ' 41' ' ' TYR . 33.9 m -104.8 -42.59 7.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.025 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.474 ' N ' HG21 ' A' ' 40' ' ' VAL . 48.9 t80 -97.68 123.76 41.73 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.809 -177.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.9 p -143.06 140.85 26.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 124.303 1.002 . . . . 0.0 109.215 177.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.573 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 57.3 p30 -98.41 166.99 11.11 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.517 ' HA ' ' OE1' ' A' ' 44' ' ' GLN . 13.2 mm100 -66.4 -38.81 88.33 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 120.988 0.423 . . . . 0.0 111.933 177.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.27 -26.86 64.47 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.573 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 66.3 t80 -59.03 -48.43 81.63 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.502 HG11 ' O ' ' A' ' 52' ' ' TYR . 61.3 t -59.41 -45.09 93.82 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 O-C-N 121.312 -0.868 . . . . 0.0 111.573 -174.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -63.64 -37.73 88.44 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 120.412 -0.515 . . . . 0.0 112.383 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 60.4 ttm -66.65 -43.01 85.76 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 114.258 1.206 . . . . 0.0 114.258 176.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 34.9 p -93.75 -20.4 20.15 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.272 0.558 . . . . 0.0 111.453 -177.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.28 21.6 72.75 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.502 ' O ' HG11 ' A' ' 47' ' ' VAL . 81.1 m-85 -115.9 138.21 51.38 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 122.909 0.484 . . . . 0.0 111.213 179.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -63.65 148.24 49.51 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.662 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.57 -32.36 73.9 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -66.21 -45.01 82.25 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 119.351 -0.94 . . . . 0.0 111.359 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -63.47 -45.44 90.8 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 119.939 -0.704 . . . . 0.0 109.749 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.4 HD13 HG22 ' A' ' 57' ' ' ILE . 90.6 mt -62.1 -48.99 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -175.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 79.0 mt -57.11 146.04 29.01 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 176.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.96 -3.91 82.27 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.875 -0.679 . . . . 0.0 113.121 177.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -137.47 151.7 48.75 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.879 1.34 . . . . 0.0 111.9 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.754 HD22 HO2' ' A' ' 900' ' ' FMN . 25.6 t-20 -81.23 151.92 27.91 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.701 -178.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 83.6 m -63.67 16.44 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.276 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.561 ' H ' ' C ' ' A' ' 61' ' ' ASN . 36.4 ptt-85 -62.47 -40.81 97.85 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 122.054 -0.404 . . . . 0.0 111.282 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -56.03 -21.53 22.12 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 84.0 mt -68.22 -35.24 77.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 122.003 0.906 . . . . 0.0 113.011 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.511 HE22 HO4' ' A' ' 900' ' ' FMN . 88.7 mt-30 -65.12 143.05 58.14 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.904 -1.044 . . . . 0.0 112.238 -178.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.606 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -154.2 -147.57 4.7 Favored Glycine 0 CA--C 1.538 1.484 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 -177.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.54 ' HB3' ' HH ' ' A' ' 95' ' ' TYR . 88.5 tttt -63.21 -41.1 99.1 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -177.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.446 ' O ' ' OE1' ' A' ' 93' ' ' GLN . 10.8 m-70 -77.1 -8.56 57.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.955 0.407 . . . . 0.0 111.086 -177.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.606 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 26.6 m -63.04 130.28 44.01 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.657 -178.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -85.4 109.55 22.4 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.8 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.92 -32.08 91.44 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.023 1.815 . . . . 0.0 113.19 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.59 -39.64 94.1 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.975 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.475 ' OE1' ' HB ' ' A' ' 90' ' ' VAL . 78.9 mm-40 -65.84 -43.54 88.21 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.8 t -59.45 -43.83 91.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -176.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -63.88 -37.97 89.35 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.027 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -63.63 -39.67 94.95 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.243 0.544 . . . . 0.0 110.156 178.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.77 -44.47 98.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.154 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -63.01 -42.71 99.9 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 113.831 -1.531 . . . . 0.0 108.36 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 96.4 m -61.64 -48.85 78.99 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.04 -41.69 92.83 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.185 -172.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 83.0 mt -63.0 -39.55 95.11 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.025 -1.047 . . . . 0.0 111.319 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -64.17 -32.59 74.22 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 177.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -90.22 0.59 57.13 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.302 -178.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.2 tttt 45.46 35.94 2.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.55 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -119.13 143.8 34.79 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -61.39 143.39 97.66 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.62 1.546 . . . . 0.0 113.674 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -140.12 143.25 30.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.697 -177.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.488 ' CG2' ' OD1' ' A' ' 107' ' ' ASN . 99.9 m -128.46 120.59 27.14 Favored 'General case' 0 C--N 1.345 0.394 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 176.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.475 ' HB ' ' OE1' ' A' ' 74' ' ' GLU . 27.8 m -138.75 157.61 29.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.73 -0.214 . . . . 0.0 111.461 177.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -101.93 133.76 46.21 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 177.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 19.0 tt -141.18 131.9 27.06 Favored 'Isoleucine or valine' 0 C--N 1.378 1.833 0 CA-C-N 121.61 2.005 . . . . 0.0 112.417 176.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.446 ' OE1' ' O ' ' A' ' 69' ' ' HIS . 85.7 mt-30 -64.6 133.74 52.9 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.884 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -134.85 158.57 43.87 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.8 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.54 ' HH ' ' HB3' ' A' ' 68' ' ' LYS . 89.8 m-85 -116.5 134.7 54.54 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.455 ' HG3' ' CE1' ' A' ' 102' ' ' PHE . 99.1 mttt -83.7 -171.76 3.77 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.184 0.516 . . . . 0.0 111.76 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.46 -43.48 98.71 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.941 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 42.5 p-10 -84.31 7.17 20.22 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.08 -0.4 87.5 Favored Glycine 0 N--CA 1.471 0.97 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.185 176.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 23.5 m -58.93 139.15 56.99 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.622 ' C ' ' SD ' ' A' ' 101' ' ' MET . 13.8 tmm? -105.06 127.28 52.81 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.593 0.235 . . . . 0.0 110.506 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.455 ' CE1' ' HG3' ' A' ' 96' ' ' LYS . 52.7 p90 -141.68 156.12 45.65 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.958 -177.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.721 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 24.4 m95 -88.66 143.98 26.58 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.485 HD22 ' HG2' ' A' ' 123' ' ' GLN . 56.4 t-20 -138.1 100.82 4.25 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -177.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 80.6 tt0 -66.32 136.57 56.0 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -177.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 40.3 tp -122.23 122.94 40.31 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.488 ' OD1' ' CG2' ' A' ' 89' ' ' THR . 97.8 m-20 -118.67 122.61 42.93 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.71 177.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 96.4 mt -120.31 128.64 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 O-C-N 123.535 0.522 . . . . 0.0 111.635 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -139.85 123.03 10.42 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 116.714 -0.221 . . . . 0.0 110.933 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -70.98 152.13 62.75 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 122.451 2.101 . . . . 0.0 112.368 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.611 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 66.8 mtt -122.82 154.32 38.38 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -128.74 94.12 3.78 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 176.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 96.1 mt -118.51 130.78 72.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.19 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 52.5 38.51 25.76 Favored 'General case' 0 CA--C 1.512 -0.501 0 O-C-N 121.414 -0.804 . . . . 0.0 111.774 176.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 58.27 30.22 19.18 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 123.844 0.715 . . . . 0.0 110.833 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -128.2 149.09 50.6 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.173 -0.676 . . . . 0.0 109.173 177.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.756 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 5.2 t -86.1 -172.25 3.98 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 118.538 0.608 . . . . 0.0 109.514 -177.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.756 ' CD2' ' O ' ' A' ' 117' ' ' THR . 65.1 m-85 -171.69 156.26 4.26 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 175.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -131.34 146.49 52.31 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 174.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -134.94 135.18 53.17 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 177.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.408 ' HA3' ' H6 ' ' A' ' 900' ' ' FMN . . . -108.75 129.2 9.42 Favored Glycine 0 CA--C 1.499 -0.908 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 178.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 96.6 mt -118.41 129.57 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.485 ' HG2' HD22 ' A' ' 104' ' ' ASN . 13.9 mp0 -121.05 113.3 19.85 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.641 0.588 . . . . 0.0 109.609 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -113.57 112.79 24.12 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.959 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -62.39 128.22 35.01 Favored 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -175.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 3.0 mt -93.53 2.29 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 113.511 -1.677 . . . . 0.0 110.199 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 20.1 m -60.56 -42.38 96.49 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.979 -1.076 . . . . 0.0 113.671 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -59.96 -42.34 93.87 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -178.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -63.01 -39.56 95.12 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.927 177.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.721 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.7 mttt -62.85 -40.79 98.54 Favored 'General case' 0 CA--C 1.502 -0.877 0 C-N-CA 118.292 -1.363 . . . . 0.0 110.621 -178.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.69 -37.93 85.92 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -178.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.483 ' CE2' HD13 ' A' ' 136' ' ' LEU . 90.7 t80 -61.67 -45.96 91.76 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.668 175.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.23 -38.93 92.81 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 120.167 -0.613 . . . . 0.0 109.539 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.07 -40.21 95.02 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 52.7 tp -60.65 -43.86 97.1 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -176.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.483 HD13 ' CE2' ' A' ' 132' ' ' TYR . 84.9 mt -62.26 -40.87 97.63 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -61.84 -41.73 98.16 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 119.398 -0.921 . . . . 0.0 109.852 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -60.81 -41.96 96.7 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -177.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.0 m -61.94 -41.14 97.63 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.877 176.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 144' ' ' THR . 87.9 mt -63.49 -41.8 98.56 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.431 -0.508 . . . . 0.0 109.884 178.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 79.9 m -61.72 -45.59 93.3 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.271 -177.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -65.3 -39.67 92.83 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 94.7 mt -64.44 -43.57 96.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 113.991 -1.458 . . . . 0.0 111.365 176.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.454 ' N ' ' O ' ' A' ' 140' ' ' LEU . 99.3 m -62.49 -46.3 89.11 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.396 -0.522 . . . . 0.0 112.25 -178.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.401 ' O ' ' OG1' ' A' ' 148' ' ' THR . . . -62.45 -40.07 95.43 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 118.875 -1.13 . . . . 0.0 109.117 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 90.1 mt -63.61 -42.8 98.19 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.689 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.1 p -60.57 -37.17 80.43 Favored 'General case' 0 C--O 1.218 -0.564 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -178.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.453 ' C ' ' O ' ' A' ' 147' ' ' SER . 27.5 m -30.06 82.82 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.41 0 O-C-N 127.003 2.689 . . . . 0.0 106.123 -176.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.689 ' N ' ' O ' ' A' ' 147' ' ' SER . 21.8 Cg_exo -62.29 144.62 95.56 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 CA-C-O 122.749 1.062 . . . . 0.0 114.432 -174.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.62 ' O ' ' CG2' ' A' ' 151' ' ' VAL . 8.9 tp -121.26 135.33 61.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 102.575 -3.12 . . . . 0.0 102.575 176.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.62 ' CG2' ' O ' ' A' ' 150' ' ' ILE . 65.5 t -169.74 94.35 0.51 Allowed Pre-proline 0 CA--C 1.507 -0.703 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 176.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -62.56 137.71 65.94 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 N-CA-C 109.843 -0.868 . . . . 0.0 109.843 -178.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.569 ' O ' ' HD2' ' A' ' 154' ' ' ARG . 45.5 mm -68.28 -44.57 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 119.991 -0.683 . . . . 0.0 110.151 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.569 ' HD2' ' O ' ' A' ' 153' ' ' ILE . 0.7 OUTLIER -156.76 -157.55 0.7 Allowed 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -86.74 104.91 16.57 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.559 0.695 . . . . 0.0 111.521 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.65 8.65 65.39 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 114.069 -1.423 . . . . 0.0 110.063 -177.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.405 HG12 ' HB2' ' A' ' 189' ' ' TYR . 96.5 mt -125.96 124.17 65.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 175.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.666 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 42.2 m -131.95 152.14 51.28 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -137.52 140.66 41.24 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.494 177.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 19.9 tp -131.21 78.49 72.49 Favored Pre-proline 0 N--CA 1.469 0.512 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.358 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -69.83 150.57 67.98 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.719 2.279 . . . . 0.0 113.033 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 92.3 mt -119.36 126.27 51.01 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.241 178.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 49.0 t -122.37 130.74 74.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 117.24 169.12 14.88 Favored Glycine 0 N--CA 1.48 1.619 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.3 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.876 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 53.6 t30 -86.19 114.7 23.23 Favored 'General case' 0 C--O 1.214 -0.803 0 CA-C-N 116.972 0.386 . . . . 0.0 110.109 -178.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.502 ' CD2' ' CZ ' ' A' ' 171' ' ' PHE . 47.1 tp -74.31 105.29 5.41 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -177.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.557 ' H ' ' HE ' ' A' ' 170' ' ' ARG . 11.4 p -87.8 167.41 13.83 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.146 0.498 . . . . 0.0 110.489 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.88 -33.96 77.26 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.92 0.39 . . . . 0.0 111.862 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.58 -42.72 95.42 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.484 178.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.876 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 87.3 mtm180 -64.93 -33.65 76.52 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 124.169 0.988 . . . . 0.0 112.884 178.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.502 ' CZ ' ' CD2' ' A' ' 166' ' ' LEU . 0.4 OUTLIER -54.73 -28.32 47.29 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 118.913 -0.565 . . . . 0.0 112.39 -178.128 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.731 ' O ' HG21 ' A' ' 175' ' ' VAL . 90.2 m-20 -61.07 -40.69 94.64 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 118.892 -1.123 . . . . 0.0 109.939 -178.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 70.2 m -59.15 -41.41 88.25 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.71 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 67.3 mt -63.67 -44.01 98.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.731 HG21 ' O ' ' A' ' 172' ' ' ASN . 33.9 m -62.56 -40.63 89.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 97.7 m -62.27 -34.2 76.1 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.131 0.491 . . . . 0.0 110.435 177.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' THR . . . . . 0.486 ' O ' HG13 ' A' ' 181' ' ' ILE . 25.1 m -61.96 -19.74 63.09 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.026 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 85.6 mt -61.04 -40.89 95.32 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -177.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 18.9 m -59.11 -43.28 91.88 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.587 ' O ' ' OG ' ' A' ' 183' ' ' SER . 90.8 m-20 -61.92 -37.6 85.29 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 120.773 0.32 . . . . 0.0 110.829 178.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 177' ' ' THR . 70.3 mt -56.77 -37.17 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 121.515 -0.741 . . . . 0.0 109.765 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 85.9 mt -61.28 -40.74 95.26 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -177.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.587 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 78.1 p -62.22 -35.38 78.71 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.406 177.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 39.2 p -88.63 25.11 1.8 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.65 0.262 . . . . 0.0 111.456 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 78.1 p -65.36 -20.01 66.2 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.732 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.37 -37.46 80.8 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.986 -178.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.666 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 99.0 m-20 -72.73 114.26 10.68 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.489 0.662 . . . . 0.0 110.924 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . 0.423 ' O ' HG21 ' A' ' 220' ' ' THR . 99.8 m-20 -63.13 -42.05 99.42 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.926 -177.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . 0.405 ' HB2' HG12 ' A' ' 157' ' ' ILE . 97.1 m-85 -112.02 131.23 55.54 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.873 -178.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 38.0 tp -121.14 128.37 52.46 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 96.7 mt -117.33 128.4 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.9 mm -114.22 128.33 71.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . 0.485 ' OD2' ' OG ' ' A' ' 195' ' ' SER . 40.1 t0 -96.09 119.54 34.77 Favored 'General case' 0 CA--C 1.552 1.037 0 O-C-N 121.873 -0.517 . . . . 0.0 110.474 177.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 99.0 mt -98.38 -4.56 34.55 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.593 175.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.485 ' OG ' ' OD2' ' A' ' 193' ' ' ASP . 78.1 p -62.35 -33.46 74.76 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -62.42 -44.09 98.12 Favored Glycine 0 CA--C 1.534 1.243 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 1.042 HD23 ' O ' ' A' ' 199' ' ' GLN . 4.8 tt -68.96 128.51 36.96 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 112.788 -1.706 . . . . 0.0 108.495 -177.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.697 ' N ' HD21 ' A' ' 197' ' ' LEU . . . -59.68 -48.96 79.62 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 121.196 0.522 . . . . 0.0 110.703 -177.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 1.042 ' O ' HD23 ' A' ' 197' ' ' LEU . 57.9 tt0 -136.22 158.51 44.23 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 114.444 -1.253 . . . . 0.0 113.506 -173.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.445 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 46.9 t -118.72 132.28 69.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -89.53 156.79 18.39 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.296 -178.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.27 -39.94 94.97 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.104 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -57.59 -32.62 67.37 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.9 m -61.64 -42.24 98.62 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.609 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.448 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -57.5 -39.03 75.59 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -176.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -61.06 -36.35 79.38 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -64.81 -39.08 93.01 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.998 177.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 95.3 mt -63.29 -44.49 99.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -178.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . 0.448 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 75.1 m-85 -62.32 -43.36 98.99 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.6 -177.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.52 -41.93 99.18 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 119.07 -1.052 . . . . 0.0 109.105 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.432 ' O ' ' HG ' ' A' ' 215' ' ' LEU . 38.3 mt -62.25 -41.5 98.5 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' SER . . . . . 0.451 ' HG ' ' N ' ' A' ' 213' ' ' HIS . 78.2 p -61.36 -42.25 98.39 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.084 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' HIS . . . . . 0.451 ' N ' ' HG ' ' A' ' 212' ' ' SER . 57.7 t-80 -64.55 -45.66 86.14 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 120.626 -0.43 . . . . 0.0 111.372 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 47.8 tp -62.5 -45.76 91.51 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 118.909 -1.116 . . . . 0.0 108.379 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 211' ' ' LEU . 90.4 mt -62.74 -40.76 98.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.141 -177.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.62 -44.54 96.22 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.751 -178.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 84.5 mt -61.91 -39.88 93.54 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 66.8 p -74.95 -11.65 60.17 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.508 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.32 36.32 17.84 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 120.6 -0.809 . . . . 0.0 113.715 -178.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' THR . . . . . 0.423 HG21 ' O ' ' A' ' 188' ' ' ASP . 97.0 m -123.21 117.29 24.98 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 119.174 1.487 . . . . 0.0 111.708 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -68.21 137.2 54.62 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.42 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 43.6 tp -111.81 130.86 55.67 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 2.8 mp -117.83 134.29 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.468 HG23 HD11 ' A' ' 224' ' ' ILE . 49.5 mm -115.67 131.31 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -178.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 44.2 p -134.3 165.57 24.81 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.916 -177.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 78.66 21.78 68.31 Favored Glycine 0 N--CA 1.464 0.528 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 97.7 mt -83.83 128.22 39.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 113.87 -1.165 . . . . 0.0 108.291 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -77.4 141.07 65.44 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.33 -39.77 85.63 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 120.984 1.122 . . . . 0.0 112.629 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -63.04 -39.71 95.56 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.356 0.598 . . . . 0.0 110.16 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 52.4 tp -63.67 -42.64 98.02 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.904 177.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.45 -37.8 88.79 Favored 'General case' 0 CA--C 1.522 -0.109 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.991 -178.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 94.0 mtp -63.22 -41.3 99.11 Favored 'General case' 0 C--O 1.248 0.989 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.917 -178.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.96 -38.45 91.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.519 176.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 31.9 mmt -65.79 -37.61 86.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.576 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -61.11 -42.33 98.32 Favored 'General case' 0 CA--C 1.516 -0.33 0 O-C-N 121.55 -0.719 . . . . 0.0 109.401 -176.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.66 -41.59 95.34 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.524 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 54.5 tp -63.3 -41.5 98.96 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 177.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -167.58 124.26 1.14 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.299 0.571 . . . . 0.0 112.507 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.36 -26.6 65.21 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.55 -1.205 . . . . 0.0 110.625 178.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -62.37 -28.93 70.11 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.729 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -56.69 -44.51 81.56 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -176.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 95.2 p -60.93 -20.07 61.63 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 123.8 0.688 . . . . 0.0 111.15 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 31.1 m -55.79 -40.21 72.35 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 97.1 mt -81.4 122.44 27.49 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -43.1 133.51 3.83 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.028 177.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 93.8 m -127.48 133.83 49.86 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.89 177.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -119.02 139.65 51.35 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.173 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' SER . . . . . 0.507 ' HG ' ' N ' ' A' ' 250' ' ' ASN . 78.0 p -61.86 -42.63 99.29 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -178.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.507 ' N ' ' HG ' ' A' ' 249' ' ' SER . 98.8 m-20 -141.83 158.73 43.44 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.776 0.798 . . . . 0.0 111.641 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 63.3 t -62.39 -44.69 99.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 114.668 -1.151 . . . . 0.0 112.22 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.82 -44.18 97.25 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.207 -0.597 . . . . 0.0 109.434 -178.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -63.87 -41.02 97.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.375 -178.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . 0.44 ' O ' HG21 ' A' ' 257' ' ' VAL . . . -64.2 -44.64 91.34 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.895 0.855 . . . . 0.0 109.832 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 76.6 t -63.18 -45.84 97.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 113.944 -1.48 . . . . 0.0 110.912 -178.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.33 -46.55 86.1 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.141 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . 0.498 ' O ' ' C ' ' A' ' 258' ' ' LEU . 32.1 m -68.11 -40.72 83.43 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 O-C-N 121.489 -0.757 . . . . 0.0 111.923 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.498 ' C ' ' O ' ' A' ' 257' ' ' VAL . 1.5 mt -29.49 -74.46 0.04 OUTLIER Pre-proline 0 C--O 1.234 0.237 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.538 -177.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' PRO . . . . . 0.476 ' CD ' ' CB ' ' A' ' 258' ' ' LEU . 43.6 Cg_endo -63.57 140.34 74.79 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 120.778 0.986 . . . . 0.0 111.96 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 259' ' ' PRO . 96.6 mt -153.15 -29.5 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 123.914 0.759 . . . . 0.0 111.883 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 78.0 mtm . . . . . 0 N--CA 1.474 0.751 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.567 -176.831 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.434 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.11 155.45 34.05 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 81.0 p -57.98 -27.58 63.59 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.784 176.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -65.54 -63.58 1.06 Allowed 'General case' 0 N--CA 1.437 -1.114 0 CA-C-O 121.004 0.43 . . . . 0.0 111.7 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -66.72 -38.06 85.94 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.323 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.501 ' O ' ' HB3' ' B' ' 7' ' ' PHE . 69.4 m -59.8 -42.53 93.63 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.877 -177.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . 0.501 ' HB3' ' O ' ' B' ' 6' ' ' SER . 43.7 t80 84.83 90.85 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.387 177.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . 0.584 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -65.45 -142.6 0.04 OUTLIER Glycine 0 C--N 1.339 0.703 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . 0.584 ' HB ' ' O ' ' B' ' 8' ' ' GLY . 74.1 mt 85.33 110.49 0.03 OUTLIER Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 122.634 0.374 . . . . 0.0 110.88 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -62.9 -24.42 74.24 Favored 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 121.314 1.343 . . . . 0.0 111.864 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.14 -40.75 98.98 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -64.21 -39.84 94.82 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.676 0.75 . . . . 0.0 109.292 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 49.2 tp -61.9 -42.38 99.01 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.419 -177.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -65.24 -32.82 74.68 Favored 'General case' 0 CA--C 1.562 1.413 0 CA-C-O 121.489 0.661 . . . . 0.0 110.624 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 72.7 t -62.24 -46.48 96.34 Favored 'Isoleucine or valine' 0 C--O 1.244 0.774 0 CA-C-N 113.189 -1.823 . . . . 0.0 110.851 177.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 93.1 mt -64.08 -43.76 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.069 -178.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . 0.473 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 99.0 mttt -63.46 -42.07 98.63 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.52 -41.43 98.5 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 118.838 -1.145 . . . . 0.0 110.142 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.52 -39.01 86.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.891 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 87.9 mt -63.9 -42.25 97.48 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.369 0.604 . . . . 0.0 110.345 175.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -63.15 -38.47 91.28 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.019 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 57.7 m170 -57.43 -40.27 78.0 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 119.54 -0.267 . . . . 0.0 111.467 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 10.0 p -114.45 129.72 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.52 ' O ' ' HG3' ' B' ' 24' ' ' ARG . 36.0 ptt180 -71.43 108.59 4.93 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.736 0.779 . . . . 0.0 112.538 -177.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.9 p -143.11 134.16 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.857 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.602 177.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' B' ' 123' ' ' GLN . . . -86.5 95.89 2.09 Favored Glycine 0 C--N 1.313 -0.742 0 C-N-CA 119.555 -1.307 . . . . 0.0 113.393 -177.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 47.0 t -125.34 128.62 72.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 174.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 34.6 m -139.09 157.23 28.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.48 178.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . 0.418 HG21 HD13 ' B' ' 29' ' ' ILE . 96.1 mt -120.54 128.58 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 O-C-N 123.721 0.638 . . . . 0.0 111.787 178.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 23.2 p -108.69 157.24 18.72 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-N 112.819 -1.991 . . . . 0.0 108.602 -176.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.435 ' C ' ' OD1' ' B' ' 37' ' ' ASN . 43.3 t0 -125.46 102.97 29.2 Favored Pre-proline 0 CA--C 1.531 0.222 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -178.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.14 -22.12 67.51 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 121.694 1.596 . . . . 0.0 111.431 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.84 -45.69 93.52 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.229 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 98.7 mt -70.64 176.88 3.82 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.786 -0.571 . . . . 0.0 111.404 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . 0.54 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 42.1 tt0 -78.23 131.37 37.1 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -175.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.516 ' O ' ' OD1' ' B' ' 36' ' ' ASP . 66.7 t0 58.2 36.91 26.12 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.582 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' ASN . . . . . 0.467 ' C ' ' O ' ' B' ' 36' ' ' ASP . 32.7 t-20 28.09 73.1 0.41 Allowed Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.54 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 91.9 Cg_endo -72.98 155.33 52.94 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 123.578 2.852 . . . . 0.0 111.732 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 96.3 mt -86.54 130.02 37.39 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.47 HG21 ' N ' ' B' ' 41' ' ' TYR . 34.5 m -109.39 -42.12 5.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 O-C-N 123.708 0.63 . . . . 0.0 112.378 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' TYR . . . . . 0.47 ' N ' HG21 ' B' ' 40' ' ' VAL . 51.2 t80 -98.73 124.1 43.36 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.485 -178.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 5.1 p -143.08 142.13 26.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 O-C-N 124.046 0.841 . . . . 0.0 109.279 177.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . 0.615 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 57.0 p30 -102.64 162.08 13.21 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.212 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' GLN . . . . . 0.509 ' HA ' ' OE1' ' B' ' 44' ' ' GLN . 12.7 mm100 -62.8 -37.42 86.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.373 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.41 -27.43 65.69 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.615 ' HB2' ' OD1' ' B' ' 43' ' ' ASN . 62.4 t80 -59.91 -43.52 94.83 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . 0.675 HG11 ' O ' ' B' ' 52' ' ' TYR . 66.1 t -61.71 -46.61 96.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.218 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -63.67 -44.36 93.97 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.439 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 60.6 ttm -62.86 -41.99 99.59 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 32.2 p -96.04 -14.86 22.62 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.35 -0.54 . . . . 0.0 112.017 -177.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' B' ' 47' ' ' VAL . . . 72.54 19.96 79.27 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 177.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . 0.675 ' O ' HG11 ' B' ' 47' ' ' VAL . 81.9 m-85 -112.99 144.94 41.71 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 122.897 0.479 . . . . 0.0 110.128 178.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -73.62 148.58 42.74 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 121.884 0.85 . . . . 0.0 111.013 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.15 -35.63 80.94 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.127 -177.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.41 -40.79 96.46 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.568 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -72.43 -32.73 66.56 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 177.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . 0.403 ' O ' ' C ' ' B' ' 58' ' ' LEU . 93.5 mt -66.1 -73.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' B' ' 57' ' ' ILE . 94.6 mt -35.27 132.51 0.38 Allowed 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.362 174.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.85 -9.16 73.43 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.831 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -136.71 149.14 47.73 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -174.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' ASN . . . . . 0.682 HD22 HO2' ' B' ' 900' ' ' FMN . 25.9 t-20 -78.72 152.09 31.75 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.889 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' CYS . . . . . . . . . . . . . 82.8 m -64.53 8.67 0.1 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.342 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . 0.519 ' H ' ' C ' ' B' ' 61' ' ' ASN . 34.6 ptt-85 -58.85 -30.95 68.08 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.487 -178.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -61.55 -30.78 70.86 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 81.0 mt -61.76 -42.77 99.41 Favored 'General case' 0 C--O 1.24 0.589 0 O-C-N 122.005 -0.435 . . . . 0.0 109.87 -178.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . 0.57 HE22 HO4' ' B' ' 900' ' ' FMN . 88.4 mt-30 -49.99 148.93 2.96 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 123.7 0.625 . . . . 0.0 109.846 -177.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -160.57 -151.36 6.18 Favored Glycine 0 CA--C 1.54 1.656 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.339 175.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . 0.445 ' HB3' ' HH ' ' B' ' 95' ' ' TYR . 88.8 tttt -60.4 -41.88 94.8 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 122.659 -0.318 . . . . 0.0 111.738 -175.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -75.81 -9.56 58.7 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 123.169 0.293 . . . . 0.0 111.406 -178.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 24.5 m -61.35 135.79 57.82 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -91.08 109.28 34.25 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.283 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.96 -38.69 86.51 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 120.884 1.056 . . . . 0.0 111.888 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.52 -40.38 91.23 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 120.527 -0.469 . . . . 0.0 109.798 -176.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' GLU . . . . . 0.459 ' OE1' ' HB ' ' B' ' 90' ' ' VAL . 78.8 mm-40 -66.87 -38.6 86.63 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.667 177.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 85.3 t -61.74 -46.01 97.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -62.91 -37.34 86.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.738 -178.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -62.57 -41.96 99.26 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 119.359 -0.936 . . . . 0.0 108.672 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.47 -43.79 98.54 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.859 -178.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -62.48 -43.01 99.86 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 83.6 m -61.11 -45.29 95.3 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.965 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.53 -40.98 96.64 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -177.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 80.2 mt -63.18 -41.79 99.27 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -62.22 -35.42 78.86 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . 0.424 ' O ' ' C ' ' B' ' 85' ' ' LYS . 98.5 m-20 -91.16 10.25 27.79 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.604 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' B' ' 84' ' ' ASN . 30.7 tttt 38.08 37.82 0.17 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 120.509 -0.477 . . . . 0.0 112.037 176.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -120.66 140.69 30.94 Favored Pre-proline 0 N--CA 1.469 0.487 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.96 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -61.63 140.29 85.75 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 121.006 1.137 . . . . 0.0 114.011 -177.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -140.94 137.44 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -177.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' THR . . . . . 0.504 ' CG2' ' OD1' ' B' ' 107' ' ' ASN . 97.0 m -121.65 122.78 40.37 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . 0.459 ' HB ' ' OE1' ' B' ' 74' ' ' GLU . 28.2 m -139.04 163.2 27.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.859 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -114.71 122.4 46.31 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.189 0.519 . . . . 0.0 109.638 175.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 20.5 tt -128.9 132.58 67.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 114.999 -1.0 . . . . 0.0 112.038 -175.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . 0.439 ' O ' ' ND2' ' B' ' 94' ' ' ASN . 84.0 mt-30 -71.9 144.01 49.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.613 177.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' ASN . . . . . 0.439 ' ND2' ' O ' ' B' ' 93' ' ' GLN . 8.2 m120 -135.48 -178.69 5.23 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.353 0.596 . . . . 0.0 110.989 -176.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' TYR . . . . . 0.445 ' HH ' ' HB3' ' B' ' 68' ' ' LYS . 95.8 m-85 -132.42 145.12 50.97 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.634 -1.167 . . . . 0.0 111.829 178.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . 0.454 ' HG3' ' CE1' ' B' ' 102' ' ' PHE . 98.7 mttt -102.47 179.59 4.26 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.0 0.429 . . . . 0.0 110.917 178.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.82 -35.49 74.84 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.17 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 38.4 p-10 -88.08 -0.67 57.33 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 119.0 0.818 . . . . 0.0 112.738 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.47 5.89 64.77 Favored Glycine 0 N--CA 1.465 0.607 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.209 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 25.7 m -67.68 129.63 40.49 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.508 177.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' MET . . . . . 0.571 ' SD ' ' N ' ' B' ' 102' ' ' PHE . 14.9 tmm? -87.98 141.82 28.27 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' PHE . . . . . 0.571 ' N ' ' SD ' ' B' ' 101' ' ' MET . 53.2 p90 -154.81 162.08 41.24 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' TRP . . . . . 0.743 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 24.7 m95 -96.36 138.76 33.47 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.324 -0.551 . . . . 0.0 111.093 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . 0.451 HD22 ' HG2' ' B' ' 123' ' ' GLN . 64.0 t-20 -132.55 106.37 7.79 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 114.737 -1.119 . . . . 0.0 113.807 -177.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -75.49 123.92 26.28 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 124.286 0.992 . . . . 0.0 109.346 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 37.9 tp -111.61 126.02 54.56 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.075 0.464 . . . . 0.0 111.989 -177.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' ASN . . . . . 0.504 ' OD1' ' CG2' ' B' ' 89' ' ' THR . 97.6 m-20 -118.79 127.91 53.97 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 176.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 96.7 mt -123.79 133.11 70.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -146.6 120.9 5.23 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -69.48 153.34 70.35 Favored 'Trans proline' 0 N--CA 1.504 2.096 0 C-N-CA 122.581 2.187 . . . . 0.0 112.629 -178.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' MET . . . . . 0.496 ' HB2' ' HB2' ' B' ' 118' ' ' TYR . 66.5 mtt -128.74 144.02 51.07 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -113.49 108.68 17.51 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 178.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . 0.611 HG12 ' HZ3' ' A' ' 18' ' ' LYS . 96.7 mt -134.6 128.3 50.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 O-C-N 121.64 -0.663 . . . . 0.0 111.736 177.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 52.89 38.66 27.46 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 123.974 0.796 . . . . 0.0 109.695 178.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 60.55 35.94 20.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.53 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -134.55 152.03 51.5 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 9.5 t -102.62 152.92 20.62 Favored 'General case' 0 C--O 1.214 -0.812 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.298 -177.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' TYR . . . . . 0.496 ' HB2' ' HB2' ' B' ' 111' ' ' MET . 95.2 m-85 -147.46 147.17 29.92 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 121.349 -0.844 . . . . 0.0 111.465 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -122.89 139.2 54.29 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 120.975 0.416 . . . . 0.0 111.57 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -128.85 134.33 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -176.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . 0.463 ' HA3' ' H6 ' ' B' ' 900' ' ' FMN . . . -109.87 125.14 7.45 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 122' ' ' ILE . . . . . 0.402 ' HB ' ' HB2' ' B' ' 107' ' ' ASN . 95.5 mt -114.84 127.75 72.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 123' ' ' GLN . . . . . 0.451 ' HG2' HD22 ' B' ' 104' ' ' ASN . 13.8 mp0 -119.8 118.5 30.99 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -116.75 120.28 38.07 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' B' ' 127' ' ' THR . 68.0 t0 -67.65 133.8 49.99 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.465 -178.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . 0.478 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 3.3 mt -107.49 16.16 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.626 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 127' ' ' THR . . . . . 0.55 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 97.8 m -63.45 -44.08 95.54 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 114.254 -1.339 . . . . 0.0 112.672 176.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 59.7 tptt -61.38 -45.79 92.87 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -177.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 129' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -62.75 -35.42 79.73 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.474 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 130' ' ' LYS . . . . . 0.743 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 98.8 mttt -63.13 -41.4 99.31 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 112.91 -1.95 . . . . 0.0 111.073 175.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.41 -41.89 96.38 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 132' ' ' TYR . . . . . 0.459 ' CE2' HD13 ' B' ' 136' ' ' LEU . 90.9 t80 -60.83 -44.76 96.51 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.941 -0.474 . . . . 0.0 111.644 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.28 -36.56 84.49 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 119.966 -0.693 . . . . 0.0 109.75 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 134' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' B' ' 130' ' ' LYS . 98.9 mttt -63.29 -38.92 93.03 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.846 177.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 52.7 tp -62.55 -41.44 98.89 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.46 0.647 . . . . 0.0 109.385 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . 0.459 HD13 ' CE2' ' B' ' 132' ' ' TYR . 85.2 mt -63.03 -41.58 99.56 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.405 178.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 137' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.95 -37.74 88.52 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 113.89 -1.505 . . . . 0.0 110.237 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -63.19 -43.66 97.58 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 120.029 -0.668 . . . . 0.0 109.952 176.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 53.4 m -61.04 -44.63 97.12 Favored 'General case' 0 C--N 1.346 0.43 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 88.3 mt -61.55 -40.44 94.69 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -177.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 81.8 m -61.6 -45.37 94.38 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.961 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -66.16 -41.49 90.3 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 92.5 mt -63.69 -43.56 98.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.63 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 144' ' ' THR . . . . . . . . . . . . . 99.1 m -61.55 -45.18 95.24 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -178.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.12 -40.7 96.75 Favored 'General case' 0 C--O 1.227 -0.121 0 C-N-CA 119.192 -1.003 . . . . 0.0 109.331 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 91.5 mt -64.18 -41.39 97.14 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 147' ' ' SER . . . . . 0.61 ' O ' ' N ' ' B' ' 149' ' ' PRO . 78.1 p -62.78 -42.25 99.62 Favored 'General case' 0 CA--C 1.477 -1.854 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 148' ' ' THR . . . . . 0.508 ' C ' ' O ' ' B' ' 147' ' ' SER . 12.3 m -25.52 85.33 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.793 0 O-C-N 124.12 0.887 . . . . 0.0 110.165 176.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 149' ' ' PRO . . . . . 0.61 ' N ' ' O ' ' B' ' 147' ' ' SER . 23.8 Cg_exo -60.83 146.48 97.42 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.112 1.874 . . . . 0.0 115.897 -177.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 9.7 tp -128.36 119.33 50.24 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.148 0 CA-C-N 114.015 -1.448 . . . . 0.0 108.029 174.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 41.6 t -153.02 93.34 3.19 Favored Pre-proline 0 C--N 1.308 -1.197 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.931 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -60.18 137.27 74.18 Favored 'Trans proline' 0 N--CA 1.488 1.181 0 CA-C-N 119.728 0.939 . . . . 0.0 109.727 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 153' ' ' ILE . . . . . 0.595 ' O ' ' HD2' ' B' ' 154' ' ' ARG . 44.5 mm -68.41 -43.3 84.18 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.499 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.351 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . 0.595 ' HD2' ' O ' ' B' ' 153' ' ' ILE . 0.8 OUTLIER -155.96 -155.92 0.59 Allowed 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.683 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 61.8 t-20 -86.84 109.73 19.49 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.87 -18.71 56.46 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -177.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 88.0 mt -108.91 125.69 65.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.098 0.475 . . . . 0.0 111.036 -176.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 158' ' ' SER . . . . . 0.649 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 57.9 m -134.96 149.77 50.27 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.933 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -132.91 146.96 52.26 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 24.3 tp -139.5 77.07 29.51 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 161' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -70.83 147.54 56.21 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.689 2.259 . . . . 0.0 114.083 -178.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 95.1 mt -113.97 133.99 55.13 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 54.7 t -128.79 132.13 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 115.03 169.43 15.99 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 120.508 -0.854 . . . . 0.0 111.276 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 165' ' ' ASN . . . . . 0.688 ' O ' ' CZ ' ' B' ' 170' ' ' ARG . 59.2 t30 -91.5 106.55 18.57 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -177.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . 0.489 ' CD2' ' CZ ' ' B' ' 171' ' ' PHE . 47.5 tp -65.25 104.83 0.99 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -174.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 167' ' ' THR . . . . . 0.459 ' H ' ' HE ' ' B' ' 170' ' ' ARG . 10.7 p -84.76 171.24 12.47 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 114.088 -1.414 . . . . 0.0 110.904 176.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -66.77 -37.69 85.1 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.671 177.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.51 -40.92 89.45 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 122.456 1.122 . . . . 0.0 111.962 -178.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 170' ' ' ARG . . . . . 0.688 ' CZ ' ' O ' ' B' ' 165' ' ' ASN . 87.6 mtm180 -62.07 -36.54 81.99 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 112.367 -2.197 . . . . 0.0 111.405 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 171' ' ' PHE . . . . . 0.489 ' CZ ' ' CD2' ' B' ' 166' ' ' LEU . 0.3 OUTLIER -54.08 -26.25 26.04 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -178.92 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 172' ' ' ASN . . . . . 0.661 ' O ' HG21 ' B' ' 175' ' ' VAL . 90.3 m-20 -62.58 -40.2 96.11 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.967 178.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 67.9 m -60.46 -41.7 94.69 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.095 0.474 . . . . 0.0 110.708 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 67.8 mt -64.17 -44.12 97.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 175' ' ' VAL . . . . . 0.661 HG21 ' O ' ' B' ' 172' ' ' ASN . 34.0 m -62.9 -40.59 89.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 176' ' ' CYS . . . . . . . . . . . . . 99.5 m -62.27 -34.71 77.08 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.415 177.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 177' ' ' THR . . . . . 0.518 ' O ' HG13 ' B' ' 181' ' ' ILE . 25.2 m -61.53 -19.82 62.54 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-O 121.001 0.429 . . . . 0.0 110.213 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 178' ' ' LEU . . . . . . . . . . . . . 86.8 mt -61.1 -39.02 88.38 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.255 -178.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 19.2 m -60.94 -44.31 97.43 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.357 177.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 180' ' ' ASN . . . . . 0.576 ' O ' ' OG ' ' B' ' 183' ' ' SER . 91.2 m-20 -62.16 -40.38 95.79 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.682 0.277 . . . . 0.0 110.538 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . 0.518 HG13 ' O ' ' B' ' 177' ' ' THR . 76.3 mt -55.45 -31.77 28.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.729 -177.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 182' ' ' LEU . . . . . . . . . . . . . 84.4 mt -62.42 -42.27 99.32 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.249 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 183' ' ' SER . . . . . 0.576 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.0 p -63.53 -33.81 76.4 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 121.876 -0.515 . . . . 0.0 110.999 178.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 33.1 p -85.23 15.77 4.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.866 0.365 . . . . 0.0 111.899 -177.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 78.7 p -59.83 -16.42 28.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.977 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.38 -40.59 94.89 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.946 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 187' ' ' ASP . . . . . 0.649 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.5 m-20 -69.97 114.37 8.07 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.535 0.684 . . . . 0.0 110.711 -178.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.9 -41.99 99.63 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-N 114.9 -1.046 . . . . 0.0 113.161 -177.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -111.45 130.7 55.63 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.197 -178.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 190' ' ' LEU . . . . . . . . . . . . . 40.5 tp -124.26 118.65 27.28 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.059 177.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 88.3 mt -107.81 127.71 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 120.613 0.244 . . . . 0.0 111.552 -177.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 49.2 mm -116.68 119.13 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 193' ' ' ASP . . . . . 0.52 ' OD2' ' OG ' ' B' ' 195' ' ' SER . 40.8 t0 -89.89 111.64 22.75 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 120.919 0.39 . . . . 0.0 111.739 -177.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 194' ' ' LEU . . . . . . . . . . . . . 98.4 mt -92.14 -2.42 56.59 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.32 175.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 195' ' ' SER . . . . . 0.52 ' OG ' ' OD2' ' B' ' 193' ' ' ASP . 78.3 p -61.25 -37.34 82.75 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.865 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -62.18 -33.89 87.36 Favored Glycine 0 N--CA 1.438 -1.195 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 197' ' ' LEU . . . . . 0.989 HD23 ' O ' ' B' ' 199' ' ' GLN . 4.7 tt -77.97 133.32 38.05 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 121.962 -0.728 . . . . 0.0 109.323 -176.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 198' ' ' ALA . . . . . 0.793 ' N ' HD21 ' B' ' 197' ' ' LEU . . . -64.55 -42.23 95.82 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.361 -176.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 199' ' ' GLN . . . . . 0.989 ' O ' HD23 ' B' ' 197' ' ' LEU . 58.8 tt0 -140.48 165.02 28.57 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.623 0.725 . . . . 0.0 112.648 -178.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 200' ' ' VAL . . . . . 0.445 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 51.0 t -120.93 132.91 69.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 O-C-N 121.037 -1.04 . . . . 0.0 109.526 177.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -93.8 148.95 21.65 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.151 0.5 . . . . 0.0 110.822 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -58.07 -33.71 69.34 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.308 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -64.93 -33.39 75.91 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.4 m -61.19 -44.59 97.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.555 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 205' ' ' ALA . . . . . 0.656 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -57.71 -29.42 64.69 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.666 -177.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -65.66 -37.46 86.58 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.312 0.577 . . . . 0.0 109.603 176.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -66.12 -38.69 88.82 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.586 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.83 -43.3 97.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.079 -178.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 209' ' ' PHE . . . . . 0.656 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 73.6 m-85 -62.47 -43.14 99.54 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 114.16 -1.382 . . . . 0.0 112.733 177.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.4 -41.64 98.75 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.379 -0.929 . . . . 0.0 109.701 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . 0.437 ' O ' ' HG ' ' B' ' 215' ' ' LEU . 39.4 mt -62.44 -42.29 99.35 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.314 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 212' ' ' SER . . . . . 0.455 ' HG ' ' N ' ' B' ' 213' ' ' HIS . 78.3 p -62.33 -36.57 82.59 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.908 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 213' ' ' HIS . . . . . 0.455 ' N ' ' HG ' ' B' ' 212' ' ' SER . 58.1 t-80 -67.26 -46.77 72.67 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.012 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 51.0 tp -63.97 -43.35 96.02 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.81 0.815 . . . . 0.0 109.83 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 215' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' B' ' 211' ' ' LEU . 91.8 mt -62.95 -43.97 97.35 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 113.502 -1.681 . . . . 0.0 111.588 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.83 -39.5 92.01 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.82 -177.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 85.6 mt -63.56 -42.02 98.39 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.362 0.601 . . . . 0.0 111.652 176.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 218' ' ' THR . . . . . . . . . . . . . 74.2 p -74.17 -17.21 60.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.987 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 81.08 66.42 1.62 Allowed Glycine 0 CA--C 1.527 0.784 0 N-CA-C 106.696 -2.562 . . . . 0.0 106.696 -178.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 220' ' ' THR . . . . . . . . . . . . . 94.2 m -147.11 104.56 3.69 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 114.652 1.352 . . . . 0.0 114.652 176.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -61.92 140.45 58.3 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.022 -175.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 44.8 tp -116.69 121.79 42.65 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.37 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 3.0 mp -110.26 128.83 66.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.916 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 224' ' ' ILE . . . . . 0.445 HG23 HD11 ' B' ' 224' ' ' ILE . 50.7 mm -109.39 126.58 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.552 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 49.4 p -133.44 157.62 45.12 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 90.1 16.95 55.03 Favored Glycine 0 CA--C 1.499 -0.918 0 CA-C-N 113.898 -1.501 . . . . 0.0 111.117 -177.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 94.8 mt -81.72 125.64 39.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 O-C-N 121.942 -0.74 . . . . 0.0 111.851 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 65.9 tttt -66.73 141.68 97.04 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.406 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.11 -37.47 94.05 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 121.364 1.376 . . . . 0.0 112.609 178.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -64.04 -43.03 96.8 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -177.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 51.3 tp -61.89 -41.34 97.78 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.527 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.15 -36.83 85.31 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.504 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 94.7 mtp -64.08 -40.83 97.11 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.73 -42.84 97.83 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 122.195 0.997 . . . . 0.0 109.238 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 32.4 mmt -63.89 -35.92 82.22 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.782 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -61.66 -40.39 94.78 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -178.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.67 -44.43 93.79 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.07 178.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 51.0 tp -62.45 -45.41 93.17 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.924 -178.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -156.68 131.78 9.12 Favored 'General case' 0 CA--C 1.511 -0.555 0 C-N-CA 120.301 -0.559 . . . . 0.0 111.956 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 240' ' ' ALA . . . . . 0.4 ' C ' ' H ' ' B' ' 242' ' ' PHE . . . -62.13 -47.28 85.25 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 176.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 241' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' B' ' 244' ' ' SER . 93.7 m-20 -42.52 -19.16 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.484 -176.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 242' ' ' PHE . . . . . 0.4 ' H ' ' C ' ' B' ' 240' ' ' ALA . 91.8 t80 -62.6 -44.82 95.33 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.138 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 243' ' ' SER . . . . . . . . . . . . . 78.0 p -57.63 -44.02 85.24 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 244' ' ' SER . . . . . 0.477 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 19.8 m -29.81 -40.61 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 96.4 mt -84.25 141.67 30.81 Favored 'General case' 0 C--N 1.313 -1.013 0 O-C-N 121.561 -0.712 . . . . 0.0 110.993 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -69.06 133.55 48.23 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 120.923 0.392 . . . . 0.0 110.285 -174.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 247' ' ' THR . . . . . . . . . . . . . 97.8 m -124.1 125.86 45.22 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.861 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -111.71 142.85 43.52 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 249' ' ' SER . . . . . 0.571 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 78.4 p -62.86 -33.04 74.43 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.058 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 250' ' ' ASN . . . . . 0.571 ' OD1' ' O ' ' B' ' 249' ' ' SER . 99.3 m-20 -147.31 157.75 43.71 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.122 -0.945 . . . . 0.0 112.004 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 69.3 t -64.9 -44.75 96.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.263 178.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 252' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.74 -46.06 91.89 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -178.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -60.94 -42.88 99.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.651 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 254' ' ' ALA . . . . . 0.401 ' O ' HG21 ' B' ' 257' ' ' VAL . . . -65.57 -41.14 93.26 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.15 178.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 255' ' ' VAL . . . . . 0.416 ' O ' ' HD2' ' B' ' 259' ' ' PRO . 76.2 t -65.02 -45.36 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.067 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.07 -47.96 80.68 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.491 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 257' ' ' VAL . . . . . 0.48 ' O ' ' C ' ' B' ' 258' ' ' LEU . 27.2 m -65.46 -40.58 88.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.577 179.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 258' ' ' LEU . . . . . 0.507 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 1.3 mt -32.74 -73.29 0.06 OUTLIER Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.507 -177.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 259' ' ' PRO . . . . . 0.52 ' O ' HG13 ' B' ' 260' ' ' ILE . 37.1 Cg_endo -61.84 141.36 89.78 Favored 'Trans proline' 0 N--CA 1.504 2.103 0 C-N-CA 121.459 1.439 . . . . 0.0 111.308 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 260' ' ' ILE . . . . . 0.52 HG13 ' O ' ' B' ' 259' ' ' PRO . 96.7 mt -159.54 -16.43 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 CA-C-N 118.692 0.678 . . . . 0.0 112.3 177.081 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 78.3 mtm . . . . . 0 C--O 1.216 -0.703 0 CA-C-O 117.785 -1.102 . . . . 0.0 111.434 -178.848 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 900' ' ' FMN . . . . . 0.754 HO2' HD22 ' A' ' 61' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 900' ' ' FMN . . . . . 0.682 HO2' HD22 ' B' ' 61' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.16 172.39 18.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.144 0.497 . . . . 0.0 110.272 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 85.4 p -73.27 -10.23 59.54 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.6 -0.688 . . . . 0.0 111.17 177.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -83.33 -62.97 1.45 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 114.713 -1.131 . . . . 0.0 112.434 176.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -69.33 -39.71 78.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.782 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.611 ' O ' ' NZ ' ' B' ' 17' ' ' LYS . 57.8 m -59.62 -41.66 90.92 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -177.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.486 ' CE2' HD13 ' A' ' 9' ' ' ILE . 32.2 t80 83.18 89.64 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.179 0.514 . . . . 0.0 112.213 177.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.517 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -63.49 -140.27 0.01 OUTLIER Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -177.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.517 ' HB ' ' O ' ' A' ' 8' ' ' GLY . 67.7 mt 82.11 108.34 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 122.686 0.394 . . . . 0.0 110.523 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.93 -21.75 68.69 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.466 1.444 . . . . 0.0 112.141 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.2 -38.39 95.86 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 121.08 -0.581 . . . . 0.0 111.896 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -65.05 -39.64 93.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.512 0.672 . . . . 0.0 109.486 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 52.9 tp -62.81 -41.41 99.29 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -62.21 -40.68 96.92 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 75.0 t -60.12 -44.36 94.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 O-C-N 122.146 -0.346 . . . . 0.0 110.91 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 91.9 mt -62.51 -43.65 98.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.468 -178.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.51 -46.52 88.05 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 119.269 -0.973 . . . . 0.0 112.306 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.677 ' HZ3' ' CG1' ' B' ' 113' ' ' ILE . 98.4 mttt -59.3 -39.77 84.05 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 118.608 -1.237 . . . . 0.0 109.02 -176.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.34 -41.89 90.22 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.306 -178.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.4 mt -62.93 -40.91 99.07 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -63.43 -38.2 90.22 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 57.9 m170 -58.62 -39.86 81.68 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 122.339 -0.226 . . . . 0.0 111.329 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.6 p -113.88 129.95 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.491 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 34.8 ptt180 -72.36 108.27 5.38 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-O 122.072 0.939 . . . . 0.0 112.161 -177.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.0 p -140.47 142.96 30.06 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 123' ' ' GLN . . . -97.45 92.77 1.34 Allowed Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.674 -178.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 53.3 t -125.44 130.17 72.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.6 m -137.4 159.54 35.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.417 HG21 HD13 ' A' ' 29' ' ' ILE . 96.6 mt -121.12 129.76 75.35 Favored 'Isoleucine or valine' 0 C--O 1.247 0.952 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 177.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 19.6 p -106.32 168.47 9.13 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.518 ' C ' ' OD1' ' A' ' 37' ' ' ASN . 62.7 t0 -133.88 102.85 12.14 Favored Pre-proline 0 C--N 1.318 -0.781 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.117 178.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . 0.492 ' HG3' HG22 ' A' ' 117' ' ' THR . 36.9 Cg_endo -63.83 -22.88 69.07 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 121.495 1.463 . . . . 0.0 111.647 -178.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.02 -35.19 79.4 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.955 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.4 mt -86.39 159.81 19.25 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.375 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.817 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 42.9 tt0 -57.43 134.35 55.98 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -176.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.514 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 56.8 t0 59.76 23.49 12.39 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 178.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.518 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 39.8 t-20 38.82 65.89 2.97 Favored Pre-proline 0 CA--C 1.542 0.65 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.129 -178.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.817 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 91.3 Cg_endo -68.55 155.18 69.85 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 124.007 3.138 . . . . 0.0 112.129 -178.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.4 mt -86.53 125.0 40.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.427 HG21 ' N ' ' A' ' 41' ' ' TYR . 19.0 m -104.66 -41.78 6.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 116.136 -0.483 . . . . 0.0 112.086 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.427 ' N ' HG21 ' A' ' 40' ' ' VAL . 45.8 t80 -96.07 123.57 39.73 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.859 -178.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.5 p -142.62 139.53 28.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 O-C-N 124.295 0.997 . . . . 0.0 109.133 177.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.59 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 58.0 p30 -98.3 167.01 11.12 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.509 ' OE1' ' HA ' ' A' ' 44' ' ' GLN . 14.4 mm100 -66.43 -39.41 88.89 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 178.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.19 -26.14 63.31 Favored Glycine 0 C--N 1.33 0.208 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.59 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 60.5 t80 -59.18 -49.3 78.39 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 -179.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.418 ' O ' ' N ' ' A' ' 51' ' ' GLY . 53.5 t -58.45 -44.9 89.88 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 O-C-N 121.423 -0.798 . . . . 0.0 111.464 -174.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -62.99 -37.16 86.07 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 120.511 -0.476 . . . . 0.0 112.116 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 59.6 ttm -68.65 -43.62 75.89 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 177.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.459 ' HG1' ' H ' ' A' ' 52' ' ' TYR . 35.4 p -90.48 -23.2 21.04 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.34 0.59 . . . . 0.0 111.48 -178.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . 78.01 21.08 71.8 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 -179.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.459 ' H ' ' HG1' ' A' ' 50' ' ' THR . 70.3 m-85 -114.46 138.87 50.04 Favored 'General case' 0 C--O 1.221 -0.42 0 C-N-CA 122.936 0.494 . . . . 0.0 111.162 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -64.21 150.14 46.45 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.646 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.78 -33.55 76.12 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.26 -44.19 84.35 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.659 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -64.62 -45.49 86.65 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.585 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 92.0 mt -61.58 -50.26 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -174.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 80.6 mt -57.26 145.48 31.72 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 176.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.3 -6.68 78.89 Favored Glycine 0 N--CA 1.46 0.235 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.208 177.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -135.6 152.73 51.54 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.685 1.243 . . . . 0.0 111.903 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.559 ' C ' ' H ' ' A' ' 63' ' ' ARG . 25.2 t-20 -81.36 152.44 27.5 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.474 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 80.3 m -63.2 16.3 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.444 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.559 ' H ' ' C ' ' A' ' 61' ' ' ASN . 35.4 ptt-85 -61.88 -41.62 98.08 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.16 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -55.44 -20.55 12.78 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -178.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.7 mt -71.23 -32.17 68.45 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.611 0.719 . . . . 0.0 112.505 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.602 HE22 HO4' ' A' ' 900' ' ' FMN . 88.2 mt-30 -65.95 141.41 58.22 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.178 -178.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.59 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -151.08 -148.5 4.81 Favored Glycine 0 CA--C 1.539 1.553 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -178.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.538 ' HB3' ' HH ' ' A' ' 95' ' ' TYR . 88.5 tttt -62.79 -39.57 94.64 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -177.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -77.83 -8.72 58.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.902 0.382 . . . . 0.0 111.114 -178.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.59 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 28.6 m -62.27 128.69 37.26 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.55 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -85.89 111.06 35.17 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.859 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -57.44 -31.87 92.5 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.959 1.773 . . . . 0.0 113.247 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.42 -40.1 95.11 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.951 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.425 ' OE1' ' HB ' ' A' ' 90' ' ' VAL . 78.9 mm-40 -65.5 -43.99 88.39 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 71.9 t -59.3 -43.86 90.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -176.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -64.35 -37.54 87.87 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.144 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -63.28 -39.89 95.85 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.304 0.573 . . . . 0.0 110.068 178.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 93.6 mt -64.01 -44.16 97.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.933 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -62.61 -43.13 99.58 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 113.633 -1.622 . . . . 0.0 108.229 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 97.0 m -61.55 -49.44 76.65 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.4 -42.57 92.03 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.381 -172.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 89.3 mt -62.77 -39.98 95.88 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 121.473 -0.767 . . . . 0.0 111.177 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 66.9 tp60 -65.07 -31.44 72.66 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -89.62 -1.33 57.99 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.22 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 46.7 tttt 47.32 39.45 8.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.529 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -122.48 143.9 40.82 Favored Pre-proline 0 CA--C 1.532 0.287 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.424 ' HA ' ' O ' ' A' ' 108' ' ' ILE . 24.8 Cg_exo -61.63 144.37 97.45 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.559 1.506 . . . . 0.0 113.569 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -139.09 142.41 33.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.563 -178.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.504 ' CG2' ' OD1' ' A' ' 107' ' ' ASN . 97.7 m -127.57 118.21 23.5 Favored 'General case' 0 C--N 1.345 0.377 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 176.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.425 ' HB ' ' OE1' ' A' ' 74' ' ' GLU . 28.3 m -138.47 157.49 30.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.675 -0.238 . . . . 0.0 111.496 178.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -100.67 133.52 45.0 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 176.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 17.1 tt -141.28 128.21 20.88 Favored 'Isoleucine or valine' 0 C--N 1.377 1.777 0 CA-C-N 121.374 1.897 . . . . 0.0 112.711 177.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -62.61 135.69 57.51 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.254 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -138.16 161.36 37.0 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.699 -179.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.538 ' HH ' ' HB3' ' A' ' 68' ' ' LYS . 89.4 m-85 -118.14 136.23 53.74 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.435 ' HE3' ' CD1' ' A' ' 102' ' ' PHE . 99.2 mttt -85.77 -171.45 3.6 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.239 0.543 . . . . 0.0 111.921 -179.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -62.51 -44.09 97.21 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.919 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 42.9 p-10 -83.42 7.36 17.05 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.84 -1.1 89.09 Favored Glycine 0 N--CA 1.471 0.99 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.258 176.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.8 m -58.31 137.89 56.83 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.679 ' SD ' ' C ' ' A' ' 101' ' ' MET . 12.5 tmm? -104.97 129.78 53.31 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.556 0.217 . . . . 0.0 110.443 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.548 ' N ' ' SD ' ' A' ' 101' ' ' MET . 53.4 p90 -142.33 158.43 43.72 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.007 -177.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.915 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 23.3 m95 -89.8 141.26 28.8 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.487 HD22 ' HG2' ' A' ' 123' ' ' GLN . 54.3 t-20 -136.58 105.0 5.74 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -176.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.411 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 80.8 tt0 -70.18 135.99 49.63 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 -177.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 41.6 tp -120.9 122.77 40.95 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.504 ' OD1' ' CG2' ' A' ' 89' ' ' THR . 98.1 m-20 -120.31 121.65 39.09 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.773 177.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 87' ' ' PRO . 96.2 mt -119.68 128.57 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 O-C-N 123.493 0.496 . . . . 0.0 111.421 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -136.31 125.76 15.84 Favored Pre-proline 0 CA--C 1.541 0.617 0 O-C-N 123.079 0.237 . . . . 0.0 110.903 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -71.31 151.75 60.46 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.666 2.244 . . . . 0.0 112.363 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.638 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 67.0 mtt -123.89 153.17 41.51 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -128.48 91.14 3.18 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 96.2 mt -117.34 131.37 70.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.429 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 49.38 39.07 15.45 Favored 'General case' 0 CA--C 1.512 -0.499 0 O-C-N 121.496 -0.752 . . . . 0.0 111.68 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 58.7 30.42 19.93 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.954 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -127.59 146.35 50.56 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.785 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 7.7 t -85.38 -170.41 3.11 Favored 'General case' 0 C--O 1.214 -0.772 0 O-C-N 121.687 -0.633 . . . . 0.0 109.334 -178.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.785 ' CD2' ' O ' ' A' ' 117' ' ' THR . 66.0 m-85 -174.0 155.38 2.51 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 177.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -131.11 145.57 52.03 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 174.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -134.33 134.1 55.04 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.8 127.08 8.56 Favored Glycine 0 CA--C 1.501 -0.832 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 96.8 mt -116.6 128.93 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.487 ' HG2' HD22 ' A' ' 104' ' ' ASN . 17.7 mp0 -119.08 115.64 24.71 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.579 0.549 . . . . 0.0 109.63 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -117.64 111.78 19.64 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.838 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 126' ' ' ILE . 67.9 t0 -62.88 131.77 49.87 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -175.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.453 ' N ' ' OD1' ' A' ' 125' ' ' ASP . 2.9 mp -95.48 3.56 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 113.542 -1.663 . . . . 0.0 109.637 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.408 ' OG1' ' OD1' ' A' ' 125' ' ' ASP . 20.0 m -60.04 -42.98 95.58 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.007 -1.058 . . . . 0.0 113.62 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -60.57 -41.69 95.11 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -177.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -63.51 -39.79 95.36 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.003 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.915 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.6 mttt -62.81 -41.06 99.14 Favored 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 118.157 -1.417 . . . . 0.0 110.535 -178.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.1 -37.66 83.54 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.653 -178.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -61.77 -45.3 94.51 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.543 176.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.73 -38.69 91.85 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.02 -40.93 97.37 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 52.8 tp -60.64 -43.36 97.66 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -177.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 83.6 mt -62.28 -40.91 97.82 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.094 178.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.56 -41.83 98.39 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 119.355 -0.938 . . . . 0.0 109.837 -178.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -60.27 -41.55 93.5 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -177.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 48.8 m -61.66 -41.09 97.06 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.071 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 144' ' ' THR . 84.4 mt -63.69 -41.72 98.11 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.449 -0.5 . . . . 0.0 109.758 177.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 96.9 m -61.39 -46.0 92.01 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.268 -177.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -65.21 -40.48 94.19 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 95.5 mt -64.78 -43.47 96.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 113.967 -1.469 . . . . 0.0 111.523 176.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.515 ' N ' ' O ' ' A' ' 140' ' ' LEU . 92.1 m -62.53 -46.48 88.18 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.478 ' O ' ' OG1' ' A' ' 148' ' ' THR . . . -62.58 -40.57 97.29 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 118.875 -1.13 . . . . 0.0 109.251 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 85.3 mt -63.8 -42.73 97.64 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.675 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.1 p -60.93 -37.67 83.12 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -178.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.478 ' OG1' ' O ' ' A' ' 145' ' ' ALA . 18.8 m -29.09 83.73 0.03 OUTLIER Pre-proline 0 C--N 1.347 0.492 0 O-C-N 126.592 2.432 . . . . 0.0 106.613 -178.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.675 ' N ' ' O ' ' A' ' 147' ' ' SER . 22.4 Cg_exo -61.94 144.04 96.07 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 CA-C-O 122.753 1.064 . . . . 0.0 113.906 -174.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.572 ' O ' ' CG2' ' A' ' 151' ' ' VAL . 9.3 tp -120.49 135.1 61.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 102.057 -3.312 . . . . 0.0 102.057 175.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.572 ' CG2' ' O ' ' A' ' 150' ' ' ILE . 95.4 t -167.89 95.11 0.62 Allowed Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 177.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -64.12 143.69 84.96 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 N-CA-C 109.822 -0.876 . . . . 0.0 109.822 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.543 ' O ' HG12 ' B' ' 255' ' ' VAL . 43.4 mm -75.84 -68.61 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.463 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.672 ' NH2' ' HD3' ' B' ' 154' ' ' ARG . 4.8 mpt_? -132.02 -160.34 1.04 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 63.3 t-20 -83.63 104.57 13.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.799 0.809 . . . . 0.0 111.415 -178.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.16 9.2 60.84 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 113.991 -1.458 . . . . 0.0 110.115 -177.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.6 mt -126.1 123.48 63.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 175.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.684 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 74.5 m -133.16 151.72 51.96 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -138.15 141.03 40.12 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.625 177.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 21.7 tp -130.51 80.48 70.13 Favored Pre-proline 0 N--CA 1.47 0.571 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.454 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -70.34 152.47 66.31 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.758 2.305 . . . . 0.0 113.229 -178.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 90.1 mt -120.88 126.39 49.92 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.175 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 48.4 t -123.28 131.2 73.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 117.41 169.32 14.89 Favored Glycine 0 N--CA 1.477 1.423 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.238 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.78 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 57.1 t30 -85.25 115.28 22.93 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 117.16 0.48 . . . . 0.0 110.07 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.539 ' CD2' ' CZ ' ' A' ' 171' ' ' PHE . 47.1 tp -73.7 104.05 4.48 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -177.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.671 HG21 ' NE ' ' A' ' 170' ' ' ARG . 10.6 p -85.92 166.85 15.63 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.588 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.85 -34.16 77.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.166 0.507 . . . . 0.0 111.779 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.45 -42.44 95.95 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.102 178.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.78 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 87.5 mtm180 -65.37 -33.75 76.7 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 124.316 1.047 . . . . 0.0 112.462 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.539 ' CZ ' ' CD2' ' A' ' 166' ' ' LEU . 0.5 OUTLIER -54.21 -28.49 41.25 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 118.986 -0.531 . . . . 0.0 112.381 -178.778 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.506 ' O ' HG21 ' A' ' 175' ' ' VAL . 91.2 m-20 -60.55 -40.71 92.57 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 118.975 -1.09 . . . . 0.0 109.7 -178.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 52.0 m -59.22 -41.31 88.34 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 121.685 -0.635 . . . . 0.0 110.777 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 66.2 mt -63.25 -44.08 99.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.506 HG21 ' O ' ' A' ' 172' ' ' ASN . 35.4 m -62.08 -40.35 87.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . 0.478 ' N ' HG23 ' A' ' 175' ' ' VAL . 98.3 m -62.21 -33.97 75.59 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.396 178.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' THR . . . . . 0.51 ' O ' HG13 ' A' ' 181' ' ' ILE . 25.3 m -62.45 -19.85 63.93 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.135 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 86.2 mt -61.1 -41.87 97.47 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 -177.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 18.4 m -59.27 -43.28 92.51 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.611 ' O ' ' OG ' ' A' ' 183' ' ' SER . 93.1 m-20 -61.78 -37.68 85.22 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 120.759 0.314 . . . . 0.0 110.661 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . 0.51 HG13 ' O ' ' A' ' 177' ' ' THR . 68.7 mt -57.15 -37.18 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 O-C-N 121.384 -0.822 . . . . 0.0 109.918 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 85.9 mt -61.16 -40.69 94.81 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -177.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.611 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 78.0 p -61.62 -33.15 73.42 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.464 177.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.437 ' OG1' ' HA ' ' A' ' 181' ' ' ILE . 21.9 p -89.88 23.32 2.79 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.672 0.272 . . . . 0.0 111.433 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 78.1 p -63.41 -21.49 66.32 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.63 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.29 -37.2 79.77 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.953 -179.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.684 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 98.6 m-20 -72.58 113.21 9.36 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.53 0.681 . . . . 0.0 110.706 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.95 -42.09 99.71 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.914 -177.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -112.88 130.89 55.94 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.862 -178.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 38.5 tp -120.82 128.81 53.2 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 96.5 mt -117.08 127.54 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.8 mm -113.17 127.4 70.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . 0.604 ' CG ' ' HG ' ' A' ' 195' ' ' SER . 40.5 t0 -95.15 117.99 31.18 Favored 'General case' 0 CA--C 1.549 0.93 0 O-C-N 121.871 -0.518 . . . . 0.0 110.538 177.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 96.1 mt -97.38 -4.93 37.48 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.661 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.604 ' HG ' ' CG ' ' A' ' 193' ' ' ASP . 78.1 p -62.99 -32.51 73.88 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.63 -44.39 98.01 Favored Glycine 0 CA--C 1.533 1.17 0 N-CA-C 108.332 -1.907 . . . . 0.0 108.332 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 1.148 HD23 ' O ' ' A' ' 199' ' ' GLN . 4.7 tt -68.34 127.76 34.12 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 112.871 -1.664 . . . . 0.0 109.289 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.659 ' N ' HD21 ' A' ' 197' ' ' LEU . . . -59.4 -50.08 75.35 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 120.179 -0.608 . . . . 0.0 110.562 -178.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 1.148 ' O ' HD23 ' A' ' 197' ' ' LEU . 58.1 tt0 -132.82 157.89 43.88 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 114.757 -1.11 . . . . 0.0 113.443 -175.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.449 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 44.1 t -117.69 132.71 66.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -88.56 155.45 19.63 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.642 -178.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.4 -39.49 93.95 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 120.135 -0.626 . . . . 0.0 109.987 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -57.85 -31.48 66.71 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -178.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.5 m -61.18 -42.3 98.32 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.413 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.495 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -57.65 -37.85 74.06 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -177.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -60.83 -37.79 83.22 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.516 -0.473 . . . . 0.0 109.749 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -66.02 -38.58 88.79 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.108 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 94.6 mt -63.11 -44.54 99.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -178.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . 0.495 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 73.3 m-85 -62.18 -43.38 98.96 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.427 -178.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -62.06 -41.95 98.68 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 119.125 -1.03 . . . . 0.0 109.072 -178.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.428 ' O ' ' HG ' ' A' ' 215' ' ' LEU . 39.4 mt -62.34 -41.78 98.85 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' SER . . . . . 0.477 ' HG ' ' N ' ' A' ' 213' ' ' HIS . 78.2 p -61.74 -43.15 99.41 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 118.993 -1.083 . . . . 0.0 110.14 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' HIS . . . . . 0.477 ' N ' ' HG ' ' A' ' 212' ' ' SER . 58.6 t-80 -64.14 -45.28 89.22 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.602 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 49.8 tp -62.19 -45.93 91.2 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 118.843 -1.143 . . . . 0.0 108.247 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 211' ' ' LEU . 88.0 mt -62.15 -41.03 97.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.423 -178.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -60.84 -44.78 96.52 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -177.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 85.3 mt -61.4 -40.04 92.93 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 67.4 p -75.55 -12.11 60.16 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.596 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.62 37.63 13.61 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 120.626 -0.797 . . . . 0.0 113.57 -178.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 91.9 m -123.92 114.64 20.09 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 119.02 1.41 . . . . 0.0 111.544 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -66.15 138.11 57.49 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.83 178.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 42.1 tp -114.02 130.11 56.57 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 4.0 mp -116.29 134.41 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 122.886 0.475 . . . . 0.0 109.741 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 49.0 mm -116.53 131.57 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -178.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 37.8 p -133.81 165.41 25.05 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -177.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 78.35 22.64 67.26 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.409 HG21 HD13 ' A' ' 227' ' ' ILE . 97.8 mt -83.96 128.55 38.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 113.947 -1.127 . . . . 0.0 108.439 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 43.1 tttt -76.31 138.39 67.94 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.25 -39.5 86.32 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 121.044 1.162 . . . . 0.0 112.595 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -63.55 -40.0 95.88 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 121.416 0.627 . . . . 0.0 109.967 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 48.8 tp -63.66 -42.6 98.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.88 177.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.27 -37.42 87.41 Favored 'General case' 0 C--O 1.227 -0.12 0 C-N-CA 120.596 -0.441 . . . . 0.0 110.89 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 94.2 mtp -63.03 -41.13 99.45 Favored 'General case' 0 C--O 1.247 0.953 0 C-N-CA 120.004 -0.679 . . . . 0.0 109.742 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.38 -38.4 91.0 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.523 177.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 30.2 mmt -65.88 -37.5 86.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.688 178.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -61.18 -41.86 97.55 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.616 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -60.66 -40.65 92.84 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.573 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 55.6 tp -63.72 -41.03 98.15 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 177.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -169.19 125.95 0.93 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.369 0.604 . . . . 0.0 112.404 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.58 -27.36 66.2 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.893 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -61.45 -28.87 69.58 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.288 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -55.73 -44.48 77.58 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -177.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 96.8 p -61.43 -21.03 63.75 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 123.779 0.674 . . . . 0.0 111.287 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 40.6 m -55.04 -38.76 68.39 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 122.313 -0.242 . . . . 0.0 111.617 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 96.3 mt -84.19 120.36 26.11 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -44.63 134.73 5.27 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.047 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 96.8 m -128.61 133.83 48.41 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.905 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -117.7 140.05 50.19 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 114.953 -1.022 . . . . 0.0 110.959 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 78.0 p -60.23 -43.89 95.66 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -178.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -142.27 161.36 38.22 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.725 0.774 . . . . 0.0 111.79 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 77.4 t -62.46 -45.0 99.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 114.614 -1.175 . . . . 0.0 112.053 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -60.48 -44.31 96.04 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.193 -0.603 . . . . 0.0 109.561 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -62.99 -43.72 98.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.668 -179.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . 0.44 ' O ' HG21 ' A' ' 257' ' ' VAL . . . -63.76 -43.25 96.98 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.94 0.876 . . . . 0.0 109.767 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . 0.481 HG13 HH11 ' B' ' 154' ' ' ARG . 56.9 t -63.37 -45.77 97.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 114.003 -1.453 . . . . 0.0 111.129 -177.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.46 -46.95 83.9 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 120.649 -0.421 . . . . 0.0 111.301 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . 0.494 ' O ' ' C ' ' A' ' 258' ' ' LEU . 21.2 m -66.45 -41.1 88.11 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 O-C-N 121.539 -0.726 . . . . 0.0 112.005 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.494 ' C ' ' O ' ' A' ' 257' ' ' VAL . 1.9 mt -29.85 -72.85 0.05 OUTLIER Pre-proline 0 N--CA 1.466 0.328 0 CA-C-O 119.497 -0.287 . . . . 0.0 111.51 -177.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' PRO . . . . . 0.453 ' CD ' ' CB ' ' A' ' 258' ' ' LEU . 44.7 Cg_endo -64.12 139.28 65.94 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 CA-C-N 119.635 0.905 . . . . 0.0 111.764 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 259' ' ' PRO . 96.5 mt -153.74 -25.03 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 O-C-N 123.638 0.586 . . . . 0.0 111.764 178.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 N--CA 1.475 0.811 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.68 -177.66 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.424 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.26 162.5 33.67 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 79.5 p -59.61 -21.8 60.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.779 177.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -74.67 -62.02 1.68 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 120.948 0.404 . . . . 0.0 111.361 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.72 -39.98 88.23 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.092 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.482 ' O ' ' HB3' ' B' ' 7' ' ' PHE . 61.0 m -60.33 -42.59 95.95 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 119.98 -0.688 . . . . 0.0 109.833 -177.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . 0.486 ' CE2' HD13 ' B' ' 9' ' ' ILE . 36.7 t80 84.79 92.86 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.339 177.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . 0.538 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -65.46 -139.87 0.03 OUTLIER Glycine 0 C--N 1.338 0.678 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . 0.538 ' HB ' ' O ' ' B' ' 8' ' ' GLY . 68.0 mt 81.61 108.35 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 122.567 0.347 . . . . 0.0 110.912 -178.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -62.94 -24.23 74.13 Favored 'Trans proline' 0 N--CA 1.499 1.814 0 C-N-CA 121.338 1.359 . . . . 0.0 111.711 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.95 -40.64 98.69 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -64.67 -39.35 93.53 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.763 0.792 . . . . 0.0 109.131 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 54.1 tp -62.41 -42.24 99.29 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.476 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -63.91 -32.39 73.91 Favored 'General case' 0 CA--C 1.562 1.431 0 CA-C-O 121.535 0.683 . . . . 0.0 110.525 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . 0.405 HG11 ' SD ' ' A' ' 111' ' ' MET . 70.0 t -62.83 -46.22 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 113.237 -1.801 . . . . 0.0 111.007 176.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 93.3 mt -64.16 -43.96 97.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.007 -178.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . 0.611 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 99.0 mttt -63.55 -41.8 98.42 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -179.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.22 -41.22 99.09 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 119.01 -1.076 . . . . 0.0 109.973 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.37 -38.73 84.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.966 -178.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 86.0 mt -63.91 -41.97 97.55 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 121.359 0.6 . . . . 0.0 110.263 175.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -63.07 -38.73 92.35 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.192 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 56.5 m170 -57.83 -39.85 78.65 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 119.557 -0.259 . . . . 0.0 111.323 -178.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 12.3 p -114.04 129.94 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.505 ' O ' ' HG3' ' B' ' 24' ' ' ARG . 35.0 ptt180 -72.0 106.21 4.19 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.711 0.767 . . . . 0.0 112.447 -177.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.6 p -142.01 133.68 26.69 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.86 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.816 177.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . 0.498 ' O ' ' N ' ' B' ' 123' ' ' GLN . . . -87.31 97.53 2.28 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 119.422 -1.37 . . . . 0.0 113.202 -176.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 49.4 t -126.41 129.07 71.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 174.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 30.0 m -138.44 156.23 29.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 121.014 -0.274 . . . . 0.0 110.429 178.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 95.8 mt -119.01 127.41 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.237 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 33.2 p -107.54 158.13 17.47 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-N 113.002 -1.908 . . . . 0.0 108.694 -177.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . 0.49 ' C ' ' OD1' ' B' ' 37' ' ' ASN . 64.1 t0 -125.18 103.07 30.09 Favored Pre-proline 0 C--O 1.236 0.381 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -178.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' PRO . . . . . 0.431 ' HG3' HG22 ' B' ' 117' ' ' THR . 37.1 Cg_endo -64.39 -21.76 66.37 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.723 1.616 . . . . 0.0 111.496 -178.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.02 -45.39 93.79 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.539 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 90.9 mt -71.23 179.45 2.85 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.913 -0.492 . . . . 0.0 111.676 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . 0.681 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 41.4 tt0 -77.13 129.67 36.31 Favored 'General case' 0 C--N 1.344 0.327 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -174.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.47 ' O ' ' C ' ' B' ' 37' ' ' ASN . 65.2 t0 58.01 38.14 26.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.461 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' ASN . . . . . 0.49 ' OD1' ' C ' ' B' ' 31' ' ' ASP . 24.3 t-20 27.69 69.73 0.49 Allowed Pre-proline 0 C--N 1.327 -0.413 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.681 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 92.1 Cg_endo -70.72 153.39 64.56 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 123.676 2.917 . . . . 0.0 111.635 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 96.0 mt -84.46 129.93 36.84 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.411 HG21 ' N ' ' B' ' 41' ' ' TYR . 18.0 m -109.55 -41.61 4.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 O-C-N 123.592 0.557 . . . . 0.0 112.339 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' TYR . . . . . 0.411 ' N ' HG21 ' B' ' 40' ' ' VAL . 48.0 t80 -96.81 123.62 40.56 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.506 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 5.8 p -142.38 140.61 28.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.222 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . 0.624 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 56.7 p30 -102.13 162.1 13.17 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.177 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' GLN . . . . . 0.489 ' OE1' ' HA ' ' B' ' 44' ' ' GLN . 13.8 mm100 -62.55 -38.12 88.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.379 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.35 -26.71 64.48 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.624 ' HB2' ' OD1' ' B' ' 43' ' ' ASN . 58.0 t80 -60.04 -43.61 95.23 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . 0.561 HG11 ' O ' ' B' ' 52' ' ' TYR . 53.3 t -61.63 -46.4 96.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.091 -178.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -63.09 -45.02 94.05 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.262 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 60.3 ttm -62.75 -42.6 99.75 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' THR . . . . . 0.44 ' HG1' ' H ' ' B' ' 52' ' ' TYR . 34.3 p -93.77 -17.63 22.93 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.968 -178.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' B' ' 47' ' ' VAL . . . 73.59 19.83 79.75 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 178.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . 0.561 ' O ' HG11 ' B' ' 47' ' ' VAL . 70.8 m-85 -112.08 145.64 39.38 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.244 -0.478 . . . . 0.0 110.172 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -74.39 148.96 40.73 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.684 0.754 . . . . 0.0 111.173 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.05 -38.15 87.65 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.698 -177.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.83 -39.94 95.89 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 120.238 -0.585 . . . . 0.0 111.854 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -73.76 -32.89 64.04 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 93.4 mt -66.2 -72.12 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 95.6 mt -37.19 131.82 0.79 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.71 175.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.28 -12.22 66.77 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.957 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -133.98 149.92 51.24 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.358 0.599 . . . . 0.0 112.595 -174.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' ASN . . . . . 0.522 ' C ' ' H ' ' B' ' 63' ' ' ARG . 25.9 t-20 -77.66 153.31 33.23 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.8 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' CYS . . . . . . . . . . . . . 84.6 m -64.91 9.12 0.1 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.524 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . 0.522 ' H ' ' C ' ' B' ' 61' ' ' ASN . 33.5 ptt-85 -58.72 -32.04 68.83 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.719 -178.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -60.33 -31.06 69.94 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 85.4 mt -61.82 -42.53 99.14 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -178.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . 0.693 HE22 HO4' ' B' ' 900' ' ' FMN . 88.2 mt-30 -50.0 146.01 5.16 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 123.624 0.577 . . . . 0.0 109.764 -178.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -156.19 -152.24 6.19 Favored Glycine 0 CA--C 1.54 1.656 0 CA-C-N 115.1 -0.955 . . . . 0.0 112.773 175.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . 0.46 ' HB3' ' HH ' ' B' ' 95' ' ' TYR . 88.9 tttt -60.19 -40.76 91.17 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.576 -0.312 . . . . 0.0 111.64 -175.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -76.36 -9.27 58.52 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 123.092 0.245 . . . . 0.0 111.434 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 26.5 m -61.25 134.3 56.84 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -91.78 110.84 46.33 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.162 -178.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.43 -39.02 89.5 Favored 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 121.035 1.157 . . . . 0.0 111.917 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.74 -41.12 90.23 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 120.508 -0.477 . . . . 0.0 109.871 -176.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' GLU . . . . . 0.428 ' OE1' ' HB ' ' B' ' 90' ' ' VAL . 79.0 mm-40 -66.36 -38.96 88.78 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.752 177.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 85.9 t -61.88 -46.26 96.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -63.21 -36.84 84.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.751 -178.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -62.24 -42.12 99.03 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 119.168 -1.013 . . . . 0.0 108.642 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . 0.406 HD13 HG21 ' B' ' 78' ' ' ILE . 95.0 mt -63.53 -43.49 98.33 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 CA-C-O 120.751 0.31 . . . . 0.0 110.574 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -62.1 -42.54 99.32 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 94.9 m -61.65 -45.79 92.52 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.137 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.49 -41.49 97.34 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -177.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 86.0 mt -62.95 -42.57 99.86 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -178.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 66.8 tp60 -62.84 -33.86 76.12 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -91.39 8.28 36.99 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.498 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 37.9 tttt 40.05 41.6 0.95 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.403 -0.519 . . . . 0.0 111.946 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -124.45 140.91 36.27 Favored Pre-proline 0 N--CA 1.47 0.57 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.171 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -61.99 141.11 88.07 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 120.99 1.127 . . . . 0.0 113.827 -178.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -139.78 136.14 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.325 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' THR . . . . . 0.514 ' CG2' ' OD1' ' B' ' 107' ' ' ASN . 92.6 m -120.12 121.26 38.42 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.831 178.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . 0.428 ' HB ' ' OE1' ' B' ' 74' ' ' GLU . 29.2 m -139.09 162.99 27.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.978 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -113.49 119.58 38.06 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.153 0.502 . . . . 0.0 109.694 175.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 20.8 tt -126.42 131.99 70.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.144 -175.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . 0.488 ' O ' ' ND2' ' B' ' 94' ' ' ASN . 85.5 mt-30 -72.56 145.57 47.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.194 177.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' B' ' 93' ' ' GLN . 8.7 m120 -138.54 -179.67 5.94 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 121.359 0.6 . . . . 0.0 110.61 -177.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' TYR . . . . . 0.46 ' HH ' ' HB3' ' B' ' 68' ' ' LYS . 93.5 m-85 -129.62 148.26 51.5 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.525 177.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . 0.42 ' HG3' ' CE1' ' B' ' 102' ' ' PHE . 98.8 mttt -104.71 -179.08 3.84 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.02 0.438 . . . . 0.0 110.59 178.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.31 -36.25 77.48 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.211 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 37.6 p-10 -87.45 -1.29 57.82 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.931 0.787 . . . . 0.0 112.832 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.99 5.07 64.45 Favored Glycine 0 N--CA 1.466 0.69 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.249 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 26.5 m -67.32 128.38 36.18 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.305 177.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' MET . . . . . 0.663 ' SD ' ' N ' ' B' ' 102' ' ' PHE . 13.9 tmm? -87.5 143.5 27.19 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' PHE . . . . . 0.663 ' N ' ' SD ' ' B' ' 101' ' ' MET . 53.2 p90 -154.86 163.86 39.66 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' TRP . . . . . 0.934 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 24.5 m95 -96.72 137.4 35.86 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.944 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . 0.436 HD22 ' HG2' ' B' ' 123' ' ' GLN . 62.7 t-20 -132.17 110.84 10.95 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 114.904 -1.043 . . . . 0.0 113.686 -176.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -80.4 124.52 28.96 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 123.842 0.713 . . . . 0.0 109.185 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 39.8 tp -111.25 125.29 53.66 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.002 0.429 . . . . 0.0 111.824 -177.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' ASN . . . . . 0.514 ' OD1' ' CG2' ' B' ' 89' ' ' THR . 97.9 m-20 -120.05 126.73 51.51 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 176.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . 0.4 HD11 HG21 ' B' ' 108' ' ' ILE . 96.4 mt -122.79 133.33 69.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -143.23 123.39 7.85 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -70.0 151.92 67.88 Favored 'Trans proline' 0 N--CA 1.504 2.119 0 C-N-CA 122.657 2.238 . . . . 0.0 112.582 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' MET . . . . . 0.487 ' HB2' ' HB2' ' B' ' 118' ' ' TYR . 67.1 mtt -128.28 143.76 51.06 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -113.79 107.28 15.52 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . 0.677 ' CG1' ' HZ3' ' A' ' 18' ' ' LYS . 96.6 mt -134.62 127.77 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 O-C-N 121.811 -0.556 . . . . 0.0 112.071 178.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 51.15 38.5 21.14 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 123.834 0.709 . . . . 0.0 109.814 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 61.21 35.42 18.36 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.526 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -132.58 149.07 52.37 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' THR . . . . . 0.431 HG22 ' HG3' ' B' ' 32' ' ' PRO . 10.0 t -101.64 153.62 19.6 Favored 'General case' 0 C--O 1.214 -0.775 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -178.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' TYR . . . . . 0.487 ' HB2' ' HB2' ' B' ' 111' ' ' MET . 96.9 m-85 -148.13 147.55 29.61 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 121.317 -0.864 . . . . 0.0 111.497 -178.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -122.27 137.93 54.67 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 123.626 0.579 . . . . 0.0 110.9 -177.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -127.32 133.99 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -177.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.94 122.87 6.72 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 94.6 mt -113.52 127.45 70.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 123' ' ' GLN . . . . . 0.498 ' N ' ' O ' ' B' ' 26' ' ' GLY . 17.8 mp0 -118.45 121.6 40.71 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -121.42 119.34 31.8 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' B' ' 127' ' ' THR . 67.9 t0 -68.31 135.54 52.05 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.57 -177.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . 0.528 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 2.8 mp -107.41 17.72 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.512 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 127' ' ' THR . . . . . 0.553 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 97.5 m -63.95 -44.15 93.68 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 114.439 -1.255 . . . . 0.0 112.687 177.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -62.18 -45.85 91.55 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -177.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 129' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -62.58 -35.1 78.42 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.43 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 130' ' ' LYS . . . . . 0.934 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 98.6 mttt -63.64 -41.33 98.25 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-N 112.817 -1.992 . . . . 0.0 110.728 175.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.71 -41.64 95.85 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 90.0 t80 -60.47 -44.57 95.75 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.831 -0.543 . . . . 0.0 111.566 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . 0.404 ' O ' ' HG3' ' B' ' 137' ' ' GLU . 97.0 mt-10 -64.47 -36.35 83.9 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.55 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.27 -39.16 93.82 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.833 177.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.76 -41.24 99.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.565 0.698 . . . . 0.0 109.378 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 84.5 mt -63.0 -41.67 99.65 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.453 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 137' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' B' ' 133' ' ' GLU . 97.1 mt-10 -65.28 -37.51 87.41 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 113.523 -1.672 . . . . 0.0 110.229 -178.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -63.43 -43.36 97.66 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.055 176.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 65.6 m -60.64 -44.57 96.23 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' B' ' 144' ' ' THR . 86.1 mt -61.5 -40.13 93.5 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -177.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 95.4 m -61.67 -45.65 93.09 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.994 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -66.38 -42.6 87.69 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 93.8 mt -63.58 -43.5 98.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 114.438 -1.256 . . . . 0.0 110.591 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 144' ' ' THR . . . . . 0.417 ' N ' ' O ' ' B' ' 140' ' ' LEU . 91.0 m -61.76 -45.07 95.47 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.65 -41.08 96.36 Favored 'General case' 0 C--O 1.226 -0.149 0 C-N-CA 119.161 -1.016 . . . . 0.0 109.435 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.87 -41.18 95.86 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 176.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 147' ' ' SER . . . . . 0.575 ' O ' ' N ' ' B' ' 149' ' ' PRO . 78.3 p -62.44 -41.82 99.01 Favored 'General case' 0 CA--C 1.478 -1.79 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 148' ' ' THR . . . . . 0.488 ' C ' ' O ' ' B' ' 147' ' ' SER . 7.1 m -26.1 86.45 0.04 OUTLIER Pre-proline 0 N--CA 1.482 1.148 0 O-C-N 124.196 0.935 . . . . 0.0 110.425 176.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 149' ' ' PRO . . . . . 0.575 ' N ' ' O ' ' B' ' 147' ' ' SER . 24.1 Cg_exo -60.8 145.96 98.16 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 121.613 1.542 . . . . 0.0 115.342 -176.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 150' ' ' ILE . . . . . 0.414 ' O ' HG23 ' B' ' 150' ' ' ILE . 9.4 tp -127.68 119.83 52.78 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.828 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 172.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 61.0 t -150.25 94.88 3.65 Favored Pre-proline 0 C--N 1.303 -1.418 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.064 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -62.28 143.03 93.43 Favored 'Trans proline' 0 N--CA 1.485 0.983 0 N-CA-C 109.512 -0.995 . . . . 0.0 109.512 -179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 153' ' ' ILE . . . . . 0.501 ' CG2' HH12 ' A' ' 154' ' ' ARG . 44.1 mm -76.19 -66.52 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . 0.672 ' HD3' ' NH2' ' A' ' 154' ' ' ARG . 4.4 mpt_? -132.06 -157.92 0.85 Allowed 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 62.5 t-20 -83.98 110.39 18.39 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.06 -18.23 55.98 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -178.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 86.4 mt -108.34 124.61 64.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.993 0.425 . . . . 0.0 111.068 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 158' ' ' SER . . . . . 0.625 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 67.0 m -135.98 149.65 48.94 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.74 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -133.83 145.67 49.94 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 22.7 tp -137.28 80.22 34.64 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 161' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -72.19 149.63 52.12 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.623 2.215 . . . . 0.0 114.048 -177.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 92.1 mt -115.29 134.52 55.05 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 55.5 t -129.98 132.66 65.4 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 113.98 169.59 16.79 Favored Glycine 0 N--CA 1.47 0.911 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.48 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 165' ' ' ASN . . . . . 0.683 ' O ' ' CZ ' ' B' ' 170' ' ' ARG . 62.9 t30 -89.97 107.39 19.09 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -177.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . 0.523 ' CD2' ' CZ ' ' B' ' 171' ' ' PHE . 44.0 tp -64.55 104.49 0.8 Allowed 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -175.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 167' ' ' THR . . . . . 0.633 HG21 ' NE ' ' B' ' 170' ' ' ARG . 10.5 p -84.19 169.74 14.49 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-N 114.116 -1.402 . . . . 0.0 110.894 177.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -66.92 -37.42 84.29 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.637 177.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.86 -40.39 87.85 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-O 122.119 0.961 . . . . 0.0 111.554 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 170' ' ' ARG . . . . . 0.683 ' CZ ' ' O ' ' B' ' 165' ' ' ASN . 88.0 mtm180 -62.48 -35.98 81.04 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 112.762 -2.017 . . . . 0.0 111.248 178.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 171' ' ' PHE . . . . . 0.523 ' CZ ' ' CD2' ' B' ' 166' ' ' LEU . 0.5 OUTLIER -54.82 -25.64 29.78 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -178.686 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 172' ' ' ASN . . . . . 0.452 ' O ' HG21 ' B' ' 175' ' ' VAL . 91.9 m-20 -62.67 -40.26 96.52 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.804 178.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 49.2 m -60.52 -41.48 94.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.145 0.498 . . . . 0.0 110.801 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 65.9 mt -63.86 -44.03 97.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 175' ' ' VAL . . . . . 0.468 HG23 ' N ' ' B' ' 176' ' ' CYS . 33.3 m -62.54 -40.21 87.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 176' ' ' CYS . . . . . 0.468 ' N ' HG23 ' B' ' 175' ' ' VAL . 99.9 m -62.02 -35.23 77.94 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.381 178.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 177' ' ' THR . . . . . 0.545 ' O ' HG13 ' B' ' 181' ' ' ILE . 24.7 m -61.32 -20.27 62.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.938 0.399 . . . . 0.0 110.184 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 178' ' ' LEU . . . . . . . . . . . . . 87.8 mt -61.1 -39.47 90.08 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.281 -177.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 19.0 m -61.85 -44.4 96.91 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.322 177.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 180' ' ' ASN . . . . . 0.606 ' O ' ' OG ' ' B' ' 183' ' ' SER . 92.9 m-20 -61.88 -40.73 96.4 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.802 0.334 . . . . 0.0 110.411 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . 0.545 HG13 ' O ' ' B' ' 177' ' ' THR . 75.1 mt -55.69 -31.2 28.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 C-N-CA 120.916 -0.314 . . . . 0.0 110.897 -178.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 182' ' ' LEU . . . . . . . . . . . . . 85.1 mt -62.8 -42.08 99.56 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.328 177.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 183' ' ' SER . . . . . 0.606 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.2 p -62.91 -32.85 74.22 Favored 'General case' 0 N--CA 1.455 -0.183 0 O-C-N 122.004 -0.435 . . . . 0.0 110.89 177.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 184' ' ' THR . . . . . 0.438 ' OG1' ' HA ' ' B' ' 181' ' ' ILE . 21.0 p -85.49 16.09 4.05 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.77 0.319 . . . . 0.0 111.775 -178.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 79.2 p -59.68 -17.52 34.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.034 -177.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.78 -40.52 95.49 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.683 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 187' ' ' ASP . . . . . 0.625 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.2 m-20 -69.31 113.34 6.55 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.519 0.676 . . . . 0.0 110.632 -178.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -62.7 -41.96 99.39 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-N 114.807 -1.088 . . . . 0.0 113.154 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -112.49 130.45 55.99 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.2 -178.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 190' ' ' LEU . . . . . . . . . . . . . 41.1 tp -124.07 118.73 27.61 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.025 177.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 86.6 mt -107.12 126.82 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-O 120.608 0.242 . . . . 0.0 111.416 -177.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 49.2 mm -115.66 117.53 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 193' ' ' ASP . . . . . 0.645 ' CG ' ' HG ' ' B' ' 195' ' ' SER . 41.2 t0 -88.49 109.74 20.29 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.04 0.448 . . . . 0.0 112.11 -177.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 194' ' ' LEU . . . . . . . . . . . . . 96.3 mt -90.34 -3.53 57.68 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.517 176.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 195' ' ' SER . . . . . 0.645 ' HG ' ' CG ' ' B' ' 193' ' ' ASP . 78.1 p -61.46 -36.68 81.12 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.896 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.04 -33.24 83.26 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 197' ' ' LEU . . . . . 1.1 HD23 ' O ' ' B' ' 199' ' ' GLN . 4.8 tt -78.38 132.83 37.53 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 122.163 -0.61 . . . . 0.0 109.489 -177.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 198' ' ' ALA . . . . . 0.74 ' N ' HD21 ' B' ' 197' ' ' LEU . . . -63.15 -44.21 96.15 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 119.454 -0.899 . . . . 0.0 110.765 -177.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 199' ' ' GLN . . . . . 1.1 ' O ' HD23 ' B' ' 197' ' ' LEU . 58.0 tt0 -137.58 165.99 25.0 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.778 0.799 . . . . 0.0 112.947 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 200' ' ' VAL . . . . . 0.495 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 47.3 t -121.46 132.07 71.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 O-C-N 120.716 -1.24 . . . . 0.0 109.384 177.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -91.09 149.26 21.89 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.15 0.5 . . . . 0.0 110.979 -178.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.22 -32.92 71.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.414 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -64.79 -32.26 73.87 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.4 m -60.3 -44.33 95.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.572 178.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 205' ' ' ALA . . . . . 0.706 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -58.51 -28.31 65.3 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -65.42 -38.68 90.64 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.224 0.535 . . . . 0.0 109.874 176.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -67.52 -38.08 83.74 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.934 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 96.3 mt -63.61 -43.42 98.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.208 0.527 . . . . 0.0 109.866 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 209' ' ' PHE . . . . . 0.706 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 71.7 m-85 -62.19 -42.99 99.8 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.275 -1.33 . . . . 0.0 112.859 177.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -63.52 -41.35 98.5 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 119.492 -0.883 . . . . 0.0 109.545 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . 0.451 ' O ' ' HG ' ' B' ' 215' ' ' LEU . 40.2 mt -62.54 -42.37 99.49 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.33 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 212' ' ' SER . . . . . 0.464 ' HG ' ' N ' ' B' ' 213' ' ' HIS . 78.2 p -63.14 -36.66 84.36 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.224 -0.59 . . . . 0.0 111.873 -179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 213' ' ' HIS . . . . . 0.464 ' N ' ' HG ' ' B' ' 212' ' ' SER . 58.8 t-80 -67.58 -46.36 72.89 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 115.362 -0.836 . . . . 0.0 112.204 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 52.8 tp -63.77 -42.73 97.74 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.963 0.887 . . . . 0.0 109.994 177.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 215' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' B' ' 211' ' ' LEU . 89.6 mt -62.94 -44.06 97.1 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 113.454 -1.703 . . . . 0.0 111.708 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.33 -39.47 93.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.743 -176.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 86.1 mt -63.79 -42.11 97.79 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.349 0.595 . . . . 0.0 111.434 176.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 218' ' ' THR . . . . . . . . . . . . . 68.6 p -74.42 -17.58 60.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.063 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 80.61 69.42 1.4 Allowed Glycine 0 CA--C 1.528 0.87 0 N-CA-C 106.424 -2.67 . . . . 0.0 106.424 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 220' ' ' THR . . . . . . . . . . . . . 96.7 m -149.02 101.4 3.16 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 177.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -59.59 140.08 56.64 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.907 0.384 . . . . 0.0 111.055 -176.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 42.7 tp -117.54 121.62 41.46 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.313 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 4.3 mp -109.09 128.72 64.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.155 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 224' ' ' ILE . . . . . 0.422 HG23 HD11 ' B' ' 224' ' ' ILE . 49.8 mm -109.86 127.3 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.573 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 43.3 p -133.16 158.15 43.54 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.574 0.702 . . . . 0.0 112.684 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 88.44 19.98 50.2 Favored Glycine 0 CA--C 1.499 -0.943 0 CA-C-N 113.762 -1.563 . . . . 0.0 111.175 -178.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 95.9 mt -83.84 125.69 40.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 O-C-N 122.12 -0.635 . . . . 0.0 111.464 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 37.4 tttt -65.51 138.67 96.95 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.494 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.2 -37.02 94.56 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 121.424 1.416 . . . . 0.0 112.538 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -64.16 -43.34 95.46 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 50.5 tp -61.92 -41.61 98.13 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.826 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.13 -36.19 83.23 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.735 0.302 . . . . 0.0 111.286 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 94.7 mtp -64.15 -40.53 96.34 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.26 -42.41 99.15 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 122.085 0.945 . . . . 0.0 109.219 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 30.4 mmt -64.06 -35.42 80.66 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 114.625 -1.171 . . . . 0.0 112.102 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -62.26 -40.24 95.55 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.891 -177.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.07 -44.11 96.69 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.09 178.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.08 -44.95 95.56 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 120.383 -0.527 . . . . 0.0 112.303 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -158.88 133.82 8.26 Favored 'General case' 0 CA--C 1.51 -0.577 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.888 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 240' ' ' ALA . . . . . . . . . . . . . . . -62.61 -47.43 83.79 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 177.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 241' ' ' ASN . . . . . 0.482 ' O ' ' HB2' ' B' ' 244' ' ' SER . 90.2 m-20 -41.65 -19.71 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.477 -176.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 242' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -61.9 -44.87 95.89 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.816 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 243' ' ' SER . . . . . 0.432 ' O ' ' N ' ' B' ' 245' ' ' LEU . 78.1 p -57.87 -44.68 86.79 Favored 'General case' 0 C--N 1.345 0.377 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 244' ' ' SER . . . . . 0.482 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 18.0 m -29.43 -36.36 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . 0.432 ' N ' ' O ' ' B' ' 243' ' ' SER . 96.4 mt -89.18 133.37 34.44 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.369 -178.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -61.48 134.48 56.92 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 121.155 0.502 . . . . 0.0 110.474 -176.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 247' ' ' THR . . . . . . . . . . . . . 95.0 m -126.34 128.52 47.21 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.047 -0.978 . . . . 0.0 111.923 178.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -112.89 144.96 41.57 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 249' ' ' SER . . . . . 0.59 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 78.2 p -63.76 -33.54 75.89 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.818 -178.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 250' ' ' ASN . . . . . 0.59 ' OD1' ' O ' ' B' ' 249' ' ' SER . 99.3 m-20 -148.45 160.36 43.13 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.049 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 79.2 t -64.63 -44.21 96.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.046 178.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 252' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -61.29 -46.11 91.7 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . 0.434 ' O ' HG13 ' B' ' 257' ' ' VAL . 92.9 m-20 -61.07 -43.75 98.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.835 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 254' ' ' ALA . . . . . . . . . . . . . . . -65.77 -40.5 92.06 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 120.069 -0.652 . . . . 0.0 111.299 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 255' ' ' VAL . . . . . 0.543 HG12 ' O ' ' A' ' 153' ' ' ILE . 56.9 t -64.72 -45.75 94.27 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.07 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -63.01 -47.72 81.9 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 119.906 -0.718 . . . . 0.0 111.487 -178.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 257' ' ' VAL . . . . . 0.441 ' O ' ' C ' ' B' ' 258' ' ' LEU . 18.8 m -64.73 -40.41 88.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.533 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 258' ' ' LEU . . . . . 0.485 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 1.7 mt -33.79 -71.33 0.1 Allowed Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.479 -177.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 259' ' ' PRO . . . . . 0.524 ' O ' HG13 ' B' ' 260' ' ' ILE . 37.6 Cg_endo -62.39 139.91 79.49 Favored 'Trans proline' 0 N--CA 1.501 1.965 0 C-N-CA 121.418 1.412 . . . . 0.0 111.193 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 260' ' ' ILE . . . . . 0.524 HG13 ' O ' ' B' ' 259' ' ' PRO . 96.6 mt -159.62 -13.48 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 CA-C-N 118.713 0.688 . . . . 0.0 112.361 176.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 C--O 1.216 -0.686 0 CA-C-O 117.859 -1.067 . . . . 0.0 111.436 -179.983 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 900' ' ' FMN . . . . . 0.602 HO4' HE22 ' A' ' 66' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 900' ' ' FMN . . . . . 0.693 HO4' HE22 ' B' ' 66' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.433 ' O ' ' OG ' ' A' ' 6' ' ' SER . . . -160.13 170.76 20.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.144 0.497 . . . . 0.0 110.196 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 80.1 p -72.66 -14.71 61.65 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.36 -0.837 . . . . 0.0 111.788 177.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -76.32 -66.59 0.78 Allowed 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 114.326 -1.306 . . . . 0.0 112.966 174.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -66.94 -39.64 87.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.908 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.562 ' O ' ' NZ ' ' B' ' 17' ' ' LYS . 49.8 m -59.25 -41.37 88.63 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -177.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.547 ' CE2' HD13 ' A' ' 9' ' ' ILE . 36.1 t80 84.37 88.23 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.127 0.489 . . . . 0.0 112.034 177.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.45 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -62.19 -137.74 0.01 OUTLIER Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 -177.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.547 HD13 ' CE2' ' A' ' 7' ' ' PHE . 55.8 mt 79.02 109.81 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 122.679 0.392 . . . . 0.0 110.637 -178.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.59 -22.06 70.43 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 121.438 1.425 . . . . 0.0 112.138 -178.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.28 -37.46 94.9 Favored Glycine 0 N--CA 1.468 0.83 0 C-N-CA 121.045 -0.598 . . . . 0.0 111.862 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -66.14 -39.31 89.75 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.514 0.673 . . . . 0.0 109.519 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.1 tp -63.33 -41.46 98.89 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -63.65 -39.9 95.49 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 67.9 t -60.03 -44.19 94.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 O-C-N 122.174 -0.329 . . . . 0.0 110.938 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 93.0 mt -62.49 -43.57 98.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 119.589 -0.844 . . . . 0.0 109.321 -178.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.436 ' NZ ' ' HA ' ' B' ' 6' ' ' SER . 98.9 mttt -62.28 -46.19 89.88 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 119.361 -0.936 . . . . 0.0 112.022 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.538 ' NZ ' HG12 ' B' ' 113' ' ' ILE . 98.4 mttt -60.46 -39.54 87.96 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 118.642 -1.223 . . . . 0.0 109.079 -176.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.58 -42.2 91.94 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.144 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.2 mt -62.95 -40.15 96.8 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 177.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.19 -39.39 94.51 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.479 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 60.7 m170 -59.29 -39.42 82.92 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 122.226 -0.297 . . . . 0.0 111.606 -178.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.8 p -113.76 130.64 67.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.474 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 34.6 ptt180 -73.41 109.99 7.35 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-O 122.062 0.934 . . . . 0.0 112.187 -177.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.9 p -141.29 143.75 27.37 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.579 ' O ' ' N ' ' A' ' 123' ' ' GLN . . . -98.91 91.2 1.07 Allowed Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.908 -178.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 52.6 t -124.55 130.45 73.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 175.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.8 m -136.62 159.73 37.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.4 mt -120.43 129.55 75.43 Favored 'Isoleucine or valine' 0 C--O 1.244 0.797 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.4 p -106.56 167.48 9.82 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.425 ' C ' ' OD1' ' A' ' 37' ' ' ASN . 58.6 t0 -133.15 104.13 12.6 Favored Pre-proline 0 C--N 1.321 -0.66 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.251 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -63.4 -24.59 71.15 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.414 1.409 . . . . 0.0 111.501 -178.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.95 -35.75 81.17 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.17 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.4 mt -84.13 157.47 21.69 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.849 178.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.696 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 43.4 tt0 -57.46 134.59 56.2 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 113.361 0.875 . . . . 0.0 113.361 -176.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.526 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 59.2 t0 60.54 23.67 13.36 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.425 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 40.6 t-20 39.23 69.2 1.73 Allowed Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.181 -176.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.696 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 93.3 Cg_endo -70.19 155.31 64.83 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 123.95 3.1 . . . . 0.0 112.123 -178.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.0 mt -88.95 122.07 39.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.524 HG21 ' N ' ' A' ' 41' ' ' TYR . 30.3 m -102.01 -45.97 11.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.243 -178.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.524 ' N ' HG21 ' A' ' 40' ' ' VAL . 48.9 t80 -93.72 124.36 37.67 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 120.185 -0.606 . . . . 0.0 111.949 -178.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.7 p -143.09 140.27 27.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.226 0.953 . . . . 0.0 109.217 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.588 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 56.9 p30 -96.49 166.43 11.69 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.474 ' HA ' ' OE1' ' A' ' 44' ' ' GLN . 14.9 mm100 -66.55 -39.82 88.72 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 177.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.89 -24.25 60.12 Favored Glycine 0 N--CA 1.453 -0.209 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.588 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 65.5 t80 -59.61 -47.86 83.92 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 -179.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.432 ' O ' ' N ' ' A' ' 51' ' ' GLY . 71.4 t -58.96 -44.54 91.24 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.646 0 O-C-N 121.301 -0.875 . . . . 0.0 111.745 -174.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -63.25 -37.29 86.68 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 120.399 -0.52 . . . . 0.0 112.301 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 59.2 ttm -66.79 -43.38 84.1 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 176.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 36.3 p -93.51 -21.18 19.62 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.346 0.593 . . . . 0.0 111.541 -177.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . 76.44 20.46 76.88 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -179.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -113.25 137.08 52.01 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 122.783 0.433 . . . . 0.0 111.12 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -62.62 146.99 50.65 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.558 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.84 -32.9 74.82 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -66.69 -43.1 85.31 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.516 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -64.67 -45.65 85.77 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.073 -0.651 . . . . 0.0 109.252 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.423 HD13 HG22 ' A' ' 57' ' ' ILE . 89.1 mt -61.26 -49.84 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -175.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.1 mt -55.53 148.27 16.02 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 176.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.28 -3.44 77.38 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.873 -0.679 . . . . 0.0 113.062 177.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -137.15 151.41 48.78 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 118.705 1.252 . . . . 0.0 112.037 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.58 ' C ' ' H ' ' A' ' 63' ' ' ARG . 25.1 t-20 -81.77 151.71 27.31 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.553 -178.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 79.2 m -62.09 15.39 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.373 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.58 ' H ' ' C ' ' A' ' 61' ' ' ASN . 35.2 ptt-85 -62.21 -41.41 98.34 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.139 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -56.04 -21.99 24.81 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.2 mt -67.33 -35.73 80.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 122.066 0.936 . . . . 0.0 112.916 177.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.615 HE22 HO4' ' A' ' 900' ' ' FMN . 88.1 mt-30 -63.21 146.38 53.51 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.847 -1.069 . . . . 0.0 112.263 -178.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.539 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -156.54 -150.93 5.8 Favored Glycine 0 CA--C 1.538 1.519 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -177.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.535 ' HB3' ' HH ' ' A' ' 95' ' ' TYR . 88.7 tttt -62.75 -41.29 99.14 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.432 ' O ' ' OE1' ' A' ' 93' ' ' GLN . 11.1 m-70 -76.21 -9.08 58.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.847 0.356 . . . . 0.0 110.916 -178.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.539 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 32.9 m -62.62 128.69 37.14 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.595 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -84.75 110.99 31.8 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.825 -179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -57.29 -31.09 89.88 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 121.997 1.798 . . . . 0.0 113.207 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.5 -39.31 93.54 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.888 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.556 ' OE1' ' HB ' ' A' ' 90' ' ' VAL . 79.1 mm-40 -65.45 -44.43 87.28 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.0 t -59.31 -44.1 91.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -176.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -63.97 -38.19 90.17 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.004 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -63.68 -39.6 94.73 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.403 0.621 . . . . 0.0 110.24 178.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 94.1 mt -63.71 -44.12 98.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.053 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -62.88 -42.52 99.8 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 113.814 -1.539 . . . . 0.0 108.309 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 97.6 m -61.24 -49.37 77.37 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.65 -42.46 92.87 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.189 -172.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.436 HD23 ' CE1' ' A' ' 119' ' ' PHE . 91.5 mt -63.45 -39.56 94.79 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.007 -1.058 . . . . 0.0 111.492 -178.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -64.06 -33.16 75.12 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -89.08 -2.63 58.64 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.381 -178.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.2 tttt 49.22 40.78 18.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.59 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -122.69 144.26 42.11 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -61.32 142.88 97.37 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 121.473 1.448 . . . . 0.0 113.543 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -139.75 141.63 34.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.589 -178.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.518 ' CG2' ' OD1' ' A' ' 107' ' ' ASN . 98.8 m -128.12 120.05 26.57 Favored 'General case' 0 C--N 1.344 0.332 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 175.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.556 ' HB ' ' OE1' ' A' ' 74' ' ' GLU . 28.4 m -138.85 158.7 30.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.465 178.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -101.76 132.39 47.51 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 177.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.404 HG23 HD11 ' A' ' 92' ' ' ILE . 19.2 tt -139.99 129.44 28.29 Favored 'Isoleucine or valine' 0 C--N 1.377 1.789 0 CA-C-N 121.557 1.98 . . . . 0.0 112.527 176.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.432 ' OE1' ' O ' ' A' ' 69' ' ' HIS . 86.1 mt-30 -62.98 133.45 54.63 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.55 -1.205 . . . . 0.0 109.948 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -134.48 158.33 44.19 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.758 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.535 ' HH ' ' HB3' ' A' ' 68' ' ' LYS . 92.7 m-85 -116.16 135.13 54.2 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -179.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -83.69 -172.51 4.19 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.161 0.505 . . . . 0.0 111.618 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.05 -42.26 99.66 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.158 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.507 ' CG ' ' HG1' ' A' ' 100' ' ' THR . 41.0 p-10 -83.31 5.84 21.84 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -178.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.51 -0.65 88.39 Favored Glycine 0 N--CA 1.47 0.925 0 O-C-N 121.547 -0.721 . . . . 0.0 112.126 176.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.507 ' HG1' ' CG ' ' A' ' 98' ' ' ASP . 24.1 m -59.83 138.32 57.83 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.649 ' C ' ' SD ' ' A' ' 101' ' ' MET . 14.9 tmm? -104.45 128.75 52.42 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.561 0.22 . . . . 0.0 110.782 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -141.44 158.55 43.72 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.888 -176.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.649 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 20.7 m95 -90.81 141.29 28.96 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.506 HD22 ' HG2' ' A' ' 123' ' ' GLN . 53.1 t-20 -136.41 106.8 6.44 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -177.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 80.5 tt0 -72.37 134.9 45.7 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 -177.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 43.9 tp -120.78 123.07 41.76 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASN . . . . . 0.518 ' OD1' ' CG2' ' A' ' 89' ' ' THR . 98.0 m-20 -118.68 123.86 45.96 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.866 177.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 96.3 mt -120.21 128.45 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 O-C-N 123.525 0.516 . . . . 0.0 111.57 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -137.96 123.09 12.35 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 116.764 -0.198 . . . . 0.0 110.925 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -70.26 150.85 65.76 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.454 2.103 . . . . 0.0 112.578 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' MET . . . . . 0.58 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 66.3 mtt -122.67 152.63 40.34 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -127.23 91.51 3.33 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 177.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.416 HG22 HD11 ' A' ' 113' ' ' ILE . 96.7 mt -117.81 130.57 72.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.275 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 53.31 36.56 23.13 Favored 'General case' 0 CA--C 1.513 -0.472 0 O-C-N 121.461 -0.774 . . . . 0.0 111.648 176.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 59.21 30.62 20.41 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 123.853 0.721 . . . . 0.0 110.813 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -127.52 149.55 50.08 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.782 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 9.9 t -85.79 -173.11 4.45 Favored 'General case' 0 C--O 1.219 -0.504 0 O-C-N 121.687 -0.633 . . . . 0.0 109.489 -178.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.782 ' CD2' ' O ' ' A' ' 117' ' ' THR . 69.0 m-85 -171.9 155.71 3.92 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 174.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.436 ' CE1' HD23 ' A' ' 82' ' ' LEU . 92.0 m-85 -131.51 146.34 52.18 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 174.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.87 135.1 55.57 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 177.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.446 ' HA3' ' H6 ' ' A' ' 900' ' ' FMN . . . -106.9 127.27 8.78 Favored Glycine 0 CA--C 1.502 -0.765 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 177.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 96.3 mt -117.89 129.27 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.579 ' N ' ' O ' ' A' ' 26' ' ' GLY . 15.9 mp0 -120.18 115.74 24.24 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 123.69 0.619 . . . . 0.0 109.793 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -115.35 113.14 23.4 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.817 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.445 ' OD1' ' OG1' ' A' ' 127' ' ' THR . 68.4 t0 -65.77 123.23 19.2 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -175.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.454 ' O ' HG22 ' A' ' 126' ' ' ILE . 3.0 mp -87.0 2.89 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 113.666 -1.606 . . . . 0.0 110.194 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.445 ' OG1' ' OD1' ' A' ' 125' ' ' ASP . 31.6 m -60.13 -42.47 94.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.042 -1.036 . . . . 0.0 113.393 -178.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -59.66 -42.6 93.2 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -178.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -62.38 -39.19 92.36 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.855 176.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.649 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.8 mttt -62.53 -40.71 97.64 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 118.31 -1.356 . . . . 0.0 110.494 -178.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.53 -37.27 85.44 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.357 -0.537 . . . . 0.0 109.657 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.539 ' CE2' HD13 ' A' ' 136' ' ' LEU . 90.6 t80 -61.74 -45.7 92.8 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.244 176.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.33 -39.44 93.91 Favored 'General case' 0 C--O 1.226 -0.179 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.48 -41.23 96.95 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 50.6 tp -61.09 -43.76 98.39 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 -177.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.539 HD13 ' CE2' ' A' ' 132' ' ' TYR . 88.5 mt -62.22 -41.08 98.06 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.882 178.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -62.76 -41.36 99.18 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 119.453 -0.899 . . . . 0.0 109.762 -178.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -60.99 -42.01 97.58 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -177.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 53.7 m -61.67 -41.34 97.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.71 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 144' ' ' THR . 87.5 mt -63.39 -41.89 98.78 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.785 178.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 87.3 m -61.65 -45.33 94.49 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.381 -177.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -65.05 -41.3 95.27 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 96.4 mt -64.45 -43.6 96.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.005 -1.452 . . . . 0.0 111.235 175.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.518 ' N ' ' O ' ' A' ' 140' ' ' LEU . 95.6 m -62.29 -46.32 89.28 Favored 'General case' 0 C--N 1.345 0.411 0 C-N-CA 120.364 -0.534 . . . . 0.0 112.185 -178.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.22 -41.21 99.08 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 118.882 -1.127 . . . . 0.0 109.15 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.6 mt -63.93 -42.67 97.3 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 178.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.702 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.2 p -59.6 -38.38 81.1 Favored 'General case' 0 C--O 1.218 -0.598 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -178.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.465 ' C ' ' O ' ' A' ' 147' ' ' SER . 86.1 m -28.97 82.37 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.32 0 O-C-N 126.944 2.653 . . . . 0.0 106.101 -178.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.702 ' N ' ' O ' ' A' ' 147' ' ' SER . 23.2 Cg_exo -61.85 145.0 97.32 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 CA-C-O 122.788 1.078 . . . . 0.0 114.301 -174.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.532 ' O ' ' CG2' ' A' ' 151' ' ' VAL . 9.5 tp -120.44 136.49 57.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 102.502 -3.147 . . . . 0.0 102.502 176.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 150' ' ' ILE . 96.3 t -167.9 93.83 0.64 Allowed Pre-proline 0 CA--C 1.506 -0.725 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 178.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -63.82 143.71 86.74 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 N-CA-C 109.901 -0.846 . . . . 0.0 109.901 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.742 ' O ' HG12 ' B' ' 255' ' ' VAL . 44.3 mm -77.03 -68.71 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.659 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ARG . . . . . 0.614 HH12 ' CG2' ' B' ' 153' ' ' ILE . 3.1 mpt_? -132.99 -161.41 1.14 Allowed 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -83.34 104.99 13.93 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.849 0.833 . . . . 0.0 111.291 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.8 10.06 60.49 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 113.904 -1.498 . . . . 0.0 110.2 -177.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.5 mt -126.98 125.67 66.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.735 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 58.7 m -132.25 152.46 51.34 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -138.37 142.28 39.64 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.481 177.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 27.4 tp -135.45 80.58 45.03 Favored Pre-proline 0 N--CA 1.468 0.454 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.386 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -70.98 151.54 62.22 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.638 2.225 . . . . 0.0 113.005 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 88.6 mt -117.65 126.79 53.14 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.184 177.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 47.7 t -122.95 130.13 74.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 116.57 167.49 14.69 Favored Glycine 0 N--CA 1.479 1.558 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.179 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.841 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 57.6 t30 -84.16 115.83 22.61 Favored 'General case' 0 C--O 1.222 -0.358 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -178.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.479 ' CD2' ' CZ ' ' A' ' 171' ' ' PHE . 45.3 tp -74.28 104.83 5.19 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 -177.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.51 ' H ' ' HE ' ' A' ' 170' ' ' ARG . 10.8 p -87.04 166.74 14.81 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.269 0.557 . . . . 0.0 110.485 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.97 -33.75 76.54 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.086 0.47 . . . . 0.0 111.773 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.12 -43.76 90.94 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.519 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . 0.841 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 87.1 mtm180 -64.99 -29.38 70.3 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 178.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.479 ' CZ ' ' CD2' ' A' ' 166' ' ' LEU . 0.5 OUTLIER -54.6 -28.98 50.28 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.502 ' O ' HG21 ' A' ' 175' ' ' VAL . 92.1 m-20 -60.89 -41.12 95.43 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 119.102 -1.039 . . . . 0.0 109.679 -177.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 60.0 m -59.45 -40.81 88.03 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.687 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.419 HD12 HG23 ' A' ' 174' ' ' ILE . 67.6 mt -63.25 -44.13 99.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.502 HG21 ' O ' ' A' ' 172' ' ' ASN . 34.5 m -63.0 -39.95 87.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' CYS . . . . . 0.489 ' N ' HG23 ' A' ' 175' ' ' VAL . 98.1 m -62.08 -34.66 76.71 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.431 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' THR . . . . . 0.484 ' O ' HG13 ' A' ' 181' ' ' ILE . 25.0 m -61.92 -19.27 62.52 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.097 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 88.2 mt -61.0 -41.02 95.72 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -177.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 17.4 m -58.97 -43.2 91.31 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ASN . . . . . 0.674 ' O ' ' OG ' ' A' ' 183' ' ' SER . 93.1 m-20 -61.76 -35.98 79.69 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 122.507 0.323 . . . . 0.0 110.748 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 177' ' ' THR . 65.2 mt -58.99 -40.54 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 121.441 -0.787 . . . . 0.0 109.538 -178.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 85.6 mt -60.53 -40.18 90.59 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -177.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' SER . . . . . 0.674 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 78.2 p -61.09 -33.5 73.44 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.419 175.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.409 ' OG1' ' HA ' ' A' ' 181' ' ' ILE . 60.0 p -91.71 23.59 3.51 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.7 0.286 . . . . 0.0 111.402 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 77.8 p -63.49 -20.86 65.95 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.674 -178.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.76 -37.65 82.58 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.929 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.735 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 98.5 m-20 -71.38 113.75 8.74 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.617 0.722 . . . . 0.0 110.928 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -62.95 -42.73 99.91 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.86 -177.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -112.06 131.36 55.48 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.981 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 39.5 tp -120.01 127.94 53.07 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 177.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 96.2 mt -115.73 125.94 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.6 mm -112.62 126.57 70.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 178.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' ASP . . . . . 0.561 ' CG ' ' HG ' ' A' ' 195' ' ' SER . 38.7 t0 -95.58 118.09 31.64 Favored 'General case' 0 CA--C 1.551 1.007 0 O-C-N 121.88 -0.512 . . . . 0.0 110.443 177.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 96.9 mt -97.67 -3.35 39.47 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.848 175.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.561 ' HG ' ' CG ' ' A' ' 193' ' ' ASP . 78.0 p -62.24 -33.42 74.55 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.86 -44.68 97.52 Favored Glycine 0 CA--C 1.535 1.288 0 N-CA-C 108.39 -1.884 . . . . 0.0 108.39 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 1.104 HD23 ' O ' ' A' ' 199' ' ' GLN . 4.7 tt -69.22 128.03 35.17 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 112.792 -1.704 . . . . 0.0 108.902 -177.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . 0.651 ' N ' HD21 ' A' ' 197' ' ' LEU . . . -60.8 -47.0 88.3 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-O 121.253 0.549 . . . . 0.0 110.48 -177.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 1.104 ' O ' HD23 ' A' ' 197' ' ' LEU . 58.4 tt0 -135.83 156.86 48.14 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-N 114.623 -1.171 . . . . 0.0 113.851 -173.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.428 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 45.3 t -118.73 132.03 69.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 O-C-N 120.924 -1.11 . . . . 0.0 108.298 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -86.95 156.01 19.97 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.582 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.11 -39.06 93.22 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 120.144 -0.623 . . . . 0.0 109.975 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -57.45 -31.98 66.46 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -178.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.4 m -61.32 -42.08 98.07 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.445 178.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.433 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -58.32 -38.42 77.07 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -176.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -61.81 -37.14 83.3 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -178.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -65.92 -38.18 88.02 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.979 177.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 94.7 mt -62.84 -44.35 99.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -178.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . 0.433 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 68.4 m-85 -62.74 -43.06 99.78 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.491 -177.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.27 -42.09 99.04 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 118.961 -1.096 . . . . 0.0 109.168 -178.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 39.8 mt -62.17 -41.87 98.72 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 78.2 p -61.52 -42.36 98.7 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 119.117 -1.033 . . . . 0.0 110.26 -179.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -63.92 -45.43 89.3 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.755 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 47.8 tp -62.45 -45.87 91.1 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.18 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 87.7 mt -62.67 -40.36 96.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.366 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.42 -44.97 95.23 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.507 -177.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 86.2 mt -61.68 -40.29 94.46 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 82.6 p -75.38 -11.41 60.04 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.501 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.88 35.14 19.75 Favored Glycine 0 C--N 1.341 0.832 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.697 -178.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 96.7 m -120.47 113.84 20.9 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 119.051 1.426 . . . . 0.0 111.772 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -66.57 136.5 55.71 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.574 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 45.0 tp -112.63 129.44 56.38 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 3.0 mp -116.3 134.58 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.445 HG23 HD11 ' A' ' 224' ' ' ILE . 49.8 mm -115.41 130.74 69.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 44.8 p -133.49 165.04 25.8 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.881 -177.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 78.53 20.46 71.57 Favored Glycine 0 C--O 1.225 -0.462 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 98.1 mt -82.32 128.04 39.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 113.767 -1.217 . . . . 0.0 108.248 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -75.67 140.44 71.42 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.09 -39.62 84.92 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 121.018 1.145 . . . . 0.0 112.483 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -63.72 -38.93 92.95 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.418 0.628 . . . . 0.0 110.198 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 52.9 tp -64.23 -42.24 96.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.791 177.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.84 -37.69 88.46 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.09 -178.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 94.0 mtp -63.33 -41.06 98.86 Favored 'General case' 0 C--O 1.249 1.041 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.82 -178.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.87 -38.89 92.78 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.468 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 36.4 mmt -66.21 -37.63 86.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.514 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -61.18 -42.74 99.12 Favored 'General case' 0 CA--C 1.514 -0.405 0 O-C-N 121.58 -0.7 . . . . 0.0 109.617 -176.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.18 -40.09 88.76 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.713 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 56.7 tp -63.3 -41.09 98.93 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -168.15 127.55 1.24 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.33 0.586 . . . . 0.0 112.532 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.47 -26.59 65.37 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.801 178.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.422 ' O ' ' HB2' ' A' ' 244' ' ' SER . 89.4 m-20 -62.67 -29.41 70.62 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.534 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -55.92 -45.64 78.67 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -175.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 98.4 p -60.99 -21.02 63.14 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 123.918 0.761 . . . . 0.0 111.44 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' SER . . . . . 0.422 ' HB2' ' O ' ' A' ' 241' ' ' ASN . 43.1 m -54.39 -40.47 68.22 Favored 'General case' 0 C--N 1.32 -0.713 0 O-C-N 122.342 -0.224 . . . . 0.0 111.553 178.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 95.0 mt -83.18 119.68 24.84 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -41.52 134.64 2.3 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.103 178.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 98.1 m -127.75 134.44 49.52 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.936 177.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -118.41 139.59 51.16 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.851 179.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' SER . . . . . 0.449 ' HG ' ' N ' ' A' ' 250' ' ' ASN . 78.0 p -61.38 -42.74 99.21 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -178.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' ASN . . . . . 0.449 ' N ' ' HG ' ' A' ' 249' ' ' SER . 99.3 m-20 -143.73 159.57 42.26 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.685 0.755 . . . . 0.0 111.599 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 75.9 t -62.53 -44.76 99.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 114.711 -1.132 . . . . 0.0 111.953 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.84 -44.28 97.16 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -64.14 -42.03 96.95 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.455 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . 0.492 ' O ' HG21 ' A' ' 257' ' ' VAL . . . -64.65 -42.47 95.4 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.868 0.842 . . . . 0.0 109.829 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' VAL . . . . . 0.431 HG12 ' O ' ' B' ' 153' ' ' ILE . 54.8 t -63.41 -46.04 96.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 113.946 -1.479 . . . . 0.0 111.173 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.7 -46.21 86.52 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 120.589 -0.445 . . . . 0.0 111.459 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . 0.495 ' O ' ' C ' ' A' ' 258' ' ' LEU . 32.9 m -66.71 -40.81 86.96 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 O-C-N 121.468 -0.77 . . . . 0.0 112.073 179.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.495 ' C ' ' O ' ' A' ' 257' ' ' VAL . 2.1 mt -29.48 -75.47 0.04 OUTLIER Pre-proline 0 C--O 1.234 0.262 0 O-C-N 123.099 0.25 . . . . 0.0 111.522 -177.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 258' ' ' LEU . 42.5 Cg_endo -63.33 139.96 74.34 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 120.789 0.992 . . . . 0.0 111.825 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 96.7 mt -151.85 -27.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 O-C-N 123.953 0.783 . . . . 0.0 111.973 178.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 78.1 mtm . . . . . 0 N--CA 1.473 0.708 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.736 -177.174 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.475 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.91 161.14 22.79 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 79.2 p -59.87 -21.7 61.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.871 177.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -74.21 -64.05 1.1 Allowed 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.969 0.414 . . . . 0.0 111.123 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -65.63 -39.43 91.45 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.281 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.484 ' O ' ' HB3' ' B' ' 7' ' ' PHE . 49.5 m -59.97 -41.88 92.94 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.094 -0.642 . . . . 0.0 109.792 -177.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . 0.545 ' CE2' HD13 ' B' ' 9' ' ' ILE . 37.8 t80 85.48 92.22 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.352 177.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' GLY . . . . . 0.469 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -65.02 -137.18 0.02 OUTLIER Glycine 0 C--N 1.338 0.687 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -178.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' ILE . . . . . 0.545 HD13 ' CE2' ' B' ' 7' ' ' PHE . 55.3 mt 78.62 109.48 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 122.613 0.365 . . . . 0.0 111.162 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -62.24 -23.87 75.68 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 121.304 1.336 . . . . 0.0 111.806 -178.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.3 -40.29 98.4 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -64.5 -39.81 94.48 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.733 0.778 . . . . 0.0 109.267 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 52.7 tp -61.88 -42.55 99.2 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.439 -177.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -65.12 -32.17 73.74 Favored 'General case' 0 CA--C 1.561 1.37 0 CA-C-O 121.479 0.657 . . . . 0.0 110.705 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 75.4 t -62.6 -46.03 97.37 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 CA-C-N 113.101 -1.863 . . . . 0.0 110.926 177.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 92.6 mt -64.04 -43.81 97.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.871 -178.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . 0.562 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 98.9 mttt -63.3 -42.44 99.04 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.21 -41.23 99.12 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 118.998 -1.081 . . . . 0.0 110.026 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.19 -38.85 84.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.867 -178.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 89.0 mt -64.31 -41.7 96.7 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 121.289 0.566 . . . . 0.0 110.122 174.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.29 -39.89 94.46 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.021 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 59.4 m170 -58.46 -39.58 80.31 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 121.121 -0.231 . . . . 0.0 111.601 -178.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 13.3 p -113.97 130.42 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.487 ' O ' ' HG3' ' B' ' 24' ' ' ARG . 34.6 ptt180 -73.15 108.04 5.82 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-O 121.726 0.774 . . . . 0.0 112.577 -177.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.6 p -143.3 133.8 22.21 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.885 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.687 177.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' GLY . . . . . 0.546 ' O ' ' N ' ' B' ' 123' ' ' GLN . . . -88.43 95.88 2.14 Favored Glycine 0 C--N 1.315 -0.626 0 C-N-CA 119.364 -1.398 . . . . 0.0 113.403 -176.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 47.7 t -125.23 129.54 73.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 174.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 31.8 m -137.97 157.29 32.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.53 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 95.8 mt -119.27 127.42 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.666 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 31.3 p -109.01 157.04 19.05 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-N 112.795 -2.002 . . . . 0.0 108.567 -177.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -124.86 104.26 30.31 Favored Pre-proline 0 C--O 1.235 0.294 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.54 -22.51 65.08 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.639 1.559 . . . . 0.0 111.59 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.13 -43.76 98.13 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.423 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 99.4 mt -73.02 174.67 7.55 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.951 -0.468 . . . . 0.0 111.378 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . 0.596 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 42.7 tt0 -73.16 131.25 41.8 Favored 'General case' 0 C--N 1.345 0.381 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -176.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.476 ' O ' ' OD1' ' B' ' 36' ' ' ASP . 66.0 t0 57.54 38.19 27.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.625 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' ASN . . . . . 0.465 ' C ' ' O ' ' B' ' 36' ' ' ASP . 29.7 t-20 28.63 71.86 0.47 Allowed Pre-proline 0 CA--C 1.535 0.368 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -178.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.596 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 92.1 Cg_endo -71.77 154.18 59.0 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 123.551 2.834 . . . . 0.0 111.84 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 95.6 mt -87.5 127.91 40.44 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.51 HG21 ' N ' ' B' ' 41' ' ' TYR . 26.7 m -108.03 -45.44 7.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 O-C-N 123.777 0.673 . . . . 0.0 112.437 -178.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' TYR . . . . . 0.51 ' N ' HG21 ' B' ' 40' ' ' VAL . 51.6 t80 -94.73 124.51 38.81 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.552 -178.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 6.0 p -142.97 140.96 27.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.311 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' ASN . . . . . 0.618 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 57.2 p30 -100.34 161.46 13.59 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.086 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' GLN . . . . . 0.453 ' HA ' ' OE1' ' B' ' 44' ' ' GLN . 14.4 mm100 -63.16 -37.98 89.37 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.502 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.17 -25.01 61.72 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.291 -0.723 . . . . 0.0 111.291 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' PHE . . . . . 0.618 ' HB2' ' OD1' ' B' ' 43' ' ' ASN . 61.3 t80 -60.33 -43.3 96.54 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' VAL . . . . . 0.459 ' O ' ' N ' ' B' ' 51' ' ' GLY . 69.4 t -61.16 -46.35 96.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.252 -178.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -62.67 -44.22 96.81 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.213 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 59.3 ttm -62.98 -42.06 99.73 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 33.8 p -96.11 -16.1 21.75 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.231 -0.588 . . . . 0.0 111.969 -178.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' B' ' 47' ' ' VAL . . . 73.08 18.3 79.11 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 178.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' TYR . . . . . 0.438 ' O ' HG11 ' B' ' 47' ' ' VAL . 82.6 m-85 -110.62 143.17 41.46 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.294 -0.453 . . . . 0.0 110.038 178.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -71.79 146.9 47.75 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-O 121.904 0.859 . . . . 0.0 110.994 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.63 -36.8 81.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.065 -177.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.37 -39.59 94.18 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.015 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -72.51 -32.04 65.83 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 177.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . . . . . . . . . 95.8 mt -66.68 -71.29 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 178.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 94.2 mt -36.61 130.97 0.71 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.38 175.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.24 -8.23 69.54 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.617 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -136.08 149.14 48.6 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -174.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' ASN . . . . . 0.538 ' C ' ' H ' ' B' ' 63' ' ' ARG . 25.7 t-20 -79.55 151.6 30.6 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.798 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' CYS . . . . . . . . . . . . . 78.3 m -62.83 7.91 0.07 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.375 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' ARG . . . . . 0.538 ' H ' ' C ' ' B' ' 61' ' ' ASN . 33.5 ptt-85 -58.79 -31.89 68.82 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.54 -0.755 . . . . 0.0 112.497 -178.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -60.93 -31.2 70.74 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 178.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 81.5 mt -61.94 -42.36 99.02 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -177.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . 0.656 HE22 HO4' ' B' ' 900' ' ' FMN . 88.0 mt-30 -48.02 151.67 0.92 Allowed 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.155 0.503 . . . . 0.0 109.888 -178.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -162.26 -152.93 6.92 Favored Glycine 0 CA--C 1.54 1.649 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.184 175.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' LYS . . . . . 0.448 ' HB3' ' HH ' ' B' ' 95' ' ' TYR . 88.8 tttt -60.87 -42.23 97.5 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 122.634 -0.333 . . . . 0.0 111.823 -175.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -74.93 -9.98 59.05 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.161 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' THR . . . . . . . . . . . . . 31.5 m -61.29 134.72 57.27 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -90.94 110.26 40.74 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.25 -178.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.84 -38.14 85.47 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 120.965 1.11 . . . . 0.0 111.828 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.38 -40.03 89.4 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 120.568 -0.453 . . . . 0.0 109.787 -176.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' GLU . . . . . 0.549 ' OE1' ' HB ' ' B' ' 90' ' ' VAL . 79.2 mm-40 -66.16 -39.65 89.95 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.889 177.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 72.1 t -61.92 -46.24 96.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -62.88 -37.45 86.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.885 -178.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -62.84 -41.53 99.38 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 119.312 -0.955 . . . . 0.0 108.79 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 95.0 mt -63.34 -43.73 98.72 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 CA-C-O 120.761 0.315 . . . . 0.0 110.714 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -62.27 -42.44 99.34 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 81.7 m -60.81 -45.75 93.19 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.994 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.5 -41.81 97.84 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -177.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.466 HD23 ' CE1' ' B' ' 119' ' ' PHE . 87.9 mt -63.57 -41.79 98.36 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -178.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 67.4 tp60 -62.21 -35.33 78.57 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -91.61 8.41 36.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.682 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 26.9 tttt 41.51 42.29 1.89 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.3 -0.56 . . . . 0.0 112.045 176.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -124.31 141.3 37.1 Favored Pre-proline 0 N--CA 1.471 0.58 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.096 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -61.73 140.12 84.29 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 120.875 1.05 . . . . 0.0 114.029 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.87 135.9 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -177.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' THR . . . . . 0.529 ' CG2' ' OD1' ' B' ' 107' ' ' ASN . 96.2 m -121.85 122.06 38.58 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' VAL . . . . . 0.549 ' HB ' ' OE1' ' B' ' 74' ' ' GLU . 26.9 m -139.31 163.28 26.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.753 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -113.6 121.47 44.27 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.131 0.491 . . . . 0.0 109.881 175.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 21.2 tt -127.87 131.47 69.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.034 -175.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -71.94 142.05 49.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.938 177.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -132.9 -178.47 4.97 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.407 0.623 . . . . 0.0 111.04 -176.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' TYR . . . . . 0.448 ' HH ' ' HB3' ' B' ' 68' ' ' LYS . 96.2 m-85 -132.2 146.03 51.74 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.813 178.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -102.93 179.29 4.32 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.056 0.455 . . . . 0.0 110.702 177.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.53 -35.16 75.31 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.243 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . 0.43 ' CG ' ' HG1' ' B' ' 100' ' ' THR . 37.0 p-10 -86.49 -1.95 58.04 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.038 0.836 . . . . 0.0 112.785 177.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.59 4.62 65.62 Favored Glycine 0 N--CA 1.465 0.612 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.165 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 100' ' ' THR . . . . . 0.43 ' HG1' ' CG ' ' B' ' 98' ' ' ASP . 25.8 m -67.65 128.98 38.46 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.331 178.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' MET . . . . . 0.531 ' SD ' ' N ' ' B' ' 102' ' ' PHE . 16.8 tmm? -87.25 143.37 27.31 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' PHE . . . . . 0.531 ' N ' ' SD ' ' B' ' 101' ' ' MET . 52.1 p90 -154.74 163.86 39.64 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' TRP . . . . . 0.677 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 22.0 m95 -97.51 137.57 36.26 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.276 -0.57 . . . . 0.0 111.086 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . 0.478 HD22 ' HG2' ' B' ' 123' ' ' GLN . 63.8 t-20 -131.9 113.4 13.4 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 114.707 -1.133 . . . . 0.0 113.957 -177.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -83.51 121.41 27.17 Favored 'General case' 0 C--N 1.318 -0.788 0 O-C-N 124.441 1.088 . . . . 0.0 109.015 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 41.2 tp -109.52 125.66 52.73 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.066 0.46 . . . . 0.0 111.95 -177.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' ASN . . . . . 0.529 ' OD1' ' CG2' ' B' ' 89' ' ' THR . 98.2 m-20 -118.34 129.6 55.53 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 176.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 96.7 mt -124.07 132.75 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -144.37 121.3 6.43 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -69.27 152.18 71.85 Favored 'Trans proline' 0 N--CA 1.503 2.043 0 C-N-CA 122.424 2.083 . . . . 0.0 112.576 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' MET . . . . . 0.449 ' HB2' ' HB2' ' B' ' 118' ' ' TYR . 66.1 mtt -128.75 142.26 51.06 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -112.51 105.27 13.45 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . 0.538 HG12 ' NZ ' ' A' ' 18' ' ' LYS . 96.8 mt -132.9 127.93 56.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 O-C-N 121.697 -0.627 . . . . 0.0 111.695 177.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 53.94 37.19 26.13 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 123.913 0.758 . . . . 0.0 109.713 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 60.58 36.28 19.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.266 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -132.63 153.23 51.27 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 177.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 11.3 t -103.23 152.31 21.64 Favored 'General case' 0 C--O 1.213 -0.82 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.16 -178.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' TYR . . . . . 0.449 ' HB2' ' HB2' ' B' ' 111' ' ' MET . 96.5 m-85 -148.04 146.95 29.09 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 121.222 -0.924 . . . . 0.0 111.278 -179.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 119' ' ' PHE . . . . . 0.466 ' CE1' HD23 ' B' ' 82' ' ' LEU . 96.7 m-85 -123.54 138.98 54.45 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 120.971 0.415 . . . . 0.0 111.512 -178.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -128.01 133.67 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -176.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . 0.474 ' HA3' ' H6 ' ' B' ' 900' ' ' FMN . . . -107.93 121.98 6.58 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 91.9 mt -113.36 127.14 70.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 123' ' ' GLN . . . . . 0.546 ' N ' ' O ' ' B' ' 26' ' ' GLY . 15.8 mp0 -118.55 122.58 42.99 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -119.68 121.21 38.74 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' B' ' 127' ' ' THR . 68.3 t0 -72.23 128.04 34.41 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.604 -177.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . 0.486 ' O ' ' HG3' ' B' ' 130' ' ' LYS . 2.9 mp -100.93 17.42 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.58 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 127' ' ' THR . . . . . 0.552 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 98.1 m -62.57 -44.14 97.07 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 114.197 -1.365 . . . . 0.0 112.846 176.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 59.9 tptt -61.67 -45.05 95.65 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -177.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 129' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -63.39 -35.04 79.1 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.683 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 130' ' ' LYS . . . . . 0.677 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 98.9 mttt -62.95 -41.63 99.57 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-N 112.833 -1.985 . . . . 0.0 110.835 174.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -64.3 -42.23 96.47 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 132' ' ' TYR . . . . . 0.533 ' CE2' HD13 ' B' ' 136' ' ' LEU . 91.6 t80 -60.13 -44.09 95.18 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 121.903 -0.498 . . . . 0.0 111.384 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 133' ' ' GLU . . . . . 0.457 ' O ' ' HG3' ' B' ' 137' ' ' GLU . 97.5 mt-10 -64.87 -36.55 84.7 Favored 'General case' 0 C--O 1.22 -0.453 0 C-N-CA 119.989 -0.684 . . . . 0.0 109.384 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 134' ' ' LYS . . . . . 0.413 ' HG3' ' O ' ' B' ' 130' ' ' LYS . 98.7 mttt -63.52 -39.8 95.36 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.604 177.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 49.6 tp -62.91 -41.4 99.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.349 0.595 . . . . 0.0 109.441 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . 0.533 HD13 ' CE2' ' B' ' 132' ' ' TYR . 88.8 mt -62.99 -41.47 99.59 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.426 177.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 137' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' B' ' 133' ' ' GLU . 97.1 mt-10 -65.06 -37.18 86.73 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 113.806 -1.543 . . . . 0.0 110.268 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.48 -43.75 96.38 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.995 177.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 67.3 m -60.94 -44.39 97.31 Favored 'General case' 0 C--N 1.346 0.449 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' B' ' 144' ' ' THR . 88.4 mt -61.73 -40.33 94.7 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -177.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 92.6 m -61.78 -45.44 93.89 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.026 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -65.66 -42.81 90.95 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 94.3 mt -63.87 -43.41 97.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.574 178.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 144' ' ' THR . . . . . 0.433 ' N ' ' O ' ' B' ' 140' ' ' LEU . 95.3 m -61.59 -45.51 93.82 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . 0.437 ' O ' ' HB ' ' B' ' 148' ' ' THR . . . -64.52 -41.73 96.21 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 119.117 -1.033 . . . . 0.0 109.295 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 86.2 mt -64.99 -40.85 95.57 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 176.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 147' ' ' SER . . . . . 0.613 ' O ' ' N ' ' B' ' 149' ' ' PRO . 78.2 p -62.06 -41.86 98.6 Favored 'General case' 0 CA--C 1.477 -1.84 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -178.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 148' ' ' THR . . . . . 0.497 ' C ' ' O ' ' B' ' 147' ' ' SER . 40.5 m -26.51 85.36 0.03 OUTLIER Pre-proline 0 N--CA 1.478 0.947 0 O-C-N 123.958 0.786 . . . . 0.0 110.188 176.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 149' ' ' PRO . . . . . 0.613 ' N ' ' O ' ' B' ' 147' ' ' SER . 24.1 Cg_exo -60.52 145.18 99.23 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.051 1.834 . . . . 0.0 115.6 -177.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 9.9 tp -125.29 119.44 55.48 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.168 0 CA-C-N 114.036 -1.438 . . . . 0.0 108.197 174.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 59.5 t -148.89 94.2 4.1 Favored Pre-proline 0 C--N 1.307 -1.274 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.806 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.04 142.88 94.1 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 CA-C-N 119.909 1.003 . . . . 0.0 109.623 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 153' ' ' ILE . . . . . 0.614 ' CG2' HH12 ' A' ' 154' ' ' ARG . 43.8 mm -77.1 -66.89 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . 0.608 ' HD3' ' NH2' ' A' ' 154' ' ' ARG . 2.7 mpt_? -132.96 -158.84 0.92 Allowed 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 177.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -84.2 109.49 17.79 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 101.02 -17.34 56.32 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -177.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 89.3 mt -109.78 126.43 66.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.859 0.362 . . . . 0.0 111.282 -177.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 158' ' ' SER . . . . . 0.702 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 60.7 m -135.29 149.05 49.71 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.718 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -132.46 149.33 52.35 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 29.8 tp -144.23 78.75 13.38 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 161' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -71.82 149.89 54.78 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.725 2.283 . . . . 0.0 114.108 -177.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 91.6 mt -113.68 133.3 55.41 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 55.9 t -128.38 132.38 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 113.49 167.45 16.55 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.184 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 165' ' ' ASN . . . . . 0.634 ' O ' ' NH1' ' B' ' 170' ' ' ARG . 52.9 t30 -88.55 107.53 18.94 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -178.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 166' ' ' LEU . . . . . 0.451 ' CD2' ' CZ ' ' B' ' 171' ' ' PHE . 48.2 tp -64.78 105.35 0.98 Allowed 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -174.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 167' ' ' THR . . . . . 0.453 ' CG2' HH21 ' B' ' 170' ' ' ARG . 10.9 p -84.94 169.74 13.74 Favored 'General case' 0 C--N 1.348 0.502 0 CA-C-N 114.019 -1.446 . . . . 0.0 110.79 177.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.2 -37.87 84.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.704 176.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.3 -40.97 90.37 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-O 122.455 1.121 . . . . 0.0 111.894 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 170' ' ' ARG . . . . . 0.634 ' NH1' ' O ' ' B' ' 165' ' ' ASN . 87.7 mtm180 -61.83 -34.81 76.63 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 112.376 -2.193 . . . . 0.0 111.178 177.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 171' ' ' PHE . . . . . 0.451 ' CZ ' ' CD2' ' B' ' 166' ' ' LEU . 0.5 OUTLIER -53.95 -26.25 24.67 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -178.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 172' ' ' ASN . . . . . 0.449 ' O ' HG21 ' B' ' 175' ' ' VAL . 92.8 m-20 -62.86 -40.56 97.86 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.875 179.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 57.1 m -60.7 -41.07 94.44 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.098 0.475 . . . . 0.0 110.747 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 174' ' ' ILE . . . . . 0.418 HD12 HG23 ' B' ' 174' ' ' ILE . 67.3 mt -63.92 -44.1 97.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 175' ' ' VAL . . . . . 0.498 HG23 ' N ' ' B' ' 176' ' ' CYS . 34.5 m -63.15 -40.22 88.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 176' ' ' CYS . . . . . 0.498 ' N ' HG23 ' B' ' 175' ' ' VAL . 99.1 m -61.88 -35.03 77.11 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.432 178.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 177' ' ' THR . . . . . 0.501 ' O ' HG13 ' B' ' 181' ' ' ILE . 25.1 m -61.74 -19.24 62.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.28 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 178' ' ' LEU . . . . . . . . . . . . . 89.4 mt -61.42 -39.01 89.19 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.328 -177.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 18.2 m -61.0 -43.81 98.35 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.259 177.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 180' ' ' ASN . . . . . 0.657 ' O ' ' OG ' ' B' ' 183' ' ' SER . 92.4 m-20 -62.13 -40.0 94.46 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.878 0.371 . . . . 0.0 110.481 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . 0.501 HG13 ' O ' ' B' ' 177' ' ' THR . 72.2 mt -56.11 -35.0 40.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 O-C-N 122.157 -0.339 . . . . 0.0 110.902 -178.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 182' ' ' LEU . . . . . . . . . . . . . 84.6 mt -61.78 -41.52 97.83 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 119.799 -0.761 . . . . 0.0 109.11 177.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 183' ' ' SER . . . . . 0.657 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.3 p -62.89 -32.6 73.9 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 121.8 -0.562 . . . . 0.0 110.915 176.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 184' ' ' THR . . . . . 0.411 ' OG1' ' HA ' ' B' ' 181' ' ' ILE . 50.9 p -87.52 15.73 6.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.835 0.35 . . . . 0.0 111.831 -178.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 79.5 p -59.35 -17.13 27.0 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.031 -177.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.02 -40.59 96.22 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.704 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 187' ' ' ASP . . . . . 0.702 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.2 m-20 -68.75 113.93 6.65 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.653 0.74 . . . . 0.0 110.622 -177.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.65 -42.36 99.57 Favored 'General case' 0 C--O 1.247 0.922 0 CA-C-N 114.772 -1.104 . . . . 0.0 113.118 -177.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -112.02 130.86 55.73 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 120.621 -0.431 . . . . 0.0 111.317 -178.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 190' ' ' LEU . . . . . . . . . . . . . 41.4 tp -123.13 117.64 25.86 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.901 178.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 83.9 mt -105.62 125.1 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 121.064 -0.254 . . . . 0.0 111.418 -178.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 49.7 mm -114.88 117.4 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 178.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 193' ' ' ASP . . . . . 0.575 ' CG ' ' HG ' ' B' ' 195' ' ' SER . 40.0 t0 -89.47 111.07 21.87 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.731 -176.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 194' ' ' LEU . . . . . . . . . . . . . 97.2 mt -92.24 -1.24 57.23 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.323 175.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 195' ' ' SER . . . . . 0.575 ' HG ' ' CG ' ' B' ' 193' ' ' ASP . 78.1 p -61.35 -37.16 82.34 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.698 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.42 -34.13 87.18 Favored Glycine 0 N--CA 1.439 -1.102 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 197' ' ' LEU . . . . . 1.049 HD23 ' O ' ' B' ' 199' ' ' GLN . 4.8 tt -78.19 132.71 37.71 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -176.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 198' ' ' ALA . . . . . 0.69 ' N ' HD21 ' B' ' 197' ' ' LEU . . . -64.5 -41.64 96.33 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.496 -178.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 199' ' ' GLN . . . . . 1.049 ' O ' HD23 ' B' ' 197' ' ' LEU . 58.9 tt0 -138.91 164.14 30.46 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 200' ' ' VAL . . . . . 0.438 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 50.2 t -121.36 132.51 70.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 O-C-N 120.688 -1.258 . . . . 0.0 109.433 176.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -90.46 149.42 22.23 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.926 -178.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.44 -32.45 70.22 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.295 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -64.6 -32.65 74.39 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.4 m -60.79 -44.32 96.98 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.274 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 205' ' ' ALA . . . . . 0.623 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -58.69 -29.56 66.73 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -177.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -65.44 -38.59 90.31 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.257 0.551 . . . . 0.0 109.672 176.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -66.89 -37.94 85.33 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.694 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.55 -43.46 98.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 120.528 -0.469 . . . . 0.0 109.808 -178.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 209' ' ' PHE . . . . . 0.623 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 65.3 m-85 -62.17 -43.02 99.75 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 114.195 -1.366 . . . . 0.0 112.767 177.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.42 -41.8 98.71 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.288 -0.965 . . . . 0.0 109.763 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . 0.405 ' O ' ' HG ' ' B' ' 215' ' ' LEU . 39.7 mt -62.27 -42.46 99.36 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.418 -179.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 78.0 p -63.15 -36.06 82.36 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.291 -0.564 . . . . 0.0 112.11 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 213' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -66.89 -46.72 74.06 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.146 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 52.0 tp -63.89 -43.17 96.83 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.765 0.793 . . . . 0.0 109.827 177.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 215' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' B' ' 211' ' ' LEU . 88.9 mt -63.2 -43.76 97.25 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 113.485 -1.689 . . . . 0.0 111.599 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.33 -39.69 91.46 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.879 -176.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 87.1 mt -63.75 -42.05 97.9 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.389 0.614 . . . . 0.0 111.587 176.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 218' ' ' THR . . . . . . . . . . . . . 75.6 p -75.13 -16.41 60.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.106 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 80.85 64.65 1.78 Allowed Glycine 0 CA--C 1.528 0.848 0 N-CA-C 106.577 -2.609 . . . . 0.0 106.577 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 220' ' ' THR . . . . . 0.4 ' O ' ' HB3' ' B' ' 215' ' ' LEU . 98.1 m -142.46 103.23 4.22 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 175.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -61.92 139.36 58.39 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.92 -176.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 42.6 tp -116.3 121.4 41.88 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.231 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 3.2 mp -110.01 128.58 66.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.223 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 224' ' ' ILE . . . . . . . . . . . . . 50.7 mm -108.86 126.05 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.735 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 51.8 p -133.0 157.16 45.89 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.511 0.672 . . . . 0.0 112.714 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 89.16 18.04 54.44 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 113.894 -1.503 . . . . 0.0 110.981 -177.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 227' ' ' ILE . . . . . . . . . . . . . 95.5 mt -82.54 125.69 39.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 121.908 -0.76 . . . . 0.0 111.586 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -65.86 140.31 97.17 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.604 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.78 -37.01 92.28 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 121.358 1.372 . . . . 0.0 112.446 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -64.39 -43.1 95.49 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 51.3 tp -61.62 -41.55 97.63 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.701 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.12 -37.07 86.13 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.756 0.312 . . . . 0.0 111.359 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 93.9 mtp -64.08 -41.17 97.42 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.442 -0.503 . . . . 0.0 109.659 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.79 -43.67 98.19 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 122.204 1.002 . . . . 0.0 109.202 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 37.3 mmt -63.76 -35.73 81.54 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.951 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -61.88 -40.52 95.68 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -178.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.31 -43.45 97.79 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.043 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 51.8 tp -61.68 -45.52 93.66 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 120.26 -0.576 . . . . 0.0 112.228 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 239' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' B' ' 240' ' ' ALA . 66.8 t0 -156.83 135.13 11.31 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 120.39 -0.524 . . . . 0.0 112.034 -179.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 240' ' ' ALA . . . . . 0.435 ' N ' ' OD1' ' B' ' 239' ' ' ASP . . . -62.59 -46.56 87.76 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 176.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 241' ' ' ASN . . . . . 0.534 ' O ' ' HB2' ' B' ' 244' ' ' SER . 92.5 m-20 -43.74 -18.96 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.421 -175.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 242' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -61.91 -45.88 91.77 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.236 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 243' ' ' SER . . . . . 0.41 ' O ' ' N ' ' B' ' 245' ' ' LEU . 77.7 p -57.95 -45.62 86.35 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 244' ' ' SER . . . . . 0.534 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 21.0 m -28.08 -38.47 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' B' ' 243' ' ' SER . 96.9 mt -87.73 138.54 31.38 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 121.521 -0.737 . . . . 0.0 110.489 178.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -66.75 134.93 53.18 Favored 'General case' 0 C--O 1.242 0.662 0 O-C-N 121.82 -0.55 . . . . 0.0 110.742 -174.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 247' ' ' THR . . . . . . . . . . . . . 97.3 m -124.6 126.81 46.4 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.919 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 248' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -111.6 143.14 42.97 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 177.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 249' ' ' SER . . . . . 0.553 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 77.9 p -62.97 -34.75 78.19 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.107 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 250' ' ' ASN . . . . . 0.553 ' OD1' ' O ' ' B' ' 249' ' ' SER . 99.3 m-20 -146.85 159.2 43.82 Favored 'General case' 0 N--CA 1.461 0.121 0 O-C-N 124.243 0.964 . . . . 0.0 112.033 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 79.7 t -64.02 -44.6 97.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.919 178.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 252' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.23 -46.01 92.16 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -178.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 253' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -61.25 -43.75 98.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.821 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 254' ' ' ALA . . . . . 0.444 ' O ' HG21 ' B' ' 257' ' ' VAL . . . -64.9 -40.24 94.78 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.133 178.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 255' ' ' VAL . . . . . 0.742 HG12 ' O ' ' A' ' 153' ' ' ILE . 55.4 t -65.12 -45.54 93.85 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.298 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.7 -47.0 85.54 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 120.286 -0.566 . . . . 0.0 111.335 -178.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 257' ' ' VAL . . . . . 0.452 ' O ' ' C ' ' B' ' 258' ' ' LEU . 28.3 m -65.95 -40.0 86.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.758 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 258' ' ' LEU . . . . . 0.519 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 1.9 mt -33.34 -74.04 0.05 OUTLIER Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.566 -178.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 259' ' ' PRO . . . . . 0.519 ' CD ' ' CB ' ' B' ' 258' ' ' LEU . 37.3 Cg_endo -61.93 141.23 88.79 Favored 'Trans proline' 0 N--CA 1.504 2.122 0 C-N-CA 121.605 1.537 . . . . 0.0 111.463 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 260' ' ' ILE . . . . . 0.492 HG13 ' O ' ' B' ' 259' ' ' PRO . 96.9 mt -159.22 -15.02 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-N 118.73 0.696 . . . . 0.0 112.311 177.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 C--O 1.216 -0.706 0 CA-C-O 117.885 -1.055 . . . . 0.0 111.553 -179.741 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 900' ' ' FMN . . . . . 0.615 HO4' HE22 ' A' ' 66' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 900' ' ' FMN . . . . . 0.656 HO4' HE22 ' B' ' 66' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.48 ' O ' ' OG ' ' A' ' 6' ' ' SER . . . -156.98 169.95 23.64 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 116.65 -1.643 . . . . 0.0 110.19 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.6 p -72.9 -18.81 61.37 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 124.902 1.376 . . . . 0.0 110.808 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -70.59 -67.02 0.53 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 114.444 -1.253 . . . . 0.0 112.189 174.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -66.71 -38.58 87.01 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.48 ' OG ' ' O ' ' A' ' 2' ' ' ALA . 64.1 m -58.97 -41.63 87.97 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 120.441 -0.503 . . . . 0.0 110.306 -177.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.68 ' CE2' HD12 ' A' ' 9' ' ' ILE . 41.1 t80 82.1 86.18 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 O-C-N 123.909 0.756 . . . . 0.0 111.301 176.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.48 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -60.86 -134.78 0.01 OUTLIER Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -177.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.68 HD12 ' CE2' ' A' ' 7' ' ' PHE . 57.2 mt 78.95 108.72 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.695 0 C-N-CA 122.583 0.353 . . . . 0.0 110.775 -178.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -63.31 -22.65 72.09 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.422 1.415 . . . . 0.0 112.134 -178.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.72 -37.83 95.29 Favored Glycine 0 C--O 1.245 0.817 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.766 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.56 -39.07 91.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.359 0.6 . . . . 0.0 109.744 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 49.8 tp -62.95 -41.62 99.56 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -62.61 -39.56 94.17 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 56.2 t -60.74 -44.24 96.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 O-C-N 122.365 -0.21 . . . . 0.0 110.986 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 93.0 mt -62.62 -43.59 98.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.181 -177.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.428 ' NZ ' ' HA ' ' B' ' 6' ' ' SER . 98.9 mttt -62.4 -46.03 90.46 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 119.331 -0.948 . . . . 0.0 112.123 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.653 ' NZ ' HG12 ' B' ' 113' ' ' ILE . 98.6 mttt -60.65 -39.51 88.6 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 118.881 -1.128 . . . . 0.0 109.082 -175.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.8 -42.34 93.23 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.092 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 20' ' ' LEU . 89.3 mt -63.26 -40.97 98.89 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.105 0.479 . . . . 0.0 109.879 178.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.41 -38.86 92.78 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.576 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 53.7 m170 -58.16 -39.83 79.87 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 122.27 -0.268 . . . . 0.0 111.592 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.0 p -114.69 130.23 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.545 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 35.6 ptt180 -72.04 109.32 5.77 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 122.245 1.021 . . . . 0.0 111.945 -177.032 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.5 p -140.21 142.9 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.555 ' O ' ' N ' ' A' ' 123' ' ' GLN . . . -98.18 93.12 1.33 Allowed Glycine 0 C--N 1.313 -0.709 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.215 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 51.6 t -125.15 129.83 73.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 175.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.1 m -136.66 158.82 37.56 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.3 mt -120.21 129.59 75.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 177.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.436 ' HB ' ' OD1' ' A' ' 37' ' ' ASN . 16.5 p -106.39 166.92 10.19 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.503 178.131 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' A' ' 37' ' ' ASN . 45.0 t0 -131.83 104.14 14.3 Favored Pre-proline 0 C--N 1.32 -0.701 0 C-N-CA 120.491 -0.483 . . . . 0.0 110.813 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.52 ' CG ' HG23 ' A' ' 117' ' ' THR . 36.7 Cg_endo -63.93 -23.11 68.36 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.379 1.386 . . . . 0.0 111.605 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.12 -34.38 76.24 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.209 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.8 mt -87.4 165.03 15.88 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.861 177.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.722 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 43.2 tt0 -63.24 132.14 50.71 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -176.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.52 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 57.1 t0 62.32 21.19 12.35 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 177.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.436 ' OD1' ' HB ' ' A' ' 30' ' ' THR . 35.0 t-20 42.73 66.59 4.2 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.816 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.722 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 89.1 Cg_endo -70.67 156.18 61.47 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 123.664 2.909 . . . . 0.0 111.993 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.3 mt -88.05 125.16 41.5 Favored 'Isoleucine or valine' 0 C--O 1.246 0.905 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.376 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.41 HG23 ' N ' ' A' ' 41' ' ' TYR . 27.2 m -105.65 -42.8 7.13 Favored 'Isoleucine or valine' 0 C--N 1.343 0.324 0 O-C-N 123.613 0.571 . . . . 0.0 111.998 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.41 ' N ' HG23 ' A' ' 40' ' ' VAL . 49.4 t80 -96.06 123.75 39.8 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.566 -178.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.1 p -142.67 139.83 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.338 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.573 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 57.6 p30 -97.39 165.12 12.17 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.474 ' HA ' ' OE1' ' A' ' 44' ' ' GLN . 13.2 mm100 -66.09 -38.03 87.26 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 177.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.88 -26.77 63.44 Favored Glycine 0 N--CA 1.453 -0.186 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.667 ' CD2' HD13 ' A' ' 57' ' ' ILE . 71.4 t80 -59.28 -47.58 84.84 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 -179.257 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.686 HG13 ' O ' ' A' ' 52' ' ' TYR . 69.5 t -59.38 -44.69 93.08 Favored 'Isoleucine or valine' 0 C--N 1.349 0.585 0 O-C-N 121.241 -0.912 . . . . 0.0 111.366 -173.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -63.73 -37.84 88.86 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.727 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 59.7 ttm -66.57 -43.82 83.93 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 175.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 36.4 p -91.87 -21.99 20.32 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.126 0.488 . . . . 0.0 111.315 -178.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . 77.83 19.56 75.21 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.686 ' O ' HG13 ' A' ' 47' ' ' VAL . 82.9 m-85 -112.58 139.31 48.27 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 122.868 0.467 . . . . 0.0 111.28 178.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -65.85 149.2 50.57 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.785 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.437 HG22 ' H ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -65.29 -32.32 73.92 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -178.207 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -66.36 -42.48 87.98 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 119.591 -0.843 . . . . 0.0 111.466 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -65.61 -45.1 84.44 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 119.886 -0.725 . . . . 0.0 109.427 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.667 HD13 ' CD2' ' A' ' 46' ' ' PHE . 97.0 mt -62.1 -46.7 95.87 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 C-N-CA 119.85 -0.74 . . . . 0.0 112.47 -174.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.2 mt -60.77 142.8 55.6 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.53 -3.08 87.33 Favored Glycine 0 N--CA 1.464 0.529 0 CA-C-O 119.234 -0.759 . . . . 0.0 112.877 177.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -136.19 152.08 50.4 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.275 1.537 . . . . 0.0 111.682 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.533 ' C ' ' H ' ' A' ' 63' ' ' ARG . 24.9 t-20 -80.27 151.89 29.33 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.194 0.521 . . . . 0.0 110.509 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 85.6 m -64.56 14.15 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.342 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.533 ' H ' ' C ' ' A' ' 61' ' ' ASN . 36.3 ptt-85 -61.14 -40.78 95.12 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 122.073 -0.392 . . . . 0.0 111.354 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -55.12 -22.91 18.47 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -178.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.4 mt -66.04 -36.62 83.74 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.402 0.62 . . . . 0.0 112.636 176.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -61.95 137.87 58.3 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.061 -178.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.498 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -147.63 -147.73 4.6 Favored Glycine 0 CA--C 1.543 1.801 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.096 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.66 -41.2 98.94 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -177.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.59 ' O ' ' NE2' ' A' ' 93' ' ' GLN . 12.5 m80 -76.84 -7.87 56.26 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.245 -177.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.498 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 27.4 m -64.02 129.38 39.81 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.22 -0.592 . . . . 0.0 109.71 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -86.47 111.9 42.57 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.809 -177.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.6 -31.38 91.59 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 121.97 1.78 . . . . 0.0 113.206 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.12 -40.11 95.48 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.111 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.443 ' OE1' ' HB ' ' A' ' 90' ' ' VAL . 78.8 mm-40 -65.31 -43.17 91.88 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.2 t -60.38 -43.69 94.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 114.189 -1.369 . . . . 0.0 107.74 -176.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -64.42 -38.06 89.71 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.646 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -63.49 -39.7 95.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.329 0.585 . . . . 0.0 110.625 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.92 -43.94 97.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.941 177.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -62.53 -42.95 99.86 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 113.925 -1.489 . . . . 0.0 108.287 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 99.3 m -61.24 -49.83 75.53 Favored 'General case' 0 C--O 1.247 0.947 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.8 -41.66 96.06 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 118.646 -0.692 . . . . 0.0 111.598 -169.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.0 mt -63.23 -39.29 94.2 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 118.702 0.683 . . . . 0.0 111.188 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 66.7 tp60 -64.87 -34.35 78.17 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -85.28 -3.54 58.86 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.599 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.2 tttt 48.57 37.59 9.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.679 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -120.64 143.89 37.39 Favored Pre-proline 0 CA--C 1.534 0.364 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -61.8 144.2 96.71 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 121.318 1.345 . . . . 0.0 113.307 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.5 p -139.39 141.39 35.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.805 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.972 HG23 ' OD1' ' A' ' 107' ' ' ASN . 97.4 m -125.64 121.82 34.63 Favored 'General case' 0 C--N 1.344 0.345 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 175.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.443 ' HB ' ' OE1' ' A' ' 74' ' ' GLU . 27.0 m -139.59 158.77 27.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 120.675 0.274 . . . . 0.0 111.274 178.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -104.7 129.25 52.91 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 176.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.426 ' O ' HG23 ' A' ' 92' ' ' ILE . 19.8 tt -138.55 130.46 37.57 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 CA-C-N 120.902 1.683 . . . . 0.0 112.207 178.323 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.59 ' NE2' ' O ' ' A' ' 69' ' ' HIS . 33.7 mt-30 -61.77 137.26 58.23 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.886 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -137.53 158.52 44.22 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.977 -178.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.432 ' CE1' ' HA3' ' A' ' 67' ' ' GLY . 93.9 m-85 -117.82 136.7 53.24 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -178.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.427 ' HG3' ' CE1' ' A' ' 102' ' ' PHE . 99.1 mttt -84.94 -173.52 4.77 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.175 0.512 . . . . 0.0 111.704 -178.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.42 -43.63 98.37 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.155 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 41.1 p-10 -83.81 6.12 22.53 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -178.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.17 -0.31 83.63 Favored Glycine 0 N--CA 1.465 0.609 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.967 176.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 23.0 m -60.65 138.04 58.11 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.664 ' SD ' ' C ' ' A' ' 101' ' ' MET . 13.2 tmm? -104.09 129.03 51.76 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.878 0.37 . . . . 0.0 111.072 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.491 ' N ' ' SD ' ' A' ' 101' ' ' MET . 53.2 p90 -142.65 159.01 43.07 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 120.276 -0.57 . . . . 0.0 109.677 -178.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.832 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 23.6 m95 -90.38 144.29 25.95 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.55 HD21 ' HG2' ' A' ' 123' ' ' GLN . 54.9 t-20 -137.44 106.08 5.86 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -177.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.517 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 80.5 tt0 -72.22 134.34 45.58 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -177.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 40.5 tp -120.05 124.78 46.71 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.972 ' OD1' HG23 ' A' ' 89' ' ' THR . 97.8 m-20 -121.11 122.11 39.34 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 176.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 96.2 mt -119.52 129.12 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 O-C-N 123.43 0.457 . . . . 0.0 111.264 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -138.36 124.57 12.78 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.878 -0.147 . . . . 0.0 110.648 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -70.81 150.27 61.52 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 122.25 1.967 . . . . 0.0 112.54 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.569 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 67.4 mtt -121.59 153.8 37.58 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -127.48 93.96 3.86 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 177.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.442 ' CD1' HG22 ' B' ' 15' ' ' VAL . 96.2 mt -119.93 130.56 74.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.529 -177.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 50.01 37.54 14.32 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 118.746 0.703 . . . . 0.0 111.736 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 59.21 29.94 19.6 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.979 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -127.53 146.61 50.45 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.676 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 5.2 t -82.78 -175.38 5.76 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.279 -0.888 . . . . 0.0 109.471 -178.092 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.676 ' CD2' ' O ' ' A' ' 117' ' ' THR . 73.0 m-85 -168.83 156.18 7.43 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 171.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -129.14 146.31 51.1 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 174.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -135.63 136.88 50.12 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.366 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -111.25 128.48 8.71 Favored Glycine 0 CA--C 1.503 -0.683 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 178.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 96.5 mt -116.99 128.9 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.555 ' N ' ' O ' ' A' ' 26' ' ' GLY . 15.1 mp0 -120.14 116.91 26.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.101 0.477 . . . . 0.0 109.959 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -116.95 114.84 24.4 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.819 -178.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.411 ' OD1' ' OG1' ' A' ' 127' ' ' THR . 68.3 t0 -63.63 125.24 23.64 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -175.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.546 ' O ' HG22 ' A' ' 126' ' ' ILE . 2.7 mp -89.93 1.08 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 CA-C-N 113.887 -1.506 . . . . 0.0 110.457 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.411 ' OG1' ' OD1' ' A' ' 125' ' ' ASP . 18.4 m -60.46 -42.72 96.77 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.257 -0.902 . . . . 0.0 112.716 -177.004 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -60.07 -43.06 95.73 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -178.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -63.28 -39.62 95.1 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.705 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.832 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.7 mttt -62.49 -40.57 97.11 Favored 'General case' 0 CA--C 1.503 -0.854 0 C-N-CA 118.486 -1.286 . . . . 0.0 110.52 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.11 -37.3 84.6 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.837 ' CE2' HD11 ' A' ' 136' ' ' LEU . 90.5 t80 -61.49 -45.26 94.98 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.43 176.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.85 -38.92 92.87 Favored 'General case' 0 C--N 1.342 0.248 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.88 -40.51 95.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.84 0.352 . . . . 0.0 110.15 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 54.5 tp -60.97 -43.6 98.55 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.837 HD11 ' CE2' ' A' ' 132' ' ' TYR . 84.9 mt -62.62 -41.53 99.07 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.196 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.34 -40.62 97.81 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.915 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -60.59 -41.84 95.52 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -177.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 63.3 m -61.33 -40.59 94.81 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.635 176.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 144' ' ' THR . 84.3 mt -63.53 -41.83 98.47 Favored 'General case' 0 C--O 1.221 -0.431 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 90.3 m -61.44 -45.97 92.05 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.295 -177.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.33 -40.14 93.3 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 95.9 mt -64.8 -43.51 96.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 113.781 -1.554 . . . . 0.0 111.281 176.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.504 ' N ' ' O ' ' A' ' 140' ' ' LEU . 90.4 m -62.24 -46.04 90.62 Favored 'General case' 0 C--N 1.344 0.361 0 C-N-CA 120.316 -0.554 . . . . 0.0 112.289 -178.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.06 -39.74 95.63 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 118.815 -1.154 . . . . 0.0 109.017 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.2 mt -63.3 -42.48 99.04 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.756 -0.657 . . . . 0.0 112.517 178.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.753 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.0 p -60.62 -39.95 90.12 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -177.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.495 ' C ' ' O ' ' A' ' 147' ' ' SER . 17.0 m -27.41 79.55 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.428 0 O-C-N 126.617 2.448 . . . . 0.0 106.733 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.753 ' N ' ' O ' ' A' ' 147' ' ' SER . 20.1 Cg_exo -62.89 145.17 94.48 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.007 1.138 . . . . 0.0 114.672 -174.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.584 ' O ' HG23 ' A' ' 151' ' ' VAL . 8.8 tp -120.57 135.45 60.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 103.124 -2.917 . . . . 0.0 103.124 175.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 150' ' ' ILE . 92.3 t -167.73 90.93 0.69 Allowed Pre-proline 0 CA--C 1.516 -0.355 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 178.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -61.39 137.34 69.47 Favored 'Trans proline' 0 C--N 1.3 -2.006 0 N-CA-C 109.465 -1.013 . . . . 0.0 109.465 -176.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.643 ' O ' ' HD2' ' A' ' 154' ' ' ARG . 45.6 mm -67.47 -44.43 86.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 119.746 -0.782 . . . . 0.0 111.069 179.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.643 ' HD2' ' O ' ' A' ' 153' ' ' ILE . 0.3 OUTLIER -159.12 -154.89 0.44 Allowed 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.082 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 63.0 t-20 -87.89 104.37 16.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 122.189 0.995 . . . . 0.0 111.897 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 89.91 8.61 66.96 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 114.243 -1.344 . . . . 0.0 111.022 -177.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.505 HG22 ' HB ' ' A' ' 153' ' ' ILE . 96.7 mt -124.09 125.71 71.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 CA-C-O 121.748 0.785 . . . . 0.0 109.477 174.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.656 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 57.8 m -132.82 151.47 52.01 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.276 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -138.96 141.96 38.4 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.546 -0.721 . . . . 0.0 111.244 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 25.9 tp -133.15 80.2 60.01 Favored Pre-proline 0 N--CA 1.471 0.581 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.141 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -69.65 149.18 67.24 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.778 2.319 . . . . 0.0 113.137 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 86.6 mt -116.99 126.13 52.44 Favored 'General case' 0 C--O 1.25 1.116 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.393 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 47.3 t -123.47 131.48 73.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 115.0 169.61 16.07 Favored Glycine 0 N--CA 1.479 1.537 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.93 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.779 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 54.2 t30 -84.96 113.14 21.19 Favored 'General case' 0 C--O 1.213 -0.835 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.52 HD21 ' CZ ' ' A' ' 171' ' ' PHE . 44.8 tp -73.66 103.48 4.26 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -177.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.67 HG23 ' HE ' ' A' ' 170' ' ' ARG . 9.8 p -86.82 167.34 14.47 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.557 178.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.22 -33.82 76.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.411 0.624 . . . . 0.0 111.6 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.1 -43.39 92.25 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.595 178.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.779 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 88.0 mtm180 -64.66 -31.22 72.35 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.134 0.974 . . . . 0.0 112.051 177.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.52 ' CZ ' HD21 ' A' ' 166' ' ' LEU . 0.5 OUTLIER -55.1 -29.38 57.5 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.564 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.578 ' O ' HG22 ' A' ' 175' ' ' VAL . 92.2 m-20 -61.12 -40.46 93.86 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 119.038 -1.065 . . . . 0.0 109.679 -177.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 52.6 m -59.71 -41.02 89.88 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.443 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 66.1 mt -63.35 -44.07 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.578 HG22 ' O ' ' A' ' 172' ' ' ASN . 26.8 m -62.57 -39.81 85.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 98.5 m -62.86 -35.16 79.05 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.303 0.573 . . . . 0.0 110.416 178.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.492 ' O ' HG13 ' A' ' 181' ' ' ILE . 25.0 m -61.7 -19.44 62.38 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.201 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.683 ' CD2' HD21 ' A' ' 211' ' ' LEU . 87.8 mt -60.97 -41.43 96.36 Favored 'General case' 0 C--O 1.247 0.967 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 -177.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 19.2 m -59.63 -42.94 93.83 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ASN . . . . . 0.587 ' O ' ' OG ' ' A' ' 183' ' ' SER . 92.1 m-20 -61.43 -37.67 84.35 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 122.588 0.355 . . . . 0.0 110.983 178.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.516 HD12 ' HA ' ' A' ' 178' ' ' LEU . 67.6 mt -58.56 -37.71 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 O-C-N 121.685 -0.634 . . . . 0.0 109.476 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 85.0 mt -60.9 -40.34 92.71 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 119.418 -0.913 . . . . 0.0 108.833 -177.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.587 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 77.8 p -62.01 -33.86 75.13 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.528 176.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 59.3 p -89.37 23.36 2.56 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 120.752 0.31 . . . . 0.0 111.66 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 78.1 p -63.0 -20.54 65.39 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.775 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.71 -37.56 82.1 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.793 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.656 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 98.7 m-20 -73.3 115.05 12.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.424 0.631 . . . . 0.0 110.902 -179.087 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.92 -42.56 99.84 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.045 -0.98 . . . . 0.0 113.03 -177.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -113.78 131.52 56.19 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.266 0.555 . . . . 0.0 110.779 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 38.9 tp -120.0 127.07 52.28 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 92.2 mt -114.27 127.15 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 118.658 0.663 . . . . 0.0 109.607 177.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.7 mm -112.23 126.71 69.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' ASP . . . . . 0.525 ' CG ' ' HG ' ' A' ' 195' ' ' SER . 39.0 t0 -94.66 118.27 31.45 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 122.046 0.927 . . . . 0.0 110.78 177.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 95.9 mt -98.56 -3.49 36.25 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.392 175.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' SER . . . . . 0.525 ' HG ' ' CG ' ' A' ' 193' ' ' ASP . 78.0 p -62.69 -33.7 75.62 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.629 0.604 . . . . 0.0 112.629 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.78 -43.63 98.98 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 108.491 -1.844 . . . . 0.0 108.491 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.936 HD23 ' N ' ' A' ' 198' ' ' ALA . 4.9 tt -70.0 129.15 38.68 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 113.104 -1.548 . . . . 0.0 108.584 -176.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.936 ' N ' HD23 ' A' ' 197' ' ' LEU . . . -60.24 -50.56 73.18 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.242 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.912 ' O ' ' CD2' ' A' ' 197' ' ' LEU . 58.4 tt0 -132.29 157.01 45.53 Favored 'General case' 0 C--O 1.204 -1.322 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -175.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.451 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 47.1 t -117.16 132.1 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 O-C-N 120.306 -1.496 . . . . 0.0 108.889 177.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -83.73 154.92 23.34 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.572 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -64.65 -39.2 93.27 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.123 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -58.26 -31.97 67.93 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 17.5 m -60.39 -41.86 94.69 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.563 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.497 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -57.22 -38.64 74.05 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -177.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -62.63 -37.01 84.61 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -64.76 -38.91 92.58 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.967 177.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 94.6 mt -63.47 -44.51 98.85 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.079 0 C-N-CA 119.598 -0.841 . . . . 0.0 108.982 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' PHE . . . . . 0.497 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 72.0 m-85 -61.53 -44.11 97.65 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.691 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.0 -41.87 98.53 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 119.347 -0.941 . . . . 0.0 109.363 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.683 HD21 ' CD2' ' A' ' 178' ' ' LEU . 38.8 mt -62.66 -42.08 99.42 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 78.1 p -61.99 -41.6 98.21 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 119.351 -0.939 . . . . 0.0 110.151 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -65.11 -45.36 85.44 Favored 'General case' 0 C--O 1.233 0.203 0 O-C-N 121.942 -0.474 . . . . 0.0 111.713 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 50.8 tp -62.36 -44.64 96.0 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 211' ' ' LEU . 85.8 mt -63.03 -40.54 98.04 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.705 -177.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.6 -44.26 96.48 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 90.5 mt -61.99 -39.81 93.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.09 0.472 . . . . 0.0 109.749 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 68.5 p -75.94 -10.96 59.85 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.308 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.63 37.39 14.0 Favored Glycine 0 C--O 1.219 -0.808 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.906 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 96.3 m -124.73 111.15 15.22 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.714 1.257 . . . . 0.0 111.309 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -62.31 138.44 58.43 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.548 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 48.0 tp -114.14 130.58 56.59 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 122.849 0.46 . . . . 0.0 109.874 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 3.3 mp -119.04 135.04 60.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.672 ' CG2' HD11 ' A' ' 227' ' ' ILE . 49.7 mm -115.14 132.24 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 38.5 p -133.57 166.8 21.74 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.863 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 78.09 19.61 74.49 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.684 -0.967 . . . . 0.0 110.684 178.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.672 HD11 ' CG2' ' A' ' 224' ' ' ILE . 97.4 mt -81.96 129.32 37.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 114.14 -1.03 . . . . 0.0 108.879 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 56.9 tttt -75.3 139.23 71.78 Favored Pre-proline 0 CA--C 1.533 0.31 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.58 -39.66 87.47 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.134 1.223 . . . . 0.0 112.526 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -62.83 -40.31 97.0 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-O 121.88 0.848 . . . . 0.0 110.262 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 49.0 tp -63.76 -42.05 97.89 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.543 176.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.31 -37.93 89.17 Favored 'General case' 0 N--CA 1.462 0.16 0 O-C-N 121.938 -0.476 . . . . 0.0 111.273 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 94.1 mtp -63.78 -41.15 98.0 Favored 'General case' 0 C--O 1.247 0.936 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.48 -38.86 92.76 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.594 177.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 32.4 mmt -65.68 -37.4 86.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.716 178.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -60.82 -41.67 96.17 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 121.558 -0.714 . . . . 0.0 109.371 -177.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.24 -41.55 97.07 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.527 0.68 . . . . 0.0 110.58 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 54.3 tp -63.02 -41.67 99.61 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 177.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 240' ' ' ALA . 67.0 t0 -166.81 128.91 1.74 Allowed 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.417 -0.802 . . . . 0.0 112.656 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.402 ' N ' ' OD1' ' A' ' 239' ' ' ASP . . . -61.19 -27.88 68.74 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.853 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.415 ' O ' ' HB2' ' A' ' 244' ' ' SER . 88.2 m-20 -60.92 -28.96 69.31 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.537 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -55.98 -43.81 77.97 Favored 'General case' 0 C--N 1.316 -0.881 0 O-C-N 121.235 -0.916 . . . . 0.0 109.048 -176.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 88.4 p -63.48 -19.27 64.6 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.039 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' SER . . . . . 0.415 ' HB2' ' O ' ' A' ' 241' ' ' ASN . 43.4 m -55.31 -38.4 68.62 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.259 178.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 96.8 mt -87.8 124.72 33.91 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 119.794 -0.762 . . . . 0.0 112.687 -176.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -49.19 134.62 17.73 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.903 -176.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.581 HG23 HD12 ' A' ' 227' ' ' ILE . 95.5 m -126.61 132.01 51.36 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.215 -1.357 . . . . 0.0 111.364 178.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 248' ' ' TYR . . . . . 0.505 ' CG ' ' HB2' ' A' ' 254' ' ' ALA . 96.0 m-85 -116.07 140.98 48.73 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.331 178.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 249' ' ' SER . . . . . 0.448 ' O ' ' OD1' ' A' ' 250' ' ' ASN . 78.1 p -60.59 -41.94 95.73 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.448 ' OD1' ' O ' ' A' ' 249' ' ' SER . 99.2 m-20 -145.45 159.63 42.8 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.613 0.72 . . . . 0.0 111.069 -178.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 251' ' ' VAL . . . . . 0.403 ' O ' HG23 ' A' ' 255' ' ' VAL . 66.0 t -61.99 -44.72 99.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 114.632 -1.167 . . . . 0.0 112.085 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.31 -43.8 98.27 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' ASP . . . . . 0.464 ' O ' HG22 ' A' ' 257' ' ' VAL . 54.0 m-20 -64.13 -42.4 96.83 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.216 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 254' ' ' ALA . . . . . 0.505 ' HB2' ' CG ' ' A' ' 248' ' ' TYR . . . -64.96 -41.81 95.14 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.973 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 255' ' ' VAL . . . . . 0.661 HG13 HH11 ' B' ' 154' ' ' ARG . 73.3 t -63.08 -45.59 98.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.009 -178.259 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.93 -47.72 79.38 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.562 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.506 ' O ' ' C ' ' A' ' 258' ' ' LEU . 27.6 m -66.75 -41.67 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 120.138 -0.625 . . . . 0.0 112.403 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.506 ' C ' ' O ' ' A' ' 257' ' ' VAL . 1.3 mt -28.37 -72.93 0.05 OUTLIER Pre-proline 0 C--N 1.346 0.452 0 CA-C-O 119.562 -0.256 . . . . 0.0 111.248 -177.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 259' ' ' PRO . . . . . 0.475 ' CD ' ' CB ' ' A' ' 258' ' ' LEU . 45.4 Cg_endo -64.13 140.43 71.61 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.005 1.137 . . . . 0.0 112.073 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 259' ' ' PRO . 96.8 mt -152.74 -27.12 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 178.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 N--CA 1.473 0.68 0 CA-C-O 118.159 -0.924 . . . . 0.0 110.622 -177.017 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.493 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.83 158.94 29.25 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 118.728 -0.653 . . . . 0.0 109.933 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 80.7 p -58.88 -25.08 63.01 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 124.177 0.923 . . . . 0.0 110.908 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -68.88 -63.31 1.08 Allowed 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.521 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -67.18 -38.09 84.8 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.496 178.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 6' ' ' SER . . . . . 0.483 ' O ' ' HB3' ' B' ' 7' ' ' PHE . 66.3 m -59.69 -42.53 93.14 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 120.442 -0.503 . . . . 0.0 109.906 -177.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 7' ' ' PHE . . . . . 0.687 ' CE2' HD12 ' B' ' 9' ' ' ILE . 41.7 t80 83.08 88.19 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 O-C-N 123.904 0.753 . . . . 0.0 110.293 177.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 8' ' ' GLY . . . . . 0.496 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -62.42 -134.98 0.01 OUTLIER Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -178.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.687 HD12 ' CE2' ' B' ' 7' ' ' PHE . 56.4 mt 79.25 108.54 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.656 0 C-N-CA 122.546 0.338 . . . . 0.0 111.059 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -62.45 -24.25 75.41 Favored 'Trans proline' 0 N--CA 1.498 1.793 0 C-N-CA 121.428 1.419 . . . . 0.0 111.792 -178.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.92 -40.45 98.88 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -64.18 -38.94 92.87 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.742 0.782 . . . . 0.0 109.626 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 51.1 tp -62.25 -42.55 99.43 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 114.757 -1.11 . . . . 0.0 112.114 -177.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -64.54 -33.33 75.66 Favored 'General case' 0 CA--C 1.563 1.466 0 CA-C-O 121.628 0.727 . . . . 0.0 110.759 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 15' ' ' VAL . . . . . 0.442 HG22 ' CD1' ' A' ' 113' ' ' ILE . 74.1 t -61.9 -46.16 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 113.094 -1.867 . . . . 0.0 111.108 176.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 94.7 mt -63.76 -43.79 98.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.07 0.462 . . . . 0.0 110.255 -178.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 17' ' ' LYS . . . . . 0.47 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 98.9 mttt -63.42 -42.51 98.73 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.41 -41.07 98.72 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.065 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.67 -39.1 87.16 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.689 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' B' ' 20' ' ' LEU . 89.3 mt -64.07 -42.0 97.15 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.05 0.452 . . . . 0.0 110.234 175.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.95 -39.2 93.91 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.121 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 52.4 m170 -57.61 -40.14 78.47 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 121.192 -0.203 . . . . 0.0 111.365 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 10.6 p -114.28 130.27 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.551 ' HG3' ' O ' ' B' ' 24' ' ' ARG . 35.5 ptt180 -71.57 107.15 4.31 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 122.176 0.989 . . . . 0.0 112.392 -177.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.0 p -142.04 133.61 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.497 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 26' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' B' ' 123' ' ' GLN . . . -89.45 97.03 2.28 Favored Glycine 0 N--CA 1.434 -1.451 0 C-N-CA 119.441 -1.361 . . . . 0.0 113.326 -175.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 50.0 t -125.43 129.4 72.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 174.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 27.3 m -138.11 156.48 30.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.803 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.41 ' HB ' ' HB3' ' B' ' 41' ' ' TYR . 95.5 mt -119.43 127.87 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 122.579 1.18 . . . . 0.0 111.17 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.447 ' HB ' ' OD1' ' B' ' 37' ' ' ASN . 18.3 p -111.57 157.73 20.03 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 113.07 -1.877 . . . . 0.0 108.27 -176.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -125.38 104.4 28.5 Favored Pre-proline 0 C--O 1.24 0.569 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.12 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 32' ' ' PRO . . . . . 0.432 ' CG ' HG23 ' B' ' 117' ' ' THR . 37.4 Cg_endo -64.76 -20.56 64.97 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 121.678 1.585 . . . . 0.0 111.564 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.37 -42.68 99.6 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.048 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 96.3 mt -74.97 -175.48 2.58 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 121.833 -0.542 . . . . 0.0 111.243 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 35' ' ' GLU . . . . . 0.713 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 42.6 tt0 -78.9 130.93 36.16 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.46 ' O ' ' OD1' ' B' ' 36' ' ' ASP . 62.4 t0 56.37 36.26 27.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.661 177.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 37' ' ' ASN . . . . . 0.447 ' OD1' ' HB ' ' B' ' 30' ' ' THR . 23.1 t-20 31.89 68.68 0.83 Allowed Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.713 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 91.4 Cg_endo -72.08 155.69 56.68 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 C-N-CA 123.332 2.688 . . . . 0.0 111.569 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 96.3 mt -87.35 129.5 38.67 Favored 'Isoleucine or valine' 0 C--O 1.247 0.943 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.406 HG23 ' N ' ' B' ' 41' ' ' TYR . 26.8 m -109.32 -42.31 5.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 O-C-N 123.943 0.777 . . . . 0.0 112.478 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 41' ' ' TYR . . . . . 0.41 ' HB3' ' HB ' ' B' ' 29' ' ' ILE . 51.9 t80 -96.99 123.91 40.83 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.4 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 5.3 p -142.6 140.37 28.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.446 177.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 43' ' ' ASN . . . . . 0.607 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 57.5 p30 -100.72 160.98 13.92 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.162 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 44' ' ' GLN . . . . . 0.468 ' OE1' ' HA ' ' B' ' 44' ' ' GLN . 12.8 mm100 -62.98 -36.95 85.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.66 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.07 -27.04 64.27 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.681 ' CD2' HD13 ' B' ' 57' ' ' ILE . 65.9 t80 -60.37 -43.09 96.9 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 0.807 HG13 ' O ' ' B' ' 52' ' ' TYR . 76.9 t -61.07 -46.16 97.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.231 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -63.31 -43.73 97.0 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 119.896 -0.721 . . . . 0.0 110.317 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 59.7 ttm -63.41 -42.48 98.75 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 35.0 p -95.15 -16.55 22.49 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.609 -178.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 51' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' B' ' 47' ' ' VAL . . . 74.45 17.19 79.79 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 178.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 52' ' ' TYR . . . . . 0.807 ' O ' HG13 ' B' ' 47' ' ' VAL . 83.8 m-85 -109.94 145.19 37.32 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 122.953 0.501 . . . . 0.0 110.328 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -75.24 148.34 39.55 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 121.254 0.549 . . . . 0.0 111.24 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 54' ' ' THR . . . . . 0.428 HG22 ' H ' ' B' ' 54' ' ' THR . 0.2 OUTLIER -60.96 -37.21 81.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.866 -176.75 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.5 -39.75 95.27 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.993 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -72.1 -33.3 67.76 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 176.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.681 HD13 ' CD2' ' B' ' 46' ' ' PHE . 94.9 mt -68.02 -59.36 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.08 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 95.9 mt -53.14 134.69 38.61 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -175.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.4 -8.34 74.97 Favored Glycine 0 CA--C 1.538 1.498 0 CA-C-N 116.166 -0.47 . . . . 0.0 113.032 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -133.16 149.05 52.08 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -175.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 61' ' ' ASN . . . . . 0.548 ' C ' ' H ' ' B' ' 63' ' ' ARG . 24.8 t-20 -78.44 150.06 33.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.517 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 62' ' ' CYS . . . . . . . . . . . . . 82.5 m -63.42 9.23 0.06 Allowed 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 63' ' ' ARG . . . . . 0.548 ' H ' ' C ' ' B' ' 61' ' ' ASN . 34.8 ptt-85 -60.54 -32.93 71.96 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.42 -176.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -58.5 -30.61 67.17 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 86.6 mt -62.02 -41.26 97.89 Favored 'General case' 0 C--O 1.238 0.463 0 O-C-N 121.757 -0.59 . . . . 0.0 109.742 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -51.71 145.31 9.53 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.851 -175.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 67' ' ' GLY . . . . . 0.448 ' HA3' ' CE1' ' B' ' 95' ' ' TYR . . . -157.03 -153.9 6.85 Favored Glycine 0 CA--C 1.535 1.318 0 O-C-N 124.259 0.974 . . . . 0.0 111.774 177.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.26 -41.7 89.45 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -175.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 69' ' ' HIS . . . . . 0.506 ' O ' ' NE2' ' B' ' 93' ' ' GLN . 11.1 m80 -76.07 -9.84 58.94 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.139 -177.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 70' ' ' THR . . . . . 0.426 ' OG1' ' N ' ' B' ' 67' ' ' GLY . 26.2 m -61.89 134.03 56.17 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.517 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -90.45 112.16 51.37 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.518 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.62 -37.96 90.88 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 121.185 1.257 . . . . 0.0 111.856 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.97 -40.07 92.01 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 120.42 -0.512 . . . . 0.0 109.761 -175.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 74' ' ' GLU . . . . . 0.445 ' OE1' ' HB ' ' B' ' 90' ' ' VAL . 78.8 mm-40 -66.76 -38.81 87.35 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.001 177.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 70.1 t -62.43 -46.06 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -62.94 -37.46 87.13 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.667 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -62.12 -41.8 98.6 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 119.315 -0.954 . . . . 0.0 108.874 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 94.1 mt -63.49 -43.7 98.48 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 CA-C-O 120.81 0.338 . . . . 0.0 110.907 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -61.38 -43.21 99.25 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 88.4 m -61.75 -45.16 95.11 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.59 0.71 . . . . 0.0 110.171 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.36 -41.83 98.92 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 86.9 mt -62.7 -42.53 99.69 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.516 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 66.8 tp60 -62.78 -34.01 76.35 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -90.78 6.86 42.52 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.414 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 30.8 tttt 42.46 37.99 1.11 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.969 176.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -121.94 141.28 33.76 Favored Pre-proline 0 N--CA 1.467 0.42 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.222 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.1 141.38 88.45 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.075 1.183 . . . . 0.0 113.754 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.5 p -139.81 136.11 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.942 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 89' ' ' THR . . . . . 0.965 HG23 ' OD1' ' B' ' 107' ' ' ASN . 96.5 m -121.05 122.6 40.43 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.445 ' HB ' ' OE1' ' B' ' 74' ' ' GLU . 27.3 m -138.92 162.86 27.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.913 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -115.38 121.51 43.01 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.978 -0.451 . . . . 0.0 109.819 174.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 21.3 tt -129.83 132.69 65.66 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 O-C-N 124.191 0.932 . . . . 0.0 111.623 -174.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 93' ' ' GLN . . . . . 0.506 ' NE2' ' O ' ' B' ' 69' ' ' HIS . 34.2 mt-30 -69.78 143.33 53.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.97 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 94' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -133.2 177.31 7.77 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 121.718 0.77 . . . . 0.0 111.43 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 95' ' ' TYR . . . . . 0.448 ' CE1' ' HA3' ' B' ' 67' ' ' GLY . 96.5 m-85 -127.27 146.57 50.39 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.267 -1.333 . . . . 0.0 112.293 176.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 96' ' ' LYS . . . . . 0.416 ' HG3' ' CE1' ' B' ' 102' ' ' PHE . 98.7 mttt -101.11 -179.88 4.17 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.338 0.589 . . . . 0.0 110.584 177.159 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.87 -36.56 79.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.306 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 38.9 p-10 -87.09 -0.44 56.66 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.466 -0.771 . . . . 0.0 112.912 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.65 3.25 64.6 Favored Glycine 0 N--CA 1.467 0.714 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.528 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 25.4 m -67.16 131.01 44.94 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 101' ' ' MET . . . . . 0.597 ' SD ' ' N ' ' B' ' 102' ' ' PHE . 14.6 tmm? -90.83 141.86 28.38 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 102' ' ' PHE . . . . . 0.597 ' N ' ' SD ' ' B' ' 101' ' ' MET . 53.4 p90 -153.35 163.94 39.02 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 177.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 103' ' ' TRP . . . . . 0.853 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 23.3 m95 -96.16 140.8 30.33 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.825 0.821 . . . . 0.0 110.428 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 104' ' ' ASN . . . . . 0.515 HD21 ' HG2' ' B' ' 123' ' ' GLN . 63.2 t-20 -132.97 109.46 9.58 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 114.806 -1.088 . . . . 0.0 113.476 -177.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 105' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' B' ' 123' ' ' GLN . 81.0 tt0 -78.78 123.11 26.86 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.221 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 41.1 tp -112.27 126.56 55.37 Favored 'General case' 0 C--N 1.346 0.445 0 CA-C-O 120.873 0.368 . . . . 0.0 111.874 -177.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 107' ' ' ASN . . . . . 0.965 ' OD1' HG23 ' B' ' 89' ' ' THR . 97.8 m-20 -120.37 126.92 51.71 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 175.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 96.4 mt -121.9 133.15 69.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.53 123.3 7.61 Favored Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 178.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -69.04 151.82 73.13 Favored 'Trans proline' 0 N--CA 1.501 1.941 0 C-N-CA 122.411 2.074 . . . . 0.0 112.471 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 111' ' ' MET . . . . . 0.477 ' HB2' ' HB2' ' B' ' 118' ' ' TYR . 67.2 mtt -128.59 143.66 51.0 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.215 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -113.24 106.59 14.81 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 106.074 -1.825 . . . . 0.0 106.074 179.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 113' ' ' ILE . . . . . 0.653 HG12 ' NZ ' ' A' ' 18' ' ' LYS . 96.8 mt -133.15 127.06 54.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-N 118.474 0.579 . . . . 0.0 111.525 178.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 52.48 37.86 24.0 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.026 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 59.92 36.03 21.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.707 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -132.68 150.2 52.19 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 177.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 117' ' ' THR . . . . . 0.432 HG23 ' CG ' ' B' ' 32' ' ' PRO . 6.9 t -100.45 153.52 19.28 Favored 'General case' 0 C--O 1.217 -0.62 0 C-N-CA 120.555 -0.458 . . . . 0.0 109.908 -177.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 118' ' ' TYR . . . . . 0.477 ' HB2' ' HB2' ' B' ' 111' ' ' MET . 90.7 m-85 -148.43 146.37 28.4 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 121.071 -1.018 . . . . 0.0 111.182 -178.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -122.59 138.6 54.53 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 120.66 0.267 . . . . 0.0 111.198 -176.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.7 p -129.28 135.8 60.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -177.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -112.59 122.74 6.02 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 89.1 mt -111.71 127.31 68.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 123' ' ' GLN . . . . . 0.515 ' HG2' HD21 ' B' ' 104' ' ' ASN . 15.3 mp0 -118.61 122.96 43.83 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -119.92 123.6 43.97 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 125' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' B' ' 127' ' ' THR . 67.2 t0 -70.37 129.05 38.27 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.634 -178.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.562 ' O ' ' HG3' ' B' ' 130' ' ' LYS . 2.7 mp -102.61 15.55 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.837 0 CA-C-O 122.052 0.93 . . . . 0.0 109.278 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 127' ' ' THR . . . . . 0.479 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 19.5 m -63.13 -44.63 95.05 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 114.225 -1.352 . . . . 0.0 113.013 175.041 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -61.34 -46.1 91.64 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 129' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -63.69 -35.16 79.64 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.548 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 130' ' ' LYS . . . . . 0.853 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 98.7 mttt -63.73 -40.6 97.14 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 113.865 -1.516 . . . . 0.0 110.547 174.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.41 -41.38 96.66 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 132' ' ' TYR . . . . . 0.821 ' CE2' HD11 ' B' ' 136' ' ' LEU . 90.1 t80 -60.56 -44.16 96.46 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 121.693 -0.629 . . . . 0.0 111.066 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.0 -36.73 84.94 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 120.328 -0.549 . . . . 0.0 109.548 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.2 -39.54 94.94 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.881 178.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 54.1 tp -62.59 -41.3 98.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.187 0.518 . . . . 0.0 109.741 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 136' ' ' LEU . . . . . 0.821 HD11 ' CE2' ' B' ' 132' ' ' TYR . 86.9 mt -62.9 -41.89 99.6 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.27 177.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 137' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.56 -36.78 84.79 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.466 -1.243 . . . . 0.0 110.432 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.05 -43.01 99.82 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.896 177.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 70.1 m -60.74 -44.38 96.75 Favored 'General case' 0 C--N 1.343 0.323 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 140' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' B' ' 144' ' ' THR . 84.2 mt -61.04 -40.25 92.88 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -177.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 91.3 m -61.85 -45.46 93.71 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.91 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -66.33 -42.12 88.63 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 93.7 mt -63.67 -43.17 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.714 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 144' ' ' THR . . . . . 0.443 ' N ' ' O ' ' B' ' 140' ' ' LEU . 90.2 m -61.75 -45.24 94.77 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.56 -40.59 97.38 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 119.074 -1.051 . . . . 0.0 109.412 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 86.1 mt -64.49 -41.51 96.41 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 147' ' ' SER . . . . . 0.641 ' O ' ' N ' ' B' ' 149' ' ' PRO . 78.1 p -60.89 -42.77 98.65 Favored 'General case' 0 CA--C 1.48 -1.726 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 148' ' ' THR . . . . . 0.494 ' C ' ' O ' ' B' ' 147' ' ' SER . 6.8 m -27.8 84.75 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.592 0 O-C-N 124.105 0.878 . . . . 0.0 110.158 177.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 149' ' ' PRO . . . . . 0.641 ' N ' ' O ' ' B' ' 147' ' ' SER . 23.0 Cg_exo -62.34 147.59 94.69 Favored 'Trans proline' 0 C--N 1.296 -2.213 0 C-N-CA 122.234 1.956 . . . . 0.0 115.641 -177.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 9.1 tp -127.74 120.17 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-N 114.004 -1.453 . . . . 0.0 107.867 174.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 63.8 t -150.71 92.95 3.82 Favored Pre-proline 0 C--N 1.314 -0.936 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.992 -178.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -60.77 137.16 71.06 Favored 'Trans proline' 0 N--CA 1.484 0.952 0 N-CA-C 109.175 -1.125 . . . . 0.0 109.175 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 153' ' ' ILE . . . . . 0.64 ' O ' ' HD2' ' B' ' 154' ' ' ARG . 45.2 mm -67.66 -43.9 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.17 178.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 154' ' ' ARG . . . . . 0.661 HH11 HG13 ' A' ' 255' ' ' VAL . 0.3 OUTLIER -158.82 -154.01 0.4 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -179.618 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 62.3 t-20 -86.89 108.49 18.8 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.69 -16.38 58.75 Favored Glycine 0 C--O 1.221 -0.713 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 157' ' ' ILE . . . . . 0.509 HG22 ' HB ' ' B' ' 153' ' ' ILE . 89.0 mt -110.13 125.59 67.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.326 0.584 . . . . 0.0 111.37 -176.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 158' ' ' SER . . . . . 0.631 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 68.3 m -134.7 148.91 50.41 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.096 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -134.45 145.45 48.86 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.226 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 30.3 tp -138.45 79.25 30.56 Favored Pre-proline 0 C--O 1.234 0.283 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 161' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -70.54 146.99 56.87 Favored 'Trans proline' 0 N--CA 1.5 1.869 0 C-N-CA 122.831 2.354 . . . . 0.0 114.4 -178.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 87.0 mt -112.51 132.97 54.82 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 54.2 t -128.55 132.79 67.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 113.23 169.1 17.17 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 120.35 -0.929 . . . . 0.0 111.266 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 165' ' ' ASN . . . . . 0.688 ' O ' ' CZ ' ' B' ' 170' ' ' ARG . 61.9 t30 -89.62 107.02 18.85 Favored 'General case' 0 C--O 1.215 -0.752 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -177.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 166' ' ' LEU . . . . . 0.508 HD21 ' CZ ' ' B' ' 171' ' ' PHE . 46.7 tp -65.86 104.49 1.1 Allowed 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 -174.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 167' ' ' THR . . . . . 0.647 HG23 ' HE ' ' B' ' 170' ' ' ARG . 9.8 p -85.37 169.97 13.18 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 114.271 -1.331 . . . . 0.0 110.901 177.207 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.84 -37.39 84.38 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.718 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.34 -41.24 89.85 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-O 123.44 1.591 . . . . 0.0 111.508 -178.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 170' ' ' ARG . . . . . 0.688 ' CZ ' ' O ' ' B' ' 165' ' ' ASN . 88.3 mtm180 -62.58 -35.28 79.01 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 112.276 -2.238 . . . . 0.0 110.653 177.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 171' ' ' PHE . . . . . 0.508 ' CZ ' HD21 ' B' ' 166' ' ' LEU . 0.5 OUTLIER -54.9 -26.25 34.59 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -178.736 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 172' ' ' ASN . . . . . 0.531 ' O ' HG22 ' B' ' 175' ' ' VAL . 92.7 m-20 -62.88 -40.3 97.12 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.784 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 48.8 m -60.17 -41.77 93.57 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.051 0.453 . . . . 0.0 110.63 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 64.8 mt -63.43 -44.29 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 175' ' ' VAL . . . . . 0.531 HG22 ' O ' ' B' ' 172' ' ' ASN . 27.3 m -62.44 -39.81 85.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 176' ' ' CYS . . . . . . . . . . . . . 96.7 m -62.69 -35.58 80.14 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.344 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 177' ' ' THR . . . . . 0.527 ' O ' HG13 ' B' ' 181' ' ' ILE . 25.1 m -61.69 -19.42 62.34 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.499 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 178' ' ' LEU . . . . . 0.656 ' CD2' HD21 ' B' ' 211' ' ' LEU . 88.2 mt -61.23 -39.36 90.01 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -178.223 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 19.2 m -61.77 -44.03 97.69 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 120.74 0.305 . . . . 0.0 110.262 177.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 180' ' ' ASN . . . . . 0.587 ' O ' ' OG ' ' B' ' 183' ' ' SER . 92.6 m-20 -61.27 -40.22 93.29 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.853 0.358 . . . . 0.0 110.494 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.527 HG13 ' O ' ' B' ' 177' ' ' THR . 72.7 mt -57.47 -32.0 40.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 O-C-N 122.284 -0.26 . . . . 0.0 110.753 -178.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 182' ' ' LEU . . . . . . . . . . . . . 83.9 mt -62.38 -41.99 99.07 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.096 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 183' ' ' SER . . . . . 0.587 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.4 p -63.28 -32.84 74.35 Favored 'General case' 0 C--N 1.334 -0.106 0 O-C-N 121.835 -0.54 . . . . 0.0 110.865 178.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 56.8 p -85.87 17.34 3.49 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.787 -177.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 78.8 p -61.5 -16.39 46.92 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.523 -176.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.17 -40.17 95.1 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 121.076 -0.25 . . . . 0.0 110.764 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 187' ' ' ASP . . . . . 0.631 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.6 m-20 -70.43 114.95 9.05 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.44 0.638 . . . . 0.0 110.635 -177.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -62.63 -42.6 99.68 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 114.922 -1.035 . . . . 0.0 113.112 -177.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -113.55 131.38 56.11 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.149 -177.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 190' ' ' LEU . . . . . . . . . . . . . 40.7 tp -123.29 119.37 29.93 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.089 177.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 84.5 mt -107.43 125.08 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 117.851 0.296 . . . . 0.0 110.89 -176.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 50.1 mm -113.7 118.83 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 193' ' ' ASP . . . . . 0.475 ' CG ' ' HG ' ' B' ' 195' ' ' SER . 41.5 t0 -90.29 112.17 23.62 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -176.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 194' ' ' LEU . . . . . . . . . . . . . 96.6 mt -94.71 -1.89 52.18 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 123.705 0.628 . . . . 0.0 109.782 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 195' ' ' SER . . . . . 0.475 ' HG ' ' CG ' ' B' ' 193' ' ' ASP . 77.9 p -60.83 -39.0 87.4 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.905 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.18 -35.19 90.47 Favored Glycine 0 N--CA 1.438 -1.205 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -178.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 197' ' ' LEU . . . . . 0.952 HD23 ' N ' ' B' ' 198' ' ' ALA . 5.3 tt -74.27 133.8 42.63 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 198' ' ' ALA . . . . . 0.952 ' N ' HD23 ' B' ' 197' ' ' LEU . . . -61.75 -47.38 85.44 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.322 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 199' ' ' GLN . . . . . 0.942 ' O ' ' CD2' ' B' ' 197' ' ' LEU . 59.2 tt0 -136.76 164.7 27.66 Favored 'General case' 0 C--O 1.209 -1.077 0 CA-C-O 122.083 0.944 . . . . 0.0 112.389 -177.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 200' ' ' VAL . . . . . 0.515 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 51.8 t -120.53 131.85 71.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 O-C-N 120.579 -1.326 . . . . 0.0 109.532 177.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -86.81 150.08 24.38 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.855 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.27 -33.17 74.1 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.253 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -63.7 -32.3 73.74 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.382 0.61 . . . . 0.0 109.481 177.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.2 m -60.81 -43.82 97.67 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.206 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 205' ' ' ALA . . . . . 0.633 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -58.26 -29.6 65.92 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -178.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -65.94 -38.35 88.39 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.431 0.634 . . . . 0.0 110.646 174.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -66.13 -38.46 88.21 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.477 178.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 95.0 mt -62.97 -45.51 98.69 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -178.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 209' ' ' PHE . . . . . 0.633 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 67.6 m-85 -61.47 -42.58 99.0 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.916 -176.257 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.82 -42.04 99.56 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 119.581 -0.847 . . . . 0.0 109.94 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 211' ' ' LEU . . . . . 0.656 HD21 ' CD2' ' B' ' 178' ' ' LEU . 38.3 mt -62.49 -42.52 99.55 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.173 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 78.1 p -63.46 -37.29 86.72 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.291 -0.564 . . . . 0.0 112.105 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 213' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -66.18 -46.64 76.63 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.214 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.404 ' O ' HG23 ' B' ' 218' ' ' THR . 53.3 tp -63.92 -42.57 97.35 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.895 0.855 . . . . 0.0 109.863 177.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 215' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' B' ' 211' ' ' LEU . 86.2 mt -62.53 -43.4 98.91 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 113.274 -1.785 . . . . 0.0 111.288 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.19 -39.77 93.83 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.749 0.309 . . . . 0.0 111.438 -177.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 92.4 mt -63.24 -41.97 99.14 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.443 0.64 . . . . 0.0 111.196 176.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 218' ' ' THR . . . . . 0.404 HG23 ' O ' ' B' ' 214' ' ' LEU . 68.3 p -74.75 -14.83 60.76 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.642 -178.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 78.14 65.46 1.87 Allowed Glycine 0 CA--C 1.528 0.885 0 N-CA-C 107.485 -2.246 . . . . 0.0 107.485 -177.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 220' ' ' THR . . . . . . . . . . . . . 95.3 m -144.08 105.31 4.24 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 175.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -62.15 140.96 58.4 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.922 -176.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 45.3 tp -117.18 121.83 42.32 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.645 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 3.5 mp -112.35 129.77 67.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.04 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 224' ' ' ILE . . . . . 0.643 ' CG2' HD11 ' B' ' 227' ' ' ILE . 50.1 mm -110.74 127.13 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 44.0 p -134.24 156.46 48.36 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 121.957 0.884 . . . . 0.0 112.495 -178.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 90.5 16.85 54.44 Favored Glycine 0 C--N 1.316 -0.564 0 CA-C-N 113.951 -1.477 . . . . 0.0 111.303 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 227' ' ' ILE . . . . . 0.643 HD11 ' CG2' ' B' ' 224' ' ' ILE . 95.5 mt -82.81 127.21 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 118.027 0.914 . . . . 0.0 111.284 -178.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 56.1 tttt -66.58 138.17 95.47 Favored Pre-proline 0 C--N 1.316 -0.868 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.525 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.9 -37.4 93.09 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 121.443 1.429 . . . . 0.0 112.616 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -62.66 -44.12 97.07 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 48.3 tp -61.68 -41.64 97.84 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.267 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.06 -37.41 87.1 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.931 -0.307 . . . . 0.0 111.414 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 94.6 mtp -64.16 -40.06 95.34 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-O 121.248 0.547 . . . . 0.0 109.629 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.43 -42.74 98.69 Favored 'General case' 0 CA--C 1.554 1.114 0 CA-C-O 122.443 1.116 . . . . 0.0 109.539 178.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 33.0 mmt -63.81 -35.86 82.0 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.507 -1.224 . . . . 0.0 111.89 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -62.06 -40.33 95.44 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.006 -178.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.01 -43.66 98.14 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 120.512 -0.475 . . . . 0.0 109.825 177.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 55.1 tp -62.57 -44.57 96.0 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.625 -178.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 239' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' B' ' 240' ' ' ALA . 66.8 t0 -159.27 132.5 7.11 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.35 -0.54 . . . . 0.0 112.106 -178.326 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 240' ' ' ALA . . . . . 0.41 ' N ' ' OD1' ' B' ' 239' ' ' ASP . . . -61.07 -46.55 90.22 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 177.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 241' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' B' ' 244' ' ' SER . 92.1 m-20 -44.06 -20.14 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.689 -175.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 242' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -60.63 -44.99 95.71 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.141 -0.624 . . . . 0.0 110.298 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 243' ' ' SER . . . . . . . . . . . . . 78.1 p -57.93 -42.87 85.78 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 178.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 244' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 20.0 m -34.61 -35.0 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -177.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 97.3 mt -88.36 132.51 34.4 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.702 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -58.28 135.41 57.13 Favored 'General case' 0 C--O 1.25 1.121 0 CA-C-O 121.906 0.86 . . . . 0.0 111.523 -178.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 247' ' ' THR . . . . . 0.604 HG23 HD12 ' B' ' 227' ' ' ILE . 98.1 m -127.13 128.09 45.63 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 114.525 -1.216 . . . . 0.0 112.004 178.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 248' ' ' TYR . . . . . 0.511 ' CG ' ' HB2' ' B' ' 254' ' ' ALA . 93.4 m-85 -112.46 143.78 43.02 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 249' ' ' SER . . . . . 0.565 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 78.2 p -62.57 -34.99 78.08 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.18 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 250' ' ' ASN . . . . . 0.565 ' OD1' ' O ' ' B' ' 249' ' ' SER . 99.0 m-20 -147.16 161.28 41.22 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 114.966 -1.015 . . . . 0.0 112.574 178.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 251' ' ' VAL . . . . . 0.406 ' O ' HG23 ' B' ' 255' ' ' VAL . 69.2 t -64.76 -44.93 96.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.788 178.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 252' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.04 -45.95 92.7 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 253' ' ' ASP . . . . . 0.477 ' O ' HG22 ' B' ' 257' ' ' VAL . 94.2 m-20 -61.23 -43.24 99.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.57 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 254' ' ' ALA . . . . . 0.511 ' HB2' ' CG ' ' B' ' 248' ' ' TYR . . . -65.73 -39.49 91.21 Favored 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.062 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 255' ' ' VAL . . . . . 0.643 HG13 HH11 ' A' ' 154' ' ' ARG . 76.2 t -65.22 -45.76 92.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.875 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.548 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.0 -48.4 78.98 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 121.588 0.709 . . . . 0.0 111.263 -177.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 257' ' ' VAL . . . . . 0.477 ' O ' ' C ' ' B' ' 258' ' ' LEU . 27.1 m -65.09 -40.83 90.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.959 -1.018 . . . . 0.0 111.464 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 258' ' ' LEU . . . . . 0.482 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 1.3 mt -31.79 -72.3 0.07 OUTLIER Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.794 -178.26 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 259' ' ' PRO . . . . . 0.513 ' O ' HG13 ' B' ' 260' ' ' ILE . 39.8 Cg_endo -63.11 140.94 81.04 Favored 'Trans proline' 0 N--CA 1.504 2.103 0 C-N-CA 121.59 1.527 . . . . 0.0 111.351 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 260' ' ' ILE . . . . . 0.535 HG22 ' O ' ' B' ' 260' ' ' ILE . 96.7 mt -158.33 -15.4 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-N 118.591 0.632 . . . . 0.0 112.573 177.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 78.0 mtm . . . . . 0 N--CA 1.466 0.339 0 CA-C-O 118.207 -0.901 . . . . 0.0 111.825 179.675 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.15 -175.16 4.59 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 88.5 p -85.11 -7.04 59.26 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.484 -0.76 . . . . 0.0 111.412 177.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -81.57 -63.45 1.39 Allowed 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 114.109 -1.405 . . . . 0.0 113.157 172.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -67.5 -38.79 84.84 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.557 ' O ' ' NZ ' ' B' ' 17' ' ' LYS . 66.9 m -59.44 -42.08 91.12 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.181 -177.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.522 ' CE2' HD12 ' A' ' 9' ' ' ILE . 46.9 t80 85.48 85.96 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 O-C-N 123.766 0.666 . . . . 0.0 111.03 177.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.646 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -58.78 -150.13 0.01 OUTLIER Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.646 ' HB ' ' O ' ' A' ' 8' ' ' GLY . 89.3 mt 91.4 111.85 0.02 OUTLIER Pre-proline 0 N--CA 1.471 0.598 0 C-N-CA 122.734 0.414 . . . . 0.0 110.775 -179.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.66 -22.03 64.77 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 121.431 1.421 . . . . 0.0 112.153 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.05 -38.68 96.36 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 120.953 -0.641 . . . . 0.0 111.917 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -65.09 -39.21 92.85 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.549 0.69 . . . . 0.0 109.968 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.6 tp -63.08 -41.5 99.42 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -63.21 -40.36 97.26 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.6 t -60.48 -44.18 95.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 O-C-N 122.242 -0.286 . . . . 0.0 110.953 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 92.9 mt -62.63 -43.74 98.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.646 -177.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.7 -45.89 90.68 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 119.411 -0.916 . . . . 0.0 112.09 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.467 ' NZ ' HG12 ' B' ' 113' ' ' ILE . 98.5 mttt -60.28 -39.26 86.22 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 118.578 -1.249 . . . . 0.0 109.074 -176.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.5 -40.93 93.14 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.242 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.8 mt -62.97 -40.71 98.55 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -63.26 -38.19 90.18 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.327 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 62.0 m170 -58.82 -39.38 81.02 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 122.2 -0.313 . . . . 0.0 111.271 -178.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.37 130.65 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.512 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 35.8 ptt180 -73.65 110.71 8.15 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 122.093 0.949 . . . . 0.0 111.961 -177.212 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.0 p -141.54 143.67 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.599 ' HA3' ' HB2' ' A' ' 123' ' ' GLN . . . -97.28 91.97 1.27 Allowed Glycine 0 C--N 1.313 -0.695 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.814 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 50.8 t -124.44 129.51 73.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.6 m -137.1 159.92 36.28 Favored 'Isoleucine or valine' 0 C--O 1.244 0.796 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.9 mt -119.88 131.29 72.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.667 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.7 p -108.11 165.88 11.15 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.555 ' C ' ' OD1' ' A' ' 37' ' ' ASN . 50.9 t0 -132.09 101.41 15.07 Favored Pre-proline 0 C--N 1.323 -0.544 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.194 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.546 ' CG ' HG23 ' A' ' 117' ' ' THR . 35.5 Cg_endo -63.53 -22.31 70.78 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.659 1.573 . . . . 0.0 111.746 -178.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.03 -36.01 82.14 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.231 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.5 mt -83.33 159.17 21.93 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.954 176.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.782 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 42.4 tt0 -58.53 135.67 57.37 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -177.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.535 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 59.8 t0 61.1 18.89 9.45 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 178.273 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.555 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 31.0 t-20 42.79 67.42 3.56 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.748 -176.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.782 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 92.2 Cg_endo -71.13 156.3 59.81 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 123.985 3.123 . . . . 0.0 112.336 -178.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.2 mt -87.16 125.45 40.98 Favored 'Isoleucine or valine' 0 C--O 1.245 0.833 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.6 m -104.52 -44.26 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 O-C-N 123.659 0.6 . . . . 0.0 112.335 -179.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -96.35 124.68 40.44 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.838 -178.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.2 p -142.36 139.57 29.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 O-C-N 124.162 0.914 . . . . 0.0 109.333 176.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.598 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 56.6 p30 -97.04 167.56 10.99 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.461 ' HA ' ' OE1' ' A' ' 44' ' ' GLN . 14.1 mm100 -66.55 -39.08 88.37 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 176.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.69 -27.16 63.54 Favored Glycine 0 N--CA 1.452 -0.241 0 N-CA-C 110.331 -1.107 . . . . 0.0 110.331 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.607 ' CD1' HD13 ' A' ' 57' ' ' ILE . 58.1 t80 -59.08 -48.28 82.16 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.586 HG13 ' O ' ' A' ' 52' ' ' TYR . 78.7 t -59.89 -44.62 94.71 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 O-C-N 121.092 -1.005 . . . . 0.0 111.708 -173.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -63.15 -38.24 90.38 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 120.496 -0.482 . . . . 0.0 112.035 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.453 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 60.2 ttm -66.85 -43.21 84.22 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 175.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 36.8 p -93.58 -21.32 19.49 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.993 0.425 . . . . 0.0 111.523 -177.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . 77.05 20.39 75.84 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.586 ' O ' HG13 ' A' ' 47' ' ' VAL . 85.4 m-85 -114.33 136.77 52.61 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.022 0.439 . . . . 0.0 111.137 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -63.57 147.63 50.94 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.703 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.439 HG22 ' H ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -64.22 -31.14 72.22 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.595 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -67.28 -42.24 84.16 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 119.615 -0.834 . . . . 0.0 111.499 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -66.55 -44.68 81.71 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.423 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.607 HD13 ' CD1' ' A' ' 46' ' ' PHE . 96.2 mt -62.03 -45.34 98.95 Favored 'Isoleucine or valine' 0 C--N 1.354 0.767 0 CA-C-O 118.046 -0.978 . . . . 0.0 111.348 -175.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.0 mt -64.37 141.22 58.85 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 -177.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.35 -0.06 86.93 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.615 178.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -137.16 152.45 49.95 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.502 1.651 . . . . 0.0 111.44 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.54 ' C ' ' H ' ' A' ' 63' ' ' ARG . 25.1 t-20 -81.88 152.25 26.93 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.245 0.545 . . . . 0.0 110.648 -178.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 83.4 m -64.16 15.36 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.34 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.54 ' H ' ' C ' ' A' ' 61' ' ' ASN . 35.8 ptt-85 -61.59 -42.19 98.5 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.255 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -55.21 -22.31 17.29 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 88.2 mt -66.39 -36.62 83.31 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 177.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -64.79 144.04 57.52 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.446 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.628 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -152.66 -147.98 4.74 Favored Glycine 0 CA--C 1.541 1.71 0 N-CA-C 111.649 -0.581 . . . . 0.0 111.649 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.16 -39.98 96.23 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -177.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.464 ' O ' ' NE2' ' A' ' 93' ' ' GLN . 8.8 m-70 -77.69 -6.97 55.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.672 0.272 . . . . 0.0 111.001 -178.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.628 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 27.9 m -64.0 128.8 37.41 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.126 -0.63 . . . . 0.0 109.729 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -85.5 109.87 25.11 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.242 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 70' ' ' THR . 52.9 Cg_exo -57.09 -31.7 91.07 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 121.91 1.74 . . . . 0.0 113.063 178.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.08 -40.16 95.64 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.172 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.503 ' OE1' ' HB ' ' A' ' 90' ' ' VAL . 79.3 mm-40 -65.91 -44.0 86.49 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 67.4 t -59.92 -44.02 93.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 114.448 -1.251 . . . . 0.0 107.799 -175.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -63.99 -37.77 88.62 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.89 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -63.35 -39.53 94.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.339 0.59 . . . . 0.0 110.228 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.89 -44.04 97.94 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 CA-C-N 114.946 -1.025 . . . . 0.0 112.0 178.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -62.96 -43.35 99.03 Favored 'General case' 0 C--O 1.251 1.141 0 CA-C-N 113.68 -1.6 . . . . 0.0 108.482 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 99.8 m -61.35 -50.08 74.35 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 119.729 -0.788 . . . . 0.0 108.962 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.89 -42.35 89.33 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 119.487 -0.292 . . . . 0.0 111.187 -173.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 89.2 mt -63.12 -39.79 95.7 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 119.09 0.859 . . . . 0.0 111.885 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -63.24 -35.32 79.94 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 177.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -89.34 -2.91 58.61 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.694 -177.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 38.0 tttt 51.45 43.97 29.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.827 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -126.8 146.62 57.91 Favored Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 108' ' ' ILE . 24.2 Cg_exo -61.83 143.49 95.91 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.345 1.363 . . . . 0.0 112.822 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.7 142.3 30.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.862 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.917 HG23 ' OD1' ' A' ' 107' ' ' ASN . 96.6 m -126.41 122.22 34.7 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 175.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.503 ' HB ' ' OE1' ' A' ' 74' ' ' GLU . 29.3 m -139.05 159.47 29.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 121.106 -0.238 . . . . 0.0 111.308 178.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -103.61 133.99 47.7 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 105.021 -2.215 . . . . 0.0 105.021 176.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.5 ' O ' HG23 ' A' ' 92' ' ' ILE . 19.2 tt -142.4 125.23 14.14 Favored 'Isoleucine or valine' 0 C--N 1.374 1.635 0 CA-C-N 121.622 2.01 . . . . 0.0 112.341 176.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.464 ' NE2' ' O ' ' A' ' 69' ' ' HIS . 34.0 mt-30 -58.87 136.55 57.86 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.377 179.107 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -136.07 159.96 40.09 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.161 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.4 ' CE1' ' HA3' ' A' ' 67' ' ' GLY . 93.8 m-85 -117.12 134.67 54.49 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -178.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.453 ' HE2' ' O ' ' A' ' 49' ' ' MET . 98.9 mttt -83.79 -174.3 5.2 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.086 0.469 . . . . 0.0 111.908 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.35 -43.13 99.54 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.102 178.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 40.9 p-10 -83.53 6.42 20.53 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -178.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.7 -1.38 87.04 Favored Glycine 0 N--CA 1.473 1.163 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.352 176.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.0 m -59.73 137.96 57.9 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.691 ' SD ' ' C ' ' A' ' 101' ' ' MET . 13.4 tmm? -105.47 129.03 53.85 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 120.959 0.409 . . . . 0.0 110.508 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.487 ' N ' ' SD ' ' A' ' 101' ' ' MET . 50.7 p90 -142.16 156.22 45.34 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.175 -176.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.724 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 20.8 m95 -88.24 142.2 27.94 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.477 HD21 ' HG2' ' A' ' 123' ' ' GLN . 54.3 t-20 -136.97 102.35 4.83 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -177.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.46 ' HB2' HD11 ' A' ' 126' ' ' ILE . 81.0 tt0 -67.75 136.77 54.75 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 -177.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 41.1 tp -121.5 122.57 40.03 Favored 'General case' 0 C--O 1.233 0.185 0 O-C-N 123.665 0.603 . . . . 0.0 112.593 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.917 ' OD1' HG23 ' A' ' 89' ' ' THR . 98.2 m-20 -118.85 123.32 44.42 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 116.724 -0.216 . . . . 0.0 110.64 177.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.432 ' O ' ' HA ' ' A' ' 87' ' ' PRO . 96.2 mt -120.03 128.77 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 O-C-N 123.468 0.48 . . . . 0.0 111.268 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -136.77 124.58 14.58 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 116.871 -0.15 . . . . 0.0 110.88 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -70.88 151.19 62.46 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.342 2.028 . . . . 0.0 112.499 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.587 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 67.2 mtt -124.03 153.13 41.78 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 179.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -129.09 95.59 4.1 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 176.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 96.5 mt -121.02 131.4 73.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.621 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 50.43 37.98 17.02 Favored 'General case' 0 CA--C 1.515 -0.398 0 O-C-N 121.567 -0.708 . . . . 0.0 111.441 176.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 58.7 30.51 20.05 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.707 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -126.81 147.9 49.99 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.814 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 5.2 t -84.85 -171.26 3.54 Favored 'General case' 0 C--O 1.214 -0.793 0 CA-C-O 118.618 -0.706 . . . . 0.0 109.323 -178.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.814 ' CD2' ' O ' ' A' ' 117' ' ' THR . 76.3 m-85 -174.96 154.95 1.93 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 175.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -130.71 146.2 52.12 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 174.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.7 134.86 56.14 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.461 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -106.81 127.85 9.03 Favored Glycine 0 CA--C 1.502 -0.774 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.408 ' HB ' ' HB2' ' A' ' 107' ' ' ASN . 96.6 mt -116.58 128.16 74.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 177.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.599 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . 17.3 mp0 -118.72 112.87 20.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.072 0.463 . . . . 0.0 109.875 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -115.07 112.16 22.17 Favored 'General case' 0 C--O 1.248 0.974 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.881 -178.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 127' ' ' THR . 68.4 t0 -62.55 131.28 48.57 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -176.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.507 ' O ' HG22 ' A' ' 126' ' ' ILE . 3.3 mp -96.64 4.32 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 113.743 -1.571 . . . . 0.0 109.884 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.461 ' N ' ' OD1' ' A' ' 125' ' ' ASP . 25.6 m -60.37 -42.34 95.6 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 121.081 -1.012 . . . . 0.0 113.388 -178.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -59.63 -42.8 93.54 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -62.8 -39.73 95.16 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.702 177.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.724 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.8 mttt -62.34 -41.21 98.4 Favored 'General case' 0 CA--C 1.503 -0.834 0 C-N-CA 118.286 -1.366 . . . . 0.0 110.64 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -62.17 -37.59 85.81 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.659 ' CE2' HD11 ' A' ' 136' ' ' LEU . 87.5 t80 -61.48 -45.44 94.21 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.672 176.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.81 -38.61 91.56 Favored 'General case' 0 CA--C 1.522 -0.116 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.06 -40.83 97.1 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.068 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 54.8 tp -60.8 -43.84 97.62 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -177.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.659 HD11 ' CE2' ' A' ' 132' ' ' TYR . 85.2 mt -62.21 -41.34 98.29 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.382 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.09 -42.55 99.33 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 119.529 -0.868 . . . . 0.0 109.799 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -60.68 -42.12 96.46 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -177.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 58.3 m -61.57 -41.12 96.95 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.642 176.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 144' ' ' THR . 83.6 mt -63.5 -42.07 98.53 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 120.63 -0.428 . . . . 0.0 109.934 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 91.5 m -61.62 -45.4 94.23 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.152 -177.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -65.08 -40.21 94.31 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 95.2 mt -64.72 -43.39 96.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.115 -1.402 . . . . 0.0 111.313 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.51 ' N ' ' O ' ' A' ' 140' ' ' LEU . 99.4 m -62.65 -46.16 89.47 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 121.811 -0.556 . . . . 0.0 112.121 -177.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.454 ' O ' ' OG1' ' A' ' 148' ' ' THR . . . -63.31 -39.42 94.51 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 118.803 -1.159 . . . . 0.0 109.051 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 81.7 mt -63.38 -42.65 98.83 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.355 178.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.711 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.2 p -59.96 -39.65 86.34 Favored 'General case' 0 C--O 1.217 -0.644 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -178.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.49 ' C ' ' O ' ' A' ' 147' ' ' SER . 21.6 m -27.1 81.72 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.418 0 O-C-N 126.971 2.669 . . . . 0.0 106.133 -178.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.711 ' N ' ' O ' ' A' ' 147' ' ' SER . 21.1 Cg_exo -62.44 146.15 95.61 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 C-N-CA 121.427 1.418 . . . . 0.0 114.538 -175.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.574 ' O ' ' CG2' ' A' ' 151' ' ' VAL . 9.6 tp -124.52 136.58 60.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 102.843 -3.021 . . . . 0.0 102.843 178.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.574 ' CG2' ' O ' ' A' ' 150' ' ' ILE . 60.1 t -169.05 96.48 0.52 Allowed Pre-proline 0 N--CA 1.437 -1.083 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 178.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -64.8 133.28 35.68 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 109.785 -0.89 . . . . 0.0 109.785 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.665 ' O ' ' HD2' ' A' ' 154' ' ' ARG . 45.9 mm -69.19 -45.13 80.09 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.909 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.395 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.665 ' HD2' ' O ' ' A' ' 153' ' ' ILE . 1.1 tpt180 -156.15 -159.32 0.88 Allowed 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.422 ' ND2' ' HE3' ' B' ' 256' ' ' LYS . 58.9 t-20 -86.16 106.18 17.09 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.697 0.76 . . . . 0.0 111.289 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 88.8 10.06 67.52 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 113.98 -1.463 . . . . 0.0 110.501 -177.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.449 HG12 ' HB2' ' A' ' 189' ' ' TYR . 96.6 mt -128.11 122.82 59.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 175.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.615 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 58.0 m -131.92 151.75 51.51 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.199 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -134.06 140.11 46.43 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.206 -0.597 . . . . 0.0 111.404 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 29.7 tp -131.18 76.49 76.27 Favored Pre-proline 0 N--CA 1.468 0.469 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.206 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -68.89 149.11 72.02 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 122.791 2.327 . . . . 0.0 113.085 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 90.0 mt -117.38 128.63 55.22 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.179 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 45.8 t -123.48 131.56 72.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 115.58 167.55 15.18 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 120.89 -0.671 . . . . 0.0 111.92 178.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.888 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 60.0 t30 -84.19 115.64 22.53 Favored 'General case' 0 C--O 1.207 -1.151 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -178.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.512 HD21 ' CZ ' ' A' ' 171' ' ' PHE . 43.5 tp -75.76 105.57 6.87 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 -177.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.643 HG23 ' NE ' ' A' ' 170' ' ' ARG . 11.4 p -88.53 167.61 13.28 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.909 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.51 -34.19 77.68 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.983 0.42 . . . . 0.0 111.945 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.76 -42.11 91.3 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.805 0.812 . . . . 0.0 110.986 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.888 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 88.2 mtm180 -64.75 -34.26 77.91 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.791 177.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.512 ' CZ ' HD21 ' A' ' 166' ' ' LEU . 0.4 OUTLIER -55.07 -28.3 51.29 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 119.025 -0.512 . . . . 0.0 111.727 -177.084 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.711 ' O ' HG22 ' A' ' 175' ' ' VAL . 91.0 m-20 -60.35 -40.6 91.31 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 118.718 -1.193 . . . . 0.0 110.02 -177.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 50.3 m -59.25 -40.78 87.03 Favored 'General case' 0 C--N 1.315 -0.923 0 O-C-N 121.569 -0.707 . . . . 0.0 110.538 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 66.8 mt -62.9 -43.96 99.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.711 HG22 ' O ' ' A' ' 172' ' ' ASN . 23.0 m -62.32 -39.91 85.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -178.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' CYS . . . . . 0.438 ' N ' HG23 ' A' ' 175' ' ' VAL . 98.3 m -62.38 -34.61 77.04 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.274 178.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.582 ' O ' HG13 ' A' ' 181' ' ' ILE . 25.1 m -61.86 -19.71 62.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.905 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.786 ' CD2' HD21 ' A' ' 211' ' ' LEU . 91.3 mt -60.99 -41.18 95.98 Favored 'General case' 0 C--O 1.248 0.99 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -177.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 19.1 m -59.75 -43.58 94.21 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ASN . . . . . 0.576 ' O ' ' OG ' ' A' ' 183' ' ' SER . 92.0 m-20 -61.47 -35.4 77.52 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.775 0.43 . . . . 0.0 110.683 178.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.582 HG13 ' O ' ' A' ' 177' ' ' THR . 67.5 mt -60.32 -41.46 87.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.504 HD21 HD21 ' A' ' 214' ' ' LEU . 84.9 mt -60.3 -40.4 90.38 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 119.342 -0.943 . . . . 0.0 108.981 -176.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.576 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 78.1 p -61.45 -33.7 74.19 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.607 176.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 58.8 p -89.39 23.71 2.46 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.79 0.329 . . . . 0.0 111.446 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 78.1 p -64.48 -20.04 65.94 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.973 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -60.56 -37.43 81.23 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.921 -178.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.615 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 98.8 m-20 -73.57 114.98 12.43 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.383 0.611 . . . . 0.0 110.582 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -62.91 -42.62 99.85 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.123 -0.944 . . . . 0.0 113.027 -177.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' TYR . . . . . 0.449 ' HB2' HG12 ' A' ' 157' ' ' ILE . 98.5 m-85 -111.61 132.06 54.83 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.783 -177.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 40.0 tp -120.62 128.36 52.95 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 95.7 mt -116.94 127.32 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 118.35 0.523 . . . . 0.0 109.599 177.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.9 mm -112.84 127.05 70.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' ASP . . . . . 0.518 ' CG ' ' HG ' ' A' ' 195' ' ' SER . 40.0 t0 -94.23 118.02 30.96 Favored 'General case' 0 CA--C 1.552 1.053 0 O-C-N 121.796 -0.565 . . . . 0.0 110.824 177.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 194' ' ' LEU . 96.0 mt -96.51 -5.07 40.28 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.825 175.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' SER . . . . . 0.518 ' HG ' ' CG ' ' A' ' 193' ' ' ASP . 78.1 p -62.87 -33.81 76.06 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -62.28 -42.0 99.72 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 118.808 -1.663 . . . . 0.0 109.025 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.954 HD23 ' N ' ' A' ' 198' ' ' ALA . 4.7 tt -72.09 127.89 33.97 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 112.2 -2.0 . . . . 0.0 108.159 -177.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.954 ' N ' HD23 ' A' ' 197' ' ' LEU . . . -60.8 -47.21 87.38 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.956 0.408 . . . . 0.0 111.062 -178.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.908 ' O ' ' CD2' ' A' ' 197' ' ' LEU . 58.5 tt0 -133.63 155.93 48.79 Favored 'General case' 0 C--O 1.2 -1.547 0 CA-C-N 114.609 -1.178 . . . . 0.0 114.052 -174.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.433 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 46.9 t -117.97 132.51 67.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 O-C-N 120.17 -1.582 . . . . 0.0 108.707 178.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -90.44 155.46 18.91 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.642 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -64.44 -39.34 93.63 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 120.254 -0.578 . . . . 0.0 109.915 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -57.81 -32.66 67.79 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-O 122.099 0.952 . . . . 0.0 108.944 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.9 m -61.14 -42.57 98.78 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.222 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.512 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -57.96 -39.42 78.1 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -177.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -62.26 -36.71 82.87 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -65.48 -39.11 91.56 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.113 177.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 93.5 mt -63.16 -44.2 99.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' PHE . . . . . 0.512 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 68.9 m-85 -61.82 -43.83 98.07 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.648 -178.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.64 -42.62 99.7 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 119.295 -0.962 . . . . 0.0 109.221 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.786 HD21 ' CD2' ' A' ' 178' ' ' LEU . 37.7 mt -62.21 -41.87 98.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.644 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 78.4 p -61.44 -41.46 97.23 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.266 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' HIS . . . . . 0.439 ' CE1' HD11 ' A' ' 217' ' ' LEU . 57.8 t-80 -64.97 -45.52 85.34 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 122.018 -0.427 . . . . 0.0 111.528 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.504 HD21 HD21 ' A' ' 182' ' ' LEU . 48.0 tp -62.12 -46.52 88.65 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 118.893 -1.123 . . . . 0.0 108.003 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 211' ' ' LEU . 90.2 mt -61.98 -40.43 95.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.588 -177.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.34 -43.47 96.4 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.442 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.439 HD11 ' CE1' ' A' ' 213' ' ' HIS . 84.6 mt -61.95 -39.96 93.91 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 69.2 p -76.43 -11.35 59.87 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.365 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 83.17 35.31 18.37 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-O 119.133 -0.815 . . . . 0.0 112.844 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 96.2 m -123.44 110.97 15.78 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 118.863 1.331 . . . . 0.0 111.713 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -61.63 138.46 58.31 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.81 178.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 50.0 tp -113.61 131.05 56.26 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 177.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 2.7 mp -118.37 135.14 59.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.561 ' CG2' HD11 ' A' ' 227' ' ' ILE . 50.1 mm -116.48 131.63 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -178.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 34.5 p -133.71 167.53 20.35 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 78.63 21.42 69.16 Favored Glycine 0 C--N 1.334 0.469 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.607 HD12 HG23 ' A' ' 247' ' ' THR . 97.6 mt -84.68 128.15 39.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 113.924 -1.138 . . . . 0.0 108.427 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 54.3 tttt -74.02 140.56 77.24 Favored Pre-proline 0 CA--C 1.535 0.377 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.32 -39.72 89.46 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 120.942 1.095 . . . . 0.0 112.489 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -64.78 -37.38 87.4 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.507 0.67 . . . . 0.0 110.28 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 52.7 tp -63.79 -42.31 97.76 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.468 177.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -65.17 -37.12 86.36 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.042 0.449 . . . . 0.0 110.873 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 94.1 mtp -63.29 -40.97 98.85 Favored 'General case' 0 C--O 1.248 0.985 0 C-N-CA 120.074 -0.65 . . . . 0.0 109.536 -178.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -64.02 -39.9 95.14 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.462 177.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 35.1 mmt -66.76 -36.73 83.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.554 177.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -60.84 -41.87 96.66 Favored 'General case' 0 CA--C 1.513 -0.479 0 O-C-N 121.432 -0.793 . . . . 0.0 109.479 -176.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.86 -39.88 90.8 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.506 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 59.0 tp -63.44 -41.05 98.65 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 240' ' ' ALA . 67.0 t0 -167.6 129.47 1.55 Allowed 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 121.487 0.661 . . . . 0.0 112.148 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.408 ' N ' ' OD1' ' A' ' 239' ' ' ASP . . . -61.04 -26.8 67.88 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.618 178.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.485 ' O ' ' HB2' ' A' ' 244' ' ' SER . 90.8 m-20 -61.24 -32.68 72.48 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.326 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -55.59 -44.38 76.89 Favored 'General case' 0 C--N 1.312 -1.065 0 O-C-N 121.214 -0.929 . . . . 0.0 109.089 -175.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 94.2 p -62.82 -20.04 64.66 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.937 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' SER . . . . . 0.485 ' HB2' ' O ' ' A' ' 241' ' ' ASN . 49.7 m -56.4 -37.76 70.59 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 122.517 0.327 . . . . 0.0 111.854 177.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 92.5 mt -83.24 130.94 35.12 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 177.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -55.29 135.08 50.18 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 114.104 -1.407 . . . . 0.0 109.626 -177.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.607 HG23 HD12 ' A' ' 227' ' ' ILE . 98.0 m -126.79 132.14 51.1 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.836 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 248' ' ' TYR . . . . . 0.431 ' CG ' ' HB2' ' A' ' 254' ' ' ALA . 97.5 m-85 -118.09 140.54 49.61 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.401 178.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 249' ' ' SER . . . . . 0.418 ' O ' ' OD1' ' A' ' 250' ' ' ASN . 78.1 p -61.39 -42.35 98.58 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -178.012 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 249' ' ' SER . 98.4 m-20 -144.03 160.5 40.75 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.72 0.772 . . . . 0.0 111.43 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 77.0 t -62.38 -44.74 99.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 114.641 -1.163 . . . . 0.0 112.044 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.73 -43.78 97.47 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.329 -0.549 . . . . 0.0 109.581 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' ASP . . . . . 0.551 ' O ' HG22 ' A' ' 257' ' ' VAL . 55.1 m-20 -63.43 -42.68 98.71 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.164 -178.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 254' ' ' ALA . . . . . 0.431 ' HB2' ' CG ' ' A' ' 248' ' ' TYR . . . -64.92 -41.88 95.18 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.729 0.776 . . . . 0.0 109.942 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 61.1 t -63.5 -45.89 96.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 114.225 -1.352 . . . . 0.0 111.304 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -63.89 -47.45 80.56 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.509 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 253' ' ' ASP . 33.4 m -66.89 -40.96 86.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 C-N-CA 119.908 -0.717 . . . . 0.0 112.481 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.483 ' C ' ' O ' ' A' ' 257' ' ' VAL . 0.9 OUTLIER -30.11 -73.42 0.05 OUTLIER Pre-proline 0 CA--C 1.533 0.293 0 O-C-N 123.166 0.291 . . . . 0.0 111.614 -176.847 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 259' ' ' PRO . . . . . 0.48 ' O ' HG13 ' A' ' 260' ' ' ILE . 43.6 Cg_endo -63.87 140.24 72.35 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 120.847 1.032 . . . . 0.0 111.857 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.48 HG13 ' O ' ' A' ' 259' ' ' PRO . 96.1 mt -152.91 -31.18 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 O-C-N 123.453 0.47 . . . . 0.0 112.16 178.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 77.3 mtm . . . . . 0 C--O 1.217 -0.617 0 CA-C-O 118.133 -0.937 . . . . 0.0 111.143 -177.213 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.521 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.62 175.32 11.65 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 100.0 p -72.09 -11.59 60.82 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.717 -0.219 . . . . 0.0 111.19 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -83.04 -60.94 2.0 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.063 0.458 . . . . 0.0 110.661 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -67.05 -39.16 86.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.253 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 6' ' ' SER . . . . . 0.537 ' O ' ' HB3' ' B' ' 7' ' ' PHE . 68.4 m -59.48 -43.28 93.33 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 120.249 -0.58 . . . . 0.0 109.6 -177.345 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 7' ' ' PHE . . . . . 0.537 ' HB3' ' O ' ' B' ' 6' ' ' SER . 48.3 t80 86.94 86.97 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.891 0.744 . . . . 0.0 110.71 177.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 8' ' ' GLY . . . . . 0.647 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -59.99 -149.72 0.01 OUTLIER Glycine 0 C--N 1.336 0.559 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.647 ' HB ' ' O ' ' B' ' 8' ' ' GLY . 88.5 mt 91.3 111.78 0.02 OUTLIER Pre-proline 0 N--CA 1.472 0.635 0 O-C-N 123.948 0.44 . . . . 0.0 110.761 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -63.86 -23.63 68.46 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 121.408 1.405 . . . . 0.0 111.788 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.58 -41.1 99.51 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -64.69 -39.33 93.47 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.843 0.83 . . . . 0.0 109.775 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 48.5 tp -61.76 -42.36 98.88 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 114.907 -1.042 . . . . 0.0 112.116 -177.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -65.15 -33.31 75.71 Favored 'General case' 0 CA--C 1.561 1.39 0 CA-C-O 121.681 0.753 . . . . 0.0 110.805 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 79.4 t -62.23 -46.46 96.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-N 112.927 -1.942 . . . . 0.0 110.912 177.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.94 -44.09 97.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.674 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 17' ' ' LYS . . . . . 0.557 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 98.9 mttt -63.53 -41.99 98.46 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.34 -41.21 98.87 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 119.028 -1.069 . . . . 0.0 110.254 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.61 -38.39 84.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.743 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 84.3 mt -63.77 -41.91 97.88 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.223 0.535 . . . . 0.0 110.255 175.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -62.87 -38.54 91.27 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.95 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 61.2 m170 -57.83 -39.86 78.67 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 121.19 -0.204 . . . . 0.0 111.156 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 14.1 p -115.28 130.74 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.523 ' HG3' ' O ' ' B' ' 24' ' ' ARG . 35.4 ptt180 -73.54 108.58 6.48 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 121.85 0.833 . . . . 0.0 112.316 -176.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.7 p -143.09 133.76 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.667 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.544 177.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 26' ' ' GLY . . . . . 0.541 ' HA3' ' HB2' ' B' ' 123' ' ' GLN . . . -86.78 96.21 2.13 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 119.629 -1.272 . . . . 0.0 113.488 -176.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 47.0 t -125.58 128.81 72.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 175.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 29.5 m -138.8 157.29 29.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.587 179.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 96.5 mt -118.91 129.3 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-O 121.676 0.751 . . . . 0.0 111.567 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.474 ' OG1' ' O ' ' B' ' 119' ' ' PHE . 9.9 p -111.85 154.49 25.07 Favored 'General case' 0 CA--C 1.502 -0.886 0 CA-C-N 113.073 -1.876 . . . . 0.0 108.819 -175.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.518 ' C ' ' OD1' ' B' ' 37' ' ' ASN . 51.0 t0 -122.77 102.3 38.55 Favored Pre-proline 0 C--O 1.237 0.415 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -177.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 32' ' ' PRO . . . . . 0.455 ' CG ' HG23 ' B' ' 117' ' ' THR . 36.5 Cg_endo -64.52 -20.65 65.98 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 121.786 1.657 . . . . 0.0 111.27 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.19 -42.38 99.23 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 120.629 -0.429 . . . . 0.0 110.002 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 96.8 mt -73.15 179.79 3.68 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 121.778 -0.576 . . . . 0.0 111.097 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 35' ' ' GLU . . . . . 0.709 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 42.0 tt0 -75.58 132.88 40.96 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -178.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.488 ' O ' ' C ' ' B' ' 37' ' ' ASN . 66.0 t0 55.86 38.78 30.44 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.709 178.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 37' ' ' ASN . . . . . 0.518 ' OD1' ' C ' ' B' ' 31' ' ' ASP . 17.6 t-20 26.91 71.37 0.42 Allowed Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.709 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 92.6 Cg_endo -72.93 154.62 53.29 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 123.554 2.836 . . . . 0.0 111.944 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 95.9 mt -85.75 130.25 36.69 Favored 'Isoleucine or valine' 0 C--O 1.246 0.889 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 17.1 m -108.39 -44.06 6.5 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 O-C-N 123.884 0.74 . . . . 0.0 112.709 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -97.07 124.93 41.21 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.529 -178.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 6.5 p -142.34 140.53 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 O-C-N 124.195 0.934 . . . . 0.0 109.348 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 43' ' ' ASN . . . . . 0.636 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 55.4 p30 -101.18 162.62 12.76 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.144 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 44' ' ' GLN . . . . . 0.443 ' OE1' ' HA ' ' B' ' 44' ' ' GLN . 13.7 mm100 -62.86 -37.81 88.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.693 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.75 -27.53 64.24 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.656 ' CD1' HD13 ' B' ' 57' ' ' ILE . 53.3 t80 -60.36 -43.72 96.27 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 0.734 HG13 ' O ' ' B' ' 52' ' ' TYR . 77.6 t -61.78 -45.99 97.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.25 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -62.98 -44.31 96.39 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.394 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 49' ' ' MET . . . . . 0.458 ' O ' ' HE2' ' B' ' 96' ' ' LYS . 60.2 ttm -63.48 -42.02 98.57 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 34.6 p -96.22 -16.1 21.63 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.931 -177.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 51' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' B' ' 47' ' ' VAL . . . 72.69 18.73 78.87 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.379 -1.089 . . . . 0.0 110.379 178.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 52' ' ' TYR . . . . . 0.734 ' O ' HG13 ' B' ' 47' ' ' VAL . 85.7 m-85 -111.28 144.03 41.11 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 122.893 0.477 . . . . 0.0 109.999 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -73.82 147.72 43.1 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.561 0.696 . . . . 0.0 111.228 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 54' ' ' THR . . . . . 0.452 HG22 ' H ' ' B' ' 54' ' ' THR . 0.2 OUTLIER -61.42 -36.01 79.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.867 -177.779 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.48 -40.09 96.18 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 120.131 -0.628 . . . . 0.0 111.884 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -73.15 -33.69 65.64 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 176.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.656 HD13 ' CD1' ' B' ' 46' ' ' PHE . 97.2 mt -64.57 -53.95 36.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 118.204 -1.398 . . . . 0.0 109.475 177.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 88.6 mt -61.77 132.35 52.84 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.004 -170.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.55 -4.36 69.38 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 121.034 -0.603 . . . . 0.0 113.382 -177.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -133.22 149.25 52.02 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -177.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 61' ' ' ASN . . . . . 0.529 ' C ' ' H ' ' B' ' 63' ' ' ARG . 24.4 t-20 -78.86 151.79 31.62 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.565 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 62' ' ' CYS . . . . . . . . . . . . . 82.7 m -64.28 8.96 0.09 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.341 -178.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 63' ' ' ARG . . . . . 0.529 ' H ' ' C ' ' B' ' 61' ' ' ASN . 34.4 ptt-85 -59.4 -32.46 70.19 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.395 -177.236 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -60.95 -30.66 70.37 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 178.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 83.9 mt -61.66 -41.95 98.23 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 121.63 -0.669 . . . . 0.0 110.114 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -51.75 150.58 3.89 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.024 -177.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 67' ' ' GLY . . . . . 0.51 ' N ' ' OG1' ' B' ' 70' ' ' THR . . . -161.13 -153.94 7.21 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.33 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -58.98 -40.55 85.18 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -175.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 10.0 m80 -76.92 -9.43 58.68 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.307 -178.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 70' ' ' THR . . . . . 0.51 ' OG1' ' N ' ' B' ' 67' ' ' GLY . 26.9 m -61.19 133.81 56.35 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -90.5 110.1 38.65 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.485 -178.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.17 -38.15 87.71 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 120.979 1.12 . . . . 0.0 111.677 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.83 -40.42 92.75 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 120.459 -0.496 . . . . 0.0 109.8 -176.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 74' ' ' GLU . . . . . 0.504 ' OE1' ' HB ' ' B' ' 90' ' ' VAL . 79.0 mm-40 -67.23 -39.44 86.21 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.789 177.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 73.9 t -61.96 -45.95 97.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -63.29 -37.05 85.75 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.655 -178.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -62.33 -41.47 98.58 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 119.393 -0.923 . . . . 0.0 108.698 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 94.2 mt -63.28 -43.76 98.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-O 120.928 0.394 . . . . 0.0 110.427 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -62.31 -42.78 99.66 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 85.1 m -61.57 -45.4 94.29 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.027 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.28 -41.15 98.24 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 85.9 mt -62.98 -42.14 99.76 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -62.48 -36.63 83.1 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -91.64 7.4 41.72 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.5 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 32.3 tttt 43.1 45.79 4.74 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.414 -0.515 . . . . 0.0 112.195 175.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -128.15 143.72 49.01 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.274 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.31 140.51 83.19 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 120.933 1.089 . . . . 0.0 113.289 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -140.82 137.16 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.361 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 89' ' ' THR . . . . . 0.926 HG23 ' OD1' ' B' ' 107' ' ' ASN . 95.7 m -121.47 123.81 42.94 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.504 ' HB ' ' OE1' ' B' ' 74' ' ' GLU . 26.9 m -138.27 163.13 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.955 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -114.62 120.42 40.09 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 174.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 92' ' ' ILE . . . . . 0.467 HD11 HG23 ' B' ' 70' ' ' THR . 20.9 tt -128.3 131.79 68.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.256 -176.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -71.44 143.46 50.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.419 177.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 94' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -132.92 -178.89 5.16 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 121.268 0.556 . . . . 0.0 111.176 -177.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 95' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -131.19 145.61 52.01 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 114.567 -1.197 . . . . 0.0 111.711 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 96' ' ' LYS . . . . . 0.458 ' HE2' ' O ' ' B' ' 49' ' ' MET . 98.6 mttt -103.01 177.09 4.93 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.317 0.58 . . . . 0.0 111.209 177.024 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.15 -35.43 75.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.716 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 38.4 p-10 -87.11 -1.78 58.14 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.168 0.895 . . . . 0.0 112.486 178.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.28 3.18 63.46 Favored Glycine 0 C--N 1.335 0.528 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.449 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 25.5 m -67.01 128.99 38.44 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 101' ' ' MET . . . . . 0.603 ' SD ' ' N ' ' B' ' 102' ' ' PHE . 15.1 tmm? -87.75 142.23 27.98 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 102' ' ' PHE . . . . . 0.603 ' N ' ' SD ' ' B' ' 101' ' ' MET . 52.8 p90 -153.9 162.09 41.49 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 103' ' ' TRP . . . . . 0.757 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 20.9 m95 -95.16 138.68 32.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.404 0.621 . . . . 0.0 110.785 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 104' ' ' ASN . . . . . 0.477 HD21 ' HG2' ' B' ' 123' ' ' GLN . 62.8 t-20 -132.66 107.19 8.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.78 -1.1 . . . . 0.0 113.567 -177.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 105' ' ' GLU . . . . . 0.455 ' HB2' HD11 ' B' ' 126' ' ' ILE . 81.7 tt0 -76.14 123.7 26.25 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.413 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 39.0 tp -111.39 125.59 54.03 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.989 0.423 . . . . 0.0 112.012 -177.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 107' ' ' ASN . . . . . 0.926 ' OD1' HG23 ' B' ' 89' ' ' THR . 98.3 m-20 -119.08 128.6 54.48 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.034 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 96.5 mt -123.61 133.06 70.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -142.85 122.96 7.95 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -69.89 152.29 68.61 Favored 'Trans proline' 0 N--CA 1.499 1.85 0 C-N-CA 122.381 2.054 . . . . 0.0 112.642 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 111' ' ' MET . . . . . 0.478 ' HB2' ' HB2' ' B' ' 118' ' ' TYR . 67.3 mtt -130.22 141.85 50.61 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -113.34 108.43 17.23 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 113' ' ' ILE . . . . . 0.467 HG12 ' NZ ' ' A' ' 18' ' ' LYS . 96.7 mt -134.52 127.93 50.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 118.279 0.491 . . . . 0.0 112.04 177.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 52.49 38.33 25.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.93 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 60.09 37.07 21.21 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.441 -178.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -132.41 153.1 51.15 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 117' ' ' THR . . . . . 0.455 HG23 ' CG ' ' B' ' 32' ' ' PRO . 9.7 t -104.95 151.85 23.4 Favored 'General case' 0 C--O 1.214 -0.766 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -178.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 118' ' ' TYR . . . . . 0.478 ' HB2' ' HB2' ' B' ' 111' ' ' MET . 96.2 m-85 -149.29 147.03 27.88 Favored 'General case' 0 C--O 1.239 0.541 0 O-C-N 121.066 -1.021 . . . . 0.0 110.889 -177.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 119' ' ' PHE . . . . . 0.474 ' O ' ' OG1' ' B' ' 30' ' ' THR . 90.9 m-85 -123.03 139.25 54.28 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 123.523 0.514 . . . . 0.0 110.846 -176.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -128.0 133.63 66.83 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.03 122.1 6.79 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 122' ' ' ILE . . . . . 0.468 ' HB ' ' HB2' ' B' ' 107' ' ' ASN . 91.2 mt -111.33 127.22 68.62 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.44 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 123' ' ' GLN . . . . . 0.541 ' HB2' ' HA3' ' B' ' 26' ' ' GLY . 17.0 mp0 -117.97 118.96 33.39 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -118.09 121.16 39.87 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 125' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' B' ' 127' ' ' THR . 68.0 t0 -69.36 133.56 47.97 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.043 -0.981 . . . . 0.0 112.261 -178.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.492 ' O ' ' HG3' ' B' ' 130' ' ' LYS . 3.2 mp -107.24 17.89 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.77 0 CA-C-O 122.397 1.094 . . . . 0.0 108.918 177.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 127' ' ' THR . . . . . 0.552 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 97.0 m -63.76 -44.21 94.13 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 113.59 -1.641 . . . . 0.0 112.403 175.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 59.2 tptt -60.91 -45.66 93.74 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -178.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 129' ' ' GLN . . . . . 0.444 ' OE1' HG23 ' B' ' 126' ' ' ILE . 88.4 mt-30 -63.34 -35.17 79.5 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.687 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 130' ' ' LYS . . . . . 0.757 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 98.7 mttt -63.1 -41.41 99.38 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 113.253 -1.794 . . . . 0.0 110.691 174.158 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.67 -42.1 95.62 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 132' ' ' TYR . . . . . 0.667 ' CE2' HD11 ' B' ' 136' ' ' LEU . 87.9 t80 -59.92 -44.4 94.34 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 121.878 -0.514 . . . . 0.0 111.388 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 133' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' B' ' 137' ' ' GLU . 97.4 mt-10 -64.94 -36.53 84.68 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.724 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 134' ' ' LYS . . . . . 0.435 ' HG3' ' O ' ' B' ' 130' ' ' LYS . 98.8 mttt -63.11 -39.31 94.33 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.756 178.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 54.4 tp -62.78 -41.25 99.16 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.401 0.62 . . . . 0.0 109.83 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 136' ' ' LEU . . . . . 0.667 HD11 ' CE2' ' B' ' 132' ' ' TYR . 87.0 mt -63.34 -41.48 98.88 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.494 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 137' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' B' ' 133' ' ' GLU . 97.2 mt-10 -64.61 -37.98 89.43 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.511 -178.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.58 -43.68 96.26 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.824 176.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 61.4 m -60.96 -44.41 97.34 Favored 'General case' 0 C--N 1.344 0.352 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 140' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' B' ' 144' ' ' THR . 84.5 mt -61.64 -40.36 94.6 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -177.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 99.3 m -61.9 -45.13 95.09 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.728 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -65.97 -42.33 90.0 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 93.9 mt -63.81 -43.2 97.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 114.515 -1.22 . . . . 0.0 110.493 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 144' ' ' THR . . . . . 0.495 ' N ' ' O ' ' B' ' 140' ' ' LEU . 99.8 m -61.7 -45.76 92.6 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.42 -40.5 97.35 Favored 'General case' 0 C--O 1.228 -0.071 0 C-N-CA 119.071 -1.052 . . . . 0.0 109.161 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 83.4 mt -64.38 -40.96 96.84 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 147' ' ' SER . . . . . 0.617 ' O ' ' N ' ' B' ' 149' ' ' PRO . 78.1 p -61.86 -41.44 97.85 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 148' ' ' THR . . . . . 0.504 ' C ' ' O ' ' B' ' 147' ' ' SER . 8.9 m -27.06 85.66 0.04 OUTLIER Pre-proline 0 N--CA 1.473 0.716 0 O-C-N 124.035 0.834 . . . . 0.0 109.999 177.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 149' ' ' PRO . . . . . 0.617 ' N ' ' O ' ' B' ' 147' ' ' SER . 24.3 Cg_exo -61.27 146.25 97.58 Favored 'Trans proline' 0 C--N 1.299 -2.036 0 C-N-CA 122.008 1.805 . . . . 0.0 115.211 -177.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 9.5 tp -127.91 123.36 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 174.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 29.9 t -152.78 96.71 2.93 Favored Pre-proline 0 C--N 1.304 -1.39 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.127 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -63.43 132.34 35.45 Favored 'Trans proline' 0 N--CA 1.486 1.062 0 CA-C-N 119.626 0.902 . . . . 0.0 109.776 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 153' ' ' ILE . . . . . 0.663 ' O ' ' HD2' ' B' ' 154' ' ' ARG . 45.8 mm -68.97 -44.33 81.48 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.437 0 C-N-CA 119.738 -0.785 . . . . 0.0 110.88 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 154' ' ' ARG . . . . . 0.663 ' HD2' ' O ' ' B' ' 153' ' ' ILE . 1.0 OUTLIER -154.96 -157.18 0.73 Allowed 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 178.678 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -86.35 110.55 19.76 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.02 -20.36 50.89 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 -177.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 88.1 mt -108.6 123.89 64.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.76 0.314 . . . . 0.0 111.738 -176.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 158' ' ' SER . . . . . 0.549 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 59.6 m -134.45 150.29 50.82 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.857 178.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -130.89 146.23 52.25 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 38.4 tp -139.61 74.58 33.28 Favored Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 161' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -69.43 148.09 66.44 Favored 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 122.754 2.303 . . . . 0.0 114.318 -177.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 92.9 mt -114.1 134.36 54.93 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 52.2 t -129.01 132.64 67.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 113.5 168.32 16.77 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 120.419 -0.896 . . . . 0.0 111.441 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 165' ' ' ASN . . . . . 0.705 ' O ' ' CZ ' ' B' ' 170' ' ' ARG . 56.2 t30 -89.09 107.79 19.24 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -179.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 166' ' ' LEU . . . . . 0.518 HD21 ' CZ ' ' B' ' 171' ' ' PHE . 43.5 tp -66.34 104.34 1.2 Allowed 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -174.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 167' ' ' THR . . . . . 0.629 HG23 ' NE ' ' B' ' 170' ' ' ARG . 10.5 p -84.51 171.16 12.76 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 113.733 -1.576 . . . . 0.0 111.091 177.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -67.18 -38.46 85.42 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.766 177.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -66.55 -40.13 88.9 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-O 123.122 1.439 . . . . 0.0 111.773 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 170' ' ' ARG . . . . . 0.705 ' CZ ' ' O ' ' B' ' 165' ' ' ASN . 88.2 mtm180 -63.31 -36.83 85.0 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 112.241 -2.254 . . . . 0.0 111.109 178.243 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 171' ' ' PHE . . . . . 0.518 ' CZ ' HD21 ' B' ' 166' ' ' LEU . 0.4 OUTLIER -53.92 -25.16 19.01 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 113.607 0.965 . . . . 0.0 113.607 -178.472 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 172' ' ' ASN . . . . . 0.645 ' O ' HG22 ' B' ' 175' ' ' VAL . 90.1 m-20 -62.73 -40.2 96.47 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.872 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 49.3 m -60.41 -41.09 93.18 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.23 0.538 . . . . 0.0 110.802 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 66.5 mt -63.56 -43.95 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 175' ' ' VAL . . . . . 0.645 HG22 ' O ' ' B' ' 172' ' ' ASN . 23.8 m -62.6 -39.86 86.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 176' ' ' CYS . . . . . 0.438 ' N ' HG23 ' B' ' 175' ' ' VAL . 98.7 m -62.49 -35.09 78.25 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.241 177.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 177' ' ' THR . . . . . 0.613 ' O ' HG13 ' B' ' 181' ' ' ILE . 25.0 m -61.41 -19.81 62.35 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.243 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 178' ' ' LEU . . . . . 0.755 ' CD2' HD21 ' B' ' 211' ' ' LEU . 93.3 mt -61.15 -39.6 90.71 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.397 -178.317 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 19.6 m -61.5 -44.22 97.46 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 176.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 180' ' ' ASN . . . . . 0.597 ' O ' ' OG ' ' B' ' 183' ' ' SER . 92.0 m-20 -61.52 -40.05 93.23 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.296 0.57 . . . . 0.0 110.29 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.613 HG13 ' O ' ' B' ' 177' ' ' THR . 70.4 mt -56.56 -35.94 46.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 O-C-N 121.978 -0.452 . . . . 0.0 110.582 -178.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 182' ' ' LEU . . . . . 0.473 HD21 HD21 ' B' ' 214' ' ' LEU . 84.1 mt -61.82 -41.79 98.22 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 119.839 -0.744 . . . . 0.0 109.187 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 183' ' ' SER . . . . . 0.597 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.2 p -62.97 -33.08 74.63 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 121.897 -0.502 . . . . 0.0 110.779 177.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 54.3 p -85.88 16.15 4.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.823 0.344 . . . . 0.0 111.753 -177.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 78.5 p -60.64 -16.68 41.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.782 -176.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -61.5 -40.5 94.83 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.882 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 187' ' ' ASP . . . . . 0.549 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.8 m-20 -70.44 115.27 9.42 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.528 0.68 . . . . 0.0 110.401 -178.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.88 -42.29 99.71 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 114.895 -1.048 . . . . 0.0 113.305 -177.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -111.46 131.67 55.05 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.674 -0.411 . . . . 0.0 111.135 -177.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 190' ' ' LEU . . . . . . . . . . . . . 42.1 tp -123.8 118.81 28.01 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.056 177.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 84.8 mt -107.87 126.66 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.049 -177.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 50.0 mm -115.25 117.62 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 193' ' ' ASP . . . . . 0.565 ' CG ' ' HG ' ' B' ' 195' ' ' SER . 42.6 t0 -87.64 112.19 22.07 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.938 -177.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 194' ' ' LEU . . . . . . . . . . . . . 96.1 mt -92.5 -2.78 55.98 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 176.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 195' ' ' SER . . . . . 0.565 ' HG ' ' CG ' ' B' ' 193' ' ' ASP . 78.2 p -61.14 -38.27 85.8 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.819 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.74 -34.1 87.48 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 197' ' ' LEU . . . . . 0.984 ' CD2' ' H ' ' B' ' 199' ' ' GLN . 4.9 tt -77.2 132.73 38.9 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 198' ' ' ALA . . . . . 0.972 ' N ' HD23 ' B' ' 197' ' ' LEU . . . -63.78 -41.8 97.88 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.854 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 199' ' ' GLN . . . . . 0.984 ' H ' ' CD2' ' B' ' 197' ' ' LEU . 58.9 tt0 -138.08 163.43 31.65 Favored 'General case' 0 C--O 1.203 -1.345 0 CA-C-O 122.096 0.951 . . . . 0.0 113.008 -178.05 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 200' ' ' VAL . . . . . 0.466 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 50.3 t -121.46 132.77 69.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 O-C-N 120.229 -1.544 . . . . 0.0 109.349 178.085 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -94.06 148.65 21.96 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.918 0.866 . . . . 0.0 111.359 -177.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -59.9 -33.12 71.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.857 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -63.87 -33.58 76.01 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.4 m -61.09 -44.45 97.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.096 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 205' ' ' ALA . . . . . 0.641 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -57.95 -31.66 67.07 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.835 -178.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -65.43 -38.16 89.06 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.216 0.531 . . . . 0.0 109.884 176.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -66.32 -38.96 88.89 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.586 178.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.7 -43.13 97.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.589 0.709 . . . . 0.0 110.463 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 209' ' ' PHE . . . . . 0.641 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 65.3 m-85 -61.93 -43.34 99.04 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 113.828 -1.533 . . . . 0.0 112.384 178.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.92 -42.4 97.39 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.836 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 211' ' ' LEU . . . . . 0.755 HD21 ' CD2' ' B' ' 178' ' ' LEU . 37.7 mt -62.42 -42.49 99.48 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.078 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 78.2 p -62.8 -36.13 82.12 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.836 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 213' ' ' HIS . . . . . 0.407 ' CE1' HD11 ' B' ' 217' ' ' LEU . 58.7 t-80 -67.08 -46.68 73.53 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 115.296 -0.866 . . . . 0.0 112.261 178.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.473 HD21 HD21 ' B' ' 182' ' ' LEU . 51.1 tp -63.79 -43.21 97.01 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 121.776 0.798 . . . . 0.0 109.487 178.323 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 215' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' B' ' 211' ' ' LEU . 90.9 mt -62.87 -43.89 97.59 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 113.607 -1.633 . . . . 0.0 111.253 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.55 -39.12 89.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.917 -177.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 217' ' ' LEU . . . . . 0.407 HD11 ' CE1' ' B' ' 213' ' ' HIS . 85.7 mt -63.02 -42.79 99.88 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.314 176.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 218' ' ' THR . . . . . 0.403 HG23 ' O ' ' B' ' 214' ' ' LEU . 66.7 p -74.24 -16.54 60.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.806 -178.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 80.45 61.21 2.23 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 107.307 -2.317 . . . . 0.0 107.307 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 220' ' ' THR . . . . . . . . . . . . . 94.9 m -141.3 106.84 5.06 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 174.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -63.57 140.2 58.85 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.689 -174.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 44.5 tp -116.03 120.89 40.56 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.557 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 3.0 mp -109.97 129.57 64.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.758 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 224' ' ' ILE . . . . . 0.489 ' CG2' HD11 ' B' ' 227' ' ' ILE . 50.8 mm -111.0 127.11 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 43.5 p -134.34 157.76 45.54 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.924 0.869 . . . . 0.0 112.688 -178.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 90.23 18.84 48.35 Favored Glycine 0 CA--C 1.5 -0.871 0 CA-C-N 113.815 -1.539 . . . . 0.0 111.182 -177.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 227' ' ' ILE . . . . . 0.614 HD12 HG23 ' B' ' 247' ' ' THR . 95.0 mt -85.29 125.44 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 118.292 1.046 . . . . 0.0 111.556 -178.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 49.5 tttt -62.87 139.97 97.36 Favored Pre-proline 0 C--N 1.313 -0.98 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.08 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.1 -37.93 93.78 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 121.373 1.382 . . . . 0.0 112.799 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -64.7 -41.67 95.84 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -178.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 50.7 tp -61.61 -41.87 98.07 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.014 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.34 -36.65 84.82 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.742 0.306 . . . . 0.0 111.123 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 94.3 mtp -63.73 -40.98 98.07 Favored 'General case' 0 C--O 1.25 1.094 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.793 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.51 -44.4 96.47 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 122.291 1.043 . . . . 0.0 109.332 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 35.6 mmt -64.25 -35.64 81.48 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.634 -1.167 . . . . 0.0 111.716 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -61.39 -40.33 93.98 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -177.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.06 -43.2 99.26 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.202 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 55.8 tp -61.58 -44.92 96.13 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 120.257 -0.577 . . . . 0.0 112.33 -178.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 239' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' B' ' 240' ' ' ALA . 66.8 t0 -158.09 134.69 9.65 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.355 -0.538 . . . . 0.0 112.141 -179.065 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 240' ' ' ALA . . . . . 0.421 ' N ' ' OD1' ' B' ' 239' ' ' ASP . . . -61.76 -46.69 88.49 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 176.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 241' ' ' ASN . . . . . 0.495 ' O ' ' HB2' ' B' ' 244' ' ' SER . 91.9 m-20 -43.21 -21.85 0.03 OUTLIER 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.361 -176.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 242' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -61.29 -45.36 94.8 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.523 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 243' ' ' SER . . . . . . . . . . . . . 77.4 p -58.18 -44.62 88.12 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 244' ' ' SER . . . . . 0.495 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 19.7 m -32.59 -37.82 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 94.9 mt -83.39 134.47 34.89 Favored 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.27 175.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -63.61 136.56 57.61 Favored 'General case' 0 C--O 1.241 0.655 0 O-C-N 121.368 -0.833 . . . . 0.0 111.645 -176.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 247' ' ' THR . . . . . 0.614 HG23 HD12 ' B' ' 227' ' ' ILE . 98.3 m -125.43 127.54 46.7 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.537 -1.211 . . . . 0.0 112.083 178.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 248' ' ' TYR . . . . . 0.45 ' CG ' ' HB2' ' B' ' 254' ' ' ALA . 96.9 m-85 -112.44 143.42 43.6 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.017 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 249' ' ' SER . . . . . 0.599 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 78.3 p -62.85 -33.31 74.99 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.144 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 250' ' ' ASN . . . . . 0.599 ' OD1' ' O ' ' B' ' 249' ' ' SER . 98.9 m-20 -148.43 160.19 43.29 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.189 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 73.6 t -64.66 -44.55 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.077 177.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 252' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.96 -46.09 92.1 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 253' ' ' ASP . . . . . 0.574 ' O ' HG22 ' B' ' 257' ' ' VAL . 90.9 m-20 -60.67 -43.37 97.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.188 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 254' ' ' ALA . . . . . 0.45 ' HB2' ' CG ' ' B' ' 248' ' ' TYR . . . -65.42 -40.47 93.4 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 120.091 -0.644 . . . . 0.0 111.332 178.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 255' ' ' VAL . . . . . 0.404 ' O ' ' HD2' ' B' ' 259' ' ' PRO . 62.2 t -64.82 -45.52 94.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.656 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 256' ' ' LYS . . . . . 0.422 ' HE3' ' ND2' ' A' ' 155' ' ' ASN . 88.7 tttt -63.36 -48.65 77.06 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.485 -178.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 257' ' ' VAL . . . . . 0.574 HG22 ' O ' ' B' ' 253' ' ' ASP . 33.0 m -64.69 -41.13 91.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.623 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 258' ' ' LEU . . . . . 0.505 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 0.9 OUTLIER -33.09 -72.87 0.06 OUTLIER Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.947 -177.948 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 259' ' ' PRO . . . . . 0.595 ' O ' HG13 ' B' ' 260' ' ' ILE . 38.4 Cg_endo -62.54 141.78 87.64 Favored 'Trans proline' 0 N--CA 1.506 2.236 0 C-N-CA 121.855 1.703 . . . . 0.0 111.243 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 260' ' ' ILE . . . . . 0.595 HG13 ' O ' ' B' ' 259' ' ' PRO . 96.6 mt -160.61 -18.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 77.2 mtm . . . . . 0 C--O 1.219 -0.547 0 CA-C-O 117.919 -1.038 . . . . 0.0 111.786 -179.738 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.234 0 N-CA-C 109.054 -1.619 . . . . 0.0 109.054 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.54 165.47 35.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 119.173 -0.442 . . . . 0.0 110.111 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.9 p -70.9 -16.54 62.69 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 121.5 0.667 . . . . 0.0 111.356 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -72.1 -65.71 0.74 Allowed 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 114.275 -1.329 . . . . 0.0 112.151 174.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -67.07 -38.21 85.36 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.538 ' O ' ' NZ ' ' B' ' 17' ' ' LYS . 60.9 m -59.4 -42.45 91.76 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.152 -177.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.521 ' HB3' ' O ' ' A' ' 6' ' ' SER . 44.6 t80 84.6 84.04 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 O-C-N 123.69 0.618 . . . . 0.0 111.801 176.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.623 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -58.99 -141.72 0.01 OUTLIER Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -177.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.623 ' HB ' ' O ' ' A' ' 8' ' ' GLY . 86.3 mt 84.64 109.92 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.626 0 C-N-CA 122.39 0.276 . . . . 0.0 110.682 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.27 -22.37 72.23 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.49 1.46 . . . . 0.0 111.994 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.41 -37.29 94.27 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.844 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.1 -39.9 93.79 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.51 0.671 . . . . 0.0 109.847 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 52.8 tp -63.23 -41.19 99.06 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.947 -0.569 . . . . 0.0 112.215 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -63.03 -41.33 99.49 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.1 t -60.36 -44.06 95.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 O-C-N 122.339 -0.226 . . . . 0.0 110.705 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 92.3 mt -62.58 -43.48 98.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.452 -177.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.43 ' NZ ' ' HA ' ' B' ' 6' ' ' SER . 98.9 mttt -62.53 -45.38 93.25 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 119.458 -0.897 . . . . 0.0 111.879 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.556 ' HZ1' HG12 ' B' ' 113' ' ' ILE . 98.4 mttt -60.44 -39.53 87.84 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 118.555 -1.258 . . . . 0.0 109.051 -176.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.85 -41.56 91.67 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.059 -0.656 . . . . 0.0 110.262 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.6 mt -63.07 -41.24 99.39 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.61 -38.79 92.45 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.383 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -58.69 -39.98 82.27 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 122.2 -0.312 . . . . 0.0 111.243 -178.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.9 p -114.61 129.3 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.496 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 34.6 ptt180 -71.11 108.71 4.77 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 122.098 0.951 . . . . 0.0 112.081 -177.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.0 p -140.07 142.59 31.49 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 178.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.416 ' HA3' ' HB2' ' A' ' 123' ' ' GLN . . . -97.84 93.48 1.4 Allowed Glycine 0 C--N 1.312 -0.783 0 C-N-CA 120.776 -0.726 . . . . 0.0 113.058 -179.108 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.9 t -124.41 130.0 73.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 175.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.3 m -136.34 159.22 38.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.6 mt -121.28 128.99 76.05 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.402 ' OG1' ' HB2' ' A' ' 119' ' ' PHE . 15.4 p -103.65 167.68 9.64 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.541 ' C ' ' OD1' ' A' ' 37' ' ' ASN . 45.6 t0 -133.37 101.23 13.45 Favored Pre-proline 0 C--N 1.32 -0.684 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.659 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.443 ' HG3' HG23 ' A' ' 117' ' ' THR . 34.8 Cg_endo -63.04 -22.58 73.66 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.411 1.407 . . . . 0.0 111.534 -179.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.4 -35.73 80.11 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.774 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 91.9 mt -85.85 161.0 19.29 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.656 177.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.744 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 43.1 tt0 -59.67 135.42 57.67 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -177.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.537 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 60.2 t0 60.65 22.37 12.23 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.877 178.234 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.541 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 22.5 t-20 40.9 67.82 2.72 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.877 -178.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.744 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 91.3 Cg_endo -71.23 156.88 58.47 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 C-N-CA 123.816 3.011 . . . . 0.0 112.493 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.4 mt -90.08 125.34 42.98 Favored 'Isoleucine or valine' 0 C--O 1.245 0.862 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.441 HG23 ' N ' ' A' ' 41' ' ' TYR . 35.3 m -105.54 -43.57 7.63 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 O-C-N 123.585 0.553 . . . . 0.0 112.102 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.441 ' N ' HG23 ' A' ' 40' ' ' VAL . 46.8 t80 -95.28 124.58 39.39 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.736 -178.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.9 p -142.58 139.55 28.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.347 177.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.593 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 56.7 p30 -96.73 166.6 11.57 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.526 ' HA ' ' OE1' ' A' ' 44' ' ' GLN . 12.6 mm100 -67.19 -37.98 84.6 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 120.961 0.41 . . . . 0.0 111.855 177.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.03 -27.51 64.9 Favored Glycine 0 C--N 1.331 0.283 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.683 ' CD2' HD13 ' A' ' 57' ' ' ILE . 71.0 t80 -59.13 -48.43 81.64 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.669 HG13 ' O ' ' A' ' 52' ' ' TYR . 54.9 t -59.58 -44.9 94.26 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.585 0 O-C-N 121.297 -0.877 . . . . 0.0 111.442 -173.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -63.64 -37.61 87.98 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 120.415 -0.514 . . . . 0.0 112.027 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.408 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 58.8 ttm -67.3 -43.59 81.35 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 175.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 39.8 p -90.06 -23.79 21.34 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.155 0.502 . . . . 0.0 111.634 -178.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.78 20.44 70.9 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 -179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.669 ' O ' HG13 ' A' ' 47' ' ' VAL . 90.4 m-85 -115.02 141.89 47.38 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.003 0.521 . . . . 0.0 111.539 178.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -65.96 149.52 50.1 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.848 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.441 HG22 ' H ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -65.7 -33.09 75.07 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -179.916 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.27 -43.71 85.67 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 119.535 -0.866 . . . . 0.0 111.286 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -64.76 -44.67 89.32 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.393 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.683 HD13 ' CD2' ' A' ' 46' ' ' PHE . 93.5 mt -61.81 -49.98 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -174.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 84.1 mt -55.94 148.67 16.73 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 176.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.01 -4.54 61.53 Favored Glycine 0 CA--C 1.52 0.377 0 CA-C-O 119.379 -0.678 . . . . 0.0 113.305 177.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -136.98 149.37 47.48 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.041 1.42 . . . . 0.0 111.711 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.57 ' C ' ' H ' ' A' ' 63' ' ' ARG . 25.8 t-20 -80.89 152.09 28.29 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.189 0.519 . . . . 0.0 110.687 -178.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 82.0 m -62.2 15.12 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.291 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.57 ' H ' ' C ' ' A' ' 61' ' ' ASN . 34.4 ptt-85 -61.93 -41.6 98.14 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.979 -0.45 . . . . 0.0 111.376 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -56.17 -21.84 25.3 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 93.0 mt -67.25 -35.64 79.98 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.757 0.789 . . . . 0.0 113.063 177.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -63.05 142.87 58.22 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.225 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.499 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -152.8 -148.79 4.97 Favored Glycine 0 CA--C 1.54 1.638 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.685 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.85 -40.69 98.23 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -177.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.6 ' O ' ' NE2' ' A' ' 93' ' ' GLN . 8.8 m-70 -76.5 -9.04 58.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.715 0.293 . . . . 0.0 111.101 -178.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.499 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 30.6 m -62.87 129.94 42.62 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.204 -0.598 . . . . 0.0 109.786 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -87.7 110.52 35.33 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.997 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.29 -32.16 92.92 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.993 1.795 . . . . 0.0 113.117 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.76 -39.6 94.67 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.979 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.49 ' OE1' ' HB ' ' A' ' 90' ' ' VAL . 79.4 mm-40 -65.09 -43.85 90.79 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.231 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.7 t -59.88 -43.94 93.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 114.273 -1.331 . . . . 0.0 107.817 -176.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.83 -37.8 88.73 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.724 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -63.26 -39.8 95.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.235 0.541 . . . . 0.0 110.295 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 95.1 mt -63.85 -44.07 98.02 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.996 178.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -62.83 -43.07 99.79 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 113.655 -1.611 . . . . 0.0 108.371 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 98.5 m -61.34 -48.76 79.82 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.57 -41.87 91.16 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.589 -172.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 90.6 mt -63.24 -40.08 96.43 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 118.831 0.741 . . . . 0.0 111.414 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 66.9 tp60 -64.49 -32.94 74.78 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -90.3 -2.36 58.0 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.533 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.2 tttt 49.35 39.17 15.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.955 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -121.89 144.06 40.08 Favored Pre-proline 0 CA--C 1.533 0.321 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.434 ' HB3' ' OD1' ' A' ' 109' ' ' ASP . 24.7 Cg_exo -61.46 143.32 97.33 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 121.402 1.402 . . . . 0.0 113.236 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.8 p -139.79 142.45 32.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.819 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.925 HG23 ' OD1' ' A' ' 107' ' ' ASN . 99.0 m -126.33 121.25 32.04 Favored 'General case' 0 C--N 1.344 0.336 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 175.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.49 ' HB ' ' OE1' ' A' ' 74' ' ' GLU . 29.9 m -138.85 158.72 30.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.323 177.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -102.87 133.58 47.72 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 176.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.424 ' O ' HG23 ' A' ' 92' ' ' ILE . 18.0 tt -140.41 129.97 27.36 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.213 0 CA-C-N 121.067 1.758 . . . . 0.0 112.438 177.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.6 ' NE2' ' O ' ' A' ' 69' ' ' HIS . 34.4 mt-30 -63.37 132.19 50.69 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.75 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -131.9 155.92 47.03 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.542 -178.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -114.84 134.52 55.07 Favored 'General case' 0 C--N 1.346 0.444 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.458 ' HG3' ' CE1' ' A' ' 102' ' ' PHE . 99.0 mttt -83.61 -174.18 5.14 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.139 0.495 . . . . 0.0 111.532 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -62.44 -41.52 98.79 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.041 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 40.9 p-10 -83.95 5.17 26.52 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 111.892 0.331 . . . . 0.0 111.892 -177.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.01 -1.77 85.12 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.004 176.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 25.0 m -60.39 137.46 58.14 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 178.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.66 ' SD ' ' C ' ' A' ' 101' ' ' MET . 14.7 tmm? -104.44 127.83 52.22 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.628 0.252 . . . . 0.0 110.711 178.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.458 ' CE1' ' HG3' ' A' ' 96' ' ' LYS . 52.6 p90 -140.7 157.01 46.06 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.244 -0.582 . . . . 0.0 109.803 -177.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.786 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 20.8 m95 -88.12 141.96 28.15 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.54 HD21 ' HG2' ' A' ' 123' ' ' GLN . 56.9 t-20 -137.38 102.92 4.93 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -177.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 80.8 tt0 -67.75 136.64 54.54 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -176.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 41.8 tp -121.74 124.22 43.71 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.925 ' OD1' HG23 ' A' ' 89' ' ' THR . 98.0 m-20 -122.43 124.49 43.76 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.671 177.282 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 87' ' ' PRO . 96.4 mt -120.57 129.28 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 O-C-N 123.436 0.46 . . . . 0.0 111.597 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.434 ' OD1' ' HB3' ' A' ' 87' ' ' PRO . 2.4 m-20 -137.81 121.6 11.68 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 110.581 -0.155 . . . . 0.0 110.581 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -69.6 150.86 69.75 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 122.432 2.088 . . . . 0.0 112.713 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.68 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 66.6 mtt -121.94 153.12 38.91 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -127.81 94.19 3.88 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 176.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.443 ' CD1' HG22 ' B' ' 15' ' ' VAL . 96.5 mt -119.05 130.97 73.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.876 -178.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 51.95 36.51 18.62 Favored 'General case' 0 CA--C 1.517 -0.292 0 O-C-N 121.406 -0.809 . . . . 0.0 111.468 176.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 59.42 30.31 19.98 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.758 -178.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -127.47 146.12 50.6 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 177.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.724 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 5.0 t -82.04 -173.2 4.36 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.578 -0.701 . . . . 0.0 109.77 -178.229 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.724 ' CD2' ' O ' ' A' ' 117' ' ' THR . 64.0 m-85 -171.11 157.44 5.16 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 173.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.402 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 97.6 m-85 -131.32 146.21 52.19 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 174.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.5 p -133.15 135.68 56.29 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 177.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -109.17 127.41 8.51 Favored Glycine 0 CA--C 1.501 -0.795 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 178.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 96.2 mt -118.99 130.1 74.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.54 ' HG2' HD21 ' A' ' 104' ' ' ASN . 16.4 mp0 -120.39 117.74 28.53 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 123.563 0.539 . . . . 0.0 109.975 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -117.83 113.59 22.0 Favored 'General case' 0 C--O 1.248 0.995 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.032 -178.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 126' ' ' ILE . 68.1 t0 -64.02 132.41 50.51 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -174.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.52 ' O ' HG22 ' A' ' 126' ' ' ILE . 2.6 mp -97.5 2.58 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 113.765 -1.561 . . . . 0.0 110.398 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 19.3 m -60.61 -43.0 97.96 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.211 -0.931 . . . . 0.0 113.397 -178.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -59.76 -42.46 93.3 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -63.06 -39.05 93.59 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.723 177.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.786 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.7 mttt -62.41 -40.69 97.34 Favored 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 118.467 -1.293 . . . . 0.0 110.631 -178.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -62.53 -36.98 84.3 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -178.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.766 ' CE2' HD11 ' A' ' 136' ' ' LEU . 89.8 t80 -61.56 -45.96 91.93 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.597 176.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.62 -38.47 91.11 Favored 'General case' 0 C--O 1.225 -0.213 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.89 -40.91 97.07 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 51.5 tp -60.91 -43.6 98.33 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 -178.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.766 HD11 ' CE2' ' A' ' 132' ' ' TYR . 87.7 mt -62.7 -41.25 99.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.168 179.068 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.16 -41.1 99.19 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.766 -178.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -60.99 -41.84 97.27 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 -177.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 66.9 m -61.85 -41.0 97.29 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.661 176.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 144' ' ' THR . 90.2 mt -63.15 -41.9 99.35 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 92.8 m -61.86 -45.46 93.7 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.151 -178.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -65.41 -41.07 93.99 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 94.9 mt -64.55 -43.47 96.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 113.968 -1.469 . . . . 0.0 111.383 177.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.424 ' N ' ' O ' ' A' ' 140' ' ' LEU . 99.1 m -62.25 -46.08 90.42 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 120.432 -0.507 . . . . 0.0 112.167 -178.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.402 ' O ' ' HB ' ' A' ' 148' ' ' THR . . . -62.02 -41.28 97.92 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 118.789 -1.164 . . . . 0.0 108.931 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.3 mt -63.88 -42.62 97.44 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 177.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.681 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.0 p -60.56 -37.28 80.75 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -178.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.454 ' C ' ' O ' ' A' ' 147' ' ' SER . 55.5 m -31.14 83.91 0.03 OUTLIER Pre-proline 0 C--N 1.344 0.359 0 O-C-N 126.79 2.556 . . . . 0.0 106.211 -178.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.681 ' N ' ' O ' ' A' ' 147' ' ' SER . 21.7 Cg_exo -62.74 145.31 94.91 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 120.849 1.033 . . . . 0.0 114.604 -175.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.651 ' O ' HG23 ' A' ' 151' ' ' VAL . 8.7 tp -121.78 136.94 57.04 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.933 0 N-CA-C 102.891 -3.003 . . . . 0.0 102.891 176.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 150' ' ' ILE . 60.1 t -170.23 94.74 0.48 Allowed Pre-proline 0 N--CA 1.445 -0.685 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 177.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.421 ' HG3' ' HG3' ' B' ' 252' ' ' LYS . 46.2 Cg_endo -63.41 143.8 89.37 Favored 'Trans proline' 0 C--N 1.298 -2.092 0 N-CA-C 109.78 -0.892 . . . . 0.0 109.78 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.555 ' O ' HG11 ' B' ' 255' ' ' VAL . 44.2 mm -77.04 -60.27 2.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.03 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.68 ' NH2' ' HD3' ' B' ' 154' ' ' ARG . 1.6 mpt_? -140.41 -157.56 0.78 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.0 t-20 -86.45 105.23 16.62 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.804 0.812 . . . . 0.0 111.5 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.11 8.55 66.6 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 114.032 -1.44 . . . . 0.0 110.615 -177.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 97.1 mt -123.93 125.57 71.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 175.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.716 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 58.5 m -132.3 151.47 51.82 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.222 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -139.34 142.84 37.6 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.575 -0.703 . . . . 0.0 111.08 177.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 16.8 tp -133.96 80.83 53.45 Favored Pre-proline 0 N--CA 1.469 0.517 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.355 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -69.25 149.89 70.7 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.788 2.325 . . . . 0.0 112.938 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 88.7 mt -119.0 128.09 54.07 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.502 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 47.7 t -124.17 131.27 73.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 116.78 169.62 15.22 Favored Glycine 0 N--CA 1.48 1.62 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.174 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.874 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 56.4 t30 -87.08 113.28 22.69 Favored 'General case' 0 C--O 1.221 -0.431 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -178.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.538 HD21 ' CZ ' ' A' ' 171' ' ' PHE . 46.7 tp -72.39 104.19 3.68 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -178.057 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.723 HG23 ' NE ' ' A' ' 170' ' ' ARG . 11.4 p -85.63 167.42 15.36 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.571 178.349 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.49 -34.85 79.24 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.937 0.398 . . . . 0.0 111.6 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.2 -41.97 94.01 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.757 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.874 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 88.0 mtm180 -64.08 -33.18 75.18 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.993 0.917 . . . . 0.0 112.368 178.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.538 ' CZ ' HD21 ' A' ' 166' ' ' LEU . 0.5 OUTLIER -53.68 -28.24 32.39 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 118.887 -0.578 . . . . 0.0 112.472 -178.766 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.592 ' O ' HG22 ' A' ' 175' ' ' VAL . 91.1 m-20 -61.0 -40.64 94.29 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 118.942 -1.103 . . . . 0.0 109.774 -178.146 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 54.7 m -59.47 -41.25 89.33 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.604 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 66.9 mt -63.69 -44.35 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.592 HG22 ' O ' ' A' ' 172' ' ' ASN . 33.5 m -62.79 -40.39 88.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' CYS . . . . . 0.429 ' N ' HG23 ' A' ' 175' ' ' VAL . 99.3 m -62.77 -34.7 77.79 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.304 0.573 . . . . 0.0 110.34 178.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.509 ' O ' HG13 ' A' ' 181' ' ' ILE . 24.6 m -62.11 -19.49 63.06 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.197 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.59 ' CD2' HD21 ' A' ' 211' ' ' LEU . 90.5 mt -60.93 -41.17 95.66 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -177.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 18.3 m -59.48 -42.96 93.3 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ASN . . . . . 0.628 ' O ' ' OG ' ' A' ' 183' ' ' SER . 91.0 m-20 -61.34 -36.63 80.72 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 122.668 0.387 . . . . 0.0 110.837 178.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.512 HD12 ' HA ' ' A' ' 178' ' ' LEU . 67.0 mt -59.02 -39.92 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 O-C-N 121.558 -0.714 . . . . 0.0 109.086 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.473 HD21 HD21 ' A' ' 214' ' ' LEU . 86.3 mt -60.71 -40.61 92.88 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -177.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.628 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 77.9 p -61.65 -33.49 74.05 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.501 176.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.417 ' OG1' ' HA ' ' A' ' 181' ' ' ILE . 66.1 p -89.69 23.37 2.69 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.581 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 78.3 p -63.46 -19.93 65.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.188 0.518 . . . . 0.0 110.752 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.49 -37.29 83.14 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.916 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.716 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 98.2 m-20 -74.18 112.93 10.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.563 0.696 . . . . 0.0 110.839 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -62.74 -42.42 99.66 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 114.967 -1.015 . . . . 0.0 113.063 -177.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -110.48 130.91 55.45 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.562 -178.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 39.2 tp -120.21 128.61 53.53 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 177.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 96.7 mt -116.1 127.53 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-N 118.59 0.632 . . . . 0.0 109.689 177.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.2 mm -113.36 126.93 70.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 178.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' ASP . . . . . 0.43 ' CG ' ' HG ' ' A' ' 195' ' ' SER . 41.3 t0 -94.67 117.89 30.84 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-O 121.379 0.609 . . . . 0.0 110.667 176.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 97.9 mt -98.59 -4.81 33.23 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.882 175.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' SER . . . . . 0.43 ' HG ' ' CG ' ' A' ' 193' ' ' ASP . 78.2 p -62.31 -33.31 74.42 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.81 -42.68 99.77 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 118.553 -1.784 . . . . 0.0 109.081 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.958 ' CD2' ' O ' ' A' ' 199' ' ' GLN . 5.0 tt -70.59 128.69 36.98 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 112.891 -1.655 . . . . 0.0 107.516 -174.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.897 ' N ' HD23 ' A' ' 197' ' ' LEU . . . -60.26 -45.3 93.77 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.745 -176.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.958 ' O ' ' CD2' ' A' ' 197' ' ' LEU . 58.8 tt0 -138.81 157.31 46.31 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 114.466 -1.243 . . . . 0.0 112.847 -174.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.482 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 47.4 t -118.23 131.71 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -87.66 156.01 19.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.543 -178.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -64.35 -38.89 92.65 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.211 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -58.68 -32.35 69.05 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -178.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.6 m -61.21 -42.32 98.38 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.481 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.476 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -57.52 -39.01 75.6 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -177.079 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -61.64 -37.11 82.79 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.54 -39.12 91.39 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.892 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 94.8 mt -63.18 -44.23 99.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -178.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' PHE . . . . . 0.476 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 71.8 m-85 -62.21 -43.58 98.5 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.743 -178.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.34 -42.04 99.07 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 119.316 -0.954 . . . . 0.0 109.231 -178.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.59 HD21 ' CD2' ' A' ' 178' ' ' LEU . 38.2 mt -62.08 -41.81 98.55 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 77.9 p -61.57 -41.14 96.96 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.07 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -64.49 -45.86 85.49 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.378 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.473 HD21 HD21 ' A' ' 182' ' ' LEU . 48.6 tp -62.31 -46.14 90.06 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 119.1 -1.04 . . . . 0.0 108.492 178.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 211' ' ' LEU . 91.2 mt -62.2 -40.8 97.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.504 -177.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.27 -44.41 95.36 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.44 -178.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 87.5 mt -61.65 -39.68 92.23 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 69.8 p -75.77 -10.79 59.73 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.244 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.07 33.59 26.1 Favored Glycine 0 C--N 1.343 0.925 0 C-N-CA 120.501 -0.857 . . . . 0.0 113.205 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 97.3 m -119.36 113.27 20.56 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.073 1.436 . . . . 0.0 111.512 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -64.98 138.03 58.11 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.752 178.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 45.6 tp -113.8 130.82 56.41 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 3.0 mp -117.85 133.33 64.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.539 ' CG2' HD11 ' A' ' 227' ' ' ILE . 49.3 mm -115.48 131.81 66.73 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.416 HG22 ' HB2' ' A' ' 248' ' ' TYR . 44.4 p -133.72 166.13 23.34 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 120.531 -0.467 . . . . 0.0 111.997 -178.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 80.04 19.76 69.19 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.715 HD12 HG23 ' A' ' 247' ' ' THR . 97.1 mt -81.9 128.45 38.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 114.059 -1.07 . . . . 0.0 108.506 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 58.6 tttt -75.68 140.72 71.61 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.6 -39.22 89.63 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 121.069 1.179 . . . . 0.0 112.672 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -64.36 -39.67 94.35 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.686 0.755 . . . . 0.0 110.188 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 52.0 tp -63.91 -42.44 97.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.688 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.84 -37.9 89.1 Favored 'General case' 0 N--CA 1.461 0.103 0 O-C-N 121.952 -0.468 . . . . 0.0 110.973 -179.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 94.2 mtp -63.61 -40.89 98.05 Favored 'General case' 0 C--O 1.248 1.026 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.468 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.88 -38.62 91.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.437 177.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 35.0 mmt -65.59 -38.27 89.01 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.63 178.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -61.29 -41.82 97.61 Favored 'General case' 0 CA--C 1.515 -0.402 0 O-C-N 121.52 -0.738 . . . . 0.0 109.525 -177.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.16 -40.99 95.95 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.549 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 56.0 tp -63.52 -41.48 98.5 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 177.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -166.94 127.39 1.55 Allowed 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -60.45 -26.41 66.73 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.66 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.426 ' O ' ' HB2' ' A' ' 244' ' ' SER . 91.3 m-20 -61.39 -33.84 74.36 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.523 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -55.22 -44.27 75.25 Favored 'General case' 0 C--N 1.311 -1.088 0 O-C-N 121.551 -0.718 . . . . 0.0 109.422 -175.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 97.9 p -61.92 -20.12 63.44 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.865 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' A' ' 241' ' ' ASN . 40.6 m -56.03 -39.24 71.65 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.697 178.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 98.7 mt -84.03 122.82 29.31 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -43.38 135.42 3.52 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.895 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.715 HG23 HD12 ' A' ' 227' ' ' ILE . 97.9 m -127.25 132.53 50.36 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.844 177.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 248' ' ' TYR . . . . . 0.432 ' CB ' ' HB2' ' A' ' 254' ' ' ALA . 97.0 m-85 -118.01 139.83 50.63 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.29 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 249' ' ' SER . . . . . 0.411 ' O ' ' OD1' ' A' ' 250' ' ' ASN . 78.3 p -61.16 -42.87 99.34 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 119.277 -0.969 . . . . 0.0 108.589 -178.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.411 ' OD1' ' O ' ' A' ' 249' ' ' SER . 99.0 m-20 -143.83 160.56 40.55 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.699 0.762 . . . . 0.0 111.434 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 54.9 t -63.09 -44.42 99.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.933 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.76 -44.96 96.08 Favored 'General case' 0 CA--C 1.513 -0.475 0 C-N-CA 120.215 -0.594 . . . . 0.0 109.668 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' ASP . . . . . 0.497 ' O ' HG22 ' A' ' 257' ' ' VAL . 54.5 m-20 -64.22 -41.36 97.06 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.361 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 254' ' ' ALA . . . . . 0.432 ' HB2' ' CB ' ' A' ' 248' ' ' TYR . . . -64.83 -42.25 95.1 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.858 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 255' ' ' VAL . . . . . 0.478 HG13 HH11 ' B' ' 154' ' ' ARG . 68.3 t -64.03 -45.73 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-N 114.111 -1.404 . . . . 0.0 110.974 -178.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.62 -47.67 80.42 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.489 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.5 ' O ' ' C ' ' A' ' 258' ' ' LEU . 24.7 m -66.58 -40.45 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 120.118 -0.633 . . . . 0.0 112.206 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.5 ' C ' ' O ' ' A' ' 257' ' ' VAL . 0.9 OUTLIER -29.36 -74.9 0.04 OUTLIER Pre-proline 0 CA--C 1.533 0.313 0 CA-C-O 119.472 -0.299 . . . . 0.0 111.253 -177.106 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 259' ' ' PRO . . . . . 0.496 ' CD ' ' CB ' ' A' ' 258' ' ' LEU . 40.3 Cg_endo -62.84 139.61 75.33 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 120.73 0.953 . . . . 0.0 111.884 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 259' ' ' PRO . 96.5 mt -151.36 -23.55 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 O-C-N 123.327 0.392 . . . . 0.0 111.97 178.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 78.4 mtm . . . . . 0 C--O 1.218 -0.566 0 CA-C-O 118.125 -0.94 . . . . 0.0 110.637 -177.545 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.451 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.51 157.36 35.3 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 78.5 p -59.86 -22.13 61.89 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 123.339 0.399 . . . . 0.0 110.948 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -70.83 -61.58 1.71 Allowed 'General case' 0 N--CA 1.426 -1.633 0 O-C-N 121.946 -0.472 . . . . 0.0 111.133 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -67.54 -37.97 83.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.349 -0.842 . . . . 0.0 112.114 178.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 6' ' ' SER . . . . . 0.527 ' O ' ' HB3' ' B' ' 7' ' ' PHE . 63.9 m -59.63 -42.87 93.7 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.009 -177.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 7' ' ' PHE . . . . . 0.527 ' HB3' ' O ' ' B' ' 6' ' ' SER . 44.8 t80 85.13 86.82 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.754 0.659 . . . . 0.0 110.431 177.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 8' ' ' GLY . . . . . 0.63 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -61.0 -140.72 0.01 OUTLIER Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 -178.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.63 ' HB ' ' O ' ' B' ' 8' ' ' GLY . 86.0 mt 83.62 109.81 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 122.438 0.295 . . . . 0.0 110.975 -178.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -62.3 -24.53 76.0 Favored 'Trans proline' 0 N--CA 1.499 1.852 0 C-N-CA 121.431 1.42 . . . . 0.0 111.714 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.62 -39.67 97.7 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -64.33 -40.03 95.07 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.66 0.743 . . . . 0.0 109.693 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 52.3 tp -62.28 -42.27 99.2 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.026 -178.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -64.64 -33.34 75.72 Favored 'General case' 0 CA--C 1.56 1.333 0 CA-C-O 121.585 0.707 . . . . 0.0 110.614 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 15' ' ' VAL . . . . . 0.443 HG22 ' CD1' ' A' ' 113' ' ' ILE . 79.3 t -62.92 -46.24 96.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 113.136 -1.847 . . . . 0.0 111.08 177.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 95.5 mt -63.83 -43.96 98.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.422 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 17' ' ' LYS . . . . . 0.538 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 98.9 mttt -63.45 -41.99 98.65 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.94 -40.91 99.09 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 118.983 -1.087 . . . . 0.0 110.177 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.92 -38.39 85.6 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.82 -178.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 86.0 mt -64.0 -42.15 97.25 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.098 0.475 . . . . 0.0 110.222 176.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.27 -39.15 93.8 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.16 -179.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -58.04 -40.0 79.79 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 121.106 -0.237 . . . . 0.0 111.102 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 8.2 p -114.7 129.44 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.506 ' HG3' ' O ' ' B' ' 24' ' ' ARG . 34.5 ptt180 -70.94 106.65 3.72 Favored 'General case' 0 CA--C 1.527 0.079 0 CA-C-O 121.87 0.843 . . . . 0.0 112.527 -177.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.5 p -142.11 133.3 25.76 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.703 177.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 26' ' ' GLY . . . . . 0.453 ' O ' ' N ' ' B' ' 123' ' ' GLN . . . -88.45 97.79 2.35 Favored Glycine 0 N--CA 1.439 -1.135 0 C-N-CA 119.506 -1.33 . . . . 0.0 113.153 -176.023 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 45.9 t -125.3 129.08 73.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 174.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 27.5 m -138.11 155.96 30.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.821 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 94.8 mt -119.89 127.06 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 122.124 0.964 . . . . 0.0 111.181 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.405 HG22 HG12 ' B' ' 39' ' ' ILE . 23.7 p -106.71 157.99 17.3 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-N 112.654 -2.066 . . . . 0.0 108.628 -176.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.534 ' C ' ' OD1' ' B' ' 37' ' ' ASN . 46.1 t0 -126.78 101.36 26.77 Favored Pre-proline 0 C--O 1.239 0.515 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 -177.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 32' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.08 -20.7 67.81 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 121.714 1.609 . . . . 0.0 111.448 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.47 -43.29 99.12 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 120.575 -0.45 . . . . 0.0 109.865 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 91.8 mt -75.16 179.55 4.99 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.715 -0.616 . . . . 0.0 111.149 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 35' ' ' GLU . . . . . 0.666 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 42.5 tt0 -75.48 132.94 41.13 Favored 'General case' 0 C--N 1.342 0.245 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -178.12 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.5 ' O ' ' OD1' ' B' ' 36' ' ' ASP . 65.9 t0 56.21 37.11 28.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.757 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 37' ' ' ASN . . . . . 0.534 ' OD1' ' C ' ' B' ' 31' ' ' ASP . 13.2 t-20 30.11 70.48 0.59 Allowed Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.666 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 92.8 Cg_endo -72.82 156.26 52.99 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 123.401 2.734 . . . . 0.0 111.89 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.405 HG12 HG22 ' B' ' 30' ' ' THR . 96.1 mt -89.28 129.48 40.19 Favored 'Isoleucine or valine' 0 C--O 1.246 0.881 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.429 HG23 ' N ' ' B' ' 41' ' ' TYR . 35.1 m -108.63 -43.44 6.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 O-C-N 123.936 0.773 . . . . 0.0 112.585 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 41' ' ' TYR . . . . . 0.429 ' N ' HG23 ' B' ' 40' ' ' VAL . 49.1 t80 -96.05 124.86 40.23 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.45 -178.205 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 6.2 p -142.53 140.97 28.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.438 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 43' ' ' ASN . . . . . 0.63 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 56.4 p30 -101.32 160.98 13.95 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.111 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 44' ' ' GLN . . . . . 0.518 ' OE1' ' HA ' ' B' ' 44' ' ' GLN . 12.1 mm100 -63.0 -36.78 84.68 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.215 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.13 -27.75 65.51 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.686 ' CD2' HD13 ' B' ' 57' ' ' ILE . 66.8 t80 -60.32 -43.76 96.09 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.29 0.567 . . . . 0.0 109.601 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 0.738 HG13 ' O ' ' B' ' 52' ' ' TYR . 53.6 t -61.42 -46.4 96.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.336 -178.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -63.4 -44.25 95.2 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.21 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 59.0 ttm -63.34 -42.51 98.93 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 36.1 p -93.33 -18.62 22.22 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 120.327 -0.549 . . . . 0.0 111.875 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 51' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' B' ' 47' ' ' VAL . . . 74.98 18.93 80.17 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 178.184 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 52' ' ' TYR . . . . . 0.738 ' O ' HG13 ' B' ' 47' ' ' VAL . 89.8 m-85 -112.59 146.04 39.29 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.149 0.58 . . . . 0.0 110.528 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -73.4 148.44 43.33 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.474 0.654 . . . . 0.0 111.316 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 54' ' ' THR . . . . . 0.413 HG22 ' H ' ' B' ' 54' ' ' THR . 0.3 OUTLIER -61.82 -37.34 84.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.699 -177.565 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.81 -40.34 96.4 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.235 -0.586 . . . . 0.0 111.722 -178.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -71.62 -32.54 68.08 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 176.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.686 HD13 ' CD2' ' B' ' 46' ' ' PHE . 91.2 mt -66.63 -66.75 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . 0.25 97.0 mt -45.29 134.07 6.73 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.53 -9.95 73.4 Favored Glycine 0 CA--C 1.536 1.352 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.916 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -134.16 148.18 50.89 Favored 'General case' 0 C--N 1.342 0.263 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -174.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 61' ' ' ASN . . . . . 0.562 ' C ' ' H ' ' B' ' 63' ' ' ARG . 25.5 t-20 -79.39 151.18 31.09 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.446 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 62' ' ' CYS . . . . . . . . . . . . . 83.0 m -62.52 9.11 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.251 -178.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 63' ' ' ARG . . . . . 0.562 ' H ' ' C ' ' B' ' 61' ' ' ASN . 33.2 ptt-85 -59.89 -32.8 71.08 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.432 -177.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -60.14 -30.03 69.03 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 178.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 87.8 mt -62.2 -41.53 98.45 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 121.779 -0.575 . . . . 0.0 109.982 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -51.28 149.28 4.09 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.914 -176.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 67' ' ' GLY . . . . . 0.403 ' N ' ' OG1' ' B' ' 70' ' ' THR . . . -159.84 -152.84 6.65 Favored Glycine 0 CA--C 1.537 1.426 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.944 177.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.73 -41.75 95.93 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -175.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 69' ' ' HIS . . . . . 0.444 ' O ' ' NE2' ' B' ' 93' ' ' GLN . 8.7 m80 -74.94 -10.57 59.61 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.259 -178.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 70' ' ' THR . . . . . 0.428 HG23 HD11 ' B' ' 92' ' ' ILE . 28.7 m -61.26 134.58 57.13 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 120.391 -0.524 . . . . 0.0 109.625 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -92.21 110.47 44.63 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.443 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.28 -38.35 88.52 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 121.023 1.149 . . . . 0.0 111.835 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.63 -39.73 89.32 Favored 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 120.451 -0.5 . . . . 0.0 109.697 -176.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 74' ' ' GLU . . . . . 0.486 ' OE1' ' HB ' ' B' ' 90' ' ' VAL . 79.1 mm-40 -66.52 -39.18 88.5 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.888 177.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -62.29 -45.58 98.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -63.12 -36.99 85.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.693 -177.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -62.43 -41.77 98.96 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 119.368 -0.933 . . . . 0.0 108.679 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 94.1 mt -63.47 -43.7 98.5 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-O 120.767 0.318 . . . . 0.0 110.508 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -61.96 -42.63 99.34 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 91.7 m -61.47 -45.14 95.51 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.966 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.82 -41.25 97.54 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -177.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 87.1 mt -62.98 -42.19 99.77 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.597 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 66.7 tp60 -62.85 -35.1 78.85 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 84' ' ' ASN . . . . . 0.429 ' O ' ' HG2' ' B' ' 86' ' ' GLU . 98.2 m-20 -92.1 6.35 46.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.594 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 30.2 tttt 42.99 40.19 2.1 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.414 -0.515 . . . . 0.0 111.823 175.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 86' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' B' ' 84' ' ' ASN . 54.6 mm-40 -122.46 141.59 35.23 Favored Pre-proline 0 N--CA 1.467 0.424 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.29 178.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 87' ' ' PRO . . . . . 0.452 ' HB3' ' OD1' ' B' ' 109' ' ' ASP . 25.6 Cg_exo -61.94 140.95 87.65 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.03 1.154 . . . . 0.0 113.716 -178.268 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.92 137.67 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.66 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 89' ' ' THR . . . . . 0.913 HG23 ' OD1' ' B' ' 107' ' ' ASN . 96.4 m -121.76 122.72 40.16 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.486 ' HB ' ' OE1' ' B' ' 74' ' ' GLU . 31.1 m -138.87 162.81 28.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.892 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -114.15 121.59 44.24 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 175.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 92' ' ' ILE . . . . . 0.428 HD11 HG23 ' B' ' 70' ' ' THR . 20.6 tt -127.47 131.46 70.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.07 -175.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 93' ' ' GLN . . . . . 0.444 ' NE2' ' O ' ' B' ' 69' ' ' HIS . 35.5 mt-30 -70.13 139.95 52.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.763 177.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 94' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -129.44 178.86 6.15 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.626 0.727 . . . . 0.0 111.385 -177.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 95' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -130.43 142.42 50.5 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 114.335 -1.302 . . . . 0.0 112.173 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 96' ' ' LYS . . . . . 0.455 ' HG3' ' CE1' ' B' ' 102' ' ' PHE . 98.7 mttt -100.47 177.68 4.96 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.129 0.49 . . . . 0.0 110.958 177.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.71 -35.09 75.44 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.777 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -85.95 -1.64 57.51 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 118.872 0.76 . . . . 0.0 112.709 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.42 3.23 65.06 Favored Glycine 0 N--CA 1.47 0.96 0 C-N-CA 121.15 -0.547 . . . . 0.0 112.495 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 27.3 m -67.44 129.21 39.19 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.665 178.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 101' ' ' MET . . . . . 0.514 ' C ' ' SD ' ' B' ' 101' ' ' MET . 16.9 tmm? -89.22 140.58 29.34 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 102' ' ' PHE . . . . . 0.481 ' N ' ' SD ' ' B' ' 101' ' ' MET . 52.8 p90 -151.66 161.89 41.92 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 103' ' ' TRP . . . . . 0.804 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 21.2 m95 -93.69 137.99 32.37 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.529 0.68 . . . . 0.0 110.813 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 104' ' ' ASN . . . . . 0.543 HD21 ' HG2' ' B' ' 123' ' ' GLN . 64.1 t-20 -133.0 106.97 7.97 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 114.74 -1.118 . . . . 0.0 113.461 -176.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 105' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' B' ' 123' ' ' GLN . 81.2 tt0 -75.09 125.04 28.09 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.75 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 40.0 tp -113.5 125.54 54.32 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.073 0.463 . . . . 0.0 112.072 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 107' ' ' ASN . . . . . 0.913 ' OD1' HG23 ' B' ' 89' ' ' THR . 98.0 m-20 -121.08 130.01 53.57 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.431 -0.804 . . . . 0.0 108.88 176.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 96.6 mt -123.8 132.81 70.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.699 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 109' ' ' ASP . . . . . 0.452 ' OD1' ' HB3' ' B' ' 87' ' ' PRO . 2.9 m-20 -142.77 120.18 7.07 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 178.179 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -67.97 152.05 77.26 Favored 'Trans proline' 0 N--CA 1.503 2.079 0 C-N-CA 122.632 2.221 . . . . 0.0 112.739 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 111' ' ' MET . . . . . 0.574 ' HB2' ' HB2' ' B' ' 118' ' ' TYR . 66.9 mtt -128.4 144.33 51.12 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -114.88 106.95 14.77 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 113' ' ' ILE . . . . . 0.556 HG12 ' HZ1' ' A' ' 18' ' ' LYS . 96.8 mt -132.88 128.18 56.51 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-N 118.428 0.558 . . . . 0.0 111.77 178.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 53.51 36.68 23.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.946 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 61.32 35.85 17.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.628 -178.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -132.85 149.99 52.2 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 7.1 t -99.83 153.2 19.33 Favored 'General case' 0 C--O 1.214 -0.766 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -177.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 118' ' ' TYR . . . . . 0.574 ' HB2' ' HB2' ' B' ' 111' ' ' MET . 89.9 m-85 -148.29 148.9 30.96 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 121.189 -0.945 . . . . 0.0 111.349 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -124.96 139.68 53.6 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 120.881 0.372 . . . . 0.0 111.181 -177.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -128.54 133.95 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -176.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.54 123.78 7.16 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.186 -0.765 . . . . 0.0 111.186 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 95.2 mt -116.38 127.66 73.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 123' ' ' GLN . . . . . 0.543 ' HG2' HD21 ' B' ' 104' ' ' ASN . 16.4 mp0 -118.47 123.9 46.29 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -121.53 119.56 32.33 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 125' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' B' ' 126' ' ' ILE . 67.9 t0 -67.42 136.18 54.31 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.426 -178.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.506 ' O ' ' HG3' ' B' ' 130' ' ' LYS . 2.7 mp -109.78 15.07 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.937 0 CA-C-O 122.174 0.988 . . . . 0.0 109.132 178.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 127' ' ' THR . . . . . 0.453 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 97.6 m -63.05 -43.8 97.61 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 113.827 -1.533 . . . . 0.0 112.347 176.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 59.8 tptt -61.26 -45.92 92.53 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -177.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 129' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -63.51 -33.92 76.63 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.47 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 130' ' ' LYS . . . . . 0.804 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 98.8 mttt -63.53 -41.35 98.47 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 113.589 -1.641 . . . . 0.0 110.856 174.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -64.44 -41.48 96.54 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 132' ' ' TYR . . . . . 0.779 ' CE2' HD11 ' B' ' 136' ' ' LEU . 90.8 t80 -60.17 -44.96 94.61 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 121.801 -0.562 . . . . 0.0 111.358 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 133' ' ' GLU . . . . . 0.445 ' O ' ' HG3' ' B' ' 137' ' ' GLU . 97.4 mt-10 -64.58 -36.25 83.63 Favored 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 134' ' ' LYS . . . . . 0.435 ' HG3' ' O ' ' B' ' 130' ' ' LYS . 98.7 mttt -63.21 -39.81 95.7 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.68 177.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 52.8 tp -62.84 -41.57 99.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.332 0.587 . . . . 0.0 109.743 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 136' ' ' LEU . . . . . 0.779 HD11 ' CE2' ' B' ' 132' ' ' TYR . 89.9 mt -62.86 -41.85 99.53 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.269 177.039 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 137' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' B' ' 133' ' ' GLU . 97.3 mt-10 -65.16 -37.25 86.8 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.302 -1.317 . . . . 0.0 110.441 -178.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -63.22 -43.48 97.99 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.899 176.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 69.7 m -60.8 -44.14 97.25 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 89.7 mt -61.64 -40.32 94.46 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -176.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 94.5 m -62.11 -45.26 94.27 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.827 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -66.09 -42.8 88.83 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 92.5 mt -63.8 -43.24 97.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.688 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 144' ' ' THR . . . . . . . . . . . . . 99.6 m -61.68 -45.04 95.69 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 -178.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 145' ' ' ALA . . . . . 0.445 ' O ' ' HB ' ' B' ' 148' ' ' THR . . . -63.27 -41.72 99.06 Favored 'General case' 0 C--O 1.227 -0.093 0 C-N-CA 118.952 -1.099 . . . . 0.0 109.346 178.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 86.1 mt -64.83 -41.18 95.94 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 176.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 147' ' ' SER . . . . . 0.595 ' O ' ' N ' ' B' ' 149' ' ' PRO . 78.2 p -62.06 -41.34 98.04 Favored 'General case' 0 CA--C 1.479 -1.769 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 148' ' ' THR . . . . . 0.482 ' C ' ' O ' ' B' ' 147' ' ' SER . 26.3 m -28.61 87.19 0.04 OUTLIER Pre-proline 0 N--CA 1.474 0.76 0 O-C-N 124.1 0.875 . . . . 0.0 109.874 176.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 149' ' ' PRO . . . . . 0.595 ' N ' ' O ' ' B' ' 147' ' ' SER . 23.8 Cg_exo -61.67 147.04 96.26 Favored 'Trans proline' 0 C--N 1.301 -1.95 0 C-N-CA 121.952 1.768 . . . . 0.0 114.942 -178.043 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 9.0 tp -127.73 121.98 57.89 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.533 0 CA-C-N 113.571 -1.65 . . . . 0.0 107.63 174.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 38.7 t -154.01 95.97 2.75 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.699 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -62.35 142.95 92.91 Favored 'Trans proline' 0 C--N 1.318 -1.046 0 N-CA-C 109.61 -0.958 . . . . 0.0 109.61 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 153' ' ' ILE . . . . . 0.487 ' O ' ' HD2' ' B' ' 154' ' ' ARG . 44.5 mm -77.21 -57.46 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.387 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 154' ' ' ARG . . . . . 0.68 ' HD3' ' NH2' ' A' ' 154' ' ' ARG . 1.2 tpt180 -141.53 -156.07 0.65 Allowed 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 61.0 t-20 -86.05 109.6 18.93 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.29 -16.72 59.59 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -178.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 86.7 mt -108.75 125.56 65.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-O 120.86 0.362 . . . . 0.0 110.994 -176.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 158' ' ' SER . . . . . 0.68 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 61.5 m -134.45 149.28 50.73 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.132 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -135.4 147.34 48.99 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.157 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 17.1 tp -140.09 79.55 21.95 Favored Pre-proline 0 CA--C 1.531 0.228 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 161' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -70.05 147.96 62.14 Favored 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 122.839 2.359 . . . . 0.0 114.099 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 91.6 mt -115.29 133.87 55.64 Favored 'General case' 0 C--N 1.342 0.239 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 53.9 t -128.17 132.94 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 114.79 169.71 16.26 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.56 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 165' ' ' ASN . . . . . 0.723 ' O ' ' CZ ' ' B' ' 170' ' ' ARG . 60.9 t30 -91.62 107.11 18.97 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -178.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 166' ' ' LEU . . . . . 0.538 HD21 ' CZ ' ' B' ' 171' ' ' PHE . 47.7 tp -65.49 104.73 1.04 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -174.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 167' ' ' THR . . . . . 0.696 HG23 ' NE ' ' B' ' 170' ' ' ARG . 11.2 p -83.88 169.92 14.6 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 114.103 -1.408 . . . . 0.0 110.797 177.108 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -66.32 -38.51 87.86 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.97 177.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.09 -40.0 90.45 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 123.427 1.584 . . . . 0.0 111.828 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 170' ' ' ARG . . . . . 0.723 ' CZ ' ' O ' ' B' ' 165' ' ' ASN . 88.2 mtm180 -62.3 -36.24 81.51 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 111.914 -2.403 . . . . 0.0 111.05 178.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 171' ' ' PHE . . . . . 0.538 ' CZ ' HD21 ' B' ' 166' ' ' LEU . 0.5 OUTLIER -53.82 -25.16 18.12 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -179.439 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 172' ' ' ASN . . . . . 0.544 ' O ' HG22 ' B' ' 175' ' ' VAL . 91.4 m-20 -62.68 -40.23 96.43 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.845 178.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 49.2 m -60.46 -41.82 94.9 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.729 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 66.7 mt -63.92 -44.39 97.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 175' ' ' VAL . . . . . 0.544 HG22 ' O ' ' B' ' 172' ' ' ASN . 33.6 m -63.12 -40.59 89.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 176' ' ' CYS . . . . . 0.428 ' N ' HG23 ' B' ' 175' ' ' VAL . 97.1 m -62.58 -35.05 78.29 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.344 178.092 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 177' ' ' THR . . . . . 0.529 ' O ' HG13 ' B' ' 181' ' ' ILE . 25.3 m -61.9 -19.54 62.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.24 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 178' ' ' LEU . . . . . 0.566 ' CD2' HD21 ' B' ' 211' ' ' LEU . 91.1 mt -61.16 -39.51 90.38 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.278 -177.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 19.3 m -61.04 -43.95 98.11 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.185 177.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 180' ' ' ASN . . . . . 0.611 ' O ' ' OG ' ' B' ' 183' ' ' SER . 91.4 m-20 -61.45 -39.94 92.65 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.9 0.381 . . . . 0.0 110.416 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.529 HG13 ' O ' ' B' ' 177' ' ' THR . 71.8 mt -56.96 -34.44 44.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 O-C-N 122.221 -0.3 . . . . 0.0 110.626 -178.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 182' ' ' LEU . . . . . 0.476 HD21 HD21 ' B' ' 214' ' ' LEU . 85.3 mt -62.08 -41.59 98.34 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.11 178.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 183' ' ' SER . . . . . 0.611 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.1 p -63.3 -32.96 74.51 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 121.853 -0.53 . . . . 0.0 110.827 177.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 64.8 p -86.16 17.29 3.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.679 -177.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 78.1 p -61.27 -16.68 47.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.654 -177.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -61.79 -39.82 93.04 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.756 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 187' ' ' ASP . . . . . 0.68 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.1 m-20 -72.11 113.35 9.05 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.504 0.669 . . . . 0.0 110.496 -177.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -62.8 -42.22 99.62 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 114.83 -1.077 . . . . 0.0 113.119 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -110.47 130.52 55.54 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.034 -177.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 190' ' ' LEU . . . . . 0.428 ' HA ' ' O ' ' B' ' 158' ' ' SER . 41.1 tp -123.46 119.33 29.69 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.139 178.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 87.2 mt -107.44 126.86 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 117.796 0.271 . . . . 0.0 111.15 -176.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 49.2 mm -116.29 117.31 55.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 193' ' ' ASP . . . . . 0.464 ' CG ' ' HG ' ' B' ' 195' ' ' SER . 43.3 t0 -88.38 111.33 21.63 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -177.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 194' ' ' LEU . . . . . . . . . . . . . 98.1 mt -93.98 -2.74 52.66 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 176.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 195' ' ' SER . . . . . 0.464 ' HG ' ' CG ' ' B' ' 193' ' ' ASP . 78.2 p -61.35 -37.32 82.89 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.872 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.98 -34.01 87.49 Favored Glycine 0 N--CA 1.436 -1.312 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 197' ' ' LEU . . . . . 1.01 HD22 ' O ' ' B' ' 199' ' ' GLN . 5.2 tt -76.23 133.25 40.17 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -177.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 198' ' ' ALA . . . . . 0.915 ' N ' HD23 ' B' ' 197' ' ' LEU . . . -63.56 -41.26 98.42 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 119.979 -0.688 . . . . 0.0 111.935 -177.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 199' ' ' GLN . . . . . 1.01 ' O ' HD22 ' B' ' 197' ' ' LEU . 59.4 tt0 -140.96 164.23 30.82 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.446 0.641 . . . . 0.0 111.864 -179.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 200' ' ' VAL . . . . . 0.502 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 49.9 t -120.98 131.73 72.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 177.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -91.13 150.03 21.55 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.875 -177.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -60.5 -33.13 72.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.28 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -63.77 -33.81 76.49 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.465 0.65 . . . . 0.0 109.388 178.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.5 m -60.79 -43.93 97.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.246 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 205' ' ' ALA . . . . . 0.64 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -58.26 -30.44 66.57 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 111.79 0.292 . . . . 0.0 111.79 -177.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -65.42 -38.27 89.42 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.307 0.575 . . . . 0.0 109.932 176.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -66.39 -39.11 88.86 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.694 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.82 -43.26 97.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-O 121.688 0.756 . . . . 0.0 110.299 -178.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 209' ' ' PHE . . . . . 0.64 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 69.1 m-85 -61.95 -43.53 98.65 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 113.888 -1.505 . . . . 0.0 112.527 177.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.17 -41.77 99.28 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 119.584 -0.846 . . . . 0.0 110.046 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 211' ' ' LEU . . . . . 0.566 HD21 ' CD2' ' B' ' 178' ' ' LEU . 37.8 mt -62.3 -42.07 99.05 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.221 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 78.2 p -63.52 -35.58 80.94 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.893 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 213' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -66.78 -46.95 73.67 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.362 -0.836 . . . . 0.0 112.141 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.476 HD21 HD21 ' B' ' 182' ' ' LEU . 52.8 tp -63.89 -42.9 97.36 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.864 0.84 . . . . 0.0 110.032 177.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 215' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' B' ' 211' ' ' LEU . 92.6 mt -63.08 -43.42 98.58 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 113.389 -1.732 . . . . 0.0 111.701 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.18 -39.41 92.57 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.913 -177.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.45 -42.3 98.64 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.322 0.582 . . . . 0.0 111.483 175.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 218' ' ' THR . . . . . . . . . . . . . 77.9 p -73.69 -15.92 61.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.716 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 78.91 63.88 2.02 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 107.051 -2.419 . . . . 0.0 107.051 -177.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 220' ' ' THR . . . . . . . . . . . . . 95.8 m -141.3 103.11 4.36 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 176.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -61.47 138.7 58.28 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.054 0.454 . . . . 0.0 110.952 -176.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 44.4 tp -115.67 121.85 43.79 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.679 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 3.2 mp -110.45 128.91 66.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.883 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 224' ' ' ILE . . . . . 0.477 ' CG2' HD11 ' B' ' 227' ' ' ILE . 49.6 mm -111.3 127.15 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 49.8 p -133.62 158.76 42.38 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.871 0.843 . . . . 0.0 112.709 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 89.47 16.4 57.07 Favored Glycine 0 CA--C 1.5 -0.896 0 CA-C-N 113.818 -1.537 . . . . 0.0 111.639 -177.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 227' ' ' ILE . . . . . 0.734 HD12 HG23 ' B' ' 247' ' ' THR . 95.5 mt -81.15 126.27 39.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 117.815 0.808 . . . . 0.0 111.498 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 55.4 tttt -66.19 141.2 97.24 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.341 -178.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.45 -37.56 94.75 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 121.491 1.461 . . . . 0.0 112.614 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -63.94 -43.55 95.5 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -178.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 51.8 tp -62.05 -41.58 98.28 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.159 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.72 -37.01 85.76 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.749 0.309 . . . . 0.0 111.362 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 94.5 mtp -64.01 -40.89 97.35 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.805 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.7 -42.55 99.69 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-O 122.422 1.106 . . . . 0.0 109.467 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 35.2 mmt -63.98 -36.61 84.53 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 114.322 -1.308 . . . . 0.0 111.862 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -61.96 -40.46 95.64 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.002 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.28 -43.91 96.59 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 120.679 -0.409 . . . . 0.0 110.057 177.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.29 -44.42 96.55 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.71 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 239' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' B' ' 240' ' ' ALA . 67.0 t0 -159.1 133.08 7.57 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.324 -0.551 . . . . 0.0 112.104 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 240' ' ' ALA . . . . . 0.418 ' N ' ' OD1' ' B' ' 239' ' ' ASP . . . -62.51 -44.75 95.6 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 176.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 241' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' B' ' 244' ' ' SER . 92.1 m-20 -45.52 -22.61 0.16 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.046 -175.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 242' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -60.81 -45.43 94.46 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 119.888 -0.725 . . . . 0.0 110.39 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 243' ' ' SER . . . . . . . . . . . . . 77.5 p -57.89 -42.21 84.15 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 244' ' ' SER . . . . . 0.477 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 19.7 m -35.1 -34.46 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 -178.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 96.6 mt -87.74 134.2 33.71 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.567 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -58.85 135.53 57.55 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-O 121.427 0.632 . . . . 0.0 110.75 -177.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 247' ' ' THR . . . . . 0.734 HG23 HD12 ' B' ' 227' ' ' ILE . 95.8 m -125.91 127.51 46.12 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.722 177.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 248' ' ' TYR . . . . . 0.471 ' CB ' ' HB2' ' B' ' 254' ' ' ALA . 96.3 m-85 -113.8 142.56 45.91 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 249' ' ' SER . . . . . 0.604 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 78.4 p -63.12 -34.08 76.84 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.339 -178.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 250' ' ' ASN . . . . . 0.604 ' OD1' ' O ' ' B' ' 249' ' ' SER . 99.2 m-20 -147.94 159.55 43.75 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.199 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 58.0 t -64.23 -44.39 97.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.885 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 252' ' ' LYS . . . . . 0.421 ' HG3' ' HG3' ' A' ' 152' ' ' PRO . 88.7 tttt -60.94 -46.74 89.5 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -177.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 253' ' ' ASP . . . . . 0.5 ' O ' HG22 ' B' ' 257' ' ' VAL . 93.7 m-20 -61.74 -43.11 99.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.654 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 254' ' ' ALA . . . . . 0.471 ' HB2' ' CB ' ' B' ' 248' ' ' TYR . . . -64.87 -40.57 95.33 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.18 178.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 255' ' ' VAL . . . . . 0.555 HG11 ' O ' ' A' ' 153' ' ' ILE . 67.8 t -64.69 -45.72 94.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.506 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -63.26 -48.21 79.14 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.226 -178.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 257' ' ' VAL . . . . . 0.5 HG22 ' O ' ' B' ' 253' ' ' ASP . 22.6 m -65.2 -40.31 88.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.594 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 258' ' ' LEU . . . . . 0.515 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 0.9 OUTLIER -31.8 -73.96 0.05 OUTLIER Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.592 -178.359 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 259' ' ' PRO . . . . . 0.538 ' O ' HG13 ' B' ' 260' ' ' ILE . 35.5 Cg_endo -61.75 141.31 90.05 Favored 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 121.51 1.474 . . . . 0.0 111.196 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 260' ' ' ILE . . . . . 0.562 HG22 ' O ' ' B' ' 260' ' ' ILE . 96.8 mt -158.44 -12.57 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-N 118.591 0.632 . . . . 0.0 112.121 177.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 78.3 mtm . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 117.99 -1.005 . . . . 0.0 111.583 179.921 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.427 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.76 179.25 8.68 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-O 121.57 0.7 . . . . 0.0 109.518 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 97.2 p -82.62 -2.18 53.11 Favored 'General case' 0 C--N 1.39 2.337 0 O-C-N 118.151 -2.843 . . . . 0.0 112.853 176.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -87.35 -64.15 1.19 Allowed 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.141 -1.391 . . . . 0.0 112.32 175.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -68.73 -39.23 80.49 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 178.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.497 ' O ' ' CB ' ' A' ' 7' ' ' PHE . 57.0 m -58.94 -42.13 89.04 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.923 -177.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.523 ' CE2' HD12 ' A' ' 9' ' ' ILE . 33.0 t80 86.38 87.59 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 O-C-N 123.816 0.697 . . . . 0.0 111.567 176.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.55 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -60.59 -143.21 0.01 OUTLIER Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.55 ' HB ' ' O ' ' A' ' 8' ' ' GLY . 65.3 mt 84.22 110.46 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.65 0 C-N-CA 122.881 0.472 . . . . 0.0 110.584 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.94 -22.44 68.47 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 121.354 1.369 . . . . 0.0 112.18 -179.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.88 -37.29 94.44 Favored Glycine 0 C--O 1.247 0.921 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.07 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -65.04 -39.04 92.77 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.349 0.595 . . . . 0.0 109.745 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.8 tp -63.29 -41.95 99.02 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -62.32 -39.54 93.37 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 68.5 t -61.08 -43.97 97.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 O-C-N 122.02 -0.425 . . . . 0.0 111.066 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 95.4 mt -62.21 -43.28 97.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.213 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.4 ' NZ ' ' HA ' ' B' ' 6' ' ' SER . 98.7 mttt -62.96 -45.03 94.39 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 119.394 -0.923 . . . . 0.0 111.877 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.718 ' HZ1' HG12 ' B' ' 113' ' ' ILE . 98.5 mttt -61.05 -39.42 89.77 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 118.666 -1.214 . . . . 0.0 108.612 -175.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.35 -42.88 92.6 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 119.941 -0.703 . . . . 0.0 110.262 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 20' ' ' LEU . 87.0 mt -63.1 -40.77 98.62 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -62.86 -38.9 92.7 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.491 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 57.5 m170 -58.88 -39.5 81.58 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 122.16 -0.337 . . . . 0.0 111.501 -178.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.3 p -114.82 130.36 69.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.462 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 31.6 ptt180 -72.9 110.15 6.99 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 121.939 0.876 . . . . 0.0 112.178 -177.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.5 p -140.96 143.3 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 177.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' A' ' 123' ' ' GLN . . . -97.81 92.56 1.29 Allowed Glycine 0 C--N 1.312 -0.758 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.777 -178.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 52.0 t -124.79 129.98 73.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 175.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.8 m -136.92 159.24 37.01 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.5 mt -119.46 128.89 75.86 Favored 'Isoleucine or valine' 0 C--O 1.245 0.855 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 176.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.45 ' OG1' ' HB2' ' A' ' 119' ' ' PHE . 24.3 p -101.83 167.22 10.22 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 177.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.401 ' C ' ' OD1' ' A' ' 37' ' ' ASN . 53.1 t0 -133.82 101.86 12.64 Favored Pre-proline 0 C--O 1.222 -0.37 0 C-N-CA 120.314 -0.554 . . . . 0.0 109.872 178.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.57 -21.04 65.99 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 121.431 1.421 . . . . 0.0 111.501 -178.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.67 -29.72 70.85 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.316 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 91.4 mt -89.79 -178.87 5.61 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.865 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.645 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 42.1 tt0 -76.3 130.25 37.85 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -177.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.515 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 58.3 t0 63.11 22.04 13.2 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 177.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.401 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 29.7 t-20 42.3 68.03 2.99 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.996 -177.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.645 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 89.6 Cg_endo -71.36 157.17 57.38 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 124.085 3.19 . . . . 0.0 112.042 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 95.9 mt -89.84 123.61 42.12 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.5 m -103.95 -43.14 8.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.1 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -96.34 123.61 40.04 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.733 -178.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.5 p -142.87 140.29 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 O-C-N 124.356 1.035 . . . . 0.0 109.229 177.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.61 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 57.7 p30 -96.49 166.13 11.84 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.466 ' HA ' ' OE1' ' A' ' 44' ' ' GLN . 14.0 mm100 -66.15 -39.84 90.11 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 177.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.98 -25.44 61.87 Favored Glycine 0 C--O 1.237 0.294 0 N-CA-C 110.389 -1.085 . . . . 0.0 110.389 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.621 ' CD2' HD13 ' A' ' 57' ' ' ILE . 67.4 t80 -59.0 -47.51 84.93 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 105.863 -1.902 . . . . 0.0 105.863 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.722 HG13 ' O ' ' A' ' 52' ' ' TYR . 53.6 t -60.04 -44.38 94.7 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 O-C-N 121.161 -0.962 . . . . 0.0 111.498 -174.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -62.44 -37.56 86.35 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 120.488 -0.485 . . . . 0.0 112.264 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 59.4 ttm -66.97 -43.64 82.55 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 176.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 34.8 p -93.48 -20.82 19.92 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.138 0.494 . . . . 0.0 111.287 -177.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . 77.82 19.44 75.47 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.722 ' O ' HG13 ' A' ' 47' ' ' VAL . 78.0 m-85 -111.79 138.79 47.9 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 122.579 0.351 . . . . 0.0 110.984 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -64.64 149.14 49.52 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.491 0.662 . . . . 0.0 109.495 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.448 HG22 ' H ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -65.85 -32.44 73.95 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.833 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.43 -42.34 83.33 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 119.381 -0.928 . . . . 0.0 111.382 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -64.65 -44.65 89.76 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.621 HD13 ' CD2' ' A' ' 46' ' ' PHE . 95.3 mt -63.76 -45.9 95.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -174.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 83.8 mt -61.09 144.7 53.05 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.14 -5.99 73.83 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.353 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -134.49 151.28 51.03 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 119.222 1.511 . . . . 0.0 112.011 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.562 ' C ' ' H ' ' A' ' 63' ' ' ARG . 25.0 t-20 -81.45 152.2 27.5 Favored 'General case' 0 N--CA 1.453 -0.316 0 O-C-N 121.882 -0.511 . . . . 0.0 110.509 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 86.0 m -63.16 15.78 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.353 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.562 ' H ' ' C ' ' A' ' 61' ' ' ASN . 35.2 ptt-85 -61.12 -42.02 97.78 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.077 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -55.65 -21.74 19.45 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -178.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.6 mt -67.44 -35.48 79.32 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 122.241 1.02 . . . . 0.0 112.864 176.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -65.65 133.3 50.83 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.753 -176.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.524 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -143.69 -148.57 4.92 Favored Glycine 0 CA--C 1.543 1.832 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -178.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.86 -41.11 99.25 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -177.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.594 ' O ' ' NE2' ' A' ' 93' ' ' GLN . 9.0 m80 -75.93 -9.79 58.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.834 0.349 . . . . 0.0 110.852 -177.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.524 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 28.5 m -60.93 130.12 44.87 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.603 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -87.54 111.09 39.36 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.713 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -57.55 -31.68 92.27 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.018 1.812 . . . . 0.0 112.99 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.7 -40.26 96.34 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.951 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.424 ' OE1' ' HB ' ' A' ' 90' ' ' VAL . 79.2 mm-40 -65.6 -43.61 89.12 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.3 t -60.4 -43.13 93.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -63.67 -37.96 89.33 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 124.07 0.856 . . . . 0.0 112.007 178.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -63.31 -39.69 95.25 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.37 0.605 . . . . 0.0 110.544 178.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.1 mt -64.1 -43.79 97.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.367 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -62.65 -43.07 99.74 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 113.653 -1.612 . . . . 0.0 108.473 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 93.8 m -60.82 -49.11 78.8 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.25 -42.46 95.34 Favored 'General case' 0 C--N 1.363 1.189 0 O-C-N 123.754 0.659 . . . . 0.0 110.782 -171.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 87.4 mt -63.01 -40.94 99.26 Favored 'General case' 0 CA--C 1.514 -0.409 0 O-C-N 120.184 -1.573 . . . . 0.0 111.692 -178.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -63.42 -41.07 98.69 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -70.55 -23.35 62.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.197 177.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 49.5 tttt 63.34 46.53 4.38 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.614 -176.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -130.71 148.32 69.65 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -62.08 142.94 94.12 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 121.441 1.427 . . . . 0.0 113.493 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.09 141.43 33.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.325 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.891 HG23 ' OD1' ' A' ' 107' ' ' ASN . 96.6 m -126.7 119.17 26.3 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 175.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.424 ' HB ' ' OE1' ' A' ' 74' ' ' GLU . 30.1 m -138.59 157.17 30.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 121.203 -0.199 . . . . 0.0 111.413 178.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -103.8 127.3 51.3 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 177.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.421 ' O ' HG23 ' A' ' 92' ' ' ILE . 18.8 tt -135.74 131.45 50.45 Favored 'Isoleucine or valine' 0 C--N 1.372 1.567 0 CA-C-N 121.716 2.053 . . . . 0.0 112.606 177.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.594 ' NE2' ' O ' ' A' ' 69' ' ' HIS . 33.7 mt-30 -63.69 135.87 57.05 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.952 -179.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -137.97 162.25 34.56 Favored 'General case' 0 C--N 1.349 0.55 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.923 -177.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.492 ' CE1' ' HA3' ' A' ' 67' ' ' GLY . 92.3 m-85 -121.38 138.3 54.32 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -178.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.488 ' HG3' ' CE1' ' A' ' 102' ' ' PHE . 99.2 mttt -86.71 -171.06 3.35 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.078 0.466 . . . . 0.0 111.525 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.69 -42.05 99.43 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.396 178.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 39.7 p-10 -85.49 7.61 22.23 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -177.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.48 -1.18 88.45 Favored Glycine 0 N--CA 1.471 0.983 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.146 177.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 23.4 m -60.06 137.63 58.05 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.678 ' SD ' ' C ' ' A' ' 101' ' ' MET . 14.1 tmm? -104.98 129.39 53.42 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 120.746 0.308 . . . . 0.0 111.231 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.488 ' CE1' ' HG3' ' A' ' 96' ' ' LYS . 53.5 p90 -141.12 158.97 43.19 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.927 -177.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.837 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 21.0 m95 -90.54 143.97 26.23 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.411 HD21 ' HG2' ' A' ' 123' ' ' GLN . 54.6 t-20 -138.46 103.54 4.91 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -176.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -70.56 135.12 48.26 Favored 'General case' 0 N--CA 1.436 -1.15 0 O-C-N 120.974 -1.079 . . . . 0.0 108.16 -176.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 38.8 tp -120.16 123.61 43.73 Favored 'General case' 0 C--O 1.234 0.285 0 O-C-N 124.07 0.856 . . . . 0.0 112.662 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.891 ' OD1' HG23 ' A' ' 89' ' ' THR . 98.1 m-20 -119.55 123.0 42.87 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.96 177.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 96.4 mt -120.9 128.46 76.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 O-C-N 123.575 0.547 . . . . 0.0 111.496 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -137.33 126.81 15.32 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.819 -0.173 . . . . 0.0 111.003 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -70.73 151.45 63.57 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.162 1.908 . . . . 0.0 112.413 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.654 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 67.2 mtt -123.36 151.5 42.46 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -126.86 96.96 4.8 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 176.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.513 ' CD1' HG22 ' B' ' 15' ' ' VAL . 96.2 mt -121.02 131.56 72.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.035 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 50.27 37.46 15.1 Favored 'General case' 0 CA--C 1.515 -0.375 0 O-C-N 121.105 -0.997 . . . . 0.0 111.365 176.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 59.93 31.82 20.88 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 123.939 0.774 . . . . 0.0 110.994 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -128.71 147.95 50.8 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.705 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 3.6 t -84.3 -175.51 5.83 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-O 118.769 -0.634 . . . . 0.0 109.434 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.705 ' CD2' ' O ' ' A' ' 117' ' ' THR . 70.1 m-85 -169.1 156.04 6.94 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 173.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.45 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 86.0 m-85 -129.32 147.83 51.19 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 173.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.7 p -137.33 137.31 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -111.97 130.29 9.56 Favored Glycine 0 CA--C 1.504 -0.644 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 178.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 97.0 mt -117.65 129.54 73.93 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 177.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.595 ' N ' ' O ' ' A' ' 26' ' ' GLY . 17.9 mp0 -118.81 117.0 27.7 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.223 0.535 . . . . 0.0 109.833 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -117.99 114.97 23.96 Favored 'General case' 0 C--O 1.254 1.329 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.813 -178.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.412 ' OD1' ' OG1' ' A' ' 127' ' ' THR . 67.4 t0 -67.72 121.97 17.09 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -175.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.478 ' O ' HG22 ' A' ' 126' ' ' ILE . 3.6 mp -85.4 1.07 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 113.778 -1.556 . . . . 0.0 110.299 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.412 ' OG1' ' OD1' ' A' ' 125' ' ' ASP . 27.5 m -59.43 -42.58 92.21 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.186 -0.946 . . . . 0.0 112.937 -177.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -58.87 -42.31 89.13 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 -178.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -63.23 -39.47 94.7 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.445 177.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.837 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.8 mttt -62.41 -40.76 97.58 Favored 'General case' 0 C--O 1.214 -0.771 0 O-C-N 120.504 -1.372 . . . . 0.0 110.084 -178.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.72 -37.41 86.41 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.752 0.658 . . . . 0.0 109.49 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.735 ' CE2' HD11 ' A' ' 136' ' ' LEU . 88.2 t80 -61.45 -45.9 92.33 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.408 176.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.34 -38.45 91.07 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.67 -40.31 96.66 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 52.2 tp -60.97 -43.35 98.91 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -177.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.735 HD11 ' CE2' ' A' ' 132' ' ' TYR . 85.3 mt -62.8 -41.27 99.21 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.827 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.97 -41.87 98.5 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 119.668 -0.813 . . . . 0.0 109.691 -178.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -60.14 -43.06 96.0 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -177.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 54.7 m -61.61 -41.41 97.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.731 176.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.457 ' O ' ' N ' ' A' ' 144' ' ' THR . 85.8 mt -63.07 -41.69 99.5 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 121.933 -0.48 . . . . 0.0 109.963 178.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 78.6 m -61.61 -45.42 94.17 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.514 -177.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -65.13 -39.99 93.83 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 95.2 mt -64.59 -43.18 96.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 113.873 -1.512 . . . . 0.0 111.232 176.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.457 ' N ' ' O ' ' A' ' 140' ' ' LEU . 89.3 m -62.18 -46.07 90.59 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 120.37 -0.532 . . . . 0.0 112.285 -178.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.34 -40.62 96.98 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 118.851 -1.14 . . . . 0.0 109.064 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.7 mt -63.44 -42.63 98.66 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.491 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.715 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.4 p -60.7 -36.42 78.75 Favored 'General case' 0 C--O 1.214 -0.803 0 C-N-CA 119.332 -0.947 . . . . 0.0 109.294 -177.19 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.438 ' C ' ' O ' ' A' ' 147' ' ' SER . 41.9 m -31.67 81.57 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.507 0 O-C-N 127.041 2.713 . . . . 0.0 105.823 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.715 ' N ' ' O ' ' A' ' 147' ' ' SER . 19.4 Cg_exo -62.51 142.07 88.84 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 CA-C-O 123.088 1.203 . . . . 0.0 114.601 -174.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.562 ' O ' HG23 ' A' ' 151' ' ' VAL . 9.0 tp -115.91 136.3 53.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 102.603 -3.11 . . . . 0.0 102.603 175.121 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 150' ' ' ILE . 82.2 t -168.46 90.5 0.64 Allowed Pre-proline 0 CA--C 1.505 -0.771 0 N-CA-C 106.001 -1.851 . . . . 0.0 106.001 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.2 135.58 55.3 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 N-CA-C 109.678 -0.931 . . . . 0.0 109.678 -177.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.669 ' O ' ' HD2' ' A' ' 154' ' ' ARG . 44.5 mm -67.45 -44.76 86.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 119.682 -0.807 . . . . 0.0 111.109 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.729 HH11 HG13 ' B' ' 255' ' ' VAL . 0.4 OUTLIER -157.31 -156.29 0.58 Allowed 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.864 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.411 ' ND2' ' HE3' ' B' ' 256' ' ' LYS . 61.4 t-20 -86.51 104.89 16.39 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.469 0.652 . . . . 0.0 111.619 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 88.56 7.96 71.22 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 114.121 -1.4 . . . . 0.0 110.245 -178.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.1 mt -123.52 123.71 67.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 174.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.609 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 69.4 m -132.38 152.57 51.4 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -137.51 143.4 41.66 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.492 177.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 16.3 tp -133.68 78.33 61.81 Favored Pre-proline 0 N--CA 1.465 0.295 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.328 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -69.2 150.19 71.33 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.68 2.253 . . . . 0.0 113.227 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 90.4 mt -118.48 125.99 51.07 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.12 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 51.4 t -122.95 131.57 73.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 117.29 168.63 14.72 Favored Glycine 0 N--CA 1.481 1.683 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.347 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.864 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 56.1 t30 -85.32 114.13 22.16 Favored 'General case' 0 C--O 1.201 -1.48 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -178.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.628 HD21 ' CZ ' ' A' ' 171' ' ' PHE . 48.2 tp -73.92 102.45 4.11 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -177.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.705 HG23 ' NE ' ' A' ' 170' ' ' ARG . 10.5 p -85.49 167.69 15.23 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.446 178.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.91 -34.93 79.27 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.955 0.407 . . . . 0.0 111.894 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.15 -46.66 86.15 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.499 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.864 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 87.6 mtm180 -61.6 -31.74 71.82 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.796 177.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.628 ' CZ ' HD21 ' A' ' 166' ' ' LEU . 0.4 OUTLIER -54.97 -28.28 50.41 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -177.53 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.637 ' O ' HG22 ' A' ' 175' ' ' VAL . 92.6 m-20 -60.8 -40.45 92.74 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 119.045 -1.062 . . . . 0.0 110.01 -178.263 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 58.7 m -59.42 -40.56 87.09 Favored 'General case' 0 C--N 1.322 -0.611 0 O-C-N 121.762 -0.586 . . . . 0.0 110.638 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 67.9 mt -63.66 -44.14 98.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.637 HG22 ' O ' ' A' ' 172' ' ' ASN . 35.2 m -62.29 -40.05 86.38 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' CYS . . . . . 0.415 ' N ' HG23 ' A' ' 175' ' ' VAL . 96.6 m -62.05 -35.24 78.02 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.318 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.519 ' O ' HG13 ' A' ' 181' ' ' ILE . 24.9 m -61.48 -19.84 62.48 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.283 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.606 ' CD2' HD21 ' A' ' 211' ' ' LEU . 87.6 mt -60.82 -40.82 94.16 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -177.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 18.5 m -59.48 -43.75 93.19 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.594 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ASN . . . . . 0.634 ' O ' ' OG ' ' A' ' 183' ' ' SER . 93.2 m-20 -61.1 -37.5 82.97 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.053 0.454 . . . . 0.0 111.059 178.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 177' ' ' THR . 66.8 mt -57.51 -39.01 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 O-C-N 121.401 -0.812 . . . . 0.0 109.165 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 87.3 mt -60.81 -40.47 92.82 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 119.439 -0.904 . . . . 0.0 108.625 -177.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.634 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 78.0 p -61.48 -34.0 74.72 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.727 176.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 53.0 p -90.45 23.58 2.93 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 122.226 -0.296 . . . . 0.0 111.514 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 78.2 p -63.04 -20.15 65.06 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.644 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.07 -36.2 79.0 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.865 -178.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.609 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 98.7 m-20 -72.55 114.0 10.2 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.568 0.699 . . . . 0.0 110.963 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -62.8 -42.48 99.73 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.919 -177.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -113.26 132.17 55.64 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.104 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 38.1 tp -120.6 128.93 53.5 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 96.4 mt -116.24 127.05 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 O-C-N 121.751 -0.593 . . . . 0.0 109.459 177.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.9 mm -113.08 126.35 70.48 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' ASP . . . . . 0.5 ' CG ' ' HG ' ' A' ' 195' ' ' SER . 40.2 t0 -95.25 120.34 35.32 Favored 'General case' 0 CA--C 1.551 1.017 0 O-C-N 121.662 -0.648 . . . . 0.0 110.48 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 194' ' ' LEU . 96.2 mt -101.01 -2.8 30.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.891 176.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' SER . . . . . 0.5 ' HG ' ' CG ' ' A' ' 193' ' ' ASP . 78.3 p -63.31 -32.32 73.71 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.85 -47.15 92.02 Favored Glycine 0 CA--C 1.54 1.61 0 N-CA-C 108.171 -1.972 . . . . 0.0 108.171 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.938 HD23 ' N ' ' A' ' 198' ' ' ALA . 4.9 tt -66.02 129.82 41.12 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 112.873 -1.664 . . . . 0.0 108.755 -177.208 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.938 ' N ' HD23 ' A' ' 197' ' ' LEU . . . -60.79 -50.98 71.26 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-O 121.417 0.627 . . . . 0.0 110.931 -179.087 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.889 ' O ' ' CD2' ' A' ' 197' ' ' LEU . 58.6 tt0 -132.76 156.78 46.46 Favored 'General case' 0 C--O 1.21 -1.017 0 CA-C-N 114.728 -1.124 . . . . 0.0 114.016 -174.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.483 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 46.1 t -117.83 130.69 72.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 O-C-N 120.424 -1.423 . . . . 0.0 108.425 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -83.76 155.86 22.84 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.237 -178.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -64.79 -39.48 93.67 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.988 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -57.24 -31.4 65.5 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 -178.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.8 m -61.42 -42.74 99.22 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.709 178.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.449 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -56.44 -39.06 72.47 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -177.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -61.26 -38.09 85.46 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 121.776 -0.578 . . . . 0.0 110.087 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -64.57 -38.87 92.52 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.916 177.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.02 -44.88 99.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' PHE . . . . . 0.449 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 67.2 m-85 -61.04 -43.82 98.31 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.009 -177.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.97 -41.59 98.18 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 118.998 -1.081 . . . . 0.0 109.202 -178.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.606 HD21 ' CD2' ' A' ' 178' ' ' LEU . 38.8 mt -62.39 -42.18 99.23 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 78.0 p -61.04 -42.45 98.5 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.463 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 60.8 t60 -64.93 -45.72 84.64 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 122.034 -0.416 . . . . 0.0 111.728 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 50.3 tp -62.41 -45.93 90.88 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 119.021 -1.071 . . . . 0.0 108.15 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 89.4 mt -62.84 -41.19 99.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.401 -177.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.03 -44.44 94.63 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.601 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 82.6 mt -61.93 -40.54 95.85 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 68.9 p -75.44 -11.72 60.1 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.241 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.96 40.17 9.6 Favored Glycine 0 C--O 1.217 -0.913 0 C-N-CA 120.617 -0.801 . . . . 0.0 113.863 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 99.9 m -125.99 115.03 19.26 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 119.104 1.452 . . . . 0.0 112.36 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -66.4 136.11 55.28 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.147 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 41.7 tp -111.97 128.69 56.24 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 2.8 mp -116.35 132.61 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.587 ' CG2' HD11 ' A' ' 227' ' ' ILE . 49.7 mm -114.35 131.39 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 39.7 p -133.38 165.75 24.12 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 120.766 -0.373 . . . . 0.0 111.583 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 79.35 20.35 69.62 Favored Glycine 0 C--O 1.224 -0.508 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 178.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.665 HD12 HG23 ' A' ' 247' ' ' THR . 97.3 mt -81.83 128.83 38.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 113.692 -1.254 . . . . 0.0 108.124 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 66.0 tttt -75.89 139.96 70.21 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.47 -38.23 89.79 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 121.108 1.205 . . . . 0.0 112.453 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -64.94 -39.23 93.19 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-O 121.29 0.566 . . . . 0.0 110.268 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 53.3 tp -63.57 -43.11 97.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.915 -1.039 . . . . 0.0 112.753 177.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.66 -37.66 88.19 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 121.96 -0.463 . . . . 0.0 111.175 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 93.7 mtp -63.2 -40.47 97.6 Favored 'General case' 0 C--O 1.251 1.16 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.704 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -64.32 -39.29 93.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.758 176.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 30.1 mmt -65.45 -37.72 87.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.746 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -60.8 -41.02 94.81 Favored 'General case' 0 CA--C 1.513 -0.447 0 O-C-N 121.48 -0.763 . . . . 0.0 109.491 -176.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.71 -39.9 93.14 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.355 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 52.7 tp -63.18 -42.05 99.3 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 176.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -168.89 128.19 1.08 Allowed 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 121.404 0.621 . . . . 0.0 112.559 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -60.22 -28.02 67.67 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.821 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -61.16 -27.56 68.49 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.674 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -56.42 -43.73 79.66 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -176.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 96.6 p -63.2 -20.84 65.79 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 124.108 0.88 . . . . 0.0 111.298 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 41.7 m -55.25 -34.25 63.85 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 122.056 -0.403 . . . . 0.0 111.763 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 94.3 mt -89.76 121.6 32.07 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -46.1 134.77 8.12 Favored 'General case' 0 C--O 1.248 0.986 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.615 -177.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.665 HG23 HD12 ' A' ' 227' ' ' ILE . 97.8 m -126.48 132.8 51.35 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 114.605 -1.18 . . . . 0.0 110.968 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 248' ' ' TYR . . . . . 0.515 ' CG ' ' HB2' ' A' ' 254' ' ' ALA . 96.4 m-85 -117.51 139.49 50.86 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.788 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 78.3 p -60.68 -42.58 97.38 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -178.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -143.74 160.75 40.17 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.606 0.717 . . . . 0.0 111.651 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.02 -44.79 99.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 114.725 -1.125 . . . . 0.0 112.301 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.89 -44.67 96.78 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -178.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' ASP . . . . . 0.432 ' O ' HG22 ' A' ' 257' ' ' VAL . 55.6 m-20 -62.75 -44.38 96.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.599 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 254' ' ' ALA . . . . . 0.515 ' HB2' ' CG ' ' A' ' 248' ' ' TYR . . . -63.59 -42.45 98.28 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.975 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 255' ' ' VAL . . . . . 0.626 HG13 HH11 ' B' ' 154' ' ' ARG . 66.8 t -63.86 -45.41 97.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-N 114.051 -1.431 . . . . 0.0 110.798 -178.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.77 -47.09 82.36 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.846 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.498 ' O ' ' C ' ' A' ' 258' ' ' LEU . 22.5 m -67.51 -41.09 85.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 O-C-N 121.453 -0.779 . . . . 0.0 112.034 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.498 ' C ' ' O ' ' A' ' 257' ' ' VAL . 1.1 mt -28.17 -74.84 0.04 OUTLIER Pre-proline 0 C--O 1.234 0.265 0 CA-C-O 119.518 -0.277 . . . . 0.0 111.542 -177.159 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 259' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 258' ' ' LEU . 39.9 Cg_endo -62.85 139.84 76.55 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 120.833 1.022 . . . . 0.0 111.934 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 259' ' ' PRO . 96.6 mt -151.8 -27.17 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 O-C-N 123.779 0.675 . . . . 0.0 111.981 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 C--O 1.216 -0.683 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.782 -177.262 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.58 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -165.18 170.26 15.11 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 84.2 p -66.82 -16.71 64.46 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -79.85 -64.21 1.24 Allowed 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.103 -177.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -66.4 -39.81 89.24 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.302 -0.863 . . . . 0.0 113.073 178.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 6' ' ' SER . . . . . 0.495 ' O ' ' CB ' ' B' ' 7' ' ' PHE . 58.9 m -59.25 -42.44 91.14 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 -178.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 7' ' ' PHE . . . . . 0.519 ' CE2' HD12 ' B' ' 9' ' ' ILE . 32.8 t80 87.01 90.96 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.742 0.651 . . . . 0.0 110.697 177.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 8' ' ' GLY . . . . . 0.549 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -63.27 -142.77 0.01 OUTLIER Glycine 0 C--N 1.339 0.727 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.549 ' HB ' ' O ' ' B' ' 8' ' ' GLY . 64.7 mt 83.88 110.38 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 122.773 0.429 . . . . 0.0 110.784 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -63.15 -23.61 73.08 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 C-N-CA 121.249 1.299 . . . . 0.0 111.812 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.24 -38.81 96.82 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -64.99 -39.07 92.92 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.473 0.654 . . . . 0.0 109.551 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 49.8 tp -61.95 -43.0 99.74 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.507 -177.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -64.45 -31.78 73.14 Favored 'General case' 0 CA--C 1.559 1.317 0 CA-C-O 121.358 0.599 . . . . 0.0 110.614 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 15' ' ' VAL . . . . . 0.513 HG22 ' CD1' ' A' ' 113' ' ' ILE . 74.6 t -63.27 -46.19 96.31 Favored 'Isoleucine or valine' 0 C--O 1.249 1.053 0 CA-C-N 113.179 -1.828 . . . . 0.0 111.198 177.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.82 -43.69 97.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.795 -178.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 17' ' ' LYS . . . . . 0.406 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 98.9 mttt -63.31 -42.53 99.04 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.88 -40.54 97.83 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 118.991 -1.084 . . . . 0.0 109.964 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.87 -39.62 89.86 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.018 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 20' ' ' LEU . 87.6 mt -63.81 -41.93 97.78 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.276 0.56 . . . . 0.0 110.33 175.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -62.87 -39.01 93.12 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.798 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 56.4 m170 -58.2 -39.68 79.62 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 121.086 -0.246 . . . . 0.0 111.521 -178.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 13.6 p -114.71 130.11 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.482 ' HG3' ' O ' ' B' ' 24' ' ' ARG . 31.6 ptt180 -72.43 108.17 5.38 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.687 0.755 . . . . 0.0 112.582 -177.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.0 p -142.6 134.22 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.731 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 26' ' ' GLY . . . . . 0.569 ' O ' ' N ' ' B' ' 123' ' ' GLN . . . -88.25 96.99 2.25 Favored Glycine 0 C--N 1.31 -0.913 0 C-N-CA 119.655 -1.26 . . . . 0.0 113.43 -176.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 48.5 t -125.74 129.19 72.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 174.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 30.2 m -138.33 156.19 29.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.473 178.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 96.1 mt -118.0 124.71 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.247 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 25.9 p -102.31 159.34 15.49 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 113.146 -1.843 . . . . 0.0 108.603 -178.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -127.43 101.74 24.25 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 32' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.3 -18.58 60.98 Favored 'Trans proline' 0 N--CA 1.49 1.309 0 C-N-CA 121.683 1.589 . . . . 0.0 111.477 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.09 -39.9 94.03 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.576 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 93.8 mt -77.16 -164.71 0.48 Allowed 'General case' 0 N--CA 1.475 0.8 0 O-C-N 122.106 -0.371 . . . . 0.0 111.057 -178.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 35' ' ' GLU . . . . . 0.679 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 42.4 tt0 -87.56 129.87 34.95 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.45 ' O ' ' OD1' ' B' ' 36' ' ' ASP . 62.8 t0 57.47 35.42 25.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.751 177.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 37' ' ' ASN . . . . . 0.424 ' C ' ' O ' ' B' ' 36' ' ' ASP . 20.0 t-20 33.04 68.95 0.92 Allowed Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.679 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 89.3 Cg_endo -72.09 155.76 56.54 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 123.745 2.963 . . . . 0.0 111.865 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 95.6 mt -88.21 127.99 40.85 Favored 'Isoleucine or valine' 0 C--O 1.246 0.908 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 27.7 m -107.73 -43.03 6.31 Favored 'Isoleucine or valine' 0 C--N 1.343 0.3 0 O-C-N 123.892 0.745 . . . . 0.0 112.603 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -97.01 123.9 40.85 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.366 -178.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 5.7 p -142.94 140.92 27.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 124.212 0.945 . . . . 0.0 109.293 177.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 43' ' ' ASN . . . . . 0.639 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 57.2 p30 -100.34 161.6 13.5 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.035 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 44' ' ' GLN . . . . . 0.442 ' OE1' ' HA ' ' B' ' 44' ' ' GLN . 13.8 mm100 -63.4 -38.02 89.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.569 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.37 -25.6 63.0 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.654 ' CE2' HD13 ' B' ' 57' ' ' ILE . 62.6 t80 -59.96 -43.86 94.79 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 0.872 HG13 ' O ' ' B' ' 52' ' ' TYR . 63.3 t -61.3 -45.69 98.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.153 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -62.87 -44.19 96.77 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.057 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 59.4 ttm -62.81 -42.83 99.88 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 34.5 p -95.62 -15.89 22.45 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.72 -178.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 51' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' B' ' 47' ' ' VAL . . . 73.46 19.22 79.64 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.336 -1.105 . . . . 0.0 110.336 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 52' ' ' TYR . . . . . 0.872 ' O ' HG13 ' B' ' 47' ' ' VAL . 78.4 m-85 -110.75 145.19 38.53 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 115.27 -0.465 . . . . 0.0 110.1 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -74.18 149.02 41.15 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 121.817 0.818 . . . . 0.0 110.874 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 54' ' ' THR . . . . . 0.412 HG22 ' H ' ' B' ' 54' ' ' THR . 0.1 OUTLIER -61.99 -37.7 85.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.084 -177.398 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.03 -39.09 93.32 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 120.085 -0.646 . . . . 0.0 112.196 -178.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -72.59 -31.51 65.26 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 177.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.654 HD13 ' CE2' ' B' ' 46' ' ' PHE . 92.1 mt -69.91 -61.73 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 97.0 mt -49.49 133.86 19.93 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 123.966 0.791 . . . . 0.0 109.984 -178.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.98 -10.19 72.21 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.712 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -131.48 149.34 52.56 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -176.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 61' ' ' ASN . . . . . 0.55 ' C ' ' H ' ' B' ' 63' ' ' ARG . 25.2 t-20 -79.62 151.49 30.56 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.619 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 62' ' ' CYS . . . . . . . . . . . . . 83.5 m -63.28 9.9 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.256 -178.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 63' ' ' ARG . . . . . 0.55 ' H ' ' C ' ' B' ' 61' ' ' ASN . 33.5 ptt-85 -60.06 -32.31 70.81 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.585 -177.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -60.5 -30.89 70.0 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 85.6 mt -62.21 -41.86 98.77 Favored 'General case' 0 C--O 1.238 0.462 0 O-C-N 121.601 -0.687 . . . . 0.0 109.758 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -50.12 143.81 7.79 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -177.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 67' ' ' GLY . . . . . 0.49 ' HA3' ' CE1' ' B' ' 95' ' ' TYR . . . -155.08 -152.86 6.3 Favored Glycine 0 C--N 1.353 1.473 0 CA-C-N 115.967 -0.561 . . . . 0.0 112.156 176.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.25 -42.43 95.27 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -175.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 69' ' ' HIS . . . . . 0.534 ' O ' ' NE2' ' B' ' 93' ' ' GLN . 9.5 m80 -74.77 -9.92 59.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.069 -178.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 70' ' ' THR . . . . . 0.437 ' OG1' ' N ' ' B' ' 67' ' ' GLY . 27.4 m -60.64 133.5 56.16 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -90.55 110.92 44.56 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.39 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.64 -38.09 90.97 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 120.978 1.119 . . . . 0.0 111.63 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.16 -40.6 90.43 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -176.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 74' ' ' GLU . . . . . 0.42 ' OE1' ' HB ' ' B' ' 90' ' ' VAL . 79.5 mm-40 -67.0 -38.29 85.73 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.963 177.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 70.2 t -63.42 -44.76 99.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.091 0.472 . . . . 0.0 109.819 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -63.18 -37.3 86.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.7 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -62.44 -42.03 99.16 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 119.276 -0.97 . . . . 0.0 108.955 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 92.6 mt -63.51 -43.72 98.44 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 CA-C-O 120.894 0.378 . . . . 0.0 110.924 -178.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -61.37 -42.54 98.87 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 83.0 m -61.33 -44.93 96.37 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.884 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.99 -42.58 99.3 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -177.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.36 -42.49 99.44 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -62.91 -39.88 95.87 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -81.61 -4.02 54.98 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.803 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 36.7 tttt 50.08 48.52 21.88 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 121.825 -0.547 . . . . 0.0 111.649 177.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -132.93 144.58 53.44 Favored Pre-proline 0 N--CA 1.472 0.673 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.334 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.43 139.62 77.7 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 120.765 0.977 . . . . 0.0 114.045 -177.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -139.98 135.55 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.592 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 89' ' ' THR . . . . . 0.88 HG23 ' OD1' ' B' ' 107' ' ' ASN . 98.9 m -119.9 120.72 37.24 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.42 ' HB ' ' OE1' ' B' ' 74' ' ' GLU . 30.7 m -138.33 161.95 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.594 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -114.42 121.21 42.88 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 175.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 92' ' ' ILE . . . . . 0.403 HD11 HG23 ' B' ' 70' ' ' THR . 20.8 tt -128.43 132.65 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.798 -175.043 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 93' ' ' GLN . . . . . 0.534 ' NE2' ' O ' ' B' ' 69' ' ' HIS . 33.9 mt-30 -71.21 141.67 50.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.076 178.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 94' ' ' ASN . . . . . 0.423 ' ND2' ' O ' ' B' ' 93' ' ' GLN . 8.9 m120 -134.92 179.95 5.99 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 121.247 0.546 . . . . 0.0 111.107 -177.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 95' ' ' TYR . . . . . 0.49 ' CE1' ' HA3' ' B' ' 67' ' ' GLY . 95.6 m-85 -130.23 149.68 51.81 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 114.524 -1.216 . . . . 0.0 111.855 177.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 96' ' ' LYS . . . . . 0.48 ' HG3' ' CE1' ' B' ' 102' ' ' PHE . 99.0 mttt -103.41 -177.07 3.26 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.269 0.557 . . . . 0.0 110.716 176.153 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.4 -35.07 76.48 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.647 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 36.6 p-10 -88.17 -0.33 56.96 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.271 -0.893 . . . . 0.0 113.042 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.38 3.73 66.83 Favored Glycine 0 N--CA 1.465 0.574 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.109 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 25.5 m -67.66 130.49 43.17 Favored 'General case' 0 N--CA 1.443 -0.801 0 O-C-N 122.159 -0.612 . . . . 0.0 109.39 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 101' ' ' MET . . . . . 0.57 ' SD ' ' N ' ' B' ' 102' ' ' PHE . 15.8 tmm? -90.15 142.47 27.69 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 102' ' ' PHE . . . . . 0.57 ' N ' ' SD ' ' B' ' 101' ' ' MET . 53.9 p90 -152.72 163.72 39.15 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 177.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 103' ' ' TRP . . . . . 0.839 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 22.1 m95 -95.65 140.16 30.87 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.342 178.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 104' ' ' ASN . . . . . 0.403 HD21 ' HG2' ' B' ' 123' ' ' GLN . 62.6 t-20 -133.94 106.47 7.28 Favored 'General case' 0 C--O 1.217 -0.631 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -177.117 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -75.03 123.88 25.97 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 125.193 1.558 . . . . 0.0 109.262 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 38.9 tp -112.81 125.71 54.64 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 123.58 0.55 . . . . 0.0 111.608 -177.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 107' ' ' ASN . . . . . 0.88 ' OD1' HG23 ' B' ' 89' ' ' THR . 98.1 m-20 -118.96 127.7 53.72 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 176.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 96.5 mt -123.12 132.97 70.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -143.33 125.03 8.4 Favored Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -70.19 152.0 66.88 Favored 'Trans proline' 0 N--CA 1.5 1.878 0 C-N-CA 122.254 1.969 . . . . 0.0 112.624 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 111' ' ' MET . . . . . 0.559 ' HB2' ' HB2' ' B' ' 118' ' ' TYR . 67.2 mtt -128.69 142.17 51.1 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -113.67 109.86 19.28 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 113' ' ' ILE . . . . . 0.718 HG12 ' HZ1' ' A' ' 18' ' ' LYS . 96.7 mt -136.11 127.92 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 O-C-N 121.352 -0.842 . . . . 0.0 111.709 178.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 52.49 37.33 22.6 Favored 'General case' 0 C--O 1.236 0.375 0 O-C-N 123.819 0.7 . . . . 0.0 109.63 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 61.71 35.74 16.78 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.519 0.676 . . . . 0.0 110.248 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -132.21 151.36 51.85 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 177.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 5.1 t -101.02 154.21 18.9 Favored 'General case' 0 C--O 1.215 -0.748 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 118' ' ' TYR . . . . . 0.559 ' HB2' ' HB2' ' B' ' 111' ' ' MET . 90.7 m-85 -149.16 145.32 27.11 Favored 'General case' 0 C--N 1.318 -0.791 0 O-C-N 121.09 -1.006 . . . . 0.0 111.152 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -120.02 139.25 52.79 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 120.812 0.339 . . . . 0.0 111.821 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -128.92 137.35 57.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -177.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -113.54 126.21 7.3 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 94.9 mt -114.29 127.92 71.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 123' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' B' ' 26' ' ' GLY . 17.6 mp0 -117.87 123.42 45.83 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -121.56 124.19 43.77 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 125' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' B' ' 127' ' ' THR . 67.5 t0 -74.94 126.06 30.2 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.556 -177.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.561 ' O ' ' HG3' ' B' ' 130' ' ' LYS . 3.5 mp -98.98 18.85 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.424 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 127' ' ' THR . . . . . 0.539 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 98.1 m -64.55 -44.75 89.79 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 114.326 -1.306 . . . . 0.0 112.781 175.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -59.96 -45.19 93.44 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 -177.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 129' ' ' GLN . . . . . 0.449 ' OE1' HG23 ' B' ' 126' ' ' ILE . 88.5 mt-30 -63.6 -35.02 79.14 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.441 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 130' ' ' LYS . . . . . 0.839 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 99.0 mttt -63.27 -42.0 99.09 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-N 113.232 -1.803 . . . . 0.0 110.822 174.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.99 -41.69 97.44 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 132' ' ' TYR . . . . . 0.748 ' CE2' HD11 ' B' ' 136' ' ' LEU . 89.0 t80 -60.43 -45.3 94.13 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.948 -0.47 . . . . 0.0 111.341 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 133' ' ' GLU . . . . . 0.403 ' O ' ' HG3' ' B' ' 137' ' ' GLU . 97.3 mt-10 -64.23 -37.05 86.09 Favored 'General case' 0 C--O 1.218 -0.586 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.438 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 134' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' B' ' 130' ' ' LYS . 99.0 mttt -62.63 -39.71 94.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.89 177.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 53.2 tp -62.68 -41.12 98.92 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 136' ' ' LEU . . . . . 0.748 HD11 ' CE2' ' B' ' 132' ' ' TYR . 87.7 mt -62.83 -41.78 99.46 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 114.858 -1.064 . . . . 0.0 111.566 177.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 137' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' B' ' 133' ' ' GLU . 97.3 mt-10 -64.69 -36.93 85.87 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.484 -178.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -63.28 -44.07 96.15 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.873 177.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 63.2 m -61.04 -44.05 97.98 Favored 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 140' ' ' LEU . . . . . 0.431 ' O ' ' N ' ' B' ' 144' ' ' THR . 85.6 mt -61.98 -40.23 94.91 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -177.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 86.1 m -61.88 -45.52 93.39 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.173 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -65.66 -41.64 92.29 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 93.0 mt -63.8 -43.12 97.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 114.458 -1.247 . . . . 0.0 110.559 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 144' ' ' THR . . . . . 0.431 ' N ' ' O ' ' B' ' 140' ' ' LEU . 89.0 m -61.69 -45.09 95.47 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -178.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 145' ' ' ALA . . . . . 0.413 ' O ' ' HB ' ' B' ' 148' ' ' THR . . . -63.8 -40.92 97.81 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 118.958 -1.097 . . . . 0.0 109.278 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 87.3 mt -64.53 -41.59 96.28 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 147' ' ' SER . . . . . 0.628 ' O ' ' N ' ' B' ' 149' ' ' PRO . 77.9 p -60.89 -42.1 97.34 Favored 'General case' 0 CA--C 1.481 -1.676 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 -178.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 148' ' ' THR . . . . . 0.469 ' C ' ' O ' ' B' ' 147' ' ' SER . 23.2 m -29.42 84.91 0.03 OUTLIER Pre-proline 0 N--CA 1.482 1.169 0 O-C-N 123.959 0.787 . . . . 0.0 110.182 178.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 149' ' ' PRO . . . . . 0.628 ' N ' ' O ' ' B' ' 147' ' ' SER . 22.0 Cg_exo -61.46 148.24 93.46 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.865 1.71 . . . . 0.0 115.849 -176.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 150' ' ' ILE . . . . . 0.405 ' O ' HG23 ' B' ' 150' ' ' ILE . 9.6 tp -125.91 117.43 48.99 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.156 0 CA-C-N 114.273 -1.33 . . . . 0.0 107.805 173.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 40.1 t -146.99 92.94 4.85 Favored Pre-proline 0 C--N 1.314 -0.946 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.592 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -60.81 136.39 65.96 Favored 'Trans proline' 0 C--N 1.316 -1.154 0 CA-C-N 120.321 1.15 . . . . 0.0 109.219 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 153' ' ' ILE . . . . . 0.674 ' O ' ' HD2' ' B' ' 154' ' ' ARG . 44.6 mm -68.4 -44.35 83.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.956 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 154' ' ' ARG . . . . . 0.719 ' HD3' ' NH2' ' A' ' 154' ' ' ARG . 0.4 OUTLIER -156.56 -154.55 0.48 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.464 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 59.3 t-20 -87.02 108.03 18.68 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 121.024 0.44 . . . . 0.0 110.156 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.79 -17.31 58.47 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 -178.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 157' ' ' ILE . . . . . 0.46 HG22 ' HB ' ' B' ' 153' ' ' ILE . 85.3 mt -109.38 124.07 65.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.275 0.56 . . . . 0.0 111.002 -176.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 158' ' ' SER . . . . . 0.542 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 74.5 m -134.74 149.75 50.49 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.738 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 159' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' B' ' 191' ' ' ILE . . . -132.25 147.27 52.4 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 18.0 tp -138.96 77.72 31.12 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 161' ' ' PRO . . . . . 0.429 ' HB3' ' HB3' ' B' ' 193' ' ' ASP . 90.1 Cg_endo -70.79 146.82 54.83 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 122.867 2.378 . . . . 0.0 114.095 -178.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 92.0 mt -113.03 133.85 54.79 Favored 'General case' 0 C--N 1.345 0.37 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 56.1 t -129.29 132.98 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 177.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 114.86 168.47 15.81 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.012 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 165' ' ' ASN . . . . . 0.768 ' O ' ' CZ ' ' B' ' 170' ' ' ARG . 61.4 t30 -90.03 106.65 18.62 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -177.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 166' ' ' LEU . . . . . 0.625 HD21 ' CZ ' ' B' ' 171' ' ' PHE . 42.3 tp -64.3 104.23 0.73 Allowed 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -174.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 167' ' ' THR . . . . . 0.692 HG23 ' NE ' ' B' ' 170' ' ' ARG . 9.6 p -85.73 168.6 14.2 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 113.806 -1.543 . . . . 0.0 111.094 177.011 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.05 -38.68 91.64 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.607 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -65.85 -41.68 91.38 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 122.402 1.096 . . . . 0.0 111.778 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 170' ' ' ARG . . . . . 0.768 ' CZ ' ' O ' ' B' ' 165' ' ' ASN . 87.8 mtm180 -61.53 -34.72 76.03 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 112.558 -2.11 . . . . 0.0 110.952 178.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 171' ' ' PHE . . . . . 0.625 ' CZ ' HD21 ' B' ' 166' ' ' LEU . 0.5 OUTLIER -54.89 -25.9 32.16 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -178.782 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 172' ' ' ASN . . . . . 0.599 ' O ' HG22 ' B' ' 175' ' ' VAL . 92.4 m-20 -62.74 -40.33 96.88 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.834 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 55.3 m -59.85 -41.41 91.36 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.013 0.435 . . . . 0.0 110.598 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 68.2 mt -63.87 -44.15 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 175' ' ' VAL . . . . . 0.599 HG22 ' O ' ' B' ' 172' ' ' ASN . 35.6 m -62.45 -40.01 86.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 176' ' ' CYS . . . . . 0.415 ' N ' HG23 ' B' ' 175' ' ' VAL . 98.1 m -61.95 -35.3 78.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.329 179.026 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 177' ' ' THR . . . . . 0.563 ' O ' HG13 ' B' ' 181' ' ' ILE . 25.0 m -61.84 -19.67 62.85 Favored 'General case' 0 C--O 1.22 -0.494 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.38 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 178' ' ' LEU . . . . . 0.57 ' CD2' HD21 ' B' ' 211' ' ' LEU . 89.6 mt -60.83 -39.24 88.29 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.238 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 18.9 m -61.74 -44.29 97.21 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.547 177.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 180' ' ' ASN . . . . . 0.592 ' O ' ' OG ' ' B' ' 183' ' ' SER . 92.3 m-20 -61.74 -39.99 93.53 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.161 0.505 . . . . 0.0 110.537 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.563 HG13 ' O ' ' B' ' 177' ' ' THR . 73.0 mt -55.99 -33.48 35.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 O-C-N 122.143 -0.348 . . . . 0.0 110.465 -178.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 182' ' ' LEU . . . . . 0.4 ' HA ' HD23 ' B' ' 182' ' ' LEU . 86.7 mt -62.38 -41.74 98.87 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.163 178.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 183' ' ' SER . . . . . 0.592 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.1 p -63.33 -32.89 74.43 Favored 'General case' 0 C--O 1.225 -0.221 0 O-C-N 121.905 -0.497 . . . . 0.0 110.768 177.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 45.9 p -86.96 17.04 4.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.907 0.384 . . . . 0.0 111.769 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 78.6 p -60.6 -16.51 38.98 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.966 -177.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.64 -40.3 94.41 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 122.075 -0.39 . . . . 0.0 110.811 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 187' ' ' ASP . . . . . 0.542 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.3 m-20 -68.52 114.41 6.9 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.576 0.703 . . . . 0.0 110.793 -178.158 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.88 -42.23 99.69 Favored 'General case' 0 C--O 1.25 1.109 0 CA-C-N 114.997 -1.001 . . . . 0.0 113.242 -178.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -113.0 131.77 55.63 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 120.711 -0.395 . . . . 0.0 111.386 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 190' ' ' LEU . . . . . . . . . . . . . 40.8 tp -123.97 118.96 28.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.372 177.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 191' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' B' ' 159' ' ' ALA . 85.6 mt -106.38 125.71 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 121.128 -0.229 . . . . 0.0 111.444 -178.118 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 48.7 mm -115.16 117.01 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 193' ' ' ASP . . . . . 0.527 ' CG ' ' HG ' ' B' ' 195' ' ' SER . 43.0 t0 -89.42 113.09 24.38 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -176.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 194' ' ' LEU . . . . . . . . . . . . . 96.2 mt -95.45 -1.1 51.55 Favored 'General case' 0 C--O 1.239 0.509 0 O-C-N 122.265 -0.272 . . . . 0.0 110.691 177.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 195' ' ' SER . . . . . 0.527 ' HG ' ' CG ' ' B' ' 193' ' ' ASP . 78.1 p -61.17 -36.7 80.54 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.0 -178.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.42 -37.37 94.0 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 197' ' ' LEU . . . . . 0.959 HD23 ' N ' ' B' ' 198' ' ' ALA . 5.2 tt -72.34 133.63 45.07 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -178.064 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 198' ' ' ALA . . . . . 0.959 ' N ' HD23 ' B' ' 197' ' ' LEU . . . -61.81 -49.19 77.32 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 119.556 -0.858 . . . . 0.0 111.137 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 199' ' ' GLN . . . . . 0.901 ' O ' ' CD2' ' B' ' 197' ' ' LEU . 58.3 tt0 -134.5 164.55 27.22 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-O 121.783 0.802 . . . . 0.0 113.04 -178.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 200' ' ' VAL . . . . . 0.504 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 50.1 t -120.19 130.72 74.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 O-C-N 120.368 -1.458 . . . . 0.0 109.502 176.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -86.15 151.56 23.56 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.658 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -62.64 -33.12 74.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.439 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -63.46 -31.93 73.23 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.6 m -60.92 -43.78 98.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.186 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 205' ' ' ALA . . . . . 0.641 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -58.73 -30.06 67.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 119.26 -0.4 . . . . 0.0 111.848 -178.202 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -64.61 -39.08 93.08 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 123.79 0.681 . . . . 0.0 110.191 175.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -66.33 -38.69 88.24 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.694 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 96.3 mt -63.14 -43.92 99.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -178.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 209' ' ' PHE . . . . . 0.641 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 64.0 m-85 -61.56 -43.57 98.62 Favored 'General case' 0 C--O 1.242 0.692 0 O-C-N 124.682 1.239 . . . . 0.0 111.856 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -62.9 -41.48 99.45 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.25 -0.98 . . . . 0.0 109.727 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 211' ' ' LEU . . . . . 0.57 HD21 ' CD2' ' B' ' 178' ' ' LEU . 37.8 mt -62.45 -42.43 99.46 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.189 -179.079 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 78.2 p -62.74 -37.58 87.14 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.283 -0.567 . . . . 0.0 112.141 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 213' ' ' HIS . . . . . . . . . . . . . 59.9 t60 -66.31 -47.21 74.27 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.34 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 53.4 tp -63.79 -43.44 96.32 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.616 0.722 . . . . 0.0 109.532 178.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 215' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' B' ' 211' ' ' LEU . 90.7 mt -63.09 -43.18 99.23 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 113.466 -1.697 . . . . 0.0 111.214 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.85 -39.46 94.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.727 -0.215 . . . . 0.0 110.933 -177.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 85.7 mt -63.25 -42.46 99.18 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.203 0.525 . . . . 0.0 111.39 176.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 218' ' ' THR . . . . . . . . . . . . . 71.9 p -75.3 -14.15 60.48 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.683 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 77.79 72.66 1.13 Allowed Glycine 0 CA--C 1.528 0.877 0 N-CA-C 107.141 -2.384 . . . . 0.0 107.141 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 220' ' ' THR . . . . . . . . . . . . . 81.7 m -151.72 100.8 2.72 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 177.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -58.59 140.09 54.88 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 121.849 -0.532 . . . . 0.0 111.103 -177.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 42.0 tp -117.49 120.72 38.97 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.171 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 2.9 mp -109.92 128.91 65.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.166 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 224' ' ' ILE . . . . . 0.555 ' CG2' HD11 ' B' ' 227' ' ' ILE . 50.4 mm -110.68 127.47 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 O-C-N 123.572 0.545 . . . . 0.0 109.532 -179.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 43.7 p -134.42 157.57 46.11 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 90.78 16.17 55.17 Favored Glycine 0 N--CA 1.442 -0.967 0 CA-C-N 113.949 -1.478 . . . . 0.0 111.228 -177.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 227' ' ' ILE . . . . . 0.675 HD12 HG23 ' B' ' 247' ' ' THR . 95.9 mt -81.74 126.63 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 CA-C-N 117.889 0.845 . . . . 0.0 111.686 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 61.2 tttt -67.01 139.28 95.43 Favored Pre-proline 0 C--N 1.316 -0.854 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.521 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.85 -37.04 92.78 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 121.354 1.37 . . . . 0.0 112.483 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -63.08 -43.48 98.4 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 53.1 tp -62.42 -41.98 99.1 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.679 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -62.95 -36.99 85.29 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.892 0.377 . . . . 0.0 111.367 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 94.6 mtp -63.75 -41.15 98.06 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.758 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.3 -43.33 99.07 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 121.995 0.902 . . . . 0.0 109.366 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 30.2 mmt -64.33 -35.85 82.22 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.896 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -61.08 -40.62 94.38 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.987 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.77 -43.05 99.82 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.287 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 52.7 tp -62.68 -44.25 96.73 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 121.883 -0.51 . . . . 0.0 112.27 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 239' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' B' ' 240' ' ' ALA . 66.7 t0 -159.28 133.42 7.62 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 120.149 -0.62 . . . . 0.0 111.982 -178.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 240' ' ' ALA . . . . . 0.4 ' N ' ' OD1' ' B' ' 239' ' ' ASP . . . -60.98 -47.76 84.95 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 241' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' B' ' 244' ' ' SER . 90.2 m-20 -43.23 -19.37 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.475 -175.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 242' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -60.34 -45.03 94.9 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.172 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 243' ' ' SER . . . . . . . . . . . . . 78.1 p -58.77 -42.03 88.01 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 244' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 25.2 m -35.25 -32.53 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -177.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 98.9 mt -90.41 131.54 36.12 Favored 'General case' 0 CA--C 1.513 -0.452 0 O-C-N 121.1 -1.0 . . . . 0.0 110.061 178.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -59.47 134.89 57.42 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 121.421 0.629 . . . . 0.0 110.376 -176.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 247' ' ' THR . . . . . 0.675 HG23 HD12 ' B' ' 227' ' ' ILE . 97.3 m -125.62 127.99 47.19 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.484 -1.235 . . . . 0.0 111.861 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 248' ' ' TYR . . . . . 0.546 ' CG ' ' HB2' ' B' ' 254' ' ' ALA . 98.1 m-85 -113.3 144.15 43.22 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 249' ' ' SER . . . . . 0.563 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 78.6 p -64.57 -33.66 76.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.476 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 250' ' ' ASN . . . . . 0.563 ' OD1' ' O ' ' B' ' 249' ' ' SER . 99.0 m-20 -147.2 160.11 42.85 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.971 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 61.7 t -64.21 -44.69 97.49 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.254 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.293 177.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 252' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.24 -45.4 94.68 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -177.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 253' ' ' ASP . . . . . 0.444 ' O ' HG22 ' B' ' 257' ' ' VAL . 93.5 m-20 -61.51 -44.24 97.42 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.75 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 254' ' ' ALA . . . . . 0.546 ' HB2' ' CG ' ' B' ' 248' ' ' TYR . . . -65.44 -40.65 93.52 Favored 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.893 178.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 255' ' ' VAL . . . . . 0.729 HG13 HH11 ' A' ' 154' ' ' ARG . 74.2 t -64.66 -45.48 95.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.3 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 256' ' ' LYS . . . . . 0.411 ' HE3' ' ND2' ' A' ' 155' ' ' ASN . 88.6 tttt -63.04 -48.46 78.62 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 120.132 -0.627 . . . . 0.0 111.118 -178.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 257' ' ' VAL . . . . . 0.486 ' O ' ' C ' ' B' ' 258' ' ' LEU . 20.1 m -65.55 -40.79 89.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.662 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 258' ' ' LEU . . . . . 0.508 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 1.0 OUTLIER -31.58 -73.67 0.05 OUTLIER Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 119.499 -0.286 . . . . 0.0 111.664 -178.009 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 259' ' ' PRO . . . . . 0.508 ' CD ' ' CB ' ' B' ' 258' ' ' LEU . 36.6 Cg_endo -61.81 139.99 83.17 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 121.531 1.487 . . . . 0.0 111.575 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 260' ' ' ILE . . . . . 0.547 HG22 ' O ' ' B' ' 260' ' ' ILE . 96.6 mt -157.47 -14.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 118.665 0.666 . . . . 0.0 112.054 177.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 78.3 mtm . . . . . 0 C--O 1.214 -0.801 0 CA-C-O 117.761 -1.114 . . . . 0.0 111.573 -179.588 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.14 171.81 17.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 118.968 -0.539 . . . . 0.0 110.226 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.5 p -71.3 -14.89 62.36 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.332 0.653 . . . . 0.0 110.757 177.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -75.53 -66.3 0.79 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.615 175.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -67.28 -39.3 85.99 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.969 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.533 ' O ' ' HB3' ' A' ' 7' ' ' PHE . 63.1 m -59.44 -42.56 92.19 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.114 -176.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.533 ' HB3' ' O ' ' A' ' 6' ' ' SER . 44.3 t80 85.52 85.69 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 O-C-N 123.707 0.63 . . . . 0.0 112.495 177.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.664 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -62.21 -152.15 0.03 OUTLIER Glycine 0 CA--C 1.529 0.967 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -177.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.664 ' HB ' ' O ' ' A' ' 8' ' ' GLY . 66.9 mt 93.63 108.89 0.02 OUTLIER Pre-proline 0 N--CA 1.472 0.66 0 C-N-CA 122.371 0.269 . . . . 0.0 110.579 -178.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.48 -22.77 71.12 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 121.539 1.493 . . . . 0.0 112.181 -178.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.403 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -63.43 -38.3 96.15 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.112 -0.566 . . . . 0.0 111.726 179.05 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -65.52 -38.7 90.43 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.654 0.74 . . . . 0.0 109.706 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 52.5 tp -62.71 -41.39 99.12 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.412 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -64.25 -39.04 93.14 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 11' ' ' GLY . 55.5 t -60.51 -44.16 95.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 O-C-N 122.186 -0.321 . . . . 0.0 110.434 -178.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 92.4 mt -62.71 -43.64 98.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 C-N-CA 119.756 -0.777 . . . . 0.0 109.3 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.424 ' NZ ' ' HA ' ' B' ' 6' ' ' SER . 98.9 mttt -62.12 -45.37 93.76 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 119.365 -0.934 . . . . 0.0 112.221 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.712 ' HZ1' HG12 ' B' ' 113' ' ' ILE . 98.7 mttt -60.1 -40.21 88.84 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 118.672 -1.211 . . . . 0.0 109.124 -176.021 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.34 -42.68 96.21 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.157 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 20' ' ' LEU . 85.7 mt -62.95 -41.18 99.43 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.118 0.485 . . . . 0.0 109.926 178.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -63.49 -37.99 89.41 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.499 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 57.6 m170 -58.92 -39.8 82.63 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 122.179 -0.326 . . . . 0.0 111.254 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.2 p -113.82 130.44 67.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.498 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 34.6 ptt180 -72.51 110.25 6.76 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.99 0.9 . . . . 0.0 112.08 -177.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.3 p -140.98 143.14 28.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.164 178.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.472 ' O ' ' N ' ' A' ' 123' ' ' GLN . . . -97.91 91.76 1.2 Allowed Glycine 0 C--N 1.312 -0.768 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.76 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.4 t -124.84 130.25 73.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 175.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.4 m -137.17 159.99 36.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.6 mt -119.85 131.14 73.13 Favored 'Isoleucine or valine' 0 C--O 1.247 0.965 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 176.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.516 HG22 HG12 ' A' ' 39' ' ' ILE . 72.6 p -108.04 165.98 11.06 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.415 ' C ' ' OD1' ' A' ' 37' ' ' ASN . 56.1 t0 -130.8 103.29 15.94 Favored Pre-proline 0 C--N 1.319 -0.719 0 C-N-CA 121.087 -0.245 . . . . 0.0 110.538 178.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.436 ' HG3' HG23 ' A' ' 117' ' ' THR . 35.0 Cg_endo -62.69 -23.61 74.63 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 121.365 1.376 . . . . 0.0 111.701 -178.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.78 -36.38 83.68 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.729 -178.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.6 mt -83.74 156.12 22.73 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.641 177.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.754 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 43.0 tt0 -58.1 138.06 56.4 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -176.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.548 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 60.0 t0 59.29 20.47 8.64 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.767 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.415 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 46.5 t-20 40.29 68.58 2.2 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.072 -177.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.754 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 91.2 Cg_endo -70.69 155.31 63.11 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 124.06 3.173 . . . . 0.0 112.649 -178.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.516 HG12 HG22 ' A' ' 30' ' ' THR . 95.8 mt -87.68 123.85 40.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.429 HG23 ' N ' ' A' ' 41' ' ' TYR . 28.0 m -104.21 -43.41 8.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.883 -178.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.429 ' N ' HG23 ' A' ' 40' ' ' VAL . 43.5 t80 -94.84 124.31 38.81 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.552 -177.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.7 p -143.35 141.1 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 O-C-N 124.314 1.009 . . . . 0.0 109.345 177.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.676 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 56.8 p30 -98.45 166.76 11.21 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.512 ' HA ' ' OE1' ' A' ' 44' ' ' GLN . 13.5 mm100 -66.7 -39.04 87.9 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 120.887 0.375 . . . . 0.0 111.868 177.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.17 -25.98 63.04 Favored Glycine 0 C--N 1.332 0.346 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.676 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 62.9 t80 -59.22 -48.42 81.67 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 -178.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.57 HG13 ' O ' ' A' ' 52' ' ' TYR . 53.7 t -58.88 -44.9 91.72 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.542 0 O-C-N 121.274 -0.891 . . . . 0.0 111.074 -173.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -63.26 -37.71 88.31 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.768 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 59.7 ttm -67.17 -44.14 80.48 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 176.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 37.9 p -90.26 -23.2 21.27 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.146 0.498 . . . . 0.0 111.845 -178.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . 77.74 19.34 75.86 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.57 ' O ' HG13 ' A' ' 47' ' ' VAL . 77.4 m-85 -112.71 138.09 50.03 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.1 0.56 . . . . 0.0 111.606 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -63.75 148.2 49.78 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.535 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.421 HG22 ' H ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -65.54 -32.41 73.98 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -179.45 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.02 -43.43 87.66 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.434 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -64.73 -44.23 90.84 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.621 178.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.628 HD13 ' CD2' ' A' ' 46' ' ' PHE . 88.3 mt -61.49 -51.3 74.46 Favored 'Isoleucine or valine' 0 C--N 1.347 0.489 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -174.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 86.0 mt -56.83 146.03 27.62 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 177.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.17 -6.63 74.88 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-O 119.339 -0.7 . . . . 0.0 112.829 176.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -135.0 150.52 50.34 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.832 1.316 . . . . 0.0 111.882 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.559 ' C ' ' H ' ' A' ' 63' ' ' ARG . 24.9 t-20 -80.17 150.75 30.06 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.241 0.543 . . . . 0.0 110.771 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.406 ' HB3' HD12 ' A' ' 65' ' ' LEU . 76.8 m -63.14 15.86 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.502 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.559 ' H ' ' C ' ' A' ' 61' ' ' ASN . 35.8 ptt-85 -61.67 -41.36 97.44 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.262 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -56.41 -20.49 19.89 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -178.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.406 HD12 ' HB3' ' A' ' 62' ' ' CYS . 87.8 mt -68.23 -34.3 75.99 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.546 0.689 . . . . 0.0 112.506 177.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -64.53 137.83 58.07 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.439 -0.8 . . . . 0.0 112.374 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.567 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -146.54 -147.06 4.49 Favored Glycine 0 CA--C 1.544 1.898 0 C-N-CA 120.825 -0.703 . . . . 0.0 111.892 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.01 -40.29 97.32 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -177.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.576 ' O ' ' NE2' ' A' ' 93' ' ' GLN . 11.8 m80 -76.77 -7.85 56.19 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.035 -178.24 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.567 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 28.9 m -63.56 128.82 37.55 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.379 -0.528 . . . . 0.0 109.807 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -84.91 109.3 19.54 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.708 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 70' ' ' THR . 51.5 Cg_exo -56.83 -32.97 93.56 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.042 1.828 . . . . 0.0 113.11 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.46 -39.54 94.0 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.207 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -64.88 -42.31 94.93 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 77.8 t -60.38 -43.65 94.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 114.242 -1.344 . . . . 0.0 107.679 -175.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -63.47 -37.72 88.4 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.928 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -63.77 -40.08 95.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.253 0.549 . . . . 0.0 110.443 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.75 -44.08 98.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-O 122.156 0.979 . . . . 0.0 111.99 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -63.25 -42.92 99.23 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 113.522 -1.672 . . . . 0.0 108.183 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 96.6 m -61.45 -49.92 74.88 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 120.061 -0.655 . . . . 0.0 109.776 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.66 -42.14 87.75 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-O 119.183 -0.437 . . . . 0.0 111.297 -174.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 84.2 mt -63.12 -39.52 94.93 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 119.386 0.994 . . . . 0.0 111.439 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -65.29 -33.22 75.47 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -88.75 -2.13 58.43 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.543 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.8 tttt 50.08 41.65 23.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.752 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -126.06 144.0 47.41 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 108' ' ' ILE . 24.6 Cg_exo -61.61 143.55 96.86 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 121.303 1.335 . . . . 0.0 113.595 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -139.51 141.62 34.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.721 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.722 HG23 ' OD1' ' A' ' 107' ' ' ASN . 91.2 m -125.47 122.42 36.6 Favored 'General case' 0 C--N 1.342 0.271 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 175.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 29.7 m -138.93 157.97 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.675 176.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -102.41 134.33 45.91 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 176.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.404 ' O ' HG23 ' A' ' 92' ' ' ILE . 18.7 tt -141.89 130.65 22.63 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.181 0 CA-C-N 120.5 1.5 . . . . 0.0 112.977 177.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.576 ' NE2' ' O ' ' A' ' 69' ' ' HIS . 34.7 mt-30 -64.75 132.7 50.32 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.871 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -134.09 156.19 48.7 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.46 -178.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -115.89 134.07 55.37 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.444 ' HG3' ' CE1' ' A' ' 102' ' ' PHE . 99.1 mttt -83.03 -173.66 4.84 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.166 0.508 . . . . 0.0 111.52 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.52 -43.11 99.61 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.65 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 40.8 p-10 -82.65 5.54 20.79 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -178.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.39 -0.3 86.99 Favored Glycine 0 N--CA 1.466 0.641 0 C-N-CA 120.879 -0.676 . . . . 0.0 112.225 176.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 26.7 m -59.18 137.74 57.85 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.657 ' SD ' ' C ' ' A' ' 101' ' ' MET . 13.4 tmm? -102.36 127.89 49.17 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.724 0.297 . . . . 0.0 110.95 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.474 ' N ' ' SD ' ' A' ' 101' ' ' MET . 53.2 p90 -140.88 159.66 41.74 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.236 -0.586 . . . . 0.0 109.762 -177.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.888 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 26.1 m95 -92.55 141.12 28.85 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.116 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.528 HD21 ' HG2' ' A' ' 123' ' ' GLN . 53.9 t-20 -137.0 104.39 5.44 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -176.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 81.2 tt0 -69.25 137.38 53.08 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -177.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 44.1 tp -121.56 123.97 43.25 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.722 ' OD1' HG23 ' A' ' 89' ' ' THR . 98.3 m-20 -119.67 123.38 43.68 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.522 177.214 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.413 ' O ' ' HA ' ' A' ' 87' ' ' PRO . 96.2 mt -121.02 128.72 76.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 O-C-N 123.345 0.403 . . . . 0.0 111.225 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -140.61 122.96 9.68 Favored Pre-proline 0 CA--C 1.541 0.596 0 CA-C-O 119.912 -0.089 . . . . 0.0 110.785 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -70.71 150.28 62.16 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 122.593 2.195 . . . . 0.0 112.912 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.594 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 66.9 mtt -122.81 153.86 38.99 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 -179.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -125.0 98.8 5.84 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.596 1.089 . . . . 0.0 108.478 176.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.469 ' CD1' HG22 ' B' ' 15' ' ' VAL . 95.7 mt -121.24 131.19 73.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.875 -178.006 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 47.63 39.57 10.15 Favored 'General case' 0 CA--C 1.516 -0.349 0 O-C-N 121.599 -0.688 . . . . 0.0 111.613 177.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 59.31 30.64 20.4 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.906 -178.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -127.81 148.54 50.45 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.754 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 5.1 t -86.01 -172.4 4.06 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 121.506 -0.746 . . . . 0.0 109.68 -178.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.754 ' CD2' ' O ' ' A' ' 117' ' ' THR . 69.7 m-85 -171.03 157.32 5.18 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 174.045 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.463 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 97.2 m-85 -130.27 145.18 51.73 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 173.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -132.95 133.32 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.28 128.22 9.13 Favored Glycine 0 CA--C 1.504 -0.636 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 178.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 96.1 mt -118.09 129.6 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 178.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.528 ' HG2' HD21 ' A' ' 104' ' ' ASN . 16.3 mp0 -119.54 115.84 24.84 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.172 0.511 . . . . 0.0 109.756 179.161 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -117.72 115.22 24.59 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.13 -177.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 126' ' ' ILE . 68.0 t0 -64.14 129.76 41.26 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -174.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.494 ' O ' HG22 ' A' ' 126' ' ' ILE . 2.6 mp -95.14 2.05 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 113.576 -1.647 . . . . 0.0 110.02 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 20.1 m -60.79 -42.39 97.49 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -178.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -60.35 -42.07 94.95 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -177.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -62.94 -39.25 94.04 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.855 177.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.888 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.6 mttt -62.22 -40.71 97.04 Favored 'General case' 0 CA--C 1.5 -0.979 0 C-N-CA 118.397 -1.321 . . . . 0.0 110.643 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -62.32 -37.4 85.46 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -178.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.661 ' CE2' HD11 ' A' ' 136' ' ' LEU . 89.4 t80 -61.75 -46.33 90.06 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.912 176.037 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.69 -38.9 92.56 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 130' ' ' LYS . 98.7 mttt -62.04 -40.45 95.77 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 53.1 tp -60.73 -43.53 97.78 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -177.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.661 HD11 ' CE2' ' A' ' 132' ' ' TYR . 86.5 mt -62.66 -41.36 99.02 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.495 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.27 -40.91 98.72 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 119.637 -0.825 . . . . 0.0 109.531 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -60.95 -41.45 96.34 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -177.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.1 m -61.99 -39.96 93.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.896 176.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.523 ' O ' ' N ' ' A' ' 144' ' ' THR . 87.7 mt -63.39 -42.03 98.78 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 99.6 m -61.85 -45.61 93.04 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.975 -177.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -64.54 -41.0 96.62 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 96.1 mt -64.7 -43.46 96.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 113.965 -1.47 . . . . 0.0 111.53 175.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.523 ' N ' ' O ' ' A' ' 140' ' ' LEU . 97.2 m -62.71 -46.07 89.82 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 120.283 -0.567 . . . . 0.0 112.358 -177.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.88 -39.84 95.7 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 118.813 -1.155 . . . . 0.0 109.138 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 87.6 mt -63.76 -42.48 97.8 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.644 178.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.679 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.1 p -60.19 -40.19 89.16 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -177.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.498 ' C ' ' O ' ' A' ' 147' ' ' SER . 93.5 m -26.64 83.57 0.03 OUTLIER Pre-proline 0 C--N 1.343 0.305 0 O-C-N 126.417 2.323 . . . . 0.0 106.814 -178.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.679 ' N ' ' O ' ' A' ' 147' ' ' SER . 22.0 Cg_exo -62.69 145.1 95.0 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 CA-C-O 122.428 0.928 . . . . 0.0 113.949 -175.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.64 ' O ' HG23 ' A' ' 151' ' ' VAL . 9.5 tp -120.25 135.98 58.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 102.378 -3.193 . . . . 0.0 102.378 175.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 150' ' ' ILE . 70.7 t -169.6 95.48 0.51 Allowed Pre-proline 0 N--CA 1.446 -0.64 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 176.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -61.83 135.71 57.51 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 N-CA-C 109.565 -0.975 . . . . 0.0 109.565 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.561 ' O ' ' HD2' ' A' ' 154' ' ' ARG . 46.1 mm -68.0 -44.28 84.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.104 179.068 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.571 ' NH2' ' HD3' ' B' ' 154' ' ' ARG . 0.3 OUTLIER -156.62 -157.65 0.72 Allowed 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 61.8 t-20 -86.94 105.88 17.41 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.871 0.843 . . . . 0.0 111.631 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 89.29 7.65 69.49 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 113.957 -1.474 . . . . 0.0 110.832 -177.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.474 HG12 ' HB2' ' A' ' 189' ' ' TYR . 96.2 mt -124.42 126.19 71.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 174.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.671 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 66.7 m -132.12 152.5 51.21 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 122.494 0.317 . . . . 0.0 110.36 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -137.91 142.02 40.62 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.612 -0.68 . . . . 0.0 111.338 177.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 15.9 tp -133.8 79.38 58.4 Favored Pre-proline 0 N--CA 1.472 0.662 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.525 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -69.65 150.76 69.32 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.782 2.322 . . . . 0.0 113.165 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 84.8 mt -116.63 125.51 51.9 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.61 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 43.2 t -122.16 130.97 74.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 115.74 169.48 15.67 Favored Glycine 0 N--CA 1.484 1.857 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.061 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.864 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 53.9 t30 -86.51 113.23 22.26 Favored 'General case' 0 C--N 1.347 0.47 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.589 HD21 ' CZ ' ' A' ' 171' ' ' PHE . 46.7 tp -71.32 104.39 3.15 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 -177.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.751 HG23 ' NE ' ' A' ' 170' ' ' ARG . 10.4 p -86.46 166.98 15.08 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.414 178.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -66.01 -34.22 77.59 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.023 0.44 . . . . 0.0 111.551 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.55 -41.83 96.09 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.36 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.864 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 87.6 mtm180 -65.41 -33.98 77.22 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.328 1.051 . . . . 0.0 112.192 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.589 ' CZ ' HD21 ' A' ' 166' ' ' LEU . 0.4 OUTLIER -54.45 -27.94 40.85 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 118.946 -0.55 . . . . 0.0 112.239 -178.695 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.633 ' O ' HG22 ' A' ' 175' ' ' VAL . 91.6 m-20 -61.06 -40.37 93.41 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 119.652 1.114 . . . . 0.0 109.702 -178.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 41.4 m -59.77 -40.47 88.33 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.801 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 68.0 mt -63.21 -44.21 99.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.633 HG22 ' O ' ' A' ' 172' ' ' ASN . 27.1 m -62.82 -39.74 86.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' CYS . . . . . 0.426 ' N ' HG23 ' A' ' 175' ' ' VAL . 98.7 m -62.5 -34.6 77.19 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.313 0.578 . . . . 0.0 110.388 178.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.584 ' O ' HG13 ' A' ' 181' ' ' ILE . 24.9 m -62.63 -20.39 64.73 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.285 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.64 ' CD2' HD21 ' A' ' 211' ' ' LEU . 86.3 mt -61.17 -41.32 96.58 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -177.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 18.7 m -60.2 -43.27 96.06 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ASN . . . . . 0.62 ' O ' ' OG ' ' A' ' 183' ' ' SER . 93.2 m-20 -62.25 -37.26 84.74 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 122.552 0.341 . . . . 0.0 110.963 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.584 HG13 ' O ' ' A' ' 177' ' ' THR . 69.6 mt -57.9 -37.63 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 O-C-N 121.536 -0.728 . . . . 0.0 109.473 -178.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.495 HD21 HD21 ' A' ' 214' ' ' LEU . 83.1 mt -61.1 -40.7 94.74 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -177.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.62 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 78.2 p -61.05 -33.0 72.61 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.228 176.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.467 ' OG1' ' HA ' ' A' ' 181' ' ' ILE . 22.6 p -89.09 23.18 2.5 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.592 0.234 . . . . 0.0 111.542 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 78.1 p -63.52 -20.84 65.95 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.216 0.531 . . . . 0.0 110.558 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.64 -37.46 81.56 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.802 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.671 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 98.8 m-20 -74.1 113.48 11.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.388 0.613 . . . . 0.0 110.615 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -63.03 -42.17 99.71 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.999 -1.001 . . . . 0.0 112.91 -177.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' TYR . . . . . 0.474 ' HB2' HG12 ' A' ' 157' ' ' ILE . 98.2 m-85 -112.12 131.72 55.28 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.619 -178.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 39.4 tp -119.72 127.59 52.99 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 93.9 mt -114.72 126.63 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 O-C-N 121.637 -0.664 . . . . 0.0 110.027 177.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.8 mm -113.09 127.19 70.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' ASP . . . . . 0.562 ' OD2' ' OG ' ' A' ' 195' ' ' SER . 38.7 t0 -95.79 119.99 35.27 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 121.79 -0.569 . . . . 0.0 110.629 176.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 96.6 mt -97.17 -3.38 41.1 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.156 174.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' SER . . . . . 0.562 ' OG ' ' OD2' ' A' ' 193' ' ' ASP . 78.2 p -62.9 -33.26 74.94 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -62.02 -43.12 99.6 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 108.477 -1.849 . . . . 0.0 108.477 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 1.065 ' CD2' ' O ' ' A' ' 199' ' ' GLN . 5.2 tt -70.47 127.87 34.2 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 113.037 -1.582 . . . . 0.0 109.074 -176.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.889 ' N ' HD23 ' A' ' 197' ' ' LEU . . . -61.02 -48.69 80.62 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 119.764 -0.774 . . . . 0.0 110.772 -177.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 1.065 ' O ' ' CD2' ' A' ' 197' ' ' LEU . 58.3 tt0 -132.59 156.52 46.74 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 114.77 -1.105 . . . . 0.0 112.183 -174.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.449 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 45.7 t -118.14 133.25 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -91.25 153.98 19.6 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.571 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.8 -38.06 89.67 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.239 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -59.42 -31.74 69.55 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -178.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 19.1 m -60.91 -42.65 98.51 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.475 177.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.449 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -58.06 -38.24 75.94 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -177.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -61.32 -37.99 85.26 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -65.59 -38.51 89.69 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.961 177.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 94.9 mt -62.94 -43.98 99.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.027 -178.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' PHE . . . . . 0.449 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 71.0 m-85 -62.01 -42.68 99.42 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.635 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -61.96 -41.8 98.41 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.173 -178.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.64 HD21 ' CD2' ' A' ' 178' ' ' LEU . 39.8 mt -61.82 -42.23 98.77 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 78.0 p -61.72 -42.09 98.49 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 119.232 -0.987 . . . . 0.0 109.734 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -64.6 -46.25 83.49 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.723 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.495 HD21 HD21 ' A' ' 182' ' ' LEU . 52.5 tp -62.39 -46.25 89.45 Favored 'General case' 0 C--N 1.344 0.354 0 C-N-CA 119.029 -1.068 . . . . 0.0 108.416 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 85.1 mt -61.72 -40.59 95.59 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.472 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.25 -44.72 95.01 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 85.2 mt -61.65 -39.57 91.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.07 0.462 . . . . 0.0 109.822 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 67.0 p -75.53 -11.58 60.05 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.481 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.88 35.39 18.95 Favored Glycine 0 C--O 1.217 -0.939 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.935 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 95.2 m -121.86 113.83 20.19 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.227 1.514 . . . . 0.0 111.148 -178.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -65.78 137.24 57.11 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.206 177.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 43.5 tp -113.21 130.63 56.16 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 3.3 mp -117.41 133.74 63.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 122.857 0.463 . . . . 0.0 109.883 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.529 ' CG2' HD11 ' A' ' 227' ' ' ILE . 49.5 mm -114.93 132.22 64.81 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 43.9 p -134.08 166.63 22.29 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 120.392 -0.523 . . . . 0.0 112.058 -178.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 78.82 20.32 71.08 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 178.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.701 HD12 HG23 ' A' ' 247' ' ' THR . 97.3 mt -81.56 128.61 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 CA-C-N 114.042 -1.079 . . . . 0.0 108.818 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 63.5 tttt -76.04 140.26 69.92 Favored Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.06 -38.92 87.3 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.187 1.258 . . . . 0.0 112.324 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -64.7 -39.39 93.57 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-O 121.619 0.723 . . . . 0.0 110.083 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 48.7 tp -63.55 -42.6 98.38 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.987 -1.006 . . . . 0.0 113.104 176.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.86 -38.05 89.65 Favored 'General case' 0 CA--C 1.521 -0.141 0 O-C-N 121.916 -0.49 . . . . 0.0 111.101 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 94.1 mtp -63.84 -41.48 97.82 Favored 'General case' 0 C--O 1.251 1.135 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.561 -178.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -64.15 -40.02 95.25 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.484 177.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 33.4 mmt -65.68 -38.35 89.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.625 177.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -61.61 -41.55 97.62 Favored 'General case' 0 CA--C 1.516 -0.35 0 O-C-N 121.406 -0.808 . . . . 0.0 109.188 -177.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.43 -41.24 93.61 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.458 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 55.9 tp -63.76 -41.84 97.93 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.229 0.825 . . . . 0.0 113.229 177.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -165.51 126.24 1.88 Allowed 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.604 -0.685 . . . . 0.0 112.684 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -60.05 -26.57 66.23 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.951 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -61.78 -29.97 70.49 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.192 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -55.82 -44.73 78.16 Favored 'General case' 0 C--N 1.312 -1.023 0 O-C-N 121.484 -0.76 . . . . 0.0 109.352 -176.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 95.5 p -62.31 -20.07 63.95 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.23 178.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 19.1 m -55.22 -38.18 68.1 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.511 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 97.2 mt -86.3 123.84 31.99 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -178.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -48.37 135.21 14.11 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 114.7 -1.137 . . . . 0.0 109.707 -176.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.701 HG23 HD12 ' A' ' 227' ' ' ILE . 98.0 m -127.87 132.29 49.37 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 114.528 -1.215 . . . . 0.0 111.333 178.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 248' ' ' TYR . . . . . 0.456 ' CB ' ' HB2' ' A' ' 254' ' ' ALA . 97.6 m-85 -116.33 139.64 50.18 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.093 178.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 78.1 p -59.67 -43.07 94.14 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 119.152 -1.019 . . . . 0.0 108.304 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -142.68 159.63 41.86 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.726 0.774 . . . . 0.0 111.312 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 75.4 t -62.61 -45.0 99.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 114.607 -1.179 . . . . 0.0 111.796 -179.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.92 -43.98 97.85 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.247 -0.581 . . . . 0.0 109.519 -178.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 253' ' ' ASP . . . . . 0.461 ' O ' HG22 ' A' ' 257' ' ' VAL . 54.6 m-20 -63.59 -41.95 98.3 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.973 -178.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 254' ' ' ALA . . . . . 0.456 ' HB2' ' CB ' ' A' ' 248' ' ' TYR . . . -64.9 -41.7 95.38 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.037 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 255' ' ' VAL . . . . . 0.448 HG13 HH11 ' B' ' 154' ' ' ARG . 77.0 t -64.02 -45.56 96.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 114.021 -1.445 . . . . 0.0 110.925 -177.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.99 -47.15 81.49 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.763 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.515 ' O ' ' C ' ' A' ' 258' ' ' LEU . 28.6 m -66.34 -40.6 87.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 120.058 -0.657 . . . . 0.0 112.429 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.515 ' C ' ' O ' ' A' ' 257' ' ' VAL . 1.4 mt -28.36 -75.44 0.04 OUTLIER Pre-proline 0 C--N 1.344 0.355 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.318 -177.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 259' ' ' PRO . . . . . 0.507 ' CD ' ' CB ' ' A' ' 258' ' ' LEU . 42.0 Cg_endo -63.46 139.7 72.12 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 CA-C-N 119.561 0.879 . . . . 0.0 111.761 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 259' ' ' PRO . 96.7 mt -151.38 -26.57 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.694 177.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 78.1 mtm . . . . . 0 N--CA 1.472 0.663 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.562 -177.013 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.459 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.1 163.71 38.67 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 80.4 p -59.85 -20.82 59.32 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 123.37 0.419 . . . . 0.0 111.27 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -74.2 -63.63 1.19 Allowed 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.091 0.472 . . . . 0.0 111.303 -178.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -67.03 -38.85 86.63 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.877 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 6' ' ' SER . . . . . 0.545 ' O ' ' HB3' ' B' ' 7' ' ' PHE . 65.7 m -60.05 -43.14 95.58 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 119.979 -0.688 . . . . 0.0 109.928 -176.384 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 7' ' ' PHE . . . . . 0.545 ' HB3' ' O ' ' B' ' 6' ' ' SER . 46.2 t80 86.39 88.91 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 O-C-N 123.751 0.657 . . . . 0.0 110.745 177.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 8' ' ' GLY . . . . . 0.692 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -64.23 -151.73 0.07 OUTLIER Glycine 0 CA--C 1.53 0.99 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.692 ' HB ' ' O ' ' B' ' 8' ' ' GLY . 67.3 mt 92.98 108.81 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 122.387 0.275 . . . . 0.0 110.87 -178.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -62.53 -24.94 75.47 Favored 'Trans proline' 0 N--CA 1.5 1.855 0 C-N-CA 121.375 1.383 . . . . 0.0 111.847 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.7 -40.5 98.13 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 110.689 -0.965 . . . . 0.0 110.689 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -64.89 -38.62 91.57 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.726 0.774 . . . . 0.0 109.506 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 52.4 tp -61.75 -42.53 99.09 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.848 -178.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -65.68 -32.81 74.58 Favored 'General case' 0 CA--C 1.562 1.442 0 CA-C-O 121.344 0.593 . . . . 0.0 110.534 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 15' ' ' VAL . . . . . 0.469 HG22 ' CD1' ' A' ' 113' ' ' ILE . 63.2 t -61.57 -46.28 96.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 113.097 -1.865 . . . . 0.0 110.664 177.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 92.9 mt -63.65 -43.91 98.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.259 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 17' ' ' LYS . . . . . 0.489 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 98.9 mttt -63.36 -41.61 98.84 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.98 -41.37 99.53 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 119.069 -1.053 . . . . 0.0 110.312 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.96 -38.8 89.91 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.656 -178.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.417 ' O ' ' O ' ' B' ' 23' ' ' VAL . 85.5 mt -64.31 -41.97 96.58 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.286 0.565 . . . . 0.0 110.295 175.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -63.15 -38.34 90.79 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.34 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 56.9 m170 -58.47 -39.64 80.49 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 121.236 -0.185 . . . . 0.0 111.087 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.417 ' O ' ' O ' ' B' ' 20' ' ' LEU . 10.0 p -113.96 130.54 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.504 ' HG3' ' O ' ' B' ' 24' ' ' ARG . 34.7 ptt180 -71.79 108.42 5.09 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 121.865 0.84 . . . . 0.0 112.446 -177.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 7.1 p -143.14 134.33 23.31 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.501 177.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 26' ' ' GLY . . . . . 0.508 ' O ' ' N ' ' B' ' 123' ' ' GLN . . . -89.59 95.76 2.13 Favored Glycine 0 N--CA 1.436 -1.332 0 C-N-CA 119.093 -1.527 . . . . 0.0 112.748 -175.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 45.9 t -124.86 129.42 73.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 174.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 27.2 m -138.6 157.25 30.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.722 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 95.9 mt -118.84 129.82 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-O 122.377 1.084 . . . . 0.0 111.167 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.508 HG22 HG12 ' B' ' 39' ' ' ILE . 44.7 p -112.0 152.81 27.69 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 112.474 -2.148 . . . . 0.0 108.475 -175.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -121.87 103.6 39.9 Favored Pre-proline 0 C--O 1.239 0.506 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -177.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 32' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.78 -22.61 69.4 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 121.907 1.738 . . . . 0.0 111.519 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.6 -42.86 99.46 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 96.0 mt -75.41 171.08 14.87 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.507 -0.745 . . . . 0.0 111.121 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 35' ' ' GLU . . . . . 0.627 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 42.3 tt0 -69.85 133.56 47.51 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -176.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.522 ' O ' ' OD1' ' B' ' 36' ' ' ASP . 66.1 t0 56.59 35.51 26.18 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.701 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 37' ' ' ASN . . . . . 0.454 ' C ' ' O ' ' B' ' 36' ' ' ASP . 40.3 t-20 28.75 71.24 0.49 Allowed Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.627 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 91.8 Cg_endo -71.85 154.76 58.56 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 123.736 2.957 . . . . 0.0 112.191 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.508 HG12 HG22 ' B' ' 30' ' ' THR . 95.6 mt -86.85 129.17 38.88 Favored 'Isoleucine or valine' 0 C--O 1.245 0.86 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.419 HG23 ' N ' ' B' ' 41' ' ' TYR . 29.8 m -109.04 -42.89 5.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 O-C-N 123.65 0.594 . . . . 0.0 112.373 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 41' ' ' TYR . . . . . 0.419 ' N ' HG23 ' B' ' 40' ' ' VAL . 46.2 t80 -95.61 124.76 39.78 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 119.85 -0.74 . . . . 0.0 111.183 -178.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 5.8 p -143.55 141.86 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 O-C-N 124.102 0.876 . . . . 0.0 109.545 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 43' ' ' ASN . . . . . 0.698 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 56.0 p30 -102.12 162.07 13.2 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.226 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 44' ' ' GLN . . . . . 0.505 ' OE1' ' HA ' ' B' ' 44' ' ' GLN . 12.9 mm100 -63.1 -37.89 88.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.303 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.48 -26.48 64.44 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.698 ' HB2' ' OD1' ' B' ' 43' ' ' ASN . 59.5 t80 -60.46 -43.3 97.02 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 0.688 HG13 ' O ' ' B' ' 52' ' ' TYR . 58.5 t -61.16 -46.33 96.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.032 -178.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -62.92 -44.23 96.64 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.341 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 59.7 ttm -63.22 -42.68 99.29 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 39.5 p -94.11 -17.29 22.95 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.934 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 51' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' B' ' 47' ' ' VAL . . . 73.67 17.74 79.26 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 178.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 52' ' ' TYR . . . . . 0.688 ' O ' HG13 ' B' ' 47' ' ' VAL . 77.3 m-85 -110.39 142.89 41.46 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.231 0.612 . . . . 0.0 110.565 178.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -71.91 147.67 46.82 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.388 0.613 . . . . 0.0 111.289 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 54' ' ' THR . . . . . 0.465 ' H ' HG22 ' B' ' 54' ' ' THR . 0.2 OUTLIER -62.62 -36.55 83.14 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.523 -176.702 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.2 -39.88 95.91 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.344 -178.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -72.72 -32.67 65.89 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 176.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.626 HD13 ' CD2' ' B' ' 46' ' ' PHE . 92.5 mt -64.96 -74.94 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 176.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 94.9 mt -36.42 132.82 0.56 Allowed 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.766 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.28 -13.56 66.59 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-N 115.874 -0.603 . . . . 0.0 113.252 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -132.72 149.07 52.33 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 117.572 0.686 . . . . 0.0 112.315 -173.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 61' ' ' ASN . . . . . 0.555 ' C ' ' H ' ' B' ' 63' ' ' ARG . 24.3 t-20 -78.6 149.73 32.89 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.437 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 62' ' ' CYS . . . . . 0.425 ' HB3' HD12 ' B' ' 65' ' ' LEU . 86.2 m -63.11 9.57 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.327 -178.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 63' ' ' ARG . . . . . 0.555 ' H ' ' C ' ' B' ' 61' ' ' ASN . 34.5 ptt-85 -59.41 -33.16 70.89 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.449 -177.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -59.73 -28.79 67.65 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 65' ' ' LEU . . . . . 0.425 HD12 ' HB3' ' B' ' 62' ' ' CYS . 83.4 mt -61.69 -41.98 98.32 Favored 'General case' 0 C--N 1.32 -0.7 0 O-C-N 121.938 -0.477 . . . . 0.0 109.751 -178.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -53.23 145.99 12.7 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.624 -176.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 67' ' ' GLY . . . . . 0.563 ' N ' ' OG1' ' B' ' 70' ' ' THR . . . -155.69 -153.22 6.48 Favored Glycine 0 CA--C 1.538 1.5 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.983 177.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.38 -41.47 89.45 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -176.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 69' ' ' HIS . . . . . 0.486 ' O ' ' NE2' ' B' ' 93' ' ' GLN . 10.9 m80 -75.44 -10.0 59.06 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 123.188 0.305 . . . . 0.0 111.171 -178.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 70' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' B' ' 67' ' ' GLY . 27.0 m -61.63 133.36 55.53 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 121.875 -0.516 . . . . 0.0 109.812 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -89.17 109.87 34.18 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.335 -178.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.16 -38.67 87.8 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 121.046 1.164 . . . . 0.0 111.811 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.13 -39.38 92.39 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 120.424 -0.511 . . . . 0.0 109.871 -175.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -66.57 -38.01 86.16 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.998 177.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 93.5 t -61.73 -45.53 98.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -63.03 -37.3 86.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.697 -178.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -62.75 -41.84 99.4 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 119.254 -0.978 . . . . 0.0 108.707 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.4 -43.73 98.62 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-O 120.781 0.324 . . . . 0.0 110.623 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -62.53 -42.47 99.55 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 99.5 m -61.45 -45.67 93.32 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.224 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.05 -40.82 97.05 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -177.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 81.4 mt -62.72 -42.34 99.61 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 67.1 tp60 -63.48 -34.6 78.12 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -91.96 8.12 38.98 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.413 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 31.0 tttt 42.81 43.03 3.26 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.356 175.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -127.33 141.51 41.06 Favored Pre-proline 0 N--CA 1.469 0.508 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.556 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -62.09 141.01 87.13 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 120.806 1.004 . . . . 0.0 114.077 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.92 137.13 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 89' ' ' THR . . . . . 0.702 HG23 ' OD1' ' B' ' 107' ' ' ASN . 98.7 m -121.11 123.59 42.69 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.897 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 30.2 m -138.41 161.72 30.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.105 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -113.75 120.66 41.56 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 120.41 -0.516 . . . . 0.0 109.645 174.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 92' ' ' ILE . . . . . 0.454 HD11 HG23 ' B' ' 70' ' ' THR . 20.8 tt -127.79 132.21 69.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.317 -174.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 93' ' ' GLN . . . . . 0.486 ' NE2' ' O ' ' B' ' 69' ' ' HIS . 35.5 mt-30 -70.35 140.39 52.17 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.261 177.076 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 94' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -131.25 177.61 7.34 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 121.516 0.674 . . . . 0.0 110.911 -178.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 95' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -128.83 143.66 50.97 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 114.447 -1.251 . . . . 0.0 111.954 177.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 96' ' ' LYS . . . . . 0.435 ' HG3' ' CE1' ' B' ' 102' ' ' PHE . 98.6 mttt -100.09 179.25 4.55 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.283 0.563 . . . . 0.0 110.553 178.12 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.93 -36.64 79.86 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.843 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 38.5 p-10 -84.79 -1.74 56.75 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 121.426 -0.796 . . . . 0.0 112.912 177.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.06 5.59 65.81 Favored Glycine 0 N--CA 1.467 0.726 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.685 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 29.1 m -68.06 129.95 41.48 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 101' ' ' MET . . . . . 0.551 ' SD ' ' N ' ' B' ' 102' ' ' PHE . 15.3 tmm? -87.56 140.48 29.48 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 102' ' ' PHE . . . . . 0.551 ' N ' ' SD ' ' B' ' 101' ' ' MET . 53.7 p90 -151.72 163.01 40.07 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 103' ' ' TRP . . . . . 0.901 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 26.3 m95 -96.35 138.51 33.83 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.589 0.709 . . . . 0.0 110.72 178.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 104' ' ' ASN . . . . . 0.501 HD21 ' HG2' ' B' ' 123' ' ' GLN . 62.8 t-20 -133.55 109.6 9.35 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 114.669 -1.15 . . . . 0.0 113.467 -176.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 105' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' B' ' 123' ' ' GLN . 81.6 tt0 -79.16 125.56 29.59 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.768 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 40.0 tp -112.62 125.37 54.21 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -176.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 107' ' ' ASN . . . . . 0.702 ' OD1' HG23 ' B' ' 89' ' ' THR . 98.2 m-20 -118.57 128.59 54.71 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 176.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 96.5 mt -123.75 132.68 70.96 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.467 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -145.93 121.9 5.76 Favored Pre-proline 0 CA--C 1.542 0.665 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -69.23 152.14 72.04 Favored 'Trans proline' 0 N--CA 1.504 2.093 0 C-N-CA 122.893 2.395 . . . . 0.0 112.942 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 111' ' ' MET . . . . . 0.483 ' HB2' ' HB2' ' B' ' 118' ' ' TYR . 67.0 mtt -129.99 143.26 50.7 Favored 'General case' 0 C--O 1.245 0.831 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 179.093 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -110.3 109.47 19.92 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 113' ' ' ILE . . . . . 0.712 HG12 ' HZ1' ' A' ' 18' ' ' LYS . 96.3 mt -132.46 128.01 57.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 177.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 50.61 38.53 19.13 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.999 178.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 61.46 37.07 16.88 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.51 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -134.21 151.26 51.22 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 177.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 6.9 t -102.47 154.41 19.12 Favored 'General case' 0 C--O 1.214 -0.785 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -177.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 118' ' ' TYR . . . . . 0.483 ' HB2' ' HB2' ' B' ' 111' ' ' MET . 96.7 m-85 -148.76 147.85 29.3 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 120.828 -1.17 . . . . 0.0 111.445 -178.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 119' ' ' PHE . . . . . 0.453 ' HB2' ' OG1' ' B' ' 30' ' ' THR . 96.3 m-85 -123.2 137.42 54.89 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 123.318 0.387 . . . . 0.0 110.758 -177.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -127.26 132.02 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -177.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.39 124.09 7.48 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 122' ' ' ILE . . . . . 0.429 ' HB ' ' HB2' ' B' ' 107' ' ' ASN . 94.4 mt -114.94 127.6 72.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -178.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 123' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' B' ' 26' ' ' GLY . 16.1 mp0 -118.67 120.47 37.53 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -119.91 120.93 37.84 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 125' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' B' ' 127' ' ' THR . 68.0 t0 -67.31 134.79 52.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.331 -0.849 . . . . 0.0 112.704 -177.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.461 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 2.6 mp -108.4 14.48 8.21 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.856 0 CA-C-O 122.054 0.93 . . . . 0.0 108.858 178.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 127' ' ' THR . . . . . 0.49 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 98.5 m -62.72 -44.15 96.97 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 113.754 -1.566 . . . . 0.0 112.47 176.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -61.7 -45.66 93.01 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -177.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 129' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -62.84 -34.65 77.78 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.316 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 130' ' ' LYS . . . . . 0.901 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 98.7 mttt -63.06 -41.58 99.5 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-N 113.47 -1.696 . . . . 0.0 111.022 174.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.69 -42.31 98.01 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 132' ' ' TYR . . . . . 0.672 ' CE2' HD11 ' B' ' 136' ' ' LEU . 89.3 t80 -60.12 -45.44 93.0 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 121.733 -0.604 . . . . 0.0 111.494 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.87 -36.6 84.86 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 120.233 -0.587 . . . . 0.0 109.601 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 134' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' B' ' 130' ' ' LYS . 98.8 mttt -62.86 -39.15 93.52 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.66 177.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 54.7 tp -62.9 -41.58 99.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.163 0.506 . . . . 0.0 109.819 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 136' ' ' LEU . . . . . 0.672 HD11 ' CE2' ' B' ' 132' ' ' TYR . 90.3 mt -62.67 -42.11 99.44 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.253 177.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 137' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.39 -36.97 85.57 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.116 -1.402 . . . . 0.0 110.299 -178.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -63.11 -43.21 99.1 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.173 175.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 62.1 m -60.8 -43.93 97.49 Favored 'General case' 0 C--N 1.344 0.354 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 140' ' ' LEU . . . . . 0.516 ' O ' ' N ' ' B' ' 144' ' ' THR . 88.1 mt -61.1 -40.42 93.68 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -176.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 98.6 m -61.88 -45.25 94.57 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.84 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -65.49 -42.78 91.78 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.96 -43.66 97.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.695 178.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 144' ' ' THR . . . . . 0.516 ' N ' ' O ' ' B' ' 140' ' ' LEU . 99.4 m -61.35 -45.69 93.34 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -177.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 145' ' ' ALA . . . . . 0.408 ' O ' ' HB ' ' B' ' 148' ' ' THR . . . -63.81 -40.81 97.51 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 119.041 -1.064 . . . . 0.0 109.581 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 90.0 mt -64.55 -40.64 95.95 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 177.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 147' ' ' SER . . . . . 0.587 ' O ' ' N ' ' B' ' 149' ' ' PRO . 77.4 p -61.36 -43.31 99.09 Favored 'General case' 0 CA--C 1.477 -1.831 0 C-N-CA 119.074 -1.05 . . . . 0.0 108.23 -178.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 148' ' ' THR . . . . . 0.511 ' C ' ' O ' ' B' ' 147' ' ' SER . 43.0 m -24.48 85.66 0.04 OUTLIER Pre-proline 0 N--CA 1.478 0.929 0 O-C-N 124.051 0.844 . . . . 0.0 110.364 176.179 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 149' ' ' PRO . . . . . 0.587 ' N ' ' O ' ' B' ' 147' ' ' SER . 24.2 Cg_exo -61.67 147.53 95.12 Favored 'Trans proline' 0 C--N 1.299 -2.04 0 C-N-CA 120.898 1.065 . . . . 0.0 113.197 -177.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 8.8 tp -126.7 124.18 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 172.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 43.0 t -155.13 95.13 2.58 Favored Pre-proline 0 C--N 1.314 -0.963 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.103 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -60.46 136.48 67.89 Favored 'Trans proline' 0 N--CA 1.484 0.931 0 N-CA-C 109.438 -1.024 . . . . 0.0 109.438 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 153' ' ' ILE . . . . . 0.547 ' O ' ' HD2' ' B' ' 154' ' ' ARG . 45.6 mm -69.22 -43.44 81.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.09 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 154' ' ' ARG . . . . . 0.571 ' HD3' ' NH2' ' A' ' 154' ' ' ARG . 0.2 OUTLIER -155.9 -156.01 0.6 Allowed 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.923 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -86.62 110.58 19.93 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 97.54 -15.89 61.36 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 157' ' ' ILE . . . . . 0.442 HG12 ' HB2' ' B' ' 189' ' ' TYR . 87.9 mt -111.35 126.15 68.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 120.651 0.262 . . . . 0.0 110.666 -176.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 158' ' ' SER . . . . . 0.659 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 71.4 m -134.22 150.45 51.05 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.13 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -133.6 147.2 51.48 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.203 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 17.1 tp -140.65 78.31 21.3 Favored Pre-proline 0 CA--C 1.532 0.254 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 161' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -70.7 148.69 59.5 Favored 'Trans proline' 0 N--CA 1.499 1.848 0 C-N-CA 122.791 2.327 . . . . 0.0 114.302 -178.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 86.0 mt -112.24 134.97 53.47 Favored 'General case' 0 C--N 1.343 0.326 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 55.7 t -129.19 131.71 67.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 112.79 169.6 17.67 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 120.436 -0.888 . . . . 0.0 111.149 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 165' ' ' ASN . . . . . 0.737 ' O ' ' CZ ' ' B' ' 170' ' ' ARG . 60.2 t30 -91.25 107.36 19.15 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -177.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 166' ' ' LEU . . . . . 0.588 HD21 ' CZ ' ' B' ' 171' ' ' PHE . 47.7 tp -64.79 104.5 0.84 Allowed 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -173.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 167' ' ' THR . . . . . 0.696 HG23 ' NE ' ' B' ' 170' ' ' ARG . 10.5 p -84.0 169.79 14.62 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 114.117 -1.401 . . . . 0.0 110.925 176.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.57 -37.61 85.31 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.769 177.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.41 -40.08 89.36 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 123.176 1.465 . . . . 0.0 111.539 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 170' ' ' ARG . . . . . 0.737 ' CZ ' ' O ' ' B' ' 165' ' ' ASN . 88.0 mtm180 -62.19 -37.63 86.0 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 112.084 -2.325 . . . . 0.0 111.152 178.104 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 171' ' ' PHE . . . . . 0.588 ' CZ ' HD21 ' B' ' 166' ' ' LEU . 0.4 OUTLIER -53.81 -25.37 19.03 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -179.249 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 172' ' ' ASN . . . . . 0.588 ' O ' HG22 ' B' ' 175' ' ' VAL . 92.1 m-20 -62.57 -40.37 96.64 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.024 -0.671 . . . . 0.0 110.773 178.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 36.4 m -60.57 -41.13 93.97 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.974 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 67.5 mt -63.69 -44.09 98.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 175' ' ' VAL . . . . . 0.588 HG22 ' O ' ' B' ' 172' ' ' ASN . 28.8 m -62.96 -39.84 86.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 176' ' ' CYS . . . . . 0.429 ' N ' HG23 ' B' ' 175' ' ' VAL . 98.8 m -62.31 -35.54 79.38 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.494 178.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 177' ' ' THR . . . . . 0.607 ' O ' HG13 ' B' ' 181' ' ' ILE . 24.9 m -61.67 -20.81 63.83 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.502 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 178' ' ' LEU . . . . . 0.604 ' CD2' HD21 ' B' ' 211' ' ' LEU . 88.2 mt -61.29 -39.91 92.2 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.241 -177.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 19.0 m -61.07 -44.69 96.99 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.523 176.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 180' ' ' ASN . . . . . 0.582 ' O ' ' OG ' ' B' ' 183' ' ' SER . 92.7 m-20 -61.94 -40.65 96.27 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.846 0.355 . . . . 0.0 110.585 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.607 HG13 ' O ' ' B' ' 177' ' ' THR . 73.9 mt -56.31 -31.78 33.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 O-C-N 122.262 -0.274 . . . . 0.0 111.022 -177.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 182' ' ' LEU . . . . . 0.465 HD21 HD21 ' B' ' 214' ' ' LEU . 82.4 mt -62.29 -41.86 98.86 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.333 177.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 183' ' ' SER . . . . . 0.582 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.2 p -62.45 -32.48 73.36 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 121.756 -0.59 . . . . 0.0 110.891 177.252 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 184' ' ' THR . . . . . 0.422 ' OG1' ' HA ' ' B' ' 181' ' ' ILE . 22.6 p -85.39 16.89 3.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.745 -178.106 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 78.5 p -61.29 -16.86 49.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.466 -176.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.0 -40.51 95.88 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 121.051 -0.259 . . . . 0.0 110.468 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 187' ' ' ASP . . . . . 0.659 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.6 m-20 -71.07 113.78 8.45 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.294 0.568 . . . . 0.0 110.378 -177.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -62.94 -42.27 99.75 Favored 'General case' 0 C--O 1.247 0.936 0 CA-C-N 114.904 -1.044 . . . . 0.0 113.149 -177.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 189' ' ' TYR . . . . . 0.442 ' HB2' HG12 ' B' ' 157' ' ' ILE . 98.2 m-85 -111.58 131.57 55.16 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.956 -178.096 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 190' ' ' LEU . . . . . . . . . . . . . 44.3 tp -123.61 119.03 28.66 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.176 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 84.6 mt -107.09 125.11 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-N 117.8 0.273 . . . . 0.0 111.303 -176.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 49.0 mm -115.63 118.4 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 193' ' ' ASP . . . . . 0.561 ' OD2' ' OG ' ' B' ' 195' ' ' SER . 40.6 t0 -91.19 113.29 25.52 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -176.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 194' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' B' ' 194' ' ' LEU . 96.3 mt -92.34 -2.23 56.52 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 123.325 0.391 . . . . 0.0 110.223 176.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 195' ' ' SER . . . . . 0.561 ' OG ' ' OD2' ' B' ' 193' ' ' ASP . 78.3 p -61.7 -37.69 85.09 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.704 -178.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.6 -34.37 88.24 Favored Glycine 0 N--CA 1.435 -1.375 0 C-N-CA 119.416 -1.373 . . . . 0.0 109.731 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 197' ' ' LEU . . . . . 1.093 ' CD2' ' O ' ' B' ' 199' ' ' GLN . 5.6 tt -76.78 132.97 39.53 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -177.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 198' ' ' ALA . . . . . 0.935 ' N ' HD23 ' B' ' 197' ' ' LEU . . . -64.48 -42.03 96.13 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 119.773 -0.771 . . . . 0.0 111.947 -178.037 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 199' ' ' GLN . . . . . 1.093 ' O ' ' CD2' ' B' ' 197' ' ' LEU . 59.0 tt0 -137.57 165.41 26.39 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.215 0.531 . . . . 0.0 111.425 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 200' ' ' VAL . . . . . 0.496 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 49.4 t -122.65 132.53 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.137 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -93.72 148.83 21.75 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.768 -177.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -60.99 -32.92 72.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.289 -178.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -63.91 -32.59 74.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.367 0.603 . . . . 0.0 109.482 177.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.3 m -60.71 -44.19 96.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.268 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 205' ' ' ALA . . . . . 0.617 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -59.45 -29.33 67.71 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 111.755 0.279 . . . . 0.0 111.755 -177.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -64.95 -38.98 92.76 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.878 175.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -66.86 -37.8 85.15 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.885 178.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.41 -43.17 98.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-O 122.009 0.909 . . . . 0.0 110.101 -178.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 209' ' ' PHE . . . . . 0.617 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 68.3 m-85 -62.28 -42.59 99.47 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 113.92 -1.491 . . . . 0.0 112.686 177.189 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.26 -41.58 99.06 Favored 'General case' 0 C--O 1.232 0.135 0 O-C-N 121.402 -0.811 . . . . 0.0 109.901 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 211' ' ' LEU . . . . . 0.604 HD21 ' CD2' ' B' ' 178' ' ' LEU . 38.8 mt -62.29 -42.21 99.16 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.317 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 78.0 p -63.84 -36.51 84.16 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.53 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 213' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -67.01 -47.29 71.91 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.176 178.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.465 HD21 HD21 ' B' ' 182' ' ' LEU . 54.2 tp -64.07 -42.6 96.93 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 121.956 0.884 . . . . 0.0 110.546 177.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 85.7 mt -62.83 -43.45 98.76 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 113.343 -1.753 . . . . 0.0 111.555 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.44 -40.04 93.0 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 -176.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 86.3 mt -63.39 -42.03 98.79 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 121.371 0.605 . . . . 0.0 111.374 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 218' ' ' THR . . . . . . . . . . . . . 69.9 p -73.88 -16.63 61.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.176 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 79.55 66.13 1.71 Allowed Glycine 0 CA--C 1.528 0.892 0 N-CA-C 106.831 -2.508 . . . . 0.0 106.831 -178.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 220' ' ' THR . . . . . . . . . . . . . 96.4 m -145.15 104.07 3.92 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 176.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -62.29 139.21 58.52 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.182 0.515 . . . . 0.0 110.954 -176.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 42.7 tp -115.87 121.84 43.56 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.532 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 3.5 mp -110.61 129.5 65.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.016 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 224' ' ' ILE . . . . . 0.477 ' CG2' HD11 ' B' ' 227' ' ' ILE . 50.0 mm -111.11 126.99 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 50.5 p -133.97 157.97 44.69 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-O 122.077 0.942 . . . . 0.0 112.72 -178.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 89.1 17.86 55.0 Favored Glycine 0 CA--C 1.502 -0.77 0 CA-C-N 113.683 -1.598 . . . . 0.0 111.588 -177.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 227' ' ' ILE . . . . . 0.71 HD12 HG23 ' B' ' 247' ' ' THR . 96.1 mt -81.17 126.26 39.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 121.808 -0.819 . . . . 0.0 111.371 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 59.4 tttt -66.57 140.53 96.54 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.298 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.75 -37.24 91.98 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 121.518 1.479 . . . . 0.0 112.363 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -64.18 -42.27 96.77 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -178.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 50.9 tp -62.52 -41.73 99.04 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.751 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.24 -37.2 86.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.784 0.326 . . . . 0.0 111.224 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 94.6 mtp -64.31 -41.0 97.04 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.663 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.78 -43.87 95.07 Favored 'General case' 0 CA--C 1.553 1.065 0 CA-C-O 122.632 1.206 . . . . 0.0 109.382 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 34.3 mmt -63.76 -36.29 83.4 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.167 -1.379 . . . . 0.0 111.894 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -63.32 -39.64 95.11 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.927 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -63.12 -44.45 95.59 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 56.1 tp -61.87 -44.72 96.25 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 120.358 -0.537 . . . . 0.0 112.027 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -157.14 132.59 9.18 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.972 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 240' ' ' ALA . . . . . . . . . . . . . . . -62.0 -45.34 94.05 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 177.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 241' ' ' ASN . . . . . 0.457 ' O ' ' HB2' ' B' ' 244' ' ' SER . 89.3 m-20 -45.45 -19.68 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.111 -175.014 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 242' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -61.7 -45.79 92.48 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.904 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 243' ' ' SER . . . . . . . . . . . . . 77.5 p -57.77 -44.14 85.98 Favored 'General case' 0 C--N 1.343 0.32 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 244' ' ' SER . . . . . 0.457 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 15.4 m -30.88 -36.14 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 95.3 mt -88.04 131.61 34.59 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.196 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -57.63 134.74 56.43 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.346 0.593 . . . . 0.0 110.918 -177.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 247' ' ' THR . . . . . 0.71 HG23 HD12 ' B' ' 227' ' ' ILE . 99.4 m -127.35 129.19 47.15 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.865 178.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 248' ' ' TYR . . . . . 0.491 ' CG ' ' HB2' ' B' ' 254' ' ' ALA . 96.5 m-85 -113.83 143.31 44.87 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 249' ' ' SER . . . . . 0.565 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 78.0 p -62.9 -34.32 77.17 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.275 -178.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 250' ' ' ASN . . . . . 0.565 ' OD1' ' O ' ' B' ' 249' ' ' SER . 99.0 m-20 -146.26 159.14 43.74 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.19 -0.913 . . . . 0.0 112.2 178.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 251' ' ' VAL . . . . . 0.434 ' O ' HG23 ' B' ' 255' ' ' VAL . 75.2 t -63.96 -44.83 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.889 178.12 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 252' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.05 -45.79 93.33 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 253' ' ' ASP . . . . . 0.467 ' O ' HG22 ' B' ' 257' ' ' VAL . 94.4 m-20 -61.09 -43.28 99.13 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.378 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 254' ' ' ALA . . . . . 0.491 ' HB2' ' CG ' ' B' ' 248' ' ' TYR . . . -65.7 -39.99 91.81 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.319 178.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 255' ' ' VAL . . . . . 0.474 HG13 HH11 ' A' ' 154' ' ' ARG . 77.4 t -64.38 -45.88 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.584 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -63.17 -48.03 80.15 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.36 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 257' ' ' VAL . . . . . 0.493 ' O ' ' C ' ' B' ' 258' ' ' LEU . 26.5 m -64.66 -40.33 88.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.776 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 258' ' ' LEU . . . . . 0.519 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 1.3 mt -31.17 -74.97 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.597 -178.287 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 259' ' ' PRO . . . . . 0.519 ' CD ' ' CB ' ' B' ' 258' ' ' LEU . 36.7 Cg_endo -62.07 142.08 91.1 Favored 'Trans proline' 0 N--CA 1.501 1.928 0 C-N-CA 121.04 1.16 . . . . 0.0 110.983 -178.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 260' ' ' ILE . . . . . 0.528 HG22 ' O ' ' B' ' 260' ' ' ILE . 96.8 mt -158.84 -14.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-N 118.72 0.691 . . . . 0.0 112.054 176.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 78.1 mtm . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 117.921 -1.037 . . . . 0.0 111.905 -179.637 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.041 -1.623 . . . . 0.0 109.041 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.81 168.49 24.27 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 116.429 -1.748 . . . . 0.0 110.18 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.2 p -70.68 -19.4 62.79 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 124.633 1.208 . . . . 0.0 110.814 178.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -70.61 -68.4 0.43 Allowed 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.531 -1.213 . . . . 0.0 112.39 175.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.22 -38.67 88.51 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.594 ' O ' ' NZ ' ' B' ' 17' ' ' LYS . 69.2 m -59.63 -41.09 89.65 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.22 -178.574 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.51 ' CE2' HD12 ' A' ' 9' ' ' ILE . 36.3 t80 83.49 89.8 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 O-C-N 123.765 0.666 . . . . 0.0 111.556 176.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.58 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -64.79 -141.18 0.02 OUTLIER Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 -177.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.58 ' HB ' ' O ' ' A' ' 8' ' ' GLY . 78.4 mt 83.53 110.74 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 122.584 0.354 . . . . 0.0 110.726 -178.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.79 -22.38 63.73 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 121.485 1.456 . . . . 0.0 112.294 -178.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.23 -37.49 94.61 Favored Glycine 0 C--O 1.245 0.843 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.94 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -64.82 -39.37 93.47 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.366 0.603 . . . . 0.0 109.8 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.0 tp -63.57 -41.12 98.41 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -63.68 -40.8 97.71 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.5 t -60.26 -44.19 95.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 O-C-N 122.317 -0.239 . . . . 0.0 110.868 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 92.8 mt -62.49 -43.91 98.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -177.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.26 -45.84 91.47 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 119.441 -0.904 . . . . 0.0 111.987 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.524 ' NZ ' HG12 ' B' ' 113' ' ' ILE . 98.9 mttt -60.66 -39.34 88.0 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 118.756 -1.178 . . . . 0.0 108.871 -175.34 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.86 -41.79 92.22 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.137 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.5 mt -62.85 -40.93 98.97 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.57 -38.27 90.49 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.484 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 57.0 m170 -58.52 -39.84 81.26 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 122.328 -0.232 . . . . 0.0 111.422 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.5 p -113.98 129.09 70.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.54 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 35.4 ptt180 -72.03 107.71 4.88 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 122.094 0.95 . . . . 0.0 111.93 -176.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.6 p -139.22 144.44 29.2 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 178.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.471 ' HA3' ' HB2' ' A' ' 123' ' ' GLN . . . -98.87 93.73 1.35 Allowed Glycine 0 C--O 1.221 -0.706 0 C-N-CA 120.749 -0.738 . . . . 0.0 113.015 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 50.5 t -125.14 129.69 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 176.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.1 m -137.04 159.1 36.7 Favored 'Isoleucine or valine' 0 C--O 1.246 0.881 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.5 mt -120.25 129.37 75.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 176.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.432 HG22 HG12 ' A' ' 39' ' ' ILE . 26.9 p -103.11 169.03 8.8 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 177.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -133.77 101.98 12.65 Favored Pre-proline 0 C--N 1.321 -0.663 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.739 178.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.54 ' HG3' HG23 ' A' ' 117' ' ' THR . 35.2 Cg_endo -63.26 -22.37 72.32 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 121.422 1.414 . . . . 0.0 111.408 -179.249 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.46 -33.9 74.54 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.155 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.1 mt -87.87 172.8 9.35 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.734 177.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.719 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 42.0 tt0 -68.86 132.11 46.23 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -176.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.509 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 56.7 t0 61.7 22.25 12.81 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.37 0.605 . . . . 0.0 112.564 177.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.401 ' OD1' ' HB ' ' A' ' 30' ' ' THR . 36.6 t-20 43.22 67.13 3.9 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.968 -178.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.719 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 95.4 Cg_endo -70.79 154.62 63.58 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 123.79 2.993 . . . . 0.0 111.979 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.432 HG12 HG22 ' A' ' 30' ' ' THR . 96.5 mt -87.34 123.54 40.16 Favored 'Isoleucine or valine' 0 C--O 1.246 0.919 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.334 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.44 HG23 ' N ' ' A' ' 41' ' ' TYR . 30.0 m -103.99 -45.14 9.53 Favored 'Isoleucine or valine' 0 C--N 1.343 0.323 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.204 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.44 ' N ' HG23 ' A' ' 40' ' ' VAL . 45.3 t80 -93.4 123.64 36.84 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.636 -178.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.1 p -142.28 140.12 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 O-C-N 124.237 0.96 . . . . 0.0 109.348 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.599 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 57.3 p30 -97.3 166.01 11.76 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.462 ' HA ' ' OE1' ' A' ' 44' ' ' GLN . 13.6 mm100 -66.41 -38.92 88.55 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 176.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.7 -26.48 62.62 Favored Glycine 0 C--N 1.33 0.201 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.644 ' CD2' HD13 ' A' ' 57' ' ' ILE . 66.7 t80 -58.86 -47.82 83.54 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.659 HG13 ' O ' ' A' ' 52' ' ' TYR . 78.5 t -59.97 -44.74 95.26 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 O-C-N 121.171 -0.956 . . . . 0.0 111.558 -173.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -63.2 -38.45 91.22 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.653 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 57.7 ttm -66.48 -44.07 83.68 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 175.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.5 p -90.11 -23.02 21.5 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.084 0.469 . . . . 0.0 111.416 -178.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . 78.05 18.97 75.83 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 -178.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.659 ' O ' HG13 ' A' ' 47' ' ' VAL . 70.4 m-85 -113.29 138.38 50.11 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 122.857 0.463 . . . . 0.0 111.28 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -63.18 148.25 48.6 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.808 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.433 HG22 ' H ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -65.97 -32.44 73.93 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -178.759 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.01 -42.03 85.66 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 119.706 -0.797 . . . . 0.0 111.483 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -64.69 -46.75 81.03 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.224 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.644 HD13 ' CD2' ' A' ' 46' ' ' PHE . 97.7 mt -60.41 -50.49 80.11 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -175.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 86.9 mt -55.84 145.3 24.99 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.25 -4.37 81.36 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.024 176.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -136.31 152.79 51.06 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.181 1.491 . . . . 0.0 111.846 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.562 ' C ' ' H ' ' A' ' 63' ' ' ARG . 25.8 t-20 -81.19 150.8 28.5 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.232 0.539 . . . . 0.0 110.453 -178.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 80.1 m -63.11 15.21 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.365 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.562 ' H ' ' C ' ' A' ' 61' ' ' ASN . 34.5 ptt-85 -61.55 -41.63 97.66 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 122.09 -0.382 . . . . 0.0 111.31 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -55.28 -22.1 17.17 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -177.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 93.4 mt -65.89 -37.1 85.25 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.538 0.685 . . . . 0.0 112.639 177.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -62.17 138.1 58.36 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.121 -178.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.529 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -147.2 -148.07 4.68 Favored Glycine 0 CA--C 1.542 1.762 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.089 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.14 -40.4 97.49 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.468 ' O ' ' NE2' ' A' ' 93' ' ' GLN . 10.9 m80 -76.61 -9.22 58.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.608 0.242 . . . . 0.0 111.008 -177.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.529 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 30.0 m -64.36 128.54 36.24 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.142 -0.623 . . . . 0.0 109.59 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -86.43 112.39 45.96 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.039 -178.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -57.48 -30.6 88.81 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 121.974 1.782 . . . . 0.0 113.09 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.75 -39.98 95.6 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.054 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -65.8 -43.61 88.18 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 177.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.9 t -60.2 -44.02 94.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 114.2 -1.364 . . . . 0.0 107.476 -176.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -64.63 -37.59 88.11 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.7 179.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -63.33 -40.03 96.18 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.391 0.615 . . . . 0.0 110.784 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.84 -44.1 98.03 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 CA-C-N 114.857 -1.065 . . . . 0.0 112.055 178.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -61.83 -42.72 99.38 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 113.91 -1.495 . . . . 0.0 108.333 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 92.3 m -60.13 -49.94 75.67 Favored 'General case' 0 C--O 1.246 0.896 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.32 -40.45 94.25 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.228 -170.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 84.8 mt -62.99 -40.33 97.43 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 118.723 0.692 . . . . 0.0 111.511 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -64.09 -40.39 96.12 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -72.06 -22.26 61.4 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.475 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.9 tttt 61.22 43.8 10.56 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.452 -176.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -126.7 149.09 67.37 Favored Pre-proline 0 N--CA 1.467 0.397 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -61.81 143.44 95.97 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 121.316 1.344 . . . . 0.0 113.368 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.04 141.72 33.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.809 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.877 HG23 ' OD1' ' A' ' 107' ' ' ASN . 96.6 m -126.31 122.18 34.73 Favored 'General case' 0 C--N 1.343 0.315 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 175.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 27.7 m -139.55 158.08 27.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.202 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -104.51 130.06 52.48 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 175.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.443 ' O ' HG23 ' A' ' 92' ' ' ILE . 18.2 tt -139.89 128.01 25.88 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.087 0 CA-C-N 120.958 1.708 . . . . 0.0 112.369 178.391 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.468 ' NE2' ' O ' ' A' ' 69' ' ' HIS . 33.9 mt-30 -60.71 136.66 58.13 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 114.495 -1.229 . . . . 0.0 109.899 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -137.06 159.69 41.14 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.671 -179.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -118.65 136.67 53.78 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.513 ' HG3' ' CE1' ' A' ' 102' ' ' PHE . 99.2 mttt -87.03 -172.92 4.2 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.036 0.446 . . . . 0.0 111.621 -177.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.31 -43.85 97.88 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.384 178.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 41.1 p-10 -82.23 5.1 21.01 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.61 0.0 84.53 Favored Glycine 0 N--CA 1.467 0.758 0 C-N-CA 120.825 -0.703 . . . . 0.0 111.911 176.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 18.2 m -61.15 138.66 58.21 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 178.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.689 ' SD ' ' C ' ' A' ' 101' ' ' MET . 13.6 tmm? -104.66 129.85 52.77 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.88 0.372 . . . . 0.0 110.891 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.513 ' CE1' ' HG3' ' A' ' 96' ' ' LYS . 54.3 p90 -141.76 158.91 43.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.666 -177.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.804 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 25.0 m95 -90.34 143.54 26.67 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.485 HD21 ' HG2' ' A' ' 123' ' ' GLN . 59.4 t-20 -138.2 101.7 4.47 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -177.203 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 80.4 tt0 -66.91 136.18 54.98 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -176.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 38.3 tp -120.35 123.74 43.84 Favored 'General case' 0 C--O 1.233 0.185 0 O-C-N 123.739 0.649 . . . . 0.0 112.424 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.877 ' OD1' HG23 ' A' ' 89' ' ' THR . 98.5 m-20 -121.38 122.67 40.33 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.598 177.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 95.5 mt -120.04 128.23 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 O-C-N 123.523 0.514 . . . . 0.0 111.215 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -136.33 122.99 14.04 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 116.942 -0.117 . . . . 0.0 110.716 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -71.78 150.81 56.63 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.281 1.988 . . . . 0.0 112.602 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.486 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 66.7 mtt -124.17 154.62 39.82 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -128.0 94.41 3.92 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 176.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.483 ' CD1' HG22 ' B' ' 15' ' ' VAL . 96.4 mt -119.69 130.84 73.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.563 -178.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 50.15 37.61 15.04 Favored 'General case' 0 CA--C 1.518 -0.252 0 O-C-N 121.661 -0.649 . . . . 0.0 111.476 176.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 58.77 29.3 18.52 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.884 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -125.89 147.56 49.44 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.751 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 8.4 t -83.79 -173.38 4.68 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.431 -0.793 . . . . 0.0 109.517 -178.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.751 ' CD2' ' O ' ' A' ' 117' ' ' THR . 83.5 m-85 -171.02 154.06 4.0 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 173.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -128.87 145.15 51.29 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 174.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.5 p -134.41 135.17 54.31 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 177.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.91 129.32 9.56 Favored Glycine 0 CA--C 1.505 -0.565 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 178.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.47 ' HB ' ' HB2' ' A' ' 107' ' ' ASN . 96.9 mt -117.77 128.82 74.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.485 ' HG2' HD21 ' A' ' 104' ' ' ASN . 17.4 mp0 -119.13 116.63 26.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.145 0.498 . . . . 0.0 109.929 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -116.09 113.38 23.07 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.112 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 126' ' ' ILE . 68.2 t0 -63.8 128.74 37.16 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -176.251 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.545 ' O ' HG22 ' A' ' 126' ' ' ILE . 2.7 mp -96.29 3.88 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 113.951 -1.477 . . . . 0.0 110.398 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.5 m -60.05 -42.64 94.9 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.335 -0.853 . . . . 0.0 113.234 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -59.87 -42.32 93.46 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -63.69 -40.13 96.05 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.521 177.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.804 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.5 mttt -62.92 -41.42 99.46 Favored 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 118.393 -1.323 . . . . 0.0 110.359 -178.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -61.68 -36.69 81.58 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.752 ' CE2' HD11 ' A' ' 136' ' ' LEU . 85.8 t80 -61.82 -44.74 96.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.369 176.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.74 -38.74 92.0 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.97 -40.91 97.2 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 54.8 tp -61.26 -43.85 98.2 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.752 HD11 ' CE2' ' A' ' 132' ' ' TYR . 86.6 mt -62.54 -41.06 98.64 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.242 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.91 -41.02 97.44 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.915 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -60.82 -42.17 97.17 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -178.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 58.3 m -61.54 -41.55 97.52 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.677 177.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.464 ' O ' ' N ' ' A' ' 144' ' ' THR . 86.9 mt -64.08 -41.88 97.15 Favored 'General case' 0 C--O 1.224 -0.274 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 91.8 m -61.22 -46.03 92.11 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.38 -177.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -64.79 -40.24 94.91 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 95.7 mt -64.47 -43.49 96.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 113.939 -1.482 . . . . 0.0 111.219 177.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.464 ' N ' ' O ' ' A' ' 140' ' ' LEU . 92.7 m -62.71 -45.95 90.39 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.773 -0.579 . . . . 0.0 112.332 -178.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.4 -40.16 96.46 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 118.853 -1.139 . . . . 0.0 108.991 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 85.2 mt -63.5 -42.57 98.5 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.472 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.746 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.1 p -60.87 -38.78 86.75 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 -178.18 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.491 ' C ' ' O ' ' A' ' 147' ' ' SER . 31.9 m -27.22 79.85 0.02 OUTLIER Pre-proline 0 N--CA 1.467 0.415 0 O-C-N 126.531 2.394 . . . . 0.0 106.591 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.746 ' N ' ' O ' ' A' ' 147' ' ' SER . 20.9 Cg_exo -62.53 144.46 94.56 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 120.947 1.098 . . . . 0.0 114.666 -173.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.566 ' O ' HG23 ' A' ' 151' ' ' VAL . 9.5 tp -121.44 135.2 62.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 102.928 -2.99 . . . . 0.0 102.928 176.111 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 150' ' ' ILE . 99.6 t -167.55 91.81 0.69 Allowed Pre-proline 0 CA--C 1.513 -0.46 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 178.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -61.49 136.26 62.26 Favored 'Trans proline' 0 C--N 1.3 -2.011 0 N-CA-C 109.323 -1.068 . . . . 0.0 109.323 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.587 ' O ' ' HD2' ' A' ' 154' ' ' ARG . 45.5 mm -67.83 -44.34 85.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 119.932 -0.707 . . . . 0.0 110.795 179.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.587 ' HD2' ' O ' ' A' ' 153' ' ' ILE . 0.2 OUTLIER -156.89 -156.39 0.61 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.437 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.468 ' ND2' ' HE3' ' B' ' 256' ' ' LYS . 63.7 t-20 -87.51 105.14 17.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 122.08 0.943 . . . . 0.0 112.008 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 88.98 9.19 68.12 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.758 -177.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.0 mt -126.19 125.36 67.62 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 CA-C-O 121.546 0.689 . . . . 0.0 109.231 174.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.566 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 42.5 m -133.26 152.22 51.93 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.061 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -137.67 141.95 41.13 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.753 -0.592 . . . . 0.0 111.286 177.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 18.0 tp -133.93 78.33 60.33 Favored Pre-proline 0 N--CA 1.47 0.564 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.243 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -70.21 151.63 66.57 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.82 2.347 . . . . 0.0 113.096 -179.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 88.3 mt -117.47 128.76 55.31 Favored 'General case' 0 C--O 1.25 1.089 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.388 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 49.3 t -123.82 130.9 73.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 115.05 170.08 16.22 Favored Glycine 0 N--CA 1.479 1.539 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.042 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.939 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 55.9 t30 -85.05 115.29 22.78 Favored 'General case' 0 C--O 1.213 -0.841 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.506 HD21 ' CZ ' ' A' ' 171' ' ' PHE . 41.8 tp -73.67 105.34 4.95 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -177.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.656 HG23 ' NE ' ' A' ' 170' ' ' ARG . 16.6 p -87.55 165.87 15.16 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.01 178.031 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -66.72 -33.51 75.8 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.506 0.669 . . . . 0.0 111.455 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.7 -41.36 92.43 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.686 178.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.939 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 87.6 mtm180 -64.71 -33.16 75.31 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 124.173 0.989 . . . . 0.0 112.233 176.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.506 ' CZ ' HD21 ' A' ' 166' ' ' LEU . 0.6 OUTLIER -54.33 -28.76 44.87 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.11 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.569 ' O ' HG22 ' A' ' 175' ' ' VAL . 92.6 m-20 -60.53 -41.19 93.94 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 119.003 -1.079 . . . . 0.0 109.857 -178.169 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 67.3 m -59.57 -41.15 89.54 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.692 -178.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 66.6 mt -63.33 -44.05 98.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 172' ' ' ASN . 30.5 m -62.72 -39.67 85.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' CYS . . . . . 0.403 ' N ' HG23 ' A' ' 175' ' ' VAL . 98.8 m -61.8 -34.5 76.02 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.262 0.553 . . . . 0.0 110.294 178.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.548 ' O ' HG13 ' A' ' 181' ' ' ILE . 25.3 m -62.22 -20.4 64.17 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.131 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.693 ' CD2' HD21 ' A' ' 211' ' ' LEU . 89.9 mt -61.12 -41.54 96.9 Favored 'General case' 0 C--O 1.246 0.887 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -178.131 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 16.9 m -58.87 -43.34 90.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.532 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ASN . . . . . 0.593 ' O ' ' OG ' ' A' ' 183' ' ' SER . 92.2 m-20 -61.98 -37.98 86.85 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 122.558 0.343 . . . . 0.0 110.954 178.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.553 HD12 HD23 ' A' ' 178' ' ' LEU . 70.3 mt -58.62 -37.9 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.438 HD21 HD21 ' A' ' 214' ' ' LEU . 86.0 mt -60.65 -40.82 93.42 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.015 -177.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.593 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 78.1 p -61.98 -33.32 74.09 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.486 176.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.475 ' OG1' ' HA ' ' A' ' 181' ' ' ILE . 19.2 p -89.67 24.69 2.25 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.561 0.219 . . . . 0.0 111.267 -178.148 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 78.0 p -63.62 -20.29 65.55 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.198 0.523 . . . . 0.0 110.746 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.17 -37.19 79.42 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.825 -178.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.566 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 99.0 m-20 -74.88 113.88 12.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.457 0.646 . . . . 0.0 110.972 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.83 -42.44 99.73 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.056 -0.975 . . . . 0.0 112.885 -177.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -112.03 131.02 55.67 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.202 0.525 . . . . 0.0 110.912 -178.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 38.6 tp -120.25 128.89 53.76 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 96.2 mt -117.05 126.59 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 118.587 0.63 . . . . 0.0 109.582 177.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.6 mm -112.66 126.43 70.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' ASP . . . . . 0.545 ' CG ' ' HG ' ' A' ' 195' ' ' SER . 39.5 t0 -94.82 118.57 31.98 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 121.949 0.881 . . . . 0.0 110.46 177.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 95.7 mt -96.93 -3.79 41.17 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.257 175.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' SER . . . . . 0.545 ' HG ' ' CG ' ' A' ' 193' ' ' ASP . 78.2 p -61.72 -32.72 72.96 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.82 -42.51 99.75 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 108.766 -1.734 . . . . 0.0 108.766 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.937 ' CD2' ' O ' ' A' ' 199' ' ' GLN . 5.1 tt -72.57 128.59 36.03 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 112.975 -1.612 . . . . 0.0 108.862 -176.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.919 ' N ' HD23 ' A' ' 197' ' ' LEU . . . -60.94 -49.01 79.17 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.203 -178.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.937 ' O ' ' CD2' ' A' ' 197' ' ' LEU . 57.7 tt0 -132.79 155.53 48.76 Favored 'General case' 0 C--O 1.206 -1.219 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -175.113 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.426 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 53.1 t -117.13 132.43 66.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 O-C-N 120.133 -1.605 . . . . 0.0 108.875 178.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -86.16 156.16 20.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.662 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.3 -38.5 90.43 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.181 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -58.37 -31.7 67.88 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -178.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 17.6 m -60.86 -42.48 97.95 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.659 177.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.523 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -57.05 -38.74 73.67 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -177.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -62.12 -37.39 84.95 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -178.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -64.94 -39.42 93.48 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.103 177.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.29 -44.64 99.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 C-N-CA 119.525 -0.87 . . . . 0.0 108.941 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' PHE . . . . . 0.523 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 69.1 m-85 -61.65 -43.56 98.63 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.413 -178.129 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.0 -42.35 99.06 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 119.313 -0.955 . . . . 0.0 109.103 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.693 HD21 ' CD2' ' A' ' 178' ' ' LEU . 40.1 mt -61.65 -42.27 98.67 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 78.1 p -61.89 -41.66 98.15 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 119.351 -0.939 . . . . 0.0 110.116 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 58.3 t60 -64.06 -45.91 86.69 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.787 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.438 HD21 HD21 ' A' ' 182' ' ' LEU . 53.9 tp -62.12 -46.14 90.37 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 211' ' ' LEU . 84.2 mt -62.56 -40.56 97.22 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.627 -176.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -61.59 -43.1 99.49 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -178.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 85.9 mt -61.8 -39.63 92.4 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 74.8 p -76.68 -11.59 59.87 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.242 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 81.26 38.63 14.45 Favored Glycine 0 C--O 1.217 -0.909 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.329 -178.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 94.7 m -123.95 112.85 17.71 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.024 1.412 . . . . 0.0 111.658 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -63.07 136.63 57.91 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.2 178.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 44.2 tp -114.43 130.63 56.72 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 3.4 mp -118.21 135.36 58.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 122.867 0.467 . . . . 0.0 109.849 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.579 ' CG2' HD11 ' A' ' 227' ' ' ILE . 49.0 mm -114.85 131.74 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 43.8 p -132.89 167.35 20.38 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 120.854 -0.338 . . . . 0.0 111.876 -178.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 77.31 20.47 74.98 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.584 HD12 HG23 ' A' ' 247' ' ' THR . 97.5 mt -81.79 128.6 38.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 114.043 -1.078 . . . . 0.0 108.77 178.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 66.9 tttt -75.43 140.82 72.59 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.09 -39.28 86.34 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 121.138 1.225 . . . . 0.0 112.496 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -64.04 -39.31 93.8 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-O 121.829 0.823 . . . . 0.0 110.318 -178.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 49.6 tp -64.18 -42.23 96.77 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.845 -1.071 . . . . 0.0 112.721 177.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.74 -37.27 87.01 Favored 'General case' 0 CA--C 1.521 -0.154 0 O-C-N 121.753 -0.592 . . . . 0.0 111.198 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 94.5 mtp -63.7 -41.35 98.13 Favored 'General case' 0 C--O 1.247 0.959 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -178.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -63.7 -40.33 96.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.668 177.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 37.7 mmt -65.33 -37.13 86.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.823 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -60.51 -41.54 94.57 Favored 'General case' 0 CA--C 1.515 -0.385 0 O-C-N 121.544 -0.723 . . . . 0.0 109.408 -177.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.59 -40.74 92.88 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.238 0.542 . . . . 0.0 110.505 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 52.2 tp -62.89 -40.96 99.15 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 177.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 240' ' ' ALA . 67.1 t0 -169.53 130.26 1.07 Allowed 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.5 -0.75 . . . . 0.0 112.486 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.416 ' N ' ' OD1' ' A' ' 239' ' ' ASP . . . -60.93 -26.89 67.82 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.811 178.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.496 ' O ' ' HB2' ' A' ' 244' ' ' SER . 87.6 m-20 -60.68 -30.42 69.91 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.691 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -55.83 -43.34 76.91 Favored 'General case' 0 C--N 1.311 -1.086 0 O-C-N 121.399 -0.813 . . . . 0.0 109.056 -176.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 94.7 p -63.15 -19.12 64.18 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.043 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' SER . . . . . 0.496 ' HB2' ' O ' ' A' ' 241' ' ' ASN . 70.9 m -54.94 -37.04 65.93 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.405 177.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 95.0 mt -89.19 119.26 29.52 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 119.732 -0.787 . . . . 0.0 112.93 -177.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -42.65 135.55 2.82 Favored 'General case' 0 C--O 1.244 0.773 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.68 -178.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.584 HG23 HD12 ' A' ' 227' ' ' ILE . 97.7 m -126.52 132.72 51.32 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.198 -1.364 . . . . 0.0 111.043 178.122 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 248' ' ' TYR . . . . . 0.453 ' CB ' ' HB2' ' A' ' 254' ' ' ALA . 96.5 m-85 -117.54 141.18 48.66 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.978 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 249' ' ' SER . . . . . 0.467 ' O ' ' OD1' ' A' ' 250' ' ' ASN . 77.3 p -62.2 -41.03 97.98 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -178.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 250' ' ' ASN . . . . . 0.467 ' OD1' ' O ' ' A' ' 249' ' ' SER . 98.9 m-20 -146.15 160.58 41.75 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.63 0.729 . . . . 0.0 111.155 -178.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 70.2 t -62.8 -45.13 99.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.142 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.04 -44.51 97.29 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.633 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' ASP . . . . . 0.461 ' O ' HG22 ' A' ' 257' ' ' VAL . 55.2 m-20 -63.74 -42.32 97.89 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.343 -178.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 254' ' ' ALA . . . . . 0.453 ' HB2' ' CB ' ' A' ' 248' ' ' TYR . . . -65.19 -41.93 94.08 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.829 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 255' ' ' VAL . . . . . 0.433 HG13 HH11 ' B' ' 154' ' ' ARG . 57.3 t -63.73 -45.61 96.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.927 -178.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.81 -47.83 79.28 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.513 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.487 ' O ' ' C ' ' A' ' 258' ' ' LEU . 21.7 m -66.36 -40.11 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 120.048 -0.661 . . . . 0.0 112.314 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.487 ' C ' ' O ' ' A' ' 257' ' ' VAL . 1.0 OUTLIER -30.18 -73.41 0.05 OUTLIER Pre-proline 0 C--N 1.345 0.41 0 C-N-CA 121.041 -0.264 . . . . 0.0 111.347 -176.892 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 259' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' A' ' 258' ' ' LEU . 41.0 Cg_endo -63.6 139.85 72.05 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 120.891 1.061 . . . . 0.0 112.117 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 259' ' ' PRO . 96.7 mt -152.12 -28.23 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 116.154 -0.476 . . . . 0.0 112.248 178.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.658 -177.151 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.558 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.7 159.58 40.81 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 118.974 -0.536 . . . . 0.0 109.994 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 79.7 p -59.59 -21.49 60.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 122.101 0.953 . . . . 0.0 110.877 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -73.66 -64.95 0.89 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.042 -177.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -66.39 -38.67 88.04 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.931 177.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 6' ' ' SER . . . . . 0.492 ' O ' ' HB3' ' B' ' 7' ' ' PHE . 68.5 m -59.87 -41.7 92.11 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 120.425 -0.51 . . . . 0.0 109.904 -178.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 7' ' ' PHE . . . . . 0.492 ' HB3' ' O ' ' B' ' 6' ' ' SER . 37.7 t80 84.54 92.98 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 O-C-N 123.844 0.715 . . . . 0.0 110.268 177.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 8' ' ' GLY . . . . . 0.588 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -67.06 -140.75 0.05 OUTLIER Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -178.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.588 ' HB ' ' O ' ' B' ' 8' ' ' GLY . 75.9 mt 82.98 110.81 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.69 0 C-N-CA 122.519 0.328 . . . . 0.0 111.045 -178.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.14 -23.65 66.65 Favored 'Trans proline' 0 N--CA 1.499 1.806 0 C-N-CA 121.369 1.379 . . . . 0.0 111.936 -178.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.08 -39.7 97.96 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -64.53 -39.7 94.26 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.587 0.708 . . . . 0.0 109.652 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 50.7 tp -61.71 -42.66 99.25 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.21 -177.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -65.3 -33.59 76.35 Favored 'General case' 0 CA--C 1.562 1.418 0 CA-C-O 121.514 0.673 . . . . 0.0 110.523 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' VAL . . . . . 0.483 HG22 ' CD1' ' A' ' 113' ' ' ILE . 76.0 t -62.83 -45.75 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 113.135 -1.848 . . . . 0.0 111.086 177.171 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 95.0 mt -64.11 -43.79 97.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.177 -178.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 17' ' ' LYS . . . . . 0.594 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 98.9 mttt -63.41 -42.13 98.74 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.38 -41.13 98.78 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.973 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.45 -38.81 85.32 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.522 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.406 ' O ' ' O ' ' B' ' 23' ' ' VAL . 83.4 mt -63.61 -42.34 98.21 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.154 0.502 . . . . 0.0 110.152 175.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -62.84 -38.61 91.45 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.128 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 55.9 m170 -57.79 -39.91 78.65 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 121.153 -0.219 . . . . 0.0 111.38 -178.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 23' ' ' VAL . . . . . 0.406 ' O ' ' O ' ' B' ' 20' ' ' LEU . 10.6 p -114.19 129.36 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.541 ' HG3' ' O ' ' B' ' 24' ' ' ARG . 35.1 ptt180 -71.84 105.9 3.97 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 121.971 0.891 . . . . 0.0 112.421 -176.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.0 p -141.77 134.45 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.471 178.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 26' ' ' GLY . . . . . 0.496 ' O ' ' N ' ' B' ' 123' ' ' GLN . . . -89.33 98.22 2.42 Favored Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 119.525 -1.321 . . . . 0.0 113.054 -175.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 48.6 t -126.03 129.01 72.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 174.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 26.9 m -138.82 156.59 28.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.857 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 96.0 mt -119.81 125.04 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 122.753 1.263 . . . . 0.0 111.595 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.445 HG22 HG12 ' B' ' 39' ' ' ILE . 37.4 p -104.17 159.45 15.68 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 113.266 -1.788 . . . . 0.0 108.844 -178.017 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -126.59 103.26 25.1 Favored Pre-proline 0 C--O 1.238 0.462 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 32' ' ' PRO . . . . . 0.45 ' HG3' HG23 ' B' ' 117' ' ' THR . 36.8 Cg_endo -64.58 -19.59 65.01 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 121.88 1.72 . . . . 0.0 111.355 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.59 -41.63 97.71 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.677 -0.409 . . . . 0.0 109.922 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 94.9 mt -77.08 -172.7 2.47 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.823 -0.548 . . . . 0.0 111.209 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 35' ' ' GLU . . . . . 0.727 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 42.0 tt0 -79.69 130.94 35.79 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.446 ' O ' ' C ' ' B' ' 37' ' ' ASN . 61.9 t0 55.21 39.61 31.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.672 177.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 37' ' ' ASN . . . . . 0.446 ' C ' ' O ' ' B' ' 36' ' ' ASP . 23.1 t-20 29.8 69.73 0.61 Allowed Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.727 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 92.8 Cg_endo -72.08 153.91 57.42 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 123.449 2.766 . . . . 0.0 111.696 178.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.445 HG12 HG22 ' B' ' 30' ' ' THR . 96.3 mt -86.58 128.33 39.62 Favored 'Isoleucine or valine' 0 C--O 1.246 0.901 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.424 HG23 ' N ' ' B' ' 41' ' ' TYR . 30.1 m -108.15 -44.77 6.94 Favored 'Isoleucine or valine' 0 C--N 1.341 0.214 0 O-C-N 123.933 0.77 . . . . 0.0 112.631 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 41' ' ' TYR . . . . . 0.424 ' N ' HG23 ' B' ' 40' ' ' VAL . 47.6 t80 -94.38 123.77 37.99 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.27 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 6.3 p -142.14 140.91 29.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 O-C-N 124.033 0.833 . . . . 0.0 109.414 178.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 43' ' ' ASN . . . . . 0.63 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 56.8 p30 -101.21 161.4 13.64 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.128 178.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 44' ' ' GLN . . . . . 0.457 ' OE1' ' HA ' ' B' ' 44' ' ' GLN . 13.1 mm100 -63.11 -37.77 88.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.624 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.89 -26.69 63.35 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.657 ' CD2' HD13 ' B' ' 57' ' ' ILE . 61.9 t80 -60.19 -43.54 95.82 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 0.812 HG13 ' O ' ' B' ' 52' ' ' TYR . 75.3 t -61.46 -45.95 97.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.276 -179.068 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -62.96 -44.69 95.35 Favored 'General case' 0 C--N 1.323 -0.543 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.251 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 57.9 ttm -63.11 -42.55 99.59 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 40.9 p -93.53 -17.28 23.56 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.776 -177.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 51' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' B' ' 47' ' ' VAL . . . 73.44 17.71 79.08 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 52' ' ' TYR . . . . . 0.812 ' O ' HG13 ' B' ' 47' ' ' VAL . 70.0 m-85 -111.12 146.01 37.58 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 122.944 0.497 . . . . 0.0 110.349 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -74.4 147.16 42.33 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.45 0.643 . . . . 0.0 111.302 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.36 -38.65 84.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.05 -177.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.23 -39.17 93.86 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 120.103 -0.639 . . . . 0.0 111.81 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -72.3 -31.66 65.9 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 176.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.657 HD13 ' CD2' ' B' ' 46' ' ' PHE . 91.8 mt -68.61 -71.67 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 176.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 96.8 mt -37.25 133.3 0.69 Allowed 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.813 178.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.1 -11.01 71.31 Favored Glycine 0 CA--C 1.537 1.418 0 CA-C-N 116.059 -0.519 . . . . 0.0 113.001 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -133.9 150.19 51.33 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -174.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 61' ' ' ASN . . . . . 0.568 ' C ' ' H ' ' B' ' 63' ' ' ARG . 25.9 t-20 -79.53 149.41 31.45 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.41 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 62' ' ' CYS . . . . . . . . . . . . . 81.8 m -62.74 10.08 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.372 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 63' ' ' ARG . . . . . 0.568 ' H ' ' C ' ' B' ' 61' ' ' ASN . 33.3 ptt-85 -60.61 -33.54 72.91 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.323 -177.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -58.92 -29.88 67.41 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 178.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 87.3 mt -62.2 -41.31 98.25 Favored 'General case' 0 C--O 1.238 0.466 0 O-C-N 121.573 -0.705 . . . . 0.0 109.686 -178.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -51.82 146.25 8.44 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.857 -176.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -156.71 -153.29 6.58 Favored Glycine 0 CA--C 1.534 1.242 0 O-C-N 123.886 0.741 . . . . 0.0 111.831 177.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.31 -41.21 93.0 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -176.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 10.1 m80 -75.95 -11.1 59.9 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.945 -178.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 70' ' ' THR . . . . . 0.43 HG23 HD11 ' B' ' 92' ' ' ILE . 28.5 m -62.02 133.7 55.68 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 120.229 -0.589 . . . . 0.0 109.427 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -91.02 112.61 54.6 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.639 -179.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.38 -37.56 89.17 Favored 'Trans proline' 0 N--CA 1.489 1.219 0 C-N-CA 121.074 1.183 . . . . 0.0 111.734 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.99 -40.51 89.41 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.793 -176.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -66.84 -39.39 87.6 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.078 177.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 75.2 t -61.82 -46.43 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -63.15 -36.99 85.45 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.76 -178.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -62.27 -42.11 99.05 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 119.371 -0.932 . . . . 0.0 109.0 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 95.5 mt -63.57 -43.44 98.25 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 CA-C-O 120.751 0.31 . . . . 0.0 110.841 -178.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -61.16 -42.39 98.47 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 76.5 m -61.15 -45.06 96.21 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.352 0.596 . . . . 0.0 110.017 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.12 -40.34 97.32 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -177.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 81.8 mt -62.65 -42.81 99.81 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.034 -0.666 . . . . 0.0 109.38 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 67.6 tp60 -63.21 -38.95 93.19 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -81.99 -4.36 56.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.92 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 45.7 tttt 50.33 43.72 26.62 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.548 176.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -127.95 146.42 59.03 Favored Pre-proline 0 N--CA 1.466 0.349 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.421 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -62.41 140.41 82.11 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 120.973 1.115 . . . . 0.0 113.893 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.58 135.9 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.725 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 89' ' ' THR . . . . . 0.87 HG23 ' OD1' ' B' ' 107' ' ' ASN . 93.7 m -121.01 123.45 42.44 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 29.4 m -138.64 162.74 28.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.76 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -115.91 119.8 37.12 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.931 -0.48 . . . . 0.0 109.78 174.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 92' ' ' ILE . . . . . 0.43 HD11 HG23 ' B' ' 70' ' ' THR . 20.6 tt -127.99 132.44 68.64 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.807 -174.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -70.98 144.42 50.5 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.899 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 94' ' ' ASN . . . . . 0.407 HD22 ' HA ' ' B' ' 94' ' ' ASN . 8.0 m120 -133.62 -179.41 5.51 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-O 121.435 0.636 . . . . 0.0 111.489 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 95' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -131.46 145.95 52.02 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.146 177.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 96' ' ' LYS . . . . . 0.501 ' HG3' ' CE2' ' B' ' 102' ' ' PHE . 98.8 mttt -103.45 -180.0 4.11 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.402 0.62 . . . . 0.0 110.658 178.111 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.46 -35.9 76.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.502 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 38.4 p-10 -86.82 -1.44 57.78 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.42 -0.8 . . . . 0.0 112.928 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.89 3.7 63.85 Favored Glycine 0 N--CA 1.466 0.695 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.464 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 21.7 m -68.48 129.41 39.84 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.274 -0.57 . . . . 0.0 109.478 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 101' ' ' MET . . . . . 0.594 ' SD ' ' N ' ' B' ' 102' ' ' PHE . 15.0 tmm? -88.3 143.44 27.02 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 102' ' ' PHE . . . . . 0.594 ' N ' ' SD ' ' B' ' 101' ' ' MET . 54.4 p90 -153.28 163.5 39.79 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 178.016 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 103' ' ' TRP . . . . . 0.826 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 25.3 m95 -95.71 139.72 31.55 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.614 0.721 . . . . 0.0 110.468 178.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 104' ' ' ASN . . . . . 0.476 HD21 ' HG2' ' B' ' 123' ' ' GLN . 64.8 t-20 -133.66 105.85 7.06 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 114.804 -1.089 . . . . 0.0 113.783 -177.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 105' ' ' GLU . . . . . 0.469 ' HB2' HD11 ' B' ' 126' ' ' ILE . 81.1 tt0 -73.87 124.24 25.75 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.999 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 37.3 tp -112.04 125.42 54.07 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-O 120.936 0.398 . . . . 0.0 111.631 -177.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 107' ' ' ASN . . . . . 0.87 ' OD1' HG23 ' B' ' 89' ' ' THR . 98.3 m-20 -120.15 127.87 52.89 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 176.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 95.8 mt -122.66 132.59 70.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -141.79 121.55 8.2 Favored Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -70.32 151.88 66.11 Favored 'Trans proline' 0 N--CA 1.501 1.924 0 C-N-CA 122.434 2.09 . . . . 0.0 112.505 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 66.6 mtt -130.87 143.12 50.5 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -112.12 107.4 16.31 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 178.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 113' ' ' ILE . . . . . 0.524 HG12 ' NZ ' ' A' ' 18' ' ' LYS . 96.8 mt -133.32 127.54 54.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-N 118.521 0.6 . . . . 0.0 111.596 177.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 52.54 38.18 25.0 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.88 178.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 58.86 37.04 24.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.53 -178.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -132.82 150.68 52.13 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 117' ' ' THR . . . . . 0.45 HG23 ' HG3' ' B' ' 32' ' ' PRO . 9.4 t -101.4 152.46 20.7 Favored 'General case' 0 C--O 1.217 -0.628 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -177.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -147.39 146.48 29.63 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 120.791 -1.193 . . . . 0.0 111.189 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -123.07 137.75 54.85 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.765 -177.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -128.86 133.36 66.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 -177.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.57 123.17 6.9 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 122' ' ' ILE . . . . . 0.517 ' HB ' ' HB2' ' B' ' 107' ' ' ASN . 92.4 mt -112.33 127.43 69.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 123' ' ' GLN . . . . . 0.496 ' N ' ' O ' ' B' ' 26' ' ' GLY . 17.5 mp0 -117.93 123.58 46.16 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -120.13 121.16 38.19 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 125' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' B' ' 127' ' ' THR . 68.2 t0 -69.39 131.72 45.25 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.588 -179.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.519 HG22 ' O ' ' B' ' 126' ' ' ILE . 2.7 mp -107.51 17.82 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.807 0 CA-C-O 122.097 0.951 . . . . 0.0 109.095 178.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 127' ' ' THR . . . . . 0.447 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 99.3 m -63.85 -44.04 94.32 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.24 -1.345 . . . . 0.0 112.501 175.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 59.9 tptt -60.88 -46.15 91.76 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 129' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -63.21 -36.19 82.81 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.146 -0.933 . . . . 0.0 111.499 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 130' ' ' LYS . . . . . 0.826 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 98.5 mttt -63.57 -41.42 98.39 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-N 113.779 -1.555 . . . . 0.0 110.511 175.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.99 -41.46 97.51 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 132' ' ' TYR . . . . . 0.76 ' CE2' HD11 ' B' ' 136' ' ' LEU . 86.2 t80 -59.78 -44.11 94.07 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 121.663 -0.648 . . . . 0.0 111.156 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 133' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' B' ' 137' ' ' GLU . 97.6 mt-10 -64.61 -36.96 85.93 Favored 'General case' 0 C--O 1.224 -0.254 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.563 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 134' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' B' ' 130' ' ' LYS . 99.0 mttt -62.94 -39.57 95.01 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.676 178.14 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 54.5 tp -63.01 -41.56 99.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.32 0.581 . . . . 0.0 109.811 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 136' ' ' LEU . . . . . 0.76 HD11 ' CE2' ' B' ' 132' ' ' TYR . 89.2 mt -63.01 -41.28 99.53 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.404 177.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 137' ' ' GLU . . . . . 0.408 ' HG3' ' O ' ' B' ' 133' ' ' GLU . 97.2 mt-10 -64.37 -36.54 84.47 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.357 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.77 -43.47 96.31 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.915 176.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 62.3 m -60.87 -45.76 93.29 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 88.5 mt -60.87 -40.33 92.53 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 99.7 m -61.86 -45.44 93.79 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.97 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -66.3 -42.1 88.8 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 94.9 mt -63.11 -43.62 99.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.642 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 144' ' ' THR . . . . . . . . . . . . . 93.4 m -61.78 -45.66 92.93 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.25 -41.31 99.04 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 119.021 -1.072 . . . . 0.0 109.369 178.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 87.5 mt -64.58 -41.12 96.47 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 177.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 147' ' ' SER . . . . . 0.64 ' O ' ' N ' ' B' ' 149' ' ' PRO . 78.2 p -61.76 -40.84 96.56 Favored 'General case' 0 CA--C 1.479 -1.779 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 148' ' ' THR . . . . . 0.486 ' C ' ' O ' ' B' ' 147' ' ' SER . 20.6 m -27.92 84.24 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.657 0 O-C-N 124.128 0.892 . . . . 0.0 110.143 177.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 149' ' ' PRO . . . . . 0.64 ' N ' ' O ' ' B' ' 147' ' ' SER . 22.8 Cg_exo -61.69 147.13 96.04 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 C-N-CA 122.044 1.829 . . . . 0.0 115.802 -176.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 9.6 tp -128.47 121.24 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-N 114.258 -1.337 . . . . 0.0 107.771 174.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 58.1 t -151.68 92.83 3.59 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.946 -178.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -60.59 136.05 64.6 Favored 'Trans proline' 0 C--N 1.32 -0.932 0 N-CA-C 109.029 -1.181 . . . . 0.0 109.029 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 153' ' ' ILE . . . . . 0.586 ' O ' ' HD2' ' B' ' 154' ' ' ARG . 45.0 mm -67.74 -43.72 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.876 178.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 154' ' ' ARG . . . . . 0.586 ' HD2' ' O ' ' B' ' 153' ' ' ILE . 0.2 OUTLIER -156.7 -155.5 0.54 Allowed 'General case' 0 C--N 1.347 0.469 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -179.718 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 62.9 t-20 -86.86 108.27 18.69 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.57 -17.42 57.64 Favored Glycine 0 C--N 1.34 0.803 0 N-CA-C 110.069 -1.213 . . . . 0.0 110.069 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 85.6 mt -110.25 125.64 67.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.144 0.497 . . . . 0.0 111.348 -176.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 158' ' ' SER . . . . . 0.521 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 47.4 m -135.1 149.6 50.07 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.87 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -132.96 145.89 51.29 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.29 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 18.0 tp -139.44 77.76 28.47 Favored Pre-proline 0 CA--C 1.531 0.227 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 161' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -71.56 150.23 56.96 Favored 'Trans proline' 0 N--CA 1.499 1.849 0 C-N-CA 122.835 2.357 . . . . 0.0 114.362 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 92.6 mt -113.83 134.93 54.49 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 55.9 t -128.46 132.93 67.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 112.8 170.61 17.97 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.198 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 165' ' ' ASN . . . . . 0.743 ' O ' ' NH1' ' B' ' 170' ' ' ARG . 61.1 t30 -90.52 107.29 19.07 Favored 'General case' 0 C--O 1.216 -0.673 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -178.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 166' ' ' LEU . . . . . 0.528 HD21 ' CZ ' ' B' ' 171' ' ' PHE . 40.3 tp -63.92 106.16 0.97 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -174.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 167' ' ' THR . . . . . 0.594 HG23 ' NH2' ' B' ' 170' ' ' ARG . 34.5 p -86.79 169.45 12.59 Favored 'General case' 0 C--N 1.353 0.729 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.285 177.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -67.61 -37.33 82.38 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.928 176.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.91 -39.55 90.69 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 123.345 1.545 . . . . 0.0 111.486 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 170' ' ' ARG . . . . . 0.743 ' NH1' ' O ' ' B' ' 165' ' ' ASN . 87.9 mtm180 -63.25 -36.36 83.42 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 112.408 -2.178 . . . . 0.0 110.842 177.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 171' ' ' PHE . . . . . 0.528 ' CZ ' HD21 ' B' ' 166' ' ' LEU . 0.5 OUTLIER -53.76 -25.29 18.18 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -179.009 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 172' ' ' ASN . . . . . 0.514 ' O ' HG22 ' B' ' 175' ' ' VAL . 93.4 m-20 -62.95 -40.57 98.09 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.01 178.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 57.2 m -60.49 -41.72 94.85 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.776 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 66.4 mt -63.52 -44.45 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -178.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 175' ' ' VAL . . . . . 0.514 HG22 ' O ' ' B' ' 172' ' ' ASN . 30.5 m -62.59 -39.92 86.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -179.081 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 176' ' ' CYS . . . . . 0.404 ' N ' HG23 ' B' ' 175' ' ' VAL . 97.2 m -61.53 -34.82 76.19 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.226 178.255 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 177' ' ' THR . . . . . 0.585 ' O ' HG13 ' B' ' 181' ' ' ILE . 25.0 m -62.27 -20.4 64.23 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.25 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 178' ' ' LEU . . . . . 0.685 ' CD2' HD21 ' B' ' 211' ' ' LEU . 91.5 mt -61.27 -38.93 88.54 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.269 -178.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 18.3 m -61.95 -44.09 97.49 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 176.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 180' ' ' ASN . . . . . 0.564 ' O ' ' OG ' ' B' ' 183' ' ' SER . 93.3 m-20 -61.8 -40.89 96.78 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.956 0.408 . . . . 0.0 110.554 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.585 HG13 ' O ' ' B' ' 177' ' ' THR . 75.0 mt -57.35 -31.64 38.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.776 -177.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 182' ' ' LEU . . . . . 0.436 HD21 HD21 ' B' ' 214' ' ' LEU . 84.5 mt -62.85 -41.68 99.45 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 119.693 -0.803 . . . . 0.0 109.202 177.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 183' ' ' SER . . . . . 0.564 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.2 p -63.54 -32.8 74.37 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 121.845 -0.534 . . . . 0.0 110.817 177.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 184' ' ' THR . . . . . 0.455 ' OG1' ' HA ' ' B' ' 181' ' ' ILE . 17.4 p -86.2 17.94 3.39 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.367 -176.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 80.3 p -61.12 -15.61 35.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.665 -177.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.45 -40.21 95.86 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 121.029 -0.268 . . . . 0.0 110.729 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 187' ' ' ASP . . . . . 0.521 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.4 m-20 -71.42 114.14 9.18 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.433 0.635 . . . . 0.0 110.831 -177.243 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.38 -42.43 99.41 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 114.803 -1.09 . . . . 0.0 113.09 -178.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -111.82 130.97 55.64 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.221 -178.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 190' ' ' LEU . . . . . . . . . . . . . 41.9 tp -124.1 118.24 26.47 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.926 177.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 87.0 mt -106.93 125.91 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-N 117.759 0.254 . . . . 0.0 111.216 -177.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 49.8 mm -115.41 118.54 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 193' ' ' ASP . . . . . 0.522 ' CG ' ' HG ' ' B' ' 195' ' ' SER . 41.7 t0 -90.47 111.67 23.02 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -176.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 194' ' ' LEU . . . . . . . . . . . . . 96.2 mt -92.45 -1.61 56.87 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 123.624 0.577 . . . . 0.0 109.627 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 195' ' ' SER . . . . . 0.522 ' HG ' ' CG ' ' B' ' 193' ' ' ASP . 77.8 p -60.88 -36.81 80.17 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.794 -178.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.46 -34.72 89.36 Favored Glycine 0 N--CA 1.439 -1.105 0 N-CA-C 109.919 -1.273 . . . . 0.0 109.919 -178.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 197' ' ' LEU . . . . . 0.979 ' CD2' ' O ' ' B' ' 199' ' ' GLN . 5.4 tt -77.22 134.01 38.73 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 198' ' ' ALA . . . . . 0.959 ' N ' HD23 ' B' ' 197' ' ' LEU . . . -63.75 -44.96 91.92 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 119.954 -0.698 . . . . 0.0 111.572 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 199' ' ' GLN . . . . . 0.979 ' O ' ' CD2' ' B' ' 197' ' ' LEU . 58.4 tt0 -136.83 163.25 31.07 Favored 'General case' 0 C--O 1.212 -0.921 0 CA-C-O 122.202 1.001 . . . . 0.0 112.602 -177.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 200' ' ' VAL . . . . . 0.463 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 55.8 t -120.65 132.17 70.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 O-C-N 120.382 -1.449 . . . . 0.0 109.583 177.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -89.7 150.24 22.41 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.79 -178.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -61.38 -33.24 73.33 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.325 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -63.15 -32.99 74.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.435 0.636 . . . . 0.0 109.357 177.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.7 m -60.65 -44.24 96.65 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.291 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 205' ' ' ALA . . . . . 0.676 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -58.15 -29.64 65.73 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -178.004 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -65.63 -38.77 90.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.502 0.668 . . . . 0.0 110.519 174.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -66.2 -39.0 89.33 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.752 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 95.4 mt -62.86 -45.72 98.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -178.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 209' ' ' PHE . . . . . 0.676 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 66.1 m-85 -61.22 -42.22 98.21 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.781 -176.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.0 -42.07 99.75 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.61 -0.836 . . . . 0.0 109.607 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 211' ' ' LEU . . . . . 0.685 HD21 ' CD2' ' B' ' 178' ' ' LEU . 39.4 mt -62.18 -42.3 99.14 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.106 -178.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 78.2 p -63.97 -35.74 81.68 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.385 -0.526 . . . . 0.0 112.0 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 213' ' ' HIS . . . . . 0.427 ' CE1' HD11 ' B' ' 217' ' ' LEU . 56.3 t-80 -66.92 -46.87 73.48 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.106 177.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.436 HD21 HD21 ' B' ' 182' ' ' LEU . 56.5 tp -63.96 -43.08 96.87 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.598 0.713 . . . . 0.0 109.88 177.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 215' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' B' ' 211' ' ' LEU . 84.9 mt -63.07 -44.46 95.74 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 113.544 -1.662 . . . . 0.0 111.368 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -61.69 -39.08 90.19 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.258 -177.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 217' ' ' LEU . . . . . 0.427 HD11 ' CE1' ' B' ' 213' ' ' HIS . 86.2 mt -62.86 -41.62 99.44 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.309 0.576 . . . . 0.0 111.023 176.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 218' ' ' THR . . . . . 0.404 HG23 ' O ' ' B' ' 214' ' ' LEU . 67.3 p -76.06 -16.26 59.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.641 -178.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 78.81 68.13 1.53 Allowed Glycine 0 CA--C 1.528 0.864 0 N-CA-C 107.573 -2.211 . . . . 0.0 107.573 -177.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 220' ' ' THR . . . . . . . . . . . . . 81.0 m -146.51 105.84 3.91 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 176.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -63.16 139.93 58.82 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.879 -175.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 40.6 tp -118.13 122.18 42.42 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.414 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 3.6 mp -112.25 129.19 68.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.249 -178.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 224' ' ' ILE . . . . . 0.539 ' CG2' HD11 ' B' ' 227' ' ' ILE . 49.5 mm -109.51 126.17 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 50.4 p -133.29 156.08 48.23 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.697 0.761 . . . . 0.0 112.559 -177.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 91.0 16.27 54.57 Favored Glycine 0 CA--C 1.504 -0.598 0 CA-C-N 114.018 -1.446 . . . . 0.0 111.319 -177.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 227' ' ' ILE . . . . . 0.592 HD12 HG23 ' B' ' 247' ' ' THR . 96.1 mt -81.48 126.48 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 118.046 0.923 . . . . 0.0 111.27 -178.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 64.3 tttt -66.24 140.23 96.74 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.392 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.71 -36.78 91.09 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.378 1.385 . . . . 0.0 112.554 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -64.0 -43.88 94.35 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -178.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 50.1 tp -61.64 -41.8 98.01 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.526 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.82 -37.1 86.12 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.881 -0.328 . . . . 0.0 111.314 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 94.7 mtp -63.83 -41.06 97.93 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.276 -0.57 . . . . 0.0 109.777 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.11 -43.71 97.68 Favored 'General case' 0 CA--C 1.553 1.082 0 CA-C-O 122.305 1.05 . . . . 0.0 109.589 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 37.9 mmt -63.96 -35.21 79.95 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.878 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -61.71 -39.99 93.45 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.989 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.7 -43.24 99.3 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 177.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 51.4 tp -61.83 -43.79 98.14 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.636 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 239' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' B' ' 240' ' ' ALA . 66.8 t0 -162.23 135.01 5.88 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.96 -178.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 240' ' ' ALA . . . . . 0.439 ' N ' ' OD1' ' B' ' 239' ' ' ASP . . . -62.09 -44.3 96.95 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 177.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 241' ' ' ASN . . . . . 0.626 ' O ' ' HB2' ' B' ' 244' ' ' SER . 89.3 m-20 -45.83 -20.2 0.08 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.289 -174.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 242' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -61.24 -45.66 93.62 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 120.083 -0.647 . . . . 0.0 110.402 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 243' ' ' SER . . . . . . . . . . . . . 77.7 p -55.96 -43.46 77.52 Favored 'General case' 0 C--O 1.225 -0.191 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 244' ' ' SER . . . . . 0.626 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 70.9 m -34.07 -33.22 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 -177.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 97.1 mt -89.96 132.56 35.27 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.667 178.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -58.69 136.78 57.77 Favored 'General case' 0 C--O 1.251 1.176 0 CA-C-O 121.833 0.825 . . . . 0.0 111.261 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 247' ' ' THR . . . . . 0.592 HG23 HD12 ' B' ' 227' ' ' ILE . 97.4 m -125.97 128.01 46.84 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.74 178.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 248' ' ' TYR . . . . . 0.49 ' CG ' ' HB2' ' B' ' 254' ' ' ALA . 95.9 m-85 -113.64 143.46 44.54 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 249' ' ' SER . . . . . 0.564 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 78.1 p -63.11 -35.8 81.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.855 0.36 . . . . 0.0 111.295 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 250' ' ' ASN . . . . . 0.564 ' OD1' ' O ' ' B' ' 249' ' ' SER . 98.6 m-20 -146.67 162.08 39.21 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.321 178.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 73.0 t -65.0 -44.74 95.99 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.175 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.924 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 252' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.38 -46.04 91.84 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -177.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 253' ' ' ASP . . . . . 0.476 ' O ' HG22 ' B' ' 257' ' ' VAL . 94.7 m-20 -61.43 -43.21 99.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.763 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 254' ' ' ALA . . . . . 0.49 ' HB2' ' CG ' ' B' ' 248' ' ' TYR . . . -65.3 -40.35 93.71 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.468 0.652 . . . . 0.0 111.08 178.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 255' ' ' VAL . . . . . . . . . . . . . 53.6 t -65.39 -45.35 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.277 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 256' ' ' LYS . . . . . 0.468 ' HE3' ' ND2' ' A' ' 155' ' ' ASN . 88.5 tttt -63.37 -48.33 78.39 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.113 -178.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 257' ' ' VAL . . . . . 0.476 HG22 ' O ' ' B' ' 253' ' ' ASP . 21.1 m -65.14 -40.22 88.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.519 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 258' ' ' LEU . . . . . 0.492 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 1.0 OUTLIER -31.9 -73.33 0.05 OUTLIER Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.826 -178.926 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 259' ' ' PRO . . . . . 0.543 ' O ' HG13 ' B' ' 260' ' ' ILE . 37.5 Cg_endo -62.25 141.47 87.98 Favored 'Trans proline' 0 N--CA 1.504 2.092 0 C-N-CA 121.572 1.515 . . . . 0.0 111.498 -178.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 260' ' ' ILE . . . . . 0.543 HG13 ' O ' ' B' ' 259' ' ' PRO . 96.9 mt -159.35 -16.48 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 118.587 0.63 . . . . 0.0 112.411 177.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 118.083 -0.96 . . . . 0.0 111.73 179.856 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.221 -1.551 . . . . 0.0 109.221 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.36 174.84 13.82 Favored 'General case' 0 CA--C 1.483 -1.624 0 CA-C-O 123.219 1.485 . . . . 0.0 109.746 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 93.9 p -80.12 -3.81 50.31 Favored 'General case' 0 CA--C 1.572 1.795 0 O-C-N 117.817 -3.052 . . . . 0.0 112.766 177.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -85.29 -64.64 1.12 Allowed 'General case' 0 C--N 1.267 -3.017 0 O-C-N 127.09 2.744 . . . . 0.0 112.304 174.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -70.06 -38.82 75.88 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.089 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.508 ' O ' ' NZ ' ' B' ' 17' ' ' LYS . 65.6 m -59.15 -41.76 89.07 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.862 -177.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.502 ' HB3' ' O ' ' A' ' 6' ' ' SER . 36.2 t80 85.14 87.33 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.364 0.602 . . . . 0.0 111.771 176.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.578 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -60.5 -142.76 0.01 OUTLIER Glycine 0 C--N 1.337 0.628 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.578 ' HB ' ' O ' ' A' ' 8' ' ' GLY . 78.0 mt 84.96 111.76 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.629 0 O-C-N 124.075 0.515 . . . . 0.0 110.655 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.68 -22.25 64.46 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.195 1.263 . . . . 0.0 112.219 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.41 -38.54 95.94 Favored Glycine 0 N--CA 1.465 0.578 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.228 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -64.86 -39.17 93.14 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 51.9 tp -63.06 -41.66 99.51 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -63.29 -40.31 97.0 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.6 t -60.76 -44.04 96.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 O-C-N 122.014 -0.429 . . . . 0.0 111.025 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 92.9 mt -62.32 -43.49 98.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 119.508 -0.877 . . . . 0.0 109.12 -177.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.441 ' NZ ' ' HA ' ' B' ' 6' ' ' SER . 98.8 mttt -62.54 -46.22 89.36 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 119.331 -0.948 . . . . 0.0 112.036 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.579 ' NZ ' HG12 ' B' ' 113' ' ' ILE . 98.6 mttt -60.23 -39.46 86.74 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 118.72 -1.192 . . . . 0.0 108.83 -176.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.35 -42.14 90.86 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 120.034 -0.666 . . . . 0.0 110.156 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.0 mt -62.99 -40.93 99.24 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -63.08 -38.85 92.83 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.949 -0.568 . . . . 0.0 112.525 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 54.4 m170 -58.44 -40.06 81.53 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 122.168 -0.332 . . . . 0.0 111.48 -178.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.0 p -114.85 130.52 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.478 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 33.3 ptt180 -72.09 111.63 7.48 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 122.126 0.965 . . . . 0.0 112.207 -177.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.6 p -141.31 143.1 28.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.571 ' O ' ' N ' ' A' ' 123' ' ' GLN . . . -97.81 90.65 1.09 Allowed Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.767 -178.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 54.4 t -124.38 129.81 73.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 176.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.3 m -137.38 159.77 35.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.6 mt -120.09 129.92 74.91 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.64 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 176.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.433 ' OG1' ' HB2' ' A' ' 119' ' ' PHE . 17.5 p -106.16 166.08 10.77 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.427 ' C ' ' OD1' ' A' ' 37' ' ' ASN . 44.3 t0 -132.78 101.7 13.98 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.534 ' CG ' HG23 ' A' ' 117' ' ' THR . 37.6 Cg_endo -64.64 -21.2 65.56 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.576 1.517 . . . . 0.0 111.572 -178.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.54 -33.61 75.28 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.399 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 88.9 mt -86.83 172.22 10.27 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.272 178.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.657 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 42.2 tt0 -67.58 133.06 48.74 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -178.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.567 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 62.8 t0 61.44 20.85 11.53 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 177.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.427 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 40.4 t-20 43.1 68.68 2.74 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.727 -177.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.657 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 88.1 Cg_endo -71.4 155.63 59.73 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 123.9 3.067 . . . . 0.0 112.39 -178.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.3 mt -87.91 124.35 41.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 O-C-N 124.047 0.842 . . . . 0.0 108.977 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.409 HG23 ' N ' ' A' ' 41' ' ' TYR . 27.6 m -105.18 -42.43 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 O-C-N 123.609 0.568 . . . . 0.0 112.332 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.409 ' N ' HG23 ' A' ' 40' ' ' VAL . 46.7 t80 -97.13 123.2 40.82 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 120.289 -0.564 . . . . 0.0 111.968 -178.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.6 p -142.56 139.73 28.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.918 177.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.684 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 55.7 p30 -95.78 165.96 12.04 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.47 ' HA ' ' OE1' ' A' ' 44' ' ' GLN . 14.0 mm100 -66.63 -39.82 88.45 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 177.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.57 -25.0 62.63 Favored Glycine 0 C--O 1.236 0.247 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.684 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 64.5 t80 -59.39 -48.48 81.47 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 105.221 -2.14 . . . . 0.0 105.221 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.569 HG13 ' O ' ' A' ' 52' ' ' TYR . 54.4 t -58.78 -44.7 90.83 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.554 0 O-C-N 121.088 -1.008 . . . . 0.0 111.623 -174.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -63.15 -35.81 81.52 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 120.441 -0.504 . . . . 0.0 112.278 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 60.9 ttm -68.08 -42.66 80.07 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 177.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 43.6 p -95.58 -20.59 18.86 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.358 0.599 . . . . 0.0 111.255 -177.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . 77.94 19.41 75.25 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.569 ' O ' HG13 ' A' ' 47' ' ' VAL . 75.0 m-85 -112.37 137.74 50.09 Favored 'General case' 0 C--O 1.222 -0.366 0 C-N-CA 122.569 0.348 . . . . 0.0 110.881 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -63.22 147.94 49.54 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.829 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.446 HG22 ' H ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -65.2 -33.79 76.84 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.983 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.61 -43.15 85.54 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.959 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -64.23 -45.12 89.6 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.354 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.575 HD13 ' CE2' ' A' ' 46' ' ' PHE . 96.1 mt -62.85 -48.37 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 -175.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.2 mt -57.49 144.99 34.72 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.03 -2.96 82.51 Favored Glycine 0 C--O 1.237 0.329 0 C-N-CA 121.062 -0.589 . . . . 0.0 113.534 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -134.78 151.47 50.99 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.916 1.358 . . . . 0.0 112.308 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.574 ' C ' ' H ' ' A' ' 63' ' ' ARG . 25.5 t-20 -81.57 149.38 28.66 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.343 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 71.4 m -61.96 16.15 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.515 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.574 ' H ' ' C ' ' A' ' 61' ' ' ASN . 36.5 ptt-85 -61.35 -41.52 97.19 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.973 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -55.91 -20.31 15.37 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.5 mt -68.77 -35.94 77.7 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.951 0.881 . . . . 0.0 112.064 177.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -64.92 136.85 57.3 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.877 -176.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.567 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -147.28 -149.09 4.89 Favored Glycine 0 CA--C 1.537 1.415 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -178.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.83 -40.03 96.14 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -177.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.47 ' O ' ' NE2' ' A' ' 93' ' ' GLN . 7.3 m-70 -76.32 -9.58 58.74 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.952 0.406 . . . . 0.0 111.003 -178.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.567 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 27.0 m -61.4 129.65 42.24 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.567 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -86.49 112.1 44.02 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.791 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -57.45 -31.12 90.44 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 121.966 1.777 . . . . 0.0 113.283 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.49 -40.67 96.1 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 120.499 -0.481 . . . . 0.0 110.815 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.422 ' OE1' ' HB ' ' A' ' 90' ' ' VAL . 79.2 mm-40 -65.53 -45.03 85.02 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.4 t -59.09 -43.62 89.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -177.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -63.87 -37.74 88.52 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.042 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -63.47 -39.79 95.39 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.497 0.665 . . . . 0.0 110.128 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.22 -44.04 97.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.96 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -62.66 -43.19 99.44 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 113.771 -1.558 . . . . 0.0 108.231 -179.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 99.3 m -61.16 -48.54 81.13 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.37 -41.34 96.94 Favored 'General case' 0 C--N 1.361 1.081 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.186 -172.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 90.2 mt -63.05 -40.08 96.65 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.632 -1.293 . . . . 0.0 111.582 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -63.03 -40.78 98.77 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -70.11 -25.19 63.39 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.457 177.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 51.5 tttt 65.23 42.81 3.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.413 -176.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -125.96 148.57 63.26 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -61.64 143.82 96.99 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.334 1.356 . . . . 0.0 112.928 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.93 141.34 31.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.457 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.945 HG23 ' OD1' ' A' ' 107' ' ' ASN . 99.6 m -128.1 120.33 27.17 Favored 'General case' 0 C--N 1.345 0.386 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 176.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.422 ' HB ' ' OE1' ' A' ' 74' ' ' GLU . 29.0 m -138.82 158.31 29.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.82 -0.173 . . . . 0.0 111.453 178.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -102.96 128.75 49.65 Favored 'General case' 0 C--O 1.247 0.931 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.459 ' O ' HG23 ' A' ' 92' ' ' ILE . 18.3 tt -137.55 129.45 41.0 Favored 'Isoleucine or valine' 0 C--N 1.378 1.837 0 CA-C-N 121.917 2.144 . . . . 0.0 112.363 177.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.47 ' NE2' ' O ' ' A' ' 69' ' ' HIS . 34.1 mt-30 -61.5 134.29 56.69 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.107 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -135.43 159.82 40.38 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.102 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.455 ' CE1' ' HA3' ' A' ' 67' ' ' GLY . 93.0 m-85 -118.46 137.22 53.32 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.49 ' HG3' ' CE1' ' A' ' 102' ' ' PHE . 99.2 mttt -85.97 -171.77 3.75 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.394 0.616 . . . . 0.0 111.754 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -62.99 -42.08 99.75 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.295 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 41.1 p-10 -84.8 8.12 18.39 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -178.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.84 -3.41 87.17 Favored Glycine 0 N--CA 1.473 1.108 0 C-N-CA 120.571 -0.824 . . . . 0.0 111.916 177.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.7 m -59.3 137.89 57.82 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 106.255 -1.758 . . . . 0.0 106.255 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.687 ' SD ' ' C ' ' A' ' 101' ' ' MET . 13.4 tmm? -107.01 129.29 54.82 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 122.184 -0.323 . . . . 0.0 111.032 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.49 ' CE1' ' HG3' ' A' ' 96' ' ' LYS . 52.9 p90 -140.61 158.62 43.71 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.404 -177.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.842 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 22.8 m95 -89.03 144.87 25.85 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.554 HD21 ' HG2' ' A' ' 123' ' ' GLN . 56.4 t-20 -139.0 102.06 4.44 Favored 'General case' 0 C--O 1.245 0.862 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -176.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 80.8 tt0 -67.27 136.43 54.91 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -177.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 40.2 tp -121.43 123.76 42.85 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -179.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.945 ' OD1' HG23 ' A' ' 89' ' ' THR . 98.1 m-20 -120.58 122.64 41.01 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 123.237 0.336 . . . . 0.0 110.742 177.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 96.3 mt -120.71 128.33 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 O-C-N 123.536 0.523 . . . . 0.0 111.505 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -138.24 125.14 13.26 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.17 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -71.56 152.12 59.36 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.399 2.066 . . . . 0.0 112.313 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.63 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 66.6 mtt -124.47 152.73 42.99 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -127.41 96.19 4.49 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 177.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.496 ' CD1' HG22 ' B' ' 15' ' ' VAL . 96.4 mt -120.34 131.28 73.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.184 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 51.13 38.33 20.6 Favored 'General case' 0 CA--C 1.511 -0.538 0 O-C-N 121.355 -0.84 . . . . 0.0 111.51 175.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 59.39 31.49 21.13 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 123.777 0.673 . . . . 0.0 111.049 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -129.55 148.73 51.48 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.76 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 7.4 t -86.58 -173.33 4.45 Favored 'General case' 0 C--O 1.209 -1.034 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -178.206 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.76 ' CD2' ' O ' ' A' ' 117' ' ' THR . 77.2 m-85 -170.5 155.71 5.16 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 175.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.433 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 83.7 m-85 -129.44 146.38 51.3 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 175.106 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -136.43 135.54 49.27 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 177.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -111.12 130.28 9.69 Favored Glycine 0 CA--C 1.5 -0.89 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 178.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 96.2 mt -119.01 129.69 74.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.571 ' N ' ' O ' ' A' ' 26' ' ' GLY . 15.7 mp0 -119.67 115.27 23.59 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -116.46 113.07 22.32 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.647 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.464 ' OD1' ' N ' ' A' ' 126' ' ' ILE . 68.3 t0 -63.75 131.15 46.97 Favored 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -176.089 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.465 ' O ' HG22 ' A' ' 126' ' ' ILE . 2.6 mp -96.01 4.29 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 113.53 -1.668 . . . . 0.0 110.136 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 29.5 m -60.92 -42.45 98.14 Favored 'General case' 0 C--N 1.364 1.237 0 O-C-N 120.595 -1.316 . . . . 0.0 113.528 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -59.49 -43.06 93.41 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -63.0 -40.07 96.66 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.792 177.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.842 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.6 mttt -62.95 -40.81 98.79 Favored 'General case' 0 CA--C 1.504 -0.814 0 C-N-CA 118.277 -1.369 . . . . 0.0 110.187 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -61.43 -38.52 87.47 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.013 -178.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.763 ' CE2' HD11 ' A' ' 136' ' ' LEU . 86.6 t80 -61.76 -45.85 92.11 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.307 176.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.82 -38.29 90.53 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -62.44 -40.21 95.85 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.391 -0.524 . . . . 0.0 109.74 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 52.9 tp -61.05 -43.59 98.65 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -178.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.763 HD11 ' CE2' ' A' ' 132' ' ' TYR . 85.7 mt -62.72 -41.24 99.05 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.002 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -62.93 -41.5 99.49 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 119.337 -0.945 . . . . 0.0 109.672 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -60.14 -42.24 94.42 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -177.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 55.4 m -61.68 -41.36 97.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.851 176.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 144' ' ' THR . 84.6 mt -63.23 -41.41 99.11 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 178.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 88.3 m -61.54 -45.63 93.34 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.102 -177.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -65.19 -40.52 94.34 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 94.5 mt -64.7 -43.17 96.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 113.9 -1.5 . . . . 0.0 111.331 176.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.502 ' N ' ' O ' ' A' ' 140' ' ' LEU . 96.4 m -62.11 -46.01 90.96 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 120.372 -0.531 . . . . 0.0 112.371 -178.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.47 ' O ' ' OG1' ' A' ' 148' ' ' THR . . . -62.93 -39.77 95.6 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 118.95 -1.1 . . . . 0.0 109.451 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.4 mt -63.32 -42.71 99.0 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.719 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.0 p -59.6 -40.22 86.78 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -177.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.47 ' C ' ' O ' ' A' ' 147' ' ' SER . 12.6 m -26.72 80.64 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.524 0 O-C-N 127.54 3.025 . . . . 0.0 106.195 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.719 ' N ' ' O ' ' A' ' 147' ' ' SER . 19.3 Cg_exo -62.19 143.66 94.65 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 121.08 1.187 . . . . 0.0 113.651 -175.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.677 ' O ' HG23 ' A' ' 151' ' ' VAL . 8.9 tp -118.69 136.07 57.07 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 175.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.677 HG23 ' O ' ' A' ' 150' ' ' ILE . 89.1 t -169.25 92.59 0.55 Allowed Pre-proline 0 CA--C 1.508 -0.673 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 178.2 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -61.89 136.47 61.79 Favored 'Trans proline' 0 N--CA 1.487 1.105 0 CA-C-N 119.598 0.892 . . . . 0.0 110.086 -177.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.692 ' O ' ' HD2' ' A' ' 154' ' ' ARG . 45.4 mm -67.34 -45.25 86.29 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.526 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.381 178.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.692 ' HD2' ' O ' ' A' ' 153' ' ' ILE . 0.7 OUTLIER -157.71 -156.4 0.58 Allowed 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.422 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 63.1 t-20 -86.93 104.78 16.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.48 0.657 . . . . 0.0 110.971 -178.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.21 7.97 67.08 Favored Glycine 0 C--O 1.224 -0.494 0 CA-C-N 114.077 -1.42 . . . . 0.0 110.015 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.6 mt -123.92 123.66 67.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 175.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.7 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 57.6 m -132.74 151.69 51.92 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -139.84 142.44 36.6 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.333 0.587 . . . . 0.0 111.309 178.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 20.7 tp -131.34 81.19 66.01 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.322 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -69.29 150.01 70.56 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.712 2.274 . . . . 0.0 113.117 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 90.6 mt -119.62 126.72 51.85 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.792 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 55.4 t -124.11 131.6 72.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 117.68 167.8 14.34 Favored Glycine 0 N--CA 1.476 1.326 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.241 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.903 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 56.2 t30 -85.11 115.02 22.67 Favored 'General case' 0 C--O 1.204 -1.305 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.57 HD21 ' CZ ' ' A' ' 171' ' ' PHE . 47.8 tp -75.12 103.42 5.29 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -177.245 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.734 HG23 ' NE ' ' A' ' 170' ' ' ARG . 10.7 p -85.29 167.95 15.15 Favored 'General case' 0 C--O 1.226 -0.14 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.637 178.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.75 -33.59 76.21 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.33 -45.17 89.04 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.149 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.903 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 87.4 mtm180 -63.27 -33.37 75.36 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.219 -0.9 . . . . 0.0 112.267 178.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.57 ' CZ ' HD21 ' A' ' 166' ' ' LEU . 0.4 OUTLIER -54.5 -28.2 43.36 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 119.086 -0.483 . . . . 0.0 111.897 -177.586 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.634 ' O ' HG22 ' A' ' 175' ' ' VAL . 91.5 m-20 -60.97 -39.81 90.99 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 118.866 -1.134 . . . . 0.0 109.842 -177.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 66.9 m -59.4 -40.92 88.14 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 121.787 -0.571 . . . . 0.0 110.484 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 67.0 mt -63.63 -44.01 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 172' ' ' ASN . 33.7 m -62.53 -40.89 89.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -178.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' CYS . . . . . 0.432 ' N ' HG23 ' A' ' 175' ' ' VAL . 96.5 m -62.33 -34.53 76.81 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.312 178.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.569 ' O ' HG13 ' A' ' 181' ' ' ILE . 25.4 m -61.91 -19.59 62.85 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.931 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.636 ' CD2' HD21 ' A' ' 211' ' ' LEU . 84.9 mt -60.87 -41.58 96.23 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -177.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 19.5 m -59.53 -43.43 93.48 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ASN . . . . . 0.622 ' O ' ' OG ' ' A' ' 183' ' ' SER . 92.5 m-20 -61.85 -37.24 83.75 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-O 121.016 0.436 . . . . 0.0 110.719 178.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.569 HG13 ' O ' ' A' ' 177' ' ' THR . 66.0 mt -58.21 -38.68 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 O-C-N 121.296 -0.877 . . . . 0.0 109.437 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.52 HD21 HD21 ' A' ' 214' ' ' LEU . 87.0 mt -60.89 -40.6 93.67 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -177.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.622 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 77.1 p -61.53 -34.02 74.83 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.526 177.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 49.4 p -89.26 25.17 1.96 Allowed 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.634 0.254 . . . . 0.0 111.304 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 78.5 p -63.6 -21.51 66.4 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.846 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -59.76 -36.96 77.71 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.14 -178.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.7 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 98.8 m-20 -72.03 112.97 8.57 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.593 0.711 . . . . 0.0 110.853 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.88 -42.78 99.89 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 114.959 -1.018 . . . . 0.0 112.802 -177.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -113.37 131.61 55.92 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.802 -178.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 38.3 tp -121.08 128.49 52.65 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 96.1 mt -116.39 127.14 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 177.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.3 mm -112.68 126.98 70.14 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' ASP . . . . . 0.497 ' CG ' ' HG ' ' A' ' 195' ' ' SER . 40.1 t0 -95.13 119.56 33.84 Favored 'General case' 0 CA--C 1.56 1.352 0 CA-C-O 119.638 -0.22 . . . . 0.0 110.913 178.105 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 95.8 mt -99.64 -4.03 31.82 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 125.022 1.451 . . . . 0.0 111.06 176.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' SER . . . . . 0.497 ' HG ' ' CG ' ' A' ' 193' ' ' ASP . 78.4 p -63.12 -32.24 73.57 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -62.08 -44.38 97.84 Favored Glycine 0 CA--C 1.544 1.851 0 N-CA-C 108.103 -1.999 . . . . 0.0 108.103 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 1.068 ' CD2' ' O ' ' A' ' 199' ' ' GLN . 6.7 tt -67.37 128.76 37.62 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 112.536 -1.832 . . . . 0.0 109.284 -178.075 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.772 ' N ' HD23 ' A' ' 197' ' ' LEU . . . -60.53 -50.38 73.79 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-O 121.402 0.62 . . . . 0.0 110.476 -178.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 1.068 ' O ' ' CD2' ' A' ' 197' ' ' LEU . 59.1 tt0 -133.55 156.5 47.7 Favored 'General case' 0 C--O 1.209 -1.034 0 CA-C-N 114.445 -1.252 . . . . 0.0 114.328 -175.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.487 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 44.9 t -116.07 131.08 69.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 O-C-N 120.321 -1.487 . . . . 0.0 108.619 178.074 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -84.21 155.74 22.36 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.759 -179.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.59 -39.47 93.79 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.045 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -57.16 -31.98 65.95 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.3 m -61.52 -42.38 98.72 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.546 178.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.454 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -56.39 -39.7 73.39 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -177.098 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -61.19 -37.41 82.84 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.634 -0.427 . . . . 0.0 109.882 -178.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.0 -38.96 92.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.835 177.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.92 -44.63 99.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 C-N-CA 119.469 -0.893 . . . . 0.0 108.734 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' PHE . . . . . 0.454 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 68.9 m-85 -62.35 -43.59 98.46 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.001 -177.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.13 -42.01 98.81 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 118.882 -1.127 . . . . 0.0 109.181 -178.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.636 HD21 ' CD2' ' A' ' 178' ' ' LEU . 41.1 mt -62.11 -41.66 98.44 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 78.3 p -61.28 -42.19 98.22 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 118.936 -1.106 . . . . 0.0 110.351 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' HIS . . . . . 0.455 ' CE1' HD11 ' A' ' 217' ' ' LEU . 59.0 t-80 -63.42 -46.02 88.28 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.76 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.52 HD21 HD21 ' A' ' 182' ' ' LEU . 52.8 tp -62.49 -46.76 87.0 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 88.4 mt -62.02 -40.53 95.99 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.902 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.46 -44.5 95.8 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.292 -178.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.455 HD11 ' CE1' ' A' ' 213' ' ' HIS . 84.0 mt -61.76 -40.18 94.23 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 75.2 p -75.81 -11.66 60.02 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.239 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 83.1 37.05 13.21 Favored Glycine 0 C--N 1.343 0.939 0 C-N-CA 120.723 -0.751 . . . . 0.0 114.027 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 99.8 m -123.2 114.68 20.6 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.046 1.423 . . . . 0.0 112.022 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -65.65 138.08 57.76 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.268 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 42.9 tp -112.37 130.01 56.11 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 3.2 mp -117.61 132.56 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.617 ' CG2' HD11 ' A' ' 227' ' ' ILE . 49.4 mm -115.33 131.43 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 42.6 p -134.01 167.67 20.2 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 78.15 19.14 75.28 Favored Glycine 0 C--O 1.223 -0.537 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.617 HD11 ' CG2' ' A' ' 224' ' ' ILE . 97.4 mt -81.53 128.35 38.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 113.611 -1.294 . . . . 0.0 108.112 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -74.01 140.2 76.97 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.29 -38.92 88.7 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 120.99 1.127 . . . . 0.0 112.627 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -64.83 -38.7 91.86 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 121.351 0.596 . . . . 0.0 109.948 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 51.2 tp -63.64 -42.76 98.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.832 177.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.48 -37.99 89.46 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.73 -178.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 94.1 mtp -63.31 -40.4 97.23 Favored 'General case' 0 C--O 1.247 0.923 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.834 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -64.04 -39.38 93.96 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.755 177.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 33.1 mmt -65.94 -36.63 83.88 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.623 178.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -61.11 -41.48 96.76 Favored 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 121.367 -0.833 . . . . 0.0 109.413 -176.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.71 -40.68 93.14 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.618 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 54.5 tp -63.61 -41.55 98.3 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 176.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -168.18 124.63 1.05 Allowed 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.254 0.55 . . . . 0.0 112.454 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.66 -27.1 66.09 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.764 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -62.49 -26.42 68.52 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.789 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -56.23 -44.21 79.38 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -176.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 99.4 p -61.78 -20.59 63.75 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 123.766 0.666 . . . . 0.0 111.283 179.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 50.1 m -57.11 -33.77 67.68 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 94.7 mt -87.79 121.79 30.65 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 119.458 -0.897 . . . . 0.0 113.261 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -46.03 135.84 7.12 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.712 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.544 HG23 HD12 ' A' ' 227' ' ' ILE . 97.8 m -127.46 132.92 49.95 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.673 179.136 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 248' ' ' TYR . . . . . 0.457 ' CG ' ' HB2' ' A' ' 254' ' ' ALA . 95.1 m-85 -118.13 139.18 51.63 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.12 178.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 78.0 p -60.47 -41.76 94.83 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -178.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -144.46 160.78 40.52 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.824 0.821 . . . . 0.0 111.604 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 72.3 t -63.23 -44.43 99.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 114.586 -1.188 . . . . 0.0 112.25 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.57 -44.54 96.08 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.036 -0.665 . . . . 0.0 109.466 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' ASP . . . . . 0.569 ' O ' HG22 ' A' ' 257' ' ' VAL . 55.6 m-20 -63.83 -42.51 97.62 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.487 -178.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 254' ' ' ALA . . . . . 0.457 ' HB2' ' CG ' ' A' ' 248' ' ' TYR . . . -63.88 -42.8 97.41 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 122.035 0.921 . . . . 0.0 109.791 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 255' ' ' VAL . . . . . 0.456 HG13 HH11 ' B' ' 154' ' ' ARG . 66.3 t -63.6 -45.71 96.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.157 -1.383 . . . . 0.0 111.143 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.84 -47.66 79.88 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.267 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 253' ' ' ASP . 33.3 m -66.48 -40.54 86.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 O-C-N 121.373 -0.829 . . . . 0.0 112.285 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.506 ' C ' ' O ' ' A' ' 257' ' ' VAL . 1.7 mt -28.64 -75.48 0.04 OUTLIER Pre-proline 0 N--CA 1.467 0.375 0 O-C-N 123.17 0.294 . . . . 0.0 111.607 -177.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 259' ' ' PRO . . . . . 0.494 ' CD ' ' CB ' ' A' ' 258' ' ' LEU . 42.7 Cg_endo -63.25 139.3 71.25 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 120.754 0.969 . . . . 0.0 111.943 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 259' ' ' PRO . 96.7 mt -151.74 -27.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 O-C-N 124.049 0.843 . . . . 0.0 111.962 178.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 78.0 mtm . . . . . 0 N--CA 1.475 0.789 0 CA-C-O 118.094 -0.955 . . . . 0.0 110.754 -177.425 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.49 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.13 165.32 36.33 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 79.4 p -66.96 -13.59 61.98 Favored 'General case' 0 CA--C 1.568 1.669 0 O-C-N 121.724 -0.61 . . . . 0.0 112.398 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -80.04 -63.25 1.45 Allowed 'General case' 0 C--N 1.311 -1.108 0 O-C-N 124.532 1.145 . . . . 0.0 109.379 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -67.05 -39.19 86.87 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.445 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 6' ' ' SER . . . . . 0.502 ' O ' ' HB3' ' B' ' 7' ' ' PHE . 66.6 m -59.68 -42.08 92.12 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.782 -177.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 7' ' ' PHE . . . . . 0.502 ' HB3' ' O ' ' B' ' 6' ' ' SER . 36.8 t80 85.85 90.96 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.573 177.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 8' ' ' GLY . . . . . 0.583 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -63.58 -141.85 0.02 OUTLIER Glycine 0 C--N 1.34 0.754 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.583 ' HB ' ' O ' ' B' ' 8' ' ' GLY . 78.5 mt 84.49 111.86 0.03 OUTLIER Pre-proline 0 CA--C 1.545 0.776 0 O-C-N 124.086 0.521 . . . . 0.0 110.796 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.79 -24.31 68.56 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 121.109 1.206 . . . . 0.0 111.783 -178.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.71 -40.43 98.76 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.604 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -64.87 -39.44 93.55 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.557 0.694 . . . . 0.0 109.234 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 50.3 tp -62.05 -42.28 99.02 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.454 -177.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -65.14 -31.15 72.19 Favored 'General case' 0 CA--C 1.562 1.439 0 CA-C-O 121.643 0.735 . . . . 0.0 110.805 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 15' ' ' VAL . . . . . 0.496 HG22 ' CD1' ' A' ' 113' ' ' ILE . 78.3 t -63.81 -46.27 94.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 113.119 -1.855 . . . . 0.0 111.276 177.093 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 95.0 mt -64.24 -43.71 97.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.761 -178.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 17' ' ' LYS . . . . . 0.508 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 98.9 mttt -63.35 -42.64 98.93 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.03 -40.91 99.15 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 119.105 -1.038 . . . . 0.0 109.726 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.32 -39.16 86.04 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.816 -178.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 84.2 mt -64.12 -42.02 97.0 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.383 0.611 . . . . 0.0 110.278 175.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -63.07 -39.08 93.65 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.831 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 53.0 m170 -57.63 -40.16 78.58 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 119.547 -0.263 . . . . 0.0 111.488 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 14.8 p -114.93 130.26 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.494 ' HG3' ' O ' ' B' ' 24' ' ' ARG . 33.2 ptt180 -71.7 109.97 5.95 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.888 0.851 . . . . 0.0 112.343 -177.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.2 p -143.19 133.53 22.16 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.8 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.514 177.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 26' ' ' GLY . . . . . 0.568 ' O ' ' N ' ' B' ' 123' ' ' GLN . . . -87.25 95.32 2.06 Favored Glycine 0 C--N 1.31 -0.87 0 C-N-CA 119.354 -1.403 . . . . 0.0 113.538 -177.092 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 49.7 t -125.54 129.11 72.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 174.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 27.6 m -139.01 156.49 27.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.58 0.229 . . . . 0.0 110.478 178.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 96.1 mt -117.98 126.88 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.61 177.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' B' ' 119' ' ' PHE . 24.1 p -106.65 157.42 17.71 Favored 'General case' 0 CA--C 1.505 -0.786 0 O-C-N 126.003 2.064 . . . . 0.0 108.688 -178.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -124.76 102.47 32.06 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 32' ' ' PRO . . . . . 0.464 ' CG ' HG23 ' B' ' 117' ' ' THR . 37.9 Cg_endo -65.54 -18.3 59.07 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 121.697 1.598 . . . . 0.0 111.473 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.24 -40.26 96.93 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.741 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 90.4 mt -76.47 -170.47 1.52 Allowed 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.823 -0.548 . . . . 0.0 111.234 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 35' ' ' GLU . . . . . 0.653 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 42.4 tt0 -82.04 131.25 35.24 Favored 'General case' 0 C--N 1.342 0.26 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.502 ' O ' ' OD1' ' B' ' 36' ' ' ASP . 66.3 t0 56.22 35.27 25.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.063 177.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 37' ' ' ASN . . . . . 0.444 ' C ' ' O ' ' B' ' 36' ' ' ASP . 28.3 t-20 33.3 70.34 0.81 Allowed Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.653 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 89.2 Cg_endo -72.66 154.19 54.47 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 123.434 2.756 . . . . 0.0 111.994 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 96.1 mt -86.47 128.81 39.17 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.401 HG23 ' N ' ' B' ' 41' ' ' TYR . 29.3 m -109.15 -42.82 5.6 Favored 'Isoleucine or valine' 0 C--N 1.341 0.231 0 O-C-N 123.681 0.613 . . . . 0.0 112.446 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 41' ' ' TYR . . . . . 0.401 ' N ' HG23 ' B' ' 40' ' ' VAL . 49.5 t80 -97.44 123.57 41.34 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.654 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 5.8 p -142.65 140.65 28.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.017 177.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 43' ' ' ASN . . . . . 0.721 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 57.4 p30 -99.98 160.73 14.09 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.289 179.054 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 44' ' ' GLN . . . . . 0.472 ' OE1' ' HA ' ' B' ' 44' ' ' GLN . 13.4 mm100 -62.94 -38.27 90.4 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.418 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.57 -25.63 63.48 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.721 ' HB2' ' OD1' ' B' ' 43' ' ' ASN . 60.5 t80 -60.03 -43.66 95.15 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 0.746 HG13 ' O ' ' B' ' 52' ' ' TYR . 53.7 t -61.07 -46.33 96.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.066 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -63.36 -43.55 97.36 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.244 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 60.8 ttm -63.06 -41.92 99.56 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 41.5 p -96.75 -16.11 21.03 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.729 -178.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 51' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' B' ' 47' ' ' VAL . . . 73.08 19.69 79.7 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 178.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 52' ' ' TYR . . . . . 0.746 ' O ' HG13 ' B' ' 47' ' ' VAL . 74.8 m-85 -111.25 145.1 39.34 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -73.78 147.48 43.41 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.897 0.856 . . . . 0.0 111.061 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 54' ' ' THR . . . . . 0.411 ' H ' HG22 ' B' ' 54' ' ' THR . 0.2 OUTLIER -61.79 -37.57 84.87 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.198 -177.43 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.04 -39.52 94.26 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 124.075 0.859 . . . . 0.0 111.322 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -72.86 -32.42 65.42 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 177.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.613 HD13 ' CE2' ' B' ' 46' ' ' PHE . 93.1 mt -67.32 -69.55 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 178.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 95.6 mt -39.36 132.36 1.48 Allowed 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.368 178.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.85 -7.45 76.88 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.516 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -132.4 149.1 52.41 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -176.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 61' ' ' ASN . . . . . 0.54 ' C ' ' H ' ' B' ' 63' ' ' ARG . 25.5 t-20 -79.17 150.07 31.8 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 114.572 -1.195 . . . . 0.0 110.843 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 62' ' ' CYS . . . . . . . . . . . . . 71.7 m -62.94 9.22 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.674 -178.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 63' ' ' ARG . . . . . 0.54 ' H ' ' C ' ' B' ' 61' ' ' ASN . 34.6 ptt-85 -59.4 -31.2 69.03 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.495 -178.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -61.54 -31.25 71.27 Favored 'General case' 0 C--O 1.239 0.531 0 O-C-N 121.878 -0.514 . . . . 0.0 111.922 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 92.4 mt -61.24 -44.28 97.51 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -178.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -46.59 144.11 2.38 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.424 0.631 . . . . 0.0 109.938 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 67' ' ' GLY . . . . . 0.555 ' N ' ' OG1' ' B' ' 70' ' ' THR . . . -155.39 -152.98 6.36 Favored Glycine 0 CA--C 1.543 1.817 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.656 176.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -60.97 -40.99 95.51 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.447 -0.376 . . . . 0.0 111.172 -175.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -75.6 -9.93 59.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.175 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 70' ' ' THR . . . . . 0.555 ' OG1' ' N ' ' B' ' 67' ' ' GLY . 25.0 m -60.66 133.52 56.18 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -90.55 111.72 49.1 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.453 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.39 -38.38 89.27 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 121.099 1.199 . . . . 0.0 111.882 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.99 -40.9 90.77 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.821 -176.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 74' ' ' GLU . . . . . 0.429 ' OE1' ' HB ' ' B' ' 90' ' ' VAL . 79.2 mm-40 -66.78 -39.35 87.78 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.835 178.237 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 71.0 t -62.59 -45.66 98.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -62.85 -37.28 86.23 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.748 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -62.48 -42.06 99.23 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.938 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.33 -43.79 98.77 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 CA-C-O 120.86 0.362 . . . . 0.0 110.735 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -61.58 -42.67 99.18 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 87.2 m -60.93 -46.58 90.12 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.79 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.86 -41.72 96.44 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -178.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 87.8 mt -62.13 -42.29 99.09 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -62.56 -39.89 95.09 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -80.2 -4.2 52.15 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.105 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 37.5 tttt 50.67 44.77 27.52 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.222 -0.591 . . . . 0.0 112.134 178.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -128.88 145.43 56.39 Favored Pre-proline 0 N--CA 1.467 0.383 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.15 140.1 81.87 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 120.905 1.07 . . . . 0.0 113.642 -178.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -140.12 136.59 37.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.909 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 89' ' ' THR . . . . . 0.941 HG23 ' OD1' ' B' ' 107' ' ' ASN . 97.4 m -122.24 122.68 39.69 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 178.185 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.429 ' HB ' ' OE1' ' B' ' 74' ' ' GLU . 30.7 m -139.4 162.82 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.854 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -113.63 120.82 42.23 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 176.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 20.6 tt -128.43 131.79 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.68 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -70.46 141.6 52.03 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.857 178.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 94' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -133.75 -179.75 5.73 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.261 0.553 . . . . 0.0 111.174 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 95' ' ' TYR . . . . . 0.461 ' CE1' ' HA3' ' B' ' 67' ' ' GLY . 96.3 m-85 -131.11 148.25 52.71 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.485 178.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 96' ' ' LYS . . . . . 0.495 ' HG3' ' CE1' ' B' ' 102' ' ' PHE . 98.7 mttt -104.35 -179.08 3.84 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.052 0.453 . . . . 0.0 110.693 177.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.72 -35.52 76.54 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.493 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 37.0 p-10 -87.37 -0.33 56.61 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.053 0.842 . . . . 0.0 112.954 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.02 3.23 65.8 Favored Glycine 0 N--CA 1.465 0.601 0 C-N-CA 121.152 -0.546 . . . . 0.0 111.892 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 24.7 m -68.16 129.56 40.3 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 101' ' ' MET . . . . . 0.569 ' SD ' ' N ' ' B' ' 102' ' ' PHE . 15.2 tmm? -90.46 142.99 27.18 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 102' ' ' PHE . . . . . 0.569 ' N ' ' SD ' ' B' ' 101' ' ' MET . 53.9 p90 -153.6 163.62 39.67 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 103' ' ' TRP . . . . . 0.851 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 23.6 m95 -95.25 140.19 30.5 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.018 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 104' ' ' ASN . . . . . 0.53 HD21 ' HG2' ' B' ' 123' ' ' GLN . 62.8 t-20 -133.71 105.63 6.93 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -176.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 105' ' ' GLU . . . . . 0.414 ' O ' ' HA ' ' B' ' 123' ' ' GLN . 81.4 tt0 -73.02 126.84 30.91 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.635 1.209 . . . . 0.0 109.02 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 39.4 tp -114.18 125.91 54.47 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 107' ' ' ASN . . . . . 0.941 ' OD1' HG23 ' B' ' 89' ' ' THR . 98.0 m-20 -119.92 127.86 53.08 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 176.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 96.2 mt -123.69 132.83 70.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -144.51 123.12 6.86 Favored Pre-proline 0 CA--C 1.538 0.483 0 O-C-N 123.482 0.488 . . . . 0.0 109.931 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -70.74 152.71 64.45 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 122.366 2.044 . . . . 0.0 112.618 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 111' ' ' MET . . . . . 0.489 ' HB2' ' HB2' ' B' ' 118' ' ' TYR . 66.4 mtt -129.18 144.09 51.09 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.18 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -113.58 111.21 21.5 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 113' ' ' ILE . . . . . 0.579 HG12 ' NZ ' ' A' ' 18' ' ' LYS . 96.8 mt -137.92 127.72 35.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 O-C-N 121.534 -0.729 . . . . 0.0 111.81 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 52.25 38.33 24.43 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 123.997 0.811 . . . . 0.0 109.626 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 61.54 36.15 17.08 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.538 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -133.8 151.66 51.64 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 117' ' ' THR . . . . . 0.464 HG23 ' CG ' ' B' ' 32' ' ' PRO . 8.8 t -102.76 154.08 19.52 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.262 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 118' ' ' TYR . . . . . 0.489 ' HB2' ' HB2' ' B' ' 111' ' ' MET . 96.8 m-85 -148.12 145.34 28.34 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.529 -0.732 . . . . 0.0 110.917 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 119' ' ' PHE . . . . . 0.431 ' O ' ' OG1' ' B' ' 30' ' ' THR . 86.4 m-85 -118.12 138.91 51.95 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.384 0.427 . . . . 0.0 111.347 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.5 p -128.22 136.15 60.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -178.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -112.2 127.88 8.27 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 122' ' ' ILE . . . . . 0.412 ' HB ' ' HB2' ' B' ' 107' ' ' ASN . 95.4 mt -117.63 128.62 74.82 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 123' ' ' GLN . . . . . 0.568 ' N ' ' O ' ' B' ' 26' ' ' GLY . 15.3 mp0 -119.12 121.54 40.02 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -120.31 121.18 38.07 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 125' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' B' ' 126' ' ' ILE . 68.3 t0 -69.12 134.16 48.97 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.083 -177.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.495 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 2.5 mp -107.3 17.16 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.493 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 127' ' ' THR . . . . . 0.461 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 98.2 m -63.36 -45.23 92.15 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 114.138 -1.392 . . . . 0.0 112.647 175.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 59.7 tptt -60.53 -45.6 93.27 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 129' ' ' GLN . . . . . 0.438 ' OE1' HG23 ' B' ' 126' ' ' ILE . 88.5 mt-30 -62.53 -36.57 83.04 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.484 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 130' ' ' LYS . . . . . 0.851 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 98.9 mttt -62.64 -41.7 99.19 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 112.737 -2.028 . . . . 0.0 111.115 174.178 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.5 -42.08 96.06 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 132' ' ' TYR . . . . . 0.762 ' CE2' HD11 ' B' ' 136' ' ' LEU . 88.1 t80 -60.76 -44.95 96.08 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.972 -0.455 . . . . 0.0 111.785 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 133' ' ' GLU . . . . . 0.43 ' O ' ' HG3' ' B' ' 137' ' ' GLU . 97.3 mt-10 -63.8 -36.49 84.06 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 119.932 -0.707 . . . . 0.0 109.367 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 134' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' B' ' 130' ' ' LYS . 98.9 mttt -62.41 -39.62 93.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.801 177.286 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 53.8 tp -62.28 -41.76 98.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.75 0.786 . . . . 0.0 109.451 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 136' ' ' LEU . . . . . 0.762 HD11 ' CE2' ' B' ' 132' ' ' TYR . 87.6 mt -63.02 -41.82 99.65 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.921 177.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 137' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' B' ' 133' ' ' GLU . 97.3 mt-10 -65.27 -36.45 84.13 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.508 -1.678 . . . . 0.0 110.276 -178.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -63.83 -43.79 95.16 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.106 -0.638 . . . . 0.0 109.649 177.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 68.2 m -61.14 -44.1 97.85 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 140' ' ' LEU . . . . . 0.468 ' O ' ' N ' ' B' ' 144' ' ' THR . 86.1 mt -61.74 -40.06 93.77 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -177.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 97.2 m -61.32 -45.58 93.85 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.059 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -66.39 -42.39 87.95 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 93.1 mt -63.52 -43.19 98.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 114.517 -1.219 . . . . 0.0 110.598 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 144' ' ' THR . . . . . 0.468 ' N ' ' O ' ' B' ' 140' ' ' LEU . 92.1 m -61.31 -45.12 95.76 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.13 -40.8 96.95 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 119.299 -0.96 . . . . 0.0 109.332 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 87.1 mt -64.55 -41.17 96.5 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 177.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 147' ' ' SER . . . . . 0.626 ' O ' ' N ' ' B' ' 149' ' ' PRO . 78.4 p -61.91 -40.91 97.08 Favored 'General case' 0 CA--C 1.476 -1.895 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 -178.433 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 148' ' ' THR . . . . . 0.491 ' C ' ' O ' ' B' ' 147' ' ' SER . 7.3 m -28.9 85.16 0.03 OUTLIER Pre-proline 0 C--N 1.353 0.738 0 O-C-N 123.745 0.653 . . . . 0.0 110.351 176.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 149' ' ' PRO . . . . . 0.626 ' N ' ' O ' ' B' ' 147' ' ' SER . 23.4 Cg_exo -61.89 146.71 96.29 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 C-N-CA 122.393 2.062 . . . . 0.0 115.57 -176.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 9.0 tp -126.67 119.81 54.47 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.21 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.036 174.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 59.3 t -151.26 93.41 3.61 Favored Pre-proline 0 C--N 1.295 -1.764 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.809 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -60.23 137.35 74.4 Favored 'Trans proline' 0 N--CA 1.489 1.238 0 CA-C-N 119.852 0.983 . . . . 0.0 109.569 -178.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 153' ' ' ILE . . . . . 0.721 ' O ' ' HD2' ' B' ' 154' ' ' ARG . 45.2 mm -68.7 -43.55 82.98 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.579 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 154' ' ' ARG . . . . . 0.721 ' HD2' ' O ' ' B' ' 153' ' ' ILE . 0.7 OUTLIER -157.16 -154.61 0.47 Allowed 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.449 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 62.0 t-20 -87.32 107.99 18.76 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.1 -18.39 55.73 Favored Glycine 0 CA--C 1.534 1.23 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 157' ' ' ILE . . . . . 0.429 HG22 ' HB ' ' B' ' 153' ' ' ILE . 85.1 mt -108.04 124.45 64.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.287 0.565 . . . . 0.0 111.16 -177.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 158' ' ' SER . . . . . 0.655 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 69.1 m -135.0 148.72 50.04 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.517 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -134.62 146.92 50.03 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 24.4 tp -137.61 80.73 31.29 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 161' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -70.63 147.73 57.9 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.666 2.244 . . . . 0.0 114.077 -178.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 90.5 mt -114.55 133.85 55.48 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 109.074 -0.714 . . . . 0.0 109.074 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 54.6 t -130.51 132.73 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 114.3 168.61 16.25 Favored Glycine 0 N--CA 1.471 0.984 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.512 178.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 165' ' ' ASN . . . . . 0.813 ' O ' ' CZ ' ' B' ' 170' ' ' ARG . 60.5 t30 -89.92 107.16 18.95 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -178.165 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 166' ' ' LEU . . . . . 0.588 HD21 ' CZ ' ' B' ' 171' ' ' PHE . 42.1 tp -65.02 104.73 0.91 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -174.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 167' ' ' THR . . . . . 0.7 HG23 ' NE ' ' B' ' 170' ' ' ARG . 10.0 p -85.38 169.57 13.57 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 113.828 -1.533 . . . . 0.0 110.83 177.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.57 -37.52 85.1 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.307 177.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.63 -39.9 88.49 Favored 'General case' 0 CA--C 1.553 1.09 0 CA-C-O 121.682 0.753 . . . . 0.0 111.798 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 170' ' ' ARG . . . . . 0.813 ' CZ ' ' O ' ' B' ' 165' ' ' ASN . 87.9 mtm180 -63.67 -36.04 82.51 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 113.193 -1.821 . . . . 0.0 110.475 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 171' ' ' PHE . . . . . 0.588 ' CZ ' HD21 ' B' ' 166' ' ' LEU . 0.4 OUTLIER -54.1 -25.55 22.52 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -178.194 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 172' ' ' ASN . . . . . 0.557 ' O ' HG22 ' B' ' 175' ' ' VAL . 92.9 m-20 -62.48 -40.53 96.96 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.672 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 59.7 m -60.12 -41.76 93.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.27 0.557 . . . . 0.0 110.51 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 67.4 mt -63.9 -44.21 97.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -179.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 175' ' ' VAL . . . . . 0.557 HG22 ' O ' ' B' ' 172' ' ' ASN . 29.8 m -62.61 -40.81 89.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -178.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 176' ' ' CYS . . . . . 0.433 ' N ' HG23 ' B' ' 175' ' ' VAL . 98.2 m -62.26 -35.44 78.97 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.291 178.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 177' ' ' THR . . . . . 0.596 ' O ' HG13 ' B' ' 181' ' ' ILE . 25.3 m -61.3 -19.45 61.78 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 178' ' ' LEU . . . . . 0.595 ' CD2' HD21 ' B' ' 211' ' ' LEU . 87.4 mt -60.97 -39.47 89.69 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.479 -178.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 18.2 m -62.03 -44.44 96.7 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.414 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 180' ' ' ASN . . . . . 0.574 ' O ' ' OG ' ' B' ' 183' ' ' SER . 92.1 m-20 -61.97 -40.3 95.12 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.121 0.486 . . . . 0.0 110.435 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.596 HG13 ' O ' ' B' ' 177' ' ' THR . 73.3 mt -56.35 -32.37 35.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 O-C-N 122.074 -0.391 . . . . 0.0 110.74 -178.137 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 182' ' ' LEU . . . . . 0.521 HD21 HD21 ' B' ' 214' ' ' LEU . 86.4 mt -62.66 -41.5 99.1 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.297 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 183' ' ' SER . . . . . 0.574 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.7 p -63.98 -32.91 74.61 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 122.129 -0.357 . . . . 0.0 110.593 177.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 44.6 p -85.88 17.96 3.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.766 0.317 . . . . 0.0 111.684 -178.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 78.6 p -60.59 -16.44 38.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.274 -177.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.82 -40.86 96.76 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.966 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 187' ' ' ASP . . . . . 0.655 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.3 m-20 -67.98 113.32 5.58 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.699 0.761 . . . . 0.0 110.776 -178.221 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.8 -42.39 99.69 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 114.697 -1.138 . . . . 0.0 113.102 -178.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -113.29 130.98 56.11 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.212 -178.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 190' ' ' LEU . . . . . 0.409 ' HA ' ' O ' ' B' ' 158' ' ' SER . 40.5 tp -123.72 118.16 26.59 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.908 178.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 84.2 mt -106.15 125.95 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-O 120.812 0.339 . . . . 0.0 111.303 -178.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 49.7 mm -114.51 117.58 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 193' ' ' ASP . . . . . 0.425 ' OD2' ' OG ' ' B' ' 195' ' ' SER . 41.9 t0 -88.43 114.62 25.23 Favored 'General case' 0 C--O 1.246 0.873 0 CA-C-O 121.65 0.738 . . . . 0.0 111.352 -177.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 194' ' ' LEU . . . . . . . . . . . . . 96.2 mt -97.1 -1.34 45.44 Favored 'General case' 0 C--N 1.356 0.858 0 O-C-N 120.39 -1.444 . . . . 0.0 110.067 176.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 195' ' ' SER . . . . . 0.425 ' OG ' ' OD2' ' B' ' 193' ' ' ASP . 78.4 p -61.19 -36.24 79.33 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 121.169 -0.213 . . . . 0.0 110.803 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.87 -35.42 91.29 Favored Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 197' ' ' LEU . . . . . 1.107 ' CD2' ' O ' ' B' ' 199' ' ' GLN . 7.0 tt -74.75 132.61 41.76 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 121.847 -0.796 . . . . 0.0 109.589 -178.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 198' ' ' ALA . . . . . 0.775 ' N ' HD23 ' B' ' 197' ' ' LEU . . . -61.33 -48.9 79.23 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 119.309 -0.957 . . . . 0.0 110.143 -178.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 199' ' ' GLN . . . . . 1.107 ' O ' ' CD2' ' B' ' 197' ' ' LEU . 57.1 tt0 -135.06 164.62 27.24 Favored 'General case' 0 C--O 1.21 -1.02 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -178.129 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 200' ' ' VAL . . . . . 0.54 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 48.3 t -119.44 130.95 73.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 119.506 -1.996 . . . . 0.0 109.403 177.047 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -87.26 150.84 23.62 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.122 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -61.49 -32.61 72.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.59 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -64.11 -32.78 74.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.2 m -60.89 -43.36 98.61 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.573 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 205' ' ' ALA . . . . . 0.687 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -58.63 -29.53 66.59 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 119.212 -0.423 . . . . 0.0 111.792 -178.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -65.75 -38.74 89.93 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 123.649 0.593 . . . . 0.0 109.68 176.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -66.57 -38.04 86.23 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.752 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 93.5 mt -63.68 -44.36 98.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -178.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 209' ' ' PHE . . . . . 0.687 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 66.9 m-85 -61.35 -43.56 98.66 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.618 179.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.39 -41.54 98.78 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.102 -1.039 . . . . 0.0 109.532 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 211' ' ' LEU . . . . . 0.595 HD21 ' CD2' ' B' ' 178' ' ' LEU . 39.9 mt -62.23 -41.94 98.86 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.316 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 78.3 p -63.3 -35.78 81.51 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 121.686 -0.634 . . . . 0.0 112.159 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 213' ' ' HIS . . . . . 0.43 ' CE1' HD11 ' B' ' 217' ' ' LEU . 58.8 t-80 -67.18 -46.83 72.77 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.839 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.521 HD21 HD21 ' B' ' 182' ' ' LEU . 54.1 tp -64.23 -43.06 96.13 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 122.069 0.938 . . . . 0.0 109.406 178.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.09 -43.74 97.66 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 113.617 -1.629 . . . . 0.0 111.379 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.12 -39.32 92.15 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.005 -177.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 217' ' ' LEU . . . . . 0.43 HD11 ' CE1' ' B' ' 213' ' ' HIS . 85.4 mt -63.7 -42.69 97.95 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.238 0.542 . . . . 0.0 111.51 176.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 218' ' ' THR . . . . . . . . . . . . . 75.9 p -74.11 -16.03 61.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.911 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 79.29 72.56 1.18 Allowed Glycine 0 CA--C 1.528 0.862 0 N-CA-C 106.517 -2.633 . . . . 0.0 106.517 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 220' ' ' THR . . . . . . . . . . . . . 93.2 m -151.85 98.2 2.44 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 177.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -56.13 139.76 46.29 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.204 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 43.1 tp -116.64 120.58 39.1 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.184 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 3.5 mp -109.13 129.23 64.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.241 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 224' ' ' ILE . . . . . 0.568 ' CG2' HD11 ' B' ' 227' ' ' ILE . 49.7 mm -111.7 126.94 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.57 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 44.5 p -134.78 157.77 45.88 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 91.07 17.55 50.57 Favored Glycine 0 CA--C 1.498 -1.027 0 CA-C-N 113.949 -1.478 . . . . 0.0 110.534 -177.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 227' ' ' ILE . . . . . 0.568 HD11 ' CG2' ' B' ' 224' ' ' ILE . 95.7 mt -83.59 125.77 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 O-C-N 121.363 -1.08 . . . . 0.0 111.355 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 56.2 tttt -63.93 139.67 97.7 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.368 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.77 -37.17 92.1 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 121.297 1.331 . . . . 0.0 112.539 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -63.83 -43.32 96.54 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 52.0 tp -61.87 -41.78 98.27 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.913 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.03 -36.51 84.24 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.801 0.334 . . . . 0.0 111.139 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 94.5 mtp -64.47 -40.64 96.07 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.78 -43.93 97.51 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 122.107 0.956 . . . . 0.0 109.004 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 33.5 mmt -63.82 -34.96 79.09 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.989 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -61.81 -40.21 94.44 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.774 -178.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.27 -43.85 96.79 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.156 178.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 52.5 tp -62.92 -44.75 95.24 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 120.137 -0.625 . . . . 0.0 112.039 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -156.51 132.32 9.62 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 120.551 -0.46 . . . . 0.0 112.001 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 240' ' ' ALA . . . . . 0.4 ' O ' ' N ' ' B' ' 242' ' ' PHE . . . -61.93 -47.94 82.66 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 176.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 241' ' ' ASN . . . . . 0.448 ' O ' ' HB2' ' B' ' 244' ' ' SER . 92.7 m-20 -42.69 -18.28 0.01 OUTLIER 'General case' 0 C--O 1.217 -0.615 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.556 -176.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 242' ' ' PHE . . . . . 0.4 ' N ' ' O ' ' B' ' 240' ' ' ALA . 89.1 t80 -60.81 -44.58 96.69 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 119.801 -0.759 . . . . 0.0 109.906 178.028 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 243' ' ' SER . . . . . . . . . . . . . 78.4 p -58.85 -42.42 89.31 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 -178.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 244' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 20.5 m -33.84 -33.04 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 99.1 mt -91.69 130.37 37.5 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 121.458 -0.776 . . . . 0.0 111.889 177.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -57.59 134.76 56.42 Favored 'General case' 0 CA--C 1.502 -0.881 0 O-C-N 121.317 -0.864 . . . . 0.0 111.726 -175.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 247' ' ' THR . . . . . 0.566 HG23 HD12 ' B' ' 227' ' ' ILE . 96.3 m -125.25 127.66 47.08 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.917 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 248' ' ' TYR . . . . . 0.49 ' CG ' ' HB2' ' B' ' 254' ' ' ALA . 97.6 m-85 -112.98 144.26 42.86 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 177.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 249' ' ' SER . . . . . 0.595 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 79.4 p -64.23 -33.46 75.86 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.218 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 250' ' ' ASN . . . . . 0.595 ' OD1' ' O ' ' B' ' 249' ' ' SER . 98.8 m-20 -147.94 159.61 43.69 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 124.509 1.13 . . . . 0.0 111.937 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 77.7 t -64.34 -44.15 97.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.443 -0.798 . . . . 0.0 112.293 178.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 252' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -60.78 -46.15 91.61 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -177.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 253' ' ' ASP . . . . . 0.594 ' O ' HG22 ' B' ' 257' ' ' VAL . 94.3 m-20 -61.37 -43.05 99.53 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.924 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 254' ' ' ALA . . . . . 0.49 ' HB2' ' CG ' ' B' ' 248' ' ' TYR . . . -65.85 -40.25 91.54 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.913 178.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 255' ' ' VAL . . . . . 0.617 HG13 HH11 ' A' ' 154' ' ' ARG . 67.3 t -65.14 -45.71 93.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.043 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.56 -48.55 78.98 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 120.204 -0.598 . . . . 0.0 111.614 -178.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 257' ' ' VAL . . . . . 0.594 HG22 ' O ' ' B' ' 253' ' ' ASP . 32.6 m -65.22 -40.63 89.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.678 -1.146 . . . . 0.0 111.302 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 258' ' ' LEU . . . . . 0.523 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 1.6 mt -32.25 -73.76 0.05 OUTLIER Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.589 -177.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 259' ' ' PRO . . . . . 0.523 ' CD ' ' CB ' ' B' ' 258' ' ' LEU . 36.3 Cg_endo -61.76 140.76 87.62 Favored 'Trans proline' 0 N--CA 1.505 2.155 0 C-N-CA 121.49 1.46 . . . . 0.0 111.133 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 260' ' ' ILE . . . . . 0.56 HG22 ' O ' ' B' ' 260' ' ' ILE . 96.7 mt -159.11 -13.82 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 O-C-N 121.33 -0.856 . . . . 0.0 112.204 177.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 C--O 1.216 -0.71 0 CA-C-O 117.792 -1.099 . . . . 0.0 111.353 -179.381 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.026 -1.629 . . . . 0.0 109.026 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.413 ' O ' ' OG ' ' A' ' 6' ' ' SER . . . -152.2 165.07 35.99 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.373 0.606 . . . . 0.0 110.201 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 80.8 p -70.53 -18.28 62.94 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.084 -1.01 . . . . 0.0 112.112 177.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -71.75 -65.07 0.81 Allowed 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 114.18 -1.373 . . . . 0.0 112.574 174.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -68.1 -37.77 81.55 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.99 0.424 . . . . 0.0 112.089 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.518 ' O ' ' HB3' ' A' ' 7' ' ' PHE . 70.9 m -59.44 -42.17 91.31 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -177.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.518 ' HB3' ' O ' ' A' ' 6' ' ' SER . 42.5 t80 83.95 86.93 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.134 0.493 . . . . 0.0 111.865 176.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.603 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -62.49 -142.92 0.01 OUTLIER Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 -178.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.603 ' HB ' ' O ' ' A' ' 8' ' ' GLY . 74.5 mt 85.64 110.27 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 122.701 0.4 . . . . 0.0 110.538 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.7 -22.35 69.82 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 121.389 1.393 . . . . 0.0 112.175 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.417 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -63.83 -38.22 95.82 Favored Glycine 0 N--CA 1.467 0.706 0 C-N-CA 121.138 -0.553 . . . . 0.0 111.919 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -65.18 -39.27 92.66 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.41 0.624 . . . . 0.0 109.614 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.2 tp -63.44 -41.15 98.67 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -63.73 -40.31 96.44 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 11' ' ' GLY . 56.3 t -60.31 -44.36 95.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 O-C-N 122.199 -0.313 . . . . 0.0 110.892 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 92.2 mt -62.78 -43.61 98.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.407 -178.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.27 -46.04 90.58 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 119.491 -0.883 . . . . 0.0 112.119 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.503 ' HZ1' HG12 ' B' ' 113' ' ' ILE . 98.4 mttt -60.39 -39.86 88.83 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 118.51 -1.276 . . . . 0.0 109.187 -176.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.84 -42.1 92.83 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.286 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 20' ' ' LEU . 87.8 mt -62.83 -40.95 99.0 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 178.05 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -63.92 -37.65 88.19 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.505 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 60.0 m170 -58.55 -40.15 82.2 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 122.221 -0.299 . . . . 0.0 111.417 -178.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.3 p -114.4 130.01 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.517 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 36.2 ptt180 -71.85 110.46 6.38 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-O 122.016 0.912 . . . . 0.0 112.229 -177.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.9 p -141.31 144.13 26.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 123' ' ' GLN . . . -97.55 90.99 1.14 Allowed Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.786 -178.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 51.4 t -124.23 129.26 74.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 176.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.7 m -137.49 159.78 34.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.7 mt -121.71 130.36 74.67 Favored 'Isoleucine or valine' 0 C--O 1.245 0.868 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 177.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.4 p -106.35 167.85 9.55 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.448 ' C ' ' OD1' ' A' ' 37' ' ' ASN . 44.0 t0 -134.5 102.42 11.62 Favored Pre-proline 0 C--N 1.32 -0.716 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.389 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.478 ' HG3' HG23 ' A' ' 117' ' ' THR . 36.4 Cg_endo -63.17 -23.08 73.07 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 121.453 1.436 . . . . 0.0 111.503 -178.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.97 -35.88 81.63 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.66 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.413 ' HB2' ' HD2' ' A' ' 38' ' ' PRO . 95.2 mt -84.31 157.35 21.54 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.498 177.163 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.71 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 43.3 tt0 -58.37 136.01 57.33 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -176.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.566 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 62.4 t0 60.29 22.8 12.25 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.448 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 42.4 t-20 38.16 70.06 1.35 Allowed Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.244 -176.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.71 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 92.7 Cg_endo -71.13 156.3 59.8 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 123.948 3.099 . . . . 0.0 112.121 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.6 mt -88.1 125.22 41.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.439 HG23 ' N ' ' A' ' 41' ' ' TYR . 33.9 m -104.8 -42.59 7.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.025 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.439 ' N ' HG23 ' A' ' 40' ' ' VAL . 48.9 t80 -97.68 123.76 41.73 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.809 -177.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.9 p -143.06 140.85 26.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 124.303 1.002 . . . . 0.0 109.215 177.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.599 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 57.3 p30 -98.41 166.99 11.11 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.517 ' HA ' ' OE1' ' A' ' 44' ' ' GLN . 13.2 mm100 -66.4 -38.81 88.33 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 120.988 0.423 . . . . 0.0 111.933 177.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.27 -26.86 64.47 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.659 ' CD2' HD13 ' A' ' 57' ' ' ILE . 66.3 t80 -59.03 -48.43 81.63 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.603 HG13 ' O ' ' A' ' 52' ' ' TYR . 61.3 t -59.41 -45.09 93.82 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 O-C-N 121.312 -0.868 . . . . 0.0 111.573 -174.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -63.64 -37.73 88.44 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 120.412 -0.515 . . . . 0.0 112.383 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 60.4 ttm -66.65 -43.01 85.76 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 114.258 1.206 . . . . 0.0 114.258 176.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 34.9 p -93.75 -20.4 20.15 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.272 0.558 . . . . 0.0 111.453 -177.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.28 21.6 72.75 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.603 ' O ' HG13 ' A' ' 47' ' ' VAL . 81.1 m-85 -115.9 138.21 51.38 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 122.909 0.484 . . . . 0.0 111.213 179.056 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -63.65 148.24 49.51 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.662 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.451 HG22 ' H ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -65.57 -32.36 73.9 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -66.21 -45.01 82.25 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 119.351 -0.94 . . . . 0.0 111.359 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -63.47 -45.44 90.8 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 119.939 -0.704 . . . . 0.0 109.749 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.659 HD13 ' CD2' ' A' ' 46' ' ' PHE . 90.6 mt -62.1 -48.99 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -175.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 79.0 mt -57.11 146.04 29.01 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 176.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.96 -3.91 82.27 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.875 -0.679 . . . . 0.0 113.121 177.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -137.47 151.7 48.75 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.879 1.34 . . . . 0.0 111.9 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.556 ' C ' ' H ' ' A' ' 63' ' ' ARG . 25.6 t-20 -81.23 151.92 27.91 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.701 -178.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 83.6 m -63.67 16.44 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.276 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.556 ' H ' ' C ' ' A' ' 61' ' ' ASN . 36.4 ptt-85 -62.47 -40.81 97.85 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 122.054 -0.404 . . . . 0.0 111.282 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -56.03 -21.53 22.12 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 84.0 mt -68.22 -35.24 77.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 122.003 0.906 . . . . 0.0 113.011 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -65.12 143.05 58.14 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.904 -1.044 . . . . 0.0 112.238 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.534 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -154.2 -147.57 4.7 Favored Glycine 0 CA--C 1.538 1.484 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 -177.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -63.21 -41.1 99.1 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -177.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.596 ' O ' ' NE2' ' A' ' 93' ' ' GLN . 7.7 m80 -77.1 -8.56 57.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.955 0.407 . . . . 0.0 111.086 -177.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.534 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 26.6 m -63.04 130.28 44.01 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.657 -178.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -85.4 109.55 22.4 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.8 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 70' ' ' THR . 50.9 Cg_exo -56.92 -32.08 91.44 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.023 1.815 . . . . 0.0 113.19 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.59 -39.64 94.1 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.975 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.485 ' OE1' ' HB ' ' A' ' 90' ' ' VAL . 78.9 mm-40 -65.84 -43.54 88.21 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.8 t -59.45 -43.83 91.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -176.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -63.88 -37.97 89.35 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.027 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -63.63 -39.67 94.95 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.243 0.544 . . . . 0.0 110.156 178.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.77 -44.47 98.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.154 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -63.01 -42.71 99.9 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 113.831 -1.531 . . . . 0.0 108.36 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 96.4 m -61.64 -48.85 78.99 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.04 -41.69 92.83 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.185 -172.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 83.0 mt -63.0 -39.55 95.11 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.025 -1.047 . . . . 0.0 111.319 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -64.17 -32.59 74.22 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 177.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -90.22 0.59 57.13 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.302 -178.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.2 tttt 45.46 35.94 2.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.55 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -119.13 143.8 34.79 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -61.39 143.39 97.66 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.62 1.546 . . . . 0.0 113.674 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -140.12 143.25 30.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.697 -177.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.897 HG23 ' OD1' ' A' ' 107' ' ' ASN . 99.9 m -128.46 120.59 27.14 Favored 'General case' 0 C--N 1.345 0.394 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 176.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.485 ' HB ' ' OE1' ' A' ' 74' ' ' GLU . 27.8 m -138.75 157.61 29.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.73 -0.214 . . . . 0.0 111.461 177.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -101.93 133.76 46.21 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 177.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.428 ' O ' HG23 ' A' ' 92' ' ' ILE . 19.0 tt -141.18 131.9 27.06 Favored 'Isoleucine or valine' 0 C--N 1.378 1.833 0 CA-C-N 121.61 2.005 . . . . 0.0 112.417 176.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.596 ' NE2' ' O ' ' A' ' 69' ' ' HIS . 34.4 mt-30 -64.6 133.74 52.9 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.884 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -134.85 158.57 43.87 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.8 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -116.5 134.7 54.54 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.514 ' HG3' ' CE1' ' A' ' 102' ' ' PHE . 99.1 mttt -83.7 -171.76 3.77 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.184 0.516 . . . . 0.0 111.76 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.46 -43.48 98.71 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.941 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.41 ' CG ' ' HG1' ' A' ' 100' ' ' THR . 42.5 p-10 -84.31 7.17 20.22 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.08 -0.4 87.5 Favored Glycine 0 N--CA 1.471 0.97 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.185 176.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.41 ' HG1' ' CG ' ' A' ' 98' ' ' ASP . 23.5 m -58.93 139.15 56.99 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 178.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.622 ' SD ' ' C ' ' A' ' 101' ' ' MET . 13.8 tmm? -105.06 127.28 52.81 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.593 0.235 . . . . 0.0 110.506 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.514 ' CE1' ' HG3' ' A' ' 96' ' ' LYS . 52.7 p90 -141.68 156.12 45.65 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.958 -177.151 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.721 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 24.4 m95 -88.66 143.98 26.58 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.547 HD21 ' HG2' ' A' ' 123' ' ' GLN . 56.4 t-20 -138.1 100.82 4.25 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -177.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.408 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 80.6 tt0 -66.32 136.57 56.0 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -177.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 40.3 tp -122.23 122.94 40.31 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.897 ' OD1' HG23 ' A' ' 89' ' ' THR . 97.8 m-20 -118.67 122.61 42.93 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.71 177.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 96.4 mt -120.31 128.64 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 O-C-N 123.535 0.522 . . . . 0.0 111.635 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -139.85 123.03 10.42 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 116.714 -0.221 . . . . 0.0 110.933 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -70.98 152.13 62.75 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 122.451 2.101 . . . . 0.0 112.368 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.661 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 66.8 mtt -122.82 154.32 38.38 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -128.74 94.12 3.78 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 176.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.462 ' CD1' HG22 ' B' ' 15' ' ' VAL . 96.1 mt -118.51 130.78 72.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.19 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 52.5 38.51 25.76 Favored 'General case' 0 CA--C 1.512 -0.501 0 O-C-N 121.414 -0.804 . . . . 0.0 111.774 176.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 58.27 30.22 19.18 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 123.844 0.715 . . . . 0.0 110.833 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -128.2 149.09 50.6 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.173 -0.676 . . . . 0.0 109.173 177.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.756 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 5.2 t -86.1 -172.25 3.98 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 118.538 0.608 . . . . 0.0 109.514 -177.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.756 ' CD2' ' O ' ' A' ' 117' ' ' THR . 65.1 m-85 -171.69 156.26 4.26 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 175.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -131.34 146.49 52.31 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 174.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -134.94 135.18 53.17 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 177.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.75 129.2 9.42 Favored Glycine 0 CA--C 1.499 -0.908 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 178.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 96.6 mt -118.41 129.57 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.547 ' HG2' HD21 ' A' ' 104' ' ' ASN . 13.9 mp0 -121.05 113.3 19.85 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.641 0.588 . . . . 0.0 109.609 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -113.57 112.79 24.12 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.959 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -62.39 128.22 35.01 Favored 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -175.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.478 ' O ' HG22 ' A' ' 126' ' ' ILE . 3.0 mt -93.53 2.29 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 113.511 -1.677 . . . . 0.0 110.199 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 20.1 m -60.56 -42.38 96.49 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.979 -1.076 . . . . 0.0 113.671 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -59.96 -42.34 93.87 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -178.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -63.01 -39.56 95.12 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.927 177.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.721 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.7 mttt -62.85 -40.79 98.54 Favored 'General case' 0 CA--C 1.502 -0.877 0 C-N-CA 118.292 -1.363 . . . . 0.0 110.621 -178.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.69 -37.93 85.92 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -178.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.672 ' CE2' HD11 ' A' ' 136' ' ' LEU . 90.7 t80 -61.67 -45.96 91.76 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.668 175.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.23 -38.93 92.81 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 120.167 -0.613 . . . . 0.0 109.539 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.07 -40.21 95.02 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 52.7 tp -60.65 -43.86 97.1 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -176.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.672 HD11 ' CE2' ' A' ' 132' ' ' TYR . 84.9 mt -62.26 -40.87 97.63 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -61.84 -41.73 98.16 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 119.398 -0.921 . . . . 0.0 109.852 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -60.81 -41.96 96.7 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -177.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.0 m -61.94 -41.14 97.63 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.877 176.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 144' ' ' THR . 87.9 mt -63.49 -41.8 98.56 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.431 -0.508 . . . . 0.0 109.884 178.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 79.9 m -61.72 -45.59 93.3 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.271 -177.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -65.3 -39.67 92.83 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 94.7 mt -64.44 -43.57 96.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 113.991 -1.458 . . . . 0.0 111.365 176.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.454 ' N ' ' O ' ' A' ' 140' ' ' LEU . 99.3 m -62.49 -46.3 89.11 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.396 -0.522 . . . . 0.0 112.25 -178.264 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.45 -40.07 95.43 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 118.875 -1.13 . . . . 0.0 109.117 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 90.1 mt -63.61 -42.8 98.19 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.689 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.1 p -60.57 -37.17 80.43 Favored 'General case' 0 C--O 1.218 -0.564 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -178.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.453 ' C ' ' O ' ' A' ' 147' ' ' SER . 27.5 m -30.06 82.82 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.41 0 O-C-N 127.003 2.689 . . . . 0.0 106.123 -176.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.689 ' N ' ' O ' ' A' ' 147' ' ' SER . 21.8 Cg_exo -62.29 144.62 95.56 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 CA-C-O 122.749 1.062 . . . . 0.0 114.432 -174.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.649 ' O ' HG23 ' A' ' 151' ' ' VAL . 8.9 tp -121.26 135.33 61.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 102.575 -3.12 . . . . 0.0 102.575 176.208 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 150' ' ' ILE . 65.5 t -169.74 94.35 0.51 Allowed Pre-proline 0 CA--C 1.507 -0.703 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 176.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -62.56 137.71 65.94 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 N-CA-C 109.843 -0.868 . . . . 0.0 109.843 -178.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.659 ' O ' ' HD2' ' A' ' 154' ' ' ARG . 45.5 mm -68.28 -44.57 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 119.991 -0.683 . . . . 0.0 110.151 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.659 ' HD2' ' O ' ' A' ' 153' ' ' ILE . 0.7 OUTLIER -156.76 -157.55 0.7 Allowed 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -86.74 104.91 16.57 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.559 0.695 . . . . 0.0 111.521 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.65 8.65 65.39 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 114.069 -1.423 . . . . 0.0 110.063 -177.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.463 HG12 ' HB2' ' A' ' 189' ' ' TYR . 96.5 mt -125.96 124.17 65.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 175.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.651 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 42.2 m -131.95 152.14 51.28 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -137.52 140.66 41.24 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.494 177.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 19.9 tp -131.21 78.49 72.49 Favored Pre-proline 0 N--CA 1.469 0.512 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.358 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -69.83 150.57 67.98 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.719 2.279 . . . . 0.0 113.033 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 92.3 mt -119.36 126.27 51.01 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.241 178.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 49.0 t -122.37 130.74 74.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 117.24 169.12 14.88 Favored Glycine 0 N--CA 1.48 1.619 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.3 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.876 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 53.6 t30 -86.19 114.7 23.23 Favored 'General case' 0 C--O 1.214 -0.803 0 CA-C-N 116.972 0.386 . . . . 0.0 110.109 -178.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.588 HD21 ' CZ ' ' A' ' 171' ' ' PHE . 47.1 tp -74.31 105.29 5.41 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -177.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.65 HG23 ' NE ' ' A' ' 170' ' ' ARG . 11.4 p -87.8 167.41 13.83 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.146 0.498 . . . . 0.0 110.489 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.88 -33.96 77.26 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.92 0.39 . . . . 0.0 111.862 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.58 -42.72 95.42 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.484 178.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.876 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 87.3 mtm180 -64.93 -33.65 76.52 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 124.169 0.988 . . . . 0.0 112.884 178.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.588 ' CZ ' HD21 ' A' ' 166' ' ' LEU . 0.4 OUTLIER -54.73 -28.32 47.29 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 118.913 -0.565 . . . . 0.0 112.39 -178.128 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.634 ' O ' HG22 ' A' ' 175' ' ' VAL . 90.2 m-20 -61.07 -40.69 94.64 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 118.892 -1.123 . . . . 0.0 109.939 -178.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 70.2 m -59.15 -41.41 88.25 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.71 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 67.3 mt -63.67 -44.01 98.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 172' ' ' ASN . 33.9 m -62.56 -40.63 89.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' CYS . . . . . 0.436 ' N ' HG23 ' A' ' 175' ' ' VAL . 97.7 m -62.27 -34.2 76.1 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.131 0.491 . . . . 0.0 110.435 177.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.501 ' O ' HG13 ' A' ' 181' ' ' ILE . 25.1 m -61.96 -19.74 63.09 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.026 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.624 ' CD2' HD21 ' A' ' 211' ' ' LEU . 85.6 mt -61.04 -40.89 95.32 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -177.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 18.9 m -59.11 -43.28 91.88 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ASN . . . . . 0.586 ' O ' ' OG ' ' A' ' 183' ' ' SER . 90.8 m-20 -61.92 -37.6 85.29 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 120.773 0.32 . . . . 0.0 110.829 178.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 177' ' ' THR . 70.3 mt -56.77 -37.17 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 121.515 -0.741 . . . . 0.0 109.765 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.509 HD21 HD21 ' A' ' 214' ' ' LEU . 85.9 mt -61.28 -40.74 95.26 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -177.132 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.586 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 78.1 p -62.22 -35.38 78.71 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.406 177.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 39.2 p -88.63 25.11 1.8 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.65 0.262 . . . . 0.0 111.456 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 78.1 p -65.36 -20.01 66.2 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.732 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.37 -37.46 80.8 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.986 -178.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.651 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 99.0 m-20 -72.73 114.26 10.68 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.489 0.662 . . . . 0.0 110.924 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.13 -42.05 99.42 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.926 -177.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' TYR . . . . . 0.463 ' HB2' HG12 ' A' ' 157' ' ' ILE . 97.1 m-85 -112.02 131.23 55.54 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.873 -178.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 38.0 tp -121.14 128.37 52.46 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 96.7 mt -117.33 128.4 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.9 mm -114.22 128.33 71.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' ASP . . . . . 0.524 ' CG ' ' HG ' ' A' ' 195' ' ' SER . 40.1 t0 -96.09 119.54 34.77 Favored 'General case' 0 CA--C 1.552 1.037 0 O-C-N 121.873 -0.517 . . . . 0.0 110.474 177.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 99.0 mt -98.38 -4.56 34.55 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.593 175.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' SER . . . . . 0.524 ' HG ' ' CG ' ' A' ' 193' ' ' ASP . 78.1 p -62.35 -33.46 74.76 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -62.42 -44.09 98.12 Favored Glycine 0 CA--C 1.534 1.243 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.938 HD23 ' N ' ' A' ' 198' ' ' ALA . 4.8 tt -68.96 128.51 36.96 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 112.788 -1.706 . . . . 0.0 108.495 -177.026 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.938 ' N ' HD23 ' A' ' 197' ' ' LEU . . . -59.68 -48.96 79.62 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 121.196 0.522 . . . . 0.0 110.703 -177.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.906 ' O ' ' CD2' ' A' ' 197' ' ' LEU . 57.9 tt0 -136.22 158.51 44.23 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 114.444 -1.253 . . . . 0.0 113.506 -173.174 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.47 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 46.9 t -118.72 132.28 69.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -89.53 156.79 18.39 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.296 -178.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.27 -39.94 94.97 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.104 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -57.59 -32.62 67.37 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.9 m -61.64 -42.24 98.62 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.609 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.448 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -57.5 -39.03 75.59 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -176.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -61.06 -36.35 79.38 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -64.81 -39.08 93.01 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.998 177.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 95.3 mt -63.29 -44.49 99.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -178.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' PHE . . . . . 0.448 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 75.1 m-85 -62.32 -43.36 98.99 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.6 -177.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.52 -41.93 99.18 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 119.07 -1.052 . . . . 0.0 109.105 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.624 HD21 ' CD2' ' A' ' 178' ' ' LEU . 38.3 mt -62.25 -41.5 98.5 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 78.2 p -61.36 -42.25 98.39 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.084 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 54.7 t60 -64.55 -45.66 86.14 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 120.626 -0.43 . . . . 0.0 111.372 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.509 HD21 HD21 ' A' ' 182' ' ' LEU . 47.8 tp -62.5 -45.76 91.51 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 118.909 -1.116 . . . . 0.0 108.379 179.019 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 211' ' ' LEU . 90.4 mt -62.74 -40.76 98.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.141 -177.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.62 -44.54 96.22 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.751 -178.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 84.5 mt -61.91 -39.88 93.54 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 66.8 p -74.95 -11.65 60.17 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.508 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.32 36.32 17.84 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 120.6 -0.809 . . . . 0.0 113.715 -178.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 97.0 m -123.21 117.29 24.98 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 119.174 1.487 . . . . 0.0 111.708 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -68.21 137.2 54.62 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.42 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 43.6 tp -111.81 130.86 55.67 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 2.8 mp -117.83 134.29 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.616 ' CG2' HD11 ' A' ' 227' ' ' ILE . 49.5 mm -115.67 131.31 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -178.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 44.2 p -134.3 165.57 24.81 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.916 -177.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 78.66 21.78 68.31 Favored Glycine 0 N--CA 1.464 0.528 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.677 HD12 HG23 ' A' ' 247' ' ' THR . 97.7 mt -83.83 128.22 39.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 113.87 -1.165 . . . . 0.0 108.291 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -77.4 141.07 65.44 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.33 -39.77 85.63 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 120.984 1.122 . . . . 0.0 112.629 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -63.04 -39.71 95.56 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.356 0.598 . . . . 0.0 110.16 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 52.4 tp -63.67 -42.64 98.02 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.904 177.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.45 -37.8 88.79 Favored 'General case' 0 CA--C 1.522 -0.109 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.991 -178.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 94.0 mtp -63.22 -41.3 99.11 Favored 'General case' 0 C--O 1.248 0.989 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.917 -178.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.96 -38.45 91.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.519 176.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 31.9 mmt -65.79 -37.61 86.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.576 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -61.11 -42.33 98.32 Favored 'General case' 0 CA--C 1.516 -0.33 0 O-C-N 121.55 -0.719 . . . . 0.0 109.401 -176.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.66 -41.59 95.34 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.524 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 54.5 tp -63.3 -41.5 98.96 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 177.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -167.58 124.26 1.14 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.299 0.571 . . . . 0.0 112.507 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.36 -26.6 65.21 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.55 -1.205 . . . . 0.0 110.625 178.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -62.37 -28.93 70.11 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.729 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -56.69 -44.51 81.56 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -176.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 95.2 p -60.93 -20.07 61.63 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 123.8 0.688 . . . . 0.0 111.15 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 31.1 m -55.79 -40.21 72.35 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 97.1 mt -81.4 122.44 27.49 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -43.1 133.51 3.83 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.028 177.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.677 HG23 HD12 ' A' ' 227' ' ' ILE . 93.8 m -127.48 133.83 49.86 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.89 177.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 248' ' ' TYR . . . . . 0.407 ' CG ' ' HB2' ' A' ' 254' ' ' ALA . 97.7 m-85 -119.02 139.65 51.35 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.173 179.204 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 78.0 p -61.86 -42.63 99.29 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -178.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -141.83 158.73 43.44 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.776 0.798 . . . . 0.0 111.641 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 63.3 t -62.39 -44.69 99.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 114.668 -1.151 . . . . 0.0 112.22 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.82 -44.18 97.25 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.207 -0.597 . . . . 0.0 109.434 -178.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 253' ' ' ASP . . . . . 0.573 ' O ' HG22 ' A' ' 257' ' ' VAL . 55.3 m-20 -63.87 -41.02 97.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.375 -178.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 254' ' ' ALA . . . . . 0.407 ' HB2' ' CG ' ' A' ' 248' ' ' TYR . . . -64.2 -44.64 91.34 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.895 0.855 . . . . 0.0 109.832 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 255' ' ' VAL . . . . . 0.427 ' O ' ' HD2' ' A' ' 259' ' ' PRO . 76.6 t -63.18 -45.84 97.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 113.944 -1.48 . . . . 0.0 110.912 -178.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.33 -46.55 86.1 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.141 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.573 HG22 ' O ' ' A' ' 253' ' ' ASP . 32.1 m -68.11 -40.72 83.43 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 O-C-N 121.489 -0.757 . . . . 0.0 111.923 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.498 ' C ' ' O ' ' A' ' 257' ' ' VAL . 1.5 mt -29.49 -74.46 0.04 OUTLIER Pre-proline 0 C--O 1.234 0.237 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.538 -177.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 259' ' ' PRO . . . . . 0.491 ' O ' HG13 ' A' ' 260' ' ' ILE . 43.6 Cg_endo -63.57 140.34 74.79 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 120.778 0.986 . . . . 0.0 111.96 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.491 HG13 ' O ' ' A' ' 259' ' ' PRO . 96.6 mt -153.15 -29.5 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 123.914 0.759 . . . . 0.0 111.883 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 78.0 mtm . . . . . 0 N--CA 1.474 0.751 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.567 -176.831 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.434 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.11 155.45 34.05 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 81.0 p -57.98 -27.58 63.59 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.784 176.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -65.54 -63.58 1.06 Allowed 'General case' 0 N--CA 1.437 -1.114 0 CA-C-O 121.004 0.43 . . . . 0.0 111.7 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -66.72 -38.06 85.94 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.323 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 6' ' ' SER . . . . . 0.523 ' O ' ' HB3' ' B' ' 7' ' ' PHE . 69.4 m -59.8 -42.53 93.63 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.877 -177.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 7' ' ' PHE . . . . . 0.523 ' HB3' ' O ' ' B' ' 6' ' ' SER . 43.7 t80 84.83 90.85 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.387 177.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 8' ' ' GLY . . . . . 0.606 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -65.45 -142.6 0.04 OUTLIER Glycine 0 C--N 1.339 0.703 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.606 ' HB ' ' O ' ' B' ' 8' ' ' GLY . 74.1 mt 85.33 110.49 0.03 OUTLIER Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 122.634 0.374 . . . . 0.0 110.88 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -62.9 -24.42 74.24 Favored 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 121.314 1.343 . . . . 0.0 111.864 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.14 -40.75 98.98 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -64.21 -39.84 94.82 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.676 0.75 . . . . 0.0 109.292 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 49.2 tp -61.9 -42.38 99.01 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.419 -177.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -65.24 -32.82 74.68 Favored 'General case' 0 CA--C 1.562 1.413 0 CA-C-O 121.489 0.661 . . . . 0.0 110.624 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 15' ' ' VAL . . . . . 0.462 HG22 ' CD1' ' A' ' 113' ' ' ILE . 72.7 t -62.24 -46.48 96.34 Favored 'Isoleucine or valine' 0 C--O 1.244 0.774 0 CA-C-N 113.189 -1.823 . . . . 0.0 110.851 177.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 93.1 mt -64.08 -43.76 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.069 -178.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 17' ' ' LYS . . . . . 0.45 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 99.0 mttt -63.46 -42.07 98.63 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.52 -41.43 98.5 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 118.838 -1.145 . . . . 0.0 110.142 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.52 -39.01 86.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.891 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' B' ' 20' ' ' LEU . 87.9 mt -63.9 -42.25 97.48 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.369 0.604 . . . . 0.0 110.345 175.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -63.15 -38.47 91.28 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.019 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 57.7 m170 -57.43 -40.27 78.0 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 119.54 -0.267 . . . . 0.0 111.467 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 10.0 p -114.45 129.72 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.534 ' HG3' ' O ' ' B' ' 24' ' ' ARG . 36.0 ptt180 -71.43 108.59 4.93 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.736 0.779 . . . . 0.0 112.538 -177.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.9 p -143.11 134.16 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.857 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.602 177.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 26' ' ' GLY . . . . . 0.445 ' HA3' ' HB2' ' B' ' 123' ' ' GLN . . . -86.5 95.89 2.09 Favored Glycine 0 C--N 1.313 -0.742 0 C-N-CA 119.555 -1.307 . . . . 0.0 113.393 -177.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 47.0 t -125.34 128.62 72.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 174.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 34.6 m -139.09 157.23 28.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.48 178.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 96.1 mt -120.54 128.58 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 O-C-N 123.721 0.638 . . . . 0.0 111.787 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 23.2 p -108.69 157.24 18.72 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-N 112.819 -1.991 . . . . 0.0 108.602 -176.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.435 ' C ' ' OD1' ' B' ' 37' ' ' ASN . 43.3 t0 -125.46 102.97 29.2 Favored Pre-proline 0 CA--C 1.531 0.222 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -178.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 32' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 117' ' ' THR . 37.0 Cg_endo -64.14 -22.12 67.51 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 121.694 1.596 . . . . 0.0 111.431 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.84 -45.69 93.52 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.229 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 98.7 mt -70.64 176.88 3.82 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.786 -0.571 . . . . 0.0 111.404 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 35' ' ' GLU . . . . . 0.549 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 42.1 tt0 -78.23 131.37 37.1 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -175.213 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.516 ' O ' ' OD1' ' B' ' 36' ' ' ASP . 66.7 t0 58.2 36.91 26.12 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.582 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 37' ' ' ASN . . . . . 0.467 ' C ' ' O ' ' B' ' 36' ' ' ASP . 32.7 t-20 28.09 73.1 0.41 Allowed Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.006 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.549 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 91.9 Cg_endo -72.98 155.33 52.94 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 123.578 2.852 . . . . 0.0 111.732 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 96.3 mt -86.54 130.02 37.39 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.412 HG23 ' N ' ' B' ' 41' ' ' TYR . 34.5 m -109.39 -42.12 5.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 O-C-N 123.708 0.63 . . . . 0.0 112.378 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 41' ' ' TYR . . . . . 0.412 ' N ' HG23 ' B' ' 40' ' ' VAL . 51.2 t80 -98.73 124.1 43.36 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.485 -178.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 5.1 p -143.08 142.13 26.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 O-C-N 124.046 0.841 . . . . 0.0 109.279 177.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 43' ' ' ASN . . . . . 0.642 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 57.0 p30 -102.64 162.08 13.21 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.212 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 44' ' ' GLN . . . . . 0.506 ' OE1' ' HA ' ' B' ' 44' ' ' GLN . 12.7 mm100 -62.8 -37.42 86.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.373 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.41 -27.43 65.69 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.677 ' CE2' HD13 ' B' ' 57' ' ' ILE . 62.4 t80 -59.91 -43.52 94.83 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 0.752 HG13 ' O ' ' B' ' 52' ' ' TYR . 66.1 t -61.71 -46.61 96.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.218 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -63.67 -44.36 93.97 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.439 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 60.6 ttm -62.86 -41.99 99.59 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 32.2 p -96.04 -14.86 22.62 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.35 -0.54 . . . . 0.0 112.017 -177.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.54 19.96 79.27 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 177.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 52' ' ' TYR . . . . . 0.752 ' O ' HG13 ' B' ' 47' ' ' VAL . 81.9 m-85 -112.99 144.94 41.71 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 122.897 0.479 . . . . 0.0 110.128 178.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -73.62 148.58 42.74 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 121.884 0.85 . . . . 0.0 111.013 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 54' ' ' THR . . . . . 0.431 ' H ' HG22 ' B' ' 54' ' ' THR . 0.1 OUTLIER -63.15 -35.63 80.94 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.127 -177.466 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.41 -40.79 96.46 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.568 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -72.43 -32.73 66.56 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 177.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.677 HD13 ' CE2' ' B' ' 46' ' ' PHE . 93.5 mt -66.1 -73.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 58' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' B' ' 57' ' ' ILE . 94.6 mt -35.27 132.51 0.38 Allowed 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.362 174.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.85 -9.16 73.43 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.831 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -136.71 149.14 47.73 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -174.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 61' ' ' ASN . . . . . 0.514 ' C ' ' H ' ' B' ' 63' ' ' ARG . 25.9 t-20 -78.72 152.09 31.75 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.889 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 62' ' ' CYS . . . . . . . . . . . . . 82.8 m -64.53 8.67 0.1 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.342 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 63' ' ' ARG . . . . . 0.514 ' H ' ' C ' ' B' ' 61' ' ' ASN . 34.6 ptt-85 -58.85 -30.95 68.08 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.487 -178.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -61.55 -30.78 70.86 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 81.0 mt -61.76 -42.77 99.41 Favored 'General case' 0 C--O 1.24 0.589 0 O-C-N 122.005 -0.435 . . . . 0.0 109.87 -178.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -49.99 148.93 2.96 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 123.7 0.625 . . . . 0.0 109.846 -177.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 67' ' ' GLY . . . . . 0.48 ' N ' ' OG1' ' B' ' 70' ' ' THR . . . -160.57 -151.36 6.18 Favored Glycine 0 CA--C 1.54 1.656 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.339 175.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.4 -41.88 94.8 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 122.659 -0.318 . . . . 0.0 111.738 -175.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 69' ' ' HIS . . . . . 0.488 ' O ' ' NE2' ' B' ' 93' ' ' GLN . 8.3 m80 -75.81 -9.56 58.7 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 123.169 0.293 . . . . 0.0 111.406 -178.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 70' ' ' THR . . . . . 0.48 ' OG1' ' N ' ' B' ' 67' ' ' GLY . 24.5 m -61.35 135.79 57.82 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -91.08 109.28 34.25 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.283 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.96 -38.69 86.51 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 120.884 1.056 . . . . 0.0 111.888 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.52 -40.38 91.23 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 120.527 -0.469 . . . . 0.0 109.798 -176.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 74' ' ' GLU . . . . . 0.477 ' OE1' ' HB ' ' B' ' 90' ' ' VAL . 78.8 mm-40 -66.87 -38.6 86.63 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.667 177.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 85.3 t -61.74 -46.01 97.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -62.91 -37.34 86.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.738 -178.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -62.57 -41.96 99.26 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 119.359 -0.936 . . . . 0.0 108.672 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.47 -43.79 98.54 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.859 -178.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -62.48 -43.01 99.86 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 83.6 m -61.11 -45.29 95.3 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.965 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.53 -40.98 96.64 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -177.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 80.2 mt -63.18 -41.79 99.27 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -62.22 -35.42 78.86 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 84' ' ' ASN . . . . . 0.424 ' O ' ' C ' ' B' ' 85' ' ' LYS . 98.5 m-20 -91.16 10.25 27.79 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.604 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 85' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' B' ' 84' ' ' ASN . 30.7 tttt 38.08 37.82 0.17 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 120.509 -0.477 . . . . 0.0 112.037 176.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -120.66 140.69 30.94 Favored Pre-proline 0 N--CA 1.469 0.487 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.96 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 87' ' ' PRO . . . . . 0.401 ' HB3' ' OD2' ' B' ' 109' ' ' ASP . 27.0 Cg_exo -61.63 140.29 85.75 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 121.006 1.137 . . . . 0.0 114.011 -177.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -140.94 137.44 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -177.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 89' ' ' THR . . . . . 0.877 HG23 ' OD1' ' B' ' 107' ' ' ASN . 97.0 m -121.65 122.78 40.37 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.477 ' HB ' ' OE1' ' B' ' 74' ' ' GLU . 28.2 m -139.04 163.2 27.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.859 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -114.71 122.4 46.31 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.189 0.519 . . . . 0.0 109.638 175.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 92' ' ' ILE . . . . . 0.472 HD11 HG23 ' B' ' 70' ' ' THR . 20.5 tt -128.9 132.58 67.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 114.999 -1.0 . . . . 0.0 112.038 -175.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 93' ' ' GLN . . . . . 0.488 ' NE2' ' O ' ' B' ' 69' ' ' HIS . 35.1 mt-30 -71.9 144.01 49.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.613 177.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 94' ' ' ASN . . . . . 0.439 ' ND2' ' O ' ' B' ' 93' ' ' GLN . 8.2 m120 -135.48 -178.69 5.23 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.353 0.596 . . . . 0.0 110.989 -176.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 95' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -132.42 145.12 50.97 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.634 -1.167 . . . . 0.0 111.829 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 96' ' ' LYS . . . . . 0.507 ' HG3' ' CE1' ' B' ' 102' ' ' PHE . 98.7 mttt -102.47 179.59 4.26 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.0 0.429 . . . . 0.0 110.917 178.277 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.82 -35.49 74.84 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.17 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 38.4 p-10 -88.08 -0.67 57.33 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 119.0 0.818 . . . . 0.0 112.738 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.47 5.89 64.77 Favored Glycine 0 N--CA 1.465 0.607 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.209 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 25.7 m -67.68 129.63 40.49 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.508 177.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 101' ' ' MET . . . . . 0.571 ' SD ' ' N ' ' B' ' 102' ' ' PHE . 14.9 tmm? -87.98 141.82 28.27 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 102' ' ' PHE . . . . . 0.571 ' N ' ' SD ' ' B' ' 101' ' ' MET . 53.2 p90 -154.81 162.08 41.24 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 103' ' ' TRP . . . . . 0.743 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 24.7 m95 -96.36 138.76 33.47 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.324 -0.551 . . . . 0.0 111.093 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 104' ' ' ASN . . . . . 0.51 HD21 ' HG2' ' B' ' 123' ' ' GLN . 64.0 t-20 -132.55 106.37 7.79 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 114.737 -1.119 . . . . 0.0 113.807 -177.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -75.49 123.92 26.28 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 124.286 0.992 . . . . 0.0 109.346 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 37.9 tp -111.61 126.02 54.56 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.075 0.464 . . . . 0.0 111.989 -177.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 107' ' ' ASN . . . . . 0.877 ' OD1' HG23 ' B' ' 89' ' ' THR . 97.6 m-20 -118.79 127.91 53.97 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 176.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 96.7 mt -123.79 133.11 70.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 109' ' ' ASP . . . . . 0.401 ' OD2' ' HB3' ' B' ' 87' ' ' PRO . 1.2 m-20 -146.6 120.9 5.23 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -69.48 153.34 70.35 Favored 'Trans proline' 0 N--CA 1.504 2.096 0 C-N-CA 122.581 2.187 . . . . 0.0 112.629 -178.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 111' ' ' MET . . . . . 0.536 ' HB2' ' HB2' ' B' ' 118' ' ' TYR . 66.5 mtt -128.74 144.02 51.07 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -113.49 108.68 17.51 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 178.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 113' ' ' ILE . . . . . 0.503 HG12 ' HZ1' ' A' ' 18' ' ' LYS . 96.7 mt -134.6 128.3 50.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 O-C-N 121.64 -0.663 . . . . 0.0 111.736 177.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 52.89 38.66 27.46 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 123.974 0.796 . . . . 0.0 109.695 178.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 60.55 35.94 20.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.53 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -134.55 152.03 51.5 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 117' ' ' THR . . . . . 0.424 HG23 ' HG3' ' B' ' 32' ' ' PRO . 9.5 t -102.62 152.92 20.62 Favored 'General case' 0 C--O 1.214 -0.812 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.298 -177.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 118' ' ' TYR . . . . . 0.536 ' HB2' ' HB2' ' B' ' 111' ' ' MET . 95.2 m-85 -147.46 147.17 29.92 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 121.349 -0.844 . . . . 0.0 111.465 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -122.89 139.2 54.29 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 120.975 0.416 . . . . 0.0 111.57 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -128.85 134.33 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -176.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -109.87 125.14 7.45 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 122' ' ' ILE . . . . . 0.431 ' HB ' ' HB2' ' B' ' 107' ' ' ASN . 95.5 mt -114.84 127.75 72.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 123' ' ' GLN . . . . . 0.51 ' HG2' HD21 ' B' ' 104' ' ' ASN . 13.8 mp0 -119.8 118.5 30.99 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -116.75 120.28 38.07 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 125' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' B' ' 126' ' ' ILE . 68.0 t0 -67.65 133.8 49.99 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.465 -178.265 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.478 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 3.3 mt -107.49 16.16 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.626 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 127' ' ' THR . . . . . 0.439 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 97.8 m -63.45 -44.08 95.54 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 114.254 -1.339 . . . . 0.0 112.672 176.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 59.7 tptt -61.38 -45.79 92.87 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -177.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 129' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -62.75 -35.42 79.73 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.474 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 130' ' ' LYS . . . . . 0.743 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 98.8 mttt -63.13 -41.4 99.31 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 112.91 -1.95 . . . . 0.0 111.073 175.015 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.41 -41.89 96.38 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 132' ' ' TYR . . . . . 0.66 ' CE2' HD11 ' B' ' 136' ' ' LEU . 90.9 t80 -60.83 -44.76 96.51 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.941 -0.474 . . . . 0.0 111.644 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.28 -36.56 84.49 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 119.966 -0.693 . . . . 0.0 109.75 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 134' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' B' ' 130' ' ' LYS . 98.9 mttt -63.29 -38.92 93.03 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.846 177.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 52.7 tp -62.55 -41.44 98.89 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.46 0.647 . . . . 0.0 109.385 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 136' ' ' LEU . . . . . 0.66 HD11 ' CE2' ' B' ' 132' ' ' TYR . 85.2 mt -63.03 -41.58 99.56 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.405 178.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 137' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.95 -37.74 88.52 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 113.89 -1.505 . . . . 0.0 110.237 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -63.19 -43.66 97.58 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 120.029 -0.668 . . . . 0.0 109.952 176.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 53.4 m -61.04 -44.63 97.12 Favored 'General case' 0 C--N 1.346 0.43 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 88.3 mt -61.55 -40.44 94.69 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -177.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 81.8 m -61.6 -45.37 94.38 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.961 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -66.16 -41.49 90.3 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 92.5 mt -63.69 -43.56 98.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.63 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 144' ' ' THR . . . . . . . . . . . . . 99.1 m -61.55 -45.18 95.24 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -178.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.12 -40.7 96.75 Favored 'General case' 0 C--O 1.227 -0.121 0 C-N-CA 119.192 -1.003 . . . . 0.0 109.331 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 91.5 mt -64.18 -41.39 97.14 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 147' ' ' SER . . . . . 0.61 ' O ' ' N ' ' B' ' 149' ' ' PRO . 78.1 p -62.78 -42.25 99.62 Favored 'General case' 0 CA--C 1.477 -1.854 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 148' ' ' THR . . . . . 0.508 ' C ' ' O ' ' B' ' 147' ' ' SER . 12.3 m -25.52 85.33 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.793 0 O-C-N 124.12 0.887 . . . . 0.0 110.165 176.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 149' ' ' PRO . . . . . 0.61 ' N ' ' O ' ' B' ' 147' ' ' SER . 23.8 Cg_exo -60.83 146.48 97.42 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.112 1.874 . . . . 0.0 115.897 -177.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 9.7 tp -128.36 119.33 50.24 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.148 0 CA-C-N 114.015 -1.448 . . . . 0.0 108.029 174.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 41.6 t -153.02 93.34 3.19 Favored Pre-proline 0 C--N 1.308 -1.197 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.931 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -60.18 137.27 74.18 Favored 'Trans proline' 0 N--CA 1.488 1.181 0 CA-C-N 119.728 0.939 . . . . 0.0 109.727 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 153' ' ' ILE . . . . . 0.694 ' O ' ' HD2' ' B' ' 154' ' ' ARG . 44.5 mm -68.41 -43.3 84.18 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.499 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.351 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 154' ' ' ARG . . . . . 0.694 ' HD2' ' O ' ' B' ' 153' ' ' ILE . 0.8 OUTLIER -155.96 -155.92 0.59 Allowed 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.683 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 61.8 t-20 -86.84 109.73 19.49 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.87 -18.71 56.46 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -177.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 157' ' ' ILE . . . . . 0.43 HG22 ' HB ' ' B' ' 153' ' ' ILE . 88.0 mt -108.91 125.69 65.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.098 0.475 . . . . 0.0 111.036 -176.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 158' ' ' SER . . . . . 0.647 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 57.9 m -134.96 149.77 50.27 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.933 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -132.91 146.96 52.26 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 24.3 tp -139.5 77.07 29.51 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 161' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -70.83 147.54 56.21 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.689 2.259 . . . . 0.0 114.083 -178.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 95.1 mt -113.97 133.99 55.13 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 54.7 t -128.79 132.13 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 115.03 169.43 15.99 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 120.508 -0.854 . . . . 0.0 111.276 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 165' ' ' ASN . . . . . 0.688 ' O ' ' CZ ' ' B' ' 170' ' ' ARG . 59.2 t30 -91.5 106.55 18.57 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -177.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 166' ' ' LEU . . . . . 0.597 HD21 ' CZ ' ' B' ' 171' ' ' PHE . 47.5 tp -65.25 104.83 0.99 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -174.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 167' ' ' THR . . . . . 0.608 HG23 ' NE ' ' B' ' 170' ' ' ARG . 10.7 p -84.76 171.24 12.47 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 114.088 -1.414 . . . . 0.0 110.904 176.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -66.77 -37.69 85.1 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.671 177.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.51 -40.92 89.45 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 122.456 1.122 . . . . 0.0 111.962 -178.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 170' ' ' ARG . . . . . 0.688 ' CZ ' ' O ' ' B' ' 165' ' ' ASN . 87.6 mtm180 -62.07 -36.54 81.99 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 112.367 -2.197 . . . . 0.0 111.405 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 171' ' ' PHE . . . . . 0.597 ' CZ ' HD21 ' B' ' 166' ' ' LEU . 0.3 OUTLIER -54.08 -26.25 26.04 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -178.92 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 172' ' ' ASN . . . . . 0.569 ' O ' HG22 ' B' ' 175' ' ' VAL . 90.3 m-20 -62.58 -40.2 96.11 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.967 178.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 67.9 m -60.46 -41.7 94.69 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.095 0.474 . . . . 0.0 110.708 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 67.8 mt -64.17 -44.12 97.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 175' ' ' VAL . . . . . 0.569 HG22 ' O ' ' B' ' 172' ' ' ASN . 34.0 m -62.9 -40.59 89.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 176' ' ' CYS . . . . . 0.438 ' N ' HG23 ' B' ' 175' ' ' VAL . 99.5 m -62.27 -34.71 77.08 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.415 177.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 177' ' ' THR . . . . . 0.535 ' O ' HG13 ' B' ' 181' ' ' ILE . 25.2 m -61.53 -19.82 62.54 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-O 121.001 0.429 . . . . 0.0 110.213 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 178' ' ' LEU . . . . . 0.608 ' CD2' HD21 ' B' ' 211' ' ' LEU . 86.8 mt -61.1 -39.02 88.38 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.255 -178.011 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 19.2 m -60.94 -44.31 97.43 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.357 177.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 180' ' ' ASN . . . . . 0.563 ' O ' ' OG ' ' B' ' 183' ' ' SER . 91.2 m-20 -62.16 -40.38 95.79 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.682 0.277 . . . . 0.0 110.538 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.535 HG13 ' O ' ' B' ' 177' ' ' THR . 76.3 mt -55.45 -31.77 28.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.729 -177.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 182' ' ' LEU . . . . . 0.474 HD21 HD21 ' B' ' 214' ' ' LEU . 84.4 mt -62.42 -42.27 99.32 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.249 178.163 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 183' ' ' SER . . . . . 0.563 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.0 p -63.53 -33.81 76.4 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 121.876 -0.515 . . . . 0.0 110.999 178.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 33.1 p -85.23 15.77 4.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.866 0.365 . . . . 0.0 111.899 -177.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 78.7 p -59.83 -16.42 28.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.977 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.38 -40.59 94.89 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.946 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 187' ' ' ASP . . . . . 0.647 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.5 m-20 -69.97 114.37 8.07 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.535 0.684 . . . . 0.0 110.711 -178.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.9 -41.99 99.63 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-N 114.9 -1.046 . . . . 0.0 113.161 -177.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 189' ' ' TYR . . . . . 0.429 ' HB2' HG12 ' B' ' 157' ' ' ILE . 96.9 m-85 -111.45 130.7 55.63 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.197 -178.102 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 190' ' ' LEU . . . . . . . . . . . . . 40.5 tp -124.26 118.65 27.28 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.059 177.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 88.3 mt -107.81 127.71 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 120.613 0.244 . . . . 0.0 111.552 -177.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 49.2 mm -116.68 119.13 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 193' ' ' ASP . . . . . 0.525 ' CG ' ' HG ' ' B' ' 195' ' ' SER . 40.8 t0 -89.89 111.64 22.75 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 120.919 0.39 . . . . 0.0 111.739 -177.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 194' ' ' LEU . . . . . . . . . . . . . 98.4 mt -92.14 -2.42 56.59 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.32 175.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 195' ' ' SER . . . . . 0.525 ' HG ' ' CG ' ' B' ' 193' ' ' ASP . 78.3 p -61.25 -37.34 82.75 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.865 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -62.18 -33.89 87.36 Favored Glycine 0 N--CA 1.438 -1.195 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 197' ' ' LEU . . . . . 1.012 HD23 ' N ' ' B' ' 198' ' ' ALA . 4.7 tt -77.97 133.32 38.05 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 121.962 -0.728 . . . . 0.0 109.323 -176.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 198' ' ' ALA . . . . . 1.012 ' N ' HD23 ' B' ' 197' ' ' LEU . . . -64.55 -42.23 95.82 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.361 -176.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 199' ' ' GLN . . . . . 0.943 ' H ' ' CD2' ' B' ' 197' ' ' LEU . 58.8 tt0 -140.48 165.02 28.57 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.623 0.725 . . . . 0.0 112.648 -178.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 200' ' ' VAL . . . . . 0.472 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 51.0 t -120.93 132.91 69.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 O-C-N 121.037 -1.04 . . . . 0.0 109.526 177.203 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -93.8 148.95 21.65 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.151 0.5 . . . . 0.0 110.822 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -58.07 -33.71 69.34 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.308 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -64.93 -33.39 75.91 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.4 m -61.19 -44.59 97.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.555 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 205' ' ' ALA . . . . . 0.656 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -57.71 -29.42 64.69 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.666 -177.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -65.66 -37.46 86.58 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.312 0.577 . . . . 0.0 109.603 176.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -66.12 -38.69 88.82 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.586 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.83 -43.3 97.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.079 -178.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 209' ' ' PHE . . . . . 0.656 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 73.6 m-85 -62.47 -43.14 99.54 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 114.16 -1.382 . . . . 0.0 112.733 177.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.4 -41.64 98.75 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.379 -0.929 . . . . 0.0 109.701 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 211' ' ' LEU . . . . . 0.608 HD21 ' CD2' ' B' ' 178' ' ' LEU . 39.4 mt -62.44 -42.29 99.35 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.314 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 78.3 p -62.33 -36.57 82.59 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.908 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 213' ' ' HIS . . . . . 0.485 ' CE1' HD11 ' B' ' 217' ' ' LEU . 58.1 t-80 -67.26 -46.77 72.67 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.012 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.474 HD21 HD21 ' B' ' 182' ' ' LEU . 51.0 tp -63.97 -43.35 96.02 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.81 0.815 . . . . 0.0 109.83 177.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 215' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' B' ' 211' ' ' LEU . 91.8 mt -62.95 -43.97 97.35 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 113.502 -1.681 . . . . 0.0 111.588 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.83 -39.5 92.01 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.82 -177.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 217' ' ' LEU . . . . . 0.485 HD11 ' CE1' ' B' ' 213' ' ' HIS . 85.6 mt -63.56 -42.02 98.39 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.362 0.601 . . . . 0.0 111.652 176.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 218' ' ' THR . . . . . 0.412 HG23 ' O ' ' B' ' 214' ' ' LEU . 74.2 p -74.17 -17.21 60.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.987 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 81.08 66.42 1.62 Allowed Glycine 0 CA--C 1.527 0.784 0 N-CA-C 106.696 -2.562 . . . . 0.0 106.696 -178.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 220' ' ' THR . . . . . . . . . . . . . 94.2 m -147.11 104.56 3.69 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 114.652 1.352 . . . . 0.0 114.652 176.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -61.92 140.45 58.3 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.022 -175.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 44.8 tp -116.69 121.79 42.65 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.37 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 3.0 mp -110.26 128.83 66.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.916 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 224' ' ' ILE . . . . . 0.534 ' CG2' HD11 ' B' ' 227' ' ' ILE . 50.7 mm -109.39 126.58 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.552 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 49.4 p -133.44 157.62 45.12 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 90.1 16.95 55.03 Favored Glycine 0 CA--C 1.499 -0.918 0 CA-C-N 113.898 -1.501 . . . . 0.0 111.117 -177.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 227' ' ' ILE . . . . . 0.733 HD12 HG23 ' B' ' 247' ' ' THR . 94.8 mt -81.72 125.64 39.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 O-C-N 121.942 -0.74 . . . . 0.0 111.851 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 65.9 tttt -66.73 141.68 97.04 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.406 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.11 -37.47 94.05 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 121.364 1.376 . . . . 0.0 112.609 178.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -64.04 -43.03 96.8 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -177.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 51.3 tp -61.89 -41.34 97.78 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.527 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.15 -36.83 85.31 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.504 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 94.7 mtp -64.08 -40.83 97.11 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.73 -42.84 97.83 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 122.195 0.997 . . . . 0.0 109.238 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 32.4 mmt -63.89 -35.92 82.22 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.782 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -61.66 -40.39 94.78 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -178.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.67 -44.43 93.79 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.07 178.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 51.0 tp -62.45 -45.41 93.17 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.924 -178.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -156.68 131.78 9.12 Favored 'General case' 0 CA--C 1.511 -0.555 0 C-N-CA 120.301 -0.559 . . . . 0.0 111.956 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 240' ' ' ALA . . . . . . . . . . . . . . . -62.13 -47.28 85.25 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 176.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 241' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' B' ' 244' ' ' SER . 93.7 m-20 -42.52 -19.16 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.484 -176.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 242' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -62.6 -44.82 95.33 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.138 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 243' ' ' SER . . . . . . . . . . . . . 78.0 p -57.63 -44.02 85.24 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 244' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 19.8 m -29.81 -40.61 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 96.4 mt -84.25 141.67 30.81 Favored 'General case' 0 C--N 1.313 -1.013 0 O-C-N 121.561 -0.712 . . . . 0.0 110.993 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -69.06 133.55 48.23 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 120.923 0.392 . . . . 0.0 110.285 -174.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 247' ' ' THR . . . . . 0.733 HG23 HD12 ' B' ' 227' ' ' ILE . 97.8 m -124.1 125.86 45.22 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.861 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 248' ' ' TYR . . . . . 0.482 ' CG ' ' HB2' ' B' ' 254' ' ' ALA . 96.9 m-85 -111.71 142.85 43.52 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 249' ' ' SER . . . . . 0.571 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 78.4 p -62.86 -33.04 74.43 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.058 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 250' ' ' ASN . . . . . 0.571 ' OD1' ' O ' ' B' ' 249' ' ' SER . 99.3 m-20 -147.31 157.75 43.71 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.122 -0.945 . . . . 0.0 112.004 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 69.3 t -64.9 -44.75 96.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.263 178.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 252' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.74 -46.06 91.89 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -178.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 253' ' ' ASP . . . . . 0.547 ' O ' HG22 ' B' ' 257' ' ' VAL . 70.3 m-20 -60.94 -42.88 99.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.651 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 254' ' ' ALA . . . . . 0.482 ' HB2' ' CG ' ' B' ' 248' ' ' TYR . . . -65.57 -41.14 93.26 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.15 178.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 255' ' ' VAL . . . . . 0.444 ' O ' ' HD2' ' B' ' 259' ' ' PRO . 76.2 t -65.02 -45.36 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.067 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.07 -47.96 80.68 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.491 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 257' ' ' VAL . . . . . 0.547 HG22 ' O ' ' B' ' 253' ' ' ASP . 27.2 m -65.46 -40.58 88.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.577 179.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 258' ' ' LEU . . . . . 0.507 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 1.3 mt -32.74 -73.29 0.06 OUTLIER Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.507 -177.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 259' ' ' PRO . . . . . 0.57 ' O ' HG13 ' B' ' 260' ' ' ILE . 37.1 Cg_endo -61.84 141.36 89.78 Favored 'Trans proline' 0 N--CA 1.504 2.103 0 C-N-CA 121.459 1.439 . . . . 0.0 111.308 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 260' ' ' ILE . . . . . 0.57 HG13 ' O ' ' B' ' 259' ' ' PRO . 96.7 mt -159.54 -16.43 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 CA-C-N 118.692 0.678 . . . . 0.0 112.3 177.081 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 78.3 mtm . . . . . 0 C--O 1.216 -0.703 0 CA-C-O 117.785 -1.102 . . . . 0.0 111.434 -178.848 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.16 172.39 18.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.144 0.497 . . . . 0.0 110.272 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 85.4 p -73.27 -10.23 59.54 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.6 -0.688 . . . . 0.0 111.17 177.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -83.33 -62.97 1.45 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 114.713 -1.131 . . . . 0.0 112.434 176.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -69.33 -39.71 78.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.782 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.611 ' O ' ' NZ ' ' B' ' 17' ' ' LYS . 57.8 m -59.62 -41.66 90.92 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -177.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.505 ' CE2' HD12 ' A' ' 9' ' ' ILE . 32.2 t80 83.18 89.64 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.179 0.514 . . . . 0.0 112.213 177.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.538 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -63.49 -140.27 0.01 OUTLIER Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -177.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.538 ' HB ' ' O ' ' A' ' 8' ' ' GLY . 67.7 mt 82.11 108.34 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 122.686 0.394 . . . . 0.0 110.523 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.93 -21.75 68.69 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.466 1.444 . . . . 0.0 112.141 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.2 -38.39 95.86 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 121.08 -0.581 . . . . 0.0 111.896 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -65.05 -39.64 93.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.512 0.672 . . . . 0.0 109.486 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 52.9 tp -62.81 -41.41 99.29 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -62.21 -40.68 96.92 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 75.0 t -60.12 -44.36 94.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 O-C-N 122.146 -0.346 . . . . 0.0 110.91 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 91.9 mt -62.51 -43.65 98.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.468 -178.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.51 -46.52 88.05 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 119.269 -0.973 . . . . 0.0 112.306 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.585 ' NZ ' HG12 ' B' ' 113' ' ' ILE . 98.4 mttt -59.3 -39.77 84.05 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 118.608 -1.237 . . . . 0.0 109.02 -176.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.34 -41.89 90.22 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.306 -178.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 20' ' ' LEU . 85.4 mt -62.93 -40.91 99.07 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -63.43 -38.2 90.22 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 57.9 m170 -58.62 -39.86 81.68 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 122.339 -0.226 . . . . 0.0 111.329 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 23' ' ' VAL . 12.6 p -113.88 129.95 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.505 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 34.8 ptt180 -72.36 108.27 5.38 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-O 122.072 0.939 . . . . 0.0 112.161 -177.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.0 p -140.47 142.96 30.06 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 123' ' ' GLN . . . -97.45 92.77 1.34 Allowed Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.674 -178.132 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 53.3 t -125.44 130.17 72.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.6 m -137.4 159.54 35.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.6 mt -121.12 129.76 75.35 Favored 'Isoleucine or valine' 0 C--O 1.247 0.952 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 177.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.441 HG22 HG12 ' A' ' 39' ' ' ILE . 19.6 p -106.32 168.47 9.13 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.518 ' C ' ' OD1' ' A' ' 37' ' ' ASN . 62.7 t0 -133.88 102.85 12.14 Favored Pre-proline 0 C--N 1.318 -0.781 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.117 178.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.549 ' HG3' HG23 ' A' ' 117' ' ' THR . 36.9 Cg_endo -63.83 -22.88 69.07 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 121.495 1.463 . . . . 0.0 111.647 -178.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.02 -35.19 79.4 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.955 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.4 mt -86.39 159.81 19.25 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.375 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.835 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 42.9 tt0 -57.43 134.35 55.98 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -176.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.514 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 56.8 t0 59.76 23.49 12.39 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 178.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.518 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 39.8 t-20 38.82 65.89 2.97 Favored Pre-proline 0 CA--C 1.542 0.65 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.129 -178.219 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.835 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 91.3 Cg_endo -68.55 155.18 69.85 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 124.007 3.138 . . . . 0.0 112.129 -178.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.441 HG12 HG22 ' A' ' 30' ' ' THR . 96.4 mt -86.53 125.0 40.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.0 m -104.66 -41.78 6.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 116.136 -0.483 . . . . 0.0 112.086 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -96.07 123.57 39.73 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.859 -178.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.5 p -142.62 139.53 28.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 O-C-N 124.295 0.997 . . . . 0.0 109.133 177.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.616 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 58.0 p30 -98.3 167.01 11.12 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.506 ' HA ' ' OE1' ' A' ' 44' ' ' GLN . 14.4 mm100 -66.43 -39.41 88.89 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 178.142 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.19 -26.14 63.31 Favored Glycine 0 C--N 1.33 0.208 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.616 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 60.5 t80 -59.18 -49.3 78.39 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 -179.03 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.6 HG13 ' O ' ' A' ' 52' ' ' TYR . 53.5 t -58.45 -44.9 89.88 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 O-C-N 121.423 -0.798 . . . . 0.0 111.464 -174.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -62.99 -37.16 86.07 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 120.511 -0.476 . . . . 0.0 112.116 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 59.6 ttm -68.65 -43.62 75.89 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 177.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 35.4 p -90.48 -23.2 21.04 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.34 0.59 . . . . 0.0 111.48 -178.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . 78.01 21.08 71.8 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 -179.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.6 ' O ' HG13 ' A' ' 47' ' ' VAL . 70.3 m-85 -114.46 138.87 50.04 Favored 'General case' 0 C--O 1.221 -0.42 0 C-N-CA 122.936 0.494 . . . . 0.0 111.162 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -64.21 150.14 46.45 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.646 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.432 HG22 ' H ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -65.78 -33.55 76.12 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -179.283 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.26 -44.19 84.35 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.659 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -64.62 -45.49 86.65 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.585 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.598 HD13 ' CD2' ' A' ' 46' ' ' PHE . 92.0 mt -61.58 -50.26 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -174.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 80.6 mt -57.26 145.48 31.72 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 176.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.3 -6.68 78.89 Favored Glycine 0 N--CA 1.46 0.235 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.208 177.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -135.6 152.73 51.54 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.685 1.243 . . . . 0.0 111.903 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.562 ' C ' ' H ' ' A' ' 63' ' ' ARG . 25.2 t-20 -81.36 152.44 27.5 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.474 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 80.3 m -63.2 16.3 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.444 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.562 ' H ' ' C ' ' A' ' 61' ' ' ASN . 35.4 ptt-85 -61.88 -41.62 98.08 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.16 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -55.44 -20.55 12.78 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -178.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.7 mt -71.23 -32.17 68.45 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.611 0.719 . . . . 0.0 112.505 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -65.95 141.41 58.22 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.178 -178.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.59 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -151.08 -148.5 4.81 Favored Glycine 0 CA--C 1.539 1.553 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -178.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.79 -39.57 94.64 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -177.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.507 ' O ' ' NE2' ' A' ' 93' ' ' GLN . 10.8 m80 -77.83 -8.72 58.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.902 0.382 . . . . 0.0 111.114 -178.141 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.59 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 28.6 m -62.27 128.69 37.26 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.55 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -85.89 111.06 35.17 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.859 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -57.44 -31.87 92.5 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.959 1.773 . . . . 0.0 113.247 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.42 -40.1 95.11 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.951 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.434 ' OE1' ' HB ' ' A' ' 90' ' ' VAL . 78.9 mm-40 -65.5 -43.99 88.39 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 71.9 t -59.3 -43.86 90.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -176.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -64.35 -37.54 87.87 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.144 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -63.28 -39.89 95.85 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.304 0.573 . . . . 0.0 110.068 178.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 93.6 mt -64.01 -44.16 97.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.933 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -62.61 -43.13 99.58 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 113.633 -1.622 . . . . 0.0 108.229 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 97.0 m -61.55 -49.44 76.65 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.4 -42.57 92.03 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.381 -172.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 89.3 mt -62.77 -39.98 95.88 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 121.473 -0.767 . . . . 0.0 111.177 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 66.9 tp60 -65.07 -31.44 72.66 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -89.62 -1.33 57.99 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.22 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 46.7 tttt 47.32 39.45 8.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.529 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -122.48 143.9 40.82 Favored Pre-proline 0 CA--C 1.532 0.287 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' A' ' 108' ' ' ILE . 24.8 Cg_exo -61.63 144.37 97.45 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.559 1.506 . . . . 0.0 113.569 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -139.09 142.41 33.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.563 -178.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.913 HG23 ' OD1' ' A' ' 107' ' ' ASN . 97.7 m -127.57 118.21 23.5 Favored 'General case' 0 C--N 1.345 0.377 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 176.198 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.434 ' HB ' ' OE1' ' A' ' 74' ' ' GLU . 28.3 m -138.47 157.49 30.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.675 -0.238 . . . . 0.0 111.496 178.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -100.67 133.52 45.0 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 176.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.456 ' O ' HG23 ' A' ' 92' ' ' ILE . 17.1 tt -141.28 128.21 20.88 Favored 'Isoleucine or valine' 0 C--N 1.377 1.777 0 CA-C-N 121.374 1.897 . . . . 0.0 112.711 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.507 ' NE2' ' O ' ' A' ' 69' ' ' HIS . 33.9 mt-30 -62.61 135.69 57.51 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.254 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -138.16 161.36 37.0 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.699 -179.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -118.14 136.23 53.74 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.474 ' HG3' ' CE1' ' A' ' 102' ' ' PHE . 99.2 mttt -85.77 -171.45 3.6 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.239 0.543 . . . . 0.0 111.921 -179.177 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -62.51 -44.09 97.21 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.919 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 42.9 p-10 -83.42 7.36 17.05 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.84 -1.1 89.09 Favored Glycine 0 N--CA 1.471 0.99 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.258 176.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.8 m -58.31 137.89 56.83 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.679 ' SD ' ' C ' ' A' ' 101' ' ' MET . 12.5 tmm? -104.97 129.78 53.31 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.556 0.217 . . . . 0.0 110.443 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.548 ' N ' ' SD ' ' A' ' 101' ' ' MET . 53.4 p90 -142.33 158.43 43.72 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.007 -177.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.915 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 23.3 m95 -89.8 141.26 28.8 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.555 HD21 ' HG2' ' A' ' 123' ' ' GLN . 54.3 t-20 -136.58 105.0 5.74 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -176.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 80.8 tt0 -70.18 135.99 49.63 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 -177.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 41.6 tp -120.9 122.77 40.95 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.913 ' OD1' HG23 ' A' ' 89' ' ' THR . 98.1 m-20 -120.31 121.65 39.09 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.773 177.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 87' ' ' PRO . 96.2 mt -119.68 128.57 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 O-C-N 123.493 0.496 . . . . 0.0 111.421 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -136.31 125.76 15.84 Favored Pre-proline 0 CA--C 1.541 0.617 0 O-C-N 123.079 0.237 . . . . 0.0 110.903 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -71.31 151.75 60.46 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.666 2.244 . . . . 0.0 112.363 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.671 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 67.0 mtt -123.89 153.17 41.51 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -128.48 91.14 3.18 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.549 ' CD1' HG22 ' B' ' 15' ' ' VAL . 96.2 mt -117.34 131.37 70.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.429 -178.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 49.38 39.07 15.45 Favored 'General case' 0 CA--C 1.512 -0.499 0 O-C-N 121.496 -0.752 . . . . 0.0 111.68 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 58.7 30.42 19.93 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.954 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -127.59 146.35 50.56 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.785 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 7.7 t -85.38 -170.41 3.11 Favored 'General case' 0 C--O 1.214 -0.772 0 O-C-N 121.687 -0.633 . . . . 0.0 109.334 -178.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.785 ' CD2' ' O ' ' A' ' 117' ' ' THR . 66.0 m-85 -174.0 155.38 2.51 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 177.071 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -131.11 145.57 52.03 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 174.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -134.33 134.1 55.04 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.8 127.08 8.56 Favored Glycine 0 CA--C 1.501 -0.832 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 96.8 mt -116.6 128.93 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.555 ' HG2' HD21 ' A' ' 104' ' ' ASN . 17.7 mp0 -119.08 115.64 24.71 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.579 0.549 . . . . 0.0 109.63 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -117.64 111.78 19.64 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.838 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 126' ' ' ILE . 67.9 t0 -62.88 131.77 49.87 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -175.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.511 ' O ' HG22 ' A' ' 126' ' ' ILE . 2.9 mp -95.48 3.56 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 113.542 -1.663 . . . . 0.0 109.637 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 20.0 m -60.04 -42.98 95.58 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.007 -1.058 . . . . 0.0 113.62 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -60.57 -41.69 95.11 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -177.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -63.51 -39.79 95.36 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.003 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.915 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.6 mttt -62.81 -41.06 99.14 Favored 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 118.157 -1.417 . . . . 0.0 110.535 -178.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.1 -37.66 83.54 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.653 -178.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.774 ' CE2' HD11 ' A' ' 136' ' ' LEU . 89.7 t80 -61.77 -45.3 94.51 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.543 176.146 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.73 -38.69 91.85 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.02 -40.93 97.37 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 52.8 tp -60.64 -43.36 97.66 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -177.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.774 HD11 ' CE2' ' A' ' 132' ' ' TYR . 83.6 mt -62.28 -40.91 97.82 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.094 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.56 -41.83 98.39 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 119.355 -0.938 . . . . 0.0 109.837 -178.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -60.27 -41.55 93.5 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -177.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 48.8 m -61.66 -41.09 97.06 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.071 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 144' ' ' THR . 84.4 mt -63.69 -41.72 98.11 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.449 -0.5 . . . . 0.0 109.758 177.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 96.9 m -61.39 -46.0 92.01 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.268 -177.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -65.21 -40.48 94.19 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 95.5 mt -64.78 -43.47 96.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 113.967 -1.469 . . . . 0.0 111.523 176.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.515 ' N ' ' O ' ' A' ' 140' ' ' LEU . 92.1 m -62.53 -46.48 88.18 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.477 ' O ' ' OG1' ' A' ' 148' ' ' THR . . . -62.58 -40.57 97.29 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 118.875 -1.13 . . . . 0.0 109.251 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 85.3 mt -63.8 -42.73 97.64 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.675 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.1 p -60.93 -37.67 83.12 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -178.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.477 ' OG1' ' O ' ' A' ' 145' ' ' ALA . 18.8 m -29.09 83.73 0.03 OUTLIER Pre-proline 0 C--N 1.347 0.492 0 O-C-N 126.592 2.432 . . . . 0.0 106.613 -178.252 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.675 ' N ' ' O ' ' A' ' 147' ' ' SER . 22.4 Cg_exo -61.94 144.04 96.07 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 CA-C-O 122.753 1.064 . . . . 0.0 113.906 -174.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.639 ' O ' HG23 ' A' ' 151' ' ' VAL . 9.3 tp -120.49 135.1 61.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 102.057 -3.312 . . . . 0.0 102.057 175.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 150' ' ' ILE . 95.4 t -167.89 95.11 0.62 Allowed Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 177.082 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -64.12 143.69 84.96 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 N-CA-C 109.822 -0.876 . . . . 0.0 109.822 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.59 ' O ' HG11 ' B' ' 255' ' ' VAL . 43.4 mm -75.84 -68.61 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.463 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.725 ' NH2' ' HD3' ' B' ' 154' ' ' ARG . 4.8 mpt_? -132.02 -160.34 1.04 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 63.3 t-20 -83.63 104.57 13.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.799 0.809 . . . . 0.0 111.415 -178.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.16 9.2 60.84 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 113.991 -1.458 . . . . 0.0 110.115 -177.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.6 mt -126.1 123.48 63.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 175.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.682 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 74.5 m -133.16 151.72 51.96 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -138.15 141.03 40.12 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.625 177.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 21.7 tp -130.51 80.48 70.13 Favored Pre-proline 0 N--CA 1.47 0.571 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.454 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -70.34 152.47 66.31 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.758 2.305 . . . . 0.0 113.229 -178.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 90.1 mt -120.88 126.39 49.92 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.175 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 48.4 t -123.28 131.2 73.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 117.41 169.32 14.89 Favored Glycine 0 N--CA 1.477 1.423 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.238 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.78 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 57.1 t30 -85.25 115.28 22.93 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 117.16 0.48 . . . . 0.0 110.07 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.595 HD21 ' CZ ' ' A' ' 171' ' ' PHE . 47.1 tp -73.7 104.05 4.48 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -177.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.736 HG23 ' NE ' ' A' ' 170' ' ' ARG . 10.6 p -85.92 166.85 15.63 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.588 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.85 -34.16 77.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.166 0.507 . . . . 0.0 111.779 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.45 -42.44 95.95 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.102 178.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.78 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 87.5 mtm180 -65.37 -33.75 76.7 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 124.316 1.047 . . . . 0.0 112.462 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.595 ' CZ ' HD21 ' A' ' 166' ' ' LEU . 0.5 OUTLIER -54.21 -28.49 41.25 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 118.986 -0.531 . . . . 0.0 112.381 -178.778 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.604 ' O ' HG22 ' A' ' 175' ' ' VAL . 91.2 m-20 -60.55 -40.71 92.57 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 118.975 -1.09 . . . . 0.0 109.7 -178.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 52.0 m -59.22 -41.31 88.34 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 121.685 -0.635 . . . . 0.0 110.777 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 66.2 mt -63.25 -44.08 99.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 172' ' ' ASN . 35.4 m -62.08 -40.35 87.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' CYS . . . . . 0.418 ' N ' HG23 ' A' ' 175' ' ' VAL . 98.3 m -62.21 -33.97 75.59 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.396 178.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.523 ' O ' HG13 ' A' ' 181' ' ' ILE . 25.3 m -62.45 -19.85 63.93 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.135 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.708 ' CD2' HD21 ' A' ' 211' ' ' LEU . 86.2 mt -61.1 -41.87 97.47 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 -177.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 18.4 m -59.27 -43.28 92.51 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ASN . . . . . 0.61 ' O ' ' OG ' ' A' ' 183' ' ' SER . 93.1 m-20 -61.78 -37.68 85.22 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 120.759 0.314 . . . . 0.0 110.661 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.523 HG13 ' O ' ' A' ' 177' ' ' THR . 68.7 mt -57.15 -37.18 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 O-C-N 121.384 -0.822 . . . . 0.0 109.918 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.527 HD21 HD21 ' A' ' 214' ' ' LEU . 85.9 mt -61.16 -40.69 94.81 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -177.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.61 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 78.0 p -61.62 -33.15 73.42 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.464 177.13 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.442 ' OG1' ' HA ' ' A' ' 181' ' ' ILE . 21.9 p -89.88 23.32 2.79 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.672 0.272 . . . . 0.0 111.433 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 78.1 p -63.41 -21.49 66.32 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.63 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.29 -37.2 79.77 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.953 -179.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.682 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 98.6 m-20 -72.58 113.21 9.36 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.53 0.681 . . . . 0.0 110.706 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.95 -42.09 99.71 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.914 -177.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -112.88 130.89 55.94 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.862 -178.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 38.5 tp -120.82 128.81 53.2 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 96.5 mt -117.08 127.54 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.8 mm -113.17 127.4 70.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' ASP . . . . . 0.488 ' CG ' ' HG ' ' A' ' 195' ' ' SER . 40.5 t0 -95.15 117.99 31.18 Favored 'General case' 0 CA--C 1.549 0.93 0 O-C-N 121.871 -0.518 . . . . 0.0 110.538 177.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 96.1 mt -97.38 -4.93 37.48 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.661 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' SER . . . . . 0.488 ' HG ' ' CG ' ' A' ' 193' ' ' ASP . 78.1 p -62.99 -32.51 73.88 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.63 -44.39 98.01 Favored Glycine 0 CA--C 1.533 1.17 0 N-CA-C 108.332 -1.907 . . . . 0.0 108.332 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.975 ' CD2' ' O ' ' A' ' 199' ' ' GLN . 4.7 tt -68.34 127.76 34.12 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 112.871 -1.664 . . . . 0.0 109.289 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.934 ' N ' HD23 ' A' ' 197' ' ' LEU . . . -59.4 -50.08 75.35 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 120.179 -0.608 . . . . 0.0 110.562 -178.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.975 ' O ' ' CD2' ' A' ' 197' ' ' LEU . 58.1 tt0 -132.82 157.89 43.88 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 114.757 -1.11 . . . . 0.0 113.443 -175.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.475 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 44.1 t -117.69 132.71 66.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.37 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -88.56 155.45 19.63 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.642 -178.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.4 -39.49 93.95 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 120.135 -0.626 . . . . 0.0 109.987 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -57.85 -31.48 66.71 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -178.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.5 m -61.18 -42.3 98.32 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.413 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.495 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -57.65 -37.85 74.06 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -177.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -60.83 -37.79 83.22 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.516 -0.473 . . . . 0.0 109.749 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -66.02 -38.58 88.79 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.108 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 94.6 mt -63.11 -44.54 99.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -178.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' PHE . . . . . 0.495 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 73.3 m-85 -62.18 -43.38 98.96 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.427 -178.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -62.06 -41.95 98.68 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 119.125 -1.03 . . . . 0.0 109.072 -178.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.708 HD21 ' CD2' ' A' ' 178' ' ' LEU . 39.4 mt -62.34 -41.78 98.85 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 78.2 p -61.74 -43.15 99.41 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 118.993 -1.083 . . . . 0.0 110.14 -179.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' HIS . . . . . 0.443 ' CE1' HD11 ' A' ' 217' ' ' LEU . 58.6 t-80 -64.14 -45.28 89.22 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.602 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.527 HD21 HD21 ' A' ' 182' ' ' LEU . 49.8 tp -62.19 -45.93 91.2 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 118.843 -1.143 . . . . 0.0 108.247 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 211' ' ' LEU . 88.0 mt -62.15 -41.03 97.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.423 -178.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -60.84 -44.78 96.52 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -177.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.443 HD11 ' CE1' ' A' ' 213' ' ' HIS . 85.3 mt -61.4 -40.04 92.93 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 67.4 p -75.55 -12.11 60.16 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.596 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.62 37.63 13.61 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 120.626 -0.797 . . . . 0.0 113.57 -178.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 91.9 m -123.92 114.64 20.09 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 119.02 1.41 . . . . 0.0 111.544 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -66.15 138.11 57.49 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.83 178.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 42.1 tp -114.02 130.11 56.57 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 4.0 mp -116.29 134.41 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 122.886 0.475 . . . . 0.0 109.741 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.576 ' CG2' HD11 ' A' ' 227' ' ' ILE . 49.0 mm -116.53 131.57 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -178.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 37.8 p -133.81 165.41 25.05 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -177.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 78.35 22.64 67.26 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.722 HD12 HG23 ' A' ' 247' ' ' THR . 97.8 mt -83.96 128.55 38.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 113.947 -1.127 . . . . 0.0 108.439 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 43.1 tttt -76.31 138.39 67.94 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.25 -39.5 86.32 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 121.044 1.162 . . . . 0.0 112.595 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -63.55 -40.0 95.88 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 121.416 0.627 . . . . 0.0 109.967 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 48.8 tp -63.66 -42.6 98.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.88 177.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.27 -37.42 87.41 Favored 'General case' 0 C--O 1.227 -0.12 0 C-N-CA 120.596 -0.441 . . . . 0.0 110.89 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 94.2 mtp -63.03 -41.13 99.45 Favored 'General case' 0 C--O 1.247 0.953 0 C-N-CA 120.004 -0.679 . . . . 0.0 109.742 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.38 -38.4 91.0 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.523 177.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 30.2 mmt -65.88 -37.5 86.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.688 178.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -61.18 -41.86 97.55 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.616 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -60.66 -40.65 92.84 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.573 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 55.6 tp -63.72 -41.03 98.15 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 177.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -169.19 125.95 0.93 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.369 0.604 . . . . 0.0 112.404 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.58 -27.36 66.2 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.893 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -61.45 -28.87 69.58 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.288 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -55.73 -44.48 77.58 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -177.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 96.8 p -61.43 -21.03 63.75 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 123.779 0.674 . . . . 0.0 111.287 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 40.6 m -55.04 -38.76 68.39 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 122.313 -0.242 . . . . 0.0 111.617 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 96.3 mt -84.19 120.36 26.11 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -44.63 134.73 5.27 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.047 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.722 HG23 HD12 ' A' ' 227' ' ' ILE . 96.8 m -128.61 133.83 48.41 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.905 178.271 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 248' ' ' TYR . . . . . 0.456 ' CB ' ' HB2' ' A' ' 254' ' ' ALA . 97.4 m-85 -117.7 140.05 50.19 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 114.953 -1.022 . . . . 0.0 110.959 179.228 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 78.0 p -60.23 -43.89 95.66 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -178.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -142.27 161.36 38.22 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.725 0.774 . . . . 0.0 111.79 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 77.4 t -62.46 -45.0 99.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 114.614 -1.175 . . . . 0.0 112.053 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -60.48 -44.31 96.04 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.193 -0.603 . . . . 0.0 109.561 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 253' ' ' ASP . . . . . 0.401 ' O ' HG22 ' A' ' 257' ' ' VAL . 54.3 m-20 -62.99 -43.72 98.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.668 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 254' ' ' ALA . . . . . 0.456 ' HB2' ' CB ' ' A' ' 248' ' ' TYR . . . -63.76 -43.25 96.98 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.94 0.876 . . . . 0.0 109.767 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 255' ' ' VAL . . . . . 0.557 HG13 HH11 ' B' ' 154' ' ' ARG . 56.9 t -63.37 -45.77 97.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 114.003 -1.453 . . . . 0.0 111.129 -177.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.46 -46.95 83.9 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 120.649 -0.421 . . . . 0.0 111.301 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.494 ' O ' ' C ' ' A' ' 258' ' ' LEU . 21.2 m -66.45 -41.1 88.11 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 O-C-N 121.539 -0.726 . . . . 0.0 112.005 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.494 ' C ' ' O ' ' A' ' 257' ' ' VAL . 1.9 mt -29.85 -72.85 0.05 OUTLIER Pre-proline 0 N--CA 1.466 0.328 0 CA-C-O 119.497 -0.287 . . . . 0.0 111.51 -177.258 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 259' ' ' PRO . . . . . 0.492 ' O ' HG13 ' A' ' 260' ' ' ILE . 44.7 Cg_endo -64.12 139.28 65.94 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 CA-C-N 119.635 0.905 . . . . 0.0 111.764 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.492 HG13 ' O ' ' A' ' 259' ' ' PRO . 96.5 mt -153.74 -25.03 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 O-C-N 123.638 0.586 . . . . 0.0 111.764 178.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 N--CA 1.475 0.811 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.68 -177.66 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.424 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.26 162.5 33.67 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 79.5 p -59.61 -21.8 60.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.779 177.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -74.67 -62.02 1.68 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 120.948 0.404 . . . . 0.0 111.361 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.72 -39.98 88.23 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.092 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 6' ' ' SER . . . . . 0.503 ' O ' ' HB3' ' B' ' 7' ' ' PHE . 61.0 m -60.33 -42.59 95.95 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 119.98 -0.688 . . . . 0.0 109.833 -177.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 7' ' ' PHE . . . . . 0.51 ' CE2' HD12 ' B' ' 9' ' ' ILE . 36.7 t80 84.79 92.86 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.339 177.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 8' ' ' GLY . . . . . 0.559 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -65.46 -139.87 0.03 OUTLIER Glycine 0 C--N 1.338 0.678 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.559 ' HB ' ' O ' ' B' ' 8' ' ' GLY . 68.0 mt 81.61 108.35 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 122.567 0.347 . . . . 0.0 110.912 -178.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -62.94 -24.23 74.13 Favored 'Trans proline' 0 N--CA 1.499 1.814 0 C-N-CA 121.338 1.359 . . . . 0.0 111.711 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.95 -40.64 98.69 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -64.67 -39.35 93.53 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.763 0.792 . . . . 0.0 109.131 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 54.1 tp -62.41 -42.24 99.29 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.476 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -63.91 -32.39 73.91 Favored 'General case' 0 CA--C 1.562 1.431 0 CA-C-O 121.535 0.683 . . . . 0.0 110.525 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 15' ' ' VAL . . . . . 0.549 HG22 ' CD1' ' A' ' 113' ' ' ILE . 70.0 t -62.83 -46.22 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 113.237 -1.801 . . . . 0.0 111.007 176.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 93.3 mt -64.16 -43.96 97.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.007 -178.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 17' ' ' LYS . . . . . 0.611 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 99.0 mttt -63.55 -41.8 98.42 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -179.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.22 -41.22 99.09 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 119.01 -1.076 . . . . 0.0 109.973 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.37 -38.73 84.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.966 -178.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 86.0 mt -63.91 -41.97 97.55 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 121.359 0.6 . . . . 0.0 110.263 175.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -63.07 -38.73 92.35 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.192 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 56.5 m170 -57.83 -39.85 78.65 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 119.557 -0.259 . . . . 0.0 111.323 -178.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 12.3 p -114.04 129.94 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.526 ' HG3' ' O ' ' B' ' 24' ' ' ARG . 35.0 ptt180 -72.0 106.21 4.19 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.711 0.767 . . . . 0.0 112.447 -177.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.403 ' O ' HG13 ' B' ' 25' ' ' VAL . 6.6 p -142.01 133.68 26.69 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.86 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.816 177.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 26' ' ' GLY . . . . . 0.498 ' O ' ' N ' ' B' ' 123' ' ' GLN . . . -87.31 97.53 2.28 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 119.422 -1.37 . . . . 0.0 113.202 -176.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 49.4 t -126.41 129.07 71.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 174.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 30.0 m -138.44 156.23 29.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 121.014 -0.274 . . . . 0.0 110.429 178.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 95.8 mt -119.01 127.41 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.237 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.437 HG22 HG12 ' B' ' 39' ' ' ILE . 33.2 p -107.54 158.13 17.47 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-N 113.002 -1.908 . . . . 0.0 108.694 -177.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 31' ' ' ASP . . . . . 0.49 ' C ' ' OD1' ' B' ' 37' ' ' ASN . 64.1 t0 -125.18 103.07 30.09 Favored Pre-proline 0 C--O 1.236 0.381 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -178.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 32' ' ' PRO . . . . . 0.491 ' HG3' HG23 ' B' ' 117' ' ' THR . 37.1 Cg_endo -64.39 -21.76 66.37 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.723 1.616 . . . . 0.0 111.496 -178.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.02 -45.39 93.79 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.539 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 90.9 mt -71.23 179.45 2.85 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.913 -0.492 . . . . 0.0 111.676 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 35' ' ' GLU . . . . . 0.699 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 41.4 tt0 -77.13 129.67 36.31 Favored 'General case' 0 C--N 1.344 0.327 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -174.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.47 ' O ' ' C ' ' B' ' 37' ' ' ASN . 65.2 t0 58.01 38.14 26.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.461 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 37' ' ' ASN . . . . . 0.49 ' OD1' ' C ' ' B' ' 31' ' ' ASP . 24.3 t-20 27.69 69.73 0.49 Allowed Pre-proline 0 C--N 1.327 -0.413 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.699 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 92.1 Cg_endo -70.72 153.39 64.56 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 123.676 2.917 . . . . 0.0 111.635 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.437 HG12 HG22 ' B' ' 30' ' ' THR . 96.0 mt -84.46 129.93 36.84 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 18.0 m -109.55 -41.61 4.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 O-C-N 123.592 0.557 . . . . 0.0 112.339 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -96.81 123.62 40.56 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.506 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 5.8 p -142.38 140.61 28.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.222 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 43' ' ' ASN . . . . . 0.651 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 56.7 p30 -102.13 162.1 13.17 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.177 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 44' ' ' GLN . . . . . 0.489 ' OE1' ' HA ' ' B' ' 44' ' ' GLN . 13.8 mm100 -62.55 -38.12 88.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.379 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.35 -26.71 64.48 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.651 ' HB2' ' OD1' ' B' ' 43' ' ' ASN . 58.0 t80 -60.04 -43.61 95.23 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 0.738 HG13 ' O ' ' B' ' 52' ' ' TYR . 53.3 t -61.63 -46.4 96.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.091 -178.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -63.09 -45.02 94.05 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.262 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 60.3 ttm -62.75 -42.6 99.75 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 34.3 p -93.77 -17.63 22.93 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.968 -178.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 51' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' B' ' 47' ' ' VAL . . . 73.59 19.83 79.75 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 178.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 52' ' ' TYR . . . . . 0.738 ' O ' HG13 ' B' ' 47' ' ' VAL . 70.8 m-85 -112.08 145.64 39.38 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.244 -0.478 . . . . 0.0 110.172 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -74.39 148.96 40.73 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.684 0.754 . . . . 0.0 111.173 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.05 -38.15 87.65 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.698 -177.087 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.83 -39.94 95.89 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 120.238 -0.585 . . . . 0.0 111.854 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -73.76 -32.89 64.04 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.613 HD13 ' CD2' ' B' ' 46' ' ' PHE . 93.4 mt -66.2 -72.12 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 95.6 mt -37.19 131.82 0.79 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.71 175.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.28 -12.22 66.77 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.957 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -133.98 149.92 51.24 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.358 0.599 . . . . 0.0 112.595 -174.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 61' ' ' ASN . . . . . 0.509 ' C ' ' H ' ' B' ' 63' ' ' ARG . 25.9 t-20 -77.66 153.31 33.23 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.8 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 62' ' ' CYS . . . . . . . . . . . . . 84.6 m -64.91 9.12 0.1 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.524 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 63' ' ' ARG . . . . . 0.509 ' H ' ' C ' ' B' ' 61' ' ' ASN . 33.5 ptt-85 -58.72 -32.04 68.83 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.719 -178.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -60.33 -31.06 69.94 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 85.4 mt -61.82 -42.53 99.14 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -178.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -50.0 146.01 5.16 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 123.624 0.577 . . . . 0.0 109.764 -178.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 67' ' ' GLY . . . . . 0.546 ' N ' ' OG1' ' B' ' 70' ' ' THR . . . -156.19 -152.24 6.19 Favored Glycine 0 CA--C 1.54 1.656 0 CA-C-N 115.1 -0.955 . . . . 0.0 112.773 175.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -60.19 -40.76 91.17 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.576 -0.312 . . . . 0.0 111.64 -175.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 69' ' ' HIS . . . . . 0.436 ' O ' ' NE2' ' B' ' 93' ' ' GLN . 11.0 m80 -76.36 -9.27 58.52 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 123.092 0.245 . . . . 0.0 111.434 -178.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 70' ' ' THR . . . . . 0.546 ' OG1' ' N ' ' B' ' 67' ' ' GLY . 26.5 m -61.25 134.3 56.84 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -91.78 110.84 46.33 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.162 -178.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.43 -39.02 89.5 Favored 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 121.035 1.157 . . . . 0.0 111.917 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.74 -41.12 90.23 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 120.508 -0.477 . . . . 0.0 109.871 -176.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 74' ' ' GLU . . . . . 0.443 ' OE1' ' HB ' ' B' ' 90' ' ' VAL . 79.0 mm-40 -66.36 -38.96 88.78 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.752 177.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 85.9 t -61.88 -46.26 96.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -63.21 -36.84 84.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.751 -178.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -62.24 -42.12 99.03 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 119.168 -1.013 . . . . 0.0 108.642 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 95.0 mt -63.53 -43.49 98.33 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 CA-C-O 120.751 0.31 . . . . 0.0 110.574 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -62.1 -42.54 99.32 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 94.9 m -61.65 -45.79 92.52 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.137 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.49 -41.49 97.34 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -177.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 86.0 mt -62.95 -42.57 99.86 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -178.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 66.8 tp60 -62.84 -33.86 76.12 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -91.39 8.28 36.99 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.498 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 37.9 tttt 40.05 41.6 0.95 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.403 -0.519 . . . . 0.0 111.946 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -124.45 140.91 36.27 Favored Pre-proline 0 N--CA 1.47 0.57 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.171 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -61.99 141.11 88.07 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 120.99 1.127 . . . . 0.0 113.827 -178.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -139.78 136.14 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.325 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 89' ' ' THR . . . . . 0.902 HG23 ' OD1' ' B' ' 107' ' ' ASN . 92.6 m -120.12 121.26 38.42 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.831 178.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.443 ' HB ' ' OE1' ' B' ' 74' ' ' GLU . 29.2 m -139.09 162.99 27.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.978 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -113.49 119.58 38.06 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.153 0.502 . . . . 0.0 109.694 175.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 20.8 tt -126.42 131.99 70.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.144 -175.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 93' ' ' GLN . . . . . 0.488 ' O ' ' ND2' ' B' ' 94' ' ' ASN . 34.3 mt-30 -72.56 145.57 47.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.194 177.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 94' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' B' ' 93' ' ' GLN . 8.7 m120 -138.54 -179.67 5.94 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 121.359 0.6 . . . . 0.0 110.61 -177.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 95' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -129.62 148.26 51.5 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.525 177.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 96' ' ' LYS . . . . . 0.468 ' HG3' ' CE1' ' B' ' 102' ' ' PHE . 98.8 mttt -104.71 -179.08 3.84 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.02 0.438 . . . . 0.0 110.59 178.059 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.31 -36.25 77.48 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.211 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 37.6 p-10 -87.45 -1.29 57.82 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.931 0.787 . . . . 0.0 112.832 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.99 5.07 64.45 Favored Glycine 0 N--CA 1.466 0.69 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.249 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 26.5 m -67.32 128.38 36.18 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.305 177.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 101' ' ' MET . . . . . 0.663 ' SD ' ' N ' ' B' ' 102' ' ' PHE . 13.9 tmm? -87.5 143.5 27.19 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 102' ' ' PHE . . . . . 0.663 ' N ' ' SD ' ' B' ' 101' ' ' MET . 53.2 p90 -154.86 163.86 39.66 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 103' ' ' TRP . . . . . 0.934 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 24.5 m95 -96.72 137.4 35.86 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.944 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 104' ' ' ASN . . . . . 0.507 HD21 ' HG2' ' B' ' 123' ' ' GLN . 62.7 t-20 -132.17 110.84 10.95 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 114.904 -1.043 . . . . 0.0 113.686 -176.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -80.4 124.52 28.96 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 123.842 0.713 . . . . 0.0 109.185 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 39.8 tp -111.25 125.29 53.66 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.002 0.429 . . . . 0.0 111.824 -177.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 107' ' ' ASN . . . . . 0.902 ' OD1' HG23 ' B' ' 89' ' ' THR . 97.9 m-20 -120.05 126.73 51.51 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 176.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 96.4 mt -122.79 133.33 69.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -143.23 123.39 7.85 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -70.0 151.92 67.88 Favored 'Trans proline' 0 N--CA 1.504 2.119 0 C-N-CA 122.657 2.238 . . . . 0.0 112.582 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 111' ' ' MET . . . . . 0.506 ' HB2' ' HB2' ' B' ' 118' ' ' TYR . 67.1 mtt -128.28 143.76 51.06 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.259 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -113.79 107.28 15.52 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 113' ' ' ILE . . . . . 0.585 HG12 ' NZ ' ' A' ' 18' ' ' LYS . 96.6 mt -134.62 127.77 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 O-C-N 121.811 -0.556 . . . . 0.0 112.071 178.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 51.15 38.5 21.14 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 123.834 0.709 . . . . 0.0 109.814 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 61.21 35.42 18.36 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.526 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -132.58 149.07 52.37 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 117' ' ' THR . . . . . 0.491 HG23 ' HG3' ' B' ' 32' ' ' PRO . 10.0 t -101.64 153.62 19.6 Favored 'General case' 0 C--O 1.214 -0.775 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -178.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 118' ' ' TYR . . . . . 0.506 ' HB2' ' HB2' ' B' ' 111' ' ' MET . 96.9 m-85 -148.13 147.55 29.61 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 121.317 -0.864 . . . . 0.0 111.497 -178.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -122.27 137.93 54.67 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 123.626 0.579 . . . . 0.0 110.9 -177.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -127.32 133.99 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -177.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.94 122.87 6.72 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 94.6 mt -113.52 127.45 70.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 123' ' ' GLN . . . . . 0.507 ' HG2' HD21 ' B' ' 104' ' ' ASN . 17.8 mp0 -118.45 121.6 40.71 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -121.42 119.34 31.8 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 125' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' B' ' 126' ' ' ILE . 67.9 t0 -68.31 135.54 52.05 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.57 -177.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.528 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 2.8 mp -107.41 17.72 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.512 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 127' ' ' THR . . . . . 0.5 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 97.5 m -63.95 -44.15 93.68 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 114.439 -1.255 . . . . 0.0 112.687 177.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -62.18 -45.85 91.55 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -177.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 129' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -62.58 -35.1 78.42 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.43 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 130' ' ' LYS . . . . . 0.934 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 98.6 mttt -63.64 -41.33 98.25 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-N 112.817 -1.992 . . . . 0.0 110.728 175.152 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.71 -41.64 95.85 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 132' ' ' TYR . . . . . 0.766 ' CE2' HD11 ' B' ' 136' ' ' LEU . 90.0 t80 -60.47 -44.57 95.75 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.831 -0.543 . . . . 0.0 111.566 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 133' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' B' ' 137' ' ' GLU . 97.0 mt-10 -64.47 -36.35 83.9 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.55 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.27 -39.16 93.82 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.833 177.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.76 -41.24 99.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.565 0.698 . . . . 0.0 109.378 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 136' ' ' LEU . . . . . 0.766 HD11 ' CE2' ' B' ' 132' ' ' TYR . 84.5 mt -63.0 -41.67 99.65 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.453 178.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 137' ' ' GLU . . . . . 0.411 ' HG3' ' O ' ' B' ' 133' ' ' GLU . 97.1 mt-10 -65.28 -37.51 87.41 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 113.523 -1.672 . . . . 0.0 110.229 -178.14 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -63.43 -43.36 97.66 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.055 176.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 65.6 m -60.64 -44.57 96.23 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 140' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' B' ' 144' ' ' THR . 86.1 mt -61.5 -40.13 93.5 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -177.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 95.4 m -61.67 -45.65 93.09 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.994 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -66.38 -42.6 87.69 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 93.8 mt -63.58 -43.5 98.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 114.438 -1.256 . . . . 0.0 110.591 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 144' ' ' THR . . . . . 0.417 ' N ' ' O ' ' B' ' 140' ' ' LEU . 91.0 m -61.76 -45.07 95.47 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.65 -41.08 96.36 Favored 'General case' 0 C--O 1.226 -0.149 0 C-N-CA 119.161 -1.016 . . . . 0.0 109.435 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.87 -41.18 95.86 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 176.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 147' ' ' SER . . . . . 0.575 ' O ' ' N ' ' B' ' 149' ' ' PRO . 78.3 p -62.44 -41.82 99.01 Favored 'General case' 0 CA--C 1.478 -1.79 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 148' ' ' THR . . . . . 0.488 ' C ' ' O ' ' B' ' 147' ' ' SER . 7.1 m -26.1 86.45 0.04 OUTLIER Pre-proline 0 N--CA 1.482 1.148 0 O-C-N 124.196 0.935 . . . . 0.0 110.425 176.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 149' ' ' PRO . . . . . 0.575 ' N ' ' O ' ' B' ' 147' ' ' SER . 24.1 Cg_exo -60.8 145.96 98.16 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 121.613 1.542 . . . . 0.0 115.342 -176.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 9.4 tp -127.68 119.83 52.78 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.828 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 172.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 61.0 t -150.25 94.88 3.65 Favored Pre-proline 0 C--N 1.303 -1.418 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.064 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -62.28 143.03 93.43 Favored 'Trans proline' 0 N--CA 1.485 0.983 0 N-CA-C 109.512 -0.995 . . . . 0.0 109.512 -179.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 153' ' ' ILE . . . . . 0.564 HG21 HH12 ' A' ' 154' ' ' ARG . 44.1 mm -76.19 -66.52 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 154' ' ' ARG . . . . . 0.725 ' HD3' ' NH2' ' A' ' 154' ' ' ARG . 4.4 mpt_? -132.06 -157.92 0.85 Allowed 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.039 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 62.5 t-20 -83.98 110.39 18.39 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.06 -18.23 55.98 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -178.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 86.4 mt -108.34 124.61 64.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.993 0.425 . . . . 0.0 111.068 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 158' ' ' SER . . . . . 0.625 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 67.0 m -135.98 149.65 48.94 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.74 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -133.83 145.67 49.94 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 22.7 tp -137.28 80.22 34.64 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 161' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -72.19 149.63 52.12 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.623 2.215 . . . . 0.0 114.048 -177.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 92.1 mt -115.29 134.52 55.05 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 55.5 t -129.98 132.66 65.4 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 113.98 169.59 16.79 Favored Glycine 0 N--CA 1.47 0.911 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.48 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 165' ' ' ASN . . . . . 0.683 ' O ' ' CZ ' ' B' ' 170' ' ' ARG . 62.9 t30 -89.97 107.39 19.09 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -177.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 166' ' ' LEU . . . . . 0.613 HD21 ' CZ ' ' B' ' 171' ' ' PHE . 44.0 tp -64.55 104.49 0.8 Allowed 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -175.017 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 167' ' ' THR . . . . . 0.685 HG23 ' NE ' ' B' ' 170' ' ' ARG . 10.5 p -84.19 169.74 14.49 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-N 114.116 -1.402 . . . . 0.0 110.894 177.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -66.92 -37.42 84.29 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.637 177.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.86 -40.39 87.85 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-O 122.119 0.961 . . . . 0.0 111.554 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 170' ' ' ARG . . . . . 0.685 ' NE ' HG23 ' B' ' 167' ' ' THR . 88.0 mtm180 -62.48 -35.98 81.04 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 112.762 -2.017 . . . . 0.0 111.248 178.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 171' ' ' PHE . . . . . 0.613 ' CZ ' HD21 ' B' ' 166' ' ' LEU . 0.5 OUTLIER -54.82 -25.64 29.78 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -178.686 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 172' ' ' ASN . . . . . 0.534 ' O ' HG22 ' B' ' 175' ' ' VAL . 91.9 m-20 -62.67 -40.26 96.52 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.804 178.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 49.2 m -60.52 -41.48 94.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.145 0.498 . . . . 0.0 110.801 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 65.9 mt -63.86 -44.03 97.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 175' ' ' VAL . . . . . 0.534 HG22 ' O ' ' B' ' 172' ' ' ASN . 33.3 m -62.54 -40.21 87.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 176' ' ' CYS . . . . . 0.418 ' N ' HG23 ' B' ' 175' ' ' VAL . 99.9 m -62.02 -35.23 77.94 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.381 178.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 177' ' ' THR . . . . . 0.556 ' O ' HG13 ' B' ' 181' ' ' ILE . 24.7 m -61.32 -20.27 62.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.938 0.399 . . . . 0.0 110.184 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 178' ' ' LEU . . . . . 0.672 ' CD2' HD21 ' B' ' 211' ' ' LEU . 87.8 mt -61.1 -39.47 90.08 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.281 -177.48 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 19.0 m -61.85 -44.4 96.91 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.322 177.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 180' ' ' ASN . . . . . 0.575 ' O ' ' OG ' ' B' ' 183' ' ' SER . 92.9 m-20 -61.88 -40.73 96.4 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.802 0.334 . . . . 0.0 110.411 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.556 HG13 ' O ' ' B' ' 177' ' ' THR . 75.1 mt -55.69 -31.2 28.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 C-N-CA 120.916 -0.314 . . . . 0.0 110.897 -178.181 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 182' ' ' LEU . . . . . 0.514 HD21 HD21 ' B' ' 214' ' ' LEU . 85.1 mt -62.8 -42.08 99.56 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.328 177.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 183' ' ' SER . . . . . 0.575 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.2 p -62.91 -32.85 74.22 Favored 'General case' 0 N--CA 1.455 -0.183 0 O-C-N 122.004 -0.435 . . . . 0.0 110.89 177.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 184' ' ' THR . . . . . 0.427 ' OG1' ' HA ' ' B' ' 181' ' ' ILE . 21.0 p -85.49 16.09 4.05 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.77 0.319 . . . . 0.0 111.775 -178.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 79.2 p -59.68 -17.52 34.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.034 -177.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.78 -40.52 95.49 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.683 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 187' ' ' ASP . . . . . 0.625 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.2 m-20 -69.31 113.34 6.55 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.519 0.676 . . . . 0.0 110.632 -178.015 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -62.7 -41.96 99.39 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-N 114.807 -1.088 . . . . 0.0 113.154 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -112.49 130.45 55.99 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.2 -178.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 190' ' ' LEU . . . . . . . . . . . . . 41.1 tp -124.07 118.73 27.61 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.025 177.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 86.6 mt -107.12 126.82 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-O 120.608 0.242 . . . . 0.0 111.416 -177.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 49.2 mm -115.66 117.53 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 193' ' ' ASP . . . . . 0.503 ' CG ' ' HG ' ' B' ' 195' ' ' SER . 41.2 t0 -88.49 109.74 20.29 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.04 0.448 . . . . 0.0 112.11 -177.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 194' ' ' LEU . . . . . . . . . . . . . 96.3 mt -90.34 -3.53 57.68 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.517 176.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 195' ' ' SER . . . . . 0.503 ' HG ' ' CG ' ' B' ' 193' ' ' ASP . 78.1 p -61.46 -36.68 81.12 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.896 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.04 -33.24 83.26 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 197' ' ' LEU . . . . . 1.01 HD23 ' N ' ' B' ' 198' ' ' ALA . 4.8 tt -78.38 132.83 37.53 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 122.163 -0.61 . . . . 0.0 109.489 -177.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 198' ' ' ALA . . . . . 1.01 ' N ' HD23 ' B' ' 197' ' ' LEU . . . -63.15 -44.21 96.15 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 119.454 -0.899 . . . . 0.0 110.765 -177.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 199' ' ' GLN . . . . . 0.972 ' O ' ' CD2' ' B' ' 197' ' ' LEU . 58.0 tt0 -137.58 165.99 25.0 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.778 0.799 . . . . 0.0 112.947 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 200' ' ' VAL . . . . . 0.524 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 47.3 t -121.46 132.07 71.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 O-C-N 120.716 -1.24 . . . . 0.0 109.384 177.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -91.09 149.26 21.89 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.15 0.5 . . . . 0.0 110.979 -178.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.22 -32.92 71.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.414 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -64.79 -32.26 73.87 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.4 m -60.3 -44.33 95.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.572 178.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 205' ' ' ALA . . . . . 0.706 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -58.51 -28.31 65.3 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -65.42 -38.68 90.64 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.224 0.535 . . . . 0.0 109.874 176.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -67.52 -38.08 83.74 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.934 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 96.3 mt -63.61 -43.42 98.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.208 0.527 . . . . 0.0 109.866 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 209' ' ' PHE . . . . . 0.706 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 71.7 m-85 -62.19 -42.99 99.8 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.275 -1.33 . . . . 0.0 112.859 177.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -63.52 -41.35 98.5 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 119.492 -0.883 . . . . 0.0 109.545 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 211' ' ' LEU . . . . . 0.672 HD21 ' CD2' ' B' ' 178' ' ' LEU . 40.2 mt -62.54 -42.37 99.49 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.33 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 78.2 p -63.14 -36.66 84.36 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.224 -0.59 . . . . 0.0 111.873 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 213' ' ' HIS . . . . . 0.414 ' CE1' HD11 ' B' ' 217' ' ' LEU . 58.8 t-80 -67.58 -46.36 72.89 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 115.362 -0.836 . . . . 0.0 112.204 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.514 HD21 HD21 ' B' ' 182' ' ' LEU . 52.8 tp -63.77 -42.73 97.74 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.963 0.887 . . . . 0.0 109.994 177.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 215' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' B' ' 211' ' ' LEU . 89.6 mt -62.94 -44.06 97.1 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 113.454 -1.703 . . . . 0.0 111.708 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.33 -39.47 93.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.743 -176.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 217' ' ' LEU . . . . . 0.414 HD11 ' CE1' ' B' ' 213' ' ' HIS . 86.1 mt -63.79 -42.11 97.79 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.349 0.595 . . . . 0.0 111.434 176.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 218' ' ' THR . . . . . 0.425 HG23 ' O ' ' B' ' 214' ' ' LEU . 68.6 p -74.42 -17.58 60.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.063 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 80.61 69.42 1.4 Allowed Glycine 0 CA--C 1.528 0.87 0 N-CA-C 106.424 -2.67 . . . . 0.0 106.424 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 220' ' ' THR . . . . . . . . . . . . . 96.7 m -149.02 101.4 3.16 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 177.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -59.59 140.08 56.64 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.907 0.384 . . . . 0.0 111.055 -176.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 42.7 tp -117.54 121.62 41.46 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.313 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 4.3 mp -109.09 128.72 64.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.155 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 224' ' ' ILE . . . . . 0.525 ' CG2' HD11 ' B' ' 227' ' ' ILE . 49.8 mm -109.86 127.3 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.573 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 43.3 p -133.16 158.15 43.54 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.574 0.702 . . . . 0.0 112.684 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 88.44 19.98 50.2 Favored Glycine 0 CA--C 1.499 -0.943 0 CA-C-N 113.762 -1.563 . . . . 0.0 111.175 -178.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 227' ' ' ILE . . . . . 0.768 HD12 HG23 ' B' ' 247' ' ' THR . 95.9 mt -83.84 125.69 40.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 O-C-N 122.12 -0.635 . . . . 0.0 111.464 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 37.4 tttt -65.51 138.67 96.95 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.494 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.2 -37.02 94.56 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 121.424 1.416 . . . . 0.0 112.538 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -64.16 -43.34 95.46 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 50.5 tp -61.92 -41.61 98.13 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.826 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.13 -36.19 83.23 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.735 0.302 . . . . 0.0 111.286 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 94.7 mtp -64.15 -40.53 96.34 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.26 -42.41 99.15 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 122.085 0.945 . . . . 0.0 109.219 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 30.4 mmt -64.06 -35.42 80.66 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 114.625 -1.171 . . . . 0.0 112.102 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -62.26 -40.24 95.55 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.891 -177.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.07 -44.11 96.69 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.09 178.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.08 -44.95 95.56 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 120.383 -0.527 . . . . 0.0 112.303 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -158.88 133.82 8.26 Favored 'General case' 0 CA--C 1.51 -0.577 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.888 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 240' ' ' ALA . . . . . . . . . . . . . . . -62.61 -47.43 83.79 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 177.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 241' ' ' ASN . . . . . 0.465 ' O ' ' HB2' ' B' ' 244' ' ' SER . 90.2 m-20 -41.65 -19.71 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.477 -176.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 242' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -61.9 -44.87 95.89 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.816 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 243' ' ' SER . . . . . 0.432 ' O ' ' N ' ' B' ' 245' ' ' LEU . 78.1 p -57.87 -44.68 86.79 Favored 'General case' 0 C--N 1.345 0.377 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 244' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 18.0 m -29.43 -36.36 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 245' ' ' LEU . . . . . 0.432 ' N ' ' O ' ' B' ' 243' ' ' SER . 96.4 mt -89.18 133.37 34.44 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.369 -178.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -61.48 134.48 56.92 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 121.155 0.502 . . . . 0.0 110.474 -176.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 247' ' ' THR . . . . . 0.768 HG23 HD12 ' B' ' 227' ' ' ILE . 95.0 m -126.34 128.52 47.21 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.047 -0.978 . . . . 0.0 111.923 178.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 248' ' ' TYR . . . . . 0.477 ' CG ' ' HB2' ' B' ' 254' ' ' ALA . 97.5 m-85 -112.89 144.96 41.57 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.206 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 249' ' ' SER . . . . . 0.59 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 78.2 p -63.76 -33.54 75.89 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.818 -178.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 250' ' ' ASN . . . . . 0.59 ' OD1' ' O ' ' B' ' 249' ' ' SER . 99.3 m-20 -148.45 160.36 43.13 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.049 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 79.2 t -64.63 -44.21 96.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.046 178.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 252' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -61.29 -46.11 91.7 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 253' ' ' ASP . . . . . 0.438 ' O ' HG13 ' B' ' 257' ' ' VAL . 92.9 m-20 -61.07 -43.75 98.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.835 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 254' ' ' ALA . . . . . 0.477 ' HB2' ' CG ' ' B' ' 248' ' ' TYR . . . -65.77 -40.5 92.06 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 120.069 -0.652 . . . . 0.0 111.299 178.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 255' ' ' VAL . . . . . 0.603 HG13 HH11 ' A' ' 154' ' ' ARG . 56.9 t -64.72 -45.75 94.27 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.07 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -63.01 -47.72 81.9 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 119.906 -0.718 . . . . 0.0 111.487 -178.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 257' ' ' VAL . . . . . 0.441 ' O ' ' C ' ' B' ' 258' ' ' LEU . 18.8 m -64.73 -40.41 88.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.533 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 258' ' ' LEU . . . . . 0.485 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 1.7 mt -33.79 -71.33 0.1 Allowed Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.479 -177.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 259' ' ' PRO . . . . . 0.569 ' O ' HG13 ' B' ' 260' ' ' ILE . 37.6 Cg_endo -62.39 139.91 79.49 Favored 'Trans proline' 0 N--CA 1.501 1.965 0 C-N-CA 121.418 1.412 . . . . 0.0 111.193 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 260' ' ' ILE . . . . . 0.569 HG13 ' O ' ' B' ' 259' ' ' PRO . 96.6 mt -159.62 -13.48 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 CA-C-N 118.713 0.688 . . . . 0.0 112.361 176.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 C--O 1.216 -0.686 0 CA-C-O 117.859 -1.067 . . . . 0.0 111.436 -179.983 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.13 170.76 20.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.144 0.497 . . . . 0.0 110.196 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 80.1 p -72.66 -14.71 61.65 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.36 -0.837 . . . . 0.0 111.788 177.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -76.32 -66.59 0.78 Allowed 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 114.326 -1.306 . . . . 0.0 112.966 174.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -66.94 -39.64 87.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.908 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.539 ' O ' ' NZ ' ' B' ' 17' ' ' LYS . 49.8 m -59.25 -41.37 88.63 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -177.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.567 ' CE2' HD12 ' A' ' 9' ' ' ILE . 36.1 t80 84.37 88.23 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.127 0.489 . . . . 0.0 112.034 177.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.47 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -62.19 -137.74 0.01 OUTLIER Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 -177.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.567 HD12 ' CE2' ' A' ' 7' ' ' PHE . 55.8 mt 79.02 109.81 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 122.679 0.392 . . . . 0.0 110.637 -178.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.59 -22.06 70.43 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 121.438 1.425 . . . . 0.0 112.138 -178.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.464 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -63.28 -37.46 94.9 Favored Glycine 0 N--CA 1.468 0.83 0 C-N-CA 121.045 -0.598 . . . . 0.0 111.862 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -66.14 -39.31 89.75 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.514 0.673 . . . . 0.0 109.519 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.1 tp -63.33 -41.46 98.89 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -63.65 -39.9 95.49 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 11' ' ' GLY . 67.9 t -60.03 -44.19 94.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 O-C-N 122.174 -0.329 . . . . 0.0 110.938 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 93.0 mt -62.49 -43.57 98.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 119.589 -0.844 . . . . 0.0 109.321 -178.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.444 ' NZ ' ' HA ' ' B' ' 6' ' ' SER . 98.9 mttt -62.28 -46.19 89.88 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 119.361 -0.936 . . . . 0.0 112.022 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.661 ' HZ1' HG12 ' B' ' 113' ' ' ILE . 98.4 mttt -60.46 -39.54 87.96 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 118.642 -1.223 . . . . 0.0 109.079 -176.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.58 -42.2 91.94 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.144 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.2 mt -62.95 -40.15 96.8 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 177.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.19 -39.39 94.51 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.479 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 60.7 m170 -59.29 -39.42 82.92 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 122.226 -0.297 . . . . 0.0 111.606 -178.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.8 p -113.76 130.64 67.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.49 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 34.6 ptt180 -73.41 109.99 7.35 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-O 122.062 0.934 . . . . 0.0 112.187 -177.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.9 p -141.29 143.75 27.37 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.579 ' O ' ' N ' ' A' ' 123' ' ' GLN . . . -98.91 91.2 1.07 Allowed Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.908 -178.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 52.6 t -124.55 130.45 73.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 175.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.8 m -136.62 159.73 37.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.4 mt -120.43 129.55 75.43 Favored 'Isoleucine or valine' 0 C--O 1.244 0.797 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.467 HG22 HG12 ' A' ' 39' ' ' ILE . 22.4 p -106.56 167.48 9.82 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.425 ' C ' ' OD1' ' A' ' 37' ' ' ASN . 58.6 t0 -133.15 104.13 12.6 Favored Pre-proline 0 C--N 1.321 -0.66 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.251 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.697 ' HG3' HG23 ' A' ' 117' ' ' THR . 36.0 Cg_endo -63.4 -24.59 71.15 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.414 1.409 . . . . 0.0 111.501 -178.257 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.95 -35.75 81.17 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.17 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.4 mt -84.13 157.47 21.69 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.849 178.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.709 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 43.4 tt0 -57.46 134.59 56.2 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 113.361 0.875 . . . . 0.0 113.361 -176.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.526 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 59.2 t0 60.54 23.67 13.36 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.425 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 40.6 t-20 39.23 69.2 1.73 Allowed Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.181 -176.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.709 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 93.3 Cg_endo -70.19 155.31 64.83 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 123.95 3.1 . . . . 0.0 112.123 -178.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.467 HG12 HG22 ' A' ' 30' ' ' THR . 96.0 mt -88.95 122.07 39.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.466 HG23 ' N ' ' A' ' 41' ' ' TYR . 30.3 m -102.01 -45.97 11.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.243 -178.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.466 ' N ' HG23 ' A' ' 40' ' ' VAL . 48.9 t80 -93.72 124.36 37.67 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 120.185 -0.606 . . . . 0.0 111.949 -178.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.7 p -143.09 140.27 27.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.226 0.953 . . . . 0.0 109.217 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.614 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 56.9 p30 -96.49 166.43 11.69 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.474 ' HA ' ' OE1' ' A' ' 44' ' ' GLN . 14.9 mm100 -66.55 -39.82 88.72 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 177.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.89 -24.25 60.12 Favored Glycine 0 N--CA 1.453 -0.209 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.631 ' CD2' HD13 ' A' ' 57' ' ' ILE . 65.5 t80 -59.61 -47.86 83.92 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 -179.092 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.579 HG13 ' O ' ' A' ' 52' ' ' TYR . 71.4 t -58.96 -44.54 91.24 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.646 0 O-C-N 121.301 -0.875 . . . . 0.0 111.745 -174.087 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -63.25 -37.29 86.68 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 120.399 -0.52 . . . . 0.0 112.301 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 59.2 ttm -66.79 -43.38 84.1 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 176.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 36.3 p -93.51 -21.18 19.62 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.346 0.593 . . . . 0.0 111.541 -177.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . 76.44 20.46 76.88 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -179.213 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.579 ' O ' HG13 ' A' ' 47' ' ' VAL . 82.1 m-85 -113.25 137.08 52.01 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 122.783 0.433 . . . . 0.0 111.12 178.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -62.62 146.99 50.65 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.558 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.426 HG22 ' H ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -64.84 -32.9 74.82 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -179.485 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -66.69 -43.1 85.31 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.516 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -64.67 -45.65 85.77 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.073 -0.651 . . . . 0.0 109.252 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.631 HD13 ' CD2' ' A' ' 46' ' ' PHE . 89.1 mt -61.26 -49.84 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -175.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.1 mt -55.53 148.27 16.02 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 176.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.28 -3.44 77.38 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.873 -0.679 . . . . 0.0 113.062 177.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -137.15 151.41 48.78 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 118.705 1.252 . . . . 0.0 112.037 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.575 ' C ' ' H ' ' A' ' 63' ' ' ARG . 25.1 t-20 -81.77 151.71 27.31 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.553 -178.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 79.2 m -62.09 15.39 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.373 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.575 ' H ' ' C ' ' A' ' 61' ' ' ASN . 35.2 ptt-85 -62.21 -41.41 98.34 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.139 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -56.04 -21.99 24.81 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.2 mt -67.33 -35.73 80.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 122.066 0.936 . . . . 0.0 112.916 177.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -63.21 146.38 53.51 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.847 -1.069 . . . . 0.0 112.263 -178.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.496 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -156.54 -150.93 5.8 Favored Glycine 0 CA--C 1.538 1.519 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -177.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.75 -41.29 99.14 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.582 ' O ' ' NE2' ' A' ' 93' ' ' GLN . 9.2 m80 -76.21 -9.08 58.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.847 0.356 . . . . 0.0 110.916 -178.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.496 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 32.9 m -62.62 128.69 37.14 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.595 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -84.75 110.99 31.8 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.825 -179.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -57.29 -31.09 89.88 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 121.997 1.798 . . . . 0.0 113.207 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.5 -39.31 93.54 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.888 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.571 ' OE1' ' HB ' ' A' ' 90' ' ' VAL . 79.1 mm-40 -65.45 -44.43 87.28 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.0 t -59.31 -44.1 91.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -176.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -63.97 -38.19 90.17 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.004 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -63.68 -39.6 94.73 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.403 0.621 . . . . 0.0 110.24 178.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 94.1 mt -63.71 -44.12 98.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.053 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -62.88 -42.52 99.8 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 113.814 -1.539 . . . . 0.0 108.309 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 97.6 m -61.24 -49.37 77.37 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.65 -42.46 92.87 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.189 -172.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.5 mt -63.45 -39.56 94.79 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.007 -1.058 . . . . 0.0 111.492 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -64.06 -33.16 75.12 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -89.08 -2.63 58.64 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.381 -178.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.2 tttt 49.22 40.78 18.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.59 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -122.69 144.26 42.11 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -61.32 142.88 97.37 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 121.473 1.448 . . . . 0.0 113.543 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -139.75 141.63 34.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.589 -178.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.93 HG23 ' OD1' ' A' ' 107' ' ' ASN . 98.8 m -128.12 120.05 26.57 Favored 'General case' 0 C--N 1.344 0.332 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 175.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.571 ' HB ' ' OE1' ' A' ' 74' ' ' GLU . 28.4 m -138.85 158.7 30.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.465 178.103 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -101.76 132.39 47.51 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 177.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.453 ' O ' HG23 ' A' ' 92' ' ' ILE . 19.2 tt -139.99 129.44 28.29 Favored 'Isoleucine or valine' 0 C--N 1.377 1.789 0 CA-C-N 121.557 1.98 . . . . 0.0 112.527 176.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.582 ' NE2' ' O ' ' A' ' 69' ' ' HIS . 34.1 mt-30 -62.98 133.45 54.63 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.55 -1.205 . . . . 0.0 109.948 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -134.48 158.33 44.19 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.758 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.428 ' CE1' ' HA3' ' A' ' 67' ' ' GLY . 92.7 m-85 -116.16 135.13 54.2 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -179.178 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.438 ' HG3' ' CE1' ' A' ' 102' ' ' PHE . 99.2 mttt -83.69 -172.51 4.19 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.161 0.505 . . . . 0.0 111.618 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.05 -42.26 99.66 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.158 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 41.0 p-10 -83.31 5.84 21.84 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.51 -0.65 88.39 Favored Glycine 0 N--CA 1.47 0.925 0 O-C-N 121.547 -0.721 . . . . 0.0 112.126 176.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.1 m -59.83 138.32 57.83 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.649 ' SD ' ' C ' ' A' ' 101' ' ' MET . 14.9 tmm? -104.45 128.75 52.42 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.561 0.22 . . . . 0.0 110.782 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.438 ' CE1' ' HG3' ' A' ' 96' ' ' LYS . 52.7 p90 -141.44 158.55 43.72 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.888 -176.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.638 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 20.7 m95 -90.81 141.29 28.96 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.571 HD21 ' HG2' ' A' ' 123' ' ' GLN . 53.1 t-20 -136.41 106.8 6.44 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -177.209 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.443 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 80.5 tt0 -72.37 134.9 45.7 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 -177.021 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 43.9 tp -120.78 123.07 41.76 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASN . . . . . 0.93 ' OD1' HG23 ' A' ' 89' ' ' THR . 98.0 m-20 -118.68 123.86 45.96 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.866 177.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 96.3 mt -120.21 128.45 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 O-C-N 123.525 0.516 . . . . 0.0 111.57 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -137.96 123.09 12.35 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 116.764 -0.198 . . . . 0.0 110.925 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -70.26 150.85 65.76 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.454 2.103 . . . . 0.0 112.578 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' MET . . . . . 0.634 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 66.3 mtt -122.67 152.63 40.34 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -127.23 91.51 3.33 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 177.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.411 ' CD1' HG22 ' B' ' 15' ' ' VAL . 96.7 mt -117.81 130.57 72.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.275 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 53.31 36.56 23.13 Favored 'General case' 0 CA--C 1.513 -0.472 0 O-C-N 121.461 -0.774 . . . . 0.0 111.648 176.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 59.21 30.62 20.41 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 123.853 0.721 . . . . 0.0 110.813 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -127.52 149.55 50.08 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.782 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 9.9 t -85.79 -173.11 4.45 Favored 'General case' 0 C--O 1.219 -0.504 0 O-C-N 121.687 -0.633 . . . . 0.0 109.489 -178.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' TYR . . . . . 0.782 ' CD2' ' O ' ' A' ' 117' ' ' THR . 69.0 m-85 -171.9 155.71 3.92 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 174.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -131.51 146.34 52.18 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 174.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.87 135.1 55.57 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 177.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -106.9 127.27 8.78 Favored Glycine 0 CA--C 1.502 -0.765 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 177.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 96.3 mt -117.89 129.27 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.579 ' N ' ' O ' ' A' ' 26' ' ' GLY . 15.9 mp0 -120.18 115.74 24.24 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 123.69 0.619 . . . . 0.0 109.793 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -115.35 113.14 23.4 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.817 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.401 ' OD1' ' C ' ' A' ' 125' ' ' ASP . 68.4 t0 -65.77 123.23 19.2 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -175.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.519 ' O ' HG22 ' A' ' 126' ' ' ILE . 3.0 mp -87.0 2.89 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 113.666 -1.606 . . . . 0.0 110.194 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 31.6 m -60.13 -42.47 94.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.042 -1.036 . . . . 0.0 113.393 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -59.66 -42.6 93.2 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -178.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -62.38 -39.19 92.36 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.855 176.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.638 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.8 mttt -62.53 -40.71 97.64 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 118.31 -1.356 . . . . 0.0 110.494 -178.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.53 -37.27 85.44 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.357 -0.537 . . . . 0.0 109.657 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.836 ' CE2' HD11 ' A' ' 136' ' ' LEU . 90.6 t80 -61.74 -45.7 92.8 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.244 176.262 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.33 -39.44 93.91 Favored 'General case' 0 C--O 1.226 -0.179 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.48 -41.23 96.95 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 50.6 tp -61.09 -43.76 98.39 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 -177.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.836 HD11 ' CE2' ' A' ' 132' ' ' TYR . 88.5 mt -62.22 -41.08 98.06 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.882 178.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -62.76 -41.36 99.18 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 119.453 -0.899 . . . . 0.0 109.762 -178.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -60.99 -42.01 97.58 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -177.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 53.7 m -61.67 -41.34 97.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.71 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 144' ' ' THR . 87.5 mt -63.39 -41.89 98.78 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.785 178.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 87.3 m -61.65 -45.33 94.49 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.381 -177.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -65.05 -41.3 95.27 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 96.4 mt -64.45 -43.6 96.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.005 -1.452 . . . . 0.0 111.235 175.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.518 ' N ' ' O ' ' A' ' 140' ' ' LEU . 95.6 m -62.29 -46.32 89.28 Favored 'General case' 0 C--N 1.345 0.411 0 C-N-CA 120.364 -0.534 . . . . 0.0 112.185 -178.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.22 -41.21 99.08 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 118.882 -1.127 . . . . 0.0 109.15 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.6 mt -63.93 -42.67 97.3 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 178.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.702 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.2 p -59.6 -38.38 81.1 Favored 'General case' 0 C--O 1.218 -0.598 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -178.043 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.465 ' C ' ' O ' ' A' ' 147' ' ' SER . 86.1 m -28.97 82.37 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.32 0 O-C-N 126.944 2.653 . . . . 0.0 106.101 -178.286 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.702 ' N ' ' O ' ' A' ' 147' ' ' SER . 23.2 Cg_exo -61.85 145.0 97.32 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 CA-C-O 122.788 1.078 . . . . 0.0 114.301 -174.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.595 ' O ' HG23 ' A' ' 151' ' ' VAL . 9.5 tp -120.44 136.49 57.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 102.502 -3.147 . . . . 0.0 102.502 176.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 150' ' ' ILE . 96.3 t -167.9 93.83 0.64 Allowed Pre-proline 0 CA--C 1.506 -0.725 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 178.015 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -63.82 143.71 86.74 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 N-CA-C 109.901 -0.846 . . . . 0.0 109.901 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.72 ' O ' HG11 ' B' ' 255' ' ' VAL . 44.3 mm -77.03 -68.71 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.659 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ARG . . . . . 0.665 ' NH2' ' HD3' ' B' ' 154' ' ' ARG . 3.1 mpt_? -132.99 -161.41 1.14 Allowed 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -83.34 104.99 13.93 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.849 0.833 . . . . 0.0 111.291 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.8 10.06 60.49 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 113.904 -1.498 . . . . 0.0 110.2 -177.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.5 mt -126.98 125.67 66.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.735 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 58.7 m -132.25 152.46 51.34 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -138.37 142.28 39.64 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.481 177.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 27.4 tp -135.45 80.58 45.03 Favored Pre-proline 0 N--CA 1.468 0.454 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.386 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -70.98 151.54 62.22 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.638 2.225 . . . . 0.0 113.005 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 88.6 mt -117.65 126.79 53.14 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.184 177.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 47.7 t -122.95 130.13 74.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 116.57 167.49 14.69 Favored Glycine 0 N--CA 1.479 1.558 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.179 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.841 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 57.6 t30 -84.16 115.83 22.61 Favored 'General case' 0 C--O 1.222 -0.358 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -178.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.56 HD21 ' CZ ' ' A' ' 171' ' ' PHE . 45.3 tp -74.28 104.83 5.19 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 -177.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.738 HG23 ' NE ' ' A' ' 170' ' ' ARG . 10.8 p -87.04 166.74 14.81 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.269 0.557 . . . . 0.0 110.485 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.97 -33.75 76.54 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.086 0.47 . . . . 0.0 111.773 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.12 -43.76 90.94 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.519 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ARG . . . . . 0.841 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 87.1 mtm180 -64.99 -29.38 70.3 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 178.18 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.56 ' CZ ' HD21 ' A' ' 166' ' ' LEU . 0.5 OUTLIER -54.6 -28.98 50.28 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.604 ' O ' HG22 ' A' ' 175' ' ' VAL . 92.1 m-20 -60.89 -41.12 95.43 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 119.102 -1.039 . . . . 0.0 109.679 -177.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 60.0 m -59.45 -40.81 88.03 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.687 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 67.6 mt -63.25 -44.13 99.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 172' ' ' ASN . 34.5 m -63.0 -39.95 87.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' CYS . . . . . 0.414 ' N ' HG23 ' A' ' 175' ' ' VAL . 98.1 m -62.08 -34.66 76.71 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.431 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.5 ' O ' HG13 ' A' ' 181' ' ' ILE . 25.0 m -61.92 -19.27 62.52 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.097 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.653 ' CD2' HD21 ' A' ' 211' ' ' LEU . 88.2 mt -61.0 -41.02 95.72 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -177.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 17.4 m -58.97 -43.2 91.31 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ASN . . . . . 0.674 ' O ' ' OG ' ' A' ' 183' ' ' SER . 93.1 m-20 -61.76 -35.98 79.69 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 122.507 0.323 . . . . 0.0 110.748 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.504 HD12 ' HA ' ' A' ' 178' ' ' LEU . 65.2 mt -58.99 -40.54 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 121.441 -0.787 . . . . 0.0 109.538 -178.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.548 HD21 HD21 ' A' ' 214' ' ' LEU . 85.6 mt -60.53 -40.18 90.59 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -177.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' SER . . . . . 0.674 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 78.2 p -61.09 -33.5 73.44 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.419 175.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.407 ' OG1' ' HA ' ' A' ' 181' ' ' ILE . 60.0 p -91.71 23.59 3.51 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.7 0.286 . . . . 0.0 111.402 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 77.8 p -63.49 -20.86 65.95 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.674 -178.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.76 -37.65 82.58 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.929 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' ASP . . . . . 0.735 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 98.5 m-20 -71.38 113.75 8.74 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.617 0.722 . . . . 0.0 110.928 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -62.95 -42.73 99.91 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.86 -177.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -112.06 131.36 55.48 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.981 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 39.5 tp -120.01 127.94 53.07 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 177.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 96.2 mt -115.73 125.94 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.6 mm -112.62 126.57 70.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 178.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' ASP . . . . . 0.507 ' OD2' ' OG ' ' A' ' 195' ' ' SER . 38.7 t0 -95.58 118.09 31.64 Favored 'General case' 0 CA--C 1.551 1.007 0 O-C-N 121.88 -0.512 . . . . 0.0 110.443 177.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 194' ' ' LEU . 96.9 mt -97.67 -3.35 39.47 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.848 175.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' SER . . . . . 0.507 ' OG ' ' OD2' ' A' ' 193' ' ' ASP . 78.0 p -62.24 -33.42 74.55 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.86 -44.68 97.52 Favored Glycine 0 CA--C 1.535 1.288 0 N-CA-C 108.39 -1.884 . . . . 0.0 108.39 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.943 HD23 ' N ' ' A' ' 198' ' ' ALA . 4.7 tt -69.22 128.03 35.17 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 112.792 -1.704 . . . . 0.0 108.902 -177.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ALA . . . . . 0.943 ' N ' HD23 ' A' ' 197' ' ' LEU . . . -60.8 -47.0 88.3 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-O 121.253 0.549 . . . . 0.0 110.48 -177.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' GLN . . . . . 0.915 ' O ' ' CD2' ' A' ' 197' ' ' LEU . 58.4 tt0 -135.83 156.86 48.14 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-N 114.623 -1.171 . . . . 0.0 113.851 -173.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.453 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 45.3 t -118.73 132.03 69.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 O-C-N 120.924 -1.11 . . . . 0.0 108.298 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -86.95 156.01 19.97 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.582 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.11 -39.06 93.22 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 120.144 -0.623 . . . . 0.0 109.975 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -57.45 -31.98 66.46 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -178.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.4 m -61.32 -42.08 98.07 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.445 178.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.433 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -58.32 -38.42 77.07 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -176.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -61.81 -37.14 83.3 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -178.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -65.92 -38.18 88.02 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.979 177.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 94.7 mt -62.84 -44.35 99.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -178.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' PHE . . . . . 0.433 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 68.4 m-85 -62.74 -43.06 99.78 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.491 -177.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.27 -42.09 99.04 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 118.961 -1.096 . . . . 0.0 109.168 -178.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.653 HD21 ' CD2' ' A' ' 178' ' ' LEU . 39.8 mt -62.17 -41.87 98.72 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 78.2 p -61.52 -42.36 98.7 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 119.117 -1.033 . . . . 0.0 110.26 -179.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -63.92 -45.43 89.3 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.755 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.548 HD21 HD21 ' A' ' 182' ' ' LEU . 47.8 tp -62.45 -45.87 91.1 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.18 178.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 87.7 mt -62.67 -40.36 96.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.366 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.42 -44.97 95.23 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.507 -177.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 86.2 mt -61.68 -40.29 94.46 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 82.6 p -75.38 -11.41 60.04 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.501 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.88 35.14 19.75 Favored Glycine 0 C--N 1.341 0.832 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.697 -178.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 96.7 m -120.47 113.84 20.9 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 119.051 1.426 . . . . 0.0 111.772 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -66.57 136.5 55.71 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.574 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 45.0 tp -112.63 129.44 56.38 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 3.0 mp -116.3 134.58 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.671 ' CG2' HD11 ' A' ' 227' ' ' ILE . 49.8 mm -115.41 130.74 69.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 44.8 p -133.49 165.04 25.8 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.881 -177.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 78.53 20.46 71.57 Favored Glycine 0 C--O 1.225 -0.462 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' ILE . . . . . 0.671 HD11 ' CG2' ' A' ' 224' ' ' ILE . 98.1 mt -82.32 128.04 39.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 113.767 -1.217 . . . . 0.0 108.248 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -75.67 140.44 71.42 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.09 -39.62 84.92 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 121.018 1.145 . . . . 0.0 112.483 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -63.72 -38.93 92.95 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.418 0.628 . . . . 0.0 110.198 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 52.9 tp -64.23 -42.24 96.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.791 177.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.84 -37.69 88.46 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.09 -178.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 94.0 mtp -63.33 -41.06 98.86 Favored 'General case' 0 C--O 1.249 1.041 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.82 -178.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.87 -38.89 92.78 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.468 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 36.4 mmt -66.21 -37.63 86.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.514 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -61.18 -42.74 99.12 Favored 'General case' 0 CA--C 1.514 -0.405 0 O-C-N 121.58 -0.7 . . . . 0.0 109.617 -176.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.18 -40.09 88.76 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.713 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 56.7 tp -63.3 -41.09 98.93 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -168.15 127.55 1.24 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.33 0.586 . . . . 0.0 112.532 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.47 -26.59 65.37 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.801 178.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.412 ' O ' ' HB2' ' A' ' 244' ' ' SER . 89.4 m-20 -62.67 -29.41 70.62 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.534 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -55.92 -45.64 78.67 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -175.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 98.4 p -60.99 -21.02 63.14 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 123.918 0.761 . . . . 0.0 111.44 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 241' ' ' ASN . 43.1 m -54.39 -40.47 68.22 Favored 'General case' 0 C--N 1.32 -0.713 0 O-C-N 122.342 -0.224 . . . . 0.0 111.553 178.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 95.0 mt -83.18 119.68 24.84 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.403 ' HA ' ' HD3' ' A' ' 246' ' ' LYS . 74.4 mmtt -41.52 134.64 2.3 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.103 178.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.637 HG23 HD12 ' A' ' 227' ' ' ILE . 98.1 m -127.75 134.44 49.52 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.936 177.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 248' ' ' TYR . . . . . 0.493 ' CB ' ' HB2' ' A' ' 254' ' ' ALA . 97.2 m-85 -118.41 139.59 51.16 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.851 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 78.0 p -61.38 -42.74 99.21 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -143.73 159.57 42.26 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.685 0.755 . . . . 0.0 111.599 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 75.9 t -62.53 -44.76 99.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 114.711 -1.132 . . . . 0.0 111.953 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.84 -44.28 97.16 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 253' ' ' ASP . . . . . 0.512 ' O ' HG22 ' A' ' 257' ' ' VAL . 55.4 m-20 -64.14 -42.03 96.95 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.455 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 254' ' ' ALA . . . . . 0.493 ' HB2' ' CB ' ' A' ' 248' ' ' TYR . . . -64.65 -42.47 95.4 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.868 0.842 . . . . 0.0 109.829 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 255' ' ' VAL . . . . . 0.422 HG13 HH11 ' B' ' 154' ' ' ARG . 54.8 t -63.41 -46.04 96.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 113.946 -1.479 . . . . 0.0 111.173 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.7 -46.21 86.52 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 120.589 -0.445 . . . . 0.0 111.459 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.512 HG22 ' O ' ' A' ' 253' ' ' ASP . 32.9 m -66.71 -40.81 86.96 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 O-C-N 121.468 -0.77 . . . . 0.0 112.073 179.024 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.495 ' C ' ' O ' ' A' ' 257' ' ' VAL . 2.1 mt -29.48 -75.47 0.04 OUTLIER Pre-proline 0 C--O 1.234 0.262 0 O-C-N 123.099 0.25 . . . . 0.0 111.522 -177.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 259' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 258' ' ' LEU . 42.5 Cg_endo -63.33 139.96 74.34 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 120.789 0.992 . . . . 0.0 111.825 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 259' ' ' PRO . 96.7 mt -151.85 -27.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 O-C-N 123.953 0.783 . . . . 0.0 111.973 178.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 78.1 mtm . . . . . 0 N--CA 1.473 0.708 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.736 -177.174 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.475 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.91 161.14 22.79 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 79.2 p -59.87 -21.7 61.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.871 177.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -74.21 -64.05 1.1 Allowed 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.969 0.414 . . . . 0.0 111.123 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -65.63 -39.43 91.45 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.281 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 6' ' ' SER . . . . . 0.504 ' O ' ' HB3' ' B' ' 7' ' ' PHE . 49.5 m -59.97 -41.88 92.94 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.094 -0.642 . . . . 0.0 109.792 -177.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 7' ' ' PHE . . . . . 0.561 ' CE2' HD12 ' B' ' 9' ' ' ILE . 37.8 t80 85.48 92.22 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.352 177.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 8' ' ' GLY . . . . . 0.49 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -65.02 -137.18 0.02 OUTLIER Glycine 0 C--N 1.338 0.687 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -178.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 9' ' ' ILE . . . . . 0.561 HD12 ' CE2' ' B' ' 7' ' ' PHE . 55.3 mt 78.62 109.48 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 122.613 0.365 . . . . 0.0 111.162 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -62.24 -23.87 75.68 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 121.304 1.336 . . . . 0.0 111.806 -178.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.3 -40.29 98.4 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -64.5 -39.81 94.48 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.733 0.778 . . . . 0.0 109.267 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 52.7 tp -61.88 -42.55 99.2 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.439 -177.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -65.12 -32.17 73.74 Favored 'General case' 0 CA--C 1.561 1.37 0 CA-C-O 121.479 0.657 . . . . 0.0 110.705 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 15' ' ' VAL . . . . . 0.411 HG22 ' CD1' ' A' ' 113' ' ' ILE . 75.4 t -62.6 -46.03 97.37 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 CA-C-N 113.101 -1.863 . . . . 0.0 110.926 177.282 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 92.6 mt -64.04 -43.81 97.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.871 -178.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 17' ' ' LYS . . . . . 0.539 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 98.9 mttt -63.3 -42.44 99.04 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.21 -41.23 99.12 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 118.998 -1.081 . . . . 0.0 110.026 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.19 -38.85 84.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.867 -178.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' B' ' 20' ' ' LEU . 89.0 mt -64.31 -41.7 96.7 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 121.289 0.566 . . . . 0.0 110.122 174.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.29 -39.89 94.46 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.021 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 59.4 m170 -58.46 -39.58 80.31 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 121.121 -0.231 . . . . 0.0 111.601 -178.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 13.3 p -113.97 130.42 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.5 ' HG3' ' O ' ' B' ' 24' ' ' ARG . 34.6 ptt180 -73.15 108.04 5.82 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-O 121.726 0.774 . . . . 0.0 112.577 -177.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.6 p -143.3 133.8 22.21 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.885 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.687 177.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 26' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' B' ' 123' ' ' GLN . . . -88.43 95.88 2.14 Favored Glycine 0 C--N 1.315 -0.626 0 C-N-CA 119.364 -1.398 . . . . 0.0 113.403 -176.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 47.7 t -125.23 129.54 73.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 174.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 31.8 m -137.97 157.29 32.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.53 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 95.8 mt -119.27 127.42 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.666 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.457 HG22 HG12 ' B' ' 39' ' ' ILE . 31.3 p -109.01 157.04 19.05 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-N 112.795 -2.002 . . . . 0.0 108.567 -177.088 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -124.86 104.26 30.31 Favored Pre-proline 0 C--O 1.235 0.294 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 32' ' ' PRO . . . . . 0.622 ' HG3' HG23 ' B' ' 117' ' ' THR . 37.0 Cg_endo -64.54 -22.51 65.08 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.639 1.559 . . . . 0.0 111.59 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.13 -43.76 98.13 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.423 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 99.4 mt -73.02 174.67 7.55 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.951 -0.468 . . . . 0.0 111.378 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 35' ' ' GLU . . . . . 0.606 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 42.7 tt0 -73.16 131.25 41.8 Favored 'General case' 0 C--N 1.345 0.381 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -176.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.476 ' O ' ' OD1' ' B' ' 36' ' ' ASP . 66.0 t0 57.54 38.19 27.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.625 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 37' ' ' ASN . . . . . 0.465 ' C ' ' O ' ' B' ' 36' ' ' ASP . 29.7 t-20 28.63 71.86 0.47 Allowed Pre-proline 0 CA--C 1.535 0.368 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -178.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.606 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 92.1 Cg_endo -71.77 154.18 59.0 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 123.551 2.834 . . . . 0.0 111.84 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.457 HG12 HG22 ' B' ' 30' ' ' THR . 95.6 mt -87.5 127.91 40.44 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.453 HG23 ' N ' ' B' ' 41' ' ' TYR . 26.7 m -108.03 -45.44 7.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 O-C-N 123.777 0.673 . . . . 0.0 112.437 -178.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 41' ' ' TYR . . . . . 0.453 ' N ' HG23 ' B' ' 40' ' ' VAL . 51.6 t80 -94.73 124.51 38.81 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.552 -178.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 6.0 p -142.97 140.96 27.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.311 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 43' ' ' ASN . . . . . 0.647 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 57.2 p30 -100.34 161.46 13.59 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.086 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 44' ' ' GLN . . . . . 0.446 ' OE1' ' HA ' ' B' ' 44' ' ' GLN . 14.4 mm100 -63.16 -37.98 89.37 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.502 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.17 -25.01 61.72 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.291 -0.723 . . . . 0.0 111.291 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 46' ' ' PHE . . . . . 0.647 ' HB2' ' OD1' ' B' ' 43' ' ' ASN . 61.3 t80 -60.33 -43.3 96.54 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 47' ' ' VAL . . . . . 0.71 HG13 ' O ' ' B' ' 52' ' ' TYR . 69.4 t -61.16 -46.35 96.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.252 -178.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -62.67 -44.22 96.81 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.213 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 59.3 ttm -62.98 -42.06 99.73 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 33.8 p -96.11 -16.1 21.75 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.231 -0.588 . . . . 0.0 111.969 -178.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 51' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' B' ' 47' ' ' VAL . . . 73.08 18.3 79.11 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 178.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 52' ' ' TYR . . . . . 0.71 ' O ' HG13 ' B' ' 47' ' ' VAL . 82.6 m-85 -110.62 143.17 41.46 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.294 -0.453 . . . . 0.0 110.038 178.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -71.79 146.9 47.75 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-O 121.904 0.859 . . . . 0.0 110.994 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 54' ' ' THR . . . . . 0.418 ' H ' HG22 ' B' ' 54' ' ' THR . 0.1 OUTLIER -61.63 -36.8 81.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.065 -177.349 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.37 -39.59 94.18 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.015 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -72.51 -32.04 65.83 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 177.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.645 HD13 ' CE2' ' B' ' 46' ' ' PHE . 95.8 mt -66.68 -71.29 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 178.023 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 94.2 mt -36.61 130.97 0.71 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.38 175.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.24 -8.23 69.54 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.617 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -136.08 149.14 48.6 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -174.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 61' ' ' ASN . . . . . 0.515 ' C ' ' H ' ' B' ' 63' ' ' ARG . 25.7 t-20 -79.55 151.6 30.6 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.798 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 62' ' ' CYS . . . . . . . . . . . . . 78.3 m -62.83 7.91 0.07 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.375 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 63' ' ' ARG . . . . . 0.515 ' H ' ' C ' ' B' ' 61' ' ' ASN . 33.5 ptt-85 -58.79 -31.89 68.82 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.54 -0.755 . . . . 0.0 112.497 -178.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -60.93 -31.2 70.74 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 178.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 81.5 mt -61.94 -42.36 99.02 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -177.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -48.02 151.67 0.92 Allowed 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.155 0.503 . . . . 0.0 109.888 -178.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 67' ' ' GLY . . . . . 0.406 ' N ' ' OG1' ' B' ' 70' ' ' THR . . . -162.26 -152.93 6.92 Favored Glycine 0 CA--C 1.54 1.649 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.184 175.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.87 -42.23 97.5 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 122.634 -0.333 . . . . 0.0 111.823 -175.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 69' ' ' HIS . . . . . 0.477 ' O ' ' NE2' ' B' ' 93' ' ' GLN . 9.5 m80 -74.93 -9.98 59.05 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.161 -178.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 70' ' ' THR . . . . . 0.406 ' OG1' ' N ' ' B' ' 67' ' ' GLY . 31.5 m -61.29 134.72 57.27 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -90.94 110.26 40.74 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.25 -178.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.84 -38.14 85.47 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 120.965 1.11 . . . . 0.0 111.828 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.38 -40.03 89.4 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 120.568 -0.453 . . . . 0.0 109.787 -176.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 74' ' ' GLU . . . . . 0.567 ' OE1' ' HB ' ' B' ' 90' ' ' VAL . 79.2 mm-40 -66.16 -39.65 89.95 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.889 177.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 72.1 t -61.92 -46.24 96.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -62.88 -37.45 86.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.885 -178.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -62.84 -41.53 99.38 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 119.312 -0.955 . . . . 0.0 108.79 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 95.0 mt -63.34 -43.73 98.72 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 CA-C-O 120.761 0.315 . . . . 0.0 110.714 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -62.27 -42.44 99.34 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 81.7 m -60.81 -45.75 93.19 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.994 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.5 -41.81 97.84 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -177.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 87.9 mt -63.57 -41.79 98.36 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 67.4 tp60 -62.21 -35.33 78.57 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -91.61 8.41 36.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.682 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 26.9 tttt 41.51 42.29 1.89 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.3 -0.56 . . . . 0.0 112.045 176.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -124.31 141.3 37.1 Favored Pre-proline 0 N--CA 1.471 0.58 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.096 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -61.73 140.12 84.29 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 120.875 1.05 . . . . 0.0 114.029 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.87 135.9 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -177.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 89' ' ' THR . . . . . 0.909 HG23 ' OD1' ' B' ' 107' ' ' ASN . 96.2 m -121.85 122.06 38.58 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 90' ' ' VAL . . . . . 0.567 ' HB ' ' OE1' ' B' ' 74' ' ' GLU . 26.9 m -139.31 163.28 26.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.753 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -113.6 121.47 44.27 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.131 0.491 . . . . 0.0 109.881 175.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 21.2 tt -127.87 131.47 69.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.034 -175.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 93' ' ' GLN . . . . . 0.477 ' NE2' ' O ' ' B' ' 69' ' ' HIS . 34.8 mt-30 -71.94 142.05 49.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.938 177.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 94' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -132.9 -178.47 4.97 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.407 0.623 . . . . 0.0 111.04 -176.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 95' ' ' TYR . . . . . 0.405 ' CE1' ' HA3' ' B' ' 67' ' ' GLY . 96.2 m-85 -132.2 146.03 51.74 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.813 178.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 96' ' ' LYS . . . . . 0.42 ' HG3' ' CE1' ' B' ' 102' ' ' PHE . 98.8 mttt -102.93 179.29 4.32 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.056 0.455 . . . . 0.0 110.702 177.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.53 -35.16 75.31 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.243 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 37.0 p-10 -86.49 -1.95 58.04 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.038 0.836 . . . . 0.0 112.785 177.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.59 4.62 65.62 Favored Glycine 0 N--CA 1.465 0.612 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.165 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 25.8 m -67.65 128.98 38.46 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.331 178.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 101' ' ' MET . . . . . 0.531 ' SD ' ' N ' ' B' ' 102' ' ' PHE . 16.8 tmm? -87.25 143.37 27.31 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 102' ' ' PHE . . . . . 0.531 ' N ' ' SD ' ' B' ' 101' ' ' MET . 52.1 p90 -154.74 163.86 39.64 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 103' ' ' TRP . . . . . 0.663 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 22.0 m95 -97.51 137.57 36.26 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.276 -0.57 . . . . 0.0 111.086 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 104' ' ' ASN . . . . . 0.546 HD21 ' HG2' ' B' ' 123' ' ' GLN . 63.8 t-20 -131.9 113.4 13.4 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 114.707 -1.133 . . . . 0.0 113.957 -177.063 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -83.51 121.41 27.17 Favored 'General case' 0 C--N 1.318 -0.788 0 O-C-N 124.441 1.088 . . . . 0.0 109.015 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 41.2 tp -109.52 125.66 52.73 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.066 0.46 . . . . 0.0 111.95 -177.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 107' ' ' ASN . . . . . 0.909 ' OD1' HG23 ' B' ' 89' ' ' THR . 98.2 m-20 -118.34 129.6 55.53 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 176.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 96.7 mt -124.07 132.75 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -144.37 121.3 6.43 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -69.27 152.18 71.85 Favored 'Trans proline' 0 N--CA 1.503 2.043 0 C-N-CA 122.424 2.083 . . . . 0.0 112.576 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 111' ' ' MET . . . . . 0.49 ' HB2' ' HB2' ' B' ' 118' ' ' TYR . 66.1 mtt -128.75 142.26 51.06 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -112.51 105.27 13.45 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 113' ' ' ILE . . . . . 0.661 HG12 ' HZ1' ' A' ' 18' ' ' LYS . 96.8 mt -132.9 127.93 56.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 O-C-N 121.697 -0.627 . . . . 0.0 111.695 177.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 53.94 37.19 26.13 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 123.913 0.758 . . . . 0.0 109.713 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 60.58 36.28 19.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.266 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -132.63 153.23 51.27 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 177.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 117' ' ' THR . . . . . 0.622 HG23 ' HG3' ' B' ' 32' ' ' PRO . 11.3 t -103.23 152.31 21.64 Favored 'General case' 0 C--O 1.213 -0.82 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.16 -178.004 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 118' ' ' TYR . . . . . 0.49 ' HB2' ' HB2' ' B' ' 111' ' ' MET . 96.5 m-85 -148.04 146.95 29.09 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 121.222 -0.924 . . . . 0.0 111.278 -179.016 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -123.54 138.98 54.45 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 120.971 0.415 . . . . 0.0 111.512 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -128.01 133.67 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -176.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.93 121.98 6.58 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 91.9 mt -113.36 127.14 70.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 123' ' ' GLN . . . . . 0.546 ' HG2' HD21 ' B' ' 104' ' ' ASN . 15.8 mp0 -118.55 122.58 42.99 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -119.68 121.21 38.74 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 125' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' B' ' 127' ' ' THR . 68.3 t0 -72.23 128.04 34.41 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.604 -177.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 126' ' ' ILE . . . . . 0.5 HG22 ' O ' ' B' ' 126' ' ' ILE . 2.9 mp -100.93 17.42 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.58 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 127' ' ' THR . . . . . 0.491 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 98.1 m -62.57 -44.14 97.07 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 114.197 -1.365 . . . . 0.0 112.846 176.176 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 59.9 tptt -61.67 -45.05 95.65 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -177.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 129' ' ' GLN . . . . . 0.406 ' OE1' HG23 ' B' ' 126' ' ' ILE . 88.1 mt-30 -63.39 -35.04 79.1 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.683 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 130' ' ' LYS . . . . . 0.663 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 98.9 mttt -62.95 -41.63 99.57 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-N 112.833 -1.985 . . . . 0.0 110.835 174.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -64.3 -42.23 96.47 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 132' ' ' TYR . . . . . 0.841 ' CE2' HD11 ' B' ' 136' ' ' LEU . 91.6 t80 -60.13 -44.09 95.18 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 121.903 -0.498 . . . . 0.0 111.384 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 133' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' B' ' 137' ' ' GLU . 97.5 mt-10 -64.87 -36.55 84.7 Favored 'General case' 0 C--O 1.22 -0.453 0 C-N-CA 119.989 -0.684 . . . . 0.0 109.384 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 134' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' B' ' 130' ' ' LYS . 98.7 mttt -63.52 -39.8 95.36 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.604 177.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 49.6 tp -62.91 -41.4 99.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.349 0.595 . . . . 0.0 109.441 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 136' ' ' LEU . . . . . 0.841 HD11 ' CE2' ' B' ' 132' ' ' TYR . 88.8 mt -62.99 -41.47 99.59 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.426 177.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 137' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' B' ' 133' ' ' GLU . 97.1 mt-10 -65.06 -37.18 86.73 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 113.806 -1.543 . . . . 0.0 110.268 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.48 -43.75 96.38 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.995 177.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 67.3 m -60.94 -44.39 97.31 Favored 'General case' 0 C--N 1.346 0.449 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 140' ' ' LEU . . . . . 0.49 ' O ' ' N ' ' B' ' 144' ' ' THR . 88.4 mt -61.73 -40.33 94.7 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -177.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 92.6 m -61.78 -45.44 93.89 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.026 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -65.66 -42.81 90.95 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 94.3 mt -63.87 -43.41 97.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.574 178.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 144' ' ' THR . . . . . 0.49 ' N ' ' O ' ' B' ' 140' ' ' LEU . 95.3 m -61.59 -45.51 93.82 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 145' ' ' ALA . . . . . 0.441 ' O ' ' HB ' ' B' ' 148' ' ' THR . . . -64.52 -41.73 96.21 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 119.117 -1.033 . . . . 0.0 109.295 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 86.2 mt -64.99 -40.85 95.57 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 176.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 147' ' ' SER . . . . . 0.613 ' O ' ' N ' ' B' ' 149' ' ' PRO . 78.2 p -62.06 -41.86 98.6 Favored 'General case' 0 CA--C 1.477 -1.84 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -178.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 148' ' ' THR . . . . . 0.497 ' C ' ' O ' ' B' ' 147' ' ' SER . 40.5 m -26.51 85.36 0.03 OUTLIER Pre-proline 0 N--CA 1.478 0.947 0 O-C-N 123.958 0.786 . . . . 0.0 110.188 176.274 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 149' ' ' PRO . . . . . 0.613 ' N ' ' O ' ' B' ' 147' ' ' SER . 24.1 Cg_exo -60.52 145.18 99.23 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.051 1.834 . . . . 0.0 115.6 -177.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 9.9 tp -125.29 119.44 55.48 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.168 0 CA-C-N 114.036 -1.438 . . . . 0.0 108.197 174.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 59.5 t -148.89 94.2 4.1 Favored Pre-proline 0 C--N 1.307 -1.274 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.806 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.04 142.88 94.1 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 CA-C-N 119.909 1.003 . . . . 0.0 109.623 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 153' ' ' ILE . . . . . 0.617 ' CG2' HH12 ' A' ' 154' ' ' ARG . 43.8 mm -77.1 -66.89 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 154' ' ' ARG . . . . . 0.665 ' HD3' ' NH2' ' A' ' 154' ' ' ARG . 2.7 mpt_? -132.96 -158.84 0.92 Allowed 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 177.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -84.2 109.49 17.79 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 101.02 -17.34 56.32 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -177.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 89.3 mt -109.78 126.43 66.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.859 0.362 . . . . 0.0 111.282 -177.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 158' ' ' SER . . . . . 0.702 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 60.7 m -135.29 149.05 49.71 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.718 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -132.46 149.33 52.35 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 29.8 tp -144.23 78.75 13.38 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 161' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -71.82 149.89 54.78 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.725 2.283 . . . . 0.0 114.108 -177.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 91.6 mt -113.68 133.3 55.41 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 55.9 t -128.38 132.38 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 113.49 167.45 16.55 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.184 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 165' ' ' ASN . . . . . 0.634 ' O ' ' NH1' ' B' ' 170' ' ' ARG . 52.9 t30 -88.55 107.53 18.94 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -178.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 166' ' ' LEU . . . . . 0.553 HD21 ' CZ ' ' B' ' 171' ' ' PHE . 48.2 tp -64.78 105.35 0.98 Allowed 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -174.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 167' ' ' THR . . . . . 0.707 HG23 ' NE ' ' B' ' 170' ' ' ARG . 10.9 p -84.94 169.74 13.74 Favored 'General case' 0 C--N 1.348 0.502 0 CA-C-N 114.019 -1.446 . . . . 0.0 110.79 177.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.2 -37.87 84.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.704 176.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.3 -40.97 90.37 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-O 122.455 1.121 . . . . 0.0 111.894 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 170' ' ' ARG . . . . . 0.707 ' NE ' HG23 ' B' ' 167' ' ' THR . 87.7 mtm180 -61.83 -34.81 76.63 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 112.376 -2.193 . . . . 0.0 111.178 177.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 171' ' ' PHE . . . . . 0.553 ' CZ ' HD21 ' B' ' 166' ' ' LEU . 0.5 OUTLIER -53.95 -26.25 24.67 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -178.996 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 172' ' ' ASN . . . . . 0.541 ' O ' HG22 ' B' ' 175' ' ' VAL . 92.8 m-20 -62.86 -40.56 97.86 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.875 179.029 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 57.1 m -60.7 -41.07 94.44 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.098 0.475 . . . . 0.0 110.747 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 67.3 mt -63.92 -44.1 97.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -178.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 175' ' ' VAL . . . . . 0.541 HG22 ' O ' ' B' ' 172' ' ' ASN . 34.5 m -63.15 -40.22 88.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 176' ' ' CYS . . . . . 0.419 ' N ' HG23 ' B' ' 175' ' ' VAL . 99.1 m -61.88 -35.03 77.11 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.432 178.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 177' ' ' THR . . . . . 0.517 ' O ' HG13 ' B' ' 181' ' ' ILE . 25.1 m -61.74 -19.24 62.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.28 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 178' ' ' LEU . . . . . 0.621 ' CD2' HD21 ' B' ' 211' ' ' LEU . 89.4 mt -61.42 -39.01 89.19 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.328 -177.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 18.2 m -61.0 -43.81 98.35 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.259 177.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 180' ' ' ASN . . . . . 0.655 ' O ' ' OG ' ' B' ' 183' ' ' SER . 92.4 m-20 -62.13 -40.0 94.46 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.878 0.371 . . . . 0.0 110.481 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.517 HG13 ' O ' ' B' ' 177' ' ' THR . 72.2 mt -56.11 -35.0 40.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 O-C-N 122.157 -0.339 . . . . 0.0 110.902 -178.106 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 182' ' ' LEU . . . . . 0.533 HD21 HD21 ' B' ' 214' ' ' LEU . 84.6 mt -61.78 -41.52 97.83 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 119.799 -0.761 . . . . 0.0 109.11 177.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 183' ' ' SER . . . . . 0.655 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.3 p -62.89 -32.6 73.9 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 121.8 -0.562 . . . . 0.0 110.915 176.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 50.9 p -87.52 15.73 6.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.835 0.35 . . . . 0.0 111.831 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 79.5 p -59.35 -17.13 27.0 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.031 -177.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.02 -40.59 96.22 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.704 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 187' ' ' ASP . . . . . 0.702 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.2 m-20 -68.75 113.93 6.65 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.653 0.74 . . . . 0.0 110.622 -177.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.65 -42.36 99.57 Favored 'General case' 0 C--O 1.247 0.922 0 CA-C-N 114.772 -1.104 . . . . 0.0 113.118 -177.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -112.02 130.86 55.73 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 120.621 -0.431 . . . . 0.0 111.317 -178.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 190' ' ' LEU . . . . . . . . . . . . . 41.4 tp -123.13 117.64 25.86 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.901 178.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 83.9 mt -105.62 125.1 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 121.064 -0.254 . . . . 0.0 111.418 -178.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 49.7 mm -114.88 117.4 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 178.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 193' ' ' ASP . . . . . 0.615 ' CG ' ' HG ' ' B' ' 195' ' ' SER . 40.0 t0 -89.47 111.07 21.87 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.731 -176.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 194' ' ' LEU . . . . . . . . . . . . . 97.2 mt -92.24 -1.24 57.23 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.323 175.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 195' ' ' SER . . . . . 0.615 ' HG ' ' CG ' ' B' ' 193' ' ' ASP . 78.1 p -61.35 -37.16 82.34 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.698 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.42 -34.13 87.18 Favored Glycine 0 N--CA 1.439 -1.102 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 197' ' ' LEU . . . . . 0.974 HD23 ' N ' ' B' ' 198' ' ' ALA . 4.8 tt -78.19 132.71 37.71 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -176.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 198' ' ' ALA . . . . . 0.974 ' N ' HD23 ' B' ' 197' ' ' LEU . . . -64.5 -41.64 96.33 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.496 -178.277 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 199' ' ' GLN . . . . . 0.947 ' H ' ' CD2' ' B' ' 197' ' ' LEU . 58.9 tt0 -138.91 164.14 30.46 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 200' ' ' VAL . . . . . 0.465 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 50.2 t -121.36 132.51 70.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 O-C-N 120.688 -1.258 . . . . 0.0 109.433 176.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -90.46 149.42 22.23 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.926 -178.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.44 -32.45 70.22 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.295 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -64.6 -32.65 74.39 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.4 m -60.79 -44.32 96.98 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.274 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 205' ' ' ALA . . . . . 0.623 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -58.69 -29.56 66.73 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -177.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -65.44 -38.59 90.31 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.257 0.551 . . . . 0.0 109.672 176.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -66.89 -37.94 85.33 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.694 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.55 -43.46 98.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 120.528 -0.469 . . . . 0.0 109.808 -178.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 209' ' ' PHE . . . . . 0.623 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 65.3 m-85 -62.17 -43.02 99.75 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 114.195 -1.366 . . . . 0.0 112.767 177.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.42 -41.8 98.71 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.288 -0.965 . . . . 0.0 109.763 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 211' ' ' LEU . . . . . 0.621 HD21 ' CD2' ' B' ' 178' ' ' LEU . 39.7 mt -62.27 -42.46 99.36 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.418 -179.083 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 78.0 p -63.15 -36.06 82.36 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.291 -0.564 . . . . 0.0 112.11 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 213' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -66.89 -46.72 74.06 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.146 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 214' ' ' LEU . . . . . 0.533 HD21 HD21 ' B' ' 182' ' ' LEU . 52.0 tp -63.89 -43.17 96.83 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.765 0.793 . . . . 0.0 109.827 177.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 215' ' ' LEU . . . . . 0.417 ' HB3' ' O ' ' B' ' 220' ' ' THR . 88.9 mt -63.2 -43.76 97.25 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 113.485 -1.689 . . . . 0.0 111.599 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.33 -39.69 91.46 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.879 -176.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 87.1 mt -63.75 -42.05 97.9 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.389 0.614 . . . . 0.0 111.587 176.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 218' ' ' THR . . . . . . . . . . . . . 75.6 p -75.13 -16.41 60.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.106 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 80.85 64.65 1.78 Allowed Glycine 0 CA--C 1.528 0.848 0 N-CA-C 106.577 -2.609 . . . . 0.0 106.577 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 220' ' ' THR . . . . . 0.417 ' O ' ' HB3' ' B' ' 215' ' ' LEU . 98.1 m -142.46 103.23 4.22 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 175.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -61.92 139.36 58.39 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.92 -176.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 42.6 tp -116.3 121.4 41.88 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.231 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 3.2 mp -110.01 128.58 66.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.223 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 224' ' ' ILE . . . . . 0.61 ' CG2' HD11 ' B' ' 227' ' ' ILE . 50.7 mm -108.86 126.05 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.735 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 51.8 p -133.0 157.16 45.89 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.511 0.672 . . . . 0.0 112.714 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 89.16 18.04 54.44 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 113.894 -1.503 . . . . 0.0 110.981 -177.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 227' ' ' ILE . . . . . 0.667 HD12 HG23 ' B' ' 247' ' ' THR . 95.5 mt -82.54 125.69 39.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 121.908 -0.76 . . . . 0.0 111.586 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -65.86 140.31 97.17 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.604 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.78 -37.01 92.28 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 121.358 1.372 . . . . 0.0 112.446 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -64.39 -43.1 95.49 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 51.3 tp -61.62 -41.55 97.63 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.701 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.12 -37.07 86.13 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.756 0.312 . . . . 0.0 111.359 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 93.9 mtp -64.08 -41.17 97.42 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.442 -0.503 . . . . 0.0 109.659 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.79 -43.67 98.19 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 122.204 1.002 . . . . 0.0 109.202 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 37.3 mmt -63.76 -35.73 81.54 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.951 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -61.88 -40.52 95.68 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -178.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.31 -43.45 97.79 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.043 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 51.8 tp -61.68 -45.52 93.66 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 120.26 -0.576 . . . . 0.0 112.228 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 239' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' B' ' 240' ' ' ALA . 66.8 t0 -156.83 135.13 11.31 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 120.39 -0.524 . . . . 0.0 112.034 -179.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 240' ' ' ALA . . . . . 0.435 ' N ' ' OD1' ' B' ' 239' ' ' ASP . . . -62.59 -46.56 87.76 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 176.223 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 241' ' ' ASN . . . . . 0.514 ' O ' ' HB2' ' B' ' 244' ' ' SER . 92.5 m-20 -43.74 -18.96 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.421 -175.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 242' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -61.91 -45.88 91.77 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.236 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 243' ' ' SER . . . . . 0.41 ' O ' ' N ' ' B' ' 245' ' ' LEU . 77.7 p -57.95 -45.62 86.35 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 244' ' ' SER . . . . . 0.514 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 21.0 m -28.08 -38.47 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 245' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' B' ' 243' ' ' SER . 96.9 mt -87.73 138.54 31.38 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 121.521 -0.737 . . . . 0.0 110.489 178.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -66.75 134.93 53.18 Favored 'General case' 0 C--O 1.242 0.662 0 O-C-N 121.82 -0.55 . . . . 0.0 110.742 -174.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 247' ' ' THR . . . . . 0.667 HG23 HD12 ' B' ' 227' ' ' ILE . 97.3 m -124.6 126.81 46.4 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.919 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 248' ' ' TYR . . . . . 0.526 ' CG ' ' HB2' ' B' ' 254' ' ' ALA . 96.2 m-85 -111.6 143.14 42.97 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 177.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 249' ' ' SER . . . . . 0.553 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 77.9 p -62.97 -34.75 78.19 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.107 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 250' ' ' ASN . . . . . 0.553 ' OD1' ' O ' ' B' ' 249' ' ' SER . 99.3 m-20 -146.85 159.2 43.82 Favored 'General case' 0 N--CA 1.461 0.121 0 O-C-N 124.243 0.964 . . . . 0.0 112.033 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 79.7 t -64.02 -44.6 97.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.919 178.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 252' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.23 -46.01 92.16 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -178.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 253' ' ' ASP . . . . . 0.523 ' O ' HG22 ' B' ' 257' ' ' VAL . 94.4 m-20 -61.25 -43.75 98.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.821 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 254' ' ' ALA . . . . . 0.526 ' HB2' ' CG ' ' B' ' 248' ' ' TYR . . . -64.9 -40.24 94.78 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.133 178.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 255' ' ' VAL . . . . . 0.72 HG11 ' O ' ' A' ' 153' ' ' ILE . 55.4 t -65.12 -45.54 93.85 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.298 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.7 -47.0 85.54 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 120.286 -0.566 . . . . 0.0 111.335 -178.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 257' ' ' VAL . . . . . 0.523 HG22 ' O ' ' B' ' 253' ' ' ASP . 28.3 m -65.95 -40.0 86.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.758 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 258' ' ' LEU . . . . . 0.519 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 1.9 mt -33.34 -74.04 0.05 OUTLIER Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.566 -178.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 259' ' ' PRO . . . . . 0.541 ' O ' HG13 ' B' ' 260' ' ' ILE . 37.3 Cg_endo -61.93 141.23 88.79 Favored 'Trans proline' 0 N--CA 1.504 2.122 0 C-N-CA 121.605 1.537 . . . . 0.0 111.463 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 260' ' ' ILE . . . . . 0.541 HG13 ' O ' ' B' ' 259' ' ' PRO . 96.9 mt -159.22 -15.02 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-N 118.73 0.696 . . . . 0.0 112.311 177.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 C--O 1.216 -0.706 0 CA-C-O 117.885 -1.055 . . . . 0.0 111.553 -179.741 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.48 ' O ' ' OG ' ' A' ' 6' ' ' SER . . . -156.98 169.95 23.64 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 116.65 -1.643 . . . . 0.0 110.19 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.6 p -72.9 -18.81 61.37 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 124.902 1.376 . . . . 0.0 110.808 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -70.59 -67.02 0.53 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 114.444 -1.253 . . . . 0.0 112.189 174.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -66.71 -38.58 87.01 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.48 ' OG ' ' O ' ' A' ' 2' ' ' ALA . 64.1 m -58.97 -41.63 87.97 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 120.441 -0.503 . . . . 0.0 110.306 -177.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.68 ' CE2' HD12 ' A' ' 9' ' ' ILE . 41.1 t80 82.1 86.18 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 O-C-N 123.909 0.756 . . . . 0.0 111.301 176.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.48 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -60.86 -134.78 0.01 OUTLIER Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -177.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.68 HD12 ' CE2' ' A' ' 7' ' ' PHE . 57.2 mt 78.95 108.72 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.695 0 C-N-CA 122.583 0.353 . . . . 0.0 110.775 -178.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -63.31 -22.65 72.09 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.422 1.415 . . . . 0.0 112.134 -178.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.72 -37.83 95.29 Favored Glycine 0 C--O 1.245 0.817 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.766 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.56 -39.07 91.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.359 0.6 . . . . 0.0 109.744 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 49.8 tp -62.95 -41.62 99.56 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -62.61 -39.56 94.17 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 56.2 t -60.74 -44.24 96.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 O-C-N 122.365 -0.21 . . . . 0.0 110.986 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 93.0 mt -62.62 -43.59 98.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.181 -177.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.428 ' NZ ' ' HA ' ' B' ' 6' ' ' SER . 98.9 mttt -62.4 -46.03 90.46 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 119.331 -0.948 . . . . 0.0 112.123 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.653 ' NZ ' HG12 ' B' ' 113' ' ' ILE . 98.6 mttt -60.65 -39.51 88.6 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 118.881 -1.128 . . . . 0.0 109.082 -175.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.8 -42.34 93.23 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.092 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 20' ' ' LEU . 89.3 mt -63.26 -40.97 98.89 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.105 0.479 . . . . 0.0 109.879 178.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.41 -38.86 92.78 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.576 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 53.7 m170 -58.16 -39.83 79.87 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 122.27 -0.268 . . . . 0.0 111.592 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.0 p -114.69 130.23 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.545 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 35.6 ptt180 -72.04 109.32 5.77 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 122.245 1.021 . . . . 0.0 111.945 -177.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.5 p -140.21 142.9 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.555 ' O ' ' N ' ' A' ' 123' ' ' GLN . . . -98.18 93.12 1.33 Allowed Glycine 0 C--N 1.313 -0.709 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.215 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 51.6 t -125.15 129.83 73.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 175.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.1 m -136.66 158.82 37.56 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.3 mt -120.21 129.59 75.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 177.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.436 ' HB ' ' OD1' ' A' ' 37' ' ' ASN . 16.5 p -106.39 166.92 10.19 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.503 178.131 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' A' ' 37' ' ' ASN . 45.0 t0 -131.83 104.14 14.3 Favored Pre-proline 0 C--N 1.32 -0.701 0 C-N-CA 120.491 -0.483 . . . . 0.0 110.813 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.52 ' CG ' HG23 ' A' ' 117' ' ' THR . 36.7 Cg_endo -63.93 -23.11 68.36 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.379 1.386 . . . . 0.0 111.605 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.12 -34.38 76.24 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.209 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.8 mt -87.4 165.03 15.88 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.861 177.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.722 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 43.2 tt0 -63.24 132.14 50.71 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -176.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.52 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 57.1 t0 62.32 21.19 12.35 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 177.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.436 ' OD1' ' HB ' ' A' ' 30' ' ' THR . 35.0 t-20 42.73 66.59 4.2 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.816 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.722 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 89.1 Cg_endo -70.67 156.18 61.47 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 123.664 2.909 . . . . 0.0 111.993 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.3 mt -88.05 125.16 41.5 Favored 'Isoleucine or valine' 0 C--O 1.246 0.905 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.376 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.41 HG23 ' N ' ' A' ' 41' ' ' TYR . 27.2 m -105.65 -42.8 7.13 Favored 'Isoleucine or valine' 0 C--N 1.343 0.324 0 O-C-N 123.613 0.571 . . . . 0.0 111.998 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.41 ' N ' HG23 ' A' ' 40' ' ' VAL . 49.4 t80 -96.06 123.75 39.8 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.566 -178.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.1 p -142.67 139.83 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.338 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.573 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 57.6 p30 -97.39 165.12 12.17 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.474 ' HA ' ' OE1' ' A' ' 44' ' ' GLN . 13.2 mm100 -66.09 -38.03 87.26 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 177.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.88 -26.77 63.44 Favored Glycine 0 N--CA 1.453 -0.186 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.667 ' CD2' HD13 ' A' ' 57' ' ' ILE . 71.4 t80 -59.28 -47.58 84.84 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 -179.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.686 HG13 ' O ' ' A' ' 52' ' ' TYR . 69.5 t -59.38 -44.69 93.08 Favored 'Isoleucine or valine' 0 C--N 1.349 0.585 0 O-C-N 121.241 -0.912 . . . . 0.0 111.366 -173.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -63.73 -37.84 88.86 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.727 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 59.7 ttm -66.57 -43.82 83.93 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 175.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 36.4 p -91.87 -21.99 20.32 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.126 0.488 . . . . 0.0 111.315 -178.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . 77.83 19.56 75.21 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.686 ' O ' HG13 ' A' ' 47' ' ' VAL . 82.9 m-85 -112.58 139.31 48.27 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 122.868 0.467 . . . . 0.0 111.28 178.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -65.85 149.2 50.57 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.785 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.437 HG22 ' H ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -65.29 -32.32 73.92 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -178.207 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -66.36 -42.48 87.98 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 119.591 -0.843 . . . . 0.0 111.466 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -65.61 -45.1 84.44 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 119.886 -0.725 . . . . 0.0 109.427 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.667 HD13 ' CD2' ' A' ' 46' ' ' PHE . 97.0 mt -62.1 -46.7 95.87 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 C-N-CA 119.85 -0.74 . . . . 0.0 112.47 -174.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.2 mt -60.77 142.8 55.6 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.53 -3.08 87.33 Favored Glycine 0 N--CA 1.464 0.529 0 CA-C-O 119.234 -0.759 . . . . 0.0 112.877 177.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -136.19 152.08 50.4 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.275 1.537 . . . . 0.0 111.682 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.533 ' C ' ' H ' ' A' ' 63' ' ' ARG . 24.9 t-20 -80.27 151.89 29.33 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.194 0.521 . . . . 0.0 110.509 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 85.6 m -64.56 14.15 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.342 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.533 ' H ' ' C ' ' A' ' 61' ' ' ASN . 36.3 ptt-85 -61.14 -40.78 95.12 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 122.073 -0.392 . . . . 0.0 111.354 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -55.12 -22.91 18.47 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -178.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.4 mt -66.04 -36.62 83.74 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.402 0.62 . . . . 0.0 112.636 176.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -61.95 137.87 58.3 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.061 -178.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.498 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -147.63 -147.73 4.6 Favored Glycine 0 CA--C 1.543 1.801 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.096 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.66 -41.2 98.94 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -177.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.59 ' O ' ' NE2' ' A' ' 93' ' ' GLN . 12.5 m80 -76.84 -7.87 56.26 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.245 -177.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.498 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 27.4 m -64.02 129.38 39.81 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.22 -0.592 . . . . 0.0 109.71 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -86.47 111.9 42.57 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.809 -177.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.6 -31.38 91.59 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 121.97 1.78 . . . . 0.0 113.206 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.12 -40.11 95.48 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.111 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.443 ' OE1' ' HB ' ' A' ' 90' ' ' VAL . 78.8 mm-40 -65.31 -43.17 91.88 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.2 t -60.38 -43.69 94.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 114.189 -1.369 . . . . 0.0 107.74 -176.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -64.42 -38.06 89.71 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.646 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -63.49 -39.7 95.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.329 0.585 . . . . 0.0 110.625 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.92 -43.94 97.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.941 177.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -62.53 -42.95 99.86 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 113.925 -1.489 . . . . 0.0 108.287 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 99.3 m -61.24 -49.83 75.53 Favored 'General case' 0 C--O 1.247 0.947 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.8 -41.66 96.06 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 118.646 -0.692 . . . . 0.0 111.598 -169.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.0 mt -63.23 -39.29 94.2 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 118.702 0.683 . . . . 0.0 111.188 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 66.7 tp60 -64.87 -34.35 78.17 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -85.28 -3.54 58.86 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.599 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.2 tttt 48.57 37.59 9.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.679 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -120.64 143.89 37.39 Favored Pre-proline 0 CA--C 1.534 0.364 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -61.8 144.2 96.71 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 121.318 1.345 . . . . 0.0 113.307 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.5 p -139.39 141.39 35.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.805 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.972 HG23 ' OD1' ' A' ' 107' ' ' ASN . 97.4 m -125.64 121.82 34.63 Favored 'General case' 0 C--N 1.344 0.345 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 175.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.443 ' HB ' ' OE1' ' A' ' 74' ' ' GLU . 27.0 m -139.59 158.77 27.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 120.675 0.274 . . . . 0.0 111.274 178.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -104.7 129.25 52.91 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 176.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.426 ' O ' HG23 ' A' ' 92' ' ' ILE . 19.8 tt -138.55 130.46 37.57 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 CA-C-N 120.902 1.683 . . . . 0.0 112.207 178.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.59 ' NE2' ' O ' ' A' ' 69' ' ' HIS . 33.7 mt-30 -61.77 137.26 58.23 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.886 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -137.53 158.52 44.22 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.977 -178.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.432 ' CE1' ' HA3' ' A' ' 67' ' ' GLY . 93.9 m-85 -117.82 136.7 53.24 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -178.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.427 ' HG3' ' CE1' ' A' ' 102' ' ' PHE . 99.1 mttt -84.94 -173.52 4.77 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.175 0.512 . . . . 0.0 111.704 -178.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.42 -43.63 98.37 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.155 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 41.1 p-10 -83.81 6.12 22.53 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -178.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.17 -0.31 83.63 Favored Glycine 0 N--CA 1.465 0.609 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.967 176.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 23.0 m -60.65 138.04 58.11 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.664 ' SD ' ' C ' ' A' ' 101' ' ' MET . 13.2 tmm? -104.09 129.03 51.76 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.878 0.37 . . . . 0.0 111.072 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.491 ' N ' ' SD ' ' A' ' 101' ' ' MET . 53.2 p90 -142.65 159.01 43.07 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 120.276 -0.57 . . . . 0.0 109.677 -178.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.832 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 23.6 m95 -90.38 144.29 25.95 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.55 HD21 ' HG2' ' A' ' 123' ' ' GLN . 54.9 t-20 -137.44 106.08 5.86 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -177.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.517 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 80.5 tt0 -72.22 134.34 45.58 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -177.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 40.5 tp -120.05 124.78 46.71 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.972 ' OD1' HG23 ' A' ' 89' ' ' THR . 97.8 m-20 -121.11 122.11 39.34 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 176.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 96.2 mt -119.52 129.12 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 O-C-N 123.43 0.457 . . . . 0.0 111.264 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -138.36 124.57 12.78 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.878 -0.147 . . . . 0.0 110.648 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -70.81 150.27 61.52 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 122.25 1.967 . . . . 0.0 112.54 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.569 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 67.4 mtt -121.59 153.8 37.58 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -127.48 93.96 3.86 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 177.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.442 ' CD1' HG22 ' B' ' 15' ' ' VAL . 96.2 mt -119.93 130.56 74.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.529 -177.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 50.01 37.54 14.32 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 118.746 0.703 . . . . 0.0 111.736 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 59.21 29.94 19.6 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.979 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -127.53 146.61 50.45 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.676 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 5.2 t -82.78 -175.38 5.76 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.279 -0.888 . . . . 0.0 109.471 -178.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.676 ' CD2' ' O ' ' A' ' 117' ' ' THR . 73.0 m-85 -168.83 156.18 7.43 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 171.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -129.14 146.31 51.1 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 174.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -135.63 136.88 50.12 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.366 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -111.25 128.48 8.71 Favored Glycine 0 CA--C 1.503 -0.683 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 178.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 96.5 mt -116.99 128.9 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.555 ' N ' ' O ' ' A' ' 26' ' ' GLY . 15.1 mp0 -120.14 116.91 26.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.101 0.477 . . . . 0.0 109.959 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -116.95 114.84 24.4 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.819 -178.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.411 ' OD1' ' OG1' ' A' ' 127' ' ' THR . 68.3 t0 -63.63 125.24 23.64 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -175.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.546 ' O ' HG22 ' A' ' 126' ' ' ILE . 2.7 mp -89.93 1.08 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 CA-C-N 113.887 -1.506 . . . . 0.0 110.457 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.411 ' OG1' ' OD1' ' A' ' 125' ' ' ASP . 18.4 m -60.46 -42.72 96.77 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.257 -0.902 . . . . 0.0 112.716 -177.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -60.07 -43.06 95.73 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -178.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -63.28 -39.62 95.1 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.705 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.832 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.7 mttt -62.49 -40.57 97.11 Favored 'General case' 0 CA--C 1.503 -0.854 0 C-N-CA 118.486 -1.286 . . . . 0.0 110.52 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.11 -37.3 84.6 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.837 ' CE2' HD11 ' A' ' 136' ' ' LEU . 90.5 t80 -61.49 -45.26 94.98 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.43 176.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.85 -38.92 92.87 Favored 'General case' 0 C--N 1.342 0.248 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.88 -40.51 95.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.84 0.352 . . . . 0.0 110.15 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 54.5 tp -60.97 -43.6 98.55 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.837 HD11 ' CE2' ' A' ' 132' ' ' TYR . 84.9 mt -62.62 -41.53 99.07 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.196 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.34 -40.62 97.81 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.915 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -60.59 -41.84 95.52 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -177.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 63.3 m -61.33 -40.59 94.81 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.635 176.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 144' ' ' THR . 84.3 mt -63.53 -41.83 98.47 Favored 'General case' 0 C--O 1.221 -0.431 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 90.3 m -61.44 -45.97 92.05 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.295 -177.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.33 -40.14 93.3 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 95.9 mt -64.8 -43.51 96.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 113.781 -1.554 . . . . 0.0 111.281 176.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.504 ' N ' ' O ' ' A' ' 140' ' ' LEU . 90.4 m -62.24 -46.04 90.62 Favored 'General case' 0 C--N 1.344 0.361 0 C-N-CA 120.316 -0.554 . . . . 0.0 112.289 -178.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.06 -39.74 95.63 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 118.815 -1.154 . . . . 0.0 109.017 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.2 mt -63.3 -42.48 99.04 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.756 -0.657 . . . . 0.0 112.517 178.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.753 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.0 p -60.62 -39.95 90.12 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -177.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.495 ' C ' ' O ' ' A' ' 147' ' ' SER . 17.0 m -27.41 79.55 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.428 0 O-C-N 126.617 2.448 . . . . 0.0 106.733 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.753 ' N ' ' O ' ' A' ' 147' ' ' SER . 20.1 Cg_exo -62.89 145.17 94.48 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.007 1.138 . . . . 0.0 114.672 -174.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.584 ' O ' HG23 ' A' ' 151' ' ' VAL . 8.8 tp -120.57 135.45 60.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 103.124 -2.917 . . . . 0.0 103.124 175.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 150' ' ' ILE . 92.3 t -167.73 90.93 0.69 Allowed Pre-proline 0 CA--C 1.516 -0.355 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 178.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -61.39 137.34 69.47 Favored 'Trans proline' 0 C--N 1.3 -2.006 0 N-CA-C 109.465 -1.013 . . . . 0.0 109.465 -176.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.643 ' O ' ' HD2' ' A' ' 154' ' ' ARG . 45.6 mm -67.47 -44.43 86.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 119.746 -0.782 . . . . 0.0 111.069 179.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.643 ' HD2' ' O ' ' A' ' 153' ' ' ILE . 0.3 OUTLIER -159.12 -154.89 0.44 Allowed 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.082 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 63.0 t-20 -87.89 104.37 16.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 122.189 0.995 . . . . 0.0 111.897 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 89.91 8.61 66.96 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 114.243 -1.344 . . . . 0.0 111.022 -177.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.505 HG22 ' HB ' ' A' ' 153' ' ' ILE . 96.7 mt -124.09 125.71 71.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 CA-C-O 121.748 0.785 . . . . 0.0 109.477 174.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.656 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 57.8 m -132.82 151.47 52.01 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.276 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -138.96 141.96 38.4 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.546 -0.721 . . . . 0.0 111.244 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 25.9 tp -133.15 80.2 60.01 Favored Pre-proline 0 N--CA 1.471 0.581 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.141 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -69.65 149.18 67.24 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.778 2.319 . . . . 0.0 113.137 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 86.6 mt -116.99 126.13 52.44 Favored 'General case' 0 C--O 1.25 1.116 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.393 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 47.3 t -123.47 131.48 73.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 115.0 169.61 16.07 Favored Glycine 0 N--CA 1.479 1.537 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.93 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.779 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 54.2 t30 -84.96 113.14 21.19 Favored 'General case' 0 C--O 1.213 -0.835 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.52 HD21 ' CZ ' ' A' ' 171' ' ' PHE . 44.8 tp -73.66 103.48 4.26 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -177.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.67 HG23 ' HE ' ' A' ' 170' ' ' ARG . 9.8 p -86.82 167.34 14.47 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.557 178.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.22 -33.82 76.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.411 0.624 . . . . 0.0 111.6 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.1 -43.39 92.25 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.595 178.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.779 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 88.0 mtm180 -64.66 -31.22 72.35 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.134 0.974 . . . . 0.0 112.051 177.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.52 ' CZ ' HD21 ' A' ' 166' ' ' LEU . 0.5 OUTLIER -55.1 -29.38 57.5 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.564 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.578 ' O ' HG22 ' A' ' 175' ' ' VAL . 92.2 m-20 -61.12 -40.46 93.86 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 119.038 -1.065 . . . . 0.0 109.679 -177.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 52.6 m -59.71 -41.02 89.88 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.443 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 66.1 mt -63.35 -44.07 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.578 HG22 ' O ' ' A' ' 172' ' ' ASN . 26.8 m -62.57 -39.81 85.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 98.5 m -62.86 -35.16 79.05 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.303 0.573 . . . . 0.0 110.416 178.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.492 ' O ' HG13 ' A' ' 181' ' ' ILE . 25.0 m -61.7 -19.44 62.38 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.201 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.683 ' CD2' HD21 ' A' ' 211' ' ' LEU . 87.8 mt -60.97 -41.43 96.36 Favored 'General case' 0 C--O 1.247 0.967 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 -177.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 19.2 m -59.63 -42.94 93.83 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.587 ' O ' ' OG ' ' A' ' 183' ' ' SER . 92.1 m-20 -61.43 -37.67 84.35 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 122.588 0.355 . . . . 0.0 110.983 178.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.516 HD12 ' HA ' ' A' ' 178' ' ' LEU . 67.6 mt -58.56 -37.71 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 O-C-N 121.685 -0.634 . . . . 0.0 109.476 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 85.0 mt -60.9 -40.34 92.71 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 119.418 -0.913 . . . . 0.0 108.833 -177.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.587 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 77.8 p -62.01 -33.86 75.13 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.528 176.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 59.3 p -89.37 23.36 2.56 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 120.752 0.31 . . . . 0.0 111.66 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 78.1 p -63.0 -20.54 65.39 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.775 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.71 -37.56 82.1 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.793 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.656 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 98.7 m-20 -73.3 115.05 12.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.424 0.631 . . . . 0.0 110.902 -179.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.92 -42.56 99.84 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.045 -0.98 . . . . 0.0 113.03 -177.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -113.78 131.52 56.19 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.266 0.555 . . . . 0.0 110.779 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 38.9 tp -120.0 127.07 52.28 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 92.2 mt -114.27 127.15 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 118.658 0.663 . . . . 0.0 109.607 177.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.7 mm -112.23 126.71 69.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' ASP . . . . . 0.525 ' CG ' ' HG ' ' A' ' 195' ' ' SER . 39.0 t0 -94.66 118.27 31.45 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 122.046 0.927 . . . . 0.0 110.78 177.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 95.9 mt -98.56 -3.49 36.25 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.392 175.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.525 ' HG ' ' CG ' ' A' ' 193' ' ' ASP . 78.0 p -62.69 -33.7 75.62 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.629 0.604 . . . . 0.0 112.629 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.78 -43.63 98.98 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 108.491 -1.844 . . . . 0.0 108.491 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.936 HD23 ' N ' ' A' ' 198' ' ' ALA . 4.9 tt -70.0 129.15 38.68 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 113.104 -1.548 . . . . 0.0 108.584 -176.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.936 ' N ' HD23 ' A' ' 197' ' ' LEU . . . -60.24 -50.56 73.18 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.242 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.912 ' O ' ' CD2' ' A' ' 197' ' ' LEU . 58.4 tt0 -132.29 157.01 45.53 Favored 'General case' 0 C--O 1.204 -1.322 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -175.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.451 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 47.1 t -117.16 132.1 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 O-C-N 120.306 -1.496 . . . . 0.0 108.889 177.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -83.73 154.92 23.34 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.572 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -64.65 -39.2 93.27 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.123 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -58.26 -31.97 67.93 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 17.5 m -60.39 -41.86 94.69 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.563 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.497 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -57.22 -38.64 74.05 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -177.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -62.63 -37.01 84.61 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -64.76 -38.91 92.58 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.967 177.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 94.6 mt -63.47 -44.51 98.85 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.079 0 C-N-CA 119.598 -0.841 . . . . 0.0 108.982 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' PHE . . . . . 0.497 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 72.0 m-85 -61.53 -44.11 97.65 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.691 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.0 -41.87 98.53 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 119.347 -0.941 . . . . 0.0 109.363 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.683 HD21 ' CD2' ' A' ' 178' ' ' LEU . 38.8 mt -62.66 -42.08 99.42 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 78.1 p -61.99 -41.6 98.21 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 119.351 -0.939 . . . . 0.0 110.151 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -65.11 -45.36 85.44 Favored 'General case' 0 C--O 1.233 0.203 0 O-C-N 121.942 -0.474 . . . . 0.0 111.713 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 50.8 tp -62.36 -44.64 96.0 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 211' ' ' LEU . 85.8 mt -63.03 -40.54 98.04 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.705 -177.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.6 -44.26 96.48 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 90.5 mt -61.99 -39.81 93.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.09 0.472 . . . . 0.0 109.749 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 68.5 p -75.94 -10.96 59.85 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.308 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.63 37.39 14.0 Favored Glycine 0 C--O 1.219 -0.808 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.906 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 96.3 m -124.73 111.15 15.22 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.714 1.257 . . . . 0.0 111.309 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -62.31 138.44 58.43 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.548 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 48.0 tp -114.14 130.58 56.59 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 122.849 0.46 . . . . 0.0 109.874 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 3.3 mp -119.04 135.04 60.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.672 ' CG2' HD11 ' A' ' 227' ' ' ILE . 49.7 mm -115.14 132.24 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 38.5 p -133.57 166.8 21.74 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.863 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 78.09 19.61 74.49 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.684 -0.967 . . . . 0.0 110.684 178.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.672 HD11 ' CG2' ' A' ' 224' ' ' ILE . 97.4 mt -81.96 129.32 37.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 114.14 -1.03 . . . . 0.0 108.879 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 56.9 tttt -75.3 139.23 71.78 Favored Pre-proline 0 CA--C 1.533 0.31 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.58 -39.66 87.47 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.134 1.223 . . . . 0.0 112.526 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -62.83 -40.31 97.0 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-O 121.88 0.848 . . . . 0.0 110.262 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 49.0 tp -63.76 -42.05 97.89 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.543 176.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.31 -37.93 89.17 Favored 'General case' 0 N--CA 1.462 0.16 0 O-C-N 121.938 -0.476 . . . . 0.0 111.273 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 94.1 mtp -63.78 -41.15 98.0 Favored 'General case' 0 C--O 1.247 0.936 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.48 -38.86 92.76 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.594 177.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 32.4 mmt -65.68 -37.4 86.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.716 178.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -60.82 -41.67 96.17 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 121.558 -0.714 . . . . 0.0 109.371 -177.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.24 -41.55 97.07 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.527 0.68 . . . . 0.0 110.58 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 54.3 tp -63.02 -41.67 99.61 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 177.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 240' ' ' ALA . 67.0 t0 -166.81 128.91 1.74 Allowed 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.417 -0.802 . . . . 0.0 112.656 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.402 ' N ' ' OD1' ' A' ' 239' ' ' ASP . . . -61.19 -27.88 68.74 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.853 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.415 ' O ' ' HB2' ' A' ' 244' ' ' SER . 88.2 m-20 -60.92 -28.96 69.31 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.537 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -55.98 -43.81 77.97 Favored 'General case' 0 C--N 1.316 -0.881 0 O-C-N 121.235 -0.916 . . . . 0.0 109.048 -176.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 88.4 p -63.48 -19.27 64.6 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.039 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' SER . . . . . 0.415 ' HB2' ' O ' ' A' ' 241' ' ' ASN . 43.4 m -55.31 -38.4 68.62 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.259 178.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 96.8 mt -87.8 124.72 33.91 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 119.794 -0.762 . . . . 0.0 112.687 -176.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -49.19 134.62 17.73 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.903 -176.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.581 HG23 HD12 ' A' ' 227' ' ' ILE . 95.5 m -126.61 132.01 51.36 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.215 -1.357 . . . . 0.0 111.364 178.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' TYR . . . . . 0.505 ' CG ' ' HB2' ' A' ' 254' ' ' ALA . 96.0 m-85 -116.07 140.98 48.73 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.331 178.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' SER . . . . . 0.448 ' O ' ' OD1' ' A' ' 250' ' ' ASN . 78.1 p -60.59 -41.94 95.73 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.448 ' OD1' ' O ' ' A' ' 249' ' ' SER . 99.2 m-20 -145.45 159.63 42.8 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.613 0.72 . . . . 0.0 111.069 -178.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' VAL . . . . . 0.403 ' O ' HG23 ' A' ' 255' ' ' VAL . 66.0 t -61.99 -44.72 99.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 114.632 -1.167 . . . . 0.0 112.085 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.31 -43.8 98.27 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ASP . . . . . 0.464 ' O ' HG22 ' A' ' 257' ' ' VAL . 54.0 m-20 -64.13 -42.4 96.83 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.216 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.505 ' HB2' ' CG ' ' A' ' 248' ' ' TYR . . . -64.96 -41.81 95.14 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.973 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' VAL . . . . . 0.661 HG13 HH11 ' B' ' 154' ' ' ARG . 73.3 t -63.08 -45.59 98.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.009 -178.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.93 -47.72 79.38 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.562 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.506 ' O ' ' C ' ' A' ' 258' ' ' LEU . 27.6 m -66.75 -41.67 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 120.138 -0.625 . . . . 0.0 112.403 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.506 ' C ' ' O ' ' A' ' 257' ' ' VAL . 1.3 mt -28.37 -72.93 0.05 OUTLIER Pre-proline 0 C--N 1.346 0.452 0 CA-C-O 119.562 -0.256 . . . . 0.0 111.248 -177.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 259' ' ' PRO . . . . . 0.475 ' CD ' ' CB ' ' A' ' 258' ' ' LEU . 45.4 Cg_endo -64.13 140.43 71.61 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.005 1.137 . . . . 0.0 112.073 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 259' ' ' PRO . 96.8 mt -152.74 -27.12 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 178.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 N--CA 1.473 0.68 0 CA-C-O 118.159 -0.924 . . . . 0.0 110.622 -177.017 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.493 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.83 158.94 29.25 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 118.728 -0.653 . . . . 0.0 109.933 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 80.7 p -58.88 -25.08 63.01 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 124.177 0.923 . . . . 0.0 110.908 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -68.88 -63.31 1.08 Allowed 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.521 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -67.18 -38.09 84.8 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.496 178.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.483 ' O ' ' HB3' ' B' ' 7' ' ' PHE . 66.3 m -59.69 -42.53 93.14 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 120.442 -0.503 . . . . 0.0 109.906 -177.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 7' ' ' PHE . . . . . 0.687 ' CE2' HD12 ' B' ' 9' ' ' ILE . 41.7 t80 83.08 88.19 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 O-C-N 123.904 0.753 . . . . 0.0 110.293 177.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 8' ' ' GLY . . . . . 0.496 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -62.42 -134.98 0.01 OUTLIER Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -178.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.687 HD12 ' CE2' ' B' ' 7' ' ' PHE . 56.4 mt 79.25 108.54 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.656 0 C-N-CA 122.546 0.338 . . . . 0.0 111.059 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -62.45 -24.25 75.41 Favored 'Trans proline' 0 N--CA 1.498 1.793 0 C-N-CA 121.428 1.419 . . . . 0.0 111.792 -178.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.92 -40.45 98.88 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -64.18 -38.94 92.87 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.742 0.782 . . . . 0.0 109.626 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 51.1 tp -62.25 -42.55 99.43 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 114.757 -1.11 . . . . 0.0 112.114 -177.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -64.54 -33.33 75.66 Favored 'General case' 0 CA--C 1.563 1.466 0 CA-C-O 121.628 0.727 . . . . 0.0 110.759 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' VAL . . . . . 0.442 HG22 ' CD1' ' A' ' 113' ' ' ILE . 74.1 t -61.9 -46.16 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 113.094 -1.867 . . . . 0.0 111.108 176.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 94.7 mt -63.76 -43.79 98.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.07 0.462 . . . . 0.0 110.255 -178.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' LYS . . . . . 0.47 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 98.9 mttt -63.42 -42.51 98.73 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.41 -41.07 98.72 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.065 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.67 -39.1 87.16 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.689 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' B' ' 20' ' ' LEU . 89.3 mt -64.07 -42.0 97.15 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.05 0.452 . . . . 0.0 110.234 175.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.95 -39.2 93.91 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.121 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 52.4 m170 -57.61 -40.14 78.47 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 121.192 -0.203 . . . . 0.0 111.365 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 10.6 p -114.28 130.27 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.551 ' HG3' ' O ' ' B' ' 24' ' ' ARG . 35.5 ptt180 -71.57 107.15 4.31 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 122.176 0.989 . . . . 0.0 112.392 -177.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.0 p -142.04 133.61 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.497 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' B' ' 123' ' ' GLN . . . -89.45 97.03 2.28 Favored Glycine 0 N--CA 1.434 -1.451 0 C-N-CA 119.441 -1.361 . . . . 0.0 113.326 -175.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 50.0 t -125.43 129.4 72.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 174.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 27.3 m -138.11 156.48 30.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.803 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.41 ' HB ' ' HB3' ' B' ' 41' ' ' TYR . 95.5 mt -119.43 127.87 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 122.579 1.18 . . . . 0.0 111.17 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.447 ' HB ' ' OD1' ' B' ' 37' ' ' ASN . 18.3 p -111.57 157.73 20.03 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 113.07 -1.877 . . . . 0.0 108.27 -176.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -125.38 104.4 28.5 Favored Pre-proline 0 C--O 1.24 0.569 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.12 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' PRO . . . . . 0.432 ' CG ' HG23 ' B' ' 117' ' ' THR . 37.4 Cg_endo -64.76 -20.56 64.97 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 121.678 1.585 . . . . 0.0 111.564 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.37 -42.68 99.6 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.048 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 96.3 mt -74.97 -175.48 2.58 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 121.833 -0.542 . . . . 0.0 111.243 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' GLU . . . . . 0.713 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 42.6 tt0 -78.9 130.93 36.16 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.46 ' O ' ' OD1' ' B' ' 36' ' ' ASP . 62.4 t0 56.37 36.26 27.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.661 177.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 37' ' ' ASN . . . . . 0.447 ' OD1' ' HB ' ' B' ' 30' ' ' THR . 23.1 t-20 31.89 68.68 0.83 Allowed Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.713 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 91.4 Cg_endo -72.08 155.69 56.68 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 C-N-CA 123.332 2.688 . . . . 0.0 111.569 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 96.3 mt -87.35 129.5 38.67 Favored 'Isoleucine or valine' 0 C--O 1.247 0.943 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.406 HG23 ' N ' ' B' ' 41' ' ' TYR . 26.8 m -109.32 -42.31 5.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 O-C-N 123.943 0.777 . . . . 0.0 112.478 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 41' ' ' TYR . . . . . 0.41 ' HB3' ' HB ' ' B' ' 29' ' ' ILE . 51.9 t80 -96.99 123.91 40.83 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.4 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 5.3 p -142.6 140.37 28.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.446 177.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 43' ' ' ASN . . . . . 0.607 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 57.5 p30 -100.72 160.98 13.92 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.162 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' GLN . . . . . 0.468 ' OE1' ' HA ' ' B' ' 44' ' ' GLN . 12.8 mm100 -62.98 -36.95 85.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.66 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.07 -27.04 64.27 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.681 ' CD2' HD13 ' B' ' 57' ' ' ILE . 65.9 t80 -60.37 -43.09 96.9 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 0.807 HG13 ' O ' ' B' ' 52' ' ' TYR . 76.9 t -61.07 -46.16 97.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.231 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -63.31 -43.73 97.0 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 119.896 -0.721 . . . . 0.0 110.317 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 59.7 ttm -63.41 -42.48 98.75 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 35.0 p -95.15 -16.55 22.49 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.609 -178.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' B' ' 47' ' ' VAL . . . 74.45 17.19 79.79 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 178.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 52' ' ' TYR . . . . . 0.807 ' O ' HG13 ' B' ' 47' ' ' VAL . 83.8 m-85 -109.94 145.19 37.32 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 122.953 0.501 . . . . 0.0 110.328 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -75.24 148.34 39.55 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 121.254 0.549 . . . . 0.0 111.24 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' THR . . . . . 0.428 HG22 ' H ' ' B' ' 54' ' ' THR . 0.2 OUTLIER -60.96 -37.21 81.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.866 -176.75 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.5 -39.75 95.27 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.993 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -72.1 -33.3 67.76 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 176.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.681 HD13 ' CD2' ' B' ' 46' ' ' PHE . 94.9 mt -68.02 -59.36 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 95.9 mt -53.14 134.69 38.61 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -175.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.4 -8.34 74.97 Favored Glycine 0 CA--C 1.538 1.498 0 CA-C-N 116.166 -0.47 . . . . 0.0 113.032 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -133.16 149.05 52.08 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -175.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 61' ' ' ASN . . . . . 0.548 ' C ' ' H ' ' B' ' 63' ' ' ARG . 24.8 t-20 -78.44 150.06 33.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.517 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 62' ' ' CYS . . . . . . . . . . . . . 82.5 m -63.42 9.23 0.06 Allowed 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 63' ' ' ARG . . . . . 0.548 ' H ' ' C ' ' B' ' 61' ' ' ASN . 34.8 ptt-85 -60.54 -32.93 71.96 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.42 -176.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -58.5 -30.61 67.17 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 86.6 mt -62.02 -41.26 97.89 Favored 'General case' 0 C--O 1.238 0.463 0 O-C-N 121.757 -0.59 . . . . 0.0 109.742 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -51.71 145.31 9.53 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.851 -175.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 67' ' ' GLY . . . . . 0.448 ' HA3' ' CE1' ' B' ' 95' ' ' TYR . . . -157.03 -153.9 6.85 Favored Glycine 0 CA--C 1.535 1.318 0 O-C-N 124.259 0.974 . . . . 0.0 111.774 177.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.26 -41.7 89.45 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -175.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 69' ' ' HIS . . . . . 0.506 ' O ' ' NE2' ' B' ' 93' ' ' GLN . 11.1 m80 -76.07 -9.84 58.94 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.139 -177.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 70' ' ' THR . . . . . 0.426 ' OG1' ' N ' ' B' ' 67' ' ' GLY . 26.2 m -61.89 134.03 56.17 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.517 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -90.45 112.16 51.37 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.518 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.62 -37.96 90.88 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 121.185 1.257 . . . . 0.0 111.856 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.97 -40.07 92.01 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 120.42 -0.512 . . . . 0.0 109.761 -175.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 74' ' ' GLU . . . . . 0.445 ' OE1' ' HB ' ' B' ' 90' ' ' VAL . 78.8 mm-40 -66.76 -38.81 87.35 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.001 177.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 70.1 t -62.43 -46.06 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -62.94 -37.46 87.13 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.667 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -62.12 -41.8 98.6 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 119.315 -0.954 . . . . 0.0 108.874 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 94.1 mt -63.49 -43.7 98.48 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 CA-C-O 120.81 0.338 . . . . 0.0 110.907 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -61.38 -43.21 99.25 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 88.4 m -61.75 -45.16 95.11 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.59 0.71 . . . . 0.0 110.171 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.36 -41.83 98.92 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 86.9 mt -62.7 -42.53 99.69 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.516 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 66.8 tp60 -62.78 -34.01 76.35 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -90.78 6.86 42.52 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.414 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 30.8 tttt 42.46 37.99 1.11 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.969 176.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -121.94 141.28 33.76 Favored Pre-proline 0 N--CA 1.467 0.42 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.222 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.1 141.38 88.45 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.075 1.183 . . . . 0.0 113.754 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.5 p -139.81 136.11 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.942 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 89' ' ' THR . . . . . 0.965 HG23 ' OD1' ' B' ' 107' ' ' ASN . 96.5 m -121.05 122.6 40.43 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.445 ' HB ' ' OE1' ' B' ' 74' ' ' GLU . 27.3 m -138.92 162.86 27.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.913 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -115.38 121.51 43.01 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.978 -0.451 . . . . 0.0 109.819 174.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 21.3 tt -129.83 132.69 65.66 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 O-C-N 124.191 0.932 . . . . 0.0 111.623 -174.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.506 ' NE2' ' O ' ' B' ' 69' ' ' HIS . 34.2 mt-30 -69.78 143.33 53.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.97 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 94' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -133.2 177.31 7.77 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 121.718 0.77 . . . . 0.0 111.43 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 95' ' ' TYR . . . . . 0.448 ' CE1' ' HA3' ' B' ' 67' ' ' GLY . 96.5 m-85 -127.27 146.57 50.39 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.267 -1.333 . . . . 0.0 112.293 176.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 96' ' ' LYS . . . . . 0.416 ' HG3' ' CE1' ' B' ' 102' ' ' PHE . 98.7 mttt -101.11 -179.88 4.17 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.338 0.589 . . . . 0.0 110.584 177.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.87 -36.56 79.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.306 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 38.9 p-10 -87.09 -0.44 56.66 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.466 -0.771 . . . . 0.0 112.912 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.65 3.25 64.6 Favored Glycine 0 N--CA 1.467 0.714 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.528 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 25.4 m -67.16 131.01 44.94 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 101' ' ' MET . . . . . 0.597 ' SD ' ' N ' ' B' ' 102' ' ' PHE . 14.6 tmm? -90.83 141.86 28.38 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 102' ' ' PHE . . . . . 0.597 ' N ' ' SD ' ' B' ' 101' ' ' MET . 53.4 p90 -153.35 163.94 39.02 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 177.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 103' ' ' TRP . . . . . 0.853 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 23.3 m95 -96.16 140.8 30.33 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.825 0.821 . . . . 0.0 110.428 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 104' ' ' ASN . . . . . 0.515 HD21 ' HG2' ' B' ' 123' ' ' GLN . 63.2 t-20 -132.97 109.46 9.58 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 114.806 -1.088 . . . . 0.0 113.476 -177.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 105' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' B' ' 123' ' ' GLN . 81.0 tt0 -78.78 123.11 26.86 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.221 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 41.1 tp -112.27 126.56 55.37 Favored 'General case' 0 C--N 1.346 0.445 0 CA-C-O 120.873 0.368 . . . . 0.0 111.874 -177.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 107' ' ' ASN . . . . . 0.965 ' OD1' HG23 ' B' ' 89' ' ' THR . 97.8 m-20 -120.37 126.92 51.71 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 175.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 96.4 mt -121.9 133.15 69.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.53 123.3 7.61 Favored Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 178.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -69.04 151.82 73.13 Favored 'Trans proline' 0 N--CA 1.501 1.941 0 C-N-CA 122.411 2.074 . . . . 0.0 112.471 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 111' ' ' MET . . . . . 0.477 ' HB2' ' HB2' ' B' ' 118' ' ' TYR . 67.2 mtt -128.59 143.66 51.0 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -113.24 106.59 14.81 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 106.074 -1.825 . . . . 0.0 106.074 179.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 113' ' ' ILE . . . . . 0.653 HG12 ' NZ ' ' A' ' 18' ' ' LYS . 96.8 mt -133.15 127.06 54.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-N 118.474 0.579 . . . . 0.0 111.525 178.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 52.48 37.86 24.0 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.026 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 59.92 36.03 21.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.707 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -132.68 150.2 52.19 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 177.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 117' ' ' THR . . . . . 0.432 HG23 ' CG ' ' B' ' 32' ' ' PRO . 6.9 t -100.45 153.52 19.28 Favored 'General case' 0 C--O 1.217 -0.62 0 C-N-CA 120.555 -0.458 . . . . 0.0 109.908 -177.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 118' ' ' TYR . . . . . 0.477 ' HB2' ' HB2' ' B' ' 111' ' ' MET . 90.7 m-85 -148.43 146.37 28.4 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 121.071 -1.018 . . . . 0.0 111.182 -178.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -122.59 138.6 54.53 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 120.66 0.267 . . . . 0.0 111.198 -176.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.7 p -129.28 135.8 60.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -177.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -112.59 122.74 6.02 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 89.1 mt -111.71 127.31 68.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 123' ' ' GLN . . . . . 0.515 ' HG2' HD21 ' B' ' 104' ' ' ASN . 15.3 mp0 -118.61 122.96 43.83 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -119.92 123.6 43.97 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 125' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' B' ' 127' ' ' THR . 67.2 t0 -70.37 129.05 38.27 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.634 -178.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.562 ' O ' ' HG3' ' B' ' 130' ' ' LYS . 2.7 mp -102.61 15.55 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.837 0 CA-C-O 122.052 0.93 . . . . 0.0 109.278 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 127' ' ' THR . . . . . 0.479 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 19.5 m -63.13 -44.63 95.05 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 114.225 -1.352 . . . . 0.0 113.013 175.041 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -61.34 -46.1 91.64 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 129' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -63.69 -35.16 79.64 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.548 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 130' ' ' LYS . . . . . 0.853 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 98.7 mttt -63.73 -40.6 97.14 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 113.865 -1.516 . . . . 0.0 110.547 174.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.41 -41.38 96.66 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 132' ' ' TYR . . . . . 0.821 ' CE2' HD11 ' B' ' 136' ' ' LEU . 90.1 t80 -60.56 -44.16 96.46 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 121.693 -0.629 . . . . 0.0 111.066 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.0 -36.73 84.94 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 120.328 -0.549 . . . . 0.0 109.548 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.2 -39.54 94.94 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.881 178.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 54.1 tp -62.59 -41.3 98.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.187 0.518 . . . . 0.0 109.741 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 136' ' ' LEU . . . . . 0.821 HD11 ' CE2' ' B' ' 132' ' ' TYR . 86.9 mt -62.9 -41.89 99.6 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.27 177.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 137' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.56 -36.78 84.79 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.466 -1.243 . . . . 0.0 110.432 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.05 -43.01 99.82 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.896 177.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 70.1 m -60.74 -44.38 96.75 Favored 'General case' 0 C--N 1.343 0.323 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 140' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' B' ' 144' ' ' THR . 84.2 mt -61.04 -40.25 92.88 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -177.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 91.3 m -61.85 -45.46 93.71 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.91 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -66.33 -42.12 88.63 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 93.7 mt -63.67 -43.17 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.714 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 144' ' ' THR . . . . . 0.443 ' N ' ' O ' ' B' ' 140' ' ' LEU . 90.2 m -61.75 -45.24 94.77 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.56 -40.59 97.38 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 119.074 -1.051 . . . . 0.0 109.412 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 86.1 mt -64.49 -41.51 96.41 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 147' ' ' SER . . . . . 0.641 ' O ' ' N ' ' B' ' 149' ' ' PRO . 78.1 p -60.89 -42.77 98.65 Favored 'General case' 0 CA--C 1.48 -1.726 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 148' ' ' THR . . . . . 0.494 ' C ' ' O ' ' B' ' 147' ' ' SER . 6.8 m -27.8 84.75 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.592 0 O-C-N 124.105 0.878 . . . . 0.0 110.158 177.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 149' ' ' PRO . . . . . 0.641 ' N ' ' O ' ' B' ' 147' ' ' SER . 23.0 Cg_exo -62.34 147.59 94.69 Favored 'Trans proline' 0 C--N 1.296 -2.213 0 C-N-CA 122.234 1.956 . . . . 0.0 115.641 -177.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 9.1 tp -127.74 120.17 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-N 114.004 -1.453 . . . . 0.0 107.867 174.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 63.8 t -150.71 92.95 3.82 Favored Pre-proline 0 C--N 1.314 -0.936 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.992 -178.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -60.77 137.16 71.06 Favored 'Trans proline' 0 N--CA 1.484 0.952 0 N-CA-C 109.175 -1.125 . . . . 0.0 109.175 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 153' ' ' ILE . . . . . 0.64 ' O ' ' HD2' ' B' ' 154' ' ' ARG . 45.2 mm -67.66 -43.9 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.17 178.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 154' ' ' ARG . . . . . 0.661 HH11 HG13 ' A' ' 255' ' ' VAL . 0.3 OUTLIER -158.82 -154.01 0.4 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -179.618 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 62.3 t-20 -86.89 108.49 18.8 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.69 -16.38 58.75 Favored Glycine 0 C--O 1.221 -0.713 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 157' ' ' ILE . . . . . 0.509 HG22 ' HB ' ' B' ' 153' ' ' ILE . 89.0 mt -110.13 125.59 67.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.326 0.584 . . . . 0.0 111.37 -176.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 158' ' ' SER . . . . . 0.631 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 68.3 m -134.7 148.91 50.41 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.096 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -134.45 145.45 48.86 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.226 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 30.3 tp -138.45 79.25 30.56 Favored Pre-proline 0 C--O 1.234 0.283 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 161' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -70.54 146.99 56.87 Favored 'Trans proline' 0 N--CA 1.5 1.869 0 C-N-CA 122.831 2.354 . . . . 0.0 114.4 -178.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 87.0 mt -112.51 132.97 54.82 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 54.2 t -128.55 132.79 67.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 113.23 169.1 17.17 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 120.35 -0.929 . . . . 0.0 111.266 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 165' ' ' ASN . . . . . 0.688 ' O ' ' CZ ' ' B' ' 170' ' ' ARG . 61.9 t30 -89.62 107.02 18.85 Favored 'General case' 0 C--O 1.215 -0.752 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -177.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 166' ' ' LEU . . . . . 0.508 HD21 ' CZ ' ' B' ' 171' ' ' PHE . 46.7 tp -65.86 104.49 1.1 Allowed 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 -174.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 167' ' ' THR . . . . . 0.647 HG23 ' HE ' ' B' ' 170' ' ' ARG . 9.8 p -85.37 169.97 13.18 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 114.271 -1.331 . . . . 0.0 110.901 177.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.84 -37.39 84.38 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.718 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.34 -41.24 89.85 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-O 123.44 1.591 . . . . 0.0 111.508 -178.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 170' ' ' ARG . . . . . 0.688 ' CZ ' ' O ' ' B' ' 165' ' ' ASN . 88.3 mtm180 -62.58 -35.28 79.01 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 112.276 -2.238 . . . . 0.0 110.653 177.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 171' ' ' PHE . . . . . 0.508 ' CZ ' HD21 ' B' ' 166' ' ' LEU . 0.5 OUTLIER -54.9 -26.25 34.59 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -178.736 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 172' ' ' ASN . . . . . 0.531 ' O ' HG22 ' B' ' 175' ' ' VAL . 92.7 m-20 -62.88 -40.3 97.12 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.784 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 48.8 m -60.17 -41.77 93.57 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.051 0.453 . . . . 0.0 110.63 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 64.8 mt -63.43 -44.29 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 175' ' ' VAL . . . . . 0.531 HG22 ' O ' ' B' ' 172' ' ' ASN . 27.3 m -62.44 -39.81 85.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 176' ' ' CYS . . . . . . . . . . . . . 96.7 m -62.69 -35.58 80.14 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.344 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 177' ' ' THR . . . . . 0.527 ' O ' HG13 ' B' ' 181' ' ' ILE . 25.1 m -61.69 -19.42 62.34 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.499 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 178' ' ' LEU . . . . . 0.656 ' CD2' HD21 ' B' ' 211' ' ' LEU . 88.2 mt -61.23 -39.36 90.01 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -178.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 19.2 m -61.77 -44.03 97.69 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 120.74 0.305 . . . . 0.0 110.262 177.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 180' ' ' ASN . . . . . 0.587 ' O ' ' OG ' ' B' ' 183' ' ' SER . 92.6 m-20 -61.27 -40.22 93.29 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.853 0.358 . . . . 0.0 110.494 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.527 HG13 ' O ' ' B' ' 177' ' ' THR . 72.7 mt -57.47 -32.0 40.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 O-C-N 122.284 -0.26 . . . . 0.0 110.753 -178.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 182' ' ' LEU . . . . . . . . . . . . . 83.9 mt -62.38 -41.99 99.07 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.096 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 183' ' ' SER . . . . . 0.587 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.4 p -63.28 -32.84 74.35 Favored 'General case' 0 C--N 1.334 -0.106 0 O-C-N 121.835 -0.54 . . . . 0.0 110.865 178.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 56.8 p -85.87 17.34 3.49 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.787 -177.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 78.8 p -61.5 -16.39 46.92 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.523 -176.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.17 -40.17 95.1 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 121.076 -0.25 . . . . 0.0 110.764 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 187' ' ' ASP . . . . . 0.631 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.6 m-20 -70.43 114.95 9.05 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.44 0.638 . . . . 0.0 110.635 -177.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -62.63 -42.6 99.68 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 114.922 -1.035 . . . . 0.0 113.112 -177.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -113.55 131.38 56.11 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.149 -177.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 190' ' ' LEU . . . . . . . . . . . . . 40.7 tp -123.29 119.37 29.93 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.089 177.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 84.5 mt -107.43 125.08 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 117.851 0.296 . . . . 0.0 110.89 -176.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 50.1 mm -113.7 118.83 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 193' ' ' ASP . . . . . 0.475 ' CG ' ' HG ' ' B' ' 195' ' ' SER . 41.5 t0 -90.29 112.17 23.62 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -176.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 194' ' ' LEU . . . . . . . . . . . . . 96.6 mt -94.71 -1.89 52.18 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 123.705 0.628 . . . . 0.0 109.782 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 195' ' ' SER . . . . . 0.475 ' HG ' ' CG ' ' B' ' 193' ' ' ASP . 77.9 p -60.83 -39.0 87.4 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.905 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.18 -35.19 90.47 Favored Glycine 0 N--CA 1.438 -1.205 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -178.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 197' ' ' LEU . . . . . 0.952 HD23 ' N ' ' B' ' 198' ' ' ALA . 5.3 tt -74.27 133.8 42.63 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 198' ' ' ALA . . . . . 0.952 ' N ' HD23 ' B' ' 197' ' ' LEU . . . -61.75 -47.38 85.44 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.322 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 199' ' ' GLN . . . . . 0.942 ' O ' ' CD2' ' B' ' 197' ' ' LEU . 59.2 tt0 -136.76 164.7 27.66 Favored 'General case' 0 C--O 1.209 -1.077 0 CA-C-O 122.083 0.944 . . . . 0.0 112.389 -177.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 200' ' ' VAL . . . . . 0.515 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 51.8 t -120.53 131.85 71.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 O-C-N 120.579 -1.326 . . . . 0.0 109.532 177.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -86.81 150.08 24.38 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.855 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.27 -33.17 74.1 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.253 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -63.7 -32.3 73.74 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.382 0.61 . . . . 0.0 109.481 177.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.2 m -60.81 -43.82 97.67 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.206 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 205' ' ' ALA . . . . . 0.633 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -58.26 -29.6 65.92 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -178.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -65.94 -38.35 88.39 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.431 0.634 . . . . 0.0 110.646 174.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -66.13 -38.46 88.21 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.477 178.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 95.0 mt -62.97 -45.51 98.69 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -178.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 209' ' ' PHE . . . . . 0.633 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 67.6 m-85 -61.47 -42.58 99.0 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.916 -176.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.82 -42.04 99.56 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 119.581 -0.847 . . . . 0.0 109.94 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 211' ' ' LEU . . . . . 0.656 HD21 ' CD2' ' B' ' 178' ' ' LEU . 38.3 mt -62.49 -42.52 99.55 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.173 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 78.1 p -63.46 -37.29 86.72 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.291 -0.564 . . . . 0.0 112.105 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 213' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -66.18 -46.64 76.63 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.214 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.404 ' O ' HG23 ' B' ' 218' ' ' THR . 53.3 tp -63.92 -42.57 97.35 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.895 0.855 . . . . 0.0 109.863 177.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 215' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' B' ' 211' ' ' LEU . 86.2 mt -62.53 -43.4 98.91 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 113.274 -1.785 . . . . 0.0 111.288 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.19 -39.77 93.83 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.749 0.309 . . . . 0.0 111.438 -177.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 92.4 mt -63.24 -41.97 99.14 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.443 0.64 . . . . 0.0 111.196 176.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 218' ' ' THR . . . . . 0.404 HG23 ' O ' ' B' ' 214' ' ' LEU . 68.3 p -74.75 -14.83 60.76 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.642 -178.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 78.14 65.46 1.87 Allowed Glycine 0 CA--C 1.528 0.885 0 N-CA-C 107.485 -2.246 . . . . 0.0 107.485 -177.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 220' ' ' THR . . . . . . . . . . . . . 95.3 m -144.08 105.31 4.24 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 175.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -62.15 140.96 58.4 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.922 -176.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 45.3 tp -117.18 121.83 42.32 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.645 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 3.5 mp -112.35 129.77 67.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.04 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 224' ' ' ILE . . . . . 0.643 ' CG2' HD11 ' B' ' 227' ' ' ILE . 50.1 mm -110.74 127.13 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 44.0 p -134.24 156.46 48.36 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 121.957 0.884 . . . . 0.0 112.495 -178.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 90.5 16.85 54.44 Favored Glycine 0 C--N 1.316 -0.564 0 CA-C-N 113.951 -1.477 . . . . 0.0 111.303 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 227' ' ' ILE . . . . . 0.643 HD11 ' CG2' ' B' ' 224' ' ' ILE . 95.5 mt -82.81 127.21 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 118.027 0.914 . . . . 0.0 111.284 -178.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 56.1 tttt -66.58 138.17 95.47 Favored Pre-proline 0 C--N 1.316 -0.868 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.525 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.9 -37.4 93.09 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 121.443 1.429 . . . . 0.0 112.616 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -62.66 -44.12 97.07 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 48.3 tp -61.68 -41.64 97.84 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.267 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.06 -37.41 87.1 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.931 -0.307 . . . . 0.0 111.414 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 94.6 mtp -64.16 -40.06 95.34 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-O 121.248 0.547 . . . . 0.0 109.629 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.43 -42.74 98.69 Favored 'General case' 0 CA--C 1.554 1.114 0 CA-C-O 122.443 1.116 . . . . 0.0 109.539 178.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 33.0 mmt -63.81 -35.86 82.0 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.507 -1.224 . . . . 0.0 111.89 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -62.06 -40.33 95.44 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.006 -178.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.01 -43.66 98.14 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 120.512 -0.475 . . . . 0.0 109.825 177.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 55.1 tp -62.57 -44.57 96.0 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.625 -178.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 239' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' B' ' 240' ' ' ALA . 66.8 t0 -159.27 132.5 7.11 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.35 -0.54 . . . . 0.0 112.106 -178.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 240' ' ' ALA . . . . . 0.41 ' N ' ' OD1' ' B' ' 239' ' ' ASP . . . -61.07 -46.55 90.22 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 177.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 241' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' B' ' 244' ' ' SER . 92.1 m-20 -44.06 -20.14 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.689 -175.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 242' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -60.63 -44.99 95.71 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.141 -0.624 . . . . 0.0 110.298 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 243' ' ' SER . . . . . . . . . . . . . 78.1 p -57.93 -42.87 85.78 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 178.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 244' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 20.0 m -34.61 -35.0 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -177.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 97.3 mt -88.36 132.51 34.4 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.702 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -58.28 135.41 57.13 Favored 'General case' 0 C--O 1.25 1.121 0 CA-C-O 121.906 0.86 . . . . 0.0 111.523 -178.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 247' ' ' THR . . . . . 0.604 HG23 HD12 ' B' ' 227' ' ' ILE . 98.1 m -127.13 128.09 45.63 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 114.525 -1.216 . . . . 0.0 112.004 178.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 248' ' ' TYR . . . . . 0.511 ' CG ' ' HB2' ' B' ' 254' ' ' ALA . 93.4 m-85 -112.46 143.78 43.02 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 249' ' ' SER . . . . . 0.565 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 78.2 p -62.57 -34.99 78.08 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.18 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 250' ' ' ASN . . . . . 0.565 ' OD1' ' O ' ' B' ' 249' ' ' SER . 99.0 m-20 -147.16 161.28 41.22 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 114.966 -1.015 . . . . 0.0 112.574 178.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 251' ' ' VAL . . . . . 0.406 ' O ' HG23 ' B' ' 255' ' ' VAL . 69.2 t -64.76 -44.93 96.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.788 178.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 252' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.04 -45.95 92.7 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 253' ' ' ASP . . . . . 0.477 ' O ' HG22 ' B' ' 257' ' ' VAL . 94.2 m-20 -61.23 -43.24 99.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.57 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 254' ' ' ALA . . . . . 0.511 ' HB2' ' CG ' ' B' ' 248' ' ' TYR . . . -65.73 -39.49 91.21 Favored 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.062 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 255' ' ' VAL . . . . . 0.643 HG13 HH11 ' A' ' 154' ' ' ARG . 76.2 t -65.22 -45.76 92.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.875 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.548 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.0 -48.4 78.98 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 121.588 0.709 . . . . 0.0 111.263 -177.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 257' ' ' VAL . . . . . 0.477 ' O ' ' C ' ' B' ' 258' ' ' LEU . 27.1 m -65.09 -40.83 90.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.959 -1.018 . . . . 0.0 111.464 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 258' ' ' LEU . . . . . 0.482 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 1.3 mt -31.79 -72.3 0.07 OUTLIER Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.794 -178.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 259' ' ' PRO . . . . . 0.513 ' O ' HG13 ' B' ' 260' ' ' ILE . 39.8 Cg_endo -63.11 140.94 81.04 Favored 'Trans proline' 0 N--CA 1.504 2.103 0 C-N-CA 121.59 1.527 . . . . 0.0 111.351 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 260' ' ' ILE . . . . . 0.535 HG22 ' O ' ' B' ' 260' ' ' ILE . 96.7 mt -158.33 -15.4 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-N 118.591 0.632 . . . . 0.0 112.573 177.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 78.0 mtm . . . . . 0 N--CA 1.466 0.339 0 CA-C-O 118.207 -0.901 . . . . 0.0 111.825 179.675 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 900' ' ' FMN . . . . . 0.41 ' C9A' " O2'" ' A' ' 900' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 900' ' ' FMN . . . . . 0.405 ' H9 ' H1'1 ' B' ' 900' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.15 -175.16 4.59 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 88.5 p -85.11 -7.04 59.26 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.484 -0.76 . . . . 0.0 111.412 177.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -81.57 -63.45 1.39 Allowed 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 114.109 -1.405 . . . . 0.0 113.157 172.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -67.5 -38.79 84.84 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.557 ' O ' ' NZ ' ' B' ' 17' ' ' LYS . 66.9 m -59.44 -42.08 91.12 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.181 -177.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.522 ' CE2' HD12 ' A' ' 9' ' ' ILE . 46.9 t80 85.48 85.96 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 O-C-N 123.766 0.666 . . . . 0.0 111.03 177.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.646 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -58.78 -150.13 0.01 OUTLIER Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.646 ' HB ' ' O ' ' A' ' 8' ' ' GLY . 89.3 mt 91.4 111.85 0.02 OUTLIER Pre-proline 0 N--CA 1.471 0.598 0 C-N-CA 122.734 0.414 . . . . 0.0 110.775 -179.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.66 -22.03 64.77 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 121.431 1.421 . . . . 0.0 112.153 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.05 -38.68 96.36 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 120.953 -0.641 . . . . 0.0 111.917 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -65.09 -39.21 92.85 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.549 0.69 . . . . 0.0 109.968 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.6 tp -63.08 -41.5 99.42 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -63.21 -40.36 97.26 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.6 t -60.48 -44.18 95.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 O-C-N 122.242 -0.286 . . . . 0.0 110.953 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 92.9 mt -62.63 -43.74 98.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.646 -177.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.7 -45.89 90.68 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 119.411 -0.916 . . . . 0.0 112.09 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.467 ' NZ ' HG12 ' B' ' 113' ' ' ILE . 98.5 mttt -60.28 -39.26 86.22 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 118.578 -1.249 . . . . 0.0 109.074 -176.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.5 -40.93 93.14 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.242 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.8 mt -62.97 -40.71 98.55 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -63.26 -38.19 90.18 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.327 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 62.0 m170 -58.82 -39.38 81.02 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 122.2 -0.313 . . . . 0.0 111.271 -178.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.37 130.65 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.512 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 35.8 ptt180 -73.65 110.71 8.15 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 122.093 0.949 . . . . 0.0 111.961 -177.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.0 p -141.54 143.67 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.599 ' HA3' ' HB2' ' A' ' 123' ' ' GLN . . . -97.28 91.97 1.27 Allowed Glycine 0 C--N 1.313 -0.695 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.814 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 50.8 t -124.44 129.51 73.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.6 m -137.1 159.92 36.28 Favored 'Isoleucine or valine' 0 C--O 1.244 0.796 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.9 mt -119.88 131.29 72.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.667 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.7 p -108.11 165.88 11.15 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.555 ' C ' ' OD1' ' A' ' 37' ' ' ASN . 50.9 t0 -132.09 101.41 15.07 Favored Pre-proline 0 C--N 1.323 -0.544 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.194 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.546 ' CG ' HG23 ' A' ' 117' ' ' THR . 35.5 Cg_endo -63.53 -22.31 70.78 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.659 1.573 . . . . 0.0 111.746 -178.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.03 -36.01 82.14 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.231 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.5 mt -83.33 159.17 21.93 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.954 176.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.782 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 42.4 tt0 -58.53 135.67 57.37 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -177.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.535 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 59.8 t0 61.1 18.89 9.45 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 178.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.555 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 31.0 t-20 42.79 67.42 3.56 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.748 -176.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.782 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 92.2 Cg_endo -71.13 156.3 59.81 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 123.985 3.123 . . . . 0.0 112.336 -178.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.2 mt -87.16 125.45 40.98 Favored 'Isoleucine or valine' 0 C--O 1.245 0.833 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.6 m -104.52 -44.26 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 O-C-N 123.659 0.6 . . . . 0.0 112.335 -179.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -96.35 124.68 40.44 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.838 -178.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.2 p -142.36 139.57 29.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 O-C-N 124.162 0.914 . . . . 0.0 109.333 176.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.598 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 56.6 p30 -97.04 167.56 10.99 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.461 ' HA ' ' OE1' ' A' ' 44' ' ' GLN . 14.1 mm100 -66.55 -39.08 88.37 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 176.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.69 -27.16 63.54 Favored Glycine 0 N--CA 1.452 -0.241 0 N-CA-C 110.331 -1.107 . . . . 0.0 110.331 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.607 ' CD1' HD13 ' A' ' 57' ' ' ILE . 58.1 t80 -59.08 -48.28 82.16 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.586 HG13 ' O ' ' A' ' 52' ' ' TYR . 78.7 t -59.89 -44.62 94.71 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 O-C-N 121.092 -1.005 . . . . 0.0 111.708 -173.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -63.15 -38.24 90.38 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 120.496 -0.482 . . . . 0.0 112.035 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.453 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 60.2 ttm -66.85 -43.21 84.22 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 175.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 36.8 p -93.58 -21.32 19.49 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.993 0.425 . . . . 0.0 111.523 -177.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . 77.05 20.39 75.84 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.586 ' O ' HG13 ' A' ' 47' ' ' VAL . 85.4 m-85 -114.33 136.77 52.61 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.022 0.439 . . . . 0.0 111.137 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -63.57 147.63 50.94 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.703 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.439 HG22 ' H ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -64.22 -31.14 72.22 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.595 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -67.28 -42.24 84.16 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 119.615 -0.834 . . . . 0.0 111.499 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -66.55 -44.68 81.71 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.423 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.607 HD13 ' CD1' ' A' ' 46' ' ' PHE . 96.2 mt -62.03 -45.34 98.95 Favored 'Isoleucine or valine' 0 C--N 1.354 0.767 0 CA-C-O 118.046 -0.978 . . . . 0.0 111.348 -175.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.0 mt -64.37 141.22 58.85 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 -177.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.35 -0.06 86.93 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.615 178.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -137.16 152.45 49.95 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.502 1.651 . . . . 0.0 111.44 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.54 ' C ' ' H ' ' A' ' 63' ' ' ARG . 25.1 t-20 -81.88 152.25 26.93 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.245 0.545 . . . . 0.0 110.648 -178.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 83.4 m -64.16 15.36 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.34 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.54 ' H ' ' C ' ' A' ' 61' ' ' ASN . 35.8 ptt-85 -61.59 -42.19 98.5 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.255 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -55.21 -22.31 17.29 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 88.2 mt -66.39 -36.62 83.31 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 177.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -64.79 144.04 57.52 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.446 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.628 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -152.66 -147.98 4.74 Favored Glycine 0 CA--C 1.541 1.71 0 N-CA-C 111.649 -0.581 . . . . 0.0 111.649 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.16 -39.98 96.23 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -177.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.464 ' O ' ' NE2' ' A' ' 93' ' ' GLN . 8.8 m-70 -77.69 -6.97 55.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.672 0.272 . . . . 0.0 111.001 -178.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.628 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 27.9 m -64.0 128.8 37.41 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.126 -0.63 . . . . 0.0 109.729 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -85.5 109.87 25.11 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.242 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 70' ' ' THR . 52.9 Cg_exo -57.09 -31.7 91.07 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 121.91 1.74 . . . . 0.0 113.063 178.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.08 -40.16 95.64 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.172 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.503 ' OE1' ' HB ' ' A' ' 90' ' ' VAL . 79.3 mm-40 -65.91 -44.0 86.49 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 67.4 t -59.92 -44.02 93.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 114.448 -1.251 . . . . 0.0 107.799 -175.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -63.99 -37.77 88.62 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.89 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -63.35 -39.53 94.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.339 0.59 . . . . 0.0 110.228 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.89 -44.04 97.94 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 CA-C-N 114.946 -1.025 . . . . 0.0 112.0 178.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -62.96 -43.35 99.03 Favored 'General case' 0 C--O 1.251 1.141 0 CA-C-N 113.68 -1.6 . . . . 0.0 108.482 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 99.8 m -61.35 -50.08 74.35 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 119.729 -0.788 . . . . 0.0 108.962 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.89 -42.35 89.33 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 119.487 -0.292 . . . . 0.0 111.187 -173.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 89.2 mt -63.12 -39.79 95.7 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 119.09 0.859 . . . . 0.0 111.885 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -63.24 -35.32 79.94 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 177.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -89.34 -2.91 58.61 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.694 -177.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 38.0 tttt 51.45 43.97 29.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.827 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -126.8 146.62 57.91 Favored Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 108' ' ' ILE . 24.2 Cg_exo -61.83 143.49 95.91 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.345 1.363 . . . . 0.0 112.822 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.7 142.3 30.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.862 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.917 HG23 ' OD1' ' A' ' 107' ' ' ASN . 96.6 m -126.41 122.22 34.7 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 175.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.503 ' HB ' ' OE1' ' A' ' 74' ' ' GLU . 29.3 m -139.05 159.47 29.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 121.106 -0.238 . . . . 0.0 111.308 178.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -103.61 133.99 47.7 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 105.021 -2.215 . . . . 0.0 105.021 176.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.5 ' O ' HG23 ' A' ' 92' ' ' ILE . 19.2 tt -142.4 125.23 14.14 Favored 'Isoleucine or valine' 0 C--N 1.374 1.635 0 CA-C-N 121.622 2.01 . . . . 0.0 112.341 176.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.464 ' NE2' ' O ' ' A' ' 69' ' ' HIS . 34.0 mt-30 -58.87 136.55 57.86 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.377 179.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -136.07 159.96 40.09 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.161 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.4 ' CE1' ' HA3' ' A' ' 67' ' ' GLY . 93.8 m-85 -117.12 134.67 54.49 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -178.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.453 ' HE2' ' O ' ' A' ' 49' ' ' MET . 98.9 mttt -83.79 -174.3 5.2 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.086 0.469 . . . . 0.0 111.908 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.35 -43.13 99.54 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.102 178.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 40.9 p-10 -83.53 6.42 20.53 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -178.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.7 -1.38 87.04 Favored Glycine 0 N--CA 1.473 1.163 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.352 176.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.0 m -59.73 137.96 57.9 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.691 ' SD ' ' C ' ' A' ' 101' ' ' MET . 13.4 tmm? -105.47 129.03 53.85 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 120.959 0.409 . . . . 0.0 110.508 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.487 ' N ' ' SD ' ' A' ' 101' ' ' MET . 50.7 p90 -142.16 156.22 45.34 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.175 -176.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.724 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 20.8 m95 -88.24 142.2 27.94 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.477 HD21 ' HG2' ' A' ' 123' ' ' GLN . 54.3 t-20 -136.97 102.35 4.83 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -177.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.46 ' HB2' HD11 ' A' ' 126' ' ' ILE . 81.0 tt0 -67.75 136.77 54.75 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 -177.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 41.1 tp -121.5 122.57 40.03 Favored 'General case' 0 C--O 1.233 0.185 0 O-C-N 123.665 0.603 . . . . 0.0 112.593 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.917 ' OD1' HG23 ' A' ' 89' ' ' THR . 98.2 m-20 -118.85 123.32 44.42 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 116.724 -0.216 . . . . 0.0 110.64 177.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.432 ' O ' ' HA ' ' A' ' 87' ' ' PRO . 96.2 mt -120.03 128.77 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 O-C-N 123.468 0.48 . . . . 0.0 111.268 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -136.77 124.58 14.58 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 116.871 -0.15 . . . . 0.0 110.88 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -70.88 151.19 62.46 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.342 2.028 . . . . 0.0 112.499 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.587 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 67.2 mtt -124.03 153.13 41.78 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 179.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -129.09 95.59 4.1 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 176.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 96.5 mt -121.02 131.4 73.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.621 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 50.43 37.98 17.02 Favored 'General case' 0 CA--C 1.515 -0.398 0 O-C-N 121.567 -0.708 . . . . 0.0 111.441 176.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 58.7 30.51 20.05 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.707 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -126.81 147.9 49.99 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.814 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 5.2 t -84.85 -171.26 3.54 Favored 'General case' 0 C--O 1.214 -0.793 0 CA-C-O 118.618 -0.706 . . . . 0.0 109.323 -178.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.814 ' CD2' ' O ' ' A' ' 117' ' ' THR . 76.3 m-85 -174.96 154.95 1.93 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 175.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -130.71 146.2 52.12 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 174.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.7 134.86 56.14 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.461 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.439 ' HA3' ' H6 ' ' A' ' 900' ' ' FMN . . . -106.81 127.85 9.03 Favored Glycine 0 CA--C 1.502 -0.774 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 178.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.408 ' HB ' ' HB2' ' A' ' 107' ' ' ASN . 96.6 mt -116.58 128.16 74.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 177.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.599 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . 17.3 mp0 -118.72 112.87 20.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.072 0.463 . . . . 0.0 109.875 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -115.07 112.16 22.17 Favored 'General case' 0 C--O 1.248 0.974 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.881 -178.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 127' ' ' THR . 68.4 t0 -62.55 131.28 48.57 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -176.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.507 ' O ' HG22 ' A' ' 126' ' ' ILE . 3.3 mp -96.64 4.32 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 113.743 -1.571 . . . . 0.0 109.884 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.461 ' N ' ' OD1' ' A' ' 125' ' ' ASP . 25.6 m -60.37 -42.34 95.6 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 121.081 -1.012 . . . . 0.0 113.388 -178.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -59.63 -42.8 93.54 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -62.8 -39.73 95.16 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.702 177.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.724 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.8 mttt -62.34 -41.21 98.4 Favored 'General case' 0 CA--C 1.503 -0.834 0 C-N-CA 118.286 -1.366 . . . . 0.0 110.64 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -62.17 -37.59 85.81 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.659 ' CE2' HD11 ' A' ' 136' ' ' LEU . 87.5 t80 -61.48 -45.44 94.21 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.672 176.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.81 -38.61 91.56 Favored 'General case' 0 CA--C 1.522 -0.116 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.06 -40.83 97.1 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.068 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 54.8 tp -60.8 -43.84 97.62 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -177.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.659 HD11 ' CE2' ' A' ' 132' ' ' TYR . 85.2 mt -62.21 -41.34 98.29 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.382 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.09 -42.55 99.33 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 119.529 -0.868 . . . . 0.0 109.799 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -60.68 -42.12 96.46 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -177.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 58.3 m -61.57 -41.12 96.95 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.642 176.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 144' ' ' THR . 83.6 mt -63.5 -42.07 98.53 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 120.63 -0.428 . . . . 0.0 109.934 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 91.5 m -61.62 -45.4 94.23 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.152 -177.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -65.08 -40.21 94.31 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 95.2 mt -64.72 -43.39 96.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.115 -1.402 . . . . 0.0 111.313 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.51 ' N ' ' O ' ' A' ' 140' ' ' LEU . 99.4 m -62.65 -46.16 89.47 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 121.811 -0.556 . . . . 0.0 112.121 -177.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.454 ' O ' ' OG1' ' A' ' 148' ' ' THR . . . -63.31 -39.42 94.51 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 118.803 -1.159 . . . . 0.0 109.051 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 81.7 mt -63.38 -42.65 98.83 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.355 178.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.711 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.2 p -59.96 -39.65 86.34 Favored 'General case' 0 C--O 1.217 -0.644 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -178.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.49 ' C ' ' O ' ' A' ' 147' ' ' SER . 21.6 m -27.1 81.72 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.418 0 O-C-N 126.971 2.669 . . . . 0.0 106.133 -178.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.711 ' N ' ' O ' ' A' ' 147' ' ' SER . 21.1 Cg_exo -62.44 146.15 95.61 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 C-N-CA 121.427 1.418 . . . . 0.0 114.538 -175.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.574 ' O ' ' CG2' ' A' ' 151' ' ' VAL . 9.6 tp -124.52 136.58 60.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 102.843 -3.021 . . . . 0.0 102.843 178.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.574 ' CG2' ' O ' ' A' ' 150' ' ' ILE . 60.1 t -169.05 96.48 0.52 Allowed Pre-proline 0 N--CA 1.437 -1.083 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 178.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -64.8 133.28 35.68 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 109.785 -0.89 . . . . 0.0 109.785 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.665 ' O ' ' HD2' ' A' ' 154' ' ' ARG . 45.9 mm -69.19 -45.13 80.09 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.909 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.395 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.665 ' HD2' ' O ' ' A' ' 153' ' ' ILE . 1.1 tpt180 -156.15 -159.32 0.88 Allowed 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.422 ' ND2' ' HE3' ' B' ' 256' ' ' LYS . 58.9 t-20 -86.16 106.18 17.09 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.697 0.76 . . . . 0.0 111.289 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 88.8 10.06 67.52 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 113.98 -1.463 . . . . 0.0 110.501 -177.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.449 HG12 ' HB2' ' A' ' 189' ' ' TYR . 96.6 mt -128.11 122.82 59.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 175.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.615 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 58.0 m -131.92 151.75 51.51 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.199 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -134.06 140.11 46.43 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.206 -0.597 . . . . 0.0 111.404 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 29.7 tp -131.18 76.49 76.27 Favored Pre-proline 0 N--CA 1.468 0.469 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.206 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -68.89 149.11 72.02 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 122.791 2.327 . . . . 0.0 113.085 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 90.0 mt -117.38 128.63 55.22 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.179 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 45.8 t -123.48 131.56 72.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 115.58 167.55 15.18 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 120.89 -0.671 . . . . 0.0 111.92 178.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.888 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 60.0 t30 -84.19 115.64 22.53 Favored 'General case' 0 C--O 1.207 -1.151 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -178.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.512 HD21 ' CZ ' ' A' ' 171' ' ' PHE . 43.5 tp -75.76 105.57 6.87 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 -177.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.643 HG23 ' NE ' ' A' ' 170' ' ' ARG . 11.4 p -88.53 167.61 13.28 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.909 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.51 -34.19 77.68 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.983 0.42 . . . . 0.0 111.945 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.76 -42.11 91.3 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.805 0.812 . . . . 0.0 110.986 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.888 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 88.2 mtm180 -64.75 -34.26 77.91 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.791 177.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.512 ' CZ ' HD21 ' A' ' 166' ' ' LEU . 0.4 OUTLIER -55.07 -28.3 51.29 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 119.025 -0.512 . . . . 0.0 111.727 -177.084 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.711 ' O ' HG22 ' A' ' 175' ' ' VAL . 91.0 m-20 -60.35 -40.6 91.31 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 118.718 -1.193 . . . . 0.0 110.02 -177.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 50.3 m -59.25 -40.78 87.03 Favored 'General case' 0 C--N 1.315 -0.923 0 O-C-N 121.569 -0.707 . . . . 0.0 110.538 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 66.8 mt -62.9 -43.96 99.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.711 HG22 ' O ' ' A' ' 172' ' ' ASN . 23.0 m -62.32 -39.91 85.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -178.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' CYS . . . . . 0.438 ' N ' HG23 ' A' ' 175' ' ' VAL . 98.3 m -62.38 -34.61 77.04 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.274 178.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.582 ' O ' HG13 ' A' ' 181' ' ' ILE . 25.1 m -61.86 -19.71 62.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.905 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.786 ' CD2' HD21 ' A' ' 211' ' ' LEU . 91.3 mt -60.99 -41.18 95.98 Favored 'General case' 0 C--O 1.248 0.99 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -177.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 19.1 m -59.75 -43.58 94.21 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.576 ' O ' ' OG ' ' A' ' 183' ' ' SER . 92.0 m-20 -61.47 -35.4 77.52 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.775 0.43 . . . . 0.0 110.683 178.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.582 HG13 ' O ' ' A' ' 177' ' ' THR . 67.5 mt -60.32 -41.46 87.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.504 HD21 HD21 ' A' ' 214' ' ' LEU . 84.9 mt -60.3 -40.4 90.38 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 119.342 -0.943 . . . . 0.0 108.981 -176.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.576 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 78.1 p -61.45 -33.7 74.19 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.607 176.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 58.8 p -89.39 23.71 2.46 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.79 0.329 . . . . 0.0 111.446 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 78.1 p -64.48 -20.04 65.94 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.973 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -60.56 -37.43 81.23 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.921 -178.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.615 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 98.8 m-20 -73.57 114.98 12.43 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.383 0.611 . . . . 0.0 110.582 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -62.91 -42.62 99.85 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.123 -0.944 . . . . 0.0 113.027 -177.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' TYR . . . . . 0.449 ' HB2' HG12 ' A' ' 157' ' ' ILE . 98.5 m-85 -111.61 132.06 54.83 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.783 -177.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 40.0 tp -120.62 128.36 52.95 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 95.7 mt -116.94 127.32 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 118.35 0.523 . . . . 0.0 109.599 177.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.9 mm -112.84 127.05 70.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' ASP . . . . . 0.518 ' CG ' ' HG ' ' A' ' 195' ' ' SER . 40.0 t0 -94.23 118.02 30.96 Favored 'General case' 0 CA--C 1.552 1.053 0 O-C-N 121.796 -0.565 . . . . 0.0 110.824 177.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 194' ' ' LEU . 96.0 mt -96.51 -5.07 40.28 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.825 175.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.518 ' HG ' ' CG ' ' A' ' 193' ' ' ASP . 78.1 p -62.87 -33.81 76.06 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -62.28 -42.0 99.72 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 118.808 -1.663 . . . . 0.0 109.025 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.954 HD23 ' N ' ' A' ' 198' ' ' ALA . 4.7 tt -72.09 127.89 33.97 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 112.2 -2.0 . . . . 0.0 108.159 -177.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.954 ' N ' HD23 ' A' ' 197' ' ' LEU . . . -60.8 -47.21 87.38 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.956 0.408 . . . . 0.0 111.062 -178.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.908 ' O ' ' CD2' ' A' ' 197' ' ' LEU . 58.5 tt0 -133.63 155.93 48.79 Favored 'General case' 0 C--O 1.2 -1.547 0 CA-C-N 114.609 -1.178 . . . . 0.0 114.052 -174.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.433 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 46.9 t -117.97 132.51 67.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 O-C-N 120.17 -1.582 . . . . 0.0 108.707 178.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -90.44 155.46 18.91 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.642 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -64.44 -39.34 93.63 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 120.254 -0.578 . . . . 0.0 109.915 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -57.81 -32.66 67.79 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-O 122.099 0.952 . . . . 0.0 108.944 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.9 m -61.14 -42.57 98.78 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.222 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.512 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -57.96 -39.42 78.1 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -177.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -62.26 -36.71 82.87 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -65.48 -39.11 91.56 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.113 177.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 93.5 mt -63.16 -44.2 99.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' PHE . . . . . 0.512 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 68.9 m-85 -61.82 -43.83 98.07 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.648 -178.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.64 -42.62 99.7 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 119.295 -0.962 . . . . 0.0 109.221 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.786 HD21 ' CD2' ' A' ' 178' ' ' LEU . 37.7 mt -62.21 -41.87 98.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.644 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 78.4 p -61.44 -41.46 97.23 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.266 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' HIS . . . . . 0.439 ' CE1' HD11 ' A' ' 217' ' ' LEU . 57.8 t-80 -64.97 -45.52 85.34 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 122.018 -0.427 . . . . 0.0 111.528 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.504 HD21 HD21 ' A' ' 182' ' ' LEU . 48.0 tp -62.12 -46.52 88.65 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 118.893 -1.123 . . . . 0.0 108.003 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 211' ' ' LEU . 90.2 mt -61.98 -40.43 95.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.588 -177.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.34 -43.47 96.4 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.442 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.439 HD11 ' CE1' ' A' ' 213' ' ' HIS . 84.6 mt -61.95 -39.96 93.91 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 69.2 p -76.43 -11.35 59.87 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.365 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 83.17 35.31 18.37 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-O 119.133 -0.815 . . . . 0.0 112.844 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 96.2 m -123.44 110.97 15.78 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 118.863 1.331 . . . . 0.0 111.713 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -61.63 138.46 58.31 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.81 178.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 50.0 tp -113.61 131.05 56.26 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 177.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 2.7 mp -118.37 135.14 59.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.561 ' CG2' HD11 ' A' ' 227' ' ' ILE . 50.1 mm -116.48 131.63 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -178.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 34.5 p -133.71 167.53 20.35 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 78.63 21.42 69.16 Favored Glycine 0 C--N 1.334 0.469 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.607 HD12 HG23 ' A' ' 247' ' ' THR . 97.6 mt -84.68 128.15 39.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 113.924 -1.138 . . . . 0.0 108.427 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 54.3 tttt -74.02 140.56 77.24 Favored Pre-proline 0 CA--C 1.535 0.377 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.32 -39.72 89.46 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 120.942 1.095 . . . . 0.0 112.489 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -64.78 -37.38 87.4 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.507 0.67 . . . . 0.0 110.28 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 52.7 tp -63.79 -42.31 97.76 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.468 177.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -65.17 -37.12 86.36 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.042 0.449 . . . . 0.0 110.873 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 94.1 mtp -63.29 -40.97 98.85 Favored 'General case' 0 C--O 1.248 0.985 0 C-N-CA 120.074 -0.65 . . . . 0.0 109.536 -178.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -64.02 -39.9 95.14 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.462 177.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 35.1 mmt -66.76 -36.73 83.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.554 177.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -60.84 -41.87 96.66 Favored 'General case' 0 CA--C 1.513 -0.479 0 O-C-N 121.432 -0.793 . . . . 0.0 109.479 -176.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.86 -39.88 90.8 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.506 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 59.0 tp -63.44 -41.05 98.65 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 240' ' ' ALA . 67.0 t0 -167.6 129.47 1.55 Allowed 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 121.487 0.661 . . . . 0.0 112.148 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.408 ' N ' ' OD1' ' A' ' 239' ' ' ASP . . . -61.04 -26.8 67.88 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.618 178.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.485 ' O ' ' HB2' ' A' ' 244' ' ' SER . 90.8 m-20 -61.24 -32.68 72.48 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.326 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -55.59 -44.38 76.89 Favored 'General case' 0 C--N 1.312 -1.065 0 O-C-N 121.214 -0.929 . . . . 0.0 109.089 -175.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 94.2 p -62.82 -20.04 64.66 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.937 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' SER . . . . . 0.485 ' HB2' ' O ' ' A' ' 241' ' ' ASN . 49.7 m -56.4 -37.76 70.59 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 122.517 0.327 . . . . 0.0 111.854 177.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 92.5 mt -83.24 130.94 35.12 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 177.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -55.29 135.08 50.18 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 114.104 -1.407 . . . . 0.0 109.626 -177.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.607 HG23 HD12 ' A' ' 227' ' ' ILE . 98.0 m -126.79 132.14 51.1 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.836 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' TYR . . . . . 0.431 ' CG ' ' HB2' ' A' ' 254' ' ' ALA . 97.5 m-85 -118.09 140.54 49.61 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.401 178.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 249' ' ' SER . . . . . 0.418 ' O ' ' OD1' ' A' ' 250' ' ' ASN . 78.1 p -61.39 -42.35 98.58 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -178.012 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 249' ' ' SER . 98.4 m-20 -144.03 160.5 40.75 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.72 0.772 . . . . 0.0 111.43 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 77.0 t -62.38 -44.74 99.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 114.641 -1.163 . . . . 0.0 112.044 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.73 -43.78 97.47 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.329 -0.549 . . . . 0.0 109.581 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' ASP . . . . . 0.551 ' O ' HG22 ' A' ' 257' ' ' VAL . 55.1 m-20 -63.43 -42.68 98.71 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.164 -178.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.431 ' HB2' ' CG ' ' A' ' 248' ' ' TYR . . . -64.92 -41.88 95.18 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.729 0.776 . . . . 0.0 109.942 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 61.1 t -63.5 -45.89 96.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 114.225 -1.352 . . . . 0.0 111.304 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -63.89 -47.45 80.56 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.509 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 253' ' ' ASP . 33.4 m -66.89 -40.96 86.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 C-N-CA 119.908 -0.717 . . . . 0.0 112.481 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.483 ' C ' ' O ' ' A' ' 257' ' ' VAL . 0.9 OUTLIER -30.11 -73.42 0.05 OUTLIER Pre-proline 0 CA--C 1.533 0.293 0 O-C-N 123.166 0.291 . . . . 0.0 111.614 -176.847 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 259' ' ' PRO . . . . . 0.48 ' O ' HG13 ' A' ' 260' ' ' ILE . 43.6 Cg_endo -63.87 140.24 72.35 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 120.847 1.032 . . . . 0.0 111.857 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.48 HG13 ' O ' ' A' ' 259' ' ' PRO . 96.1 mt -152.91 -31.18 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 O-C-N 123.453 0.47 . . . . 0.0 112.16 178.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 77.3 mtm . . . . . 0 C--O 1.217 -0.617 0 CA-C-O 118.133 -0.937 . . . . 0.0 111.143 -177.213 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.521 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.62 175.32 11.65 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 100.0 p -72.09 -11.59 60.82 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.717 -0.219 . . . . 0.0 111.19 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -83.04 -60.94 2.0 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.063 0.458 . . . . 0.0 110.661 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -67.05 -39.16 86.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.253 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.537 ' O ' ' HB3' ' B' ' 7' ' ' PHE . 68.4 m -59.48 -43.28 93.33 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 120.249 -0.58 . . . . 0.0 109.6 -177.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 7' ' ' PHE . . . . . 0.537 ' HB3' ' O ' ' B' ' 6' ' ' SER . 48.3 t80 86.94 86.97 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.891 0.744 . . . . 0.0 110.71 177.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 8' ' ' GLY . . . . . 0.647 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -59.99 -149.72 0.01 OUTLIER Glycine 0 C--N 1.336 0.559 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.647 ' HB ' ' O ' ' B' ' 8' ' ' GLY . 88.5 mt 91.3 111.78 0.02 OUTLIER Pre-proline 0 N--CA 1.472 0.635 0 O-C-N 123.948 0.44 . . . . 0.0 110.761 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -63.86 -23.63 68.46 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 121.408 1.405 . . . . 0.0 111.788 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.58 -41.1 99.51 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -64.69 -39.33 93.47 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.843 0.83 . . . . 0.0 109.775 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 48.5 tp -61.76 -42.36 98.88 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 114.907 -1.042 . . . . 0.0 112.116 -177.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -65.15 -33.31 75.71 Favored 'General case' 0 CA--C 1.561 1.39 0 CA-C-O 121.681 0.753 . . . . 0.0 110.805 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 79.4 t -62.23 -46.46 96.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-N 112.927 -1.942 . . . . 0.0 110.912 177.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.94 -44.09 97.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.674 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 17' ' ' LYS . . . . . 0.557 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 98.9 mttt -63.53 -41.99 98.46 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.34 -41.21 98.87 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 119.028 -1.069 . . . . 0.0 110.254 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.61 -38.39 84.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.743 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 84.3 mt -63.77 -41.91 97.88 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.223 0.535 . . . . 0.0 110.255 175.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -62.87 -38.54 91.27 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.95 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 61.2 m170 -57.83 -39.86 78.67 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 121.19 -0.204 . . . . 0.0 111.156 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 14.1 p -115.28 130.74 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.523 ' HG3' ' O ' ' B' ' 24' ' ' ARG . 35.4 ptt180 -73.54 108.58 6.48 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 121.85 0.833 . . . . 0.0 112.316 -176.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.7 p -143.09 133.76 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.667 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.544 177.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 26' ' ' GLY . . . . . 0.541 ' HA3' ' HB2' ' B' ' 123' ' ' GLN . . . -86.78 96.21 2.13 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 119.629 -1.272 . . . . 0.0 113.488 -176.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 47.0 t -125.58 128.81 72.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 175.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 29.5 m -138.8 157.29 29.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.587 179.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 96.5 mt -118.91 129.3 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-O 121.676 0.751 . . . . 0.0 111.567 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.474 ' OG1' ' O ' ' B' ' 119' ' ' PHE . 9.9 p -111.85 154.49 25.07 Favored 'General case' 0 CA--C 1.502 -0.886 0 CA-C-N 113.073 -1.876 . . . . 0.0 108.819 -175.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.518 ' C ' ' OD1' ' B' ' 37' ' ' ASN . 51.0 t0 -122.77 102.3 38.55 Favored Pre-proline 0 C--O 1.237 0.415 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -177.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 32' ' ' PRO . . . . . 0.455 ' CG ' HG23 ' B' ' 117' ' ' THR . 36.5 Cg_endo -64.52 -20.65 65.98 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 121.786 1.657 . . . . 0.0 111.27 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.19 -42.38 99.23 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 120.629 -0.429 . . . . 0.0 110.002 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 96.8 mt -73.15 179.79 3.68 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 121.778 -0.576 . . . . 0.0 111.097 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 35' ' ' GLU . . . . . 0.709 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 42.0 tt0 -75.58 132.88 40.96 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -178.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.488 ' O ' ' C ' ' B' ' 37' ' ' ASN . 66.0 t0 55.86 38.78 30.44 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.709 178.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 37' ' ' ASN . . . . . 0.518 ' OD1' ' C ' ' B' ' 31' ' ' ASP . 17.6 t-20 26.91 71.37 0.42 Allowed Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.709 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 92.6 Cg_endo -72.93 154.62 53.29 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 123.554 2.836 . . . . 0.0 111.944 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 95.9 mt -85.75 130.25 36.69 Favored 'Isoleucine or valine' 0 C--O 1.246 0.889 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 17.1 m -108.39 -44.06 6.5 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 O-C-N 123.884 0.74 . . . . 0.0 112.709 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -97.07 124.93 41.21 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.529 -178.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 6.5 p -142.34 140.53 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 O-C-N 124.195 0.934 . . . . 0.0 109.348 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 43' ' ' ASN . . . . . 0.636 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 55.4 p30 -101.18 162.62 12.76 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.144 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 44' ' ' GLN . . . . . 0.443 ' OE1' ' HA ' ' B' ' 44' ' ' GLN . 13.7 mm100 -62.86 -37.81 88.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.693 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.75 -27.53 64.24 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.656 ' CD1' HD13 ' B' ' 57' ' ' ILE . 53.3 t80 -60.36 -43.72 96.27 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 0.734 HG13 ' O ' ' B' ' 52' ' ' TYR . 77.6 t -61.78 -45.99 97.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.25 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -62.98 -44.31 96.39 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.394 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 49' ' ' MET . . . . . 0.458 ' O ' ' HE2' ' B' ' 96' ' ' LYS . 60.2 ttm -63.48 -42.02 98.57 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 34.6 p -96.22 -16.1 21.63 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.931 -177.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 51' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' B' ' 47' ' ' VAL . . . 72.69 18.73 78.87 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.379 -1.089 . . . . 0.0 110.379 178.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 52' ' ' TYR . . . . . 0.734 ' O ' HG13 ' B' ' 47' ' ' VAL . 85.7 m-85 -111.28 144.03 41.11 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 122.893 0.477 . . . . 0.0 109.999 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -73.82 147.72 43.1 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.561 0.696 . . . . 0.0 111.228 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 54' ' ' THR . . . . . 0.452 HG22 ' H ' ' B' ' 54' ' ' THR . 0.2 OUTLIER -61.42 -36.01 79.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.867 -177.779 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.48 -40.09 96.18 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 120.131 -0.628 . . . . 0.0 111.884 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -73.15 -33.69 65.64 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 176.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.656 HD13 ' CD1' ' B' ' 46' ' ' PHE . 97.2 mt -64.57 -53.95 36.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 118.204 -1.398 . . . . 0.0 109.475 177.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 88.6 mt -61.77 132.35 52.84 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.004 -170.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.55 -4.36 69.38 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 121.034 -0.603 . . . . 0.0 113.382 -177.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -133.22 149.25 52.02 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -177.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 61' ' ' ASN . . . . . 0.529 ' C ' ' H ' ' B' ' 63' ' ' ARG . 24.4 t-20 -78.86 151.79 31.62 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.565 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 62' ' ' CYS . . . . . . . . . . . . . 82.7 m -64.28 8.96 0.09 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.341 -178.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 63' ' ' ARG . . . . . 0.529 ' H ' ' C ' ' B' ' 61' ' ' ASN . 34.4 ptt-85 -59.4 -32.46 70.19 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.395 -177.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -60.95 -30.66 70.37 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 178.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 83.9 mt -61.66 -41.95 98.23 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 121.63 -0.669 . . . . 0.0 110.114 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -51.75 150.58 3.89 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.024 -177.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 67' ' ' GLY . . . . . 0.51 ' N ' ' OG1' ' B' ' 70' ' ' THR . . . -161.13 -153.94 7.21 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.33 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -58.98 -40.55 85.18 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -175.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 10.0 m80 -76.92 -9.43 58.68 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.307 -178.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 70' ' ' THR . . . . . 0.51 ' OG1' ' N ' ' B' ' 67' ' ' GLY . 26.9 m -61.19 133.81 56.35 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -90.5 110.1 38.65 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.485 -178.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.17 -38.15 87.71 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 120.979 1.12 . . . . 0.0 111.677 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.83 -40.42 92.75 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 120.459 -0.496 . . . . 0.0 109.8 -176.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 74' ' ' GLU . . . . . 0.504 ' OE1' ' HB ' ' B' ' 90' ' ' VAL . 79.0 mm-40 -67.23 -39.44 86.21 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.789 177.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 73.9 t -61.96 -45.95 97.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -63.29 -37.05 85.75 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.655 -178.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -62.33 -41.47 98.58 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 119.393 -0.923 . . . . 0.0 108.698 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 94.2 mt -63.28 -43.76 98.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-O 120.928 0.394 . . . . 0.0 110.427 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -62.31 -42.78 99.66 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 85.1 m -61.57 -45.4 94.29 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.027 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.28 -41.15 98.24 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 85.9 mt -62.98 -42.14 99.76 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -62.48 -36.63 83.1 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -91.64 7.4 41.72 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.5 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 32.3 tttt 43.1 45.79 4.74 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.414 -0.515 . . . . 0.0 112.195 175.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -128.15 143.72 49.01 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.274 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.31 140.51 83.19 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 120.933 1.089 . . . . 0.0 113.289 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -140.82 137.16 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.361 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 89' ' ' THR . . . . . 0.926 HG23 ' OD1' ' B' ' 107' ' ' ASN . 95.7 m -121.47 123.81 42.94 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.504 ' HB ' ' OE1' ' B' ' 74' ' ' GLU . 26.9 m -138.27 163.13 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.955 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -114.62 120.42 40.09 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 174.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 92' ' ' ILE . . . . . 0.467 HD11 HG23 ' B' ' 70' ' ' THR . 20.9 tt -128.3 131.79 68.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.256 -176.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -71.44 143.46 50.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.419 177.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 94' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -132.92 -178.89 5.16 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 121.268 0.556 . . . . 0.0 111.176 -177.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 95' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -131.19 145.61 52.01 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 114.567 -1.197 . . . . 0.0 111.711 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 96' ' ' LYS . . . . . 0.458 ' HE2' ' O ' ' B' ' 49' ' ' MET . 98.6 mttt -103.01 177.09 4.93 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.317 0.58 . . . . 0.0 111.209 177.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.15 -35.43 75.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.716 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 38.4 p-10 -87.11 -1.78 58.14 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.168 0.895 . . . . 0.0 112.486 178.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.28 3.18 63.46 Favored Glycine 0 C--N 1.335 0.528 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.449 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 25.5 m -67.01 128.99 38.44 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 101' ' ' MET . . . . . 0.603 ' SD ' ' N ' ' B' ' 102' ' ' PHE . 15.1 tmm? -87.75 142.23 27.98 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 102' ' ' PHE . . . . . 0.603 ' N ' ' SD ' ' B' ' 101' ' ' MET . 52.8 p90 -153.9 162.09 41.49 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 103' ' ' TRP . . . . . 0.757 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 20.9 m95 -95.16 138.68 32.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.404 0.621 . . . . 0.0 110.785 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 104' ' ' ASN . . . . . 0.477 HD21 ' HG2' ' B' ' 123' ' ' GLN . 62.8 t-20 -132.66 107.19 8.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.78 -1.1 . . . . 0.0 113.567 -177.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 105' ' ' GLU . . . . . 0.455 ' HB2' HD11 ' B' ' 126' ' ' ILE . 81.7 tt0 -76.14 123.7 26.25 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.413 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 39.0 tp -111.39 125.59 54.03 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.989 0.423 . . . . 0.0 112.012 -177.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 107' ' ' ASN . . . . . 0.926 ' OD1' HG23 ' B' ' 89' ' ' THR . 98.3 m-20 -119.08 128.6 54.48 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.034 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 96.5 mt -123.61 133.06 70.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -142.85 122.96 7.95 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -69.89 152.29 68.61 Favored 'Trans proline' 0 N--CA 1.499 1.85 0 C-N-CA 122.381 2.054 . . . . 0.0 112.642 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 111' ' ' MET . . . . . 0.478 ' HB2' ' HB2' ' B' ' 118' ' ' TYR . 67.3 mtt -130.22 141.85 50.61 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -113.34 108.43 17.23 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 113' ' ' ILE . . . . . 0.467 HG12 ' NZ ' ' A' ' 18' ' ' LYS . 96.7 mt -134.52 127.93 50.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 118.279 0.491 . . . . 0.0 112.04 177.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 52.49 38.33 25.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.93 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 60.09 37.07 21.21 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.441 -178.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -132.41 153.1 51.15 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 117' ' ' THR . . . . . 0.455 HG23 ' CG ' ' B' ' 32' ' ' PRO . 9.7 t -104.95 151.85 23.4 Favored 'General case' 0 C--O 1.214 -0.766 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -178.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 118' ' ' TYR . . . . . 0.478 ' HB2' ' HB2' ' B' ' 111' ' ' MET . 96.2 m-85 -149.29 147.03 27.88 Favored 'General case' 0 C--O 1.239 0.541 0 O-C-N 121.066 -1.021 . . . . 0.0 110.889 -177.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 119' ' ' PHE . . . . . 0.474 ' O ' ' OG1' ' B' ' 30' ' ' THR . 90.9 m-85 -123.03 139.25 54.28 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 123.523 0.514 . . . . 0.0 110.846 -176.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -128.0 133.63 66.83 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 121' ' ' GLY . . . . . 0.536 ' HA3' ' H6 ' ' B' ' 900' ' ' FMN . . . -107.03 122.1 6.79 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 122' ' ' ILE . . . . . 0.468 ' HB ' ' HB2' ' B' ' 107' ' ' ASN . 91.2 mt -111.33 127.22 68.62 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.44 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 123' ' ' GLN . . . . . 0.541 ' HB2' ' HA3' ' B' ' 26' ' ' GLY . 17.0 mp0 -117.97 118.96 33.39 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -118.09 121.16 39.87 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 125' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' B' ' 127' ' ' THR . 68.0 t0 -69.36 133.56 47.97 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.043 -0.981 . . . . 0.0 112.261 -178.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.492 ' O ' ' HG3' ' B' ' 130' ' ' LYS . 3.2 mp -107.24 17.89 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.77 0 CA-C-O 122.397 1.094 . . . . 0.0 108.918 177.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 127' ' ' THR . . . . . 0.552 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 97.0 m -63.76 -44.21 94.13 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 113.59 -1.641 . . . . 0.0 112.403 175.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 59.2 tptt -60.91 -45.66 93.74 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -178.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 129' ' ' GLN . . . . . 0.444 ' OE1' HG23 ' B' ' 126' ' ' ILE . 88.4 mt-30 -63.34 -35.17 79.5 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.687 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 130' ' ' LYS . . . . . 0.757 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 98.7 mttt -63.1 -41.41 99.38 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 113.253 -1.794 . . . . 0.0 110.691 174.158 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.67 -42.1 95.62 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 132' ' ' TYR . . . . . 0.667 ' CE2' HD11 ' B' ' 136' ' ' LEU . 87.9 t80 -59.92 -44.4 94.34 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 121.878 -0.514 . . . . 0.0 111.388 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 133' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' B' ' 137' ' ' GLU . 97.4 mt-10 -64.94 -36.53 84.68 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.724 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 134' ' ' LYS . . . . . 0.435 ' HG3' ' O ' ' B' ' 130' ' ' LYS . 98.8 mttt -63.11 -39.31 94.33 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.756 178.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 54.4 tp -62.78 -41.25 99.16 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.401 0.62 . . . . 0.0 109.83 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 136' ' ' LEU . . . . . 0.667 HD11 ' CE2' ' B' ' 132' ' ' TYR . 87.0 mt -63.34 -41.48 98.88 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.494 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 137' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' B' ' 133' ' ' GLU . 97.2 mt-10 -64.61 -37.98 89.43 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.511 -178.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.58 -43.68 96.26 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.824 176.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 61.4 m -60.96 -44.41 97.34 Favored 'General case' 0 C--N 1.344 0.352 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 140' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' B' ' 144' ' ' THR . 84.5 mt -61.64 -40.36 94.6 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -177.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 99.3 m -61.9 -45.13 95.09 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.728 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -65.97 -42.33 90.0 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 93.9 mt -63.81 -43.2 97.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 114.515 -1.22 . . . . 0.0 110.493 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 144' ' ' THR . . . . . 0.495 ' N ' ' O ' ' B' ' 140' ' ' LEU . 99.8 m -61.7 -45.76 92.6 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.42 -40.5 97.35 Favored 'General case' 0 C--O 1.228 -0.071 0 C-N-CA 119.071 -1.052 . . . . 0.0 109.161 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 83.4 mt -64.38 -40.96 96.84 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 147' ' ' SER . . . . . 0.617 ' O ' ' N ' ' B' ' 149' ' ' PRO . 78.1 p -61.86 -41.44 97.85 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 148' ' ' THR . . . . . 0.504 ' C ' ' O ' ' B' ' 147' ' ' SER . 8.9 m -27.06 85.66 0.04 OUTLIER Pre-proline 0 N--CA 1.473 0.716 0 O-C-N 124.035 0.834 . . . . 0.0 109.999 177.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 149' ' ' PRO . . . . . 0.617 ' N ' ' O ' ' B' ' 147' ' ' SER . 24.3 Cg_exo -61.27 146.25 97.58 Favored 'Trans proline' 0 C--N 1.299 -2.036 0 C-N-CA 122.008 1.805 . . . . 0.0 115.211 -177.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 9.5 tp -127.91 123.36 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 174.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 29.9 t -152.78 96.71 2.93 Favored Pre-proline 0 C--N 1.304 -1.39 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.127 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -63.43 132.34 35.45 Favored 'Trans proline' 0 N--CA 1.486 1.062 0 CA-C-N 119.626 0.902 . . . . 0.0 109.776 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 153' ' ' ILE . . . . . 0.663 ' O ' ' HD2' ' B' ' 154' ' ' ARG . 45.8 mm -68.97 -44.33 81.48 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.437 0 C-N-CA 119.738 -0.785 . . . . 0.0 110.88 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 154' ' ' ARG . . . . . 0.663 ' HD2' ' O ' ' B' ' 153' ' ' ILE . 1.0 OUTLIER -154.96 -157.18 0.73 Allowed 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 178.678 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -86.35 110.55 19.76 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.02 -20.36 50.89 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 -177.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 88.1 mt -108.6 123.89 64.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.76 0.314 . . . . 0.0 111.738 -176.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 158' ' ' SER . . . . . 0.549 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 59.6 m -134.45 150.29 50.82 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.857 178.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -130.89 146.23 52.25 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 38.4 tp -139.61 74.58 33.28 Favored Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 161' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -69.43 148.09 66.44 Favored 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 122.754 2.303 . . . . 0.0 114.318 -177.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 92.9 mt -114.1 134.36 54.93 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 52.2 t -129.01 132.64 67.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 113.5 168.32 16.77 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 120.419 -0.896 . . . . 0.0 111.441 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 165' ' ' ASN . . . . . 0.705 ' O ' ' CZ ' ' B' ' 170' ' ' ARG . 56.2 t30 -89.09 107.79 19.24 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -179.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 166' ' ' LEU . . . . . 0.518 HD21 ' CZ ' ' B' ' 171' ' ' PHE . 43.5 tp -66.34 104.34 1.2 Allowed 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -174.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 167' ' ' THR . . . . . 0.629 HG23 ' NE ' ' B' ' 170' ' ' ARG . 10.5 p -84.51 171.16 12.76 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 113.733 -1.576 . . . . 0.0 111.091 177.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -67.18 -38.46 85.42 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.766 177.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -66.55 -40.13 88.9 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-O 123.122 1.439 . . . . 0.0 111.773 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 170' ' ' ARG . . . . . 0.705 ' CZ ' ' O ' ' B' ' 165' ' ' ASN . 88.2 mtm180 -63.31 -36.83 85.0 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 112.241 -2.254 . . . . 0.0 111.109 178.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 171' ' ' PHE . . . . . 0.518 ' CZ ' HD21 ' B' ' 166' ' ' LEU . 0.4 OUTLIER -53.92 -25.16 19.01 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 113.607 0.965 . . . . 0.0 113.607 -178.472 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 172' ' ' ASN . . . . . 0.645 ' O ' HG22 ' B' ' 175' ' ' VAL . 90.1 m-20 -62.73 -40.2 96.47 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.872 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 49.3 m -60.41 -41.09 93.18 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.23 0.538 . . . . 0.0 110.802 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 66.5 mt -63.56 -43.95 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 175' ' ' VAL . . . . . 0.645 HG22 ' O ' ' B' ' 172' ' ' ASN . 23.8 m -62.6 -39.86 86.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 176' ' ' CYS . . . . . 0.438 ' N ' HG23 ' B' ' 175' ' ' VAL . 98.7 m -62.49 -35.09 78.25 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.241 177.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 177' ' ' THR . . . . . 0.613 ' O ' HG13 ' B' ' 181' ' ' ILE . 25.0 m -61.41 -19.81 62.35 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.243 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 178' ' ' LEU . . . . . 0.755 ' CD2' HD21 ' B' ' 211' ' ' LEU . 93.3 mt -61.15 -39.6 90.71 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.397 -178.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 19.6 m -61.5 -44.22 97.46 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 176.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 180' ' ' ASN . . . . . 0.597 ' O ' ' OG ' ' B' ' 183' ' ' SER . 92.0 m-20 -61.52 -40.05 93.23 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.296 0.57 . . . . 0.0 110.29 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.613 HG13 ' O ' ' B' ' 177' ' ' THR . 70.4 mt -56.56 -35.94 46.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 O-C-N 121.978 -0.452 . . . . 0.0 110.582 -178.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 182' ' ' LEU . . . . . 0.473 HD21 HD21 ' B' ' 214' ' ' LEU . 84.1 mt -61.82 -41.79 98.22 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 119.839 -0.744 . . . . 0.0 109.187 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 183' ' ' SER . . . . . 0.597 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.2 p -62.97 -33.08 74.63 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 121.897 -0.502 . . . . 0.0 110.779 177.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 54.3 p -85.88 16.15 4.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.823 0.344 . . . . 0.0 111.753 -177.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 78.5 p -60.64 -16.68 41.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.782 -176.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -61.5 -40.5 94.83 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.882 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 187' ' ' ASP . . . . . 0.549 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.8 m-20 -70.44 115.27 9.42 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.528 0.68 . . . . 0.0 110.401 -178.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.88 -42.29 99.71 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 114.895 -1.048 . . . . 0.0 113.305 -177.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -111.46 131.67 55.05 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.674 -0.411 . . . . 0.0 111.135 -177.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 190' ' ' LEU . . . . . . . . . . . . . 42.1 tp -123.8 118.81 28.01 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.056 177.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 84.8 mt -107.87 126.66 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.049 -177.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 50.0 mm -115.25 117.62 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 193' ' ' ASP . . . . . 0.565 ' CG ' ' HG ' ' B' ' 195' ' ' SER . 42.6 t0 -87.64 112.19 22.07 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.938 -177.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 194' ' ' LEU . . . . . . . . . . . . . 96.1 mt -92.5 -2.78 55.98 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 176.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 195' ' ' SER . . . . . 0.565 ' HG ' ' CG ' ' B' ' 193' ' ' ASP . 78.2 p -61.14 -38.27 85.8 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.819 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.74 -34.1 87.48 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 197' ' ' LEU . . . . . 0.984 ' CD2' ' H ' ' B' ' 199' ' ' GLN . 4.9 tt -77.2 132.73 38.9 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 198' ' ' ALA . . . . . 0.972 ' N ' HD23 ' B' ' 197' ' ' LEU . . . -63.78 -41.8 97.88 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.854 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 199' ' ' GLN . . . . . 0.984 ' H ' ' CD2' ' B' ' 197' ' ' LEU . 58.9 tt0 -138.08 163.43 31.65 Favored 'General case' 0 C--O 1.203 -1.345 0 CA-C-O 122.096 0.951 . . . . 0.0 113.008 -178.05 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 200' ' ' VAL . . . . . 0.466 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 50.3 t -121.46 132.77 69.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 O-C-N 120.229 -1.544 . . . . 0.0 109.349 178.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -94.06 148.65 21.96 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.918 0.866 . . . . 0.0 111.359 -177.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -59.9 -33.12 71.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.857 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -63.87 -33.58 76.01 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.4 m -61.09 -44.45 97.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.096 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 205' ' ' ALA . . . . . 0.641 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -57.95 -31.66 67.07 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.835 -178.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -65.43 -38.16 89.06 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.216 0.531 . . . . 0.0 109.884 176.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -66.32 -38.96 88.89 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.586 178.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.7 -43.13 97.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.589 0.709 . . . . 0.0 110.463 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 209' ' ' PHE . . . . . 0.641 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 65.3 m-85 -61.93 -43.34 99.04 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 113.828 -1.533 . . . . 0.0 112.384 178.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.92 -42.4 97.39 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.836 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 211' ' ' LEU . . . . . 0.755 HD21 ' CD2' ' B' ' 178' ' ' LEU . 37.7 mt -62.42 -42.49 99.48 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.078 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 78.2 p -62.8 -36.13 82.12 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.836 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 213' ' ' HIS . . . . . 0.407 ' CE1' HD11 ' B' ' 217' ' ' LEU . 58.7 t-80 -67.08 -46.68 73.53 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 115.296 -0.866 . . . . 0.0 112.261 178.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.473 HD21 HD21 ' B' ' 182' ' ' LEU . 51.1 tp -63.79 -43.21 97.01 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 121.776 0.798 . . . . 0.0 109.487 178.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 215' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' B' ' 211' ' ' LEU . 90.9 mt -62.87 -43.89 97.59 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 113.607 -1.633 . . . . 0.0 111.253 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.55 -39.12 89.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.917 -177.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 217' ' ' LEU . . . . . 0.407 HD11 ' CE1' ' B' ' 213' ' ' HIS . 85.7 mt -63.02 -42.79 99.88 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.314 176.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 218' ' ' THR . . . . . 0.403 HG23 ' O ' ' B' ' 214' ' ' LEU . 66.7 p -74.24 -16.54 60.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.806 -178.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 80.45 61.21 2.23 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 107.307 -2.317 . . . . 0.0 107.307 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 220' ' ' THR . . . . . . . . . . . . . 94.9 m -141.3 106.84 5.06 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 174.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -63.57 140.2 58.85 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.689 -174.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 44.5 tp -116.03 120.89 40.56 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.557 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 3.0 mp -109.97 129.57 64.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.758 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 224' ' ' ILE . . . . . 0.489 ' CG2' HD11 ' B' ' 227' ' ' ILE . 50.8 mm -111.0 127.11 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 43.5 p -134.34 157.76 45.54 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.924 0.869 . . . . 0.0 112.688 -178.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 90.23 18.84 48.35 Favored Glycine 0 CA--C 1.5 -0.871 0 CA-C-N 113.815 -1.539 . . . . 0.0 111.182 -177.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 227' ' ' ILE . . . . . 0.614 HD12 HG23 ' B' ' 247' ' ' THR . 95.0 mt -85.29 125.44 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 118.292 1.046 . . . . 0.0 111.556 -178.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 49.5 tttt -62.87 139.97 97.36 Favored Pre-proline 0 C--N 1.313 -0.98 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.08 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.1 -37.93 93.78 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 121.373 1.382 . . . . 0.0 112.799 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -64.7 -41.67 95.84 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -178.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 50.7 tp -61.61 -41.87 98.07 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.014 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.34 -36.65 84.82 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.742 0.306 . . . . 0.0 111.123 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 94.3 mtp -63.73 -40.98 98.07 Favored 'General case' 0 C--O 1.25 1.094 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.793 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.51 -44.4 96.47 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 122.291 1.043 . . . . 0.0 109.332 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 35.6 mmt -64.25 -35.64 81.48 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.634 -1.167 . . . . 0.0 111.716 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -61.39 -40.33 93.98 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -177.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.06 -43.2 99.26 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.202 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 55.8 tp -61.58 -44.92 96.13 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 120.257 -0.577 . . . . 0.0 112.33 -178.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 239' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' B' ' 240' ' ' ALA . 66.8 t0 -158.09 134.69 9.65 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.355 -0.538 . . . . 0.0 112.141 -179.065 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 240' ' ' ALA . . . . . 0.421 ' N ' ' OD1' ' B' ' 239' ' ' ASP . . . -61.76 -46.69 88.49 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 176.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 241' ' ' ASN . . . . . 0.495 ' O ' ' HB2' ' B' ' 244' ' ' SER . 91.9 m-20 -43.21 -21.85 0.03 OUTLIER 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.361 -176.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 242' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -61.29 -45.36 94.8 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.523 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 243' ' ' SER . . . . . . . . . . . . . 77.4 p -58.18 -44.62 88.12 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 244' ' ' SER . . . . . 0.495 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 19.7 m -32.59 -37.82 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 94.9 mt -83.39 134.47 34.89 Favored 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.27 175.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -63.61 136.56 57.61 Favored 'General case' 0 C--O 1.241 0.655 0 O-C-N 121.368 -0.833 . . . . 0.0 111.645 -176.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 247' ' ' THR . . . . . 0.614 HG23 HD12 ' B' ' 227' ' ' ILE . 98.3 m -125.43 127.54 46.7 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.537 -1.211 . . . . 0.0 112.083 178.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 248' ' ' TYR . . . . . 0.45 ' CG ' ' HB2' ' B' ' 254' ' ' ALA . 96.9 m-85 -112.44 143.42 43.6 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.017 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 249' ' ' SER . . . . . 0.599 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 78.3 p -62.85 -33.31 74.99 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.144 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 250' ' ' ASN . . . . . 0.599 ' OD1' ' O ' ' B' ' 249' ' ' SER . 98.9 m-20 -148.43 160.19 43.29 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.189 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 73.6 t -64.66 -44.55 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.077 177.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 252' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.96 -46.09 92.1 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 253' ' ' ASP . . . . . 0.574 ' O ' HG22 ' B' ' 257' ' ' VAL . 90.9 m-20 -60.67 -43.37 97.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.188 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 254' ' ' ALA . . . . . 0.45 ' HB2' ' CG ' ' B' ' 248' ' ' TYR . . . -65.42 -40.47 93.4 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 120.091 -0.644 . . . . 0.0 111.332 178.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 255' ' ' VAL . . . . . 0.404 ' O ' ' HD2' ' B' ' 259' ' ' PRO . 62.2 t -64.82 -45.52 94.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.656 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 256' ' ' LYS . . . . . 0.422 ' HE3' ' ND2' ' A' ' 155' ' ' ASN . 88.7 tttt -63.36 -48.65 77.06 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.485 -178.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 257' ' ' VAL . . . . . 0.574 HG22 ' O ' ' B' ' 253' ' ' ASP . 33.0 m -64.69 -41.13 91.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.623 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 258' ' ' LEU . . . . . 0.505 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 0.9 OUTLIER -33.09 -72.87 0.06 OUTLIER Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.947 -177.948 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 259' ' ' PRO . . . . . 0.595 ' O ' HG13 ' B' ' 260' ' ' ILE . 38.4 Cg_endo -62.54 141.78 87.64 Favored 'Trans proline' 0 N--CA 1.506 2.236 0 C-N-CA 121.855 1.703 . . . . 0.0 111.243 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 260' ' ' ILE . . . . . 0.595 HG13 ' O ' ' B' ' 259' ' ' PRO . 96.6 mt -160.61 -18.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 77.2 mtm . . . . . 0 C--O 1.219 -0.547 0 CA-C-O 117.919 -1.038 . . . . 0.0 111.786 -179.738 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 900' ' ' FMN . . . . . 0.439 ' H6 ' ' HA3' ' A' ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 900' ' ' FMN . . . . . 0.536 ' H6 ' ' HA3' ' B' ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.234 0 N-CA-C 109.054 -1.619 . . . . 0.0 109.054 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.54 165.47 35.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 119.173 -0.442 . . . . 0.0 110.111 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.9 p -70.9 -16.54 62.69 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 121.5 0.667 . . . . 0.0 111.356 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -72.1 -65.71 0.74 Allowed 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 114.275 -1.329 . . . . 0.0 112.151 174.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -67.07 -38.21 85.36 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.538 ' O ' ' NZ ' ' B' ' 17' ' ' LYS . 60.9 m -59.4 -42.45 91.76 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.152 -177.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.521 ' HB3' ' O ' ' A' ' 6' ' ' SER . 44.6 t80 84.6 84.04 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 O-C-N 123.69 0.618 . . . . 0.0 111.801 176.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.623 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -58.99 -141.72 0.01 OUTLIER Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -177.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.623 ' HB ' ' O ' ' A' ' 8' ' ' GLY . 86.3 mt 84.64 109.92 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.626 0 C-N-CA 122.39 0.276 . . . . 0.0 110.682 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.27 -22.37 72.23 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.49 1.46 . . . . 0.0 111.994 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.41 -37.29 94.27 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.844 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.1 -39.9 93.79 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.51 0.671 . . . . 0.0 109.847 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 52.8 tp -63.23 -41.19 99.06 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.947 -0.569 . . . . 0.0 112.215 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -63.03 -41.33 99.49 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.1 t -60.36 -44.06 95.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 O-C-N 122.339 -0.226 . . . . 0.0 110.705 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 92.3 mt -62.58 -43.48 98.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.452 -177.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.43 ' NZ ' ' HA ' ' B' ' 6' ' ' SER . 98.9 mttt -62.53 -45.38 93.25 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 119.458 -0.897 . . . . 0.0 111.879 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.556 ' HZ1' HG12 ' B' ' 113' ' ' ILE . 98.4 mttt -60.44 -39.53 87.84 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 118.555 -1.258 . . . . 0.0 109.051 -176.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.85 -41.56 91.67 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.059 -0.656 . . . . 0.0 110.262 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.6 mt -63.07 -41.24 99.39 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.61 -38.79 92.45 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.383 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -58.69 -39.98 82.27 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 122.2 -0.312 . . . . 0.0 111.243 -178.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.9 p -114.61 129.3 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.496 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 34.6 ptt180 -71.11 108.71 4.77 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 122.098 0.951 . . . . 0.0 112.081 -177.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.0 p -140.07 142.59 31.49 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 178.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.416 ' HA3' ' HB2' ' A' ' 123' ' ' GLN . . . -97.84 93.48 1.4 Allowed Glycine 0 C--N 1.312 -0.783 0 C-N-CA 120.776 -0.726 . . . . 0.0 113.058 -179.108 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.9 t -124.41 130.0 73.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 175.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.3 m -136.34 159.22 38.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.6 mt -121.28 128.99 76.05 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.402 ' OG1' ' HB2' ' A' ' 119' ' ' PHE . 15.4 p -103.65 167.68 9.64 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.541 ' C ' ' OD1' ' A' ' 37' ' ' ASN . 45.6 t0 -133.37 101.23 13.45 Favored Pre-proline 0 C--N 1.32 -0.684 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.659 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.443 ' HG3' HG23 ' A' ' 117' ' ' THR . 34.8 Cg_endo -63.04 -22.58 73.66 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.411 1.407 . . . . 0.0 111.534 -179.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.4 -35.73 80.11 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.774 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 91.9 mt -85.85 161.0 19.29 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.656 177.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.744 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 43.1 tt0 -59.67 135.42 57.67 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -177.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.537 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 60.2 t0 60.65 22.37 12.23 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.877 178.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.541 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 22.5 t-20 40.9 67.82 2.72 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.877 -178.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.744 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 91.3 Cg_endo -71.23 156.88 58.47 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 C-N-CA 123.816 3.011 . . . . 0.0 112.493 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.4 mt -90.08 125.34 42.98 Favored 'Isoleucine or valine' 0 C--O 1.245 0.862 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.441 HG23 ' N ' ' A' ' 41' ' ' TYR . 35.3 m -105.54 -43.57 7.63 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 O-C-N 123.585 0.553 . . . . 0.0 112.102 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.441 ' N ' HG23 ' A' ' 40' ' ' VAL . 46.8 t80 -95.28 124.58 39.39 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.736 -178.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.9 p -142.58 139.55 28.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.347 177.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.593 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 56.7 p30 -96.73 166.6 11.57 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.526 ' HA ' ' OE1' ' A' ' 44' ' ' GLN . 12.6 mm100 -67.19 -37.98 84.6 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 120.961 0.41 . . . . 0.0 111.855 177.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.03 -27.51 64.9 Favored Glycine 0 C--N 1.331 0.283 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.683 ' CD2' HD13 ' A' ' 57' ' ' ILE . 71.0 t80 -59.13 -48.43 81.64 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.669 HG13 ' O ' ' A' ' 52' ' ' TYR . 54.9 t -59.58 -44.9 94.26 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.585 0 O-C-N 121.297 -0.877 . . . . 0.0 111.442 -173.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -63.64 -37.61 87.98 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 120.415 -0.514 . . . . 0.0 112.027 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.408 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 58.8 ttm -67.3 -43.59 81.35 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 175.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 39.8 p -90.06 -23.79 21.34 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.155 0.502 . . . . 0.0 111.634 -178.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.78 20.44 70.9 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 -179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.669 ' O ' HG13 ' A' ' 47' ' ' VAL . 90.4 m-85 -115.02 141.89 47.38 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.003 0.521 . . . . 0.0 111.539 178.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -65.96 149.52 50.1 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.848 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.441 HG22 ' H ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -65.7 -33.09 75.07 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -179.916 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.27 -43.71 85.67 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 119.535 -0.866 . . . . 0.0 111.286 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -64.76 -44.67 89.32 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.393 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.683 HD13 ' CD2' ' A' ' 46' ' ' PHE . 93.5 mt -61.81 -49.98 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -174.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 84.1 mt -55.94 148.67 16.73 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 176.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.01 -4.54 61.53 Favored Glycine 0 CA--C 1.52 0.377 0 CA-C-O 119.379 -0.678 . . . . 0.0 113.305 177.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -136.98 149.37 47.48 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.041 1.42 . . . . 0.0 111.711 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.57 ' C ' ' H ' ' A' ' 63' ' ' ARG . 25.8 t-20 -80.89 152.09 28.29 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.189 0.519 . . . . 0.0 110.687 -178.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 82.0 m -62.2 15.12 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.291 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.57 ' H ' ' C ' ' A' ' 61' ' ' ASN . 34.4 ptt-85 -61.93 -41.6 98.14 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.979 -0.45 . . . . 0.0 111.376 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -56.17 -21.84 25.3 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 93.0 mt -67.25 -35.64 79.98 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.757 0.789 . . . . 0.0 113.063 177.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -63.05 142.87 58.22 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.225 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.499 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -152.8 -148.79 4.97 Favored Glycine 0 CA--C 1.54 1.638 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.685 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.85 -40.69 98.23 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -177.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.6 ' O ' ' NE2' ' A' ' 93' ' ' GLN . 8.8 m-70 -76.5 -9.04 58.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.715 0.293 . . . . 0.0 111.101 -178.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.499 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 30.6 m -62.87 129.94 42.62 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.204 -0.598 . . . . 0.0 109.786 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -87.7 110.52 35.33 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.997 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.29 -32.16 92.92 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.993 1.795 . . . . 0.0 113.117 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.76 -39.6 94.67 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.979 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.49 ' OE1' ' HB ' ' A' ' 90' ' ' VAL . 79.4 mm-40 -65.09 -43.85 90.79 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.7 t -59.88 -43.94 93.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 114.273 -1.331 . . . . 0.0 107.817 -176.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.83 -37.8 88.73 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.724 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -63.26 -39.8 95.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.235 0.541 . . . . 0.0 110.295 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 95.1 mt -63.85 -44.07 98.02 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.996 178.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -62.83 -43.07 99.79 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 113.655 -1.611 . . . . 0.0 108.371 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 98.5 m -61.34 -48.76 79.82 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.57 -41.87 91.16 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.589 -172.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 90.6 mt -63.24 -40.08 96.43 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 118.831 0.741 . . . . 0.0 111.414 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 66.9 tp60 -64.49 -32.94 74.78 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -90.3 -2.36 58.0 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.533 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.2 tttt 49.35 39.17 15.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.955 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -121.89 144.06 40.08 Favored Pre-proline 0 CA--C 1.533 0.321 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.434 ' HB3' ' OD1' ' A' ' 109' ' ' ASP . 24.7 Cg_exo -61.46 143.32 97.33 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 121.402 1.402 . . . . 0.0 113.236 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.8 p -139.79 142.45 32.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.819 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.925 HG23 ' OD1' ' A' ' 107' ' ' ASN . 99.0 m -126.33 121.25 32.04 Favored 'General case' 0 C--N 1.344 0.336 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 175.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.49 ' HB ' ' OE1' ' A' ' 74' ' ' GLU . 29.9 m -138.85 158.72 30.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.323 177.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -102.87 133.58 47.72 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 176.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.424 ' O ' HG23 ' A' ' 92' ' ' ILE . 18.0 tt -140.41 129.97 27.36 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.213 0 CA-C-N 121.067 1.758 . . . . 0.0 112.438 177.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.6 ' NE2' ' O ' ' A' ' 69' ' ' HIS . 34.4 mt-30 -63.37 132.19 50.69 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.75 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -131.9 155.92 47.03 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.542 -178.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -114.84 134.52 55.07 Favored 'General case' 0 C--N 1.346 0.444 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.458 ' HG3' ' CE1' ' A' ' 102' ' ' PHE . 99.0 mttt -83.61 -174.18 5.14 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.139 0.495 . . . . 0.0 111.532 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -62.44 -41.52 98.79 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.041 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 40.9 p-10 -83.95 5.17 26.52 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 111.892 0.331 . . . . 0.0 111.892 -177.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.01 -1.77 85.12 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.004 176.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 25.0 m -60.39 137.46 58.14 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 178.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.66 ' SD ' ' C ' ' A' ' 101' ' ' MET . 14.7 tmm? -104.44 127.83 52.22 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.628 0.252 . . . . 0.0 110.711 178.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.458 ' CE1' ' HG3' ' A' ' 96' ' ' LYS . 52.6 p90 -140.7 157.01 46.06 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.244 -0.582 . . . . 0.0 109.803 -177.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.786 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 20.8 m95 -88.12 141.96 28.15 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.54 HD21 ' HG2' ' A' ' 123' ' ' GLN . 56.9 t-20 -137.38 102.92 4.93 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -177.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 80.8 tt0 -67.75 136.64 54.54 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -176.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 41.8 tp -121.74 124.22 43.71 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.925 ' OD1' HG23 ' A' ' 89' ' ' THR . 98.0 m-20 -122.43 124.49 43.76 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.671 177.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 87' ' ' PRO . 96.4 mt -120.57 129.28 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 O-C-N 123.436 0.46 . . . . 0.0 111.597 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.434 ' OD1' ' HB3' ' A' ' 87' ' ' PRO . 2.4 m-20 -137.81 121.6 11.68 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 110.581 -0.155 . . . . 0.0 110.581 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -69.6 150.86 69.75 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 122.432 2.088 . . . . 0.0 112.713 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.68 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 66.6 mtt -121.94 153.12 38.91 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -127.81 94.19 3.88 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 176.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.443 ' CD1' HG22 ' B' ' 15' ' ' VAL . 96.5 mt -119.05 130.97 73.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.876 -178.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 51.95 36.51 18.62 Favored 'General case' 0 CA--C 1.517 -0.292 0 O-C-N 121.406 -0.809 . . . . 0.0 111.468 176.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 59.42 30.31 19.98 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.758 -178.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -127.47 146.12 50.6 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 177.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.724 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 5.0 t -82.04 -173.2 4.36 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.578 -0.701 . . . . 0.0 109.77 -178.229 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.724 ' CD2' ' O ' ' A' ' 117' ' ' THR . 64.0 m-85 -171.11 157.44 5.16 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 173.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.402 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 97.6 m-85 -131.32 146.21 52.19 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 174.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.5 p -133.15 135.68 56.29 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 177.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.5 ' N ' HM73 ' A' ' 900' ' ' FMN . . . -109.17 127.41 8.51 Favored Glycine 0 CA--C 1.501 -0.795 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 178.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 96.2 mt -118.99 130.1 74.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.54 ' HG2' HD21 ' A' ' 104' ' ' ASN . 16.4 mp0 -120.39 117.74 28.53 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 123.563 0.539 . . . . 0.0 109.975 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -117.83 113.59 22.0 Favored 'General case' 0 C--O 1.248 0.995 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.032 -178.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 126' ' ' ILE . 68.1 t0 -64.02 132.41 50.51 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -174.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.52 ' O ' HG22 ' A' ' 126' ' ' ILE . 2.6 mp -97.5 2.58 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 113.765 -1.561 . . . . 0.0 110.398 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 19.3 m -60.61 -43.0 97.96 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.211 -0.931 . . . . 0.0 113.397 -178.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -59.76 -42.46 93.3 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -63.06 -39.05 93.59 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.723 177.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.786 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.7 mttt -62.41 -40.69 97.34 Favored 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 118.467 -1.293 . . . . 0.0 110.631 -178.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -62.53 -36.98 84.3 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -178.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.766 ' CE2' HD11 ' A' ' 136' ' ' LEU . 89.8 t80 -61.56 -45.96 91.93 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.597 176.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.62 -38.47 91.11 Favored 'General case' 0 C--O 1.225 -0.213 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.89 -40.91 97.07 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 51.5 tp -60.91 -43.6 98.33 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 -178.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.766 HD11 ' CE2' ' A' ' 132' ' ' TYR . 87.7 mt -62.7 -41.25 99.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.168 179.068 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.16 -41.1 99.19 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.766 -178.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -60.99 -41.84 97.27 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 -177.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 66.9 m -61.85 -41.0 97.29 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.661 176.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 144' ' ' THR . 90.2 mt -63.15 -41.9 99.35 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 92.8 m -61.86 -45.46 93.7 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.151 -178.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -65.41 -41.07 93.99 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 94.9 mt -64.55 -43.47 96.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 113.968 -1.469 . . . . 0.0 111.383 177.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.424 ' N ' ' O ' ' A' ' 140' ' ' LEU . 99.1 m -62.25 -46.08 90.42 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 120.432 -0.507 . . . . 0.0 112.167 -178.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.402 ' O ' ' HB ' ' A' ' 148' ' ' THR . . . -62.02 -41.28 97.92 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 118.789 -1.164 . . . . 0.0 108.931 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.3 mt -63.88 -42.62 97.44 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 177.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.681 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.0 p -60.56 -37.28 80.75 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -178.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.454 ' C ' ' O ' ' A' ' 147' ' ' SER . 55.5 m -31.14 83.91 0.03 OUTLIER Pre-proline 0 C--N 1.344 0.359 0 O-C-N 126.79 2.556 . . . . 0.0 106.211 -178.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.681 ' N ' ' O ' ' A' ' 147' ' ' SER . 21.7 Cg_exo -62.74 145.31 94.91 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 120.849 1.033 . . . . 0.0 114.604 -175.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.651 ' O ' HG23 ' A' ' 151' ' ' VAL . 8.7 tp -121.78 136.94 57.04 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.933 0 N-CA-C 102.891 -3.003 . . . . 0.0 102.891 176.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 150' ' ' ILE . 60.1 t -170.23 94.74 0.48 Allowed Pre-proline 0 N--CA 1.445 -0.685 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 177.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.421 ' HG3' ' HG3' ' B' ' 252' ' ' LYS . 46.2 Cg_endo -63.41 143.8 89.37 Favored 'Trans proline' 0 C--N 1.298 -2.092 0 N-CA-C 109.78 -0.892 . . . . 0.0 109.78 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.555 ' O ' HG11 ' B' ' 255' ' ' VAL . 44.2 mm -77.04 -60.27 2.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.03 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.68 ' NH2' ' HD3' ' B' ' 154' ' ' ARG . 1.6 mpt_? -140.41 -157.56 0.78 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.0 t-20 -86.45 105.23 16.62 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.804 0.812 . . . . 0.0 111.5 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.11 8.55 66.6 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 114.032 -1.44 . . . . 0.0 110.615 -177.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 97.1 mt -123.93 125.57 71.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 175.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.716 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 58.5 m -132.3 151.47 51.82 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.222 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -139.34 142.84 37.6 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.575 -0.703 . . . . 0.0 111.08 177.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 16.8 tp -133.96 80.83 53.45 Favored Pre-proline 0 N--CA 1.469 0.517 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.355 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -69.25 149.89 70.7 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.788 2.325 . . . . 0.0 112.938 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 88.7 mt -119.0 128.09 54.07 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.502 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 47.7 t -124.17 131.27 73.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 116.78 169.62 15.22 Favored Glycine 0 N--CA 1.48 1.62 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.174 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.874 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 56.4 t30 -87.08 113.28 22.69 Favored 'General case' 0 C--O 1.221 -0.431 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -178.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.538 HD21 ' CZ ' ' A' ' 171' ' ' PHE . 46.7 tp -72.39 104.19 3.68 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -178.057 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.723 HG23 ' NE ' ' A' ' 170' ' ' ARG . 11.4 p -85.63 167.42 15.36 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.571 178.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.49 -34.85 79.24 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.937 0.398 . . . . 0.0 111.6 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.2 -41.97 94.01 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.757 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.874 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 88.0 mtm180 -64.08 -33.18 75.18 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.993 0.917 . . . . 0.0 112.368 178.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.538 ' CZ ' HD21 ' A' ' 166' ' ' LEU . 0.5 OUTLIER -53.68 -28.24 32.39 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 118.887 -0.578 . . . . 0.0 112.472 -178.766 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.592 ' O ' HG22 ' A' ' 175' ' ' VAL . 91.1 m-20 -61.0 -40.64 94.29 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 118.942 -1.103 . . . . 0.0 109.774 -178.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 54.7 m -59.47 -41.25 89.33 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.604 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 66.9 mt -63.69 -44.35 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.592 HG22 ' O ' ' A' ' 172' ' ' ASN . 33.5 m -62.79 -40.39 88.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' CYS . . . . . 0.429 ' N ' HG23 ' A' ' 175' ' ' VAL . 99.3 m -62.77 -34.7 77.79 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.304 0.573 . . . . 0.0 110.34 178.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.509 ' O ' HG13 ' A' ' 181' ' ' ILE . 24.6 m -62.11 -19.49 63.06 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.197 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.59 ' CD2' HD21 ' A' ' 211' ' ' LEU . 90.5 mt -60.93 -41.17 95.66 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -177.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 18.3 m -59.48 -42.96 93.3 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.628 ' O ' ' OG ' ' A' ' 183' ' ' SER . 91.0 m-20 -61.34 -36.63 80.72 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 122.668 0.387 . . . . 0.0 110.837 178.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.512 HD12 ' HA ' ' A' ' 178' ' ' LEU . 67.0 mt -59.02 -39.92 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 O-C-N 121.558 -0.714 . . . . 0.0 109.086 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.473 HD21 HD21 ' A' ' 214' ' ' LEU . 86.3 mt -60.71 -40.61 92.88 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -177.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.628 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 77.9 p -61.65 -33.49 74.05 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.501 176.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.417 ' OG1' ' HA ' ' A' ' 181' ' ' ILE . 66.1 p -89.69 23.37 2.69 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.581 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 78.3 p -63.46 -19.93 65.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.188 0.518 . . . . 0.0 110.752 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.49 -37.29 83.14 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.916 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.716 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 98.2 m-20 -74.18 112.93 10.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.563 0.696 . . . . 0.0 110.839 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -62.74 -42.42 99.66 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 114.967 -1.015 . . . . 0.0 113.063 -177.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -110.48 130.91 55.45 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.562 -178.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 39.2 tp -120.21 128.61 53.53 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 177.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 96.7 mt -116.1 127.53 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-N 118.59 0.632 . . . . 0.0 109.689 177.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.2 mm -113.36 126.93 70.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 178.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' ASP . . . . . 0.43 ' CG ' ' HG ' ' A' ' 195' ' ' SER . 41.3 t0 -94.67 117.89 30.84 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-O 121.379 0.609 . . . . 0.0 110.667 176.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 97.9 mt -98.59 -4.81 33.23 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.882 175.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.43 ' HG ' ' CG ' ' A' ' 193' ' ' ASP . 78.2 p -62.31 -33.31 74.42 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.81 -42.68 99.77 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 118.553 -1.784 . . . . 0.0 109.081 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.958 ' CD2' ' O ' ' A' ' 199' ' ' GLN . 5.0 tt -70.59 128.69 36.98 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 112.891 -1.655 . . . . 0.0 107.516 -174.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.897 ' N ' HD23 ' A' ' 197' ' ' LEU . . . -60.26 -45.3 93.77 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.745 -176.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.958 ' O ' ' CD2' ' A' ' 197' ' ' LEU . 58.8 tt0 -138.81 157.31 46.31 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 114.466 -1.243 . . . . 0.0 112.847 -174.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.482 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 47.4 t -118.23 131.71 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -87.66 156.01 19.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.543 -178.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -64.35 -38.89 92.65 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.211 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -58.68 -32.35 69.05 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -178.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.6 m -61.21 -42.32 98.38 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.481 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.476 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -57.52 -39.01 75.6 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -177.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -61.64 -37.11 82.79 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.54 -39.12 91.39 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.892 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 94.8 mt -63.18 -44.23 99.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -178.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' PHE . . . . . 0.476 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 71.8 m-85 -62.21 -43.58 98.5 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.743 -178.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.34 -42.04 99.07 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 119.316 -0.954 . . . . 0.0 109.231 -178.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.59 HD21 ' CD2' ' A' ' 178' ' ' LEU . 38.2 mt -62.08 -41.81 98.55 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 77.9 p -61.57 -41.14 96.96 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.07 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -64.49 -45.86 85.49 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.378 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.473 HD21 HD21 ' A' ' 182' ' ' LEU . 48.6 tp -62.31 -46.14 90.06 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 119.1 -1.04 . . . . 0.0 108.492 178.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 211' ' ' LEU . 91.2 mt -62.2 -40.8 97.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.504 -177.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.27 -44.41 95.36 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.44 -178.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 87.5 mt -61.65 -39.68 92.23 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 69.8 p -75.77 -10.79 59.73 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.244 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.07 33.59 26.1 Favored Glycine 0 C--N 1.343 0.925 0 C-N-CA 120.501 -0.857 . . . . 0.0 113.205 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 97.3 m -119.36 113.27 20.56 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.073 1.436 . . . . 0.0 111.512 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -64.98 138.03 58.11 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.752 178.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 45.6 tp -113.8 130.82 56.41 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 3.0 mp -117.85 133.33 64.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.539 ' CG2' HD11 ' A' ' 227' ' ' ILE . 49.3 mm -115.48 131.81 66.73 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.416 HG22 ' HB2' ' A' ' 248' ' ' TYR . 44.4 p -133.72 166.13 23.34 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 120.531 -0.467 . . . . 0.0 111.997 -178.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 80.04 19.76 69.19 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.715 HD12 HG23 ' A' ' 247' ' ' THR . 97.1 mt -81.9 128.45 38.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 114.059 -1.07 . . . . 0.0 108.506 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 58.6 tttt -75.68 140.72 71.61 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.6 -39.22 89.63 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 121.069 1.179 . . . . 0.0 112.672 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -64.36 -39.67 94.35 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.686 0.755 . . . . 0.0 110.188 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 52.0 tp -63.91 -42.44 97.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.688 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.84 -37.9 89.1 Favored 'General case' 0 N--CA 1.461 0.103 0 O-C-N 121.952 -0.468 . . . . 0.0 110.973 -179.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 94.2 mtp -63.61 -40.89 98.05 Favored 'General case' 0 C--O 1.248 1.026 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.468 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.88 -38.62 91.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.437 177.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 35.0 mmt -65.59 -38.27 89.01 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.63 178.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -61.29 -41.82 97.61 Favored 'General case' 0 CA--C 1.515 -0.402 0 O-C-N 121.52 -0.738 . . . . 0.0 109.525 -177.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.16 -40.99 95.95 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.549 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 56.0 tp -63.52 -41.48 98.5 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 177.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -166.94 127.39 1.55 Allowed 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -60.45 -26.41 66.73 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.66 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.426 ' O ' ' HB2' ' A' ' 244' ' ' SER . 91.3 m-20 -61.39 -33.84 74.36 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.523 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -55.22 -44.27 75.25 Favored 'General case' 0 C--N 1.311 -1.088 0 O-C-N 121.551 -0.718 . . . . 0.0 109.422 -175.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 97.9 p -61.92 -20.12 63.44 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.865 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' A' ' 241' ' ' ASN . 40.6 m -56.03 -39.24 71.65 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.697 178.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 98.7 mt -84.03 122.82 29.31 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -43.38 135.42 3.52 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.895 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.715 HG23 HD12 ' A' ' 227' ' ' ILE . 97.9 m -127.25 132.53 50.36 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.844 177.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' TYR . . . . . 0.432 ' CB ' ' HB2' ' A' ' 254' ' ' ALA . 97.0 m-85 -118.01 139.83 50.63 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.29 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' SER . . . . . 0.411 ' O ' ' OD1' ' A' ' 250' ' ' ASN . 78.3 p -61.16 -42.87 99.34 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 119.277 -0.969 . . . . 0.0 108.589 -178.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.411 ' OD1' ' O ' ' A' ' 249' ' ' SER . 99.0 m-20 -143.83 160.56 40.55 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.699 0.762 . . . . 0.0 111.434 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 54.9 t -63.09 -44.42 99.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.933 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.76 -44.96 96.08 Favored 'General case' 0 CA--C 1.513 -0.475 0 C-N-CA 120.215 -0.594 . . . . 0.0 109.668 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' ASP . . . . . 0.497 ' O ' HG22 ' A' ' 257' ' ' VAL . 54.5 m-20 -64.22 -41.36 97.06 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.361 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.432 ' HB2' ' CB ' ' A' ' 248' ' ' TYR . . . -64.83 -42.25 95.1 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.858 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 255' ' ' VAL . . . . . 0.478 HG13 HH11 ' B' ' 154' ' ' ARG . 68.3 t -64.03 -45.73 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-N 114.111 -1.404 . . . . 0.0 110.974 -178.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.62 -47.67 80.42 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.489 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.5 ' O ' ' C ' ' A' ' 258' ' ' LEU . 24.7 m -66.58 -40.45 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 120.118 -0.633 . . . . 0.0 112.206 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.5 ' C ' ' O ' ' A' ' 257' ' ' VAL . 0.9 OUTLIER -29.36 -74.9 0.04 OUTLIER Pre-proline 0 CA--C 1.533 0.313 0 CA-C-O 119.472 -0.299 . . . . 0.0 111.253 -177.106 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 259' ' ' PRO . . . . . 0.496 ' CD ' ' CB ' ' A' ' 258' ' ' LEU . 40.3 Cg_endo -62.84 139.61 75.33 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 120.73 0.953 . . . . 0.0 111.884 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 259' ' ' PRO . 96.5 mt -151.36 -23.55 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 O-C-N 123.327 0.392 . . . . 0.0 111.97 178.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 78.4 mtm . . . . . 0 C--O 1.218 -0.566 0 CA-C-O 118.125 -0.94 . . . . 0.0 110.637 -177.545 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.451 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.51 157.36 35.3 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 78.5 p -59.86 -22.13 61.89 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 123.339 0.399 . . . . 0.0 110.948 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -70.83 -61.58 1.71 Allowed 'General case' 0 N--CA 1.426 -1.633 0 O-C-N 121.946 -0.472 . . . . 0.0 111.133 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -67.54 -37.97 83.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.349 -0.842 . . . . 0.0 112.114 178.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.527 ' O ' ' HB3' ' B' ' 7' ' ' PHE . 63.9 m -59.63 -42.87 93.7 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.009 -177.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 7' ' ' PHE . . . . . 0.527 ' HB3' ' O ' ' B' ' 6' ' ' SER . 44.8 t80 85.13 86.82 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.754 0.659 . . . . 0.0 110.431 177.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 8' ' ' GLY . . . . . 0.63 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -61.0 -140.72 0.01 OUTLIER Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 -178.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.63 ' HB ' ' O ' ' B' ' 8' ' ' GLY . 86.0 mt 83.62 109.81 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 122.438 0.295 . . . . 0.0 110.975 -178.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -62.3 -24.53 76.0 Favored 'Trans proline' 0 N--CA 1.499 1.852 0 C-N-CA 121.431 1.42 . . . . 0.0 111.714 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.62 -39.67 97.7 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -64.33 -40.03 95.07 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.66 0.743 . . . . 0.0 109.693 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 52.3 tp -62.28 -42.27 99.2 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.026 -178.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -64.64 -33.34 75.72 Favored 'General case' 0 CA--C 1.56 1.333 0 CA-C-O 121.585 0.707 . . . . 0.0 110.614 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' VAL . . . . . 0.443 HG22 ' CD1' ' A' ' 113' ' ' ILE . 79.3 t -62.92 -46.24 96.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 113.136 -1.847 . . . . 0.0 111.08 177.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 95.5 mt -63.83 -43.96 98.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.422 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 17' ' ' LYS . . . . . 0.538 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 98.9 mttt -63.45 -41.99 98.65 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.94 -40.91 99.09 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 118.983 -1.087 . . . . 0.0 110.177 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.92 -38.39 85.6 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.82 -178.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 86.0 mt -64.0 -42.15 97.25 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.098 0.475 . . . . 0.0 110.222 176.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.27 -39.15 93.8 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.16 -179.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -58.04 -40.0 79.79 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 121.106 -0.237 . . . . 0.0 111.102 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 8.2 p -114.7 129.44 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.506 ' HG3' ' O ' ' B' ' 24' ' ' ARG . 34.5 ptt180 -70.94 106.65 3.72 Favored 'General case' 0 CA--C 1.527 0.079 0 CA-C-O 121.87 0.843 . . . . 0.0 112.527 -177.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.5 p -142.11 133.3 25.76 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.703 177.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' GLY . . . . . 0.453 ' O ' ' N ' ' B' ' 123' ' ' GLN . . . -88.45 97.79 2.35 Favored Glycine 0 N--CA 1.439 -1.135 0 C-N-CA 119.506 -1.33 . . . . 0.0 113.153 -176.023 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 45.9 t -125.3 129.08 73.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 174.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 27.5 m -138.11 155.96 30.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.821 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 94.8 mt -119.89 127.06 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 122.124 0.964 . . . . 0.0 111.181 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.405 HG22 HG12 ' B' ' 39' ' ' ILE . 23.7 p -106.71 157.99 17.3 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-N 112.654 -2.066 . . . . 0.0 108.628 -176.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.534 ' C ' ' OD1' ' B' ' 37' ' ' ASN . 46.1 t0 -126.78 101.36 26.77 Favored Pre-proline 0 C--O 1.239 0.515 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 -177.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 32' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.08 -20.7 67.81 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 121.714 1.609 . . . . 0.0 111.448 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.47 -43.29 99.12 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 120.575 -0.45 . . . . 0.0 109.865 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 91.8 mt -75.16 179.55 4.99 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.715 -0.616 . . . . 0.0 111.149 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 35' ' ' GLU . . . . . 0.666 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 42.5 tt0 -75.48 132.94 41.13 Favored 'General case' 0 C--N 1.342 0.245 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -178.12 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.5 ' O ' ' OD1' ' B' ' 36' ' ' ASP . 65.9 t0 56.21 37.11 28.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.757 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 37' ' ' ASN . . . . . 0.534 ' OD1' ' C ' ' B' ' 31' ' ' ASP . 13.2 t-20 30.11 70.48 0.59 Allowed Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.666 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 92.8 Cg_endo -72.82 156.26 52.99 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 123.401 2.734 . . . . 0.0 111.89 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.405 HG12 HG22 ' B' ' 30' ' ' THR . 96.1 mt -89.28 129.48 40.19 Favored 'Isoleucine or valine' 0 C--O 1.246 0.881 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.429 HG23 ' N ' ' B' ' 41' ' ' TYR . 35.1 m -108.63 -43.44 6.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 O-C-N 123.936 0.773 . . . . 0.0 112.585 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 41' ' ' TYR . . . . . 0.429 ' N ' HG23 ' B' ' 40' ' ' VAL . 49.1 t80 -96.05 124.86 40.23 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.45 -178.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 6.2 p -142.53 140.97 28.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.438 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 43' ' ' ASN . . . . . 0.63 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 56.4 p30 -101.32 160.98 13.95 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.111 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 44' ' ' GLN . . . . . 0.518 ' OE1' ' HA ' ' B' ' 44' ' ' GLN . 12.1 mm100 -63.0 -36.78 84.68 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.215 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.13 -27.75 65.51 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.686 ' CD2' HD13 ' B' ' 57' ' ' ILE . 66.8 t80 -60.32 -43.76 96.09 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.29 0.567 . . . . 0.0 109.601 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 0.738 HG13 ' O ' ' B' ' 52' ' ' TYR . 53.6 t -61.42 -46.4 96.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.336 -178.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -63.4 -44.25 95.2 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.21 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 59.0 ttm -63.34 -42.51 98.93 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 36.1 p -93.33 -18.62 22.22 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 120.327 -0.549 . . . . 0.0 111.875 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 51' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' B' ' 47' ' ' VAL . . . 74.98 18.93 80.17 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 178.184 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 52' ' ' TYR . . . . . 0.738 ' O ' HG13 ' B' ' 47' ' ' VAL . 89.8 m-85 -112.59 146.04 39.29 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.149 0.58 . . . . 0.0 110.528 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -73.4 148.44 43.33 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.474 0.654 . . . . 0.0 111.316 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 54' ' ' THR . . . . . 0.413 HG22 ' H ' ' B' ' 54' ' ' THR . 0.3 OUTLIER -61.82 -37.34 84.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.699 -177.565 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.81 -40.34 96.4 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.235 -0.586 . . . . 0.0 111.722 -178.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -71.62 -32.54 68.08 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 176.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.686 HD13 ' CD2' ' B' ' 46' ' ' PHE . 91.2 mt -66.63 -66.75 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . 0.25 97.0 mt -45.29 134.07 6.73 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.53 -9.95 73.4 Favored Glycine 0 CA--C 1.536 1.352 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.916 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -134.16 148.18 50.89 Favored 'General case' 0 C--N 1.342 0.263 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -174.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 61' ' ' ASN . . . . . 0.562 ' C ' ' H ' ' B' ' 63' ' ' ARG . 25.5 t-20 -79.39 151.18 31.09 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.446 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 62' ' ' CYS . . . . . . . . . . . . . 83.0 m -62.52 9.11 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.251 -178.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 63' ' ' ARG . . . . . 0.562 ' H ' ' C ' ' B' ' 61' ' ' ASN . 33.2 ptt-85 -59.89 -32.8 71.08 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.432 -177.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -60.14 -30.03 69.03 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 178.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 87.8 mt -62.2 -41.53 98.45 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 121.779 -0.575 . . . . 0.0 109.982 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -51.28 149.28 4.09 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.914 -176.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 67' ' ' GLY . . . . . 0.403 ' N ' ' OG1' ' B' ' 70' ' ' THR . . . -159.84 -152.84 6.65 Favored Glycine 0 CA--C 1.537 1.426 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.944 177.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.73 -41.75 95.93 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -175.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 69' ' ' HIS . . . . . 0.444 ' O ' ' NE2' ' B' ' 93' ' ' GLN . 8.7 m80 -74.94 -10.57 59.61 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.259 -178.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 70' ' ' THR . . . . . 0.428 HG23 HD11 ' B' ' 92' ' ' ILE . 28.7 m -61.26 134.58 57.13 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 120.391 -0.524 . . . . 0.0 109.625 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -92.21 110.47 44.63 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.443 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.28 -38.35 88.52 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 121.023 1.149 . . . . 0.0 111.835 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.63 -39.73 89.32 Favored 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 120.451 -0.5 . . . . 0.0 109.697 -176.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 74' ' ' GLU . . . . . 0.486 ' OE1' ' HB ' ' B' ' 90' ' ' VAL . 79.1 mm-40 -66.52 -39.18 88.5 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.888 177.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -62.29 -45.58 98.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -63.12 -36.99 85.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.693 -177.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -62.43 -41.77 98.96 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 119.368 -0.933 . . . . 0.0 108.679 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 94.1 mt -63.47 -43.7 98.5 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-O 120.767 0.318 . . . . 0.0 110.508 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -61.96 -42.63 99.34 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 91.7 m -61.47 -45.14 95.51 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.966 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.82 -41.25 97.54 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -177.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 87.1 mt -62.98 -42.19 99.77 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.597 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 66.7 tp60 -62.85 -35.1 78.85 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 84' ' ' ASN . . . . . 0.429 ' O ' ' HG2' ' B' ' 86' ' ' GLU . 98.2 m-20 -92.1 6.35 46.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.594 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 30.2 tttt 42.99 40.19 2.1 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.414 -0.515 . . . . 0.0 111.823 175.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 86' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' B' ' 84' ' ' ASN . 54.6 mm-40 -122.46 141.59 35.23 Favored Pre-proline 0 N--CA 1.467 0.424 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.29 178.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 87' ' ' PRO . . . . . 0.452 ' HB3' ' OD1' ' B' ' 109' ' ' ASP . 25.6 Cg_exo -61.94 140.95 87.65 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.03 1.154 . . . . 0.0 113.716 -178.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.92 137.67 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.66 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 89' ' ' THR . . . . . 0.913 HG23 ' OD1' ' B' ' 107' ' ' ASN . 96.4 m -121.76 122.72 40.16 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.486 ' HB ' ' OE1' ' B' ' 74' ' ' GLU . 31.1 m -138.87 162.81 28.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.892 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -114.15 121.59 44.24 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 175.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 92' ' ' ILE . . . . . 0.428 HD11 HG23 ' B' ' 70' ' ' THR . 20.6 tt -127.47 131.46 70.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.07 -175.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.444 ' NE2' ' O ' ' B' ' 69' ' ' HIS . 35.5 mt-30 -70.13 139.95 52.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.763 177.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 94' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -129.44 178.86 6.15 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.626 0.727 . . . . 0.0 111.385 -177.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 95' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -130.43 142.42 50.5 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 114.335 -1.302 . . . . 0.0 112.173 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 96' ' ' LYS . . . . . 0.455 ' HG3' ' CE1' ' B' ' 102' ' ' PHE . 98.7 mttt -100.47 177.68 4.96 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.129 0.49 . . . . 0.0 110.958 177.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.71 -35.09 75.44 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.777 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -85.95 -1.64 57.51 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 118.872 0.76 . . . . 0.0 112.709 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.42 3.23 65.06 Favored Glycine 0 N--CA 1.47 0.96 0 C-N-CA 121.15 -0.547 . . . . 0.0 112.495 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 27.3 m -67.44 129.21 39.19 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.665 178.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 101' ' ' MET . . . . . 0.514 ' C ' ' SD ' ' B' ' 101' ' ' MET . 16.9 tmm? -89.22 140.58 29.34 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 102' ' ' PHE . . . . . 0.481 ' N ' ' SD ' ' B' ' 101' ' ' MET . 52.8 p90 -151.66 161.89 41.92 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 103' ' ' TRP . . . . . 0.804 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 21.2 m95 -93.69 137.99 32.37 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.529 0.68 . . . . 0.0 110.813 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 104' ' ' ASN . . . . . 0.543 HD21 ' HG2' ' B' ' 123' ' ' GLN . 64.1 t-20 -133.0 106.97 7.97 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 114.74 -1.118 . . . . 0.0 113.461 -176.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 105' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' B' ' 123' ' ' GLN . 81.2 tt0 -75.09 125.04 28.09 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.75 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 40.0 tp -113.5 125.54 54.32 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.073 0.463 . . . . 0.0 112.072 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 107' ' ' ASN . . . . . 0.913 ' OD1' HG23 ' B' ' 89' ' ' THR . 98.0 m-20 -121.08 130.01 53.57 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.431 -0.804 . . . . 0.0 108.88 176.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 96.6 mt -123.8 132.81 70.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.699 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 109' ' ' ASP . . . . . 0.452 ' OD1' ' HB3' ' B' ' 87' ' ' PRO . 2.9 m-20 -142.77 120.18 7.07 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 178.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -67.97 152.05 77.26 Favored 'Trans proline' 0 N--CA 1.503 2.079 0 C-N-CA 122.632 2.221 . . . . 0.0 112.739 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 111' ' ' MET . . . . . 0.574 ' HB2' ' HB2' ' B' ' 118' ' ' TYR . 66.9 mtt -128.4 144.33 51.12 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -114.88 106.95 14.77 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 113' ' ' ILE . . . . . 0.556 HG12 ' HZ1' ' A' ' 18' ' ' LYS . 96.8 mt -132.88 128.18 56.51 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-N 118.428 0.558 . . . . 0.0 111.77 178.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 53.51 36.68 23.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.946 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 61.32 35.85 17.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.628 -178.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -132.85 149.99 52.2 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 7.1 t -99.83 153.2 19.33 Favored 'General case' 0 C--O 1.214 -0.766 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -177.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 118' ' ' TYR . . . . . 0.574 ' HB2' ' HB2' ' B' ' 111' ' ' MET . 89.9 m-85 -148.29 148.9 30.96 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 121.189 -0.945 . . . . 0.0 111.349 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -124.96 139.68 53.6 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 120.881 0.372 . . . . 0.0 111.181 -177.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -128.54 133.95 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -176.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 121' ' ' GLY . . . . . 0.516 ' N ' HM73 ' B' ' 900' ' ' FMN . . . -108.54 123.78 7.16 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.186 -0.765 . . . . 0.0 111.186 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 95.2 mt -116.38 127.66 73.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 123' ' ' GLN . . . . . 0.543 ' HG2' HD21 ' B' ' 104' ' ' ASN . 16.4 mp0 -118.47 123.9 46.29 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -121.53 119.56 32.33 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 125' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' B' ' 126' ' ' ILE . 67.9 t0 -67.42 136.18 54.31 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.426 -178.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.506 ' O ' ' HG3' ' B' ' 130' ' ' LYS . 2.7 mp -109.78 15.07 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.937 0 CA-C-O 122.174 0.988 . . . . 0.0 109.132 178.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 127' ' ' THR . . . . . 0.453 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 97.6 m -63.05 -43.8 97.61 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 113.827 -1.533 . . . . 0.0 112.347 176.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 59.8 tptt -61.26 -45.92 92.53 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -177.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 129' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -63.51 -33.92 76.63 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.47 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 130' ' ' LYS . . . . . 0.804 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 98.8 mttt -63.53 -41.35 98.47 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 113.589 -1.641 . . . . 0.0 110.856 174.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -64.44 -41.48 96.54 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 132' ' ' TYR . . . . . 0.779 ' CE2' HD11 ' B' ' 136' ' ' LEU . 90.8 t80 -60.17 -44.96 94.61 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 121.801 -0.562 . . . . 0.0 111.358 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 133' ' ' GLU . . . . . 0.445 ' O ' ' HG3' ' B' ' 137' ' ' GLU . 97.4 mt-10 -64.58 -36.25 83.63 Favored 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 134' ' ' LYS . . . . . 0.435 ' HG3' ' O ' ' B' ' 130' ' ' LYS . 98.7 mttt -63.21 -39.81 95.7 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.68 177.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 52.8 tp -62.84 -41.57 99.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.332 0.587 . . . . 0.0 109.743 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 136' ' ' LEU . . . . . 0.779 HD11 ' CE2' ' B' ' 132' ' ' TYR . 89.9 mt -62.86 -41.85 99.53 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.269 177.039 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 137' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' B' ' 133' ' ' GLU . 97.3 mt-10 -65.16 -37.25 86.8 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.302 -1.317 . . . . 0.0 110.441 -178.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -63.22 -43.48 97.99 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.899 176.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 69.7 m -60.8 -44.14 97.25 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 89.7 mt -61.64 -40.32 94.46 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -176.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 94.5 m -62.11 -45.26 94.27 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.827 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -66.09 -42.8 88.83 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 92.5 mt -63.8 -43.24 97.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.688 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 144' ' ' THR . . . . . . . . . . . . . 99.6 m -61.68 -45.04 95.69 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 -178.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 145' ' ' ALA . . . . . 0.445 ' O ' ' HB ' ' B' ' 148' ' ' THR . . . -63.27 -41.72 99.06 Favored 'General case' 0 C--O 1.227 -0.093 0 C-N-CA 118.952 -1.099 . . . . 0.0 109.346 178.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 86.1 mt -64.83 -41.18 95.94 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 176.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 147' ' ' SER . . . . . 0.595 ' O ' ' N ' ' B' ' 149' ' ' PRO . 78.2 p -62.06 -41.34 98.04 Favored 'General case' 0 CA--C 1.479 -1.769 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 148' ' ' THR . . . . . 0.482 ' C ' ' O ' ' B' ' 147' ' ' SER . 26.3 m -28.61 87.19 0.04 OUTLIER Pre-proline 0 N--CA 1.474 0.76 0 O-C-N 124.1 0.875 . . . . 0.0 109.874 176.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 149' ' ' PRO . . . . . 0.595 ' N ' ' O ' ' B' ' 147' ' ' SER . 23.8 Cg_exo -61.67 147.04 96.26 Favored 'Trans proline' 0 C--N 1.301 -1.95 0 C-N-CA 121.952 1.768 . . . . 0.0 114.942 -178.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 9.0 tp -127.73 121.98 57.89 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.533 0 CA-C-N 113.571 -1.65 . . . . 0.0 107.63 174.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 38.7 t -154.01 95.97 2.75 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.699 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -62.35 142.95 92.91 Favored 'Trans proline' 0 C--N 1.318 -1.046 0 N-CA-C 109.61 -0.958 . . . . 0.0 109.61 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 153' ' ' ILE . . . . . 0.487 ' O ' ' HD2' ' B' ' 154' ' ' ARG . 44.5 mm -77.21 -57.46 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.387 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 154' ' ' ARG . . . . . 0.68 ' HD3' ' NH2' ' A' ' 154' ' ' ARG . 1.2 tpt180 -141.53 -156.07 0.65 Allowed 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 61.0 t-20 -86.05 109.6 18.93 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.29 -16.72 59.59 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -178.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 86.7 mt -108.75 125.56 65.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-O 120.86 0.362 . . . . 0.0 110.994 -176.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 158' ' ' SER . . . . . 0.68 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 61.5 m -134.45 149.28 50.73 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.132 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -135.4 147.34 48.99 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.157 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 17.1 tp -140.09 79.55 21.95 Favored Pre-proline 0 CA--C 1.531 0.228 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 161' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -70.05 147.96 62.14 Favored 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 122.839 2.359 . . . . 0.0 114.099 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 91.6 mt -115.29 133.87 55.64 Favored 'General case' 0 C--N 1.342 0.239 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 53.9 t -128.17 132.94 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 114.79 169.71 16.26 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.56 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 165' ' ' ASN . . . . . 0.723 ' O ' ' CZ ' ' B' ' 170' ' ' ARG . 60.9 t30 -91.62 107.11 18.97 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -178.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 166' ' ' LEU . . . . . 0.538 HD21 ' CZ ' ' B' ' 171' ' ' PHE . 47.7 tp -65.49 104.73 1.04 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -174.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 167' ' ' THR . . . . . 0.696 HG23 ' NE ' ' B' ' 170' ' ' ARG . 11.2 p -83.88 169.92 14.6 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 114.103 -1.408 . . . . 0.0 110.797 177.108 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -66.32 -38.51 87.86 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.97 177.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.09 -40.0 90.45 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 123.427 1.584 . . . . 0.0 111.828 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 170' ' ' ARG . . . . . 0.723 ' CZ ' ' O ' ' B' ' 165' ' ' ASN . 88.2 mtm180 -62.3 -36.24 81.51 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 111.914 -2.403 . . . . 0.0 111.05 178.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 171' ' ' PHE . . . . . 0.538 ' CZ ' HD21 ' B' ' 166' ' ' LEU . 0.5 OUTLIER -53.82 -25.16 18.12 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -179.439 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 172' ' ' ASN . . . . . 0.544 ' O ' HG22 ' B' ' 175' ' ' VAL . 91.4 m-20 -62.68 -40.23 96.43 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.845 178.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 49.2 m -60.46 -41.82 94.9 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.729 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 66.7 mt -63.92 -44.39 97.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 175' ' ' VAL . . . . . 0.544 HG22 ' O ' ' B' ' 172' ' ' ASN . 33.6 m -63.12 -40.59 89.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 176' ' ' CYS . . . . . 0.428 ' N ' HG23 ' B' ' 175' ' ' VAL . 97.1 m -62.58 -35.05 78.29 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.344 178.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 177' ' ' THR . . . . . 0.529 ' O ' HG13 ' B' ' 181' ' ' ILE . 25.3 m -61.9 -19.54 62.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.24 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 178' ' ' LEU . . . . . 0.566 ' CD2' HD21 ' B' ' 211' ' ' LEU . 91.1 mt -61.16 -39.51 90.38 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.278 -177.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 19.3 m -61.04 -43.95 98.11 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.185 177.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 180' ' ' ASN . . . . . 0.611 ' O ' ' OG ' ' B' ' 183' ' ' SER . 91.4 m-20 -61.45 -39.94 92.65 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.9 0.381 . . . . 0.0 110.416 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.529 HG13 ' O ' ' B' ' 177' ' ' THR . 71.8 mt -56.96 -34.44 44.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 O-C-N 122.221 -0.3 . . . . 0.0 110.626 -178.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 182' ' ' LEU . . . . . 0.476 HD21 HD21 ' B' ' 214' ' ' LEU . 85.3 mt -62.08 -41.59 98.34 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.11 178.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 183' ' ' SER . . . . . 0.611 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.1 p -63.3 -32.96 74.51 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 121.853 -0.53 . . . . 0.0 110.827 177.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 64.8 p -86.16 17.29 3.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.679 -177.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 78.1 p -61.27 -16.68 47.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.654 -177.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -61.79 -39.82 93.04 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.756 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 187' ' ' ASP . . . . . 0.68 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.1 m-20 -72.11 113.35 9.05 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.504 0.669 . . . . 0.0 110.496 -177.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -62.8 -42.22 99.62 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 114.83 -1.077 . . . . 0.0 113.119 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -110.47 130.52 55.54 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.034 -177.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 190' ' ' LEU . . . . . 0.428 ' HA ' ' O ' ' B' ' 158' ' ' SER . 41.1 tp -123.46 119.33 29.69 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.139 178.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 87.2 mt -107.44 126.86 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 117.796 0.271 . . . . 0.0 111.15 -176.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 49.2 mm -116.29 117.31 55.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 193' ' ' ASP . . . . . 0.464 ' CG ' ' HG ' ' B' ' 195' ' ' SER . 43.3 t0 -88.38 111.33 21.63 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -177.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 194' ' ' LEU . . . . . . . . . . . . . 98.1 mt -93.98 -2.74 52.66 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 176.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 195' ' ' SER . . . . . 0.464 ' HG ' ' CG ' ' B' ' 193' ' ' ASP . 78.2 p -61.35 -37.32 82.89 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.872 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.98 -34.01 87.49 Favored Glycine 0 N--CA 1.436 -1.312 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 197' ' ' LEU . . . . . 1.01 HD22 ' O ' ' B' ' 199' ' ' GLN . 5.2 tt -76.23 133.25 40.17 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -177.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 198' ' ' ALA . . . . . 0.915 ' N ' HD23 ' B' ' 197' ' ' LEU . . . -63.56 -41.26 98.42 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 119.979 -0.688 . . . . 0.0 111.935 -177.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 199' ' ' GLN . . . . . 1.01 ' O ' HD22 ' B' ' 197' ' ' LEU . 59.4 tt0 -140.96 164.23 30.82 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.446 0.641 . . . . 0.0 111.864 -179.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 200' ' ' VAL . . . . . 0.502 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 49.9 t -120.98 131.73 72.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 177.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -91.13 150.03 21.55 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.875 -177.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -60.5 -33.13 72.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.28 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -63.77 -33.81 76.49 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.465 0.65 . . . . 0.0 109.388 178.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.5 m -60.79 -43.93 97.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.246 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 205' ' ' ALA . . . . . 0.64 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -58.26 -30.44 66.57 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 111.79 0.292 . . . . 0.0 111.79 -177.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -65.42 -38.27 89.42 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.307 0.575 . . . . 0.0 109.932 176.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -66.39 -39.11 88.86 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.694 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.82 -43.26 97.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-O 121.688 0.756 . . . . 0.0 110.299 -178.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 209' ' ' PHE . . . . . 0.64 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 69.1 m-85 -61.95 -43.53 98.65 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 113.888 -1.505 . . . . 0.0 112.527 177.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.17 -41.77 99.28 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 119.584 -0.846 . . . . 0.0 110.046 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 211' ' ' LEU . . . . . 0.566 HD21 ' CD2' ' B' ' 178' ' ' LEU . 37.8 mt -62.3 -42.07 99.05 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.221 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 78.2 p -63.52 -35.58 80.94 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.893 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 213' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -66.78 -46.95 73.67 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.362 -0.836 . . . . 0.0 112.141 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.476 HD21 HD21 ' B' ' 182' ' ' LEU . 52.8 tp -63.89 -42.9 97.36 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.864 0.84 . . . . 0.0 110.032 177.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 215' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' B' ' 211' ' ' LEU . 92.6 mt -63.08 -43.42 98.58 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 113.389 -1.732 . . . . 0.0 111.701 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.18 -39.41 92.57 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.913 -177.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.45 -42.3 98.64 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.322 0.582 . . . . 0.0 111.483 175.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 218' ' ' THR . . . . . . . . . . . . . 77.9 p -73.69 -15.92 61.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.716 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 78.91 63.88 2.02 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 107.051 -2.419 . . . . 0.0 107.051 -177.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 220' ' ' THR . . . . . . . . . . . . . 95.8 m -141.3 103.11 4.36 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 176.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -61.47 138.7 58.28 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.054 0.454 . . . . 0.0 110.952 -176.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 44.4 tp -115.67 121.85 43.79 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.679 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 3.2 mp -110.45 128.91 66.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.883 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 224' ' ' ILE . . . . . 0.477 ' CG2' HD11 ' B' ' 227' ' ' ILE . 49.6 mm -111.3 127.15 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 49.8 p -133.62 158.76 42.38 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.871 0.843 . . . . 0.0 112.709 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 89.47 16.4 57.07 Favored Glycine 0 CA--C 1.5 -0.896 0 CA-C-N 113.818 -1.537 . . . . 0.0 111.639 -177.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 227' ' ' ILE . . . . . 0.734 HD12 HG23 ' B' ' 247' ' ' THR . 95.5 mt -81.15 126.27 39.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 117.815 0.808 . . . . 0.0 111.498 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 55.4 tttt -66.19 141.2 97.24 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.341 -178.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.45 -37.56 94.75 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 121.491 1.461 . . . . 0.0 112.614 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -63.94 -43.55 95.5 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -178.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 51.8 tp -62.05 -41.58 98.28 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.159 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.72 -37.01 85.76 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.749 0.309 . . . . 0.0 111.362 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 94.5 mtp -64.01 -40.89 97.35 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.805 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.7 -42.55 99.69 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-O 122.422 1.106 . . . . 0.0 109.467 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 35.2 mmt -63.98 -36.61 84.53 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 114.322 -1.308 . . . . 0.0 111.862 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -61.96 -40.46 95.64 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.002 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.28 -43.91 96.59 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 120.679 -0.409 . . . . 0.0 110.057 177.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.29 -44.42 96.55 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.71 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 239' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' B' ' 240' ' ' ALA . 67.0 t0 -159.1 133.08 7.57 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.324 -0.551 . . . . 0.0 112.104 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 240' ' ' ALA . . . . . 0.418 ' N ' ' OD1' ' B' ' 239' ' ' ASP . . . -62.51 -44.75 95.6 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 176.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 241' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' B' ' 244' ' ' SER . 92.1 m-20 -45.52 -22.61 0.16 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.046 -175.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 242' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -60.81 -45.43 94.46 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 119.888 -0.725 . . . . 0.0 110.39 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 243' ' ' SER . . . . . . . . . . . . . 77.5 p -57.89 -42.21 84.15 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 244' ' ' SER . . . . . 0.477 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 19.7 m -35.1 -34.46 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 -178.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 96.6 mt -87.74 134.2 33.71 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.567 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -58.85 135.53 57.55 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-O 121.427 0.632 . . . . 0.0 110.75 -177.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 247' ' ' THR . . . . . 0.734 HG23 HD12 ' B' ' 227' ' ' ILE . 95.8 m -125.91 127.51 46.12 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.722 177.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 248' ' ' TYR . . . . . 0.471 ' CB ' ' HB2' ' B' ' 254' ' ' ALA . 96.3 m-85 -113.8 142.56 45.91 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 249' ' ' SER . . . . . 0.604 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 78.4 p -63.12 -34.08 76.84 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.339 -178.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 250' ' ' ASN . . . . . 0.604 ' OD1' ' O ' ' B' ' 249' ' ' SER . 99.2 m-20 -147.94 159.55 43.75 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.199 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 58.0 t -64.23 -44.39 97.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.885 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 252' ' ' LYS . . . . . 0.421 ' HG3' ' HG3' ' A' ' 152' ' ' PRO . 88.7 tttt -60.94 -46.74 89.5 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -177.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 253' ' ' ASP . . . . . 0.5 ' O ' HG22 ' B' ' 257' ' ' VAL . 93.7 m-20 -61.74 -43.11 99.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.654 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 254' ' ' ALA . . . . . 0.471 ' HB2' ' CB ' ' B' ' 248' ' ' TYR . . . -64.87 -40.57 95.33 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.18 178.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 255' ' ' VAL . . . . . 0.555 HG11 ' O ' ' A' ' 153' ' ' ILE . 67.8 t -64.69 -45.72 94.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.506 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -63.26 -48.21 79.14 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.226 -178.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 257' ' ' VAL . . . . . 0.5 HG22 ' O ' ' B' ' 253' ' ' ASP . 22.6 m -65.2 -40.31 88.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.594 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 258' ' ' LEU . . . . . 0.515 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 0.9 OUTLIER -31.8 -73.96 0.05 OUTLIER Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.592 -178.359 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 259' ' ' PRO . . . . . 0.538 ' O ' HG13 ' B' ' 260' ' ' ILE . 35.5 Cg_endo -61.75 141.31 90.05 Favored 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 121.51 1.474 . . . . 0.0 111.196 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 260' ' ' ILE . . . . . 0.562 HG22 ' O ' ' B' ' 260' ' ' ILE . 96.8 mt -158.44 -12.57 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-N 118.591 0.632 . . . . 0.0 112.121 177.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 78.3 mtm . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 117.99 -1.005 . . . . 0.0 111.583 179.921 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 900' ' ' FMN . . . . . 0.5 HM73 ' N ' ' A' ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 900' ' ' FMN . . . . . 0.516 HM73 ' N ' ' B' ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.427 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.76 179.25 8.68 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-O 121.57 0.7 . . . . 0.0 109.518 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 97.2 p -82.62 -2.18 53.11 Favored 'General case' 0 C--N 1.39 2.337 0 O-C-N 118.151 -2.843 . . . . 0.0 112.853 176.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -87.35 -64.15 1.19 Allowed 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.141 -1.391 . . . . 0.0 112.32 175.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -68.73 -39.23 80.49 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 178.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.497 ' O ' ' CB ' ' A' ' 7' ' ' PHE . 57.0 m -58.94 -42.13 89.04 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.923 -177.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.523 ' CE2' HD12 ' A' ' 9' ' ' ILE . 33.0 t80 86.38 87.59 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 O-C-N 123.816 0.697 . . . . 0.0 111.567 176.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.55 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -60.59 -143.21 0.01 OUTLIER Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.55 ' HB ' ' O ' ' A' ' 8' ' ' GLY . 65.3 mt 84.22 110.46 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.65 0 C-N-CA 122.881 0.472 . . . . 0.0 110.584 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.94 -22.44 68.47 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 121.354 1.369 . . . . 0.0 112.18 -179.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.88 -37.29 94.44 Favored Glycine 0 C--O 1.247 0.921 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.07 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -65.04 -39.04 92.77 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.349 0.595 . . . . 0.0 109.745 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.8 tp -63.29 -41.95 99.02 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -62.32 -39.54 93.37 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 68.5 t -61.08 -43.97 97.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 O-C-N 122.02 -0.425 . . . . 0.0 111.066 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 95.4 mt -62.21 -43.28 97.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.213 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.4 ' NZ ' ' HA ' ' B' ' 6' ' ' SER . 98.7 mttt -62.96 -45.03 94.39 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 119.394 -0.923 . . . . 0.0 111.877 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.718 ' HZ1' HG12 ' B' ' 113' ' ' ILE . 98.5 mttt -61.05 -39.42 89.77 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 118.666 -1.214 . . . . 0.0 108.612 -175.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.35 -42.88 92.6 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 119.941 -0.703 . . . . 0.0 110.262 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 20' ' ' LEU . 87.0 mt -63.1 -40.77 98.62 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -62.86 -38.9 92.7 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.491 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 57.5 m170 -58.88 -39.5 81.58 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 122.16 -0.337 . . . . 0.0 111.501 -178.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.3 p -114.82 130.36 69.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.462 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 31.6 ptt180 -72.9 110.15 6.99 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 121.939 0.876 . . . . 0.0 112.178 -177.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.5 p -140.96 143.3 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 177.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' A' ' 123' ' ' GLN . . . -97.81 92.56 1.29 Allowed Glycine 0 C--N 1.312 -0.758 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.777 -178.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 52.0 t -124.79 129.98 73.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 175.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.8 m -136.92 159.24 37.01 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.5 mt -119.46 128.89 75.86 Favored 'Isoleucine or valine' 0 C--O 1.245 0.855 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 176.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.45 ' OG1' ' HB2' ' A' ' 119' ' ' PHE . 24.3 p -101.83 167.22 10.22 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 177.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.401 ' C ' ' OD1' ' A' ' 37' ' ' ASN . 53.1 t0 -133.82 101.86 12.64 Favored Pre-proline 0 C--O 1.222 -0.37 0 C-N-CA 120.314 -0.554 . . . . 0.0 109.872 178.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.57 -21.04 65.99 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 121.431 1.421 . . . . 0.0 111.501 -178.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.67 -29.72 70.85 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.316 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 91.4 mt -89.79 -178.87 5.61 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.865 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.645 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 42.1 tt0 -76.3 130.25 37.85 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -177.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.515 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 58.3 t0 63.11 22.04 13.2 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 177.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.401 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 29.7 t-20 42.3 68.03 2.99 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.996 -177.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.645 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 89.6 Cg_endo -71.36 157.17 57.38 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 124.085 3.19 . . . . 0.0 112.042 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 95.9 mt -89.84 123.61 42.12 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.5 m -103.95 -43.14 8.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.1 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -96.34 123.61 40.04 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.733 -178.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.5 p -142.87 140.29 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 O-C-N 124.356 1.035 . . . . 0.0 109.229 177.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.61 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 57.7 p30 -96.49 166.13 11.84 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.466 ' HA ' ' OE1' ' A' ' 44' ' ' GLN . 14.0 mm100 -66.15 -39.84 90.11 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 177.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.98 -25.44 61.87 Favored Glycine 0 C--O 1.237 0.294 0 N-CA-C 110.389 -1.085 . . . . 0.0 110.389 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.621 ' CD2' HD13 ' A' ' 57' ' ' ILE . 67.4 t80 -59.0 -47.51 84.93 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 105.863 -1.902 . . . . 0.0 105.863 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.722 HG13 ' O ' ' A' ' 52' ' ' TYR . 53.6 t -60.04 -44.38 94.7 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 O-C-N 121.161 -0.962 . . . . 0.0 111.498 -174.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -62.44 -37.56 86.35 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 120.488 -0.485 . . . . 0.0 112.264 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 59.4 ttm -66.97 -43.64 82.55 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 176.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 34.8 p -93.48 -20.82 19.92 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.138 0.494 . . . . 0.0 111.287 -177.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . 77.82 19.44 75.47 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.722 ' O ' HG13 ' A' ' 47' ' ' VAL . 78.0 m-85 -111.79 138.79 47.9 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 122.579 0.351 . . . . 0.0 110.984 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -64.64 149.14 49.52 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.491 0.662 . . . . 0.0 109.495 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.448 HG22 ' H ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -65.85 -32.44 73.95 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.833 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.43 -42.34 83.33 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 119.381 -0.928 . . . . 0.0 111.382 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -64.65 -44.65 89.76 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.621 HD13 ' CD2' ' A' ' 46' ' ' PHE . 95.3 mt -63.76 -45.9 95.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -174.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 83.8 mt -61.09 144.7 53.05 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.14 -5.99 73.83 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.353 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -134.49 151.28 51.03 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 119.222 1.511 . . . . 0.0 112.011 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.562 ' C ' ' H ' ' A' ' 63' ' ' ARG . 25.0 t-20 -81.45 152.2 27.5 Favored 'General case' 0 N--CA 1.453 -0.316 0 O-C-N 121.882 -0.511 . . . . 0.0 110.509 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 86.0 m -63.16 15.78 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.353 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.562 ' H ' ' C ' ' A' ' 61' ' ' ASN . 35.2 ptt-85 -61.12 -42.02 97.78 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.077 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -55.65 -21.74 19.45 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -178.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.6 mt -67.44 -35.48 79.32 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 122.241 1.02 . . . . 0.0 112.864 176.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -65.65 133.3 50.83 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.753 -176.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.524 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -143.69 -148.57 4.92 Favored Glycine 0 CA--C 1.543 1.832 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -178.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.86 -41.11 99.25 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -177.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.594 ' O ' ' NE2' ' A' ' 93' ' ' GLN . 9.0 m80 -75.93 -9.79 58.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.834 0.349 . . . . 0.0 110.852 -177.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.524 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 28.5 m -60.93 130.12 44.87 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.603 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -87.54 111.09 39.36 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.713 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -57.55 -31.68 92.27 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.018 1.812 . . . . 0.0 112.99 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.7 -40.26 96.34 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.951 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.424 ' OE1' ' HB ' ' A' ' 90' ' ' VAL . 79.2 mm-40 -65.6 -43.61 89.12 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.3 t -60.4 -43.13 93.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -63.67 -37.96 89.33 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 124.07 0.856 . . . . 0.0 112.007 178.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -63.31 -39.69 95.25 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.37 0.605 . . . . 0.0 110.544 178.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.1 mt -64.1 -43.79 97.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.367 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -62.65 -43.07 99.74 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 113.653 -1.612 . . . . 0.0 108.473 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 93.8 m -60.82 -49.11 78.8 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.25 -42.46 95.34 Favored 'General case' 0 C--N 1.363 1.189 0 O-C-N 123.754 0.659 . . . . 0.0 110.782 -171.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 87.4 mt -63.01 -40.94 99.26 Favored 'General case' 0 CA--C 1.514 -0.409 0 O-C-N 120.184 -1.573 . . . . 0.0 111.692 -178.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -63.42 -41.07 98.69 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -70.55 -23.35 62.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.197 177.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 49.5 tttt 63.34 46.53 4.38 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.614 -176.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -130.71 148.32 69.65 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -62.08 142.94 94.12 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 121.441 1.427 . . . . 0.0 113.493 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.09 141.43 33.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.325 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.891 HG23 ' OD1' ' A' ' 107' ' ' ASN . 96.6 m -126.7 119.17 26.3 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 175.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.424 ' HB ' ' OE1' ' A' ' 74' ' ' GLU . 30.1 m -138.59 157.17 30.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 121.203 -0.199 . . . . 0.0 111.413 178.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -103.8 127.3 51.3 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 177.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.421 ' O ' HG23 ' A' ' 92' ' ' ILE . 18.8 tt -135.74 131.45 50.45 Favored 'Isoleucine or valine' 0 C--N 1.372 1.567 0 CA-C-N 121.716 2.053 . . . . 0.0 112.606 177.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.594 ' NE2' ' O ' ' A' ' 69' ' ' HIS . 33.7 mt-30 -63.69 135.87 57.05 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.952 -179.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -137.97 162.25 34.56 Favored 'General case' 0 C--N 1.349 0.55 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.923 -177.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.492 ' CE1' ' HA3' ' A' ' 67' ' ' GLY . 92.3 m-85 -121.38 138.3 54.32 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -178.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.488 ' HG3' ' CE1' ' A' ' 102' ' ' PHE . 99.2 mttt -86.71 -171.06 3.35 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.078 0.466 . . . . 0.0 111.525 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.69 -42.05 99.43 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.396 178.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 39.7 p-10 -85.49 7.61 22.23 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -177.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.48 -1.18 88.45 Favored Glycine 0 N--CA 1.471 0.983 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.146 177.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 23.4 m -60.06 137.63 58.05 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.678 ' SD ' ' C ' ' A' ' 101' ' ' MET . 14.1 tmm? -104.98 129.39 53.42 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 120.746 0.308 . . . . 0.0 111.231 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.488 ' CE1' ' HG3' ' A' ' 96' ' ' LYS . 53.5 p90 -141.12 158.97 43.19 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.927 -177.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.837 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 21.0 m95 -90.54 143.97 26.23 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.411 HD21 ' HG2' ' A' ' 123' ' ' GLN . 54.6 t-20 -138.46 103.54 4.91 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -176.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -70.56 135.12 48.26 Favored 'General case' 0 N--CA 1.436 -1.15 0 O-C-N 120.974 -1.079 . . . . 0.0 108.16 -176.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 38.8 tp -120.16 123.61 43.73 Favored 'General case' 0 C--O 1.234 0.285 0 O-C-N 124.07 0.856 . . . . 0.0 112.662 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.891 ' OD1' HG23 ' A' ' 89' ' ' THR . 98.1 m-20 -119.55 123.0 42.87 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.96 177.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 96.4 mt -120.9 128.46 76.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 O-C-N 123.575 0.547 . . . . 0.0 111.496 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -137.33 126.81 15.32 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.819 -0.173 . . . . 0.0 111.003 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -70.73 151.45 63.57 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.162 1.908 . . . . 0.0 112.413 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.654 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 67.2 mtt -123.36 151.5 42.46 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -126.86 96.96 4.8 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 176.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.513 ' CD1' HG22 ' B' ' 15' ' ' VAL . 96.2 mt -121.02 131.56 72.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.035 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 50.27 37.46 15.1 Favored 'General case' 0 CA--C 1.515 -0.375 0 O-C-N 121.105 -0.997 . . . . 0.0 111.365 176.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 59.93 31.82 20.88 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 123.939 0.774 . . . . 0.0 110.994 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -128.71 147.95 50.8 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.705 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 3.6 t -84.3 -175.51 5.83 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-O 118.769 -0.634 . . . . 0.0 109.434 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.705 ' CD2' ' O ' ' A' ' 117' ' ' THR . 70.1 m-85 -169.1 156.04 6.94 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 173.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.45 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 86.0 m-85 -129.32 147.83 51.19 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 173.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.7 p -137.33 137.31 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -111.97 130.29 9.56 Favored Glycine 0 CA--C 1.504 -0.644 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 178.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 97.0 mt -117.65 129.54 73.93 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 177.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.595 ' N ' ' O ' ' A' ' 26' ' ' GLY . 17.9 mp0 -118.81 117.0 27.7 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.223 0.535 . . . . 0.0 109.833 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -117.99 114.97 23.96 Favored 'General case' 0 C--O 1.254 1.329 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.813 -178.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.412 ' OD1' ' OG1' ' A' ' 127' ' ' THR . 67.4 t0 -67.72 121.97 17.09 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -175.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.478 ' O ' HG22 ' A' ' 126' ' ' ILE . 3.6 mp -85.4 1.07 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 113.778 -1.556 . . . . 0.0 110.299 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.412 ' OG1' ' OD1' ' A' ' 125' ' ' ASP . 27.5 m -59.43 -42.58 92.21 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.186 -0.946 . . . . 0.0 112.937 -177.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -58.87 -42.31 89.13 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 -178.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -63.23 -39.47 94.7 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.445 177.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.837 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.8 mttt -62.41 -40.76 97.58 Favored 'General case' 0 C--O 1.214 -0.771 0 O-C-N 120.504 -1.372 . . . . 0.0 110.084 -178.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.72 -37.41 86.41 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.752 0.658 . . . . 0.0 109.49 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.735 ' CE2' HD11 ' A' ' 136' ' ' LEU . 88.2 t80 -61.45 -45.9 92.33 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.408 176.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.34 -38.45 91.07 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.67 -40.31 96.66 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 52.2 tp -60.97 -43.35 98.91 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -177.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.735 HD11 ' CE2' ' A' ' 132' ' ' TYR . 85.3 mt -62.8 -41.27 99.21 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.827 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.97 -41.87 98.5 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 119.668 -0.813 . . . . 0.0 109.691 -178.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -60.14 -43.06 96.0 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -177.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 54.7 m -61.61 -41.41 97.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.731 176.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.457 ' O ' ' N ' ' A' ' 144' ' ' THR . 85.8 mt -63.07 -41.69 99.5 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 121.933 -0.48 . . . . 0.0 109.963 178.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 78.6 m -61.61 -45.42 94.17 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.514 -177.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -65.13 -39.99 93.83 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 95.2 mt -64.59 -43.18 96.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 113.873 -1.512 . . . . 0.0 111.232 176.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.457 ' N ' ' O ' ' A' ' 140' ' ' LEU . 89.3 m -62.18 -46.07 90.59 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 120.37 -0.532 . . . . 0.0 112.285 -178.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.34 -40.62 96.98 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 118.851 -1.14 . . . . 0.0 109.064 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.7 mt -63.44 -42.63 98.66 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.491 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.715 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.4 p -60.7 -36.42 78.75 Favored 'General case' 0 C--O 1.214 -0.803 0 C-N-CA 119.332 -0.947 . . . . 0.0 109.294 -177.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.438 ' C ' ' O ' ' A' ' 147' ' ' SER . 41.9 m -31.67 81.57 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.507 0 O-C-N 127.041 2.713 . . . . 0.0 105.823 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.715 ' N ' ' O ' ' A' ' 147' ' ' SER . 19.4 Cg_exo -62.51 142.07 88.84 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 CA-C-O 123.088 1.203 . . . . 0.0 114.601 -174.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.562 ' O ' HG23 ' A' ' 151' ' ' VAL . 9.0 tp -115.91 136.3 53.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 102.603 -3.11 . . . . 0.0 102.603 175.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 150' ' ' ILE . 82.2 t -168.46 90.5 0.64 Allowed Pre-proline 0 CA--C 1.505 -0.771 0 N-CA-C 106.001 -1.851 . . . . 0.0 106.001 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.2 135.58 55.3 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 N-CA-C 109.678 -0.931 . . . . 0.0 109.678 -177.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.669 ' O ' ' HD2' ' A' ' 154' ' ' ARG . 44.5 mm -67.45 -44.76 86.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 119.682 -0.807 . . . . 0.0 111.109 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.729 HH11 HG13 ' B' ' 255' ' ' VAL . 0.4 OUTLIER -157.31 -156.29 0.58 Allowed 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.864 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.411 ' ND2' ' HE3' ' B' ' 256' ' ' LYS . 61.4 t-20 -86.51 104.89 16.39 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.469 0.652 . . . . 0.0 111.619 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 88.56 7.96 71.22 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 114.121 -1.4 . . . . 0.0 110.245 -178.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.1 mt -123.52 123.71 67.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 174.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.609 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 69.4 m -132.38 152.57 51.4 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -137.51 143.4 41.66 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.492 177.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 16.3 tp -133.68 78.33 61.81 Favored Pre-proline 0 N--CA 1.465 0.295 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.328 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -69.2 150.19 71.33 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.68 2.253 . . . . 0.0 113.227 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 90.4 mt -118.48 125.99 51.07 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.12 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 51.4 t -122.95 131.57 73.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 117.29 168.63 14.72 Favored Glycine 0 N--CA 1.481 1.683 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.347 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.864 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 56.1 t30 -85.32 114.13 22.16 Favored 'General case' 0 C--O 1.201 -1.48 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -178.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.628 HD21 ' CZ ' ' A' ' 171' ' ' PHE . 48.2 tp -73.92 102.45 4.11 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -177.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.705 HG23 ' NE ' ' A' ' 170' ' ' ARG . 10.5 p -85.49 167.69 15.23 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.446 178.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.91 -34.93 79.27 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.955 0.407 . . . . 0.0 111.894 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.15 -46.66 86.15 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.499 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.864 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 87.6 mtm180 -61.6 -31.74 71.82 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.796 177.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.628 ' CZ ' HD21 ' A' ' 166' ' ' LEU . 0.4 OUTLIER -54.97 -28.28 50.41 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -177.53 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.637 ' O ' HG22 ' A' ' 175' ' ' VAL . 92.6 m-20 -60.8 -40.45 92.74 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 119.045 -1.062 . . . . 0.0 110.01 -178.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 58.7 m -59.42 -40.56 87.09 Favored 'General case' 0 C--N 1.322 -0.611 0 O-C-N 121.762 -0.586 . . . . 0.0 110.638 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 67.9 mt -63.66 -44.14 98.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.637 HG22 ' O ' ' A' ' 172' ' ' ASN . 35.2 m -62.29 -40.05 86.38 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' CYS . . . . . 0.415 ' N ' HG23 ' A' ' 175' ' ' VAL . 96.6 m -62.05 -35.24 78.02 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.318 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.519 ' O ' HG13 ' A' ' 181' ' ' ILE . 24.9 m -61.48 -19.84 62.48 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.283 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.606 ' CD2' HD21 ' A' ' 211' ' ' LEU . 87.6 mt -60.82 -40.82 94.16 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -177.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 18.5 m -59.48 -43.75 93.19 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.594 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.634 ' O ' ' OG ' ' A' ' 183' ' ' SER . 93.2 m-20 -61.1 -37.5 82.97 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.053 0.454 . . . . 0.0 111.059 178.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 177' ' ' THR . 66.8 mt -57.51 -39.01 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 O-C-N 121.401 -0.812 . . . . 0.0 109.165 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 87.3 mt -60.81 -40.47 92.82 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 119.439 -0.904 . . . . 0.0 108.625 -177.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.634 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 78.0 p -61.48 -34.0 74.72 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.727 176.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 53.0 p -90.45 23.58 2.93 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 122.226 -0.296 . . . . 0.0 111.514 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 78.2 p -63.04 -20.15 65.06 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.644 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.07 -36.2 79.0 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.865 -178.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.609 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 98.7 m-20 -72.55 114.0 10.2 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.568 0.699 . . . . 0.0 110.963 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -62.8 -42.48 99.73 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.919 -177.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -113.26 132.17 55.64 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.104 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 38.1 tp -120.6 128.93 53.5 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 96.4 mt -116.24 127.05 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 O-C-N 121.751 -0.593 . . . . 0.0 109.459 177.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.9 mm -113.08 126.35 70.48 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' ASP . . . . . 0.5 ' CG ' ' HG ' ' A' ' 195' ' ' SER . 40.2 t0 -95.25 120.34 35.32 Favored 'General case' 0 CA--C 1.551 1.017 0 O-C-N 121.662 -0.648 . . . . 0.0 110.48 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 194' ' ' LEU . 96.2 mt -101.01 -2.8 30.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.891 176.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.5 ' HG ' ' CG ' ' A' ' 193' ' ' ASP . 78.3 p -63.31 -32.32 73.71 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.85 -47.15 92.02 Favored Glycine 0 CA--C 1.54 1.61 0 N-CA-C 108.171 -1.972 . . . . 0.0 108.171 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.938 HD23 ' N ' ' A' ' 198' ' ' ALA . 4.9 tt -66.02 129.82 41.12 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 112.873 -1.664 . . . . 0.0 108.755 -177.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.938 ' N ' HD23 ' A' ' 197' ' ' LEU . . . -60.79 -50.98 71.26 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-O 121.417 0.627 . . . . 0.0 110.931 -179.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.889 ' O ' ' CD2' ' A' ' 197' ' ' LEU . 58.6 tt0 -132.76 156.78 46.46 Favored 'General case' 0 C--O 1.21 -1.017 0 CA-C-N 114.728 -1.124 . . . . 0.0 114.016 -174.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.483 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 46.1 t -117.83 130.69 72.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 O-C-N 120.424 -1.423 . . . . 0.0 108.425 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -83.76 155.86 22.84 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.237 -178.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -64.79 -39.48 93.67 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.988 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -57.24 -31.4 65.5 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 -178.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.8 m -61.42 -42.74 99.22 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.709 178.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.449 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -56.44 -39.06 72.47 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -177.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -61.26 -38.09 85.46 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 121.776 -0.578 . . . . 0.0 110.087 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -64.57 -38.87 92.52 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.916 177.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.02 -44.88 99.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' PHE . . . . . 0.449 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 67.2 m-85 -61.04 -43.82 98.31 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.009 -177.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.97 -41.59 98.18 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 118.998 -1.081 . . . . 0.0 109.202 -178.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.606 HD21 ' CD2' ' A' ' 178' ' ' LEU . 38.8 mt -62.39 -42.18 99.23 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 78.0 p -61.04 -42.45 98.5 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.463 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 60.8 t60 -64.93 -45.72 84.64 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 122.034 -0.416 . . . . 0.0 111.728 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 50.3 tp -62.41 -45.93 90.88 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 119.021 -1.071 . . . . 0.0 108.15 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 89.4 mt -62.84 -41.19 99.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.401 -177.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.03 -44.44 94.63 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.601 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 82.6 mt -61.93 -40.54 95.85 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 68.9 p -75.44 -11.72 60.1 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.241 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.96 40.17 9.6 Favored Glycine 0 C--O 1.217 -0.913 0 C-N-CA 120.617 -0.801 . . . . 0.0 113.863 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 99.9 m -125.99 115.03 19.26 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 119.104 1.452 . . . . 0.0 112.36 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -66.4 136.11 55.28 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.147 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 41.7 tp -111.97 128.69 56.24 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 2.8 mp -116.35 132.61 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.587 ' CG2' HD11 ' A' ' 227' ' ' ILE . 49.7 mm -114.35 131.39 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 39.7 p -133.38 165.75 24.12 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 120.766 -0.373 . . . . 0.0 111.583 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 79.35 20.35 69.62 Favored Glycine 0 C--O 1.224 -0.508 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 178.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.665 HD12 HG23 ' A' ' 247' ' ' THR . 97.3 mt -81.83 128.83 38.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 113.692 -1.254 . . . . 0.0 108.124 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 66.0 tttt -75.89 139.96 70.21 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.47 -38.23 89.79 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 121.108 1.205 . . . . 0.0 112.453 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -64.94 -39.23 93.19 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-O 121.29 0.566 . . . . 0.0 110.268 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 53.3 tp -63.57 -43.11 97.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.915 -1.039 . . . . 0.0 112.753 177.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.66 -37.66 88.19 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 121.96 -0.463 . . . . 0.0 111.175 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 93.7 mtp -63.2 -40.47 97.6 Favored 'General case' 0 C--O 1.251 1.16 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.704 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -64.32 -39.29 93.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.758 176.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 30.1 mmt -65.45 -37.72 87.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.746 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -60.8 -41.02 94.81 Favored 'General case' 0 CA--C 1.513 -0.447 0 O-C-N 121.48 -0.763 . . . . 0.0 109.491 -176.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.71 -39.9 93.14 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.355 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 52.7 tp -63.18 -42.05 99.3 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 176.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -168.89 128.19 1.08 Allowed 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 121.404 0.621 . . . . 0.0 112.559 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -60.22 -28.02 67.67 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.821 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -61.16 -27.56 68.49 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.674 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -56.42 -43.73 79.66 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -176.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 96.6 p -63.2 -20.84 65.79 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 124.108 0.88 . . . . 0.0 111.298 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 41.7 m -55.25 -34.25 63.85 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 122.056 -0.403 . . . . 0.0 111.763 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 94.3 mt -89.76 121.6 32.07 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -46.1 134.77 8.12 Favored 'General case' 0 C--O 1.248 0.986 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.615 -177.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.665 HG23 HD12 ' A' ' 227' ' ' ILE . 97.8 m -126.48 132.8 51.35 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 114.605 -1.18 . . . . 0.0 110.968 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' TYR . . . . . 0.515 ' CG ' ' HB2' ' A' ' 254' ' ' ALA . 96.4 m-85 -117.51 139.49 50.86 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.788 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 78.3 p -60.68 -42.58 97.38 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -178.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -143.74 160.75 40.17 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.606 0.717 . . . . 0.0 111.651 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.02 -44.79 99.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 114.725 -1.125 . . . . 0.0 112.301 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.89 -44.67 96.78 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -178.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' ASP . . . . . 0.432 ' O ' HG22 ' A' ' 257' ' ' VAL . 55.6 m-20 -62.75 -44.38 96.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.599 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.515 ' HB2' ' CG ' ' A' ' 248' ' ' TYR . . . -63.59 -42.45 98.28 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.975 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' VAL . . . . . 0.626 HG13 HH11 ' B' ' 154' ' ' ARG . 66.8 t -63.86 -45.41 97.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-N 114.051 -1.431 . . . . 0.0 110.798 -178.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.77 -47.09 82.36 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.846 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.498 ' O ' ' C ' ' A' ' 258' ' ' LEU . 22.5 m -67.51 -41.09 85.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 O-C-N 121.453 -0.779 . . . . 0.0 112.034 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.498 ' C ' ' O ' ' A' ' 257' ' ' VAL . 1.1 mt -28.17 -74.84 0.04 OUTLIER Pre-proline 0 C--O 1.234 0.265 0 CA-C-O 119.518 -0.277 . . . . 0.0 111.542 -177.159 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 259' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 258' ' ' LEU . 39.9 Cg_endo -62.85 139.84 76.55 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 120.833 1.022 . . . . 0.0 111.934 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 259' ' ' PRO . 96.6 mt -151.8 -27.17 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 O-C-N 123.779 0.675 . . . . 0.0 111.981 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 C--O 1.216 -0.683 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.782 -177.262 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.58 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -165.18 170.26 15.11 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 84.2 p -66.82 -16.71 64.46 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -79.85 -64.21 1.24 Allowed 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.103 -177.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -66.4 -39.81 89.24 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.302 -0.863 . . . . 0.0 113.073 178.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.495 ' O ' ' CB ' ' B' ' 7' ' ' PHE . 58.9 m -59.25 -42.44 91.14 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 -178.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' PHE . . . . . 0.519 ' CE2' HD12 ' B' ' 9' ' ' ILE . 32.8 t80 87.01 90.96 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.742 0.651 . . . . 0.0 110.697 177.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 8' ' ' GLY . . . . . 0.549 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -63.27 -142.77 0.01 OUTLIER Glycine 0 C--N 1.339 0.727 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.549 ' HB ' ' O ' ' B' ' 8' ' ' GLY . 64.7 mt 83.88 110.38 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 122.773 0.429 . . . . 0.0 110.784 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -63.15 -23.61 73.08 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 C-N-CA 121.249 1.299 . . . . 0.0 111.812 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.24 -38.81 96.82 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -64.99 -39.07 92.92 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.473 0.654 . . . . 0.0 109.551 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 49.8 tp -61.95 -43.0 99.74 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.507 -177.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -64.45 -31.78 73.14 Favored 'General case' 0 CA--C 1.559 1.317 0 CA-C-O 121.358 0.599 . . . . 0.0 110.614 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' VAL . . . . . 0.513 HG22 ' CD1' ' A' ' 113' ' ' ILE . 74.6 t -63.27 -46.19 96.31 Favored 'Isoleucine or valine' 0 C--O 1.249 1.053 0 CA-C-N 113.179 -1.828 . . . . 0.0 111.198 177.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.82 -43.69 97.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.795 -178.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 17' ' ' LYS . . . . . 0.406 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 98.9 mttt -63.31 -42.53 99.04 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.88 -40.54 97.83 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 118.991 -1.084 . . . . 0.0 109.964 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.87 -39.62 89.86 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.018 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 20' ' ' LEU . 87.6 mt -63.81 -41.93 97.78 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.276 0.56 . . . . 0.0 110.33 175.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -62.87 -39.01 93.12 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.798 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 56.4 m170 -58.2 -39.68 79.62 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 121.086 -0.246 . . . . 0.0 111.521 -178.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 13.6 p -114.71 130.11 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.482 ' HG3' ' O ' ' B' ' 24' ' ' ARG . 31.6 ptt180 -72.43 108.17 5.38 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.687 0.755 . . . . 0.0 112.582 -177.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.0 p -142.6 134.22 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.731 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 26' ' ' GLY . . . . . 0.569 ' O ' ' N ' ' B' ' 123' ' ' GLN . . . -88.25 96.99 2.25 Favored Glycine 0 C--N 1.31 -0.913 0 C-N-CA 119.655 -1.26 . . . . 0.0 113.43 -176.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 48.5 t -125.74 129.19 72.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 174.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 30.2 m -138.33 156.19 29.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.473 178.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 96.1 mt -118.0 124.71 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.247 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 25.9 p -102.31 159.34 15.49 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 113.146 -1.843 . . . . 0.0 108.603 -178.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -127.43 101.74 24.25 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 32' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.3 -18.58 60.98 Favored 'Trans proline' 0 N--CA 1.49 1.309 0 C-N-CA 121.683 1.589 . . . . 0.0 111.477 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.09 -39.9 94.03 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.576 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 93.8 mt -77.16 -164.71 0.48 Allowed 'General case' 0 N--CA 1.475 0.8 0 O-C-N 122.106 -0.371 . . . . 0.0 111.057 -178.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 35' ' ' GLU . . . . . 0.679 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 42.4 tt0 -87.56 129.87 34.95 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.45 ' O ' ' OD1' ' B' ' 36' ' ' ASP . 62.8 t0 57.47 35.42 25.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.751 177.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 37' ' ' ASN . . . . . 0.424 ' C ' ' O ' ' B' ' 36' ' ' ASP . 20.0 t-20 33.04 68.95 0.92 Allowed Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.679 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 89.3 Cg_endo -72.09 155.76 56.54 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 123.745 2.963 . . . . 0.0 111.865 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 95.6 mt -88.21 127.99 40.85 Favored 'Isoleucine or valine' 0 C--O 1.246 0.908 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 27.7 m -107.73 -43.03 6.31 Favored 'Isoleucine or valine' 0 C--N 1.343 0.3 0 O-C-N 123.892 0.745 . . . . 0.0 112.603 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -97.01 123.9 40.85 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.366 -178.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 5.7 p -142.94 140.92 27.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 124.212 0.945 . . . . 0.0 109.293 177.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 43' ' ' ASN . . . . . 0.639 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 57.2 p30 -100.34 161.6 13.5 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.035 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 44' ' ' GLN . . . . . 0.442 ' OE1' ' HA ' ' B' ' 44' ' ' GLN . 13.8 mm100 -63.4 -38.02 89.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.569 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.37 -25.6 63.0 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.654 ' CE2' HD13 ' B' ' 57' ' ' ILE . 62.6 t80 -59.96 -43.86 94.79 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 0.872 HG13 ' O ' ' B' ' 52' ' ' TYR . 63.3 t -61.3 -45.69 98.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.153 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -62.87 -44.19 96.77 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.057 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 59.4 ttm -62.81 -42.83 99.88 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 34.5 p -95.62 -15.89 22.45 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.72 -178.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 51' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' B' ' 47' ' ' VAL . . . 73.46 19.22 79.64 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.336 -1.105 . . . . 0.0 110.336 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 52' ' ' TYR . . . . . 0.872 ' O ' HG13 ' B' ' 47' ' ' VAL . 78.4 m-85 -110.75 145.19 38.53 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 115.27 -0.465 . . . . 0.0 110.1 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -74.18 149.02 41.15 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 121.817 0.818 . . . . 0.0 110.874 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 54' ' ' THR . . . . . 0.412 HG22 ' H ' ' B' ' 54' ' ' THR . 0.1 OUTLIER -61.99 -37.7 85.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.084 -177.398 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.03 -39.09 93.32 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 120.085 -0.646 . . . . 0.0 112.196 -178.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -72.59 -31.51 65.26 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 177.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.654 HD13 ' CE2' ' B' ' 46' ' ' PHE . 92.1 mt -69.91 -61.73 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 97.0 mt -49.49 133.86 19.93 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 123.966 0.791 . . . . 0.0 109.984 -178.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.98 -10.19 72.21 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.712 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -131.48 149.34 52.56 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -176.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 61' ' ' ASN . . . . . 0.577 ' OD1' " C2'" ' B' ' 900' ' ' FMN . 25.2 t-20 -79.62 151.49 30.56 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.619 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 62' ' ' CYS . . . . . . . . . . . . . 83.5 m -63.28 9.9 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.256 -178.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 63' ' ' ARG . . . . . 0.55 ' H ' ' C ' ' B' ' 61' ' ' ASN . 33.5 ptt-85 -60.06 -32.31 70.81 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.585 -177.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -60.5 -30.89 70.0 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 85.6 mt -62.21 -41.86 98.77 Favored 'General case' 0 C--O 1.238 0.462 0 O-C-N 121.601 -0.687 . . . . 0.0 109.758 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -50.12 143.81 7.79 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -177.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 67' ' ' GLY . . . . . 0.49 ' HA3' ' CE1' ' B' ' 95' ' ' TYR . . . -155.08 -152.86 6.3 Favored Glycine 0 C--N 1.353 1.473 0 CA-C-N 115.967 -0.561 . . . . 0.0 112.156 176.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.25 -42.43 95.27 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -175.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 69' ' ' HIS . . . . . 0.534 ' O ' ' NE2' ' B' ' 93' ' ' GLN . 9.5 m80 -74.77 -9.92 59.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.069 -178.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 70' ' ' THR . . . . . 0.437 ' OG1' ' N ' ' B' ' 67' ' ' GLY . 27.4 m -60.64 133.5 56.16 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -90.55 110.92 44.56 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.39 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.64 -38.09 90.97 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 120.978 1.119 . . . . 0.0 111.63 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.16 -40.6 90.43 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -176.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 74' ' ' GLU . . . . . 0.42 ' OE1' ' HB ' ' B' ' 90' ' ' VAL . 79.5 mm-40 -67.0 -38.29 85.73 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.963 177.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 70.2 t -63.42 -44.76 99.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.091 0.472 . . . . 0.0 109.819 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -63.18 -37.3 86.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.7 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -62.44 -42.03 99.16 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 119.276 -0.97 . . . . 0.0 108.955 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 92.6 mt -63.51 -43.72 98.44 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 CA-C-O 120.894 0.378 . . . . 0.0 110.924 -178.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -61.37 -42.54 98.87 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 83.0 m -61.33 -44.93 96.37 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.884 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.99 -42.58 99.3 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -177.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.36 -42.49 99.44 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -62.91 -39.88 95.87 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -81.61 -4.02 54.98 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.803 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 36.7 tttt 50.08 48.52 21.88 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 121.825 -0.547 . . . . 0.0 111.649 177.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -132.93 144.58 53.44 Favored Pre-proline 0 N--CA 1.472 0.673 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.334 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.43 139.62 77.7 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 120.765 0.977 . . . . 0.0 114.045 -177.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -139.98 135.55 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.592 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 89' ' ' THR . . . . . 0.88 HG23 ' OD1' ' B' ' 107' ' ' ASN . 98.9 m -119.9 120.72 37.24 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.42 ' HB ' ' OE1' ' B' ' 74' ' ' GLU . 30.7 m -138.33 161.95 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.594 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -114.42 121.21 42.88 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 175.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 92' ' ' ILE . . . . . 0.403 HD11 HG23 ' B' ' 70' ' ' THR . 20.8 tt -128.43 132.65 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.798 -175.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.534 ' NE2' ' O ' ' B' ' 69' ' ' HIS . 33.9 mt-30 -71.21 141.67 50.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.076 178.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 94' ' ' ASN . . . . . 0.423 ' ND2' ' O ' ' B' ' 93' ' ' GLN . 8.9 m120 -134.92 179.95 5.99 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 121.247 0.546 . . . . 0.0 111.107 -177.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 95' ' ' TYR . . . . . 0.49 ' CE1' ' HA3' ' B' ' 67' ' ' GLY . 95.6 m-85 -130.23 149.68 51.81 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 114.524 -1.216 . . . . 0.0 111.855 177.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 96' ' ' LYS . . . . . 0.48 ' HG3' ' CE1' ' B' ' 102' ' ' PHE . 99.0 mttt -103.41 -177.07 3.26 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.269 0.557 . . . . 0.0 110.716 176.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.4 -35.07 76.48 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.647 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 36.6 p-10 -88.17 -0.33 56.96 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.271 -0.893 . . . . 0.0 113.042 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.38 3.73 66.83 Favored Glycine 0 N--CA 1.465 0.574 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.109 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 25.5 m -67.66 130.49 43.17 Favored 'General case' 0 N--CA 1.443 -0.801 0 O-C-N 122.159 -0.612 . . . . 0.0 109.39 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 101' ' ' MET . . . . . 0.57 ' SD ' ' N ' ' B' ' 102' ' ' PHE . 15.8 tmm? -90.15 142.47 27.69 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 102' ' ' PHE . . . . . 0.57 ' N ' ' SD ' ' B' ' 101' ' ' MET . 53.9 p90 -152.72 163.72 39.15 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 177.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 103' ' ' TRP . . . . . 0.839 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 22.1 m95 -95.65 140.16 30.87 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.342 178.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 104' ' ' ASN . . . . . 0.403 HD21 ' HG2' ' B' ' 123' ' ' GLN . 62.6 t-20 -133.94 106.47 7.28 Favored 'General case' 0 C--O 1.217 -0.631 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -177.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -75.03 123.88 25.97 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 125.193 1.558 . . . . 0.0 109.262 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 38.9 tp -112.81 125.71 54.64 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 123.58 0.55 . . . . 0.0 111.608 -177.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 107' ' ' ASN . . . . . 0.88 ' OD1' HG23 ' B' ' 89' ' ' THR . 98.1 m-20 -118.96 127.7 53.72 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 176.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 96.5 mt -123.12 132.97 70.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -143.33 125.03 8.4 Favored Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -70.19 152.0 66.88 Favored 'Trans proline' 0 N--CA 1.5 1.878 0 C-N-CA 122.254 1.969 . . . . 0.0 112.624 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 111' ' ' MET . . . . . 0.559 ' HB2' ' HB2' ' B' ' 118' ' ' TYR . 67.2 mtt -128.69 142.17 51.1 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -113.67 109.86 19.28 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 113' ' ' ILE . . . . . 0.718 HG12 ' HZ1' ' A' ' 18' ' ' LYS . 96.7 mt -136.11 127.92 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 O-C-N 121.352 -0.842 . . . . 0.0 111.709 178.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 52.49 37.33 22.6 Favored 'General case' 0 C--O 1.236 0.375 0 O-C-N 123.819 0.7 . . . . 0.0 109.63 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 61.71 35.74 16.78 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.519 0.676 . . . . 0.0 110.248 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -132.21 151.36 51.85 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 177.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 5.1 t -101.02 154.21 18.9 Favored 'General case' 0 C--O 1.215 -0.748 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 118' ' ' TYR . . . . . 0.559 ' HB2' ' HB2' ' B' ' 111' ' ' MET . 90.7 m-85 -149.16 145.32 27.11 Favored 'General case' 0 C--N 1.318 -0.791 0 O-C-N 121.09 -1.006 . . . . 0.0 111.152 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -120.02 139.25 52.79 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 120.812 0.339 . . . . 0.0 111.821 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -128.92 137.35 57.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -177.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -113.54 126.21 7.3 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 94.9 mt -114.29 127.92 71.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 123' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' B' ' 26' ' ' GLY . 17.6 mp0 -117.87 123.42 45.83 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -121.56 124.19 43.77 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 125' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' B' ' 127' ' ' THR . 67.5 t0 -74.94 126.06 30.2 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.556 -177.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.561 ' O ' ' HG3' ' B' ' 130' ' ' LYS . 3.5 mp -98.98 18.85 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.424 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 127' ' ' THR . . . . . 0.539 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 98.1 m -64.55 -44.75 89.79 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 114.326 -1.306 . . . . 0.0 112.781 175.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -59.96 -45.19 93.44 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 -177.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 129' ' ' GLN . . . . . 0.449 ' OE1' HG23 ' B' ' 126' ' ' ILE . 88.5 mt-30 -63.6 -35.02 79.14 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.441 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 130' ' ' LYS . . . . . 0.839 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 99.0 mttt -63.27 -42.0 99.09 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-N 113.232 -1.803 . . . . 0.0 110.822 174.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.99 -41.69 97.44 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 132' ' ' TYR . . . . . 0.748 ' CE2' HD11 ' B' ' 136' ' ' LEU . 89.0 t80 -60.43 -45.3 94.13 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.948 -0.47 . . . . 0.0 111.341 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 133' ' ' GLU . . . . . 0.403 ' O ' ' HG3' ' B' ' 137' ' ' GLU . 97.3 mt-10 -64.23 -37.05 86.09 Favored 'General case' 0 C--O 1.218 -0.586 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.438 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 134' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' B' ' 130' ' ' LYS . 99.0 mttt -62.63 -39.71 94.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.89 177.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 53.2 tp -62.68 -41.12 98.92 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 136' ' ' LEU . . . . . 0.748 HD11 ' CE2' ' B' ' 132' ' ' TYR . 87.7 mt -62.83 -41.78 99.46 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 114.858 -1.064 . . . . 0.0 111.566 177.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 137' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' B' ' 133' ' ' GLU . 97.3 mt-10 -64.69 -36.93 85.87 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.484 -178.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -63.28 -44.07 96.15 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.873 177.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 63.2 m -61.04 -44.05 97.98 Favored 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 140' ' ' LEU . . . . . 0.431 ' O ' ' N ' ' B' ' 144' ' ' THR . 85.6 mt -61.98 -40.23 94.91 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -177.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 86.1 m -61.88 -45.52 93.39 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.173 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -65.66 -41.64 92.29 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 93.0 mt -63.8 -43.12 97.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 114.458 -1.247 . . . . 0.0 110.559 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 144' ' ' THR . . . . . 0.431 ' N ' ' O ' ' B' ' 140' ' ' LEU . 89.0 m -61.69 -45.09 95.47 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -178.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 145' ' ' ALA . . . . . 0.413 ' O ' ' HB ' ' B' ' 148' ' ' THR . . . -63.8 -40.92 97.81 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 118.958 -1.097 . . . . 0.0 109.278 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 87.3 mt -64.53 -41.59 96.28 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 147' ' ' SER . . . . . 0.628 ' O ' ' N ' ' B' ' 149' ' ' PRO . 77.9 p -60.89 -42.1 97.34 Favored 'General case' 0 CA--C 1.481 -1.676 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 -178.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 148' ' ' THR . . . . . 0.469 ' C ' ' O ' ' B' ' 147' ' ' SER . 23.2 m -29.42 84.91 0.03 OUTLIER Pre-proline 0 N--CA 1.482 1.169 0 O-C-N 123.959 0.787 . . . . 0.0 110.182 178.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 149' ' ' PRO . . . . . 0.628 ' N ' ' O ' ' B' ' 147' ' ' SER . 22.0 Cg_exo -61.46 148.24 93.46 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.865 1.71 . . . . 0.0 115.849 -176.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 150' ' ' ILE . . . . . 0.405 ' O ' HG23 ' B' ' 150' ' ' ILE . 9.6 tp -125.91 117.43 48.99 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.156 0 CA-C-N 114.273 -1.33 . . . . 0.0 107.805 173.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 40.1 t -146.99 92.94 4.85 Favored Pre-proline 0 C--N 1.314 -0.946 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.592 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -60.81 136.39 65.96 Favored 'Trans proline' 0 C--N 1.316 -1.154 0 CA-C-N 120.321 1.15 . . . . 0.0 109.219 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 153' ' ' ILE . . . . . 0.674 ' O ' ' HD2' ' B' ' 154' ' ' ARG . 44.6 mm -68.4 -44.35 83.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.956 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 154' ' ' ARG . . . . . 0.719 ' HD3' ' NH2' ' A' ' 154' ' ' ARG . 0.4 OUTLIER -156.56 -154.55 0.48 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.464 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 59.3 t-20 -87.02 108.03 18.68 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 121.024 0.44 . . . . 0.0 110.156 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.79 -17.31 58.47 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 -178.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 157' ' ' ILE . . . . . 0.46 HG22 ' HB ' ' B' ' 153' ' ' ILE . 85.3 mt -109.38 124.07 65.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.275 0.56 . . . . 0.0 111.002 -176.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 158' ' ' SER . . . . . 0.542 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 74.5 m -134.74 149.75 50.49 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.738 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 159' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' B' ' 191' ' ' ILE . . . -132.25 147.27 52.4 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 18.0 tp -138.96 77.72 31.12 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 161' ' ' PRO . . . . . 0.429 ' HB3' ' HB3' ' B' ' 193' ' ' ASP . 90.1 Cg_endo -70.79 146.82 54.83 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 122.867 2.378 . . . . 0.0 114.095 -178.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 92.0 mt -113.03 133.85 54.79 Favored 'General case' 0 C--N 1.345 0.37 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 56.1 t -129.29 132.98 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 177.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 114.86 168.47 15.81 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.012 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 165' ' ' ASN . . . . . 0.768 ' O ' ' CZ ' ' B' ' 170' ' ' ARG . 61.4 t30 -90.03 106.65 18.62 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -177.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 166' ' ' LEU . . . . . 0.625 HD21 ' CZ ' ' B' ' 171' ' ' PHE . 42.3 tp -64.3 104.23 0.73 Allowed 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -174.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 167' ' ' THR . . . . . 0.692 HG23 ' NE ' ' B' ' 170' ' ' ARG . 9.6 p -85.73 168.6 14.2 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 113.806 -1.543 . . . . 0.0 111.094 177.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.05 -38.68 91.64 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.607 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -65.85 -41.68 91.38 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 122.402 1.096 . . . . 0.0 111.778 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 170' ' ' ARG . . . . . 0.768 ' CZ ' ' O ' ' B' ' 165' ' ' ASN . 87.8 mtm180 -61.53 -34.72 76.03 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 112.558 -2.11 . . . . 0.0 110.952 178.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 171' ' ' PHE . . . . . 0.625 ' CZ ' HD21 ' B' ' 166' ' ' LEU . 0.5 OUTLIER -54.89 -25.9 32.16 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -178.782 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 172' ' ' ASN . . . . . 0.599 ' O ' HG22 ' B' ' 175' ' ' VAL . 92.4 m-20 -62.74 -40.33 96.88 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.834 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 55.3 m -59.85 -41.41 91.36 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.013 0.435 . . . . 0.0 110.598 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 68.2 mt -63.87 -44.15 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 175' ' ' VAL . . . . . 0.599 HG22 ' O ' ' B' ' 172' ' ' ASN . 35.6 m -62.45 -40.01 86.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 176' ' ' CYS . . . . . 0.415 ' N ' HG23 ' B' ' 175' ' ' VAL . 98.1 m -61.95 -35.3 78.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.329 179.026 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 177' ' ' THR . . . . . 0.563 ' O ' HG13 ' B' ' 181' ' ' ILE . 25.0 m -61.84 -19.67 62.85 Favored 'General case' 0 C--O 1.22 -0.494 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.38 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 178' ' ' LEU . . . . . 0.57 ' CD2' HD21 ' B' ' 211' ' ' LEU . 89.6 mt -60.83 -39.24 88.29 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.238 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 18.9 m -61.74 -44.29 97.21 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.547 177.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 180' ' ' ASN . . . . . 0.592 ' O ' ' OG ' ' B' ' 183' ' ' SER . 92.3 m-20 -61.74 -39.99 93.53 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.161 0.505 . . . . 0.0 110.537 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.563 HG13 ' O ' ' B' ' 177' ' ' THR . 73.0 mt -55.99 -33.48 35.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 O-C-N 122.143 -0.348 . . . . 0.0 110.465 -178.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 182' ' ' LEU . . . . . 0.4 ' HA ' HD23 ' B' ' 182' ' ' LEU . 86.7 mt -62.38 -41.74 98.87 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.163 178.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 183' ' ' SER . . . . . 0.592 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.1 p -63.33 -32.89 74.43 Favored 'General case' 0 C--O 1.225 -0.221 0 O-C-N 121.905 -0.497 . . . . 0.0 110.768 177.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 45.9 p -86.96 17.04 4.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.907 0.384 . . . . 0.0 111.769 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 78.6 p -60.6 -16.51 38.98 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.966 -177.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.64 -40.3 94.41 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 122.075 -0.39 . . . . 0.0 110.811 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 187' ' ' ASP . . . . . 0.542 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.3 m-20 -68.52 114.41 6.9 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.576 0.703 . . . . 0.0 110.793 -178.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.88 -42.23 99.69 Favored 'General case' 0 C--O 1.25 1.109 0 CA-C-N 114.997 -1.001 . . . . 0.0 113.242 -178.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -113.0 131.77 55.63 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 120.711 -0.395 . . . . 0.0 111.386 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 190' ' ' LEU . . . . . . . . . . . . . 40.8 tp -123.97 118.96 28.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.372 177.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 191' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' B' ' 159' ' ' ALA . 85.6 mt -106.38 125.71 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 121.128 -0.229 . . . . 0.0 111.444 -178.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 48.7 mm -115.16 117.01 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 193' ' ' ASP . . . . . 0.527 ' CG ' ' HG ' ' B' ' 195' ' ' SER . 43.0 t0 -89.42 113.09 24.38 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -176.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 194' ' ' LEU . . . . . . . . . . . . . 96.2 mt -95.45 -1.1 51.55 Favored 'General case' 0 C--O 1.239 0.509 0 O-C-N 122.265 -0.272 . . . . 0.0 110.691 177.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 195' ' ' SER . . . . . 0.527 ' HG ' ' CG ' ' B' ' 193' ' ' ASP . 78.1 p -61.17 -36.7 80.54 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.0 -178.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.42 -37.37 94.0 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 197' ' ' LEU . . . . . 0.959 HD23 ' N ' ' B' ' 198' ' ' ALA . 5.2 tt -72.34 133.63 45.07 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -178.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 198' ' ' ALA . . . . . 0.959 ' N ' HD23 ' B' ' 197' ' ' LEU . . . -61.81 -49.19 77.32 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 119.556 -0.858 . . . . 0.0 111.137 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 199' ' ' GLN . . . . . 0.901 ' O ' ' CD2' ' B' ' 197' ' ' LEU . 58.3 tt0 -134.5 164.55 27.22 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-O 121.783 0.802 . . . . 0.0 113.04 -178.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 200' ' ' VAL . . . . . 0.504 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 50.1 t -120.19 130.72 74.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 O-C-N 120.368 -1.458 . . . . 0.0 109.502 176.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -86.15 151.56 23.56 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.658 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -62.64 -33.12 74.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.439 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -63.46 -31.93 73.23 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.6 m -60.92 -43.78 98.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.186 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 205' ' ' ALA . . . . . 0.641 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -58.73 -30.06 67.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 119.26 -0.4 . . . . 0.0 111.848 -178.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -64.61 -39.08 93.08 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 123.79 0.681 . . . . 0.0 110.191 175.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -66.33 -38.69 88.24 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.694 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 96.3 mt -63.14 -43.92 99.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -178.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 209' ' ' PHE . . . . . 0.641 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 64.0 m-85 -61.56 -43.57 98.62 Favored 'General case' 0 C--O 1.242 0.692 0 O-C-N 124.682 1.239 . . . . 0.0 111.856 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -62.9 -41.48 99.45 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.25 -0.98 . . . . 0.0 109.727 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 211' ' ' LEU . . . . . 0.57 HD21 ' CD2' ' B' ' 178' ' ' LEU . 37.8 mt -62.45 -42.43 99.46 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.189 -179.079 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 78.2 p -62.74 -37.58 87.14 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.283 -0.567 . . . . 0.0 112.141 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 213' ' ' HIS . . . . . . . . . . . . . 59.9 t60 -66.31 -47.21 74.27 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.34 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 53.4 tp -63.79 -43.44 96.32 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.616 0.722 . . . . 0.0 109.532 178.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 215' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' B' ' 211' ' ' LEU . 90.7 mt -63.09 -43.18 99.23 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 113.466 -1.697 . . . . 0.0 111.214 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.85 -39.46 94.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.727 -0.215 . . . . 0.0 110.933 -177.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 85.7 mt -63.25 -42.46 99.18 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.203 0.525 . . . . 0.0 111.39 176.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 218' ' ' THR . . . . . . . . . . . . . 71.9 p -75.3 -14.15 60.48 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.683 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 77.79 72.66 1.13 Allowed Glycine 0 CA--C 1.528 0.877 0 N-CA-C 107.141 -2.384 . . . . 0.0 107.141 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 220' ' ' THR . . . . . . . . . . . . . 81.7 m -151.72 100.8 2.72 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 177.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -58.59 140.09 54.88 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 121.849 -0.532 . . . . 0.0 111.103 -177.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 42.0 tp -117.49 120.72 38.97 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.171 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 2.9 mp -109.92 128.91 65.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.166 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 224' ' ' ILE . . . . . 0.555 ' CG2' HD11 ' B' ' 227' ' ' ILE . 50.4 mm -110.68 127.47 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 O-C-N 123.572 0.545 . . . . 0.0 109.532 -179.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 43.7 p -134.42 157.57 46.11 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 90.78 16.17 55.17 Favored Glycine 0 N--CA 1.442 -0.967 0 CA-C-N 113.949 -1.478 . . . . 0.0 111.228 -177.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 227' ' ' ILE . . . . . 0.675 HD12 HG23 ' B' ' 247' ' ' THR . 95.9 mt -81.74 126.63 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 CA-C-N 117.889 0.845 . . . . 0.0 111.686 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 61.2 tttt -67.01 139.28 95.43 Favored Pre-proline 0 C--N 1.316 -0.854 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.521 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.85 -37.04 92.78 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 121.354 1.37 . . . . 0.0 112.483 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -63.08 -43.48 98.4 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 53.1 tp -62.42 -41.98 99.1 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.679 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -62.95 -36.99 85.29 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.892 0.377 . . . . 0.0 111.367 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 94.6 mtp -63.75 -41.15 98.06 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.758 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.3 -43.33 99.07 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 121.995 0.902 . . . . 0.0 109.366 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 30.2 mmt -64.33 -35.85 82.22 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.896 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -61.08 -40.62 94.38 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.987 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.77 -43.05 99.82 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.287 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 52.7 tp -62.68 -44.25 96.73 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 121.883 -0.51 . . . . 0.0 112.27 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 239' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' B' ' 240' ' ' ALA . 66.7 t0 -159.28 133.42 7.62 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 120.149 -0.62 . . . . 0.0 111.982 -178.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 240' ' ' ALA . . . . . 0.4 ' N ' ' OD1' ' B' ' 239' ' ' ASP . . . -60.98 -47.76 84.95 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 241' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' B' ' 244' ' ' SER . 90.2 m-20 -43.23 -19.37 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.475 -175.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 242' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -60.34 -45.03 94.9 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.172 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 243' ' ' SER . . . . . . . . . . . . . 78.1 p -58.77 -42.03 88.01 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 244' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 25.2 m -35.25 -32.53 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -177.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 98.9 mt -90.41 131.54 36.12 Favored 'General case' 0 CA--C 1.513 -0.452 0 O-C-N 121.1 -1.0 . . . . 0.0 110.061 178.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -59.47 134.89 57.42 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 121.421 0.629 . . . . 0.0 110.376 -176.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 247' ' ' THR . . . . . 0.675 HG23 HD12 ' B' ' 227' ' ' ILE . 97.3 m -125.62 127.99 47.19 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.484 -1.235 . . . . 0.0 111.861 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 248' ' ' TYR . . . . . 0.546 ' CG ' ' HB2' ' B' ' 254' ' ' ALA . 98.1 m-85 -113.3 144.15 43.22 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 249' ' ' SER . . . . . 0.563 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 78.6 p -64.57 -33.66 76.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.476 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 250' ' ' ASN . . . . . 0.563 ' OD1' ' O ' ' B' ' 249' ' ' SER . 99.0 m-20 -147.2 160.11 42.85 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.971 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 61.7 t -64.21 -44.69 97.49 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.254 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.293 177.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 252' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.24 -45.4 94.68 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -177.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 253' ' ' ASP . . . . . 0.444 ' O ' HG22 ' B' ' 257' ' ' VAL . 93.5 m-20 -61.51 -44.24 97.42 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.75 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 254' ' ' ALA . . . . . 0.546 ' HB2' ' CG ' ' B' ' 248' ' ' TYR . . . -65.44 -40.65 93.52 Favored 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.893 178.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 255' ' ' VAL . . . . . 0.729 HG13 HH11 ' A' ' 154' ' ' ARG . 74.2 t -64.66 -45.48 95.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.3 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 256' ' ' LYS . . . . . 0.411 ' HE3' ' ND2' ' A' ' 155' ' ' ASN . 88.6 tttt -63.04 -48.46 78.62 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 120.132 -0.627 . . . . 0.0 111.118 -178.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 257' ' ' VAL . . . . . 0.486 ' O ' ' C ' ' B' ' 258' ' ' LEU . 20.1 m -65.55 -40.79 89.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.662 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 258' ' ' LEU . . . . . 0.508 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 1.0 OUTLIER -31.58 -73.67 0.05 OUTLIER Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 119.499 -0.286 . . . . 0.0 111.664 -178.009 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 259' ' ' PRO . . . . . 0.508 ' CD ' ' CB ' ' B' ' 258' ' ' LEU . 36.6 Cg_endo -61.81 139.99 83.17 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 121.531 1.487 . . . . 0.0 111.575 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 260' ' ' ILE . . . . . 0.547 HG22 ' O ' ' B' ' 260' ' ' ILE . 96.6 mt -157.47 -14.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 118.665 0.666 . . . . 0.0 112.054 177.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 78.3 mtm . . . . . 0 C--O 1.214 -0.801 0 CA-C-O 117.761 -1.114 . . . . 0.0 111.573 -179.588 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 900' ' ' FMN . . . . . 0.552 " C2'" ' OD1' ' A' ' 61' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 900' ' ' FMN . . . . . 0.577 " C2'" ' OD1' ' B' ' 61' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.14 171.81 17.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 118.968 -0.539 . . . . 0.0 110.226 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.5 p -71.3 -14.89 62.36 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.332 0.653 . . . . 0.0 110.757 177.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -75.53 -66.3 0.79 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.615 175.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -67.28 -39.3 85.99 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.969 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.533 ' O ' ' HB3' ' A' ' 7' ' ' PHE . 63.1 m -59.44 -42.56 92.19 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.114 -176.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.533 ' HB3' ' O ' ' A' ' 6' ' ' SER . 44.3 t80 85.52 85.69 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 O-C-N 123.707 0.63 . . . . 0.0 112.495 177.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.664 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -62.21 -152.15 0.03 OUTLIER Glycine 0 CA--C 1.529 0.967 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -177.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.664 ' HB ' ' O ' ' A' ' 8' ' ' GLY . 66.9 mt 93.63 108.89 0.02 OUTLIER Pre-proline 0 N--CA 1.472 0.66 0 C-N-CA 122.371 0.269 . . . . 0.0 110.579 -178.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.48 -22.77 71.12 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 121.539 1.493 . . . . 0.0 112.181 -178.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.403 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -63.43 -38.3 96.15 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.112 -0.566 . . . . 0.0 111.726 179.05 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -65.52 -38.7 90.43 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.654 0.74 . . . . 0.0 109.706 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 52.5 tp -62.71 -41.39 99.12 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.412 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -64.25 -39.04 93.14 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 11' ' ' GLY . 55.5 t -60.51 -44.16 95.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 O-C-N 122.186 -0.321 . . . . 0.0 110.434 -178.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 92.4 mt -62.71 -43.64 98.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 C-N-CA 119.756 -0.777 . . . . 0.0 109.3 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.424 ' NZ ' ' HA ' ' B' ' 6' ' ' SER . 98.9 mttt -62.12 -45.37 93.76 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 119.365 -0.934 . . . . 0.0 112.221 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.712 ' HZ1' HG12 ' B' ' 113' ' ' ILE . 98.7 mttt -60.1 -40.21 88.84 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 118.672 -1.211 . . . . 0.0 109.124 -176.021 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.34 -42.68 96.21 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.157 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 20' ' ' LEU . 85.7 mt -62.95 -41.18 99.43 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.118 0.485 . . . . 0.0 109.926 178.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -63.49 -37.99 89.41 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.499 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 57.6 m170 -58.92 -39.8 82.63 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 122.179 -0.326 . . . . 0.0 111.254 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.2 p -113.82 130.44 67.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.498 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 34.6 ptt180 -72.51 110.25 6.76 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.99 0.9 . . . . 0.0 112.08 -177.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.3 p -140.98 143.14 28.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.164 178.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.472 ' O ' ' N ' ' A' ' 123' ' ' GLN . . . -97.91 91.76 1.2 Allowed Glycine 0 C--N 1.312 -0.768 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.76 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.4 t -124.84 130.25 73.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 175.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.4 m -137.17 159.99 36.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.6 mt -119.85 131.14 73.13 Favored 'Isoleucine or valine' 0 C--O 1.247 0.965 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 176.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.516 HG22 HG12 ' A' ' 39' ' ' ILE . 72.6 p -108.04 165.98 11.06 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.415 ' C ' ' OD1' ' A' ' 37' ' ' ASN . 56.1 t0 -130.8 103.29 15.94 Favored Pre-proline 0 C--N 1.319 -0.719 0 C-N-CA 121.087 -0.245 . . . . 0.0 110.538 178.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.436 ' HG3' HG23 ' A' ' 117' ' ' THR . 35.0 Cg_endo -62.69 -23.61 74.63 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 121.365 1.376 . . . . 0.0 111.701 -178.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.78 -36.38 83.68 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.729 -178.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.6 mt -83.74 156.12 22.73 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.641 177.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.754 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 43.0 tt0 -58.1 138.06 56.4 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -176.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.548 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 60.0 t0 59.29 20.47 8.64 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.767 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.415 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 46.5 t-20 40.29 68.58 2.2 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.072 -177.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.754 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 91.2 Cg_endo -70.69 155.31 63.11 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 124.06 3.173 . . . . 0.0 112.649 -178.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.516 HG12 HG22 ' A' ' 30' ' ' THR . 95.8 mt -87.68 123.85 40.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.429 HG23 ' N ' ' A' ' 41' ' ' TYR . 28.0 m -104.21 -43.41 8.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.883 -178.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.429 ' N ' HG23 ' A' ' 40' ' ' VAL . 43.5 t80 -94.84 124.31 38.81 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.552 -177.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.7 p -143.35 141.1 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 O-C-N 124.314 1.009 . . . . 0.0 109.345 177.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.676 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 56.8 p30 -98.45 166.76 11.21 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.512 ' HA ' ' OE1' ' A' ' 44' ' ' GLN . 13.5 mm100 -66.7 -39.04 87.9 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 120.887 0.375 . . . . 0.0 111.868 177.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.17 -25.98 63.04 Favored Glycine 0 C--N 1.332 0.346 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.676 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 62.9 t80 -59.22 -48.42 81.67 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 -178.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.57 HG13 ' O ' ' A' ' 52' ' ' TYR . 53.7 t -58.88 -44.9 91.72 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.542 0 O-C-N 121.274 -0.891 . . . . 0.0 111.074 -173.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -63.26 -37.71 88.31 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.768 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 59.7 ttm -67.17 -44.14 80.48 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 176.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 37.9 p -90.26 -23.2 21.27 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.146 0.498 . . . . 0.0 111.845 -178.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . 77.74 19.34 75.86 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.57 ' O ' HG13 ' A' ' 47' ' ' VAL . 77.4 m-85 -112.71 138.09 50.03 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.1 0.56 . . . . 0.0 111.606 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -63.75 148.2 49.78 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.535 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.421 HG22 ' H ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -65.54 -32.41 73.98 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -179.45 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.02 -43.43 87.66 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.434 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -64.73 -44.23 90.84 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.621 178.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.628 HD13 ' CD2' ' A' ' 46' ' ' PHE . 88.3 mt -61.49 -51.3 74.46 Favored 'Isoleucine or valine' 0 C--N 1.347 0.489 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -174.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 86.0 mt -56.83 146.03 27.62 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 177.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.17 -6.63 74.88 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-O 119.339 -0.7 . . . . 0.0 112.829 176.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -135.0 150.52 50.34 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.832 1.316 . . . . 0.0 111.882 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.559 ' C ' ' H ' ' A' ' 63' ' ' ARG . 24.9 t-20 -80.17 150.75 30.06 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.241 0.543 . . . . 0.0 110.771 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.406 ' HB3' HD12 ' A' ' 65' ' ' LEU . 76.8 m -63.14 15.86 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.502 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.559 ' H ' ' C ' ' A' ' 61' ' ' ASN . 35.8 ptt-85 -61.67 -41.36 97.44 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.262 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -56.41 -20.49 19.89 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -178.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.406 HD12 ' HB3' ' A' ' 62' ' ' CYS . 87.8 mt -68.23 -34.3 75.99 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.546 0.689 . . . . 0.0 112.506 177.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -64.53 137.83 58.07 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.439 -0.8 . . . . 0.0 112.374 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.567 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -146.54 -147.06 4.49 Favored Glycine 0 CA--C 1.544 1.898 0 C-N-CA 120.825 -0.703 . . . . 0.0 111.892 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.01 -40.29 97.32 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -177.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.576 ' O ' ' NE2' ' A' ' 93' ' ' GLN . 11.8 m80 -76.77 -7.85 56.19 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.035 -178.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.567 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 28.9 m -63.56 128.82 37.55 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.379 -0.528 . . . . 0.0 109.807 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -84.91 109.3 19.54 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.708 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 70' ' ' THR . 51.5 Cg_exo -56.83 -32.97 93.56 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.042 1.828 . . . . 0.0 113.11 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.46 -39.54 94.0 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.207 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -64.88 -42.31 94.93 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 77.8 t -60.38 -43.65 94.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 114.242 -1.344 . . . . 0.0 107.679 -175.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -63.47 -37.72 88.4 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.928 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -63.77 -40.08 95.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.253 0.549 . . . . 0.0 110.443 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.75 -44.08 98.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-O 122.156 0.979 . . . . 0.0 111.99 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -63.25 -42.92 99.23 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 113.522 -1.672 . . . . 0.0 108.183 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 96.6 m -61.45 -49.92 74.88 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 120.061 -0.655 . . . . 0.0 109.776 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.66 -42.14 87.75 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-O 119.183 -0.437 . . . . 0.0 111.297 -174.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 84.2 mt -63.12 -39.52 94.93 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 119.386 0.994 . . . . 0.0 111.439 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -65.29 -33.22 75.47 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -88.75 -2.13 58.43 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.543 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.8 tttt 50.08 41.65 23.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.752 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -126.06 144.0 47.41 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 108' ' ' ILE . 24.6 Cg_exo -61.61 143.55 96.86 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 121.303 1.335 . . . . 0.0 113.595 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -139.51 141.62 34.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.721 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.722 HG23 ' OD1' ' A' ' 107' ' ' ASN . 91.2 m -125.47 122.42 36.6 Favored 'General case' 0 C--N 1.342 0.271 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 175.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 29.7 m -138.93 157.97 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.675 176.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -102.41 134.33 45.91 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 176.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.404 ' O ' HG23 ' A' ' 92' ' ' ILE . 18.7 tt -141.89 130.65 22.63 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.181 0 CA-C-N 120.5 1.5 . . . . 0.0 112.977 177.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.576 ' NE2' ' O ' ' A' ' 69' ' ' HIS . 34.7 mt-30 -64.75 132.7 50.32 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.871 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -134.09 156.19 48.7 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.46 -178.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -115.89 134.07 55.37 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.444 ' HG3' ' CE1' ' A' ' 102' ' ' PHE . 99.1 mttt -83.03 -173.66 4.84 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.166 0.508 . . . . 0.0 111.52 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.52 -43.11 99.61 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.65 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 40.8 p-10 -82.65 5.54 20.79 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -178.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.39 -0.3 86.99 Favored Glycine 0 N--CA 1.466 0.641 0 C-N-CA 120.879 -0.676 . . . . 0.0 112.225 176.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 26.7 m -59.18 137.74 57.85 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.657 ' SD ' ' C ' ' A' ' 101' ' ' MET . 13.4 tmm? -102.36 127.89 49.17 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.724 0.297 . . . . 0.0 110.95 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.474 ' N ' ' SD ' ' A' ' 101' ' ' MET . 53.2 p90 -140.88 159.66 41.74 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.236 -0.586 . . . . 0.0 109.762 -177.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.888 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 26.1 m95 -92.55 141.12 28.85 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.116 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.528 HD21 ' HG2' ' A' ' 123' ' ' GLN . 53.9 t-20 -137.0 104.39 5.44 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -176.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 81.2 tt0 -69.25 137.38 53.08 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -177.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 44.1 tp -121.56 123.97 43.25 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.722 ' OD1' HG23 ' A' ' 89' ' ' THR . 98.3 m-20 -119.67 123.38 43.68 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.522 177.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.413 ' O ' ' HA ' ' A' ' 87' ' ' PRO . 96.2 mt -121.02 128.72 76.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 O-C-N 123.345 0.403 . . . . 0.0 111.225 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -140.61 122.96 9.68 Favored Pre-proline 0 CA--C 1.541 0.596 0 CA-C-O 119.912 -0.089 . . . . 0.0 110.785 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -70.71 150.28 62.16 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 122.593 2.195 . . . . 0.0 112.912 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.594 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 66.9 mtt -122.81 153.86 38.99 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 -179.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -125.0 98.8 5.84 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.596 1.089 . . . . 0.0 108.478 176.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.469 ' CD1' HG22 ' B' ' 15' ' ' VAL . 95.7 mt -121.24 131.19 73.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.875 -178.006 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 47.63 39.57 10.15 Favored 'General case' 0 CA--C 1.516 -0.349 0 O-C-N 121.599 -0.688 . . . . 0.0 111.613 177.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 59.31 30.64 20.4 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.906 -178.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -127.81 148.54 50.45 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.754 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 5.1 t -86.01 -172.4 4.06 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 121.506 -0.746 . . . . 0.0 109.68 -178.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.754 ' CD2' ' O ' ' A' ' 117' ' ' THR . 69.7 m-85 -171.03 157.32 5.18 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 174.045 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.463 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 97.2 m-85 -130.27 145.18 51.73 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 173.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -132.95 133.32 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.28 128.22 9.13 Favored Glycine 0 CA--C 1.504 -0.636 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 178.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 96.1 mt -118.09 129.6 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 178.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.528 ' HG2' HD21 ' A' ' 104' ' ' ASN . 16.3 mp0 -119.54 115.84 24.84 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.172 0.511 . . . . 0.0 109.756 179.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -117.72 115.22 24.59 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.13 -177.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 126' ' ' ILE . 68.0 t0 -64.14 129.76 41.26 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -174.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.494 ' O ' HG22 ' A' ' 126' ' ' ILE . 2.6 mp -95.14 2.05 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 113.576 -1.647 . . . . 0.0 110.02 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 20.1 m -60.79 -42.39 97.49 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -178.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -60.35 -42.07 94.95 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -177.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -62.94 -39.25 94.04 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.855 177.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.888 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.6 mttt -62.22 -40.71 97.04 Favored 'General case' 0 CA--C 1.5 -0.979 0 C-N-CA 118.397 -1.321 . . . . 0.0 110.643 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -62.32 -37.4 85.46 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -178.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.661 ' CE2' HD11 ' A' ' 136' ' ' LEU . 89.4 t80 -61.75 -46.33 90.06 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.912 176.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.69 -38.9 92.56 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 130' ' ' LYS . 98.7 mttt -62.04 -40.45 95.77 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 53.1 tp -60.73 -43.53 97.78 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -177.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.661 HD11 ' CE2' ' A' ' 132' ' ' TYR . 86.5 mt -62.66 -41.36 99.02 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.495 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.27 -40.91 98.72 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 119.637 -0.825 . . . . 0.0 109.531 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -60.95 -41.45 96.34 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -177.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.1 m -61.99 -39.96 93.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.896 176.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.523 ' O ' ' N ' ' A' ' 144' ' ' THR . 87.7 mt -63.39 -42.03 98.78 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 99.6 m -61.85 -45.61 93.04 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.975 -177.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -64.54 -41.0 96.62 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 96.1 mt -64.7 -43.46 96.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 113.965 -1.47 . . . . 0.0 111.53 175.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.523 ' N ' ' O ' ' A' ' 140' ' ' LEU . 97.2 m -62.71 -46.07 89.82 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 120.283 -0.567 . . . . 0.0 112.358 -177.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.88 -39.84 95.7 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 118.813 -1.155 . . . . 0.0 109.138 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 87.6 mt -63.76 -42.48 97.8 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.644 178.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.679 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.1 p -60.19 -40.19 89.16 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -177.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.498 ' C ' ' O ' ' A' ' 147' ' ' SER . 93.5 m -26.64 83.57 0.03 OUTLIER Pre-proline 0 C--N 1.343 0.305 0 O-C-N 126.417 2.323 . . . . 0.0 106.814 -178.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.679 ' N ' ' O ' ' A' ' 147' ' ' SER . 22.0 Cg_exo -62.69 145.1 95.0 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 CA-C-O 122.428 0.928 . . . . 0.0 113.949 -175.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.64 ' O ' HG23 ' A' ' 151' ' ' VAL . 9.5 tp -120.25 135.98 58.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 102.378 -3.193 . . . . 0.0 102.378 175.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 150' ' ' ILE . 70.7 t -169.6 95.48 0.51 Allowed Pre-proline 0 N--CA 1.446 -0.64 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 176.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -61.83 135.71 57.51 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 N-CA-C 109.565 -0.975 . . . . 0.0 109.565 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.561 ' O ' ' HD2' ' A' ' 154' ' ' ARG . 46.1 mm -68.0 -44.28 84.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.104 179.068 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.571 ' NH2' ' HD3' ' B' ' 154' ' ' ARG . 0.3 OUTLIER -156.62 -157.65 0.72 Allowed 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 61.8 t-20 -86.94 105.88 17.41 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.871 0.843 . . . . 0.0 111.631 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 89.29 7.65 69.49 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 113.957 -1.474 . . . . 0.0 110.832 -177.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.474 HG12 ' HB2' ' A' ' 189' ' ' TYR . 96.2 mt -124.42 126.19 71.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 174.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.671 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 66.7 m -132.12 152.5 51.21 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 122.494 0.317 . . . . 0.0 110.36 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -137.91 142.02 40.62 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.612 -0.68 . . . . 0.0 111.338 177.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 15.9 tp -133.8 79.38 58.4 Favored Pre-proline 0 N--CA 1.472 0.662 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.525 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -69.65 150.76 69.32 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.782 2.322 . . . . 0.0 113.165 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 84.8 mt -116.63 125.51 51.9 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.61 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 43.2 t -122.16 130.97 74.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 115.74 169.48 15.67 Favored Glycine 0 N--CA 1.484 1.857 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.061 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.864 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 53.9 t30 -86.51 113.23 22.26 Favored 'General case' 0 C--N 1.347 0.47 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.589 HD21 ' CZ ' ' A' ' 171' ' ' PHE . 46.7 tp -71.32 104.39 3.15 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 -177.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.751 HG23 ' NE ' ' A' ' 170' ' ' ARG . 10.4 p -86.46 166.98 15.08 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.414 178.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -66.01 -34.22 77.59 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.023 0.44 . . . . 0.0 111.551 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.55 -41.83 96.09 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.36 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.864 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 87.6 mtm180 -65.41 -33.98 77.22 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.328 1.051 . . . . 0.0 112.192 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.589 ' CZ ' HD21 ' A' ' 166' ' ' LEU . 0.4 OUTLIER -54.45 -27.94 40.85 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 118.946 -0.55 . . . . 0.0 112.239 -178.695 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.633 ' O ' HG22 ' A' ' 175' ' ' VAL . 91.6 m-20 -61.06 -40.37 93.41 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 119.652 1.114 . . . . 0.0 109.702 -178.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 41.4 m -59.77 -40.47 88.33 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.801 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 68.0 mt -63.21 -44.21 99.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.633 HG22 ' O ' ' A' ' 172' ' ' ASN . 27.1 m -62.82 -39.74 86.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' CYS . . . . . 0.426 ' N ' HG23 ' A' ' 175' ' ' VAL . 98.7 m -62.5 -34.6 77.19 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.313 0.578 . . . . 0.0 110.388 178.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.584 ' O ' HG13 ' A' ' 181' ' ' ILE . 24.9 m -62.63 -20.39 64.73 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.285 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.64 ' CD2' HD21 ' A' ' 211' ' ' LEU . 86.3 mt -61.17 -41.32 96.58 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -177.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 18.7 m -60.2 -43.27 96.06 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.62 ' O ' ' OG ' ' A' ' 183' ' ' SER . 93.2 m-20 -62.25 -37.26 84.74 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 122.552 0.341 . . . . 0.0 110.963 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.584 HG13 ' O ' ' A' ' 177' ' ' THR . 69.6 mt -57.9 -37.63 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 O-C-N 121.536 -0.728 . . . . 0.0 109.473 -178.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.495 HD21 HD21 ' A' ' 214' ' ' LEU . 83.1 mt -61.1 -40.7 94.74 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -177.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.62 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 78.2 p -61.05 -33.0 72.61 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.228 176.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.467 ' OG1' ' HA ' ' A' ' 181' ' ' ILE . 22.6 p -89.09 23.18 2.5 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.592 0.234 . . . . 0.0 111.542 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 78.1 p -63.52 -20.84 65.95 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.216 0.531 . . . . 0.0 110.558 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.64 -37.46 81.56 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.802 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.671 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 98.8 m-20 -74.1 113.48 11.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.388 0.613 . . . . 0.0 110.615 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -63.03 -42.17 99.71 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.999 -1.001 . . . . 0.0 112.91 -177.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' TYR . . . . . 0.474 ' HB2' HG12 ' A' ' 157' ' ' ILE . 98.2 m-85 -112.12 131.72 55.28 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.619 -178.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 39.4 tp -119.72 127.59 52.99 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 93.9 mt -114.72 126.63 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 O-C-N 121.637 -0.664 . . . . 0.0 110.027 177.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.8 mm -113.09 127.19 70.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' ASP . . . . . 0.562 ' OD2' ' OG ' ' A' ' 195' ' ' SER . 38.7 t0 -95.79 119.99 35.27 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 121.79 -0.569 . . . . 0.0 110.629 176.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 96.6 mt -97.17 -3.38 41.1 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.156 174.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.562 ' OG ' ' OD2' ' A' ' 193' ' ' ASP . 78.2 p -62.9 -33.26 74.94 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -62.02 -43.12 99.6 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 108.477 -1.849 . . . . 0.0 108.477 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 1.065 ' CD2' ' O ' ' A' ' 199' ' ' GLN . 5.2 tt -70.47 127.87 34.2 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 113.037 -1.582 . . . . 0.0 109.074 -176.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.889 ' N ' HD23 ' A' ' 197' ' ' LEU . . . -61.02 -48.69 80.62 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 119.764 -0.774 . . . . 0.0 110.772 -177.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 1.065 ' O ' ' CD2' ' A' ' 197' ' ' LEU . 58.3 tt0 -132.59 156.52 46.74 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 114.77 -1.105 . . . . 0.0 112.183 -174.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.449 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 45.7 t -118.14 133.25 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -91.25 153.98 19.6 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.571 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.8 -38.06 89.67 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.239 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -59.42 -31.74 69.55 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -178.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 19.1 m -60.91 -42.65 98.51 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.475 177.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.449 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -58.06 -38.24 75.94 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -177.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -61.32 -37.99 85.26 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -65.59 -38.51 89.69 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.961 177.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 94.9 mt -62.94 -43.98 99.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.027 -178.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' PHE . . . . . 0.449 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 71.0 m-85 -62.01 -42.68 99.42 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.635 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -61.96 -41.8 98.41 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.173 -178.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.64 HD21 ' CD2' ' A' ' 178' ' ' LEU . 39.8 mt -61.82 -42.23 98.77 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 78.0 p -61.72 -42.09 98.49 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 119.232 -0.987 . . . . 0.0 109.734 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -64.6 -46.25 83.49 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.723 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.495 HD21 HD21 ' A' ' 182' ' ' LEU . 52.5 tp -62.39 -46.25 89.45 Favored 'General case' 0 C--N 1.344 0.354 0 C-N-CA 119.029 -1.068 . . . . 0.0 108.416 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 85.1 mt -61.72 -40.59 95.59 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.472 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.25 -44.72 95.01 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 85.2 mt -61.65 -39.57 91.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.07 0.462 . . . . 0.0 109.822 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 67.0 p -75.53 -11.58 60.05 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.481 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.88 35.39 18.95 Favored Glycine 0 C--O 1.217 -0.939 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.935 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 95.2 m -121.86 113.83 20.19 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.227 1.514 . . . . 0.0 111.148 -178.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -65.78 137.24 57.11 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.206 177.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 43.5 tp -113.21 130.63 56.16 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 3.3 mp -117.41 133.74 63.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 122.857 0.463 . . . . 0.0 109.883 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.529 ' CG2' HD11 ' A' ' 227' ' ' ILE . 49.5 mm -114.93 132.22 64.81 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 43.9 p -134.08 166.63 22.29 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 120.392 -0.523 . . . . 0.0 112.058 -178.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 78.82 20.32 71.08 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 178.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.701 HD12 HG23 ' A' ' 247' ' ' THR . 97.3 mt -81.56 128.61 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 CA-C-N 114.042 -1.079 . . . . 0.0 108.818 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 63.5 tttt -76.04 140.26 69.92 Favored Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.06 -38.92 87.3 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.187 1.258 . . . . 0.0 112.324 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -64.7 -39.39 93.57 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-O 121.619 0.723 . . . . 0.0 110.083 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 48.7 tp -63.55 -42.6 98.38 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.987 -1.006 . . . . 0.0 113.104 176.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.86 -38.05 89.65 Favored 'General case' 0 CA--C 1.521 -0.141 0 O-C-N 121.916 -0.49 . . . . 0.0 111.101 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 94.1 mtp -63.84 -41.48 97.82 Favored 'General case' 0 C--O 1.251 1.135 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.561 -178.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -64.15 -40.02 95.25 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.484 177.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 33.4 mmt -65.68 -38.35 89.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.625 177.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -61.61 -41.55 97.62 Favored 'General case' 0 CA--C 1.516 -0.35 0 O-C-N 121.406 -0.808 . . . . 0.0 109.188 -177.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.43 -41.24 93.61 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.458 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 55.9 tp -63.76 -41.84 97.93 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.229 0.825 . . . . 0.0 113.229 177.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -165.51 126.24 1.88 Allowed 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.604 -0.685 . . . . 0.0 112.684 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -60.05 -26.57 66.23 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.951 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -61.78 -29.97 70.49 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.192 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -55.82 -44.73 78.16 Favored 'General case' 0 C--N 1.312 -1.023 0 O-C-N 121.484 -0.76 . . . . 0.0 109.352 -176.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 95.5 p -62.31 -20.07 63.95 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.23 178.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 19.1 m -55.22 -38.18 68.1 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.511 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 97.2 mt -86.3 123.84 31.99 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -178.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -48.37 135.21 14.11 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 114.7 -1.137 . . . . 0.0 109.707 -176.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.701 HG23 HD12 ' A' ' 227' ' ' ILE . 98.0 m -127.87 132.29 49.37 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 114.528 -1.215 . . . . 0.0 111.333 178.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 248' ' ' TYR . . . . . 0.456 ' CB ' ' HB2' ' A' ' 254' ' ' ALA . 97.6 m-85 -116.33 139.64 50.18 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.093 178.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 78.1 p -59.67 -43.07 94.14 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 119.152 -1.019 . . . . 0.0 108.304 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -142.68 159.63 41.86 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.726 0.774 . . . . 0.0 111.312 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 75.4 t -62.61 -45.0 99.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 114.607 -1.179 . . . . 0.0 111.796 -179.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.92 -43.98 97.85 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.247 -0.581 . . . . 0.0 109.519 -178.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' ASP . . . . . 0.461 ' O ' HG22 ' A' ' 257' ' ' VAL . 54.6 m-20 -63.59 -41.95 98.3 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.973 -178.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.456 ' HB2' ' CB ' ' A' ' 248' ' ' TYR . . . -64.9 -41.7 95.38 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.037 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 255' ' ' VAL . . . . . 0.448 HG13 HH11 ' B' ' 154' ' ' ARG . 77.0 t -64.02 -45.56 96.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 114.021 -1.445 . . . . 0.0 110.925 -177.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.99 -47.15 81.49 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.763 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.515 ' O ' ' C ' ' A' ' 258' ' ' LEU . 28.6 m -66.34 -40.6 87.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 120.058 -0.657 . . . . 0.0 112.429 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.515 ' C ' ' O ' ' A' ' 257' ' ' VAL . 1.4 mt -28.36 -75.44 0.04 OUTLIER Pre-proline 0 C--N 1.344 0.355 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.318 -177.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 259' ' ' PRO . . . . . 0.507 ' CD ' ' CB ' ' A' ' 258' ' ' LEU . 42.0 Cg_endo -63.46 139.7 72.12 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 CA-C-N 119.561 0.879 . . . . 0.0 111.761 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 259' ' ' PRO . 96.7 mt -151.38 -26.57 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.694 177.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 78.1 mtm . . . . . 0 N--CA 1.472 0.663 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.562 -177.013 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.459 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.1 163.71 38.67 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 80.4 p -59.85 -20.82 59.32 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 123.37 0.419 . . . . 0.0 111.27 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -74.2 -63.63 1.19 Allowed 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.091 0.472 . . . . 0.0 111.303 -178.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -67.03 -38.85 86.63 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.877 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.545 ' O ' ' HB3' ' B' ' 7' ' ' PHE . 65.7 m -60.05 -43.14 95.58 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 119.979 -0.688 . . . . 0.0 109.928 -176.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 7' ' ' PHE . . . . . 0.545 ' HB3' ' O ' ' B' ' 6' ' ' SER . 46.2 t80 86.39 88.91 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 O-C-N 123.751 0.657 . . . . 0.0 110.745 177.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 8' ' ' GLY . . . . . 0.692 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -64.23 -151.73 0.07 OUTLIER Glycine 0 CA--C 1.53 0.99 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.692 ' HB ' ' O ' ' B' ' 8' ' ' GLY . 67.3 mt 92.98 108.81 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 122.387 0.275 . . . . 0.0 110.87 -178.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -62.53 -24.94 75.47 Favored 'Trans proline' 0 N--CA 1.5 1.855 0 C-N-CA 121.375 1.383 . . . . 0.0 111.847 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.7 -40.5 98.13 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 110.689 -0.965 . . . . 0.0 110.689 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -64.89 -38.62 91.57 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.726 0.774 . . . . 0.0 109.506 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 52.4 tp -61.75 -42.53 99.09 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.848 -178.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -65.68 -32.81 74.58 Favored 'General case' 0 CA--C 1.562 1.442 0 CA-C-O 121.344 0.593 . . . . 0.0 110.534 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' VAL . . . . . 0.469 HG22 ' CD1' ' A' ' 113' ' ' ILE . 63.2 t -61.57 -46.28 96.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 113.097 -1.865 . . . . 0.0 110.664 177.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 92.9 mt -63.65 -43.91 98.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.259 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 17' ' ' LYS . . . . . 0.489 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 98.9 mttt -63.36 -41.61 98.84 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.98 -41.37 99.53 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 119.069 -1.053 . . . . 0.0 110.312 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.96 -38.8 89.91 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.656 -178.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.417 ' O ' ' O ' ' B' ' 23' ' ' VAL . 85.5 mt -64.31 -41.97 96.58 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.286 0.565 . . . . 0.0 110.295 175.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -63.15 -38.34 90.79 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.34 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 56.9 m170 -58.47 -39.64 80.49 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 121.236 -0.185 . . . . 0.0 111.087 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.417 ' O ' ' O ' ' B' ' 20' ' ' LEU . 10.0 p -113.96 130.54 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.504 ' HG3' ' O ' ' B' ' 24' ' ' ARG . 34.7 ptt180 -71.79 108.42 5.09 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 121.865 0.84 . . . . 0.0 112.446 -177.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 7.1 p -143.14 134.33 23.31 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.501 177.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' GLY . . . . . 0.508 ' O ' ' N ' ' B' ' 123' ' ' GLN . . . -89.59 95.76 2.13 Favored Glycine 0 N--CA 1.436 -1.332 0 C-N-CA 119.093 -1.527 . . . . 0.0 112.748 -175.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 45.9 t -124.86 129.42 73.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 174.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 27.2 m -138.6 157.25 30.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.722 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 95.9 mt -118.84 129.82 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-O 122.377 1.084 . . . . 0.0 111.167 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.508 HG22 HG12 ' B' ' 39' ' ' ILE . 44.7 p -112.0 152.81 27.69 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 112.474 -2.148 . . . . 0.0 108.475 -175.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -121.87 103.6 39.9 Favored Pre-proline 0 C--O 1.239 0.506 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -177.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 32' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.78 -22.61 69.4 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 121.907 1.738 . . . . 0.0 111.519 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.6 -42.86 99.46 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 96.0 mt -75.41 171.08 14.87 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.507 -0.745 . . . . 0.0 111.121 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 35' ' ' GLU . . . . . 0.627 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 42.3 tt0 -69.85 133.56 47.51 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -176.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.522 ' O ' ' OD1' ' B' ' 36' ' ' ASP . 66.1 t0 56.59 35.51 26.18 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.701 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 37' ' ' ASN . . . . . 0.454 ' C ' ' O ' ' B' ' 36' ' ' ASP . 40.3 t-20 28.75 71.24 0.49 Allowed Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.627 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 91.8 Cg_endo -71.85 154.76 58.56 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 123.736 2.957 . . . . 0.0 112.191 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.508 HG12 HG22 ' B' ' 30' ' ' THR . 95.6 mt -86.85 129.17 38.88 Favored 'Isoleucine or valine' 0 C--O 1.245 0.86 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.419 HG23 ' N ' ' B' ' 41' ' ' TYR . 29.8 m -109.04 -42.89 5.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 O-C-N 123.65 0.594 . . . . 0.0 112.373 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 41' ' ' TYR . . . . . 0.419 ' N ' HG23 ' B' ' 40' ' ' VAL . 46.2 t80 -95.61 124.76 39.78 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 119.85 -0.74 . . . . 0.0 111.183 -178.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 5.8 p -143.55 141.86 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 O-C-N 124.102 0.876 . . . . 0.0 109.545 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 43' ' ' ASN . . . . . 0.698 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 56.0 p30 -102.12 162.07 13.2 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.226 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 44' ' ' GLN . . . . . 0.505 ' OE1' ' HA ' ' B' ' 44' ' ' GLN . 12.9 mm100 -63.1 -37.89 88.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.303 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.48 -26.48 64.44 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.698 ' HB2' ' OD1' ' B' ' 43' ' ' ASN . 59.5 t80 -60.46 -43.3 97.02 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 0.688 HG13 ' O ' ' B' ' 52' ' ' TYR . 58.5 t -61.16 -46.33 96.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.032 -178.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -62.92 -44.23 96.64 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.341 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 59.7 ttm -63.22 -42.68 99.29 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 39.5 p -94.11 -17.29 22.95 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.934 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 51' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' B' ' 47' ' ' VAL . . . 73.67 17.74 79.26 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 178.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 52' ' ' TYR . . . . . 0.688 ' O ' HG13 ' B' ' 47' ' ' VAL . 77.3 m-85 -110.39 142.89 41.46 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.231 0.612 . . . . 0.0 110.565 178.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -71.91 147.67 46.82 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.388 0.613 . . . . 0.0 111.289 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 54' ' ' THR . . . . . 0.465 ' H ' HG22 ' B' ' 54' ' ' THR . 0.2 OUTLIER -62.62 -36.55 83.14 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.523 -176.702 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.2 -39.88 95.91 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.344 -178.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -72.72 -32.67 65.89 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 176.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.626 HD13 ' CD2' ' B' ' 46' ' ' PHE . 92.5 mt -64.96 -74.94 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 176.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 94.9 mt -36.42 132.82 0.56 Allowed 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.766 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.28 -13.56 66.59 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-N 115.874 -0.603 . . . . 0.0 113.252 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -132.72 149.07 52.33 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 117.572 0.686 . . . . 0.0 112.315 -173.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 61' ' ' ASN . . . . . 0.555 ' C ' ' H ' ' B' ' 63' ' ' ARG . 24.3 t-20 -78.6 149.73 32.89 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.437 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 62' ' ' CYS . . . . . 0.425 ' HB3' HD12 ' B' ' 65' ' ' LEU . 86.2 m -63.11 9.57 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.327 -178.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 63' ' ' ARG . . . . . 0.555 ' H ' ' C ' ' B' ' 61' ' ' ASN . 34.5 ptt-85 -59.41 -33.16 70.89 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.449 -177.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -59.73 -28.79 67.65 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 65' ' ' LEU . . . . . 0.425 HD12 ' HB3' ' B' ' 62' ' ' CYS . 83.4 mt -61.69 -41.98 98.32 Favored 'General case' 0 C--N 1.32 -0.7 0 O-C-N 121.938 -0.477 . . . . 0.0 109.751 -178.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -53.23 145.99 12.7 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.624 -176.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 67' ' ' GLY . . . . . 0.563 ' N ' ' OG1' ' B' ' 70' ' ' THR . . . -155.69 -153.22 6.48 Favored Glycine 0 CA--C 1.538 1.5 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.983 177.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.38 -41.47 89.45 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -176.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 69' ' ' HIS . . . . . 0.486 ' O ' ' NE2' ' B' ' 93' ' ' GLN . 10.9 m80 -75.44 -10.0 59.06 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 123.188 0.305 . . . . 0.0 111.171 -178.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 70' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' B' ' 67' ' ' GLY . 27.0 m -61.63 133.36 55.53 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 121.875 -0.516 . . . . 0.0 109.812 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -89.17 109.87 34.18 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.335 -178.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.16 -38.67 87.8 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 121.046 1.164 . . . . 0.0 111.811 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.13 -39.38 92.39 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 120.424 -0.511 . . . . 0.0 109.871 -175.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -66.57 -38.01 86.16 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.998 177.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 93.5 t -61.73 -45.53 98.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -63.03 -37.3 86.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.697 -178.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -62.75 -41.84 99.4 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 119.254 -0.978 . . . . 0.0 108.707 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.4 -43.73 98.62 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-O 120.781 0.324 . . . . 0.0 110.623 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -62.53 -42.47 99.55 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 99.5 m -61.45 -45.67 93.32 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.224 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.05 -40.82 97.05 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -177.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 81.4 mt -62.72 -42.34 99.61 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 67.1 tp60 -63.48 -34.6 78.12 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -91.96 8.12 38.98 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.413 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 31.0 tttt 42.81 43.03 3.26 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.356 175.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -127.33 141.51 41.06 Favored Pre-proline 0 N--CA 1.469 0.508 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.556 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -62.09 141.01 87.13 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 120.806 1.004 . . . . 0.0 114.077 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.92 137.13 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 89' ' ' THR . . . . . 0.702 HG23 ' OD1' ' B' ' 107' ' ' ASN . 98.7 m -121.11 123.59 42.69 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.897 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 30.2 m -138.41 161.72 30.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.105 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -113.75 120.66 41.56 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 120.41 -0.516 . . . . 0.0 109.645 174.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 92' ' ' ILE . . . . . 0.454 HD11 HG23 ' B' ' 70' ' ' THR . 20.8 tt -127.79 132.21 69.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.317 -174.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.486 ' NE2' ' O ' ' B' ' 69' ' ' HIS . 35.5 mt-30 -70.35 140.39 52.17 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.261 177.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 94' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -131.25 177.61 7.34 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 121.516 0.674 . . . . 0.0 110.911 -178.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 95' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -128.83 143.66 50.97 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 114.447 -1.251 . . . . 0.0 111.954 177.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 96' ' ' LYS . . . . . 0.435 ' HG3' ' CE1' ' B' ' 102' ' ' PHE . 98.6 mttt -100.09 179.25 4.55 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.283 0.563 . . . . 0.0 110.553 178.12 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.93 -36.64 79.86 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.843 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 38.5 p-10 -84.79 -1.74 56.75 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 121.426 -0.796 . . . . 0.0 112.912 177.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.06 5.59 65.81 Favored Glycine 0 N--CA 1.467 0.726 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.685 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 29.1 m -68.06 129.95 41.48 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 101' ' ' MET . . . . . 0.551 ' SD ' ' N ' ' B' ' 102' ' ' PHE . 15.3 tmm? -87.56 140.48 29.48 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 102' ' ' PHE . . . . . 0.551 ' N ' ' SD ' ' B' ' 101' ' ' MET . 53.7 p90 -151.72 163.01 40.07 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 103' ' ' TRP . . . . . 0.901 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 26.3 m95 -96.35 138.51 33.83 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.589 0.709 . . . . 0.0 110.72 178.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 104' ' ' ASN . . . . . 0.501 HD21 ' HG2' ' B' ' 123' ' ' GLN . 62.8 t-20 -133.55 109.6 9.35 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 114.669 -1.15 . . . . 0.0 113.467 -176.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 105' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' B' ' 123' ' ' GLN . 81.6 tt0 -79.16 125.56 29.59 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.768 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 40.0 tp -112.62 125.37 54.21 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -176.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 107' ' ' ASN . . . . . 0.702 ' OD1' HG23 ' B' ' 89' ' ' THR . 98.2 m-20 -118.57 128.59 54.71 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 176.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 96.5 mt -123.75 132.68 70.96 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.467 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -145.93 121.9 5.76 Favored Pre-proline 0 CA--C 1.542 0.665 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -69.23 152.14 72.04 Favored 'Trans proline' 0 N--CA 1.504 2.093 0 C-N-CA 122.893 2.395 . . . . 0.0 112.942 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 111' ' ' MET . . . . . 0.483 ' HB2' ' HB2' ' B' ' 118' ' ' TYR . 67.0 mtt -129.99 143.26 50.7 Favored 'General case' 0 C--O 1.245 0.831 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 179.093 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -110.3 109.47 19.92 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 113' ' ' ILE . . . . . 0.712 HG12 ' HZ1' ' A' ' 18' ' ' LYS . 96.3 mt -132.46 128.01 57.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 177.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 50.61 38.53 19.13 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.999 178.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 61.46 37.07 16.88 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.51 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -134.21 151.26 51.22 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 177.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 6.9 t -102.47 154.41 19.12 Favored 'General case' 0 C--O 1.214 -0.785 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -177.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 118' ' ' TYR . . . . . 0.483 ' HB2' ' HB2' ' B' ' 111' ' ' MET . 96.7 m-85 -148.76 147.85 29.3 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 120.828 -1.17 . . . . 0.0 111.445 -178.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 119' ' ' PHE . . . . . 0.453 ' HB2' ' OG1' ' B' ' 30' ' ' THR . 96.3 m-85 -123.2 137.42 54.89 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 123.318 0.387 . . . . 0.0 110.758 -177.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -127.26 132.02 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -177.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 121' ' ' GLY . . . . . 0.404 ' N ' HM73 ' B' ' 900' ' ' FMN . . . -107.39 124.09 7.48 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 122' ' ' ILE . . . . . 0.429 ' HB ' ' HB2' ' B' ' 107' ' ' ASN . 94.4 mt -114.94 127.6 72.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -178.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 123' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' B' ' 26' ' ' GLY . 16.1 mp0 -118.67 120.47 37.53 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -119.91 120.93 37.84 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 125' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' B' ' 127' ' ' THR . 68.0 t0 -67.31 134.79 52.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.331 -0.849 . . . . 0.0 112.704 -177.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.461 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 2.6 mp -108.4 14.48 8.21 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.856 0 CA-C-O 122.054 0.93 . . . . 0.0 108.858 178.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 127' ' ' THR . . . . . 0.49 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 98.5 m -62.72 -44.15 96.97 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 113.754 -1.566 . . . . 0.0 112.47 176.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -61.7 -45.66 93.01 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -177.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 129' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -62.84 -34.65 77.78 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.316 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 130' ' ' LYS . . . . . 0.901 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 98.7 mttt -63.06 -41.58 99.5 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-N 113.47 -1.696 . . . . 0.0 111.022 174.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.69 -42.31 98.01 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 132' ' ' TYR . . . . . 0.672 ' CE2' HD11 ' B' ' 136' ' ' LEU . 89.3 t80 -60.12 -45.44 93.0 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 121.733 -0.604 . . . . 0.0 111.494 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.87 -36.6 84.86 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 120.233 -0.587 . . . . 0.0 109.601 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 134' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' B' ' 130' ' ' LYS . 98.8 mttt -62.86 -39.15 93.52 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.66 177.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 54.7 tp -62.9 -41.58 99.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.163 0.506 . . . . 0.0 109.819 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 136' ' ' LEU . . . . . 0.672 HD11 ' CE2' ' B' ' 132' ' ' TYR . 90.3 mt -62.67 -42.11 99.44 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.253 177.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 137' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.39 -36.97 85.57 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.116 -1.402 . . . . 0.0 110.299 -178.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -63.11 -43.21 99.1 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.173 175.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 62.1 m -60.8 -43.93 97.49 Favored 'General case' 0 C--N 1.344 0.354 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 140' ' ' LEU . . . . . 0.516 ' O ' ' N ' ' B' ' 144' ' ' THR . 88.1 mt -61.1 -40.42 93.68 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -176.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 98.6 m -61.88 -45.25 94.57 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.84 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -65.49 -42.78 91.78 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.96 -43.66 97.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.695 178.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 144' ' ' THR . . . . . 0.516 ' N ' ' O ' ' B' ' 140' ' ' LEU . 99.4 m -61.35 -45.69 93.34 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -177.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 145' ' ' ALA . . . . . 0.408 ' O ' ' HB ' ' B' ' 148' ' ' THR . . . -63.81 -40.81 97.51 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 119.041 -1.064 . . . . 0.0 109.581 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 90.0 mt -64.55 -40.64 95.95 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 177.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 147' ' ' SER . . . . . 0.587 ' O ' ' N ' ' B' ' 149' ' ' PRO . 77.4 p -61.36 -43.31 99.09 Favored 'General case' 0 CA--C 1.477 -1.831 0 C-N-CA 119.074 -1.05 . . . . 0.0 108.23 -178.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 148' ' ' THR . . . . . 0.511 ' C ' ' O ' ' B' ' 147' ' ' SER . 43.0 m -24.48 85.66 0.04 OUTLIER Pre-proline 0 N--CA 1.478 0.929 0 O-C-N 124.051 0.844 . . . . 0.0 110.364 176.179 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 149' ' ' PRO . . . . . 0.587 ' N ' ' O ' ' B' ' 147' ' ' SER . 24.2 Cg_exo -61.67 147.53 95.12 Favored 'Trans proline' 0 C--N 1.299 -2.04 0 C-N-CA 120.898 1.065 . . . . 0.0 113.197 -177.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 8.8 tp -126.7 124.18 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 172.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 43.0 t -155.13 95.13 2.58 Favored Pre-proline 0 C--N 1.314 -0.963 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.103 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -60.46 136.48 67.89 Favored 'Trans proline' 0 N--CA 1.484 0.931 0 N-CA-C 109.438 -1.024 . . . . 0.0 109.438 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 153' ' ' ILE . . . . . 0.547 ' O ' ' HD2' ' B' ' 154' ' ' ARG . 45.6 mm -69.22 -43.44 81.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.09 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 154' ' ' ARG . . . . . 0.571 ' HD3' ' NH2' ' A' ' 154' ' ' ARG . 0.2 OUTLIER -155.9 -156.01 0.6 Allowed 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.923 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -86.62 110.58 19.93 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 97.54 -15.89 61.36 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 157' ' ' ILE . . . . . 0.442 HG12 ' HB2' ' B' ' 189' ' ' TYR . 87.9 mt -111.35 126.15 68.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 120.651 0.262 . . . . 0.0 110.666 -176.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 158' ' ' SER . . . . . 0.659 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 71.4 m -134.22 150.45 51.05 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.13 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -133.6 147.2 51.48 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.203 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 17.1 tp -140.65 78.31 21.3 Favored Pre-proline 0 CA--C 1.532 0.254 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 161' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -70.7 148.69 59.5 Favored 'Trans proline' 0 N--CA 1.499 1.848 0 C-N-CA 122.791 2.327 . . . . 0.0 114.302 -178.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 86.0 mt -112.24 134.97 53.47 Favored 'General case' 0 C--N 1.343 0.326 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 55.7 t -129.19 131.71 67.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 112.79 169.6 17.67 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 120.436 -0.888 . . . . 0.0 111.149 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 165' ' ' ASN . . . . . 0.737 ' O ' ' CZ ' ' B' ' 170' ' ' ARG . 60.2 t30 -91.25 107.36 19.15 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -177.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 166' ' ' LEU . . . . . 0.588 HD21 ' CZ ' ' B' ' 171' ' ' PHE . 47.7 tp -64.79 104.5 0.84 Allowed 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -173.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 167' ' ' THR . . . . . 0.696 HG23 ' NE ' ' B' ' 170' ' ' ARG . 10.5 p -84.0 169.79 14.62 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 114.117 -1.401 . . . . 0.0 110.925 176.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.57 -37.61 85.31 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.769 177.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.41 -40.08 89.36 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 123.176 1.465 . . . . 0.0 111.539 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 170' ' ' ARG . . . . . 0.737 ' CZ ' ' O ' ' B' ' 165' ' ' ASN . 88.0 mtm180 -62.19 -37.63 86.0 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 112.084 -2.325 . . . . 0.0 111.152 178.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 171' ' ' PHE . . . . . 0.588 ' CZ ' HD21 ' B' ' 166' ' ' LEU . 0.4 OUTLIER -53.81 -25.37 19.03 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -179.249 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 172' ' ' ASN . . . . . 0.588 ' O ' HG22 ' B' ' 175' ' ' VAL . 92.1 m-20 -62.57 -40.37 96.64 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.024 -0.671 . . . . 0.0 110.773 178.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 36.4 m -60.57 -41.13 93.97 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.974 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 67.5 mt -63.69 -44.09 98.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 175' ' ' VAL . . . . . 0.588 HG22 ' O ' ' B' ' 172' ' ' ASN . 28.8 m -62.96 -39.84 86.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 176' ' ' CYS . . . . . 0.429 ' N ' HG23 ' B' ' 175' ' ' VAL . 98.8 m -62.31 -35.54 79.38 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.494 178.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 177' ' ' THR . . . . . 0.607 ' O ' HG13 ' B' ' 181' ' ' ILE . 24.9 m -61.67 -20.81 63.83 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.502 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 178' ' ' LEU . . . . . 0.604 ' CD2' HD21 ' B' ' 211' ' ' LEU . 88.2 mt -61.29 -39.91 92.2 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.241 -177.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 19.0 m -61.07 -44.69 96.99 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.523 176.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 180' ' ' ASN . . . . . 0.582 ' O ' ' OG ' ' B' ' 183' ' ' SER . 92.7 m-20 -61.94 -40.65 96.27 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.846 0.355 . . . . 0.0 110.585 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.607 HG13 ' O ' ' B' ' 177' ' ' THR . 73.9 mt -56.31 -31.78 33.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 O-C-N 122.262 -0.274 . . . . 0.0 111.022 -177.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 182' ' ' LEU . . . . . 0.465 HD21 HD21 ' B' ' 214' ' ' LEU . 82.4 mt -62.29 -41.86 98.86 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.333 177.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 183' ' ' SER . . . . . 0.582 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.2 p -62.45 -32.48 73.36 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 121.756 -0.59 . . . . 0.0 110.891 177.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 184' ' ' THR . . . . . 0.422 ' OG1' ' HA ' ' B' ' 181' ' ' ILE . 22.6 p -85.39 16.89 3.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.745 -178.106 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 78.5 p -61.29 -16.86 49.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.466 -176.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.0 -40.51 95.88 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 121.051 -0.259 . . . . 0.0 110.468 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 187' ' ' ASP . . . . . 0.659 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.6 m-20 -71.07 113.78 8.45 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.294 0.568 . . . . 0.0 110.378 -177.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -62.94 -42.27 99.75 Favored 'General case' 0 C--O 1.247 0.936 0 CA-C-N 114.904 -1.044 . . . . 0.0 113.149 -177.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 189' ' ' TYR . . . . . 0.442 ' HB2' HG12 ' B' ' 157' ' ' ILE . 98.2 m-85 -111.58 131.57 55.16 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.956 -178.096 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 190' ' ' LEU . . . . . . . . . . . . . 44.3 tp -123.61 119.03 28.66 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.176 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 84.6 mt -107.09 125.11 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-N 117.8 0.273 . . . . 0.0 111.303 -176.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 49.0 mm -115.63 118.4 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 193' ' ' ASP . . . . . 0.561 ' OD2' ' OG ' ' B' ' 195' ' ' SER . 40.6 t0 -91.19 113.29 25.52 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -176.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 194' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' B' ' 194' ' ' LEU . 96.3 mt -92.34 -2.23 56.52 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 123.325 0.391 . . . . 0.0 110.223 176.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 195' ' ' SER . . . . . 0.561 ' OG ' ' OD2' ' B' ' 193' ' ' ASP . 78.3 p -61.7 -37.69 85.09 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.704 -178.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.6 -34.37 88.24 Favored Glycine 0 N--CA 1.435 -1.375 0 C-N-CA 119.416 -1.373 . . . . 0.0 109.731 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 197' ' ' LEU . . . . . 1.093 ' CD2' ' O ' ' B' ' 199' ' ' GLN . 5.6 tt -76.78 132.97 39.53 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -177.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 198' ' ' ALA . . . . . 0.935 ' N ' HD23 ' B' ' 197' ' ' LEU . . . -64.48 -42.03 96.13 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 119.773 -0.771 . . . . 0.0 111.947 -178.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 199' ' ' GLN . . . . . 1.093 ' O ' ' CD2' ' B' ' 197' ' ' LEU . 59.0 tt0 -137.57 165.41 26.39 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.215 0.531 . . . . 0.0 111.425 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 200' ' ' VAL . . . . . 0.496 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 49.4 t -122.65 132.53 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -93.72 148.83 21.75 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.768 -177.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -60.99 -32.92 72.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.289 -178.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -63.91 -32.59 74.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.367 0.603 . . . . 0.0 109.482 177.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.3 m -60.71 -44.19 96.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.268 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 205' ' ' ALA . . . . . 0.617 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -59.45 -29.33 67.71 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 111.755 0.279 . . . . 0.0 111.755 -177.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -64.95 -38.98 92.76 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.878 175.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -66.86 -37.8 85.15 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.885 178.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.41 -43.17 98.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-O 122.009 0.909 . . . . 0.0 110.101 -178.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 209' ' ' PHE . . . . . 0.617 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 68.3 m-85 -62.28 -42.59 99.47 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 113.92 -1.491 . . . . 0.0 112.686 177.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.26 -41.58 99.06 Favored 'General case' 0 C--O 1.232 0.135 0 O-C-N 121.402 -0.811 . . . . 0.0 109.901 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 211' ' ' LEU . . . . . 0.604 HD21 ' CD2' ' B' ' 178' ' ' LEU . 38.8 mt -62.29 -42.21 99.16 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.317 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 78.0 p -63.84 -36.51 84.16 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.53 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 213' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -67.01 -47.29 71.91 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.176 178.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.465 HD21 HD21 ' B' ' 182' ' ' LEU . 54.2 tp -64.07 -42.6 96.93 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 121.956 0.884 . . . . 0.0 110.546 177.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 85.7 mt -62.83 -43.45 98.76 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 113.343 -1.753 . . . . 0.0 111.555 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.44 -40.04 93.0 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 -176.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 86.3 mt -63.39 -42.03 98.79 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 121.371 0.605 . . . . 0.0 111.374 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 218' ' ' THR . . . . . . . . . . . . . 69.9 p -73.88 -16.63 61.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.176 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 79.55 66.13 1.71 Allowed Glycine 0 CA--C 1.528 0.892 0 N-CA-C 106.831 -2.508 . . . . 0.0 106.831 -178.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 220' ' ' THR . . . . . . . . . . . . . 96.4 m -145.15 104.07 3.92 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 176.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -62.29 139.21 58.52 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.182 0.515 . . . . 0.0 110.954 -176.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 42.7 tp -115.87 121.84 43.56 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.532 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 3.5 mp -110.61 129.5 65.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.016 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 224' ' ' ILE . . . . . 0.477 ' CG2' HD11 ' B' ' 227' ' ' ILE . 50.0 mm -111.11 126.99 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 50.5 p -133.97 157.97 44.69 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-O 122.077 0.942 . . . . 0.0 112.72 -178.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 89.1 17.86 55.0 Favored Glycine 0 CA--C 1.502 -0.77 0 CA-C-N 113.683 -1.598 . . . . 0.0 111.588 -177.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 227' ' ' ILE . . . . . 0.71 HD12 HG23 ' B' ' 247' ' ' THR . 96.1 mt -81.17 126.26 39.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 121.808 -0.819 . . . . 0.0 111.371 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 59.4 tttt -66.57 140.53 96.54 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.298 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.75 -37.24 91.98 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 121.518 1.479 . . . . 0.0 112.363 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -64.18 -42.27 96.77 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -178.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 50.9 tp -62.52 -41.73 99.04 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.751 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.24 -37.2 86.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.784 0.326 . . . . 0.0 111.224 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 94.6 mtp -64.31 -41.0 97.04 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.663 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.78 -43.87 95.07 Favored 'General case' 0 CA--C 1.553 1.065 0 CA-C-O 122.632 1.206 . . . . 0.0 109.382 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 34.3 mmt -63.76 -36.29 83.4 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.167 -1.379 . . . . 0.0 111.894 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -63.32 -39.64 95.11 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.927 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -63.12 -44.45 95.59 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 56.1 tp -61.87 -44.72 96.25 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 120.358 -0.537 . . . . 0.0 112.027 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -157.14 132.59 9.18 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.972 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 240' ' ' ALA . . . . . . . . . . . . . . . -62.0 -45.34 94.05 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 177.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 241' ' ' ASN . . . . . 0.457 ' O ' ' HB2' ' B' ' 244' ' ' SER . 89.3 m-20 -45.45 -19.68 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.111 -175.014 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 242' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -61.7 -45.79 92.48 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.904 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 243' ' ' SER . . . . . . . . . . . . . 77.5 p -57.77 -44.14 85.98 Favored 'General case' 0 C--N 1.343 0.32 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 244' ' ' SER . . . . . 0.457 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 15.4 m -30.88 -36.14 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 95.3 mt -88.04 131.61 34.59 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.196 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -57.63 134.74 56.43 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.346 0.593 . . . . 0.0 110.918 -177.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 247' ' ' THR . . . . . 0.71 HG23 HD12 ' B' ' 227' ' ' ILE . 99.4 m -127.35 129.19 47.15 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.865 178.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 248' ' ' TYR . . . . . 0.491 ' CG ' ' HB2' ' B' ' 254' ' ' ALA . 96.5 m-85 -113.83 143.31 44.87 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 249' ' ' SER . . . . . 0.565 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 78.0 p -62.9 -34.32 77.17 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.275 -178.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 250' ' ' ASN . . . . . 0.565 ' OD1' ' O ' ' B' ' 249' ' ' SER . 99.0 m-20 -146.26 159.14 43.74 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.19 -0.913 . . . . 0.0 112.2 178.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 251' ' ' VAL . . . . . 0.434 ' O ' HG23 ' B' ' 255' ' ' VAL . 75.2 t -63.96 -44.83 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.889 178.12 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 252' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.05 -45.79 93.33 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 253' ' ' ASP . . . . . 0.467 ' O ' HG22 ' B' ' 257' ' ' VAL . 94.4 m-20 -61.09 -43.28 99.13 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.378 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 254' ' ' ALA . . . . . 0.491 ' HB2' ' CG ' ' B' ' 248' ' ' TYR . . . -65.7 -39.99 91.81 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.319 178.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 255' ' ' VAL . . . . . 0.474 HG13 HH11 ' A' ' 154' ' ' ARG . 77.4 t -64.38 -45.88 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.584 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -63.17 -48.03 80.15 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.36 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 257' ' ' VAL . . . . . 0.493 ' O ' ' C ' ' B' ' 258' ' ' LEU . 26.5 m -64.66 -40.33 88.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.776 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 258' ' ' LEU . . . . . 0.519 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 1.3 mt -31.17 -74.97 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.597 -178.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 259' ' ' PRO . . . . . 0.519 ' CD ' ' CB ' ' B' ' 258' ' ' LEU . 36.7 Cg_endo -62.07 142.08 91.1 Favored 'Trans proline' 0 N--CA 1.501 1.928 0 C-N-CA 121.04 1.16 . . . . 0.0 110.983 -178.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 260' ' ' ILE . . . . . 0.528 HG22 ' O ' ' B' ' 260' ' ' ILE . 96.8 mt -158.84 -14.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-N 118.72 0.691 . . . . 0.0 112.054 176.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 78.1 mtm . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 117.921 -1.037 . . . . 0.0 111.905 -179.637 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 900' ' ' FMN . . . . . 0.52 ' C9A' " O2'" ' A' ' 900' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 900' ' ' FMN . . . . . 0.506 " O2'" ' C9A' ' B' ' 900' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.041 -1.623 . . . . 0.0 109.041 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.81 168.49 24.27 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 116.429 -1.748 . . . . 0.0 110.18 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.2 p -70.68 -19.4 62.79 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 124.633 1.208 . . . . 0.0 110.814 178.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -70.61 -68.4 0.43 Allowed 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.531 -1.213 . . . . 0.0 112.39 175.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.22 -38.67 88.51 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.594 ' O ' ' NZ ' ' B' ' 17' ' ' LYS . 69.2 m -59.63 -41.09 89.65 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.22 -178.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.51 ' CE2' HD12 ' A' ' 9' ' ' ILE . 36.3 t80 83.49 89.8 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 O-C-N 123.765 0.666 . . . . 0.0 111.556 176.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.58 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -64.79 -141.18 0.02 OUTLIER Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 -177.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.58 ' HB ' ' O ' ' A' ' 8' ' ' GLY . 78.4 mt 83.53 110.74 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 122.584 0.354 . . . . 0.0 110.726 -178.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.79 -22.38 63.73 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 121.485 1.456 . . . . 0.0 112.294 -178.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.23 -37.49 94.61 Favored Glycine 0 C--O 1.245 0.843 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.94 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -64.82 -39.37 93.47 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.366 0.603 . . . . 0.0 109.8 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.0 tp -63.57 -41.12 98.41 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -63.68 -40.8 97.71 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.5 t -60.26 -44.19 95.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 O-C-N 122.317 -0.239 . . . . 0.0 110.868 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 92.8 mt -62.49 -43.91 98.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -177.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.26 -45.84 91.47 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 119.441 -0.904 . . . . 0.0 111.987 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.524 ' NZ ' HG12 ' B' ' 113' ' ' ILE . 98.9 mttt -60.66 -39.34 88.0 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 118.756 -1.178 . . . . 0.0 108.871 -175.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.86 -41.79 92.22 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.137 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.5 mt -62.85 -40.93 98.97 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.57 -38.27 90.49 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.484 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 57.0 m170 -58.52 -39.84 81.26 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 122.328 -0.232 . . . . 0.0 111.422 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.5 p -113.98 129.09 70.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.54 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 35.4 ptt180 -72.03 107.71 4.88 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 122.094 0.95 . . . . 0.0 111.93 -176.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.6 p -139.22 144.44 29.2 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 178.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.471 ' HA3' ' HB2' ' A' ' 123' ' ' GLN . . . -98.87 93.73 1.35 Allowed Glycine 0 C--O 1.221 -0.706 0 C-N-CA 120.749 -0.738 . . . . 0.0 113.015 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 50.5 t -125.14 129.69 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 176.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.1 m -137.04 159.1 36.7 Favored 'Isoleucine or valine' 0 C--O 1.246 0.881 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.5 mt -120.25 129.37 75.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 176.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.432 HG22 HG12 ' A' ' 39' ' ' ILE . 26.9 p -103.11 169.03 8.8 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 177.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -133.77 101.98 12.65 Favored Pre-proline 0 C--N 1.321 -0.663 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.739 178.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.54 ' HG3' HG23 ' A' ' 117' ' ' THR . 35.2 Cg_endo -63.26 -22.37 72.32 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 121.422 1.414 . . . . 0.0 111.408 -179.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.46 -33.9 74.54 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.155 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.1 mt -87.87 172.8 9.35 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.734 177.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.719 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 42.0 tt0 -68.86 132.11 46.23 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -176.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.509 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 56.7 t0 61.7 22.25 12.81 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.37 0.605 . . . . 0.0 112.564 177.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.401 ' OD1' ' HB ' ' A' ' 30' ' ' THR . 36.6 t-20 43.22 67.13 3.9 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.968 -178.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.719 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 95.4 Cg_endo -70.79 154.62 63.58 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 123.79 2.993 . . . . 0.0 111.979 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.432 HG12 HG22 ' A' ' 30' ' ' THR . 96.5 mt -87.34 123.54 40.16 Favored 'Isoleucine or valine' 0 C--O 1.246 0.919 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.334 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.44 HG23 ' N ' ' A' ' 41' ' ' TYR . 30.0 m -103.99 -45.14 9.53 Favored 'Isoleucine or valine' 0 C--N 1.343 0.323 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.204 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.44 ' N ' HG23 ' A' ' 40' ' ' VAL . 45.3 t80 -93.4 123.64 36.84 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.636 -178.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.1 p -142.28 140.12 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 O-C-N 124.237 0.96 . . . . 0.0 109.348 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.599 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 57.3 p30 -97.3 166.01 11.76 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.462 ' HA ' ' OE1' ' A' ' 44' ' ' GLN . 13.6 mm100 -66.41 -38.92 88.55 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 176.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.7 -26.48 62.62 Favored Glycine 0 C--N 1.33 0.201 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.644 ' CD2' HD13 ' A' ' 57' ' ' ILE . 66.7 t80 -58.86 -47.82 83.54 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.659 HG13 ' O ' ' A' ' 52' ' ' TYR . 78.5 t -59.97 -44.74 95.26 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 O-C-N 121.171 -0.956 . . . . 0.0 111.558 -173.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -63.2 -38.45 91.22 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.653 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 57.7 ttm -66.48 -44.07 83.68 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 175.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.5 p -90.11 -23.02 21.5 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.084 0.469 . . . . 0.0 111.416 -178.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . 78.05 18.97 75.83 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 -178.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.659 ' O ' HG13 ' A' ' 47' ' ' VAL . 70.4 m-85 -113.29 138.38 50.11 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 122.857 0.463 . . . . 0.0 111.28 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -63.18 148.25 48.6 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.808 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.433 HG22 ' H ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -65.97 -32.44 73.93 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -178.759 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.01 -42.03 85.66 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 119.706 -0.797 . . . . 0.0 111.483 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -64.69 -46.75 81.03 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.224 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.644 HD13 ' CD2' ' A' ' 46' ' ' PHE . 97.7 mt -60.41 -50.49 80.11 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -175.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 86.9 mt -55.84 145.3 24.99 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.25 -4.37 81.36 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.024 176.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -136.31 152.79 51.06 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.181 1.491 . . . . 0.0 111.846 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.562 ' C ' ' H ' ' A' ' 63' ' ' ARG . 25.8 t-20 -81.19 150.8 28.5 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.232 0.539 . . . . 0.0 110.453 -178.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 80.1 m -63.11 15.21 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.365 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.562 ' H ' ' C ' ' A' ' 61' ' ' ASN . 34.5 ptt-85 -61.55 -41.63 97.66 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 122.09 -0.382 . . . . 0.0 111.31 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -55.28 -22.1 17.17 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -177.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 93.4 mt -65.89 -37.1 85.25 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.538 0.685 . . . . 0.0 112.639 177.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -62.17 138.1 58.36 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.121 -178.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.529 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -147.2 -148.07 4.68 Favored Glycine 0 CA--C 1.542 1.762 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.089 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.14 -40.4 97.49 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.468 ' O ' ' NE2' ' A' ' 93' ' ' GLN . 10.9 m80 -76.61 -9.22 58.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.608 0.242 . . . . 0.0 111.008 -177.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.529 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 30.0 m -64.36 128.54 36.24 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.142 -0.623 . . . . 0.0 109.59 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -86.43 112.39 45.96 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.039 -178.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -57.48 -30.6 88.81 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 121.974 1.782 . . . . 0.0 113.09 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.75 -39.98 95.6 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.054 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -65.8 -43.61 88.18 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 177.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.9 t -60.2 -44.02 94.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 114.2 -1.364 . . . . 0.0 107.476 -176.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -64.63 -37.59 88.11 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.7 179.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -63.33 -40.03 96.18 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.391 0.615 . . . . 0.0 110.784 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.84 -44.1 98.03 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 CA-C-N 114.857 -1.065 . . . . 0.0 112.055 178.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -61.83 -42.72 99.38 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 113.91 -1.495 . . . . 0.0 108.333 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 92.3 m -60.13 -49.94 75.67 Favored 'General case' 0 C--O 1.246 0.896 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.32 -40.45 94.25 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.228 -170.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 84.8 mt -62.99 -40.33 97.43 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 118.723 0.692 . . . . 0.0 111.511 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -64.09 -40.39 96.12 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -72.06 -22.26 61.4 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.475 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.9 tttt 61.22 43.8 10.56 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.452 -176.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -126.7 149.09 67.37 Favored Pre-proline 0 N--CA 1.467 0.397 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -61.81 143.44 95.97 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 121.316 1.344 . . . . 0.0 113.368 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.04 141.72 33.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.809 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.877 HG23 ' OD1' ' A' ' 107' ' ' ASN . 96.6 m -126.31 122.18 34.73 Favored 'General case' 0 C--N 1.343 0.315 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 175.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 27.7 m -139.55 158.08 27.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.202 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -104.51 130.06 52.48 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 175.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.443 ' O ' HG23 ' A' ' 92' ' ' ILE . 18.2 tt -139.89 128.01 25.88 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.087 0 CA-C-N 120.958 1.708 . . . . 0.0 112.369 178.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.468 ' NE2' ' O ' ' A' ' 69' ' ' HIS . 33.9 mt-30 -60.71 136.66 58.13 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 114.495 -1.229 . . . . 0.0 109.899 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -137.06 159.69 41.14 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.671 -179.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -118.65 136.67 53.78 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.513 ' HG3' ' CE1' ' A' ' 102' ' ' PHE . 99.2 mttt -87.03 -172.92 4.2 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.036 0.446 . . . . 0.0 111.621 -177.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.31 -43.85 97.88 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.384 178.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 41.1 p-10 -82.23 5.1 21.01 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.61 0.0 84.53 Favored Glycine 0 N--CA 1.467 0.758 0 C-N-CA 120.825 -0.703 . . . . 0.0 111.911 176.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 18.2 m -61.15 138.66 58.21 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 178.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.689 ' SD ' ' C ' ' A' ' 101' ' ' MET . 13.6 tmm? -104.66 129.85 52.77 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.88 0.372 . . . . 0.0 110.891 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.513 ' CE1' ' HG3' ' A' ' 96' ' ' LYS . 54.3 p90 -141.76 158.91 43.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.666 -177.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.804 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 25.0 m95 -90.34 143.54 26.67 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.485 HD21 ' HG2' ' A' ' 123' ' ' GLN . 59.4 t-20 -138.2 101.7 4.47 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -177.203 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 80.4 tt0 -66.91 136.18 54.98 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -176.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 38.3 tp -120.35 123.74 43.84 Favored 'General case' 0 C--O 1.233 0.185 0 O-C-N 123.739 0.649 . . . . 0.0 112.424 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.877 ' OD1' HG23 ' A' ' 89' ' ' THR . 98.5 m-20 -121.38 122.67 40.33 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.598 177.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 95.5 mt -120.04 128.23 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 O-C-N 123.523 0.514 . . . . 0.0 111.215 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -136.33 122.99 14.04 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 116.942 -0.117 . . . . 0.0 110.716 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -71.78 150.81 56.63 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.281 1.988 . . . . 0.0 112.602 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.486 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 66.7 mtt -124.17 154.62 39.82 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -128.0 94.41 3.92 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 176.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.483 ' CD1' HG22 ' B' ' 15' ' ' VAL . 96.4 mt -119.69 130.84 73.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.563 -178.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 50.15 37.61 15.04 Favored 'General case' 0 CA--C 1.518 -0.252 0 O-C-N 121.661 -0.649 . . . . 0.0 111.476 176.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 58.77 29.3 18.52 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.884 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -125.89 147.56 49.44 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.751 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 8.4 t -83.79 -173.38 4.68 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.431 -0.793 . . . . 0.0 109.517 -178.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.751 ' CD2' ' O ' ' A' ' 117' ' ' THR . 83.5 m-85 -171.02 154.06 4.0 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 173.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -128.87 145.15 51.29 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 174.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.5 p -134.41 135.17 54.31 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 177.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.466 ' N ' HM73 ' A' ' 900' ' ' FMN . . . -107.91 129.32 9.56 Favored Glycine 0 CA--C 1.505 -0.565 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 178.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.47 ' HB ' ' HB2' ' A' ' 107' ' ' ASN . 96.9 mt -117.77 128.82 74.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.485 ' HG2' HD21 ' A' ' 104' ' ' ASN . 17.4 mp0 -119.13 116.63 26.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.145 0.498 . . . . 0.0 109.929 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -116.09 113.38 23.07 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.112 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 126' ' ' ILE . 68.2 t0 -63.8 128.74 37.16 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -176.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.545 ' O ' HG22 ' A' ' 126' ' ' ILE . 2.7 mp -96.29 3.88 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 113.951 -1.477 . . . . 0.0 110.398 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.5 m -60.05 -42.64 94.9 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.335 -0.853 . . . . 0.0 113.234 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -59.87 -42.32 93.46 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -63.69 -40.13 96.05 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.521 177.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.804 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.5 mttt -62.92 -41.42 99.46 Favored 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 118.393 -1.323 . . . . 0.0 110.359 -178.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -61.68 -36.69 81.58 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.752 ' CE2' HD11 ' A' ' 136' ' ' LEU . 85.8 t80 -61.82 -44.74 96.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.369 176.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.74 -38.74 92.0 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.97 -40.91 97.2 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 54.8 tp -61.26 -43.85 98.2 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.752 HD11 ' CE2' ' A' ' 132' ' ' TYR . 86.6 mt -62.54 -41.06 98.64 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.242 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.91 -41.02 97.44 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.915 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -60.82 -42.17 97.17 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -178.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 58.3 m -61.54 -41.55 97.52 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.677 177.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.464 ' O ' ' N ' ' A' ' 144' ' ' THR . 86.9 mt -64.08 -41.88 97.15 Favored 'General case' 0 C--O 1.224 -0.274 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 91.8 m -61.22 -46.03 92.11 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.38 -177.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -64.79 -40.24 94.91 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 95.7 mt -64.47 -43.49 96.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 113.939 -1.482 . . . . 0.0 111.219 177.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.464 ' N ' ' O ' ' A' ' 140' ' ' LEU . 92.7 m -62.71 -45.95 90.39 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.773 -0.579 . . . . 0.0 112.332 -178.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.4 -40.16 96.46 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 118.853 -1.139 . . . . 0.0 108.991 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 85.2 mt -63.5 -42.57 98.5 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.472 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.746 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.1 p -60.87 -38.78 86.75 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 -178.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.491 ' C ' ' O ' ' A' ' 147' ' ' SER . 31.9 m -27.22 79.85 0.02 OUTLIER Pre-proline 0 N--CA 1.467 0.415 0 O-C-N 126.531 2.394 . . . . 0.0 106.591 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.746 ' N ' ' O ' ' A' ' 147' ' ' SER . 20.9 Cg_exo -62.53 144.46 94.56 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 120.947 1.098 . . . . 0.0 114.666 -173.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.566 ' O ' HG23 ' A' ' 151' ' ' VAL . 9.5 tp -121.44 135.2 62.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 102.928 -2.99 . . . . 0.0 102.928 176.111 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 150' ' ' ILE . 99.6 t -167.55 91.81 0.69 Allowed Pre-proline 0 CA--C 1.513 -0.46 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 178.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -61.49 136.26 62.26 Favored 'Trans proline' 0 C--N 1.3 -2.011 0 N-CA-C 109.323 -1.068 . . . . 0.0 109.323 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.587 ' O ' ' HD2' ' A' ' 154' ' ' ARG . 45.5 mm -67.83 -44.34 85.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 119.932 -0.707 . . . . 0.0 110.795 179.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.587 ' HD2' ' O ' ' A' ' 153' ' ' ILE . 0.2 OUTLIER -156.89 -156.39 0.61 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.437 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.468 ' ND2' ' HE3' ' B' ' 256' ' ' LYS . 63.7 t-20 -87.51 105.14 17.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 122.08 0.943 . . . . 0.0 112.008 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 88.98 9.19 68.12 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.758 -177.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.0 mt -126.19 125.36 67.62 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 CA-C-O 121.546 0.689 . . . . 0.0 109.231 174.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.566 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 42.5 m -133.26 152.22 51.93 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.061 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -137.67 141.95 41.13 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.753 -0.592 . . . . 0.0 111.286 177.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 18.0 tp -133.93 78.33 60.33 Favored Pre-proline 0 N--CA 1.47 0.564 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.243 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -70.21 151.63 66.57 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.82 2.347 . . . . 0.0 113.096 -179.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 88.3 mt -117.47 128.76 55.31 Favored 'General case' 0 C--O 1.25 1.089 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.388 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 49.3 t -123.82 130.9 73.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 115.05 170.08 16.22 Favored Glycine 0 N--CA 1.479 1.539 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.042 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.939 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 55.9 t30 -85.05 115.29 22.78 Favored 'General case' 0 C--O 1.213 -0.841 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.506 HD21 ' CZ ' ' A' ' 171' ' ' PHE . 41.8 tp -73.67 105.34 4.95 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -177.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.656 HG23 ' NE ' ' A' ' 170' ' ' ARG . 16.6 p -87.55 165.87 15.16 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.01 178.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -66.72 -33.51 75.8 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.506 0.669 . . . . 0.0 111.455 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.7 -41.36 92.43 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.686 178.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.939 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 87.6 mtm180 -64.71 -33.16 75.31 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 124.173 0.989 . . . . 0.0 112.233 176.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.506 ' CZ ' HD21 ' A' ' 166' ' ' LEU . 0.6 OUTLIER -54.33 -28.76 44.87 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.11 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.569 ' O ' HG22 ' A' ' 175' ' ' VAL . 92.6 m-20 -60.53 -41.19 93.94 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 119.003 -1.079 . . . . 0.0 109.857 -178.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 67.3 m -59.57 -41.15 89.54 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.692 -178.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 66.6 mt -63.33 -44.05 98.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 172' ' ' ASN . 30.5 m -62.72 -39.67 85.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' CYS . . . . . 0.403 ' N ' HG23 ' A' ' 175' ' ' VAL . 98.8 m -61.8 -34.5 76.02 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.262 0.553 . . . . 0.0 110.294 178.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.548 ' O ' HG13 ' A' ' 181' ' ' ILE . 25.3 m -62.22 -20.4 64.17 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.131 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.693 ' CD2' HD21 ' A' ' 211' ' ' LEU . 89.9 mt -61.12 -41.54 96.9 Favored 'General case' 0 C--O 1.246 0.887 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -178.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 16.9 m -58.87 -43.34 90.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.532 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.593 ' O ' ' OG ' ' A' ' 183' ' ' SER . 92.2 m-20 -61.98 -37.98 86.85 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 122.558 0.343 . . . . 0.0 110.954 178.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.553 HD12 HD23 ' A' ' 178' ' ' LEU . 70.3 mt -58.62 -37.9 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.438 HD21 HD21 ' A' ' 214' ' ' LEU . 86.0 mt -60.65 -40.82 93.42 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.015 -177.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.593 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 78.1 p -61.98 -33.32 74.09 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.486 176.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.475 ' OG1' ' HA ' ' A' ' 181' ' ' ILE . 19.2 p -89.67 24.69 2.25 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.561 0.219 . . . . 0.0 111.267 -178.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 78.0 p -63.62 -20.29 65.55 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.198 0.523 . . . . 0.0 110.746 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.17 -37.19 79.42 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.825 -178.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.566 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 99.0 m-20 -74.88 113.88 12.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.457 0.646 . . . . 0.0 110.972 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.83 -42.44 99.73 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.056 -0.975 . . . . 0.0 112.885 -177.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -112.03 131.02 55.67 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.202 0.525 . . . . 0.0 110.912 -178.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 38.6 tp -120.25 128.89 53.76 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 96.2 mt -117.05 126.59 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 118.587 0.63 . . . . 0.0 109.582 177.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.6 mm -112.66 126.43 70.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' ASP . . . . . 0.545 ' CG ' ' HG ' ' A' ' 195' ' ' SER . 39.5 t0 -94.82 118.57 31.98 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 121.949 0.881 . . . . 0.0 110.46 177.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 95.7 mt -96.93 -3.79 41.17 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.257 175.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.545 ' HG ' ' CG ' ' A' ' 193' ' ' ASP . 78.2 p -61.72 -32.72 72.96 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.82 -42.51 99.75 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 108.766 -1.734 . . . . 0.0 108.766 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.937 ' CD2' ' O ' ' A' ' 199' ' ' GLN . 5.1 tt -72.57 128.59 36.03 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 112.975 -1.612 . . . . 0.0 108.862 -176.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.919 ' N ' HD23 ' A' ' 197' ' ' LEU . . . -60.94 -49.01 79.17 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.203 -178.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.937 ' O ' ' CD2' ' A' ' 197' ' ' LEU . 57.7 tt0 -132.79 155.53 48.76 Favored 'General case' 0 C--O 1.206 -1.219 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -175.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.426 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 53.1 t -117.13 132.43 66.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 O-C-N 120.133 -1.605 . . . . 0.0 108.875 178.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -86.16 156.16 20.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.662 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.3 -38.5 90.43 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.181 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -58.37 -31.7 67.88 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -178.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 17.6 m -60.86 -42.48 97.95 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.659 177.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.523 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -57.05 -38.74 73.67 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -177.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -62.12 -37.39 84.95 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -178.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -64.94 -39.42 93.48 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.103 177.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.29 -44.64 99.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 C-N-CA 119.525 -0.87 . . . . 0.0 108.941 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' PHE . . . . . 0.523 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 69.1 m-85 -61.65 -43.56 98.63 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.413 -178.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.0 -42.35 99.06 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 119.313 -0.955 . . . . 0.0 109.103 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.693 HD21 ' CD2' ' A' ' 178' ' ' LEU . 40.1 mt -61.65 -42.27 98.67 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 78.1 p -61.89 -41.66 98.15 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 119.351 -0.939 . . . . 0.0 110.116 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 58.3 t60 -64.06 -45.91 86.69 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.787 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.438 HD21 HD21 ' A' ' 182' ' ' LEU . 53.9 tp -62.12 -46.14 90.37 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 211' ' ' LEU . 84.2 mt -62.56 -40.56 97.22 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.627 -176.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -61.59 -43.1 99.49 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -178.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 85.9 mt -61.8 -39.63 92.4 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 74.8 p -76.68 -11.59 59.87 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.242 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 81.26 38.63 14.45 Favored Glycine 0 C--O 1.217 -0.909 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.329 -178.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 94.7 m -123.95 112.85 17.71 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.024 1.412 . . . . 0.0 111.658 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -63.07 136.63 57.91 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.2 178.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 44.2 tp -114.43 130.63 56.72 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 3.4 mp -118.21 135.36 58.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 122.867 0.467 . . . . 0.0 109.849 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.579 ' CG2' HD11 ' A' ' 227' ' ' ILE . 49.0 mm -114.85 131.74 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 43.8 p -132.89 167.35 20.38 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 120.854 -0.338 . . . . 0.0 111.876 -178.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 77.31 20.47 74.98 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.584 HD12 HG23 ' A' ' 247' ' ' THR . 97.5 mt -81.79 128.6 38.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 114.043 -1.078 . . . . 0.0 108.77 178.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 66.9 tttt -75.43 140.82 72.59 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.09 -39.28 86.34 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 121.138 1.225 . . . . 0.0 112.496 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -64.04 -39.31 93.8 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-O 121.829 0.823 . . . . 0.0 110.318 -178.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 49.6 tp -64.18 -42.23 96.77 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.845 -1.071 . . . . 0.0 112.721 177.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.74 -37.27 87.01 Favored 'General case' 0 CA--C 1.521 -0.154 0 O-C-N 121.753 -0.592 . . . . 0.0 111.198 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 94.5 mtp -63.7 -41.35 98.13 Favored 'General case' 0 C--O 1.247 0.959 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -178.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -63.7 -40.33 96.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.668 177.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 37.7 mmt -65.33 -37.13 86.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.823 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -60.51 -41.54 94.57 Favored 'General case' 0 CA--C 1.515 -0.385 0 O-C-N 121.544 -0.723 . . . . 0.0 109.408 -177.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.59 -40.74 92.88 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.238 0.542 . . . . 0.0 110.505 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 52.2 tp -62.89 -40.96 99.15 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 177.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 240' ' ' ALA . 67.1 t0 -169.53 130.26 1.07 Allowed 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.5 -0.75 . . . . 0.0 112.486 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.416 ' N ' ' OD1' ' A' ' 239' ' ' ASP . . . -60.93 -26.89 67.82 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.811 178.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.496 ' O ' ' HB2' ' A' ' 244' ' ' SER . 87.6 m-20 -60.68 -30.42 69.91 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.691 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -55.83 -43.34 76.91 Favored 'General case' 0 C--N 1.311 -1.086 0 O-C-N 121.399 -0.813 . . . . 0.0 109.056 -176.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 94.7 p -63.15 -19.12 64.18 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.043 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' SER . . . . . 0.496 ' HB2' ' O ' ' A' ' 241' ' ' ASN . 70.9 m -54.94 -37.04 65.93 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.405 177.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 95.0 mt -89.19 119.26 29.52 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 119.732 -0.787 . . . . 0.0 112.93 -177.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -42.65 135.55 2.82 Favored 'General case' 0 C--O 1.244 0.773 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.68 -178.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.584 HG23 HD12 ' A' ' 227' ' ' ILE . 97.7 m -126.52 132.72 51.32 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.198 -1.364 . . . . 0.0 111.043 178.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 248' ' ' TYR . . . . . 0.453 ' CB ' ' HB2' ' A' ' 254' ' ' ALA . 96.5 m-85 -117.54 141.18 48.66 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.978 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 249' ' ' SER . . . . . 0.467 ' O ' ' OD1' ' A' ' 250' ' ' ASN . 77.3 p -62.2 -41.03 97.98 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -178.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' ASN . . . . . 0.467 ' OD1' ' O ' ' A' ' 249' ' ' SER . 98.9 m-20 -146.15 160.58 41.75 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.63 0.729 . . . . 0.0 111.155 -178.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 70.2 t -62.8 -45.13 99.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.142 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.04 -44.51 97.29 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.633 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' ASP . . . . . 0.461 ' O ' HG22 ' A' ' 257' ' ' VAL . 55.2 m-20 -63.74 -42.32 97.89 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.343 -178.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.453 ' HB2' ' CB ' ' A' ' 248' ' ' TYR . . . -65.19 -41.93 94.08 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.829 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 255' ' ' VAL . . . . . 0.433 HG13 HH11 ' B' ' 154' ' ' ARG . 57.3 t -63.73 -45.61 96.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.927 -178.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.81 -47.83 79.28 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.513 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.487 ' O ' ' C ' ' A' ' 258' ' ' LEU . 21.7 m -66.36 -40.11 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 120.048 -0.661 . . . . 0.0 112.314 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.487 ' C ' ' O ' ' A' ' 257' ' ' VAL . 1.0 OUTLIER -30.18 -73.41 0.05 OUTLIER Pre-proline 0 C--N 1.345 0.41 0 C-N-CA 121.041 -0.264 . . . . 0.0 111.347 -176.892 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 259' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' A' ' 258' ' ' LEU . 41.0 Cg_endo -63.6 139.85 72.05 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 120.891 1.061 . . . . 0.0 112.117 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 259' ' ' PRO . 96.7 mt -152.12 -28.23 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 116.154 -0.476 . . . . 0.0 112.248 178.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.658 -177.151 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.558 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.7 159.58 40.81 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 118.974 -0.536 . . . . 0.0 109.994 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 79.7 p -59.59 -21.49 60.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 122.101 0.953 . . . . 0.0 110.877 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -73.66 -64.95 0.89 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.042 -177.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -66.39 -38.67 88.04 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.931 177.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.492 ' O ' ' HB3' ' B' ' 7' ' ' PHE . 68.5 m -59.87 -41.7 92.11 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 120.425 -0.51 . . . . 0.0 109.904 -178.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 7' ' ' PHE . . . . . 0.492 ' HB3' ' O ' ' B' ' 6' ' ' SER . 37.7 t80 84.54 92.98 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 O-C-N 123.844 0.715 . . . . 0.0 110.268 177.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 8' ' ' GLY . . . . . 0.588 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -67.06 -140.75 0.05 OUTLIER Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -178.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.588 ' HB ' ' O ' ' B' ' 8' ' ' GLY . 75.9 mt 82.98 110.81 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.69 0 C-N-CA 122.519 0.328 . . . . 0.0 111.045 -178.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.14 -23.65 66.65 Favored 'Trans proline' 0 N--CA 1.499 1.806 0 C-N-CA 121.369 1.379 . . . . 0.0 111.936 -178.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.08 -39.7 97.96 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -64.53 -39.7 94.26 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.587 0.708 . . . . 0.0 109.652 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 50.7 tp -61.71 -42.66 99.25 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.21 -177.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -65.3 -33.59 76.35 Favored 'General case' 0 CA--C 1.562 1.418 0 CA-C-O 121.514 0.673 . . . . 0.0 110.523 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' VAL . . . . . 0.483 HG22 ' CD1' ' A' ' 113' ' ' ILE . 76.0 t -62.83 -45.75 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 113.135 -1.848 . . . . 0.0 111.086 177.171 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 95.0 mt -64.11 -43.79 97.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.177 -178.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 17' ' ' LYS . . . . . 0.594 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 98.9 mttt -63.41 -42.13 98.74 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.38 -41.13 98.78 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.973 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.45 -38.81 85.32 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.522 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.406 ' O ' ' O ' ' B' ' 23' ' ' VAL . 83.4 mt -63.61 -42.34 98.21 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.154 0.502 . . . . 0.0 110.152 175.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -62.84 -38.61 91.45 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.128 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 55.9 m170 -57.79 -39.91 78.65 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 121.153 -0.219 . . . . 0.0 111.38 -178.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 23' ' ' VAL . . . . . 0.406 ' O ' ' O ' ' B' ' 20' ' ' LEU . 10.6 p -114.19 129.36 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.541 ' HG3' ' O ' ' B' ' 24' ' ' ARG . 35.1 ptt180 -71.84 105.9 3.97 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 121.971 0.891 . . . . 0.0 112.421 -176.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.0 p -141.77 134.45 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.471 178.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 26' ' ' GLY . . . . . 0.496 ' O ' ' N ' ' B' ' 123' ' ' GLN . . . -89.33 98.22 2.42 Favored Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 119.525 -1.321 . . . . 0.0 113.054 -175.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 48.6 t -126.03 129.01 72.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 174.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 26.9 m -138.82 156.59 28.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.857 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 96.0 mt -119.81 125.04 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 122.753 1.263 . . . . 0.0 111.595 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.445 HG22 HG12 ' B' ' 39' ' ' ILE . 37.4 p -104.17 159.45 15.68 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 113.266 -1.788 . . . . 0.0 108.844 -178.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -126.59 103.26 25.1 Favored Pre-proline 0 C--O 1.238 0.462 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 32' ' ' PRO . . . . . 0.45 ' HG3' HG23 ' B' ' 117' ' ' THR . 36.8 Cg_endo -64.58 -19.59 65.01 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 121.88 1.72 . . . . 0.0 111.355 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.59 -41.63 97.71 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.677 -0.409 . . . . 0.0 109.922 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 94.9 mt -77.08 -172.7 2.47 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.823 -0.548 . . . . 0.0 111.209 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 35' ' ' GLU . . . . . 0.727 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 42.0 tt0 -79.69 130.94 35.79 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.446 ' O ' ' C ' ' B' ' 37' ' ' ASN . 61.9 t0 55.21 39.61 31.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.672 177.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 37' ' ' ASN . . . . . 0.446 ' C ' ' O ' ' B' ' 36' ' ' ASP . 23.1 t-20 29.8 69.73 0.61 Allowed Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.727 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 92.8 Cg_endo -72.08 153.91 57.42 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 123.449 2.766 . . . . 0.0 111.696 178.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.445 HG12 HG22 ' B' ' 30' ' ' THR . 96.3 mt -86.58 128.33 39.62 Favored 'Isoleucine or valine' 0 C--O 1.246 0.901 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.424 HG23 ' N ' ' B' ' 41' ' ' TYR . 30.1 m -108.15 -44.77 6.94 Favored 'Isoleucine or valine' 0 C--N 1.341 0.214 0 O-C-N 123.933 0.77 . . . . 0.0 112.631 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 41' ' ' TYR . . . . . 0.424 ' N ' HG23 ' B' ' 40' ' ' VAL . 47.6 t80 -94.38 123.77 37.99 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.27 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 6.3 p -142.14 140.91 29.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 O-C-N 124.033 0.833 . . . . 0.0 109.414 178.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 43' ' ' ASN . . . . . 0.63 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 56.8 p30 -101.21 161.4 13.64 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.128 178.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 44' ' ' GLN . . . . . 0.457 ' OE1' ' HA ' ' B' ' 44' ' ' GLN . 13.1 mm100 -63.11 -37.77 88.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.624 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.89 -26.69 63.35 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.657 ' CD2' HD13 ' B' ' 57' ' ' ILE . 61.9 t80 -60.19 -43.54 95.82 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 0.812 HG13 ' O ' ' B' ' 52' ' ' TYR . 75.3 t -61.46 -45.95 97.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.276 -179.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -62.96 -44.69 95.35 Favored 'General case' 0 C--N 1.323 -0.543 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.251 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 57.9 ttm -63.11 -42.55 99.59 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 40.9 p -93.53 -17.28 23.56 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.776 -177.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' B' ' 47' ' ' VAL . . . 73.44 17.71 79.08 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 52' ' ' TYR . . . . . 0.812 ' O ' HG13 ' B' ' 47' ' ' VAL . 70.0 m-85 -111.12 146.01 37.58 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 122.944 0.497 . . . . 0.0 110.349 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -74.4 147.16 42.33 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.45 0.643 . . . . 0.0 111.302 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.36 -38.65 84.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.05 -177.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.23 -39.17 93.86 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 120.103 -0.639 . . . . 0.0 111.81 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -72.3 -31.66 65.9 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 176.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.657 HD13 ' CD2' ' B' ' 46' ' ' PHE . 91.8 mt -68.61 -71.67 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 176.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 96.8 mt -37.25 133.3 0.69 Allowed 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.813 178.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.1 -11.01 71.31 Favored Glycine 0 CA--C 1.537 1.418 0 CA-C-N 116.059 -0.519 . . . . 0.0 113.001 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -133.9 150.19 51.33 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -174.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 61' ' ' ASN . . . . . 0.568 ' C ' ' H ' ' B' ' 63' ' ' ARG . 25.9 t-20 -79.53 149.41 31.45 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.41 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 62' ' ' CYS . . . . . . . . . . . . . 81.8 m -62.74 10.08 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.372 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 63' ' ' ARG . . . . . 0.568 ' H ' ' C ' ' B' ' 61' ' ' ASN . 33.3 ptt-85 -60.61 -33.54 72.91 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.323 -177.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -58.92 -29.88 67.41 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 178.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 87.3 mt -62.2 -41.31 98.25 Favored 'General case' 0 C--O 1.238 0.466 0 O-C-N 121.573 -0.705 . . . . 0.0 109.686 -178.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -51.82 146.25 8.44 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.857 -176.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -156.71 -153.29 6.58 Favored Glycine 0 CA--C 1.534 1.242 0 O-C-N 123.886 0.741 . . . . 0.0 111.831 177.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.31 -41.21 93.0 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -176.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 10.1 m80 -75.95 -11.1 59.9 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.945 -178.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 70' ' ' THR . . . . . 0.43 HG23 HD11 ' B' ' 92' ' ' ILE . 28.5 m -62.02 133.7 55.68 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 120.229 -0.589 . . . . 0.0 109.427 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -91.02 112.61 54.6 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.639 -179.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.38 -37.56 89.17 Favored 'Trans proline' 0 N--CA 1.489 1.219 0 C-N-CA 121.074 1.183 . . . . 0.0 111.734 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.99 -40.51 89.41 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.793 -176.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -66.84 -39.39 87.6 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.078 177.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 75.2 t -61.82 -46.43 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -63.15 -36.99 85.45 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.76 -178.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -62.27 -42.11 99.05 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 119.371 -0.932 . . . . 0.0 109.0 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 95.5 mt -63.57 -43.44 98.25 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 CA-C-O 120.751 0.31 . . . . 0.0 110.841 -178.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -61.16 -42.39 98.47 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 76.5 m -61.15 -45.06 96.21 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.352 0.596 . . . . 0.0 110.017 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.12 -40.34 97.32 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -177.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 81.8 mt -62.65 -42.81 99.81 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.034 -0.666 . . . . 0.0 109.38 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 67.6 tp60 -63.21 -38.95 93.19 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -81.99 -4.36 56.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.92 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 45.7 tttt 50.33 43.72 26.62 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.548 176.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -127.95 146.42 59.03 Favored Pre-proline 0 N--CA 1.466 0.349 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.421 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -62.41 140.41 82.11 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 120.973 1.115 . . . . 0.0 113.893 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.58 135.9 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.725 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 89' ' ' THR . . . . . 0.87 HG23 ' OD1' ' B' ' 107' ' ' ASN . 93.7 m -121.01 123.45 42.44 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 29.4 m -138.64 162.74 28.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.76 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -115.91 119.8 37.12 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.931 -0.48 . . . . 0.0 109.78 174.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 92' ' ' ILE . . . . . 0.43 HD11 HG23 ' B' ' 70' ' ' THR . 20.6 tt -127.99 132.44 68.64 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.807 -174.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -70.98 144.42 50.5 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.899 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 94' ' ' ASN . . . . . 0.407 HD22 ' HA ' ' B' ' 94' ' ' ASN . 8.0 m120 -133.62 -179.41 5.51 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-O 121.435 0.636 . . . . 0.0 111.489 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 95' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -131.46 145.95 52.02 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.146 177.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 96' ' ' LYS . . . . . 0.501 ' HG3' ' CE2' ' B' ' 102' ' ' PHE . 98.8 mttt -103.45 -180.0 4.11 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.402 0.62 . . . . 0.0 110.658 178.111 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.46 -35.9 76.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.502 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 38.4 p-10 -86.82 -1.44 57.78 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.42 -0.8 . . . . 0.0 112.928 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.89 3.7 63.85 Favored Glycine 0 N--CA 1.466 0.695 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.464 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 21.7 m -68.48 129.41 39.84 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.274 -0.57 . . . . 0.0 109.478 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 101' ' ' MET . . . . . 0.594 ' SD ' ' N ' ' B' ' 102' ' ' PHE . 15.0 tmm? -88.3 143.44 27.02 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 102' ' ' PHE . . . . . 0.594 ' N ' ' SD ' ' B' ' 101' ' ' MET . 54.4 p90 -153.28 163.5 39.79 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 178.016 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 103' ' ' TRP . . . . . 0.826 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 25.3 m95 -95.71 139.72 31.55 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.614 0.721 . . . . 0.0 110.468 178.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 104' ' ' ASN . . . . . 0.476 HD21 ' HG2' ' B' ' 123' ' ' GLN . 64.8 t-20 -133.66 105.85 7.06 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 114.804 -1.089 . . . . 0.0 113.783 -177.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 105' ' ' GLU . . . . . 0.469 ' HB2' HD11 ' B' ' 126' ' ' ILE . 81.1 tt0 -73.87 124.24 25.75 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.999 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 37.3 tp -112.04 125.42 54.07 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-O 120.936 0.398 . . . . 0.0 111.631 -177.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 107' ' ' ASN . . . . . 0.87 ' OD1' HG23 ' B' ' 89' ' ' THR . 98.3 m-20 -120.15 127.87 52.89 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 176.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 95.8 mt -122.66 132.59 70.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -141.79 121.55 8.2 Favored Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -70.32 151.88 66.11 Favored 'Trans proline' 0 N--CA 1.501 1.924 0 C-N-CA 122.434 2.09 . . . . 0.0 112.505 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 66.6 mtt -130.87 143.12 50.5 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -112.12 107.4 16.31 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 178.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 113' ' ' ILE . . . . . 0.524 HG12 ' NZ ' ' A' ' 18' ' ' LYS . 96.8 mt -133.32 127.54 54.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-N 118.521 0.6 . . . . 0.0 111.596 177.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 52.54 38.18 25.0 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.88 178.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 58.86 37.04 24.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.53 -178.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -132.82 150.68 52.13 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 117' ' ' THR . . . . . 0.45 HG23 ' HG3' ' B' ' 32' ' ' PRO . 9.4 t -101.4 152.46 20.7 Favored 'General case' 0 C--O 1.217 -0.628 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -177.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -147.39 146.48 29.63 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 120.791 -1.193 . . . . 0.0 111.189 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -123.07 137.75 54.85 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.765 -177.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -128.86 133.36 66.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 -177.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 121' ' ' GLY . . . . . 0.472 ' N ' HM73 ' B' ' 900' ' ' FMN . . . -108.57 123.17 6.9 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 122' ' ' ILE . . . . . 0.517 ' HB ' ' HB2' ' B' ' 107' ' ' ASN . 92.4 mt -112.33 127.43 69.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 123' ' ' GLN . . . . . 0.496 ' N ' ' O ' ' B' ' 26' ' ' GLY . 17.5 mp0 -117.93 123.58 46.16 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -120.13 121.16 38.19 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 125' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' B' ' 127' ' ' THR . 68.2 t0 -69.39 131.72 45.25 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.588 -179.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.519 HG22 ' O ' ' B' ' 126' ' ' ILE . 2.7 mp -107.51 17.82 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.807 0 CA-C-O 122.097 0.951 . . . . 0.0 109.095 178.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 127' ' ' THR . . . . . 0.447 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 99.3 m -63.85 -44.04 94.32 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.24 -1.345 . . . . 0.0 112.501 175.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 59.9 tptt -60.88 -46.15 91.76 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 129' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -63.21 -36.19 82.81 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.146 -0.933 . . . . 0.0 111.499 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 130' ' ' LYS . . . . . 0.826 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 98.5 mttt -63.57 -41.42 98.39 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-N 113.779 -1.555 . . . . 0.0 110.511 175.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.99 -41.46 97.51 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 132' ' ' TYR . . . . . 0.76 ' CE2' HD11 ' B' ' 136' ' ' LEU . 86.2 t80 -59.78 -44.11 94.07 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 121.663 -0.648 . . . . 0.0 111.156 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 133' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' B' ' 137' ' ' GLU . 97.6 mt-10 -64.61 -36.96 85.93 Favored 'General case' 0 C--O 1.224 -0.254 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.563 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 134' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' B' ' 130' ' ' LYS . 99.0 mttt -62.94 -39.57 95.01 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.676 178.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 54.5 tp -63.01 -41.56 99.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.32 0.581 . . . . 0.0 109.811 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 136' ' ' LEU . . . . . 0.76 HD11 ' CE2' ' B' ' 132' ' ' TYR . 89.2 mt -63.01 -41.28 99.53 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.404 177.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 137' ' ' GLU . . . . . 0.408 ' HG3' ' O ' ' B' ' 133' ' ' GLU . 97.2 mt-10 -64.37 -36.54 84.47 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.357 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.77 -43.47 96.31 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.915 176.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 62.3 m -60.87 -45.76 93.29 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 88.5 mt -60.87 -40.33 92.53 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 99.7 m -61.86 -45.44 93.79 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.97 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -66.3 -42.1 88.8 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 94.9 mt -63.11 -43.62 99.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.642 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 144' ' ' THR . . . . . . . . . . . . . 93.4 m -61.78 -45.66 92.93 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.25 -41.31 99.04 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 119.021 -1.072 . . . . 0.0 109.369 178.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 87.5 mt -64.58 -41.12 96.47 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 177.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 147' ' ' SER . . . . . 0.64 ' O ' ' N ' ' B' ' 149' ' ' PRO . 78.2 p -61.76 -40.84 96.56 Favored 'General case' 0 CA--C 1.479 -1.779 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 148' ' ' THR . . . . . 0.486 ' C ' ' O ' ' B' ' 147' ' ' SER . 20.6 m -27.92 84.24 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.657 0 O-C-N 124.128 0.892 . . . . 0.0 110.143 177.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 149' ' ' PRO . . . . . 0.64 ' N ' ' O ' ' B' ' 147' ' ' SER . 22.8 Cg_exo -61.69 147.13 96.04 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 C-N-CA 122.044 1.829 . . . . 0.0 115.802 -176.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 9.6 tp -128.47 121.24 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-N 114.258 -1.337 . . . . 0.0 107.771 174.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 58.1 t -151.68 92.83 3.59 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.946 -178.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -60.59 136.05 64.6 Favored 'Trans proline' 0 C--N 1.32 -0.932 0 N-CA-C 109.029 -1.181 . . . . 0.0 109.029 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 153' ' ' ILE . . . . . 0.586 ' O ' ' HD2' ' B' ' 154' ' ' ARG . 45.0 mm -67.74 -43.72 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.876 178.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 154' ' ' ARG . . . . . 0.586 ' HD2' ' O ' ' B' ' 153' ' ' ILE . 0.2 OUTLIER -156.7 -155.5 0.54 Allowed 'General case' 0 C--N 1.347 0.469 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -179.718 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 62.9 t-20 -86.86 108.27 18.69 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.57 -17.42 57.64 Favored Glycine 0 C--N 1.34 0.803 0 N-CA-C 110.069 -1.213 . . . . 0.0 110.069 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 85.6 mt -110.25 125.64 67.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.144 0.497 . . . . 0.0 111.348 -176.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 158' ' ' SER . . . . . 0.521 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 47.4 m -135.1 149.6 50.07 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.87 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -132.96 145.89 51.29 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.29 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 18.0 tp -139.44 77.76 28.47 Favored Pre-proline 0 CA--C 1.531 0.227 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 161' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -71.56 150.23 56.96 Favored 'Trans proline' 0 N--CA 1.499 1.849 0 C-N-CA 122.835 2.357 . . . . 0.0 114.362 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 92.6 mt -113.83 134.93 54.49 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 55.9 t -128.46 132.93 67.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 112.8 170.61 17.97 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.198 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 165' ' ' ASN . . . . . 0.743 ' O ' ' NH1' ' B' ' 170' ' ' ARG . 61.1 t30 -90.52 107.29 19.07 Favored 'General case' 0 C--O 1.216 -0.673 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -178.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 166' ' ' LEU . . . . . 0.528 HD21 ' CZ ' ' B' ' 171' ' ' PHE . 40.3 tp -63.92 106.16 0.97 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -174.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 167' ' ' THR . . . . . 0.594 HG23 ' NH2' ' B' ' 170' ' ' ARG . 34.5 p -86.79 169.45 12.59 Favored 'General case' 0 C--N 1.353 0.729 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.285 177.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -67.61 -37.33 82.38 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.928 176.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.91 -39.55 90.69 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 123.345 1.545 . . . . 0.0 111.486 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 170' ' ' ARG . . . . . 0.743 ' NH1' ' O ' ' B' ' 165' ' ' ASN . 87.9 mtm180 -63.25 -36.36 83.42 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 112.408 -2.178 . . . . 0.0 110.842 177.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 171' ' ' PHE . . . . . 0.528 ' CZ ' HD21 ' B' ' 166' ' ' LEU . 0.5 OUTLIER -53.76 -25.29 18.18 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -179.009 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 172' ' ' ASN . . . . . 0.514 ' O ' HG22 ' B' ' 175' ' ' VAL . 93.4 m-20 -62.95 -40.57 98.09 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.01 178.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 57.2 m -60.49 -41.72 94.85 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.776 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 66.4 mt -63.52 -44.45 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -178.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 175' ' ' VAL . . . . . 0.514 HG22 ' O ' ' B' ' 172' ' ' ASN . 30.5 m -62.59 -39.92 86.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -179.081 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 176' ' ' CYS . . . . . 0.404 ' N ' HG23 ' B' ' 175' ' ' VAL . 97.2 m -61.53 -34.82 76.19 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.226 178.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 177' ' ' THR . . . . . 0.585 ' O ' HG13 ' B' ' 181' ' ' ILE . 25.0 m -62.27 -20.4 64.23 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.25 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 178' ' ' LEU . . . . . 0.685 ' CD2' HD21 ' B' ' 211' ' ' LEU . 91.5 mt -61.27 -38.93 88.54 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.269 -178.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 18.3 m -61.95 -44.09 97.49 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 176.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 180' ' ' ASN . . . . . 0.564 ' O ' ' OG ' ' B' ' 183' ' ' SER . 93.3 m-20 -61.8 -40.89 96.78 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.956 0.408 . . . . 0.0 110.554 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.585 HG13 ' O ' ' B' ' 177' ' ' THR . 75.0 mt -57.35 -31.64 38.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.776 -177.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 182' ' ' LEU . . . . . 0.436 HD21 HD21 ' B' ' 214' ' ' LEU . 84.5 mt -62.85 -41.68 99.45 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 119.693 -0.803 . . . . 0.0 109.202 177.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 183' ' ' SER . . . . . 0.564 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.2 p -63.54 -32.8 74.37 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 121.845 -0.534 . . . . 0.0 110.817 177.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 184' ' ' THR . . . . . 0.455 ' OG1' ' HA ' ' B' ' 181' ' ' ILE . 17.4 p -86.2 17.94 3.39 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.367 -176.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 80.3 p -61.12 -15.61 35.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.665 -177.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.45 -40.21 95.86 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 121.029 -0.268 . . . . 0.0 110.729 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 187' ' ' ASP . . . . . 0.521 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.4 m-20 -71.42 114.14 9.18 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.433 0.635 . . . . 0.0 110.831 -177.243 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.38 -42.43 99.41 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 114.803 -1.09 . . . . 0.0 113.09 -178.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -111.82 130.97 55.64 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.221 -178.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 190' ' ' LEU . . . . . . . . . . . . . 41.9 tp -124.1 118.24 26.47 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.926 177.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 87.0 mt -106.93 125.91 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-N 117.759 0.254 . . . . 0.0 111.216 -177.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 49.8 mm -115.41 118.54 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 193' ' ' ASP . . . . . 0.522 ' CG ' ' HG ' ' B' ' 195' ' ' SER . 41.7 t0 -90.47 111.67 23.02 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -176.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 194' ' ' LEU . . . . . . . . . . . . . 96.2 mt -92.45 -1.61 56.87 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 123.624 0.577 . . . . 0.0 109.627 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 195' ' ' SER . . . . . 0.522 ' HG ' ' CG ' ' B' ' 193' ' ' ASP . 77.8 p -60.88 -36.81 80.17 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.794 -178.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.46 -34.72 89.36 Favored Glycine 0 N--CA 1.439 -1.105 0 N-CA-C 109.919 -1.273 . . . . 0.0 109.919 -178.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 197' ' ' LEU . . . . . 0.979 ' CD2' ' O ' ' B' ' 199' ' ' GLN . 5.4 tt -77.22 134.01 38.73 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 198' ' ' ALA . . . . . 0.959 ' N ' HD23 ' B' ' 197' ' ' LEU . . . -63.75 -44.96 91.92 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 119.954 -0.698 . . . . 0.0 111.572 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 199' ' ' GLN . . . . . 0.979 ' O ' ' CD2' ' B' ' 197' ' ' LEU . 58.4 tt0 -136.83 163.25 31.07 Favored 'General case' 0 C--O 1.212 -0.921 0 CA-C-O 122.202 1.001 . . . . 0.0 112.602 -177.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 200' ' ' VAL . . . . . 0.463 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 55.8 t -120.65 132.17 70.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 O-C-N 120.382 -1.449 . . . . 0.0 109.583 177.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -89.7 150.24 22.41 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.79 -178.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -61.38 -33.24 73.33 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.325 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -63.15 -32.99 74.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.435 0.636 . . . . 0.0 109.357 177.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.7 m -60.65 -44.24 96.65 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.291 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 205' ' ' ALA . . . . . 0.676 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -58.15 -29.64 65.73 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -178.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -65.63 -38.77 90.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.502 0.668 . . . . 0.0 110.519 174.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -66.2 -39.0 89.33 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.752 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 95.4 mt -62.86 -45.72 98.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -178.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 209' ' ' PHE . . . . . 0.676 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 66.1 m-85 -61.22 -42.22 98.21 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.781 -176.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.0 -42.07 99.75 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.61 -0.836 . . . . 0.0 109.607 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 211' ' ' LEU . . . . . 0.685 HD21 ' CD2' ' B' ' 178' ' ' LEU . 39.4 mt -62.18 -42.3 99.14 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.106 -178.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 78.2 p -63.97 -35.74 81.68 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.385 -0.526 . . . . 0.0 112.0 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 213' ' ' HIS . . . . . 0.427 ' CE1' HD11 ' B' ' 217' ' ' LEU . 56.3 t-80 -66.92 -46.87 73.48 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.106 177.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.436 HD21 HD21 ' B' ' 182' ' ' LEU . 56.5 tp -63.96 -43.08 96.87 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.598 0.713 . . . . 0.0 109.88 177.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 215' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' B' ' 211' ' ' LEU . 84.9 mt -63.07 -44.46 95.74 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 113.544 -1.662 . . . . 0.0 111.368 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -61.69 -39.08 90.19 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.258 -177.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 217' ' ' LEU . . . . . 0.427 HD11 ' CE1' ' B' ' 213' ' ' HIS . 86.2 mt -62.86 -41.62 99.44 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.309 0.576 . . . . 0.0 111.023 176.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 218' ' ' THR . . . . . 0.404 HG23 ' O ' ' B' ' 214' ' ' LEU . 67.3 p -76.06 -16.26 59.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.641 -178.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 78.81 68.13 1.53 Allowed Glycine 0 CA--C 1.528 0.864 0 N-CA-C 107.573 -2.211 . . . . 0.0 107.573 -177.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 220' ' ' THR . . . . . . . . . . . . . 81.0 m -146.51 105.84 3.91 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 176.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -63.16 139.93 58.82 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.879 -175.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 40.6 tp -118.13 122.18 42.42 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.414 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 3.6 mp -112.25 129.19 68.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.249 -178.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 224' ' ' ILE . . . . . 0.539 ' CG2' HD11 ' B' ' 227' ' ' ILE . 49.5 mm -109.51 126.17 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 50.4 p -133.29 156.08 48.23 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.697 0.761 . . . . 0.0 112.559 -177.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 91.0 16.27 54.57 Favored Glycine 0 CA--C 1.504 -0.598 0 CA-C-N 114.018 -1.446 . . . . 0.0 111.319 -177.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 227' ' ' ILE . . . . . 0.592 HD12 HG23 ' B' ' 247' ' ' THR . 96.1 mt -81.48 126.48 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 118.046 0.923 . . . . 0.0 111.27 -178.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 64.3 tttt -66.24 140.23 96.74 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.392 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.71 -36.78 91.09 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.378 1.385 . . . . 0.0 112.554 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -64.0 -43.88 94.35 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -178.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 50.1 tp -61.64 -41.8 98.01 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.526 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.82 -37.1 86.12 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.881 -0.328 . . . . 0.0 111.314 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 94.7 mtp -63.83 -41.06 97.93 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.276 -0.57 . . . . 0.0 109.777 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.11 -43.71 97.68 Favored 'General case' 0 CA--C 1.553 1.082 0 CA-C-O 122.305 1.05 . . . . 0.0 109.589 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 37.9 mmt -63.96 -35.21 79.95 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.878 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -61.71 -39.99 93.45 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.989 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.7 -43.24 99.3 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 177.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 51.4 tp -61.83 -43.79 98.14 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.636 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 239' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' B' ' 240' ' ' ALA . 66.8 t0 -162.23 135.01 5.88 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.96 -178.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 240' ' ' ALA . . . . . 0.439 ' N ' ' OD1' ' B' ' 239' ' ' ASP . . . -62.09 -44.3 96.95 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 177.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 241' ' ' ASN . . . . . 0.626 ' O ' ' HB2' ' B' ' 244' ' ' SER . 89.3 m-20 -45.83 -20.2 0.08 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.289 -174.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 242' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -61.24 -45.66 93.62 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 120.083 -0.647 . . . . 0.0 110.402 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 243' ' ' SER . . . . . . . . . . . . . 77.7 p -55.96 -43.46 77.52 Favored 'General case' 0 C--O 1.225 -0.191 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 244' ' ' SER . . . . . 0.626 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 70.9 m -34.07 -33.22 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 -177.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 97.1 mt -89.96 132.56 35.27 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.667 178.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -58.69 136.78 57.77 Favored 'General case' 0 C--O 1.251 1.176 0 CA-C-O 121.833 0.825 . . . . 0.0 111.261 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 247' ' ' THR . . . . . 0.592 HG23 HD12 ' B' ' 227' ' ' ILE . 97.4 m -125.97 128.01 46.84 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.74 178.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 248' ' ' TYR . . . . . 0.49 ' CG ' ' HB2' ' B' ' 254' ' ' ALA . 95.9 m-85 -113.64 143.46 44.54 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 249' ' ' SER . . . . . 0.564 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 78.1 p -63.11 -35.8 81.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.855 0.36 . . . . 0.0 111.295 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 250' ' ' ASN . . . . . 0.564 ' OD1' ' O ' ' B' ' 249' ' ' SER . 98.6 m-20 -146.67 162.08 39.21 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.321 178.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 73.0 t -65.0 -44.74 95.99 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.175 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.924 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 252' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.38 -46.04 91.84 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -177.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 253' ' ' ASP . . . . . 0.476 ' O ' HG22 ' B' ' 257' ' ' VAL . 94.7 m-20 -61.43 -43.21 99.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.763 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 254' ' ' ALA . . . . . 0.49 ' HB2' ' CG ' ' B' ' 248' ' ' TYR . . . -65.3 -40.35 93.71 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.468 0.652 . . . . 0.0 111.08 178.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 255' ' ' VAL . . . . . . . . . . . . . 53.6 t -65.39 -45.35 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.277 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 256' ' ' LYS . . . . . 0.468 ' HE3' ' ND2' ' A' ' 155' ' ' ASN . 88.5 tttt -63.37 -48.33 78.39 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.113 -178.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 257' ' ' VAL . . . . . 0.476 HG22 ' O ' ' B' ' 253' ' ' ASP . 21.1 m -65.14 -40.22 88.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.519 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 258' ' ' LEU . . . . . 0.492 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 1.0 OUTLIER -31.9 -73.33 0.05 OUTLIER Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.826 -178.926 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 259' ' ' PRO . . . . . 0.543 ' O ' HG13 ' B' ' 260' ' ' ILE . 37.5 Cg_endo -62.25 141.47 87.98 Favored 'Trans proline' 0 N--CA 1.504 2.092 0 C-N-CA 121.572 1.515 . . . . 0.0 111.498 -178.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 260' ' ' ILE . . . . . 0.543 HG13 ' O ' ' B' ' 259' ' ' PRO . 96.9 mt -159.35 -16.48 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 118.587 0.63 . . . . 0.0 112.411 177.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 118.083 -0.96 . . . . 0.0 111.73 179.856 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 900' ' ' FMN . . . . . 0.466 HM73 ' N ' ' A' ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 900' ' ' FMN . . . . . 0.472 HM73 ' N ' ' B' ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.221 -1.551 . . . . 0.0 109.221 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.36 174.84 13.82 Favored 'General case' 0 CA--C 1.483 -1.624 0 CA-C-O 123.219 1.485 . . . . 0.0 109.746 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 93.9 p -80.12 -3.81 50.31 Favored 'General case' 0 CA--C 1.572 1.795 0 O-C-N 117.817 -3.052 . . . . 0.0 112.766 177.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -85.29 -64.64 1.12 Allowed 'General case' 0 C--N 1.267 -3.017 0 O-C-N 127.09 2.744 . . . . 0.0 112.304 174.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -70.06 -38.82 75.88 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.089 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.508 ' O ' ' NZ ' ' B' ' 17' ' ' LYS . 65.6 m -59.15 -41.76 89.07 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.862 -177.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.502 ' HB3' ' O ' ' A' ' 6' ' ' SER . 36.2 t80 85.14 87.33 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.364 0.602 . . . . 0.0 111.771 176.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.578 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -60.5 -142.76 0.01 OUTLIER Glycine 0 C--N 1.337 0.628 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.578 ' HB ' ' O ' ' A' ' 8' ' ' GLY . 78.0 mt 84.96 111.76 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.629 0 O-C-N 124.075 0.515 . . . . 0.0 110.655 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.68 -22.25 64.46 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.195 1.263 . . . . 0.0 112.219 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.41 -38.54 95.94 Favored Glycine 0 N--CA 1.465 0.578 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.228 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -64.86 -39.17 93.14 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 51.9 tp -63.06 -41.66 99.51 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -63.29 -40.31 97.0 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.6 t -60.76 -44.04 96.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 O-C-N 122.014 -0.429 . . . . 0.0 111.025 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 92.9 mt -62.32 -43.49 98.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 119.508 -0.877 . . . . 0.0 109.12 -177.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.441 ' NZ ' ' HA ' ' B' ' 6' ' ' SER . 98.8 mttt -62.54 -46.22 89.36 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 119.331 -0.948 . . . . 0.0 112.036 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.579 ' NZ ' HG12 ' B' ' 113' ' ' ILE . 98.6 mttt -60.23 -39.46 86.74 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 118.72 -1.192 . . . . 0.0 108.83 -176.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.35 -42.14 90.86 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 120.034 -0.666 . . . . 0.0 110.156 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.0 mt -62.99 -40.93 99.24 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -63.08 -38.85 92.83 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.949 -0.568 . . . . 0.0 112.525 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 54.4 m170 -58.44 -40.06 81.53 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 122.168 -0.332 . . . . 0.0 111.48 -178.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.0 p -114.85 130.52 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.478 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 33.3 ptt180 -72.09 111.63 7.48 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 122.126 0.965 . . . . 0.0 112.207 -177.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.6 p -141.31 143.1 28.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.571 ' O ' ' N ' ' A' ' 123' ' ' GLN . . . -97.81 90.65 1.09 Allowed Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.767 -178.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 54.4 t -124.38 129.81 73.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 176.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.3 m -137.38 159.77 35.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.6 mt -120.09 129.92 74.91 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.64 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 176.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.433 ' OG1' ' HB2' ' A' ' 119' ' ' PHE . 17.5 p -106.16 166.08 10.77 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.427 ' C ' ' OD1' ' A' ' 37' ' ' ASN . 44.3 t0 -132.78 101.7 13.98 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.534 ' CG ' HG23 ' A' ' 117' ' ' THR . 37.6 Cg_endo -64.64 -21.2 65.56 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.576 1.517 . . . . 0.0 111.572 -178.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.54 -33.61 75.28 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.399 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 88.9 mt -86.83 172.22 10.27 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.272 178.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.657 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 42.2 tt0 -67.58 133.06 48.74 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -178.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.567 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 62.8 t0 61.44 20.85 11.53 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 177.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.427 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 40.4 t-20 43.1 68.68 2.74 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.727 -177.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.657 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 88.1 Cg_endo -71.4 155.63 59.73 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 123.9 3.067 . . . . 0.0 112.39 -178.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.3 mt -87.91 124.35 41.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 O-C-N 124.047 0.842 . . . . 0.0 108.977 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.409 HG23 ' N ' ' A' ' 41' ' ' TYR . 27.6 m -105.18 -42.43 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 O-C-N 123.609 0.568 . . . . 0.0 112.332 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.409 ' N ' HG23 ' A' ' 40' ' ' VAL . 46.7 t80 -97.13 123.2 40.82 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 120.289 -0.564 . . . . 0.0 111.968 -178.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.6 p -142.56 139.73 28.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.918 177.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.684 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 55.7 p30 -95.78 165.96 12.04 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.47 ' HA ' ' OE1' ' A' ' 44' ' ' GLN . 14.0 mm100 -66.63 -39.82 88.45 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 177.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.57 -25.0 62.63 Favored Glycine 0 C--O 1.236 0.247 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.684 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 64.5 t80 -59.39 -48.48 81.47 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 105.221 -2.14 . . . . 0.0 105.221 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.569 HG13 ' O ' ' A' ' 52' ' ' TYR . 54.4 t -58.78 -44.7 90.83 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.554 0 O-C-N 121.088 -1.008 . . . . 0.0 111.623 -174.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -63.15 -35.81 81.52 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 120.441 -0.504 . . . . 0.0 112.278 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 60.9 ttm -68.08 -42.66 80.07 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 177.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 43.6 p -95.58 -20.59 18.86 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.358 0.599 . . . . 0.0 111.255 -177.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . 77.94 19.41 75.25 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.569 ' O ' HG13 ' A' ' 47' ' ' VAL . 75.0 m-85 -112.37 137.74 50.09 Favored 'General case' 0 C--O 1.222 -0.366 0 C-N-CA 122.569 0.348 . . . . 0.0 110.881 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -63.22 147.94 49.54 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.829 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.446 HG22 ' H ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -65.2 -33.79 76.84 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.983 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.61 -43.15 85.54 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.959 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -64.23 -45.12 89.6 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.354 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.575 HD13 ' CE2' ' A' ' 46' ' ' PHE . 96.1 mt -62.85 -48.37 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 -175.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.2 mt -57.49 144.99 34.72 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.03 -2.96 82.51 Favored Glycine 0 C--O 1.237 0.329 0 C-N-CA 121.062 -0.589 . . . . 0.0 113.534 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -134.78 151.47 50.99 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.916 1.358 . . . . 0.0 112.308 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.574 ' C ' ' H ' ' A' ' 63' ' ' ARG . 25.5 t-20 -81.57 149.38 28.66 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.343 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 71.4 m -61.96 16.15 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.515 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.574 ' H ' ' C ' ' A' ' 61' ' ' ASN . 36.5 ptt-85 -61.35 -41.52 97.19 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.973 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -55.91 -20.31 15.37 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.5 mt -68.77 -35.94 77.7 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.951 0.881 . . . . 0.0 112.064 177.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -64.92 136.85 57.3 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.877 -176.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.567 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -147.28 -149.09 4.89 Favored Glycine 0 CA--C 1.537 1.415 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -178.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.83 -40.03 96.14 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -177.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.47 ' O ' ' NE2' ' A' ' 93' ' ' GLN . 7.3 m-70 -76.32 -9.58 58.74 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.952 0.406 . . . . 0.0 111.003 -178.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.567 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 27.0 m -61.4 129.65 42.24 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.567 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -86.49 112.1 44.02 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.791 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -57.45 -31.12 90.44 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 121.966 1.777 . . . . 0.0 113.283 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.49 -40.67 96.1 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 120.499 -0.481 . . . . 0.0 110.815 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.422 ' OE1' ' HB ' ' A' ' 90' ' ' VAL . 79.2 mm-40 -65.53 -45.03 85.02 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.4 t -59.09 -43.62 89.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -177.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -63.87 -37.74 88.52 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.042 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -63.47 -39.79 95.39 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.497 0.665 . . . . 0.0 110.128 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.22 -44.04 97.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.96 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -62.66 -43.19 99.44 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 113.771 -1.558 . . . . 0.0 108.231 -179.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 99.3 m -61.16 -48.54 81.13 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.37 -41.34 96.94 Favored 'General case' 0 C--N 1.361 1.081 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.186 -172.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 90.2 mt -63.05 -40.08 96.65 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.632 -1.293 . . . . 0.0 111.582 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -63.03 -40.78 98.77 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -70.11 -25.19 63.39 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.457 177.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 51.5 tttt 65.23 42.81 3.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.413 -176.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -125.96 148.57 63.26 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -61.64 143.82 96.99 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.334 1.356 . . . . 0.0 112.928 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.93 141.34 31.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.457 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.945 HG23 ' OD1' ' A' ' 107' ' ' ASN . 99.6 m -128.1 120.33 27.17 Favored 'General case' 0 C--N 1.345 0.386 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 176.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.422 ' HB ' ' OE1' ' A' ' 74' ' ' GLU . 29.0 m -138.82 158.31 29.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.82 -0.173 . . . . 0.0 111.453 178.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -102.96 128.75 49.65 Favored 'General case' 0 C--O 1.247 0.931 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.459 ' O ' HG23 ' A' ' 92' ' ' ILE . 18.3 tt -137.55 129.45 41.0 Favored 'Isoleucine or valine' 0 C--N 1.378 1.837 0 CA-C-N 121.917 2.144 . . . . 0.0 112.363 177.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.47 ' NE2' ' O ' ' A' ' 69' ' ' HIS . 34.1 mt-30 -61.5 134.29 56.69 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.107 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -135.43 159.82 40.38 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.102 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.455 ' CE1' ' HA3' ' A' ' 67' ' ' GLY . 93.0 m-85 -118.46 137.22 53.32 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.49 ' HG3' ' CE1' ' A' ' 102' ' ' PHE . 99.2 mttt -85.97 -171.77 3.75 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.394 0.616 . . . . 0.0 111.754 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -62.99 -42.08 99.75 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.295 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 41.1 p-10 -84.8 8.12 18.39 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -178.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.84 -3.41 87.17 Favored Glycine 0 N--CA 1.473 1.108 0 C-N-CA 120.571 -0.824 . . . . 0.0 111.916 177.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.7 m -59.3 137.89 57.82 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 106.255 -1.758 . . . . 0.0 106.255 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.687 ' SD ' ' C ' ' A' ' 101' ' ' MET . 13.4 tmm? -107.01 129.29 54.82 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 122.184 -0.323 . . . . 0.0 111.032 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.49 ' CE1' ' HG3' ' A' ' 96' ' ' LYS . 52.9 p90 -140.61 158.62 43.71 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.404 -177.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.842 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 22.8 m95 -89.03 144.87 25.85 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.554 HD21 ' HG2' ' A' ' 123' ' ' GLN . 56.4 t-20 -139.0 102.06 4.44 Favored 'General case' 0 C--O 1.245 0.862 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -176.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 80.8 tt0 -67.27 136.43 54.91 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -177.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 40.2 tp -121.43 123.76 42.85 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -179.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.945 ' OD1' HG23 ' A' ' 89' ' ' THR . 98.1 m-20 -120.58 122.64 41.01 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 123.237 0.336 . . . . 0.0 110.742 177.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 96.3 mt -120.71 128.33 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 O-C-N 123.536 0.523 . . . . 0.0 111.505 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -138.24 125.14 13.26 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.17 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -71.56 152.12 59.36 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.399 2.066 . . . . 0.0 112.313 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.63 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 66.6 mtt -124.47 152.73 42.99 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -127.41 96.19 4.49 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 177.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.496 ' CD1' HG22 ' B' ' 15' ' ' VAL . 96.4 mt -120.34 131.28 73.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.184 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 51.13 38.33 20.6 Favored 'General case' 0 CA--C 1.511 -0.538 0 O-C-N 121.355 -0.84 . . . . 0.0 111.51 175.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 59.39 31.49 21.13 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 123.777 0.673 . . . . 0.0 111.049 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -129.55 148.73 51.48 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.76 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 7.4 t -86.58 -173.33 4.45 Favored 'General case' 0 C--O 1.209 -1.034 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -178.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.76 ' CD2' ' O ' ' A' ' 117' ' ' THR . 77.2 m-85 -170.5 155.71 5.16 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 175.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.433 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 83.7 m-85 -129.44 146.38 51.3 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 175.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -136.43 135.54 49.27 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 177.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.498 ' N ' HM73 ' A' ' 900' ' ' FMN . . . -111.12 130.28 9.69 Favored Glycine 0 CA--C 1.5 -0.89 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 178.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 96.2 mt -119.01 129.69 74.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.571 ' N ' ' O ' ' A' ' 26' ' ' GLY . 15.7 mp0 -119.67 115.27 23.59 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -116.46 113.07 22.32 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.647 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.464 ' OD1' ' N ' ' A' ' 126' ' ' ILE . 68.3 t0 -63.75 131.15 46.97 Favored 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -176.089 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.465 ' O ' HG22 ' A' ' 126' ' ' ILE . 2.6 mp -96.01 4.29 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 113.53 -1.668 . . . . 0.0 110.136 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 29.5 m -60.92 -42.45 98.14 Favored 'General case' 0 C--N 1.364 1.237 0 O-C-N 120.595 -1.316 . . . . 0.0 113.528 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -59.49 -43.06 93.41 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -63.0 -40.07 96.66 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.792 177.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.842 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.6 mttt -62.95 -40.81 98.79 Favored 'General case' 0 CA--C 1.504 -0.814 0 C-N-CA 118.277 -1.369 . . . . 0.0 110.187 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -61.43 -38.52 87.47 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.013 -178.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.763 ' CE2' HD11 ' A' ' 136' ' ' LEU . 86.6 t80 -61.76 -45.85 92.11 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.307 176.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.82 -38.29 90.53 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -62.44 -40.21 95.85 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.391 -0.524 . . . . 0.0 109.74 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 52.9 tp -61.05 -43.59 98.65 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -178.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.763 HD11 ' CE2' ' A' ' 132' ' ' TYR . 85.7 mt -62.72 -41.24 99.05 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.002 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -62.93 -41.5 99.49 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 119.337 -0.945 . . . . 0.0 109.672 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -60.14 -42.24 94.42 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -177.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 55.4 m -61.68 -41.36 97.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.851 176.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 144' ' ' THR . 84.6 mt -63.23 -41.41 99.11 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 178.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 88.3 m -61.54 -45.63 93.34 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.102 -177.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -65.19 -40.52 94.34 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 94.5 mt -64.7 -43.17 96.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 113.9 -1.5 . . . . 0.0 111.331 176.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.502 ' N ' ' O ' ' A' ' 140' ' ' LEU . 96.4 m -62.11 -46.01 90.96 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 120.372 -0.531 . . . . 0.0 112.371 -178.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.47 ' O ' ' OG1' ' A' ' 148' ' ' THR . . . -62.93 -39.77 95.6 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 118.95 -1.1 . . . . 0.0 109.451 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.4 mt -63.32 -42.71 99.0 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.719 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.0 p -59.6 -40.22 86.78 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -177.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.47 ' C ' ' O ' ' A' ' 147' ' ' SER . 12.6 m -26.72 80.64 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.524 0 O-C-N 127.54 3.025 . . . . 0.0 106.195 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.719 ' N ' ' O ' ' A' ' 147' ' ' SER . 19.3 Cg_exo -62.19 143.66 94.65 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 121.08 1.187 . . . . 0.0 113.651 -175.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.677 ' O ' HG23 ' A' ' 151' ' ' VAL . 8.9 tp -118.69 136.07 57.07 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 175.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.677 HG23 ' O ' ' A' ' 150' ' ' ILE . 89.1 t -169.25 92.59 0.55 Allowed Pre-proline 0 CA--C 1.508 -0.673 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 178.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -61.89 136.47 61.79 Favored 'Trans proline' 0 N--CA 1.487 1.105 0 CA-C-N 119.598 0.892 . . . . 0.0 110.086 -177.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.692 ' O ' ' HD2' ' A' ' 154' ' ' ARG . 45.4 mm -67.34 -45.25 86.29 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.526 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.381 178.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.692 ' HD2' ' O ' ' A' ' 153' ' ' ILE . 0.7 OUTLIER -157.71 -156.4 0.58 Allowed 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.422 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 63.1 t-20 -86.93 104.78 16.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.48 0.657 . . . . 0.0 110.971 -178.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.21 7.97 67.08 Favored Glycine 0 C--O 1.224 -0.494 0 CA-C-N 114.077 -1.42 . . . . 0.0 110.015 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.6 mt -123.92 123.66 67.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 175.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.7 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 57.6 m -132.74 151.69 51.92 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -139.84 142.44 36.6 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.333 0.587 . . . . 0.0 111.309 178.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 20.7 tp -131.34 81.19 66.01 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.322 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -69.29 150.01 70.56 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.712 2.274 . . . . 0.0 113.117 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 90.6 mt -119.62 126.72 51.85 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.792 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 55.4 t -124.11 131.6 72.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 117.68 167.8 14.34 Favored Glycine 0 N--CA 1.476 1.326 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.241 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.903 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 56.2 t30 -85.11 115.02 22.67 Favored 'General case' 0 C--O 1.204 -1.305 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.57 HD21 ' CZ ' ' A' ' 171' ' ' PHE . 47.8 tp -75.12 103.42 5.29 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -177.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.734 HG23 ' NE ' ' A' ' 170' ' ' ARG . 10.7 p -85.29 167.95 15.15 Favored 'General case' 0 C--O 1.226 -0.14 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.637 178.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.75 -33.59 76.21 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.33 -45.17 89.04 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.149 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.903 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 87.4 mtm180 -63.27 -33.37 75.36 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.219 -0.9 . . . . 0.0 112.267 178.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.57 ' CZ ' HD21 ' A' ' 166' ' ' LEU . 0.4 OUTLIER -54.5 -28.2 43.36 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 119.086 -0.483 . . . . 0.0 111.897 -177.586 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.634 ' O ' HG22 ' A' ' 175' ' ' VAL . 91.5 m-20 -60.97 -39.81 90.99 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 118.866 -1.134 . . . . 0.0 109.842 -177.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 66.9 m -59.4 -40.92 88.14 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 121.787 -0.571 . . . . 0.0 110.484 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 67.0 mt -63.63 -44.01 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 172' ' ' ASN . 33.7 m -62.53 -40.89 89.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -178.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' CYS . . . . . 0.432 ' N ' HG23 ' A' ' 175' ' ' VAL . 96.5 m -62.33 -34.53 76.81 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.312 178.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.569 ' O ' HG13 ' A' ' 181' ' ' ILE . 25.4 m -61.91 -19.59 62.85 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.931 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.636 ' CD2' HD21 ' A' ' 211' ' ' LEU . 84.9 mt -60.87 -41.58 96.23 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -177.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 19.5 m -59.53 -43.43 93.48 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.622 ' O ' ' OG ' ' A' ' 183' ' ' SER . 92.5 m-20 -61.85 -37.24 83.75 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-O 121.016 0.436 . . . . 0.0 110.719 178.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.569 HG13 ' O ' ' A' ' 177' ' ' THR . 66.0 mt -58.21 -38.68 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 O-C-N 121.296 -0.877 . . . . 0.0 109.437 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.52 HD21 HD21 ' A' ' 214' ' ' LEU . 87.0 mt -60.89 -40.6 93.67 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -177.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.622 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 77.1 p -61.53 -34.02 74.83 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.526 177.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 49.4 p -89.26 25.17 1.96 Allowed 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.634 0.254 . . . . 0.0 111.304 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 78.5 p -63.6 -21.51 66.4 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.846 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -59.76 -36.96 77.71 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.14 -178.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.7 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 98.8 m-20 -72.03 112.97 8.57 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.593 0.711 . . . . 0.0 110.853 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.88 -42.78 99.89 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 114.959 -1.018 . . . . 0.0 112.802 -177.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -113.37 131.61 55.92 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.802 -178.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 38.3 tp -121.08 128.49 52.65 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 96.1 mt -116.39 127.14 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 177.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.3 mm -112.68 126.98 70.14 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' ASP . . . . . 0.497 ' CG ' ' HG ' ' A' ' 195' ' ' SER . 40.1 t0 -95.13 119.56 33.84 Favored 'General case' 0 CA--C 1.56 1.352 0 CA-C-O 119.638 -0.22 . . . . 0.0 110.913 178.105 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 95.8 mt -99.64 -4.03 31.82 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 125.022 1.451 . . . . 0.0 111.06 176.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.497 ' HG ' ' CG ' ' A' ' 193' ' ' ASP . 78.4 p -63.12 -32.24 73.57 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -62.08 -44.38 97.84 Favored Glycine 0 CA--C 1.544 1.851 0 N-CA-C 108.103 -1.999 . . . . 0.0 108.103 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 1.068 ' CD2' ' O ' ' A' ' 199' ' ' GLN . 6.7 tt -67.37 128.76 37.62 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 112.536 -1.832 . . . . 0.0 109.284 -178.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.772 ' N ' HD23 ' A' ' 197' ' ' LEU . . . -60.53 -50.38 73.79 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-O 121.402 0.62 . . . . 0.0 110.476 -178.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 1.068 ' O ' ' CD2' ' A' ' 197' ' ' LEU . 59.1 tt0 -133.55 156.5 47.7 Favored 'General case' 0 C--O 1.209 -1.034 0 CA-C-N 114.445 -1.252 . . . . 0.0 114.328 -175.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.487 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 44.9 t -116.07 131.08 69.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 O-C-N 120.321 -1.487 . . . . 0.0 108.619 178.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -84.21 155.74 22.36 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.759 -179.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.59 -39.47 93.79 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.045 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -57.16 -31.98 65.95 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.3 m -61.52 -42.38 98.72 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.546 178.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.454 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -56.39 -39.7 73.39 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -177.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -61.19 -37.41 82.84 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.634 -0.427 . . . . 0.0 109.882 -178.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.0 -38.96 92.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.835 177.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.92 -44.63 99.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 C-N-CA 119.469 -0.893 . . . . 0.0 108.734 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' PHE . . . . . 0.454 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 68.9 m-85 -62.35 -43.59 98.46 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.001 -177.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.13 -42.01 98.81 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 118.882 -1.127 . . . . 0.0 109.181 -178.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.636 HD21 ' CD2' ' A' ' 178' ' ' LEU . 41.1 mt -62.11 -41.66 98.44 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 78.3 p -61.28 -42.19 98.22 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 118.936 -1.106 . . . . 0.0 110.351 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' HIS . . . . . 0.455 ' CE1' HD11 ' A' ' 217' ' ' LEU . 59.0 t-80 -63.42 -46.02 88.28 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.76 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.52 HD21 HD21 ' A' ' 182' ' ' LEU . 52.8 tp -62.49 -46.76 87.0 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 88.4 mt -62.02 -40.53 95.99 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.902 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.46 -44.5 95.8 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.292 -178.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.455 HD11 ' CE1' ' A' ' 213' ' ' HIS . 84.0 mt -61.76 -40.18 94.23 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 75.2 p -75.81 -11.66 60.02 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.239 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 83.1 37.05 13.21 Favored Glycine 0 C--N 1.343 0.939 0 C-N-CA 120.723 -0.751 . . . . 0.0 114.027 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 99.8 m -123.2 114.68 20.6 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.046 1.423 . . . . 0.0 112.022 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -65.65 138.08 57.76 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.268 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 42.9 tp -112.37 130.01 56.11 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 3.2 mp -117.61 132.56 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.617 ' CG2' HD11 ' A' ' 227' ' ' ILE . 49.4 mm -115.33 131.43 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 42.6 p -134.01 167.67 20.2 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 78.15 19.14 75.28 Favored Glycine 0 C--O 1.223 -0.537 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.617 HD11 ' CG2' ' A' ' 224' ' ' ILE . 97.4 mt -81.53 128.35 38.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 113.611 -1.294 . . . . 0.0 108.112 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -74.01 140.2 76.97 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.29 -38.92 88.7 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 120.99 1.127 . . . . 0.0 112.627 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -64.83 -38.7 91.86 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 121.351 0.596 . . . . 0.0 109.948 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 51.2 tp -63.64 -42.76 98.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.832 177.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.48 -37.99 89.46 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.73 -178.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 94.1 mtp -63.31 -40.4 97.23 Favored 'General case' 0 C--O 1.247 0.923 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.834 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -64.04 -39.38 93.96 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.755 177.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 33.1 mmt -65.94 -36.63 83.88 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.623 178.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -61.11 -41.48 96.76 Favored 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 121.367 -0.833 . . . . 0.0 109.413 -176.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.71 -40.68 93.14 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.618 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 54.5 tp -63.61 -41.55 98.3 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 176.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -168.18 124.63 1.05 Allowed 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.254 0.55 . . . . 0.0 112.454 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.66 -27.1 66.09 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.764 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -62.49 -26.42 68.52 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.789 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -56.23 -44.21 79.38 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -176.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 99.4 p -61.78 -20.59 63.75 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 123.766 0.666 . . . . 0.0 111.283 179.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 50.1 m -57.11 -33.77 67.68 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 94.7 mt -87.79 121.79 30.65 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 119.458 -0.897 . . . . 0.0 113.261 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -46.03 135.84 7.12 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.712 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.544 HG23 HD12 ' A' ' 227' ' ' ILE . 97.8 m -127.46 132.92 49.95 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.673 179.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 248' ' ' TYR . . . . . 0.457 ' CG ' ' HB2' ' A' ' 254' ' ' ALA . 95.1 m-85 -118.13 139.18 51.63 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.12 178.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 78.0 p -60.47 -41.76 94.83 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -178.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -144.46 160.78 40.52 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.824 0.821 . . . . 0.0 111.604 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 72.3 t -63.23 -44.43 99.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 114.586 -1.188 . . . . 0.0 112.25 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.57 -44.54 96.08 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.036 -0.665 . . . . 0.0 109.466 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' ASP . . . . . 0.569 ' O ' HG22 ' A' ' 257' ' ' VAL . 55.6 m-20 -63.83 -42.51 97.62 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.487 -178.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.457 ' HB2' ' CG ' ' A' ' 248' ' ' TYR . . . -63.88 -42.8 97.41 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 122.035 0.921 . . . . 0.0 109.791 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' VAL . . . . . 0.456 HG13 HH11 ' B' ' 154' ' ' ARG . 66.3 t -63.6 -45.71 96.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.157 -1.383 . . . . 0.0 111.143 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.84 -47.66 79.88 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.267 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 253' ' ' ASP . 33.3 m -66.48 -40.54 86.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 O-C-N 121.373 -0.829 . . . . 0.0 112.285 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.506 ' C ' ' O ' ' A' ' 257' ' ' VAL . 1.7 mt -28.64 -75.48 0.04 OUTLIER Pre-proline 0 N--CA 1.467 0.375 0 O-C-N 123.17 0.294 . . . . 0.0 111.607 -177.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 259' ' ' PRO . . . . . 0.494 ' CD ' ' CB ' ' A' ' 258' ' ' LEU . 42.7 Cg_endo -63.25 139.3 71.25 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 120.754 0.969 . . . . 0.0 111.943 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 259' ' ' PRO . 96.7 mt -151.74 -27.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 O-C-N 124.049 0.843 . . . . 0.0 111.962 178.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 78.0 mtm . . . . . 0 N--CA 1.475 0.789 0 CA-C-O 118.094 -0.955 . . . . 0.0 110.754 -177.425 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.49 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.13 165.32 36.33 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 79.4 p -66.96 -13.59 61.98 Favored 'General case' 0 CA--C 1.568 1.669 0 O-C-N 121.724 -0.61 . . . . 0.0 112.398 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -80.04 -63.25 1.45 Allowed 'General case' 0 C--N 1.311 -1.108 0 O-C-N 124.532 1.145 . . . . 0.0 109.379 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -67.05 -39.19 86.87 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.445 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.502 ' O ' ' HB3' ' B' ' 7' ' ' PHE . 66.6 m -59.68 -42.08 92.12 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.782 -177.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 7' ' ' PHE . . . . . 0.502 ' HB3' ' O ' ' B' ' 6' ' ' SER . 36.8 t80 85.85 90.96 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.573 177.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 8' ' ' GLY . . . . . 0.583 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -63.58 -141.85 0.02 OUTLIER Glycine 0 C--N 1.34 0.754 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.583 ' HB ' ' O ' ' B' ' 8' ' ' GLY . 78.5 mt 84.49 111.86 0.03 OUTLIER Pre-proline 0 CA--C 1.545 0.776 0 O-C-N 124.086 0.521 . . . . 0.0 110.796 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.79 -24.31 68.56 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 121.109 1.206 . . . . 0.0 111.783 -178.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.71 -40.43 98.76 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.604 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -64.87 -39.44 93.55 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.557 0.694 . . . . 0.0 109.234 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 50.3 tp -62.05 -42.28 99.02 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.454 -177.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -65.14 -31.15 72.19 Favored 'General case' 0 CA--C 1.562 1.439 0 CA-C-O 121.643 0.735 . . . . 0.0 110.805 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' VAL . . . . . 0.496 HG22 ' CD1' ' A' ' 113' ' ' ILE . 78.3 t -63.81 -46.27 94.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 113.119 -1.855 . . . . 0.0 111.276 177.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 95.0 mt -64.24 -43.71 97.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.761 -178.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 17' ' ' LYS . . . . . 0.508 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 98.9 mttt -63.35 -42.64 98.93 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.03 -40.91 99.15 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 119.105 -1.038 . . . . 0.0 109.726 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.32 -39.16 86.04 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.816 -178.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 84.2 mt -64.12 -42.02 97.0 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.383 0.611 . . . . 0.0 110.278 175.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -63.07 -39.08 93.65 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.831 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 53.0 m170 -57.63 -40.16 78.58 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 119.547 -0.263 . . . . 0.0 111.488 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 14.8 p -114.93 130.26 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.494 ' HG3' ' O ' ' B' ' 24' ' ' ARG . 33.2 ptt180 -71.7 109.97 5.95 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.888 0.851 . . . . 0.0 112.343 -177.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.2 p -143.19 133.53 22.16 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.8 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.514 177.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 26' ' ' GLY . . . . . 0.568 ' O ' ' N ' ' B' ' 123' ' ' GLN . . . -87.25 95.32 2.06 Favored Glycine 0 C--N 1.31 -0.87 0 C-N-CA 119.354 -1.403 . . . . 0.0 113.538 -177.092 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 49.7 t -125.54 129.11 72.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 174.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 27.6 m -139.01 156.49 27.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.58 0.229 . . . . 0.0 110.478 178.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 96.1 mt -117.98 126.88 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.61 177.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' B' ' 119' ' ' PHE . 24.1 p -106.65 157.42 17.71 Favored 'General case' 0 CA--C 1.505 -0.786 0 O-C-N 126.003 2.064 . . . . 0.0 108.688 -178.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -124.76 102.47 32.06 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 32' ' ' PRO . . . . . 0.464 ' CG ' HG23 ' B' ' 117' ' ' THR . 37.9 Cg_endo -65.54 -18.3 59.07 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 121.697 1.598 . . . . 0.0 111.473 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.24 -40.26 96.93 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.741 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 90.4 mt -76.47 -170.47 1.52 Allowed 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.823 -0.548 . . . . 0.0 111.234 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 35' ' ' GLU . . . . . 0.653 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 42.4 tt0 -82.04 131.25 35.24 Favored 'General case' 0 C--N 1.342 0.26 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.502 ' O ' ' OD1' ' B' ' 36' ' ' ASP . 66.3 t0 56.22 35.27 25.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.063 177.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 37' ' ' ASN . . . . . 0.444 ' C ' ' O ' ' B' ' 36' ' ' ASP . 28.3 t-20 33.3 70.34 0.81 Allowed Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.653 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 89.2 Cg_endo -72.66 154.19 54.47 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 123.434 2.756 . . . . 0.0 111.994 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 96.1 mt -86.47 128.81 39.17 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.401 HG23 ' N ' ' B' ' 41' ' ' TYR . 29.3 m -109.15 -42.82 5.6 Favored 'Isoleucine or valine' 0 C--N 1.341 0.231 0 O-C-N 123.681 0.613 . . . . 0.0 112.446 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 41' ' ' TYR . . . . . 0.401 ' N ' HG23 ' B' ' 40' ' ' VAL . 49.5 t80 -97.44 123.57 41.34 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.654 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 5.8 p -142.65 140.65 28.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.017 177.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 43' ' ' ASN . . . . . 0.721 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 57.4 p30 -99.98 160.73 14.09 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.289 179.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 44' ' ' GLN . . . . . 0.472 ' OE1' ' HA ' ' B' ' 44' ' ' GLN . 13.4 mm100 -62.94 -38.27 90.4 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.418 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.57 -25.63 63.48 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.721 ' HB2' ' OD1' ' B' ' 43' ' ' ASN . 60.5 t80 -60.03 -43.66 95.15 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 0.746 HG13 ' O ' ' B' ' 52' ' ' TYR . 53.7 t -61.07 -46.33 96.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.066 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -63.36 -43.55 97.36 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.244 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 60.8 ttm -63.06 -41.92 99.56 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 41.5 p -96.75 -16.11 21.03 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.729 -178.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 51' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' B' ' 47' ' ' VAL . . . 73.08 19.69 79.7 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 178.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 52' ' ' TYR . . . . . 0.746 ' O ' HG13 ' B' ' 47' ' ' VAL . 74.8 m-85 -111.25 145.1 39.34 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -73.78 147.48 43.41 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.897 0.856 . . . . 0.0 111.061 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 54' ' ' THR . . . . . 0.411 ' H ' HG22 ' B' ' 54' ' ' THR . 0.2 OUTLIER -61.79 -37.57 84.87 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.198 -177.43 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.04 -39.52 94.26 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 124.075 0.859 . . . . 0.0 111.322 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -72.86 -32.42 65.42 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 177.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.613 HD13 ' CE2' ' B' ' 46' ' ' PHE . 93.1 mt -67.32 -69.55 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 178.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 95.6 mt -39.36 132.36 1.48 Allowed 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.368 178.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.85 -7.45 76.88 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.516 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -132.4 149.1 52.41 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -176.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 61' ' ' ASN . . . . . 0.54 ' C ' ' H ' ' B' ' 63' ' ' ARG . 25.5 t-20 -79.17 150.07 31.8 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 114.572 -1.195 . . . . 0.0 110.843 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 62' ' ' CYS . . . . . . . . . . . . . 71.7 m -62.94 9.22 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.674 -178.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 63' ' ' ARG . . . . . 0.54 ' H ' ' C ' ' B' ' 61' ' ' ASN . 34.6 ptt-85 -59.4 -31.2 69.03 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.495 -178.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -61.54 -31.25 71.27 Favored 'General case' 0 C--O 1.239 0.531 0 O-C-N 121.878 -0.514 . . . . 0.0 111.922 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 92.4 mt -61.24 -44.28 97.51 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -178.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -46.59 144.11 2.38 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.424 0.631 . . . . 0.0 109.938 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 67' ' ' GLY . . . . . 0.555 ' N ' ' OG1' ' B' ' 70' ' ' THR . . . -155.39 -152.98 6.36 Favored Glycine 0 CA--C 1.543 1.817 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.656 176.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -60.97 -40.99 95.51 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.447 -0.376 . . . . 0.0 111.172 -175.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -75.6 -9.93 59.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.175 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 70' ' ' THR . . . . . 0.555 ' OG1' ' N ' ' B' ' 67' ' ' GLY . 25.0 m -60.66 133.52 56.18 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -90.55 111.72 49.1 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.453 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.39 -38.38 89.27 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 121.099 1.199 . . . . 0.0 111.882 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.99 -40.9 90.77 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.821 -176.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 74' ' ' GLU . . . . . 0.429 ' OE1' ' HB ' ' B' ' 90' ' ' VAL . 79.2 mm-40 -66.78 -39.35 87.78 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.835 178.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 71.0 t -62.59 -45.66 98.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -62.85 -37.28 86.23 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.748 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -62.48 -42.06 99.23 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.938 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.33 -43.79 98.77 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 CA-C-O 120.86 0.362 . . . . 0.0 110.735 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -61.58 -42.67 99.18 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 87.2 m -60.93 -46.58 90.12 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.79 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.86 -41.72 96.44 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -178.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 87.8 mt -62.13 -42.29 99.09 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -62.56 -39.89 95.09 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -80.2 -4.2 52.15 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.105 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 37.5 tttt 50.67 44.77 27.52 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.222 -0.591 . . . . 0.0 112.134 178.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -128.88 145.43 56.39 Favored Pre-proline 0 N--CA 1.467 0.383 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.15 140.1 81.87 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 120.905 1.07 . . . . 0.0 113.642 -178.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -140.12 136.59 37.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.909 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 89' ' ' THR . . . . . 0.941 HG23 ' OD1' ' B' ' 107' ' ' ASN . 97.4 m -122.24 122.68 39.69 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 178.185 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.429 ' HB ' ' OE1' ' B' ' 74' ' ' GLU . 30.7 m -139.4 162.82 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.854 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -113.63 120.82 42.23 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 176.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 20.6 tt -128.43 131.79 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.68 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -70.46 141.6 52.03 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.857 178.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 94' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -133.75 -179.75 5.73 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.261 0.553 . . . . 0.0 111.174 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 95' ' ' TYR . . . . . 0.461 ' CE1' ' HA3' ' B' ' 67' ' ' GLY . 96.3 m-85 -131.11 148.25 52.71 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.485 178.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 96' ' ' LYS . . . . . 0.495 ' HG3' ' CE1' ' B' ' 102' ' ' PHE . 98.7 mttt -104.35 -179.08 3.84 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.052 0.453 . . . . 0.0 110.693 177.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.72 -35.52 76.54 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.493 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 37.0 p-10 -87.37 -0.33 56.61 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.053 0.842 . . . . 0.0 112.954 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.02 3.23 65.8 Favored Glycine 0 N--CA 1.465 0.601 0 C-N-CA 121.152 -0.546 . . . . 0.0 111.892 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 24.7 m -68.16 129.56 40.3 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 101' ' ' MET . . . . . 0.569 ' SD ' ' N ' ' B' ' 102' ' ' PHE . 15.2 tmm? -90.46 142.99 27.18 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 102' ' ' PHE . . . . . 0.569 ' N ' ' SD ' ' B' ' 101' ' ' MET . 53.9 p90 -153.6 163.62 39.67 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 103' ' ' TRP . . . . . 0.851 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 23.6 m95 -95.25 140.19 30.5 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.018 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 104' ' ' ASN . . . . . 0.53 HD21 ' HG2' ' B' ' 123' ' ' GLN . 62.8 t-20 -133.71 105.63 6.93 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -176.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 105' ' ' GLU . . . . . 0.414 ' O ' ' HA ' ' B' ' 123' ' ' GLN . 81.4 tt0 -73.02 126.84 30.91 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.635 1.209 . . . . 0.0 109.02 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 39.4 tp -114.18 125.91 54.47 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 107' ' ' ASN . . . . . 0.941 ' OD1' HG23 ' B' ' 89' ' ' THR . 98.0 m-20 -119.92 127.86 53.08 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 176.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 96.2 mt -123.69 132.83 70.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -144.51 123.12 6.86 Favored Pre-proline 0 CA--C 1.538 0.483 0 O-C-N 123.482 0.488 . . . . 0.0 109.931 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -70.74 152.71 64.45 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 122.366 2.044 . . . . 0.0 112.618 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 111' ' ' MET . . . . . 0.489 ' HB2' ' HB2' ' B' ' 118' ' ' TYR . 66.4 mtt -129.18 144.09 51.09 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.18 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -113.58 111.21 21.5 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 113' ' ' ILE . . . . . 0.579 HG12 ' NZ ' ' A' ' 18' ' ' LYS . 96.8 mt -137.92 127.72 35.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 O-C-N 121.534 -0.729 . . . . 0.0 111.81 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 52.25 38.33 24.43 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 123.997 0.811 . . . . 0.0 109.626 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 61.54 36.15 17.08 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.538 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -133.8 151.66 51.64 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 117' ' ' THR . . . . . 0.464 HG23 ' CG ' ' B' ' 32' ' ' PRO . 8.8 t -102.76 154.08 19.52 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.262 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 118' ' ' TYR . . . . . 0.489 ' HB2' ' HB2' ' B' ' 111' ' ' MET . 96.8 m-85 -148.12 145.34 28.34 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.529 -0.732 . . . . 0.0 110.917 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 119' ' ' PHE . . . . . 0.431 ' O ' ' OG1' ' B' ' 30' ' ' THR . 86.4 m-85 -118.12 138.91 51.95 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.384 0.427 . . . . 0.0 111.347 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.5 p -128.22 136.15 60.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -178.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 121' ' ' GLY . . . . . 0.516 ' N ' HM73 ' B' ' 900' ' ' FMN . . . -112.2 127.88 8.27 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 122' ' ' ILE . . . . . 0.412 ' HB ' ' HB2' ' B' ' 107' ' ' ASN . 95.4 mt -117.63 128.62 74.82 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 123' ' ' GLN . . . . . 0.568 ' N ' ' O ' ' B' ' 26' ' ' GLY . 15.3 mp0 -119.12 121.54 40.02 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -120.31 121.18 38.07 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 125' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' B' ' 126' ' ' ILE . 68.3 t0 -69.12 134.16 48.97 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.083 -177.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.495 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 2.5 mp -107.3 17.16 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.493 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 127' ' ' THR . . . . . 0.461 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 98.2 m -63.36 -45.23 92.15 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 114.138 -1.392 . . . . 0.0 112.647 175.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 59.7 tptt -60.53 -45.6 93.27 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 129' ' ' GLN . . . . . 0.438 ' OE1' HG23 ' B' ' 126' ' ' ILE . 88.5 mt-30 -62.53 -36.57 83.04 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.484 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 130' ' ' LYS . . . . . 0.851 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 98.9 mttt -62.64 -41.7 99.19 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 112.737 -2.028 . . . . 0.0 111.115 174.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.5 -42.08 96.06 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 132' ' ' TYR . . . . . 0.762 ' CE2' HD11 ' B' ' 136' ' ' LEU . 88.1 t80 -60.76 -44.95 96.08 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.972 -0.455 . . . . 0.0 111.785 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 133' ' ' GLU . . . . . 0.43 ' O ' ' HG3' ' B' ' 137' ' ' GLU . 97.3 mt-10 -63.8 -36.49 84.06 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 119.932 -0.707 . . . . 0.0 109.367 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 134' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' B' ' 130' ' ' LYS . 98.9 mttt -62.41 -39.62 93.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.801 177.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 53.8 tp -62.28 -41.76 98.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.75 0.786 . . . . 0.0 109.451 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 136' ' ' LEU . . . . . 0.762 HD11 ' CE2' ' B' ' 132' ' ' TYR . 87.6 mt -63.02 -41.82 99.65 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.921 177.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 137' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' B' ' 133' ' ' GLU . 97.3 mt-10 -65.27 -36.45 84.13 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.508 -1.678 . . . . 0.0 110.276 -178.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -63.83 -43.79 95.16 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.106 -0.638 . . . . 0.0 109.649 177.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 68.2 m -61.14 -44.1 97.85 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 140' ' ' LEU . . . . . 0.468 ' O ' ' N ' ' B' ' 144' ' ' THR . 86.1 mt -61.74 -40.06 93.77 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -177.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 97.2 m -61.32 -45.58 93.85 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.059 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -66.39 -42.39 87.95 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 93.1 mt -63.52 -43.19 98.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 114.517 -1.219 . . . . 0.0 110.598 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 144' ' ' THR . . . . . 0.468 ' N ' ' O ' ' B' ' 140' ' ' LEU . 92.1 m -61.31 -45.12 95.76 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.13 -40.8 96.95 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 119.299 -0.96 . . . . 0.0 109.332 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 87.1 mt -64.55 -41.17 96.5 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 177.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 147' ' ' SER . . . . . 0.626 ' O ' ' N ' ' B' ' 149' ' ' PRO . 78.4 p -61.91 -40.91 97.08 Favored 'General case' 0 CA--C 1.476 -1.895 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 -178.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 148' ' ' THR . . . . . 0.491 ' C ' ' O ' ' B' ' 147' ' ' SER . 7.3 m -28.9 85.16 0.03 OUTLIER Pre-proline 0 C--N 1.353 0.738 0 O-C-N 123.745 0.653 . . . . 0.0 110.351 176.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 149' ' ' PRO . . . . . 0.626 ' N ' ' O ' ' B' ' 147' ' ' SER . 23.4 Cg_exo -61.89 146.71 96.29 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 C-N-CA 122.393 2.062 . . . . 0.0 115.57 -176.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 9.0 tp -126.67 119.81 54.47 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.21 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.036 174.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 59.3 t -151.26 93.41 3.61 Favored Pre-proline 0 C--N 1.295 -1.764 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.809 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -60.23 137.35 74.4 Favored 'Trans proline' 0 N--CA 1.489 1.238 0 CA-C-N 119.852 0.983 . . . . 0.0 109.569 -178.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 153' ' ' ILE . . . . . 0.721 ' O ' ' HD2' ' B' ' 154' ' ' ARG . 45.2 mm -68.7 -43.55 82.98 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.579 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 154' ' ' ARG . . . . . 0.721 ' HD2' ' O ' ' B' ' 153' ' ' ILE . 0.7 OUTLIER -157.16 -154.61 0.47 Allowed 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.449 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 62.0 t-20 -87.32 107.99 18.76 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.1 -18.39 55.73 Favored Glycine 0 CA--C 1.534 1.23 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 157' ' ' ILE . . . . . 0.429 HG22 ' HB ' ' B' ' 153' ' ' ILE . 85.1 mt -108.04 124.45 64.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.287 0.565 . . . . 0.0 111.16 -177.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 158' ' ' SER . . . . . 0.655 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 69.1 m -135.0 148.72 50.04 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.517 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -134.62 146.92 50.03 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 24.4 tp -137.61 80.73 31.29 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 161' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -70.63 147.73 57.9 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.666 2.244 . . . . 0.0 114.077 -178.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 90.5 mt -114.55 133.85 55.48 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 109.074 -0.714 . . . . 0.0 109.074 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 54.6 t -130.51 132.73 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 114.3 168.61 16.25 Favored Glycine 0 N--CA 1.471 0.984 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.512 178.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 165' ' ' ASN . . . . . 0.813 ' O ' ' CZ ' ' B' ' 170' ' ' ARG . 60.5 t30 -89.92 107.16 18.95 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -178.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 166' ' ' LEU . . . . . 0.588 HD21 ' CZ ' ' B' ' 171' ' ' PHE . 42.1 tp -65.02 104.73 0.91 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -174.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 167' ' ' THR . . . . . 0.7 HG23 ' NE ' ' B' ' 170' ' ' ARG . 10.0 p -85.38 169.57 13.57 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 113.828 -1.533 . . . . 0.0 110.83 177.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.57 -37.52 85.1 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.307 177.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.63 -39.9 88.49 Favored 'General case' 0 CA--C 1.553 1.09 0 CA-C-O 121.682 0.753 . . . . 0.0 111.798 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 170' ' ' ARG . . . . . 0.813 ' CZ ' ' O ' ' B' ' 165' ' ' ASN . 87.9 mtm180 -63.67 -36.04 82.51 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 113.193 -1.821 . . . . 0.0 110.475 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 171' ' ' PHE . . . . . 0.588 ' CZ ' HD21 ' B' ' 166' ' ' LEU . 0.4 OUTLIER -54.1 -25.55 22.52 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -178.194 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 172' ' ' ASN . . . . . 0.557 ' O ' HG22 ' B' ' 175' ' ' VAL . 92.9 m-20 -62.48 -40.53 96.96 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.672 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 59.7 m -60.12 -41.76 93.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.27 0.557 . . . . 0.0 110.51 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 67.4 mt -63.9 -44.21 97.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -179.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 175' ' ' VAL . . . . . 0.557 HG22 ' O ' ' B' ' 172' ' ' ASN . 29.8 m -62.61 -40.81 89.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -178.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 176' ' ' CYS . . . . . 0.433 ' N ' HG23 ' B' ' 175' ' ' VAL . 98.2 m -62.26 -35.44 78.97 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.291 178.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 177' ' ' THR . . . . . 0.596 ' O ' HG13 ' B' ' 181' ' ' ILE . 25.3 m -61.3 -19.45 61.78 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 178' ' ' LEU . . . . . 0.595 ' CD2' HD21 ' B' ' 211' ' ' LEU . 87.4 mt -60.97 -39.47 89.69 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.479 -178.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 18.2 m -62.03 -44.44 96.7 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.414 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 180' ' ' ASN . . . . . 0.574 ' O ' ' OG ' ' B' ' 183' ' ' SER . 92.1 m-20 -61.97 -40.3 95.12 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.121 0.486 . . . . 0.0 110.435 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.596 HG13 ' O ' ' B' ' 177' ' ' THR . 73.3 mt -56.35 -32.37 35.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 O-C-N 122.074 -0.391 . . . . 0.0 110.74 -178.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 182' ' ' LEU . . . . . 0.521 HD21 HD21 ' B' ' 214' ' ' LEU . 86.4 mt -62.66 -41.5 99.1 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 183' ' ' SER . . . . . 0.574 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.7 p -63.98 -32.91 74.61 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 122.129 -0.357 . . . . 0.0 110.593 177.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 44.6 p -85.88 17.96 3.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.766 0.317 . . . . 0.0 111.684 -178.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 78.6 p -60.59 -16.44 38.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.274 -177.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.82 -40.86 96.76 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.966 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 187' ' ' ASP . . . . . 0.655 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.3 m-20 -67.98 113.32 5.58 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.699 0.761 . . . . 0.0 110.776 -178.221 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.8 -42.39 99.69 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 114.697 -1.138 . . . . 0.0 113.102 -178.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -113.29 130.98 56.11 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.212 -178.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 190' ' ' LEU . . . . . 0.409 ' HA ' ' O ' ' B' ' 158' ' ' SER . 40.5 tp -123.72 118.16 26.59 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.908 178.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 84.2 mt -106.15 125.95 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-O 120.812 0.339 . . . . 0.0 111.303 -178.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 49.7 mm -114.51 117.58 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 193' ' ' ASP . . . . . 0.425 ' OD2' ' OG ' ' B' ' 195' ' ' SER . 41.9 t0 -88.43 114.62 25.23 Favored 'General case' 0 C--O 1.246 0.873 0 CA-C-O 121.65 0.738 . . . . 0.0 111.352 -177.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 194' ' ' LEU . . . . . . . . . . . . . 96.2 mt -97.1 -1.34 45.44 Favored 'General case' 0 C--N 1.356 0.858 0 O-C-N 120.39 -1.444 . . . . 0.0 110.067 176.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 195' ' ' SER . . . . . 0.425 ' OG ' ' OD2' ' B' ' 193' ' ' ASP . 78.4 p -61.19 -36.24 79.33 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 121.169 -0.213 . . . . 0.0 110.803 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.87 -35.42 91.29 Favored Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 197' ' ' LEU . . . . . 1.107 ' CD2' ' O ' ' B' ' 199' ' ' GLN . 7.0 tt -74.75 132.61 41.76 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 121.847 -0.796 . . . . 0.0 109.589 -178.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 198' ' ' ALA . . . . . 0.775 ' N ' HD23 ' B' ' 197' ' ' LEU . . . -61.33 -48.9 79.23 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 119.309 -0.957 . . . . 0.0 110.143 -178.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 199' ' ' GLN . . . . . 1.107 ' O ' ' CD2' ' B' ' 197' ' ' LEU . 57.1 tt0 -135.06 164.62 27.24 Favored 'General case' 0 C--O 1.21 -1.02 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -178.129 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 200' ' ' VAL . . . . . 0.54 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 48.3 t -119.44 130.95 73.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 119.506 -1.996 . . . . 0.0 109.403 177.047 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -87.26 150.84 23.62 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.122 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -61.49 -32.61 72.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.59 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -64.11 -32.78 74.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.2 m -60.89 -43.36 98.61 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.573 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 205' ' ' ALA . . . . . 0.687 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -58.63 -29.53 66.59 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 119.212 -0.423 . . . . 0.0 111.792 -178.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -65.75 -38.74 89.93 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 123.649 0.593 . . . . 0.0 109.68 176.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -66.57 -38.04 86.23 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.752 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 93.5 mt -63.68 -44.36 98.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -178.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 209' ' ' PHE . . . . . 0.687 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 66.9 m-85 -61.35 -43.56 98.66 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.618 179.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.39 -41.54 98.78 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.102 -1.039 . . . . 0.0 109.532 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 211' ' ' LEU . . . . . 0.595 HD21 ' CD2' ' B' ' 178' ' ' LEU . 39.9 mt -62.23 -41.94 98.86 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.316 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 78.3 p -63.3 -35.78 81.51 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 121.686 -0.634 . . . . 0.0 112.159 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 213' ' ' HIS . . . . . 0.43 ' CE1' HD11 ' B' ' 217' ' ' LEU . 58.8 t-80 -67.18 -46.83 72.77 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.839 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.521 HD21 HD21 ' B' ' 182' ' ' LEU . 54.1 tp -64.23 -43.06 96.13 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 122.069 0.938 . . . . 0.0 109.406 178.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.09 -43.74 97.66 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 113.617 -1.629 . . . . 0.0 111.379 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.12 -39.32 92.15 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.005 -177.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 217' ' ' LEU . . . . . 0.43 HD11 ' CE1' ' B' ' 213' ' ' HIS . 85.4 mt -63.7 -42.69 97.95 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.238 0.542 . . . . 0.0 111.51 176.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 218' ' ' THR . . . . . . . . . . . . . 75.9 p -74.11 -16.03 61.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.911 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 79.29 72.56 1.18 Allowed Glycine 0 CA--C 1.528 0.862 0 N-CA-C 106.517 -2.633 . . . . 0.0 106.517 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 220' ' ' THR . . . . . . . . . . . . . 93.2 m -151.85 98.2 2.44 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 177.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -56.13 139.76 46.29 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.204 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 43.1 tp -116.64 120.58 39.1 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.184 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 3.5 mp -109.13 129.23 64.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.241 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 224' ' ' ILE . . . . . 0.568 ' CG2' HD11 ' B' ' 227' ' ' ILE . 49.7 mm -111.7 126.94 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.57 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 44.5 p -134.78 157.77 45.88 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 91.07 17.55 50.57 Favored Glycine 0 CA--C 1.498 -1.027 0 CA-C-N 113.949 -1.478 . . . . 0.0 110.534 -177.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 227' ' ' ILE . . . . . 0.568 HD11 ' CG2' ' B' ' 224' ' ' ILE . 95.7 mt -83.59 125.77 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 O-C-N 121.363 -1.08 . . . . 0.0 111.355 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 56.2 tttt -63.93 139.67 97.7 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.368 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.77 -37.17 92.1 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 121.297 1.331 . . . . 0.0 112.539 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -63.83 -43.32 96.54 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 52.0 tp -61.87 -41.78 98.27 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.913 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.03 -36.51 84.24 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.801 0.334 . . . . 0.0 111.139 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 94.5 mtp -64.47 -40.64 96.07 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.78 -43.93 97.51 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 122.107 0.956 . . . . 0.0 109.004 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 33.5 mmt -63.82 -34.96 79.09 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.989 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -61.81 -40.21 94.44 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.774 -178.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.27 -43.85 96.79 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.156 178.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 52.5 tp -62.92 -44.75 95.24 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 120.137 -0.625 . . . . 0.0 112.039 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -156.51 132.32 9.62 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 120.551 -0.46 . . . . 0.0 112.001 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 240' ' ' ALA . . . . . 0.4 ' O ' ' N ' ' B' ' 242' ' ' PHE . . . -61.93 -47.94 82.66 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 176.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 241' ' ' ASN . . . . . 0.448 ' O ' ' HB2' ' B' ' 244' ' ' SER . 92.7 m-20 -42.69 -18.28 0.01 OUTLIER 'General case' 0 C--O 1.217 -0.615 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.556 -176.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 242' ' ' PHE . . . . . 0.4 ' N ' ' O ' ' B' ' 240' ' ' ALA . 89.1 t80 -60.81 -44.58 96.69 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 119.801 -0.759 . . . . 0.0 109.906 178.028 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 243' ' ' SER . . . . . . . . . . . . . 78.4 p -58.85 -42.42 89.31 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 -178.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 244' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 20.5 m -33.84 -33.04 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 99.1 mt -91.69 130.37 37.5 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 121.458 -0.776 . . . . 0.0 111.889 177.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -57.59 134.76 56.42 Favored 'General case' 0 CA--C 1.502 -0.881 0 O-C-N 121.317 -0.864 . . . . 0.0 111.726 -175.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 247' ' ' THR . . . . . 0.566 HG23 HD12 ' B' ' 227' ' ' ILE . 96.3 m -125.25 127.66 47.08 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.917 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 248' ' ' TYR . . . . . 0.49 ' CG ' ' HB2' ' B' ' 254' ' ' ALA . 97.6 m-85 -112.98 144.26 42.86 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 177.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 249' ' ' SER . . . . . 0.595 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 79.4 p -64.23 -33.46 75.86 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.218 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 250' ' ' ASN . . . . . 0.595 ' OD1' ' O ' ' B' ' 249' ' ' SER . 98.8 m-20 -147.94 159.61 43.69 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 124.509 1.13 . . . . 0.0 111.937 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 77.7 t -64.34 -44.15 97.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.443 -0.798 . . . . 0.0 112.293 178.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 252' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -60.78 -46.15 91.61 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -177.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 253' ' ' ASP . . . . . 0.594 ' O ' HG22 ' B' ' 257' ' ' VAL . 94.3 m-20 -61.37 -43.05 99.53 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.924 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 254' ' ' ALA . . . . . 0.49 ' HB2' ' CG ' ' B' ' 248' ' ' TYR . . . -65.85 -40.25 91.54 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.913 178.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 255' ' ' VAL . . . . . 0.617 HG13 HH11 ' A' ' 154' ' ' ARG . 67.3 t -65.14 -45.71 93.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.043 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.56 -48.55 78.98 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 120.204 -0.598 . . . . 0.0 111.614 -178.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 257' ' ' VAL . . . . . 0.594 HG22 ' O ' ' B' ' 253' ' ' ASP . 32.6 m -65.22 -40.63 89.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.678 -1.146 . . . . 0.0 111.302 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 258' ' ' LEU . . . . . 0.523 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 1.6 mt -32.25 -73.76 0.05 OUTLIER Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.589 -177.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 259' ' ' PRO . . . . . 0.523 ' CD ' ' CB ' ' B' ' 258' ' ' LEU . 36.3 Cg_endo -61.76 140.76 87.62 Favored 'Trans proline' 0 N--CA 1.505 2.155 0 C-N-CA 121.49 1.46 . . . . 0.0 111.133 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 260' ' ' ILE . . . . . 0.56 HG22 ' O ' ' B' ' 260' ' ' ILE . 96.7 mt -159.11 -13.82 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 O-C-N 121.33 -0.856 . . . . 0.0 112.204 177.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 C--O 1.216 -0.71 0 CA-C-O 117.792 -1.099 . . . . 0.0 111.353 -179.381 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 900' ' ' FMN . . . . . 0.498 HM73 ' N ' ' A' ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 900' ' ' FMN . . . . . 0.516 HM73 ' N ' ' B' ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.026 -1.629 . . . . 0.0 109.026 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.413 ' O ' ' OG ' ' A' ' 6' ' ' SER . . . -152.2 165.07 35.99 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.373 0.606 . . . . 0.0 110.201 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 80.8 p -70.53 -18.28 62.94 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.084 -1.01 . . . . 0.0 112.112 177.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -71.75 -65.07 0.81 Allowed 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 114.18 -1.373 . . . . 0.0 112.574 174.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -68.1 -37.77 81.55 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.99 0.424 . . . . 0.0 112.089 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.518 ' O ' ' HB3' ' A' ' 7' ' ' PHE . 70.9 m -59.44 -42.17 91.31 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -177.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.518 ' HB3' ' O ' ' A' ' 6' ' ' SER . 42.5 t80 83.95 86.93 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.134 0.493 . . . . 0.0 111.865 176.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.603 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -62.49 -142.92 0.01 OUTLIER Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 -178.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.603 ' HB ' ' O ' ' A' ' 8' ' ' GLY . 74.5 mt 85.64 110.27 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 122.701 0.4 . . . . 0.0 110.538 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.7 -22.35 69.82 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 121.389 1.393 . . . . 0.0 112.175 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.417 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -63.83 -38.22 95.82 Favored Glycine 0 N--CA 1.467 0.706 0 C-N-CA 121.138 -0.553 . . . . 0.0 111.919 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -65.18 -39.27 92.66 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.41 0.624 . . . . 0.0 109.614 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.2 tp -63.44 -41.15 98.67 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -63.73 -40.31 96.44 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 11' ' ' GLY . 56.3 t -60.31 -44.36 95.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 O-C-N 122.199 -0.313 . . . . 0.0 110.892 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 92.2 mt -62.78 -43.61 98.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.407 -178.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.27 -46.04 90.58 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 119.491 -0.883 . . . . 0.0 112.119 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.503 ' HZ1' HG12 ' B' ' 113' ' ' ILE . 98.4 mttt -60.39 -39.86 88.83 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 118.51 -1.276 . . . . 0.0 109.187 -176.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.84 -42.1 92.83 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.286 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 20' ' ' LEU . 87.8 mt -62.83 -40.95 99.0 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 178.05 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -63.92 -37.65 88.19 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.505 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 60.0 m170 -58.55 -40.15 82.2 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 122.221 -0.299 . . . . 0.0 111.417 -178.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.3 p -114.4 130.01 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.517 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 36.2 ptt180 -71.85 110.46 6.38 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-O 122.016 0.912 . . . . 0.0 112.229 -177.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.9 p -141.31 144.13 26.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 123' ' ' GLN . . . -97.55 90.99 1.14 Allowed Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.786 -178.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 51.4 t -124.23 129.26 74.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 176.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.7 m -137.49 159.78 34.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.7 mt -121.71 130.36 74.67 Favored 'Isoleucine or valine' 0 C--O 1.245 0.868 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 177.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.4 p -106.35 167.85 9.55 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.448 ' C ' ' OD1' ' A' ' 37' ' ' ASN . 44.0 t0 -134.5 102.42 11.62 Favored Pre-proline 0 C--N 1.32 -0.716 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.389 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.478 ' HG3' HG23 ' A' ' 117' ' ' THR . 36.4 Cg_endo -63.17 -23.08 73.07 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 121.453 1.436 . . . . 0.0 111.503 -178.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.97 -35.88 81.63 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.66 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.413 ' HB2' ' HD2' ' A' ' 38' ' ' PRO . 95.2 mt -84.31 157.35 21.54 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.498 177.163 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.71 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 43.3 tt0 -58.37 136.01 57.33 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -176.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.566 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 62.4 t0 60.29 22.8 12.25 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.448 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 42.4 t-20 38.16 70.06 1.35 Allowed Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.244 -176.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.71 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 92.7 Cg_endo -71.13 156.3 59.8 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 123.948 3.099 . . . . 0.0 112.121 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.6 mt -88.1 125.22 41.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.439 HG23 ' N ' ' A' ' 41' ' ' TYR . 33.9 m -104.8 -42.59 7.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.025 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.439 ' N ' HG23 ' A' ' 40' ' ' VAL . 48.9 t80 -97.68 123.76 41.73 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.809 -177.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.9 p -143.06 140.85 26.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 124.303 1.002 . . . . 0.0 109.215 177.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.599 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 57.3 p30 -98.41 166.99 11.11 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.517 ' HA ' ' OE1' ' A' ' 44' ' ' GLN . 13.2 mm100 -66.4 -38.81 88.33 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 120.988 0.423 . . . . 0.0 111.933 177.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.27 -26.86 64.47 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.659 ' CD2' HD13 ' A' ' 57' ' ' ILE . 66.3 t80 -59.03 -48.43 81.63 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.603 HG13 ' O ' ' A' ' 52' ' ' TYR . 61.3 t -59.41 -45.09 93.82 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 O-C-N 121.312 -0.868 . . . . 0.0 111.573 -174.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -63.64 -37.73 88.44 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 120.412 -0.515 . . . . 0.0 112.383 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 60.4 ttm -66.65 -43.01 85.76 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 114.258 1.206 . . . . 0.0 114.258 176.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 34.9 p -93.75 -20.4 20.15 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.272 0.558 . . . . 0.0 111.453 -177.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.28 21.6 72.75 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.603 ' O ' HG13 ' A' ' 47' ' ' VAL . 81.1 m-85 -115.9 138.21 51.38 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 122.909 0.484 . . . . 0.0 111.213 179.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -63.65 148.24 49.51 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.662 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.451 HG22 ' H ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -65.57 -32.36 73.9 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -66.21 -45.01 82.25 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 119.351 -0.94 . . . . 0.0 111.359 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -63.47 -45.44 90.8 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 119.939 -0.704 . . . . 0.0 109.749 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.659 HD13 ' CD2' ' A' ' 46' ' ' PHE . 90.6 mt -62.1 -48.99 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -175.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 79.0 mt -57.11 146.04 29.01 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 176.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.96 -3.91 82.27 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.875 -0.679 . . . . 0.0 113.121 177.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -137.47 151.7 48.75 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.879 1.34 . . . . 0.0 111.9 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.556 ' C ' ' H ' ' A' ' 63' ' ' ARG . 25.6 t-20 -81.23 151.92 27.91 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.701 -178.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 83.6 m -63.67 16.44 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.276 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.556 ' H ' ' C ' ' A' ' 61' ' ' ASN . 36.4 ptt-85 -62.47 -40.81 97.85 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 122.054 -0.404 . . . . 0.0 111.282 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -56.03 -21.53 22.12 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 84.0 mt -68.22 -35.24 77.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 122.003 0.906 . . . . 0.0 113.011 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -65.12 143.05 58.14 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.904 -1.044 . . . . 0.0 112.238 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.534 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -154.2 -147.57 4.7 Favored Glycine 0 CA--C 1.538 1.484 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 -177.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -63.21 -41.1 99.1 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -177.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.596 ' O ' ' NE2' ' A' ' 93' ' ' GLN . 7.7 m80 -77.1 -8.56 57.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.955 0.407 . . . . 0.0 111.086 -177.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.534 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 26.6 m -63.04 130.28 44.01 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.657 -178.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -85.4 109.55 22.4 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.8 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 70' ' ' THR . 50.9 Cg_exo -56.92 -32.08 91.44 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.023 1.815 . . . . 0.0 113.19 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.59 -39.64 94.1 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.975 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.485 ' OE1' ' HB ' ' A' ' 90' ' ' VAL . 78.9 mm-40 -65.84 -43.54 88.21 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.8 t -59.45 -43.83 91.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -176.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -63.88 -37.97 89.35 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.027 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -63.63 -39.67 94.95 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.243 0.544 . . . . 0.0 110.156 178.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.77 -44.47 98.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.154 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -63.01 -42.71 99.9 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 113.831 -1.531 . . . . 0.0 108.36 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 96.4 m -61.64 -48.85 78.99 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.04 -41.69 92.83 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.185 -172.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 83.0 mt -63.0 -39.55 95.11 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.025 -1.047 . . . . 0.0 111.319 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -64.17 -32.59 74.22 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 177.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -90.22 0.59 57.13 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.302 -178.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.2 tttt 45.46 35.94 2.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.55 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -119.13 143.8 34.79 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -61.39 143.39 97.66 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.62 1.546 . . . . 0.0 113.674 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -140.12 143.25 30.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.697 -177.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.897 HG23 ' OD1' ' A' ' 107' ' ' ASN . 99.9 m -128.46 120.59 27.14 Favored 'General case' 0 C--N 1.345 0.394 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 176.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.485 ' HB ' ' OE1' ' A' ' 74' ' ' GLU . 27.8 m -138.75 157.61 29.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.73 -0.214 . . . . 0.0 111.461 177.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -101.93 133.76 46.21 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 177.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.428 ' O ' HG23 ' A' ' 92' ' ' ILE . 19.0 tt -141.18 131.9 27.06 Favored 'Isoleucine or valine' 0 C--N 1.378 1.833 0 CA-C-N 121.61 2.005 . . . . 0.0 112.417 176.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.596 ' NE2' ' O ' ' A' ' 69' ' ' HIS . 34.4 mt-30 -64.6 133.74 52.9 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.884 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -134.85 158.57 43.87 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.8 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -116.5 134.7 54.54 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.514 ' HG3' ' CE1' ' A' ' 102' ' ' PHE . 99.1 mttt -83.7 -171.76 3.77 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.184 0.516 . . . . 0.0 111.76 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.46 -43.48 98.71 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.941 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.41 ' CG ' ' HG1' ' A' ' 100' ' ' THR . 42.5 p-10 -84.31 7.17 20.22 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.08 -0.4 87.5 Favored Glycine 0 N--CA 1.471 0.97 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.185 176.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.41 ' HG1' ' CG ' ' A' ' 98' ' ' ASP . 23.5 m -58.93 139.15 56.99 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 178.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.622 ' SD ' ' C ' ' A' ' 101' ' ' MET . 13.8 tmm? -105.06 127.28 52.81 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.593 0.235 . . . . 0.0 110.506 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.514 ' CE1' ' HG3' ' A' ' 96' ' ' LYS . 52.7 p90 -141.68 156.12 45.65 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.958 -177.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.721 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 24.4 m95 -88.66 143.98 26.58 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.547 HD21 ' HG2' ' A' ' 123' ' ' GLN . 56.4 t-20 -138.1 100.82 4.25 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -177.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.408 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 80.6 tt0 -66.32 136.57 56.0 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -177.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 40.3 tp -122.23 122.94 40.31 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.897 ' OD1' HG23 ' A' ' 89' ' ' THR . 97.8 m-20 -118.67 122.61 42.93 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.71 177.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 96.4 mt -120.31 128.64 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 O-C-N 123.535 0.522 . . . . 0.0 111.635 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -139.85 123.03 10.42 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 116.714 -0.221 . . . . 0.0 110.933 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -70.98 152.13 62.75 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 122.451 2.101 . . . . 0.0 112.368 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.661 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 66.8 mtt -122.82 154.32 38.38 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -128.74 94.12 3.78 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 176.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.462 ' CD1' HG22 ' B' ' 15' ' ' VAL . 96.1 mt -118.51 130.78 72.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.19 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 52.5 38.51 25.76 Favored 'General case' 0 CA--C 1.512 -0.501 0 O-C-N 121.414 -0.804 . . . . 0.0 111.774 176.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 58.27 30.22 19.18 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 123.844 0.715 . . . . 0.0 110.833 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -128.2 149.09 50.6 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.173 -0.676 . . . . 0.0 109.173 177.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.756 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 5.2 t -86.1 -172.25 3.98 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 118.538 0.608 . . . . 0.0 109.514 -177.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.756 ' CD2' ' O ' ' A' ' 117' ' ' THR . 65.1 m-85 -171.69 156.26 4.26 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 175.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -131.34 146.49 52.31 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 174.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -134.94 135.18 53.17 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 177.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.464 ' HA3' ' H6 ' ' A' ' 900' ' ' FMN . . . -108.75 129.2 9.42 Favored Glycine 0 CA--C 1.499 -0.908 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 178.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 96.6 mt -118.41 129.57 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.547 ' HG2' HD21 ' A' ' 104' ' ' ASN . 13.9 mp0 -121.05 113.3 19.85 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.641 0.588 . . . . 0.0 109.609 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -113.57 112.79 24.12 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.959 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -62.39 128.22 35.01 Favored 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -175.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.478 ' O ' HG22 ' A' ' 126' ' ' ILE . 3.0 mt -93.53 2.29 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 113.511 -1.677 . . . . 0.0 110.199 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 20.1 m -60.56 -42.38 96.49 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.979 -1.076 . . . . 0.0 113.671 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -59.96 -42.34 93.87 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -178.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -63.01 -39.56 95.12 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.927 177.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.721 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.7 mttt -62.85 -40.79 98.54 Favored 'General case' 0 CA--C 1.502 -0.877 0 C-N-CA 118.292 -1.363 . . . . 0.0 110.621 -178.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.69 -37.93 85.92 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -178.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.672 ' CE2' HD11 ' A' ' 136' ' ' LEU . 90.7 t80 -61.67 -45.96 91.76 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.668 175.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.23 -38.93 92.81 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 120.167 -0.613 . . . . 0.0 109.539 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.07 -40.21 95.02 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 52.7 tp -60.65 -43.86 97.1 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -176.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.672 HD11 ' CE2' ' A' ' 132' ' ' TYR . 84.9 mt -62.26 -40.87 97.63 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -61.84 -41.73 98.16 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 119.398 -0.921 . . . . 0.0 109.852 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -60.81 -41.96 96.7 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -177.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.0 m -61.94 -41.14 97.63 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.877 176.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 144' ' ' THR . 87.9 mt -63.49 -41.8 98.56 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.431 -0.508 . . . . 0.0 109.884 178.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 79.9 m -61.72 -45.59 93.3 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.271 -177.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -65.3 -39.67 92.83 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 94.7 mt -64.44 -43.57 96.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 113.991 -1.458 . . . . 0.0 111.365 176.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.454 ' N ' ' O ' ' A' ' 140' ' ' LEU . 99.3 m -62.49 -46.3 89.11 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.396 -0.522 . . . . 0.0 112.25 -178.264 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.45 -40.07 95.43 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 118.875 -1.13 . . . . 0.0 109.117 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 90.1 mt -63.61 -42.8 98.19 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.689 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.1 p -60.57 -37.17 80.43 Favored 'General case' 0 C--O 1.218 -0.564 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -178.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.453 ' C ' ' O ' ' A' ' 147' ' ' SER . 27.5 m -30.06 82.82 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.41 0 O-C-N 127.003 2.689 . . . . 0.0 106.123 -176.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.689 ' N ' ' O ' ' A' ' 147' ' ' SER . 21.8 Cg_exo -62.29 144.62 95.56 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 CA-C-O 122.749 1.062 . . . . 0.0 114.432 -174.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.649 ' O ' HG23 ' A' ' 151' ' ' VAL . 8.9 tp -121.26 135.33 61.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 102.575 -3.12 . . . . 0.0 102.575 176.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 150' ' ' ILE . 65.5 t -169.74 94.35 0.51 Allowed Pre-proline 0 CA--C 1.507 -0.703 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 176.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -62.56 137.71 65.94 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 N-CA-C 109.843 -0.868 . . . . 0.0 109.843 -178.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.659 ' O ' ' HD2' ' A' ' 154' ' ' ARG . 45.5 mm -68.28 -44.57 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 119.991 -0.683 . . . . 0.0 110.151 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.659 ' HD2' ' O ' ' A' ' 153' ' ' ILE . 0.7 OUTLIER -156.76 -157.55 0.7 Allowed 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -86.74 104.91 16.57 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.559 0.695 . . . . 0.0 111.521 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.65 8.65 65.39 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 114.069 -1.423 . . . . 0.0 110.063 -177.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.463 HG12 ' HB2' ' A' ' 189' ' ' TYR . 96.5 mt -125.96 124.17 65.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 175.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.651 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 42.2 m -131.95 152.14 51.28 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -137.52 140.66 41.24 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.494 177.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 19.9 tp -131.21 78.49 72.49 Favored Pre-proline 0 N--CA 1.469 0.512 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.358 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -69.83 150.57 67.98 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.719 2.279 . . . . 0.0 113.033 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 92.3 mt -119.36 126.27 51.01 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.241 178.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 49.0 t -122.37 130.74 74.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 117.24 169.12 14.88 Favored Glycine 0 N--CA 1.48 1.619 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.3 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.876 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 53.6 t30 -86.19 114.7 23.23 Favored 'General case' 0 C--O 1.214 -0.803 0 CA-C-N 116.972 0.386 . . . . 0.0 110.109 -178.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.588 HD21 ' CZ ' ' A' ' 171' ' ' PHE . 47.1 tp -74.31 105.29 5.41 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -177.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.65 HG23 ' NE ' ' A' ' 170' ' ' ARG . 11.4 p -87.8 167.41 13.83 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.146 0.498 . . . . 0.0 110.489 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.88 -33.96 77.26 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.92 0.39 . . . . 0.0 111.862 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.58 -42.72 95.42 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.484 178.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.876 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 87.3 mtm180 -64.93 -33.65 76.52 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 124.169 0.988 . . . . 0.0 112.884 178.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.588 ' CZ ' HD21 ' A' ' 166' ' ' LEU . 0.4 OUTLIER -54.73 -28.32 47.29 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 118.913 -0.565 . . . . 0.0 112.39 -178.128 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.634 ' O ' HG22 ' A' ' 175' ' ' VAL . 90.2 m-20 -61.07 -40.69 94.64 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 118.892 -1.123 . . . . 0.0 109.939 -178.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 70.2 m -59.15 -41.41 88.25 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.71 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 67.3 mt -63.67 -44.01 98.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 172' ' ' ASN . 33.9 m -62.56 -40.63 89.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' CYS . . . . . 0.436 ' N ' HG23 ' A' ' 175' ' ' VAL . 97.7 m -62.27 -34.2 76.1 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.131 0.491 . . . . 0.0 110.435 177.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.501 ' O ' HG13 ' A' ' 181' ' ' ILE . 25.1 m -61.96 -19.74 63.09 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.026 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.624 ' CD2' HD21 ' A' ' 211' ' ' LEU . 85.6 mt -61.04 -40.89 95.32 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -177.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 18.9 m -59.11 -43.28 91.88 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.586 ' O ' ' OG ' ' A' ' 183' ' ' SER . 90.8 m-20 -61.92 -37.6 85.29 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 120.773 0.32 . . . . 0.0 110.829 178.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 177' ' ' THR . 70.3 mt -56.77 -37.17 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 121.515 -0.741 . . . . 0.0 109.765 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.509 HD21 HD21 ' A' ' 214' ' ' LEU . 85.9 mt -61.28 -40.74 95.26 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -177.132 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.586 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 78.1 p -62.22 -35.38 78.71 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.406 177.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 39.2 p -88.63 25.11 1.8 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.65 0.262 . . . . 0.0 111.456 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 78.1 p -65.36 -20.01 66.2 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.732 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.37 -37.46 80.8 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.986 -178.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.651 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 99.0 m-20 -72.73 114.26 10.68 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.489 0.662 . . . . 0.0 110.924 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.13 -42.05 99.42 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.926 -177.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' TYR . . . . . 0.463 ' HB2' HG12 ' A' ' 157' ' ' ILE . 97.1 m-85 -112.02 131.23 55.54 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.873 -178.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 38.0 tp -121.14 128.37 52.46 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 96.7 mt -117.33 128.4 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.9 mm -114.22 128.33 71.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' ASP . . . . . 0.524 ' CG ' ' HG ' ' A' ' 195' ' ' SER . 40.1 t0 -96.09 119.54 34.77 Favored 'General case' 0 CA--C 1.552 1.037 0 O-C-N 121.873 -0.517 . . . . 0.0 110.474 177.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 99.0 mt -98.38 -4.56 34.55 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.593 175.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.524 ' HG ' ' CG ' ' A' ' 193' ' ' ASP . 78.1 p -62.35 -33.46 74.76 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -62.42 -44.09 98.12 Favored Glycine 0 CA--C 1.534 1.243 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.938 HD23 ' N ' ' A' ' 198' ' ' ALA . 4.8 tt -68.96 128.51 36.96 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 112.788 -1.706 . . . . 0.0 108.495 -177.026 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.938 ' N ' HD23 ' A' ' 197' ' ' LEU . . . -59.68 -48.96 79.62 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 121.196 0.522 . . . . 0.0 110.703 -177.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.906 ' O ' ' CD2' ' A' ' 197' ' ' LEU . 57.9 tt0 -136.22 158.51 44.23 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 114.444 -1.253 . . . . 0.0 113.506 -173.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.47 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 46.9 t -118.72 132.28 69.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -89.53 156.79 18.39 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.296 -178.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.27 -39.94 94.97 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.104 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -57.59 -32.62 67.37 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.9 m -61.64 -42.24 98.62 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.609 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.448 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -57.5 -39.03 75.59 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -176.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -61.06 -36.35 79.38 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -64.81 -39.08 93.01 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.998 177.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 95.3 mt -63.29 -44.49 99.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -178.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' PHE . . . . . 0.448 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 75.1 m-85 -62.32 -43.36 98.99 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.6 -177.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.52 -41.93 99.18 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 119.07 -1.052 . . . . 0.0 109.105 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.624 HD21 ' CD2' ' A' ' 178' ' ' LEU . 38.3 mt -62.25 -41.5 98.5 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 78.2 p -61.36 -42.25 98.39 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.084 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 54.7 t60 -64.55 -45.66 86.14 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 120.626 -0.43 . . . . 0.0 111.372 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.509 HD21 HD21 ' A' ' 182' ' ' LEU . 47.8 tp -62.5 -45.76 91.51 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 118.909 -1.116 . . . . 0.0 108.379 179.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 211' ' ' LEU . 90.4 mt -62.74 -40.76 98.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.141 -177.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.62 -44.54 96.22 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.751 -178.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 84.5 mt -61.91 -39.88 93.54 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 66.8 p -74.95 -11.65 60.17 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.508 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.32 36.32 17.84 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 120.6 -0.809 . . . . 0.0 113.715 -178.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 97.0 m -123.21 117.29 24.98 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 119.174 1.487 . . . . 0.0 111.708 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -68.21 137.2 54.62 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.42 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 43.6 tp -111.81 130.86 55.67 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 2.8 mp -117.83 134.29 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.616 ' CG2' HD11 ' A' ' 227' ' ' ILE . 49.5 mm -115.67 131.31 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -178.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 44.2 p -134.3 165.57 24.81 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.916 -177.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 78.66 21.78 68.31 Favored Glycine 0 N--CA 1.464 0.528 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.677 HD12 HG23 ' A' ' 247' ' ' THR . 97.7 mt -83.83 128.22 39.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 113.87 -1.165 . . . . 0.0 108.291 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -77.4 141.07 65.44 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.33 -39.77 85.63 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 120.984 1.122 . . . . 0.0 112.629 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -63.04 -39.71 95.56 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.356 0.598 . . . . 0.0 110.16 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 52.4 tp -63.67 -42.64 98.02 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.904 177.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.45 -37.8 88.79 Favored 'General case' 0 CA--C 1.522 -0.109 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.991 -178.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 94.0 mtp -63.22 -41.3 99.11 Favored 'General case' 0 C--O 1.248 0.989 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.917 -178.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.96 -38.45 91.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.519 176.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 31.9 mmt -65.79 -37.61 86.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.576 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -61.11 -42.33 98.32 Favored 'General case' 0 CA--C 1.516 -0.33 0 O-C-N 121.55 -0.719 . . . . 0.0 109.401 -176.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.66 -41.59 95.34 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.524 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 54.5 tp -63.3 -41.5 98.96 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 177.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -167.58 124.26 1.14 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.299 0.571 . . . . 0.0 112.507 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.36 -26.6 65.21 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.55 -1.205 . . . . 0.0 110.625 178.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -62.37 -28.93 70.11 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.729 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -56.69 -44.51 81.56 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -176.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 95.2 p -60.93 -20.07 61.63 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 123.8 0.688 . . . . 0.0 111.15 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 31.1 m -55.79 -40.21 72.35 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 97.1 mt -81.4 122.44 27.49 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -43.1 133.51 3.83 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.028 177.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.677 HG23 HD12 ' A' ' 227' ' ' ILE . 93.8 m -127.48 133.83 49.86 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.89 177.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' TYR . . . . . 0.407 ' CG ' ' HB2' ' A' ' 254' ' ' ALA . 97.7 m-85 -119.02 139.65 51.35 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.173 179.204 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 78.0 p -61.86 -42.63 99.29 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -178.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -141.83 158.73 43.44 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.776 0.798 . . . . 0.0 111.641 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 63.3 t -62.39 -44.69 99.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 114.668 -1.151 . . . . 0.0 112.22 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.82 -44.18 97.25 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.207 -0.597 . . . . 0.0 109.434 -178.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' ASP . . . . . 0.573 ' O ' HG22 ' A' ' 257' ' ' VAL . 55.3 m-20 -63.87 -41.02 97.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.375 -178.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.407 ' HB2' ' CG ' ' A' ' 248' ' ' TYR . . . -64.2 -44.64 91.34 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.895 0.855 . . . . 0.0 109.832 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 255' ' ' VAL . . . . . 0.427 ' O ' ' HD2' ' A' ' 259' ' ' PRO . 76.6 t -63.18 -45.84 97.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 113.944 -1.48 . . . . 0.0 110.912 -178.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.33 -46.55 86.1 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.141 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.573 HG22 ' O ' ' A' ' 253' ' ' ASP . 32.1 m -68.11 -40.72 83.43 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 O-C-N 121.489 -0.757 . . . . 0.0 111.923 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.498 ' C ' ' O ' ' A' ' 257' ' ' VAL . 1.5 mt -29.49 -74.46 0.04 OUTLIER Pre-proline 0 C--O 1.234 0.237 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.538 -177.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 259' ' ' PRO . . . . . 0.491 ' O ' HG13 ' A' ' 260' ' ' ILE . 43.6 Cg_endo -63.57 140.34 74.79 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 120.778 0.986 . . . . 0.0 111.96 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.491 HG13 ' O ' ' A' ' 259' ' ' PRO . 96.6 mt -153.15 -29.5 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 123.914 0.759 . . . . 0.0 111.883 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 78.0 mtm . . . . . 0 N--CA 1.474 0.751 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.567 -176.831 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.434 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.11 155.45 34.05 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 81.0 p -57.98 -27.58 63.59 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.784 176.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -65.54 -63.58 1.06 Allowed 'General case' 0 N--CA 1.437 -1.114 0 CA-C-O 121.004 0.43 . . . . 0.0 111.7 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -66.72 -38.06 85.94 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.323 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.523 ' O ' ' HB3' ' B' ' 7' ' ' PHE . 69.4 m -59.8 -42.53 93.63 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.877 -177.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 7' ' ' PHE . . . . . 0.523 ' HB3' ' O ' ' B' ' 6' ' ' SER . 43.7 t80 84.83 90.85 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.387 177.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 8' ' ' GLY . . . . . 0.606 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -65.45 -142.6 0.04 OUTLIER Glycine 0 C--N 1.339 0.703 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.606 ' HB ' ' O ' ' B' ' 8' ' ' GLY . 74.1 mt 85.33 110.49 0.03 OUTLIER Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 122.634 0.374 . . . . 0.0 110.88 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -62.9 -24.42 74.24 Favored 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 121.314 1.343 . . . . 0.0 111.864 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.14 -40.75 98.98 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -64.21 -39.84 94.82 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.676 0.75 . . . . 0.0 109.292 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 49.2 tp -61.9 -42.38 99.01 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.419 -177.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -65.24 -32.82 74.68 Favored 'General case' 0 CA--C 1.562 1.413 0 CA-C-O 121.489 0.661 . . . . 0.0 110.624 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' VAL . . . . . 0.462 HG22 ' CD1' ' A' ' 113' ' ' ILE . 72.7 t -62.24 -46.48 96.34 Favored 'Isoleucine or valine' 0 C--O 1.244 0.774 0 CA-C-N 113.189 -1.823 . . . . 0.0 110.851 177.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 93.1 mt -64.08 -43.76 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.069 -178.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 17' ' ' LYS . . . . . 0.45 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 99.0 mttt -63.46 -42.07 98.63 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.52 -41.43 98.5 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 118.838 -1.145 . . . . 0.0 110.142 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.52 -39.01 86.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.891 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' B' ' 20' ' ' LEU . 87.9 mt -63.9 -42.25 97.48 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.369 0.604 . . . . 0.0 110.345 175.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -63.15 -38.47 91.28 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.019 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 57.7 m170 -57.43 -40.27 78.0 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 119.54 -0.267 . . . . 0.0 111.467 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 10.0 p -114.45 129.72 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.534 ' HG3' ' O ' ' B' ' 24' ' ' ARG . 36.0 ptt180 -71.43 108.59 4.93 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.736 0.779 . . . . 0.0 112.538 -177.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.9 p -143.11 134.16 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.857 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.602 177.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' GLY . . . . . 0.445 ' HA3' ' HB2' ' B' ' 123' ' ' GLN . . . -86.5 95.89 2.09 Favored Glycine 0 C--N 1.313 -0.742 0 C-N-CA 119.555 -1.307 . . . . 0.0 113.393 -177.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 47.0 t -125.34 128.62 72.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 174.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 34.6 m -139.09 157.23 28.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.48 178.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 96.1 mt -120.54 128.58 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 O-C-N 123.721 0.638 . . . . 0.0 111.787 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 23.2 p -108.69 157.24 18.72 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-N 112.819 -1.991 . . . . 0.0 108.602 -176.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.435 ' C ' ' OD1' ' B' ' 37' ' ' ASN . 43.3 t0 -125.46 102.97 29.2 Favored Pre-proline 0 CA--C 1.531 0.222 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -178.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 32' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 117' ' ' THR . 37.0 Cg_endo -64.14 -22.12 67.51 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 121.694 1.596 . . . . 0.0 111.431 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.84 -45.69 93.52 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.229 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 98.7 mt -70.64 176.88 3.82 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.786 -0.571 . . . . 0.0 111.404 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 35' ' ' GLU . . . . . 0.549 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 42.1 tt0 -78.23 131.37 37.1 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -175.213 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.516 ' O ' ' OD1' ' B' ' 36' ' ' ASP . 66.7 t0 58.2 36.91 26.12 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.582 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 37' ' ' ASN . . . . . 0.467 ' C ' ' O ' ' B' ' 36' ' ' ASP . 32.7 t-20 28.09 73.1 0.41 Allowed Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.549 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 91.9 Cg_endo -72.98 155.33 52.94 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 123.578 2.852 . . . . 0.0 111.732 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 96.3 mt -86.54 130.02 37.39 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.412 HG23 ' N ' ' B' ' 41' ' ' TYR . 34.5 m -109.39 -42.12 5.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 O-C-N 123.708 0.63 . . . . 0.0 112.378 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 41' ' ' TYR . . . . . 0.412 ' N ' HG23 ' B' ' 40' ' ' VAL . 51.2 t80 -98.73 124.1 43.36 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.485 -178.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 5.1 p -143.08 142.13 26.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 O-C-N 124.046 0.841 . . . . 0.0 109.279 177.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 43' ' ' ASN . . . . . 0.642 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 57.0 p30 -102.64 162.08 13.21 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.212 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 44' ' ' GLN . . . . . 0.506 ' OE1' ' HA ' ' B' ' 44' ' ' GLN . 12.7 mm100 -62.8 -37.42 86.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.373 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.41 -27.43 65.69 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.677 ' CE2' HD13 ' B' ' 57' ' ' ILE . 62.4 t80 -59.91 -43.52 94.83 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 0.752 HG13 ' O ' ' B' ' 52' ' ' TYR . 66.1 t -61.71 -46.61 96.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.218 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -63.67 -44.36 93.97 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.439 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 60.6 ttm -62.86 -41.99 99.59 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 32.2 p -96.04 -14.86 22.62 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.35 -0.54 . . . . 0.0 112.017 -177.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.54 19.96 79.27 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 177.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 52' ' ' TYR . . . . . 0.752 ' O ' HG13 ' B' ' 47' ' ' VAL . 81.9 m-85 -112.99 144.94 41.71 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 122.897 0.479 . . . . 0.0 110.128 178.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -73.62 148.58 42.74 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 121.884 0.85 . . . . 0.0 111.013 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 54' ' ' THR . . . . . 0.431 ' H ' HG22 ' B' ' 54' ' ' THR . 0.1 OUTLIER -63.15 -35.63 80.94 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.127 -177.466 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.41 -40.79 96.46 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.568 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -72.43 -32.73 66.56 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 177.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.677 HD13 ' CE2' ' B' ' 46' ' ' PHE . 93.5 mt -66.1 -73.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 58' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' B' ' 57' ' ' ILE . 94.6 mt -35.27 132.51 0.38 Allowed 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.362 174.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.85 -9.16 73.43 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.831 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -136.71 149.14 47.73 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -174.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 61' ' ' ASN . . . . . 0.514 ' C ' ' H ' ' B' ' 63' ' ' ARG . 25.9 t-20 -78.72 152.09 31.75 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.889 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 62' ' ' CYS . . . . . . . . . . . . . 82.8 m -64.53 8.67 0.1 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.342 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 63' ' ' ARG . . . . . 0.514 ' H ' ' C ' ' B' ' 61' ' ' ASN . 34.6 ptt-85 -58.85 -30.95 68.08 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.487 -178.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -61.55 -30.78 70.86 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 81.0 mt -61.76 -42.77 99.41 Favored 'General case' 0 C--O 1.24 0.589 0 O-C-N 122.005 -0.435 . . . . 0.0 109.87 -178.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -49.99 148.93 2.96 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 123.7 0.625 . . . . 0.0 109.846 -177.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 67' ' ' GLY . . . . . 0.48 ' N ' ' OG1' ' B' ' 70' ' ' THR . . . -160.57 -151.36 6.18 Favored Glycine 0 CA--C 1.54 1.656 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.339 175.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.4 -41.88 94.8 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 122.659 -0.318 . . . . 0.0 111.738 -175.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 69' ' ' HIS . . . . . 0.488 ' O ' ' NE2' ' B' ' 93' ' ' GLN . 8.3 m80 -75.81 -9.56 58.7 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 123.169 0.293 . . . . 0.0 111.406 -178.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 70' ' ' THR . . . . . 0.48 ' OG1' ' N ' ' B' ' 67' ' ' GLY . 24.5 m -61.35 135.79 57.82 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -91.08 109.28 34.25 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.283 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.96 -38.69 86.51 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 120.884 1.056 . . . . 0.0 111.888 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.52 -40.38 91.23 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 120.527 -0.469 . . . . 0.0 109.798 -176.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 74' ' ' GLU . . . . . 0.477 ' OE1' ' HB ' ' B' ' 90' ' ' VAL . 78.8 mm-40 -66.87 -38.6 86.63 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.667 177.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 85.3 t -61.74 -46.01 97.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -62.91 -37.34 86.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.738 -178.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -62.57 -41.96 99.26 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 119.359 -0.936 . . . . 0.0 108.672 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.47 -43.79 98.54 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.859 -178.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -62.48 -43.01 99.86 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 83.6 m -61.11 -45.29 95.3 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.965 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.53 -40.98 96.64 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -177.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 80.2 mt -63.18 -41.79 99.27 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -62.22 -35.42 78.86 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 84' ' ' ASN . . . . . 0.424 ' O ' ' C ' ' B' ' 85' ' ' LYS . 98.5 m-20 -91.16 10.25 27.79 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.604 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 85' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' B' ' 84' ' ' ASN . 30.7 tttt 38.08 37.82 0.17 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 120.509 -0.477 . . . . 0.0 112.037 176.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -120.66 140.69 30.94 Favored Pre-proline 0 N--CA 1.469 0.487 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.96 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 87' ' ' PRO . . . . . 0.401 ' HB3' ' OD2' ' B' ' 109' ' ' ASP . 27.0 Cg_exo -61.63 140.29 85.75 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 121.006 1.137 . . . . 0.0 114.011 -177.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -140.94 137.44 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -177.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 89' ' ' THR . . . . . 0.877 HG23 ' OD1' ' B' ' 107' ' ' ASN . 97.0 m -121.65 122.78 40.37 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.477 ' HB ' ' OE1' ' B' ' 74' ' ' GLU . 28.2 m -139.04 163.2 27.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.859 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -114.71 122.4 46.31 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.189 0.519 . . . . 0.0 109.638 175.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 92' ' ' ILE . . . . . 0.472 HD11 HG23 ' B' ' 70' ' ' THR . 20.5 tt -128.9 132.58 67.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 114.999 -1.0 . . . . 0.0 112.038 -175.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.488 ' NE2' ' O ' ' B' ' 69' ' ' HIS . 35.1 mt-30 -71.9 144.01 49.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.613 177.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 94' ' ' ASN . . . . . 0.439 ' ND2' ' O ' ' B' ' 93' ' ' GLN . 8.2 m120 -135.48 -178.69 5.23 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.353 0.596 . . . . 0.0 110.989 -176.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 95' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -132.42 145.12 50.97 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.634 -1.167 . . . . 0.0 111.829 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 96' ' ' LYS . . . . . 0.507 ' HG3' ' CE1' ' B' ' 102' ' ' PHE . 98.7 mttt -102.47 179.59 4.26 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.0 0.429 . . . . 0.0 110.917 178.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.82 -35.49 74.84 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.17 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 38.4 p-10 -88.08 -0.67 57.33 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 119.0 0.818 . . . . 0.0 112.738 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.47 5.89 64.77 Favored Glycine 0 N--CA 1.465 0.607 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.209 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 25.7 m -67.68 129.63 40.49 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.508 177.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 101' ' ' MET . . . . . 0.571 ' SD ' ' N ' ' B' ' 102' ' ' PHE . 14.9 tmm? -87.98 141.82 28.27 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 102' ' ' PHE . . . . . 0.571 ' N ' ' SD ' ' B' ' 101' ' ' MET . 53.2 p90 -154.81 162.08 41.24 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 103' ' ' TRP . . . . . 0.743 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 24.7 m95 -96.36 138.76 33.47 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.324 -0.551 . . . . 0.0 111.093 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 104' ' ' ASN . . . . . 0.51 HD21 ' HG2' ' B' ' 123' ' ' GLN . 64.0 t-20 -132.55 106.37 7.79 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 114.737 -1.119 . . . . 0.0 113.807 -177.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -75.49 123.92 26.28 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 124.286 0.992 . . . . 0.0 109.346 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 37.9 tp -111.61 126.02 54.56 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.075 0.464 . . . . 0.0 111.989 -177.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 107' ' ' ASN . . . . . 0.877 ' OD1' HG23 ' B' ' 89' ' ' THR . 97.6 m-20 -118.79 127.91 53.97 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 176.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 96.7 mt -123.79 133.11 70.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 109' ' ' ASP . . . . . 0.401 ' OD2' ' HB3' ' B' ' 87' ' ' PRO . 1.2 m-20 -146.6 120.9 5.23 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -69.48 153.34 70.35 Favored 'Trans proline' 0 N--CA 1.504 2.096 0 C-N-CA 122.581 2.187 . . . . 0.0 112.629 -178.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 111' ' ' MET . . . . . 0.536 ' HB2' ' HB2' ' B' ' 118' ' ' TYR . 66.5 mtt -128.74 144.02 51.07 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -113.49 108.68 17.51 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 178.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 113' ' ' ILE . . . . . 0.503 HG12 ' HZ1' ' A' ' 18' ' ' LYS . 96.7 mt -134.6 128.3 50.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 O-C-N 121.64 -0.663 . . . . 0.0 111.736 177.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 52.89 38.66 27.46 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 123.974 0.796 . . . . 0.0 109.695 178.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 60.55 35.94 20.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.53 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -134.55 152.03 51.5 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 117' ' ' THR . . . . . 0.424 HG23 ' HG3' ' B' ' 32' ' ' PRO . 9.5 t -102.62 152.92 20.62 Favored 'General case' 0 C--O 1.214 -0.812 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.298 -177.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 118' ' ' TYR . . . . . 0.536 ' HB2' ' HB2' ' B' ' 111' ' ' MET . 95.2 m-85 -147.46 147.17 29.92 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 121.349 -0.844 . . . . 0.0 111.465 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -122.89 139.2 54.29 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 120.975 0.416 . . . . 0.0 111.57 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -128.85 134.33 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -176.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 121' ' ' GLY . . . . . 0.509 ' HA3' ' H6 ' ' B' ' 900' ' ' FMN . . . -109.87 125.14 7.45 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 122' ' ' ILE . . . . . 0.431 ' HB ' ' HB2' ' B' ' 107' ' ' ASN . 95.5 mt -114.84 127.75 72.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 123' ' ' GLN . . . . . 0.51 ' HG2' HD21 ' B' ' 104' ' ' ASN . 13.8 mp0 -119.8 118.5 30.99 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -116.75 120.28 38.07 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 125' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' B' ' 126' ' ' ILE . 68.0 t0 -67.65 133.8 49.99 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.465 -178.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.478 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 3.3 mt -107.49 16.16 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.626 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 127' ' ' THR . . . . . 0.439 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 97.8 m -63.45 -44.08 95.54 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 114.254 -1.339 . . . . 0.0 112.672 176.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 59.7 tptt -61.38 -45.79 92.87 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -177.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 129' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -62.75 -35.42 79.73 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.474 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 130' ' ' LYS . . . . . 0.743 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 98.8 mttt -63.13 -41.4 99.31 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 112.91 -1.95 . . . . 0.0 111.073 175.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.41 -41.89 96.38 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 132' ' ' TYR . . . . . 0.66 ' CE2' HD11 ' B' ' 136' ' ' LEU . 90.9 t80 -60.83 -44.76 96.51 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.941 -0.474 . . . . 0.0 111.644 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.28 -36.56 84.49 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 119.966 -0.693 . . . . 0.0 109.75 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 134' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' B' ' 130' ' ' LYS . 98.9 mttt -63.29 -38.92 93.03 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.846 177.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 52.7 tp -62.55 -41.44 98.89 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.46 0.647 . . . . 0.0 109.385 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 136' ' ' LEU . . . . . 0.66 HD11 ' CE2' ' B' ' 132' ' ' TYR . 85.2 mt -63.03 -41.58 99.56 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.405 178.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 137' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.95 -37.74 88.52 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 113.89 -1.505 . . . . 0.0 110.237 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -63.19 -43.66 97.58 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 120.029 -0.668 . . . . 0.0 109.952 176.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 53.4 m -61.04 -44.63 97.12 Favored 'General case' 0 C--N 1.346 0.43 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 88.3 mt -61.55 -40.44 94.69 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -177.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 81.8 m -61.6 -45.37 94.38 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.961 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -66.16 -41.49 90.3 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 92.5 mt -63.69 -43.56 98.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.63 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 144' ' ' THR . . . . . . . . . . . . . 99.1 m -61.55 -45.18 95.24 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -178.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.12 -40.7 96.75 Favored 'General case' 0 C--O 1.227 -0.121 0 C-N-CA 119.192 -1.003 . . . . 0.0 109.331 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 91.5 mt -64.18 -41.39 97.14 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 147' ' ' SER . . . . . 0.61 ' O ' ' N ' ' B' ' 149' ' ' PRO . 78.1 p -62.78 -42.25 99.62 Favored 'General case' 0 CA--C 1.477 -1.854 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 148' ' ' THR . . . . . 0.508 ' C ' ' O ' ' B' ' 147' ' ' SER . 12.3 m -25.52 85.33 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.793 0 O-C-N 124.12 0.887 . . . . 0.0 110.165 176.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 149' ' ' PRO . . . . . 0.61 ' N ' ' O ' ' B' ' 147' ' ' SER . 23.8 Cg_exo -60.83 146.48 97.42 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.112 1.874 . . . . 0.0 115.897 -177.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 9.7 tp -128.36 119.33 50.24 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.148 0 CA-C-N 114.015 -1.448 . . . . 0.0 108.029 174.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 41.6 t -153.02 93.34 3.19 Favored Pre-proline 0 C--N 1.308 -1.197 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.931 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -60.18 137.27 74.18 Favored 'Trans proline' 0 N--CA 1.488 1.181 0 CA-C-N 119.728 0.939 . . . . 0.0 109.727 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 153' ' ' ILE . . . . . 0.694 ' O ' ' HD2' ' B' ' 154' ' ' ARG . 44.5 mm -68.41 -43.3 84.18 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.499 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.351 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 154' ' ' ARG . . . . . 0.694 ' HD2' ' O ' ' B' ' 153' ' ' ILE . 0.8 OUTLIER -155.96 -155.92 0.59 Allowed 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.683 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 61.8 t-20 -86.84 109.73 19.49 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.87 -18.71 56.46 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -177.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 157' ' ' ILE . . . . . 0.43 HG22 ' HB ' ' B' ' 153' ' ' ILE . 88.0 mt -108.91 125.69 65.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.098 0.475 . . . . 0.0 111.036 -176.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 158' ' ' SER . . . . . 0.647 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 57.9 m -134.96 149.77 50.27 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.933 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -132.91 146.96 52.26 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 24.3 tp -139.5 77.07 29.51 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 161' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -70.83 147.54 56.21 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.689 2.259 . . . . 0.0 114.083 -178.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 95.1 mt -113.97 133.99 55.13 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 54.7 t -128.79 132.13 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 115.03 169.43 15.99 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 120.508 -0.854 . . . . 0.0 111.276 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 165' ' ' ASN . . . . . 0.688 ' O ' ' CZ ' ' B' ' 170' ' ' ARG . 59.2 t30 -91.5 106.55 18.57 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -177.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 166' ' ' LEU . . . . . 0.597 HD21 ' CZ ' ' B' ' 171' ' ' PHE . 47.5 tp -65.25 104.83 0.99 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -174.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 167' ' ' THR . . . . . 0.608 HG23 ' NE ' ' B' ' 170' ' ' ARG . 10.7 p -84.76 171.24 12.47 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 114.088 -1.414 . . . . 0.0 110.904 176.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -66.77 -37.69 85.1 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.671 177.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.51 -40.92 89.45 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 122.456 1.122 . . . . 0.0 111.962 -178.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 170' ' ' ARG . . . . . 0.688 ' CZ ' ' O ' ' B' ' 165' ' ' ASN . 87.6 mtm180 -62.07 -36.54 81.99 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 112.367 -2.197 . . . . 0.0 111.405 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 171' ' ' PHE . . . . . 0.597 ' CZ ' HD21 ' B' ' 166' ' ' LEU . 0.3 OUTLIER -54.08 -26.25 26.04 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -178.92 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 172' ' ' ASN . . . . . 0.569 ' O ' HG22 ' B' ' 175' ' ' VAL . 90.3 m-20 -62.58 -40.2 96.11 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.967 178.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 67.9 m -60.46 -41.7 94.69 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.095 0.474 . . . . 0.0 110.708 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 67.8 mt -64.17 -44.12 97.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 175' ' ' VAL . . . . . 0.569 HG22 ' O ' ' B' ' 172' ' ' ASN . 34.0 m -62.9 -40.59 89.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 176' ' ' CYS . . . . . 0.438 ' N ' HG23 ' B' ' 175' ' ' VAL . 99.5 m -62.27 -34.71 77.08 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.415 177.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 177' ' ' THR . . . . . 0.535 ' O ' HG13 ' B' ' 181' ' ' ILE . 25.2 m -61.53 -19.82 62.54 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-O 121.001 0.429 . . . . 0.0 110.213 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 178' ' ' LEU . . . . . 0.608 ' CD2' HD21 ' B' ' 211' ' ' LEU . 86.8 mt -61.1 -39.02 88.38 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.255 -178.011 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 19.2 m -60.94 -44.31 97.43 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.357 177.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 180' ' ' ASN . . . . . 0.563 ' O ' ' OG ' ' B' ' 183' ' ' SER . 91.2 m-20 -62.16 -40.38 95.79 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.682 0.277 . . . . 0.0 110.538 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.535 HG13 ' O ' ' B' ' 177' ' ' THR . 76.3 mt -55.45 -31.77 28.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.729 -177.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 182' ' ' LEU . . . . . 0.474 HD21 HD21 ' B' ' 214' ' ' LEU . 84.4 mt -62.42 -42.27 99.32 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.249 178.163 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 183' ' ' SER . . . . . 0.563 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.0 p -63.53 -33.81 76.4 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 121.876 -0.515 . . . . 0.0 110.999 178.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 33.1 p -85.23 15.77 4.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.866 0.365 . . . . 0.0 111.899 -177.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 78.7 p -59.83 -16.42 28.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.977 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.38 -40.59 94.89 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.946 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 187' ' ' ASP . . . . . 0.647 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.5 m-20 -69.97 114.37 8.07 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.535 0.684 . . . . 0.0 110.711 -178.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.9 -41.99 99.63 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-N 114.9 -1.046 . . . . 0.0 113.161 -177.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 189' ' ' TYR . . . . . 0.429 ' HB2' HG12 ' B' ' 157' ' ' ILE . 96.9 m-85 -111.45 130.7 55.63 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.197 -178.102 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 190' ' ' LEU . . . . . . . . . . . . . 40.5 tp -124.26 118.65 27.28 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.059 177.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 88.3 mt -107.81 127.71 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 120.613 0.244 . . . . 0.0 111.552 -177.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 49.2 mm -116.68 119.13 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 193' ' ' ASP . . . . . 0.525 ' CG ' ' HG ' ' B' ' 195' ' ' SER . 40.8 t0 -89.89 111.64 22.75 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 120.919 0.39 . . . . 0.0 111.739 -177.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 194' ' ' LEU . . . . . . . . . . . . . 98.4 mt -92.14 -2.42 56.59 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.32 175.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 195' ' ' SER . . . . . 0.525 ' HG ' ' CG ' ' B' ' 193' ' ' ASP . 78.3 p -61.25 -37.34 82.75 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.865 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -62.18 -33.89 87.36 Favored Glycine 0 N--CA 1.438 -1.195 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 197' ' ' LEU . . . . . 1.012 HD23 ' N ' ' B' ' 198' ' ' ALA . 4.7 tt -77.97 133.32 38.05 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 121.962 -0.728 . . . . 0.0 109.323 -176.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 198' ' ' ALA . . . . . 1.012 ' N ' HD23 ' B' ' 197' ' ' LEU . . . -64.55 -42.23 95.82 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.361 -176.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 199' ' ' GLN . . . . . 0.943 ' H ' ' CD2' ' B' ' 197' ' ' LEU . 58.8 tt0 -140.48 165.02 28.57 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.623 0.725 . . . . 0.0 112.648 -178.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 200' ' ' VAL . . . . . 0.472 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 51.0 t -120.93 132.91 69.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 O-C-N 121.037 -1.04 . . . . 0.0 109.526 177.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -93.8 148.95 21.65 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.151 0.5 . . . . 0.0 110.822 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -58.07 -33.71 69.34 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.308 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -64.93 -33.39 75.91 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.4 m -61.19 -44.59 97.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.555 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 205' ' ' ALA . . . . . 0.656 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -57.71 -29.42 64.69 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.666 -177.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -65.66 -37.46 86.58 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.312 0.577 . . . . 0.0 109.603 176.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -66.12 -38.69 88.82 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.586 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.83 -43.3 97.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.079 -178.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 209' ' ' PHE . . . . . 0.656 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 73.6 m-85 -62.47 -43.14 99.54 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 114.16 -1.382 . . . . 0.0 112.733 177.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.4 -41.64 98.75 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.379 -0.929 . . . . 0.0 109.701 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 211' ' ' LEU . . . . . 0.608 HD21 ' CD2' ' B' ' 178' ' ' LEU . 39.4 mt -62.44 -42.29 99.35 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.314 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 78.3 p -62.33 -36.57 82.59 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.908 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 213' ' ' HIS . . . . . 0.485 ' CE1' HD11 ' B' ' 217' ' ' LEU . 58.1 t-80 -67.26 -46.77 72.67 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.012 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.474 HD21 HD21 ' B' ' 182' ' ' LEU . 51.0 tp -63.97 -43.35 96.02 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.81 0.815 . . . . 0.0 109.83 177.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 215' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' B' ' 211' ' ' LEU . 91.8 mt -62.95 -43.97 97.35 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 113.502 -1.681 . . . . 0.0 111.588 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.83 -39.5 92.01 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.82 -177.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 217' ' ' LEU . . . . . 0.485 HD11 ' CE1' ' B' ' 213' ' ' HIS . 85.6 mt -63.56 -42.02 98.39 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.362 0.601 . . . . 0.0 111.652 176.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 218' ' ' THR . . . . . 0.412 HG23 ' O ' ' B' ' 214' ' ' LEU . 74.2 p -74.17 -17.21 60.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.987 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 81.08 66.42 1.62 Allowed Glycine 0 CA--C 1.527 0.784 0 N-CA-C 106.696 -2.562 . . . . 0.0 106.696 -178.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 220' ' ' THR . . . . . . . . . . . . . 94.2 m -147.11 104.56 3.69 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 114.652 1.352 . . . . 0.0 114.652 176.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -61.92 140.45 58.3 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.022 -175.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 44.8 tp -116.69 121.79 42.65 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.37 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 3.0 mp -110.26 128.83 66.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.916 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 224' ' ' ILE . . . . . 0.534 ' CG2' HD11 ' B' ' 227' ' ' ILE . 50.7 mm -109.39 126.58 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.552 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 49.4 p -133.44 157.62 45.12 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 90.1 16.95 55.03 Favored Glycine 0 CA--C 1.499 -0.918 0 CA-C-N 113.898 -1.501 . . . . 0.0 111.117 -177.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 227' ' ' ILE . . . . . 0.733 HD12 HG23 ' B' ' 247' ' ' THR . 94.8 mt -81.72 125.64 39.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 O-C-N 121.942 -0.74 . . . . 0.0 111.851 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 65.9 tttt -66.73 141.68 97.04 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.406 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.11 -37.47 94.05 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 121.364 1.376 . . . . 0.0 112.609 178.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -64.04 -43.03 96.8 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -177.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 51.3 tp -61.89 -41.34 97.78 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.527 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.15 -36.83 85.31 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.504 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 94.7 mtp -64.08 -40.83 97.11 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.73 -42.84 97.83 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 122.195 0.997 . . . . 0.0 109.238 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 32.4 mmt -63.89 -35.92 82.22 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.782 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -61.66 -40.39 94.78 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -178.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.67 -44.43 93.79 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.07 178.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 51.0 tp -62.45 -45.41 93.17 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.924 -178.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -156.68 131.78 9.12 Favored 'General case' 0 CA--C 1.511 -0.555 0 C-N-CA 120.301 -0.559 . . . . 0.0 111.956 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 240' ' ' ALA . . . . . . . . . . . . . . . -62.13 -47.28 85.25 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 176.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 241' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' B' ' 244' ' ' SER . 93.7 m-20 -42.52 -19.16 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.484 -176.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 242' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -62.6 -44.82 95.33 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.138 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 243' ' ' SER . . . . . . . . . . . . . 78.0 p -57.63 -44.02 85.24 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 244' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 19.8 m -29.81 -40.61 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 96.4 mt -84.25 141.67 30.81 Favored 'General case' 0 C--N 1.313 -1.013 0 O-C-N 121.561 -0.712 . . . . 0.0 110.993 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -69.06 133.55 48.23 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 120.923 0.392 . . . . 0.0 110.285 -174.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 247' ' ' THR . . . . . 0.733 HG23 HD12 ' B' ' 227' ' ' ILE . 97.8 m -124.1 125.86 45.22 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.861 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 248' ' ' TYR . . . . . 0.482 ' CG ' ' HB2' ' B' ' 254' ' ' ALA . 96.9 m-85 -111.71 142.85 43.52 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 249' ' ' SER . . . . . 0.571 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 78.4 p -62.86 -33.04 74.43 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.058 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 250' ' ' ASN . . . . . 0.571 ' OD1' ' O ' ' B' ' 249' ' ' SER . 99.3 m-20 -147.31 157.75 43.71 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.122 -0.945 . . . . 0.0 112.004 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 69.3 t -64.9 -44.75 96.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.263 178.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 252' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.74 -46.06 91.89 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -178.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 253' ' ' ASP . . . . . 0.547 ' O ' HG22 ' B' ' 257' ' ' VAL . 70.3 m-20 -60.94 -42.88 99.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.651 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 254' ' ' ALA . . . . . 0.482 ' HB2' ' CG ' ' B' ' 248' ' ' TYR . . . -65.57 -41.14 93.26 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.15 178.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 255' ' ' VAL . . . . . 0.444 ' O ' ' HD2' ' B' ' 259' ' ' PRO . 76.2 t -65.02 -45.36 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.067 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.07 -47.96 80.68 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.491 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 257' ' ' VAL . . . . . 0.547 HG22 ' O ' ' B' ' 253' ' ' ASP . 27.2 m -65.46 -40.58 88.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.577 179.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 258' ' ' LEU . . . . . 0.507 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 1.3 mt -32.74 -73.29 0.06 OUTLIER Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.507 -177.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 259' ' ' PRO . . . . . 0.57 ' O ' HG13 ' B' ' 260' ' ' ILE . 37.1 Cg_endo -61.84 141.36 89.78 Favored 'Trans proline' 0 N--CA 1.504 2.103 0 C-N-CA 121.459 1.439 . . . . 0.0 111.308 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 260' ' ' ILE . . . . . 0.57 HG13 ' O ' ' B' ' 259' ' ' PRO . 96.7 mt -159.54 -16.43 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 CA-C-N 118.692 0.678 . . . . 0.0 112.3 177.081 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 78.3 mtm . . . . . 0 C--O 1.216 -0.703 0 CA-C-O 117.785 -1.102 . . . . 0.0 111.434 -178.848 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 900' ' ' FMN . . . . . 0.464 ' H6 ' ' HA3' ' A' ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 900' ' ' FMN . . . . . 0.509 ' H6 ' ' HA3' ' B' ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.16 172.39 18.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.144 0.497 . . . . 0.0 110.272 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 85.4 p -73.27 -10.23 59.54 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.6 -0.688 . . . . 0.0 111.17 177.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -83.33 -62.97 1.45 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 114.713 -1.131 . . . . 0.0 112.434 176.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -69.33 -39.71 78.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.782 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.611 ' O ' ' NZ ' ' B' ' 17' ' ' LYS . 57.8 m -59.62 -41.66 90.92 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -177.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.505 ' CE2' HD12 ' A' ' 9' ' ' ILE . 32.2 t80 83.18 89.64 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.179 0.514 . . . . 0.0 112.213 177.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.538 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -63.49 -140.27 0.01 OUTLIER Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -177.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.538 ' HB ' ' O ' ' A' ' 8' ' ' GLY . 67.7 mt 82.11 108.34 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 122.686 0.394 . . . . 0.0 110.523 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.93 -21.75 68.69 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.466 1.444 . . . . 0.0 112.141 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.2 -38.39 95.86 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 121.08 -0.581 . . . . 0.0 111.896 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -65.05 -39.64 93.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.512 0.672 . . . . 0.0 109.486 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 52.9 tp -62.81 -41.41 99.29 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -62.21 -40.68 96.92 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 75.0 t -60.12 -44.36 94.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 O-C-N 122.146 -0.346 . . . . 0.0 110.91 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 91.9 mt -62.51 -43.65 98.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.468 -178.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.51 -46.52 88.05 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 119.269 -0.973 . . . . 0.0 112.306 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.585 ' NZ ' HG12 ' B' ' 113' ' ' ILE . 98.4 mttt -59.3 -39.77 84.05 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 118.608 -1.237 . . . . 0.0 109.02 -176.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.34 -41.89 90.22 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.306 -178.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 20' ' ' LEU . 85.4 mt -62.93 -40.91 99.07 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -63.43 -38.2 90.22 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 57.9 m170 -58.62 -39.86 81.68 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 122.339 -0.226 . . . . 0.0 111.329 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 23' ' ' VAL . 12.6 p -113.88 129.95 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.505 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 34.8 ptt180 -72.36 108.27 5.38 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-O 122.072 0.939 . . . . 0.0 112.161 -177.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.0 p -140.47 142.96 30.06 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 123' ' ' GLN . . . -97.45 92.77 1.34 Allowed Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.674 -178.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 53.3 t -125.44 130.17 72.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.6 m -137.4 159.54 35.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.6 mt -121.12 129.76 75.35 Favored 'Isoleucine or valine' 0 C--O 1.247 0.952 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 177.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.441 HG22 HG12 ' A' ' 39' ' ' ILE . 19.6 p -106.32 168.47 9.13 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.518 ' C ' ' OD1' ' A' ' 37' ' ' ASN . 62.7 t0 -133.88 102.85 12.14 Favored Pre-proline 0 C--N 1.318 -0.781 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.117 178.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.549 ' HG3' HG23 ' A' ' 117' ' ' THR . 36.9 Cg_endo -63.83 -22.88 69.07 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 121.495 1.463 . . . . 0.0 111.647 -178.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.02 -35.19 79.4 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.955 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.4 mt -86.39 159.81 19.25 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.375 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.835 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 42.9 tt0 -57.43 134.35 55.98 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -176.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.514 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 56.8 t0 59.76 23.49 12.39 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 178.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.518 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 39.8 t-20 38.82 65.89 2.97 Favored Pre-proline 0 CA--C 1.542 0.65 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.129 -178.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.835 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 91.3 Cg_endo -68.55 155.18 69.85 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 124.007 3.138 . . . . 0.0 112.129 -178.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.441 HG12 HG22 ' A' ' 30' ' ' THR . 96.4 mt -86.53 125.0 40.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.0 m -104.66 -41.78 6.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 116.136 -0.483 . . . . 0.0 112.086 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -96.07 123.57 39.73 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.859 -178.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.5 p -142.62 139.53 28.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 O-C-N 124.295 0.997 . . . . 0.0 109.133 177.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.616 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 58.0 p30 -98.3 167.01 11.12 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.506 ' HA ' ' OE1' ' A' ' 44' ' ' GLN . 14.4 mm100 -66.43 -39.41 88.89 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 178.142 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.19 -26.14 63.31 Favored Glycine 0 C--N 1.33 0.208 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.616 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 60.5 t80 -59.18 -49.3 78.39 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 -179.03 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.6 HG13 ' O ' ' A' ' 52' ' ' TYR . 53.5 t -58.45 -44.9 89.88 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 O-C-N 121.423 -0.798 . . . . 0.0 111.464 -174.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -62.99 -37.16 86.07 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 120.511 -0.476 . . . . 0.0 112.116 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 59.6 ttm -68.65 -43.62 75.89 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 177.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 35.4 p -90.48 -23.2 21.04 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.34 0.59 . . . . 0.0 111.48 -178.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . 78.01 21.08 71.8 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 -179.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.6 ' O ' HG13 ' A' ' 47' ' ' VAL . 70.3 m-85 -114.46 138.87 50.04 Favored 'General case' 0 C--O 1.221 -0.42 0 C-N-CA 122.936 0.494 . . . . 0.0 111.162 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -64.21 150.14 46.45 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.646 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.432 HG22 ' H ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -65.78 -33.55 76.12 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -179.283 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.26 -44.19 84.35 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.659 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -64.62 -45.49 86.65 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.585 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.598 HD13 ' CD2' ' A' ' 46' ' ' PHE . 92.0 mt -61.58 -50.26 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -174.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 80.6 mt -57.26 145.48 31.72 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 176.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.3 -6.68 78.89 Favored Glycine 0 N--CA 1.46 0.235 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.208 177.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -135.6 152.73 51.54 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.685 1.243 . . . . 0.0 111.903 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.562 ' C ' ' H ' ' A' ' 63' ' ' ARG . 25.2 t-20 -81.36 152.44 27.5 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.474 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 80.3 m -63.2 16.3 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.444 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.562 ' H ' ' C ' ' A' ' 61' ' ' ASN . 35.4 ptt-85 -61.88 -41.62 98.08 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.16 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -55.44 -20.55 12.78 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -178.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.7 mt -71.23 -32.17 68.45 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.611 0.719 . . . . 0.0 112.505 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -65.95 141.41 58.22 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.178 -178.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.59 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -151.08 -148.5 4.81 Favored Glycine 0 CA--C 1.539 1.553 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -178.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.79 -39.57 94.64 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -177.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.507 ' O ' ' NE2' ' A' ' 93' ' ' GLN . 10.8 m80 -77.83 -8.72 58.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.902 0.382 . . . . 0.0 111.114 -178.141 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.59 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 28.6 m -62.27 128.69 37.26 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.55 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -85.89 111.06 35.17 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.859 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -57.44 -31.87 92.5 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.959 1.773 . . . . 0.0 113.247 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.42 -40.1 95.11 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.951 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.434 ' OE1' ' HB ' ' A' ' 90' ' ' VAL . 78.9 mm-40 -65.5 -43.99 88.39 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 71.9 t -59.3 -43.86 90.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -176.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -64.35 -37.54 87.87 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.144 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -63.28 -39.89 95.85 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.304 0.573 . . . . 0.0 110.068 178.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 93.6 mt -64.01 -44.16 97.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.933 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -62.61 -43.13 99.58 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 113.633 -1.622 . . . . 0.0 108.229 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 97.0 m -61.55 -49.44 76.65 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.4 -42.57 92.03 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.381 -172.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 89.3 mt -62.77 -39.98 95.88 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 121.473 -0.767 . . . . 0.0 111.177 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 66.9 tp60 -65.07 -31.44 72.66 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -89.62 -1.33 57.99 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.22 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 46.7 tttt 47.32 39.45 8.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.529 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -122.48 143.9 40.82 Favored Pre-proline 0 CA--C 1.532 0.287 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' A' ' 108' ' ' ILE . 24.8 Cg_exo -61.63 144.37 97.45 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.559 1.506 . . . . 0.0 113.569 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -139.09 142.41 33.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.563 -178.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.913 HG23 ' OD1' ' A' ' 107' ' ' ASN . 97.7 m -127.57 118.21 23.5 Favored 'General case' 0 C--N 1.345 0.377 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 176.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.434 ' HB ' ' OE1' ' A' ' 74' ' ' GLU . 28.3 m -138.47 157.49 30.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.675 -0.238 . . . . 0.0 111.496 178.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -100.67 133.52 45.0 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 176.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.456 ' O ' HG23 ' A' ' 92' ' ' ILE . 17.1 tt -141.28 128.21 20.88 Favored 'Isoleucine or valine' 0 C--N 1.377 1.777 0 CA-C-N 121.374 1.897 . . . . 0.0 112.711 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.507 ' NE2' ' O ' ' A' ' 69' ' ' HIS . 33.9 mt-30 -62.61 135.69 57.51 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.254 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -138.16 161.36 37.0 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.699 -179.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -118.14 136.23 53.74 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.474 ' HG3' ' CE1' ' A' ' 102' ' ' PHE . 99.2 mttt -85.77 -171.45 3.6 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.239 0.543 . . . . 0.0 111.921 -179.177 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -62.51 -44.09 97.21 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.919 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 42.9 p-10 -83.42 7.36 17.05 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.84 -1.1 89.09 Favored Glycine 0 N--CA 1.471 0.99 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.258 176.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.8 m -58.31 137.89 56.83 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.679 ' SD ' ' C ' ' A' ' 101' ' ' MET . 12.5 tmm? -104.97 129.78 53.31 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.556 0.217 . . . . 0.0 110.443 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.548 ' N ' ' SD ' ' A' ' 101' ' ' MET . 53.4 p90 -142.33 158.43 43.72 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.007 -177.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.915 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 23.3 m95 -89.8 141.26 28.8 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.555 HD21 ' HG2' ' A' ' 123' ' ' GLN . 54.3 t-20 -136.58 105.0 5.74 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -176.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 80.8 tt0 -70.18 135.99 49.63 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 -177.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 41.6 tp -120.9 122.77 40.95 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.913 ' OD1' HG23 ' A' ' 89' ' ' THR . 98.1 m-20 -120.31 121.65 39.09 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.773 177.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 87' ' ' PRO . 96.2 mt -119.68 128.57 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 O-C-N 123.493 0.496 . . . . 0.0 111.421 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -136.31 125.76 15.84 Favored Pre-proline 0 CA--C 1.541 0.617 0 O-C-N 123.079 0.237 . . . . 0.0 110.903 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -71.31 151.75 60.46 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.666 2.244 . . . . 0.0 112.363 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.671 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 67.0 mtt -123.89 153.17 41.51 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -128.48 91.14 3.18 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.549 ' CD1' HG22 ' B' ' 15' ' ' VAL . 96.2 mt -117.34 131.37 70.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.429 -178.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 49.38 39.07 15.45 Favored 'General case' 0 CA--C 1.512 -0.499 0 O-C-N 121.496 -0.752 . . . . 0.0 111.68 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 58.7 30.42 19.93 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.954 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -127.59 146.35 50.56 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.785 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 7.7 t -85.38 -170.41 3.11 Favored 'General case' 0 C--O 1.214 -0.772 0 O-C-N 121.687 -0.633 . . . . 0.0 109.334 -178.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.785 ' CD2' ' O ' ' A' ' 117' ' ' THR . 66.0 m-85 -174.0 155.38 2.51 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 177.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -131.11 145.57 52.03 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 174.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -134.33 134.1 55.04 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.8 127.08 8.56 Favored Glycine 0 CA--C 1.501 -0.832 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 96.8 mt -116.6 128.93 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.555 ' HG2' HD21 ' A' ' 104' ' ' ASN . 17.7 mp0 -119.08 115.64 24.71 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.579 0.549 . . . . 0.0 109.63 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -117.64 111.78 19.64 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.838 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 126' ' ' ILE . 67.9 t0 -62.88 131.77 49.87 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -175.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.511 ' O ' HG22 ' A' ' 126' ' ' ILE . 2.9 mp -95.48 3.56 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 113.542 -1.663 . . . . 0.0 109.637 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 20.0 m -60.04 -42.98 95.58 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.007 -1.058 . . . . 0.0 113.62 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -60.57 -41.69 95.11 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -177.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -63.51 -39.79 95.36 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.003 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.915 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.6 mttt -62.81 -41.06 99.14 Favored 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 118.157 -1.417 . . . . 0.0 110.535 -178.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.1 -37.66 83.54 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.653 -178.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.774 ' CE2' HD11 ' A' ' 136' ' ' LEU . 89.7 t80 -61.77 -45.3 94.51 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.543 176.146 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.73 -38.69 91.85 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.02 -40.93 97.37 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 52.8 tp -60.64 -43.36 97.66 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -177.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.774 HD11 ' CE2' ' A' ' 132' ' ' TYR . 83.6 mt -62.28 -40.91 97.82 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.094 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.56 -41.83 98.39 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 119.355 -0.938 . . . . 0.0 109.837 -178.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -60.27 -41.55 93.5 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -177.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 48.8 m -61.66 -41.09 97.06 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.071 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 144' ' ' THR . 84.4 mt -63.69 -41.72 98.11 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.449 -0.5 . . . . 0.0 109.758 177.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 96.9 m -61.39 -46.0 92.01 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.268 -177.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -65.21 -40.48 94.19 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 95.5 mt -64.78 -43.47 96.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 113.967 -1.469 . . . . 0.0 111.523 176.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.515 ' N ' ' O ' ' A' ' 140' ' ' LEU . 92.1 m -62.53 -46.48 88.18 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.477 ' O ' ' OG1' ' A' ' 148' ' ' THR . . . -62.58 -40.57 97.29 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 118.875 -1.13 . . . . 0.0 109.251 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 85.3 mt -63.8 -42.73 97.64 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.675 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.1 p -60.93 -37.67 83.12 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -178.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.477 ' OG1' ' O ' ' A' ' 145' ' ' ALA . 18.8 m -29.09 83.73 0.03 OUTLIER Pre-proline 0 C--N 1.347 0.492 0 O-C-N 126.592 2.432 . . . . 0.0 106.613 -178.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.675 ' N ' ' O ' ' A' ' 147' ' ' SER . 22.4 Cg_exo -61.94 144.04 96.07 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 CA-C-O 122.753 1.064 . . . . 0.0 113.906 -174.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.639 ' O ' HG23 ' A' ' 151' ' ' VAL . 9.3 tp -120.49 135.1 61.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 102.057 -3.312 . . . . 0.0 102.057 175.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 150' ' ' ILE . 95.4 t -167.89 95.11 0.62 Allowed Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 177.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -64.12 143.69 84.96 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 N-CA-C 109.822 -0.876 . . . . 0.0 109.822 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.59 ' O ' HG11 ' B' ' 255' ' ' VAL . 43.4 mm -75.84 -68.61 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.463 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.725 ' NH2' ' HD3' ' B' ' 154' ' ' ARG . 4.8 mpt_? -132.02 -160.34 1.04 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 63.3 t-20 -83.63 104.57 13.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.799 0.809 . . . . 0.0 111.415 -178.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.16 9.2 60.84 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 113.991 -1.458 . . . . 0.0 110.115 -177.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.6 mt -126.1 123.48 63.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 175.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.682 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 74.5 m -133.16 151.72 51.96 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -138.15 141.03 40.12 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.625 177.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 21.7 tp -130.51 80.48 70.13 Favored Pre-proline 0 N--CA 1.47 0.571 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.454 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -70.34 152.47 66.31 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.758 2.305 . . . . 0.0 113.229 -178.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 90.1 mt -120.88 126.39 49.92 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.175 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 48.4 t -123.28 131.2 73.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 117.41 169.32 14.89 Favored Glycine 0 N--CA 1.477 1.423 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.238 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.78 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 57.1 t30 -85.25 115.28 22.93 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 117.16 0.48 . . . . 0.0 110.07 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.595 HD21 ' CZ ' ' A' ' 171' ' ' PHE . 47.1 tp -73.7 104.05 4.48 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -177.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.736 HG23 ' NE ' ' A' ' 170' ' ' ARG . 10.6 p -85.92 166.85 15.63 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.588 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.85 -34.16 77.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.166 0.507 . . . . 0.0 111.779 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.45 -42.44 95.95 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.102 178.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.78 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 87.5 mtm180 -65.37 -33.75 76.7 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 124.316 1.047 . . . . 0.0 112.462 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.595 ' CZ ' HD21 ' A' ' 166' ' ' LEU . 0.5 OUTLIER -54.21 -28.49 41.25 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 118.986 -0.531 . . . . 0.0 112.381 -178.778 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.604 ' O ' HG22 ' A' ' 175' ' ' VAL . 91.2 m-20 -60.55 -40.71 92.57 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 118.975 -1.09 . . . . 0.0 109.7 -178.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 52.0 m -59.22 -41.31 88.34 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 121.685 -0.635 . . . . 0.0 110.777 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 66.2 mt -63.25 -44.08 99.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 172' ' ' ASN . 35.4 m -62.08 -40.35 87.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' CYS . . . . . 0.418 ' N ' HG23 ' A' ' 175' ' ' VAL . 98.3 m -62.21 -33.97 75.59 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.396 178.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.523 ' O ' HG13 ' A' ' 181' ' ' ILE . 25.3 m -62.45 -19.85 63.93 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.135 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.708 ' CD2' HD21 ' A' ' 211' ' ' LEU . 86.2 mt -61.1 -41.87 97.47 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 -177.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 18.4 m -59.27 -43.28 92.51 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.61 ' O ' ' OG ' ' A' ' 183' ' ' SER . 93.1 m-20 -61.78 -37.68 85.22 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 120.759 0.314 . . . . 0.0 110.661 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.523 HG13 ' O ' ' A' ' 177' ' ' THR . 68.7 mt -57.15 -37.18 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 O-C-N 121.384 -0.822 . . . . 0.0 109.918 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.527 HD21 HD21 ' A' ' 214' ' ' LEU . 85.9 mt -61.16 -40.69 94.81 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -177.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.61 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 78.0 p -61.62 -33.15 73.42 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.464 177.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.442 ' OG1' ' HA ' ' A' ' 181' ' ' ILE . 21.9 p -89.88 23.32 2.79 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.672 0.272 . . . . 0.0 111.433 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 78.1 p -63.41 -21.49 66.32 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.63 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.29 -37.2 79.77 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.953 -179.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.682 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 98.6 m-20 -72.58 113.21 9.36 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.53 0.681 . . . . 0.0 110.706 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.95 -42.09 99.71 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.914 -177.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -112.88 130.89 55.94 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.862 -178.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 38.5 tp -120.82 128.81 53.2 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 96.5 mt -117.08 127.54 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.8 mm -113.17 127.4 70.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' ASP . . . . . 0.488 ' CG ' ' HG ' ' A' ' 195' ' ' SER . 40.5 t0 -95.15 117.99 31.18 Favored 'General case' 0 CA--C 1.549 0.93 0 O-C-N 121.871 -0.518 . . . . 0.0 110.538 177.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 96.1 mt -97.38 -4.93 37.48 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.661 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.488 ' HG ' ' CG ' ' A' ' 193' ' ' ASP . 78.1 p -62.99 -32.51 73.88 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.63 -44.39 98.01 Favored Glycine 0 CA--C 1.533 1.17 0 N-CA-C 108.332 -1.907 . . . . 0.0 108.332 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.975 ' CD2' ' O ' ' A' ' 199' ' ' GLN . 4.7 tt -68.34 127.76 34.12 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 112.871 -1.664 . . . . 0.0 109.289 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.934 ' N ' HD23 ' A' ' 197' ' ' LEU . . . -59.4 -50.08 75.35 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 120.179 -0.608 . . . . 0.0 110.562 -178.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.975 ' O ' ' CD2' ' A' ' 197' ' ' LEU . 58.1 tt0 -132.82 157.89 43.88 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 114.757 -1.11 . . . . 0.0 113.443 -175.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.475 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 44.1 t -117.69 132.71 66.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -88.56 155.45 19.63 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.642 -178.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.4 -39.49 93.95 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 120.135 -0.626 . . . . 0.0 109.987 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -57.85 -31.48 66.71 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -178.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.5 m -61.18 -42.3 98.32 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.413 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.495 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -57.65 -37.85 74.06 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -177.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -60.83 -37.79 83.22 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.516 -0.473 . . . . 0.0 109.749 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -66.02 -38.58 88.79 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.108 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 94.6 mt -63.11 -44.54 99.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -178.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' PHE . . . . . 0.495 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 73.3 m-85 -62.18 -43.38 98.96 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.427 -178.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -62.06 -41.95 98.68 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 119.125 -1.03 . . . . 0.0 109.072 -178.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.708 HD21 ' CD2' ' A' ' 178' ' ' LEU . 39.4 mt -62.34 -41.78 98.85 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 78.2 p -61.74 -43.15 99.41 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 118.993 -1.083 . . . . 0.0 110.14 -179.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' HIS . . . . . 0.443 ' CE1' HD11 ' A' ' 217' ' ' LEU . 58.6 t-80 -64.14 -45.28 89.22 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.602 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.527 HD21 HD21 ' A' ' 182' ' ' LEU . 49.8 tp -62.19 -45.93 91.2 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 118.843 -1.143 . . . . 0.0 108.247 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 211' ' ' LEU . 88.0 mt -62.15 -41.03 97.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.423 -178.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -60.84 -44.78 96.52 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -177.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.443 HD11 ' CE1' ' A' ' 213' ' ' HIS . 85.3 mt -61.4 -40.04 92.93 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 67.4 p -75.55 -12.11 60.16 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.596 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.62 37.63 13.61 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 120.626 -0.797 . . . . 0.0 113.57 -178.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 91.9 m -123.92 114.64 20.09 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 119.02 1.41 . . . . 0.0 111.544 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -66.15 138.11 57.49 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.83 178.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 42.1 tp -114.02 130.11 56.57 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 4.0 mp -116.29 134.41 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 122.886 0.475 . . . . 0.0 109.741 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.576 ' CG2' HD11 ' A' ' 227' ' ' ILE . 49.0 mm -116.53 131.57 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -178.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 37.8 p -133.81 165.41 25.05 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -177.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 78.35 22.64 67.26 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.722 HD12 HG23 ' A' ' 247' ' ' THR . 97.8 mt -83.96 128.55 38.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 113.947 -1.127 . . . . 0.0 108.439 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 43.1 tttt -76.31 138.39 67.94 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.25 -39.5 86.32 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 121.044 1.162 . . . . 0.0 112.595 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -63.55 -40.0 95.88 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 121.416 0.627 . . . . 0.0 109.967 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 48.8 tp -63.66 -42.6 98.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.88 177.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.27 -37.42 87.41 Favored 'General case' 0 C--O 1.227 -0.12 0 C-N-CA 120.596 -0.441 . . . . 0.0 110.89 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 94.2 mtp -63.03 -41.13 99.45 Favored 'General case' 0 C--O 1.247 0.953 0 C-N-CA 120.004 -0.679 . . . . 0.0 109.742 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.38 -38.4 91.0 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.523 177.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 30.2 mmt -65.88 -37.5 86.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.688 178.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -61.18 -41.86 97.55 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.616 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -60.66 -40.65 92.84 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.573 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 55.6 tp -63.72 -41.03 98.15 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 177.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -169.19 125.95 0.93 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.369 0.604 . . . . 0.0 112.404 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.58 -27.36 66.2 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.893 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -61.45 -28.87 69.58 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.288 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -55.73 -44.48 77.58 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -177.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 96.8 p -61.43 -21.03 63.75 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 123.779 0.674 . . . . 0.0 111.287 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 40.6 m -55.04 -38.76 68.39 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 122.313 -0.242 . . . . 0.0 111.617 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 96.3 mt -84.19 120.36 26.11 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -44.63 134.73 5.27 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.047 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.722 HG23 HD12 ' A' ' 227' ' ' ILE . 96.8 m -128.61 133.83 48.41 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.905 178.271 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' TYR . . . . . 0.456 ' CB ' ' HB2' ' A' ' 254' ' ' ALA . 97.4 m-85 -117.7 140.05 50.19 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 114.953 -1.022 . . . . 0.0 110.959 179.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 78.0 p -60.23 -43.89 95.66 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -178.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -142.27 161.36 38.22 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.725 0.774 . . . . 0.0 111.79 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 77.4 t -62.46 -45.0 99.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 114.614 -1.175 . . . . 0.0 112.053 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -60.48 -44.31 96.04 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.193 -0.603 . . . . 0.0 109.561 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' ASP . . . . . 0.401 ' O ' HG22 ' A' ' 257' ' ' VAL . 54.3 m-20 -62.99 -43.72 98.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.668 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.456 ' HB2' ' CB ' ' A' ' 248' ' ' TYR . . . -63.76 -43.25 96.98 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.94 0.876 . . . . 0.0 109.767 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 255' ' ' VAL . . . . . 0.557 HG13 HH11 ' B' ' 154' ' ' ARG . 56.9 t -63.37 -45.77 97.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 114.003 -1.453 . . . . 0.0 111.129 -177.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.46 -46.95 83.9 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 120.649 -0.421 . . . . 0.0 111.301 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.494 ' O ' ' C ' ' A' ' 258' ' ' LEU . 21.2 m -66.45 -41.1 88.11 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 O-C-N 121.539 -0.726 . . . . 0.0 112.005 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.494 ' C ' ' O ' ' A' ' 257' ' ' VAL . 1.9 mt -29.85 -72.85 0.05 OUTLIER Pre-proline 0 N--CA 1.466 0.328 0 CA-C-O 119.497 -0.287 . . . . 0.0 111.51 -177.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 259' ' ' PRO . . . . . 0.492 ' O ' HG13 ' A' ' 260' ' ' ILE . 44.7 Cg_endo -64.12 139.28 65.94 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 CA-C-N 119.635 0.905 . . . . 0.0 111.764 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.492 HG13 ' O ' ' A' ' 259' ' ' PRO . 96.5 mt -153.74 -25.03 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 O-C-N 123.638 0.586 . . . . 0.0 111.764 178.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 N--CA 1.475 0.811 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.68 -177.66 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.424 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.26 162.5 33.67 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 79.5 p -59.61 -21.8 60.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.779 177.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -74.67 -62.02 1.68 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 120.948 0.404 . . . . 0.0 111.361 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.72 -39.98 88.23 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.092 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.503 ' O ' ' HB3' ' B' ' 7' ' ' PHE . 61.0 m -60.33 -42.59 95.95 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 119.98 -0.688 . . . . 0.0 109.833 -177.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 7' ' ' PHE . . . . . 0.51 ' CE2' HD12 ' B' ' 9' ' ' ILE . 36.7 t80 84.79 92.86 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.339 177.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 8' ' ' GLY . . . . . 0.559 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -65.46 -139.87 0.03 OUTLIER Glycine 0 C--N 1.338 0.678 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.559 ' HB ' ' O ' ' B' ' 8' ' ' GLY . 68.0 mt 81.61 108.35 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 122.567 0.347 . . . . 0.0 110.912 -178.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -62.94 -24.23 74.13 Favored 'Trans proline' 0 N--CA 1.499 1.814 0 C-N-CA 121.338 1.359 . . . . 0.0 111.711 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.95 -40.64 98.69 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -64.67 -39.35 93.53 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.763 0.792 . . . . 0.0 109.131 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 54.1 tp -62.41 -42.24 99.29 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.476 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -63.91 -32.39 73.91 Favored 'General case' 0 CA--C 1.562 1.431 0 CA-C-O 121.535 0.683 . . . . 0.0 110.525 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' VAL . . . . . 0.549 HG22 ' CD1' ' A' ' 113' ' ' ILE . 70.0 t -62.83 -46.22 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 113.237 -1.801 . . . . 0.0 111.007 176.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 93.3 mt -64.16 -43.96 97.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.007 -178.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 17' ' ' LYS . . . . . 0.611 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 99.0 mttt -63.55 -41.8 98.42 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -179.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.22 -41.22 99.09 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 119.01 -1.076 . . . . 0.0 109.973 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.37 -38.73 84.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.966 -178.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 86.0 mt -63.91 -41.97 97.55 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 121.359 0.6 . . . . 0.0 110.263 175.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -63.07 -38.73 92.35 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.192 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 56.5 m170 -57.83 -39.85 78.65 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 119.557 -0.259 . . . . 0.0 111.323 -178.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 12.3 p -114.04 129.94 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.526 ' HG3' ' O ' ' B' ' 24' ' ' ARG . 35.0 ptt180 -72.0 106.21 4.19 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.711 0.767 . . . . 0.0 112.447 -177.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.403 ' O ' HG13 ' B' ' 25' ' ' VAL . 6.6 p -142.01 133.68 26.69 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.86 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.816 177.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 26' ' ' GLY . . . . . 0.498 ' O ' ' N ' ' B' ' 123' ' ' GLN . . . -87.31 97.53 2.28 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 119.422 -1.37 . . . . 0.0 113.202 -176.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 49.4 t -126.41 129.07 71.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 174.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 30.0 m -138.44 156.23 29.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 121.014 -0.274 . . . . 0.0 110.429 178.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 95.8 mt -119.01 127.41 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.237 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.437 HG22 HG12 ' B' ' 39' ' ' ILE . 33.2 p -107.54 158.13 17.47 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-N 113.002 -1.908 . . . . 0.0 108.694 -177.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 31' ' ' ASP . . . . . 0.49 ' C ' ' OD1' ' B' ' 37' ' ' ASN . 64.1 t0 -125.18 103.07 30.09 Favored Pre-proline 0 C--O 1.236 0.381 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -178.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 32' ' ' PRO . . . . . 0.491 ' HG3' HG23 ' B' ' 117' ' ' THR . 37.1 Cg_endo -64.39 -21.76 66.37 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.723 1.616 . . . . 0.0 111.496 -178.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.02 -45.39 93.79 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.539 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 90.9 mt -71.23 179.45 2.85 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.913 -0.492 . . . . 0.0 111.676 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 35' ' ' GLU . . . . . 0.699 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 41.4 tt0 -77.13 129.67 36.31 Favored 'General case' 0 C--N 1.344 0.327 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -174.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.47 ' O ' ' C ' ' B' ' 37' ' ' ASN . 65.2 t0 58.01 38.14 26.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.461 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 37' ' ' ASN . . . . . 0.49 ' OD1' ' C ' ' B' ' 31' ' ' ASP . 24.3 t-20 27.69 69.73 0.49 Allowed Pre-proline 0 C--N 1.327 -0.413 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.699 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 92.1 Cg_endo -70.72 153.39 64.56 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 123.676 2.917 . . . . 0.0 111.635 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.437 HG12 HG22 ' B' ' 30' ' ' THR . 96.0 mt -84.46 129.93 36.84 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 18.0 m -109.55 -41.61 4.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 O-C-N 123.592 0.557 . . . . 0.0 112.339 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -96.81 123.62 40.56 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.506 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 5.8 p -142.38 140.61 28.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.222 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 43' ' ' ASN . . . . . 0.651 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 56.7 p30 -102.13 162.1 13.17 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.177 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 44' ' ' GLN . . . . . 0.489 ' OE1' ' HA ' ' B' ' 44' ' ' GLN . 13.8 mm100 -62.55 -38.12 88.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.379 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.35 -26.71 64.48 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.651 ' HB2' ' OD1' ' B' ' 43' ' ' ASN . 58.0 t80 -60.04 -43.61 95.23 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 0.738 HG13 ' O ' ' B' ' 52' ' ' TYR . 53.3 t -61.63 -46.4 96.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.091 -178.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -63.09 -45.02 94.05 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.262 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 60.3 ttm -62.75 -42.6 99.75 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 34.3 p -93.77 -17.63 22.93 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.968 -178.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 51' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' B' ' 47' ' ' VAL . . . 73.59 19.83 79.75 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 178.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 52' ' ' TYR . . . . . 0.738 ' O ' HG13 ' B' ' 47' ' ' VAL . 70.8 m-85 -112.08 145.64 39.38 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.244 -0.478 . . . . 0.0 110.172 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -74.39 148.96 40.73 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.684 0.754 . . . . 0.0 111.173 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.05 -38.15 87.65 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.698 -177.087 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.83 -39.94 95.89 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 120.238 -0.585 . . . . 0.0 111.854 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -73.76 -32.89 64.04 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.613 HD13 ' CD2' ' B' ' 46' ' ' PHE . 93.4 mt -66.2 -72.12 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 95.6 mt -37.19 131.82 0.79 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.71 175.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.28 -12.22 66.77 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.957 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -133.98 149.92 51.24 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.358 0.599 . . . . 0.0 112.595 -174.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 61' ' ' ASN . . . . . 0.509 ' C ' ' H ' ' B' ' 63' ' ' ARG . 25.9 t-20 -77.66 153.31 33.23 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.8 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 62' ' ' CYS . . . . . . . . . . . . . 84.6 m -64.91 9.12 0.1 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.524 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 63' ' ' ARG . . . . . 0.509 ' H ' ' C ' ' B' ' 61' ' ' ASN . 33.5 ptt-85 -58.72 -32.04 68.83 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.719 -178.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -60.33 -31.06 69.94 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 85.4 mt -61.82 -42.53 99.14 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -178.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -50.0 146.01 5.16 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 123.624 0.577 . . . . 0.0 109.764 -178.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 67' ' ' GLY . . . . . 0.546 ' N ' ' OG1' ' B' ' 70' ' ' THR . . . -156.19 -152.24 6.19 Favored Glycine 0 CA--C 1.54 1.656 0 CA-C-N 115.1 -0.955 . . . . 0.0 112.773 175.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -60.19 -40.76 91.17 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.576 -0.312 . . . . 0.0 111.64 -175.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 69' ' ' HIS . . . . . 0.436 ' O ' ' NE2' ' B' ' 93' ' ' GLN . 11.0 m80 -76.36 -9.27 58.52 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 123.092 0.245 . . . . 0.0 111.434 -178.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 70' ' ' THR . . . . . 0.546 ' OG1' ' N ' ' B' ' 67' ' ' GLY . 26.5 m -61.25 134.3 56.84 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -91.78 110.84 46.33 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.162 -178.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.43 -39.02 89.5 Favored 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 121.035 1.157 . . . . 0.0 111.917 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.74 -41.12 90.23 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 120.508 -0.477 . . . . 0.0 109.871 -176.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 74' ' ' GLU . . . . . 0.443 ' OE1' ' HB ' ' B' ' 90' ' ' VAL . 79.0 mm-40 -66.36 -38.96 88.78 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.752 177.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 85.9 t -61.88 -46.26 96.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -63.21 -36.84 84.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.751 -178.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -62.24 -42.12 99.03 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 119.168 -1.013 . . . . 0.0 108.642 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 95.0 mt -63.53 -43.49 98.33 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 CA-C-O 120.751 0.31 . . . . 0.0 110.574 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -62.1 -42.54 99.32 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 94.9 m -61.65 -45.79 92.52 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.137 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.49 -41.49 97.34 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -177.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 86.0 mt -62.95 -42.57 99.86 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -178.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 66.8 tp60 -62.84 -33.86 76.12 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -91.39 8.28 36.99 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.498 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 37.9 tttt 40.05 41.6 0.95 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.403 -0.519 . . . . 0.0 111.946 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -124.45 140.91 36.27 Favored Pre-proline 0 N--CA 1.47 0.57 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.171 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -61.99 141.11 88.07 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 120.99 1.127 . . . . 0.0 113.827 -178.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -139.78 136.14 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.325 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 89' ' ' THR . . . . . 0.902 HG23 ' OD1' ' B' ' 107' ' ' ASN . 92.6 m -120.12 121.26 38.42 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.831 178.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.443 ' HB ' ' OE1' ' B' ' 74' ' ' GLU . 29.2 m -139.09 162.99 27.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.978 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -113.49 119.58 38.06 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.153 0.502 . . . . 0.0 109.694 175.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 20.8 tt -126.42 131.99 70.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.144 -175.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.488 ' O ' ' ND2' ' B' ' 94' ' ' ASN . 34.3 mt-30 -72.56 145.57 47.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.194 177.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 94' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' B' ' 93' ' ' GLN . 8.7 m120 -138.54 -179.67 5.94 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 121.359 0.6 . . . . 0.0 110.61 -177.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 95' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -129.62 148.26 51.5 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.525 177.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 96' ' ' LYS . . . . . 0.468 ' HG3' ' CE1' ' B' ' 102' ' ' PHE . 98.8 mttt -104.71 -179.08 3.84 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.02 0.438 . . . . 0.0 110.59 178.059 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.31 -36.25 77.48 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.211 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 37.6 p-10 -87.45 -1.29 57.82 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.931 0.787 . . . . 0.0 112.832 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.99 5.07 64.45 Favored Glycine 0 N--CA 1.466 0.69 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.249 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 26.5 m -67.32 128.38 36.18 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.305 177.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 101' ' ' MET . . . . . 0.663 ' SD ' ' N ' ' B' ' 102' ' ' PHE . 13.9 tmm? -87.5 143.5 27.19 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 102' ' ' PHE . . . . . 0.663 ' N ' ' SD ' ' B' ' 101' ' ' MET . 53.2 p90 -154.86 163.86 39.66 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 103' ' ' TRP . . . . . 0.934 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 24.5 m95 -96.72 137.4 35.86 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.944 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 104' ' ' ASN . . . . . 0.507 HD21 ' HG2' ' B' ' 123' ' ' GLN . 62.7 t-20 -132.17 110.84 10.95 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 114.904 -1.043 . . . . 0.0 113.686 -176.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -80.4 124.52 28.96 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 123.842 0.713 . . . . 0.0 109.185 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 39.8 tp -111.25 125.29 53.66 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.002 0.429 . . . . 0.0 111.824 -177.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 107' ' ' ASN . . . . . 0.902 ' OD1' HG23 ' B' ' 89' ' ' THR . 97.9 m-20 -120.05 126.73 51.51 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 176.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 96.4 mt -122.79 133.33 69.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -143.23 123.39 7.85 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -70.0 151.92 67.88 Favored 'Trans proline' 0 N--CA 1.504 2.119 0 C-N-CA 122.657 2.238 . . . . 0.0 112.582 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 111' ' ' MET . . . . . 0.506 ' HB2' ' HB2' ' B' ' 118' ' ' TYR . 67.1 mtt -128.28 143.76 51.06 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -113.79 107.28 15.52 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 113' ' ' ILE . . . . . 0.585 HG12 ' NZ ' ' A' ' 18' ' ' LYS . 96.6 mt -134.62 127.77 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 O-C-N 121.811 -0.556 . . . . 0.0 112.071 178.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 51.15 38.5 21.14 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 123.834 0.709 . . . . 0.0 109.814 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 61.21 35.42 18.36 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.526 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -132.58 149.07 52.37 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 117' ' ' THR . . . . . 0.491 HG23 ' HG3' ' B' ' 32' ' ' PRO . 10.0 t -101.64 153.62 19.6 Favored 'General case' 0 C--O 1.214 -0.775 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -178.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 118' ' ' TYR . . . . . 0.506 ' HB2' ' HB2' ' B' ' 111' ' ' MET . 96.9 m-85 -148.13 147.55 29.61 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 121.317 -0.864 . . . . 0.0 111.497 -178.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -122.27 137.93 54.67 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 123.626 0.579 . . . . 0.0 110.9 -177.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -127.32 133.99 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -177.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.94 122.87 6.72 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 94.6 mt -113.52 127.45 70.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 123' ' ' GLN . . . . . 0.507 ' HG2' HD21 ' B' ' 104' ' ' ASN . 17.8 mp0 -118.45 121.6 40.71 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -121.42 119.34 31.8 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 125' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' B' ' 126' ' ' ILE . 67.9 t0 -68.31 135.54 52.05 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.57 -177.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.528 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 2.8 mp -107.41 17.72 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.512 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 127' ' ' THR . . . . . 0.5 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 97.5 m -63.95 -44.15 93.68 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 114.439 -1.255 . . . . 0.0 112.687 177.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -62.18 -45.85 91.55 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -177.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 129' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -62.58 -35.1 78.42 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.43 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 130' ' ' LYS . . . . . 0.934 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 98.6 mttt -63.64 -41.33 98.25 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-N 112.817 -1.992 . . . . 0.0 110.728 175.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.71 -41.64 95.85 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 132' ' ' TYR . . . . . 0.766 ' CE2' HD11 ' B' ' 136' ' ' LEU . 90.0 t80 -60.47 -44.57 95.75 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.831 -0.543 . . . . 0.0 111.566 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 133' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' B' ' 137' ' ' GLU . 97.0 mt-10 -64.47 -36.35 83.9 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.55 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.27 -39.16 93.82 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.833 177.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.76 -41.24 99.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.565 0.698 . . . . 0.0 109.378 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 136' ' ' LEU . . . . . 0.766 HD11 ' CE2' ' B' ' 132' ' ' TYR . 84.5 mt -63.0 -41.67 99.65 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.453 178.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 137' ' ' GLU . . . . . 0.411 ' HG3' ' O ' ' B' ' 133' ' ' GLU . 97.1 mt-10 -65.28 -37.51 87.41 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 113.523 -1.672 . . . . 0.0 110.229 -178.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -63.43 -43.36 97.66 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.055 176.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 65.6 m -60.64 -44.57 96.23 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 140' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' B' ' 144' ' ' THR . 86.1 mt -61.5 -40.13 93.5 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -177.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 95.4 m -61.67 -45.65 93.09 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.994 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -66.38 -42.6 87.69 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 93.8 mt -63.58 -43.5 98.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 114.438 -1.256 . . . . 0.0 110.591 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 144' ' ' THR . . . . . 0.417 ' N ' ' O ' ' B' ' 140' ' ' LEU . 91.0 m -61.76 -45.07 95.47 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.65 -41.08 96.36 Favored 'General case' 0 C--O 1.226 -0.149 0 C-N-CA 119.161 -1.016 . . . . 0.0 109.435 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.87 -41.18 95.86 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 176.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 147' ' ' SER . . . . . 0.575 ' O ' ' N ' ' B' ' 149' ' ' PRO . 78.3 p -62.44 -41.82 99.01 Favored 'General case' 0 CA--C 1.478 -1.79 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 148' ' ' THR . . . . . 0.488 ' C ' ' O ' ' B' ' 147' ' ' SER . 7.1 m -26.1 86.45 0.04 OUTLIER Pre-proline 0 N--CA 1.482 1.148 0 O-C-N 124.196 0.935 . . . . 0.0 110.425 176.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 149' ' ' PRO . . . . . 0.575 ' N ' ' O ' ' B' ' 147' ' ' SER . 24.1 Cg_exo -60.8 145.96 98.16 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 121.613 1.542 . . . . 0.0 115.342 -176.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 9.4 tp -127.68 119.83 52.78 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.828 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 172.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 61.0 t -150.25 94.88 3.65 Favored Pre-proline 0 C--N 1.303 -1.418 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.064 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -62.28 143.03 93.43 Favored 'Trans proline' 0 N--CA 1.485 0.983 0 N-CA-C 109.512 -0.995 . . . . 0.0 109.512 -179.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 153' ' ' ILE . . . . . 0.564 HG21 HH12 ' A' ' 154' ' ' ARG . 44.1 mm -76.19 -66.52 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 154' ' ' ARG . . . . . 0.725 ' HD3' ' NH2' ' A' ' 154' ' ' ARG . 4.4 mpt_? -132.06 -157.92 0.85 Allowed 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.039 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 62.5 t-20 -83.98 110.39 18.39 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.06 -18.23 55.98 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -178.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 86.4 mt -108.34 124.61 64.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.993 0.425 . . . . 0.0 111.068 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 158' ' ' SER . . . . . 0.625 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 67.0 m -135.98 149.65 48.94 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.74 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -133.83 145.67 49.94 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 22.7 tp -137.28 80.22 34.64 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 161' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -72.19 149.63 52.12 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.623 2.215 . . . . 0.0 114.048 -177.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 92.1 mt -115.29 134.52 55.05 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 55.5 t -129.98 132.66 65.4 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 113.98 169.59 16.79 Favored Glycine 0 N--CA 1.47 0.911 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.48 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 165' ' ' ASN . . . . . 0.683 ' O ' ' CZ ' ' B' ' 170' ' ' ARG . 62.9 t30 -89.97 107.39 19.09 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -177.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 166' ' ' LEU . . . . . 0.613 HD21 ' CZ ' ' B' ' 171' ' ' PHE . 44.0 tp -64.55 104.49 0.8 Allowed 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -175.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 167' ' ' THR . . . . . 0.685 HG23 ' NE ' ' B' ' 170' ' ' ARG . 10.5 p -84.19 169.74 14.49 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-N 114.116 -1.402 . . . . 0.0 110.894 177.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -66.92 -37.42 84.29 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.637 177.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.86 -40.39 87.85 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-O 122.119 0.961 . . . . 0.0 111.554 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 170' ' ' ARG . . . . . 0.685 ' NE ' HG23 ' B' ' 167' ' ' THR . 88.0 mtm180 -62.48 -35.98 81.04 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 112.762 -2.017 . . . . 0.0 111.248 178.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 171' ' ' PHE . . . . . 0.613 ' CZ ' HD21 ' B' ' 166' ' ' LEU . 0.5 OUTLIER -54.82 -25.64 29.78 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -178.686 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 172' ' ' ASN . . . . . 0.534 ' O ' HG22 ' B' ' 175' ' ' VAL . 91.9 m-20 -62.67 -40.26 96.52 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.804 178.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 49.2 m -60.52 -41.48 94.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.145 0.498 . . . . 0.0 110.801 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 65.9 mt -63.86 -44.03 97.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 175' ' ' VAL . . . . . 0.534 HG22 ' O ' ' B' ' 172' ' ' ASN . 33.3 m -62.54 -40.21 87.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 176' ' ' CYS . . . . . 0.418 ' N ' HG23 ' B' ' 175' ' ' VAL . 99.9 m -62.02 -35.23 77.94 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.381 178.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 177' ' ' THR . . . . . 0.556 ' O ' HG13 ' B' ' 181' ' ' ILE . 24.7 m -61.32 -20.27 62.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.938 0.399 . . . . 0.0 110.184 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 178' ' ' LEU . . . . . 0.672 ' CD2' HD21 ' B' ' 211' ' ' LEU . 87.8 mt -61.1 -39.47 90.08 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.281 -177.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 19.0 m -61.85 -44.4 96.91 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.322 177.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 180' ' ' ASN . . . . . 0.575 ' O ' ' OG ' ' B' ' 183' ' ' SER . 92.9 m-20 -61.88 -40.73 96.4 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.802 0.334 . . . . 0.0 110.411 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.556 HG13 ' O ' ' B' ' 177' ' ' THR . 75.1 mt -55.69 -31.2 28.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 C-N-CA 120.916 -0.314 . . . . 0.0 110.897 -178.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 182' ' ' LEU . . . . . 0.514 HD21 HD21 ' B' ' 214' ' ' LEU . 85.1 mt -62.8 -42.08 99.56 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.328 177.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 183' ' ' SER . . . . . 0.575 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.2 p -62.91 -32.85 74.22 Favored 'General case' 0 N--CA 1.455 -0.183 0 O-C-N 122.004 -0.435 . . . . 0.0 110.89 177.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 184' ' ' THR . . . . . 0.427 ' OG1' ' HA ' ' B' ' 181' ' ' ILE . 21.0 p -85.49 16.09 4.05 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.77 0.319 . . . . 0.0 111.775 -178.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 79.2 p -59.68 -17.52 34.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.034 -177.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.78 -40.52 95.49 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.683 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 187' ' ' ASP . . . . . 0.625 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.2 m-20 -69.31 113.34 6.55 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.519 0.676 . . . . 0.0 110.632 -178.015 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -62.7 -41.96 99.39 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-N 114.807 -1.088 . . . . 0.0 113.154 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -112.49 130.45 55.99 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.2 -178.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 190' ' ' LEU . . . . . . . . . . . . . 41.1 tp -124.07 118.73 27.61 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.025 177.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 86.6 mt -107.12 126.82 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-O 120.608 0.242 . . . . 0.0 111.416 -177.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 49.2 mm -115.66 117.53 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 193' ' ' ASP . . . . . 0.503 ' CG ' ' HG ' ' B' ' 195' ' ' SER . 41.2 t0 -88.49 109.74 20.29 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.04 0.448 . . . . 0.0 112.11 -177.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 194' ' ' LEU . . . . . . . . . . . . . 96.3 mt -90.34 -3.53 57.68 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.517 176.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 195' ' ' SER . . . . . 0.503 ' HG ' ' CG ' ' B' ' 193' ' ' ASP . 78.1 p -61.46 -36.68 81.12 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.896 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.04 -33.24 83.26 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 197' ' ' LEU . . . . . 1.01 HD23 ' N ' ' B' ' 198' ' ' ALA . 4.8 tt -78.38 132.83 37.53 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 122.163 -0.61 . . . . 0.0 109.489 -177.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 198' ' ' ALA . . . . . 1.01 ' N ' HD23 ' B' ' 197' ' ' LEU . . . -63.15 -44.21 96.15 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 119.454 -0.899 . . . . 0.0 110.765 -177.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 199' ' ' GLN . . . . . 0.972 ' O ' ' CD2' ' B' ' 197' ' ' LEU . 58.0 tt0 -137.58 165.99 25.0 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.778 0.799 . . . . 0.0 112.947 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 200' ' ' VAL . . . . . 0.524 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 47.3 t -121.46 132.07 71.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 O-C-N 120.716 -1.24 . . . . 0.0 109.384 177.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -91.09 149.26 21.89 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.15 0.5 . . . . 0.0 110.979 -178.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.22 -32.92 71.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.414 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -64.79 -32.26 73.87 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.4 m -60.3 -44.33 95.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.572 178.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 205' ' ' ALA . . . . . 0.706 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -58.51 -28.31 65.3 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -65.42 -38.68 90.64 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.224 0.535 . . . . 0.0 109.874 176.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -67.52 -38.08 83.74 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.934 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 96.3 mt -63.61 -43.42 98.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.208 0.527 . . . . 0.0 109.866 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 209' ' ' PHE . . . . . 0.706 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 71.7 m-85 -62.19 -42.99 99.8 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.275 -1.33 . . . . 0.0 112.859 177.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -63.52 -41.35 98.5 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 119.492 -0.883 . . . . 0.0 109.545 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 211' ' ' LEU . . . . . 0.672 HD21 ' CD2' ' B' ' 178' ' ' LEU . 40.2 mt -62.54 -42.37 99.49 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.33 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 78.2 p -63.14 -36.66 84.36 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.224 -0.59 . . . . 0.0 111.873 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 213' ' ' HIS . . . . . 0.414 ' CE1' HD11 ' B' ' 217' ' ' LEU . 58.8 t-80 -67.58 -46.36 72.89 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 115.362 -0.836 . . . . 0.0 112.204 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.514 HD21 HD21 ' B' ' 182' ' ' LEU . 52.8 tp -63.77 -42.73 97.74 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.963 0.887 . . . . 0.0 109.994 177.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 215' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' B' ' 211' ' ' LEU . 89.6 mt -62.94 -44.06 97.1 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 113.454 -1.703 . . . . 0.0 111.708 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.33 -39.47 93.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.743 -176.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 217' ' ' LEU . . . . . 0.414 HD11 ' CE1' ' B' ' 213' ' ' HIS . 86.1 mt -63.79 -42.11 97.79 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.349 0.595 . . . . 0.0 111.434 176.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 218' ' ' THR . . . . . 0.425 HG23 ' O ' ' B' ' 214' ' ' LEU . 68.6 p -74.42 -17.58 60.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.063 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 80.61 69.42 1.4 Allowed Glycine 0 CA--C 1.528 0.87 0 N-CA-C 106.424 -2.67 . . . . 0.0 106.424 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 220' ' ' THR . . . . . . . . . . . . . 96.7 m -149.02 101.4 3.16 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 177.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -59.59 140.08 56.64 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.907 0.384 . . . . 0.0 111.055 -176.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 42.7 tp -117.54 121.62 41.46 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.313 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 4.3 mp -109.09 128.72 64.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.155 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 224' ' ' ILE . . . . . 0.525 ' CG2' HD11 ' B' ' 227' ' ' ILE . 49.8 mm -109.86 127.3 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.573 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 43.3 p -133.16 158.15 43.54 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.574 0.702 . . . . 0.0 112.684 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 88.44 19.98 50.2 Favored Glycine 0 CA--C 1.499 -0.943 0 CA-C-N 113.762 -1.563 . . . . 0.0 111.175 -178.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 227' ' ' ILE . . . . . 0.768 HD12 HG23 ' B' ' 247' ' ' THR . 95.9 mt -83.84 125.69 40.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 O-C-N 122.12 -0.635 . . . . 0.0 111.464 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 37.4 tttt -65.51 138.67 96.95 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.494 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.2 -37.02 94.56 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 121.424 1.416 . . . . 0.0 112.538 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -64.16 -43.34 95.46 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 50.5 tp -61.92 -41.61 98.13 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.826 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.13 -36.19 83.23 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.735 0.302 . . . . 0.0 111.286 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 94.7 mtp -64.15 -40.53 96.34 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.26 -42.41 99.15 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 122.085 0.945 . . . . 0.0 109.219 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 30.4 mmt -64.06 -35.42 80.66 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 114.625 -1.171 . . . . 0.0 112.102 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -62.26 -40.24 95.55 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.891 -177.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.07 -44.11 96.69 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.09 178.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.08 -44.95 95.56 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 120.383 -0.527 . . . . 0.0 112.303 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -158.88 133.82 8.26 Favored 'General case' 0 CA--C 1.51 -0.577 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.888 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 240' ' ' ALA . . . . . . . . . . . . . . . -62.61 -47.43 83.79 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 177.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 241' ' ' ASN . . . . . 0.465 ' O ' ' HB2' ' B' ' 244' ' ' SER . 90.2 m-20 -41.65 -19.71 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.477 -176.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 242' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -61.9 -44.87 95.89 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.816 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 243' ' ' SER . . . . . 0.432 ' O ' ' N ' ' B' ' 245' ' ' LEU . 78.1 p -57.87 -44.68 86.79 Favored 'General case' 0 C--N 1.345 0.377 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 244' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 18.0 m -29.43 -36.36 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 245' ' ' LEU . . . . . 0.432 ' N ' ' O ' ' B' ' 243' ' ' SER . 96.4 mt -89.18 133.37 34.44 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.369 -178.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -61.48 134.48 56.92 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 121.155 0.502 . . . . 0.0 110.474 -176.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 247' ' ' THR . . . . . 0.768 HG23 HD12 ' B' ' 227' ' ' ILE . 95.0 m -126.34 128.52 47.21 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.047 -0.978 . . . . 0.0 111.923 178.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 248' ' ' TYR . . . . . 0.477 ' CG ' ' HB2' ' B' ' 254' ' ' ALA . 97.5 m-85 -112.89 144.96 41.57 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 249' ' ' SER . . . . . 0.59 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 78.2 p -63.76 -33.54 75.89 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.818 -178.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 250' ' ' ASN . . . . . 0.59 ' OD1' ' O ' ' B' ' 249' ' ' SER . 99.3 m-20 -148.45 160.36 43.13 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.049 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 79.2 t -64.63 -44.21 96.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.046 178.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 252' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -61.29 -46.11 91.7 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 253' ' ' ASP . . . . . 0.438 ' O ' HG13 ' B' ' 257' ' ' VAL . 92.9 m-20 -61.07 -43.75 98.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.835 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 254' ' ' ALA . . . . . 0.477 ' HB2' ' CG ' ' B' ' 248' ' ' TYR . . . -65.77 -40.5 92.06 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 120.069 -0.652 . . . . 0.0 111.299 178.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 255' ' ' VAL . . . . . 0.603 HG13 HH11 ' A' ' 154' ' ' ARG . 56.9 t -64.72 -45.75 94.27 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.07 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -63.01 -47.72 81.9 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 119.906 -0.718 . . . . 0.0 111.487 -178.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 257' ' ' VAL . . . . . 0.441 ' O ' ' C ' ' B' ' 258' ' ' LEU . 18.8 m -64.73 -40.41 88.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.533 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 258' ' ' LEU . . . . . 0.485 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 1.7 mt -33.79 -71.33 0.1 Allowed Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.479 -177.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 259' ' ' PRO . . . . . 0.569 ' O ' HG13 ' B' ' 260' ' ' ILE . 37.6 Cg_endo -62.39 139.91 79.49 Favored 'Trans proline' 0 N--CA 1.501 1.965 0 C-N-CA 121.418 1.412 . . . . 0.0 111.193 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 260' ' ' ILE . . . . . 0.569 HG13 ' O ' ' B' ' 259' ' ' PRO . 96.6 mt -159.62 -13.48 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 CA-C-N 118.713 0.688 . . . . 0.0 112.361 176.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 C--O 1.216 -0.686 0 CA-C-O 117.859 -1.067 . . . . 0.0 111.436 -179.983 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 900' ' ' FMN . . . . . 0.466 ' C9A' " O2'" ' A' ' 900' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 900' ' ' FMN . . . . . 0.45 " O2'" ' C9A' ' B' ' 900' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.13 170.76 20.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.144 0.497 . . . . 0.0 110.196 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 80.1 p -72.66 -14.71 61.65 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.36 -0.837 . . . . 0.0 111.788 177.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -76.32 -66.59 0.78 Allowed 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 114.326 -1.306 . . . . 0.0 112.966 174.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -66.94 -39.64 87.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.908 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.539 ' O ' ' NZ ' ' B' ' 17' ' ' LYS . 49.8 m -59.25 -41.37 88.63 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -177.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.567 ' CE2' HD12 ' A' ' 9' ' ' ILE . 36.1 t80 84.37 88.23 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.127 0.489 . . . . 0.0 112.034 177.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.47 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -62.19 -137.74 0.01 OUTLIER Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 -177.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.567 HD12 ' CE2' ' A' ' 7' ' ' PHE . 55.8 mt 79.02 109.81 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 122.679 0.392 . . . . 0.0 110.637 -178.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.59 -22.06 70.43 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 121.438 1.425 . . . . 0.0 112.138 -178.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.464 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -63.28 -37.46 94.9 Favored Glycine 0 N--CA 1.468 0.83 0 C-N-CA 121.045 -0.598 . . . . 0.0 111.862 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -66.14 -39.31 89.75 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.514 0.673 . . . . 0.0 109.519 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.1 tp -63.33 -41.46 98.89 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -63.65 -39.9 95.49 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 11' ' ' GLY . 67.9 t -60.03 -44.19 94.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 O-C-N 122.174 -0.329 . . . . 0.0 110.938 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 93.0 mt -62.49 -43.57 98.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 119.589 -0.844 . . . . 0.0 109.321 -178.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.444 ' NZ ' ' HA ' ' B' ' 6' ' ' SER . 98.9 mttt -62.28 -46.19 89.88 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 119.361 -0.936 . . . . 0.0 112.022 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.661 ' HZ1' HG12 ' B' ' 113' ' ' ILE . 98.4 mttt -60.46 -39.54 87.96 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 118.642 -1.223 . . . . 0.0 109.079 -176.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.58 -42.2 91.94 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.144 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.2 mt -62.95 -40.15 96.8 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 177.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.19 -39.39 94.51 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.479 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 60.7 m170 -59.29 -39.42 82.92 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 122.226 -0.297 . . . . 0.0 111.606 -178.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.8 p -113.76 130.64 67.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.49 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 34.6 ptt180 -73.41 109.99 7.35 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-O 122.062 0.934 . . . . 0.0 112.187 -177.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.9 p -141.29 143.75 27.37 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.579 ' O ' ' N ' ' A' ' 123' ' ' GLN . . . -98.91 91.2 1.07 Allowed Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.908 -178.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 52.6 t -124.55 130.45 73.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 175.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.8 m -136.62 159.73 37.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.4 mt -120.43 129.55 75.43 Favored 'Isoleucine or valine' 0 C--O 1.244 0.797 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.467 HG22 HG12 ' A' ' 39' ' ' ILE . 22.4 p -106.56 167.48 9.82 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.425 ' C ' ' OD1' ' A' ' 37' ' ' ASN . 58.6 t0 -133.15 104.13 12.6 Favored Pre-proline 0 C--N 1.321 -0.66 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.251 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.697 ' HG3' HG23 ' A' ' 117' ' ' THR . 36.0 Cg_endo -63.4 -24.59 71.15 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.414 1.409 . . . . 0.0 111.501 -178.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.95 -35.75 81.17 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.17 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.4 mt -84.13 157.47 21.69 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.849 178.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.709 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 43.4 tt0 -57.46 134.59 56.2 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 113.361 0.875 . . . . 0.0 113.361 -176.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.526 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 59.2 t0 60.54 23.67 13.36 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.425 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 40.6 t-20 39.23 69.2 1.73 Allowed Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.181 -176.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.709 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 93.3 Cg_endo -70.19 155.31 64.83 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 123.95 3.1 . . . . 0.0 112.123 -178.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.467 HG12 HG22 ' A' ' 30' ' ' THR . 96.0 mt -88.95 122.07 39.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.466 HG23 ' N ' ' A' ' 41' ' ' TYR . 30.3 m -102.01 -45.97 11.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.243 -178.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.466 ' N ' HG23 ' A' ' 40' ' ' VAL . 48.9 t80 -93.72 124.36 37.67 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 120.185 -0.606 . . . . 0.0 111.949 -178.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.7 p -143.09 140.27 27.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.226 0.953 . . . . 0.0 109.217 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.614 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 56.9 p30 -96.49 166.43 11.69 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.474 ' HA ' ' OE1' ' A' ' 44' ' ' GLN . 14.9 mm100 -66.55 -39.82 88.72 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 177.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.89 -24.25 60.12 Favored Glycine 0 N--CA 1.453 -0.209 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.631 ' CD2' HD13 ' A' ' 57' ' ' ILE . 65.5 t80 -59.61 -47.86 83.92 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 -179.092 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.579 HG13 ' O ' ' A' ' 52' ' ' TYR . 71.4 t -58.96 -44.54 91.24 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.646 0 O-C-N 121.301 -0.875 . . . . 0.0 111.745 -174.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -63.25 -37.29 86.68 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 120.399 -0.52 . . . . 0.0 112.301 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 59.2 ttm -66.79 -43.38 84.1 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 176.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 36.3 p -93.51 -21.18 19.62 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.346 0.593 . . . . 0.0 111.541 -177.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . 76.44 20.46 76.88 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -179.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.579 ' O ' HG13 ' A' ' 47' ' ' VAL . 82.1 m-85 -113.25 137.08 52.01 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 122.783 0.433 . . . . 0.0 111.12 178.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -62.62 146.99 50.65 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.558 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.426 HG22 ' H ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -64.84 -32.9 74.82 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -179.485 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -66.69 -43.1 85.31 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.516 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -64.67 -45.65 85.77 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.073 -0.651 . . . . 0.0 109.252 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.631 HD13 ' CD2' ' A' ' 46' ' ' PHE . 89.1 mt -61.26 -49.84 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -175.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.1 mt -55.53 148.27 16.02 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 176.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.28 -3.44 77.38 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.873 -0.679 . . . . 0.0 113.062 177.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -137.15 151.41 48.78 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 118.705 1.252 . . . . 0.0 112.037 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.575 ' C ' ' H ' ' A' ' 63' ' ' ARG . 25.1 t-20 -81.77 151.71 27.31 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.553 -178.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 79.2 m -62.09 15.39 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.373 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.575 ' H ' ' C ' ' A' ' 61' ' ' ASN . 35.2 ptt-85 -62.21 -41.41 98.34 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.139 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -56.04 -21.99 24.81 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.2 mt -67.33 -35.73 80.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 122.066 0.936 . . . . 0.0 112.916 177.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -63.21 146.38 53.51 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.847 -1.069 . . . . 0.0 112.263 -178.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.496 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -156.54 -150.93 5.8 Favored Glycine 0 CA--C 1.538 1.519 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -177.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.75 -41.29 99.14 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.582 ' O ' ' NE2' ' A' ' 93' ' ' GLN . 9.2 m80 -76.21 -9.08 58.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.847 0.356 . . . . 0.0 110.916 -178.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.496 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 32.9 m -62.62 128.69 37.14 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.595 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -84.75 110.99 31.8 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.825 -179.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -57.29 -31.09 89.88 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 121.997 1.798 . . . . 0.0 113.207 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.5 -39.31 93.54 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.888 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.571 ' OE1' ' HB ' ' A' ' 90' ' ' VAL . 79.1 mm-40 -65.45 -44.43 87.28 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.0 t -59.31 -44.1 91.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -176.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -63.97 -38.19 90.17 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.004 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -63.68 -39.6 94.73 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.403 0.621 . . . . 0.0 110.24 178.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 94.1 mt -63.71 -44.12 98.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.053 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -62.88 -42.52 99.8 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 113.814 -1.539 . . . . 0.0 108.309 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 97.6 m -61.24 -49.37 77.37 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.65 -42.46 92.87 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.189 -172.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.5 mt -63.45 -39.56 94.79 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.007 -1.058 . . . . 0.0 111.492 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -64.06 -33.16 75.12 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -89.08 -2.63 58.64 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.381 -178.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.2 tttt 49.22 40.78 18.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.59 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -122.69 144.26 42.11 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -61.32 142.88 97.37 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 121.473 1.448 . . . . 0.0 113.543 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -139.75 141.63 34.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.589 -178.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.93 HG23 ' OD1' ' A' ' 107' ' ' ASN . 98.8 m -128.12 120.05 26.57 Favored 'General case' 0 C--N 1.344 0.332 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 175.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.571 ' HB ' ' OE1' ' A' ' 74' ' ' GLU . 28.4 m -138.85 158.7 30.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.465 178.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -101.76 132.39 47.51 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 177.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.453 ' O ' HG23 ' A' ' 92' ' ' ILE . 19.2 tt -139.99 129.44 28.29 Favored 'Isoleucine or valine' 0 C--N 1.377 1.789 0 CA-C-N 121.557 1.98 . . . . 0.0 112.527 176.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.582 ' NE2' ' O ' ' A' ' 69' ' ' HIS . 34.1 mt-30 -62.98 133.45 54.63 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.55 -1.205 . . . . 0.0 109.948 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -134.48 158.33 44.19 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.758 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.428 ' CE1' ' HA3' ' A' ' 67' ' ' GLY . 92.7 m-85 -116.16 135.13 54.2 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -179.178 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.438 ' HG3' ' CE1' ' A' ' 102' ' ' PHE . 99.2 mttt -83.69 -172.51 4.19 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.161 0.505 . . . . 0.0 111.618 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.05 -42.26 99.66 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.158 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 41.0 p-10 -83.31 5.84 21.84 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.51 -0.65 88.39 Favored Glycine 0 N--CA 1.47 0.925 0 O-C-N 121.547 -0.721 . . . . 0.0 112.126 176.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.1 m -59.83 138.32 57.83 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.649 ' SD ' ' C ' ' A' ' 101' ' ' MET . 14.9 tmm? -104.45 128.75 52.42 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.561 0.22 . . . . 0.0 110.782 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.438 ' CE1' ' HG3' ' A' ' 96' ' ' LYS . 52.7 p90 -141.44 158.55 43.72 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.888 -176.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.638 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 20.7 m95 -90.81 141.29 28.96 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.571 HD21 ' HG2' ' A' ' 123' ' ' GLN . 53.1 t-20 -136.41 106.8 6.44 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -177.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.443 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 80.5 tt0 -72.37 134.9 45.7 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 -177.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 43.9 tp -120.78 123.07 41.76 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASN . . . . . 0.93 ' OD1' HG23 ' A' ' 89' ' ' THR . 98.0 m-20 -118.68 123.86 45.96 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.866 177.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 96.3 mt -120.21 128.45 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 O-C-N 123.525 0.516 . . . . 0.0 111.57 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -137.96 123.09 12.35 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 116.764 -0.198 . . . . 0.0 110.925 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -70.26 150.85 65.76 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.454 2.103 . . . . 0.0 112.578 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' MET . . . . . 0.634 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 66.3 mtt -122.67 152.63 40.34 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -127.23 91.51 3.33 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 177.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.411 ' CD1' HG22 ' B' ' 15' ' ' VAL . 96.7 mt -117.81 130.57 72.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.275 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 53.31 36.56 23.13 Favored 'General case' 0 CA--C 1.513 -0.472 0 O-C-N 121.461 -0.774 . . . . 0.0 111.648 176.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 59.21 30.62 20.41 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 123.853 0.721 . . . . 0.0 110.813 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -127.52 149.55 50.08 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.782 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 9.9 t -85.79 -173.11 4.45 Favored 'General case' 0 C--O 1.219 -0.504 0 O-C-N 121.687 -0.633 . . . . 0.0 109.489 -178.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.782 ' CD2' ' O ' ' A' ' 117' ' ' THR . 69.0 m-85 -171.9 155.71 3.92 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 174.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -131.51 146.34 52.18 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 174.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.87 135.1 55.57 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 177.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.496 ' HA3' ' H6 ' ' A' ' 900' ' ' FMN . . . -106.9 127.27 8.78 Favored Glycine 0 CA--C 1.502 -0.765 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 177.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 96.3 mt -117.89 129.27 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.579 ' N ' ' O ' ' A' ' 26' ' ' GLY . 15.9 mp0 -120.18 115.74 24.24 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 123.69 0.619 . . . . 0.0 109.793 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -115.35 113.14 23.4 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.817 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.401 ' OD1' ' C ' ' A' ' 125' ' ' ASP . 68.4 t0 -65.77 123.23 19.2 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -175.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.519 ' O ' HG22 ' A' ' 126' ' ' ILE . 3.0 mp -87.0 2.89 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 113.666 -1.606 . . . . 0.0 110.194 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 31.6 m -60.13 -42.47 94.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.042 -1.036 . . . . 0.0 113.393 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -59.66 -42.6 93.2 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -178.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -62.38 -39.19 92.36 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.855 176.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.638 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.8 mttt -62.53 -40.71 97.64 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 118.31 -1.356 . . . . 0.0 110.494 -178.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.53 -37.27 85.44 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.357 -0.537 . . . . 0.0 109.657 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.836 ' CE2' HD11 ' A' ' 136' ' ' LEU . 90.6 t80 -61.74 -45.7 92.8 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.244 176.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.33 -39.44 93.91 Favored 'General case' 0 C--O 1.226 -0.179 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.48 -41.23 96.95 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 50.6 tp -61.09 -43.76 98.39 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 -177.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.836 HD11 ' CE2' ' A' ' 132' ' ' TYR . 88.5 mt -62.22 -41.08 98.06 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.882 178.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -62.76 -41.36 99.18 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 119.453 -0.899 . . . . 0.0 109.762 -178.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -60.99 -42.01 97.58 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -177.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 53.7 m -61.67 -41.34 97.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.71 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 144' ' ' THR . 87.5 mt -63.39 -41.89 98.78 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.785 178.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 87.3 m -61.65 -45.33 94.49 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.381 -177.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -65.05 -41.3 95.27 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 96.4 mt -64.45 -43.6 96.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.005 -1.452 . . . . 0.0 111.235 175.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.518 ' N ' ' O ' ' A' ' 140' ' ' LEU . 95.6 m -62.29 -46.32 89.28 Favored 'General case' 0 C--N 1.345 0.411 0 C-N-CA 120.364 -0.534 . . . . 0.0 112.185 -178.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.22 -41.21 99.08 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 118.882 -1.127 . . . . 0.0 109.15 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.6 mt -63.93 -42.67 97.3 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 178.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.702 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.2 p -59.6 -38.38 81.1 Favored 'General case' 0 C--O 1.218 -0.598 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -178.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.465 ' C ' ' O ' ' A' ' 147' ' ' SER . 86.1 m -28.97 82.37 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.32 0 O-C-N 126.944 2.653 . . . . 0.0 106.101 -178.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.702 ' N ' ' O ' ' A' ' 147' ' ' SER . 23.2 Cg_exo -61.85 145.0 97.32 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 CA-C-O 122.788 1.078 . . . . 0.0 114.301 -174.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.595 ' O ' HG23 ' A' ' 151' ' ' VAL . 9.5 tp -120.44 136.49 57.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 102.502 -3.147 . . . . 0.0 102.502 176.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 150' ' ' ILE . 96.3 t -167.9 93.83 0.64 Allowed Pre-proline 0 CA--C 1.506 -0.725 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 178.015 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -63.82 143.71 86.74 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 N-CA-C 109.901 -0.846 . . . . 0.0 109.901 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.72 ' O ' HG11 ' B' ' 255' ' ' VAL . 44.3 mm -77.03 -68.71 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.659 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ARG . . . . . 0.665 ' NH2' ' HD3' ' B' ' 154' ' ' ARG . 3.1 mpt_? -132.99 -161.41 1.14 Allowed 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -83.34 104.99 13.93 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.849 0.833 . . . . 0.0 111.291 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.8 10.06 60.49 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 113.904 -1.498 . . . . 0.0 110.2 -177.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.5 mt -126.98 125.67 66.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.735 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 58.7 m -132.25 152.46 51.34 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -138.37 142.28 39.64 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.481 177.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 27.4 tp -135.45 80.58 45.03 Favored Pre-proline 0 N--CA 1.468 0.454 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.386 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -70.98 151.54 62.22 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.638 2.225 . . . . 0.0 113.005 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 88.6 mt -117.65 126.79 53.14 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.184 177.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 47.7 t -122.95 130.13 74.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 116.57 167.49 14.69 Favored Glycine 0 N--CA 1.479 1.558 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.179 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.841 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 57.6 t30 -84.16 115.83 22.61 Favored 'General case' 0 C--O 1.222 -0.358 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -178.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.56 HD21 ' CZ ' ' A' ' 171' ' ' PHE . 45.3 tp -74.28 104.83 5.19 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 -177.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.738 HG23 ' NE ' ' A' ' 170' ' ' ARG . 10.8 p -87.04 166.74 14.81 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.269 0.557 . . . . 0.0 110.485 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.97 -33.75 76.54 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.086 0.47 . . . . 0.0 111.773 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.12 -43.76 90.94 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.519 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ARG . . . . . 0.841 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 87.1 mtm180 -64.99 -29.38 70.3 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 178.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.56 ' CZ ' HD21 ' A' ' 166' ' ' LEU . 0.5 OUTLIER -54.6 -28.98 50.28 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.604 ' O ' HG22 ' A' ' 175' ' ' VAL . 92.1 m-20 -60.89 -41.12 95.43 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 119.102 -1.039 . . . . 0.0 109.679 -177.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 60.0 m -59.45 -40.81 88.03 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.687 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 67.6 mt -63.25 -44.13 99.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 172' ' ' ASN . 34.5 m -63.0 -39.95 87.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' CYS . . . . . 0.414 ' N ' HG23 ' A' ' 175' ' ' VAL . 98.1 m -62.08 -34.66 76.71 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.431 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.5 ' O ' HG13 ' A' ' 181' ' ' ILE . 25.0 m -61.92 -19.27 62.52 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.097 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.653 ' CD2' HD21 ' A' ' 211' ' ' LEU . 88.2 mt -61.0 -41.02 95.72 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -177.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 17.4 m -58.97 -43.2 91.31 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ASN . . . . . 0.674 ' O ' ' OG ' ' A' ' 183' ' ' SER . 93.1 m-20 -61.76 -35.98 79.69 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 122.507 0.323 . . . . 0.0 110.748 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.504 HD12 ' HA ' ' A' ' 178' ' ' LEU . 65.2 mt -58.99 -40.54 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 121.441 -0.787 . . . . 0.0 109.538 -178.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.548 HD21 HD21 ' A' ' 214' ' ' LEU . 85.6 mt -60.53 -40.18 90.59 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -177.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.674 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 78.2 p -61.09 -33.5 73.44 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.419 175.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.407 ' OG1' ' HA ' ' A' ' 181' ' ' ILE . 60.0 p -91.71 23.59 3.51 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.7 0.286 . . . . 0.0 111.402 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 77.8 p -63.49 -20.86 65.95 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.674 -178.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.76 -37.65 82.58 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.929 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.735 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 98.5 m-20 -71.38 113.75 8.74 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.617 0.722 . . . . 0.0 110.928 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -62.95 -42.73 99.91 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.86 -177.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -112.06 131.36 55.48 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.981 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 39.5 tp -120.01 127.94 53.07 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 177.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 96.2 mt -115.73 125.94 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.6 mm -112.62 126.57 70.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 178.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' ASP . . . . . 0.507 ' OD2' ' OG ' ' A' ' 195' ' ' SER . 38.7 t0 -95.58 118.09 31.64 Favored 'General case' 0 CA--C 1.551 1.007 0 O-C-N 121.88 -0.512 . . . . 0.0 110.443 177.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 194' ' ' LEU . 96.9 mt -97.67 -3.35 39.47 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.848 175.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.507 ' OG ' ' OD2' ' A' ' 193' ' ' ASP . 78.0 p -62.24 -33.42 74.55 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.86 -44.68 97.52 Favored Glycine 0 CA--C 1.535 1.288 0 N-CA-C 108.39 -1.884 . . . . 0.0 108.39 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.943 HD23 ' N ' ' A' ' 198' ' ' ALA . 4.7 tt -69.22 128.03 35.17 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 112.792 -1.704 . . . . 0.0 108.902 -177.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.943 ' N ' HD23 ' A' ' 197' ' ' LEU . . . -60.8 -47.0 88.3 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-O 121.253 0.549 . . . . 0.0 110.48 -177.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.915 ' O ' ' CD2' ' A' ' 197' ' ' LEU . 58.4 tt0 -135.83 156.86 48.14 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-N 114.623 -1.171 . . . . 0.0 113.851 -173.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.453 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 45.3 t -118.73 132.03 69.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 O-C-N 120.924 -1.11 . . . . 0.0 108.298 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -86.95 156.01 19.97 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.582 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.11 -39.06 93.22 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 120.144 -0.623 . . . . 0.0 109.975 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -57.45 -31.98 66.46 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -178.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.4 m -61.32 -42.08 98.07 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.445 178.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.433 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -58.32 -38.42 77.07 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -176.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -61.81 -37.14 83.3 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -178.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -65.92 -38.18 88.02 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.979 177.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 94.7 mt -62.84 -44.35 99.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -178.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' PHE . . . . . 0.433 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 68.4 m-85 -62.74 -43.06 99.78 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.491 -177.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.27 -42.09 99.04 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 118.961 -1.096 . . . . 0.0 109.168 -178.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.653 HD21 ' CD2' ' A' ' 178' ' ' LEU . 39.8 mt -62.17 -41.87 98.72 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 78.2 p -61.52 -42.36 98.7 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 119.117 -1.033 . . . . 0.0 110.26 -179.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -63.92 -45.43 89.3 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.755 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.548 HD21 HD21 ' A' ' 182' ' ' LEU . 47.8 tp -62.45 -45.87 91.1 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.18 178.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 87.7 mt -62.67 -40.36 96.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.366 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.42 -44.97 95.23 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.507 -177.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 86.2 mt -61.68 -40.29 94.46 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 82.6 p -75.38 -11.41 60.04 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.501 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.88 35.14 19.75 Favored Glycine 0 C--N 1.341 0.832 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.697 -178.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 96.7 m -120.47 113.84 20.9 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 119.051 1.426 . . . . 0.0 111.772 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -66.57 136.5 55.71 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.574 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 45.0 tp -112.63 129.44 56.38 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 3.0 mp -116.3 134.58 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.671 ' CG2' HD11 ' A' ' 227' ' ' ILE . 49.8 mm -115.41 130.74 69.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 44.8 p -133.49 165.04 25.8 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.881 -177.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 78.53 20.46 71.57 Favored Glycine 0 C--O 1.225 -0.462 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.671 HD11 ' CG2' ' A' ' 224' ' ' ILE . 98.1 mt -82.32 128.04 39.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 113.767 -1.217 . . . . 0.0 108.248 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -75.67 140.44 71.42 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.09 -39.62 84.92 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 121.018 1.145 . . . . 0.0 112.483 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -63.72 -38.93 92.95 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.418 0.628 . . . . 0.0 110.198 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 52.9 tp -64.23 -42.24 96.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.791 177.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.84 -37.69 88.46 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.09 -178.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 94.0 mtp -63.33 -41.06 98.86 Favored 'General case' 0 C--O 1.249 1.041 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.82 -178.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.87 -38.89 92.78 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.468 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 36.4 mmt -66.21 -37.63 86.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.514 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -61.18 -42.74 99.12 Favored 'General case' 0 CA--C 1.514 -0.405 0 O-C-N 121.58 -0.7 . . . . 0.0 109.617 -176.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.18 -40.09 88.76 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.713 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 56.7 tp -63.3 -41.09 98.93 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -168.15 127.55 1.24 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.33 0.586 . . . . 0.0 112.532 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.47 -26.59 65.37 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.801 178.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.412 ' O ' ' HB2' ' A' ' 244' ' ' SER . 89.4 m-20 -62.67 -29.41 70.62 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.534 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -55.92 -45.64 78.67 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -175.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 98.4 p -60.99 -21.02 63.14 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 123.918 0.761 . . . . 0.0 111.44 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 241' ' ' ASN . 43.1 m -54.39 -40.47 68.22 Favored 'General case' 0 C--N 1.32 -0.713 0 O-C-N 122.342 -0.224 . . . . 0.0 111.553 178.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 95.0 mt -83.18 119.68 24.84 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.403 ' HA ' ' HD3' ' A' ' 246' ' ' LYS . 74.4 mmtt -41.52 134.64 2.3 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.103 178.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.637 HG23 HD12 ' A' ' 227' ' ' ILE . 98.1 m -127.75 134.44 49.52 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.936 177.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' TYR . . . . . 0.493 ' CB ' ' HB2' ' A' ' 254' ' ' ALA . 97.2 m-85 -118.41 139.59 51.16 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.851 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 78.0 p -61.38 -42.74 99.21 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -143.73 159.57 42.26 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.685 0.755 . . . . 0.0 111.599 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 75.9 t -62.53 -44.76 99.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 114.711 -1.132 . . . . 0.0 111.953 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.84 -44.28 97.16 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' ASP . . . . . 0.512 ' O ' HG22 ' A' ' 257' ' ' VAL . 55.4 m-20 -64.14 -42.03 96.95 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.455 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.493 ' HB2' ' CB ' ' A' ' 248' ' ' TYR . . . -64.65 -42.47 95.4 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.868 0.842 . . . . 0.0 109.829 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 255' ' ' VAL . . . . . 0.422 HG13 HH11 ' B' ' 154' ' ' ARG . 54.8 t -63.41 -46.04 96.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 113.946 -1.479 . . . . 0.0 111.173 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.7 -46.21 86.52 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 120.589 -0.445 . . . . 0.0 111.459 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.512 HG22 ' O ' ' A' ' 253' ' ' ASP . 32.9 m -66.71 -40.81 86.96 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 O-C-N 121.468 -0.77 . . . . 0.0 112.073 179.024 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.495 ' C ' ' O ' ' A' ' 257' ' ' VAL . 2.1 mt -29.48 -75.47 0.04 OUTLIER Pre-proline 0 C--O 1.234 0.262 0 O-C-N 123.099 0.25 . . . . 0.0 111.522 -177.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 259' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 258' ' ' LEU . 42.5 Cg_endo -63.33 139.96 74.34 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 120.789 0.992 . . . . 0.0 111.825 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 259' ' ' PRO . 96.7 mt -151.85 -27.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 O-C-N 123.953 0.783 . . . . 0.0 111.973 178.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 78.1 mtm . . . . . 0 N--CA 1.473 0.708 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.736 -177.174 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.475 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.91 161.14 22.79 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 79.2 p -59.87 -21.7 61.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.871 177.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -74.21 -64.05 1.1 Allowed 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.969 0.414 . . . . 0.0 111.123 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -65.63 -39.43 91.45 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.281 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.504 ' O ' ' HB3' ' B' ' 7' ' ' PHE . 49.5 m -59.97 -41.88 92.94 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.094 -0.642 . . . . 0.0 109.792 -177.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 7' ' ' PHE . . . . . 0.561 ' CE2' HD12 ' B' ' 9' ' ' ILE . 37.8 t80 85.48 92.22 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.352 177.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 8' ' ' GLY . . . . . 0.49 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -65.02 -137.18 0.02 OUTLIER Glycine 0 C--N 1.338 0.687 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -178.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 9' ' ' ILE . . . . . 0.561 HD12 ' CE2' ' B' ' 7' ' ' PHE . 55.3 mt 78.62 109.48 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 122.613 0.365 . . . . 0.0 111.162 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -62.24 -23.87 75.68 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 121.304 1.336 . . . . 0.0 111.806 -178.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.3 -40.29 98.4 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -64.5 -39.81 94.48 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.733 0.778 . . . . 0.0 109.267 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 52.7 tp -61.88 -42.55 99.2 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.439 -177.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -65.12 -32.17 73.74 Favored 'General case' 0 CA--C 1.561 1.37 0 CA-C-O 121.479 0.657 . . . . 0.0 110.705 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 15' ' ' VAL . . . . . 0.411 HG22 ' CD1' ' A' ' 113' ' ' ILE . 75.4 t -62.6 -46.03 97.37 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 CA-C-N 113.101 -1.863 . . . . 0.0 110.926 177.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 92.6 mt -64.04 -43.81 97.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.871 -178.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 17' ' ' LYS . . . . . 0.539 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 98.9 mttt -63.3 -42.44 99.04 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.21 -41.23 99.12 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 118.998 -1.081 . . . . 0.0 110.026 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.19 -38.85 84.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.867 -178.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' B' ' 20' ' ' LEU . 89.0 mt -64.31 -41.7 96.7 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 121.289 0.566 . . . . 0.0 110.122 174.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.29 -39.89 94.46 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.021 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 59.4 m170 -58.46 -39.58 80.31 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 121.121 -0.231 . . . . 0.0 111.601 -178.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 13.3 p -113.97 130.42 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.5 ' HG3' ' O ' ' B' ' 24' ' ' ARG . 34.6 ptt180 -73.15 108.04 5.82 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-O 121.726 0.774 . . . . 0.0 112.577 -177.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.6 p -143.3 133.8 22.21 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.885 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.687 177.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 26' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' B' ' 123' ' ' GLN . . . -88.43 95.88 2.14 Favored Glycine 0 C--N 1.315 -0.626 0 C-N-CA 119.364 -1.398 . . . . 0.0 113.403 -176.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 47.7 t -125.23 129.54 73.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 174.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 31.8 m -137.97 157.29 32.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.53 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 95.8 mt -119.27 127.42 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.666 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.457 HG22 HG12 ' B' ' 39' ' ' ILE . 31.3 p -109.01 157.04 19.05 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-N 112.795 -2.002 . . . . 0.0 108.567 -177.088 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -124.86 104.26 30.31 Favored Pre-proline 0 C--O 1.235 0.294 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 32' ' ' PRO . . . . . 0.622 ' HG3' HG23 ' B' ' 117' ' ' THR . 37.0 Cg_endo -64.54 -22.51 65.08 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.639 1.559 . . . . 0.0 111.59 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.13 -43.76 98.13 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.423 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 99.4 mt -73.02 174.67 7.55 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.951 -0.468 . . . . 0.0 111.378 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 35' ' ' GLU . . . . . 0.606 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 42.7 tt0 -73.16 131.25 41.8 Favored 'General case' 0 C--N 1.345 0.381 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -176.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.476 ' O ' ' OD1' ' B' ' 36' ' ' ASP . 66.0 t0 57.54 38.19 27.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.625 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 37' ' ' ASN . . . . . 0.465 ' C ' ' O ' ' B' ' 36' ' ' ASP . 29.7 t-20 28.63 71.86 0.47 Allowed Pre-proline 0 CA--C 1.535 0.368 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -178.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.606 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 92.1 Cg_endo -71.77 154.18 59.0 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 123.551 2.834 . . . . 0.0 111.84 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.457 HG12 HG22 ' B' ' 30' ' ' THR . 95.6 mt -87.5 127.91 40.44 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.453 HG23 ' N ' ' B' ' 41' ' ' TYR . 26.7 m -108.03 -45.44 7.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 O-C-N 123.777 0.673 . . . . 0.0 112.437 -178.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 41' ' ' TYR . . . . . 0.453 ' N ' HG23 ' B' ' 40' ' ' VAL . 51.6 t80 -94.73 124.51 38.81 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.552 -178.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 6.0 p -142.97 140.96 27.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.311 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 43' ' ' ASN . . . . . 0.647 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 57.2 p30 -100.34 161.46 13.59 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.086 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 44' ' ' GLN . . . . . 0.446 ' OE1' ' HA ' ' B' ' 44' ' ' GLN . 14.4 mm100 -63.16 -37.98 89.37 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.502 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.17 -25.01 61.72 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.291 -0.723 . . . . 0.0 111.291 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 46' ' ' PHE . . . . . 0.647 ' HB2' ' OD1' ' B' ' 43' ' ' ASN . 61.3 t80 -60.33 -43.3 96.54 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 47' ' ' VAL . . . . . 0.71 HG13 ' O ' ' B' ' 52' ' ' TYR . 69.4 t -61.16 -46.35 96.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.252 -178.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -62.67 -44.22 96.81 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.213 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 59.3 ttm -62.98 -42.06 99.73 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 33.8 p -96.11 -16.1 21.75 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.231 -0.588 . . . . 0.0 111.969 -178.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 51' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' B' ' 47' ' ' VAL . . . 73.08 18.3 79.11 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 178.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 52' ' ' TYR . . . . . 0.71 ' O ' HG13 ' B' ' 47' ' ' VAL . 82.6 m-85 -110.62 143.17 41.46 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.294 -0.453 . . . . 0.0 110.038 178.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -71.79 146.9 47.75 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-O 121.904 0.859 . . . . 0.0 110.994 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 54' ' ' THR . . . . . 0.418 ' H ' HG22 ' B' ' 54' ' ' THR . 0.1 OUTLIER -61.63 -36.8 81.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.065 -177.349 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.37 -39.59 94.18 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.015 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -72.51 -32.04 65.83 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 177.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.645 HD13 ' CE2' ' B' ' 46' ' ' PHE . 95.8 mt -66.68 -71.29 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 178.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 94.2 mt -36.61 130.97 0.71 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.38 175.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.24 -8.23 69.54 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.617 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -136.08 149.14 48.6 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -174.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 61' ' ' ASN . . . . . 0.521 ' OD1' " H3'" ' B' ' 900' ' ' FMN . 25.7 t-20 -79.55 151.6 30.6 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.798 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 62' ' ' CYS . . . . . . . . . . . . . 78.3 m -62.83 7.91 0.07 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.375 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 63' ' ' ARG . . . . . 0.515 ' H ' ' C ' ' B' ' 61' ' ' ASN . 33.5 ptt-85 -58.79 -31.89 68.82 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.54 -0.755 . . . . 0.0 112.497 -178.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -60.93 -31.2 70.74 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 178.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 81.5 mt -61.94 -42.36 99.02 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -177.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -48.02 151.67 0.92 Allowed 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.155 0.503 . . . . 0.0 109.888 -178.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 67' ' ' GLY . . . . . 0.406 ' N ' ' OG1' ' B' ' 70' ' ' THR . . . -162.26 -152.93 6.92 Favored Glycine 0 CA--C 1.54 1.649 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.184 175.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.87 -42.23 97.5 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 122.634 -0.333 . . . . 0.0 111.823 -175.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 69' ' ' HIS . . . . . 0.477 ' O ' ' NE2' ' B' ' 93' ' ' GLN . 9.5 m80 -74.93 -9.98 59.05 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.161 -178.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 70' ' ' THR . . . . . 0.406 ' OG1' ' N ' ' B' ' 67' ' ' GLY . 31.5 m -61.29 134.72 57.27 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -90.94 110.26 40.74 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.25 -178.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.84 -38.14 85.47 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 120.965 1.11 . . . . 0.0 111.828 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.38 -40.03 89.4 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 120.568 -0.453 . . . . 0.0 109.787 -176.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 74' ' ' GLU . . . . . 0.567 ' OE1' ' HB ' ' B' ' 90' ' ' VAL . 79.2 mm-40 -66.16 -39.65 89.95 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.889 177.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 72.1 t -61.92 -46.24 96.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -62.88 -37.45 86.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.885 -178.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -62.84 -41.53 99.38 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 119.312 -0.955 . . . . 0.0 108.79 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 95.0 mt -63.34 -43.73 98.72 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 CA-C-O 120.761 0.315 . . . . 0.0 110.714 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -62.27 -42.44 99.34 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 81.7 m -60.81 -45.75 93.19 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.994 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.5 -41.81 97.84 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -177.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 87.9 mt -63.57 -41.79 98.36 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 67.4 tp60 -62.21 -35.33 78.57 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -91.61 8.41 36.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.682 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 26.9 tttt 41.51 42.29 1.89 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.3 -0.56 . . . . 0.0 112.045 176.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -124.31 141.3 37.1 Favored Pre-proline 0 N--CA 1.471 0.58 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.096 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -61.73 140.12 84.29 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 120.875 1.05 . . . . 0.0 114.029 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.87 135.9 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -177.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 89' ' ' THR . . . . . 0.909 HG23 ' OD1' ' B' ' 107' ' ' ASN . 96.2 m -121.85 122.06 38.58 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 90' ' ' VAL . . . . . 0.567 ' HB ' ' OE1' ' B' ' 74' ' ' GLU . 26.9 m -139.31 163.28 26.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.753 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -113.6 121.47 44.27 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.131 0.491 . . . . 0.0 109.881 175.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 21.2 tt -127.87 131.47 69.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.034 -175.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.477 ' NE2' ' O ' ' B' ' 69' ' ' HIS . 34.8 mt-30 -71.94 142.05 49.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.938 177.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 94' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -132.9 -178.47 4.97 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.407 0.623 . . . . 0.0 111.04 -176.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 95' ' ' TYR . . . . . 0.405 ' CE1' ' HA3' ' B' ' 67' ' ' GLY . 96.2 m-85 -132.2 146.03 51.74 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.813 178.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 96' ' ' LYS . . . . . 0.42 ' HG3' ' CE1' ' B' ' 102' ' ' PHE . 98.8 mttt -102.93 179.29 4.32 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.056 0.455 . . . . 0.0 110.702 177.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.53 -35.16 75.31 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.243 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 37.0 p-10 -86.49 -1.95 58.04 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.038 0.836 . . . . 0.0 112.785 177.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.59 4.62 65.62 Favored Glycine 0 N--CA 1.465 0.612 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.165 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 25.8 m -67.65 128.98 38.46 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.331 178.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 101' ' ' MET . . . . . 0.531 ' SD ' ' N ' ' B' ' 102' ' ' PHE . 16.8 tmm? -87.25 143.37 27.31 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 102' ' ' PHE . . . . . 0.531 ' N ' ' SD ' ' B' ' 101' ' ' MET . 52.1 p90 -154.74 163.86 39.64 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 103' ' ' TRP . . . . . 0.663 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 22.0 m95 -97.51 137.57 36.26 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.276 -0.57 . . . . 0.0 111.086 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 104' ' ' ASN . . . . . 0.546 HD21 ' HG2' ' B' ' 123' ' ' GLN . 63.8 t-20 -131.9 113.4 13.4 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 114.707 -1.133 . . . . 0.0 113.957 -177.063 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -83.51 121.41 27.17 Favored 'General case' 0 C--N 1.318 -0.788 0 O-C-N 124.441 1.088 . . . . 0.0 109.015 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 41.2 tp -109.52 125.66 52.73 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.066 0.46 . . . . 0.0 111.95 -177.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 107' ' ' ASN . . . . . 0.909 ' OD1' HG23 ' B' ' 89' ' ' THR . 98.2 m-20 -118.34 129.6 55.53 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 176.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 96.7 mt -124.07 132.75 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -144.37 121.3 6.43 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -69.27 152.18 71.85 Favored 'Trans proline' 0 N--CA 1.503 2.043 0 C-N-CA 122.424 2.083 . . . . 0.0 112.576 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 111' ' ' MET . . . . . 0.49 ' HB2' ' HB2' ' B' ' 118' ' ' TYR . 66.1 mtt -128.75 142.26 51.06 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -112.51 105.27 13.45 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 113' ' ' ILE . . . . . 0.661 HG12 ' HZ1' ' A' ' 18' ' ' LYS . 96.8 mt -132.9 127.93 56.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 O-C-N 121.697 -0.627 . . . . 0.0 111.695 177.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 53.94 37.19 26.13 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 123.913 0.758 . . . . 0.0 109.713 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 60.58 36.28 19.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.266 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -132.63 153.23 51.27 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 177.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 117' ' ' THR . . . . . 0.622 HG23 ' HG3' ' B' ' 32' ' ' PRO . 11.3 t -103.23 152.31 21.64 Favored 'General case' 0 C--O 1.213 -0.82 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.16 -178.004 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 118' ' ' TYR . . . . . 0.49 ' HB2' ' HB2' ' B' ' 111' ' ' MET . 96.5 m-85 -148.04 146.95 29.09 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 121.222 -0.924 . . . . 0.0 111.278 -179.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -123.54 138.98 54.45 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 120.971 0.415 . . . . 0.0 111.512 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -128.01 133.67 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -176.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 121' ' ' GLY . . . . . 0.518 ' HA3' ' H6 ' ' B' ' 900' ' ' FMN . . . -107.93 121.98 6.58 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 91.9 mt -113.36 127.14 70.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 123' ' ' GLN . . . . . 0.546 ' HG2' HD21 ' B' ' 104' ' ' ASN . 15.8 mp0 -118.55 122.58 42.99 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -119.68 121.21 38.74 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 125' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' B' ' 127' ' ' THR . 68.3 t0 -72.23 128.04 34.41 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.604 -177.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.5 HG22 ' O ' ' B' ' 126' ' ' ILE . 2.9 mp -100.93 17.42 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.58 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 127' ' ' THR . . . . . 0.491 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 98.1 m -62.57 -44.14 97.07 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 114.197 -1.365 . . . . 0.0 112.846 176.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 59.9 tptt -61.67 -45.05 95.65 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -177.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 129' ' ' GLN . . . . . 0.406 ' OE1' HG23 ' B' ' 126' ' ' ILE . 88.1 mt-30 -63.39 -35.04 79.1 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.683 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 130' ' ' LYS . . . . . 0.663 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 98.9 mttt -62.95 -41.63 99.57 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-N 112.833 -1.985 . . . . 0.0 110.835 174.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -64.3 -42.23 96.47 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 132' ' ' TYR . . . . . 0.841 ' CE2' HD11 ' B' ' 136' ' ' LEU . 91.6 t80 -60.13 -44.09 95.18 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 121.903 -0.498 . . . . 0.0 111.384 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 133' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' B' ' 137' ' ' GLU . 97.5 mt-10 -64.87 -36.55 84.7 Favored 'General case' 0 C--O 1.22 -0.453 0 C-N-CA 119.989 -0.684 . . . . 0.0 109.384 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 134' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' B' ' 130' ' ' LYS . 98.7 mttt -63.52 -39.8 95.36 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.604 177.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 49.6 tp -62.91 -41.4 99.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.349 0.595 . . . . 0.0 109.441 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 136' ' ' LEU . . . . . 0.841 HD11 ' CE2' ' B' ' 132' ' ' TYR . 88.8 mt -62.99 -41.47 99.59 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.426 177.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 137' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' B' ' 133' ' ' GLU . 97.1 mt-10 -65.06 -37.18 86.73 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 113.806 -1.543 . . . . 0.0 110.268 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.48 -43.75 96.38 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.995 177.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 67.3 m -60.94 -44.39 97.31 Favored 'General case' 0 C--N 1.346 0.449 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 140' ' ' LEU . . . . . 0.49 ' O ' ' N ' ' B' ' 144' ' ' THR . 88.4 mt -61.73 -40.33 94.7 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -177.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 92.6 m -61.78 -45.44 93.89 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.026 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -65.66 -42.81 90.95 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 94.3 mt -63.87 -43.41 97.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.574 178.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 144' ' ' THR . . . . . 0.49 ' N ' ' O ' ' B' ' 140' ' ' LEU . 95.3 m -61.59 -45.51 93.82 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 145' ' ' ALA . . . . . 0.441 ' O ' ' HB ' ' B' ' 148' ' ' THR . . . -64.52 -41.73 96.21 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 119.117 -1.033 . . . . 0.0 109.295 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 86.2 mt -64.99 -40.85 95.57 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 176.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 147' ' ' SER . . . . . 0.613 ' O ' ' N ' ' B' ' 149' ' ' PRO . 78.2 p -62.06 -41.86 98.6 Favored 'General case' 0 CA--C 1.477 -1.84 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -178.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 148' ' ' THR . . . . . 0.497 ' C ' ' O ' ' B' ' 147' ' ' SER . 40.5 m -26.51 85.36 0.03 OUTLIER Pre-proline 0 N--CA 1.478 0.947 0 O-C-N 123.958 0.786 . . . . 0.0 110.188 176.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 149' ' ' PRO . . . . . 0.613 ' N ' ' O ' ' B' ' 147' ' ' SER . 24.1 Cg_exo -60.52 145.18 99.23 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.051 1.834 . . . . 0.0 115.6 -177.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 9.9 tp -125.29 119.44 55.48 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.168 0 CA-C-N 114.036 -1.438 . . . . 0.0 108.197 174.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 59.5 t -148.89 94.2 4.1 Favored Pre-proline 0 C--N 1.307 -1.274 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.806 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.04 142.88 94.1 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 CA-C-N 119.909 1.003 . . . . 0.0 109.623 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 153' ' ' ILE . . . . . 0.617 ' CG2' HH12 ' A' ' 154' ' ' ARG . 43.8 mm -77.1 -66.89 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 154' ' ' ARG . . . . . 0.665 ' HD3' ' NH2' ' A' ' 154' ' ' ARG . 2.7 mpt_? -132.96 -158.84 0.92 Allowed 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 177.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -84.2 109.49 17.79 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 101.02 -17.34 56.32 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -177.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 89.3 mt -109.78 126.43 66.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.859 0.362 . . . . 0.0 111.282 -177.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 158' ' ' SER . . . . . 0.702 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 60.7 m -135.29 149.05 49.71 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.718 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -132.46 149.33 52.35 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 29.8 tp -144.23 78.75 13.38 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 161' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -71.82 149.89 54.78 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.725 2.283 . . . . 0.0 114.108 -177.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 91.6 mt -113.68 133.3 55.41 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 55.9 t -128.38 132.38 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 113.49 167.45 16.55 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.184 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 165' ' ' ASN . . . . . 0.634 ' O ' ' NH1' ' B' ' 170' ' ' ARG . 52.9 t30 -88.55 107.53 18.94 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -178.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 166' ' ' LEU . . . . . 0.553 HD21 ' CZ ' ' B' ' 171' ' ' PHE . 48.2 tp -64.78 105.35 0.98 Allowed 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -174.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 167' ' ' THR . . . . . 0.707 HG23 ' NE ' ' B' ' 170' ' ' ARG . 10.9 p -84.94 169.74 13.74 Favored 'General case' 0 C--N 1.348 0.502 0 CA-C-N 114.019 -1.446 . . . . 0.0 110.79 177.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.2 -37.87 84.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.704 176.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.3 -40.97 90.37 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-O 122.455 1.121 . . . . 0.0 111.894 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 170' ' ' ARG . . . . . 0.707 ' NE ' HG23 ' B' ' 167' ' ' THR . 87.7 mtm180 -61.83 -34.81 76.63 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 112.376 -2.193 . . . . 0.0 111.178 177.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 171' ' ' PHE . . . . . 0.553 ' CZ ' HD21 ' B' ' 166' ' ' LEU . 0.5 OUTLIER -53.95 -26.25 24.67 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -178.996 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 172' ' ' ASN . . . . . 0.541 ' O ' HG22 ' B' ' 175' ' ' VAL . 92.8 m-20 -62.86 -40.56 97.86 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.875 179.029 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 57.1 m -60.7 -41.07 94.44 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.098 0.475 . . . . 0.0 110.747 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 67.3 mt -63.92 -44.1 97.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -178.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 175' ' ' VAL . . . . . 0.541 HG22 ' O ' ' B' ' 172' ' ' ASN . 34.5 m -63.15 -40.22 88.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 176' ' ' CYS . . . . . 0.419 ' N ' HG23 ' B' ' 175' ' ' VAL . 99.1 m -61.88 -35.03 77.11 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.432 178.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 177' ' ' THR . . . . . 0.517 ' O ' HG13 ' B' ' 181' ' ' ILE . 25.1 m -61.74 -19.24 62.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.28 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 178' ' ' LEU . . . . . 0.621 ' CD2' HD21 ' B' ' 211' ' ' LEU . 89.4 mt -61.42 -39.01 89.19 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.328 -177.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 18.2 m -61.0 -43.81 98.35 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.259 177.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 180' ' ' ASN . . . . . 0.655 ' O ' ' OG ' ' B' ' 183' ' ' SER . 92.4 m-20 -62.13 -40.0 94.46 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.878 0.371 . . . . 0.0 110.481 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.517 HG13 ' O ' ' B' ' 177' ' ' THR . 72.2 mt -56.11 -35.0 40.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 O-C-N 122.157 -0.339 . . . . 0.0 110.902 -178.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 182' ' ' LEU . . . . . 0.533 HD21 HD21 ' B' ' 214' ' ' LEU . 84.6 mt -61.78 -41.52 97.83 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 119.799 -0.761 . . . . 0.0 109.11 177.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 183' ' ' SER . . . . . 0.655 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.3 p -62.89 -32.6 73.9 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 121.8 -0.562 . . . . 0.0 110.915 176.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 50.9 p -87.52 15.73 6.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.835 0.35 . . . . 0.0 111.831 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 79.5 p -59.35 -17.13 27.0 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.031 -177.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.02 -40.59 96.22 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.704 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 187' ' ' ASP . . . . . 0.702 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.2 m-20 -68.75 113.93 6.65 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.653 0.74 . . . . 0.0 110.622 -177.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.65 -42.36 99.57 Favored 'General case' 0 C--O 1.247 0.922 0 CA-C-N 114.772 -1.104 . . . . 0.0 113.118 -177.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -112.02 130.86 55.73 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 120.621 -0.431 . . . . 0.0 111.317 -178.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 190' ' ' LEU . . . . . . . . . . . . . 41.4 tp -123.13 117.64 25.86 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.901 178.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 83.9 mt -105.62 125.1 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 121.064 -0.254 . . . . 0.0 111.418 -178.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 49.7 mm -114.88 117.4 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 178.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 193' ' ' ASP . . . . . 0.615 ' CG ' ' HG ' ' B' ' 195' ' ' SER . 40.0 t0 -89.47 111.07 21.87 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.731 -176.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 194' ' ' LEU . . . . . . . . . . . . . 97.2 mt -92.24 -1.24 57.23 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.323 175.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 195' ' ' SER . . . . . 0.615 ' HG ' ' CG ' ' B' ' 193' ' ' ASP . 78.1 p -61.35 -37.16 82.34 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.698 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.42 -34.13 87.18 Favored Glycine 0 N--CA 1.439 -1.102 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 197' ' ' LEU . . . . . 0.974 HD23 ' N ' ' B' ' 198' ' ' ALA . 4.8 tt -78.19 132.71 37.71 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -176.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 198' ' ' ALA . . . . . 0.974 ' N ' HD23 ' B' ' 197' ' ' LEU . . . -64.5 -41.64 96.33 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.496 -178.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 199' ' ' GLN . . . . . 0.947 ' H ' ' CD2' ' B' ' 197' ' ' LEU . 58.9 tt0 -138.91 164.14 30.46 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 200' ' ' VAL . . . . . 0.465 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 50.2 t -121.36 132.51 70.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 O-C-N 120.688 -1.258 . . . . 0.0 109.433 176.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -90.46 149.42 22.23 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.926 -178.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.44 -32.45 70.22 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.295 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -64.6 -32.65 74.39 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.4 m -60.79 -44.32 96.98 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.274 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 205' ' ' ALA . . . . . 0.623 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -58.69 -29.56 66.73 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -177.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -65.44 -38.59 90.31 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.257 0.551 . . . . 0.0 109.672 176.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -66.89 -37.94 85.33 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.694 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.55 -43.46 98.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 120.528 -0.469 . . . . 0.0 109.808 -178.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 209' ' ' PHE . . . . . 0.623 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 65.3 m-85 -62.17 -43.02 99.75 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 114.195 -1.366 . . . . 0.0 112.767 177.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.42 -41.8 98.71 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.288 -0.965 . . . . 0.0 109.763 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 211' ' ' LEU . . . . . 0.621 HD21 ' CD2' ' B' ' 178' ' ' LEU . 39.7 mt -62.27 -42.46 99.36 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.418 -179.083 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 78.0 p -63.15 -36.06 82.36 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.291 -0.564 . . . . 0.0 112.11 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 213' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -66.89 -46.72 74.06 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.146 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 214' ' ' LEU . . . . . 0.533 HD21 HD21 ' B' ' 182' ' ' LEU . 52.0 tp -63.89 -43.17 96.83 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.765 0.793 . . . . 0.0 109.827 177.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 215' ' ' LEU . . . . . 0.417 ' HB3' ' O ' ' B' ' 220' ' ' THR . 88.9 mt -63.2 -43.76 97.25 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 113.485 -1.689 . . . . 0.0 111.599 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.33 -39.69 91.46 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.879 -176.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 87.1 mt -63.75 -42.05 97.9 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.389 0.614 . . . . 0.0 111.587 176.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 218' ' ' THR . . . . . . . . . . . . . 75.6 p -75.13 -16.41 60.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.106 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 80.85 64.65 1.78 Allowed Glycine 0 CA--C 1.528 0.848 0 N-CA-C 106.577 -2.609 . . . . 0.0 106.577 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 220' ' ' THR . . . . . 0.417 ' O ' ' HB3' ' B' ' 215' ' ' LEU . 98.1 m -142.46 103.23 4.22 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 175.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -61.92 139.36 58.39 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.92 -176.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 42.6 tp -116.3 121.4 41.88 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.231 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 3.2 mp -110.01 128.58 66.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.223 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 224' ' ' ILE . . . . . 0.61 ' CG2' HD11 ' B' ' 227' ' ' ILE . 50.7 mm -108.86 126.05 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.735 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 51.8 p -133.0 157.16 45.89 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.511 0.672 . . . . 0.0 112.714 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 89.16 18.04 54.44 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 113.894 -1.503 . . . . 0.0 110.981 -177.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 227' ' ' ILE . . . . . 0.667 HD12 HG23 ' B' ' 247' ' ' THR . 95.5 mt -82.54 125.69 39.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 121.908 -0.76 . . . . 0.0 111.586 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -65.86 140.31 97.17 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.604 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.78 -37.01 92.28 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 121.358 1.372 . . . . 0.0 112.446 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -64.39 -43.1 95.49 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 51.3 tp -61.62 -41.55 97.63 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.701 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.12 -37.07 86.13 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.756 0.312 . . . . 0.0 111.359 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 93.9 mtp -64.08 -41.17 97.42 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.442 -0.503 . . . . 0.0 109.659 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.79 -43.67 98.19 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 122.204 1.002 . . . . 0.0 109.202 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 37.3 mmt -63.76 -35.73 81.54 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.951 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -61.88 -40.52 95.68 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -178.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.31 -43.45 97.79 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.043 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 51.8 tp -61.68 -45.52 93.66 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 120.26 -0.576 . . . . 0.0 112.228 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 239' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' B' ' 240' ' ' ALA . 66.8 t0 -156.83 135.13 11.31 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 120.39 -0.524 . . . . 0.0 112.034 -179.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 240' ' ' ALA . . . . . 0.435 ' N ' ' OD1' ' B' ' 239' ' ' ASP . . . -62.59 -46.56 87.76 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 176.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 241' ' ' ASN . . . . . 0.514 ' O ' ' HB2' ' B' ' 244' ' ' SER . 92.5 m-20 -43.74 -18.96 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.421 -175.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 242' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -61.91 -45.88 91.77 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.236 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 243' ' ' SER . . . . . 0.41 ' O ' ' N ' ' B' ' 245' ' ' LEU . 77.7 p -57.95 -45.62 86.35 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 244' ' ' SER . . . . . 0.514 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 21.0 m -28.08 -38.47 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 245' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' B' ' 243' ' ' SER . 96.9 mt -87.73 138.54 31.38 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 121.521 -0.737 . . . . 0.0 110.489 178.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -66.75 134.93 53.18 Favored 'General case' 0 C--O 1.242 0.662 0 O-C-N 121.82 -0.55 . . . . 0.0 110.742 -174.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 247' ' ' THR . . . . . 0.667 HG23 HD12 ' B' ' 227' ' ' ILE . 97.3 m -124.6 126.81 46.4 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.919 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 248' ' ' TYR . . . . . 0.526 ' CG ' ' HB2' ' B' ' 254' ' ' ALA . 96.2 m-85 -111.6 143.14 42.97 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 177.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 249' ' ' SER . . . . . 0.553 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 77.9 p -62.97 -34.75 78.19 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.107 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 250' ' ' ASN . . . . . 0.553 ' OD1' ' O ' ' B' ' 249' ' ' SER . 99.3 m-20 -146.85 159.2 43.82 Favored 'General case' 0 N--CA 1.461 0.121 0 O-C-N 124.243 0.964 . . . . 0.0 112.033 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 79.7 t -64.02 -44.6 97.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.919 178.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 252' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.23 -46.01 92.16 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -178.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 253' ' ' ASP . . . . . 0.523 ' O ' HG22 ' B' ' 257' ' ' VAL . 94.4 m-20 -61.25 -43.75 98.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.821 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 254' ' ' ALA . . . . . 0.526 ' HB2' ' CG ' ' B' ' 248' ' ' TYR . . . -64.9 -40.24 94.78 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.133 178.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 255' ' ' VAL . . . . . 0.72 HG11 ' O ' ' A' ' 153' ' ' ILE . 55.4 t -65.12 -45.54 93.85 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.298 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.7 -47.0 85.54 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 120.286 -0.566 . . . . 0.0 111.335 -178.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 257' ' ' VAL . . . . . 0.523 HG22 ' O ' ' B' ' 253' ' ' ASP . 28.3 m -65.95 -40.0 86.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.758 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 258' ' ' LEU . . . . . 0.519 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 1.9 mt -33.34 -74.04 0.05 OUTLIER Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.566 -178.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 259' ' ' PRO . . . . . 0.541 ' O ' HG13 ' B' ' 260' ' ' ILE . 37.3 Cg_endo -61.93 141.23 88.79 Favored 'Trans proline' 0 N--CA 1.504 2.122 0 C-N-CA 121.605 1.537 . . . . 0.0 111.463 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 260' ' ' ILE . . . . . 0.541 HG13 ' O ' ' B' ' 259' ' ' PRO . 96.9 mt -159.22 -15.02 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-N 118.73 0.696 . . . . 0.0 112.311 177.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 C--O 1.216 -0.706 0 CA-C-O 117.885 -1.055 . . . . 0.0 111.553 -179.741 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 900' ' ' FMN . . . . . 0.543 " H3'" ' OD1' ' A' ' 61' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 900' ' ' FMN . . . . . 0.521 " H3'" ' OD1' ' B' ' 61' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.48 ' O ' ' OG ' ' A' ' 6' ' ' SER . . . -156.98 169.95 23.64 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 116.65 -1.643 . . . . 0.0 110.19 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.6 p -72.9 -18.81 61.37 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 124.902 1.376 . . . . 0.0 110.808 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -70.59 -67.02 0.53 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 114.444 -1.253 . . . . 0.0 112.189 174.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -66.71 -38.58 87.01 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.48 ' OG ' ' O ' ' A' ' 2' ' ' ALA . 64.1 m -58.97 -41.63 87.97 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 120.441 -0.503 . . . . 0.0 110.306 -177.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.68 ' CE2' HD12 ' A' ' 9' ' ' ILE . 41.1 t80 82.1 86.18 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 O-C-N 123.909 0.756 . . . . 0.0 111.301 176.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.48 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -60.86 -134.78 0.01 OUTLIER Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -177.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.68 HD12 ' CE2' ' A' ' 7' ' ' PHE . 57.2 mt 78.95 108.72 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.695 0 C-N-CA 122.583 0.353 . . . . 0.0 110.775 -178.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -63.31 -22.65 72.09 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.422 1.415 . . . . 0.0 112.134 -178.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.72 -37.83 95.29 Favored Glycine 0 C--O 1.245 0.817 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.766 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.56 -39.07 91.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.359 0.6 . . . . 0.0 109.744 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 49.8 tp -62.95 -41.62 99.56 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -62.61 -39.56 94.17 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 56.2 t -60.74 -44.24 96.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 O-C-N 122.365 -0.21 . . . . 0.0 110.986 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 93.0 mt -62.62 -43.59 98.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.181 -177.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.428 ' NZ ' ' HA ' ' B' ' 6' ' ' SER . 98.9 mttt -62.4 -46.03 90.46 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 119.331 -0.948 . . . . 0.0 112.123 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.653 ' NZ ' HG12 ' B' ' 113' ' ' ILE . 98.6 mttt -60.65 -39.51 88.6 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 118.881 -1.128 . . . . 0.0 109.082 -175.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.8 -42.34 93.23 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.092 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 20' ' ' LEU . 89.3 mt -63.26 -40.97 98.89 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.105 0.479 . . . . 0.0 109.879 178.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.41 -38.86 92.78 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.576 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 53.7 m170 -58.16 -39.83 79.87 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 122.27 -0.268 . . . . 0.0 111.592 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.0 p -114.69 130.23 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.545 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 35.6 ptt180 -72.04 109.32 5.77 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 122.245 1.021 . . . . 0.0 111.945 -177.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.5 p -140.21 142.9 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.555 ' O ' ' N ' ' A' ' 123' ' ' GLN . . . -98.18 93.12 1.33 Allowed Glycine 0 C--N 1.313 -0.709 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.215 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 51.6 t -125.15 129.83 73.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 175.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.1 m -136.66 158.82 37.56 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.3 mt -120.21 129.59 75.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 177.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.436 ' HB ' ' OD1' ' A' ' 37' ' ' ASN . 16.5 p -106.39 166.92 10.19 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.503 178.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' A' ' 37' ' ' ASN . 45.0 t0 -131.83 104.14 14.3 Favored Pre-proline 0 C--N 1.32 -0.701 0 C-N-CA 120.491 -0.483 . . . . 0.0 110.813 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.52 ' CG ' HG23 ' A' ' 117' ' ' THR . 36.7 Cg_endo -63.93 -23.11 68.36 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.379 1.386 . . . . 0.0 111.605 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.12 -34.38 76.24 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.209 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.8 mt -87.4 165.03 15.88 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.861 177.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.722 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 43.2 tt0 -63.24 132.14 50.71 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -176.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.52 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 57.1 t0 62.32 21.19 12.35 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 177.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.436 ' OD1' ' HB ' ' A' ' 30' ' ' THR . 35.0 t-20 42.73 66.59 4.2 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.816 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.722 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 89.1 Cg_endo -70.67 156.18 61.47 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 123.664 2.909 . . . . 0.0 111.993 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.3 mt -88.05 125.16 41.5 Favored 'Isoleucine or valine' 0 C--O 1.246 0.905 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.376 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.41 HG23 ' N ' ' A' ' 41' ' ' TYR . 27.2 m -105.65 -42.8 7.13 Favored 'Isoleucine or valine' 0 C--N 1.343 0.324 0 O-C-N 123.613 0.571 . . . . 0.0 111.998 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.41 ' N ' HG23 ' A' ' 40' ' ' VAL . 49.4 t80 -96.06 123.75 39.8 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.566 -178.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.1 p -142.67 139.83 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.338 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.573 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 57.6 p30 -97.39 165.12 12.17 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.474 ' OE1' ' HA ' ' A' ' 44' ' ' GLN . 13.2 mm100 -66.09 -38.03 87.26 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 177.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.88 -26.77 63.44 Favored Glycine 0 N--CA 1.453 -0.186 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.667 ' CD2' HD13 ' A' ' 57' ' ' ILE . 71.4 t80 -59.28 -47.58 84.84 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 -179.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.686 HG13 ' O ' ' A' ' 52' ' ' TYR . 69.5 t -59.38 -44.69 93.08 Favored 'Isoleucine or valine' 0 C--N 1.349 0.585 0 O-C-N 121.241 -0.912 . . . . 0.0 111.366 -173.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -63.73 -37.84 88.86 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.727 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 59.7 ttm -66.57 -43.82 83.93 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 175.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 36.4 p -91.87 -21.99 20.32 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.126 0.488 . . . . 0.0 111.315 -178.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . 77.83 19.56 75.21 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.686 ' O ' HG13 ' A' ' 47' ' ' VAL . 82.9 m-85 -112.58 139.31 48.27 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 122.868 0.467 . . . . 0.0 111.28 178.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -65.85 149.2 50.57 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.785 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.437 HG22 ' H ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -65.29 -32.32 73.92 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -178.207 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -66.36 -42.48 87.98 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 119.591 -0.843 . . . . 0.0 111.466 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -65.61 -45.1 84.44 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 119.886 -0.725 . . . . 0.0 109.427 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.667 HD13 ' CD2' ' A' ' 46' ' ' PHE . 97.0 mt -62.1 -46.7 95.87 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 C-N-CA 119.85 -0.74 . . . . 0.0 112.47 -174.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.2 mt -60.77 142.8 55.6 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.53 -3.08 87.33 Favored Glycine 0 N--CA 1.464 0.529 0 CA-C-O 119.234 -0.759 . . . . 0.0 112.877 177.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -136.19 152.08 50.4 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.275 1.537 . . . . 0.0 111.682 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.533 ' C ' ' H ' ' A' ' 63' ' ' ARG . 24.9 t-20 -80.27 151.89 29.33 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.194 0.521 . . . . 0.0 110.509 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 85.6 m -64.56 14.15 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.342 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.533 ' H ' ' C ' ' A' ' 61' ' ' ASN . 36.3 ptt-85 -61.14 -40.78 95.12 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 122.073 -0.392 . . . . 0.0 111.354 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -55.12 -22.91 18.47 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -178.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.4 mt -66.04 -36.62 83.74 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.402 0.62 . . . . 0.0 112.636 176.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -61.95 137.87 58.3 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.061 -178.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.498 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -147.63 -147.73 4.6 Favored Glycine 0 CA--C 1.543 1.801 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.096 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.66 -41.2 98.94 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -177.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.445 ' O ' ' OE1' ' A' ' 93' ' ' GLN . 9.3 m-70 -76.84 -7.87 56.26 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.245 -177.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.498 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 27.4 m -64.02 129.38 39.81 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.22 -0.592 . . . . 0.0 109.71 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -86.47 111.9 42.57 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.809 -177.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.6 -31.38 91.59 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 121.97 1.78 . . . . 0.0 113.206 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.12 -40.11 95.48 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.111 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.443 ' OE1' ' HB ' ' A' ' 90' ' ' VAL . 78.8 mm-40 -65.31 -43.17 91.88 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.2 t -60.38 -43.69 94.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 114.189 -1.369 . . . . 0.0 107.74 -176.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -64.42 -38.06 89.71 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.646 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -63.49 -39.7 95.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.329 0.585 . . . . 0.0 110.625 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.92 -43.94 97.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.941 177.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -62.53 -42.95 99.86 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 113.925 -1.489 . . . . 0.0 108.287 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 99.3 m -61.24 -49.83 75.53 Favored 'General case' 0 C--O 1.247 0.947 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.8 -41.66 96.06 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 118.646 -0.692 . . . . 0.0 111.598 -169.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.0 mt -63.23 -39.29 94.2 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 118.702 0.683 . . . . 0.0 111.188 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 66.7 tp60 -64.87 -34.35 78.17 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -85.28 -3.54 58.86 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.599 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.2 tttt 48.57 37.59 9.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.679 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -120.64 143.89 37.39 Favored Pre-proline 0 CA--C 1.534 0.364 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -61.8 144.2 96.71 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 121.318 1.345 . . . . 0.0 113.307 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.5 p -139.39 141.39 35.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.805 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.972 HG23 ' OD1' ' A' ' 107' ' ' ASN . 97.4 m -125.64 121.82 34.63 Favored 'General case' 0 C--N 1.344 0.345 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 175.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.443 ' HB ' ' OE1' ' A' ' 74' ' ' GLU . 27.0 m -139.59 158.77 27.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 120.675 0.274 . . . . 0.0 111.274 178.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -104.7 129.25 52.91 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 176.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.426 HG23 ' O ' ' A' ' 92' ' ' ILE . 19.8 tt -138.55 130.46 37.57 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 CA-C-N 120.902 1.683 . . . . 0.0 112.207 178.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.445 ' OE1' ' O ' ' A' ' 69' ' ' HIS . 86.7 mt-30 -61.77 137.26 58.23 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.886 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -137.53 158.52 44.22 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.977 -178.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.432 ' CE1' ' HA3' ' A' ' 67' ' ' GLY . 93.9 m-85 -117.82 136.7 53.24 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -178.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.427 ' HG3' ' CE1' ' A' ' 102' ' ' PHE . 99.1 mttt -84.94 -173.52 4.77 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.175 0.512 . . . . 0.0 111.704 -178.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.42 -43.63 98.37 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.155 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 41.1 p-10 -83.81 6.12 22.53 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -178.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.17 -0.31 83.63 Favored Glycine 0 N--CA 1.465 0.609 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.967 176.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 23.0 m -60.65 138.04 58.11 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.664 ' SD ' ' C ' ' A' ' 101' ' ' MET . 13.2 tmm? -104.09 129.03 51.76 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.878 0.37 . . . . 0.0 111.072 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.491 ' N ' ' SD ' ' A' ' 101' ' ' MET . 53.2 p90 -142.65 159.01 43.07 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 120.276 -0.57 . . . . 0.0 109.677 -178.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.832 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 23.6 m95 -90.38 144.29 25.95 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.55 HD21 ' HG2' ' A' ' 123' ' ' GLN . 54.9 t-20 -137.44 106.08 5.86 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -177.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.517 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 80.5 tt0 -72.22 134.34 45.58 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -177.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 40.5 tp -120.05 124.78 46.71 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.972 ' OD1' HG23 ' A' ' 89' ' ' THR . 97.8 m-20 -121.11 122.11 39.34 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 176.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 96.2 mt -119.52 129.12 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 O-C-N 123.43 0.457 . . . . 0.0 111.264 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -138.36 124.57 12.78 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.878 -0.147 . . . . 0.0 110.648 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -70.81 150.27 61.52 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 122.25 1.967 . . . . 0.0 112.54 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.569 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 67.4 mtt -121.59 153.8 37.58 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -127.48 93.96 3.86 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 177.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.442 ' CD1' HG22 ' B' ' 15' ' ' VAL . 96.2 mt -119.93 130.56 74.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.529 -177.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 50.01 37.54 14.32 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 118.746 0.703 . . . . 0.0 111.736 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 59.21 29.94 19.6 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.979 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -127.53 146.61 50.45 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.676 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 5.2 t -82.78 -175.38 5.76 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.279 -0.888 . . . . 0.0 109.471 -178.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.676 ' CD2' ' O ' ' A' ' 117' ' ' THR . 73.0 m-85 -168.83 156.18 7.43 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 171.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -129.14 146.31 51.1 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 174.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -135.63 136.88 50.12 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.366 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -111.25 128.48 8.71 Favored Glycine 0 CA--C 1.503 -0.683 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 178.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 96.5 mt -116.99 128.9 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.555 ' N ' ' O ' ' A' ' 26' ' ' GLY . 15.1 mp0 -120.14 116.91 26.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.101 0.477 . . . . 0.0 109.959 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -116.95 114.84 24.4 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.819 -178.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.411 ' OD1' ' OG1' ' A' ' 127' ' ' THR . 68.3 t0 -63.63 125.24 23.64 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -175.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.546 HG22 ' O ' ' A' ' 126' ' ' ILE . 2.7 mp -89.93 1.08 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 CA-C-N 113.887 -1.506 . . . . 0.0 110.457 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.411 ' OG1' ' OD1' ' A' ' 125' ' ' ASP . 18.4 m -60.46 -42.72 96.77 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.257 -0.902 . . . . 0.0 112.716 -177.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -60.07 -43.06 95.73 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -178.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -63.28 -39.62 95.1 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.705 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.832 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.7 mttt -62.49 -40.57 97.11 Favored 'General case' 0 CA--C 1.503 -0.854 0 C-N-CA 118.486 -1.286 . . . . 0.0 110.52 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.11 -37.3 84.6 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.837 ' CE2' HD11 ' A' ' 136' ' ' LEU . 90.5 t80 -61.49 -45.26 94.98 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.43 176.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.85 -38.92 92.87 Favored 'General case' 0 C--N 1.342 0.248 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.88 -40.51 95.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.84 0.352 . . . . 0.0 110.15 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 54.5 tp -60.97 -43.6 98.55 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.837 HD11 ' CE2' ' A' ' 132' ' ' TYR . 84.9 mt -62.62 -41.53 99.07 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.196 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.34 -40.62 97.81 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.915 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -60.59 -41.84 95.52 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -177.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 63.3 m -61.33 -40.59 94.81 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.635 176.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 144' ' ' THR . 84.3 mt -63.53 -41.83 98.47 Favored 'General case' 0 C--O 1.221 -0.431 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 90.3 m -61.44 -45.97 92.05 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.295 -177.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.33 -40.14 93.3 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 95.9 mt -64.8 -43.51 96.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 113.781 -1.554 . . . . 0.0 111.281 176.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.504 ' N ' ' O ' ' A' ' 140' ' ' LEU . 90.4 m -62.24 -46.04 90.62 Favored 'General case' 0 C--N 1.344 0.361 0 C-N-CA 120.316 -0.554 . . . . 0.0 112.289 -178.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.06 -39.74 95.63 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 118.815 -1.154 . . . . 0.0 109.017 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.2 mt -63.3 -42.48 99.04 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.756 -0.657 . . . . 0.0 112.517 178.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.753 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.0 p -60.62 -39.95 90.12 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -177.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.495 ' C ' ' O ' ' A' ' 147' ' ' SER . 17.0 m -27.41 79.55 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.428 0 O-C-N 126.617 2.448 . . . . 0.0 106.733 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.753 ' N ' ' O ' ' A' ' 147' ' ' SER . 20.1 Cg_exo -62.89 145.17 94.48 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.007 1.138 . . . . 0.0 114.672 -174.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.584 ' O ' HG23 ' A' ' 151' ' ' VAL . 8.8 tp -120.57 135.45 60.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 103.124 -2.917 . . . . 0.0 103.124 175.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 150' ' ' ILE . 92.3 t -167.73 90.93 0.69 Allowed Pre-proline 0 CA--C 1.516 -0.355 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 178.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -61.39 137.34 69.47 Favored 'Trans proline' 0 C--N 1.3 -2.006 0 N-CA-C 109.465 -1.013 . . . . 0.0 109.465 -176.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.643 ' O ' ' HD2' ' A' ' 154' ' ' ARG . 45.6 mm -67.47 -44.43 86.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 119.746 -0.782 . . . . 0.0 111.069 179.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.643 ' HD2' ' O ' ' A' ' 153' ' ' ILE . 0.3 OUTLIER -159.12 -154.89 0.44 Allowed 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.082 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 63.0 t-20 -87.89 104.37 16.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 122.189 0.995 . . . . 0.0 111.897 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 89.91 8.61 66.96 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 114.243 -1.344 . . . . 0.0 111.022 -177.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.505 HG22 ' HB ' ' A' ' 153' ' ' ILE . 96.7 mt -124.09 125.71 71.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 CA-C-O 121.748 0.785 . . . . 0.0 109.477 174.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.656 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 57.8 m -132.82 151.47 52.01 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.276 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -138.96 141.96 38.4 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.546 -0.721 . . . . 0.0 111.244 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 25.9 tp -133.15 80.2 60.01 Favored Pre-proline 0 N--CA 1.471 0.581 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.141 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -69.65 149.18 67.24 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.778 2.319 . . . . 0.0 113.137 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 86.6 mt -116.99 126.13 52.44 Favored 'General case' 0 C--O 1.25 1.116 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.393 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 47.3 t -123.47 131.48 73.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 115.0 169.61 16.07 Favored Glycine 0 N--CA 1.479 1.537 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.93 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.779 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 54.2 t30 -84.96 113.14 21.19 Favored 'General case' 0 C--O 1.213 -0.835 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.52 HD21 ' CZ ' ' A' ' 171' ' ' PHE . 44.8 tp -73.66 103.48 4.26 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -177.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.67 HG23 ' HE ' ' A' ' 170' ' ' ARG . 9.8 p -86.82 167.34 14.47 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.557 178.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.22 -33.82 76.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.411 0.624 . . . . 0.0 111.6 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.1 -43.39 92.25 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.595 178.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.779 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 88.0 mtm180 -64.66 -31.22 72.35 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.134 0.974 . . . . 0.0 112.051 177.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.52 ' CZ ' HD21 ' A' ' 166' ' ' LEU . 0.5 OUTLIER -55.1 -29.38 57.5 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.564 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.578 ' O ' HG22 ' A' ' 175' ' ' VAL . 92.2 m-20 -61.12 -40.46 93.86 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 119.038 -1.065 . . . . 0.0 109.679 -177.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 52.6 m -59.71 -41.02 89.88 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.443 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 66.1 mt -63.35 -44.07 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.578 HG22 ' O ' ' A' ' 172' ' ' ASN . 26.8 m -62.57 -39.81 85.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 98.5 m -62.86 -35.16 79.05 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.303 0.573 . . . . 0.0 110.416 178.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.492 ' O ' HG13 ' A' ' 181' ' ' ILE . 25.0 m -61.7 -19.44 62.38 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.201 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.683 ' CD2' HD21 ' A' ' 211' ' ' LEU . 87.8 mt -60.97 -41.43 96.36 Favored 'General case' 0 C--O 1.247 0.967 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 -177.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 19.2 m -59.63 -42.94 93.83 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . 0.587 ' O ' ' OG ' ' A' ' 183' ' ' SER . 92.1 m-20 -61.43 -37.67 84.35 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 122.588 0.355 . . . . 0.0 110.983 178.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.516 HD12 ' HA ' ' A' ' 178' ' ' LEU . 67.6 mt -58.56 -37.71 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 O-C-N 121.685 -0.634 . . . . 0.0 109.476 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 85.0 mt -60.9 -40.34 92.71 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 119.418 -0.913 . . . . 0.0 108.833 -177.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.587 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 77.8 p -62.01 -33.86 75.13 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.528 176.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 59.3 p -89.37 23.36 2.56 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 120.752 0.31 . . . . 0.0 111.66 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 78.1 p -63.0 -20.54 65.39 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.775 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.71 -37.56 82.1 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.793 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.656 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 98.7 m-20 -73.3 115.05 12.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.424 0.631 . . . . 0.0 110.902 -179.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.92 -42.56 99.84 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.045 -0.98 . . . . 0.0 113.03 -177.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -113.78 131.52 56.19 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.266 0.555 . . . . 0.0 110.779 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 38.9 tp -120.0 127.07 52.28 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 92.2 mt -114.27 127.15 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 118.658 0.663 . . . . 0.0 109.607 177.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.7 mm -112.23 126.71 69.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . 0.525 ' CG ' ' HG ' ' A' ' 195' ' ' SER . 39.0 t0 -94.66 118.27 31.45 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 122.046 0.927 . . . . 0.0 110.78 177.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 95.9 mt -98.56 -3.49 36.25 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.392 175.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . 0.525 ' HG ' ' CG ' ' A' ' 193' ' ' ASP . 78.0 p -62.69 -33.7 75.62 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.629 0.604 . . . . 0.0 112.629 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.78 -43.63 98.98 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 108.491 -1.844 . . . . 0.0 108.491 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.936 HD23 ' N ' ' A' ' 198' ' ' ALA . 4.9 tt -70.0 129.15 38.68 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 113.104 -1.548 . . . . 0.0 108.584 -176.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.936 ' N ' HD23 ' A' ' 197' ' ' LEU . . . -60.24 -50.56 73.18 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.242 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.912 ' O ' ' CD2' ' A' ' 197' ' ' LEU . 58.4 tt0 -132.29 157.01 45.53 Favored 'General case' 0 C--O 1.204 -1.322 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -175.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.451 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 47.1 t -117.16 132.1 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 O-C-N 120.306 -1.496 . . . . 0.0 108.889 177.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -83.73 154.92 23.34 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.572 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -64.65 -39.2 93.27 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.123 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -58.26 -31.97 67.93 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 17.5 m -60.39 -41.86 94.69 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.563 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.497 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -57.22 -38.64 74.05 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -177.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -62.63 -37.01 84.61 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -64.76 -38.91 92.58 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.967 177.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 94.6 mt -63.47 -44.51 98.85 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.079 0 C-N-CA 119.598 -0.841 . . . . 0.0 108.982 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . 0.497 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 72.0 m-85 -61.53 -44.11 97.65 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.691 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.0 -41.87 98.53 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 119.347 -0.941 . . . . 0.0 109.363 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.683 HD21 ' CD2' ' A' ' 178' ' ' LEU . 38.8 mt -62.66 -42.08 99.42 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 78.1 p -61.99 -41.6 98.21 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 119.351 -0.939 . . . . 0.0 110.151 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -65.11 -45.36 85.44 Favored 'General case' 0 C--O 1.233 0.203 0 O-C-N 121.942 -0.474 . . . . 0.0 111.713 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 50.8 tp -62.36 -44.64 96.0 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 211' ' ' LEU . 85.8 mt -63.03 -40.54 98.04 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.705 -177.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.6 -44.26 96.48 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 90.5 mt -61.99 -39.81 93.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.09 0.472 . . . . 0.0 109.749 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 68.5 p -75.94 -10.96 59.85 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.308 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.63 37.39 14.0 Favored Glycine 0 C--O 1.219 -0.808 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.906 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 96.3 m -124.73 111.15 15.22 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.714 1.257 . . . . 0.0 111.309 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -62.31 138.44 58.43 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.548 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 48.0 tp -114.14 130.58 56.59 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 122.849 0.46 . . . . 0.0 109.874 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 3.3 mp -119.04 135.04 60.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.672 ' CG2' HD11 ' A' ' 227' ' ' ILE . 49.7 mm -115.14 132.24 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 38.5 p -133.57 166.8 21.74 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.863 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 78.09 19.61 74.49 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.684 -0.967 . . . . 0.0 110.684 178.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.672 HD11 ' CG2' ' A' ' 224' ' ' ILE . 97.4 mt -81.96 129.32 37.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 114.14 -1.03 . . . . 0.0 108.879 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 56.9 tttt -75.3 139.23 71.78 Favored Pre-proline 0 CA--C 1.533 0.31 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.58 -39.66 87.47 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.134 1.223 . . . . 0.0 112.526 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -62.83 -40.31 97.0 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-O 121.88 0.848 . . . . 0.0 110.262 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 49.0 tp -63.76 -42.05 97.89 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.543 176.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.31 -37.93 89.17 Favored 'General case' 0 N--CA 1.462 0.16 0 O-C-N 121.938 -0.476 . . . . 0.0 111.273 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 94.1 mtp -63.78 -41.15 98.0 Favored 'General case' 0 C--O 1.247 0.936 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.48 -38.86 92.76 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.594 177.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 32.4 mmt -65.68 -37.4 86.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.716 178.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -60.82 -41.67 96.17 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 121.558 -0.714 . . . . 0.0 109.371 -177.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.24 -41.55 97.07 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.527 0.68 . . . . 0.0 110.58 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 54.3 tp -63.02 -41.67 99.61 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 177.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 240' ' ' ALA . 67.0 t0 -166.81 128.91 1.74 Allowed 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.417 -0.802 . . . . 0.0 112.656 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.402 ' N ' ' OD1' ' A' ' 239' ' ' ASP . . . -61.19 -27.88 68.74 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.853 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.415 ' O ' ' HB2' ' A' ' 244' ' ' SER . 88.2 m-20 -60.92 -28.96 69.31 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.537 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -55.98 -43.81 77.97 Favored 'General case' 0 C--N 1.316 -0.881 0 O-C-N 121.235 -0.916 . . . . 0.0 109.048 -176.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 88.4 p -63.48 -19.27 64.6 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.039 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . 0.415 ' HB2' ' O ' ' A' ' 241' ' ' ASN . 43.4 m -55.31 -38.4 68.62 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.259 178.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 96.8 mt -87.8 124.72 33.91 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 119.794 -0.762 . . . . 0.0 112.687 -176.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -49.19 134.62 17.73 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.903 -176.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.581 HG23 HD12 ' A' ' 227' ' ' ILE . 95.5 m -126.61 132.01 51.36 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.215 -1.357 . . . . 0.0 111.364 178.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' TYR . . . . . 0.505 ' CG ' ' HB2' ' A' ' 254' ' ' ALA . 96.0 m-85 -116.07 140.98 48.73 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.331 178.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' SER . . . . . 0.448 ' O ' ' OD1' ' A' ' 250' ' ' ASN . 78.1 p -60.59 -41.94 95.73 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.448 ' OD1' ' O ' ' A' ' 249' ' ' SER . 99.2 m-20 -145.45 159.63 42.8 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.613 0.72 . . . . 0.0 111.069 -178.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . 0.403 ' O ' HG23 ' A' ' 255' ' ' VAL . 66.0 t -61.99 -44.72 99.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 114.632 -1.167 . . . . 0.0 112.085 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.31 -43.8 98.27 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . 0.464 ' O ' HG22 ' A' ' 257' ' ' VAL . 54.0 m-20 -64.13 -42.4 96.83 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.216 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . 0.505 ' HB2' ' CG ' ' A' ' 248' ' ' TYR . . . -64.96 -41.81 95.14 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.973 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . 0.661 HG13 HH11 ' B' ' 154' ' ' ARG . 73.3 t -63.08 -45.59 98.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.009 -178.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.93 -47.72 79.38 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.562 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.506 ' O ' ' C ' ' A' ' 258' ' ' LEU . 27.6 m -66.75 -41.67 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 120.138 -0.625 . . . . 0.0 112.403 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.506 ' C ' ' O ' ' A' ' 257' ' ' VAL . 1.3 mt -28.37 -72.93 0.05 OUTLIER Pre-proline 0 C--N 1.346 0.452 0 CA-C-O 119.562 -0.256 . . . . 0.0 111.248 -177.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' PRO . . . . . 0.475 ' CD ' ' CB ' ' A' ' 258' ' ' LEU . 45.4 Cg_endo -64.13 140.43 71.61 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.005 1.137 . . . . 0.0 112.073 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 259' ' ' PRO . 96.8 mt -152.74 -27.12 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 178.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 N--CA 1.473 0.68 0 CA-C-O 118.159 -0.924 . . . . 0.0 110.622 -177.017 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.493 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.83 158.94 29.25 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 118.728 -0.653 . . . . 0.0 109.933 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 80.7 p -58.88 -25.08 63.01 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 124.177 0.923 . . . . 0.0 110.908 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -68.88 -63.31 1.08 Allowed 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.521 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -67.18 -38.09 84.8 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.496 178.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . 0.483 ' O ' ' HB3' ' B' ' 7' ' ' PHE . 66.3 m -59.69 -42.53 93.14 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 120.442 -0.503 . . . . 0.0 109.906 -177.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . 0.687 ' CE2' HD12 ' B' ' 9' ' ' ILE . 41.7 t80 83.08 88.19 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 O-C-N 123.904 0.753 . . . . 0.0 110.293 177.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . 0.496 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -62.42 -134.98 0.01 OUTLIER Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -178.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.687 HD12 ' CE2' ' B' ' 7' ' ' PHE . 56.4 mt 79.25 108.54 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.656 0 C-N-CA 122.546 0.338 . . . . 0.0 111.059 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -62.45 -24.25 75.41 Favored 'Trans proline' 0 N--CA 1.498 1.793 0 C-N-CA 121.428 1.419 . . . . 0.0 111.792 -178.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.92 -40.45 98.88 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -64.18 -38.94 92.87 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.742 0.782 . . . . 0.0 109.626 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 51.1 tp -62.25 -42.55 99.43 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 114.757 -1.11 . . . . 0.0 112.114 -177.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -64.54 -33.33 75.66 Favored 'General case' 0 CA--C 1.563 1.466 0 CA-C-O 121.628 0.727 . . . . 0.0 110.759 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . 0.442 HG22 ' CD1' ' A' ' 113' ' ' ILE . 74.1 t -61.9 -46.16 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 113.094 -1.867 . . . . 0.0 111.108 176.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 94.7 mt -63.76 -43.79 98.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.07 0.462 . . . . 0.0 110.255 -178.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . 0.47 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 98.9 mttt -63.42 -42.51 98.73 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.41 -41.07 98.72 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.065 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.67 -39.1 87.16 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.689 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' B' ' 20' ' ' LEU . 89.3 mt -64.07 -42.0 97.15 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.05 0.452 . . . . 0.0 110.234 175.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.95 -39.2 93.91 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.121 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 52.4 m170 -57.61 -40.14 78.47 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 121.192 -0.203 . . . . 0.0 111.365 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 10.6 p -114.28 130.27 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.551 ' O ' ' HG3' ' B' ' 24' ' ' ARG . 35.5 ptt180 -71.57 107.15 4.31 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 122.176 0.989 . . . . 0.0 112.392 -177.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.0 p -142.04 133.61 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.497 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' B' ' 123' ' ' GLN . . . -89.45 97.03 2.28 Favored Glycine 0 N--CA 1.434 -1.451 0 C-N-CA 119.441 -1.361 . . . . 0.0 113.326 -175.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 50.0 t -125.43 129.4 72.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 174.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 27.3 m -138.11 156.48 30.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.803 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.41 ' HB ' ' HB3' ' B' ' 41' ' ' TYR . 95.5 mt -119.43 127.87 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 122.579 1.18 . . . . 0.0 111.17 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.447 ' HB ' ' OD1' ' B' ' 37' ' ' ASN . 18.3 p -111.57 157.73 20.03 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 113.07 -1.877 . . . . 0.0 108.27 -176.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -125.38 104.4 28.5 Favored Pre-proline 0 C--O 1.24 0.569 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.12 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' PRO . . . . . 0.432 ' CG ' HG23 ' B' ' 117' ' ' THR . 37.4 Cg_endo -64.76 -20.56 64.97 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 121.678 1.585 . . . . 0.0 111.564 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.37 -42.68 99.6 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.048 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 96.3 mt -74.97 -175.48 2.58 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 121.833 -0.542 . . . . 0.0 111.243 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . 0.713 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 42.6 tt0 -78.9 130.93 36.16 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.46 ' O ' ' OD1' ' B' ' 36' ' ' ASP . 62.4 t0 56.37 36.26 27.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.661 177.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' ASN . . . . . 0.447 ' OD1' ' HB ' ' B' ' 30' ' ' THR . 23.1 t-20 31.89 68.68 0.83 Allowed Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.713 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 91.4 Cg_endo -72.08 155.69 56.68 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 C-N-CA 123.332 2.688 . . . . 0.0 111.569 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 96.3 mt -87.35 129.5 38.67 Favored 'Isoleucine or valine' 0 C--O 1.247 0.943 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.406 HG23 ' N ' ' B' ' 41' ' ' TYR . 26.8 m -109.32 -42.31 5.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 O-C-N 123.943 0.777 . . . . 0.0 112.478 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' TYR . . . . . 0.41 ' HB3' ' HB ' ' B' ' 29' ' ' ILE . 51.9 t80 -96.99 123.91 40.83 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.4 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 5.3 p -142.6 140.37 28.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.446 177.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . 0.607 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 57.5 p30 -100.72 160.98 13.92 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.162 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' GLN . . . . . 0.468 ' OE1' ' HA ' ' B' ' 44' ' ' GLN . 12.8 mm100 -62.98 -36.95 85.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.66 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.07 -27.04 64.27 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.681 ' CD2' HD13 ' B' ' 57' ' ' ILE . 65.9 t80 -60.37 -43.09 96.9 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 0.807 HG13 ' O ' ' B' ' 52' ' ' TYR . 76.9 t -61.07 -46.16 97.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.231 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -63.31 -43.73 97.0 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 119.896 -0.721 . . . . 0.0 110.317 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 59.7 ttm -63.41 -42.48 98.75 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 35.0 p -95.15 -16.55 22.49 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.609 -178.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' B' ' 47' ' ' VAL . . . 74.45 17.19 79.79 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 178.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . 0.807 ' O ' HG13 ' B' ' 47' ' ' VAL . 83.8 m-85 -109.94 145.19 37.32 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 122.953 0.501 . . . . 0.0 110.328 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -75.24 148.34 39.55 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 121.254 0.549 . . . . 0.0 111.24 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . 0.428 HG22 ' H ' ' B' ' 54' ' ' THR . 0.2 OUTLIER -60.96 -37.21 81.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.866 -176.75 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.5 -39.75 95.27 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.993 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -72.1 -33.3 67.76 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 176.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.681 HD13 ' CD2' ' B' ' 46' ' ' PHE . 94.9 mt -68.02 -59.36 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 95.9 mt -53.14 134.69 38.61 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -175.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.4 -8.34 74.97 Favored Glycine 0 CA--C 1.538 1.498 0 CA-C-N 116.166 -0.47 . . . . 0.0 113.032 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -133.16 149.05 52.08 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -175.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' ASN . . . . . 0.548 ' C ' ' H ' ' B' ' 63' ' ' ARG . 24.8 t-20 -78.44 150.06 33.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.517 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' CYS . . . . . . . . . . . . . 82.5 m -63.42 9.23 0.06 Allowed 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' ARG . . . . . 0.548 ' H ' ' C ' ' B' ' 61' ' ' ASN . 34.8 ptt-85 -60.54 -32.93 71.96 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.42 -176.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -58.5 -30.61 67.17 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 86.6 mt -62.02 -41.26 97.89 Favored 'General case' 0 C--O 1.238 0.463 0 O-C-N 121.757 -0.59 . . . . 0.0 109.742 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -51.71 145.31 9.53 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.851 -175.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . 0.448 ' HA3' ' CE1' ' B' ' 95' ' ' TYR . . . -157.03 -153.9 6.85 Favored Glycine 0 CA--C 1.535 1.318 0 O-C-N 124.259 0.974 . . . . 0.0 111.774 177.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.26 -41.7 89.45 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -175.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -76.07 -9.84 58.94 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.139 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' THR . . . . . 0.426 ' OG1' ' N ' ' B' ' 67' ' ' GLY . 26.2 m -61.89 134.03 56.17 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.517 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -90.45 112.16 51.37 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.518 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.62 -37.96 90.88 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 121.185 1.257 . . . . 0.0 111.856 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.97 -40.07 92.01 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 120.42 -0.512 . . . . 0.0 109.761 -175.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' GLU . . . . . 0.445 ' OE1' ' HB ' ' B' ' 90' ' ' VAL . 78.8 mm-40 -66.76 -38.81 87.35 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.001 177.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 70.1 t -62.43 -46.06 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -62.94 -37.46 87.13 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.667 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -62.12 -41.8 98.6 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 119.315 -0.954 . . . . 0.0 108.874 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 94.1 mt -63.49 -43.7 98.48 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 CA-C-O 120.81 0.338 . . . . 0.0 110.907 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -61.38 -43.21 99.25 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 88.4 m -61.75 -45.16 95.11 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.59 0.71 . . . . 0.0 110.171 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.36 -41.83 98.92 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 86.9 mt -62.7 -42.53 99.69 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.516 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 66.8 tp60 -62.78 -34.01 76.35 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -90.78 6.86 42.52 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.414 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 30.8 tttt 42.46 37.99 1.11 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.969 176.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -121.94 141.28 33.76 Favored Pre-proline 0 N--CA 1.467 0.42 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.222 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.1 141.38 88.45 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.075 1.183 . . . . 0.0 113.754 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.5 p -139.81 136.11 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.942 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 89' ' ' THR . . . . . 0.965 HG23 ' OD1' ' B' ' 107' ' ' ASN . 96.5 m -121.05 122.6 40.43 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.445 ' HB ' ' OE1' ' B' ' 74' ' ' GLU . 27.3 m -138.92 162.86 27.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.913 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -115.38 121.51 43.01 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.978 -0.451 . . . . 0.0 109.819 174.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 21.3 tt -129.83 132.69 65.66 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 O-C-N 124.191 0.932 . . . . 0.0 111.623 -174.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -69.78 143.33 53.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.97 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 94' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -133.2 177.31 7.77 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 121.718 0.77 . . . . 0.0 111.43 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 95' ' ' TYR . . . . . 0.448 ' CE1' ' HA3' ' B' ' 67' ' ' GLY . 96.5 m-85 -127.27 146.57 50.39 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.267 -1.333 . . . . 0.0 112.293 176.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . 0.416 ' HG3' ' CE1' ' B' ' 102' ' ' PHE . 98.7 mttt -101.11 -179.88 4.17 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.338 0.589 . . . . 0.0 110.584 177.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.87 -36.56 79.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.306 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 38.9 p-10 -87.09 -0.44 56.66 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.466 -0.771 . . . . 0.0 112.912 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.65 3.25 64.6 Favored Glycine 0 N--CA 1.467 0.714 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.528 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 25.4 m -67.16 131.01 44.94 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 101' ' ' MET . . . . . 0.597 ' SD ' ' N ' ' B' ' 102' ' ' PHE . 14.6 tmm? -90.83 141.86 28.38 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 102' ' ' PHE . . . . . 0.597 ' N ' ' SD ' ' B' ' 101' ' ' MET . 53.4 p90 -153.35 163.94 39.02 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 177.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 103' ' ' TRP . . . . . 0.853 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 23.3 m95 -96.16 140.8 30.33 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.825 0.821 . . . . 0.0 110.428 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . 0.515 HD21 ' HG2' ' B' ' 123' ' ' GLN . 63.2 t-20 -132.97 109.46 9.58 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 114.806 -1.088 . . . . 0.0 113.476 -177.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 105' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' B' ' 123' ' ' GLN . 81.0 tt0 -78.78 123.11 26.86 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.221 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 41.1 tp -112.27 126.56 55.37 Favored 'General case' 0 C--N 1.346 0.445 0 CA-C-O 120.873 0.368 . . . . 0.0 111.874 -177.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 107' ' ' ASN . . . . . 0.965 ' OD1' HG23 ' B' ' 89' ' ' THR . 97.8 m-20 -120.37 126.92 51.71 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 175.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 96.4 mt -121.9 133.15 69.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.53 123.3 7.61 Favored Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 178.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -69.04 151.82 73.13 Favored 'Trans proline' 0 N--CA 1.501 1.941 0 C-N-CA 122.411 2.074 . . . . 0.0 112.471 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . 0.477 ' HB2' ' HB2' ' B' ' 118' ' ' TYR . 67.2 mtt -128.59 143.66 51.0 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -113.24 106.59 14.81 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 106.074 -1.825 . . . . 0.0 106.074 179.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . 0.653 HG12 ' NZ ' ' A' ' 18' ' ' LYS . 96.8 mt -133.15 127.06 54.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-N 118.474 0.579 . . . . 0.0 111.525 178.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 52.48 37.86 24.0 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.026 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 59.92 36.03 21.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.707 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -132.68 150.2 52.19 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 177.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 117' ' ' THR . . . . . 0.432 HG23 ' CG ' ' B' ' 32' ' ' PRO . 6.9 t -100.45 153.52 19.28 Favored 'General case' 0 C--O 1.217 -0.62 0 C-N-CA 120.555 -0.458 . . . . 0.0 109.908 -177.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 118' ' ' TYR . . . . . 0.477 ' HB2' ' HB2' ' B' ' 111' ' ' MET . 90.7 m-85 -148.43 146.37 28.4 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 121.071 -1.018 . . . . 0.0 111.182 -178.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -122.59 138.6 54.53 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 120.66 0.267 . . . . 0.0 111.198 -176.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.7 p -129.28 135.8 60.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -177.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -112.59 122.74 6.02 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 89.1 mt -111.71 127.31 68.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 123' ' ' GLN . . . . . 0.515 ' HG2' HD21 ' B' ' 104' ' ' ASN . 15.3 mp0 -118.61 122.96 43.83 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -119.92 123.6 43.97 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' B' ' 127' ' ' THR . 67.2 t0 -70.37 129.05 38.27 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.634 -178.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.562 ' O ' ' HG3' ' B' ' 130' ' ' LYS . 2.7 mp -102.61 15.55 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.837 0 CA-C-O 122.052 0.93 . . . . 0.0 109.278 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 127' ' ' THR . . . . . 0.479 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 19.5 m -63.13 -44.63 95.05 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 114.225 -1.352 . . . . 0.0 113.013 175.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -61.34 -46.1 91.64 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 129' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -63.69 -35.16 79.64 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.548 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 130' ' ' LYS . . . . . 0.853 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 98.7 mttt -63.73 -40.6 97.14 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 113.865 -1.516 . . . . 0.0 110.547 174.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.41 -41.38 96.66 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 132' ' ' TYR . . . . . 0.821 ' CE2' HD11 ' B' ' 136' ' ' LEU . 90.1 t80 -60.56 -44.16 96.46 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 121.693 -0.629 . . . . 0.0 111.066 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.0 -36.73 84.94 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 120.328 -0.549 . . . . 0.0 109.548 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.2 -39.54 94.94 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.881 178.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 54.1 tp -62.59 -41.3 98.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.187 0.518 . . . . 0.0 109.741 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 136' ' ' LEU . . . . . 0.821 HD11 ' CE2' ' B' ' 132' ' ' TYR . 86.9 mt -62.9 -41.89 99.6 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.27 177.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 137' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.56 -36.78 84.79 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.466 -1.243 . . . . 0.0 110.432 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.05 -43.01 99.82 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.896 177.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 70.1 m -60.74 -44.38 96.75 Favored 'General case' 0 C--N 1.343 0.323 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' B' ' 144' ' ' THR . 84.2 mt -61.04 -40.25 92.88 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -177.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 91.3 m -61.85 -45.46 93.71 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.91 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -66.33 -42.12 88.63 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 93.7 mt -63.67 -43.17 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.714 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 144' ' ' THR . . . . . 0.443 ' N ' ' O ' ' B' ' 140' ' ' LEU . 90.2 m -61.75 -45.24 94.77 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.56 -40.59 97.38 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 119.074 -1.051 . . . . 0.0 109.412 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 86.1 mt -64.49 -41.51 96.41 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 147' ' ' SER . . . . . 0.641 ' O ' ' N ' ' B' ' 149' ' ' PRO . 78.1 p -60.89 -42.77 98.65 Favored 'General case' 0 CA--C 1.48 -1.726 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 148' ' ' THR . . . . . 0.494 ' C ' ' O ' ' B' ' 147' ' ' SER . 6.8 m -27.8 84.75 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.592 0 O-C-N 124.105 0.878 . . . . 0.0 110.158 177.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 149' ' ' PRO . . . . . 0.641 ' N ' ' O ' ' B' ' 147' ' ' SER . 23.0 Cg_exo -62.34 147.59 94.69 Favored 'Trans proline' 0 C--N 1.296 -2.213 0 C-N-CA 122.234 1.956 . . . . 0.0 115.641 -177.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 9.1 tp -127.74 120.17 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-N 114.004 -1.453 . . . . 0.0 107.867 174.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 63.8 t -150.71 92.95 3.82 Favored Pre-proline 0 C--N 1.314 -0.936 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.992 -178.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -60.77 137.16 71.06 Favored 'Trans proline' 0 N--CA 1.484 0.952 0 N-CA-C 109.175 -1.125 . . . . 0.0 109.175 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 153' ' ' ILE . . . . . 0.64 ' O ' ' HD2' ' B' ' 154' ' ' ARG . 45.2 mm -67.66 -43.9 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.17 178.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 154' ' ' ARG . . . . . 0.661 HH11 HG13 ' A' ' 255' ' ' VAL . 0.3 OUTLIER -158.82 -154.01 0.4 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -179.618 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 62.3 t-20 -86.89 108.49 18.8 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.69 -16.38 58.75 Favored Glycine 0 C--O 1.221 -0.713 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 157' ' ' ILE . . . . . 0.509 HG22 ' HB ' ' B' ' 153' ' ' ILE . 89.0 mt -110.13 125.59 67.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.326 0.584 . . . . 0.0 111.37 -176.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 158' ' ' SER . . . . . 0.631 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 68.3 m -134.7 148.91 50.41 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.096 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -134.45 145.45 48.86 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.226 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 30.3 tp -138.45 79.25 30.56 Favored Pre-proline 0 C--O 1.234 0.283 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 161' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -70.54 146.99 56.87 Favored 'Trans proline' 0 N--CA 1.5 1.869 0 C-N-CA 122.831 2.354 . . . . 0.0 114.4 -178.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 87.0 mt -112.51 132.97 54.82 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 54.2 t -128.55 132.79 67.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 113.23 169.1 17.17 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 120.35 -0.929 . . . . 0.0 111.266 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 165' ' ' ASN . . . . . 0.688 ' O ' ' CZ ' ' B' ' 170' ' ' ARG . 61.9 t30 -89.62 107.02 18.85 Favored 'General case' 0 C--O 1.215 -0.752 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -177.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 166' ' ' LEU . . . . . 0.508 HD21 ' CZ ' ' B' ' 171' ' ' PHE . 46.7 tp -65.86 104.49 1.1 Allowed 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 -174.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 167' ' ' THR . . . . . 0.647 HG23 ' HE ' ' B' ' 170' ' ' ARG . 9.8 p -85.37 169.97 13.18 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 114.271 -1.331 . . . . 0.0 110.901 177.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.84 -37.39 84.38 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.718 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.34 -41.24 89.85 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-O 123.44 1.591 . . . . 0.0 111.508 -178.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 170' ' ' ARG . . . . . 0.688 ' CZ ' ' O ' ' B' ' 165' ' ' ASN . 88.3 mtm180 -62.58 -35.28 79.01 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 112.276 -2.238 . . . . 0.0 110.653 177.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 171' ' ' PHE . . . . . 0.508 ' CZ ' HD21 ' B' ' 166' ' ' LEU . 0.5 OUTLIER -54.9 -26.25 34.59 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -178.736 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 172' ' ' ASN . . . . . 0.531 ' O ' HG22 ' B' ' 175' ' ' VAL . 92.7 m-20 -62.88 -40.3 97.12 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.784 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 48.8 m -60.17 -41.77 93.57 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.051 0.453 . . . . 0.0 110.63 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 64.8 mt -63.43 -44.29 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 175' ' ' VAL . . . . . 0.531 HG22 ' O ' ' B' ' 172' ' ' ASN . 27.3 m -62.44 -39.81 85.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 176' ' ' CYS . . . . . . . . . . . . . 96.7 m -62.69 -35.58 80.14 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.344 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 177' ' ' THR . . . . . 0.527 ' O ' HG13 ' B' ' 181' ' ' ILE . 25.1 m -61.69 -19.42 62.34 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.499 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 178' ' ' LEU . . . . . 0.656 ' CD2' HD21 ' B' ' 211' ' ' LEU . 88.2 mt -61.23 -39.36 90.01 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -178.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 19.2 m -61.77 -44.03 97.69 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 120.74 0.305 . . . . 0.0 110.262 177.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 180' ' ' ASN . . . . . 0.587 ' O ' ' OG ' ' B' ' 183' ' ' SER . 92.6 m-20 -61.27 -40.22 93.29 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.853 0.358 . . . . 0.0 110.494 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.527 HG13 ' O ' ' B' ' 177' ' ' THR . 72.7 mt -57.47 -32.0 40.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 O-C-N 122.284 -0.26 . . . . 0.0 110.753 -178.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 182' ' ' LEU . . . . . . . . . . . . . 83.9 mt -62.38 -41.99 99.07 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.096 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . 0.587 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.4 p -63.28 -32.84 74.35 Favored 'General case' 0 C--N 1.334 -0.106 0 O-C-N 121.835 -0.54 . . . . 0.0 110.865 178.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 56.8 p -85.87 17.34 3.49 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.787 -177.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 78.8 p -61.5 -16.39 46.92 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.523 -176.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.17 -40.17 95.1 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 121.076 -0.25 . . . . 0.0 110.764 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 187' ' ' ASP . . . . . 0.631 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.6 m-20 -70.43 114.95 9.05 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.44 0.638 . . . . 0.0 110.635 -177.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -62.63 -42.6 99.68 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 114.922 -1.035 . . . . 0.0 113.112 -177.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -113.55 131.38 56.11 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.149 -177.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 190' ' ' LEU . . . . . . . . . . . . . 40.7 tp -123.29 119.37 29.93 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.089 177.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 84.5 mt -107.43 125.08 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 117.851 0.296 . . . . 0.0 110.89 -176.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 50.1 mm -113.7 118.83 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 193' ' ' ASP . . . . . 0.475 ' CG ' ' HG ' ' B' ' 195' ' ' SER . 41.5 t0 -90.29 112.17 23.62 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -176.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 194' ' ' LEU . . . . . . . . . . . . . 96.6 mt -94.71 -1.89 52.18 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 123.705 0.628 . . . . 0.0 109.782 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 195' ' ' SER . . . . . 0.475 ' HG ' ' CG ' ' B' ' 193' ' ' ASP . 77.9 p -60.83 -39.0 87.4 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.905 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.18 -35.19 90.47 Favored Glycine 0 N--CA 1.438 -1.205 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -178.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 197' ' ' LEU . . . . . 0.952 HD23 ' N ' ' B' ' 198' ' ' ALA . 5.3 tt -74.27 133.8 42.63 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 198' ' ' ALA . . . . . 0.952 ' N ' HD23 ' B' ' 197' ' ' LEU . . . -61.75 -47.38 85.44 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.322 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 199' ' ' GLN . . . . . 0.942 ' O ' ' CD2' ' B' ' 197' ' ' LEU . 59.2 tt0 -136.76 164.7 27.66 Favored 'General case' 0 C--O 1.209 -1.077 0 CA-C-O 122.083 0.944 . . . . 0.0 112.389 -177.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 200' ' ' VAL . . . . . 0.515 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 51.8 t -120.53 131.85 71.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 O-C-N 120.579 -1.326 . . . . 0.0 109.532 177.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -86.81 150.08 24.38 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.855 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.27 -33.17 74.1 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.253 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -63.7 -32.3 73.74 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.382 0.61 . . . . 0.0 109.481 177.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.2 m -60.81 -43.82 97.67 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.206 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 205' ' ' ALA . . . . . 0.633 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -58.26 -29.6 65.92 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -178.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -65.94 -38.35 88.39 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.431 0.634 . . . . 0.0 110.646 174.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -66.13 -38.46 88.21 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.477 178.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 95.0 mt -62.97 -45.51 98.69 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -178.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 209' ' ' PHE . . . . . 0.633 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 67.6 m-85 -61.47 -42.58 99.0 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.916 -176.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.82 -42.04 99.56 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 119.581 -0.847 . . . . 0.0 109.94 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 211' ' ' LEU . . . . . 0.656 HD21 ' CD2' ' B' ' 178' ' ' LEU . 38.3 mt -62.49 -42.52 99.55 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.173 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 78.1 p -63.46 -37.29 86.72 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.291 -0.564 . . . . 0.0 112.105 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 213' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -66.18 -46.64 76.63 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.214 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.404 ' O ' HG23 ' B' ' 218' ' ' THR . 53.3 tp -63.92 -42.57 97.35 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.895 0.855 . . . . 0.0 109.863 177.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 215' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' B' ' 211' ' ' LEU . 86.2 mt -62.53 -43.4 98.91 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 113.274 -1.785 . . . . 0.0 111.288 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.19 -39.77 93.83 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.749 0.309 . . . . 0.0 111.438 -177.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 92.4 mt -63.24 -41.97 99.14 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.443 0.64 . . . . 0.0 111.196 176.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 218' ' ' THR . . . . . 0.404 HG23 ' O ' ' B' ' 214' ' ' LEU . 68.3 p -74.75 -14.83 60.76 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.642 -178.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 78.14 65.46 1.87 Allowed Glycine 0 CA--C 1.528 0.885 0 N-CA-C 107.485 -2.246 . . . . 0.0 107.485 -177.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 220' ' ' THR . . . . . . . . . . . . . 95.3 m -144.08 105.31 4.24 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 175.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -62.15 140.96 58.4 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.922 -176.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 45.3 tp -117.18 121.83 42.32 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.645 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 3.5 mp -112.35 129.77 67.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.04 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 224' ' ' ILE . . . . . 0.643 ' CG2' HD11 ' B' ' 227' ' ' ILE . 50.1 mm -110.74 127.13 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 44.0 p -134.24 156.46 48.36 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 121.957 0.884 . . . . 0.0 112.495 -178.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 90.5 16.85 54.44 Favored Glycine 0 C--N 1.316 -0.564 0 CA-C-N 113.951 -1.477 . . . . 0.0 111.303 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 227' ' ' ILE . . . . . 0.643 HD11 ' CG2' ' B' ' 224' ' ' ILE . 95.5 mt -82.81 127.21 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 118.027 0.914 . . . . 0.0 111.284 -178.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 56.1 tttt -66.58 138.17 95.47 Favored Pre-proline 0 C--N 1.316 -0.868 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.525 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.9 -37.4 93.09 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 121.443 1.429 . . . . 0.0 112.616 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -62.66 -44.12 97.07 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 48.3 tp -61.68 -41.64 97.84 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.267 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.06 -37.41 87.1 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.931 -0.307 . . . . 0.0 111.414 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 94.6 mtp -64.16 -40.06 95.34 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-O 121.248 0.547 . . . . 0.0 109.629 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.43 -42.74 98.69 Favored 'General case' 0 CA--C 1.554 1.114 0 CA-C-O 122.443 1.116 . . . . 0.0 109.539 178.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 33.0 mmt -63.81 -35.86 82.0 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.507 -1.224 . . . . 0.0 111.89 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -62.06 -40.33 95.44 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.006 -178.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.01 -43.66 98.14 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 120.512 -0.475 . . . . 0.0 109.825 177.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 55.1 tp -62.57 -44.57 96.0 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.625 -178.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 239' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' B' ' 240' ' ' ALA . 66.8 t0 -159.27 132.5 7.11 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.35 -0.54 . . . . 0.0 112.106 -178.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 240' ' ' ALA . . . . . 0.41 ' N ' ' OD1' ' B' ' 239' ' ' ASP . . . -61.07 -46.55 90.22 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 177.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 241' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' B' ' 244' ' ' SER . 92.1 m-20 -44.06 -20.14 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.689 -175.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 242' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -60.63 -44.99 95.71 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.141 -0.624 . . . . 0.0 110.298 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 243' ' ' SER . . . . . . . . . . . . . 78.1 p -57.93 -42.87 85.78 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 178.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 244' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 20.0 m -34.61 -35.0 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -177.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 97.3 mt -88.36 132.51 34.4 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.702 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -58.28 135.41 57.13 Favored 'General case' 0 C--O 1.25 1.121 0 CA-C-O 121.906 0.86 . . . . 0.0 111.523 -178.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 247' ' ' THR . . . . . 0.604 HG23 HD12 ' B' ' 227' ' ' ILE . 98.1 m -127.13 128.09 45.63 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 114.525 -1.216 . . . . 0.0 112.004 178.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 248' ' ' TYR . . . . . 0.511 ' CG ' ' HB2' ' B' ' 254' ' ' ALA . 93.4 m-85 -112.46 143.78 43.02 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 249' ' ' SER . . . . . 0.565 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 78.2 p -62.57 -34.99 78.08 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.18 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 250' ' ' ASN . . . . . 0.565 ' OD1' ' O ' ' B' ' 249' ' ' SER . 99.0 m-20 -147.16 161.28 41.22 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 114.966 -1.015 . . . . 0.0 112.574 178.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 251' ' ' VAL . . . . . 0.406 ' O ' HG23 ' B' ' 255' ' ' VAL . 69.2 t -64.76 -44.93 96.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.788 178.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 252' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.04 -45.95 92.7 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . 0.477 ' O ' HG22 ' B' ' 257' ' ' VAL . 94.2 m-20 -61.23 -43.24 99.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.57 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 254' ' ' ALA . . . . . 0.511 ' HB2' ' CG ' ' B' ' 248' ' ' TYR . . . -65.73 -39.49 91.21 Favored 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.062 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 255' ' ' VAL . . . . . 0.643 HG13 HH11 ' A' ' 154' ' ' ARG . 76.2 t -65.22 -45.76 92.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.875 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.548 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.0 -48.4 78.98 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 121.588 0.709 . . . . 0.0 111.263 -177.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 257' ' ' VAL . . . . . 0.477 HG22 ' O ' ' B' ' 253' ' ' ASP . 27.1 m -65.09 -40.83 90.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.959 -1.018 . . . . 0.0 111.464 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 258' ' ' LEU . . . . . 0.482 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 1.3 mt -31.79 -72.3 0.07 OUTLIER Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.794 -178.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 259' ' ' PRO . . . . . 0.513 ' O ' HG13 ' B' ' 260' ' ' ILE . 39.8 Cg_endo -63.11 140.94 81.04 Favored 'Trans proline' 0 N--CA 1.504 2.103 0 C-N-CA 121.59 1.527 . . . . 0.0 111.351 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 260' ' ' ILE . . . . . 0.535 ' O ' HG22 ' B' ' 260' ' ' ILE . 96.7 mt -158.33 -15.4 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-N 118.591 0.632 . . . . 0.0 112.573 177.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 78.0 mtm . . . . . 0 N--CA 1.466 0.339 0 CA-C-O 118.207 -0.901 . . . . 0.0 111.825 179.675 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.15 -175.16 4.59 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 88.5 p -85.11 -7.04 59.26 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.484 -0.76 . . . . 0.0 111.412 177.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -81.57 -63.45 1.39 Allowed 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 114.109 -1.405 . . . . 0.0 113.157 172.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -67.5 -38.79 84.84 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.557 ' O ' ' NZ ' ' B' ' 17' ' ' LYS . 66.9 m -59.44 -42.08 91.12 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.181 -177.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.522 ' CE2' HD12 ' A' ' 9' ' ' ILE . 46.9 t80 85.48 85.96 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 O-C-N 123.766 0.666 . . . . 0.0 111.03 177.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.646 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -58.78 -150.13 0.01 OUTLIER Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.646 ' HB ' ' O ' ' A' ' 8' ' ' GLY . 89.3 mt 91.4 111.85 0.02 OUTLIER Pre-proline 0 N--CA 1.471 0.598 0 C-N-CA 122.734 0.414 . . . . 0.0 110.775 -179.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.66 -22.03 64.77 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 121.431 1.421 . . . . 0.0 112.153 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.05 -38.68 96.36 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 120.953 -0.641 . . . . 0.0 111.917 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -65.09 -39.21 92.85 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.549 0.69 . . . . 0.0 109.968 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.6 tp -63.08 -41.5 99.42 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -63.21 -40.36 97.26 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.6 t -60.48 -44.18 95.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 O-C-N 122.242 -0.286 . . . . 0.0 110.953 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 92.9 mt -62.63 -43.74 98.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.646 -177.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.7 -45.89 90.68 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 119.411 -0.916 . . . . 0.0 112.09 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.467 ' NZ ' HG12 ' B' ' 113' ' ' ILE . 98.5 mttt -60.28 -39.26 86.22 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 118.578 -1.249 . . . . 0.0 109.074 -176.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.5 -40.93 93.14 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.242 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.8 mt -62.97 -40.71 98.55 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -63.26 -38.19 90.18 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.327 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 62.0 m170 -58.82 -39.38 81.02 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 122.2 -0.313 . . . . 0.0 111.271 -178.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.37 130.65 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.512 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 35.8 ptt180 -73.65 110.71 8.15 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 122.093 0.949 . . . . 0.0 111.961 -177.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.0 p -141.54 143.67 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.599 ' HA3' ' HB2' ' A' ' 123' ' ' GLN . . . -97.28 91.97 1.27 Allowed Glycine 0 C--N 1.313 -0.695 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.814 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 50.8 t -124.44 129.51 73.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.6 m -137.1 159.92 36.28 Favored 'Isoleucine or valine' 0 C--O 1.244 0.796 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.9 mt -119.88 131.29 72.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.667 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.7 p -108.11 165.88 11.15 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.555 ' C ' ' OD1' ' A' ' 37' ' ' ASN . 50.9 t0 -132.09 101.41 15.07 Favored Pre-proline 0 C--N 1.323 -0.544 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.194 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.546 ' CG ' HG23 ' A' ' 117' ' ' THR . 35.5 Cg_endo -63.53 -22.31 70.78 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.659 1.573 . . . . 0.0 111.746 -178.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.03 -36.01 82.14 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.231 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.5 mt -83.33 159.17 21.93 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.954 176.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.782 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 42.4 tt0 -58.53 135.67 57.37 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -177.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.535 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 59.8 t0 61.1 18.89 9.45 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 178.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.555 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 31.0 t-20 42.79 67.42 3.56 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.748 -176.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.782 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 92.2 Cg_endo -71.13 156.3 59.81 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 123.985 3.123 . . . . 0.0 112.336 -178.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.2 mt -87.16 125.45 40.98 Favored 'Isoleucine or valine' 0 C--O 1.245 0.833 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.6 m -104.52 -44.26 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 O-C-N 123.659 0.6 . . . . 0.0 112.335 -179.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -96.35 124.68 40.44 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.838 -178.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.2 p -142.36 139.57 29.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 O-C-N 124.162 0.914 . . . . 0.0 109.333 176.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.598 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 56.6 p30 -97.04 167.56 10.99 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.461 ' OE1' ' HA ' ' A' ' 44' ' ' GLN . 14.1 mm100 -66.55 -39.08 88.37 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 176.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.69 -27.16 63.54 Favored Glycine 0 N--CA 1.452 -0.241 0 N-CA-C 110.331 -1.107 . . . . 0.0 110.331 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.607 ' CD1' HD13 ' A' ' 57' ' ' ILE . 58.1 t80 -59.08 -48.28 82.16 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.586 HG13 ' O ' ' A' ' 52' ' ' TYR . 78.7 t -59.89 -44.62 94.71 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 O-C-N 121.092 -1.005 . . . . 0.0 111.708 -173.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -63.15 -38.24 90.38 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 120.496 -0.482 . . . . 0.0 112.035 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.453 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 60.2 ttm -66.85 -43.21 84.22 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 175.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 36.8 p -93.58 -21.32 19.49 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.993 0.425 . . . . 0.0 111.523 -177.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . 77.05 20.39 75.84 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.586 ' O ' HG13 ' A' ' 47' ' ' VAL . 85.4 m-85 -114.33 136.77 52.61 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.022 0.439 . . . . 0.0 111.137 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -63.57 147.63 50.94 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.703 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.439 HG22 ' H ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -64.22 -31.14 72.22 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.595 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -67.28 -42.24 84.16 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 119.615 -0.834 . . . . 0.0 111.499 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -66.55 -44.68 81.71 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.423 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.607 HD13 ' CD1' ' A' ' 46' ' ' PHE . 96.2 mt -62.03 -45.34 98.95 Favored 'Isoleucine or valine' 0 C--N 1.354 0.767 0 CA-C-O 118.046 -0.978 . . . . 0.0 111.348 -175.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.0 mt -64.37 141.22 58.85 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 -177.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.35 -0.06 86.93 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.615 178.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -137.16 152.45 49.95 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.502 1.651 . . . . 0.0 111.44 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.54 ' C ' ' H ' ' A' ' 63' ' ' ARG . 25.1 t-20 -81.88 152.25 26.93 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.245 0.545 . . . . 0.0 110.648 -178.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 83.4 m -64.16 15.36 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.34 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.54 ' H ' ' C ' ' A' ' 61' ' ' ASN . 35.8 ptt-85 -61.59 -42.19 98.5 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.255 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -55.21 -22.31 17.29 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 88.2 mt -66.39 -36.62 83.31 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 177.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -64.79 144.04 57.52 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.446 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.628 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -152.66 -147.98 4.74 Favored Glycine 0 CA--C 1.541 1.71 0 N-CA-C 111.649 -0.581 . . . . 0.0 111.649 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.16 -39.98 96.23 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -177.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -77.69 -6.97 55.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.672 0.272 . . . . 0.0 111.001 -178.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.628 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 27.9 m -64.0 128.8 37.41 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.126 -0.63 . . . . 0.0 109.729 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -85.5 109.87 25.11 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.242 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 70' ' ' THR . 52.9 Cg_exo -57.09 -31.7 91.07 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 121.91 1.74 . . . . 0.0 113.063 178.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.08 -40.16 95.64 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.172 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.503 ' OE1' ' HB ' ' A' ' 90' ' ' VAL . 79.3 mm-40 -65.91 -44.0 86.49 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 67.4 t -59.92 -44.02 93.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 114.448 -1.251 . . . . 0.0 107.799 -175.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -63.99 -37.77 88.62 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.89 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -63.35 -39.53 94.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.339 0.59 . . . . 0.0 110.228 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.89 -44.04 97.94 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 CA-C-N 114.946 -1.025 . . . . 0.0 112.0 178.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -62.96 -43.35 99.03 Favored 'General case' 0 C--O 1.251 1.141 0 CA-C-N 113.68 -1.6 . . . . 0.0 108.482 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 99.8 m -61.35 -50.08 74.35 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 119.729 -0.788 . . . . 0.0 108.962 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.89 -42.35 89.33 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 119.487 -0.292 . . . . 0.0 111.187 -173.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 89.2 mt -63.12 -39.79 95.7 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 119.09 0.859 . . . . 0.0 111.885 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -63.24 -35.32 79.94 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 177.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -89.34 -2.91 58.61 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.694 -177.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 38.0 tttt 51.45 43.97 29.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.827 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -126.8 146.62 57.91 Favored Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 108' ' ' ILE . 24.2 Cg_exo -61.83 143.49 95.91 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.345 1.363 . . . . 0.0 112.822 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.7 142.3 30.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.862 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.917 HG23 ' OD1' ' A' ' 107' ' ' ASN . 96.6 m -126.41 122.22 34.7 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 175.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.503 ' HB ' ' OE1' ' A' ' 74' ' ' GLU . 29.3 m -139.05 159.47 29.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 121.106 -0.238 . . . . 0.0 111.308 178.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -103.61 133.99 47.7 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 105.021 -2.215 . . . . 0.0 105.021 176.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.5 HG23 ' O ' ' A' ' 92' ' ' ILE . 19.2 tt -142.4 125.23 14.14 Favored 'Isoleucine or valine' 0 C--N 1.374 1.635 0 CA-C-N 121.622 2.01 . . . . 0.0 112.341 176.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -58.87 136.55 57.86 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.377 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -136.07 159.96 40.09 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.161 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.4 ' CE1' ' HA3' ' A' ' 67' ' ' GLY . 93.8 m-85 -117.12 134.67 54.49 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -178.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.453 ' HE2' ' O ' ' A' ' 49' ' ' MET . 98.9 mttt -83.79 -174.3 5.2 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.086 0.469 . . . . 0.0 111.908 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.35 -43.13 99.54 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.102 178.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 40.9 p-10 -83.53 6.42 20.53 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -178.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.7 -1.38 87.04 Favored Glycine 0 N--CA 1.473 1.163 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.352 176.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.0 m -59.73 137.96 57.9 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.691 ' SD ' ' C ' ' A' ' 101' ' ' MET . 13.4 tmm? -105.47 129.03 53.85 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 120.959 0.409 . . . . 0.0 110.508 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.487 ' N ' ' SD ' ' A' ' 101' ' ' MET . 50.7 p90 -142.16 156.22 45.34 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.175 -176.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.724 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 20.8 m95 -88.24 142.2 27.94 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.477 HD21 ' HG2' ' A' ' 123' ' ' GLN . 54.3 t-20 -136.97 102.35 4.83 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -177.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.46 ' HB2' HD11 ' A' ' 126' ' ' ILE . 81.0 tt0 -67.75 136.77 54.75 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 -177.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 41.1 tp -121.5 122.57 40.03 Favored 'General case' 0 C--O 1.233 0.185 0 O-C-N 123.665 0.603 . . . . 0.0 112.593 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.917 ' OD1' HG23 ' A' ' 89' ' ' THR . 98.2 m-20 -118.85 123.32 44.42 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 116.724 -0.216 . . . . 0.0 110.64 177.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.432 ' O ' ' HA ' ' A' ' 87' ' ' PRO . 96.2 mt -120.03 128.77 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 O-C-N 123.468 0.48 . . . . 0.0 111.268 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -136.77 124.58 14.58 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 116.871 -0.15 . . . . 0.0 110.88 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -70.88 151.19 62.46 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.342 2.028 . . . . 0.0 112.499 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.587 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 67.2 mtt -124.03 153.13 41.78 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 179.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -129.09 95.59 4.1 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 176.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 96.5 mt -121.02 131.4 73.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.621 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 50.43 37.98 17.02 Favored 'General case' 0 CA--C 1.515 -0.398 0 O-C-N 121.567 -0.708 . . . . 0.0 111.441 176.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 58.7 30.51 20.05 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.707 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -126.81 147.9 49.99 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.814 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 5.2 t -84.85 -171.26 3.54 Favored 'General case' 0 C--O 1.214 -0.793 0 CA-C-O 118.618 -0.706 . . . . 0.0 109.323 -178.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.814 ' CD2' ' O ' ' A' ' 117' ' ' THR . 76.3 m-85 -174.96 154.95 1.93 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 175.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -130.71 146.2 52.12 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 174.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.7 134.86 56.14 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.461 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -106.81 127.85 9.03 Favored Glycine 0 CA--C 1.502 -0.774 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.408 ' HB ' ' HB2' ' A' ' 107' ' ' ASN . 96.6 mt -116.58 128.16 74.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 177.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.599 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . 17.3 mp0 -118.72 112.87 20.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.072 0.463 . . . . 0.0 109.875 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -115.07 112.16 22.17 Favored 'General case' 0 C--O 1.248 0.974 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.881 -178.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 127' ' ' THR . 68.4 t0 -62.55 131.28 48.57 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -176.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.507 HG22 ' O ' ' A' ' 126' ' ' ILE . 3.3 mp -96.64 4.32 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 113.743 -1.571 . . . . 0.0 109.884 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.461 ' N ' ' OD1' ' A' ' 125' ' ' ASP . 25.6 m -60.37 -42.34 95.6 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 121.081 -1.012 . . . . 0.0 113.388 -178.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -59.63 -42.8 93.54 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -62.8 -39.73 95.16 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.702 177.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.724 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.8 mttt -62.34 -41.21 98.4 Favored 'General case' 0 CA--C 1.503 -0.834 0 C-N-CA 118.286 -1.366 . . . . 0.0 110.64 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -62.17 -37.59 85.81 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.659 ' CE2' HD11 ' A' ' 136' ' ' LEU . 87.5 t80 -61.48 -45.44 94.21 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.672 176.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.81 -38.61 91.56 Favored 'General case' 0 CA--C 1.522 -0.116 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.06 -40.83 97.1 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.068 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 54.8 tp -60.8 -43.84 97.62 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -177.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.659 HD11 ' CE2' ' A' ' 132' ' ' TYR . 85.2 mt -62.21 -41.34 98.29 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.382 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.09 -42.55 99.33 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 119.529 -0.868 . . . . 0.0 109.799 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -60.68 -42.12 96.46 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -177.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 58.3 m -61.57 -41.12 96.95 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.642 176.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 144' ' ' THR . 83.6 mt -63.5 -42.07 98.53 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 120.63 -0.428 . . . . 0.0 109.934 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 91.5 m -61.62 -45.4 94.23 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.152 -177.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -65.08 -40.21 94.31 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 95.2 mt -64.72 -43.39 96.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.115 -1.402 . . . . 0.0 111.313 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.51 ' N ' ' O ' ' A' ' 140' ' ' LEU . 99.4 m -62.65 -46.16 89.47 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 121.811 -0.556 . . . . 0.0 112.121 -177.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.454 ' O ' ' OG1' ' A' ' 148' ' ' THR . . . -63.31 -39.42 94.51 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 118.803 -1.159 . . . . 0.0 109.051 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 81.7 mt -63.38 -42.65 98.83 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.355 178.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.711 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.2 p -59.96 -39.65 86.34 Favored 'General case' 0 C--O 1.217 -0.644 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -178.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.49 ' C ' ' O ' ' A' ' 147' ' ' SER . 21.6 m -27.1 81.72 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.418 0 O-C-N 126.971 2.669 . . . . 0.0 106.133 -178.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.711 ' N ' ' O ' ' A' ' 147' ' ' SER . 21.1 Cg_exo -62.44 146.15 95.61 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 C-N-CA 121.427 1.418 . . . . 0.0 114.538 -175.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.574 ' O ' ' CG2' ' A' ' 151' ' ' VAL . 9.6 tp -124.52 136.58 60.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 102.843 -3.021 . . . . 0.0 102.843 178.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.574 ' CG2' ' O ' ' A' ' 150' ' ' ILE . 60.1 t -169.05 96.48 0.52 Allowed Pre-proline 0 N--CA 1.437 -1.083 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 178.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -64.8 133.28 35.68 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 109.785 -0.89 . . . . 0.0 109.785 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.665 ' O ' ' HD2' ' A' ' 154' ' ' ARG . 45.9 mm -69.19 -45.13 80.09 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.909 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.395 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.665 ' HD2' ' O ' ' A' ' 153' ' ' ILE . 1.1 tpt180 -156.15 -159.32 0.88 Allowed 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.422 ' ND2' ' HE3' ' B' ' 256' ' ' LYS . 58.9 t-20 -86.16 106.18 17.09 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.697 0.76 . . . . 0.0 111.289 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 88.8 10.06 67.52 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 113.98 -1.463 . . . . 0.0 110.501 -177.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.449 HG12 ' HB2' ' A' ' 189' ' ' TYR . 96.6 mt -128.11 122.82 59.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 175.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.615 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 58.0 m -131.92 151.75 51.51 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.199 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -134.06 140.11 46.43 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.206 -0.597 . . . . 0.0 111.404 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 29.7 tp -131.18 76.49 76.27 Favored Pre-proline 0 N--CA 1.468 0.469 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.206 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -68.89 149.11 72.02 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 122.791 2.327 . . . . 0.0 113.085 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 90.0 mt -117.38 128.63 55.22 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.179 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 45.8 t -123.48 131.56 72.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 115.58 167.55 15.18 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 120.89 -0.671 . . . . 0.0 111.92 178.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.888 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 60.0 t30 -84.19 115.64 22.53 Favored 'General case' 0 C--O 1.207 -1.151 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -178.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.512 HD21 ' CZ ' ' A' ' 171' ' ' PHE . 43.5 tp -75.76 105.57 6.87 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 -177.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.643 HG23 ' NE ' ' A' ' 170' ' ' ARG . 11.4 p -88.53 167.61 13.28 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.909 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.51 -34.19 77.68 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.983 0.42 . . . . 0.0 111.945 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.76 -42.11 91.3 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.805 0.812 . . . . 0.0 110.986 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.888 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 88.2 mtm180 -64.75 -34.26 77.91 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.791 177.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.512 ' CZ ' HD21 ' A' ' 166' ' ' LEU . 0.4 OUTLIER -55.07 -28.3 51.29 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 119.025 -0.512 . . . . 0.0 111.727 -177.084 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.711 ' O ' HG22 ' A' ' 175' ' ' VAL . 91.0 m-20 -60.35 -40.6 91.31 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 118.718 -1.193 . . . . 0.0 110.02 -177.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 50.3 m -59.25 -40.78 87.03 Favored 'General case' 0 C--N 1.315 -0.923 0 O-C-N 121.569 -0.707 . . . . 0.0 110.538 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 66.8 mt -62.9 -43.96 99.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.711 HG22 ' O ' ' A' ' 172' ' ' ASN . 23.0 m -62.32 -39.91 85.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -178.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . 0.438 ' N ' HG23 ' A' ' 175' ' ' VAL . 98.3 m -62.38 -34.61 77.04 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.274 178.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.582 ' O ' HG13 ' A' ' 181' ' ' ILE . 25.1 m -61.86 -19.71 62.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.905 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.786 ' CD2' HD21 ' A' ' 211' ' ' LEU . 91.3 mt -60.99 -41.18 95.98 Favored 'General case' 0 C--O 1.248 0.99 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -177.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 19.1 m -59.75 -43.58 94.21 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . 0.576 ' O ' ' OG ' ' A' ' 183' ' ' SER . 92.0 m-20 -61.47 -35.4 77.52 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.775 0.43 . . . . 0.0 110.683 178.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.582 HG13 ' O ' ' A' ' 177' ' ' THR . 67.5 mt -60.32 -41.46 87.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.504 HD21 HD21 ' A' ' 214' ' ' LEU . 84.9 mt -60.3 -40.4 90.38 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 119.342 -0.943 . . . . 0.0 108.981 -176.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.576 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 78.1 p -61.45 -33.7 74.19 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.607 176.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 58.8 p -89.39 23.71 2.46 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.79 0.329 . . . . 0.0 111.446 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 78.1 p -64.48 -20.04 65.94 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.973 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -60.56 -37.43 81.23 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.921 -178.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.615 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 98.8 m-20 -73.57 114.98 12.43 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.383 0.611 . . . . 0.0 110.582 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -62.91 -42.62 99.85 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.123 -0.944 . . . . 0.0 113.027 -177.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . 0.449 ' HB2' HG12 ' A' ' 157' ' ' ILE . 98.5 m-85 -111.61 132.06 54.83 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.783 -177.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 40.0 tp -120.62 128.36 52.95 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 95.7 mt -116.94 127.32 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 118.35 0.523 . . . . 0.0 109.599 177.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.9 mm -112.84 127.05 70.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . 0.518 ' CG ' ' HG ' ' A' ' 195' ' ' SER . 40.0 t0 -94.23 118.02 30.96 Favored 'General case' 0 CA--C 1.552 1.053 0 O-C-N 121.796 -0.565 . . . . 0.0 110.824 177.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 194' ' ' LEU . 96.0 mt -96.51 -5.07 40.28 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.825 175.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . 0.518 ' HG ' ' CG ' ' A' ' 193' ' ' ASP . 78.1 p -62.87 -33.81 76.06 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -62.28 -42.0 99.72 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 118.808 -1.663 . . . . 0.0 109.025 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.954 HD23 ' N ' ' A' ' 198' ' ' ALA . 4.7 tt -72.09 127.89 33.97 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 112.2 -2.0 . . . . 0.0 108.159 -177.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.954 ' N ' HD23 ' A' ' 197' ' ' LEU . . . -60.8 -47.21 87.38 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.956 0.408 . . . . 0.0 111.062 -178.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.908 ' O ' ' CD2' ' A' ' 197' ' ' LEU . 58.5 tt0 -133.63 155.93 48.79 Favored 'General case' 0 C--O 1.2 -1.547 0 CA-C-N 114.609 -1.178 . . . . 0.0 114.052 -174.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.433 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 46.9 t -117.97 132.51 67.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 O-C-N 120.17 -1.582 . . . . 0.0 108.707 178.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -90.44 155.46 18.91 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.642 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -64.44 -39.34 93.63 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 120.254 -0.578 . . . . 0.0 109.915 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -57.81 -32.66 67.79 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-O 122.099 0.952 . . . . 0.0 108.944 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.9 m -61.14 -42.57 98.78 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.222 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.512 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -57.96 -39.42 78.1 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -177.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -62.26 -36.71 82.87 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -65.48 -39.11 91.56 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.113 177.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 93.5 mt -63.16 -44.2 99.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . 0.512 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 68.9 m-85 -61.82 -43.83 98.07 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.648 -178.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.64 -42.62 99.7 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 119.295 -0.962 . . . . 0.0 109.221 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.786 HD21 ' CD2' ' A' ' 178' ' ' LEU . 37.7 mt -62.21 -41.87 98.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.644 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 78.4 p -61.44 -41.46 97.23 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.266 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' HIS . . . . . 0.439 ' CE1' HD11 ' A' ' 217' ' ' LEU . 57.8 t-80 -64.97 -45.52 85.34 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 122.018 -0.427 . . . . 0.0 111.528 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.504 HD21 HD21 ' A' ' 182' ' ' LEU . 48.0 tp -62.12 -46.52 88.65 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 118.893 -1.123 . . . . 0.0 108.003 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 211' ' ' LEU . 90.2 mt -61.98 -40.43 95.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.588 -177.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.34 -43.47 96.4 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.442 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.439 HD11 ' CE1' ' A' ' 213' ' ' HIS . 84.6 mt -61.95 -39.96 93.91 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 69.2 p -76.43 -11.35 59.87 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.365 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 83.17 35.31 18.37 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-O 119.133 -0.815 . . . . 0.0 112.844 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 96.2 m -123.44 110.97 15.78 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 118.863 1.331 . . . . 0.0 111.713 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -61.63 138.46 58.31 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.81 178.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 50.0 tp -113.61 131.05 56.26 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 177.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 2.7 mp -118.37 135.14 59.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.561 ' CG2' HD11 ' A' ' 227' ' ' ILE . 50.1 mm -116.48 131.63 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -178.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 34.5 p -133.71 167.53 20.35 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 78.63 21.42 69.16 Favored Glycine 0 C--N 1.334 0.469 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.607 HD12 HG23 ' A' ' 247' ' ' THR . 97.6 mt -84.68 128.15 39.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 113.924 -1.138 . . . . 0.0 108.427 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 54.3 tttt -74.02 140.56 77.24 Favored Pre-proline 0 CA--C 1.535 0.377 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.32 -39.72 89.46 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 120.942 1.095 . . . . 0.0 112.489 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -64.78 -37.38 87.4 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.507 0.67 . . . . 0.0 110.28 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 52.7 tp -63.79 -42.31 97.76 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.468 177.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -65.17 -37.12 86.36 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.042 0.449 . . . . 0.0 110.873 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 94.1 mtp -63.29 -40.97 98.85 Favored 'General case' 0 C--O 1.248 0.985 0 C-N-CA 120.074 -0.65 . . . . 0.0 109.536 -178.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -64.02 -39.9 95.14 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.462 177.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 35.1 mmt -66.76 -36.73 83.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.554 177.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -60.84 -41.87 96.66 Favored 'General case' 0 CA--C 1.513 -0.479 0 O-C-N 121.432 -0.793 . . . . 0.0 109.479 -176.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.86 -39.88 90.8 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.506 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 59.0 tp -63.44 -41.05 98.65 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 240' ' ' ALA . 67.0 t0 -167.6 129.47 1.55 Allowed 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 121.487 0.661 . . . . 0.0 112.148 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.408 ' N ' ' OD1' ' A' ' 239' ' ' ASP . . . -61.04 -26.8 67.88 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.618 178.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.485 ' O ' ' HB2' ' A' ' 244' ' ' SER . 90.8 m-20 -61.24 -32.68 72.48 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.326 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -55.59 -44.38 76.89 Favored 'General case' 0 C--N 1.312 -1.065 0 O-C-N 121.214 -0.929 . . . . 0.0 109.089 -175.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 94.2 p -62.82 -20.04 64.66 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.937 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . 0.485 ' HB2' ' O ' ' A' ' 241' ' ' ASN . 49.7 m -56.4 -37.76 70.59 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 122.517 0.327 . . . . 0.0 111.854 177.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 92.5 mt -83.24 130.94 35.12 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 177.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -55.29 135.08 50.18 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 114.104 -1.407 . . . . 0.0 109.626 -177.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.607 HG23 HD12 ' A' ' 227' ' ' ILE . 98.0 m -126.79 132.14 51.1 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.836 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' TYR . . . . . 0.431 ' CG ' ' HB2' ' A' ' 254' ' ' ALA . 97.5 m-85 -118.09 140.54 49.61 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.401 178.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' SER . . . . . 0.418 ' O ' ' OD1' ' A' ' 250' ' ' ASN . 78.1 p -61.39 -42.35 98.58 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -178.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 249' ' ' SER . 98.4 m-20 -144.03 160.5 40.75 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.72 0.772 . . . . 0.0 111.43 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 77.0 t -62.38 -44.74 99.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 114.641 -1.163 . . . . 0.0 112.044 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.73 -43.78 97.47 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.329 -0.549 . . . . 0.0 109.581 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . 0.551 ' O ' HG22 ' A' ' 257' ' ' VAL . 55.1 m-20 -63.43 -42.68 98.71 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.164 -178.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . 0.431 ' HB2' ' CG ' ' A' ' 248' ' ' TYR . . . -64.92 -41.88 95.18 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.729 0.776 . . . . 0.0 109.942 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 61.1 t -63.5 -45.89 96.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 114.225 -1.352 . . . . 0.0 111.304 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -63.89 -47.45 80.56 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.509 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 253' ' ' ASP . 33.4 m -66.89 -40.96 86.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 C-N-CA 119.908 -0.717 . . . . 0.0 112.481 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.483 ' C ' ' O ' ' A' ' 257' ' ' VAL . 0.9 OUTLIER -30.11 -73.42 0.05 OUTLIER Pre-proline 0 CA--C 1.533 0.293 0 O-C-N 123.166 0.291 . . . . 0.0 111.614 -176.847 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' PRO . . . . . 0.48 ' O ' HG13 ' A' ' 260' ' ' ILE . 43.6 Cg_endo -63.87 140.24 72.35 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 120.847 1.032 . . . . 0.0 111.857 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.48 HG13 ' O ' ' A' ' 259' ' ' PRO . 96.1 mt -152.91 -31.18 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 O-C-N 123.453 0.47 . . . . 0.0 112.16 178.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 77.3 mtm . . . . . 0 C--O 1.217 -0.617 0 CA-C-O 118.133 -0.937 . . . . 0.0 111.143 -177.213 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.521 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.62 175.32 11.65 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 100.0 p -72.09 -11.59 60.82 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.717 -0.219 . . . . 0.0 111.19 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -83.04 -60.94 2.0 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.063 0.458 . . . . 0.0 110.661 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -67.05 -39.16 86.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.253 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . 0.537 ' O ' ' HB3' ' B' ' 7' ' ' PHE . 68.4 m -59.48 -43.28 93.33 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 120.249 -0.58 . . . . 0.0 109.6 -177.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . 0.537 ' HB3' ' O ' ' B' ' 6' ' ' SER . 48.3 t80 86.94 86.97 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.891 0.744 . . . . 0.0 110.71 177.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . 0.647 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -59.99 -149.72 0.01 OUTLIER Glycine 0 C--N 1.336 0.559 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.647 ' HB ' ' O ' ' B' ' 8' ' ' GLY . 88.5 mt 91.3 111.78 0.02 OUTLIER Pre-proline 0 N--CA 1.472 0.635 0 O-C-N 123.948 0.44 . . . . 0.0 110.761 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -63.86 -23.63 68.46 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 121.408 1.405 . . . . 0.0 111.788 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.58 -41.1 99.51 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -64.69 -39.33 93.47 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.843 0.83 . . . . 0.0 109.775 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 48.5 tp -61.76 -42.36 98.88 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 114.907 -1.042 . . . . 0.0 112.116 -177.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -65.15 -33.31 75.71 Favored 'General case' 0 CA--C 1.561 1.39 0 CA-C-O 121.681 0.753 . . . . 0.0 110.805 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 79.4 t -62.23 -46.46 96.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-N 112.927 -1.942 . . . . 0.0 110.912 177.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.94 -44.09 97.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.674 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . 0.557 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 98.9 mttt -63.53 -41.99 98.46 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.34 -41.21 98.87 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 119.028 -1.069 . . . . 0.0 110.254 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.61 -38.39 84.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.743 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 84.3 mt -63.77 -41.91 97.88 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.223 0.535 . . . . 0.0 110.255 175.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -62.87 -38.54 91.27 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.95 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 61.2 m170 -57.83 -39.86 78.67 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 121.19 -0.204 . . . . 0.0 111.156 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 14.1 p -115.28 130.74 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.523 ' O ' ' HG3' ' B' ' 24' ' ' ARG . 35.4 ptt180 -73.54 108.58 6.48 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 121.85 0.833 . . . . 0.0 112.316 -176.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.7 p -143.09 133.76 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.667 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.544 177.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . 0.541 ' HA3' ' HB2' ' B' ' 123' ' ' GLN . . . -86.78 96.21 2.13 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 119.629 -1.272 . . . . 0.0 113.488 -176.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 47.0 t -125.58 128.81 72.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 175.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 29.5 m -138.8 157.29 29.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.587 179.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 96.5 mt -118.91 129.3 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-O 121.676 0.751 . . . . 0.0 111.567 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.474 ' OG1' ' O ' ' B' ' 119' ' ' PHE . 9.9 p -111.85 154.49 25.07 Favored 'General case' 0 CA--C 1.502 -0.886 0 CA-C-N 113.073 -1.876 . . . . 0.0 108.819 -175.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.518 ' C ' ' OD1' ' B' ' 37' ' ' ASN . 51.0 t0 -122.77 102.3 38.55 Favored Pre-proline 0 C--O 1.237 0.415 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -177.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' PRO . . . . . 0.455 ' CG ' HG23 ' B' ' 117' ' ' THR . 36.5 Cg_endo -64.52 -20.65 65.98 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 121.786 1.657 . . . . 0.0 111.27 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.19 -42.38 99.23 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 120.629 -0.429 . . . . 0.0 110.002 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 96.8 mt -73.15 179.79 3.68 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 121.778 -0.576 . . . . 0.0 111.097 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . 0.709 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 42.0 tt0 -75.58 132.88 40.96 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -178.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.488 ' O ' ' C ' ' B' ' 37' ' ' ASN . 66.0 t0 55.86 38.78 30.44 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.709 178.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' ASN . . . . . 0.518 ' OD1' ' C ' ' B' ' 31' ' ' ASP . 17.6 t-20 26.91 71.37 0.42 Allowed Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.709 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 92.6 Cg_endo -72.93 154.62 53.29 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 123.554 2.836 . . . . 0.0 111.944 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 95.9 mt -85.75 130.25 36.69 Favored 'Isoleucine or valine' 0 C--O 1.246 0.889 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 17.1 m -108.39 -44.06 6.5 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 O-C-N 123.884 0.74 . . . . 0.0 112.709 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -97.07 124.93 41.21 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.529 -178.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 6.5 p -142.34 140.53 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 O-C-N 124.195 0.934 . . . . 0.0 109.348 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . 0.636 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 55.4 p30 -101.18 162.62 12.76 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.144 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' GLN . . . . . 0.443 ' OE1' ' HA ' ' B' ' 44' ' ' GLN . 13.7 mm100 -62.86 -37.81 88.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.693 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.75 -27.53 64.24 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.656 ' CD1' HD13 ' B' ' 57' ' ' ILE . 53.3 t80 -60.36 -43.72 96.27 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 0.734 HG13 ' O ' ' B' ' 52' ' ' TYR . 77.6 t -61.78 -45.99 97.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.25 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -62.98 -44.31 96.39 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.394 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . 0.458 ' O ' ' HE2' ' B' ' 96' ' ' LYS . 60.2 ttm -63.48 -42.02 98.57 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 34.6 p -96.22 -16.1 21.63 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.931 -177.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' B' ' 47' ' ' VAL . . . 72.69 18.73 78.87 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.379 -1.089 . . . . 0.0 110.379 178.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . 0.734 ' O ' HG13 ' B' ' 47' ' ' VAL . 85.7 m-85 -111.28 144.03 41.11 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 122.893 0.477 . . . . 0.0 109.999 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -73.82 147.72 43.1 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.561 0.696 . . . . 0.0 111.228 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . 0.452 HG22 ' H ' ' B' ' 54' ' ' THR . 0.2 OUTLIER -61.42 -36.01 79.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.867 -177.779 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.48 -40.09 96.18 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 120.131 -0.628 . . . . 0.0 111.884 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -73.15 -33.69 65.64 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 176.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.656 HD13 ' CD1' ' B' ' 46' ' ' PHE . 97.2 mt -64.57 -53.95 36.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 118.204 -1.398 . . . . 0.0 109.475 177.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 88.6 mt -61.77 132.35 52.84 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.004 -170.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.55 -4.36 69.38 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 121.034 -0.603 . . . . 0.0 113.382 -177.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -133.22 149.25 52.02 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -177.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' ASN . . . . . 0.529 ' C ' ' H ' ' B' ' 63' ' ' ARG . 24.4 t-20 -78.86 151.79 31.62 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.565 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' CYS . . . . . . . . . . . . . 82.7 m -64.28 8.96 0.09 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.341 -178.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' ARG . . . . . 0.529 ' H ' ' C ' ' B' ' 61' ' ' ASN . 34.4 ptt-85 -59.4 -32.46 70.19 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.395 -177.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -60.95 -30.66 70.37 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 178.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 83.9 mt -61.66 -41.95 98.23 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 121.63 -0.669 . . . . 0.0 110.114 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -51.75 150.58 3.89 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.024 -177.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . 0.51 ' N ' ' OG1' ' B' ' 70' ' ' THR . . . -161.13 -153.94 7.21 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.33 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -58.98 -40.55 85.18 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -175.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -76.92 -9.43 58.68 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.307 -178.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' THR . . . . . 0.51 ' OG1' ' N ' ' B' ' 67' ' ' GLY . 26.9 m -61.19 133.81 56.35 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -90.5 110.1 38.65 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.485 -178.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.17 -38.15 87.71 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 120.979 1.12 . . . . 0.0 111.677 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.83 -40.42 92.75 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 120.459 -0.496 . . . . 0.0 109.8 -176.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' GLU . . . . . 0.504 ' OE1' ' HB ' ' B' ' 90' ' ' VAL . 79.0 mm-40 -67.23 -39.44 86.21 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.789 177.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 73.9 t -61.96 -45.95 97.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -63.29 -37.05 85.75 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.655 -178.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -62.33 -41.47 98.58 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 119.393 -0.923 . . . . 0.0 108.698 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 94.2 mt -63.28 -43.76 98.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-O 120.928 0.394 . . . . 0.0 110.427 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -62.31 -42.78 99.66 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 85.1 m -61.57 -45.4 94.29 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.027 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.28 -41.15 98.24 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 85.9 mt -62.98 -42.14 99.76 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -62.48 -36.63 83.1 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -91.64 7.4 41.72 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.5 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 32.3 tttt 43.1 45.79 4.74 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.414 -0.515 . . . . 0.0 112.195 175.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -128.15 143.72 49.01 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.274 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.31 140.51 83.19 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 120.933 1.089 . . . . 0.0 113.289 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -140.82 137.16 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.361 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 89' ' ' THR . . . . . 0.926 HG23 ' OD1' ' B' ' 107' ' ' ASN . 95.7 m -121.47 123.81 42.94 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.504 ' HB ' ' OE1' ' B' ' 74' ' ' GLU . 26.9 m -138.27 163.13 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.955 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -114.62 120.42 40.09 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 174.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . 0.467 HD11 HG23 ' B' ' 70' ' ' THR . 20.9 tt -128.3 131.79 68.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.256 -176.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -71.44 143.46 50.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.419 177.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 94' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -132.92 -178.89 5.16 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 121.268 0.556 . . . . 0.0 111.176 -177.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 95' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -131.19 145.61 52.01 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 114.567 -1.197 . . . . 0.0 111.711 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . 0.458 ' HE2' ' O ' ' B' ' 49' ' ' MET . 98.6 mttt -103.01 177.09 4.93 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.317 0.58 . . . . 0.0 111.209 177.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.15 -35.43 75.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.716 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 38.4 p-10 -87.11 -1.78 58.14 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.168 0.895 . . . . 0.0 112.486 178.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.28 3.18 63.46 Favored Glycine 0 C--N 1.335 0.528 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.449 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 25.5 m -67.01 128.99 38.44 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 101' ' ' MET . . . . . 0.603 ' SD ' ' N ' ' B' ' 102' ' ' PHE . 15.1 tmm? -87.75 142.23 27.98 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 102' ' ' PHE . . . . . 0.603 ' N ' ' SD ' ' B' ' 101' ' ' MET . 52.8 p90 -153.9 162.09 41.49 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 103' ' ' TRP . . . . . 0.757 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 20.9 m95 -95.16 138.68 32.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.404 0.621 . . . . 0.0 110.785 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . 0.477 HD21 ' HG2' ' B' ' 123' ' ' GLN . 62.8 t-20 -132.66 107.19 8.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.78 -1.1 . . . . 0.0 113.567 -177.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 105' ' ' GLU . . . . . 0.455 ' HB2' HD11 ' B' ' 126' ' ' ILE . 81.7 tt0 -76.14 123.7 26.25 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.413 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 39.0 tp -111.39 125.59 54.03 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.989 0.423 . . . . 0.0 112.012 -177.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 107' ' ' ASN . . . . . 0.926 ' OD1' HG23 ' B' ' 89' ' ' THR . 98.3 m-20 -119.08 128.6 54.48 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 96.5 mt -123.61 133.06 70.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -142.85 122.96 7.95 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -69.89 152.29 68.61 Favored 'Trans proline' 0 N--CA 1.499 1.85 0 C-N-CA 122.381 2.054 . . . . 0.0 112.642 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . 0.478 ' HB2' ' HB2' ' B' ' 118' ' ' TYR . 67.3 mtt -130.22 141.85 50.61 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -113.34 108.43 17.23 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . 0.467 HG12 ' NZ ' ' A' ' 18' ' ' LYS . 96.7 mt -134.52 127.93 50.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 118.279 0.491 . . . . 0.0 112.04 177.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 52.49 38.33 25.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.93 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 60.09 37.07 21.21 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.441 -178.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -132.41 153.1 51.15 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 117' ' ' THR . . . . . 0.455 HG23 ' CG ' ' B' ' 32' ' ' PRO . 9.7 t -104.95 151.85 23.4 Favored 'General case' 0 C--O 1.214 -0.766 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -178.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 118' ' ' TYR . . . . . 0.478 ' HB2' ' HB2' ' B' ' 111' ' ' MET . 96.2 m-85 -149.29 147.03 27.88 Favored 'General case' 0 C--O 1.239 0.541 0 O-C-N 121.066 -1.021 . . . . 0.0 110.889 -177.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 119' ' ' PHE . . . . . 0.474 ' O ' ' OG1' ' B' ' 30' ' ' THR . 90.9 m-85 -123.03 139.25 54.28 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 123.523 0.514 . . . . 0.0 110.846 -176.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -128.0 133.63 66.83 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.03 122.1 6.79 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 122' ' ' ILE . . . . . 0.468 ' HB ' ' HB2' ' B' ' 107' ' ' ASN . 91.2 mt -111.33 127.22 68.62 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.44 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 123' ' ' GLN . . . . . 0.541 ' HB2' ' HA3' ' B' ' 26' ' ' GLY . 17.0 mp0 -117.97 118.96 33.39 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -118.09 121.16 39.87 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' B' ' 127' ' ' THR . 68.0 t0 -69.36 133.56 47.97 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.043 -0.981 . . . . 0.0 112.261 -178.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.492 ' O ' ' HG3' ' B' ' 130' ' ' LYS . 3.2 mp -107.24 17.89 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.77 0 CA-C-O 122.397 1.094 . . . . 0.0 108.918 177.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 127' ' ' THR . . . . . 0.552 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 97.0 m -63.76 -44.21 94.13 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 113.59 -1.641 . . . . 0.0 112.403 175.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 59.2 tptt -60.91 -45.66 93.74 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -178.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 129' ' ' GLN . . . . . 0.444 ' OE1' HG23 ' B' ' 126' ' ' ILE . 88.4 mt-30 -63.34 -35.17 79.5 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.687 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 130' ' ' LYS . . . . . 0.757 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 98.7 mttt -63.1 -41.41 99.38 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 113.253 -1.794 . . . . 0.0 110.691 174.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.67 -42.1 95.62 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 132' ' ' TYR . . . . . 0.667 ' CE2' HD11 ' B' ' 136' ' ' LEU . 87.9 t80 -59.92 -44.4 94.34 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 121.878 -0.514 . . . . 0.0 111.388 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' B' ' 137' ' ' GLU . 97.4 mt-10 -64.94 -36.53 84.68 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.724 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 134' ' ' LYS . . . . . 0.435 ' HG3' ' O ' ' B' ' 130' ' ' LYS . 98.8 mttt -63.11 -39.31 94.33 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.756 178.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 54.4 tp -62.78 -41.25 99.16 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.401 0.62 . . . . 0.0 109.83 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 136' ' ' LEU . . . . . 0.667 HD11 ' CE2' ' B' ' 132' ' ' TYR . 87.0 mt -63.34 -41.48 98.88 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.494 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 137' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' B' ' 133' ' ' GLU . 97.2 mt-10 -64.61 -37.98 89.43 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.511 -178.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.58 -43.68 96.26 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.824 176.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 61.4 m -60.96 -44.41 97.34 Favored 'General case' 0 C--N 1.344 0.352 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' B' ' 144' ' ' THR . 84.5 mt -61.64 -40.36 94.6 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -177.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 99.3 m -61.9 -45.13 95.09 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.728 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -65.97 -42.33 90.0 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 93.9 mt -63.81 -43.2 97.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 114.515 -1.22 . . . . 0.0 110.493 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 144' ' ' THR . . . . . 0.495 ' N ' ' O ' ' B' ' 140' ' ' LEU . 99.8 m -61.7 -45.76 92.6 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.42 -40.5 97.35 Favored 'General case' 0 C--O 1.228 -0.071 0 C-N-CA 119.071 -1.052 . . . . 0.0 109.161 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 83.4 mt -64.38 -40.96 96.84 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 147' ' ' SER . . . . . 0.617 ' O ' ' N ' ' B' ' 149' ' ' PRO . 78.1 p -61.86 -41.44 97.85 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 148' ' ' THR . . . . . 0.504 ' C ' ' O ' ' B' ' 147' ' ' SER . 8.9 m -27.06 85.66 0.04 OUTLIER Pre-proline 0 N--CA 1.473 0.716 0 O-C-N 124.035 0.834 . . . . 0.0 109.999 177.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 149' ' ' PRO . . . . . 0.617 ' N ' ' O ' ' B' ' 147' ' ' SER . 24.3 Cg_exo -61.27 146.25 97.58 Favored 'Trans proline' 0 C--N 1.299 -2.036 0 C-N-CA 122.008 1.805 . . . . 0.0 115.211 -177.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 9.5 tp -127.91 123.36 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 174.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 29.9 t -152.78 96.71 2.93 Favored Pre-proline 0 C--N 1.304 -1.39 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.127 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -63.43 132.34 35.45 Favored 'Trans proline' 0 N--CA 1.486 1.062 0 CA-C-N 119.626 0.902 . . . . 0.0 109.776 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 153' ' ' ILE . . . . . 0.663 ' O ' ' HD2' ' B' ' 154' ' ' ARG . 45.8 mm -68.97 -44.33 81.48 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.437 0 C-N-CA 119.738 -0.785 . . . . 0.0 110.88 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 154' ' ' ARG . . . . . 0.663 ' HD2' ' O ' ' B' ' 153' ' ' ILE . 1.0 OUTLIER -154.96 -157.18 0.73 Allowed 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 178.678 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -86.35 110.55 19.76 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.02 -20.36 50.89 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 -177.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 88.1 mt -108.6 123.89 64.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.76 0.314 . . . . 0.0 111.738 -176.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 158' ' ' SER . . . . . 0.549 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 59.6 m -134.45 150.29 50.82 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.857 178.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -130.89 146.23 52.25 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 38.4 tp -139.61 74.58 33.28 Favored Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 161' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -69.43 148.09 66.44 Favored 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 122.754 2.303 . . . . 0.0 114.318 -177.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 92.9 mt -114.1 134.36 54.93 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 52.2 t -129.01 132.64 67.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 113.5 168.32 16.77 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 120.419 -0.896 . . . . 0.0 111.441 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 165' ' ' ASN . . . . . 0.705 ' O ' ' CZ ' ' B' ' 170' ' ' ARG . 56.2 t30 -89.09 107.79 19.24 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -179.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 166' ' ' LEU . . . . . 0.518 HD21 ' CZ ' ' B' ' 171' ' ' PHE . 43.5 tp -66.34 104.34 1.2 Allowed 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -174.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 167' ' ' THR . . . . . 0.629 HG23 ' NE ' ' B' ' 170' ' ' ARG . 10.5 p -84.51 171.16 12.76 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 113.733 -1.576 . . . . 0.0 111.091 177.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -67.18 -38.46 85.42 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.766 177.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -66.55 -40.13 88.9 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-O 123.122 1.439 . . . . 0.0 111.773 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 170' ' ' ARG . . . . . 0.705 ' CZ ' ' O ' ' B' ' 165' ' ' ASN . 88.2 mtm180 -63.31 -36.83 85.0 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 112.241 -2.254 . . . . 0.0 111.109 178.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 171' ' ' PHE . . . . . 0.518 ' CZ ' HD21 ' B' ' 166' ' ' LEU . 0.4 OUTLIER -53.92 -25.16 19.01 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 113.607 0.965 . . . . 0.0 113.607 -178.472 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 172' ' ' ASN . . . . . 0.645 ' O ' HG22 ' B' ' 175' ' ' VAL . 90.1 m-20 -62.73 -40.2 96.47 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.872 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 49.3 m -60.41 -41.09 93.18 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.23 0.538 . . . . 0.0 110.802 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 66.5 mt -63.56 -43.95 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 175' ' ' VAL . . . . . 0.645 HG22 ' O ' ' B' ' 172' ' ' ASN . 23.8 m -62.6 -39.86 86.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 176' ' ' CYS . . . . . 0.438 ' N ' HG23 ' B' ' 175' ' ' VAL . 98.7 m -62.49 -35.09 78.25 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.241 177.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 177' ' ' THR . . . . . 0.613 ' O ' HG13 ' B' ' 181' ' ' ILE . 25.0 m -61.41 -19.81 62.35 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.243 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 178' ' ' LEU . . . . . 0.755 ' CD2' HD21 ' B' ' 211' ' ' LEU . 93.3 mt -61.15 -39.6 90.71 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.397 -178.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 19.6 m -61.5 -44.22 97.46 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 176.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 180' ' ' ASN . . . . . 0.597 ' O ' ' OG ' ' B' ' 183' ' ' SER . 92.0 m-20 -61.52 -40.05 93.23 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.296 0.57 . . . . 0.0 110.29 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.613 HG13 ' O ' ' B' ' 177' ' ' THR . 70.4 mt -56.56 -35.94 46.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 O-C-N 121.978 -0.452 . . . . 0.0 110.582 -178.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 182' ' ' LEU . . . . . 0.473 HD21 HD21 ' B' ' 214' ' ' LEU . 84.1 mt -61.82 -41.79 98.22 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 119.839 -0.744 . . . . 0.0 109.187 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . 0.597 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.2 p -62.97 -33.08 74.63 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 121.897 -0.502 . . . . 0.0 110.779 177.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 54.3 p -85.88 16.15 4.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.823 0.344 . . . . 0.0 111.753 -177.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 78.5 p -60.64 -16.68 41.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.782 -176.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -61.5 -40.5 94.83 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.882 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 187' ' ' ASP . . . . . 0.549 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.8 m-20 -70.44 115.27 9.42 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.528 0.68 . . . . 0.0 110.401 -178.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.88 -42.29 99.71 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 114.895 -1.048 . . . . 0.0 113.305 -177.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -111.46 131.67 55.05 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.674 -0.411 . . . . 0.0 111.135 -177.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 190' ' ' LEU . . . . . . . . . . . . . 42.1 tp -123.8 118.81 28.01 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.056 177.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 84.8 mt -107.87 126.66 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.049 -177.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 50.0 mm -115.25 117.62 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 193' ' ' ASP . . . . . 0.565 ' CG ' ' HG ' ' B' ' 195' ' ' SER . 42.6 t0 -87.64 112.19 22.07 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.938 -177.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 194' ' ' LEU . . . . . . . . . . . . . 96.1 mt -92.5 -2.78 55.98 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 176.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 195' ' ' SER . . . . . 0.565 ' HG ' ' CG ' ' B' ' 193' ' ' ASP . 78.2 p -61.14 -38.27 85.8 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.819 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.74 -34.1 87.48 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 197' ' ' LEU . . . . . 0.984 ' CD2' ' H ' ' B' ' 199' ' ' GLN . 4.9 tt -77.2 132.73 38.9 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 198' ' ' ALA . . . . . 0.972 ' N ' HD23 ' B' ' 197' ' ' LEU . . . -63.78 -41.8 97.88 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.854 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 199' ' ' GLN . . . . . 0.984 ' H ' ' CD2' ' B' ' 197' ' ' LEU . 58.9 tt0 -138.08 163.43 31.65 Favored 'General case' 0 C--O 1.203 -1.345 0 CA-C-O 122.096 0.951 . . . . 0.0 113.008 -178.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 200' ' ' VAL . . . . . 0.466 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 50.3 t -121.46 132.77 69.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 O-C-N 120.229 -1.544 . . . . 0.0 109.349 178.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -94.06 148.65 21.96 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.918 0.866 . . . . 0.0 111.359 -177.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -59.9 -33.12 71.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.857 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -63.87 -33.58 76.01 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.4 m -61.09 -44.45 97.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.096 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 205' ' ' ALA . . . . . 0.641 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -57.95 -31.66 67.07 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.835 -178.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -65.43 -38.16 89.06 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.216 0.531 . . . . 0.0 109.884 176.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -66.32 -38.96 88.89 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.586 178.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.7 -43.13 97.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.589 0.709 . . . . 0.0 110.463 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 209' ' ' PHE . . . . . 0.641 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 65.3 m-85 -61.93 -43.34 99.04 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 113.828 -1.533 . . . . 0.0 112.384 178.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.92 -42.4 97.39 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.836 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 211' ' ' LEU . . . . . 0.755 HD21 ' CD2' ' B' ' 178' ' ' LEU . 37.7 mt -62.42 -42.49 99.48 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.078 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 78.2 p -62.8 -36.13 82.12 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.836 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 213' ' ' HIS . . . . . 0.407 ' CE1' HD11 ' B' ' 217' ' ' LEU . 58.7 t-80 -67.08 -46.68 73.53 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 115.296 -0.866 . . . . 0.0 112.261 178.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.473 HD21 HD21 ' B' ' 182' ' ' LEU . 51.1 tp -63.79 -43.21 97.01 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 121.776 0.798 . . . . 0.0 109.487 178.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 215' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' B' ' 211' ' ' LEU . 90.9 mt -62.87 -43.89 97.59 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 113.607 -1.633 . . . . 0.0 111.253 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.55 -39.12 89.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.917 -177.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . 0.407 HD11 ' CE1' ' B' ' 213' ' ' HIS . 85.7 mt -63.02 -42.79 99.88 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.314 176.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 218' ' ' THR . . . . . 0.403 HG23 ' O ' ' B' ' 214' ' ' LEU . 66.7 p -74.24 -16.54 60.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.806 -178.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 80.45 61.21 2.23 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 107.307 -2.317 . . . . 0.0 107.307 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 220' ' ' THR . . . . . . . . . . . . . 94.9 m -141.3 106.84 5.06 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 174.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -63.57 140.2 58.85 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.689 -174.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 44.5 tp -116.03 120.89 40.56 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.557 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 3.0 mp -109.97 129.57 64.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.758 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 224' ' ' ILE . . . . . 0.489 ' CG2' HD11 ' B' ' 227' ' ' ILE . 50.8 mm -111.0 127.11 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 43.5 p -134.34 157.76 45.54 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.924 0.869 . . . . 0.0 112.688 -178.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 90.23 18.84 48.35 Favored Glycine 0 CA--C 1.5 -0.871 0 CA-C-N 113.815 -1.539 . . . . 0.0 111.182 -177.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 227' ' ' ILE . . . . . 0.614 HD12 HG23 ' B' ' 247' ' ' THR . 95.0 mt -85.29 125.44 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 118.292 1.046 . . . . 0.0 111.556 -178.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 49.5 tttt -62.87 139.97 97.36 Favored Pre-proline 0 C--N 1.313 -0.98 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.08 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.1 -37.93 93.78 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 121.373 1.382 . . . . 0.0 112.799 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -64.7 -41.67 95.84 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -178.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 50.7 tp -61.61 -41.87 98.07 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.014 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.34 -36.65 84.82 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.742 0.306 . . . . 0.0 111.123 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 94.3 mtp -63.73 -40.98 98.07 Favored 'General case' 0 C--O 1.25 1.094 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.793 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.51 -44.4 96.47 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 122.291 1.043 . . . . 0.0 109.332 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 35.6 mmt -64.25 -35.64 81.48 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.634 -1.167 . . . . 0.0 111.716 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -61.39 -40.33 93.98 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -177.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.06 -43.2 99.26 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.202 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 55.8 tp -61.58 -44.92 96.13 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 120.257 -0.577 . . . . 0.0 112.33 -178.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 239' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' B' ' 240' ' ' ALA . 66.8 t0 -158.09 134.69 9.65 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.355 -0.538 . . . . 0.0 112.141 -179.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 240' ' ' ALA . . . . . 0.421 ' N ' ' OD1' ' B' ' 239' ' ' ASP . . . -61.76 -46.69 88.49 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 176.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 241' ' ' ASN . . . . . 0.495 ' O ' ' HB2' ' B' ' 244' ' ' SER . 91.9 m-20 -43.21 -21.85 0.03 OUTLIER 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.361 -176.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 242' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -61.29 -45.36 94.8 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.523 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 243' ' ' SER . . . . . . . . . . . . . 77.4 p -58.18 -44.62 88.12 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 244' ' ' SER . . . . . 0.495 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 19.7 m -32.59 -37.82 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 94.9 mt -83.39 134.47 34.89 Favored 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.27 175.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -63.61 136.56 57.61 Favored 'General case' 0 C--O 1.241 0.655 0 O-C-N 121.368 -0.833 . . . . 0.0 111.645 -176.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 247' ' ' THR . . . . . 0.614 HG23 HD12 ' B' ' 227' ' ' ILE . 98.3 m -125.43 127.54 46.7 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.537 -1.211 . . . . 0.0 112.083 178.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 248' ' ' TYR . . . . . 0.45 ' CG ' ' HB2' ' B' ' 254' ' ' ALA . 96.9 m-85 -112.44 143.42 43.6 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 249' ' ' SER . . . . . 0.599 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 78.3 p -62.85 -33.31 74.99 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.144 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 250' ' ' ASN . . . . . 0.599 ' OD1' ' O ' ' B' ' 249' ' ' SER . 98.9 m-20 -148.43 160.19 43.29 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.189 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 73.6 t -64.66 -44.55 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.077 177.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 252' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.96 -46.09 92.1 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . 0.574 ' O ' HG22 ' B' ' 257' ' ' VAL . 90.9 m-20 -60.67 -43.37 97.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.188 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 254' ' ' ALA . . . . . 0.45 ' HB2' ' CG ' ' B' ' 248' ' ' TYR . . . -65.42 -40.47 93.4 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 120.091 -0.644 . . . . 0.0 111.332 178.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 255' ' ' VAL . . . . . 0.404 ' O ' ' HD2' ' B' ' 259' ' ' PRO . 62.2 t -64.82 -45.52 94.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.656 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 256' ' ' LYS . . . . . 0.422 ' HE3' ' ND2' ' A' ' 155' ' ' ASN . 88.7 tttt -63.36 -48.65 77.06 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.485 -178.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 257' ' ' VAL . . . . . 0.574 HG22 ' O ' ' B' ' 253' ' ' ASP . 33.0 m -64.69 -41.13 91.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.623 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 258' ' ' LEU . . . . . 0.505 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 0.9 OUTLIER -33.09 -72.87 0.06 OUTLIER Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.947 -177.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 259' ' ' PRO . . . . . 0.595 ' O ' HG13 ' B' ' 260' ' ' ILE . 38.4 Cg_endo -62.54 141.78 87.64 Favored 'Trans proline' 0 N--CA 1.506 2.236 0 C-N-CA 121.855 1.703 . . . . 0.0 111.243 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 260' ' ' ILE . . . . . 0.595 HG13 ' O ' ' B' ' 259' ' ' PRO . 96.6 mt -160.61 -18.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 77.2 mtm . . . . . 0 C--O 1.219 -0.547 0 CA-C-O 117.919 -1.038 . . . . 0.0 111.786 -179.738 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.234 0 N-CA-C 109.054 -1.619 . . . . 0.0 109.054 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.54 165.47 35.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 119.173 -0.442 . . . . 0.0 110.111 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.9 p -70.9 -16.54 62.69 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 121.5 0.667 . . . . 0.0 111.356 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -72.1 -65.71 0.74 Allowed 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 114.275 -1.329 . . . . 0.0 112.151 174.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -67.07 -38.21 85.36 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.538 ' O ' ' NZ ' ' B' ' 17' ' ' LYS . 60.9 m -59.4 -42.45 91.76 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.152 -177.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.521 ' HB3' ' O ' ' A' ' 6' ' ' SER . 44.6 t80 84.6 84.04 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 O-C-N 123.69 0.618 . . . . 0.0 111.801 176.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.623 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -58.99 -141.72 0.01 OUTLIER Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -177.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.623 ' HB ' ' O ' ' A' ' 8' ' ' GLY . 86.3 mt 84.64 109.92 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.626 0 C-N-CA 122.39 0.276 . . . . 0.0 110.682 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.27 -22.37 72.23 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.49 1.46 . . . . 0.0 111.994 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.41 -37.29 94.27 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.844 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.1 -39.9 93.79 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.51 0.671 . . . . 0.0 109.847 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 52.8 tp -63.23 -41.19 99.06 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.947 -0.569 . . . . 0.0 112.215 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -63.03 -41.33 99.49 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.1 t -60.36 -44.06 95.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 O-C-N 122.339 -0.226 . . . . 0.0 110.705 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 92.3 mt -62.58 -43.48 98.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.452 -177.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.43 ' NZ ' ' HA ' ' B' ' 6' ' ' SER . 98.9 mttt -62.53 -45.38 93.25 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 119.458 -0.897 . . . . 0.0 111.879 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.556 ' HZ1' HG12 ' B' ' 113' ' ' ILE . 98.4 mttt -60.44 -39.53 87.84 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 118.555 -1.258 . . . . 0.0 109.051 -176.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.85 -41.56 91.67 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.059 -0.656 . . . . 0.0 110.262 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.6 mt -63.07 -41.24 99.39 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.61 -38.79 92.45 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.383 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 62.6 m170 -58.69 -39.98 82.27 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 122.2 -0.312 . . . . 0.0 111.243 -178.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.9 p -114.61 129.3 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.496 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 34.6 ptt180 -71.11 108.71 4.77 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 122.098 0.951 . . . . 0.0 112.081 -177.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.0 p -140.07 142.59 31.49 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 178.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.416 ' HA3' ' HB2' ' A' ' 123' ' ' GLN . . . -97.84 93.48 1.4 Allowed Glycine 0 C--N 1.312 -0.783 0 C-N-CA 120.776 -0.726 . . . . 0.0 113.058 -179.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.9 t -124.41 130.0 73.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 175.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.3 m -136.34 159.22 38.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.6 mt -121.28 128.99 76.05 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.402 ' OG1' ' HB2' ' A' ' 119' ' ' PHE . 15.4 p -103.65 167.68 9.64 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.541 ' C ' ' OD1' ' A' ' 37' ' ' ASN . 45.6 t0 -133.37 101.23 13.45 Favored Pre-proline 0 C--N 1.32 -0.684 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.659 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.443 ' HG3' HG23 ' A' ' 117' ' ' THR . 34.8 Cg_endo -63.04 -22.58 73.66 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.411 1.407 . . . . 0.0 111.534 -179.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.4 -35.73 80.11 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.774 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 91.9 mt -85.85 161.0 19.29 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.656 177.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.744 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 43.1 tt0 -59.67 135.42 57.67 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -177.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.537 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 60.2 t0 60.65 22.37 12.23 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.877 178.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.541 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 22.5 t-20 40.9 67.82 2.72 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.877 -178.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.744 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 91.3 Cg_endo -71.23 156.88 58.47 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 C-N-CA 123.816 3.011 . . . . 0.0 112.493 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.4 mt -90.08 125.34 42.98 Favored 'Isoleucine or valine' 0 C--O 1.245 0.862 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.441 HG23 ' N ' ' A' ' 41' ' ' TYR . 35.3 m -105.54 -43.57 7.63 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 O-C-N 123.585 0.553 . . . . 0.0 112.102 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.441 ' N ' HG23 ' A' ' 40' ' ' VAL . 46.8 t80 -95.28 124.58 39.39 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.736 -178.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.9 p -142.58 139.55 28.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.347 177.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.593 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 56.7 p30 -96.73 166.6 11.57 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.526 ' OE1' ' HA ' ' A' ' 44' ' ' GLN . 12.6 mm100 -67.19 -37.98 84.6 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 120.961 0.41 . . . . 0.0 111.855 177.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.03 -27.51 64.9 Favored Glycine 0 C--N 1.331 0.283 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.683 ' CD2' HD13 ' A' ' 57' ' ' ILE . 71.0 t80 -59.13 -48.43 81.64 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.669 HG13 ' O ' ' A' ' 52' ' ' TYR . 54.9 t -59.58 -44.9 94.26 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.585 0 O-C-N 121.297 -0.877 . . . . 0.0 111.442 -173.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -63.64 -37.61 87.98 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 120.415 -0.514 . . . . 0.0 112.027 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.408 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 58.8 ttm -67.3 -43.59 81.35 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 175.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 39.8 p -90.06 -23.79 21.34 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.155 0.502 . . . . 0.0 111.634 -178.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.78 20.44 70.9 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 -179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.669 ' O ' HG13 ' A' ' 47' ' ' VAL . 90.4 m-85 -115.02 141.89 47.38 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.003 0.521 . . . . 0.0 111.539 178.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -65.96 149.52 50.1 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.848 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.441 HG22 ' H ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -65.7 -33.09 75.07 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -179.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.27 -43.71 85.67 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 119.535 -0.866 . . . . 0.0 111.286 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -64.76 -44.67 89.32 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.393 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.683 HD13 ' CD2' ' A' ' 46' ' ' PHE . 93.5 mt -61.81 -49.98 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -174.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 84.1 mt -55.94 148.67 16.73 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 176.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.01 -4.54 61.53 Favored Glycine 0 CA--C 1.52 0.377 0 CA-C-O 119.379 -0.678 . . . . 0.0 113.305 177.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -136.98 149.37 47.48 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.041 1.42 . . . . 0.0 111.711 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.57 ' C ' ' H ' ' A' ' 63' ' ' ARG . 25.8 t-20 -80.89 152.09 28.29 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.189 0.519 . . . . 0.0 110.687 -178.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 82.0 m -62.2 15.12 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.291 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.57 ' H ' ' C ' ' A' ' 61' ' ' ASN . 34.4 ptt-85 -61.93 -41.6 98.14 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.979 -0.45 . . . . 0.0 111.376 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -56.17 -21.84 25.3 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 93.0 mt -67.25 -35.64 79.98 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.757 0.789 . . . . 0.0 113.063 177.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -63.05 142.87 58.22 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.225 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.499 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -152.8 -148.79 4.97 Favored Glycine 0 CA--C 1.54 1.638 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.685 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.85 -40.69 98.23 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -177.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.452 ' O ' ' OE1' ' A' ' 93' ' ' GLN . 8.8 m-70 -76.5 -9.04 58.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.715 0.293 . . . . 0.0 111.101 -178.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.499 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 30.6 m -62.87 129.94 42.62 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.204 -0.598 . . . . 0.0 109.786 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -87.7 110.52 35.33 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.997 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.29 -32.16 92.92 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.993 1.795 . . . . 0.0 113.117 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.76 -39.6 94.67 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.979 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.49 ' OE1' ' HB ' ' A' ' 90' ' ' VAL . 79.4 mm-40 -65.09 -43.85 90.79 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.7 t -59.88 -43.94 93.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 114.273 -1.331 . . . . 0.0 107.817 -176.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.83 -37.8 88.73 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.724 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -63.26 -39.8 95.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.235 0.541 . . . . 0.0 110.295 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 95.1 mt -63.85 -44.07 98.02 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.996 178.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -62.83 -43.07 99.79 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 113.655 -1.611 . . . . 0.0 108.371 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 98.5 m -61.34 -48.76 79.82 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.57 -41.87 91.16 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.589 -172.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 90.6 mt -63.24 -40.08 96.43 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 118.831 0.741 . . . . 0.0 111.414 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 66.9 tp60 -64.49 -32.94 74.78 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -90.3 -2.36 58.0 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.533 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.2 tttt 49.35 39.17 15.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.955 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -121.89 144.06 40.08 Favored Pre-proline 0 CA--C 1.533 0.321 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.434 ' HB3' ' OD1' ' A' ' 109' ' ' ASP . 24.7 Cg_exo -61.46 143.32 97.33 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 121.402 1.402 . . . . 0.0 113.236 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.8 p -139.79 142.45 32.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.819 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.925 HG23 ' OD1' ' A' ' 107' ' ' ASN . 99.0 m -126.33 121.25 32.04 Favored 'General case' 0 C--N 1.344 0.336 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 175.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.49 ' HB ' ' OE1' ' A' ' 74' ' ' GLU . 29.9 m -138.85 158.72 30.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.323 177.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -102.87 133.58 47.72 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 176.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.424 HG23 ' O ' ' A' ' 92' ' ' ILE . 18.0 tt -140.41 129.97 27.36 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.213 0 CA-C-N 121.067 1.758 . . . . 0.0 112.438 177.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.452 ' OE1' ' O ' ' A' ' 69' ' ' HIS . 86.1 mt-30 -63.37 132.19 50.69 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.75 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -131.9 155.92 47.03 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.542 -178.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -114.84 134.52 55.07 Favored 'General case' 0 C--N 1.346 0.444 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.458 ' HG3' ' CE1' ' A' ' 102' ' ' PHE . 99.0 mttt -83.61 -174.18 5.14 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.139 0.495 . . . . 0.0 111.532 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -62.44 -41.52 98.79 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.041 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 40.9 p-10 -83.95 5.17 26.52 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 111.892 0.331 . . . . 0.0 111.892 -177.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.01 -1.77 85.12 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.004 176.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 25.0 m -60.39 137.46 58.14 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 178.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.66 ' SD ' ' C ' ' A' ' 101' ' ' MET . 14.7 tmm? -104.44 127.83 52.22 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.628 0.252 . . . . 0.0 110.711 178.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.458 ' CE1' ' HG3' ' A' ' 96' ' ' LYS . 52.6 p90 -140.7 157.01 46.06 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.244 -0.582 . . . . 0.0 109.803 -177.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.786 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 20.8 m95 -88.12 141.96 28.15 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.54 HD21 ' HG2' ' A' ' 123' ' ' GLN . 56.9 t-20 -137.38 102.92 4.93 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -177.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 80.8 tt0 -67.75 136.64 54.54 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -176.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 41.8 tp -121.74 124.22 43.71 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.925 ' OD1' HG23 ' A' ' 89' ' ' THR . 98.0 m-20 -122.43 124.49 43.76 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.671 177.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 87' ' ' PRO . 96.4 mt -120.57 129.28 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 O-C-N 123.436 0.46 . . . . 0.0 111.597 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.434 ' OD1' ' HB3' ' A' ' 87' ' ' PRO . 2.4 m-20 -137.81 121.6 11.68 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 110.581 -0.155 . . . . 0.0 110.581 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -69.6 150.86 69.75 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 122.432 2.088 . . . . 0.0 112.713 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.68 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 66.6 mtt -121.94 153.12 38.91 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -127.81 94.19 3.88 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 176.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.443 ' CD1' HG22 ' B' ' 15' ' ' VAL . 96.5 mt -119.05 130.97 73.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.876 -178.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 51.95 36.51 18.62 Favored 'General case' 0 CA--C 1.517 -0.292 0 O-C-N 121.406 -0.809 . . . . 0.0 111.468 176.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 59.42 30.31 19.98 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.758 -178.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -127.47 146.12 50.6 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 177.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.724 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 5.0 t -82.04 -173.2 4.36 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.578 -0.701 . . . . 0.0 109.77 -178.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.724 ' CD2' ' O ' ' A' ' 117' ' ' THR . 64.0 m-85 -171.11 157.44 5.16 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 173.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.402 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 97.6 m-85 -131.32 146.21 52.19 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 174.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.5 p -133.15 135.68 56.29 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 177.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -109.17 127.41 8.51 Favored Glycine 0 CA--C 1.501 -0.795 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 178.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 96.2 mt -118.99 130.1 74.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.54 ' HG2' HD21 ' A' ' 104' ' ' ASN . 16.4 mp0 -120.39 117.74 28.53 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 123.563 0.539 . . . . 0.0 109.975 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -117.83 113.59 22.0 Favored 'General case' 0 C--O 1.248 0.995 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.032 -178.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 126' ' ' ILE . 68.1 t0 -64.02 132.41 50.51 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -174.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.52 HG22 ' O ' ' A' ' 126' ' ' ILE . 2.6 mp -97.5 2.58 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 113.765 -1.561 . . . . 0.0 110.398 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 19.3 m -60.61 -43.0 97.96 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.211 -0.931 . . . . 0.0 113.397 -178.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -59.76 -42.46 93.3 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -63.06 -39.05 93.59 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.723 177.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.786 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.7 mttt -62.41 -40.69 97.34 Favored 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 118.467 -1.293 . . . . 0.0 110.631 -178.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -62.53 -36.98 84.3 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -178.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.766 ' CE2' HD11 ' A' ' 136' ' ' LEU . 89.8 t80 -61.56 -45.96 91.93 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.597 176.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.62 -38.47 91.11 Favored 'General case' 0 C--O 1.225 -0.213 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.89 -40.91 97.07 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 51.5 tp -60.91 -43.6 98.33 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 -178.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.766 HD11 ' CE2' ' A' ' 132' ' ' TYR . 87.7 mt -62.7 -41.25 99.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.168 179.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.16 -41.1 99.19 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.766 -178.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -60.99 -41.84 97.27 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 -177.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 66.9 m -61.85 -41.0 97.29 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.661 176.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 144' ' ' THR . 90.2 mt -63.15 -41.9 99.35 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 92.8 m -61.86 -45.46 93.7 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.151 -178.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -65.41 -41.07 93.99 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 94.9 mt -64.55 -43.47 96.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 113.968 -1.469 . . . . 0.0 111.383 177.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.424 ' N ' ' O ' ' A' ' 140' ' ' LEU . 99.1 m -62.25 -46.08 90.42 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 120.432 -0.507 . . . . 0.0 112.167 -178.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.402 ' O ' ' HB ' ' A' ' 148' ' ' THR . . . -62.02 -41.28 97.92 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 118.789 -1.164 . . . . 0.0 108.931 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.3 mt -63.88 -42.62 97.44 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 177.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.681 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.0 p -60.56 -37.28 80.75 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -178.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.454 ' C ' ' O ' ' A' ' 147' ' ' SER . 55.5 m -31.14 83.91 0.03 OUTLIER Pre-proline 0 C--N 1.344 0.359 0 O-C-N 126.79 2.556 . . . . 0.0 106.211 -178.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.681 ' N ' ' O ' ' A' ' 147' ' ' SER . 21.7 Cg_exo -62.74 145.31 94.91 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 120.849 1.033 . . . . 0.0 114.604 -175.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.651 ' O ' HG23 ' A' ' 151' ' ' VAL . 8.7 tp -121.78 136.94 57.04 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.933 0 N-CA-C 102.891 -3.003 . . . . 0.0 102.891 176.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 150' ' ' ILE . 60.1 t -170.23 94.74 0.48 Allowed Pre-proline 0 N--CA 1.445 -0.685 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 177.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.421 ' HG3' ' HG3' ' B' ' 252' ' ' LYS . 46.2 Cg_endo -63.41 143.8 89.37 Favored 'Trans proline' 0 C--N 1.298 -2.092 0 N-CA-C 109.78 -0.892 . . . . 0.0 109.78 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.555 ' O ' HG11 ' B' ' 255' ' ' VAL . 44.2 mm -77.04 -60.27 2.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.03 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.68 ' NH2' ' HD3' ' B' ' 154' ' ' ARG . 1.6 mpt_? -140.41 -157.56 0.78 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.0 t-20 -86.45 105.23 16.62 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.804 0.812 . . . . 0.0 111.5 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.11 8.55 66.6 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 114.032 -1.44 . . . . 0.0 110.615 -177.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 97.1 mt -123.93 125.57 71.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 175.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.716 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 58.5 m -132.3 151.47 51.82 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.222 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -139.34 142.84 37.6 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.575 -0.703 . . . . 0.0 111.08 177.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 16.8 tp -133.96 80.83 53.45 Favored Pre-proline 0 N--CA 1.469 0.517 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.355 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -69.25 149.89 70.7 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.788 2.325 . . . . 0.0 112.938 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 88.7 mt -119.0 128.09 54.07 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.502 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 47.7 t -124.17 131.27 73.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 116.78 169.62 15.22 Favored Glycine 0 N--CA 1.48 1.62 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.174 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.874 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 56.4 t30 -87.08 113.28 22.69 Favored 'General case' 0 C--O 1.221 -0.431 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -178.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.538 HD21 ' CZ ' ' A' ' 171' ' ' PHE . 46.7 tp -72.39 104.19 3.68 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -178.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.723 HG23 ' NE ' ' A' ' 170' ' ' ARG . 11.4 p -85.63 167.42 15.36 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.571 178.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.49 -34.85 79.24 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.937 0.398 . . . . 0.0 111.6 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.2 -41.97 94.01 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.757 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.874 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 88.0 mtm180 -64.08 -33.18 75.18 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.993 0.917 . . . . 0.0 112.368 178.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.538 ' CZ ' HD21 ' A' ' 166' ' ' LEU . 0.5 OUTLIER -53.68 -28.24 32.39 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 118.887 -0.578 . . . . 0.0 112.472 -178.766 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.592 ' O ' HG22 ' A' ' 175' ' ' VAL . 91.1 m-20 -61.0 -40.64 94.29 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 118.942 -1.103 . . . . 0.0 109.774 -178.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 54.7 m -59.47 -41.25 89.33 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.604 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 66.9 mt -63.69 -44.35 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.592 HG22 ' O ' ' A' ' 172' ' ' ASN . 33.5 m -62.79 -40.39 88.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . 0.429 ' N ' HG23 ' A' ' 175' ' ' VAL . 99.3 m -62.77 -34.7 77.79 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.304 0.573 . . . . 0.0 110.34 178.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.509 ' O ' HG13 ' A' ' 181' ' ' ILE . 24.6 m -62.11 -19.49 63.06 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.197 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.59 ' CD2' HD21 ' A' ' 211' ' ' LEU . 90.5 mt -60.93 -41.17 95.66 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -177.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 18.3 m -59.48 -42.96 93.3 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . 0.628 ' O ' ' OG ' ' A' ' 183' ' ' SER . 91.0 m-20 -61.34 -36.63 80.72 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 122.668 0.387 . . . . 0.0 110.837 178.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.512 HD12 ' HA ' ' A' ' 178' ' ' LEU . 67.0 mt -59.02 -39.92 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 O-C-N 121.558 -0.714 . . . . 0.0 109.086 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.473 HD21 HD21 ' A' ' 214' ' ' LEU . 86.3 mt -60.71 -40.61 92.88 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -177.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.628 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 77.9 p -61.65 -33.49 74.05 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.501 176.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.417 ' OG1' ' HA ' ' A' ' 181' ' ' ILE . 66.1 p -89.69 23.37 2.69 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.581 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 78.3 p -63.46 -19.93 65.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.188 0.518 . . . . 0.0 110.752 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.49 -37.29 83.14 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.916 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.716 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 98.2 m-20 -74.18 112.93 10.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.563 0.696 . . . . 0.0 110.839 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -62.74 -42.42 99.66 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 114.967 -1.015 . . . . 0.0 113.063 -177.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -110.48 130.91 55.45 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.562 -178.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 39.2 tp -120.21 128.61 53.53 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 177.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 96.7 mt -116.1 127.53 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-N 118.59 0.632 . . . . 0.0 109.689 177.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.2 mm -113.36 126.93 70.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 178.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . 0.43 ' CG ' ' HG ' ' A' ' 195' ' ' SER . 41.3 t0 -94.67 117.89 30.84 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-O 121.379 0.609 . . . . 0.0 110.667 176.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 97.9 mt -98.59 -4.81 33.23 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.882 175.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . 0.43 ' HG ' ' CG ' ' A' ' 193' ' ' ASP . 78.2 p -62.31 -33.31 74.42 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.81 -42.68 99.77 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 118.553 -1.784 . . . . 0.0 109.081 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.958 ' CD2' ' O ' ' A' ' 199' ' ' GLN . 5.0 tt -70.59 128.69 36.98 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 112.891 -1.655 . . . . 0.0 107.516 -174.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.897 ' N ' HD23 ' A' ' 197' ' ' LEU . . . -60.26 -45.3 93.77 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.745 -176.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.958 ' O ' ' CD2' ' A' ' 197' ' ' LEU . 58.8 tt0 -138.81 157.31 46.31 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 114.466 -1.243 . . . . 0.0 112.847 -174.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.482 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 47.4 t -118.23 131.71 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -87.66 156.01 19.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.543 -178.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -64.35 -38.89 92.65 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.211 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -58.68 -32.35 69.05 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -178.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.6 m -61.21 -42.32 98.38 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.481 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.476 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -57.52 -39.01 75.6 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -177.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -61.64 -37.11 82.79 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.54 -39.12 91.39 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.892 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 94.8 mt -63.18 -44.23 99.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -178.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . 0.476 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 71.8 m-85 -62.21 -43.58 98.5 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.743 -178.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.34 -42.04 99.07 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 119.316 -0.954 . . . . 0.0 109.231 -178.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.59 HD21 ' CD2' ' A' ' 178' ' ' LEU . 38.2 mt -62.08 -41.81 98.55 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 77.9 p -61.57 -41.14 96.96 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.07 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -64.49 -45.86 85.49 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.378 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.473 HD21 HD21 ' A' ' 182' ' ' LEU . 48.6 tp -62.31 -46.14 90.06 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 119.1 -1.04 . . . . 0.0 108.492 178.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 211' ' ' LEU . 91.2 mt -62.2 -40.8 97.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.504 -177.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.27 -44.41 95.36 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.44 -178.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 87.5 mt -61.65 -39.68 92.23 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 69.8 p -75.77 -10.79 59.73 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.244 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.07 33.59 26.1 Favored Glycine 0 C--N 1.343 0.925 0 C-N-CA 120.501 -0.857 . . . . 0.0 113.205 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 97.3 m -119.36 113.27 20.56 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.073 1.436 . . . . 0.0 111.512 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -64.98 138.03 58.11 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.752 178.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 45.6 tp -113.8 130.82 56.41 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 3.0 mp -117.85 133.33 64.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.539 ' CG2' HD11 ' A' ' 227' ' ' ILE . 49.3 mm -115.48 131.81 66.73 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.416 HG22 ' HB2' ' A' ' 248' ' ' TYR . 44.4 p -133.72 166.13 23.34 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 120.531 -0.467 . . . . 0.0 111.997 -178.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 80.04 19.76 69.19 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.715 HD12 HG23 ' A' ' 247' ' ' THR . 97.1 mt -81.9 128.45 38.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 114.059 -1.07 . . . . 0.0 108.506 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 58.6 tttt -75.68 140.72 71.61 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.6 -39.22 89.63 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 121.069 1.179 . . . . 0.0 112.672 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -64.36 -39.67 94.35 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.686 0.755 . . . . 0.0 110.188 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 52.0 tp -63.91 -42.44 97.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.688 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.84 -37.9 89.1 Favored 'General case' 0 N--CA 1.461 0.103 0 O-C-N 121.952 -0.468 . . . . 0.0 110.973 -179.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 94.2 mtp -63.61 -40.89 98.05 Favored 'General case' 0 C--O 1.248 1.026 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.468 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.88 -38.62 91.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.437 177.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 35.0 mmt -65.59 -38.27 89.01 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.63 178.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -61.29 -41.82 97.61 Favored 'General case' 0 CA--C 1.515 -0.402 0 O-C-N 121.52 -0.738 . . . . 0.0 109.525 -177.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.16 -40.99 95.95 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.549 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 56.0 tp -63.52 -41.48 98.5 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 177.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -166.94 127.39 1.55 Allowed 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -60.45 -26.41 66.73 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.66 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.426 ' O ' ' HB2' ' A' ' 244' ' ' SER . 91.3 m-20 -61.39 -33.84 74.36 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.523 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -55.22 -44.27 75.25 Favored 'General case' 0 C--N 1.311 -1.088 0 O-C-N 121.551 -0.718 . . . . 0.0 109.422 -175.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 97.9 p -61.92 -20.12 63.44 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.865 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' A' ' 241' ' ' ASN . 40.6 m -56.03 -39.24 71.65 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.697 178.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 98.7 mt -84.03 122.82 29.31 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -43.38 135.42 3.52 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.895 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.715 HG23 HD12 ' A' ' 227' ' ' ILE . 97.9 m -127.25 132.53 50.36 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.844 177.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' TYR . . . . . 0.432 ' CB ' ' HB2' ' A' ' 254' ' ' ALA . 97.0 m-85 -118.01 139.83 50.63 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.29 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' SER . . . . . 0.411 ' O ' ' OD1' ' A' ' 250' ' ' ASN . 78.3 p -61.16 -42.87 99.34 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 119.277 -0.969 . . . . 0.0 108.589 -178.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.411 ' OD1' ' O ' ' A' ' 249' ' ' SER . 99.0 m-20 -143.83 160.56 40.55 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.699 0.762 . . . . 0.0 111.434 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 54.9 t -63.09 -44.42 99.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.933 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.76 -44.96 96.08 Favored 'General case' 0 CA--C 1.513 -0.475 0 C-N-CA 120.215 -0.594 . . . . 0.0 109.668 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . 0.497 ' O ' HG22 ' A' ' 257' ' ' VAL . 54.5 m-20 -64.22 -41.36 97.06 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.361 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . 0.432 ' HB2' ' CB ' ' A' ' 248' ' ' TYR . . . -64.83 -42.25 95.1 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.858 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . 0.478 HG13 HH11 ' B' ' 154' ' ' ARG . 68.3 t -64.03 -45.73 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-N 114.111 -1.404 . . . . 0.0 110.974 -178.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.62 -47.67 80.42 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.489 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.5 ' O ' ' C ' ' A' ' 258' ' ' LEU . 24.7 m -66.58 -40.45 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 120.118 -0.633 . . . . 0.0 112.206 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.5 ' C ' ' O ' ' A' ' 257' ' ' VAL . 0.9 OUTLIER -29.36 -74.9 0.04 OUTLIER Pre-proline 0 CA--C 1.533 0.313 0 CA-C-O 119.472 -0.299 . . . . 0.0 111.253 -177.106 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' PRO . . . . . 0.496 ' CD ' ' CB ' ' A' ' 258' ' ' LEU . 40.3 Cg_endo -62.84 139.61 75.33 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 120.73 0.953 . . . . 0.0 111.884 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 259' ' ' PRO . 96.5 mt -151.36 -23.55 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 O-C-N 123.327 0.392 . . . . 0.0 111.97 178.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 78.4 mtm . . . . . 0 C--O 1.218 -0.566 0 CA-C-O 118.125 -0.94 . . . . 0.0 110.637 -177.545 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.451 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.51 157.36 35.3 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 78.5 p -59.86 -22.13 61.89 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 123.339 0.399 . . . . 0.0 110.948 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -70.83 -61.58 1.71 Allowed 'General case' 0 N--CA 1.426 -1.633 0 O-C-N 121.946 -0.472 . . . . 0.0 111.133 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -67.54 -37.97 83.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.349 -0.842 . . . . 0.0 112.114 178.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . 0.527 ' O ' ' HB3' ' B' ' 7' ' ' PHE . 63.9 m -59.63 -42.87 93.7 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.009 -177.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . 0.527 ' HB3' ' O ' ' B' ' 6' ' ' SER . 44.8 t80 85.13 86.82 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.754 0.659 . . . . 0.0 110.431 177.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . 0.63 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -61.0 -140.72 0.01 OUTLIER Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 -178.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.63 ' HB ' ' O ' ' B' ' 8' ' ' GLY . 86.0 mt 83.62 109.81 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 122.438 0.295 . . . . 0.0 110.975 -178.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -62.3 -24.53 76.0 Favored 'Trans proline' 0 N--CA 1.499 1.852 0 C-N-CA 121.431 1.42 . . . . 0.0 111.714 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.62 -39.67 97.7 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -64.33 -40.03 95.07 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.66 0.743 . . . . 0.0 109.693 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 52.3 tp -62.28 -42.27 99.2 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.026 -178.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -64.64 -33.34 75.72 Favored 'General case' 0 CA--C 1.56 1.333 0 CA-C-O 121.585 0.707 . . . . 0.0 110.614 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . 0.443 HG22 ' CD1' ' A' ' 113' ' ' ILE . 79.3 t -62.92 -46.24 96.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 113.136 -1.847 . . . . 0.0 111.08 177.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 95.5 mt -63.83 -43.96 98.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.422 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . 0.538 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 98.9 mttt -63.45 -41.99 98.65 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.94 -40.91 99.09 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 118.983 -1.087 . . . . 0.0 110.177 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.92 -38.39 85.6 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.82 -178.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 86.0 mt -64.0 -42.15 97.25 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.098 0.475 . . . . 0.0 110.222 176.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.27 -39.15 93.8 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.16 -179.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -58.04 -40.0 79.79 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 121.106 -0.237 . . . . 0.0 111.102 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 8.2 p -114.7 129.44 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.506 ' O ' ' HG3' ' B' ' 24' ' ' ARG . 34.5 ptt180 -70.94 106.65 3.72 Favored 'General case' 0 CA--C 1.527 0.079 0 CA-C-O 121.87 0.843 . . . . 0.0 112.527 -177.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.5 p -142.11 133.3 25.76 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.703 177.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . 0.453 ' O ' ' N ' ' B' ' 123' ' ' GLN . . . -88.45 97.79 2.35 Favored Glycine 0 N--CA 1.439 -1.135 0 C-N-CA 119.506 -1.33 . . . . 0.0 113.153 -176.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 45.9 t -125.3 129.08 73.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 174.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 27.5 m -138.11 155.96 30.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.821 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 94.8 mt -119.89 127.06 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 122.124 0.964 . . . . 0.0 111.181 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.405 HG22 HG12 ' B' ' 39' ' ' ILE . 23.7 p -106.71 157.99 17.3 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-N 112.654 -2.066 . . . . 0.0 108.628 -176.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.534 ' C ' ' OD1' ' B' ' 37' ' ' ASN . 46.1 t0 -126.78 101.36 26.77 Favored Pre-proline 0 C--O 1.239 0.515 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 -177.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.08 -20.7 67.81 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 121.714 1.609 . . . . 0.0 111.448 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.47 -43.29 99.12 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 120.575 -0.45 . . . . 0.0 109.865 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 91.8 mt -75.16 179.55 4.99 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.715 -0.616 . . . . 0.0 111.149 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . 0.666 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 42.5 tt0 -75.48 132.94 41.13 Favored 'General case' 0 C--N 1.342 0.245 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -178.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.5 ' O ' ' OD1' ' B' ' 36' ' ' ASP . 65.9 t0 56.21 37.11 28.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.757 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' ASN . . . . . 0.534 ' OD1' ' C ' ' B' ' 31' ' ' ASP . 13.2 t-20 30.11 70.48 0.59 Allowed Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.666 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 92.8 Cg_endo -72.82 156.26 52.99 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 123.401 2.734 . . . . 0.0 111.89 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.405 HG12 HG22 ' B' ' 30' ' ' THR . 96.1 mt -89.28 129.48 40.19 Favored 'Isoleucine or valine' 0 C--O 1.246 0.881 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.429 HG23 ' N ' ' B' ' 41' ' ' TYR . 35.1 m -108.63 -43.44 6.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 O-C-N 123.936 0.773 . . . . 0.0 112.585 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' TYR . . . . . 0.429 ' N ' HG23 ' B' ' 40' ' ' VAL . 49.1 t80 -96.05 124.86 40.23 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.45 -178.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 6.2 p -142.53 140.97 28.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.438 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . 0.63 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 56.4 p30 -101.32 160.98 13.95 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.111 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' GLN . . . . . 0.518 ' OE1' ' HA ' ' B' ' 44' ' ' GLN . 12.1 mm100 -63.0 -36.78 84.68 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.215 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.13 -27.75 65.51 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.686 ' CD2' HD13 ' B' ' 57' ' ' ILE . 66.8 t80 -60.32 -43.76 96.09 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.29 0.567 . . . . 0.0 109.601 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 0.738 HG13 ' O ' ' B' ' 52' ' ' TYR . 53.6 t -61.42 -46.4 96.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.336 -178.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -63.4 -44.25 95.2 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.21 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 59.0 ttm -63.34 -42.51 98.93 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 36.1 p -93.33 -18.62 22.22 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 120.327 -0.549 . . . . 0.0 111.875 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' B' ' 47' ' ' VAL . . . 74.98 18.93 80.17 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 178.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . 0.738 ' O ' HG13 ' B' ' 47' ' ' VAL . 89.8 m-85 -112.59 146.04 39.29 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.149 0.58 . . . . 0.0 110.528 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -73.4 148.44 43.33 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.474 0.654 . . . . 0.0 111.316 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . 0.413 HG22 ' H ' ' B' ' 54' ' ' THR . 0.3 OUTLIER -61.82 -37.34 84.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.699 -177.565 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.81 -40.34 96.4 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.235 -0.586 . . . . 0.0 111.722 -178.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -71.62 -32.54 68.08 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 176.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.686 HD13 ' CD2' ' B' ' 46' ' ' PHE . 91.2 mt -66.63 -66.75 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . 0.25 97.0 mt -45.29 134.07 6.73 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.53 -9.95 73.4 Favored Glycine 0 CA--C 1.536 1.352 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.916 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -134.16 148.18 50.89 Favored 'General case' 0 C--N 1.342 0.263 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -174.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' ASN . . . . . 0.562 ' C ' ' H ' ' B' ' 63' ' ' ARG . 25.5 t-20 -79.39 151.18 31.09 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.446 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' CYS . . . . . . . . . . . . . 83.0 m -62.52 9.11 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.251 -178.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' ARG . . . . . 0.562 ' H ' ' C ' ' B' ' 61' ' ' ASN . 33.2 ptt-85 -59.89 -32.8 71.08 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.432 -177.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -60.14 -30.03 69.03 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 178.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 87.8 mt -62.2 -41.53 98.45 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 121.779 -0.575 . . . . 0.0 109.982 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -51.28 149.28 4.09 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.914 -176.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . 0.403 ' N ' ' OG1' ' B' ' 70' ' ' THR . . . -159.84 -152.84 6.65 Favored Glycine 0 CA--C 1.537 1.426 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.944 177.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.73 -41.75 95.93 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -175.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -74.94 -10.57 59.61 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.259 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' THR . . . . . 0.428 HG23 HD11 ' B' ' 92' ' ' ILE . 28.7 m -61.26 134.58 57.13 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 120.391 -0.524 . . . . 0.0 109.625 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -92.21 110.47 44.63 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.443 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.28 -38.35 88.52 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 121.023 1.149 . . . . 0.0 111.835 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.63 -39.73 89.32 Favored 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 120.451 -0.5 . . . . 0.0 109.697 -176.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' GLU . . . . . 0.486 ' OE1' ' HB ' ' B' ' 90' ' ' VAL . 79.1 mm-40 -66.52 -39.18 88.5 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.888 177.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -62.29 -45.58 98.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -63.12 -36.99 85.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.693 -177.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -62.43 -41.77 98.96 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 119.368 -0.933 . . . . 0.0 108.679 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 94.1 mt -63.47 -43.7 98.5 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-O 120.767 0.318 . . . . 0.0 110.508 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -61.96 -42.63 99.34 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 91.7 m -61.47 -45.14 95.51 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.966 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.82 -41.25 97.54 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -177.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 87.1 mt -62.98 -42.19 99.77 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.597 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 66.7 tp60 -62.85 -35.1 78.85 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . 0.429 ' O ' ' HG2' ' B' ' 86' ' ' GLU . 98.2 m-20 -92.1 6.35 46.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.594 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 30.2 tttt 42.99 40.19 2.1 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.414 -0.515 . . . . 0.0 111.823 175.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 86' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' B' ' 84' ' ' ASN . 54.6 mm-40 -122.46 141.59 35.23 Favored Pre-proline 0 N--CA 1.467 0.424 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.29 178.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 87' ' ' PRO . . . . . 0.452 ' HB3' ' OD1' ' B' ' 109' ' ' ASP . 25.6 Cg_exo -61.94 140.95 87.65 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.03 1.154 . . . . 0.0 113.716 -178.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.92 137.67 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.66 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 89' ' ' THR . . . . . 0.913 HG23 ' OD1' ' B' ' 107' ' ' ASN . 96.4 m -121.76 122.72 40.16 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.486 ' HB ' ' OE1' ' B' ' 74' ' ' GLU . 31.1 m -138.87 162.81 28.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.892 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -114.15 121.59 44.24 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 175.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . 0.428 HD11 HG23 ' B' ' 70' ' ' THR . 20.6 tt -127.47 131.46 70.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.07 -175.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -70.13 139.95 52.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.763 177.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 94' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -129.44 178.86 6.15 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.626 0.727 . . . . 0.0 111.385 -177.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 95' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -130.43 142.42 50.5 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 114.335 -1.302 . . . . 0.0 112.173 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . 0.455 ' HG3' ' CE1' ' B' ' 102' ' ' PHE . 98.7 mttt -100.47 177.68 4.96 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.129 0.49 . . . . 0.0 110.958 177.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.71 -35.09 75.44 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.777 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -85.95 -1.64 57.51 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 118.872 0.76 . . . . 0.0 112.709 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.42 3.23 65.06 Favored Glycine 0 N--CA 1.47 0.96 0 C-N-CA 121.15 -0.547 . . . . 0.0 112.495 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 27.3 m -67.44 129.21 39.19 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.665 178.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 101' ' ' MET . . . . . 0.514 ' SD ' ' C ' ' B' ' 101' ' ' MET . 16.9 tmm? -89.22 140.58 29.34 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 102' ' ' PHE . . . . . 0.481 ' N ' ' SD ' ' B' ' 101' ' ' MET . 52.8 p90 -151.66 161.89 41.92 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 103' ' ' TRP . . . . . 0.804 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 21.2 m95 -93.69 137.99 32.37 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.529 0.68 . . . . 0.0 110.813 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . 0.543 HD21 ' HG2' ' B' ' 123' ' ' GLN . 64.1 t-20 -133.0 106.97 7.97 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 114.74 -1.118 . . . . 0.0 113.461 -176.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 105' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' B' ' 123' ' ' GLN . 81.2 tt0 -75.09 125.04 28.09 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.75 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 40.0 tp -113.5 125.54 54.32 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.073 0.463 . . . . 0.0 112.072 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 107' ' ' ASN . . . . . 0.913 ' OD1' HG23 ' B' ' 89' ' ' THR . 98.0 m-20 -121.08 130.01 53.57 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.431 -0.804 . . . . 0.0 108.88 176.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 96.6 mt -123.8 132.81 70.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.699 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . 0.452 ' OD1' ' HB3' ' B' ' 87' ' ' PRO . 2.9 m-20 -142.77 120.18 7.07 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 178.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -67.97 152.05 77.26 Favored 'Trans proline' 0 N--CA 1.503 2.079 0 C-N-CA 122.632 2.221 . . . . 0.0 112.739 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . 0.574 ' HB2' ' HB2' ' B' ' 118' ' ' TYR . 66.9 mtt -128.4 144.33 51.12 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -114.88 106.95 14.77 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . 0.556 HG12 ' HZ1' ' A' ' 18' ' ' LYS . 96.8 mt -132.88 128.18 56.51 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-N 118.428 0.558 . . . . 0.0 111.77 178.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 53.51 36.68 23.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.946 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 61.32 35.85 17.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.628 -178.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -132.85 149.99 52.2 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 7.1 t -99.83 153.2 19.33 Favored 'General case' 0 C--O 1.214 -0.766 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -177.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 118' ' ' TYR . . . . . 0.574 ' HB2' ' HB2' ' B' ' 111' ' ' MET . 89.9 m-85 -148.29 148.9 30.96 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 121.189 -0.945 . . . . 0.0 111.349 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -124.96 139.68 53.6 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 120.881 0.372 . . . . 0.0 111.181 -177.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -128.54 133.95 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -176.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.54 123.78 7.16 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.186 -0.765 . . . . 0.0 111.186 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 95.2 mt -116.38 127.66 73.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 123' ' ' GLN . . . . . 0.543 ' HG2' HD21 ' B' ' 104' ' ' ASN . 16.4 mp0 -118.47 123.9 46.29 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -121.53 119.56 32.33 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' B' ' 126' ' ' ILE . 67.9 t0 -67.42 136.18 54.31 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.426 -178.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.506 ' O ' ' HG3' ' B' ' 130' ' ' LYS . 2.7 mp -109.78 15.07 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.937 0 CA-C-O 122.174 0.988 . . . . 0.0 109.132 178.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 127' ' ' THR . . . . . 0.453 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 97.6 m -63.05 -43.8 97.61 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 113.827 -1.533 . . . . 0.0 112.347 176.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 59.8 tptt -61.26 -45.92 92.53 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -177.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 129' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -63.51 -33.92 76.63 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.47 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 130' ' ' LYS . . . . . 0.804 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 98.8 mttt -63.53 -41.35 98.47 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 113.589 -1.641 . . . . 0.0 110.856 174.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -64.44 -41.48 96.54 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 132' ' ' TYR . . . . . 0.779 ' CE2' HD11 ' B' ' 136' ' ' LEU . 90.8 t80 -60.17 -44.96 94.61 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 121.801 -0.562 . . . . 0.0 111.358 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . 0.445 ' O ' ' HG3' ' B' ' 137' ' ' GLU . 97.4 mt-10 -64.58 -36.25 83.63 Favored 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 134' ' ' LYS . . . . . 0.435 ' HG3' ' O ' ' B' ' 130' ' ' LYS . 98.7 mttt -63.21 -39.81 95.7 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.68 177.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 52.8 tp -62.84 -41.57 99.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.332 0.587 . . . . 0.0 109.743 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 136' ' ' LEU . . . . . 0.779 HD11 ' CE2' ' B' ' 132' ' ' TYR . 89.9 mt -62.86 -41.85 99.53 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.269 177.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 137' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' B' ' 133' ' ' GLU . 97.3 mt-10 -65.16 -37.25 86.8 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.302 -1.317 . . . . 0.0 110.441 -178.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -63.22 -43.48 97.99 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.899 176.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 69.7 m -60.8 -44.14 97.25 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 89.7 mt -61.64 -40.32 94.46 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -176.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 94.5 m -62.11 -45.26 94.27 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.827 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -66.09 -42.8 88.83 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 92.5 mt -63.8 -43.24 97.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.688 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 144' ' ' THR . . . . . . . . . . . . . 99.6 m -61.68 -45.04 95.69 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 -178.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . 0.445 ' O ' ' HB ' ' B' ' 148' ' ' THR . . . -63.27 -41.72 99.06 Favored 'General case' 0 C--O 1.227 -0.093 0 C-N-CA 118.952 -1.099 . . . . 0.0 109.346 178.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 86.1 mt -64.83 -41.18 95.94 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 176.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 147' ' ' SER . . . . . 0.595 ' O ' ' N ' ' B' ' 149' ' ' PRO . 78.2 p -62.06 -41.34 98.04 Favored 'General case' 0 CA--C 1.479 -1.769 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 148' ' ' THR . . . . . 0.482 ' C ' ' O ' ' B' ' 147' ' ' SER . 26.3 m -28.61 87.19 0.04 OUTLIER Pre-proline 0 N--CA 1.474 0.76 0 O-C-N 124.1 0.875 . . . . 0.0 109.874 176.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 149' ' ' PRO . . . . . 0.595 ' N ' ' O ' ' B' ' 147' ' ' SER . 23.8 Cg_exo -61.67 147.04 96.26 Favored 'Trans proline' 0 C--N 1.301 -1.95 0 C-N-CA 121.952 1.768 . . . . 0.0 114.942 -178.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 9.0 tp -127.73 121.98 57.89 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.533 0 CA-C-N 113.571 -1.65 . . . . 0.0 107.63 174.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 38.7 t -154.01 95.97 2.75 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.699 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -62.35 142.95 92.91 Favored 'Trans proline' 0 C--N 1.318 -1.046 0 N-CA-C 109.61 -0.958 . . . . 0.0 109.61 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 153' ' ' ILE . . . . . 0.487 ' O ' ' HD2' ' B' ' 154' ' ' ARG . 44.5 mm -77.21 -57.46 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.387 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 154' ' ' ARG . . . . . 0.68 ' HD3' ' NH2' ' A' ' 154' ' ' ARG . 1.2 tpt180 -141.53 -156.07 0.65 Allowed 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 61.0 t-20 -86.05 109.6 18.93 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.29 -16.72 59.59 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -178.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 86.7 mt -108.75 125.56 65.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-O 120.86 0.362 . . . . 0.0 110.994 -176.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 158' ' ' SER . . . . . 0.68 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 61.5 m -134.45 149.28 50.73 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.132 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -135.4 147.34 48.99 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.157 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 17.1 tp -140.09 79.55 21.95 Favored Pre-proline 0 CA--C 1.531 0.228 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 161' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -70.05 147.96 62.14 Favored 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 122.839 2.359 . . . . 0.0 114.099 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 91.6 mt -115.29 133.87 55.64 Favored 'General case' 0 C--N 1.342 0.239 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 53.9 t -128.17 132.94 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 114.79 169.71 16.26 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.56 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 165' ' ' ASN . . . . . 0.723 ' O ' ' CZ ' ' B' ' 170' ' ' ARG . 60.9 t30 -91.62 107.11 18.97 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -178.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 166' ' ' LEU . . . . . 0.538 HD21 ' CZ ' ' B' ' 171' ' ' PHE . 47.7 tp -65.49 104.73 1.04 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -174.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 167' ' ' THR . . . . . 0.696 HG23 ' NE ' ' B' ' 170' ' ' ARG . 11.2 p -83.88 169.92 14.6 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 114.103 -1.408 . . . . 0.0 110.797 177.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -66.32 -38.51 87.86 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.97 177.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.09 -40.0 90.45 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 123.427 1.584 . . . . 0.0 111.828 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 170' ' ' ARG . . . . . 0.723 ' CZ ' ' O ' ' B' ' 165' ' ' ASN . 88.2 mtm180 -62.3 -36.24 81.51 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 111.914 -2.403 . . . . 0.0 111.05 178.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 171' ' ' PHE . . . . . 0.538 ' CZ ' HD21 ' B' ' 166' ' ' LEU . 0.5 OUTLIER -53.82 -25.16 18.12 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -179.439 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 172' ' ' ASN . . . . . 0.544 ' O ' HG22 ' B' ' 175' ' ' VAL . 91.4 m-20 -62.68 -40.23 96.43 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.845 178.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 49.2 m -60.46 -41.82 94.9 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.729 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 66.7 mt -63.92 -44.39 97.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 175' ' ' VAL . . . . . 0.544 HG22 ' O ' ' B' ' 172' ' ' ASN . 33.6 m -63.12 -40.59 89.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 176' ' ' CYS . . . . . 0.428 ' N ' HG23 ' B' ' 175' ' ' VAL . 97.1 m -62.58 -35.05 78.29 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.344 178.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 177' ' ' THR . . . . . 0.529 ' O ' HG13 ' B' ' 181' ' ' ILE . 25.3 m -61.9 -19.54 62.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.24 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 178' ' ' LEU . . . . . 0.566 ' CD2' HD21 ' B' ' 211' ' ' LEU . 91.1 mt -61.16 -39.51 90.38 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.278 -177.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 19.3 m -61.04 -43.95 98.11 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.185 177.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 180' ' ' ASN . . . . . 0.611 ' O ' ' OG ' ' B' ' 183' ' ' SER . 91.4 m-20 -61.45 -39.94 92.65 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.9 0.381 . . . . 0.0 110.416 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.529 HG13 ' O ' ' B' ' 177' ' ' THR . 71.8 mt -56.96 -34.44 44.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 O-C-N 122.221 -0.3 . . . . 0.0 110.626 -178.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 182' ' ' LEU . . . . . 0.476 HD21 HD21 ' B' ' 214' ' ' LEU . 85.3 mt -62.08 -41.59 98.34 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.11 178.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . 0.611 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.1 p -63.3 -32.96 74.51 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 121.853 -0.53 . . . . 0.0 110.827 177.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 64.8 p -86.16 17.29 3.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.679 -177.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 78.1 p -61.27 -16.68 47.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.654 -177.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -61.79 -39.82 93.04 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.756 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 187' ' ' ASP . . . . . 0.68 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.1 m-20 -72.11 113.35 9.05 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.504 0.669 . . . . 0.0 110.496 -177.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -62.8 -42.22 99.62 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 114.83 -1.077 . . . . 0.0 113.119 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -110.47 130.52 55.54 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.034 -177.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 190' ' ' LEU . . . . . 0.428 ' HA ' ' O ' ' B' ' 158' ' ' SER . 41.1 tp -123.46 119.33 29.69 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.139 178.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 87.2 mt -107.44 126.86 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 117.796 0.271 . . . . 0.0 111.15 -176.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 49.2 mm -116.29 117.31 55.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 193' ' ' ASP . . . . . 0.464 ' CG ' ' HG ' ' B' ' 195' ' ' SER . 43.3 t0 -88.38 111.33 21.63 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -177.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 194' ' ' LEU . . . . . . . . . . . . . 98.1 mt -93.98 -2.74 52.66 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 176.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 195' ' ' SER . . . . . 0.464 ' HG ' ' CG ' ' B' ' 193' ' ' ASP . 78.2 p -61.35 -37.32 82.89 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.872 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.98 -34.01 87.49 Favored Glycine 0 N--CA 1.436 -1.312 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 197' ' ' LEU . . . . . 1.01 HD22 ' O ' ' B' ' 199' ' ' GLN . 5.2 tt -76.23 133.25 40.17 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -177.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 198' ' ' ALA . . . . . 0.915 ' N ' HD23 ' B' ' 197' ' ' LEU . . . -63.56 -41.26 98.42 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 119.979 -0.688 . . . . 0.0 111.935 -177.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 199' ' ' GLN . . . . . 1.01 ' O ' HD22 ' B' ' 197' ' ' LEU . 59.4 tt0 -140.96 164.23 30.82 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.446 0.641 . . . . 0.0 111.864 -179.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 200' ' ' VAL . . . . . 0.502 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 49.9 t -120.98 131.73 72.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 177.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -91.13 150.03 21.55 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.875 -177.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -60.5 -33.13 72.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.28 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -63.77 -33.81 76.49 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.465 0.65 . . . . 0.0 109.388 178.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.5 m -60.79 -43.93 97.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.246 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 205' ' ' ALA . . . . . 0.64 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -58.26 -30.44 66.57 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 111.79 0.292 . . . . 0.0 111.79 -177.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -65.42 -38.27 89.42 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.307 0.575 . . . . 0.0 109.932 176.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -66.39 -39.11 88.86 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.694 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.82 -43.26 97.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-O 121.688 0.756 . . . . 0.0 110.299 -178.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 209' ' ' PHE . . . . . 0.64 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 69.1 m-85 -61.95 -43.53 98.65 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 113.888 -1.505 . . . . 0.0 112.527 177.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.17 -41.77 99.28 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 119.584 -0.846 . . . . 0.0 110.046 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 211' ' ' LEU . . . . . 0.566 HD21 ' CD2' ' B' ' 178' ' ' LEU . 37.8 mt -62.3 -42.07 99.05 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.221 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 78.2 p -63.52 -35.58 80.94 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.893 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 213' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -66.78 -46.95 73.67 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.362 -0.836 . . . . 0.0 112.141 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.476 HD21 HD21 ' B' ' 182' ' ' LEU . 52.8 tp -63.89 -42.9 97.36 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.864 0.84 . . . . 0.0 110.032 177.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 215' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' B' ' 211' ' ' LEU . 92.6 mt -63.08 -43.42 98.58 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 113.389 -1.732 . . . . 0.0 111.701 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.18 -39.41 92.57 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.913 -177.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.45 -42.3 98.64 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.322 0.582 . . . . 0.0 111.483 175.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 218' ' ' THR . . . . . . . . . . . . . 77.9 p -73.69 -15.92 61.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.716 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 78.91 63.88 2.02 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 107.051 -2.419 . . . . 0.0 107.051 -177.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 220' ' ' THR . . . . . . . . . . . . . 95.8 m -141.3 103.11 4.36 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 176.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -61.47 138.7 58.28 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.054 0.454 . . . . 0.0 110.952 -176.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 44.4 tp -115.67 121.85 43.79 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.679 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 3.2 mp -110.45 128.91 66.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.883 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 224' ' ' ILE . . . . . 0.477 ' CG2' HD11 ' B' ' 227' ' ' ILE . 49.6 mm -111.3 127.15 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 49.8 p -133.62 158.76 42.38 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.871 0.843 . . . . 0.0 112.709 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 89.47 16.4 57.07 Favored Glycine 0 CA--C 1.5 -0.896 0 CA-C-N 113.818 -1.537 . . . . 0.0 111.639 -177.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 227' ' ' ILE . . . . . 0.734 HD12 HG23 ' B' ' 247' ' ' THR . 95.5 mt -81.15 126.27 39.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 117.815 0.808 . . . . 0.0 111.498 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 55.4 tttt -66.19 141.2 97.24 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.341 -178.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.45 -37.56 94.75 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 121.491 1.461 . . . . 0.0 112.614 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -63.94 -43.55 95.5 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -178.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 51.8 tp -62.05 -41.58 98.28 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.159 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.72 -37.01 85.76 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.749 0.309 . . . . 0.0 111.362 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 94.5 mtp -64.01 -40.89 97.35 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.805 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.7 -42.55 99.69 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-O 122.422 1.106 . . . . 0.0 109.467 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 35.2 mmt -63.98 -36.61 84.53 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 114.322 -1.308 . . . . 0.0 111.862 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -61.96 -40.46 95.64 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.002 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.28 -43.91 96.59 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 120.679 -0.409 . . . . 0.0 110.057 177.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.29 -44.42 96.55 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.71 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 239' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' B' ' 240' ' ' ALA . 67.0 t0 -159.1 133.08 7.57 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.324 -0.551 . . . . 0.0 112.104 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 240' ' ' ALA . . . . . 0.418 ' N ' ' OD1' ' B' ' 239' ' ' ASP . . . -62.51 -44.75 95.6 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 176.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 241' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' B' ' 244' ' ' SER . 92.1 m-20 -45.52 -22.61 0.16 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.046 -175.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 242' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -60.81 -45.43 94.46 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 119.888 -0.725 . . . . 0.0 110.39 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 243' ' ' SER . . . . . . . . . . . . . 77.5 p -57.89 -42.21 84.15 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 244' ' ' SER . . . . . 0.477 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 19.7 m -35.1 -34.46 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 -178.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 96.6 mt -87.74 134.2 33.71 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.567 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -58.85 135.53 57.55 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-O 121.427 0.632 . . . . 0.0 110.75 -177.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 247' ' ' THR . . . . . 0.734 HG23 HD12 ' B' ' 227' ' ' ILE . 95.8 m -125.91 127.51 46.12 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.722 177.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 248' ' ' TYR . . . . . 0.471 ' CB ' ' HB2' ' B' ' 254' ' ' ALA . 96.3 m-85 -113.8 142.56 45.91 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 249' ' ' SER . . . . . 0.604 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 78.4 p -63.12 -34.08 76.84 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.339 -178.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 250' ' ' ASN . . . . . 0.604 ' OD1' ' O ' ' B' ' 249' ' ' SER . 99.2 m-20 -147.94 159.55 43.75 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.199 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 58.0 t -64.23 -44.39 97.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.885 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 252' ' ' LYS . . . . . 0.421 ' HG3' ' HG3' ' A' ' 152' ' ' PRO . 88.7 tttt -60.94 -46.74 89.5 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -177.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . 0.5 ' O ' HG22 ' B' ' 257' ' ' VAL . 93.7 m-20 -61.74 -43.11 99.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.654 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 254' ' ' ALA . . . . . 0.471 ' HB2' ' CB ' ' B' ' 248' ' ' TYR . . . -64.87 -40.57 95.33 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.18 178.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 255' ' ' VAL . . . . . 0.555 HG11 ' O ' ' A' ' 153' ' ' ILE . 67.8 t -64.69 -45.72 94.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.506 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -63.26 -48.21 79.14 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.226 -178.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 257' ' ' VAL . . . . . 0.5 HG22 ' O ' ' B' ' 253' ' ' ASP . 22.6 m -65.2 -40.31 88.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.594 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 258' ' ' LEU . . . . . 0.515 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 0.9 OUTLIER -31.8 -73.96 0.05 OUTLIER Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.592 -178.359 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 259' ' ' PRO . . . . . 0.538 ' O ' HG13 ' B' ' 260' ' ' ILE . 35.5 Cg_endo -61.75 141.31 90.05 Favored 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 121.51 1.474 . . . . 0.0 111.196 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 260' ' ' ILE . . . . . 0.562 ' O ' HG22 ' B' ' 260' ' ' ILE . 96.8 mt -158.44 -12.57 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-N 118.591 0.632 . . . . 0.0 112.121 177.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 78.3 mtm . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 117.99 -1.005 . . . . 0.0 111.583 179.921 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.427 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.76 179.25 8.68 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-O 121.57 0.7 . . . . 0.0 109.518 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 97.2 p -82.62 -2.18 53.11 Favored 'General case' 0 C--N 1.39 2.337 0 O-C-N 118.151 -2.843 . . . . 0.0 112.853 176.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -87.35 -64.15 1.19 Allowed 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.141 -1.391 . . . . 0.0 112.32 175.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -68.73 -39.23 80.49 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 178.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.497 ' O ' ' CB ' ' A' ' 7' ' ' PHE . 57.0 m -58.94 -42.13 89.04 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.923 -177.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.523 ' CE2' HD12 ' A' ' 9' ' ' ILE . 33.0 t80 86.38 87.59 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 O-C-N 123.816 0.697 . . . . 0.0 111.567 176.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.55 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -60.59 -143.21 0.01 OUTLIER Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.55 ' HB ' ' O ' ' A' ' 8' ' ' GLY . 65.3 mt 84.22 110.46 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.65 0 C-N-CA 122.881 0.472 . . . . 0.0 110.584 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.94 -22.44 68.47 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 121.354 1.369 . . . . 0.0 112.18 -179.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.88 -37.29 94.44 Favored Glycine 0 C--O 1.247 0.921 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.07 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -65.04 -39.04 92.77 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.349 0.595 . . . . 0.0 109.745 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.8 tp -63.29 -41.95 99.02 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -62.32 -39.54 93.37 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 68.5 t -61.08 -43.97 97.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 O-C-N 122.02 -0.425 . . . . 0.0 111.066 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 95.4 mt -62.21 -43.28 97.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.213 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.4 ' NZ ' ' HA ' ' B' ' 6' ' ' SER . 98.7 mttt -62.96 -45.03 94.39 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 119.394 -0.923 . . . . 0.0 111.877 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.718 ' HZ1' HG12 ' B' ' 113' ' ' ILE . 98.5 mttt -61.05 -39.42 89.77 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 118.666 -1.214 . . . . 0.0 108.612 -175.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.35 -42.88 92.6 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 119.941 -0.703 . . . . 0.0 110.262 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 20' ' ' LEU . 87.0 mt -63.1 -40.77 98.62 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -62.86 -38.9 92.7 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.491 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 57.5 m170 -58.88 -39.5 81.58 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 122.16 -0.337 . . . . 0.0 111.501 -178.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.3 p -114.82 130.36 69.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.462 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 31.6 ptt180 -72.9 110.15 6.99 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 121.939 0.876 . . . . 0.0 112.178 -177.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.5 p -140.96 143.3 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 177.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' A' ' 123' ' ' GLN . . . -97.81 92.56 1.29 Allowed Glycine 0 C--N 1.312 -0.758 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.777 -178.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 52.0 t -124.79 129.98 73.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 175.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.8 m -136.92 159.24 37.01 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.5 mt -119.46 128.89 75.86 Favored 'Isoleucine or valine' 0 C--O 1.245 0.855 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 176.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.45 ' OG1' ' HB2' ' A' ' 119' ' ' PHE . 24.3 p -101.83 167.22 10.22 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 177.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.401 ' C ' ' OD1' ' A' ' 37' ' ' ASN . 53.1 t0 -133.82 101.86 12.64 Favored Pre-proline 0 C--O 1.222 -0.37 0 C-N-CA 120.314 -0.554 . . . . 0.0 109.872 178.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.57 -21.04 65.99 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 121.431 1.421 . . . . 0.0 111.501 -178.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.67 -29.72 70.85 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.316 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 91.4 mt -89.79 -178.87 5.61 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.865 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.645 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 42.1 tt0 -76.3 130.25 37.85 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -177.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.515 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 58.3 t0 63.11 22.04 13.2 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 177.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.401 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 29.7 t-20 42.3 68.03 2.99 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.996 -177.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.645 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 89.6 Cg_endo -71.36 157.17 57.38 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 124.085 3.19 . . . . 0.0 112.042 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 95.9 mt -89.84 123.61 42.12 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.5 m -103.95 -43.14 8.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.1 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -96.34 123.61 40.04 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.733 -178.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.5 p -142.87 140.29 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 O-C-N 124.356 1.035 . . . . 0.0 109.229 177.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.61 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 57.7 p30 -96.49 166.13 11.84 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.466 ' OE1' ' HA ' ' A' ' 44' ' ' GLN . 14.0 mm100 -66.15 -39.84 90.11 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 177.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.98 -25.44 61.87 Favored Glycine 0 C--O 1.237 0.294 0 N-CA-C 110.389 -1.085 . . . . 0.0 110.389 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.621 ' CD2' HD13 ' A' ' 57' ' ' ILE . 67.4 t80 -59.0 -47.51 84.93 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 105.863 -1.902 . . . . 0.0 105.863 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.722 HG13 ' O ' ' A' ' 52' ' ' TYR . 53.6 t -60.04 -44.38 94.7 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 O-C-N 121.161 -0.962 . . . . 0.0 111.498 -174.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -62.44 -37.56 86.35 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 120.488 -0.485 . . . . 0.0 112.264 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 59.4 ttm -66.97 -43.64 82.55 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 176.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 34.8 p -93.48 -20.82 19.92 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.138 0.494 . . . . 0.0 111.287 -177.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . 77.82 19.44 75.47 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.722 ' O ' HG13 ' A' ' 47' ' ' VAL . 78.0 m-85 -111.79 138.79 47.9 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 122.579 0.351 . . . . 0.0 110.984 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -64.64 149.14 49.52 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.491 0.662 . . . . 0.0 109.495 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.448 HG22 ' H ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -65.85 -32.44 73.95 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.833 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.43 -42.34 83.33 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 119.381 -0.928 . . . . 0.0 111.382 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -64.65 -44.65 89.76 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.621 HD13 ' CD2' ' A' ' 46' ' ' PHE . 95.3 mt -63.76 -45.9 95.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -174.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 83.8 mt -61.09 144.7 53.05 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.14 -5.99 73.83 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.353 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -134.49 151.28 51.03 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 119.222 1.511 . . . . 0.0 112.011 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.562 ' C ' ' H ' ' A' ' 63' ' ' ARG . 25.0 t-20 -81.45 152.2 27.5 Favored 'General case' 0 N--CA 1.453 -0.316 0 O-C-N 121.882 -0.511 . . . . 0.0 110.509 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 86.0 m -63.16 15.78 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.353 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.562 ' H ' ' C ' ' A' ' 61' ' ' ASN . 35.2 ptt-85 -61.12 -42.02 97.78 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.077 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -55.65 -21.74 19.45 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -178.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.6 mt -67.44 -35.48 79.32 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 122.241 1.02 . . . . 0.0 112.864 176.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -65.65 133.3 50.83 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.753 -176.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.524 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -143.69 -148.57 4.92 Favored Glycine 0 CA--C 1.543 1.832 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -178.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.86 -41.11 99.25 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -177.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.444 ' O ' ' OE1' ' A' ' 93' ' ' GLN . 17.2 m-70 -75.93 -9.79 58.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.834 0.349 . . . . 0.0 110.852 -177.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.524 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 28.5 m -60.93 130.12 44.87 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.603 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -87.54 111.09 39.36 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.713 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -57.55 -31.68 92.27 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.018 1.812 . . . . 0.0 112.99 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.7 -40.26 96.34 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.951 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.424 ' OE1' ' HB ' ' A' ' 90' ' ' VAL . 79.2 mm-40 -65.6 -43.61 89.12 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.3 t -60.4 -43.13 93.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -63.67 -37.96 89.33 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 124.07 0.856 . . . . 0.0 112.007 178.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -63.31 -39.69 95.25 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.37 0.605 . . . . 0.0 110.544 178.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.1 mt -64.1 -43.79 97.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.367 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -62.65 -43.07 99.74 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 113.653 -1.612 . . . . 0.0 108.473 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 93.8 m -60.82 -49.11 78.8 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.25 -42.46 95.34 Favored 'General case' 0 C--N 1.363 1.189 0 O-C-N 123.754 0.659 . . . . 0.0 110.782 -171.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 87.4 mt -63.01 -40.94 99.26 Favored 'General case' 0 CA--C 1.514 -0.409 0 O-C-N 120.184 -1.573 . . . . 0.0 111.692 -178.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -63.42 -41.07 98.69 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -70.55 -23.35 62.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.197 177.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 49.5 tttt 63.34 46.53 4.38 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.614 -176.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -130.71 148.32 69.65 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -62.08 142.94 94.12 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 121.441 1.427 . . . . 0.0 113.493 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.09 141.43 33.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.325 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.891 HG23 ' OD1' ' A' ' 107' ' ' ASN . 96.6 m -126.7 119.17 26.3 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 175.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.424 ' HB ' ' OE1' ' A' ' 74' ' ' GLU . 30.1 m -138.59 157.17 30.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 121.203 -0.199 . . . . 0.0 111.413 178.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -103.8 127.3 51.3 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 177.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.421 HG23 ' O ' ' A' ' 92' ' ' ILE . 18.8 tt -135.74 131.45 50.45 Favored 'Isoleucine or valine' 0 C--N 1.372 1.567 0 CA-C-N 121.716 2.053 . . . . 0.0 112.606 177.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.444 ' OE1' ' O ' ' A' ' 69' ' ' HIS . 87.5 mt-30 -63.69 135.87 57.05 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.952 -179.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -137.97 162.25 34.56 Favored 'General case' 0 C--N 1.349 0.55 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.923 -177.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.492 ' CE1' ' HA3' ' A' ' 67' ' ' GLY . 92.3 m-85 -121.38 138.3 54.32 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -178.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.488 ' HG3' ' CE1' ' A' ' 102' ' ' PHE . 99.2 mttt -86.71 -171.06 3.35 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.078 0.466 . . . . 0.0 111.525 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.69 -42.05 99.43 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.396 178.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 39.7 p-10 -85.49 7.61 22.23 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -177.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.48 -1.18 88.45 Favored Glycine 0 N--CA 1.471 0.983 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.146 177.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 23.4 m -60.06 137.63 58.05 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.678 ' SD ' ' C ' ' A' ' 101' ' ' MET . 14.1 tmm? -104.98 129.39 53.42 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 120.746 0.308 . . . . 0.0 111.231 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.488 ' CE1' ' HG3' ' A' ' 96' ' ' LYS . 53.5 p90 -141.12 158.97 43.19 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.927 -177.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.837 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 21.0 m95 -90.54 143.97 26.23 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.411 HD21 ' HG2' ' A' ' 123' ' ' GLN . 54.6 t-20 -138.46 103.54 4.91 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -176.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -70.56 135.12 48.26 Favored 'General case' 0 N--CA 1.436 -1.15 0 O-C-N 120.974 -1.079 . . . . 0.0 108.16 -176.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 38.8 tp -120.16 123.61 43.73 Favored 'General case' 0 C--O 1.234 0.285 0 O-C-N 124.07 0.856 . . . . 0.0 112.662 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.891 ' OD1' HG23 ' A' ' 89' ' ' THR . 98.1 m-20 -119.55 123.0 42.87 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.96 177.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 96.4 mt -120.9 128.46 76.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 O-C-N 123.575 0.547 . . . . 0.0 111.496 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -137.33 126.81 15.32 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.819 -0.173 . . . . 0.0 111.003 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -70.73 151.45 63.57 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.162 1.908 . . . . 0.0 112.413 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.654 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 67.2 mtt -123.36 151.5 42.46 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -126.86 96.96 4.8 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 176.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.513 ' CD1' HG22 ' B' ' 15' ' ' VAL . 96.2 mt -121.02 131.56 72.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.035 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 50.27 37.46 15.1 Favored 'General case' 0 CA--C 1.515 -0.375 0 O-C-N 121.105 -0.997 . . . . 0.0 111.365 176.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 59.93 31.82 20.88 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 123.939 0.774 . . . . 0.0 110.994 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -128.71 147.95 50.8 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.705 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 3.6 t -84.3 -175.51 5.83 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-O 118.769 -0.634 . . . . 0.0 109.434 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.705 ' CD2' ' O ' ' A' ' 117' ' ' THR . 70.1 m-85 -169.1 156.04 6.94 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 173.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.45 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 86.0 m-85 -129.32 147.83 51.19 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 173.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.7 p -137.33 137.31 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -111.97 130.29 9.56 Favored Glycine 0 CA--C 1.504 -0.644 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 178.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 97.0 mt -117.65 129.54 73.93 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 177.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.595 ' N ' ' O ' ' A' ' 26' ' ' GLY . 17.9 mp0 -118.81 117.0 27.7 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.223 0.535 . . . . 0.0 109.833 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -117.99 114.97 23.96 Favored 'General case' 0 C--O 1.254 1.329 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.813 -178.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.412 ' OD1' ' OG1' ' A' ' 127' ' ' THR . 67.4 t0 -67.72 121.97 17.09 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -175.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.478 HG22 ' O ' ' A' ' 126' ' ' ILE . 3.6 mp -85.4 1.07 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 113.778 -1.556 . . . . 0.0 110.299 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.412 ' OG1' ' OD1' ' A' ' 125' ' ' ASP . 27.5 m -59.43 -42.58 92.21 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.186 -0.946 . . . . 0.0 112.937 -177.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -58.87 -42.31 89.13 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 -178.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -63.23 -39.47 94.7 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.445 177.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.837 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.8 mttt -62.41 -40.76 97.58 Favored 'General case' 0 C--O 1.214 -0.771 0 O-C-N 120.504 -1.372 . . . . 0.0 110.084 -178.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.72 -37.41 86.41 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.752 0.658 . . . . 0.0 109.49 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.735 ' CE2' HD11 ' A' ' 136' ' ' LEU . 88.2 t80 -61.45 -45.9 92.33 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.408 176.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.34 -38.45 91.07 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.67 -40.31 96.66 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 52.2 tp -60.97 -43.35 98.91 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -177.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.735 HD11 ' CE2' ' A' ' 132' ' ' TYR . 85.3 mt -62.8 -41.27 99.21 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.827 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.97 -41.87 98.5 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 119.668 -0.813 . . . . 0.0 109.691 -178.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -60.14 -43.06 96.0 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -177.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 54.7 m -61.61 -41.41 97.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.731 176.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.457 ' O ' ' N ' ' A' ' 144' ' ' THR . 85.8 mt -63.07 -41.69 99.5 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 121.933 -0.48 . . . . 0.0 109.963 178.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 78.6 m -61.61 -45.42 94.17 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.514 -177.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -65.13 -39.99 93.83 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 95.2 mt -64.59 -43.18 96.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 113.873 -1.512 . . . . 0.0 111.232 176.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.457 ' N ' ' O ' ' A' ' 140' ' ' LEU . 89.3 m -62.18 -46.07 90.59 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 120.37 -0.532 . . . . 0.0 112.285 -178.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.34 -40.62 96.98 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 118.851 -1.14 . . . . 0.0 109.064 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.7 mt -63.44 -42.63 98.66 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.491 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.715 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.4 p -60.7 -36.42 78.75 Favored 'General case' 0 C--O 1.214 -0.803 0 C-N-CA 119.332 -0.947 . . . . 0.0 109.294 -177.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.438 ' C ' ' O ' ' A' ' 147' ' ' SER . 41.9 m -31.67 81.57 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.507 0 O-C-N 127.041 2.713 . . . . 0.0 105.823 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.715 ' N ' ' O ' ' A' ' 147' ' ' SER . 19.4 Cg_exo -62.51 142.07 88.84 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 CA-C-O 123.088 1.203 . . . . 0.0 114.601 -174.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.562 ' O ' HG23 ' A' ' 151' ' ' VAL . 9.0 tp -115.91 136.3 53.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 102.603 -3.11 . . . . 0.0 102.603 175.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 150' ' ' ILE . 82.2 t -168.46 90.5 0.64 Allowed Pre-proline 0 CA--C 1.505 -0.771 0 N-CA-C 106.001 -1.851 . . . . 0.0 106.001 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.2 135.58 55.3 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 N-CA-C 109.678 -0.931 . . . . 0.0 109.678 -177.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.669 ' O ' ' HD2' ' A' ' 154' ' ' ARG . 44.5 mm -67.45 -44.76 86.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 119.682 -0.807 . . . . 0.0 111.109 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.729 HH11 HG13 ' B' ' 255' ' ' VAL . 0.4 OUTLIER -157.31 -156.29 0.58 Allowed 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.864 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.411 ' ND2' ' HE3' ' B' ' 256' ' ' LYS . 61.4 t-20 -86.51 104.89 16.39 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.469 0.652 . . . . 0.0 111.619 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 88.56 7.96 71.22 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 114.121 -1.4 . . . . 0.0 110.245 -178.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.1 mt -123.52 123.71 67.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 174.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.609 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 69.4 m -132.38 152.57 51.4 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -137.51 143.4 41.66 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.492 177.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 16.3 tp -133.68 78.33 61.81 Favored Pre-proline 0 N--CA 1.465 0.295 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.328 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -69.2 150.19 71.33 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.68 2.253 . . . . 0.0 113.227 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 90.4 mt -118.48 125.99 51.07 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.12 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 51.4 t -122.95 131.57 73.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 117.29 168.63 14.72 Favored Glycine 0 N--CA 1.481 1.683 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.347 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.864 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 56.1 t30 -85.32 114.13 22.16 Favored 'General case' 0 C--O 1.201 -1.48 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -178.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.628 HD21 ' CZ ' ' A' ' 171' ' ' PHE . 48.2 tp -73.92 102.45 4.11 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -177.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.705 HG23 ' NE ' ' A' ' 170' ' ' ARG . 10.5 p -85.49 167.69 15.23 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.446 178.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.91 -34.93 79.27 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.955 0.407 . . . . 0.0 111.894 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.15 -46.66 86.15 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.499 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.864 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 87.6 mtm180 -61.6 -31.74 71.82 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.796 177.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.628 ' CZ ' HD21 ' A' ' 166' ' ' LEU . 0.4 OUTLIER -54.97 -28.28 50.41 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -177.53 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.637 ' O ' HG22 ' A' ' 175' ' ' VAL . 92.6 m-20 -60.8 -40.45 92.74 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 119.045 -1.062 . . . . 0.0 110.01 -178.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 58.7 m -59.42 -40.56 87.09 Favored 'General case' 0 C--N 1.322 -0.611 0 O-C-N 121.762 -0.586 . . . . 0.0 110.638 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 67.9 mt -63.66 -44.14 98.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.637 HG22 ' O ' ' A' ' 172' ' ' ASN . 35.2 m -62.29 -40.05 86.38 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . 0.415 ' N ' HG23 ' A' ' 175' ' ' VAL . 96.6 m -62.05 -35.24 78.02 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.318 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.519 ' O ' HG13 ' A' ' 181' ' ' ILE . 24.9 m -61.48 -19.84 62.48 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.283 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.606 ' CD2' HD21 ' A' ' 211' ' ' LEU . 87.6 mt -60.82 -40.82 94.16 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -177.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 18.5 m -59.48 -43.75 93.19 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.594 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . 0.634 ' O ' ' OG ' ' A' ' 183' ' ' SER . 93.2 m-20 -61.1 -37.5 82.97 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.053 0.454 . . . . 0.0 111.059 178.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 177' ' ' THR . 66.8 mt -57.51 -39.01 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 O-C-N 121.401 -0.812 . . . . 0.0 109.165 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 87.3 mt -60.81 -40.47 92.82 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 119.439 -0.904 . . . . 0.0 108.625 -177.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.634 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 78.0 p -61.48 -34.0 74.72 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.727 176.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 53.0 p -90.45 23.58 2.93 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 122.226 -0.296 . . . . 0.0 111.514 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 78.2 p -63.04 -20.15 65.06 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.644 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.07 -36.2 79.0 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.865 -178.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.609 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 98.7 m-20 -72.55 114.0 10.2 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.568 0.699 . . . . 0.0 110.963 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -62.8 -42.48 99.73 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.919 -177.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -113.26 132.17 55.64 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.104 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 38.1 tp -120.6 128.93 53.5 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 96.4 mt -116.24 127.05 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 O-C-N 121.751 -0.593 . . . . 0.0 109.459 177.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.9 mm -113.08 126.35 70.48 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . 0.5 ' CG ' ' HG ' ' A' ' 195' ' ' SER . 40.2 t0 -95.25 120.34 35.32 Favored 'General case' 0 CA--C 1.551 1.017 0 O-C-N 121.662 -0.648 . . . . 0.0 110.48 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 194' ' ' LEU . 96.2 mt -101.01 -2.8 30.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.891 176.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . 0.5 ' HG ' ' CG ' ' A' ' 193' ' ' ASP . 78.3 p -63.31 -32.32 73.71 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.85 -47.15 92.02 Favored Glycine 0 CA--C 1.54 1.61 0 N-CA-C 108.171 -1.972 . . . . 0.0 108.171 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.938 HD23 ' N ' ' A' ' 198' ' ' ALA . 4.9 tt -66.02 129.82 41.12 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 112.873 -1.664 . . . . 0.0 108.755 -177.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.938 ' N ' HD23 ' A' ' 197' ' ' LEU . . . -60.79 -50.98 71.26 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-O 121.417 0.627 . . . . 0.0 110.931 -179.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.889 ' O ' ' CD2' ' A' ' 197' ' ' LEU . 58.6 tt0 -132.76 156.78 46.46 Favored 'General case' 0 C--O 1.21 -1.017 0 CA-C-N 114.728 -1.124 . . . . 0.0 114.016 -174.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.483 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 46.1 t -117.83 130.69 72.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 O-C-N 120.424 -1.423 . . . . 0.0 108.425 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -83.76 155.86 22.84 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.237 -178.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -64.79 -39.48 93.67 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.988 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -57.24 -31.4 65.5 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 -178.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.8 m -61.42 -42.74 99.22 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.709 178.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.449 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -56.44 -39.06 72.47 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -177.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -61.26 -38.09 85.46 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 121.776 -0.578 . . . . 0.0 110.087 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -64.57 -38.87 92.52 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.916 177.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.02 -44.88 99.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . 0.449 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 67.2 m-85 -61.04 -43.82 98.31 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.009 -177.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.97 -41.59 98.18 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 118.998 -1.081 . . . . 0.0 109.202 -178.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.606 HD21 ' CD2' ' A' ' 178' ' ' LEU . 38.8 mt -62.39 -42.18 99.23 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 78.0 p -61.04 -42.45 98.5 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.463 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' HIS . . . . . 0.483 ' CE1' HD11 ' A' ' 217' ' ' LEU . 58.5 t-80 -64.93 -45.72 84.64 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 122.034 -0.416 . . . . 0.0 111.728 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 50.3 tp -62.41 -45.93 90.88 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 119.021 -1.071 . . . . 0.0 108.15 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 89.4 mt -62.84 -41.19 99.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.401 -177.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.03 -44.44 94.63 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.601 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.483 HD11 ' CE1' ' A' ' 213' ' ' HIS . 82.6 mt -61.93 -40.54 95.85 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 68.9 p -75.44 -11.72 60.1 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.241 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.96 40.17 9.6 Favored Glycine 0 C--O 1.217 -0.913 0 C-N-CA 120.617 -0.801 . . . . 0.0 113.863 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 99.9 m -125.99 115.03 19.26 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 119.104 1.452 . . . . 0.0 112.36 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -66.4 136.11 55.28 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.147 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 41.7 tp -111.97 128.69 56.24 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 2.8 mp -116.35 132.61 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.587 ' CG2' HD11 ' A' ' 227' ' ' ILE . 49.7 mm -114.35 131.39 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 39.7 p -133.38 165.75 24.12 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 120.766 -0.373 . . . . 0.0 111.583 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 79.35 20.35 69.62 Favored Glycine 0 C--O 1.224 -0.508 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 178.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.665 HD12 HG23 ' A' ' 247' ' ' THR . 97.3 mt -81.83 128.83 38.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 113.692 -1.254 . . . . 0.0 108.124 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 66.0 tttt -75.89 139.96 70.21 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.47 -38.23 89.79 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 121.108 1.205 . . . . 0.0 112.453 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -64.94 -39.23 93.19 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-O 121.29 0.566 . . . . 0.0 110.268 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 53.3 tp -63.57 -43.11 97.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.915 -1.039 . . . . 0.0 112.753 177.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.66 -37.66 88.19 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 121.96 -0.463 . . . . 0.0 111.175 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 93.7 mtp -63.2 -40.47 97.6 Favored 'General case' 0 C--O 1.251 1.16 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.704 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -64.32 -39.29 93.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.758 176.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 30.1 mmt -65.45 -37.72 87.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.746 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -60.8 -41.02 94.81 Favored 'General case' 0 CA--C 1.513 -0.447 0 O-C-N 121.48 -0.763 . . . . 0.0 109.491 -176.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.71 -39.9 93.14 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.355 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 52.7 tp -63.18 -42.05 99.3 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 176.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -168.89 128.19 1.08 Allowed 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 121.404 0.621 . . . . 0.0 112.559 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -60.22 -28.02 67.67 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.821 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -61.16 -27.56 68.49 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.674 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -56.42 -43.73 79.66 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -176.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 96.6 p -63.2 -20.84 65.79 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 124.108 0.88 . . . . 0.0 111.298 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 41.7 m -55.25 -34.25 63.85 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 122.056 -0.403 . . . . 0.0 111.763 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 94.3 mt -89.76 121.6 32.07 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -46.1 134.77 8.12 Favored 'General case' 0 C--O 1.248 0.986 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.615 -177.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.665 HG23 HD12 ' A' ' 227' ' ' ILE . 97.8 m -126.48 132.8 51.35 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 114.605 -1.18 . . . . 0.0 110.968 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' TYR . . . . . 0.515 ' CG ' ' HB2' ' A' ' 254' ' ' ALA . 96.4 m-85 -117.51 139.49 50.86 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.788 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 78.3 p -60.68 -42.58 97.38 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -178.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -143.74 160.75 40.17 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.606 0.717 . . . . 0.0 111.651 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.02 -44.79 99.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 114.725 -1.125 . . . . 0.0 112.301 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.89 -44.67 96.78 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -178.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . 0.432 ' O ' HG22 ' A' ' 257' ' ' VAL . 55.6 m-20 -62.75 -44.38 96.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.599 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . 0.515 ' HB2' ' CG ' ' A' ' 248' ' ' TYR . . . -63.59 -42.45 98.28 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.975 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . 0.626 HG13 HH11 ' B' ' 154' ' ' ARG . 66.8 t -63.86 -45.41 97.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-N 114.051 -1.431 . . . . 0.0 110.798 -178.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.77 -47.09 82.36 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.846 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.498 ' O ' ' C ' ' A' ' 258' ' ' LEU . 22.5 m -67.51 -41.09 85.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 O-C-N 121.453 -0.779 . . . . 0.0 112.034 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.498 ' C ' ' O ' ' A' ' 257' ' ' VAL . 1.1 mt -28.17 -74.84 0.04 OUTLIER Pre-proline 0 C--O 1.234 0.265 0 CA-C-O 119.518 -0.277 . . . . 0.0 111.542 -177.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 258' ' ' LEU . 39.9 Cg_endo -62.85 139.84 76.55 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 120.833 1.022 . . . . 0.0 111.934 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 259' ' ' PRO . 96.6 mt -151.8 -27.17 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 O-C-N 123.779 0.675 . . . . 0.0 111.981 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 C--O 1.216 -0.683 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.782 -177.262 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.58 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -165.18 170.26 15.11 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 84.2 p -66.82 -16.71 64.46 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -79.85 -64.21 1.24 Allowed 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.103 -177.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -66.4 -39.81 89.24 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.302 -0.863 . . . . 0.0 113.073 178.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . 0.495 ' O ' ' CB ' ' B' ' 7' ' ' PHE . 58.9 m -59.25 -42.44 91.14 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 -178.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . 0.519 ' CE2' HD12 ' B' ' 9' ' ' ILE . 32.8 t80 87.01 90.96 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.742 0.651 . . . . 0.0 110.697 177.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . 0.549 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -63.27 -142.77 0.01 OUTLIER Glycine 0 C--N 1.339 0.727 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.549 ' HB ' ' O ' ' B' ' 8' ' ' GLY . 64.7 mt 83.88 110.38 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 122.773 0.429 . . . . 0.0 110.784 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -63.15 -23.61 73.08 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 C-N-CA 121.249 1.299 . . . . 0.0 111.812 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.24 -38.81 96.82 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -64.99 -39.07 92.92 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.473 0.654 . . . . 0.0 109.551 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 49.8 tp -61.95 -43.0 99.74 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.507 -177.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -64.45 -31.78 73.14 Favored 'General case' 0 CA--C 1.559 1.317 0 CA-C-O 121.358 0.599 . . . . 0.0 110.614 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . 0.513 HG22 ' CD1' ' A' ' 113' ' ' ILE . 74.6 t -63.27 -46.19 96.31 Favored 'Isoleucine or valine' 0 C--O 1.249 1.053 0 CA-C-N 113.179 -1.828 . . . . 0.0 111.198 177.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.82 -43.69 97.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.795 -178.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . 0.406 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 98.9 mttt -63.31 -42.53 99.04 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.88 -40.54 97.83 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 118.991 -1.084 . . . . 0.0 109.964 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.87 -39.62 89.86 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.018 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 20' ' ' LEU . 87.6 mt -63.81 -41.93 97.78 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.276 0.56 . . . . 0.0 110.33 175.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -62.87 -39.01 93.12 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.798 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 56.4 m170 -58.2 -39.68 79.62 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 121.086 -0.246 . . . . 0.0 111.521 -178.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 13.6 p -114.71 130.11 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.482 ' O ' ' HG3' ' B' ' 24' ' ' ARG . 31.6 ptt180 -72.43 108.17 5.38 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.687 0.755 . . . . 0.0 112.582 -177.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.0 p -142.6 134.22 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.731 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . 0.569 ' O ' ' N ' ' B' ' 123' ' ' GLN . . . -88.25 96.99 2.25 Favored Glycine 0 C--N 1.31 -0.913 0 C-N-CA 119.655 -1.26 . . . . 0.0 113.43 -176.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 48.5 t -125.74 129.19 72.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 174.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 30.2 m -138.33 156.19 29.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.473 178.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 96.1 mt -118.0 124.71 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.247 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 25.9 p -102.31 159.34 15.49 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 113.146 -1.843 . . . . 0.0 108.603 -178.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -127.43 101.74 24.25 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.3 -18.58 60.98 Favored 'Trans proline' 0 N--CA 1.49 1.309 0 C-N-CA 121.683 1.589 . . . . 0.0 111.477 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.09 -39.9 94.03 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.576 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 93.8 mt -77.16 -164.71 0.48 Allowed 'General case' 0 N--CA 1.475 0.8 0 O-C-N 122.106 -0.371 . . . . 0.0 111.057 -178.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . 0.679 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 42.4 tt0 -87.56 129.87 34.95 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.45 ' O ' ' OD1' ' B' ' 36' ' ' ASP . 62.8 t0 57.47 35.42 25.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.751 177.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' ASN . . . . . 0.424 ' C ' ' O ' ' B' ' 36' ' ' ASP . 20.0 t-20 33.04 68.95 0.92 Allowed Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.679 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 89.3 Cg_endo -72.09 155.76 56.54 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 123.745 2.963 . . . . 0.0 111.865 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 95.6 mt -88.21 127.99 40.85 Favored 'Isoleucine or valine' 0 C--O 1.246 0.908 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 27.7 m -107.73 -43.03 6.31 Favored 'Isoleucine or valine' 0 C--N 1.343 0.3 0 O-C-N 123.892 0.745 . . . . 0.0 112.603 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -97.01 123.9 40.85 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.366 -178.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 5.7 p -142.94 140.92 27.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 124.212 0.945 . . . . 0.0 109.293 177.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . 0.639 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 57.2 p30 -100.34 161.6 13.5 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.035 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' GLN . . . . . 0.442 ' OE1' ' HA ' ' B' ' 44' ' ' GLN . 13.8 mm100 -63.4 -38.02 89.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.569 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.37 -25.6 63.0 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.654 ' CE2' HD13 ' B' ' 57' ' ' ILE . 62.6 t80 -59.96 -43.86 94.79 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 0.872 HG13 ' O ' ' B' ' 52' ' ' TYR . 63.3 t -61.3 -45.69 98.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.153 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -62.87 -44.19 96.77 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.057 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 59.4 ttm -62.81 -42.83 99.88 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 34.5 p -95.62 -15.89 22.45 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.72 -178.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' B' ' 47' ' ' VAL . . . 73.46 19.22 79.64 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.336 -1.105 . . . . 0.0 110.336 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . 0.872 ' O ' HG13 ' B' ' 47' ' ' VAL . 78.4 m-85 -110.75 145.19 38.53 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 115.27 -0.465 . . . . 0.0 110.1 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -74.18 149.02 41.15 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 121.817 0.818 . . . . 0.0 110.874 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . 0.412 HG22 ' H ' ' B' ' 54' ' ' THR . 0.1 OUTLIER -61.99 -37.7 85.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.084 -177.398 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.03 -39.09 93.32 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 120.085 -0.646 . . . . 0.0 112.196 -178.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -72.59 -31.51 65.26 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 177.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.654 HD13 ' CE2' ' B' ' 46' ' ' PHE . 92.1 mt -69.91 -61.73 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 97.0 mt -49.49 133.86 19.93 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 123.966 0.791 . . . . 0.0 109.984 -178.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.98 -10.19 72.21 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.712 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -131.48 149.34 52.56 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -176.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' ASN . . . . . 0.55 ' C ' ' H ' ' B' ' 63' ' ' ARG . 25.2 t-20 -79.62 151.49 30.56 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.619 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' CYS . . . . . . . . . . . . . 83.5 m -63.28 9.9 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.256 -178.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' ARG . . . . . 0.55 ' H ' ' C ' ' B' ' 61' ' ' ASN . 33.5 ptt-85 -60.06 -32.31 70.81 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.585 -177.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -60.5 -30.89 70.0 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 85.6 mt -62.21 -41.86 98.77 Favored 'General case' 0 C--O 1.238 0.462 0 O-C-N 121.601 -0.687 . . . . 0.0 109.758 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -50.12 143.81 7.79 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -177.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . 0.49 ' HA3' ' CE1' ' B' ' 95' ' ' TYR . . . -155.08 -152.86 6.3 Favored Glycine 0 C--N 1.353 1.473 0 CA-C-N 115.967 -0.561 . . . . 0.0 112.156 176.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.25 -42.43 95.27 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -175.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -74.77 -9.92 59.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.069 -178.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' THR . . . . . 0.437 ' OG1' ' N ' ' B' ' 67' ' ' GLY . 27.4 m -60.64 133.5 56.16 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -90.55 110.92 44.56 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.39 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.64 -38.09 90.97 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 120.978 1.119 . . . . 0.0 111.63 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.16 -40.6 90.43 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -176.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' GLU . . . . . 0.42 ' OE1' ' HB ' ' B' ' 90' ' ' VAL . 79.5 mm-40 -67.0 -38.29 85.73 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.963 177.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 70.2 t -63.42 -44.76 99.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.091 0.472 . . . . 0.0 109.819 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -63.18 -37.3 86.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.7 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -62.44 -42.03 99.16 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 119.276 -0.97 . . . . 0.0 108.955 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 92.6 mt -63.51 -43.72 98.44 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 CA-C-O 120.894 0.378 . . . . 0.0 110.924 -178.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -61.37 -42.54 98.87 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 83.0 m -61.33 -44.93 96.37 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.884 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.99 -42.58 99.3 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -177.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.36 -42.49 99.44 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -62.91 -39.88 95.87 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -81.61 -4.02 54.98 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.803 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 36.7 tttt 50.08 48.52 21.88 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 121.825 -0.547 . . . . 0.0 111.649 177.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -132.93 144.58 53.44 Favored Pre-proline 0 N--CA 1.472 0.673 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.334 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.43 139.62 77.7 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 120.765 0.977 . . . . 0.0 114.045 -177.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -139.98 135.55 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.592 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 89' ' ' THR . . . . . 0.88 HG23 ' OD1' ' B' ' 107' ' ' ASN . 98.9 m -119.9 120.72 37.24 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.42 ' HB ' ' OE1' ' B' ' 74' ' ' GLU . 30.7 m -138.33 161.95 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.594 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -114.42 121.21 42.88 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 175.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . 0.403 HD11 HG23 ' B' ' 70' ' ' THR . 20.8 tt -128.43 132.65 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.798 -175.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . 0.423 ' O ' ' ND2' ' B' ' 94' ' ' ASN . 85.7 mt-30 -71.21 141.67 50.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.076 178.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 94' ' ' ASN . . . . . 0.423 ' ND2' ' O ' ' B' ' 93' ' ' GLN . 8.9 m120 -134.92 179.95 5.99 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 121.247 0.546 . . . . 0.0 111.107 -177.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 95' ' ' TYR . . . . . 0.49 ' CE1' ' HA3' ' B' ' 67' ' ' GLY . 95.6 m-85 -130.23 149.68 51.81 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 114.524 -1.216 . . . . 0.0 111.855 177.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . 0.48 ' HG3' ' CE1' ' B' ' 102' ' ' PHE . 99.0 mttt -103.41 -177.07 3.26 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.269 0.557 . . . . 0.0 110.716 176.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.4 -35.07 76.48 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.647 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 36.6 p-10 -88.17 -0.33 56.96 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.271 -0.893 . . . . 0.0 113.042 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.38 3.73 66.83 Favored Glycine 0 N--CA 1.465 0.574 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.109 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 25.5 m -67.66 130.49 43.17 Favored 'General case' 0 N--CA 1.443 -0.801 0 O-C-N 122.159 -0.612 . . . . 0.0 109.39 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 101' ' ' MET . . . . . 0.57 ' SD ' ' N ' ' B' ' 102' ' ' PHE . 15.8 tmm? -90.15 142.47 27.69 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 102' ' ' PHE . . . . . 0.57 ' N ' ' SD ' ' B' ' 101' ' ' MET . 53.9 p90 -152.72 163.72 39.15 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 177.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 103' ' ' TRP . . . . . 0.839 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 22.1 m95 -95.65 140.16 30.87 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.342 178.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . 0.403 HD21 ' HG2' ' B' ' 123' ' ' GLN . 62.6 t-20 -133.94 106.47 7.28 Favored 'General case' 0 C--O 1.217 -0.631 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -177.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -75.03 123.88 25.97 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 125.193 1.558 . . . . 0.0 109.262 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 38.9 tp -112.81 125.71 54.64 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 123.58 0.55 . . . . 0.0 111.608 -177.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 107' ' ' ASN . . . . . 0.88 ' OD1' HG23 ' B' ' 89' ' ' THR . 98.1 m-20 -118.96 127.7 53.72 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 176.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 96.5 mt -123.12 132.97 70.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -143.33 125.03 8.4 Favored Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -70.19 152.0 66.88 Favored 'Trans proline' 0 N--CA 1.5 1.878 0 C-N-CA 122.254 1.969 . . . . 0.0 112.624 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . 0.559 ' HB2' ' HB2' ' B' ' 118' ' ' TYR . 67.2 mtt -128.69 142.17 51.1 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -113.67 109.86 19.28 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . 0.718 HG12 ' HZ1' ' A' ' 18' ' ' LYS . 96.7 mt -136.11 127.92 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 O-C-N 121.352 -0.842 . . . . 0.0 111.709 178.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 52.49 37.33 22.6 Favored 'General case' 0 C--O 1.236 0.375 0 O-C-N 123.819 0.7 . . . . 0.0 109.63 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 61.71 35.74 16.78 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.519 0.676 . . . . 0.0 110.248 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -132.21 151.36 51.85 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 177.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 5.1 t -101.02 154.21 18.9 Favored 'General case' 0 C--O 1.215 -0.748 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 118' ' ' TYR . . . . . 0.559 ' HB2' ' HB2' ' B' ' 111' ' ' MET . 90.7 m-85 -149.16 145.32 27.11 Favored 'General case' 0 C--N 1.318 -0.791 0 O-C-N 121.09 -1.006 . . . . 0.0 111.152 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -120.02 139.25 52.79 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 120.812 0.339 . . . . 0.0 111.821 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -128.92 137.35 57.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -177.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -113.54 126.21 7.3 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 94.9 mt -114.29 127.92 71.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 123' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' B' ' 26' ' ' GLY . 17.6 mp0 -117.87 123.42 45.83 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -121.56 124.19 43.77 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' B' ' 127' ' ' THR . 67.5 t0 -74.94 126.06 30.2 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.556 -177.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.561 ' O ' ' HG3' ' B' ' 130' ' ' LYS . 3.5 mp -98.98 18.85 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.424 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 127' ' ' THR . . . . . 0.539 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 98.1 m -64.55 -44.75 89.79 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 114.326 -1.306 . . . . 0.0 112.781 175.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -59.96 -45.19 93.44 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 -177.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 129' ' ' GLN . . . . . 0.449 ' OE1' HG23 ' B' ' 126' ' ' ILE . 88.5 mt-30 -63.6 -35.02 79.14 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.441 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 130' ' ' LYS . . . . . 0.839 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 99.0 mttt -63.27 -42.0 99.09 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-N 113.232 -1.803 . . . . 0.0 110.822 174.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.99 -41.69 97.44 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 132' ' ' TYR . . . . . 0.748 ' CE2' HD11 ' B' ' 136' ' ' LEU . 89.0 t80 -60.43 -45.3 94.13 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.948 -0.47 . . . . 0.0 111.341 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . 0.403 ' O ' ' HG3' ' B' ' 137' ' ' GLU . 97.3 mt-10 -64.23 -37.05 86.09 Favored 'General case' 0 C--O 1.218 -0.586 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.438 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 134' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' B' ' 130' ' ' LYS . 99.0 mttt -62.63 -39.71 94.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.89 177.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 53.2 tp -62.68 -41.12 98.92 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 136' ' ' LEU . . . . . 0.748 HD11 ' CE2' ' B' ' 132' ' ' TYR . 87.7 mt -62.83 -41.78 99.46 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 114.858 -1.064 . . . . 0.0 111.566 177.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 137' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' B' ' 133' ' ' GLU . 97.3 mt-10 -64.69 -36.93 85.87 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.484 -178.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -63.28 -44.07 96.15 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.873 177.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 63.2 m -61.04 -44.05 97.98 Favored 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . 0.431 ' O ' ' N ' ' B' ' 144' ' ' THR . 85.6 mt -61.98 -40.23 94.91 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -177.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 86.1 m -61.88 -45.52 93.39 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.173 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -65.66 -41.64 92.29 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 93.0 mt -63.8 -43.12 97.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 114.458 -1.247 . . . . 0.0 110.559 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 144' ' ' THR . . . . . 0.431 ' N ' ' O ' ' B' ' 140' ' ' LEU . 89.0 m -61.69 -45.09 95.47 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -178.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . 0.413 ' O ' ' HB ' ' B' ' 148' ' ' THR . . . -63.8 -40.92 97.81 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 118.958 -1.097 . . . . 0.0 109.278 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 87.3 mt -64.53 -41.59 96.28 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 147' ' ' SER . . . . . 0.628 ' O ' ' N ' ' B' ' 149' ' ' PRO . 77.9 p -60.89 -42.1 97.34 Favored 'General case' 0 CA--C 1.481 -1.676 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 -178.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 148' ' ' THR . . . . . 0.469 ' C ' ' O ' ' B' ' 147' ' ' SER . 23.2 m -29.42 84.91 0.03 OUTLIER Pre-proline 0 N--CA 1.482 1.169 0 O-C-N 123.959 0.787 . . . . 0.0 110.182 178.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 149' ' ' PRO . . . . . 0.628 ' N ' ' O ' ' B' ' 147' ' ' SER . 22.0 Cg_exo -61.46 148.24 93.46 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.865 1.71 . . . . 0.0 115.849 -176.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 150' ' ' ILE . . . . . 0.405 ' O ' HG23 ' B' ' 150' ' ' ILE . 9.6 tp -125.91 117.43 48.99 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.156 0 CA-C-N 114.273 -1.33 . . . . 0.0 107.805 173.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 40.1 t -146.99 92.94 4.85 Favored Pre-proline 0 C--N 1.314 -0.946 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.592 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -60.81 136.39 65.96 Favored 'Trans proline' 0 C--N 1.316 -1.154 0 CA-C-N 120.321 1.15 . . . . 0.0 109.219 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 153' ' ' ILE . . . . . 0.674 ' O ' ' HD2' ' B' ' 154' ' ' ARG . 44.6 mm -68.4 -44.35 83.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.956 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 154' ' ' ARG . . . . . 0.719 ' HD3' ' NH2' ' A' ' 154' ' ' ARG . 0.4 OUTLIER -156.56 -154.55 0.48 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.464 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 59.3 t-20 -87.02 108.03 18.68 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 121.024 0.44 . . . . 0.0 110.156 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.79 -17.31 58.47 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 -178.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 157' ' ' ILE . . . . . 0.46 HG22 ' HB ' ' B' ' 153' ' ' ILE . 85.3 mt -109.38 124.07 65.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.275 0.56 . . . . 0.0 111.002 -176.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 158' ' ' SER . . . . . 0.542 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 74.5 m -134.74 149.75 50.49 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.738 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 159' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' B' ' 191' ' ' ILE . . . -132.25 147.27 52.4 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 18.0 tp -138.96 77.72 31.12 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 161' ' ' PRO . . . . . 0.429 ' HB3' ' HB3' ' B' ' 193' ' ' ASP . 90.1 Cg_endo -70.79 146.82 54.83 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 122.867 2.378 . . . . 0.0 114.095 -178.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 92.0 mt -113.03 133.85 54.79 Favored 'General case' 0 C--N 1.345 0.37 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 56.1 t -129.29 132.98 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 177.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 114.86 168.47 15.81 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.012 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 165' ' ' ASN . . . . . 0.768 ' O ' ' CZ ' ' B' ' 170' ' ' ARG . 61.4 t30 -90.03 106.65 18.62 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -177.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 166' ' ' LEU . . . . . 0.625 HD21 ' CZ ' ' B' ' 171' ' ' PHE . 42.3 tp -64.3 104.23 0.73 Allowed 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -174.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 167' ' ' THR . . . . . 0.692 HG23 ' NE ' ' B' ' 170' ' ' ARG . 9.6 p -85.73 168.6 14.2 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 113.806 -1.543 . . . . 0.0 111.094 177.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.05 -38.68 91.64 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.607 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -65.85 -41.68 91.38 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 122.402 1.096 . . . . 0.0 111.778 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 170' ' ' ARG . . . . . 0.768 ' CZ ' ' O ' ' B' ' 165' ' ' ASN . 87.8 mtm180 -61.53 -34.72 76.03 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 112.558 -2.11 . . . . 0.0 110.952 178.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 171' ' ' PHE . . . . . 0.625 ' CZ ' HD21 ' B' ' 166' ' ' LEU . 0.5 OUTLIER -54.89 -25.9 32.16 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -178.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 172' ' ' ASN . . . . . 0.599 ' O ' HG22 ' B' ' 175' ' ' VAL . 92.4 m-20 -62.74 -40.33 96.88 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.834 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 55.3 m -59.85 -41.41 91.36 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.013 0.435 . . . . 0.0 110.598 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 68.2 mt -63.87 -44.15 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 175' ' ' VAL . . . . . 0.599 HG22 ' O ' ' B' ' 172' ' ' ASN . 35.6 m -62.45 -40.01 86.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 176' ' ' CYS . . . . . 0.415 ' N ' HG23 ' B' ' 175' ' ' VAL . 98.1 m -61.95 -35.3 78.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.329 179.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 177' ' ' THR . . . . . 0.563 ' O ' HG13 ' B' ' 181' ' ' ILE . 25.0 m -61.84 -19.67 62.85 Favored 'General case' 0 C--O 1.22 -0.494 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.38 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 178' ' ' LEU . . . . . 0.57 ' CD2' HD21 ' B' ' 211' ' ' LEU . 89.6 mt -60.83 -39.24 88.29 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.238 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 18.9 m -61.74 -44.29 97.21 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.547 177.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 180' ' ' ASN . . . . . 0.592 ' O ' ' OG ' ' B' ' 183' ' ' SER . 92.3 m-20 -61.74 -39.99 93.53 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.161 0.505 . . . . 0.0 110.537 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.563 HG13 ' O ' ' B' ' 177' ' ' THR . 73.0 mt -55.99 -33.48 35.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 O-C-N 122.143 -0.348 . . . . 0.0 110.465 -178.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 182' ' ' LEU . . . . . 0.4 ' HA ' HD23 ' B' ' 182' ' ' LEU . 86.7 mt -62.38 -41.74 98.87 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.163 178.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . 0.592 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.1 p -63.33 -32.89 74.43 Favored 'General case' 0 C--O 1.225 -0.221 0 O-C-N 121.905 -0.497 . . . . 0.0 110.768 177.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 45.9 p -86.96 17.04 4.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.907 0.384 . . . . 0.0 111.769 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 78.6 p -60.6 -16.51 38.98 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.966 -177.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.64 -40.3 94.41 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 122.075 -0.39 . . . . 0.0 110.811 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 187' ' ' ASP . . . . . 0.542 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.3 m-20 -68.52 114.41 6.9 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.576 0.703 . . . . 0.0 110.793 -178.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.88 -42.23 99.69 Favored 'General case' 0 C--O 1.25 1.109 0 CA-C-N 114.997 -1.001 . . . . 0.0 113.242 -178.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -113.0 131.77 55.63 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 120.711 -0.395 . . . . 0.0 111.386 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 190' ' ' LEU . . . . . . . . . . . . . 40.8 tp -123.97 118.96 28.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.372 177.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 191' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' B' ' 159' ' ' ALA . 85.6 mt -106.38 125.71 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 121.128 -0.229 . . . . 0.0 111.444 -178.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 48.7 mm -115.16 117.01 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 193' ' ' ASP . . . . . 0.527 ' CG ' ' HG ' ' B' ' 195' ' ' SER . 43.0 t0 -89.42 113.09 24.38 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -176.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 194' ' ' LEU . . . . . . . . . . . . . 96.2 mt -95.45 -1.1 51.55 Favored 'General case' 0 C--O 1.239 0.509 0 O-C-N 122.265 -0.272 . . . . 0.0 110.691 177.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 195' ' ' SER . . . . . 0.527 ' HG ' ' CG ' ' B' ' 193' ' ' ASP . 78.1 p -61.17 -36.7 80.54 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.0 -178.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.42 -37.37 94.0 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 197' ' ' LEU . . . . . 0.959 HD23 ' N ' ' B' ' 198' ' ' ALA . 5.2 tt -72.34 133.63 45.07 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -178.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 198' ' ' ALA . . . . . 0.959 ' N ' HD23 ' B' ' 197' ' ' LEU . . . -61.81 -49.19 77.32 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 119.556 -0.858 . . . . 0.0 111.137 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 199' ' ' GLN . . . . . 0.901 ' O ' ' CD2' ' B' ' 197' ' ' LEU . 58.3 tt0 -134.5 164.55 27.22 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-O 121.783 0.802 . . . . 0.0 113.04 -178.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 200' ' ' VAL . . . . . 0.504 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 50.1 t -120.19 130.72 74.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 O-C-N 120.368 -1.458 . . . . 0.0 109.502 176.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -86.15 151.56 23.56 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.658 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -62.64 -33.12 74.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.439 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -63.46 -31.93 73.23 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.6 m -60.92 -43.78 98.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.186 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 205' ' ' ALA . . . . . 0.641 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -58.73 -30.06 67.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 119.26 -0.4 . . . . 0.0 111.848 -178.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -64.61 -39.08 93.08 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 123.79 0.681 . . . . 0.0 110.191 175.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -66.33 -38.69 88.24 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.694 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 96.3 mt -63.14 -43.92 99.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -178.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 209' ' ' PHE . . . . . 0.641 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 64.0 m-85 -61.56 -43.57 98.62 Favored 'General case' 0 C--O 1.242 0.692 0 O-C-N 124.682 1.239 . . . . 0.0 111.856 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -62.9 -41.48 99.45 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.25 -0.98 . . . . 0.0 109.727 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 211' ' ' LEU . . . . . 0.57 HD21 ' CD2' ' B' ' 178' ' ' LEU . 37.8 mt -62.45 -42.43 99.46 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.189 -179.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 78.2 p -62.74 -37.58 87.14 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.283 -0.567 . . . . 0.0 112.141 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 213' ' ' HIS . . . . . 0.459 ' CE1' HD11 ' B' ' 217' ' ' LEU . 58.8 t-80 -66.31 -47.21 74.27 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.34 178.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 53.4 tp -63.79 -43.44 96.32 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.616 0.722 . . . . 0.0 109.532 178.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 215' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' B' ' 211' ' ' LEU . 90.7 mt -63.09 -43.18 99.23 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 113.466 -1.697 . . . . 0.0 111.214 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.85 -39.46 94.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.727 -0.215 . . . . 0.0 110.933 -177.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . 0.459 HD11 ' CE1' ' B' ' 213' ' ' HIS . 85.7 mt -63.25 -42.46 99.18 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.203 0.525 . . . . 0.0 111.39 176.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 218' ' ' THR . . . . . . . . . . . . . 71.9 p -75.3 -14.15 60.48 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.683 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 77.79 72.66 1.13 Allowed Glycine 0 CA--C 1.528 0.877 0 N-CA-C 107.141 -2.384 . . . . 0.0 107.141 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 220' ' ' THR . . . . . . . . . . . . . 81.7 m -151.72 100.8 2.72 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 177.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -58.59 140.09 54.88 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 121.849 -0.532 . . . . 0.0 111.103 -177.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 42.0 tp -117.49 120.72 38.97 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.171 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 2.9 mp -109.92 128.91 65.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.166 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 224' ' ' ILE . . . . . 0.555 ' CG2' HD11 ' B' ' 227' ' ' ILE . 50.4 mm -110.68 127.47 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 O-C-N 123.572 0.545 . . . . 0.0 109.532 -179.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 43.7 p -134.42 157.57 46.11 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 90.78 16.17 55.17 Favored Glycine 0 N--CA 1.442 -0.967 0 CA-C-N 113.949 -1.478 . . . . 0.0 111.228 -177.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 227' ' ' ILE . . . . . 0.675 HD12 HG23 ' B' ' 247' ' ' THR . 95.9 mt -81.74 126.63 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 CA-C-N 117.889 0.845 . . . . 0.0 111.686 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 61.2 tttt -67.01 139.28 95.43 Favored Pre-proline 0 C--N 1.316 -0.854 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.521 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.85 -37.04 92.78 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 121.354 1.37 . . . . 0.0 112.483 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -63.08 -43.48 98.4 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 53.1 tp -62.42 -41.98 99.1 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.679 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -62.95 -36.99 85.29 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.892 0.377 . . . . 0.0 111.367 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 94.6 mtp -63.75 -41.15 98.06 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.758 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.3 -43.33 99.07 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 121.995 0.902 . . . . 0.0 109.366 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 30.2 mmt -64.33 -35.85 82.22 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.896 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -61.08 -40.62 94.38 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.987 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.77 -43.05 99.82 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.287 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 52.7 tp -62.68 -44.25 96.73 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 121.883 -0.51 . . . . 0.0 112.27 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 239' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' B' ' 240' ' ' ALA . 66.7 t0 -159.28 133.42 7.62 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 120.149 -0.62 . . . . 0.0 111.982 -178.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 240' ' ' ALA . . . . . 0.4 ' N ' ' OD1' ' B' ' 239' ' ' ASP . . . -60.98 -47.76 84.95 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 241' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' B' ' 244' ' ' SER . 90.2 m-20 -43.23 -19.37 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.475 -175.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 242' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -60.34 -45.03 94.9 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.172 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 243' ' ' SER . . . . . . . . . . . . . 78.1 p -58.77 -42.03 88.01 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 244' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 25.2 m -35.25 -32.53 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -177.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 98.9 mt -90.41 131.54 36.12 Favored 'General case' 0 CA--C 1.513 -0.452 0 O-C-N 121.1 -1.0 . . . . 0.0 110.061 178.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -59.47 134.89 57.42 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 121.421 0.629 . . . . 0.0 110.376 -176.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 247' ' ' THR . . . . . 0.675 HG23 HD12 ' B' ' 227' ' ' ILE . 97.3 m -125.62 127.99 47.19 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.484 -1.235 . . . . 0.0 111.861 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 248' ' ' TYR . . . . . 0.546 ' CG ' ' HB2' ' B' ' 254' ' ' ALA . 98.1 m-85 -113.3 144.15 43.22 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 249' ' ' SER . . . . . 0.563 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 78.6 p -64.57 -33.66 76.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.476 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 250' ' ' ASN . . . . . 0.563 ' OD1' ' O ' ' B' ' 249' ' ' SER . 99.0 m-20 -147.2 160.11 42.85 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.971 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 61.7 t -64.21 -44.69 97.49 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.254 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.293 177.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 252' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.24 -45.4 94.68 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -177.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . 0.444 ' O ' HG22 ' B' ' 257' ' ' VAL . 93.5 m-20 -61.51 -44.24 97.42 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.75 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 254' ' ' ALA . . . . . 0.546 ' HB2' ' CG ' ' B' ' 248' ' ' TYR . . . -65.44 -40.65 93.52 Favored 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.893 178.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 255' ' ' VAL . . . . . 0.729 HG13 HH11 ' A' ' 154' ' ' ARG . 74.2 t -64.66 -45.48 95.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.3 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 256' ' ' LYS . . . . . 0.411 ' HE3' ' ND2' ' A' ' 155' ' ' ASN . 88.6 tttt -63.04 -48.46 78.62 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 120.132 -0.627 . . . . 0.0 111.118 -178.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 257' ' ' VAL . . . . . 0.486 ' O ' ' C ' ' B' ' 258' ' ' LEU . 20.1 m -65.55 -40.79 89.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.662 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 258' ' ' LEU . . . . . 0.508 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 1.0 OUTLIER -31.58 -73.67 0.05 OUTLIER Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 119.499 -0.286 . . . . 0.0 111.664 -178.009 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 259' ' ' PRO . . . . . 0.508 ' CD ' ' CB ' ' B' ' 258' ' ' LEU . 36.6 Cg_endo -61.81 139.99 83.17 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 121.531 1.487 . . . . 0.0 111.575 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 260' ' ' ILE . . . . . 0.547 ' O ' HG22 ' B' ' 260' ' ' ILE . 96.6 mt -157.47 -14.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 118.665 0.666 . . . . 0.0 112.054 177.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 78.3 mtm . . . . . 0 C--O 1.214 -0.801 0 CA-C-O 117.761 -1.114 . . . . 0.0 111.573 -179.588 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.14 171.81 17.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 118.968 -0.539 . . . . 0.0 110.226 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.5 p -71.3 -14.89 62.36 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.332 0.653 . . . . 0.0 110.757 177.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -75.53 -66.3 0.79 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.615 175.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -67.28 -39.3 85.99 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.969 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.533 ' O ' ' HB3' ' A' ' 7' ' ' PHE . 63.1 m -59.44 -42.56 92.19 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.114 -176.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.533 ' HB3' ' O ' ' A' ' 6' ' ' SER . 44.3 t80 85.52 85.69 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 O-C-N 123.707 0.63 . . . . 0.0 112.495 177.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.664 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -62.21 -152.15 0.03 OUTLIER Glycine 0 CA--C 1.529 0.967 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -177.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.664 ' HB ' ' O ' ' A' ' 8' ' ' GLY . 66.9 mt 93.63 108.89 0.02 OUTLIER Pre-proline 0 N--CA 1.472 0.66 0 C-N-CA 122.371 0.269 . . . . 0.0 110.579 -178.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.48 -22.77 71.12 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 121.539 1.493 . . . . 0.0 112.181 -178.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.403 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -63.43 -38.3 96.15 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.112 -0.566 . . . . 0.0 111.726 179.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -65.52 -38.7 90.43 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.654 0.74 . . . . 0.0 109.706 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 52.5 tp -62.71 -41.39 99.12 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.412 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -64.25 -39.04 93.14 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 11' ' ' GLY . 55.5 t -60.51 -44.16 95.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 O-C-N 122.186 -0.321 . . . . 0.0 110.434 -178.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 92.4 mt -62.71 -43.64 98.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 C-N-CA 119.756 -0.777 . . . . 0.0 109.3 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.424 ' NZ ' ' HA ' ' B' ' 6' ' ' SER . 98.9 mttt -62.12 -45.37 93.76 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 119.365 -0.934 . . . . 0.0 112.221 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.712 ' HZ1' HG12 ' B' ' 113' ' ' ILE . 98.7 mttt -60.1 -40.21 88.84 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 118.672 -1.211 . . . . 0.0 109.124 -176.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.34 -42.68 96.21 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.157 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 20' ' ' LEU . 85.7 mt -62.95 -41.18 99.43 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.118 0.485 . . . . 0.0 109.926 178.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -63.49 -37.99 89.41 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.499 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 57.6 m170 -58.92 -39.8 82.63 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 122.179 -0.326 . . . . 0.0 111.254 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.2 p -113.82 130.44 67.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.498 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 34.6 ptt180 -72.51 110.25 6.76 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.99 0.9 . . . . 0.0 112.08 -177.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.3 p -140.98 143.14 28.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.164 178.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.472 ' O ' ' N ' ' A' ' 123' ' ' GLN . . . -97.91 91.76 1.2 Allowed Glycine 0 C--N 1.312 -0.768 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.76 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.4 t -124.84 130.25 73.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 175.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.4 m -137.17 159.99 36.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.6 mt -119.85 131.14 73.13 Favored 'Isoleucine or valine' 0 C--O 1.247 0.965 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 176.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.516 HG22 HG12 ' A' ' 39' ' ' ILE . 72.6 p -108.04 165.98 11.06 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.415 ' C ' ' OD1' ' A' ' 37' ' ' ASN . 56.1 t0 -130.8 103.29 15.94 Favored Pre-proline 0 C--N 1.319 -0.719 0 C-N-CA 121.087 -0.245 . . . . 0.0 110.538 178.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.436 ' HG3' HG23 ' A' ' 117' ' ' THR . 35.0 Cg_endo -62.69 -23.61 74.63 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 121.365 1.376 . . . . 0.0 111.701 -178.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.78 -36.38 83.68 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.729 -178.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.6 mt -83.74 156.12 22.73 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.641 177.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.754 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 43.0 tt0 -58.1 138.06 56.4 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -176.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.548 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 60.0 t0 59.29 20.47 8.64 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.767 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.415 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 46.5 t-20 40.29 68.58 2.2 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.072 -177.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.754 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 91.2 Cg_endo -70.69 155.31 63.11 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 124.06 3.173 . . . . 0.0 112.649 -178.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.516 HG12 HG22 ' A' ' 30' ' ' THR . 95.8 mt -87.68 123.85 40.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.429 HG23 ' N ' ' A' ' 41' ' ' TYR . 28.0 m -104.21 -43.41 8.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.883 -178.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.429 ' N ' HG23 ' A' ' 40' ' ' VAL . 43.5 t80 -94.84 124.31 38.81 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.552 -177.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.7 p -143.35 141.1 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 O-C-N 124.314 1.009 . . . . 0.0 109.345 177.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.676 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 56.8 p30 -98.45 166.76 11.21 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.512 ' OE1' ' HA ' ' A' ' 44' ' ' GLN . 13.5 mm100 -66.7 -39.04 87.9 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 120.887 0.375 . . . . 0.0 111.868 177.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.17 -25.98 63.04 Favored Glycine 0 C--N 1.332 0.346 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.676 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 62.9 t80 -59.22 -48.42 81.67 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 -178.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.57 HG13 ' O ' ' A' ' 52' ' ' TYR . 53.7 t -58.88 -44.9 91.72 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.542 0 O-C-N 121.274 -0.891 . . . . 0.0 111.074 -173.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -63.26 -37.71 88.31 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.768 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 59.7 ttm -67.17 -44.14 80.48 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 176.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 37.9 p -90.26 -23.2 21.27 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.146 0.498 . . . . 0.0 111.845 -178.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . 77.74 19.34 75.86 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.57 ' O ' HG13 ' A' ' 47' ' ' VAL . 77.4 m-85 -112.71 138.09 50.03 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.1 0.56 . . . . 0.0 111.606 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -63.75 148.2 49.78 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.535 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.421 HG22 ' H ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -65.54 -32.41 73.98 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -179.45 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.02 -43.43 87.66 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.434 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -64.73 -44.23 90.84 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.621 178.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.628 HD13 ' CD2' ' A' ' 46' ' ' PHE . 88.3 mt -61.49 -51.3 74.46 Favored 'Isoleucine or valine' 0 C--N 1.347 0.489 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -174.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 86.0 mt -56.83 146.03 27.62 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 177.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.17 -6.63 74.88 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-O 119.339 -0.7 . . . . 0.0 112.829 176.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -135.0 150.52 50.34 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.832 1.316 . . . . 0.0 111.882 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.559 ' C ' ' H ' ' A' ' 63' ' ' ARG . 24.9 t-20 -80.17 150.75 30.06 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.241 0.543 . . . . 0.0 110.771 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.406 ' HB3' HD12 ' A' ' 65' ' ' LEU . 76.8 m -63.14 15.86 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.502 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.559 ' H ' ' C ' ' A' ' 61' ' ' ASN . 35.8 ptt-85 -61.67 -41.36 97.44 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.262 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -56.41 -20.49 19.89 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -178.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.406 HD12 ' HB3' ' A' ' 62' ' ' CYS . 87.8 mt -68.23 -34.3 75.99 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.546 0.689 . . . . 0.0 112.506 177.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -64.53 137.83 58.07 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.439 -0.8 . . . . 0.0 112.374 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.567 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -146.54 -147.06 4.49 Favored Glycine 0 CA--C 1.544 1.898 0 C-N-CA 120.825 -0.703 . . . . 0.0 111.892 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.01 -40.29 97.32 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -177.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.439 ' O ' ' OE1' ' A' ' 93' ' ' GLN . 12.6 m-70 -76.77 -7.85 56.19 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.035 -178.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.567 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 28.9 m -63.56 128.82 37.55 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.379 -0.528 . . . . 0.0 109.807 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -84.91 109.3 19.54 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.708 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 70' ' ' THR . 51.5 Cg_exo -56.83 -32.97 93.56 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.042 1.828 . . . . 0.0 113.11 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.46 -39.54 94.0 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.207 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -64.88 -42.31 94.93 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 77.8 t -60.38 -43.65 94.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 114.242 -1.344 . . . . 0.0 107.679 -175.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -63.47 -37.72 88.4 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.928 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -63.77 -40.08 95.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.253 0.549 . . . . 0.0 110.443 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.75 -44.08 98.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-O 122.156 0.979 . . . . 0.0 111.99 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -63.25 -42.92 99.23 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 113.522 -1.672 . . . . 0.0 108.183 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 96.6 m -61.45 -49.92 74.88 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 120.061 -0.655 . . . . 0.0 109.776 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.66 -42.14 87.75 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-O 119.183 -0.437 . . . . 0.0 111.297 -174.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 84.2 mt -63.12 -39.52 94.93 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 119.386 0.994 . . . . 0.0 111.439 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -65.29 -33.22 75.47 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -88.75 -2.13 58.43 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.543 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.8 tttt 50.08 41.65 23.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.752 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -126.06 144.0 47.41 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 108' ' ' ILE . 24.6 Cg_exo -61.61 143.55 96.86 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 121.303 1.335 . . . . 0.0 113.595 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -139.51 141.62 34.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.721 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.722 HG23 ' OD1' ' A' ' 107' ' ' ASN . 91.2 m -125.47 122.42 36.6 Favored 'General case' 0 C--N 1.342 0.271 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 175.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 29.7 m -138.93 157.97 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.675 176.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -102.41 134.33 45.91 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 176.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.404 HG23 ' O ' ' A' ' 92' ' ' ILE . 18.7 tt -141.89 130.65 22.63 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.181 0 CA-C-N 120.5 1.5 . . . . 0.0 112.977 177.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.439 ' OE1' ' O ' ' A' ' 69' ' ' HIS . 86.0 mt-30 -64.75 132.7 50.32 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.871 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -134.09 156.19 48.7 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.46 -178.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -115.89 134.07 55.37 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.444 ' HG3' ' CE1' ' A' ' 102' ' ' PHE . 99.1 mttt -83.03 -173.66 4.84 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.166 0.508 . . . . 0.0 111.52 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.52 -43.11 99.61 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.65 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 40.8 p-10 -82.65 5.54 20.79 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -178.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.39 -0.3 86.99 Favored Glycine 0 N--CA 1.466 0.641 0 C-N-CA 120.879 -0.676 . . . . 0.0 112.225 176.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 26.7 m -59.18 137.74 57.85 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.657 ' SD ' ' C ' ' A' ' 101' ' ' MET . 13.4 tmm? -102.36 127.89 49.17 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.724 0.297 . . . . 0.0 110.95 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.474 ' N ' ' SD ' ' A' ' 101' ' ' MET . 53.2 p90 -140.88 159.66 41.74 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.236 -0.586 . . . . 0.0 109.762 -177.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.888 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 26.1 m95 -92.55 141.12 28.85 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.528 HD21 ' HG2' ' A' ' 123' ' ' GLN . 53.9 t-20 -137.0 104.39 5.44 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -176.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 81.2 tt0 -69.25 137.38 53.08 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -177.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 44.1 tp -121.56 123.97 43.25 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.722 ' OD1' HG23 ' A' ' 89' ' ' THR . 98.3 m-20 -119.67 123.38 43.68 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.522 177.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.413 ' O ' ' HA ' ' A' ' 87' ' ' PRO . 96.2 mt -121.02 128.72 76.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 O-C-N 123.345 0.403 . . . . 0.0 111.225 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -140.61 122.96 9.68 Favored Pre-proline 0 CA--C 1.541 0.596 0 CA-C-O 119.912 -0.089 . . . . 0.0 110.785 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -70.71 150.28 62.16 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 122.593 2.195 . . . . 0.0 112.912 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.594 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 66.9 mtt -122.81 153.86 38.99 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 -179.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -125.0 98.8 5.84 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.596 1.089 . . . . 0.0 108.478 176.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.469 ' CD1' HG22 ' B' ' 15' ' ' VAL . 95.7 mt -121.24 131.19 73.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.875 -178.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 47.63 39.57 10.15 Favored 'General case' 0 CA--C 1.516 -0.349 0 O-C-N 121.599 -0.688 . . . . 0.0 111.613 177.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 59.31 30.64 20.4 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.906 -178.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -127.81 148.54 50.45 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.754 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 5.1 t -86.01 -172.4 4.06 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 121.506 -0.746 . . . . 0.0 109.68 -178.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.754 ' CD2' ' O ' ' A' ' 117' ' ' THR . 69.7 m-85 -171.03 157.32 5.18 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 174.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.463 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 97.2 m-85 -130.27 145.18 51.73 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 173.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -132.95 133.32 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.28 128.22 9.13 Favored Glycine 0 CA--C 1.504 -0.636 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 178.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 96.1 mt -118.09 129.6 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 178.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.528 ' HG2' HD21 ' A' ' 104' ' ' ASN . 16.3 mp0 -119.54 115.84 24.84 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.172 0.511 . . . . 0.0 109.756 179.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -117.72 115.22 24.59 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.13 -177.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 126' ' ' ILE . 68.0 t0 -64.14 129.76 41.26 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -174.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.494 HG22 ' O ' ' A' ' 126' ' ' ILE . 2.6 mp -95.14 2.05 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 113.576 -1.647 . . . . 0.0 110.02 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 20.1 m -60.79 -42.39 97.49 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -178.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -60.35 -42.07 94.95 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -177.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -62.94 -39.25 94.04 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.855 177.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.888 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.6 mttt -62.22 -40.71 97.04 Favored 'General case' 0 CA--C 1.5 -0.979 0 C-N-CA 118.397 -1.321 . . . . 0.0 110.643 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -62.32 -37.4 85.46 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -178.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.661 ' CE2' HD11 ' A' ' 136' ' ' LEU . 89.4 t80 -61.75 -46.33 90.06 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.912 176.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.69 -38.9 92.56 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 130' ' ' LYS . 98.7 mttt -62.04 -40.45 95.77 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 53.1 tp -60.73 -43.53 97.78 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -177.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.661 HD11 ' CE2' ' A' ' 132' ' ' TYR . 86.5 mt -62.66 -41.36 99.02 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.495 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.27 -40.91 98.72 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 119.637 -0.825 . . . . 0.0 109.531 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -60.95 -41.45 96.34 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -177.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.1 m -61.99 -39.96 93.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.896 176.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.523 ' O ' ' N ' ' A' ' 144' ' ' THR . 87.7 mt -63.39 -42.03 98.78 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 99.6 m -61.85 -45.61 93.04 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.975 -177.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -64.54 -41.0 96.62 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 96.1 mt -64.7 -43.46 96.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 113.965 -1.47 . . . . 0.0 111.53 175.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.523 ' N ' ' O ' ' A' ' 140' ' ' LEU . 97.2 m -62.71 -46.07 89.82 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 120.283 -0.567 . . . . 0.0 112.358 -177.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.88 -39.84 95.7 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 118.813 -1.155 . . . . 0.0 109.138 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 87.6 mt -63.76 -42.48 97.8 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.644 178.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.679 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.1 p -60.19 -40.19 89.16 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -177.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.498 ' C ' ' O ' ' A' ' 147' ' ' SER . 93.5 m -26.64 83.57 0.03 OUTLIER Pre-proline 0 C--N 1.343 0.305 0 O-C-N 126.417 2.323 . . . . 0.0 106.814 -178.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.679 ' N ' ' O ' ' A' ' 147' ' ' SER . 22.0 Cg_exo -62.69 145.1 95.0 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 CA-C-O 122.428 0.928 . . . . 0.0 113.949 -175.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.64 ' O ' HG23 ' A' ' 151' ' ' VAL . 9.5 tp -120.25 135.98 58.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 102.378 -3.193 . . . . 0.0 102.378 175.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 150' ' ' ILE . 70.7 t -169.6 95.48 0.51 Allowed Pre-proline 0 N--CA 1.446 -0.64 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 176.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -61.83 135.71 57.51 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 N-CA-C 109.565 -0.975 . . . . 0.0 109.565 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.561 ' O ' ' HD2' ' A' ' 154' ' ' ARG . 46.1 mm -68.0 -44.28 84.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.104 179.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.571 ' NH2' ' HD3' ' B' ' 154' ' ' ARG . 0.3 OUTLIER -156.62 -157.65 0.72 Allowed 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 61.8 t-20 -86.94 105.88 17.41 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.871 0.843 . . . . 0.0 111.631 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 89.29 7.65 69.49 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 113.957 -1.474 . . . . 0.0 110.832 -177.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.474 HG12 ' HB2' ' A' ' 189' ' ' TYR . 96.2 mt -124.42 126.19 71.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 174.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.671 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 66.7 m -132.12 152.5 51.21 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 122.494 0.317 . . . . 0.0 110.36 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -137.91 142.02 40.62 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.612 -0.68 . . . . 0.0 111.338 177.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 15.9 tp -133.8 79.38 58.4 Favored Pre-proline 0 N--CA 1.472 0.662 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.525 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -69.65 150.76 69.32 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.782 2.322 . . . . 0.0 113.165 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 84.8 mt -116.63 125.51 51.9 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.61 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 43.2 t -122.16 130.97 74.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 115.74 169.48 15.67 Favored Glycine 0 N--CA 1.484 1.857 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.061 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.864 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 53.9 t30 -86.51 113.23 22.26 Favored 'General case' 0 C--N 1.347 0.47 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.589 HD21 ' CZ ' ' A' ' 171' ' ' PHE . 46.7 tp -71.32 104.39 3.15 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 -177.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.751 HG23 ' NE ' ' A' ' 170' ' ' ARG . 10.4 p -86.46 166.98 15.08 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.414 178.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -66.01 -34.22 77.59 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.023 0.44 . . . . 0.0 111.551 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.55 -41.83 96.09 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.36 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.864 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 87.6 mtm180 -65.41 -33.98 77.22 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.328 1.051 . . . . 0.0 112.192 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.589 ' CZ ' HD21 ' A' ' 166' ' ' LEU . 0.4 OUTLIER -54.45 -27.94 40.85 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 118.946 -0.55 . . . . 0.0 112.239 -178.695 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.633 ' O ' HG22 ' A' ' 175' ' ' VAL . 91.6 m-20 -61.06 -40.37 93.41 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 119.652 1.114 . . . . 0.0 109.702 -178.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 41.4 m -59.77 -40.47 88.33 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.801 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 68.0 mt -63.21 -44.21 99.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.633 HG22 ' O ' ' A' ' 172' ' ' ASN . 27.1 m -62.82 -39.74 86.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . 0.426 ' N ' HG23 ' A' ' 175' ' ' VAL . 98.7 m -62.5 -34.6 77.19 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.313 0.578 . . . . 0.0 110.388 178.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.584 ' O ' HG13 ' A' ' 181' ' ' ILE . 24.9 m -62.63 -20.39 64.73 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.285 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.64 ' CD2' HD21 ' A' ' 211' ' ' LEU . 86.3 mt -61.17 -41.32 96.58 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -177.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 18.7 m -60.2 -43.27 96.06 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . 0.62 ' O ' ' OG ' ' A' ' 183' ' ' SER . 93.2 m-20 -62.25 -37.26 84.74 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 122.552 0.341 . . . . 0.0 110.963 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.584 HG13 ' O ' ' A' ' 177' ' ' THR . 69.6 mt -57.9 -37.63 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 O-C-N 121.536 -0.728 . . . . 0.0 109.473 -178.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.495 HD21 HD21 ' A' ' 214' ' ' LEU . 83.1 mt -61.1 -40.7 94.74 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -177.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.62 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 78.2 p -61.05 -33.0 72.61 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.228 176.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.467 ' OG1' ' HA ' ' A' ' 181' ' ' ILE . 22.6 p -89.09 23.18 2.5 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.592 0.234 . . . . 0.0 111.542 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 78.1 p -63.52 -20.84 65.95 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.216 0.531 . . . . 0.0 110.558 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.64 -37.46 81.56 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.802 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.671 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 98.8 m-20 -74.1 113.48 11.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.388 0.613 . . . . 0.0 110.615 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -63.03 -42.17 99.71 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.999 -1.001 . . . . 0.0 112.91 -177.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . 0.474 ' HB2' HG12 ' A' ' 157' ' ' ILE . 98.2 m-85 -112.12 131.72 55.28 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.619 -178.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 39.4 tp -119.72 127.59 52.99 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 93.9 mt -114.72 126.63 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 O-C-N 121.637 -0.664 . . . . 0.0 110.027 177.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.8 mm -113.09 127.19 70.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . 0.562 ' OD2' ' OG ' ' A' ' 195' ' ' SER . 38.7 t0 -95.79 119.99 35.27 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 121.79 -0.569 . . . . 0.0 110.629 176.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 96.6 mt -97.17 -3.38 41.1 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.156 174.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . 0.562 ' OG ' ' OD2' ' A' ' 193' ' ' ASP . 78.2 p -62.9 -33.26 74.94 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -62.02 -43.12 99.6 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 108.477 -1.849 . . . . 0.0 108.477 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 1.065 ' CD2' ' O ' ' A' ' 199' ' ' GLN . 5.2 tt -70.47 127.87 34.2 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 113.037 -1.582 . . . . 0.0 109.074 -176.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.889 ' N ' HD23 ' A' ' 197' ' ' LEU . . . -61.02 -48.69 80.62 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 119.764 -0.774 . . . . 0.0 110.772 -177.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 1.065 ' O ' ' CD2' ' A' ' 197' ' ' LEU . 58.3 tt0 -132.59 156.52 46.74 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 114.77 -1.105 . . . . 0.0 112.183 -174.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.449 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 45.7 t -118.14 133.25 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -91.25 153.98 19.6 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.571 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.8 -38.06 89.67 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.239 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -59.42 -31.74 69.55 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -178.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 19.1 m -60.91 -42.65 98.51 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.475 177.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.449 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -58.06 -38.24 75.94 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -177.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -61.32 -37.99 85.26 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -65.59 -38.51 89.69 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.961 177.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 94.9 mt -62.94 -43.98 99.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.027 -178.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . 0.449 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 71.0 m-85 -62.01 -42.68 99.42 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.635 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -61.96 -41.8 98.41 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.173 -178.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.64 HD21 ' CD2' ' A' ' 178' ' ' LEU . 39.8 mt -61.82 -42.23 98.77 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 78.0 p -61.72 -42.09 98.49 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 119.232 -0.987 . . . . 0.0 109.734 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -64.6 -46.25 83.49 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.723 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.495 HD21 HD21 ' A' ' 182' ' ' LEU . 52.5 tp -62.39 -46.25 89.45 Favored 'General case' 0 C--N 1.344 0.354 0 C-N-CA 119.029 -1.068 . . . . 0.0 108.416 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 85.1 mt -61.72 -40.59 95.59 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.472 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.25 -44.72 95.01 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 85.2 mt -61.65 -39.57 91.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.07 0.462 . . . . 0.0 109.822 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 67.0 p -75.53 -11.58 60.05 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.481 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.88 35.39 18.95 Favored Glycine 0 C--O 1.217 -0.939 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.935 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 95.2 m -121.86 113.83 20.19 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.227 1.514 . . . . 0.0 111.148 -178.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -65.78 137.24 57.11 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.206 177.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 43.5 tp -113.21 130.63 56.16 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 3.3 mp -117.41 133.74 63.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 122.857 0.463 . . . . 0.0 109.883 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.529 ' CG2' HD11 ' A' ' 227' ' ' ILE . 49.5 mm -114.93 132.22 64.81 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 43.9 p -134.08 166.63 22.29 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 120.392 -0.523 . . . . 0.0 112.058 -178.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 78.82 20.32 71.08 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 178.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.701 HD12 HG23 ' A' ' 247' ' ' THR . 97.3 mt -81.56 128.61 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 CA-C-N 114.042 -1.079 . . . . 0.0 108.818 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 63.5 tttt -76.04 140.26 69.92 Favored Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.06 -38.92 87.3 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.187 1.258 . . . . 0.0 112.324 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -64.7 -39.39 93.57 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-O 121.619 0.723 . . . . 0.0 110.083 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 48.7 tp -63.55 -42.6 98.38 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.987 -1.006 . . . . 0.0 113.104 176.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.86 -38.05 89.65 Favored 'General case' 0 CA--C 1.521 -0.141 0 O-C-N 121.916 -0.49 . . . . 0.0 111.101 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 94.1 mtp -63.84 -41.48 97.82 Favored 'General case' 0 C--O 1.251 1.135 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.561 -178.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -64.15 -40.02 95.25 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.484 177.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 33.4 mmt -65.68 -38.35 89.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.625 177.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -61.61 -41.55 97.62 Favored 'General case' 0 CA--C 1.516 -0.35 0 O-C-N 121.406 -0.808 . . . . 0.0 109.188 -177.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.43 -41.24 93.61 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.458 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 55.9 tp -63.76 -41.84 97.93 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.229 0.825 . . . . 0.0 113.229 177.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -165.51 126.24 1.88 Allowed 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.604 -0.685 . . . . 0.0 112.684 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -60.05 -26.57 66.23 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.951 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -61.78 -29.97 70.49 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.192 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -55.82 -44.73 78.16 Favored 'General case' 0 C--N 1.312 -1.023 0 O-C-N 121.484 -0.76 . . . . 0.0 109.352 -176.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 95.5 p -62.31 -20.07 63.95 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.23 178.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 19.1 m -55.22 -38.18 68.1 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.511 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 97.2 mt -86.3 123.84 31.99 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -178.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -48.37 135.21 14.11 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 114.7 -1.137 . . . . 0.0 109.707 -176.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.701 HG23 HD12 ' A' ' 227' ' ' ILE . 98.0 m -127.87 132.29 49.37 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 114.528 -1.215 . . . . 0.0 111.333 178.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' TYR . . . . . 0.456 ' CB ' ' HB2' ' A' ' 254' ' ' ALA . 97.6 m-85 -116.33 139.64 50.18 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.093 178.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 78.1 p -59.67 -43.07 94.14 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 119.152 -1.019 . . . . 0.0 108.304 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -142.68 159.63 41.86 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.726 0.774 . . . . 0.0 111.312 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 75.4 t -62.61 -45.0 99.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 114.607 -1.179 . . . . 0.0 111.796 -179.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.92 -43.98 97.85 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.247 -0.581 . . . . 0.0 109.519 -178.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . 0.461 ' O ' HG22 ' A' ' 257' ' ' VAL . 54.6 m-20 -63.59 -41.95 98.3 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.973 -178.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . 0.456 ' HB2' ' CB ' ' A' ' 248' ' ' TYR . . . -64.9 -41.7 95.38 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.037 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . 0.448 HG13 HH11 ' B' ' 154' ' ' ARG . 77.0 t -64.02 -45.56 96.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 114.021 -1.445 . . . . 0.0 110.925 -177.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.99 -47.15 81.49 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.763 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.515 ' O ' ' C ' ' A' ' 258' ' ' LEU . 28.6 m -66.34 -40.6 87.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 120.058 -0.657 . . . . 0.0 112.429 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.515 ' C ' ' O ' ' A' ' 257' ' ' VAL . 1.4 mt -28.36 -75.44 0.04 OUTLIER Pre-proline 0 C--N 1.344 0.355 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.318 -177.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' PRO . . . . . 0.507 ' CD ' ' CB ' ' A' ' 258' ' ' LEU . 42.0 Cg_endo -63.46 139.7 72.12 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 CA-C-N 119.561 0.879 . . . . 0.0 111.761 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 259' ' ' PRO . 96.7 mt -151.38 -26.57 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.694 177.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 78.1 mtm . . . . . 0 N--CA 1.472 0.663 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.562 -177.013 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.459 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.1 163.71 38.67 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 80.4 p -59.85 -20.82 59.32 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 123.37 0.419 . . . . 0.0 111.27 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -74.2 -63.63 1.19 Allowed 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.091 0.472 . . . . 0.0 111.303 -178.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -67.03 -38.85 86.63 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.877 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . 0.545 ' O ' ' HB3' ' B' ' 7' ' ' PHE . 65.7 m -60.05 -43.14 95.58 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 119.979 -0.688 . . . . 0.0 109.928 -176.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . 0.545 ' HB3' ' O ' ' B' ' 6' ' ' SER . 46.2 t80 86.39 88.91 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 O-C-N 123.751 0.657 . . . . 0.0 110.745 177.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . 0.692 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -64.23 -151.73 0.07 OUTLIER Glycine 0 CA--C 1.53 0.99 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.692 ' HB ' ' O ' ' B' ' 8' ' ' GLY . 67.3 mt 92.98 108.81 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 122.387 0.275 . . . . 0.0 110.87 -178.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -62.53 -24.94 75.47 Favored 'Trans proline' 0 N--CA 1.5 1.855 0 C-N-CA 121.375 1.383 . . . . 0.0 111.847 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.7 -40.5 98.13 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 110.689 -0.965 . . . . 0.0 110.689 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -64.89 -38.62 91.57 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.726 0.774 . . . . 0.0 109.506 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 52.4 tp -61.75 -42.53 99.09 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.848 -178.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -65.68 -32.81 74.58 Favored 'General case' 0 CA--C 1.562 1.442 0 CA-C-O 121.344 0.593 . . . . 0.0 110.534 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . 0.469 HG22 ' CD1' ' A' ' 113' ' ' ILE . 63.2 t -61.57 -46.28 96.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 113.097 -1.865 . . . . 0.0 110.664 177.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 92.9 mt -63.65 -43.91 98.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.259 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . 0.489 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 98.9 mttt -63.36 -41.61 98.84 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.98 -41.37 99.53 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 119.069 -1.053 . . . . 0.0 110.312 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.96 -38.8 89.91 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.656 -178.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.417 ' O ' ' O ' ' B' ' 23' ' ' VAL . 85.5 mt -64.31 -41.97 96.58 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.286 0.565 . . . . 0.0 110.295 175.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -63.15 -38.34 90.79 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.34 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 56.9 m170 -58.47 -39.64 80.49 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 121.236 -0.185 . . . . 0.0 111.087 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.417 ' O ' ' O ' ' B' ' 20' ' ' LEU . 10.0 p -113.96 130.54 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.504 ' O ' ' HG3' ' B' ' 24' ' ' ARG . 34.7 ptt180 -71.79 108.42 5.09 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 121.865 0.84 . . . . 0.0 112.446 -177.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 7.1 p -143.14 134.33 23.31 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.501 177.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . 0.508 ' O ' ' N ' ' B' ' 123' ' ' GLN . . . -89.59 95.76 2.13 Favored Glycine 0 N--CA 1.436 -1.332 0 C-N-CA 119.093 -1.527 . . . . 0.0 112.748 -175.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 45.9 t -124.86 129.42 73.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 174.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 27.2 m -138.6 157.25 30.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.722 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 95.9 mt -118.84 129.82 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-O 122.377 1.084 . . . . 0.0 111.167 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.508 HG22 HG12 ' B' ' 39' ' ' ILE . 44.7 p -112.0 152.81 27.69 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 112.474 -2.148 . . . . 0.0 108.475 -175.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -121.87 103.6 39.9 Favored Pre-proline 0 C--O 1.239 0.506 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -177.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.78 -22.61 69.4 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 121.907 1.738 . . . . 0.0 111.519 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.6 -42.86 99.46 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 96.0 mt -75.41 171.08 14.87 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.507 -0.745 . . . . 0.0 111.121 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . 0.627 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 42.3 tt0 -69.85 133.56 47.51 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -176.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.522 ' O ' ' OD1' ' B' ' 36' ' ' ASP . 66.1 t0 56.59 35.51 26.18 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.701 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' ASN . . . . . 0.454 ' C ' ' O ' ' B' ' 36' ' ' ASP . 40.3 t-20 28.75 71.24 0.49 Allowed Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.627 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 91.8 Cg_endo -71.85 154.76 58.56 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 123.736 2.957 . . . . 0.0 112.191 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.508 HG12 HG22 ' B' ' 30' ' ' THR . 95.6 mt -86.85 129.17 38.88 Favored 'Isoleucine or valine' 0 C--O 1.245 0.86 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.419 HG23 ' N ' ' B' ' 41' ' ' TYR . 29.8 m -109.04 -42.89 5.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 O-C-N 123.65 0.594 . . . . 0.0 112.373 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' TYR . . . . . 0.419 ' N ' HG23 ' B' ' 40' ' ' VAL . 46.2 t80 -95.61 124.76 39.78 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 119.85 -0.74 . . . . 0.0 111.183 -178.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 5.8 p -143.55 141.86 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 O-C-N 124.102 0.876 . . . . 0.0 109.545 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . 0.698 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 56.0 p30 -102.12 162.07 13.2 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.226 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' GLN . . . . . 0.505 ' OE1' ' HA ' ' B' ' 44' ' ' GLN . 12.9 mm100 -63.1 -37.89 88.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.303 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.48 -26.48 64.44 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.698 ' HB2' ' OD1' ' B' ' 43' ' ' ASN . 59.5 t80 -60.46 -43.3 97.02 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 0.688 HG13 ' O ' ' B' ' 52' ' ' TYR . 58.5 t -61.16 -46.33 96.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.032 -178.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -62.92 -44.23 96.64 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.341 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 59.7 ttm -63.22 -42.68 99.29 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 39.5 p -94.11 -17.29 22.95 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.934 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' B' ' 47' ' ' VAL . . . 73.67 17.74 79.26 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 178.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . 0.688 ' O ' HG13 ' B' ' 47' ' ' VAL . 77.3 m-85 -110.39 142.89 41.46 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.231 0.612 . . . . 0.0 110.565 178.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -71.91 147.67 46.82 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.388 0.613 . . . . 0.0 111.289 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . 0.465 ' H ' HG22 ' B' ' 54' ' ' THR . 0.2 OUTLIER -62.62 -36.55 83.14 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.523 -176.702 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.2 -39.88 95.91 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.344 -178.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -72.72 -32.67 65.89 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 176.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.626 HD13 ' CD2' ' B' ' 46' ' ' PHE . 92.5 mt -64.96 -74.94 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 176.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 94.9 mt -36.42 132.82 0.56 Allowed 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.766 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.28 -13.56 66.59 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-N 115.874 -0.603 . . . . 0.0 113.252 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -132.72 149.07 52.33 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 117.572 0.686 . . . . 0.0 112.315 -173.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' ASN . . . . . 0.555 ' C ' ' H ' ' B' ' 63' ' ' ARG . 24.3 t-20 -78.6 149.73 32.89 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.437 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' CYS . . . . . 0.425 ' HB3' HD12 ' B' ' 65' ' ' LEU . 86.2 m -63.11 9.57 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.327 -178.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' ARG . . . . . 0.555 ' H ' ' C ' ' B' ' 61' ' ' ASN . 34.5 ptt-85 -59.41 -33.16 70.89 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.449 -177.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -59.73 -28.79 67.65 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . 0.425 HD12 ' HB3' ' B' ' 62' ' ' CYS . 83.4 mt -61.69 -41.98 98.32 Favored 'General case' 0 C--N 1.32 -0.7 0 O-C-N 121.938 -0.477 . . . . 0.0 109.751 -178.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -53.23 145.99 12.7 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.624 -176.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . 0.563 ' N ' ' OG1' ' B' ' 70' ' ' THR . . . -155.69 -153.22 6.48 Favored Glycine 0 CA--C 1.538 1.5 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.983 177.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.38 -41.47 89.45 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -176.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -75.44 -10.0 59.06 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 123.188 0.305 . . . . 0.0 111.171 -178.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' B' ' 67' ' ' GLY . 27.0 m -61.63 133.36 55.53 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 121.875 -0.516 . . . . 0.0 109.812 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -89.17 109.87 34.18 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.335 -178.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.16 -38.67 87.8 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 121.046 1.164 . . . . 0.0 111.811 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.13 -39.38 92.39 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 120.424 -0.511 . . . . 0.0 109.871 -175.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -66.57 -38.01 86.16 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.998 177.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 93.5 t -61.73 -45.53 98.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -63.03 -37.3 86.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.697 -178.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -62.75 -41.84 99.4 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 119.254 -0.978 . . . . 0.0 108.707 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.4 -43.73 98.62 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-O 120.781 0.324 . . . . 0.0 110.623 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -62.53 -42.47 99.55 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 99.5 m -61.45 -45.67 93.32 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.224 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.05 -40.82 97.05 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -177.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 81.4 mt -62.72 -42.34 99.61 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 67.1 tp60 -63.48 -34.6 78.12 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -91.96 8.12 38.98 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.413 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 31.0 tttt 42.81 43.03 3.26 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.356 175.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -127.33 141.51 41.06 Favored Pre-proline 0 N--CA 1.469 0.508 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.556 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -62.09 141.01 87.13 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 120.806 1.004 . . . . 0.0 114.077 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.92 137.13 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 89' ' ' THR . . . . . 0.702 HG23 ' OD1' ' B' ' 107' ' ' ASN . 98.7 m -121.11 123.59 42.69 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.897 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 30.2 m -138.41 161.72 30.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.105 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -113.75 120.66 41.56 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 120.41 -0.516 . . . . 0.0 109.645 174.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . 0.454 HD11 HG23 ' B' ' 70' ' ' THR . 20.8 tt -127.79 132.21 69.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.317 -174.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -70.35 140.39 52.17 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.261 177.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 94' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -131.25 177.61 7.34 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 121.516 0.674 . . . . 0.0 110.911 -178.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 95' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -128.83 143.66 50.97 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 114.447 -1.251 . . . . 0.0 111.954 177.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . 0.435 ' HG3' ' CE1' ' B' ' 102' ' ' PHE . 98.6 mttt -100.09 179.25 4.55 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.283 0.563 . . . . 0.0 110.553 178.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.93 -36.64 79.86 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.843 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 38.5 p-10 -84.79 -1.74 56.75 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 121.426 -0.796 . . . . 0.0 112.912 177.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.06 5.59 65.81 Favored Glycine 0 N--CA 1.467 0.726 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.685 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 29.1 m -68.06 129.95 41.48 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 101' ' ' MET . . . . . 0.551 ' SD ' ' N ' ' B' ' 102' ' ' PHE . 15.3 tmm? -87.56 140.48 29.48 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 102' ' ' PHE . . . . . 0.551 ' N ' ' SD ' ' B' ' 101' ' ' MET . 53.7 p90 -151.72 163.01 40.07 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 103' ' ' TRP . . . . . 0.901 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 26.3 m95 -96.35 138.51 33.83 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.589 0.709 . . . . 0.0 110.72 178.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . 0.501 HD21 ' HG2' ' B' ' 123' ' ' GLN . 62.8 t-20 -133.55 109.6 9.35 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 114.669 -1.15 . . . . 0.0 113.467 -176.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 105' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' B' ' 123' ' ' GLN . 81.6 tt0 -79.16 125.56 29.59 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.768 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 40.0 tp -112.62 125.37 54.21 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -176.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 107' ' ' ASN . . . . . 0.702 ' OD1' HG23 ' B' ' 89' ' ' THR . 98.2 m-20 -118.57 128.59 54.71 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 176.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 96.5 mt -123.75 132.68 70.96 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.467 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -145.93 121.9 5.76 Favored Pre-proline 0 CA--C 1.542 0.665 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -69.23 152.14 72.04 Favored 'Trans proline' 0 N--CA 1.504 2.093 0 C-N-CA 122.893 2.395 . . . . 0.0 112.942 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . 0.483 ' HB2' ' HB2' ' B' ' 118' ' ' TYR . 67.0 mtt -129.99 143.26 50.7 Favored 'General case' 0 C--O 1.245 0.831 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 179.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -110.3 109.47 19.92 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . 0.712 HG12 ' HZ1' ' A' ' 18' ' ' LYS . 96.3 mt -132.46 128.01 57.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 177.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 50.61 38.53 19.13 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.999 178.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 61.46 37.07 16.88 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.51 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -134.21 151.26 51.22 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 177.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 6.9 t -102.47 154.41 19.12 Favored 'General case' 0 C--O 1.214 -0.785 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -177.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 118' ' ' TYR . . . . . 0.483 ' HB2' ' HB2' ' B' ' 111' ' ' MET . 96.7 m-85 -148.76 147.85 29.3 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 120.828 -1.17 . . . . 0.0 111.445 -178.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 119' ' ' PHE . . . . . 0.453 ' HB2' ' OG1' ' B' ' 30' ' ' THR . 96.3 m-85 -123.2 137.42 54.89 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 123.318 0.387 . . . . 0.0 110.758 -177.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -127.26 132.02 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -177.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.39 124.09 7.48 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 122' ' ' ILE . . . . . 0.429 ' HB ' ' HB2' ' B' ' 107' ' ' ASN . 94.4 mt -114.94 127.6 72.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -178.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 123' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' B' ' 26' ' ' GLY . 16.1 mp0 -118.67 120.47 37.53 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -119.91 120.93 37.84 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' B' ' 127' ' ' THR . 68.0 t0 -67.31 134.79 52.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.331 -0.849 . . . . 0.0 112.704 -177.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.461 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 2.6 mp -108.4 14.48 8.21 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.856 0 CA-C-O 122.054 0.93 . . . . 0.0 108.858 178.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 127' ' ' THR . . . . . 0.49 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 98.5 m -62.72 -44.15 96.97 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 113.754 -1.566 . . . . 0.0 112.47 176.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -61.7 -45.66 93.01 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -177.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 129' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -62.84 -34.65 77.78 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.316 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 130' ' ' LYS . . . . . 0.901 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 98.7 mttt -63.06 -41.58 99.5 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-N 113.47 -1.696 . . . . 0.0 111.022 174.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.69 -42.31 98.01 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 132' ' ' TYR . . . . . 0.672 ' CE2' HD11 ' B' ' 136' ' ' LEU . 89.3 t80 -60.12 -45.44 93.0 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 121.733 -0.604 . . . . 0.0 111.494 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.87 -36.6 84.86 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 120.233 -0.587 . . . . 0.0 109.601 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 134' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' B' ' 130' ' ' LYS . 98.8 mttt -62.86 -39.15 93.52 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.66 177.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 54.7 tp -62.9 -41.58 99.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.163 0.506 . . . . 0.0 109.819 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 136' ' ' LEU . . . . . 0.672 HD11 ' CE2' ' B' ' 132' ' ' TYR . 90.3 mt -62.67 -42.11 99.44 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.253 177.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 137' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.39 -36.97 85.57 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.116 -1.402 . . . . 0.0 110.299 -178.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -63.11 -43.21 99.1 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.173 175.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 62.1 m -60.8 -43.93 97.49 Favored 'General case' 0 C--N 1.344 0.354 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . 0.516 ' O ' ' N ' ' B' ' 144' ' ' THR . 88.1 mt -61.1 -40.42 93.68 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -176.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 98.6 m -61.88 -45.25 94.57 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.84 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -65.49 -42.78 91.78 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.96 -43.66 97.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.695 178.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 144' ' ' THR . . . . . 0.516 ' N ' ' O ' ' B' ' 140' ' ' LEU . 99.4 m -61.35 -45.69 93.34 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -177.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . 0.408 ' O ' ' HB ' ' B' ' 148' ' ' THR . . . -63.81 -40.81 97.51 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 119.041 -1.064 . . . . 0.0 109.581 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 90.0 mt -64.55 -40.64 95.95 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 177.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 147' ' ' SER . . . . . 0.587 ' O ' ' N ' ' B' ' 149' ' ' PRO . 77.4 p -61.36 -43.31 99.09 Favored 'General case' 0 CA--C 1.477 -1.831 0 C-N-CA 119.074 -1.05 . . . . 0.0 108.23 -178.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 148' ' ' THR . . . . . 0.511 ' C ' ' O ' ' B' ' 147' ' ' SER . 43.0 m -24.48 85.66 0.04 OUTLIER Pre-proline 0 N--CA 1.478 0.929 0 O-C-N 124.051 0.844 . . . . 0.0 110.364 176.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 149' ' ' PRO . . . . . 0.587 ' N ' ' O ' ' B' ' 147' ' ' SER . 24.2 Cg_exo -61.67 147.53 95.12 Favored 'Trans proline' 0 C--N 1.299 -2.04 0 C-N-CA 120.898 1.065 . . . . 0.0 113.197 -177.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 8.8 tp -126.7 124.18 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 172.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 43.0 t -155.13 95.13 2.58 Favored Pre-proline 0 C--N 1.314 -0.963 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.103 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -60.46 136.48 67.89 Favored 'Trans proline' 0 N--CA 1.484 0.931 0 N-CA-C 109.438 -1.024 . . . . 0.0 109.438 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 153' ' ' ILE . . . . . 0.547 ' O ' ' HD2' ' B' ' 154' ' ' ARG . 45.6 mm -69.22 -43.44 81.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.09 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 154' ' ' ARG . . . . . 0.571 ' HD3' ' NH2' ' A' ' 154' ' ' ARG . 0.2 OUTLIER -155.9 -156.01 0.6 Allowed 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -86.62 110.58 19.93 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 97.54 -15.89 61.36 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 157' ' ' ILE . . . . . 0.442 HG12 ' HB2' ' B' ' 189' ' ' TYR . 87.9 mt -111.35 126.15 68.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 120.651 0.262 . . . . 0.0 110.666 -176.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 158' ' ' SER . . . . . 0.659 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 71.4 m -134.22 150.45 51.05 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.13 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -133.6 147.2 51.48 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.203 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 17.1 tp -140.65 78.31 21.3 Favored Pre-proline 0 CA--C 1.532 0.254 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 161' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -70.7 148.69 59.5 Favored 'Trans proline' 0 N--CA 1.499 1.848 0 C-N-CA 122.791 2.327 . . . . 0.0 114.302 -178.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 86.0 mt -112.24 134.97 53.47 Favored 'General case' 0 C--N 1.343 0.326 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 55.7 t -129.19 131.71 67.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 112.79 169.6 17.67 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 120.436 -0.888 . . . . 0.0 111.149 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 165' ' ' ASN . . . . . 0.737 ' O ' ' CZ ' ' B' ' 170' ' ' ARG . 60.2 t30 -91.25 107.36 19.15 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -177.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 166' ' ' LEU . . . . . 0.588 HD21 ' CZ ' ' B' ' 171' ' ' PHE . 47.7 tp -64.79 104.5 0.84 Allowed 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -173.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 167' ' ' THR . . . . . 0.696 HG23 ' NE ' ' B' ' 170' ' ' ARG . 10.5 p -84.0 169.79 14.62 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 114.117 -1.401 . . . . 0.0 110.925 176.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.57 -37.61 85.31 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.769 177.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.41 -40.08 89.36 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 123.176 1.465 . . . . 0.0 111.539 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 170' ' ' ARG . . . . . 0.737 ' CZ ' ' O ' ' B' ' 165' ' ' ASN . 88.0 mtm180 -62.19 -37.63 86.0 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 112.084 -2.325 . . . . 0.0 111.152 178.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 171' ' ' PHE . . . . . 0.588 ' CZ ' HD21 ' B' ' 166' ' ' LEU . 0.4 OUTLIER -53.81 -25.37 19.03 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -179.249 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 172' ' ' ASN . . . . . 0.588 ' O ' HG22 ' B' ' 175' ' ' VAL . 92.1 m-20 -62.57 -40.37 96.64 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.024 -0.671 . . . . 0.0 110.773 178.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 36.4 m -60.57 -41.13 93.97 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.974 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 67.5 mt -63.69 -44.09 98.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 175' ' ' VAL . . . . . 0.588 HG22 ' O ' ' B' ' 172' ' ' ASN . 28.8 m -62.96 -39.84 86.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 176' ' ' CYS . . . . . 0.429 ' N ' HG23 ' B' ' 175' ' ' VAL . 98.8 m -62.31 -35.54 79.38 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.494 178.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 177' ' ' THR . . . . . 0.607 ' O ' HG13 ' B' ' 181' ' ' ILE . 24.9 m -61.67 -20.81 63.83 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.502 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 178' ' ' LEU . . . . . 0.604 ' CD2' HD21 ' B' ' 211' ' ' LEU . 88.2 mt -61.29 -39.91 92.2 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.241 -177.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 19.0 m -61.07 -44.69 96.99 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.523 176.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 180' ' ' ASN . . . . . 0.582 ' O ' ' OG ' ' B' ' 183' ' ' SER . 92.7 m-20 -61.94 -40.65 96.27 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.846 0.355 . . . . 0.0 110.585 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.607 HG13 ' O ' ' B' ' 177' ' ' THR . 73.9 mt -56.31 -31.78 33.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 O-C-N 122.262 -0.274 . . . . 0.0 111.022 -177.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 182' ' ' LEU . . . . . 0.465 HD21 HD21 ' B' ' 214' ' ' LEU . 82.4 mt -62.29 -41.86 98.86 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.333 177.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . 0.582 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.2 p -62.45 -32.48 73.36 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 121.756 -0.59 . . . . 0.0 110.891 177.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 184' ' ' THR . . . . . 0.422 ' OG1' ' HA ' ' B' ' 181' ' ' ILE . 22.6 p -85.39 16.89 3.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.745 -178.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 78.5 p -61.29 -16.86 49.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.466 -176.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.0 -40.51 95.88 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 121.051 -0.259 . . . . 0.0 110.468 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 187' ' ' ASP . . . . . 0.659 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.6 m-20 -71.07 113.78 8.45 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.294 0.568 . . . . 0.0 110.378 -177.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -62.94 -42.27 99.75 Favored 'General case' 0 C--O 1.247 0.936 0 CA-C-N 114.904 -1.044 . . . . 0.0 113.149 -177.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 189' ' ' TYR . . . . . 0.442 ' HB2' HG12 ' B' ' 157' ' ' ILE . 98.2 m-85 -111.58 131.57 55.16 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.956 -178.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 190' ' ' LEU . . . . . . . . . . . . . 44.3 tp -123.61 119.03 28.66 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.176 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 84.6 mt -107.09 125.11 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-N 117.8 0.273 . . . . 0.0 111.303 -176.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 49.0 mm -115.63 118.4 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 193' ' ' ASP . . . . . 0.561 ' OD2' ' OG ' ' B' ' 195' ' ' SER . 40.6 t0 -91.19 113.29 25.52 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -176.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 194' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' B' ' 194' ' ' LEU . 96.3 mt -92.34 -2.23 56.52 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 123.325 0.391 . . . . 0.0 110.223 176.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 195' ' ' SER . . . . . 0.561 ' OG ' ' OD2' ' B' ' 193' ' ' ASP . 78.3 p -61.7 -37.69 85.09 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.704 -178.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.6 -34.37 88.24 Favored Glycine 0 N--CA 1.435 -1.375 0 C-N-CA 119.416 -1.373 . . . . 0.0 109.731 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 197' ' ' LEU . . . . . 1.093 ' CD2' ' O ' ' B' ' 199' ' ' GLN . 5.6 tt -76.78 132.97 39.53 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -177.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 198' ' ' ALA . . . . . 0.935 ' N ' HD23 ' B' ' 197' ' ' LEU . . . -64.48 -42.03 96.13 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 119.773 -0.771 . . . . 0.0 111.947 -178.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 199' ' ' GLN . . . . . 1.093 ' O ' ' CD2' ' B' ' 197' ' ' LEU . 59.0 tt0 -137.57 165.41 26.39 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.215 0.531 . . . . 0.0 111.425 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 200' ' ' VAL . . . . . 0.496 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 49.4 t -122.65 132.53 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -93.72 148.83 21.75 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.768 -177.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -60.99 -32.92 72.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.289 -178.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -63.91 -32.59 74.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.367 0.603 . . . . 0.0 109.482 177.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.3 m -60.71 -44.19 96.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.268 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 205' ' ' ALA . . . . . 0.617 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -59.45 -29.33 67.71 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 111.755 0.279 . . . . 0.0 111.755 -177.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -64.95 -38.98 92.76 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.878 175.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -66.86 -37.8 85.15 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.885 178.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.41 -43.17 98.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-O 122.009 0.909 . . . . 0.0 110.101 -178.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 209' ' ' PHE . . . . . 0.617 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 68.3 m-85 -62.28 -42.59 99.47 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 113.92 -1.491 . . . . 0.0 112.686 177.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.26 -41.58 99.06 Favored 'General case' 0 C--O 1.232 0.135 0 O-C-N 121.402 -0.811 . . . . 0.0 109.901 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 211' ' ' LEU . . . . . 0.604 HD21 ' CD2' ' B' ' 178' ' ' LEU . 38.8 mt -62.29 -42.21 99.16 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.317 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 78.0 p -63.84 -36.51 84.16 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.53 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 213' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -67.01 -47.29 71.91 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.176 178.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.465 HD21 HD21 ' B' ' 182' ' ' LEU . 54.2 tp -64.07 -42.6 96.93 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 121.956 0.884 . . . . 0.0 110.546 177.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 85.7 mt -62.83 -43.45 98.76 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 113.343 -1.753 . . . . 0.0 111.555 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.44 -40.04 93.0 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 -176.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 86.3 mt -63.39 -42.03 98.79 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 121.371 0.605 . . . . 0.0 111.374 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 218' ' ' THR . . . . . . . . . . . . . 69.9 p -73.88 -16.63 61.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.176 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 79.55 66.13 1.71 Allowed Glycine 0 CA--C 1.528 0.892 0 N-CA-C 106.831 -2.508 . . . . 0.0 106.831 -178.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 220' ' ' THR . . . . . . . . . . . . . 96.4 m -145.15 104.07 3.92 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 176.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -62.29 139.21 58.52 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.182 0.515 . . . . 0.0 110.954 -176.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 42.7 tp -115.87 121.84 43.56 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.532 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 3.5 mp -110.61 129.5 65.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.016 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 224' ' ' ILE . . . . . 0.477 ' CG2' HD11 ' B' ' 227' ' ' ILE . 50.0 mm -111.11 126.99 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 50.5 p -133.97 157.97 44.69 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-O 122.077 0.942 . . . . 0.0 112.72 -178.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 89.1 17.86 55.0 Favored Glycine 0 CA--C 1.502 -0.77 0 CA-C-N 113.683 -1.598 . . . . 0.0 111.588 -177.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 227' ' ' ILE . . . . . 0.71 HD12 HG23 ' B' ' 247' ' ' THR . 96.1 mt -81.17 126.26 39.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 121.808 -0.819 . . . . 0.0 111.371 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 59.4 tttt -66.57 140.53 96.54 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.298 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.75 -37.24 91.98 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 121.518 1.479 . . . . 0.0 112.363 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -64.18 -42.27 96.77 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -178.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 50.9 tp -62.52 -41.73 99.04 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.751 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.24 -37.2 86.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.784 0.326 . . . . 0.0 111.224 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 94.6 mtp -64.31 -41.0 97.04 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.663 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.78 -43.87 95.07 Favored 'General case' 0 CA--C 1.553 1.065 0 CA-C-O 122.632 1.206 . . . . 0.0 109.382 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 34.3 mmt -63.76 -36.29 83.4 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.167 -1.379 . . . . 0.0 111.894 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -63.32 -39.64 95.11 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.927 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -63.12 -44.45 95.59 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 56.1 tp -61.87 -44.72 96.25 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 120.358 -0.537 . . . . 0.0 112.027 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -157.14 132.59 9.18 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.972 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 240' ' ' ALA . . . . . . . . . . . . . . . -62.0 -45.34 94.05 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 177.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 241' ' ' ASN . . . . . 0.457 ' O ' ' HB2' ' B' ' 244' ' ' SER . 89.3 m-20 -45.45 -19.68 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.111 -175.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 242' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -61.7 -45.79 92.48 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.904 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 243' ' ' SER . . . . . . . . . . . . . 77.5 p -57.77 -44.14 85.98 Favored 'General case' 0 C--N 1.343 0.32 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 244' ' ' SER . . . . . 0.457 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 15.4 m -30.88 -36.14 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 95.3 mt -88.04 131.61 34.59 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.196 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -57.63 134.74 56.43 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.346 0.593 . . . . 0.0 110.918 -177.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 247' ' ' THR . . . . . 0.71 HG23 HD12 ' B' ' 227' ' ' ILE . 99.4 m -127.35 129.19 47.15 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.865 178.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 248' ' ' TYR . . . . . 0.491 ' CG ' ' HB2' ' B' ' 254' ' ' ALA . 96.5 m-85 -113.83 143.31 44.87 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 249' ' ' SER . . . . . 0.565 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 78.0 p -62.9 -34.32 77.17 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.275 -178.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 250' ' ' ASN . . . . . 0.565 ' OD1' ' O ' ' B' ' 249' ' ' SER . 99.0 m-20 -146.26 159.14 43.74 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.19 -0.913 . . . . 0.0 112.2 178.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 251' ' ' VAL . . . . . 0.434 ' O ' HG23 ' B' ' 255' ' ' VAL . 75.2 t -63.96 -44.83 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.889 178.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 252' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.05 -45.79 93.33 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . 0.467 ' O ' HG22 ' B' ' 257' ' ' VAL . 94.4 m-20 -61.09 -43.28 99.13 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.378 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 254' ' ' ALA . . . . . 0.491 ' HB2' ' CG ' ' B' ' 248' ' ' TYR . . . -65.7 -39.99 91.81 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.319 178.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 255' ' ' VAL . . . . . 0.474 HG13 HH11 ' A' ' 154' ' ' ARG . 77.4 t -64.38 -45.88 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.584 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -63.17 -48.03 80.15 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.36 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 257' ' ' VAL . . . . . 0.493 ' O ' ' C ' ' B' ' 258' ' ' LEU . 26.5 m -64.66 -40.33 88.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.776 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 258' ' ' LEU . . . . . 0.519 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 1.3 mt -31.17 -74.97 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.597 -178.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 259' ' ' PRO . . . . . 0.519 ' CD ' ' CB ' ' B' ' 258' ' ' LEU . 36.7 Cg_endo -62.07 142.08 91.1 Favored 'Trans proline' 0 N--CA 1.501 1.928 0 C-N-CA 121.04 1.16 . . . . 0.0 110.983 -178.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 260' ' ' ILE . . . . . 0.528 ' O ' HG22 ' B' ' 260' ' ' ILE . 96.8 mt -158.84 -14.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-N 118.72 0.691 . . . . 0.0 112.054 176.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 78.1 mtm . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 117.921 -1.037 . . . . 0.0 111.905 -179.637 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.041 -1.623 . . . . 0.0 109.041 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.81 168.49 24.27 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 116.429 -1.748 . . . . 0.0 110.18 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.2 p -70.68 -19.4 62.79 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 124.633 1.208 . . . . 0.0 110.814 178.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -70.61 -68.4 0.43 Allowed 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.531 -1.213 . . . . 0.0 112.39 175.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.22 -38.67 88.51 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.594 ' O ' ' NZ ' ' B' ' 17' ' ' LYS . 69.2 m -59.63 -41.09 89.65 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.22 -178.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.51 ' CE2' HD12 ' A' ' 9' ' ' ILE . 36.3 t80 83.49 89.8 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 O-C-N 123.765 0.666 . . . . 0.0 111.556 176.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.58 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -64.79 -141.18 0.02 OUTLIER Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 -177.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.58 ' HB ' ' O ' ' A' ' 8' ' ' GLY . 78.4 mt 83.53 110.74 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 122.584 0.354 . . . . 0.0 110.726 -178.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.79 -22.38 63.73 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 121.485 1.456 . . . . 0.0 112.294 -178.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.23 -37.49 94.61 Favored Glycine 0 C--O 1.245 0.843 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.94 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -64.82 -39.37 93.47 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.366 0.603 . . . . 0.0 109.8 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.0 tp -63.57 -41.12 98.41 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -63.68 -40.8 97.71 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.5 t -60.26 -44.19 95.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 O-C-N 122.317 -0.239 . . . . 0.0 110.868 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 92.8 mt -62.49 -43.91 98.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -177.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.26 -45.84 91.47 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 119.441 -0.904 . . . . 0.0 111.987 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.524 ' NZ ' HG12 ' B' ' 113' ' ' ILE . 98.9 mttt -60.66 -39.34 88.0 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 118.756 -1.178 . . . . 0.0 108.871 -175.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.86 -41.79 92.22 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.137 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.5 mt -62.85 -40.93 98.97 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.57 -38.27 90.49 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.484 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 57.0 m170 -58.52 -39.84 81.26 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 122.328 -0.232 . . . . 0.0 111.422 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.5 p -113.98 129.09 70.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.54 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 35.4 ptt180 -72.03 107.71 4.88 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 122.094 0.95 . . . . 0.0 111.93 -176.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.6 p -139.22 144.44 29.2 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 178.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.471 ' HA3' ' HB2' ' A' ' 123' ' ' GLN . . . -98.87 93.73 1.35 Allowed Glycine 0 C--O 1.221 -0.706 0 C-N-CA 120.749 -0.738 . . . . 0.0 113.015 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 50.5 t -125.14 129.69 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 176.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.1 m -137.04 159.1 36.7 Favored 'Isoleucine or valine' 0 C--O 1.246 0.881 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.5 mt -120.25 129.37 75.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 176.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.432 HG22 HG12 ' A' ' 39' ' ' ILE . 26.9 p -103.11 169.03 8.8 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 177.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -133.77 101.98 12.65 Favored Pre-proline 0 C--N 1.321 -0.663 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.739 178.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.54 ' HG3' HG23 ' A' ' 117' ' ' THR . 35.2 Cg_endo -63.26 -22.37 72.32 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 121.422 1.414 . . . . 0.0 111.408 -179.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.46 -33.9 74.54 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.155 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.1 mt -87.87 172.8 9.35 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.734 177.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.719 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 42.0 tt0 -68.86 132.11 46.23 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -176.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.509 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 56.7 t0 61.7 22.25 12.81 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.37 0.605 . . . . 0.0 112.564 177.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.401 ' OD1' ' HB ' ' A' ' 30' ' ' THR . 36.6 t-20 43.22 67.13 3.9 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.968 -178.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.719 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 95.4 Cg_endo -70.79 154.62 63.58 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 123.79 2.993 . . . . 0.0 111.979 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.432 HG12 HG22 ' A' ' 30' ' ' THR . 96.5 mt -87.34 123.54 40.16 Favored 'Isoleucine or valine' 0 C--O 1.246 0.919 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.334 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.44 HG23 ' N ' ' A' ' 41' ' ' TYR . 30.0 m -103.99 -45.14 9.53 Favored 'Isoleucine or valine' 0 C--N 1.343 0.323 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.204 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.44 ' N ' HG23 ' A' ' 40' ' ' VAL . 45.3 t80 -93.4 123.64 36.84 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.636 -178.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.1 p -142.28 140.12 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 O-C-N 124.237 0.96 . . . . 0.0 109.348 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.599 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 57.3 p30 -97.3 166.01 11.76 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.462 ' OE1' ' HA ' ' A' ' 44' ' ' GLN . 13.6 mm100 -66.41 -38.92 88.55 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 176.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.7 -26.48 62.62 Favored Glycine 0 C--N 1.33 0.201 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.644 ' CD2' HD13 ' A' ' 57' ' ' ILE . 66.7 t80 -58.86 -47.82 83.54 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.659 HG13 ' O ' ' A' ' 52' ' ' TYR . 78.5 t -59.97 -44.74 95.26 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 O-C-N 121.171 -0.956 . . . . 0.0 111.558 -173.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -63.2 -38.45 91.22 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.653 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 57.7 ttm -66.48 -44.07 83.68 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 175.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.5 p -90.11 -23.02 21.5 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.084 0.469 . . . . 0.0 111.416 -178.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . 78.05 18.97 75.83 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 -178.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.659 ' O ' HG13 ' A' ' 47' ' ' VAL . 70.4 m-85 -113.29 138.38 50.11 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 122.857 0.463 . . . . 0.0 111.28 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -63.18 148.25 48.6 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.808 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.433 HG22 ' H ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -65.97 -32.44 73.93 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -178.759 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.01 -42.03 85.66 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 119.706 -0.797 . . . . 0.0 111.483 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -64.69 -46.75 81.03 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.224 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.644 HD13 ' CD2' ' A' ' 46' ' ' PHE . 97.7 mt -60.41 -50.49 80.11 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -175.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 86.9 mt -55.84 145.3 24.99 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.25 -4.37 81.36 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.024 176.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -136.31 152.79 51.06 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.181 1.491 . . . . 0.0 111.846 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.562 ' C ' ' H ' ' A' ' 63' ' ' ARG . 25.8 t-20 -81.19 150.8 28.5 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.232 0.539 . . . . 0.0 110.453 -178.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 80.1 m -63.11 15.21 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.365 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.562 ' H ' ' C ' ' A' ' 61' ' ' ASN . 34.5 ptt-85 -61.55 -41.63 97.66 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 122.09 -0.382 . . . . 0.0 111.31 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -55.28 -22.1 17.17 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -177.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 93.4 mt -65.89 -37.1 85.25 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.538 0.685 . . . . 0.0 112.639 177.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -62.17 138.1 58.36 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.121 -178.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.529 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -147.2 -148.07 4.68 Favored Glycine 0 CA--C 1.542 1.762 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.089 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.14 -40.4 97.49 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -76.61 -9.22 58.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.608 0.242 . . . . 0.0 111.008 -177.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.529 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 30.0 m -64.36 128.54 36.24 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.142 -0.623 . . . . 0.0 109.59 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -86.43 112.39 45.96 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.039 -178.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -57.48 -30.6 88.81 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 121.974 1.782 . . . . 0.0 113.09 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.75 -39.98 95.6 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.054 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -65.8 -43.61 88.18 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 177.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.9 t -60.2 -44.02 94.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 114.2 -1.364 . . . . 0.0 107.476 -176.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -64.63 -37.59 88.11 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.7 179.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -63.33 -40.03 96.18 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.391 0.615 . . . . 0.0 110.784 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.84 -44.1 98.03 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 CA-C-N 114.857 -1.065 . . . . 0.0 112.055 178.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -61.83 -42.72 99.38 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 113.91 -1.495 . . . . 0.0 108.333 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 92.3 m -60.13 -49.94 75.67 Favored 'General case' 0 C--O 1.246 0.896 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.32 -40.45 94.25 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.228 -170.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 84.8 mt -62.99 -40.33 97.43 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 118.723 0.692 . . . . 0.0 111.511 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -64.09 -40.39 96.12 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -72.06 -22.26 61.4 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.475 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.9 tttt 61.22 43.8 10.56 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.452 -176.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -126.7 149.09 67.37 Favored Pre-proline 0 N--CA 1.467 0.397 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -61.81 143.44 95.97 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 121.316 1.344 . . . . 0.0 113.368 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.04 141.72 33.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.809 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.877 HG23 ' OD1' ' A' ' 107' ' ' ASN . 96.6 m -126.31 122.18 34.73 Favored 'General case' 0 C--N 1.343 0.315 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 175.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 27.7 m -139.55 158.08 27.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.202 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -104.51 130.06 52.48 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 175.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.443 HG23 ' O ' ' A' ' 92' ' ' ILE . 18.2 tt -139.89 128.01 25.88 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.087 0 CA-C-N 120.958 1.708 . . . . 0.0 112.369 178.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.71 136.66 58.13 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 114.495 -1.229 . . . . 0.0 109.899 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -137.06 159.69 41.14 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.671 -179.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -118.65 136.67 53.78 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.513 ' HG3' ' CE1' ' A' ' 102' ' ' PHE . 99.2 mttt -87.03 -172.92 4.2 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.036 0.446 . . . . 0.0 111.621 -177.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.31 -43.85 97.88 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.384 178.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 41.1 p-10 -82.23 5.1 21.01 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.61 0.0 84.53 Favored Glycine 0 N--CA 1.467 0.758 0 C-N-CA 120.825 -0.703 . . . . 0.0 111.911 176.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 18.2 m -61.15 138.66 58.21 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 178.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.689 ' SD ' ' C ' ' A' ' 101' ' ' MET . 13.6 tmm? -104.66 129.85 52.77 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.88 0.372 . . . . 0.0 110.891 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.513 ' CE1' ' HG3' ' A' ' 96' ' ' LYS . 54.3 p90 -141.76 158.91 43.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.666 -177.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.804 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 25.0 m95 -90.34 143.54 26.67 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.485 HD21 ' HG2' ' A' ' 123' ' ' GLN . 59.4 t-20 -138.2 101.7 4.47 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -177.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 80.4 tt0 -66.91 136.18 54.98 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -176.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 38.3 tp -120.35 123.74 43.84 Favored 'General case' 0 C--O 1.233 0.185 0 O-C-N 123.739 0.649 . . . . 0.0 112.424 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.877 ' OD1' HG23 ' A' ' 89' ' ' THR . 98.5 m-20 -121.38 122.67 40.33 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.598 177.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 95.5 mt -120.04 128.23 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 O-C-N 123.523 0.514 . . . . 0.0 111.215 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -136.33 122.99 14.04 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 116.942 -0.117 . . . . 0.0 110.716 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -71.78 150.81 56.63 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.281 1.988 . . . . 0.0 112.602 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.486 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 66.7 mtt -124.17 154.62 39.82 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -128.0 94.41 3.92 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 176.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.483 ' CD1' HG22 ' B' ' 15' ' ' VAL . 96.4 mt -119.69 130.84 73.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.563 -178.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 50.15 37.61 15.04 Favored 'General case' 0 CA--C 1.518 -0.252 0 O-C-N 121.661 -0.649 . . . . 0.0 111.476 176.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 58.77 29.3 18.52 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.884 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -125.89 147.56 49.44 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.751 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 8.4 t -83.79 -173.38 4.68 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.431 -0.793 . . . . 0.0 109.517 -178.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.751 ' CD2' ' O ' ' A' ' 117' ' ' THR . 83.5 m-85 -171.02 154.06 4.0 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 173.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -128.87 145.15 51.29 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 174.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.5 p -134.41 135.17 54.31 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 177.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.91 129.32 9.56 Favored Glycine 0 CA--C 1.505 -0.565 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 178.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.47 ' HB ' ' HB2' ' A' ' 107' ' ' ASN . 96.9 mt -117.77 128.82 74.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.485 ' HG2' HD21 ' A' ' 104' ' ' ASN . 17.4 mp0 -119.13 116.63 26.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.145 0.498 . . . . 0.0 109.929 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -116.09 113.38 23.07 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.112 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 126' ' ' ILE . 68.2 t0 -63.8 128.74 37.16 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -176.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.545 HG22 ' O ' ' A' ' 126' ' ' ILE . 2.7 mp -96.29 3.88 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 113.951 -1.477 . . . . 0.0 110.398 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.5 m -60.05 -42.64 94.9 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.335 -0.853 . . . . 0.0 113.234 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -59.87 -42.32 93.46 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -63.69 -40.13 96.05 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.521 177.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.804 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.5 mttt -62.92 -41.42 99.46 Favored 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 118.393 -1.323 . . . . 0.0 110.359 -178.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -61.68 -36.69 81.58 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.752 ' CE2' HD11 ' A' ' 136' ' ' LEU . 85.8 t80 -61.82 -44.74 96.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.369 176.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.74 -38.74 92.0 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.97 -40.91 97.2 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 54.8 tp -61.26 -43.85 98.2 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.752 HD11 ' CE2' ' A' ' 132' ' ' TYR . 86.6 mt -62.54 -41.06 98.64 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.242 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.91 -41.02 97.44 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.915 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -60.82 -42.17 97.17 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -178.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 58.3 m -61.54 -41.55 97.52 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.677 177.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.464 ' O ' ' N ' ' A' ' 144' ' ' THR . 86.9 mt -64.08 -41.88 97.15 Favored 'General case' 0 C--O 1.224 -0.274 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 91.8 m -61.22 -46.03 92.11 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.38 -177.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -64.79 -40.24 94.91 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 95.7 mt -64.47 -43.49 96.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 113.939 -1.482 . . . . 0.0 111.219 177.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.464 ' N ' ' O ' ' A' ' 140' ' ' LEU . 92.7 m -62.71 -45.95 90.39 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.773 -0.579 . . . . 0.0 112.332 -178.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.4 -40.16 96.46 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 118.853 -1.139 . . . . 0.0 108.991 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 85.2 mt -63.5 -42.57 98.5 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.472 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.746 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.1 p -60.87 -38.78 86.75 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 -178.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.491 ' C ' ' O ' ' A' ' 147' ' ' SER . 31.9 m -27.22 79.85 0.02 OUTLIER Pre-proline 0 N--CA 1.467 0.415 0 O-C-N 126.531 2.394 . . . . 0.0 106.591 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.746 ' N ' ' O ' ' A' ' 147' ' ' SER . 20.9 Cg_exo -62.53 144.46 94.56 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 120.947 1.098 . . . . 0.0 114.666 -173.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.566 ' O ' HG23 ' A' ' 151' ' ' VAL . 9.5 tp -121.44 135.2 62.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 102.928 -2.99 . . . . 0.0 102.928 176.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 150' ' ' ILE . 99.6 t -167.55 91.81 0.69 Allowed Pre-proline 0 CA--C 1.513 -0.46 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 178.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -61.49 136.26 62.26 Favored 'Trans proline' 0 C--N 1.3 -2.011 0 N-CA-C 109.323 -1.068 . . . . 0.0 109.323 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.587 ' O ' ' HD2' ' A' ' 154' ' ' ARG . 45.5 mm -67.83 -44.34 85.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 119.932 -0.707 . . . . 0.0 110.795 179.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.587 ' HD2' ' O ' ' A' ' 153' ' ' ILE . 0.2 OUTLIER -156.89 -156.39 0.61 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.437 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.468 ' ND2' ' HE3' ' B' ' 256' ' ' LYS . 63.7 t-20 -87.51 105.14 17.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 122.08 0.943 . . . . 0.0 112.008 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 88.98 9.19 68.12 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.758 -177.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.0 mt -126.19 125.36 67.62 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 CA-C-O 121.546 0.689 . . . . 0.0 109.231 174.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.566 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 42.5 m -133.26 152.22 51.93 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.061 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -137.67 141.95 41.13 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.753 -0.592 . . . . 0.0 111.286 177.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 18.0 tp -133.93 78.33 60.33 Favored Pre-proline 0 N--CA 1.47 0.564 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.243 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -70.21 151.63 66.57 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.82 2.347 . . . . 0.0 113.096 -179.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 88.3 mt -117.47 128.76 55.31 Favored 'General case' 0 C--O 1.25 1.089 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.388 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 49.3 t -123.82 130.9 73.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 115.05 170.08 16.22 Favored Glycine 0 N--CA 1.479 1.539 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.042 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.939 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 55.9 t30 -85.05 115.29 22.78 Favored 'General case' 0 C--O 1.213 -0.841 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.506 HD21 ' CZ ' ' A' ' 171' ' ' PHE . 41.8 tp -73.67 105.34 4.95 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -177.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.656 HG23 ' NE ' ' A' ' 170' ' ' ARG . 16.6 p -87.55 165.87 15.16 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.01 178.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -66.72 -33.51 75.8 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.506 0.669 . . . . 0.0 111.455 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.7 -41.36 92.43 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.686 178.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.939 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 87.6 mtm180 -64.71 -33.16 75.31 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 124.173 0.989 . . . . 0.0 112.233 176.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.506 ' CZ ' HD21 ' A' ' 166' ' ' LEU . 0.6 OUTLIER -54.33 -28.76 44.87 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.11 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.569 ' O ' HG22 ' A' ' 175' ' ' VAL . 92.6 m-20 -60.53 -41.19 93.94 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 119.003 -1.079 . . . . 0.0 109.857 -178.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 67.3 m -59.57 -41.15 89.54 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.692 -178.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 66.6 mt -63.33 -44.05 98.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 172' ' ' ASN . 30.5 m -62.72 -39.67 85.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . 0.403 ' N ' HG23 ' A' ' 175' ' ' VAL . 98.8 m -61.8 -34.5 76.02 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.262 0.553 . . . . 0.0 110.294 178.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.548 ' O ' HG13 ' A' ' 181' ' ' ILE . 25.3 m -62.22 -20.4 64.17 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.131 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.693 ' CD2' HD21 ' A' ' 211' ' ' LEU . 89.9 mt -61.12 -41.54 96.9 Favored 'General case' 0 C--O 1.246 0.887 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -178.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 16.9 m -58.87 -43.34 90.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.532 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . 0.593 ' O ' ' OG ' ' A' ' 183' ' ' SER . 92.2 m-20 -61.98 -37.98 86.85 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 122.558 0.343 . . . . 0.0 110.954 178.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.553 HD12 HD23 ' A' ' 178' ' ' LEU . 70.3 mt -58.62 -37.9 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.438 HD21 HD21 ' A' ' 214' ' ' LEU . 86.0 mt -60.65 -40.82 93.42 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.015 -177.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.593 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 78.1 p -61.98 -33.32 74.09 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.486 176.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.475 ' OG1' ' HA ' ' A' ' 181' ' ' ILE . 19.2 p -89.67 24.69 2.25 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.561 0.219 . . . . 0.0 111.267 -178.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 78.0 p -63.62 -20.29 65.55 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.198 0.523 . . . . 0.0 110.746 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.17 -37.19 79.42 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.825 -178.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.566 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 99.0 m-20 -74.88 113.88 12.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.457 0.646 . . . . 0.0 110.972 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.83 -42.44 99.73 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.056 -0.975 . . . . 0.0 112.885 -177.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -112.03 131.02 55.67 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.202 0.525 . . . . 0.0 110.912 -178.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 38.6 tp -120.25 128.89 53.76 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 96.2 mt -117.05 126.59 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 118.587 0.63 . . . . 0.0 109.582 177.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.6 mm -112.66 126.43 70.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . 0.545 ' CG ' ' HG ' ' A' ' 195' ' ' SER . 39.5 t0 -94.82 118.57 31.98 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 121.949 0.881 . . . . 0.0 110.46 177.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 95.7 mt -96.93 -3.79 41.17 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.257 175.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . 0.545 ' HG ' ' CG ' ' A' ' 193' ' ' ASP . 78.2 p -61.72 -32.72 72.96 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.82 -42.51 99.75 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 108.766 -1.734 . . . . 0.0 108.766 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.937 ' CD2' ' O ' ' A' ' 199' ' ' GLN . 5.1 tt -72.57 128.59 36.03 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 112.975 -1.612 . . . . 0.0 108.862 -176.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.919 ' N ' HD23 ' A' ' 197' ' ' LEU . . . -60.94 -49.01 79.17 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.203 -178.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.937 ' O ' ' CD2' ' A' ' 197' ' ' LEU . 57.7 tt0 -132.79 155.53 48.76 Favored 'General case' 0 C--O 1.206 -1.219 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -175.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.426 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 53.1 t -117.13 132.43 66.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 O-C-N 120.133 -1.605 . . . . 0.0 108.875 178.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -86.16 156.16 20.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.662 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.3 -38.5 90.43 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.181 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -58.37 -31.7 67.88 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -178.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 17.6 m -60.86 -42.48 97.95 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.659 177.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.523 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -57.05 -38.74 73.67 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -177.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -62.12 -37.39 84.95 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -178.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -64.94 -39.42 93.48 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.103 177.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.29 -44.64 99.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 C-N-CA 119.525 -0.87 . . . . 0.0 108.941 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . 0.523 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 69.1 m-85 -61.65 -43.56 98.63 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.413 -178.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.0 -42.35 99.06 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 119.313 -0.955 . . . . 0.0 109.103 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.693 HD21 ' CD2' ' A' ' 178' ' ' LEU . 40.1 mt -61.65 -42.27 98.67 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 78.1 p -61.89 -41.66 98.15 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 119.351 -0.939 . . . . 0.0 110.116 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' HIS . . . . . 0.445 ' CE1' HD11 ' A' ' 217' ' ' LEU . 55.7 t-80 -64.06 -45.91 86.69 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.787 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.438 HD21 HD21 ' A' ' 182' ' ' LEU . 53.9 tp -62.12 -46.14 90.37 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 211' ' ' LEU . 84.2 mt -62.56 -40.56 97.22 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.627 -176.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -61.59 -43.1 99.49 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -178.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.445 HD11 ' CE1' ' A' ' 213' ' ' HIS . 85.9 mt -61.8 -39.63 92.4 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 74.8 p -76.68 -11.59 59.87 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.242 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 81.26 38.63 14.45 Favored Glycine 0 C--O 1.217 -0.909 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.329 -178.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 94.7 m -123.95 112.85 17.71 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.024 1.412 . . . . 0.0 111.658 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -63.07 136.63 57.91 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.2 178.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 44.2 tp -114.43 130.63 56.72 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 3.4 mp -118.21 135.36 58.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 122.867 0.467 . . . . 0.0 109.849 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.579 ' CG2' HD11 ' A' ' 227' ' ' ILE . 49.0 mm -114.85 131.74 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 43.8 p -132.89 167.35 20.38 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 120.854 -0.338 . . . . 0.0 111.876 -178.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 77.31 20.47 74.98 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.584 HD12 HG23 ' A' ' 247' ' ' THR . 97.5 mt -81.79 128.6 38.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 114.043 -1.078 . . . . 0.0 108.77 178.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 66.9 tttt -75.43 140.82 72.59 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.09 -39.28 86.34 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 121.138 1.225 . . . . 0.0 112.496 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -64.04 -39.31 93.8 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-O 121.829 0.823 . . . . 0.0 110.318 -178.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 49.6 tp -64.18 -42.23 96.77 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.845 -1.071 . . . . 0.0 112.721 177.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.74 -37.27 87.01 Favored 'General case' 0 CA--C 1.521 -0.154 0 O-C-N 121.753 -0.592 . . . . 0.0 111.198 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 94.5 mtp -63.7 -41.35 98.13 Favored 'General case' 0 C--O 1.247 0.959 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -178.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -63.7 -40.33 96.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.668 177.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 37.7 mmt -65.33 -37.13 86.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.823 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -60.51 -41.54 94.57 Favored 'General case' 0 CA--C 1.515 -0.385 0 O-C-N 121.544 -0.723 . . . . 0.0 109.408 -177.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.59 -40.74 92.88 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.238 0.542 . . . . 0.0 110.505 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 52.2 tp -62.89 -40.96 99.15 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 177.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 240' ' ' ALA . 67.1 t0 -169.53 130.26 1.07 Allowed 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.5 -0.75 . . . . 0.0 112.486 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.416 ' N ' ' OD1' ' A' ' 239' ' ' ASP . . . -60.93 -26.89 67.82 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.811 178.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.496 ' O ' ' HB2' ' A' ' 244' ' ' SER . 87.6 m-20 -60.68 -30.42 69.91 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.691 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -55.83 -43.34 76.91 Favored 'General case' 0 C--N 1.311 -1.086 0 O-C-N 121.399 -0.813 . . . . 0.0 109.056 -176.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 94.7 p -63.15 -19.12 64.18 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.043 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . 0.496 ' HB2' ' O ' ' A' ' 241' ' ' ASN . 70.9 m -54.94 -37.04 65.93 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.405 177.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 95.0 mt -89.19 119.26 29.52 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 119.732 -0.787 . . . . 0.0 112.93 -177.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -42.65 135.55 2.82 Favored 'General case' 0 C--O 1.244 0.773 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.68 -178.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.584 HG23 HD12 ' A' ' 227' ' ' ILE . 97.7 m -126.52 132.72 51.32 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.198 -1.364 . . . . 0.0 111.043 178.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' TYR . . . . . 0.453 ' CB ' ' HB2' ' A' ' 254' ' ' ALA . 96.5 m-85 -117.54 141.18 48.66 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.978 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' SER . . . . . 0.467 ' O ' ' OD1' ' A' ' 250' ' ' ASN . 77.3 p -62.2 -41.03 97.98 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -178.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . 0.467 ' OD1' ' O ' ' A' ' 249' ' ' SER . 98.9 m-20 -146.15 160.58 41.75 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.63 0.729 . . . . 0.0 111.155 -178.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 70.2 t -62.8 -45.13 99.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.142 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.04 -44.51 97.29 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.633 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . 0.461 ' O ' HG22 ' A' ' 257' ' ' VAL . 55.2 m-20 -63.74 -42.32 97.89 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.343 -178.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . 0.453 ' HB2' ' CB ' ' A' ' 248' ' ' TYR . . . -65.19 -41.93 94.08 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.829 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . 0.433 HG13 HH11 ' B' ' 154' ' ' ARG . 57.3 t -63.73 -45.61 96.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.927 -178.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.81 -47.83 79.28 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.513 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.487 ' O ' ' C ' ' A' ' 258' ' ' LEU . 21.7 m -66.36 -40.11 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 120.048 -0.661 . . . . 0.0 112.314 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.487 ' C ' ' O ' ' A' ' 257' ' ' VAL . 1.0 OUTLIER -30.18 -73.41 0.05 OUTLIER Pre-proline 0 C--N 1.345 0.41 0 C-N-CA 121.041 -0.264 . . . . 0.0 111.347 -176.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' A' ' 258' ' ' LEU . 41.0 Cg_endo -63.6 139.85 72.05 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 120.891 1.061 . . . . 0.0 112.117 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 259' ' ' PRO . 96.7 mt -152.12 -28.23 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 116.154 -0.476 . . . . 0.0 112.248 178.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.658 -177.151 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.558 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.7 159.58 40.81 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 118.974 -0.536 . . . . 0.0 109.994 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 79.7 p -59.59 -21.49 60.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 122.101 0.953 . . . . 0.0 110.877 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -73.66 -64.95 0.89 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.042 -177.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -66.39 -38.67 88.04 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.931 177.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . 0.492 ' O ' ' HB3' ' B' ' 7' ' ' PHE . 68.5 m -59.87 -41.7 92.11 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 120.425 -0.51 . . . . 0.0 109.904 -178.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . 0.492 ' HB3' ' O ' ' B' ' 6' ' ' SER . 37.7 t80 84.54 92.98 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 O-C-N 123.844 0.715 . . . . 0.0 110.268 177.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . 0.588 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -67.06 -140.75 0.05 OUTLIER Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -178.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.588 ' HB ' ' O ' ' B' ' 8' ' ' GLY . 75.9 mt 82.98 110.81 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.69 0 C-N-CA 122.519 0.328 . . . . 0.0 111.045 -178.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.14 -23.65 66.65 Favored 'Trans proline' 0 N--CA 1.499 1.806 0 C-N-CA 121.369 1.379 . . . . 0.0 111.936 -178.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.08 -39.7 97.96 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -64.53 -39.7 94.26 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.587 0.708 . . . . 0.0 109.652 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 50.7 tp -61.71 -42.66 99.25 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.21 -177.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -65.3 -33.59 76.35 Favored 'General case' 0 CA--C 1.562 1.418 0 CA-C-O 121.514 0.673 . . . . 0.0 110.523 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . 0.483 HG22 ' CD1' ' A' ' 113' ' ' ILE . 76.0 t -62.83 -45.75 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 113.135 -1.848 . . . . 0.0 111.086 177.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 95.0 mt -64.11 -43.79 97.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.177 -178.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . 0.594 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 98.9 mttt -63.41 -42.13 98.74 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.38 -41.13 98.78 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.973 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.45 -38.81 85.32 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.522 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.406 ' O ' ' O ' ' B' ' 23' ' ' VAL . 83.4 mt -63.61 -42.34 98.21 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.154 0.502 . . . . 0.0 110.152 175.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -62.84 -38.61 91.45 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.128 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 55.9 m170 -57.79 -39.91 78.65 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 121.153 -0.219 . . . . 0.0 111.38 -178.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . 0.406 ' O ' ' O ' ' B' ' 20' ' ' LEU . 10.6 p -114.19 129.36 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.541 ' O ' ' HG3' ' B' ' 24' ' ' ARG . 35.1 ptt180 -71.84 105.9 3.97 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 121.971 0.891 . . . . 0.0 112.421 -176.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.0 p -141.77 134.45 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.471 178.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . 0.496 ' O ' ' N ' ' B' ' 123' ' ' GLN . . . -89.33 98.22 2.42 Favored Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 119.525 -1.321 . . . . 0.0 113.054 -175.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 48.6 t -126.03 129.01 72.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 174.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 26.9 m -138.82 156.59 28.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.857 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 96.0 mt -119.81 125.04 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 122.753 1.263 . . . . 0.0 111.595 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.445 HG22 HG12 ' B' ' 39' ' ' ILE . 37.4 p -104.17 159.45 15.68 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 113.266 -1.788 . . . . 0.0 108.844 -178.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -126.59 103.26 25.1 Favored Pre-proline 0 C--O 1.238 0.462 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' PRO . . . . . 0.45 ' HG3' HG23 ' B' ' 117' ' ' THR . 36.8 Cg_endo -64.58 -19.59 65.01 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 121.88 1.72 . . . . 0.0 111.355 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.59 -41.63 97.71 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.677 -0.409 . . . . 0.0 109.922 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 94.9 mt -77.08 -172.7 2.47 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.823 -0.548 . . . . 0.0 111.209 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . 0.727 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 42.0 tt0 -79.69 130.94 35.79 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.446 ' O ' ' C ' ' B' ' 37' ' ' ASN . 61.9 t0 55.21 39.61 31.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.672 177.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' ASN . . . . . 0.446 ' C ' ' O ' ' B' ' 36' ' ' ASP . 23.1 t-20 29.8 69.73 0.61 Allowed Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.727 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 92.8 Cg_endo -72.08 153.91 57.42 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 123.449 2.766 . . . . 0.0 111.696 178.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.445 HG12 HG22 ' B' ' 30' ' ' THR . 96.3 mt -86.58 128.33 39.62 Favored 'Isoleucine or valine' 0 C--O 1.246 0.901 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.424 HG23 ' N ' ' B' ' 41' ' ' TYR . 30.1 m -108.15 -44.77 6.94 Favored 'Isoleucine or valine' 0 C--N 1.341 0.214 0 O-C-N 123.933 0.77 . . . . 0.0 112.631 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' TYR . . . . . 0.424 ' N ' HG23 ' B' ' 40' ' ' VAL . 47.6 t80 -94.38 123.77 37.99 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.27 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 6.3 p -142.14 140.91 29.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 O-C-N 124.033 0.833 . . . . 0.0 109.414 178.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . 0.63 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 56.8 p30 -101.21 161.4 13.64 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.128 178.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' GLN . . . . . 0.457 ' OE1' ' HA ' ' B' ' 44' ' ' GLN . 13.1 mm100 -63.11 -37.77 88.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.624 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.89 -26.69 63.35 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.657 ' CD2' HD13 ' B' ' 57' ' ' ILE . 61.9 t80 -60.19 -43.54 95.82 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 0.812 HG13 ' O ' ' B' ' 52' ' ' TYR . 75.3 t -61.46 -45.95 97.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.276 -179.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -62.96 -44.69 95.35 Favored 'General case' 0 C--N 1.323 -0.543 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.251 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 57.9 ttm -63.11 -42.55 99.59 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 40.9 p -93.53 -17.28 23.56 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.776 -177.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' B' ' 47' ' ' VAL . . . 73.44 17.71 79.08 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . 0.812 ' O ' HG13 ' B' ' 47' ' ' VAL . 70.0 m-85 -111.12 146.01 37.58 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 122.944 0.497 . . . . 0.0 110.349 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -74.4 147.16 42.33 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.45 0.643 . . . . 0.0 111.302 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.36 -38.65 84.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.05 -177.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.23 -39.17 93.86 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 120.103 -0.639 . . . . 0.0 111.81 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -72.3 -31.66 65.9 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 176.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.657 HD13 ' CD2' ' B' ' 46' ' ' PHE . 91.8 mt -68.61 -71.67 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 176.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 96.8 mt -37.25 133.3 0.69 Allowed 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.813 178.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.1 -11.01 71.31 Favored Glycine 0 CA--C 1.537 1.418 0 CA-C-N 116.059 -0.519 . . . . 0.0 113.001 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -133.9 150.19 51.33 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -174.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' ASN . . . . . 0.568 ' C ' ' H ' ' B' ' 63' ' ' ARG . 25.9 t-20 -79.53 149.41 31.45 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.41 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' CYS . . . . . . . . . . . . . 81.8 m -62.74 10.08 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.372 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' ARG . . . . . 0.568 ' H ' ' C ' ' B' ' 61' ' ' ASN . 33.3 ptt-85 -60.61 -33.54 72.91 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.323 -177.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -58.92 -29.88 67.41 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 178.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 87.3 mt -62.2 -41.31 98.25 Favored 'General case' 0 C--O 1.238 0.466 0 O-C-N 121.573 -0.705 . . . . 0.0 109.686 -178.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -51.82 146.25 8.44 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.857 -176.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -156.71 -153.29 6.58 Favored Glycine 0 CA--C 1.534 1.242 0 O-C-N 123.886 0.741 . . . . 0.0 111.831 177.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.31 -41.21 93.0 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -176.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -75.95 -11.1 59.9 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.945 -178.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' THR . . . . . 0.43 HG23 HD11 ' B' ' 92' ' ' ILE . 28.5 m -62.02 133.7 55.68 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 120.229 -0.589 . . . . 0.0 109.427 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -91.02 112.61 54.6 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.639 -179.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.38 -37.56 89.17 Favored 'Trans proline' 0 N--CA 1.489 1.219 0 C-N-CA 121.074 1.183 . . . . 0.0 111.734 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.99 -40.51 89.41 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.793 -176.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -66.84 -39.39 87.6 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.078 177.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 75.2 t -61.82 -46.43 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -63.15 -36.99 85.45 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.76 -178.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -62.27 -42.11 99.05 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 119.371 -0.932 . . . . 0.0 109.0 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 95.5 mt -63.57 -43.44 98.25 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 CA-C-O 120.751 0.31 . . . . 0.0 110.841 -178.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -61.16 -42.39 98.47 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 76.5 m -61.15 -45.06 96.21 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.352 0.596 . . . . 0.0 110.017 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.12 -40.34 97.32 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -177.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 81.8 mt -62.65 -42.81 99.81 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.034 -0.666 . . . . 0.0 109.38 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 67.6 tp60 -63.21 -38.95 93.19 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -81.99 -4.36 56.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.92 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 45.7 tttt 50.33 43.72 26.62 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.548 176.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -127.95 146.42 59.03 Favored Pre-proline 0 N--CA 1.466 0.349 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.421 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -62.41 140.41 82.11 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 120.973 1.115 . . . . 0.0 113.893 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.58 135.9 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.725 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 89' ' ' THR . . . . . 0.87 HG23 ' OD1' ' B' ' 107' ' ' ASN . 93.7 m -121.01 123.45 42.44 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 29.4 m -138.64 162.74 28.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.76 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -115.91 119.8 37.12 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.931 -0.48 . . . . 0.0 109.78 174.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . 0.43 HD11 HG23 ' B' ' 70' ' ' THR . 20.6 tt -127.99 132.44 68.64 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.807 -174.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -70.98 144.42 50.5 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.899 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 94' ' ' ASN . . . . . 0.407 HD22 ' HA ' ' B' ' 94' ' ' ASN . 8.0 m120 -133.62 -179.41 5.51 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-O 121.435 0.636 . . . . 0.0 111.489 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 95' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -131.46 145.95 52.02 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.146 177.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . 0.501 ' HG3' ' CE2' ' B' ' 102' ' ' PHE . 98.8 mttt -103.45 -180.0 4.11 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.402 0.62 . . . . 0.0 110.658 178.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.46 -35.9 76.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.502 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 38.4 p-10 -86.82 -1.44 57.78 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.42 -0.8 . . . . 0.0 112.928 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.89 3.7 63.85 Favored Glycine 0 N--CA 1.466 0.695 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.464 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 21.7 m -68.48 129.41 39.84 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.274 -0.57 . . . . 0.0 109.478 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 101' ' ' MET . . . . . 0.594 ' SD ' ' N ' ' B' ' 102' ' ' PHE . 15.0 tmm? -88.3 143.44 27.02 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 102' ' ' PHE . . . . . 0.594 ' N ' ' SD ' ' B' ' 101' ' ' MET . 54.4 p90 -153.28 163.5 39.79 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 178.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 103' ' ' TRP . . . . . 0.826 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 25.3 m95 -95.71 139.72 31.55 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.614 0.721 . . . . 0.0 110.468 178.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . 0.476 HD21 ' HG2' ' B' ' 123' ' ' GLN . 64.8 t-20 -133.66 105.85 7.06 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 114.804 -1.089 . . . . 0.0 113.783 -177.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 105' ' ' GLU . . . . . 0.469 ' HB2' HD11 ' B' ' 126' ' ' ILE . 81.1 tt0 -73.87 124.24 25.75 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.999 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 37.3 tp -112.04 125.42 54.07 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-O 120.936 0.398 . . . . 0.0 111.631 -177.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 107' ' ' ASN . . . . . 0.87 ' OD1' HG23 ' B' ' 89' ' ' THR . 98.3 m-20 -120.15 127.87 52.89 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 176.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 95.8 mt -122.66 132.59 70.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -141.79 121.55 8.2 Favored Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -70.32 151.88 66.11 Favored 'Trans proline' 0 N--CA 1.501 1.924 0 C-N-CA 122.434 2.09 . . . . 0.0 112.505 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 66.6 mtt -130.87 143.12 50.5 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -112.12 107.4 16.31 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 178.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . 0.524 HG12 ' NZ ' ' A' ' 18' ' ' LYS . 96.8 mt -133.32 127.54 54.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-N 118.521 0.6 . . . . 0.0 111.596 177.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 52.54 38.18 25.0 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.88 178.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 58.86 37.04 24.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.53 -178.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -132.82 150.68 52.13 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 117' ' ' THR . . . . . 0.45 HG23 ' HG3' ' B' ' 32' ' ' PRO . 9.4 t -101.4 152.46 20.7 Favored 'General case' 0 C--O 1.217 -0.628 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -177.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -147.39 146.48 29.63 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 120.791 -1.193 . . . . 0.0 111.189 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -123.07 137.75 54.85 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.765 -177.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -128.86 133.36 66.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 -177.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.57 123.17 6.9 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 122' ' ' ILE . . . . . 0.517 ' HB ' ' HB2' ' B' ' 107' ' ' ASN . 92.4 mt -112.33 127.43 69.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 123' ' ' GLN . . . . . 0.496 ' N ' ' O ' ' B' ' 26' ' ' GLY . 17.5 mp0 -117.93 123.58 46.16 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -120.13 121.16 38.19 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' B' ' 127' ' ' THR . 68.2 t0 -69.39 131.72 45.25 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.588 -179.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.519 HG22 ' O ' ' B' ' 126' ' ' ILE . 2.7 mp -107.51 17.82 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.807 0 CA-C-O 122.097 0.951 . . . . 0.0 109.095 178.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 127' ' ' THR . . . . . 0.447 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 99.3 m -63.85 -44.04 94.32 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.24 -1.345 . . . . 0.0 112.501 175.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 59.9 tptt -60.88 -46.15 91.76 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 129' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -63.21 -36.19 82.81 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.146 -0.933 . . . . 0.0 111.499 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 130' ' ' LYS . . . . . 0.826 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 98.5 mttt -63.57 -41.42 98.39 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-N 113.779 -1.555 . . . . 0.0 110.511 175.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.99 -41.46 97.51 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 132' ' ' TYR . . . . . 0.76 ' CE2' HD11 ' B' ' 136' ' ' LEU . 86.2 t80 -59.78 -44.11 94.07 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 121.663 -0.648 . . . . 0.0 111.156 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' B' ' 137' ' ' GLU . 97.6 mt-10 -64.61 -36.96 85.93 Favored 'General case' 0 C--O 1.224 -0.254 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.563 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 134' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' B' ' 130' ' ' LYS . 99.0 mttt -62.94 -39.57 95.01 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.676 178.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 54.5 tp -63.01 -41.56 99.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.32 0.581 . . . . 0.0 109.811 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 136' ' ' LEU . . . . . 0.76 HD11 ' CE2' ' B' ' 132' ' ' TYR . 89.2 mt -63.01 -41.28 99.53 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.404 177.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 137' ' ' GLU . . . . . 0.408 ' HG3' ' O ' ' B' ' 133' ' ' GLU . 97.2 mt-10 -64.37 -36.54 84.47 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.357 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.77 -43.47 96.31 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.915 176.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 62.3 m -60.87 -45.76 93.29 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 88.5 mt -60.87 -40.33 92.53 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 99.7 m -61.86 -45.44 93.79 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.97 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -66.3 -42.1 88.8 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 94.9 mt -63.11 -43.62 99.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.642 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 144' ' ' THR . . . . . . . . . . . . . 93.4 m -61.78 -45.66 92.93 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.25 -41.31 99.04 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 119.021 -1.072 . . . . 0.0 109.369 178.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 87.5 mt -64.58 -41.12 96.47 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 177.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 147' ' ' SER . . . . . 0.64 ' O ' ' N ' ' B' ' 149' ' ' PRO . 78.2 p -61.76 -40.84 96.56 Favored 'General case' 0 CA--C 1.479 -1.779 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 148' ' ' THR . . . . . 0.486 ' C ' ' O ' ' B' ' 147' ' ' SER . 20.6 m -27.92 84.24 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.657 0 O-C-N 124.128 0.892 . . . . 0.0 110.143 177.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 149' ' ' PRO . . . . . 0.64 ' N ' ' O ' ' B' ' 147' ' ' SER . 22.8 Cg_exo -61.69 147.13 96.04 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 C-N-CA 122.044 1.829 . . . . 0.0 115.802 -176.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 9.6 tp -128.47 121.24 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-N 114.258 -1.337 . . . . 0.0 107.771 174.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 58.1 t -151.68 92.83 3.59 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.946 -178.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -60.59 136.05 64.6 Favored 'Trans proline' 0 C--N 1.32 -0.932 0 N-CA-C 109.029 -1.181 . . . . 0.0 109.029 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 153' ' ' ILE . . . . . 0.586 ' O ' ' HD2' ' B' ' 154' ' ' ARG . 45.0 mm -67.74 -43.72 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.876 178.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 154' ' ' ARG . . . . . 0.586 ' HD2' ' O ' ' B' ' 153' ' ' ILE . 0.2 OUTLIER -156.7 -155.5 0.54 Allowed 'General case' 0 C--N 1.347 0.469 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -179.718 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 62.9 t-20 -86.86 108.27 18.69 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.57 -17.42 57.64 Favored Glycine 0 C--N 1.34 0.803 0 N-CA-C 110.069 -1.213 . . . . 0.0 110.069 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 85.6 mt -110.25 125.64 67.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.144 0.497 . . . . 0.0 111.348 -176.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 158' ' ' SER . . . . . 0.521 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 47.4 m -135.1 149.6 50.07 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.87 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -132.96 145.89 51.29 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.29 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 18.0 tp -139.44 77.76 28.47 Favored Pre-proline 0 CA--C 1.531 0.227 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 161' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -71.56 150.23 56.96 Favored 'Trans proline' 0 N--CA 1.499 1.849 0 C-N-CA 122.835 2.357 . . . . 0.0 114.362 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 92.6 mt -113.83 134.93 54.49 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 55.9 t -128.46 132.93 67.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 112.8 170.61 17.97 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.198 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 165' ' ' ASN . . . . . 0.743 ' O ' ' NH1' ' B' ' 170' ' ' ARG . 61.1 t30 -90.52 107.29 19.07 Favored 'General case' 0 C--O 1.216 -0.673 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -178.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 166' ' ' LEU . . . . . 0.528 HD21 ' CZ ' ' B' ' 171' ' ' PHE . 40.3 tp -63.92 106.16 0.97 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -174.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 167' ' ' THR . . . . . 0.594 HG23 ' NH2' ' B' ' 170' ' ' ARG . 34.5 p -86.79 169.45 12.59 Favored 'General case' 0 C--N 1.353 0.729 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.285 177.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -67.61 -37.33 82.38 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.928 176.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.91 -39.55 90.69 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 123.345 1.545 . . . . 0.0 111.486 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 170' ' ' ARG . . . . . 0.743 ' NH1' ' O ' ' B' ' 165' ' ' ASN . 87.9 mtm180 -63.25 -36.36 83.42 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 112.408 -2.178 . . . . 0.0 110.842 177.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 171' ' ' PHE . . . . . 0.528 ' CZ ' HD21 ' B' ' 166' ' ' LEU . 0.5 OUTLIER -53.76 -25.29 18.18 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -179.009 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 172' ' ' ASN . . . . . 0.514 ' O ' HG22 ' B' ' 175' ' ' VAL . 93.4 m-20 -62.95 -40.57 98.09 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.01 178.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 57.2 m -60.49 -41.72 94.85 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.776 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 66.4 mt -63.52 -44.45 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -178.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 175' ' ' VAL . . . . . 0.514 HG22 ' O ' ' B' ' 172' ' ' ASN . 30.5 m -62.59 -39.92 86.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -179.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 176' ' ' CYS . . . . . 0.404 ' N ' HG23 ' B' ' 175' ' ' VAL . 97.2 m -61.53 -34.82 76.19 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.226 178.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 177' ' ' THR . . . . . 0.585 ' O ' HG13 ' B' ' 181' ' ' ILE . 25.0 m -62.27 -20.4 64.23 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.25 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 178' ' ' LEU . . . . . 0.685 ' CD2' HD21 ' B' ' 211' ' ' LEU . 91.5 mt -61.27 -38.93 88.54 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.269 -178.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 18.3 m -61.95 -44.09 97.49 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 176.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 180' ' ' ASN . . . . . 0.564 ' O ' ' OG ' ' B' ' 183' ' ' SER . 93.3 m-20 -61.8 -40.89 96.78 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.956 0.408 . . . . 0.0 110.554 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.585 HG13 ' O ' ' B' ' 177' ' ' THR . 75.0 mt -57.35 -31.64 38.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.776 -177.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 182' ' ' LEU . . . . . 0.436 HD21 HD21 ' B' ' 214' ' ' LEU . 84.5 mt -62.85 -41.68 99.45 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 119.693 -0.803 . . . . 0.0 109.202 177.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . 0.564 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.2 p -63.54 -32.8 74.37 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 121.845 -0.534 . . . . 0.0 110.817 177.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 184' ' ' THR . . . . . 0.455 ' OG1' ' HA ' ' B' ' 181' ' ' ILE . 17.4 p -86.2 17.94 3.39 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.367 -176.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 80.3 p -61.12 -15.61 35.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.665 -177.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.45 -40.21 95.86 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 121.029 -0.268 . . . . 0.0 110.729 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 187' ' ' ASP . . . . . 0.521 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.4 m-20 -71.42 114.14 9.18 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.433 0.635 . . . . 0.0 110.831 -177.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.38 -42.43 99.41 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 114.803 -1.09 . . . . 0.0 113.09 -178.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -111.82 130.97 55.64 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.221 -178.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 190' ' ' LEU . . . . . . . . . . . . . 41.9 tp -124.1 118.24 26.47 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.926 177.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 87.0 mt -106.93 125.91 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-N 117.759 0.254 . . . . 0.0 111.216 -177.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 49.8 mm -115.41 118.54 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 193' ' ' ASP . . . . . 0.522 ' CG ' ' HG ' ' B' ' 195' ' ' SER . 41.7 t0 -90.47 111.67 23.02 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -176.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 194' ' ' LEU . . . . . . . . . . . . . 96.2 mt -92.45 -1.61 56.87 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 123.624 0.577 . . . . 0.0 109.627 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 195' ' ' SER . . . . . 0.522 ' HG ' ' CG ' ' B' ' 193' ' ' ASP . 77.8 p -60.88 -36.81 80.17 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.794 -178.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.46 -34.72 89.36 Favored Glycine 0 N--CA 1.439 -1.105 0 N-CA-C 109.919 -1.273 . . . . 0.0 109.919 -178.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 197' ' ' LEU . . . . . 0.979 ' CD2' ' O ' ' B' ' 199' ' ' GLN . 5.4 tt -77.22 134.01 38.73 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 198' ' ' ALA . . . . . 0.959 ' N ' HD23 ' B' ' 197' ' ' LEU . . . -63.75 -44.96 91.92 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 119.954 -0.698 . . . . 0.0 111.572 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 199' ' ' GLN . . . . . 0.979 ' O ' ' CD2' ' B' ' 197' ' ' LEU . 58.4 tt0 -136.83 163.25 31.07 Favored 'General case' 0 C--O 1.212 -0.921 0 CA-C-O 122.202 1.001 . . . . 0.0 112.602 -177.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 200' ' ' VAL . . . . . 0.463 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 55.8 t -120.65 132.17 70.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 O-C-N 120.382 -1.449 . . . . 0.0 109.583 177.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -89.7 150.24 22.41 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.79 -178.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -61.38 -33.24 73.33 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.325 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -63.15 -32.99 74.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.435 0.636 . . . . 0.0 109.357 177.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.7 m -60.65 -44.24 96.65 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.291 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 205' ' ' ALA . . . . . 0.676 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -58.15 -29.64 65.73 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -178.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -65.63 -38.77 90.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.502 0.668 . . . . 0.0 110.519 174.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -66.2 -39.0 89.33 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.752 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 95.4 mt -62.86 -45.72 98.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -178.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 209' ' ' PHE . . . . . 0.676 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 66.1 m-85 -61.22 -42.22 98.21 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.781 -176.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.0 -42.07 99.75 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.61 -0.836 . . . . 0.0 109.607 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 211' ' ' LEU . . . . . 0.685 HD21 ' CD2' ' B' ' 178' ' ' LEU . 39.4 mt -62.18 -42.3 99.14 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.106 -178.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 78.2 p -63.97 -35.74 81.68 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.385 -0.526 . . . . 0.0 112.0 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 213' ' ' HIS . . . . . 0.427 ' CE1' HD11 ' B' ' 217' ' ' LEU . 56.3 t-80 -66.92 -46.87 73.48 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.106 177.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.436 HD21 HD21 ' B' ' 182' ' ' LEU . 56.5 tp -63.96 -43.08 96.87 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.598 0.713 . . . . 0.0 109.88 177.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 215' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' B' ' 211' ' ' LEU . 84.9 mt -63.07 -44.46 95.74 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 113.544 -1.662 . . . . 0.0 111.368 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -61.69 -39.08 90.19 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.258 -177.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . 0.427 HD11 ' CE1' ' B' ' 213' ' ' HIS . 86.2 mt -62.86 -41.62 99.44 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.309 0.576 . . . . 0.0 111.023 176.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 218' ' ' THR . . . . . 0.404 HG23 ' O ' ' B' ' 214' ' ' LEU . 67.3 p -76.06 -16.26 59.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.641 -178.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 78.81 68.13 1.53 Allowed Glycine 0 CA--C 1.528 0.864 0 N-CA-C 107.573 -2.211 . . . . 0.0 107.573 -177.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 220' ' ' THR . . . . . . . . . . . . . 81.0 m -146.51 105.84 3.91 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 176.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -63.16 139.93 58.82 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.879 -175.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 40.6 tp -118.13 122.18 42.42 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.414 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 3.6 mp -112.25 129.19 68.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.249 -178.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 224' ' ' ILE . . . . . 0.539 ' CG2' HD11 ' B' ' 227' ' ' ILE . 49.5 mm -109.51 126.17 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 50.4 p -133.29 156.08 48.23 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.697 0.761 . . . . 0.0 112.559 -177.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 91.0 16.27 54.57 Favored Glycine 0 CA--C 1.504 -0.598 0 CA-C-N 114.018 -1.446 . . . . 0.0 111.319 -177.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 227' ' ' ILE . . . . . 0.592 HD12 HG23 ' B' ' 247' ' ' THR . 96.1 mt -81.48 126.48 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 118.046 0.923 . . . . 0.0 111.27 -178.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 64.3 tttt -66.24 140.23 96.74 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.392 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.71 -36.78 91.09 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.378 1.385 . . . . 0.0 112.554 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -64.0 -43.88 94.35 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -178.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 50.1 tp -61.64 -41.8 98.01 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.526 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.82 -37.1 86.12 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.881 -0.328 . . . . 0.0 111.314 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 94.7 mtp -63.83 -41.06 97.93 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.276 -0.57 . . . . 0.0 109.777 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.11 -43.71 97.68 Favored 'General case' 0 CA--C 1.553 1.082 0 CA-C-O 122.305 1.05 . . . . 0.0 109.589 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 37.9 mmt -63.96 -35.21 79.95 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.878 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -61.71 -39.99 93.45 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.989 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.7 -43.24 99.3 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 177.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 51.4 tp -61.83 -43.79 98.14 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.636 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 239' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' B' ' 240' ' ' ALA . 66.8 t0 -162.23 135.01 5.88 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.96 -178.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 240' ' ' ALA . . . . . 0.439 ' N ' ' OD1' ' B' ' 239' ' ' ASP . . . -62.09 -44.3 96.95 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 177.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 241' ' ' ASN . . . . . 0.626 ' O ' ' HB2' ' B' ' 244' ' ' SER . 89.3 m-20 -45.83 -20.2 0.08 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.289 -174.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 242' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -61.24 -45.66 93.62 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 120.083 -0.647 . . . . 0.0 110.402 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 243' ' ' SER . . . . . . . . . . . . . 77.7 p -55.96 -43.46 77.52 Favored 'General case' 0 C--O 1.225 -0.191 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 244' ' ' SER . . . . . 0.626 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 70.9 m -34.07 -33.22 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 -177.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 97.1 mt -89.96 132.56 35.27 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.667 178.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -58.69 136.78 57.77 Favored 'General case' 0 C--O 1.251 1.176 0 CA-C-O 121.833 0.825 . . . . 0.0 111.261 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 247' ' ' THR . . . . . 0.592 HG23 HD12 ' B' ' 227' ' ' ILE . 97.4 m -125.97 128.01 46.84 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.74 178.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 248' ' ' TYR . . . . . 0.49 ' CG ' ' HB2' ' B' ' 254' ' ' ALA . 95.9 m-85 -113.64 143.46 44.54 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 249' ' ' SER . . . . . 0.564 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 78.1 p -63.11 -35.8 81.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.855 0.36 . . . . 0.0 111.295 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 250' ' ' ASN . . . . . 0.564 ' OD1' ' O ' ' B' ' 249' ' ' SER . 98.6 m-20 -146.67 162.08 39.21 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.321 178.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 73.0 t -65.0 -44.74 95.99 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.175 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.924 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 252' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.38 -46.04 91.84 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -177.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . 0.476 ' O ' HG22 ' B' ' 257' ' ' VAL . 94.7 m-20 -61.43 -43.21 99.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.763 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 254' ' ' ALA . . . . . 0.49 ' HB2' ' CG ' ' B' ' 248' ' ' TYR . . . -65.3 -40.35 93.71 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.468 0.652 . . . . 0.0 111.08 178.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 255' ' ' VAL . . . . . . . . . . . . . 53.6 t -65.39 -45.35 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.277 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 256' ' ' LYS . . . . . 0.468 ' HE3' ' ND2' ' A' ' 155' ' ' ASN . 88.5 tttt -63.37 -48.33 78.39 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.113 -178.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 257' ' ' VAL . . . . . 0.476 HG22 ' O ' ' B' ' 253' ' ' ASP . 21.1 m -65.14 -40.22 88.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.519 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 258' ' ' LEU . . . . . 0.492 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 1.0 OUTLIER -31.9 -73.33 0.05 OUTLIER Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.826 -178.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 259' ' ' PRO . . . . . 0.543 ' O ' HG13 ' B' ' 260' ' ' ILE . 37.5 Cg_endo -62.25 141.47 87.98 Favored 'Trans proline' 0 N--CA 1.504 2.092 0 C-N-CA 121.572 1.515 . . . . 0.0 111.498 -178.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 260' ' ' ILE . . . . . 0.543 HG13 ' O ' ' B' ' 259' ' ' PRO . 96.9 mt -159.35 -16.48 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 118.587 0.63 . . . . 0.0 112.411 177.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 118.083 -0.96 . . . . 0.0 111.73 179.856 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.221 -1.551 . . . . 0.0 109.221 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.36 174.84 13.82 Favored 'General case' 0 CA--C 1.483 -1.624 0 CA-C-O 123.219 1.485 . . . . 0.0 109.746 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 93.9 p -80.12 -3.81 50.31 Favored 'General case' 0 CA--C 1.572 1.795 0 O-C-N 117.817 -3.052 . . . . 0.0 112.766 177.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -85.29 -64.64 1.12 Allowed 'General case' 0 C--N 1.267 -3.017 0 O-C-N 127.09 2.744 . . . . 0.0 112.304 174.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -70.06 -38.82 75.88 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.089 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.508 ' O ' ' NZ ' ' B' ' 17' ' ' LYS . 65.6 m -59.15 -41.76 89.07 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.862 -177.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.502 ' HB3' ' O ' ' A' ' 6' ' ' SER . 36.2 t80 85.14 87.33 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.364 0.602 . . . . 0.0 111.771 176.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.578 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -60.5 -142.76 0.01 OUTLIER Glycine 0 C--N 1.337 0.628 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.578 ' HB ' ' O ' ' A' ' 8' ' ' GLY . 78.0 mt 84.96 111.76 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.629 0 O-C-N 124.075 0.515 . . . . 0.0 110.655 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.68 -22.25 64.46 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.195 1.263 . . . . 0.0 112.219 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.41 -38.54 95.94 Favored Glycine 0 N--CA 1.465 0.578 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.228 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -64.86 -39.17 93.14 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 51.9 tp -63.06 -41.66 99.51 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -63.29 -40.31 97.0 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.6 t -60.76 -44.04 96.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 O-C-N 122.014 -0.429 . . . . 0.0 111.025 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 92.9 mt -62.32 -43.49 98.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 119.508 -0.877 . . . . 0.0 109.12 -177.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.441 ' NZ ' ' HA ' ' B' ' 6' ' ' SER . 98.8 mttt -62.54 -46.22 89.36 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 119.331 -0.948 . . . . 0.0 112.036 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.579 ' NZ ' HG12 ' B' ' 113' ' ' ILE . 98.6 mttt -60.23 -39.46 86.74 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 118.72 -1.192 . . . . 0.0 108.83 -176.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.35 -42.14 90.86 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 120.034 -0.666 . . . . 0.0 110.156 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.0 mt -62.99 -40.93 99.24 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -63.08 -38.85 92.83 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.949 -0.568 . . . . 0.0 112.525 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 54.4 m170 -58.44 -40.06 81.53 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 122.168 -0.332 . . . . 0.0 111.48 -178.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.0 p -114.85 130.52 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.478 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 33.3 ptt180 -72.09 111.63 7.48 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 122.126 0.965 . . . . 0.0 112.207 -177.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.6 p -141.31 143.1 28.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.571 ' O ' ' N ' ' A' ' 123' ' ' GLN . . . -97.81 90.65 1.09 Allowed Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.767 -178.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 54.4 t -124.38 129.81 73.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 176.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.3 m -137.38 159.77 35.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.6 mt -120.09 129.92 74.91 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.64 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 176.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.433 ' OG1' ' HB2' ' A' ' 119' ' ' PHE . 17.5 p -106.16 166.08 10.77 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.427 ' C ' ' OD1' ' A' ' 37' ' ' ASN . 44.3 t0 -132.78 101.7 13.98 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.534 ' CG ' HG23 ' A' ' 117' ' ' THR . 37.6 Cg_endo -64.64 -21.2 65.56 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.576 1.517 . . . . 0.0 111.572 -178.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.54 -33.61 75.28 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.399 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 88.9 mt -86.83 172.22 10.27 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.272 178.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.657 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 42.2 tt0 -67.58 133.06 48.74 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -178.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.567 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 62.8 t0 61.44 20.85 11.53 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 177.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.427 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 40.4 t-20 43.1 68.68 2.74 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.727 -177.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.657 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 88.1 Cg_endo -71.4 155.63 59.73 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 123.9 3.067 . . . . 0.0 112.39 -178.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.3 mt -87.91 124.35 41.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 O-C-N 124.047 0.842 . . . . 0.0 108.977 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.409 HG23 ' N ' ' A' ' 41' ' ' TYR . 27.6 m -105.18 -42.43 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 O-C-N 123.609 0.568 . . . . 0.0 112.332 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.409 ' N ' HG23 ' A' ' 40' ' ' VAL . 46.7 t80 -97.13 123.2 40.82 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 120.289 -0.564 . . . . 0.0 111.968 -178.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.6 p -142.56 139.73 28.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.918 177.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.684 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 55.7 p30 -95.78 165.96 12.04 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.47 ' OE1' ' HA ' ' A' ' 44' ' ' GLN . 14.0 mm100 -66.63 -39.82 88.45 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 177.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.57 -25.0 62.63 Favored Glycine 0 C--O 1.236 0.247 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.684 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 64.5 t80 -59.39 -48.48 81.47 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 105.221 -2.14 . . . . 0.0 105.221 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.569 HG13 ' O ' ' A' ' 52' ' ' TYR . 54.4 t -58.78 -44.7 90.83 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.554 0 O-C-N 121.088 -1.008 . . . . 0.0 111.623 -174.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -63.15 -35.81 81.52 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 120.441 -0.504 . . . . 0.0 112.278 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 60.9 ttm -68.08 -42.66 80.07 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 177.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 43.6 p -95.58 -20.59 18.86 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.358 0.599 . . . . 0.0 111.255 -177.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . 77.94 19.41 75.25 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.569 ' O ' HG13 ' A' ' 47' ' ' VAL . 75.0 m-85 -112.37 137.74 50.09 Favored 'General case' 0 C--O 1.222 -0.366 0 C-N-CA 122.569 0.348 . . . . 0.0 110.881 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -63.22 147.94 49.54 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.829 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.446 HG22 ' H ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -65.2 -33.79 76.84 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.61 -43.15 85.54 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.959 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -64.23 -45.12 89.6 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.354 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.575 HD13 ' CE2' ' A' ' 46' ' ' PHE . 96.1 mt -62.85 -48.37 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 -175.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.2 mt -57.49 144.99 34.72 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.03 -2.96 82.51 Favored Glycine 0 C--O 1.237 0.329 0 C-N-CA 121.062 -0.589 . . . . 0.0 113.534 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -134.78 151.47 50.99 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.916 1.358 . . . . 0.0 112.308 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.574 ' C ' ' H ' ' A' ' 63' ' ' ARG . 25.5 t-20 -81.57 149.38 28.66 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.343 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 71.4 m -61.96 16.15 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.515 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.574 ' H ' ' C ' ' A' ' 61' ' ' ASN . 36.5 ptt-85 -61.35 -41.52 97.19 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.973 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -55.91 -20.31 15.37 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.5 mt -68.77 -35.94 77.7 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.951 0.881 . . . . 0.0 112.064 177.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -64.92 136.85 57.3 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.877 -176.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.567 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -147.28 -149.09 4.89 Favored Glycine 0 CA--C 1.537 1.415 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -178.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.83 -40.03 96.14 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -177.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -76.32 -9.58 58.74 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.952 0.406 . . . . 0.0 111.003 -178.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.567 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 27.0 m -61.4 129.65 42.24 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.567 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -86.49 112.1 44.02 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.791 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -57.45 -31.12 90.44 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 121.966 1.777 . . . . 0.0 113.283 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.49 -40.67 96.1 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 120.499 -0.481 . . . . 0.0 110.815 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.422 ' OE1' ' HB ' ' A' ' 90' ' ' VAL . 79.2 mm-40 -65.53 -45.03 85.02 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.4 t -59.09 -43.62 89.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -177.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -63.87 -37.74 88.52 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.042 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -63.47 -39.79 95.39 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.497 0.665 . . . . 0.0 110.128 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.22 -44.04 97.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.96 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -62.66 -43.19 99.44 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 113.771 -1.558 . . . . 0.0 108.231 -179.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 99.3 m -61.16 -48.54 81.13 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.37 -41.34 96.94 Favored 'General case' 0 C--N 1.361 1.081 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.186 -172.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 90.2 mt -63.05 -40.08 96.65 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.632 -1.293 . . . . 0.0 111.582 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -63.03 -40.78 98.77 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -70.11 -25.19 63.39 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.457 177.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 51.5 tttt 65.23 42.81 3.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.413 -176.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -125.96 148.57 63.26 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -61.64 143.82 96.99 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.334 1.356 . . . . 0.0 112.928 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.93 141.34 31.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.457 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.945 HG23 ' OD1' ' A' ' 107' ' ' ASN . 99.6 m -128.1 120.33 27.17 Favored 'General case' 0 C--N 1.345 0.386 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 176.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.422 ' HB ' ' OE1' ' A' ' 74' ' ' GLU . 29.0 m -138.82 158.31 29.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.82 -0.173 . . . . 0.0 111.453 178.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -102.96 128.75 49.65 Favored 'General case' 0 C--O 1.247 0.931 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.459 HG23 ' O ' ' A' ' 92' ' ' ILE . 18.3 tt -137.55 129.45 41.0 Favored 'Isoleucine or valine' 0 C--N 1.378 1.837 0 CA-C-N 121.917 2.144 . . . . 0.0 112.363 177.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -61.5 134.29 56.69 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.107 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -135.43 159.82 40.38 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.102 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.455 ' CE1' ' HA3' ' A' ' 67' ' ' GLY . 93.0 m-85 -118.46 137.22 53.32 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.49 ' HG3' ' CE1' ' A' ' 102' ' ' PHE . 99.2 mttt -85.97 -171.77 3.75 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.394 0.616 . . . . 0.0 111.754 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -62.99 -42.08 99.75 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.295 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 41.1 p-10 -84.8 8.12 18.39 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -178.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.84 -3.41 87.17 Favored Glycine 0 N--CA 1.473 1.108 0 C-N-CA 120.571 -0.824 . . . . 0.0 111.916 177.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.7 m -59.3 137.89 57.82 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 106.255 -1.758 . . . . 0.0 106.255 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.687 ' SD ' ' C ' ' A' ' 101' ' ' MET . 13.4 tmm? -107.01 129.29 54.82 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 122.184 -0.323 . . . . 0.0 111.032 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.49 ' CE1' ' HG3' ' A' ' 96' ' ' LYS . 52.9 p90 -140.61 158.62 43.71 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.404 -177.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.842 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 22.8 m95 -89.03 144.87 25.85 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.554 HD21 ' HG2' ' A' ' 123' ' ' GLN . 56.4 t-20 -139.0 102.06 4.44 Favored 'General case' 0 C--O 1.245 0.862 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -176.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 80.8 tt0 -67.27 136.43 54.91 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -177.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 40.2 tp -121.43 123.76 42.85 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -179.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.945 ' OD1' HG23 ' A' ' 89' ' ' THR . 98.1 m-20 -120.58 122.64 41.01 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 123.237 0.336 . . . . 0.0 110.742 177.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 96.3 mt -120.71 128.33 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 O-C-N 123.536 0.523 . . . . 0.0 111.505 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -138.24 125.14 13.26 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.17 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -71.56 152.12 59.36 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.399 2.066 . . . . 0.0 112.313 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.63 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 66.6 mtt -124.47 152.73 42.99 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -127.41 96.19 4.49 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 177.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.496 ' CD1' HG22 ' B' ' 15' ' ' VAL . 96.4 mt -120.34 131.28 73.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.184 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 51.13 38.33 20.6 Favored 'General case' 0 CA--C 1.511 -0.538 0 O-C-N 121.355 -0.84 . . . . 0.0 111.51 175.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 59.39 31.49 21.13 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 123.777 0.673 . . . . 0.0 111.049 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -129.55 148.73 51.48 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.76 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 7.4 t -86.58 -173.33 4.45 Favored 'General case' 0 C--O 1.209 -1.034 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -178.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.76 ' CD2' ' O ' ' A' ' 117' ' ' THR . 77.2 m-85 -170.5 155.71 5.16 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 175.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.433 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 83.7 m-85 -129.44 146.38 51.3 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 175.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -136.43 135.54 49.27 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 177.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -111.12 130.28 9.69 Favored Glycine 0 CA--C 1.5 -0.89 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 178.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 96.2 mt -119.01 129.69 74.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.571 ' N ' ' O ' ' A' ' 26' ' ' GLY . 15.7 mp0 -119.67 115.27 23.59 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -116.46 113.07 22.32 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.647 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.464 ' OD1' ' N ' ' A' ' 126' ' ' ILE . 68.3 t0 -63.75 131.15 46.97 Favored 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -176.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.465 HG22 ' O ' ' A' ' 126' ' ' ILE . 2.6 mp -96.01 4.29 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 113.53 -1.668 . . . . 0.0 110.136 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 29.5 m -60.92 -42.45 98.14 Favored 'General case' 0 C--N 1.364 1.237 0 O-C-N 120.595 -1.316 . . . . 0.0 113.528 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -59.49 -43.06 93.41 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -63.0 -40.07 96.66 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.792 177.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.842 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.6 mttt -62.95 -40.81 98.79 Favored 'General case' 0 CA--C 1.504 -0.814 0 C-N-CA 118.277 -1.369 . . . . 0.0 110.187 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -61.43 -38.52 87.47 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.013 -178.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.763 ' CE2' HD11 ' A' ' 136' ' ' LEU . 86.6 t80 -61.76 -45.85 92.11 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.307 176.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.82 -38.29 90.53 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -62.44 -40.21 95.85 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.391 -0.524 . . . . 0.0 109.74 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 52.9 tp -61.05 -43.59 98.65 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -178.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.763 HD11 ' CE2' ' A' ' 132' ' ' TYR . 85.7 mt -62.72 -41.24 99.05 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.002 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -62.93 -41.5 99.49 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 119.337 -0.945 . . . . 0.0 109.672 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -60.14 -42.24 94.42 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -177.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 55.4 m -61.68 -41.36 97.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.851 176.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 144' ' ' THR . 84.6 mt -63.23 -41.41 99.11 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 178.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 88.3 m -61.54 -45.63 93.34 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.102 -177.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -65.19 -40.52 94.34 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 94.5 mt -64.7 -43.17 96.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 113.9 -1.5 . . . . 0.0 111.331 176.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.502 ' N ' ' O ' ' A' ' 140' ' ' LEU . 96.4 m -62.11 -46.01 90.96 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 120.372 -0.531 . . . . 0.0 112.371 -178.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.47 ' O ' ' OG1' ' A' ' 148' ' ' THR . . . -62.93 -39.77 95.6 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 118.95 -1.1 . . . . 0.0 109.451 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.4 mt -63.32 -42.71 99.0 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.719 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.0 p -59.6 -40.22 86.78 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -177.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.47 ' OG1' ' O ' ' A' ' 145' ' ' ALA . 12.6 m -26.72 80.64 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.524 0 O-C-N 127.54 3.025 . . . . 0.0 106.195 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.719 ' N ' ' O ' ' A' ' 147' ' ' SER . 19.3 Cg_exo -62.19 143.66 94.65 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 121.08 1.187 . . . . 0.0 113.651 -175.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.677 ' O ' HG23 ' A' ' 151' ' ' VAL . 8.9 tp -118.69 136.07 57.07 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 175.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.677 HG23 ' O ' ' A' ' 150' ' ' ILE . 89.1 t -169.25 92.59 0.55 Allowed Pre-proline 0 CA--C 1.508 -0.673 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 178.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -61.89 136.47 61.79 Favored 'Trans proline' 0 N--CA 1.487 1.105 0 CA-C-N 119.598 0.892 . . . . 0.0 110.086 -177.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.692 ' O ' ' HD2' ' A' ' 154' ' ' ARG . 45.4 mm -67.34 -45.25 86.29 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.526 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.381 178.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.692 ' HD2' ' O ' ' A' ' 153' ' ' ILE . 0.7 OUTLIER -157.71 -156.4 0.58 Allowed 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.422 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 63.1 t-20 -86.93 104.78 16.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.48 0.657 . . . . 0.0 110.971 -178.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.21 7.97 67.08 Favored Glycine 0 C--O 1.224 -0.494 0 CA-C-N 114.077 -1.42 . . . . 0.0 110.015 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.6 mt -123.92 123.66 67.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 175.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.7 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 57.6 m -132.74 151.69 51.92 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -139.84 142.44 36.6 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.333 0.587 . . . . 0.0 111.309 178.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 20.7 tp -131.34 81.19 66.01 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.322 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -69.29 150.01 70.56 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.712 2.274 . . . . 0.0 113.117 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 90.6 mt -119.62 126.72 51.85 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.792 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 55.4 t -124.11 131.6 72.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 117.68 167.8 14.34 Favored Glycine 0 N--CA 1.476 1.326 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.241 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.903 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 56.2 t30 -85.11 115.02 22.67 Favored 'General case' 0 C--O 1.204 -1.305 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.57 HD21 ' CZ ' ' A' ' 171' ' ' PHE . 47.8 tp -75.12 103.42 5.29 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -177.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.734 HG23 ' NE ' ' A' ' 170' ' ' ARG . 10.7 p -85.29 167.95 15.15 Favored 'General case' 0 C--O 1.226 -0.14 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.637 178.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.75 -33.59 76.21 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.33 -45.17 89.04 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.149 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.903 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 87.4 mtm180 -63.27 -33.37 75.36 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.219 -0.9 . . . . 0.0 112.267 178.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.57 ' CZ ' HD21 ' A' ' 166' ' ' LEU . 0.4 OUTLIER -54.5 -28.2 43.36 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 119.086 -0.483 . . . . 0.0 111.897 -177.586 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.634 ' O ' HG22 ' A' ' 175' ' ' VAL . 91.5 m-20 -60.97 -39.81 90.99 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 118.866 -1.134 . . . . 0.0 109.842 -177.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 66.9 m -59.4 -40.92 88.14 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 121.787 -0.571 . . . . 0.0 110.484 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 67.0 mt -63.63 -44.01 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 172' ' ' ASN . 33.7 m -62.53 -40.89 89.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -178.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . 0.432 ' N ' HG23 ' A' ' 175' ' ' VAL . 96.5 m -62.33 -34.53 76.81 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.312 178.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.569 ' O ' HG13 ' A' ' 181' ' ' ILE . 25.4 m -61.91 -19.59 62.85 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.931 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.636 ' CD2' HD21 ' A' ' 211' ' ' LEU . 84.9 mt -60.87 -41.58 96.23 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -177.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 19.5 m -59.53 -43.43 93.48 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . 0.622 ' O ' ' OG ' ' A' ' 183' ' ' SER . 92.5 m-20 -61.85 -37.24 83.75 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-O 121.016 0.436 . . . . 0.0 110.719 178.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.569 HG13 ' O ' ' A' ' 177' ' ' THR . 66.0 mt -58.21 -38.68 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 O-C-N 121.296 -0.877 . . . . 0.0 109.437 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.52 HD21 HD21 ' A' ' 214' ' ' LEU . 87.0 mt -60.89 -40.6 93.67 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -177.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.622 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 77.1 p -61.53 -34.02 74.83 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.526 177.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 49.4 p -89.26 25.17 1.96 Allowed 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.634 0.254 . . . . 0.0 111.304 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 78.5 p -63.6 -21.51 66.4 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.846 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -59.76 -36.96 77.71 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.14 -178.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.7 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 98.8 m-20 -72.03 112.97 8.57 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.593 0.711 . . . . 0.0 110.853 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.88 -42.78 99.89 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 114.959 -1.018 . . . . 0.0 112.802 -177.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -113.37 131.61 55.92 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.802 -178.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 38.3 tp -121.08 128.49 52.65 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 96.1 mt -116.39 127.14 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 177.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.3 mm -112.68 126.98 70.14 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . 0.497 ' CG ' ' HG ' ' A' ' 195' ' ' SER . 40.1 t0 -95.13 119.56 33.84 Favored 'General case' 0 CA--C 1.56 1.352 0 CA-C-O 119.638 -0.22 . . . . 0.0 110.913 178.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 95.8 mt -99.64 -4.03 31.82 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 125.022 1.451 . . . . 0.0 111.06 176.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . 0.497 ' HG ' ' CG ' ' A' ' 193' ' ' ASP . 78.4 p -63.12 -32.24 73.57 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -62.08 -44.38 97.84 Favored Glycine 0 CA--C 1.544 1.851 0 N-CA-C 108.103 -1.999 . . . . 0.0 108.103 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 1.068 ' CD2' ' O ' ' A' ' 199' ' ' GLN . 6.7 tt -67.37 128.76 37.62 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 112.536 -1.832 . . . . 0.0 109.284 -178.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.772 ' N ' HD23 ' A' ' 197' ' ' LEU . . . -60.53 -50.38 73.79 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-O 121.402 0.62 . . . . 0.0 110.476 -178.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 1.068 ' O ' ' CD2' ' A' ' 197' ' ' LEU . 59.1 tt0 -133.55 156.5 47.7 Favored 'General case' 0 C--O 1.209 -1.034 0 CA-C-N 114.445 -1.252 . . . . 0.0 114.328 -175.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.487 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 44.9 t -116.07 131.08 69.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 O-C-N 120.321 -1.487 . . . . 0.0 108.619 178.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -84.21 155.74 22.36 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.759 -179.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.59 -39.47 93.79 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.045 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -57.16 -31.98 65.95 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.3 m -61.52 -42.38 98.72 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.546 178.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.454 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -56.39 -39.7 73.39 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -177.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -61.19 -37.41 82.84 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.634 -0.427 . . . . 0.0 109.882 -178.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.0 -38.96 92.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.835 177.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.92 -44.63 99.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 C-N-CA 119.469 -0.893 . . . . 0.0 108.734 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . 0.454 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 68.9 m-85 -62.35 -43.59 98.46 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.001 -177.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.13 -42.01 98.81 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 118.882 -1.127 . . . . 0.0 109.181 -178.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.636 HD21 ' CD2' ' A' ' 178' ' ' LEU . 41.1 mt -62.11 -41.66 98.44 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 78.3 p -61.28 -42.19 98.22 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 118.936 -1.106 . . . . 0.0 110.351 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' HIS . . . . . 0.455 ' CE1' HD11 ' A' ' 217' ' ' LEU . 59.0 t-80 -63.42 -46.02 88.28 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.76 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.52 HD21 HD21 ' A' ' 182' ' ' LEU . 52.8 tp -62.49 -46.76 87.0 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 88.4 mt -62.02 -40.53 95.99 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.902 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.46 -44.5 95.8 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.292 -178.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.455 HD11 ' CE1' ' A' ' 213' ' ' HIS . 84.0 mt -61.76 -40.18 94.23 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 75.2 p -75.81 -11.66 60.02 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.239 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 83.1 37.05 13.21 Favored Glycine 0 C--N 1.343 0.939 0 C-N-CA 120.723 -0.751 . . . . 0.0 114.027 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 99.8 m -123.2 114.68 20.6 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.046 1.423 . . . . 0.0 112.022 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -65.65 138.08 57.76 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.268 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 42.9 tp -112.37 130.01 56.11 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 3.2 mp -117.61 132.56 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.617 ' CG2' HD11 ' A' ' 227' ' ' ILE . 49.4 mm -115.33 131.43 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 42.6 p -134.01 167.67 20.2 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 78.15 19.14 75.28 Favored Glycine 0 C--O 1.223 -0.537 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.617 HD11 ' CG2' ' A' ' 224' ' ' ILE . 97.4 mt -81.53 128.35 38.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 113.611 -1.294 . . . . 0.0 108.112 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -74.01 140.2 76.97 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.29 -38.92 88.7 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 120.99 1.127 . . . . 0.0 112.627 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -64.83 -38.7 91.86 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 121.351 0.596 . . . . 0.0 109.948 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 51.2 tp -63.64 -42.76 98.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.832 177.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.48 -37.99 89.46 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.73 -178.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 94.1 mtp -63.31 -40.4 97.23 Favored 'General case' 0 C--O 1.247 0.923 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.834 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -64.04 -39.38 93.96 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.755 177.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 33.1 mmt -65.94 -36.63 83.88 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.623 178.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -61.11 -41.48 96.76 Favored 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 121.367 -0.833 . . . . 0.0 109.413 -176.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.71 -40.68 93.14 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.618 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 54.5 tp -63.61 -41.55 98.3 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 176.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -168.18 124.63 1.05 Allowed 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.254 0.55 . . . . 0.0 112.454 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.66 -27.1 66.09 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.764 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -62.49 -26.42 68.52 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.789 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -56.23 -44.21 79.38 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -176.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 99.4 p -61.78 -20.59 63.75 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 123.766 0.666 . . . . 0.0 111.283 179.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 50.1 m -57.11 -33.77 67.68 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 94.7 mt -87.79 121.79 30.65 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 119.458 -0.897 . . . . 0.0 113.261 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -46.03 135.84 7.12 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.712 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.544 HG23 HD12 ' A' ' 227' ' ' ILE . 97.8 m -127.46 132.92 49.95 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.673 179.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' TYR . . . . . 0.457 ' CG ' ' HB2' ' A' ' 254' ' ' ALA . 95.1 m-85 -118.13 139.18 51.63 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.12 178.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 78.0 p -60.47 -41.76 94.83 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -178.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -144.46 160.78 40.52 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.824 0.821 . . . . 0.0 111.604 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 72.3 t -63.23 -44.43 99.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 114.586 -1.188 . . . . 0.0 112.25 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.57 -44.54 96.08 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.036 -0.665 . . . . 0.0 109.466 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . 0.569 ' O ' HG22 ' A' ' 257' ' ' VAL . 55.6 m-20 -63.83 -42.51 97.62 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.487 -178.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . 0.457 ' HB2' ' CG ' ' A' ' 248' ' ' TYR . . . -63.88 -42.8 97.41 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 122.035 0.921 . . . . 0.0 109.791 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . 0.456 HG13 HH11 ' B' ' 154' ' ' ARG . 66.3 t -63.6 -45.71 96.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.157 -1.383 . . . . 0.0 111.143 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.84 -47.66 79.88 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.267 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 253' ' ' ASP . 33.3 m -66.48 -40.54 86.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 O-C-N 121.373 -0.829 . . . . 0.0 112.285 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.506 ' C ' ' O ' ' A' ' 257' ' ' VAL . 1.7 mt -28.64 -75.48 0.04 OUTLIER Pre-proline 0 N--CA 1.467 0.375 0 O-C-N 123.17 0.294 . . . . 0.0 111.607 -177.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' PRO . . . . . 0.494 ' CD ' ' CB ' ' A' ' 258' ' ' LEU . 42.7 Cg_endo -63.25 139.3 71.25 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 120.754 0.969 . . . . 0.0 111.943 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 259' ' ' PRO . 96.7 mt -151.74 -27.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 O-C-N 124.049 0.843 . . . . 0.0 111.962 178.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 78.0 mtm . . . . . 0 N--CA 1.475 0.789 0 CA-C-O 118.094 -0.955 . . . . 0.0 110.754 -177.425 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.49 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.13 165.32 36.33 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 79.4 p -66.96 -13.59 61.98 Favored 'General case' 0 CA--C 1.568 1.669 0 O-C-N 121.724 -0.61 . . . . 0.0 112.398 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -80.04 -63.25 1.45 Allowed 'General case' 0 C--N 1.311 -1.108 0 O-C-N 124.532 1.145 . . . . 0.0 109.379 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -67.05 -39.19 86.87 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.445 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . 0.502 ' O ' ' HB3' ' B' ' 7' ' ' PHE . 66.6 m -59.68 -42.08 92.12 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.782 -177.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . 0.502 ' HB3' ' O ' ' B' ' 6' ' ' SER . 36.8 t80 85.85 90.96 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.573 177.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . 0.583 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -63.58 -141.85 0.02 OUTLIER Glycine 0 C--N 1.34 0.754 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.583 ' HB ' ' O ' ' B' ' 8' ' ' GLY . 78.5 mt 84.49 111.86 0.03 OUTLIER Pre-proline 0 CA--C 1.545 0.776 0 O-C-N 124.086 0.521 . . . . 0.0 110.796 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.79 -24.31 68.56 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 121.109 1.206 . . . . 0.0 111.783 -178.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.71 -40.43 98.76 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.604 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -64.87 -39.44 93.55 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.557 0.694 . . . . 0.0 109.234 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 50.3 tp -62.05 -42.28 99.02 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.454 -177.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -65.14 -31.15 72.19 Favored 'General case' 0 CA--C 1.562 1.439 0 CA-C-O 121.643 0.735 . . . . 0.0 110.805 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . 0.496 HG22 ' CD1' ' A' ' 113' ' ' ILE . 78.3 t -63.81 -46.27 94.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 113.119 -1.855 . . . . 0.0 111.276 177.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 95.0 mt -64.24 -43.71 97.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.761 -178.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . 0.508 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 98.9 mttt -63.35 -42.64 98.93 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.03 -40.91 99.15 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 119.105 -1.038 . . . . 0.0 109.726 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.32 -39.16 86.04 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.816 -178.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 84.2 mt -64.12 -42.02 97.0 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.383 0.611 . . . . 0.0 110.278 175.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -63.07 -39.08 93.65 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.831 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 53.0 m170 -57.63 -40.16 78.58 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 119.547 -0.263 . . . . 0.0 111.488 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 14.8 p -114.93 130.26 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.494 ' O ' ' HG3' ' B' ' 24' ' ' ARG . 33.2 ptt180 -71.7 109.97 5.95 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.888 0.851 . . . . 0.0 112.343 -177.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.2 p -143.19 133.53 22.16 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.8 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.514 177.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . 0.568 ' O ' ' N ' ' B' ' 123' ' ' GLN . . . -87.25 95.32 2.06 Favored Glycine 0 C--N 1.31 -0.87 0 C-N-CA 119.354 -1.403 . . . . 0.0 113.538 -177.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 49.7 t -125.54 129.11 72.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 174.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 27.6 m -139.01 156.49 27.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.58 0.229 . . . . 0.0 110.478 178.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 96.1 mt -117.98 126.88 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.61 177.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' B' ' 119' ' ' PHE . 24.1 p -106.65 157.42 17.71 Favored 'General case' 0 CA--C 1.505 -0.786 0 O-C-N 126.003 2.064 . . . . 0.0 108.688 -178.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -124.76 102.47 32.06 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' PRO . . . . . 0.464 ' CG ' HG23 ' B' ' 117' ' ' THR . 37.9 Cg_endo -65.54 -18.3 59.07 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 121.697 1.598 . . . . 0.0 111.473 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.24 -40.26 96.93 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.741 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 90.4 mt -76.47 -170.47 1.52 Allowed 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.823 -0.548 . . . . 0.0 111.234 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . 0.653 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 42.4 tt0 -82.04 131.25 35.24 Favored 'General case' 0 C--N 1.342 0.26 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.502 ' O ' ' OD1' ' B' ' 36' ' ' ASP . 66.3 t0 56.22 35.27 25.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.063 177.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' ASN . . . . . 0.444 ' C ' ' O ' ' B' ' 36' ' ' ASP . 28.3 t-20 33.3 70.34 0.81 Allowed Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.653 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 89.2 Cg_endo -72.66 154.19 54.47 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 123.434 2.756 . . . . 0.0 111.994 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 96.1 mt -86.47 128.81 39.17 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.401 HG23 ' N ' ' B' ' 41' ' ' TYR . 29.3 m -109.15 -42.82 5.6 Favored 'Isoleucine or valine' 0 C--N 1.341 0.231 0 O-C-N 123.681 0.613 . . . . 0.0 112.446 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' TYR . . . . . 0.401 ' N ' HG23 ' B' ' 40' ' ' VAL . 49.5 t80 -97.44 123.57 41.34 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.654 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 5.8 p -142.65 140.65 28.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.017 177.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . 0.721 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 57.4 p30 -99.98 160.73 14.09 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.289 179.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' GLN . . . . . 0.472 ' OE1' ' HA ' ' B' ' 44' ' ' GLN . 13.4 mm100 -62.94 -38.27 90.4 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.418 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.57 -25.63 63.48 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.721 ' HB2' ' OD1' ' B' ' 43' ' ' ASN . 60.5 t80 -60.03 -43.66 95.15 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 0.746 HG13 ' O ' ' B' ' 52' ' ' TYR . 53.7 t -61.07 -46.33 96.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.066 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -63.36 -43.55 97.36 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.244 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 60.8 ttm -63.06 -41.92 99.56 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 41.5 p -96.75 -16.11 21.03 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.729 -178.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' B' ' 47' ' ' VAL . . . 73.08 19.69 79.7 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 178.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . 0.746 ' O ' HG13 ' B' ' 47' ' ' VAL . 74.8 m-85 -111.25 145.1 39.34 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -73.78 147.48 43.41 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.897 0.856 . . . . 0.0 111.061 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . 0.411 ' H ' HG22 ' B' ' 54' ' ' THR . 0.2 OUTLIER -61.79 -37.57 84.87 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.198 -177.43 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.04 -39.52 94.26 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 124.075 0.859 . . . . 0.0 111.322 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -72.86 -32.42 65.42 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 177.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.613 HD13 ' CE2' ' B' ' 46' ' ' PHE . 93.1 mt -67.32 -69.55 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 178.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 95.6 mt -39.36 132.36 1.48 Allowed 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.368 178.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.85 -7.45 76.88 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.516 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -132.4 149.1 52.41 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -176.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' ASN . . . . . 0.54 ' C ' ' H ' ' B' ' 63' ' ' ARG . 25.5 t-20 -79.17 150.07 31.8 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 114.572 -1.195 . . . . 0.0 110.843 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' CYS . . . . . . . . . . . . . 71.7 m -62.94 9.22 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.674 -178.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' ARG . . . . . 0.54 ' H ' ' C ' ' B' ' 61' ' ' ASN . 34.6 ptt-85 -59.4 -31.2 69.03 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.495 -178.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -61.54 -31.25 71.27 Favored 'General case' 0 C--O 1.239 0.531 0 O-C-N 121.878 -0.514 . . . . 0.0 111.922 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 92.4 mt -61.24 -44.28 97.51 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -178.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -46.59 144.11 2.38 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.424 0.631 . . . . 0.0 109.938 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . 0.555 ' N ' ' OG1' ' B' ' 70' ' ' THR . . . -155.39 -152.98 6.36 Favored Glycine 0 CA--C 1.543 1.817 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.656 176.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -60.97 -40.99 95.51 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.447 -0.376 . . . . 0.0 111.172 -175.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -75.6 -9.93 59.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.175 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' THR . . . . . 0.555 ' OG1' ' N ' ' B' ' 67' ' ' GLY . 25.0 m -60.66 133.52 56.18 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -90.55 111.72 49.1 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.453 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.39 -38.38 89.27 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 121.099 1.199 . . . . 0.0 111.882 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.99 -40.9 90.77 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.821 -176.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' GLU . . . . . 0.429 ' OE1' ' HB ' ' B' ' 90' ' ' VAL . 79.2 mm-40 -66.78 -39.35 87.78 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.835 178.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 71.0 t -62.59 -45.66 98.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -62.85 -37.28 86.23 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.748 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -62.48 -42.06 99.23 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.938 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.33 -43.79 98.77 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 CA-C-O 120.86 0.362 . . . . 0.0 110.735 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -61.58 -42.67 99.18 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 87.2 m -60.93 -46.58 90.12 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.79 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.86 -41.72 96.44 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -178.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 87.8 mt -62.13 -42.29 99.09 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -62.56 -39.89 95.09 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -80.2 -4.2 52.15 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.105 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 37.5 tttt 50.67 44.77 27.52 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.222 -0.591 . . . . 0.0 112.134 178.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -128.88 145.43 56.39 Favored Pre-proline 0 N--CA 1.467 0.383 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.15 140.1 81.87 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 120.905 1.07 . . . . 0.0 113.642 -178.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -140.12 136.59 37.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.909 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 89' ' ' THR . . . . . 0.941 HG23 ' OD1' ' B' ' 107' ' ' ASN . 97.4 m -122.24 122.68 39.69 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 178.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.429 ' HB ' ' OE1' ' B' ' 74' ' ' GLU . 30.7 m -139.4 162.82 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.854 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -113.63 120.82 42.23 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 176.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 20.6 tt -128.43 131.79 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.68 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -70.46 141.6 52.03 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.857 178.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 94' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -133.75 -179.75 5.73 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.261 0.553 . . . . 0.0 111.174 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 95' ' ' TYR . . . . . 0.461 ' CE1' ' HA3' ' B' ' 67' ' ' GLY . 96.3 m-85 -131.11 148.25 52.71 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.485 178.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . 0.495 ' HG3' ' CE1' ' B' ' 102' ' ' PHE . 98.7 mttt -104.35 -179.08 3.84 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.052 0.453 . . . . 0.0 110.693 177.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.72 -35.52 76.54 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.493 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 37.0 p-10 -87.37 -0.33 56.61 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.053 0.842 . . . . 0.0 112.954 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.02 3.23 65.8 Favored Glycine 0 N--CA 1.465 0.601 0 C-N-CA 121.152 -0.546 . . . . 0.0 111.892 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 24.7 m -68.16 129.56 40.3 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 101' ' ' MET . . . . . 0.569 ' SD ' ' N ' ' B' ' 102' ' ' PHE . 15.2 tmm? -90.46 142.99 27.18 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 102' ' ' PHE . . . . . 0.569 ' N ' ' SD ' ' B' ' 101' ' ' MET . 53.9 p90 -153.6 163.62 39.67 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 103' ' ' TRP . . . . . 0.851 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 23.6 m95 -95.25 140.19 30.5 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.018 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . 0.53 HD21 ' HG2' ' B' ' 123' ' ' GLN . 62.8 t-20 -133.71 105.63 6.93 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -176.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 105' ' ' GLU . . . . . 0.414 ' O ' ' HA ' ' B' ' 123' ' ' GLN . 81.4 tt0 -73.02 126.84 30.91 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.635 1.209 . . . . 0.0 109.02 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 39.4 tp -114.18 125.91 54.47 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 107' ' ' ASN . . . . . 0.941 ' OD1' HG23 ' B' ' 89' ' ' THR . 98.0 m-20 -119.92 127.86 53.08 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 176.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 96.2 mt -123.69 132.83 70.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -144.51 123.12 6.86 Favored Pre-proline 0 CA--C 1.538 0.483 0 O-C-N 123.482 0.488 . . . . 0.0 109.931 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -70.74 152.71 64.45 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 122.366 2.044 . . . . 0.0 112.618 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . 0.489 ' HB2' ' HB2' ' B' ' 118' ' ' TYR . 66.4 mtt -129.18 144.09 51.09 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -113.58 111.21 21.5 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . 0.579 HG12 ' NZ ' ' A' ' 18' ' ' LYS . 96.8 mt -137.92 127.72 35.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 O-C-N 121.534 -0.729 . . . . 0.0 111.81 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 52.25 38.33 24.43 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 123.997 0.811 . . . . 0.0 109.626 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 61.54 36.15 17.08 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.538 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -133.8 151.66 51.64 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 117' ' ' THR . . . . . 0.464 HG23 ' CG ' ' B' ' 32' ' ' PRO . 8.8 t -102.76 154.08 19.52 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.262 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 118' ' ' TYR . . . . . 0.489 ' HB2' ' HB2' ' B' ' 111' ' ' MET . 96.8 m-85 -148.12 145.34 28.34 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.529 -0.732 . . . . 0.0 110.917 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 119' ' ' PHE . . . . . 0.431 ' O ' ' OG1' ' B' ' 30' ' ' THR . 86.4 m-85 -118.12 138.91 51.95 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.384 0.427 . . . . 0.0 111.347 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.5 p -128.22 136.15 60.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -178.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -112.2 127.88 8.27 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 122' ' ' ILE . . . . . 0.412 ' HB ' ' HB2' ' B' ' 107' ' ' ASN . 95.4 mt -117.63 128.62 74.82 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 123' ' ' GLN . . . . . 0.568 ' N ' ' O ' ' B' ' 26' ' ' GLY . 15.3 mp0 -119.12 121.54 40.02 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -120.31 121.18 38.07 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' B' ' 126' ' ' ILE . 68.3 t0 -69.12 134.16 48.97 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.083 -177.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.495 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 2.5 mp -107.3 17.16 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.493 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 127' ' ' THR . . . . . 0.461 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 98.2 m -63.36 -45.23 92.15 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 114.138 -1.392 . . . . 0.0 112.647 175.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 59.7 tptt -60.53 -45.6 93.27 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 129' ' ' GLN . . . . . 0.438 ' OE1' HG23 ' B' ' 126' ' ' ILE . 88.5 mt-30 -62.53 -36.57 83.04 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.484 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 130' ' ' LYS . . . . . 0.851 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 98.9 mttt -62.64 -41.7 99.19 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 112.737 -2.028 . . . . 0.0 111.115 174.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.5 -42.08 96.06 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 132' ' ' TYR . . . . . 0.762 ' CE2' HD11 ' B' ' 136' ' ' LEU . 88.1 t80 -60.76 -44.95 96.08 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.972 -0.455 . . . . 0.0 111.785 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . 0.43 ' O ' ' HG3' ' B' ' 137' ' ' GLU . 97.3 mt-10 -63.8 -36.49 84.06 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 119.932 -0.707 . . . . 0.0 109.367 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 134' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' B' ' 130' ' ' LYS . 98.9 mttt -62.41 -39.62 93.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.801 177.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 53.8 tp -62.28 -41.76 98.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.75 0.786 . . . . 0.0 109.451 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 136' ' ' LEU . . . . . 0.762 HD11 ' CE2' ' B' ' 132' ' ' TYR . 87.6 mt -63.02 -41.82 99.65 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.921 177.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 137' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' B' ' 133' ' ' GLU . 97.3 mt-10 -65.27 -36.45 84.13 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.508 -1.678 . . . . 0.0 110.276 -178.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -63.83 -43.79 95.16 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.106 -0.638 . . . . 0.0 109.649 177.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 68.2 m -61.14 -44.1 97.85 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . 0.468 ' O ' ' N ' ' B' ' 144' ' ' THR . 86.1 mt -61.74 -40.06 93.77 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -177.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 97.2 m -61.32 -45.58 93.85 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.059 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -66.39 -42.39 87.95 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 93.1 mt -63.52 -43.19 98.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 114.517 -1.219 . . . . 0.0 110.598 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 144' ' ' THR . . . . . 0.468 ' N ' ' O ' ' B' ' 140' ' ' LEU . 92.1 m -61.31 -45.12 95.76 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.13 -40.8 96.95 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 119.299 -0.96 . . . . 0.0 109.332 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 87.1 mt -64.55 -41.17 96.5 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 177.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 147' ' ' SER . . . . . 0.626 ' O ' ' N ' ' B' ' 149' ' ' PRO . 78.4 p -61.91 -40.91 97.08 Favored 'General case' 0 CA--C 1.476 -1.895 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 -178.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 148' ' ' THR . . . . . 0.491 ' C ' ' O ' ' B' ' 147' ' ' SER . 7.3 m -28.9 85.16 0.03 OUTLIER Pre-proline 0 C--N 1.353 0.738 0 O-C-N 123.745 0.653 . . . . 0.0 110.351 176.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 149' ' ' PRO . . . . . 0.626 ' N ' ' O ' ' B' ' 147' ' ' SER . 23.4 Cg_exo -61.89 146.71 96.29 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 C-N-CA 122.393 2.062 . . . . 0.0 115.57 -176.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 9.0 tp -126.67 119.81 54.47 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.21 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.036 174.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 59.3 t -151.26 93.41 3.61 Favored Pre-proline 0 C--N 1.295 -1.764 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.809 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -60.23 137.35 74.4 Favored 'Trans proline' 0 N--CA 1.489 1.238 0 CA-C-N 119.852 0.983 . . . . 0.0 109.569 -178.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 153' ' ' ILE . . . . . 0.721 ' O ' ' HD2' ' B' ' 154' ' ' ARG . 45.2 mm -68.7 -43.55 82.98 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.579 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 154' ' ' ARG . . . . . 0.721 ' HD2' ' O ' ' B' ' 153' ' ' ILE . 0.7 OUTLIER -157.16 -154.61 0.47 Allowed 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.449 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 62.0 t-20 -87.32 107.99 18.76 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.1 -18.39 55.73 Favored Glycine 0 CA--C 1.534 1.23 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 157' ' ' ILE . . . . . 0.429 HG22 ' HB ' ' B' ' 153' ' ' ILE . 85.1 mt -108.04 124.45 64.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.287 0.565 . . . . 0.0 111.16 -177.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 158' ' ' SER . . . . . 0.655 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 69.1 m -135.0 148.72 50.04 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.517 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -134.62 146.92 50.03 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 24.4 tp -137.61 80.73 31.29 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 161' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -70.63 147.73 57.9 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.666 2.244 . . . . 0.0 114.077 -178.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 90.5 mt -114.55 133.85 55.48 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 109.074 -0.714 . . . . 0.0 109.074 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 54.6 t -130.51 132.73 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 114.3 168.61 16.25 Favored Glycine 0 N--CA 1.471 0.984 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.512 178.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 165' ' ' ASN . . . . . 0.813 ' O ' ' CZ ' ' B' ' 170' ' ' ARG . 60.5 t30 -89.92 107.16 18.95 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -178.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 166' ' ' LEU . . . . . 0.588 HD21 ' CZ ' ' B' ' 171' ' ' PHE . 42.1 tp -65.02 104.73 0.91 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -174.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 167' ' ' THR . . . . . 0.7 HG23 ' NE ' ' B' ' 170' ' ' ARG . 10.0 p -85.38 169.57 13.57 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 113.828 -1.533 . . . . 0.0 110.83 177.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.57 -37.52 85.1 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.307 177.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.63 -39.9 88.49 Favored 'General case' 0 CA--C 1.553 1.09 0 CA-C-O 121.682 0.753 . . . . 0.0 111.798 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 170' ' ' ARG . . . . . 0.813 ' CZ ' ' O ' ' B' ' 165' ' ' ASN . 87.9 mtm180 -63.67 -36.04 82.51 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 113.193 -1.821 . . . . 0.0 110.475 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 171' ' ' PHE . . . . . 0.588 ' CZ ' HD21 ' B' ' 166' ' ' LEU . 0.4 OUTLIER -54.1 -25.55 22.52 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -178.194 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 172' ' ' ASN . . . . . 0.557 ' O ' HG22 ' B' ' 175' ' ' VAL . 92.9 m-20 -62.48 -40.53 96.96 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.672 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 59.7 m -60.12 -41.76 93.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.27 0.557 . . . . 0.0 110.51 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 67.4 mt -63.9 -44.21 97.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -179.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 175' ' ' VAL . . . . . 0.557 HG22 ' O ' ' B' ' 172' ' ' ASN . 29.8 m -62.61 -40.81 89.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -178.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 176' ' ' CYS . . . . . 0.433 ' N ' HG23 ' B' ' 175' ' ' VAL . 98.2 m -62.26 -35.44 78.97 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.291 178.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 177' ' ' THR . . . . . 0.596 ' O ' HG13 ' B' ' 181' ' ' ILE . 25.3 m -61.3 -19.45 61.78 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 178' ' ' LEU . . . . . 0.595 ' CD2' HD21 ' B' ' 211' ' ' LEU . 87.4 mt -60.97 -39.47 89.69 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.479 -178.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 18.2 m -62.03 -44.44 96.7 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.414 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 180' ' ' ASN . . . . . 0.574 ' O ' ' OG ' ' B' ' 183' ' ' SER . 92.1 m-20 -61.97 -40.3 95.12 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.121 0.486 . . . . 0.0 110.435 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.596 HG13 ' O ' ' B' ' 177' ' ' THR . 73.3 mt -56.35 -32.37 35.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 O-C-N 122.074 -0.391 . . . . 0.0 110.74 -178.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 182' ' ' LEU . . . . . 0.521 HD21 HD21 ' B' ' 214' ' ' LEU . 86.4 mt -62.66 -41.5 99.1 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . 0.574 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.7 p -63.98 -32.91 74.61 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 122.129 -0.357 . . . . 0.0 110.593 177.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 44.6 p -85.88 17.96 3.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.766 0.317 . . . . 0.0 111.684 -178.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 78.6 p -60.59 -16.44 38.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.274 -177.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.82 -40.86 96.76 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.966 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 187' ' ' ASP . . . . . 0.655 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.3 m-20 -67.98 113.32 5.58 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.699 0.761 . . . . 0.0 110.776 -178.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.8 -42.39 99.69 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 114.697 -1.138 . . . . 0.0 113.102 -178.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -113.29 130.98 56.11 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.212 -178.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 190' ' ' LEU . . . . . 0.409 ' HA ' ' O ' ' B' ' 158' ' ' SER . 40.5 tp -123.72 118.16 26.59 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.908 178.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 84.2 mt -106.15 125.95 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-O 120.812 0.339 . . . . 0.0 111.303 -178.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 49.7 mm -114.51 117.58 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 193' ' ' ASP . . . . . 0.425 ' OD2' ' OG ' ' B' ' 195' ' ' SER . 41.9 t0 -88.43 114.62 25.23 Favored 'General case' 0 C--O 1.246 0.873 0 CA-C-O 121.65 0.738 . . . . 0.0 111.352 -177.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 194' ' ' LEU . . . . . . . . . . . . . 96.2 mt -97.1 -1.34 45.44 Favored 'General case' 0 C--N 1.356 0.858 0 O-C-N 120.39 -1.444 . . . . 0.0 110.067 176.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 195' ' ' SER . . . . . 0.425 ' OG ' ' OD2' ' B' ' 193' ' ' ASP . 78.4 p -61.19 -36.24 79.33 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 121.169 -0.213 . . . . 0.0 110.803 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.87 -35.42 91.29 Favored Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 197' ' ' LEU . . . . . 1.107 ' CD2' ' O ' ' B' ' 199' ' ' GLN . 7.0 tt -74.75 132.61 41.76 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 121.847 -0.796 . . . . 0.0 109.589 -178.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 198' ' ' ALA . . . . . 0.775 ' N ' HD23 ' B' ' 197' ' ' LEU . . . -61.33 -48.9 79.23 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 119.309 -0.957 . . . . 0.0 110.143 -178.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 199' ' ' GLN . . . . . 1.107 ' O ' ' CD2' ' B' ' 197' ' ' LEU . 57.1 tt0 -135.06 164.62 27.24 Favored 'General case' 0 C--O 1.21 -1.02 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -178.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 200' ' ' VAL . . . . . 0.54 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 48.3 t -119.44 130.95 73.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 119.506 -1.996 . . . . 0.0 109.403 177.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -87.26 150.84 23.62 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.122 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -61.49 -32.61 72.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.59 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -64.11 -32.78 74.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.2 m -60.89 -43.36 98.61 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.573 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 205' ' ' ALA . . . . . 0.687 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -58.63 -29.53 66.59 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 119.212 -0.423 . . . . 0.0 111.792 -178.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -65.75 -38.74 89.93 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 123.649 0.593 . . . . 0.0 109.68 176.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -66.57 -38.04 86.23 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.752 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 93.5 mt -63.68 -44.36 98.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -178.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 209' ' ' PHE . . . . . 0.687 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 66.9 m-85 -61.35 -43.56 98.66 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.618 179.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.39 -41.54 98.78 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.102 -1.039 . . . . 0.0 109.532 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 211' ' ' LEU . . . . . 0.595 HD21 ' CD2' ' B' ' 178' ' ' LEU . 39.9 mt -62.23 -41.94 98.86 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.316 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 78.3 p -63.3 -35.78 81.51 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 121.686 -0.634 . . . . 0.0 112.159 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 213' ' ' HIS . . . . . 0.43 ' CE1' HD11 ' B' ' 217' ' ' LEU . 58.8 t-80 -67.18 -46.83 72.77 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.839 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.521 HD21 HD21 ' B' ' 182' ' ' LEU . 54.1 tp -64.23 -43.06 96.13 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 122.069 0.938 . . . . 0.0 109.406 178.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.09 -43.74 97.66 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 113.617 -1.629 . . . . 0.0 111.379 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.12 -39.32 92.15 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.005 -177.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . 0.43 HD11 ' CE1' ' B' ' 213' ' ' HIS . 85.4 mt -63.7 -42.69 97.95 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.238 0.542 . . . . 0.0 111.51 176.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 218' ' ' THR . . . . . . . . . . . . . 75.9 p -74.11 -16.03 61.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.911 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 79.29 72.56 1.18 Allowed Glycine 0 CA--C 1.528 0.862 0 N-CA-C 106.517 -2.633 . . . . 0.0 106.517 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 220' ' ' THR . . . . . . . . . . . . . 93.2 m -151.85 98.2 2.44 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 177.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -56.13 139.76 46.29 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.204 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 43.1 tp -116.64 120.58 39.1 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.184 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 3.5 mp -109.13 129.23 64.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.241 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 224' ' ' ILE . . . . . 0.568 ' CG2' HD11 ' B' ' 227' ' ' ILE . 49.7 mm -111.7 126.94 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.57 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 44.5 p -134.78 157.77 45.88 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 91.07 17.55 50.57 Favored Glycine 0 CA--C 1.498 -1.027 0 CA-C-N 113.949 -1.478 . . . . 0.0 110.534 -177.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 227' ' ' ILE . . . . . 0.568 HD11 ' CG2' ' B' ' 224' ' ' ILE . 95.7 mt -83.59 125.77 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 O-C-N 121.363 -1.08 . . . . 0.0 111.355 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 56.2 tttt -63.93 139.67 97.7 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.368 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.77 -37.17 92.1 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 121.297 1.331 . . . . 0.0 112.539 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -63.83 -43.32 96.54 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 52.0 tp -61.87 -41.78 98.27 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.913 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.03 -36.51 84.24 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.801 0.334 . . . . 0.0 111.139 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 94.5 mtp -64.47 -40.64 96.07 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.78 -43.93 97.51 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 122.107 0.956 . . . . 0.0 109.004 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 33.5 mmt -63.82 -34.96 79.09 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.989 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -61.81 -40.21 94.44 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.774 -178.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.27 -43.85 96.79 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.156 178.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 52.5 tp -62.92 -44.75 95.24 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 120.137 -0.625 . . . . 0.0 112.039 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -156.51 132.32 9.62 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 120.551 -0.46 . . . . 0.0 112.001 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 240' ' ' ALA . . . . . 0.4 ' O ' ' N ' ' B' ' 242' ' ' PHE . . . -61.93 -47.94 82.66 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 176.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 241' ' ' ASN . . . . . 0.448 ' O ' ' HB2' ' B' ' 244' ' ' SER . 92.7 m-20 -42.69 -18.28 0.01 OUTLIER 'General case' 0 C--O 1.217 -0.615 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.556 -176.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 242' ' ' PHE . . . . . 0.4 ' N ' ' O ' ' B' ' 240' ' ' ALA . 89.1 t80 -60.81 -44.58 96.69 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 119.801 -0.759 . . . . 0.0 109.906 178.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 243' ' ' SER . . . . . . . . . . . . . 78.4 p -58.85 -42.42 89.31 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 -178.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 244' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 20.5 m -33.84 -33.04 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 99.1 mt -91.69 130.37 37.5 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 121.458 -0.776 . . . . 0.0 111.889 177.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -57.59 134.76 56.42 Favored 'General case' 0 CA--C 1.502 -0.881 0 O-C-N 121.317 -0.864 . . . . 0.0 111.726 -175.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 247' ' ' THR . . . . . 0.566 HG23 HD12 ' B' ' 227' ' ' ILE . 96.3 m -125.25 127.66 47.08 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.917 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 248' ' ' TYR . . . . . 0.49 ' CG ' ' HB2' ' B' ' 254' ' ' ALA . 97.6 m-85 -112.98 144.26 42.86 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 177.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 249' ' ' SER . . . . . 0.595 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 79.4 p -64.23 -33.46 75.86 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.218 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 250' ' ' ASN . . . . . 0.595 ' OD1' ' O ' ' B' ' 249' ' ' SER . 98.8 m-20 -147.94 159.61 43.69 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 124.509 1.13 . . . . 0.0 111.937 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 77.7 t -64.34 -44.15 97.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.443 -0.798 . . . . 0.0 112.293 178.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 252' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -60.78 -46.15 91.61 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -177.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . 0.594 ' O ' HG22 ' B' ' 257' ' ' VAL . 94.3 m-20 -61.37 -43.05 99.53 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.924 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 254' ' ' ALA . . . . . 0.49 ' HB2' ' CG ' ' B' ' 248' ' ' TYR . . . -65.85 -40.25 91.54 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.913 178.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 255' ' ' VAL . . . . . 0.617 HG13 HH11 ' A' ' 154' ' ' ARG . 67.3 t -65.14 -45.71 93.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.043 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.56 -48.55 78.98 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 120.204 -0.598 . . . . 0.0 111.614 -178.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 257' ' ' VAL . . . . . 0.594 HG22 ' O ' ' B' ' 253' ' ' ASP . 32.6 m -65.22 -40.63 89.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.678 -1.146 . . . . 0.0 111.302 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 258' ' ' LEU . . . . . 0.523 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 1.6 mt -32.25 -73.76 0.05 OUTLIER Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.589 -177.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 259' ' ' PRO . . . . . 0.523 ' CD ' ' CB ' ' B' ' 258' ' ' LEU . 36.3 Cg_endo -61.76 140.76 87.62 Favored 'Trans proline' 0 N--CA 1.505 2.155 0 C-N-CA 121.49 1.46 . . . . 0.0 111.133 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 260' ' ' ILE . . . . . 0.56 ' O ' HG22 ' B' ' 260' ' ' ILE . 96.7 mt -159.11 -13.82 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 O-C-N 121.33 -0.856 . . . . 0.0 112.204 177.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 C--O 1.216 -0.71 0 CA-C-O 117.792 -1.099 . . . . 0.0 111.353 -179.381 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.026 -1.629 . . . . 0.0 109.026 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.413 ' O ' ' OG ' ' A' ' 6' ' ' SER . . . -152.2 165.07 35.99 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.373 0.606 . . . . 0.0 110.201 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 80.8 p -70.53 -18.28 62.94 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.084 -1.01 . . . . 0.0 112.112 177.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -71.75 -65.07 0.81 Allowed 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 114.18 -1.373 . . . . 0.0 112.574 174.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -68.1 -37.77 81.55 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.99 0.424 . . . . 0.0 112.089 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.518 ' O ' ' HB3' ' A' ' 7' ' ' PHE . 70.9 m -59.44 -42.17 91.31 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -177.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.518 ' HB3' ' O ' ' A' ' 6' ' ' SER . 42.5 t80 83.95 86.93 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.134 0.493 . . . . 0.0 111.865 176.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.603 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -62.49 -142.92 0.01 OUTLIER Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 -178.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.603 ' HB ' ' O ' ' A' ' 8' ' ' GLY . 74.5 mt 85.64 110.27 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 122.701 0.4 . . . . 0.0 110.538 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.7 -22.35 69.82 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 121.389 1.393 . . . . 0.0 112.175 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.417 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -63.83 -38.22 95.82 Favored Glycine 0 N--CA 1.467 0.706 0 C-N-CA 121.138 -0.553 . . . . 0.0 111.919 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -65.18 -39.27 92.66 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.41 0.624 . . . . 0.0 109.614 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.2 tp -63.44 -41.15 98.67 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -63.73 -40.31 96.44 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 11' ' ' GLY . 56.3 t -60.31 -44.36 95.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 O-C-N 122.199 -0.313 . . . . 0.0 110.892 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 92.2 mt -62.78 -43.61 98.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.407 -178.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.27 -46.04 90.58 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 119.491 -0.883 . . . . 0.0 112.119 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.503 ' HZ1' HG12 ' B' ' 113' ' ' ILE . 98.4 mttt -60.39 -39.86 88.83 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 118.51 -1.276 . . . . 0.0 109.187 -176.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.84 -42.1 92.83 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.286 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 20' ' ' LEU . 87.8 mt -62.83 -40.95 99.0 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 178.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -63.92 -37.65 88.19 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.505 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 60.0 m170 -58.55 -40.15 82.2 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 122.221 -0.299 . . . . 0.0 111.417 -178.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.3 p -114.4 130.01 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.517 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 36.2 ptt180 -71.85 110.46 6.38 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-O 122.016 0.912 . . . . 0.0 112.229 -177.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.9 p -141.31 144.13 26.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 123' ' ' GLN . . . -97.55 90.99 1.14 Allowed Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.786 -178.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 51.4 t -124.23 129.26 74.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 176.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.7 m -137.49 159.78 34.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.7 mt -121.71 130.36 74.67 Favored 'Isoleucine or valine' 0 C--O 1.245 0.868 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 177.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.4 p -106.35 167.85 9.55 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.448 ' C ' ' OD1' ' A' ' 37' ' ' ASN . 44.0 t0 -134.5 102.42 11.62 Favored Pre-proline 0 C--N 1.32 -0.716 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.389 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.478 ' HG3' HG23 ' A' ' 117' ' ' THR . 36.4 Cg_endo -63.17 -23.08 73.07 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 121.453 1.436 . . . . 0.0 111.503 -178.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.97 -35.88 81.63 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.66 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.413 ' HB2' ' HD2' ' A' ' 38' ' ' PRO . 95.2 mt -84.31 157.35 21.54 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.498 177.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.71 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 43.3 tt0 -58.37 136.01 57.33 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -176.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.566 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 62.4 t0 60.29 22.8 12.25 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.448 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 42.4 t-20 38.16 70.06 1.35 Allowed Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.244 -176.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.71 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 92.7 Cg_endo -71.13 156.3 59.8 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 123.948 3.099 . . . . 0.0 112.121 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.6 mt -88.1 125.22 41.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.439 HG23 ' N ' ' A' ' 41' ' ' TYR . 33.9 m -104.8 -42.59 7.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.025 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.439 ' N ' HG23 ' A' ' 40' ' ' VAL . 48.9 t80 -97.68 123.76 41.73 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.809 -177.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.9 p -143.06 140.85 26.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 124.303 1.002 . . . . 0.0 109.215 177.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.599 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 57.3 p30 -98.41 166.99 11.11 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.517 ' OE1' ' HA ' ' A' ' 44' ' ' GLN . 13.2 mm100 -66.4 -38.81 88.33 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 120.988 0.423 . . . . 0.0 111.933 177.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.27 -26.86 64.47 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.659 ' CD2' HD13 ' A' ' 57' ' ' ILE . 66.3 t80 -59.03 -48.43 81.63 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.603 HG13 ' O ' ' A' ' 52' ' ' TYR . 61.3 t -59.41 -45.09 93.82 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 O-C-N 121.312 -0.868 . . . . 0.0 111.573 -174.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -63.64 -37.73 88.44 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 120.412 -0.515 . . . . 0.0 112.383 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 60.4 ttm -66.65 -43.01 85.76 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 114.258 1.206 . . . . 0.0 114.258 176.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 34.9 p -93.75 -20.4 20.15 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.272 0.558 . . . . 0.0 111.453 -177.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.28 21.6 72.75 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.603 ' O ' HG13 ' A' ' 47' ' ' VAL . 81.1 m-85 -115.9 138.21 51.38 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 122.909 0.484 . . . . 0.0 111.213 179.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -63.65 148.24 49.51 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.662 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.451 HG22 ' H ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -65.57 -32.36 73.9 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -66.21 -45.01 82.25 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 119.351 -0.94 . . . . 0.0 111.359 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -63.47 -45.44 90.8 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 119.939 -0.704 . . . . 0.0 109.749 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.659 HD13 ' CD2' ' A' ' 46' ' ' PHE . 90.6 mt -62.1 -48.99 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -175.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 79.0 mt -57.11 146.04 29.01 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 176.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.96 -3.91 82.27 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.875 -0.679 . . . . 0.0 113.121 177.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -137.47 151.7 48.75 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.879 1.34 . . . . 0.0 111.9 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.556 ' C ' ' H ' ' A' ' 63' ' ' ARG . 25.6 t-20 -81.23 151.92 27.91 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.701 -178.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 83.6 m -63.67 16.44 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.276 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.556 ' H ' ' C ' ' A' ' 61' ' ' ASN . 36.4 ptt-85 -62.47 -40.81 97.85 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 122.054 -0.404 . . . . 0.0 111.282 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -56.03 -21.53 22.12 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 84.0 mt -68.22 -35.24 77.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 122.003 0.906 . . . . 0.0 113.011 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -65.12 143.05 58.14 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.904 -1.044 . . . . 0.0 112.238 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.534 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -154.2 -147.57 4.7 Favored Glycine 0 CA--C 1.538 1.484 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 -177.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -63.21 -41.1 99.1 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -177.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.446 ' O ' ' OE1' ' A' ' 93' ' ' GLN . 10.8 m-70 -77.1 -8.56 57.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.955 0.407 . . . . 0.0 111.086 -177.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.534 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 26.6 m -63.04 130.28 44.01 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.657 -178.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -85.4 109.55 22.4 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.8 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 70' ' ' THR . 50.9 Cg_exo -56.92 -32.08 91.44 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.023 1.815 . . . . 0.0 113.19 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.59 -39.64 94.1 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.975 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.485 ' OE1' ' HB ' ' A' ' 90' ' ' VAL . 78.9 mm-40 -65.84 -43.54 88.21 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.8 t -59.45 -43.83 91.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -176.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -63.88 -37.97 89.35 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.027 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -63.63 -39.67 94.95 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.243 0.544 . . . . 0.0 110.156 178.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.77 -44.47 98.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.154 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -63.01 -42.71 99.9 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 113.831 -1.531 . . . . 0.0 108.36 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 96.4 m -61.64 -48.85 78.99 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.04 -41.69 92.83 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.185 -172.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 83.0 mt -63.0 -39.55 95.11 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.025 -1.047 . . . . 0.0 111.319 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -64.17 -32.59 74.22 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 177.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -90.22 0.59 57.13 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.302 -178.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.2 tttt 45.46 35.94 2.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.55 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -119.13 143.8 34.79 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -61.39 143.39 97.66 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.62 1.546 . . . . 0.0 113.674 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -140.12 143.25 30.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.697 -177.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.897 HG23 ' OD1' ' A' ' 107' ' ' ASN . 99.9 m -128.46 120.59 27.14 Favored 'General case' 0 C--N 1.345 0.394 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 176.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.485 ' HB ' ' OE1' ' A' ' 74' ' ' GLU . 27.8 m -138.75 157.61 29.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.73 -0.214 . . . . 0.0 111.461 177.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -101.93 133.76 46.21 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 177.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.428 HG23 ' O ' ' A' ' 92' ' ' ILE . 19.0 tt -141.18 131.9 27.06 Favored 'Isoleucine or valine' 0 C--N 1.378 1.833 0 CA-C-N 121.61 2.005 . . . . 0.0 112.417 176.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.446 ' OE1' ' O ' ' A' ' 69' ' ' HIS . 85.7 mt-30 -64.6 133.74 52.9 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.884 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -134.85 158.57 43.87 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.8 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -116.5 134.7 54.54 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.514 ' HG3' ' CE1' ' A' ' 102' ' ' PHE . 99.1 mttt -83.7 -171.76 3.77 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.184 0.516 . . . . 0.0 111.76 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.46 -43.48 98.71 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.941 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.41 ' CG ' ' HG1' ' A' ' 100' ' ' THR . 42.5 p-10 -84.31 7.17 20.22 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.08 -0.4 87.5 Favored Glycine 0 N--CA 1.471 0.97 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.185 176.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.41 ' HG1' ' CG ' ' A' ' 98' ' ' ASP . 23.5 m -58.93 139.15 56.99 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 178.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.622 ' SD ' ' C ' ' A' ' 101' ' ' MET . 13.8 tmm? -105.06 127.28 52.81 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.593 0.235 . . . . 0.0 110.506 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.514 ' CE1' ' HG3' ' A' ' 96' ' ' LYS . 52.7 p90 -141.68 156.12 45.65 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.958 -177.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.721 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 24.4 m95 -88.66 143.98 26.58 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.547 HD21 ' HG2' ' A' ' 123' ' ' GLN . 56.4 t-20 -138.1 100.82 4.25 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -177.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.408 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 80.6 tt0 -66.32 136.57 56.0 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -177.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 40.3 tp -122.23 122.94 40.31 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.897 ' OD1' HG23 ' A' ' 89' ' ' THR . 97.8 m-20 -118.67 122.61 42.93 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.71 177.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 96.4 mt -120.31 128.64 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 O-C-N 123.535 0.522 . . . . 0.0 111.635 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -139.85 123.03 10.42 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 116.714 -0.221 . . . . 0.0 110.933 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -70.98 152.13 62.75 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 122.451 2.101 . . . . 0.0 112.368 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.661 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 66.8 mtt -122.82 154.32 38.38 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -128.74 94.12 3.78 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 176.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.462 ' CD1' HG22 ' B' ' 15' ' ' VAL . 96.1 mt -118.51 130.78 72.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.19 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 52.5 38.51 25.76 Favored 'General case' 0 CA--C 1.512 -0.501 0 O-C-N 121.414 -0.804 . . . . 0.0 111.774 176.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 58.27 30.22 19.18 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 123.844 0.715 . . . . 0.0 110.833 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -128.2 149.09 50.6 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.173 -0.676 . . . . 0.0 109.173 177.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.756 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 5.2 t -86.1 -172.25 3.98 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 118.538 0.608 . . . . 0.0 109.514 -177.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.756 ' CD2' ' O ' ' A' ' 117' ' ' THR . 65.1 m-85 -171.69 156.26 4.26 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 175.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -131.34 146.49 52.31 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 174.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -134.94 135.18 53.17 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 177.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.75 129.2 9.42 Favored Glycine 0 CA--C 1.499 -0.908 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 178.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 96.6 mt -118.41 129.57 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.547 ' HG2' HD21 ' A' ' 104' ' ' ASN . 13.9 mp0 -121.05 113.3 19.85 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.641 0.588 . . . . 0.0 109.609 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -113.57 112.79 24.12 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.959 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -62.39 128.22 35.01 Favored 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -175.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.478 HG22 ' O ' ' A' ' 126' ' ' ILE . 3.0 mt -93.53 2.29 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 113.511 -1.677 . . . . 0.0 110.199 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 20.1 m -60.56 -42.38 96.49 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.979 -1.076 . . . . 0.0 113.671 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -59.96 -42.34 93.87 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -178.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -63.01 -39.56 95.12 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.927 177.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.721 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.7 mttt -62.85 -40.79 98.54 Favored 'General case' 0 CA--C 1.502 -0.877 0 C-N-CA 118.292 -1.363 . . . . 0.0 110.621 -178.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.69 -37.93 85.92 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -178.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.672 ' CE2' HD11 ' A' ' 136' ' ' LEU . 90.7 t80 -61.67 -45.96 91.76 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.668 175.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.23 -38.93 92.81 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 120.167 -0.613 . . . . 0.0 109.539 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.07 -40.21 95.02 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 52.7 tp -60.65 -43.86 97.1 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -176.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.672 HD11 ' CE2' ' A' ' 132' ' ' TYR . 84.9 mt -62.26 -40.87 97.63 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -61.84 -41.73 98.16 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 119.398 -0.921 . . . . 0.0 109.852 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -60.81 -41.96 96.7 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -177.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.0 m -61.94 -41.14 97.63 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.877 176.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 144' ' ' THR . 87.9 mt -63.49 -41.8 98.56 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.431 -0.508 . . . . 0.0 109.884 178.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 79.9 m -61.72 -45.59 93.3 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.271 -177.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -65.3 -39.67 92.83 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 94.7 mt -64.44 -43.57 96.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 113.991 -1.458 . . . . 0.0 111.365 176.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.454 ' N ' ' O ' ' A' ' 140' ' ' LEU . 99.3 m -62.49 -46.3 89.11 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.396 -0.522 . . . . 0.0 112.25 -178.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.45 -40.07 95.43 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 118.875 -1.13 . . . . 0.0 109.117 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 90.1 mt -63.61 -42.8 98.19 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.689 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.1 p -60.57 -37.17 80.43 Favored 'General case' 0 C--O 1.218 -0.564 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -178.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.453 ' C ' ' O ' ' A' ' 147' ' ' SER . 27.5 m -30.06 82.82 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.41 0 O-C-N 127.003 2.689 . . . . 0.0 106.123 -176.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.689 ' N ' ' O ' ' A' ' 147' ' ' SER . 21.8 Cg_exo -62.29 144.62 95.56 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 CA-C-O 122.749 1.062 . . . . 0.0 114.432 -174.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.649 ' O ' HG23 ' A' ' 151' ' ' VAL . 8.9 tp -121.26 135.33 61.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 102.575 -3.12 . . . . 0.0 102.575 176.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 150' ' ' ILE . 65.5 t -169.74 94.35 0.51 Allowed Pre-proline 0 CA--C 1.507 -0.703 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 176.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -62.56 137.71 65.94 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 N-CA-C 109.843 -0.868 . . . . 0.0 109.843 -178.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.659 ' O ' ' HD2' ' A' ' 154' ' ' ARG . 45.5 mm -68.28 -44.57 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 119.991 -0.683 . . . . 0.0 110.151 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.659 ' HD2' ' O ' ' A' ' 153' ' ' ILE . 0.7 OUTLIER -156.76 -157.55 0.7 Allowed 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -86.74 104.91 16.57 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.559 0.695 . . . . 0.0 111.521 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.65 8.65 65.39 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 114.069 -1.423 . . . . 0.0 110.063 -177.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.463 HG12 ' HB2' ' A' ' 189' ' ' TYR . 96.5 mt -125.96 124.17 65.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 175.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.651 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 42.2 m -131.95 152.14 51.28 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -137.52 140.66 41.24 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.494 177.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 19.9 tp -131.21 78.49 72.49 Favored Pre-proline 0 N--CA 1.469 0.512 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.358 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -69.83 150.57 67.98 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.719 2.279 . . . . 0.0 113.033 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 92.3 mt -119.36 126.27 51.01 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.241 178.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 49.0 t -122.37 130.74 74.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 117.24 169.12 14.88 Favored Glycine 0 N--CA 1.48 1.619 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.3 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.876 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 53.6 t30 -86.19 114.7 23.23 Favored 'General case' 0 C--O 1.214 -0.803 0 CA-C-N 116.972 0.386 . . . . 0.0 110.109 -178.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.588 HD21 ' CZ ' ' A' ' 171' ' ' PHE . 47.1 tp -74.31 105.29 5.41 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -177.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.65 HG23 ' NE ' ' A' ' 170' ' ' ARG . 11.4 p -87.8 167.41 13.83 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.146 0.498 . . . . 0.0 110.489 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.88 -33.96 77.26 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.92 0.39 . . . . 0.0 111.862 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.58 -42.72 95.42 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.484 178.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.876 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 87.3 mtm180 -64.93 -33.65 76.52 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 124.169 0.988 . . . . 0.0 112.884 178.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.588 ' CZ ' HD21 ' A' ' 166' ' ' LEU . 0.4 OUTLIER -54.73 -28.32 47.29 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 118.913 -0.565 . . . . 0.0 112.39 -178.128 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.634 ' O ' HG22 ' A' ' 175' ' ' VAL . 90.2 m-20 -61.07 -40.69 94.64 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 118.892 -1.123 . . . . 0.0 109.939 -178.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 70.2 m -59.15 -41.41 88.25 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.71 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 67.3 mt -63.67 -44.01 98.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 172' ' ' ASN . 33.9 m -62.56 -40.63 89.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . 0.436 ' N ' HG23 ' A' ' 175' ' ' VAL . 97.7 m -62.27 -34.2 76.1 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.131 0.491 . . . . 0.0 110.435 177.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.501 ' O ' HG13 ' A' ' 181' ' ' ILE . 25.1 m -61.96 -19.74 63.09 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.026 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.624 ' CD2' HD21 ' A' ' 211' ' ' LEU . 85.6 mt -61.04 -40.89 95.32 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -177.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 18.9 m -59.11 -43.28 91.88 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . 0.586 ' O ' ' OG ' ' A' ' 183' ' ' SER . 90.8 m-20 -61.92 -37.6 85.29 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 120.773 0.32 . . . . 0.0 110.829 178.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 177' ' ' THR . 70.3 mt -56.77 -37.17 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 121.515 -0.741 . . . . 0.0 109.765 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.509 HD21 HD21 ' A' ' 214' ' ' LEU . 85.9 mt -61.28 -40.74 95.26 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -177.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.586 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 78.1 p -62.22 -35.38 78.71 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.406 177.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 39.2 p -88.63 25.11 1.8 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.65 0.262 . . . . 0.0 111.456 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 78.1 p -65.36 -20.01 66.2 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.732 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.37 -37.46 80.8 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.986 -178.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.651 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 99.0 m-20 -72.73 114.26 10.68 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.489 0.662 . . . . 0.0 110.924 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.13 -42.05 99.42 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.926 -177.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . 0.463 ' HB2' HG12 ' A' ' 157' ' ' ILE . 97.1 m-85 -112.02 131.23 55.54 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.873 -178.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 38.0 tp -121.14 128.37 52.46 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 96.7 mt -117.33 128.4 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.9 mm -114.22 128.33 71.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . 0.524 ' CG ' ' HG ' ' A' ' 195' ' ' SER . 40.1 t0 -96.09 119.54 34.77 Favored 'General case' 0 CA--C 1.552 1.037 0 O-C-N 121.873 -0.517 . . . . 0.0 110.474 177.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 99.0 mt -98.38 -4.56 34.55 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.593 175.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . 0.524 ' HG ' ' CG ' ' A' ' 193' ' ' ASP . 78.1 p -62.35 -33.46 74.76 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -62.42 -44.09 98.12 Favored Glycine 0 CA--C 1.534 1.243 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.938 HD23 ' N ' ' A' ' 198' ' ' ALA . 4.8 tt -68.96 128.51 36.96 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 112.788 -1.706 . . . . 0.0 108.495 -177.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.938 ' N ' HD23 ' A' ' 197' ' ' LEU . . . -59.68 -48.96 79.62 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 121.196 0.522 . . . . 0.0 110.703 -177.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.906 ' O ' ' CD2' ' A' ' 197' ' ' LEU . 57.9 tt0 -136.22 158.51 44.23 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 114.444 -1.253 . . . . 0.0 113.506 -173.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.47 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 46.9 t -118.72 132.28 69.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -89.53 156.79 18.39 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.296 -178.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.27 -39.94 94.97 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.104 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -57.59 -32.62 67.37 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.9 m -61.64 -42.24 98.62 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.609 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.448 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -57.5 -39.03 75.59 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -176.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -61.06 -36.35 79.38 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -64.81 -39.08 93.01 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.998 177.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 95.3 mt -63.29 -44.49 99.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -178.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . 0.448 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 75.1 m-85 -62.32 -43.36 98.99 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.6 -177.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.52 -41.93 99.18 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 119.07 -1.052 . . . . 0.0 109.105 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.624 HD21 ' CD2' ' A' ' 178' ' ' LEU . 38.3 mt -62.25 -41.5 98.5 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 78.2 p -61.36 -42.25 98.39 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.084 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' HIS . . . . . 0.502 ' CE1' HD11 ' A' ' 217' ' ' LEU . 57.7 t-80 -64.55 -45.66 86.14 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 120.626 -0.43 . . . . 0.0 111.372 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.509 HD21 HD21 ' A' ' 182' ' ' LEU . 47.8 tp -62.5 -45.76 91.51 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 118.909 -1.116 . . . . 0.0 108.379 179.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 211' ' ' LEU . 90.4 mt -62.74 -40.76 98.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.141 -177.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.62 -44.54 96.22 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.751 -178.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.502 HD11 ' CE1' ' A' ' 213' ' ' HIS . 84.5 mt -61.91 -39.88 93.54 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 66.8 p -74.95 -11.65 60.17 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.508 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.32 36.32 17.84 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 120.6 -0.809 . . . . 0.0 113.715 -178.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 97.0 m -123.21 117.29 24.98 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 119.174 1.487 . . . . 0.0 111.708 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -68.21 137.2 54.62 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.42 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 43.6 tp -111.81 130.86 55.67 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 2.8 mp -117.83 134.29 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.616 ' CG2' HD11 ' A' ' 227' ' ' ILE . 49.5 mm -115.67 131.31 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -178.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 44.2 p -134.3 165.57 24.81 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.916 -177.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 78.66 21.78 68.31 Favored Glycine 0 N--CA 1.464 0.528 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.677 HD12 HG23 ' A' ' 247' ' ' THR . 97.7 mt -83.83 128.22 39.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 113.87 -1.165 . . . . 0.0 108.291 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -77.4 141.07 65.44 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.33 -39.77 85.63 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 120.984 1.122 . . . . 0.0 112.629 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -63.04 -39.71 95.56 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.356 0.598 . . . . 0.0 110.16 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 52.4 tp -63.67 -42.64 98.02 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.904 177.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.45 -37.8 88.79 Favored 'General case' 0 CA--C 1.522 -0.109 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.991 -178.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 94.0 mtp -63.22 -41.3 99.11 Favored 'General case' 0 C--O 1.248 0.989 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.917 -178.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.96 -38.45 91.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.519 176.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 31.9 mmt -65.79 -37.61 86.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.576 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -61.11 -42.33 98.32 Favored 'General case' 0 CA--C 1.516 -0.33 0 O-C-N 121.55 -0.719 . . . . 0.0 109.401 -176.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.66 -41.59 95.34 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.524 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 54.5 tp -63.3 -41.5 98.96 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 177.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -167.58 124.26 1.14 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.299 0.571 . . . . 0.0 112.507 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.36 -26.6 65.21 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.55 -1.205 . . . . 0.0 110.625 178.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -62.37 -28.93 70.11 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.729 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -56.69 -44.51 81.56 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -176.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 95.2 p -60.93 -20.07 61.63 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 123.8 0.688 . . . . 0.0 111.15 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 31.1 m -55.79 -40.21 72.35 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 97.1 mt -81.4 122.44 27.49 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -43.1 133.51 3.83 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.028 177.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.677 HG23 HD12 ' A' ' 227' ' ' ILE . 93.8 m -127.48 133.83 49.86 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.89 177.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' TYR . . . . . 0.407 ' CG ' ' HB2' ' A' ' 254' ' ' ALA . 97.7 m-85 -119.02 139.65 51.35 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.173 179.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 78.0 p -61.86 -42.63 99.29 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -178.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -141.83 158.73 43.44 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.776 0.798 . . . . 0.0 111.641 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 63.3 t -62.39 -44.69 99.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 114.668 -1.151 . . . . 0.0 112.22 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.82 -44.18 97.25 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.207 -0.597 . . . . 0.0 109.434 -178.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . 0.573 ' O ' HG22 ' A' ' 257' ' ' VAL . 55.3 m-20 -63.87 -41.02 97.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.375 -178.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . 0.407 ' HB2' ' CG ' ' A' ' 248' ' ' TYR . . . -64.2 -44.64 91.34 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.895 0.855 . . . . 0.0 109.832 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . 0.427 ' O ' ' HD2' ' A' ' 259' ' ' PRO . 76.6 t -63.18 -45.84 97.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 113.944 -1.48 . . . . 0.0 110.912 -178.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.33 -46.55 86.1 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.141 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.573 HG22 ' O ' ' A' ' 253' ' ' ASP . 32.1 m -68.11 -40.72 83.43 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 O-C-N 121.489 -0.757 . . . . 0.0 111.923 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.498 ' C ' ' O ' ' A' ' 257' ' ' VAL . 1.5 mt -29.49 -74.46 0.04 OUTLIER Pre-proline 0 C--O 1.234 0.237 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.538 -177.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' PRO . . . . . 0.491 ' O ' HG13 ' A' ' 260' ' ' ILE . 43.6 Cg_endo -63.57 140.34 74.79 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 120.778 0.986 . . . . 0.0 111.96 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.491 HG13 ' O ' ' A' ' 259' ' ' PRO . 96.6 mt -153.15 -29.5 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 123.914 0.759 . . . . 0.0 111.883 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 78.0 mtm . . . . . 0 N--CA 1.474 0.751 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.567 -176.831 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.434 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.11 155.45 34.05 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 81.0 p -57.98 -27.58 63.59 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.784 176.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -65.54 -63.58 1.06 Allowed 'General case' 0 N--CA 1.437 -1.114 0 CA-C-O 121.004 0.43 . . . . 0.0 111.7 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -66.72 -38.06 85.94 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.323 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . 0.523 ' O ' ' HB3' ' B' ' 7' ' ' PHE . 69.4 m -59.8 -42.53 93.63 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.877 -177.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . 0.523 ' HB3' ' O ' ' B' ' 6' ' ' SER . 43.7 t80 84.83 90.85 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.387 177.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . 0.606 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -65.45 -142.6 0.04 OUTLIER Glycine 0 C--N 1.339 0.703 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.606 ' HB ' ' O ' ' B' ' 8' ' ' GLY . 74.1 mt 85.33 110.49 0.03 OUTLIER Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 122.634 0.374 . . . . 0.0 110.88 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -62.9 -24.42 74.24 Favored 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 121.314 1.343 . . . . 0.0 111.864 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.14 -40.75 98.98 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -64.21 -39.84 94.82 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.676 0.75 . . . . 0.0 109.292 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 49.2 tp -61.9 -42.38 99.01 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.419 -177.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -65.24 -32.82 74.68 Favored 'General case' 0 CA--C 1.562 1.413 0 CA-C-O 121.489 0.661 . . . . 0.0 110.624 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . 0.462 HG22 ' CD1' ' A' ' 113' ' ' ILE . 72.7 t -62.24 -46.48 96.34 Favored 'Isoleucine or valine' 0 C--O 1.244 0.774 0 CA-C-N 113.189 -1.823 . . . . 0.0 110.851 177.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 93.1 mt -64.08 -43.76 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.069 -178.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . 0.45 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 99.0 mttt -63.46 -42.07 98.63 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.52 -41.43 98.5 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 118.838 -1.145 . . . . 0.0 110.142 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.52 -39.01 86.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.891 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' B' ' 20' ' ' LEU . 87.9 mt -63.9 -42.25 97.48 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.369 0.604 . . . . 0.0 110.345 175.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -63.15 -38.47 91.28 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.019 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 57.7 m170 -57.43 -40.27 78.0 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 119.54 -0.267 . . . . 0.0 111.467 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 10.0 p -114.45 129.72 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.534 ' O ' ' HG3' ' B' ' 24' ' ' ARG . 36.0 ptt180 -71.43 108.59 4.93 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.736 0.779 . . . . 0.0 112.538 -177.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.9 p -143.11 134.16 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.857 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.602 177.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . 0.445 ' HA3' ' HB2' ' B' ' 123' ' ' GLN . . . -86.5 95.89 2.09 Favored Glycine 0 C--N 1.313 -0.742 0 C-N-CA 119.555 -1.307 . . . . 0.0 113.393 -177.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 47.0 t -125.34 128.62 72.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 174.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 34.6 m -139.09 157.23 28.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.48 178.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 96.1 mt -120.54 128.58 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 O-C-N 123.721 0.638 . . . . 0.0 111.787 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 23.2 p -108.69 157.24 18.72 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-N 112.819 -1.991 . . . . 0.0 108.602 -176.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.435 ' C ' ' OD1' ' B' ' 37' ' ' ASN . 43.3 t0 -125.46 102.97 29.2 Favored Pre-proline 0 CA--C 1.531 0.222 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -178.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 117' ' ' THR . 37.0 Cg_endo -64.14 -22.12 67.51 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 121.694 1.596 . . . . 0.0 111.431 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.84 -45.69 93.52 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.229 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 98.7 mt -70.64 176.88 3.82 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.786 -0.571 . . . . 0.0 111.404 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . 0.549 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 42.1 tt0 -78.23 131.37 37.1 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -175.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.516 ' O ' ' OD1' ' B' ' 36' ' ' ASP . 66.7 t0 58.2 36.91 26.12 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.582 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' ASN . . . . . 0.467 ' C ' ' O ' ' B' ' 36' ' ' ASP . 32.7 t-20 28.09 73.1 0.41 Allowed Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.549 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 91.9 Cg_endo -72.98 155.33 52.94 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 123.578 2.852 . . . . 0.0 111.732 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 96.3 mt -86.54 130.02 37.39 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.412 HG23 ' N ' ' B' ' 41' ' ' TYR . 34.5 m -109.39 -42.12 5.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 O-C-N 123.708 0.63 . . . . 0.0 112.378 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' TYR . . . . . 0.412 ' N ' HG23 ' B' ' 40' ' ' VAL . 51.2 t80 -98.73 124.1 43.36 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.485 -178.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 5.1 p -143.08 142.13 26.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 O-C-N 124.046 0.841 . . . . 0.0 109.279 177.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . 0.642 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 57.0 p30 -102.64 162.08 13.21 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.212 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' GLN . . . . . 0.506 ' OE1' ' HA ' ' B' ' 44' ' ' GLN . 12.7 mm100 -62.8 -37.42 86.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.373 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.41 -27.43 65.69 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.677 ' CE2' HD13 ' B' ' 57' ' ' ILE . 62.4 t80 -59.91 -43.52 94.83 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 0.752 HG13 ' O ' ' B' ' 52' ' ' TYR . 66.1 t -61.71 -46.61 96.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.218 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -63.67 -44.36 93.97 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.439 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 60.6 ttm -62.86 -41.99 99.59 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 32.2 p -96.04 -14.86 22.62 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.35 -0.54 . . . . 0.0 112.017 -177.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.54 19.96 79.27 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 177.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . 0.752 ' O ' HG13 ' B' ' 47' ' ' VAL . 81.9 m-85 -112.99 144.94 41.71 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 122.897 0.479 . . . . 0.0 110.128 178.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -73.62 148.58 42.74 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 121.884 0.85 . . . . 0.0 111.013 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . 0.431 ' H ' HG22 ' B' ' 54' ' ' THR . 0.1 OUTLIER -63.15 -35.63 80.94 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.127 -177.466 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.41 -40.79 96.46 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.568 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -72.43 -32.73 66.56 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 177.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.677 HD13 ' CE2' ' B' ' 46' ' ' PHE . 93.5 mt -66.1 -73.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' B' ' 57' ' ' ILE . 94.6 mt -35.27 132.51 0.38 Allowed 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.362 174.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.85 -9.16 73.43 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.831 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -136.71 149.14 47.73 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -174.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' ASN . . . . . 0.514 ' C ' ' H ' ' B' ' 63' ' ' ARG . 25.9 t-20 -78.72 152.09 31.75 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.889 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' CYS . . . . . . . . . . . . . 82.8 m -64.53 8.67 0.1 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.342 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' ARG . . . . . 0.514 ' H ' ' C ' ' B' ' 61' ' ' ASN . 34.6 ptt-85 -58.85 -30.95 68.08 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.487 -178.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -61.55 -30.78 70.86 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 81.0 mt -61.76 -42.77 99.41 Favored 'General case' 0 C--O 1.24 0.589 0 O-C-N 122.005 -0.435 . . . . 0.0 109.87 -178.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -49.99 148.93 2.96 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 123.7 0.625 . . . . 0.0 109.846 -177.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . 0.48 ' N ' ' OG1' ' B' ' 70' ' ' THR . . . -160.57 -151.36 6.18 Favored Glycine 0 CA--C 1.54 1.656 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.339 175.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.4 -41.88 94.8 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 122.659 -0.318 . . . . 0.0 111.738 -175.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -75.81 -9.56 58.7 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 123.169 0.293 . . . . 0.0 111.406 -178.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' THR . . . . . 0.48 ' OG1' ' N ' ' B' ' 67' ' ' GLY . 24.5 m -61.35 135.79 57.82 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -91.08 109.28 34.25 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.283 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.96 -38.69 86.51 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 120.884 1.056 . . . . 0.0 111.888 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.52 -40.38 91.23 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 120.527 -0.469 . . . . 0.0 109.798 -176.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' GLU . . . . . 0.477 ' OE1' ' HB ' ' B' ' 90' ' ' VAL . 78.8 mm-40 -66.87 -38.6 86.63 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.667 177.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 85.3 t -61.74 -46.01 97.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -62.91 -37.34 86.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.738 -178.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -62.57 -41.96 99.26 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 119.359 -0.936 . . . . 0.0 108.672 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.47 -43.79 98.54 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.859 -178.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -62.48 -43.01 99.86 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 83.6 m -61.11 -45.29 95.3 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.965 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.53 -40.98 96.64 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -177.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 80.2 mt -63.18 -41.79 99.27 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -62.22 -35.42 78.86 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . 0.424 ' O ' ' C ' ' B' ' 85' ' ' LYS . 98.5 m-20 -91.16 10.25 27.79 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.604 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' B' ' 84' ' ' ASN . 30.7 tttt 38.08 37.82 0.17 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 120.509 -0.477 . . . . 0.0 112.037 176.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -120.66 140.69 30.94 Favored Pre-proline 0 N--CA 1.469 0.487 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.96 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 87' ' ' PRO . . . . . 0.401 ' HB3' ' OD2' ' B' ' 109' ' ' ASP . 27.0 Cg_exo -61.63 140.29 85.75 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 121.006 1.137 . . . . 0.0 114.011 -177.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -140.94 137.44 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -177.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 89' ' ' THR . . . . . 0.877 HG23 ' OD1' ' B' ' 107' ' ' ASN . 97.0 m -121.65 122.78 40.37 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.477 ' HB ' ' OE1' ' B' ' 74' ' ' GLU . 28.2 m -139.04 163.2 27.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.859 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -114.71 122.4 46.31 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.189 0.519 . . . . 0.0 109.638 175.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . 0.472 HD11 HG23 ' B' ' 70' ' ' THR . 20.5 tt -128.9 132.58 67.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 114.999 -1.0 . . . . 0.0 112.038 -175.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . 0.439 ' O ' ' ND2' ' B' ' 94' ' ' ASN . 84.0 mt-30 -71.9 144.01 49.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.613 177.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 94' ' ' ASN . . . . . 0.439 ' ND2' ' O ' ' B' ' 93' ' ' GLN . 8.2 m120 -135.48 -178.69 5.23 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.353 0.596 . . . . 0.0 110.989 -176.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 95' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -132.42 145.12 50.97 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.634 -1.167 . . . . 0.0 111.829 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . 0.507 ' HG3' ' CE1' ' B' ' 102' ' ' PHE . 98.7 mttt -102.47 179.59 4.26 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.0 0.429 . . . . 0.0 110.917 178.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.82 -35.49 74.84 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.17 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 38.4 p-10 -88.08 -0.67 57.33 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 119.0 0.818 . . . . 0.0 112.738 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.47 5.89 64.77 Favored Glycine 0 N--CA 1.465 0.607 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.209 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 25.7 m -67.68 129.63 40.49 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.508 177.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 101' ' ' MET . . . . . 0.571 ' SD ' ' N ' ' B' ' 102' ' ' PHE . 14.9 tmm? -87.98 141.82 28.27 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 102' ' ' PHE . . . . . 0.571 ' N ' ' SD ' ' B' ' 101' ' ' MET . 53.2 p90 -154.81 162.08 41.24 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 103' ' ' TRP . . . . . 0.743 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 24.7 m95 -96.36 138.76 33.47 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.324 -0.551 . . . . 0.0 111.093 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . 0.51 HD21 ' HG2' ' B' ' 123' ' ' GLN . 64.0 t-20 -132.55 106.37 7.79 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 114.737 -1.119 . . . . 0.0 113.807 -177.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -75.49 123.92 26.28 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 124.286 0.992 . . . . 0.0 109.346 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 37.9 tp -111.61 126.02 54.56 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.075 0.464 . . . . 0.0 111.989 -177.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 107' ' ' ASN . . . . . 0.877 ' OD1' HG23 ' B' ' 89' ' ' THR . 97.6 m-20 -118.79 127.91 53.97 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 176.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 96.7 mt -123.79 133.11 70.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . 0.401 ' OD2' ' HB3' ' B' ' 87' ' ' PRO . 1.2 m-20 -146.6 120.9 5.23 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -69.48 153.34 70.35 Favored 'Trans proline' 0 N--CA 1.504 2.096 0 C-N-CA 122.581 2.187 . . . . 0.0 112.629 -178.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . 0.536 ' HB2' ' HB2' ' B' ' 118' ' ' TYR . 66.5 mtt -128.74 144.02 51.07 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -113.49 108.68 17.51 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 178.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . 0.503 HG12 ' HZ1' ' A' ' 18' ' ' LYS . 96.7 mt -134.6 128.3 50.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 O-C-N 121.64 -0.663 . . . . 0.0 111.736 177.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 52.89 38.66 27.46 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 123.974 0.796 . . . . 0.0 109.695 178.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 60.55 35.94 20.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.53 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -134.55 152.03 51.5 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 117' ' ' THR . . . . . 0.424 HG23 ' HG3' ' B' ' 32' ' ' PRO . 9.5 t -102.62 152.92 20.62 Favored 'General case' 0 C--O 1.214 -0.812 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.298 -177.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 118' ' ' TYR . . . . . 0.536 ' HB2' ' HB2' ' B' ' 111' ' ' MET . 95.2 m-85 -147.46 147.17 29.92 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 121.349 -0.844 . . . . 0.0 111.465 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -122.89 139.2 54.29 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 120.975 0.416 . . . . 0.0 111.57 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -128.85 134.33 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -176.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -109.87 125.14 7.45 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 122' ' ' ILE . . . . . 0.431 ' HB ' ' HB2' ' B' ' 107' ' ' ASN . 95.5 mt -114.84 127.75 72.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 123' ' ' GLN . . . . . 0.51 ' HG2' HD21 ' B' ' 104' ' ' ASN . 13.8 mp0 -119.8 118.5 30.99 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -116.75 120.28 38.07 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' B' ' 126' ' ' ILE . 68.0 t0 -67.65 133.8 49.99 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.465 -178.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.478 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 3.3 mt -107.49 16.16 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.626 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 127' ' ' THR . . . . . 0.439 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 97.8 m -63.45 -44.08 95.54 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 114.254 -1.339 . . . . 0.0 112.672 176.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 59.7 tptt -61.38 -45.79 92.87 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -177.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 129' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -62.75 -35.42 79.73 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.474 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 130' ' ' LYS . . . . . 0.743 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 98.8 mttt -63.13 -41.4 99.31 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 112.91 -1.95 . . . . 0.0 111.073 175.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.41 -41.89 96.38 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 132' ' ' TYR . . . . . 0.66 ' CE2' HD11 ' B' ' 136' ' ' LEU . 90.9 t80 -60.83 -44.76 96.51 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.941 -0.474 . . . . 0.0 111.644 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.28 -36.56 84.49 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 119.966 -0.693 . . . . 0.0 109.75 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 134' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' B' ' 130' ' ' LYS . 98.9 mttt -63.29 -38.92 93.03 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.846 177.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 52.7 tp -62.55 -41.44 98.89 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.46 0.647 . . . . 0.0 109.385 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 136' ' ' LEU . . . . . 0.66 HD11 ' CE2' ' B' ' 132' ' ' TYR . 85.2 mt -63.03 -41.58 99.56 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.405 178.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 137' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.95 -37.74 88.52 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 113.89 -1.505 . . . . 0.0 110.237 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -63.19 -43.66 97.58 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 120.029 -0.668 . . . . 0.0 109.952 176.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 53.4 m -61.04 -44.63 97.12 Favored 'General case' 0 C--N 1.346 0.43 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 88.3 mt -61.55 -40.44 94.69 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -177.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 81.8 m -61.6 -45.37 94.38 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.961 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -66.16 -41.49 90.3 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 92.5 mt -63.69 -43.56 98.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.63 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 144' ' ' THR . . . . . . . . . . . . . 99.1 m -61.55 -45.18 95.24 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -178.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.12 -40.7 96.75 Favored 'General case' 0 C--O 1.227 -0.121 0 C-N-CA 119.192 -1.003 . . . . 0.0 109.331 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 91.5 mt -64.18 -41.39 97.14 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 147' ' ' SER . . . . . 0.61 ' O ' ' N ' ' B' ' 149' ' ' PRO . 78.1 p -62.78 -42.25 99.62 Favored 'General case' 0 CA--C 1.477 -1.854 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 148' ' ' THR . . . . . 0.508 ' C ' ' O ' ' B' ' 147' ' ' SER . 12.3 m -25.52 85.33 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.793 0 O-C-N 124.12 0.887 . . . . 0.0 110.165 176.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 149' ' ' PRO . . . . . 0.61 ' N ' ' O ' ' B' ' 147' ' ' SER . 23.8 Cg_exo -60.83 146.48 97.42 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.112 1.874 . . . . 0.0 115.897 -177.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 9.7 tp -128.36 119.33 50.24 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.148 0 CA-C-N 114.015 -1.448 . . . . 0.0 108.029 174.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 41.6 t -153.02 93.34 3.19 Favored Pre-proline 0 C--N 1.308 -1.197 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.931 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -60.18 137.27 74.18 Favored 'Trans proline' 0 N--CA 1.488 1.181 0 CA-C-N 119.728 0.939 . . . . 0.0 109.727 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 153' ' ' ILE . . . . . 0.694 ' O ' ' HD2' ' B' ' 154' ' ' ARG . 44.5 mm -68.41 -43.3 84.18 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.499 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.351 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 154' ' ' ARG . . . . . 0.694 ' HD2' ' O ' ' B' ' 153' ' ' ILE . 0.8 OUTLIER -155.96 -155.92 0.59 Allowed 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.683 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 61.8 t-20 -86.84 109.73 19.49 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.87 -18.71 56.46 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -177.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 157' ' ' ILE . . . . . 0.43 HG22 ' HB ' ' B' ' 153' ' ' ILE . 88.0 mt -108.91 125.69 65.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.098 0.475 . . . . 0.0 111.036 -176.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 158' ' ' SER . . . . . 0.647 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 57.9 m -134.96 149.77 50.27 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.933 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -132.91 146.96 52.26 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 24.3 tp -139.5 77.07 29.51 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 161' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -70.83 147.54 56.21 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.689 2.259 . . . . 0.0 114.083 -178.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 95.1 mt -113.97 133.99 55.13 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 54.7 t -128.79 132.13 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 115.03 169.43 15.99 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 120.508 -0.854 . . . . 0.0 111.276 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 165' ' ' ASN . . . . . 0.688 ' O ' ' CZ ' ' B' ' 170' ' ' ARG . 59.2 t30 -91.5 106.55 18.57 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -177.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 166' ' ' LEU . . . . . 0.597 HD21 ' CZ ' ' B' ' 171' ' ' PHE . 47.5 tp -65.25 104.83 0.99 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -174.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 167' ' ' THR . . . . . 0.608 HG23 ' NE ' ' B' ' 170' ' ' ARG . 10.7 p -84.76 171.24 12.47 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 114.088 -1.414 . . . . 0.0 110.904 176.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -66.77 -37.69 85.1 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.671 177.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.51 -40.92 89.45 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 122.456 1.122 . . . . 0.0 111.962 -178.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 170' ' ' ARG . . . . . 0.688 ' CZ ' ' O ' ' B' ' 165' ' ' ASN . 87.6 mtm180 -62.07 -36.54 81.99 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 112.367 -2.197 . . . . 0.0 111.405 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 171' ' ' PHE . . . . . 0.597 ' CZ ' HD21 ' B' ' 166' ' ' LEU . 0.3 OUTLIER -54.08 -26.25 26.04 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -178.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 172' ' ' ASN . . . . . 0.569 ' O ' HG22 ' B' ' 175' ' ' VAL . 90.3 m-20 -62.58 -40.2 96.11 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.967 178.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 67.9 m -60.46 -41.7 94.69 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.095 0.474 . . . . 0.0 110.708 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 67.8 mt -64.17 -44.12 97.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 175' ' ' VAL . . . . . 0.569 HG22 ' O ' ' B' ' 172' ' ' ASN . 34.0 m -62.9 -40.59 89.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 176' ' ' CYS . . . . . 0.438 ' N ' HG23 ' B' ' 175' ' ' VAL . 99.5 m -62.27 -34.71 77.08 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.415 177.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 177' ' ' THR . . . . . 0.535 ' O ' HG13 ' B' ' 181' ' ' ILE . 25.2 m -61.53 -19.82 62.54 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-O 121.001 0.429 . . . . 0.0 110.213 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 178' ' ' LEU . . . . . 0.608 ' CD2' HD21 ' B' ' 211' ' ' LEU . 86.8 mt -61.1 -39.02 88.38 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.255 -178.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 19.2 m -60.94 -44.31 97.43 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.357 177.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 180' ' ' ASN . . . . . 0.563 ' O ' ' OG ' ' B' ' 183' ' ' SER . 91.2 m-20 -62.16 -40.38 95.79 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.682 0.277 . . . . 0.0 110.538 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.535 HG13 ' O ' ' B' ' 177' ' ' THR . 76.3 mt -55.45 -31.77 28.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.729 -177.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 182' ' ' LEU . . . . . 0.474 HD21 HD21 ' B' ' 214' ' ' LEU . 84.4 mt -62.42 -42.27 99.32 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.249 178.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . 0.563 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.0 p -63.53 -33.81 76.4 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 121.876 -0.515 . . . . 0.0 110.999 178.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 33.1 p -85.23 15.77 4.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.866 0.365 . . . . 0.0 111.899 -177.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 78.7 p -59.83 -16.42 28.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.977 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.38 -40.59 94.89 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.946 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 187' ' ' ASP . . . . . 0.647 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.5 m-20 -69.97 114.37 8.07 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.535 0.684 . . . . 0.0 110.711 -178.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.9 -41.99 99.63 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-N 114.9 -1.046 . . . . 0.0 113.161 -177.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 189' ' ' TYR . . . . . 0.429 ' HB2' HG12 ' B' ' 157' ' ' ILE . 96.9 m-85 -111.45 130.7 55.63 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.197 -178.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 190' ' ' LEU . . . . . . . . . . . . . 40.5 tp -124.26 118.65 27.28 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.059 177.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 88.3 mt -107.81 127.71 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 120.613 0.244 . . . . 0.0 111.552 -177.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 49.2 mm -116.68 119.13 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 193' ' ' ASP . . . . . 0.525 ' CG ' ' HG ' ' B' ' 195' ' ' SER . 40.8 t0 -89.89 111.64 22.75 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 120.919 0.39 . . . . 0.0 111.739 -177.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 194' ' ' LEU . . . . . . . . . . . . . 98.4 mt -92.14 -2.42 56.59 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.32 175.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 195' ' ' SER . . . . . 0.525 ' HG ' ' CG ' ' B' ' 193' ' ' ASP . 78.3 p -61.25 -37.34 82.75 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.865 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -62.18 -33.89 87.36 Favored Glycine 0 N--CA 1.438 -1.195 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 197' ' ' LEU . . . . . 1.012 HD23 ' N ' ' B' ' 198' ' ' ALA . 4.7 tt -77.97 133.32 38.05 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 121.962 -0.728 . . . . 0.0 109.323 -176.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 198' ' ' ALA . . . . . 1.012 ' N ' HD23 ' B' ' 197' ' ' LEU . . . -64.55 -42.23 95.82 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.361 -176.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 199' ' ' GLN . . . . . 0.943 ' H ' ' CD2' ' B' ' 197' ' ' LEU . 58.8 tt0 -140.48 165.02 28.57 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.623 0.725 . . . . 0.0 112.648 -178.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 200' ' ' VAL . . . . . 0.472 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 51.0 t -120.93 132.91 69.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 O-C-N 121.037 -1.04 . . . . 0.0 109.526 177.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -93.8 148.95 21.65 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.151 0.5 . . . . 0.0 110.822 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -58.07 -33.71 69.34 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.308 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -64.93 -33.39 75.91 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.4 m -61.19 -44.59 97.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.555 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 205' ' ' ALA . . . . . 0.656 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -57.71 -29.42 64.69 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.666 -177.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -65.66 -37.46 86.58 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.312 0.577 . . . . 0.0 109.603 176.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -66.12 -38.69 88.82 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.586 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.83 -43.3 97.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.079 -178.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 209' ' ' PHE . . . . . 0.656 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 73.6 m-85 -62.47 -43.14 99.54 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 114.16 -1.382 . . . . 0.0 112.733 177.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.4 -41.64 98.75 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.379 -0.929 . . . . 0.0 109.701 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 211' ' ' LEU . . . . . 0.608 HD21 ' CD2' ' B' ' 178' ' ' LEU . 39.4 mt -62.44 -42.29 99.35 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.314 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 78.3 p -62.33 -36.57 82.59 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.908 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 213' ' ' HIS . . . . . 0.485 ' CE1' HD11 ' B' ' 217' ' ' LEU . 58.1 t-80 -67.26 -46.77 72.67 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.012 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.474 HD21 HD21 ' B' ' 182' ' ' LEU . 51.0 tp -63.97 -43.35 96.02 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.81 0.815 . . . . 0.0 109.83 177.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 215' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' B' ' 211' ' ' LEU . 91.8 mt -62.95 -43.97 97.35 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 113.502 -1.681 . . . . 0.0 111.588 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.83 -39.5 92.01 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.82 -177.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . 0.485 HD11 ' CE1' ' B' ' 213' ' ' HIS . 85.6 mt -63.56 -42.02 98.39 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.362 0.601 . . . . 0.0 111.652 176.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 218' ' ' THR . . . . . 0.412 HG23 ' O ' ' B' ' 214' ' ' LEU . 74.2 p -74.17 -17.21 60.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.987 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 81.08 66.42 1.62 Allowed Glycine 0 CA--C 1.527 0.784 0 N-CA-C 106.696 -2.562 . . . . 0.0 106.696 -178.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 220' ' ' THR . . . . . . . . . . . . . 94.2 m -147.11 104.56 3.69 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 114.652 1.352 . . . . 0.0 114.652 176.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -61.92 140.45 58.3 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.022 -175.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 44.8 tp -116.69 121.79 42.65 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.37 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 3.0 mp -110.26 128.83 66.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.916 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 224' ' ' ILE . . . . . 0.534 ' CG2' HD11 ' B' ' 227' ' ' ILE . 50.7 mm -109.39 126.58 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.552 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 49.4 p -133.44 157.62 45.12 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 90.1 16.95 55.03 Favored Glycine 0 CA--C 1.499 -0.918 0 CA-C-N 113.898 -1.501 . . . . 0.0 111.117 -177.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 227' ' ' ILE . . . . . 0.733 HD12 HG23 ' B' ' 247' ' ' THR . 94.8 mt -81.72 125.64 39.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 O-C-N 121.942 -0.74 . . . . 0.0 111.851 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 65.9 tttt -66.73 141.68 97.04 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.406 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.11 -37.47 94.05 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 121.364 1.376 . . . . 0.0 112.609 178.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -64.04 -43.03 96.8 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -177.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 51.3 tp -61.89 -41.34 97.78 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.527 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.15 -36.83 85.31 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.504 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 94.7 mtp -64.08 -40.83 97.11 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.73 -42.84 97.83 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 122.195 0.997 . . . . 0.0 109.238 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 32.4 mmt -63.89 -35.92 82.22 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.782 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -61.66 -40.39 94.78 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -178.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.67 -44.43 93.79 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.07 178.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 51.0 tp -62.45 -45.41 93.17 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.924 -178.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -156.68 131.78 9.12 Favored 'General case' 0 CA--C 1.511 -0.555 0 C-N-CA 120.301 -0.559 . . . . 0.0 111.956 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 240' ' ' ALA . . . . . . . . . . . . . . . -62.13 -47.28 85.25 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 176.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 241' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' B' ' 244' ' ' SER . 93.7 m-20 -42.52 -19.16 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.484 -176.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 242' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -62.6 -44.82 95.33 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.138 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 243' ' ' SER . . . . . . . . . . . . . 78.0 p -57.63 -44.02 85.24 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 244' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 19.8 m -29.81 -40.61 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 96.4 mt -84.25 141.67 30.81 Favored 'General case' 0 C--N 1.313 -1.013 0 O-C-N 121.561 -0.712 . . . . 0.0 110.993 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -69.06 133.55 48.23 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 120.923 0.392 . . . . 0.0 110.285 -174.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 247' ' ' THR . . . . . 0.733 HG23 HD12 ' B' ' 227' ' ' ILE . 97.8 m -124.1 125.86 45.22 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.861 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 248' ' ' TYR . . . . . 0.482 ' CG ' ' HB2' ' B' ' 254' ' ' ALA . 96.9 m-85 -111.71 142.85 43.52 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 249' ' ' SER . . . . . 0.571 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 78.4 p -62.86 -33.04 74.43 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.058 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 250' ' ' ASN . . . . . 0.571 ' OD1' ' O ' ' B' ' 249' ' ' SER . 99.3 m-20 -147.31 157.75 43.71 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.122 -0.945 . . . . 0.0 112.004 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 69.3 t -64.9 -44.75 96.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.263 178.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 252' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.74 -46.06 91.89 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -178.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . 0.547 ' O ' HG22 ' B' ' 257' ' ' VAL . 70.3 m-20 -60.94 -42.88 99.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.651 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 254' ' ' ALA . . . . . 0.482 ' HB2' ' CG ' ' B' ' 248' ' ' TYR . . . -65.57 -41.14 93.26 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.15 178.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 255' ' ' VAL . . . . . 0.444 ' O ' ' HD2' ' B' ' 259' ' ' PRO . 76.2 t -65.02 -45.36 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.067 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.07 -47.96 80.68 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.491 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 257' ' ' VAL . . . . . 0.547 HG22 ' O ' ' B' ' 253' ' ' ASP . 27.2 m -65.46 -40.58 88.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.577 179.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 258' ' ' LEU . . . . . 0.507 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 1.3 mt -32.74 -73.29 0.06 OUTLIER Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.507 -177.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 259' ' ' PRO . . . . . 0.57 ' O ' HG13 ' B' ' 260' ' ' ILE . 37.1 Cg_endo -61.84 141.36 89.78 Favored 'Trans proline' 0 N--CA 1.504 2.103 0 C-N-CA 121.459 1.439 . . . . 0.0 111.308 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 260' ' ' ILE . . . . . 0.57 HG13 ' O ' ' B' ' 259' ' ' PRO . 96.7 mt -159.54 -16.43 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 CA-C-N 118.692 0.678 . . . . 0.0 112.3 177.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 78.3 mtm . . . . . 0 C--O 1.216 -0.703 0 CA-C-O 117.785 -1.102 . . . . 0.0 111.434 -178.848 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.16 172.39 18.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.144 0.497 . . . . 0.0 110.272 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 85.4 p -73.27 -10.23 59.54 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.6 -0.688 . . . . 0.0 111.17 177.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -83.33 -62.97 1.45 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 114.713 -1.131 . . . . 0.0 112.434 176.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -69.33 -39.71 78.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.782 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.611 ' O ' ' NZ ' ' B' ' 17' ' ' LYS . 57.8 m -59.62 -41.66 90.92 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -177.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.505 ' CE2' HD12 ' A' ' 9' ' ' ILE . 32.2 t80 83.18 89.64 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.179 0.514 . . . . 0.0 112.213 177.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.538 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -63.49 -140.27 0.01 OUTLIER Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -177.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.538 ' HB ' ' O ' ' A' ' 8' ' ' GLY . 67.7 mt 82.11 108.34 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 122.686 0.394 . . . . 0.0 110.523 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.93 -21.75 68.69 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.466 1.444 . . . . 0.0 112.141 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.2 -38.39 95.86 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 121.08 -0.581 . . . . 0.0 111.896 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -65.05 -39.64 93.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.512 0.672 . . . . 0.0 109.486 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 52.9 tp -62.81 -41.41 99.29 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -62.21 -40.68 96.92 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 75.0 t -60.12 -44.36 94.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 O-C-N 122.146 -0.346 . . . . 0.0 110.91 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 91.9 mt -62.51 -43.65 98.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.468 -178.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.51 -46.52 88.05 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 119.269 -0.973 . . . . 0.0 112.306 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.585 ' NZ ' HG12 ' B' ' 113' ' ' ILE . 98.4 mttt -59.3 -39.77 84.05 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 118.608 -1.237 . . . . 0.0 109.02 -176.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.34 -41.89 90.22 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.306 -178.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 20' ' ' LEU . 85.4 mt -62.93 -40.91 99.07 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -63.43 -38.2 90.22 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 57.9 m170 -58.62 -39.86 81.68 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 122.339 -0.226 . . . . 0.0 111.329 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 23' ' ' VAL . 12.6 p -113.88 129.95 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.505 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 34.8 ptt180 -72.36 108.27 5.38 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-O 122.072 0.939 . . . . 0.0 112.161 -177.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.0 p -140.47 142.96 30.06 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 123' ' ' GLN . . . -97.45 92.77 1.34 Allowed Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.674 -178.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 53.3 t -125.44 130.17 72.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.6 m -137.4 159.54 35.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.6 mt -121.12 129.76 75.35 Favored 'Isoleucine or valine' 0 C--O 1.247 0.952 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 177.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.441 HG22 HG12 ' A' ' 39' ' ' ILE . 19.6 p -106.32 168.47 9.13 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.518 ' C ' ' OD1' ' A' ' 37' ' ' ASN . 62.7 t0 -133.88 102.85 12.14 Favored Pre-proline 0 C--N 1.318 -0.781 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.117 178.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.549 ' HG3' HG23 ' A' ' 117' ' ' THR . 36.9 Cg_endo -63.83 -22.88 69.07 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 121.495 1.463 . . . . 0.0 111.647 -178.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.02 -35.19 79.4 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.955 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.4 mt -86.39 159.81 19.25 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.375 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.835 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 42.9 tt0 -57.43 134.35 55.98 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -176.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.514 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 56.8 t0 59.76 23.49 12.39 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 178.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.518 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 39.8 t-20 38.82 65.89 2.97 Favored Pre-proline 0 CA--C 1.542 0.65 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.129 -178.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.835 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 91.3 Cg_endo -68.55 155.18 69.85 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 124.007 3.138 . . . . 0.0 112.129 -178.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.441 HG12 HG22 ' A' ' 30' ' ' THR . 96.4 mt -86.53 125.0 40.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.0 m -104.66 -41.78 6.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 116.136 -0.483 . . . . 0.0 112.086 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -96.07 123.57 39.73 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.859 -178.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.5 p -142.62 139.53 28.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 O-C-N 124.295 0.997 . . . . 0.0 109.133 177.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.616 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 58.0 p30 -98.3 167.01 11.12 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.506 ' OE1' ' HA ' ' A' ' 44' ' ' GLN . 14.4 mm100 -66.43 -39.41 88.89 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 178.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.19 -26.14 63.31 Favored Glycine 0 C--N 1.33 0.208 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.616 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 60.5 t80 -59.18 -49.3 78.39 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 -179.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.6 HG13 ' O ' ' A' ' 52' ' ' TYR . 53.5 t -58.45 -44.9 89.88 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 O-C-N 121.423 -0.798 . . . . 0.0 111.464 -174.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -62.99 -37.16 86.07 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 120.511 -0.476 . . . . 0.0 112.116 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 59.6 ttm -68.65 -43.62 75.89 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 177.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 35.4 p -90.48 -23.2 21.04 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.34 0.59 . . . . 0.0 111.48 -178.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . 78.01 21.08 71.8 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 -179.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.6 ' O ' HG13 ' A' ' 47' ' ' VAL . 70.3 m-85 -114.46 138.87 50.04 Favored 'General case' 0 C--O 1.221 -0.42 0 C-N-CA 122.936 0.494 . . . . 0.0 111.162 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -64.21 150.14 46.45 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.646 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.432 HG22 ' H ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -65.78 -33.55 76.12 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -179.283 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.26 -44.19 84.35 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.659 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -64.62 -45.49 86.65 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.585 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.598 HD13 ' CD2' ' A' ' 46' ' ' PHE . 92.0 mt -61.58 -50.26 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -174.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 80.6 mt -57.26 145.48 31.72 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 176.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.3 -6.68 78.89 Favored Glycine 0 N--CA 1.46 0.235 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.208 177.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -135.6 152.73 51.54 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.685 1.243 . . . . 0.0 111.903 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.562 ' C ' ' H ' ' A' ' 63' ' ' ARG . 25.2 t-20 -81.36 152.44 27.5 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.474 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 80.3 m -63.2 16.3 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.444 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.562 ' H ' ' C ' ' A' ' 61' ' ' ASN . 35.4 ptt-85 -61.88 -41.62 98.08 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.16 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -55.44 -20.55 12.78 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -178.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.7 mt -71.23 -32.17 68.45 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.611 0.719 . . . . 0.0 112.505 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -65.95 141.41 58.22 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.178 -178.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.59 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -151.08 -148.5 4.81 Favored Glycine 0 CA--C 1.539 1.553 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -178.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.79 -39.57 94.64 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -177.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -77.83 -8.72 58.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.902 0.382 . . . . 0.0 111.114 -178.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.59 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 28.6 m -62.27 128.69 37.26 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.55 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -85.89 111.06 35.17 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.859 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -57.44 -31.87 92.5 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.959 1.773 . . . . 0.0 113.247 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.42 -40.1 95.11 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.951 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.434 ' OE1' ' HB ' ' A' ' 90' ' ' VAL . 78.9 mm-40 -65.5 -43.99 88.39 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 71.9 t -59.3 -43.86 90.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -176.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -64.35 -37.54 87.87 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.144 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -63.28 -39.89 95.85 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.304 0.573 . . . . 0.0 110.068 178.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 93.6 mt -64.01 -44.16 97.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.933 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -62.61 -43.13 99.58 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 113.633 -1.622 . . . . 0.0 108.229 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 97.0 m -61.55 -49.44 76.65 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.4 -42.57 92.03 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.381 -172.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 89.3 mt -62.77 -39.98 95.88 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 121.473 -0.767 . . . . 0.0 111.177 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 66.9 tp60 -65.07 -31.44 72.66 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -89.62 -1.33 57.99 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.22 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 46.7 tttt 47.32 39.45 8.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.529 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -122.48 143.9 40.82 Favored Pre-proline 0 CA--C 1.532 0.287 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' A' ' 108' ' ' ILE . 24.8 Cg_exo -61.63 144.37 97.45 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.559 1.506 . . . . 0.0 113.569 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -139.09 142.41 33.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.563 -178.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.913 HG23 ' OD1' ' A' ' 107' ' ' ASN . 97.7 m -127.57 118.21 23.5 Favored 'General case' 0 C--N 1.345 0.377 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 176.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.434 ' HB ' ' OE1' ' A' ' 74' ' ' GLU . 28.3 m -138.47 157.49 30.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.675 -0.238 . . . . 0.0 111.496 178.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -100.67 133.52 45.0 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 176.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.456 HG23 ' O ' ' A' ' 92' ' ' ILE . 17.1 tt -141.28 128.21 20.88 Favored 'Isoleucine or valine' 0 C--N 1.377 1.777 0 CA-C-N 121.374 1.897 . . . . 0.0 112.711 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -62.61 135.69 57.51 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.254 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -138.16 161.36 37.0 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.699 -179.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -118.14 136.23 53.74 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.474 ' HG3' ' CE1' ' A' ' 102' ' ' PHE . 99.2 mttt -85.77 -171.45 3.6 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.239 0.543 . . . . 0.0 111.921 -179.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -62.51 -44.09 97.21 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.919 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 42.9 p-10 -83.42 7.36 17.05 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.84 -1.1 89.09 Favored Glycine 0 N--CA 1.471 0.99 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.258 176.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.8 m -58.31 137.89 56.83 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.679 ' SD ' ' C ' ' A' ' 101' ' ' MET . 12.5 tmm? -104.97 129.78 53.31 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.556 0.217 . . . . 0.0 110.443 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.548 ' N ' ' SD ' ' A' ' 101' ' ' MET . 53.4 p90 -142.33 158.43 43.72 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.007 -177.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.915 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 23.3 m95 -89.8 141.26 28.8 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.555 HD21 ' HG2' ' A' ' 123' ' ' GLN . 54.3 t-20 -136.58 105.0 5.74 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -176.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 80.8 tt0 -70.18 135.99 49.63 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 -177.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 41.6 tp -120.9 122.77 40.95 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.913 ' OD1' HG23 ' A' ' 89' ' ' THR . 98.1 m-20 -120.31 121.65 39.09 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.773 177.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 87' ' ' PRO . 96.2 mt -119.68 128.57 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 O-C-N 123.493 0.496 . . . . 0.0 111.421 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -136.31 125.76 15.84 Favored Pre-proline 0 CA--C 1.541 0.617 0 O-C-N 123.079 0.237 . . . . 0.0 110.903 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -71.31 151.75 60.46 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.666 2.244 . . . . 0.0 112.363 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.671 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 67.0 mtt -123.89 153.17 41.51 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -128.48 91.14 3.18 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.549 ' CD1' HG22 ' B' ' 15' ' ' VAL . 96.2 mt -117.34 131.37 70.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.429 -178.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 49.38 39.07 15.45 Favored 'General case' 0 CA--C 1.512 -0.499 0 O-C-N 121.496 -0.752 . . . . 0.0 111.68 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 58.7 30.42 19.93 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.954 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -127.59 146.35 50.56 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.785 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 7.7 t -85.38 -170.41 3.11 Favored 'General case' 0 C--O 1.214 -0.772 0 O-C-N 121.687 -0.633 . . . . 0.0 109.334 -178.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.785 ' CD2' ' O ' ' A' ' 117' ' ' THR . 66.0 m-85 -174.0 155.38 2.51 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 177.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -131.11 145.57 52.03 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 174.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -134.33 134.1 55.04 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.8 127.08 8.56 Favored Glycine 0 CA--C 1.501 -0.832 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 96.8 mt -116.6 128.93 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.555 ' HG2' HD21 ' A' ' 104' ' ' ASN . 17.7 mp0 -119.08 115.64 24.71 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.579 0.549 . . . . 0.0 109.63 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -117.64 111.78 19.64 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.838 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 126' ' ' ILE . 67.9 t0 -62.88 131.77 49.87 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -175.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.511 HG22 ' O ' ' A' ' 126' ' ' ILE . 2.9 mp -95.48 3.56 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 113.542 -1.663 . . . . 0.0 109.637 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 20.0 m -60.04 -42.98 95.58 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.007 -1.058 . . . . 0.0 113.62 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -60.57 -41.69 95.11 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -177.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -63.51 -39.79 95.36 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.003 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.915 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.6 mttt -62.81 -41.06 99.14 Favored 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 118.157 -1.417 . . . . 0.0 110.535 -178.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.1 -37.66 83.54 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.653 -178.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.774 ' CE2' HD11 ' A' ' 136' ' ' LEU . 89.7 t80 -61.77 -45.3 94.51 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.543 176.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.73 -38.69 91.85 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.02 -40.93 97.37 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 52.8 tp -60.64 -43.36 97.66 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -177.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.774 HD11 ' CE2' ' A' ' 132' ' ' TYR . 83.6 mt -62.28 -40.91 97.82 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.094 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.56 -41.83 98.39 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 119.355 -0.938 . . . . 0.0 109.837 -178.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -60.27 -41.55 93.5 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -177.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 48.8 m -61.66 -41.09 97.06 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.071 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 144' ' ' THR . 84.4 mt -63.69 -41.72 98.11 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.449 -0.5 . . . . 0.0 109.758 177.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 96.9 m -61.39 -46.0 92.01 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.268 -177.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -65.21 -40.48 94.19 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 95.5 mt -64.78 -43.47 96.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 113.967 -1.469 . . . . 0.0 111.523 176.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.515 ' N ' ' O ' ' A' ' 140' ' ' LEU . 92.1 m -62.53 -46.48 88.18 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.477 ' O ' ' OG1' ' A' ' 148' ' ' THR . . . -62.58 -40.57 97.29 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 118.875 -1.13 . . . . 0.0 109.251 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 85.3 mt -63.8 -42.73 97.64 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.675 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.1 p -60.93 -37.67 83.12 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -178.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.477 ' OG1' ' O ' ' A' ' 145' ' ' ALA . 18.8 m -29.09 83.73 0.03 OUTLIER Pre-proline 0 C--N 1.347 0.492 0 O-C-N 126.592 2.432 . . . . 0.0 106.613 -178.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.675 ' N ' ' O ' ' A' ' 147' ' ' SER . 22.4 Cg_exo -61.94 144.04 96.07 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 CA-C-O 122.753 1.064 . . . . 0.0 113.906 -174.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.639 ' O ' HG23 ' A' ' 151' ' ' VAL . 9.3 tp -120.49 135.1 61.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 102.057 -3.312 . . . . 0.0 102.057 175.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 150' ' ' ILE . 95.4 t -167.89 95.11 0.62 Allowed Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 177.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -64.12 143.69 84.96 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 N-CA-C 109.822 -0.876 . . . . 0.0 109.822 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.59 ' O ' HG11 ' B' ' 255' ' ' VAL . 43.4 mm -75.84 -68.61 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.463 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.725 ' NH2' ' HD3' ' B' ' 154' ' ' ARG . 4.8 mpt_? -132.02 -160.34 1.04 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 63.3 t-20 -83.63 104.57 13.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.799 0.809 . . . . 0.0 111.415 -178.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.16 9.2 60.84 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 113.991 -1.458 . . . . 0.0 110.115 -177.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.6 mt -126.1 123.48 63.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 175.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.682 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 74.5 m -133.16 151.72 51.96 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -138.15 141.03 40.12 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.625 177.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 21.7 tp -130.51 80.48 70.13 Favored Pre-proline 0 N--CA 1.47 0.571 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.454 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -70.34 152.47 66.31 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.758 2.305 . . . . 0.0 113.229 -178.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 90.1 mt -120.88 126.39 49.92 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.175 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 48.4 t -123.28 131.2 73.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 117.41 169.32 14.89 Favored Glycine 0 N--CA 1.477 1.423 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.238 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.78 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 57.1 t30 -85.25 115.28 22.93 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 117.16 0.48 . . . . 0.0 110.07 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.595 HD21 ' CZ ' ' A' ' 171' ' ' PHE . 47.1 tp -73.7 104.05 4.48 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -177.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.736 HG23 ' NE ' ' A' ' 170' ' ' ARG . 10.6 p -85.92 166.85 15.63 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.588 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.85 -34.16 77.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.166 0.507 . . . . 0.0 111.779 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.45 -42.44 95.95 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.102 178.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.78 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 87.5 mtm180 -65.37 -33.75 76.7 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 124.316 1.047 . . . . 0.0 112.462 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.595 ' CZ ' HD21 ' A' ' 166' ' ' LEU . 0.5 OUTLIER -54.21 -28.49 41.25 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 118.986 -0.531 . . . . 0.0 112.381 -178.778 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.604 ' O ' HG22 ' A' ' 175' ' ' VAL . 91.2 m-20 -60.55 -40.71 92.57 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 118.975 -1.09 . . . . 0.0 109.7 -178.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 52.0 m -59.22 -41.31 88.34 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 121.685 -0.635 . . . . 0.0 110.777 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 66.2 mt -63.25 -44.08 99.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 172' ' ' ASN . 35.4 m -62.08 -40.35 87.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . 0.418 ' N ' HG23 ' A' ' 175' ' ' VAL . 98.3 m -62.21 -33.97 75.59 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.396 178.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.523 ' O ' HG13 ' A' ' 181' ' ' ILE . 25.3 m -62.45 -19.85 63.93 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.135 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.708 ' CD2' HD21 ' A' ' 211' ' ' LEU . 86.2 mt -61.1 -41.87 97.47 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 -177.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 18.4 m -59.27 -43.28 92.51 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . 0.61 ' O ' ' OG ' ' A' ' 183' ' ' SER . 93.1 m-20 -61.78 -37.68 85.22 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 120.759 0.314 . . . . 0.0 110.661 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.523 HG13 ' O ' ' A' ' 177' ' ' THR . 68.7 mt -57.15 -37.18 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 O-C-N 121.384 -0.822 . . . . 0.0 109.918 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.527 HD21 HD21 ' A' ' 214' ' ' LEU . 85.9 mt -61.16 -40.69 94.81 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -177.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.61 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 78.0 p -61.62 -33.15 73.42 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.464 177.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.442 ' OG1' ' HA ' ' A' ' 181' ' ' ILE . 21.9 p -89.88 23.32 2.79 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.672 0.272 . . . . 0.0 111.433 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 78.1 p -63.41 -21.49 66.32 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.63 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.29 -37.2 79.77 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.953 -179.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.682 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 98.6 m-20 -72.58 113.21 9.36 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.53 0.681 . . . . 0.0 110.706 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.95 -42.09 99.71 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.914 -177.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -112.88 130.89 55.94 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.862 -178.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 38.5 tp -120.82 128.81 53.2 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 96.5 mt -117.08 127.54 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.8 mm -113.17 127.4 70.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . 0.488 ' CG ' ' HG ' ' A' ' 195' ' ' SER . 40.5 t0 -95.15 117.99 31.18 Favored 'General case' 0 CA--C 1.549 0.93 0 O-C-N 121.871 -0.518 . . . . 0.0 110.538 177.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 96.1 mt -97.38 -4.93 37.48 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.661 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . 0.488 ' HG ' ' CG ' ' A' ' 193' ' ' ASP . 78.1 p -62.99 -32.51 73.88 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.63 -44.39 98.01 Favored Glycine 0 CA--C 1.533 1.17 0 N-CA-C 108.332 -1.907 . . . . 0.0 108.332 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.975 ' CD2' ' O ' ' A' ' 199' ' ' GLN . 4.7 tt -68.34 127.76 34.12 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 112.871 -1.664 . . . . 0.0 109.289 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.934 ' N ' HD23 ' A' ' 197' ' ' LEU . . . -59.4 -50.08 75.35 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 120.179 -0.608 . . . . 0.0 110.562 -178.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.975 ' O ' ' CD2' ' A' ' 197' ' ' LEU . 58.1 tt0 -132.82 157.89 43.88 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 114.757 -1.11 . . . . 0.0 113.443 -175.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.475 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 44.1 t -117.69 132.71 66.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -88.56 155.45 19.63 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.642 -178.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.4 -39.49 93.95 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 120.135 -0.626 . . . . 0.0 109.987 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -57.85 -31.48 66.71 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -178.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.5 m -61.18 -42.3 98.32 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.413 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.495 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -57.65 -37.85 74.06 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -177.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -60.83 -37.79 83.22 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.516 -0.473 . . . . 0.0 109.749 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -66.02 -38.58 88.79 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.108 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 94.6 mt -63.11 -44.54 99.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -178.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . 0.495 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 73.3 m-85 -62.18 -43.38 98.96 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.427 -178.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -62.06 -41.95 98.68 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 119.125 -1.03 . . . . 0.0 109.072 -178.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.708 HD21 ' CD2' ' A' ' 178' ' ' LEU . 39.4 mt -62.34 -41.78 98.85 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 78.2 p -61.74 -43.15 99.41 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 118.993 -1.083 . . . . 0.0 110.14 -179.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' HIS . . . . . 0.443 ' CE1' HD11 ' A' ' 217' ' ' LEU . 58.6 t-80 -64.14 -45.28 89.22 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.602 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.527 HD21 HD21 ' A' ' 182' ' ' LEU . 49.8 tp -62.19 -45.93 91.2 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 118.843 -1.143 . . . . 0.0 108.247 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 211' ' ' LEU . 88.0 mt -62.15 -41.03 97.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.423 -178.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -60.84 -44.78 96.52 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -177.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.443 HD11 ' CE1' ' A' ' 213' ' ' HIS . 85.3 mt -61.4 -40.04 92.93 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 67.4 p -75.55 -12.11 60.16 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.596 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.62 37.63 13.61 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 120.626 -0.797 . . . . 0.0 113.57 -178.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 91.9 m -123.92 114.64 20.09 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 119.02 1.41 . . . . 0.0 111.544 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -66.15 138.11 57.49 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.83 178.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 42.1 tp -114.02 130.11 56.57 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 4.0 mp -116.29 134.41 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 122.886 0.475 . . . . 0.0 109.741 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.576 ' CG2' HD11 ' A' ' 227' ' ' ILE . 49.0 mm -116.53 131.57 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -178.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 37.8 p -133.81 165.41 25.05 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -177.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 78.35 22.64 67.26 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.722 HD12 HG23 ' A' ' 247' ' ' THR . 97.8 mt -83.96 128.55 38.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 113.947 -1.127 . . . . 0.0 108.439 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 43.1 tttt -76.31 138.39 67.94 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.25 -39.5 86.32 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 121.044 1.162 . . . . 0.0 112.595 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -63.55 -40.0 95.88 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 121.416 0.627 . . . . 0.0 109.967 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 48.8 tp -63.66 -42.6 98.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.88 177.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.27 -37.42 87.41 Favored 'General case' 0 C--O 1.227 -0.12 0 C-N-CA 120.596 -0.441 . . . . 0.0 110.89 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 94.2 mtp -63.03 -41.13 99.45 Favored 'General case' 0 C--O 1.247 0.953 0 C-N-CA 120.004 -0.679 . . . . 0.0 109.742 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.38 -38.4 91.0 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.523 177.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 30.2 mmt -65.88 -37.5 86.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.688 178.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -61.18 -41.86 97.55 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.616 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -60.66 -40.65 92.84 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.573 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 55.6 tp -63.72 -41.03 98.15 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 177.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -169.19 125.95 0.93 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.369 0.604 . . . . 0.0 112.404 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.58 -27.36 66.2 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.893 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -61.45 -28.87 69.58 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.288 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -55.73 -44.48 77.58 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -177.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 96.8 p -61.43 -21.03 63.75 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 123.779 0.674 . . . . 0.0 111.287 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 40.6 m -55.04 -38.76 68.39 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 122.313 -0.242 . . . . 0.0 111.617 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 96.3 mt -84.19 120.36 26.11 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -44.63 134.73 5.27 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.047 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.722 HG23 HD12 ' A' ' 227' ' ' ILE . 96.8 m -128.61 133.83 48.41 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.905 178.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' TYR . . . . . 0.456 ' CB ' ' HB2' ' A' ' 254' ' ' ALA . 97.4 m-85 -117.7 140.05 50.19 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 114.953 -1.022 . . . . 0.0 110.959 179.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 78.0 p -60.23 -43.89 95.66 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -178.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -142.27 161.36 38.22 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.725 0.774 . . . . 0.0 111.79 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 77.4 t -62.46 -45.0 99.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 114.614 -1.175 . . . . 0.0 112.053 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -60.48 -44.31 96.04 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.193 -0.603 . . . . 0.0 109.561 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . 0.401 ' O ' HG22 ' A' ' 257' ' ' VAL . 54.3 m-20 -62.99 -43.72 98.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.668 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . 0.456 ' HB2' ' CB ' ' A' ' 248' ' ' TYR . . . -63.76 -43.25 96.98 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.94 0.876 . . . . 0.0 109.767 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . 0.557 HG13 HH11 ' B' ' 154' ' ' ARG . 56.9 t -63.37 -45.77 97.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 114.003 -1.453 . . . . 0.0 111.129 -177.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.46 -46.95 83.9 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 120.649 -0.421 . . . . 0.0 111.301 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.494 ' O ' ' C ' ' A' ' 258' ' ' LEU . 21.2 m -66.45 -41.1 88.11 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 O-C-N 121.539 -0.726 . . . . 0.0 112.005 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.494 ' C ' ' O ' ' A' ' 257' ' ' VAL . 1.9 mt -29.85 -72.85 0.05 OUTLIER Pre-proline 0 N--CA 1.466 0.328 0 CA-C-O 119.497 -0.287 . . . . 0.0 111.51 -177.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' PRO . . . . . 0.492 ' O ' HG13 ' A' ' 260' ' ' ILE . 44.7 Cg_endo -64.12 139.28 65.94 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 CA-C-N 119.635 0.905 . . . . 0.0 111.764 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.492 HG13 ' O ' ' A' ' 259' ' ' PRO . 96.5 mt -153.74 -25.03 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 O-C-N 123.638 0.586 . . . . 0.0 111.764 178.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 N--CA 1.475 0.811 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.68 -177.66 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.424 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.26 162.5 33.67 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 79.5 p -59.61 -21.8 60.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.779 177.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -74.67 -62.02 1.68 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 120.948 0.404 . . . . 0.0 111.361 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.72 -39.98 88.23 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.092 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . 0.503 ' O ' ' HB3' ' B' ' 7' ' ' PHE . 61.0 m -60.33 -42.59 95.95 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 119.98 -0.688 . . . . 0.0 109.833 -177.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . 0.51 ' CE2' HD12 ' B' ' 9' ' ' ILE . 36.7 t80 84.79 92.86 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.339 177.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . 0.559 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -65.46 -139.87 0.03 OUTLIER Glycine 0 C--N 1.338 0.678 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.559 ' HB ' ' O ' ' B' ' 8' ' ' GLY . 68.0 mt 81.61 108.35 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 122.567 0.347 . . . . 0.0 110.912 -178.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -62.94 -24.23 74.13 Favored 'Trans proline' 0 N--CA 1.499 1.814 0 C-N-CA 121.338 1.359 . . . . 0.0 111.711 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.95 -40.64 98.69 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -64.67 -39.35 93.53 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.763 0.792 . . . . 0.0 109.131 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 54.1 tp -62.41 -42.24 99.29 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.476 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -63.91 -32.39 73.91 Favored 'General case' 0 CA--C 1.562 1.431 0 CA-C-O 121.535 0.683 . . . . 0.0 110.525 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . 0.549 HG22 ' CD1' ' A' ' 113' ' ' ILE . 70.0 t -62.83 -46.22 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 113.237 -1.801 . . . . 0.0 111.007 176.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 93.3 mt -64.16 -43.96 97.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.007 -178.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . 0.611 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 99.0 mttt -63.55 -41.8 98.42 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -179.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.22 -41.22 99.09 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 119.01 -1.076 . . . . 0.0 109.973 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.37 -38.73 84.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.966 -178.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 86.0 mt -63.91 -41.97 97.55 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 121.359 0.6 . . . . 0.0 110.263 175.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -63.07 -38.73 92.35 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.192 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 56.5 m170 -57.83 -39.85 78.65 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 119.557 -0.259 . . . . 0.0 111.323 -178.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 12.3 p -114.04 129.94 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.526 ' O ' ' HG3' ' B' ' 24' ' ' ARG . 35.0 ptt180 -72.0 106.21 4.19 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.711 0.767 . . . . 0.0 112.447 -177.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.403 ' O ' HG13 ' B' ' 25' ' ' VAL . 6.6 p -142.01 133.68 26.69 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.86 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.816 177.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . 0.498 ' O ' ' N ' ' B' ' 123' ' ' GLN . . . -87.31 97.53 2.28 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 119.422 -1.37 . . . . 0.0 113.202 -176.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 49.4 t -126.41 129.07 71.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 174.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 30.0 m -138.44 156.23 29.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 121.014 -0.274 . . . . 0.0 110.429 178.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 95.8 mt -119.01 127.41 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.237 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.437 HG22 HG12 ' B' ' 39' ' ' ILE . 33.2 p -107.54 158.13 17.47 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-N 113.002 -1.908 . . . . 0.0 108.694 -177.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . 0.49 ' C ' ' OD1' ' B' ' 37' ' ' ASN . 64.1 t0 -125.18 103.07 30.09 Favored Pre-proline 0 C--O 1.236 0.381 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -178.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' PRO . . . . . 0.491 ' HG3' HG23 ' B' ' 117' ' ' THR . 37.1 Cg_endo -64.39 -21.76 66.37 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.723 1.616 . . . . 0.0 111.496 -178.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.02 -45.39 93.79 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.539 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 90.9 mt -71.23 179.45 2.85 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.913 -0.492 . . . . 0.0 111.676 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . 0.699 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 41.4 tt0 -77.13 129.67 36.31 Favored 'General case' 0 C--N 1.344 0.327 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -174.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.47 ' O ' ' C ' ' B' ' 37' ' ' ASN . 65.2 t0 58.01 38.14 26.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.461 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' ASN . . . . . 0.49 ' OD1' ' C ' ' B' ' 31' ' ' ASP . 24.3 t-20 27.69 69.73 0.49 Allowed Pre-proline 0 C--N 1.327 -0.413 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.699 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 92.1 Cg_endo -70.72 153.39 64.56 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 123.676 2.917 . . . . 0.0 111.635 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.437 HG12 HG22 ' B' ' 30' ' ' THR . 96.0 mt -84.46 129.93 36.84 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 18.0 m -109.55 -41.61 4.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 O-C-N 123.592 0.557 . . . . 0.0 112.339 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -96.81 123.62 40.56 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.506 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 5.8 p -142.38 140.61 28.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.222 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . 0.651 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 56.7 p30 -102.13 162.1 13.17 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.177 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' GLN . . . . . 0.489 ' OE1' ' HA ' ' B' ' 44' ' ' GLN . 13.8 mm100 -62.55 -38.12 88.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.379 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.35 -26.71 64.48 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.651 ' HB2' ' OD1' ' B' ' 43' ' ' ASN . 58.0 t80 -60.04 -43.61 95.23 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 0.738 HG13 ' O ' ' B' ' 52' ' ' TYR . 53.3 t -61.63 -46.4 96.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.091 -178.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -63.09 -45.02 94.05 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.262 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 60.3 ttm -62.75 -42.6 99.75 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 34.3 p -93.77 -17.63 22.93 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.968 -178.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' B' ' 47' ' ' VAL . . . 73.59 19.83 79.75 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 178.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . 0.738 ' O ' HG13 ' B' ' 47' ' ' VAL . 70.8 m-85 -112.08 145.64 39.38 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.244 -0.478 . . . . 0.0 110.172 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -74.39 148.96 40.73 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.684 0.754 . . . . 0.0 111.173 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.05 -38.15 87.65 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.698 -177.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.83 -39.94 95.89 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 120.238 -0.585 . . . . 0.0 111.854 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -73.76 -32.89 64.04 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.613 HD13 ' CD2' ' B' ' 46' ' ' PHE . 93.4 mt -66.2 -72.12 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 95.6 mt -37.19 131.82 0.79 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.71 175.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.28 -12.22 66.77 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.957 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -133.98 149.92 51.24 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.358 0.599 . . . . 0.0 112.595 -174.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' ASN . . . . . 0.509 ' C ' ' H ' ' B' ' 63' ' ' ARG . 25.9 t-20 -77.66 153.31 33.23 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.8 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' CYS . . . . . . . . . . . . . 84.6 m -64.91 9.12 0.1 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.524 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' ARG . . . . . 0.509 ' H ' ' C ' ' B' ' 61' ' ' ASN . 33.5 ptt-85 -58.72 -32.04 68.83 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.719 -178.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -60.33 -31.06 69.94 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 85.4 mt -61.82 -42.53 99.14 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -178.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -50.0 146.01 5.16 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 123.624 0.577 . . . . 0.0 109.764 -178.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . 0.546 ' N ' ' OG1' ' B' ' 70' ' ' THR . . . -156.19 -152.24 6.19 Favored Glycine 0 CA--C 1.54 1.656 0 CA-C-N 115.1 -0.955 . . . . 0.0 112.773 175.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -60.19 -40.76 91.17 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.576 -0.312 . . . . 0.0 111.64 -175.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -76.36 -9.27 58.52 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 123.092 0.245 . . . . 0.0 111.434 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' THR . . . . . 0.546 ' OG1' ' N ' ' B' ' 67' ' ' GLY . 26.5 m -61.25 134.3 56.84 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -91.78 110.84 46.33 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.162 -178.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.43 -39.02 89.5 Favored 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 121.035 1.157 . . . . 0.0 111.917 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.74 -41.12 90.23 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 120.508 -0.477 . . . . 0.0 109.871 -176.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' GLU . . . . . 0.443 ' OE1' ' HB ' ' B' ' 90' ' ' VAL . 79.0 mm-40 -66.36 -38.96 88.78 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.752 177.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 85.9 t -61.88 -46.26 96.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -63.21 -36.84 84.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.751 -178.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -62.24 -42.12 99.03 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 119.168 -1.013 . . . . 0.0 108.642 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 95.0 mt -63.53 -43.49 98.33 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 CA-C-O 120.751 0.31 . . . . 0.0 110.574 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -62.1 -42.54 99.32 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 94.9 m -61.65 -45.79 92.52 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.137 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.49 -41.49 97.34 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -177.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 86.0 mt -62.95 -42.57 99.86 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -178.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 66.8 tp60 -62.84 -33.86 76.12 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -91.39 8.28 36.99 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.498 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 37.9 tttt 40.05 41.6 0.95 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.403 -0.519 . . . . 0.0 111.946 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -124.45 140.91 36.27 Favored Pre-proline 0 N--CA 1.47 0.57 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.171 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -61.99 141.11 88.07 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 120.99 1.127 . . . . 0.0 113.827 -178.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -139.78 136.14 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.325 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 89' ' ' THR . . . . . 0.902 HG23 ' OD1' ' B' ' 107' ' ' ASN . 92.6 m -120.12 121.26 38.42 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.831 178.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.443 ' HB ' ' OE1' ' B' ' 74' ' ' GLU . 29.2 m -139.09 162.99 27.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.978 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -113.49 119.58 38.06 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.153 0.502 . . . . 0.0 109.694 175.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 20.8 tt -126.42 131.99 70.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.144 -175.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . 0.488 ' O ' ' ND2' ' B' ' 94' ' ' ASN . 85.5 mt-30 -72.56 145.57 47.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.194 177.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 94' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' B' ' 93' ' ' GLN . 8.7 m120 -138.54 -179.67 5.94 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 121.359 0.6 . . . . 0.0 110.61 -177.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 95' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -129.62 148.26 51.5 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.525 177.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . 0.468 ' HG3' ' CE1' ' B' ' 102' ' ' PHE . 98.8 mttt -104.71 -179.08 3.84 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.02 0.438 . . . . 0.0 110.59 178.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.31 -36.25 77.48 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.211 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 37.6 p-10 -87.45 -1.29 57.82 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.931 0.787 . . . . 0.0 112.832 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.99 5.07 64.45 Favored Glycine 0 N--CA 1.466 0.69 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.249 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 26.5 m -67.32 128.38 36.18 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.305 177.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 101' ' ' MET . . . . . 0.663 ' SD ' ' N ' ' B' ' 102' ' ' PHE . 13.9 tmm? -87.5 143.5 27.19 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 102' ' ' PHE . . . . . 0.663 ' N ' ' SD ' ' B' ' 101' ' ' MET . 53.2 p90 -154.86 163.86 39.66 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 103' ' ' TRP . . . . . 0.934 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 24.5 m95 -96.72 137.4 35.86 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.944 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . 0.507 HD21 ' HG2' ' B' ' 123' ' ' GLN . 62.7 t-20 -132.17 110.84 10.95 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 114.904 -1.043 . . . . 0.0 113.686 -176.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -80.4 124.52 28.96 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 123.842 0.713 . . . . 0.0 109.185 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 39.8 tp -111.25 125.29 53.66 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.002 0.429 . . . . 0.0 111.824 -177.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 107' ' ' ASN . . . . . 0.902 ' OD1' HG23 ' B' ' 89' ' ' THR . 97.9 m-20 -120.05 126.73 51.51 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 176.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 96.4 mt -122.79 133.33 69.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -143.23 123.39 7.85 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -70.0 151.92 67.88 Favored 'Trans proline' 0 N--CA 1.504 2.119 0 C-N-CA 122.657 2.238 . . . . 0.0 112.582 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . 0.506 ' HB2' ' HB2' ' B' ' 118' ' ' TYR . 67.1 mtt -128.28 143.76 51.06 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -113.79 107.28 15.52 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . 0.585 HG12 ' NZ ' ' A' ' 18' ' ' LYS . 96.6 mt -134.62 127.77 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 O-C-N 121.811 -0.556 . . . . 0.0 112.071 178.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 51.15 38.5 21.14 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 123.834 0.709 . . . . 0.0 109.814 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 61.21 35.42 18.36 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.526 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -132.58 149.07 52.37 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 117' ' ' THR . . . . . 0.491 HG23 ' HG3' ' B' ' 32' ' ' PRO . 10.0 t -101.64 153.62 19.6 Favored 'General case' 0 C--O 1.214 -0.775 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -178.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 118' ' ' TYR . . . . . 0.506 ' HB2' ' HB2' ' B' ' 111' ' ' MET . 96.9 m-85 -148.13 147.55 29.61 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 121.317 -0.864 . . . . 0.0 111.497 -178.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -122.27 137.93 54.67 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 123.626 0.579 . . . . 0.0 110.9 -177.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -127.32 133.99 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -177.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.94 122.87 6.72 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 94.6 mt -113.52 127.45 70.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 123' ' ' GLN . . . . . 0.507 ' HG2' HD21 ' B' ' 104' ' ' ASN . 17.8 mp0 -118.45 121.6 40.71 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -121.42 119.34 31.8 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' B' ' 126' ' ' ILE . 67.9 t0 -68.31 135.54 52.05 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.57 -177.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.528 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 2.8 mp -107.41 17.72 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.512 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 127' ' ' THR . . . . . 0.5 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 97.5 m -63.95 -44.15 93.68 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 114.439 -1.255 . . . . 0.0 112.687 177.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -62.18 -45.85 91.55 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -177.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 129' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -62.58 -35.1 78.42 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.43 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 130' ' ' LYS . . . . . 0.934 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 98.6 mttt -63.64 -41.33 98.25 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-N 112.817 -1.992 . . . . 0.0 110.728 175.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.71 -41.64 95.85 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 132' ' ' TYR . . . . . 0.766 ' CE2' HD11 ' B' ' 136' ' ' LEU . 90.0 t80 -60.47 -44.57 95.75 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.831 -0.543 . . . . 0.0 111.566 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' B' ' 137' ' ' GLU . 97.0 mt-10 -64.47 -36.35 83.9 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.55 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.27 -39.16 93.82 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.833 177.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.76 -41.24 99.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.565 0.698 . . . . 0.0 109.378 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 136' ' ' LEU . . . . . 0.766 HD11 ' CE2' ' B' ' 132' ' ' TYR . 84.5 mt -63.0 -41.67 99.65 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.453 178.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 137' ' ' GLU . . . . . 0.411 ' HG3' ' O ' ' B' ' 133' ' ' GLU . 97.1 mt-10 -65.28 -37.51 87.41 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 113.523 -1.672 . . . . 0.0 110.229 -178.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -63.43 -43.36 97.66 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.055 176.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 65.6 m -60.64 -44.57 96.23 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' B' ' 144' ' ' THR . 86.1 mt -61.5 -40.13 93.5 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -177.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 95.4 m -61.67 -45.65 93.09 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.994 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -66.38 -42.6 87.69 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 93.8 mt -63.58 -43.5 98.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 114.438 -1.256 . . . . 0.0 110.591 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 144' ' ' THR . . . . . 0.417 ' N ' ' O ' ' B' ' 140' ' ' LEU . 91.0 m -61.76 -45.07 95.47 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.65 -41.08 96.36 Favored 'General case' 0 C--O 1.226 -0.149 0 C-N-CA 119.161 -1.016 . . . . 0.0 109.435 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.87 -41.18 95.86 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 176.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 147' ' ' SER . . . . . 0.575 ' O ' ' N ' ' B' ' 149' ' ' PRO . 78.3 p -62.44 -41.82 99.01 Favored 'General case' 0 CA--C 1.478 -1.79 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 148' ' ' THR . . . . . 0.488 ' C ' ' O ' ' B' ' 147' ' ' SER . 7.1 m -26.1 86.45 0.04 OUTLIER Pre-proline 0 N--CA 1.482 1.148 0 O-C-N 124.196 0.935 . . . . 0.0 110.425 176.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 149' ' ' PRO . . . . . 0.575 ' N ' ' O ' ' B' ' 147' ' ' SER . 24.1 Cg_exo -60.8 145.96 98.16 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 121.613 1.542 . . . . 0.0 115.342 -176.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 9.4 tp -127.68 119.83 52.78 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.828 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 172.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 61.0 t -150.25 94.88 3.65 Favored Pre-proline 0 C--N 1.303 -1.418 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.064 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -62.28 143.03 93.43 Favored 'Trans proline' 0 N--CA 1.485 0.983 0 N-CA-C 109.512 -0.995 . . . . 0.0 109.512 -179.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 153' ' ' ILE . . . . . 0.564 HG21 HH12 ' A' ' 154' ' ' ARG . 44.1 mm -76.19 -66.52 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 154' ' ' ARG . . . . . 0.725 ' HD3' ' NH2' ' A' ' 154' ' ' ARG . 4.4 mpt_? -132.06 -157.92 0.85 Allowed 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 62.5 t-20 -83.98 110.39 18.39 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.06 -18.23 55.98 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -178.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 86.4 mt -108.34 124.61 64.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.993 0.425 . . . . 0.0 111.068 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 158' ' ' SER . . . . . 0.625 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 67.0 m -135.98 149.65 48.94 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.74 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -133.83 145.67 49.94 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 22.7 tp -137.28 80.22 34.64 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 161' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -72.19 149.63 52.12 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.623 2.215 . . . . 0.0 114.048 -177.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 92.1 mt -115.29 134.52 55.05 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 55.5 t -129.98 132.66 65.4 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 113.98 169.59 16.79 Favored Glycine 0 N--CA 1.47 0.911 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.48 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 165' ' ' ASN . . . . . 0.683 ' O ' ' CZ ' ' B' ' 170' ' ' ARG . 62.9 t30 -89.97 107.39 19.09 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -177.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 166' ' ' LEU . . . . . 0.613 HD21 ' CZ ' ' B' ' 171' ' ' PHE . 44.0 tp -64.55 104.49 0.8 Allowed 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -175.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 167' ' ' THR . . . . . 0.685 HG23 ' NE ' ' B' ' 170' ' ' ARG . 10.5 p -84.19 169.74 14.49 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-N 114.116 -1.402 . . . . 0.0 110.894 177.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -66.92 -37.42 84.29 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.637 177.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.86 -40.39 87.85 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-O 122.119 0.961 . . . . 0.0 111.554 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 170' ' ' ARG . . . . . 0.685 ' NE ' HG23 ' B' ' 167' ' ' THR . 88.0 mtm180 -62.48 -35.98 81.04 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 112.762 -2.017 . . . . 0.0 111.248 178.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 171' ' ' PHE . . . . . 0.613 ' CZ ' HD21 ' B' ' 166' ' ' LEU . 0.5 OUTLIER -54.82 -25.64 29.78 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -178.686 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 172' ' ' ASN . . . . . 0.534 ' O ' HG22 ' B' ' 175' ' ' VAL . 91.9 m-20 -62.67 -40.26 96.52 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.804 178.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 49.2 m -60.52 -41.48 94.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.145 0.498 . . . . 0.0 110.801 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 65.9 mt -63.86 -44.03 97.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 175' ' ' VAL . . . . . 0.534 HG22 ' O ' ' B' ' 172' ' ' ASN . 33.3 m -62.54 -40.21 87.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 176' ' ' CYS . . . . . 0.418 ' N ' HG23 ' B' ' 175' ' ' VAL . 99.9 m -62.02 -35.23 77.94 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.381 178.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 177' ' ' THR . . . . . 0.556 ' O ' HG13 ' B' ' 181' ' ' ILE . 24.7 m -61.32 -20.27 62.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.938 0.399 . . . . 0.0 110.184 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 178' ' ' LEU . . . . . 0.672 ' CD2' HD21 ' B' ' 211' ' ' LEU . 87.8 mt -61.1 -39.47 90.08 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.281 -177.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 19.0 m -61.85 -44.4 96.91 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.322 177.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 180' ' ' ASN . . . . . 0.575 ' O ' ' OG ' ' B' ' 183' ' ' SER . 92.9 m-20 -61.88 -40.73 96.4 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.802 0.334 . . . . 0.0 110.411 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.556 HG13 ' O ' ' B' ' 177' ' ' THR . 75.1 mt -55.69 -31.2 28.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 C-N-CA 120.916 -0.314 . . . . 0.0 110.897 -178.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 182' ' ' LEU . . . . . 0.514 HD21 HD21 ' B' ' 214' ' ' LEU . 85.1 mt -62.8 -42.08 99.56 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.328 177.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . 0.575 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.2 p -62.91 -32.85 74.22 Favored 'General case' 0 N--CA 1.455 -0.183 0 O-C-N 122.004 -0.435 . . . . 0.0 110.89 177.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 184' ' ' THR . . . . . 0.427 ' OG1' ' HA ' ' B' ' 181' ' ' ILE . 21.0 p -85.49 16.09 4.05 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.77 0.319 . . . . 0.0 111.775 -178.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 79.2 p -59.68 -17.52 34.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.034 -177.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.78 -40.52 95.49 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.683 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 187' ' ' ASP . . . . . 0.625 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.2 m-20 -69.31 113.34 6.55 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.519 0.676 . . . . 0.0 110.632 -178.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -62.7 -41.96 99.39 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-N 114.807 -1.088 . . . . 0.0 113.154 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -112.49 130.45 55.99 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.2 -178.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 190' ' ' LEU . . . . . . . . . . . . . 41.1 tp -124.07 118.73 27.61 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.025 177.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 86.6 mt -107.12 126.82 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-O 120.608 0.242 . . . . 0.0 111.416 -177.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 49.2 mm -115.66 117.53 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 193' ' ' ASP . . . . . 0.503 ' CG ' ' HG ' ' B' ' 195' ' ' SER . 41.2 t0 -88.49 109.74 20.29 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.04 0.448 . . . . 0.0 112.11 -177.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 194' ' ' LEU . . . . . . . . . . . . . 96.3 mt -90.34 -3.53 57.68 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.517 176.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 195' ' ' SER . . . . . 0.503 ' HG ' ' CG ' ' B' ' 193' ' ' ASP . 78.1 p -61.46 -36.68 81.12 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.896 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.04 -33.24 83.26 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 197' ' ' LEU . . . . . 1.01 HD23 ' N ' ' B' ' 198' ' ' ALA . 4.8 tt -78.38 132.83 37.53 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 122.163 -0.61 . . . . 0.0 109.489 -177.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 198' ' ' ALA . . . . . 1.01 ' N ' HD23 ' B' ' 197' ' ' LEU . . . -63.15 -44.21 96.15 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 119.454 -0.899 . . . . 0.0 110.765 -177.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 199' ' ' GLN . . . . . 0.972 ' O ' ' CD2' ' B' ' 197' ' ' LEU . 58.0 tt0 -137.58 165.99 25.0 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.778 0.799 . . . . 0.0 112.947 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 200' ' ' VAL . . . . . 0.524 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 47.3 t -121.46 132.07 71.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 O-C-N 120.716 -1.24 . . . . 0.0 109.384 177.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -91.09 149.26 21.89 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.15 0.5 . . . . 0.0 110.979 -178.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.22 -32.92 71.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.414 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -64.79 -32.26 73.87 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.4 m -60.3 -44.33 95.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.572 178.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 205' ' ' ALA . . . . . 0.706 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -58.51 -28.31 65.3 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -65.42 -38.68 90.64 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.224 0.535 . . . . 0.0 109.874 176.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -67.52 -38.08 83.74 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.934 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 96.3 mt -63.61 -43.42 98.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.208 0.527 . . . . 0.0 109.866 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 209' ' ' PHE . . . . . 0.706 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 71.7 m-85 -62.19 -42.99 99.8 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.275 -1.33 . . . . 0.0 112.859 177.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -63.52 -41.35 98.5 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 119.492 -0.883 . . . . 0.0 109.545 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 211' ' ' LEU . . . . . 0.672 HD21 ' CD2' ' B' ' 178' ' ' LEU . 40.2 mt -62.54 -42.37 99.49 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.33 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 78.2 p -63.14 -36.66 84.36 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.224 -0.59 . . . . 0.0 111.873 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 213' ' ' HIS . . . . . 0.414 ' CE1' HD11 ' B' ' 217' ' ' LEU . 58.8 t-80 -67.58 -46.36 72.89 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 115.362 -0.836 . . . . 0.0 112.204 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.514 HD21 HD21 ' B' ' 182' ' ' LEU . 52.8 tp -63.77 -42.73 97.74 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.963 0.887 . . . . 0.0 109.994 177.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 215' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' B' ' 211' ' ' LEU . 89.6 mt -62.94 -44.06 97.1 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 113.454 -1.703 . . . . 0.0 111.708 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.33 -39.47 93.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.743 -176.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . 0.414 HD11 ' CE1' ' B' ' 213' ' ' HIS . 86.1 mt -63.79 -42.11 97.79 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.349 0.595 . . . . 0.0 111.434 176.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 218' ' ' THR . . . . . 0.425 HG23 ' O ' ' B' ' 214' ' ' LEU . 68.6 p -74.42 -17.58 60.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.063 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 80.61 69.42 1.4 Allowed Glycine 0 CA--C 1.528 0.87 0 N-CA-C 106.424 -2.67 . . . . 0.0 106.424 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 220' ' ' THR . . . . . . . . . . . . . 96.7 m -149.02 101.4 3.16 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 177.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -59.59 140.08 56.64 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.907 0.384 . . . . 0.0 111.055 -176.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 42.7 tp -117.54 121.62 41.46 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.313 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 4.3 mp -109.09 128.72 64.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.155 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 224' ' ' ILE . . . . . 0.525 ' CG2' HD11 ' B' ' 227' ' ' ILE . 49.8 mm -109.86 127.3 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.573 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 43.3 p -133.16 158.15 43.54 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.574 0.702 . . . . 0.0 112.684 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 88.44 19.98 50.2 Favored Glycine 0 CA--C 1.499 -0.943 0 CA-C-N 113.762 -1.563 . . . . 0.0 111.175 -178.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 227' ' ' ILE . . . . . 0.768 HD12 HG23 ' B' ' 247' ' ' THR . 95.9 mt -83.84 125.69 40.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 O-C-N 122.12 -0.635 . . . . 0.0 111.464 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 37.4 tttt -65.51 138.67 96.95 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.494 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.2 -37.02 94.56 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 121.424 1.416 . . . . 0.0 112.538 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -64.16 -43.34 95.46 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 50.5 tp -61.92 -41.61 98.13 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.826 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.13 -36.19 83.23 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.735 0.302 . . . . 0.0 111.286 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 94.7 mtp -64.15 -40.53 96.34 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.26 -42.41 99.15 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 122.085 0.945 . . . . 0.0 109.219 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 30.4 mmt -64.06 -35.42 80.66 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 114.625 -1.171 . . . . 0.0 112.102 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -62.26 -40.24 95.55 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.891 -177.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.07 -44.11 96.69 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.09 178.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.08 -44.95 95.56 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 120.383 -0.527 . . . . 0.0 112.303 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -158.88 133.82 8.26 Favored 'General case' 0 CA--C 1.51 -0.577 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.888 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 240' ' ' ALA . . . . . . . . . . . . . . . -62.61 -47.43 83.79 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 177.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 241' ' ' ASN . . . . . 0.465 ' O ' ' HB2' ' B' ' 244' ' ' SER . 90.2 m-20 -41.65 -19.71 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.477 -176.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 242' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -61.9 -44.87 95.89 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.816 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 243' ' ' SER . . . . . 0.432 ' O ' ' N ' ' B' ' 245' ' ' LEU . 78.1 p -57.87 -44.68 86.79 Favored 'General case' 0 C--N 1.345 0.377 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 244' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 18.0 m -29.43 -36.36 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . 0.432 ' N ' ' O ' ' B' ' 243' ' ' SER . 96.4 mt -89.18 133.37 34.44 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.369 -178.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -61.48 134.48 56.92 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 121.155 0.502 . . . . 0.0 110.474 -176.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 247' ' ' THR . . . . . 0.768 HG23 HD12 ' B' ' 227' ' ' ILE . 95.0 m -126.34 128.52 47.21 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.047 -0.978 . . . . 0.0 111.923 178.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 248' ' ' TYR . . . . . 0.477 ' CG ' ' HB2' ' B' ' 254' ' ' ALA . 97.5 m-85 -112.89 144.96 41.57 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 249' ' ' SER . . . . . 0.59 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 78.2 p -63.76 -33.54 75.89 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.818 -178.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 250' ' ' ASN . . . . . 0.59 ' OD1' ' O ' ' B' ' 249' ' ' SER . 99.3 m-20 -148.45 160.36 43.13 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.049 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 79.2 t -64.63 -44.21 96.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.046 178.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 252' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -61.29 -46.11 91.7 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . 0.438 ' O ' HG13 ' B' ' 257' ' ' VAL . 92.9 m-20 -61.07 -43.75 98.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.835 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 254' ' ' ALA . . . . . 0.477 ' HB2' ' CG ' ' B' ' 248' ' ' TYR . . . -65.77 -40.5 92.06 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 120.069 -0.652 . . . . 0.0 111.299 178.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 255' ' ' VAL . . . . . 0.603 HG13 HH11 ' A' ' 154' ' ' ARG . 56.9 t -64.72 -45.75 94.27 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.07 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -63.01 -47.72 81.9 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 119.906 -0.718 . . . . 0.0 111.487 -178.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 257' ' ' VAL . . . . . 0.441 ' O ' ' C ' ' B' ' 258' ' ' LEU . 18.8 m -64.73 -40.41 88.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.533 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 258' ' ' LEU . . . . . 0.485 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 1.7 mt -33.79 -71.33 0.1 Allowed Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.479 -177.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 259' ' ' PRO . . . . . 0.569 ' O ' HG13 ' B' ' 260' ' ' ILE . 37.6 Cg_endo -62.39 139.91 79.49 Favored 'Trans proline' 0 N--CA 1.501 1.965 0 C-N-CA 121.418 1.412 . . . . 0.0 111.193 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 260' ' ' ILE . . . . . 0.569 HG13 ' O ' ' B' ' 259' ' ' PRO . 96.6 mt -159.62 -13.48 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 CA-C-N 118.713 0.688 . . . . 0.0 112.361 176.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 C--O 1.216 -0.686 0 CA-C-O 117.859 -1.067 . . . . 0.0 111.436 -179.983 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.13 170.76 20.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.144 0.497 . . . . 0.0 110.196 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 80.1 p -72.66 -14.71 61.65 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.36 -0.837 . . . . 0.0 111.788 177.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -76.32 -66.59 0.78 Allowed 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 114.326 -1.306 . . . . 0.0 112.966 174.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -66.94 -39.64 87.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.908 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.539 ' O ' ' NZ ' ' B' ' 17' ' ' LYS . 49.8 m -59.25 -41.37 88.63 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -177.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.567 ' CE2' HD12 ' A' ' 9' ' ' ILE . 36.1 t80 84.37 88.23 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.127 0.489 . . . . 0.0 112.034 177.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.47 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -62.19 -137.74 0.01 OUTLIER Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 -177.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.567 HD12 ' CE2' ' A' ' 7' ' ' PHE . 55.8 mt 79.02 109.81 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 122.679 0.392 . . . . 0.0 110.637 -178.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.59 -22.06 70.43 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 121.438 1.425 . . . . 0.0 112.138 -178.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.464 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -63.28 -37.46 94.9 Favored Glycine 0 N--CA 1.468 0.83 0 C-N-CA 121.045 -0.598 . . . . 0.0 111.862 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -66.14 -39.31 89.75 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.514 0.673 . . . . 0.0 109.519 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.1 tp -63.33 -41.46 98.89 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -63.65 -39.9 95.49 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 11' ' ' GLY . 67.9 t -60.03 -44.19 94.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 O-C-N 122.174 -0.329 . . . . 0.0 110.938 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 93.0 mt -62.49 -43.57 98.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 119.589 -0.844 . . . . 0.0 109.321 -178.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.444 ' NZ ' ' HA ' ' B' ' 6' ' ' SER . 98.9 mttt -62.28 -46.19 89.88 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 119.361 -0.936 . . . . 0.0 112.022 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.661 ' HZ1' HG12 ' B' ' 113' ' ' ILE . 98.4 mttt -60.46 -39.54 87.96 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 118.642 -1.223 . . . . 0.0 109.079 -176.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.58 -42.2 91.94 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.144 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.2 mt -62.95 -40.15 96.8 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 177.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.19 -39.39 94.51 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.479 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 60.7 m170 -59.29 -39.42 82.92 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 122.226 -0.297 . . . . 0.0 111.606 -178.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.8 p -113.76 130.64 67.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.49 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 34.6 ptt180 -73.41 109.99 7.35 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-O 122.062 0.934 . . . . 0.0 112.187 -177.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.9 p -141.29 143.75 27.37 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.579 ' O ' ' N ' ' A' ' 123' ' ' GLN . . . -98.91 91.2 1.07 Allowed Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.908 -178.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 52.6 t -124.55 130.45 73.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 175.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.8 m -136.62 159.73 37.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.4 mt -120.43 129.55 75.43 Favored 'Isoleucine or valine' 0 C--O 1.244 0.797 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.467 HG22 HG12 ' A' ' 39' ' ' ILE . 22.4 p -106.56 167.48 9.82 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.425 ' C ' ' OD1' ' A' ' 37' ' ' ASN . 58.6 t0 -133.15 104.13 12.6 Favored Pre-proline 0 C--N 1.321 -0.66 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.251 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.697 ' HG3' HG23 ' A' ' 117' ' ' THR . 36.0 Cg_endo -63.4 -24.59 71.15 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.414 1.409 . . . . 0.0 111.501 -178.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.95 -35.75 81.17 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.17 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.4 mt -84.13 157.47 21.69 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.849 178.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.709 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 43.4 tt0 -57.46 134.59 56.2 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 113.361 0.875 . . . . 0.0 113.361 -176.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.526 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 59.2 t0 60.54 23.67 13.36 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.425 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 40.6 t-20 39.23 69.2 1.73 Allowed Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.181 -176.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.709 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 93.3 Cg_endo -70.19 155.31 64.83 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 123.95 3.1 . . . . 0.0 112.123 -178.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.467 HG12 HG22 ' A' ' 30' ' ' THR . 96.0 mt -88.95 122.07 39.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.466 HG23 ' N ' ' A' ' 41' ' ' TYR . 30.3 m -102.01 -45.97 11.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.243 -178.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.466 ' N ' HG23 ' A' ' 40' ' ' VAL . 48.9 t80 -93.72 124.36 37.67 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 120.185 -0.606 . . . . 0.0 111.949 -178.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.7 p -143.09 140.27 27.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.226 0.953 . . . . 0.0 109.217 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.614 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 56.9 p30 -96.49 166.43 11.69 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.474 ' OE1' ' HA ' ' A' ' 44' ' ' GLN . 14.9 mm100 -66.55 -39.82 88.72 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 177.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.89 -24.25 60.12 Favored Glycine 0 N--CA 1.453 -0.209 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.631 ' CD2' HD13 ' A' ' 57' ' ' ILE . 65.5 t80 -59.61 -47.86 83.92 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 -179.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.579 HG13 ' O ' ' A' ' 52' ' ' TYR . 71.4 t -58.96 -44.54 91.24 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.646 0 O-C-N 121.301 -0.875 . . . . 0.0 111.745 -174.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -63.25 -37.29 86.68 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 120.399 -0.52 . . . . 0.0 112.301 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 59.2 ttm -66.79 -43.38 84.1 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 176.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 36.3 p -93.51 -21.18 19.62 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.346 0.593 . . . . 0.0 111.541 -177.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . 76.44 20.46 76.88 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -179.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.579 ' O ' HG13 ' A' ' 47' ' ' VAL . 82.1 m-85 -113.25 137.08 52.01 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 122.783 0.433 . . . . 0.0 111.12 178.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -62.62 146.99 50.65 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.558 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.426 HG22 ' H ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -64.84 -32.9 74.82 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -179.485 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -66.69 -43.1 85.31 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.516 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -64.67 -45.65 85.77 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.073 -0.651 . . . . 0.0 109.252 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.631 HD13 ' CD2' ' A' ' 46' ' ' PHE . 89.1 mt -61.26 -49.84 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -175.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.1 mt -55.53 148.27 16.02 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 176.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.28 -3.44 77.38 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.873 -0.679 . . . . 0.0 113.062 177.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -137.15 151.41 48.78 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 118.705 1.252 . . . . 0.0 112.037 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.575 ' C ' ' H ' ' A' ' 63' ' ' ARG . 25.1 t-20 -81.77 151.71 27.31 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.553 -178.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 79.2 m -62.09 15.39 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.373 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.575 ' H ' ' C ' ' A' ' 61' ' ' ASN . 35.2 ptt-85 -62.21 -41.41 98.34 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.139 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -56.04 -21.99 24.81 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.2 mt -67.33 -35.73 80.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 122.066 0.936 . . . . 0.0 112.916 177.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -63.21 146.38 53.51 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.847 -1.069 . . . . 0.0 112.263 -178.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.496 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -156.54 -150.93 5.8 Favored Glycine 0 CA--C 1.538 1.519 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -177.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.75 -41.29 99.14 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.432 ' O ' ' OE1' ' A' ' 93' ' ' GLN . 11.1 m-70 -76.21 -9.08 58.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.847 0.356 . . . . 0.0 110.916 -178.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.496 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 32.9 m -62.62 128.69 37.14 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.595 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -84.75 110.99 31.8 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.825 -179.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -57.29 -31.09 89.88 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 121.997 1.798 . . . . 0.0 113.207 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.5 -39.31 93.54 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.888 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.571 ' OE1' ' HB ' ' A' ' 90' ' ' VAL . 79.1 mm-40 -65.45 -44.43 87.28 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.0 t -59.31 -44.1 91.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -176.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -63.97 -38.19 90.17 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.004 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -63.68 -39.6 94.73 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.403 0.621 . . . . 0.0 110.24 178.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 94.1 mt -63.71 -44.12 98.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.053 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -62.88 -42.52 99.8 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 113.814 -1.539 . . . . 0.0 108.309 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 97.6 m -61.24 -49.37 77.37 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.65 -42.46 92.87 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.189 -172.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.5 mt -63.45 -39.56 94.79 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.007 -1.058 . . . . 0.0 111.492 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -64.06 -33.16 75.12 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -89.08 -2.63 58.64 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.381 -178.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.2 tttt 49.22 40.78 18.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.59 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -122.69 144.26 42.11 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -61.32 142.88 97.37 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 121.473 1.448 . . . . 0.0 113.543 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -139.75 141.63 34.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.589 -178.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.93 HG23 ' OD1' ' A' ' 107' ' ' ASN . 98.8 m -128.12 120.05 26.57 Favored 'General case' 0 C--N 1.344 0.332 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 175.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.571 ' HB ' ' OE1' ' A' ' 74' ' ' GLU . 28.4 m -138.85 158.7 30.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.465 178.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -101.76 132.39 47.51 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 177.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.453 HG23 ' O ' ' A' ' 92' ' ' ILE . 19.2 tt -139.99 129.44 28.29 Favored 'Isoleucine or valine' 0 C--N 1.377 1.789 0 CA-C-N 121.557 1.98 . . . . 0.0 112.527 176.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.432 ' OE1' ' O ' ' A' ' 69' ' ' HIS . 86.1 mt-30 -62.98 133.45 54.63 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.55 -1.205 . . . . 0.0 109.948 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -134.48 158.33 44.19 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.758 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.428 ' CE1' ' HA3' ' A' ' 67' ' ' GLY . 92.7 m-85 -116.16 135.13 54.2 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -179.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.438 ' HG3' ' CE1' ' A' ' 102' ' ' PHE . 99.2 mttt -83.69 -172.51 4.19 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.161 0.505 . . . . 0.0 111.618 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.05 -42.26 99.66 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.158 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 41.0 p-10 -83.31 5.84 21.84 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.51 -0.65 88.39 Favored Glycine 0 N--CA 1.47 0.925 0 O-C-N 121.547 -0.721 . . . . 0.0 112.126 176.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.1 m -59.83 138.32 57.83 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.649 ' SD ' ' C ' ' A' ' 101' ' ' MET . 14.9 tmm? -104.45 128.75 52.42 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.561 0.22 . . . . 0.0 110.782 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.438 ' CE1' ' HG3' ' A' ' 96' ' ' LYS . 52.7 p90 -141.44 158.55 43.72 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.888 -176.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.638 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 20.7 m95 -90.81 141.29 28.96 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.571 HD21 ' HG2' ' A' ' 123' ' ' GLN . 53.1 t-20 -136.41 106.8 6.44 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -177.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.443 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 80.5 tt0 -72.37 134.9 45.7 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 -177.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 43.9 tp -120.78 123.07 41.76 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASN . . . . . 0.93 ' OD1' HG23 ' A' ' 89' ' ' THR . 98.0 m-20 -118.68 123.86 45.96 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.866 177.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 96.3 mt -120.21 128.45 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 O-C-N 123.525 0.516 . . . . 0.0 111.57 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -137.96 123.09 12.35 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 116.764 -0.198 . . . . 0.0 110.925 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -70.26 150.85 65.76 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.454 2.103 . . . . 0.0 112.578 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . 0.634 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 66.3 mtt -122.67 152.63 40.34 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -127.23 91.51 3.33 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 177.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.411 ' CD1' HG22 ' B' ' 15' ' ' VAL . 96.7 mt -117.81 130.57 72.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.275 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 53.31 36.56 23.13 Favored 'General case' 0 CA--C 1.513 -0.472 0 O-C-N 121.461 -0.774 . . . . 0.0 111.648 176.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 59.21 30.62 20.41 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 123.853 0.721 . . . . 0.0 110.813 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -127.52 149.55 50.08 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.782 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 9.9 t -85.79 -173.11 4.45 Favored 'General case' 0 C--O 1.219 -0.504 0 O-C-N 121.687 -0.633 . . . . 0.0 109.489 -178.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' TYR . . . . . 0.782 ' CD2' ' O ' ' A' ' 117' ' ' THR . 69.0 m-85 -171.9 155.71 3.92 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 174.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -131.51 146.34 52.18 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 174.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.87 135.1 55.57 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 177.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -106.9 127.27 8.78 Favored Glycine 0 CA--C 1.502 -0.765 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 177.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 96.3 mt -117.89 129.27 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.579 ' N ' ' O ' ' A' ' 26' ' ' GLY . 15.9 mp0 -120.18 115.74 24.24 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 123.69 0.619 . . . . 0.0 109.793 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -115.35 113.14 23.4 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.817 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.401 ' OD1' ' C ' ' A' ' 125' ' ' ASP . 68.4 t0 -65.77 123.23 19.2 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -175.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.519 HG22 ' O ' ' A' ' 126' ' ' ILE . 3.0 mp -87.0 2.89 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 113.666 -1.606 . . . . 0.0 110.194 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 31.6 m -60.13 -42.47 94.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.042 -1.036 . . . . 0.0 113.393 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -59.66 -42.6 93.2 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -178.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -62.38 -39.19 92.36 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.855 176.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.638 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.8 mttt -62.53 -40.71 97.64 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 118.31 -1.356 . . . . 0.0 110.494 -178.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.53 -37.27 85.44 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.357 -0.537 . . . . 0.0 109.657 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.836 ' CE2' HD11 ' A' ' 136' ' ' LEU . 90.6 t80 -61.74 -45.7 92.8 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.244 176.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.33 -39.44 93.91 Favored 'General case' 0 C--O 1.226 -0.179 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.48 -41.23 96.95 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 50.6 tp -61.09 -43.76 98.39 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 -177.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.836 HD11 ' CE2' ' A' ' 132' ' ' TYR . 88.5 mt -62.22 -41.08 98.06 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.882 178.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -62.76 -41.36 99.18 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 119.453 -0.899 . . . . 0.0 109.762 -178.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -60.99 -42.01 97.58 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -177.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 53.7 m -61.67 -41.34 97.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.71 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 144' ' ' THR . 87.5 mt -63.39 -41.89 98.78 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.785 178.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 87.3 m -61.65 -45.33 94.49 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.381 -177.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -65.05 -41.3 95.27 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 96.4 mt -64.45 -43.6 96.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.005 -1.452 . . . . 0.0 111.235 175.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.518 ' N ' ' O ' ' A' ' 140' ' ' LEU . 95.6 m -62.29 -46.32 89.28 Favored 'General case' 0 C--N 1.345 0.411 0 C-N-CA 120.364 -0.534 . . . . 0.0 112.185 -178.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.22 -41.21 99.08 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 118.882 -1.127 . . . . 0.0 109.15 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.6 mt -63.93 -42.67 97.3 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 178.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.702 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.2 p -59.6 -38.38 81.1 Favored 'General case' 0 C--O 1.218 -0.598 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -178.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.465 ' C ' ' O ' ' A' ' 147' ' ' SER . 86.1 m -28.97 82.37 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.32 0 O-C-N 126.944 2.653 . . . . 0.0 106.101 -178.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.702 ' N ' ' O ' ' A' ' 147' ' ' SER . 23.2 Cg_exo -61.85 145.0 97.32 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 CA-C-O 122.788 1.078 . . . . 0.0 114.301 -174.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.595 ' O ' HG23 ' A' ' 151' ' ' VAL . 9.5 tp -120.44 136.49 57.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 102.502 -3.147 . . . . 0.0 102.502 176.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 150' ' ' ILE . 96.3 t -167.9 93.83 0.64 Allowed Pre-proline 0 CA--C 1.506 -0.725 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 178.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -63.82 143.71 86.74 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 N-CA-C 109.901 -0.846 . . . . 0.0 109.901 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.72 ' O ' HG11 ' B' ' 255' ' ' VAL . 44.3 mm -77.03 -68.71 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.659 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ARG . . . . . 0.665 ' NH2' ' HD3' ' B' ' 154' ' ' ARG . 3.1 mpt_? -132.99 -161.41 1.14 Allowed 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -83.34 104.99 13.93 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.849 0.833 . . . . 0.0 111.291 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.8 10.06 60.49 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 113.904 -1.498 . . . . 0.0 110.2 -177.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.5 mt -126.98 125.67 66.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.735 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 58.7 m -132.25 152.46 51.34 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -138.37 142.28 39.64 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.481 177.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 27.4 tp -135.45 80.58 45.03 Favored Pre-proline 0 N--CA 1.468 0.454 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.386 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -70.98 151.54 62.22 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.638 2.225 . . . . 0.0 113.005 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 88.6 mt -117.65 126.79 53.14 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.184 177.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 47.7 t -122.95 130.13 74.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 116.57 167.49 14.69 Favored Glycine 0 N--CA 1.479 1.558 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.179 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.841 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 57.6 t30 -84.16 115.83 22.61 Favored 'General case' 0 C--O 1.222 -0.358 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -178.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.56 HD21 ' CZ ' ' A' ' 171' ' ' PHE . 45.3 tp -74.28 104.83 5.19 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 -177.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.738 HG23 ' NE ' ' A' ' 170' ' ' ARG . 10.8 p -87.04 166.74 14.81 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.269 0.557 . . . . 0.0 110.485 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.97 -33.75 76.54 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.086 0.47 . . . . 0.0 111.773 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.12 -43.76 90.94 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.519 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ARG . . . . . 0.841 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 87.1 mtm180 -64.99 -29.38 70.3 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 178.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.56 ' CZ ' HD21 ' A' ' 166' ' ' LEU . 0.5 OUTLIER -54.6 -28.98 50.28 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.604 ' O ' HG22 ' A' ' 175' ' ' VAL . 92.1 m-20 -60.89 -41.12 95.43 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 119.102 -1.039 . . . . 0.0 109.679 -177.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 60.0 m -59.45 -40.81 88.03 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.687 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 67.6 mt -63.25 -44.13 99.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 172' ' ' ASN . 34.5 m -63.0 -39.95 87.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' CYS . . . . . 0.414 ' N ' HG23 ' A' ' 175' ' ' VAL . 98.1 m -62.08 -34.66 76.71 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.431 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.5 ' O ' HG13 ' A' ' 181' ' ' ILE . 25.0 m -61.92 -19.27 62.52 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.097 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.653 ' CD2' HD21 ' A' ' 211' ' ' LEU . 88.2 mt -61.0 -41.02 95.72 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -177.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 17.4 m -58.97 -43.2 91.31 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ASN . . . . . 0.674 ' O ' ' OG ' ' A' ' 183' ' ' SER . 93.1 m-20 -61.76 -35.98 79.69 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 122.507 0.323 . . . . 0.0 110.748 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.504 HD12 ' HA ' ' A' ' 178' ' ' LEU . 65.2 mt -58.99 -40.54 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 121.441 -0.787 . . . . 0.0 109.538 -178.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.548 HD21 HD21 ' A' ' 214' ' ' LEU . 85.6 mt -60.53 -40.18 90.59 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -177.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . 0.674 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 78.2 p -61.09 -33.5 73.44 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.419 175.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.407 ' OG1' ' HA ' ' A' ' 181' ' ' ILE . 60.0 p -91.71 23.59 3.51 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.7 0.286 . . . . 0.0 111.402 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 77.8 p -63.49 -20.86 65.95 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.674 -178.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.76 -37.65 82.58 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.929 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . 0.735 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 98.5 m-20 -71.38 113.75 8.74 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.617 0.722 . . . . 0.0 110.928 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -62.95 -42.73 99.91 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.86 -177.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -112.06 131.36 55.48 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.981 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 39.5 tp -120.01 127.94 53.07 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 177.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 96.2 mt -115.73 125.94 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.6 mm -112.62 126.57 70.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 178.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' ASP . . . . . 0.507 ' OD2' ' OG ' ' A' ' 195' ' ' SER . 38.7 t0 -95.58 118.09 31.64 Favored 'General case' 0 CA--C 1.551 1.007 0 O-C-N 121.88 -0.512 . . . . 0.0 110.443 177.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 194' ' ' LEU . 96.9 mt -97.67 -3.35 39.47 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.848 175.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . 0.507 ' OG ' ' OD2' ' A' ' 193' ' ' ASP . 78.0 p -62.24 -33.42 74.55 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.86 -44.68 97.52 Favored Glycine 0 CA--C 1.535 1.288 0 N-CA-C 108.39 -1.884 . . . . 0.0 108.39 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.943 HD23 ' N ' ' A' ' 198' ' ' ALA . 4.7 tt -69.22 128.03 35.17 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 112.792 -1.704 . . . . 0.0 108.902 -177.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ALA . . . . . 0.943 ' N ' HD23 ' A' ' 197' ' ' LEU . . . -60.8 -47.0 88.3 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-O 121.253 0.549 . . . . 0.0 110.48 -177.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . 0.915 ' O ' ' CD2' ' A' ' 197' ' ' LEU . 58.4 tt0 -135.83 156.86 48.14 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-N 114.623 -1.171 . . . . 0.0 113.851 -173.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.453 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 45.3 t -118.73 132.03 69.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 O-C-N 120.924 -1.11 . . . . 0.0 108.298 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -86.95 156.01 19.97 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.582 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.11 -39.06 93.22 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 120.144 -0.623 . . . . 0.0 109.975 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -57.45 -31.98 66.46 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -178.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.4 m -61.32 -42.08 98.07 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.445 178.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.433 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -58.32 -38.42 77.07 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -176.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -61.81 -37.14 83.3 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -178.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -65.92 -38.18 88.02 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.979 177.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 94.7 mt -62.84 -44.35 99.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -178.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . 0.433 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 68.4 m-85 -62.74 -43.06 99.78 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.491 -177.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.27 -42.09 99.04 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 118.961 -1.096 . . . . 0.0 109.168 -178.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.653 HD21 ' CD2' ' A' ' 178' ' ' LEU . 39.8 mt -62.17 -41.87 98.72 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 78.2 p -61.52 -42.36 98.7 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 119.117 -1.033 . . . . 0.0 110.26 -179.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -63.92 -45.43 89.3 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.755 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.548 HD21 HD21 ' A' ' 182' ' ' LEU . 47.8 tp -62.45 -45.87 91.1 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.18 178.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 87.7 mt -62.67 -40.36 96.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.366 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.42 -44.97 95.23 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.507 -177.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 86.2 mt -61.68 -40.29 94.46 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 82.6 p -75.38 -11.41 60.04 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.501 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.88 35.14 19.75 Favored Glycine 0 C--N 1.341 0.832 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.697 -178.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 96.7 m -120.47 113.84 20.9 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 119.051 1.426 . . . . 0.0 111.772 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -66.57 136.5 55.71 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.574 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 45.0 tp -112.63 129.44 56.38 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 3.0 mp -116.3 134.58 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.671 ' CG2' HD11 ' A' ' 227' ' ' ILE . 49.8 mm -115.41 130.74 69.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 44.8 p -133.49 165.04 25.8 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.881 -177.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 78.53 20.46 71.57 Favored Glycine 0 C--O 1.225 -0.462 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' ILE . . . . . 0.671 HD11 ' CG2' ' A' ' 224' ' ' ILE . 98.1 mt -82.32 128.04 39.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 113.767 -1.217 . . . . 0.0 108.248 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -75.67 140.44 71.42 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.09 -39.62 84.92 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 121.018 1.145 . . . . 0.0 112.483 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -63.72 -38.93 92.95 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.418 0.628 . . . . 0.0 110.198 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 52.9 tp -64.23 -42.24 96.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.791 177.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.84 -37.69 88.46 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.09 -178.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 94.0 mtp -63.33 -41.06 98.86 Favored 'General case' 0 C--O 1.249 1.041 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.82 -178.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.87 -38.89 92.78 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.468 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 36.4 mmt -66.21 -37.63 86.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.514 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -61.18 -42.74 99.12 Favored 'General case' 0 CA--C 1.514 -0.405 0 O-C-N 121.58 -0.7 . . . . 0.0 109.617 -176.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.18 -40.09 88.76 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.713 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 56.7 tp -63.3 -41.09 98.93 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -168.15 127.55 1.24 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.33 0.586 . . . . 0.0 112.532 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.47 -26.59 65.37 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.801 178.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.412 ' O ' ' HB2' ' A' ' 244' ' ' SER . 89.4 m-20 -62.67 -29.41 70.62 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.534 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -55.92 -45.64 78.67 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -175.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 98.4 p -60.99 -21.02 63.14 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 123.918 0.761 . . . . 0.0 111.44 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 241' ' ' ASN . 43.1 m -54.39 -40.47 68.22 Favored 'General case' 0 C--N 1.32 -0.713 0 O-C-N 122.342 -0.224 . . . . 0.0 111.553 178.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 95.0 mt -83.18 119.68 24.84 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.403 ' HA ' ' HD3' ' A' ' 246' ' ' LYS . 74.4 mmtt -41.52 134.64 2.3 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.103 178.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.637 HG23 HD12 ' A' ' 227' ' ' ILE . 98.1 m -127.75 134.44 49.52 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.936 177.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' TYR . . . . . 0.493 ' CB ' ' HB2' ' A' ' 254' ' ' ALA . 97.2 m-85 -118.41 139.59 51.16 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.851 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 78.0 p -61.38 -42.74 99.21 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -143.73 159.57 42.26 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.685 0.755 . . . . 0.0 111.599 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 75.9 t -62.53 -44.76 99.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 114.711 -1.132 . . . . 0.0 111.953 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.84 -44.28 97.16 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . 0.512 ' O ' HG22 ' A' ' 257' ' ' VAL . 55.4 m-20 -64.14 -42.03 96.95 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.455 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . 0.493 ' HB2' ' CB ' ' A' ' 248' ' ' TYR . . . -64.65 -42.47 95.4 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.868 0.842 . . . . 0.0 109.829 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' VAL . . . . . 0.422 HG13 HH11 ' B' ' 154' ' ' ARG . 54.8 t -63.41 -46.04 96.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 113.946 -1.479 . . . . 0.0 111.173 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.7 -46.21 86.52 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 120.589 -0.445 . . . . 0.0 111.459 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.512 HG22 ' O ' ' A' ' 253' ' ' ASP . 32.9 m -66.71 -40.81 86.96 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 O-C-N 121.468 -0.77 . . . . 0.0 112.073 179.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.495 ' C ' ' O ' ' A' ' 257' ' ' VAL . 2.1 mt -29.48 -75.47 0.04 OUTLIER Pre-proline 0 C--O 1.234 0.262 0 O-C-N 123.099 0.25 . . . . 0.0 111.522 -177.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 258' ' ' LEU . 42.5 Cg_endo -63.33 139.96 74.34 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 120.789 0.992 . . . . 0.0 111.825 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 259' ' ' PRO . 96.7 mt -151.85 -27.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 O-C-N 123.953 0.783 . . . . 0.0 111.973 178.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 78.1 mtm . . . . . 0 N--CA 1.473 0.708 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.736 -177.174 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.475 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.91 161.14 22.79 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 79.2 p -59.87 -21.7 61.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.871 177.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -74.21 -64.05 1.1 Allowed 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.969 0.414 . . . . 0.0 111.123 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -65.63 -39.43 91.45 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.281 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . 0.504 ' O ' ' HB3' ' B' ' 7' ' ' PHE . 49.5 m -59.97 -41.88 92.94 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.094 -0.642 . . . . 0.0 109.792 -177.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . 0.561 ' CE2' HD12 ' B' ' 9' ' ' ILE . 37.8 t80 85.48 92.22 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.352 177.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' GLY . . . . . 0.49 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -65.02 -137.18 0.02 OUTLIER Glycine 0 C--N 1.338 0.687 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -178.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' ILE . . . . . 0.561 HD12 ' CE2' ' B' ' 7' ' ' PHE . 55.3 mt 78.62 109.48 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 122.613 0.365 . . . . 0.0 111.162 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -62.24 -23.87 75.68 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 121.304 1.336 . . . . 0.0 111.806 -178.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.3 -40.29 98.4 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -64.5 -39.81 94.48 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.733 0.778 . . . . 0.0 109.267 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 52.7 tp -61.88 -42.55 99.2 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.439 -177.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -65.12 -32.17 73.74 Favored 'General case' 0 CA--C 1.561 1.37 0 CA-C-O 121.479 0.657 . . . . 0.0 110.705 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' VAL . . . . . 0.411 HG22 ' CD1' ' A' ' 113' ' ' ILE . 75.4 t -62.6 -46.03 97.37 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 CA-C-N 113.101 -1.863 . . . . 0.0 110.926 177.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 92.6 mt -64.04 -43.81 97.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.871 -178.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . 0.539 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 98.9 mttt -63.3 -42.44 99.04 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.21 -41.23 99.12 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 118.998 -1.081 . . . . 0.0 110.026 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.19 -38.85 84.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.867 -178.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' B' ' 20' ' ' LEU . 89.0 mt -64.31 -41.7 96.7 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 121.289 0.566 . . . . 0.0 110.122 174.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.29 -39.89 94.46 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.021 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 59.4 m170 -58.46 -39.58 80.31 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 121.121 -0.231 . . . . 0.0 111.601 -178.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 13.3 p -113.97 130.42 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.5 ' O ' ' HG3' ' B' ' 24' ' ' ARG . 34.6 ptt180 -73.15 108.04 5.82 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-O 121.726 0.774 . . . . 0.0 112.577 -177.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.6 p -143.3 133.8 22.21 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.885 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.687 177.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' B' ' 123' ' ' GLN . . . -88.43 95.88 2.14 Favored Glycine 0 C--N 1.315 -0.626 0 C-N-CA 119.364 -1.398 . . . . 0.0 113.403 -176.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 47.7 t -125.23 129.54 73.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 174.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 31.8 m -137.97 157.29 32.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.53 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 95.8 mt -119.27 127.42 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.666 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.457 HG22 HG12 ' B' ' 39' ' ' ILE . 31.3 p -109.01 157.04 19.05 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-N 112.795 -2.002 . . . . 0.0 108.567 -177.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -124.86 104.26 30.31 Favored Pre-proline 0 C--O 1.235 0.294 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' PRO . . . . . 0.622 ' HG3' HG23 ' B' ' 117' ' ' THR . 37.0 Cg_endo -64.54 -22.51 65.08 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.639 1.559 . . . . 0.0 111.59 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.13 -43.76 98.13 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.423 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 99.4 mt -73.02 174.67 7.55 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.951 -0.468 . . . . 0.0 111.378 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . 0.606 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 42.7 tt0 -73.16 131.25 41.8 Favored 'General case' 0 C--N 1.345 0.381 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -176.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.476 ' O ' ' OD1' ' B' ' 36' ' ' ASP . 66.0 t0 57.54 38.19 27.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.625 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' ASN . . . . . 0.465 ' C ' ' O ' ' B' ' 36' ' ' ASP . 29.7 t-20 28.63 71.86 0.47 Allowed Pre-proline 0 CA--C 1.535 0.368 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -178.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.606 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 92.1 Cg_endo -71.77 154.18 59.0 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 123.551 2.834 . . . . 0.0 111.84 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.457 HG12 HG22 ' B' ' 30' ' ' THR . 95.6 mt -87.5 127.91 40.44 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.453 HG23 ' N ' ' B' ' 41' ' ' TYR . 26.7 m -108.03 -45.44 7.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 O-C-N 123.777 0.673 . . . . 0.0 112.437 -178.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' TYR . . . . . 0.453 ' N ' HG23 ' B' ' 40' ' ' VAL . 51.6 t80 -94.73 124.51 38.81 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.552 -178.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 6.0 p -142.97 140.96 27.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.311 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' ASN . . . . . 0.647 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 57.2 p30 -100.34 161.46 13.59 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.086 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' GLN . . . . . 0.446 ' OE1' ' HA ' ' B' ' 44' ' ' GLN . 14.4 mm100 -63.16 -37.98 89.37 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.502 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.17 -25.01 61.72 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.291 -0.723 . . . . 0.0 111.291 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' PHE . . . . . 0.647 ' HB2' ' OD1' ' B' ' 43' ' ' ASN . 61.3 t80 -60.33 -43.3 96.54 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' VAL . . . . . 0.71 HG13 ' O ' ' B' ' 52' ' ' TYR . 69.4 t -61.16 -46.35 96.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.252 -178.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -62.67 -44.22 96.81 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.213 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 59.3 ttm -62.98 -42.06 99.73 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 33.8 p -96.11 -16.1 21.75 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.231 -0.588 . . . . 0.0 111.969 -178.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' B' ' 47' ' ' VAL . . . 73.08 18.3 79.11 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 178.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' TYR . . . . . 0.71 ' O ' HG13 ' B' ' 47' ' ' VAL . 82.6 m-85 -110.62 143.17 41.46 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.294 -0.453 . . . . 0.0 110.038 178.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -71.79 146.9 47.75 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-O 121.904 0.859 . . . . 0.0 110.994 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . 0.418 ' H ' HG22 ' B' ' 54' ' ' THR . 0.1 OUTLIER -61.63 -36.8 81.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.065 -177.349 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.37 -39.59 94.18 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.015 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -72.51 -32.04 65.83 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 177.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.645 HD13 ' CE2' ' B' ' 46' ' ' PHE . 95.8 mt -66.68 -71.29 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 178.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 94.2 mt -36.61 130.97 0.71 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.38 175.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.24 -8.23 69.54 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.617 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -136.08 149.14 48.6 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -174.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' ASN . . . . . 0.515 ' C ' ' H ' ' B' ' 63' ' ' ARG . 25.7 t-20 -79.55 151.6 30.6 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.798 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' CYS . . . . . . . . . . . . . 78.3 m -62.83 7.91 0.07 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.375 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' ARG . . . . . 0.515 ' H ' ' C ' ' B' ' 61' ' ' ASN . 33.5 ptt-85 -58.79 -31.89 68.82 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.54 -0.755 . . . . 0.0 112.497 -178.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -60.93 -31.2 70.74 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 178.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 81.5 mt -61.94 -42.36 99.02 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -177.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -48.02 151.67 0.92 Allowed 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.155 0.503 . . . . 0.0 109.888 -178.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . 0.406 ' N ' ' OG1' ' B' ' 70' ' ' THR . . . -162.26 -152.93 6.92 Favored Glycine 0 CA--C 1.54 1.649 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.184 175.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.87 -42.23 97.5 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 122.634 -0.333 . . . . 0.0 111.823 -175.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -74.93 -9.98 59.05 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.161 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' THR . . . . . 0.406 ' OG1' ' N ' ' B' ' 67' ' ' GLY . 31.5 m -61.29 134.72 57.27 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -90.94 110.26 40.74 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.25 -178.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.84 -38.14 85.47 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 120.965 1.11 . . . . 0.0 111.828 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.38 -40.03 89.4 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 120.568 -0.453 . . . . 0.0 109.787 -176.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' GLU . . . . . 0.567 ' OE1' ' HB ' ' B' ' 90' ' ' VAL . 79.2 mm-40 -66.16 -39.65 89.95 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.889 177.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 72.1 t -61.92 -46.24 96.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -62.88 -37.45 86.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.885 -178.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -62.84 -41.53 99.38 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 119.312 -0.955 . . . . 0.0 108.79 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 95.0 mt -63.34 -43.73 98.72 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 CA-C-O 120.761 0.315 . . . . 0.0 110.714 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -62.27 -42.44 99.34 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 81.7 m -60.81 -45.75 93.19 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.994 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.5 -41.81 97.84 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -177.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 87.9 mt -63.57 -41.79 98.36 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 67.4 tp60 -62.21 -35.33 78.57 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -91.61 8.41 36.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.682 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 26.9 tttt 41.51 42.29 1.89 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.3 -0.56 . . . . 0.0 112.045 176.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -124.31 141.3 37.1 Favored Pre-proline 0 N--CA 1.471 0.58 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.096 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -61.73 140.12 84.29 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 120.875 1.05 . . . . 0.0 114.029 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.87 135.9 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -177.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 89' ' ' THR . . . . . 0.909 HG23 ' OD1' ' B' ' 107' ' ' ASN . 96.2 m -121.85 122.06 38.58 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 90' ' ' VAL . . . . . 0.567 ' HB ' ' OE1' ' B' ' 74' ' ' GLU . 26.9 m -139.31 163.28 26.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.753 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -113.6 121.47 44.27 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.131 0.491 . . . . 0.0 109.881 175.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 21.2 tt -127.87 131.47 69.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.034 -175.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -71.94 142.05 49.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.938 177.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 94' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -132.9 -178.47 4.97 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.407 0.623 . . . . 0.0 111.04 -176.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 95' ' ' TYR . . . . . 0.405 ' CE1' ' HA3' ' B' ' 67' ' ' GLY . 96.2 m-85 -132.2 146.03 51.74 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.813 178.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . 0.42 ' HG3' ' CE1' ' B' ' 102' ' ' PHE . 98.8 mttt -102.93 179.29 4.32 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.056 0.455 . . . . 0.0 110.702 177.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.53 -35.16 75.31 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.243 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 37.0 p-10 -86.49 -1.95 58.04 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.038 0.836 . . . . 0.0 112.785 177.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.59 4.62 65.62 Favored Glycine 0 N--CA 1.465 0.612 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.165 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 25.8 m -67.65 128.98 38.46 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.331 178.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 101' ' ' MET . . . . . 0.531 ' SD ' ' N ' ' B' ' 102' ' ' PHE . 16.8 tmm? -87.25 143.37 27.31 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 102' ' ' PHE . . . . . 0.531 ' N ' ' SD ' ' B' ' 101' ' ' MET . 52.1 p90 -154.74 163.86 39.64 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 103' ' ' TRP . . . . . 0.663 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 22.0 m95 -97.51 137.57 36.26 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.276 -0.57 . . . . 0.0 111.086 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . 0.546 HD21 ' HG2' ' B' ' 123' ' ' GLN . 63.8 t-20 -131.9 113.4 13.4 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 114.707 -1.133 . . . . 0.0 113.957 -177.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -83.51 121.41 27.17 Favored 'General case' 0 C--N 1.318 -0.788 0 O-C-N 124.441 1.088 . . . . 0.0 109.015 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 41.2 tp -109.52 125.66 52.73 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.066 0.46 . . . . 0.0 111.95 -177.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 107' ' ' ASN . . . . . 0.909 ' OD1' HG23 ' B' ' 89' ' ' THR . 98.2 m-20 -118.34 129.6 55.53 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 176.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 96.7 mt -124.07 132.75 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -144.37 121.3 6.43 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -69.27 152.18 71.85 Favored 'Trans proline' 0 N--CA 1.503 2.043 0 C-N-CA 122.424 2.083 . . . . 0.0 112.576 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . 0.49 ' HB2' ' HB2' ' B' ' 118' ' ' TYR . 66.1 mtt -128.75 142.26 51.06 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -112.51 105.27 13.45 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . 0.661 HG12 ' HZ1' ' A' ' 18' ' ' LYS . 96.8 mt -132.9 127.93 56.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 O-C-N 121.697 -0.627 . . . . 0.0 111.695 177.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 53.94 37.19 26.13 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 123.913 0.758 . . . . 0.0 109.713 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 60.58 36.28 19.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.266 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -132.63 153.23 51.27 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 177.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 117' ' ' THR . . . . . 0.622 HG23 ' HG3' ' B' ' 32' ' ' PRO . 11.3 t -103.23 152.31 21.64 Favored 'General case' 0 C--O 1.213 -0.82 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.16 -178.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 118' ' ' TYR . . . . . 0.49 ' HB2' ' HB2' ' B' ' 111' ' ' MET . 96.5 m-85 -148.04 146.95 29.09 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 121.222 -0.924 . . . . 0.0 111.278 -179.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -123.54 138.98 54.45 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 120.971 0.415 . . . . 0.0 111.512 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -128.01 133.67 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -176.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.93 121.98 6.58 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 91.9 mt -113.36 127.14 70.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 123' ' ' GLN . . . . . 0.546 ' HG2' HD21 ' B' ' 104' ' ' ASN . 15.8 mp0 -118.55 122.58 42.99 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -119.68 121.21 38.74 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' B' ' 127' ' ' THR . 68.3 t0 -72.23 128.04 34.41 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.604 -177.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 126' ' ' ILE . . . . . 0.5 HG22 ' O ' ' B' ' 126' ' ' ILE . 2.9 mp -100.93 17.42 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.58 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 127' ' ' THR . . . . . 0.491 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 98.1 m -62.57 -44.14 97.07 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 114.197 -1.365 . . . . 0.0 112.846 176.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 59.9 tptt -61.67 -45.05 95.65 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -177.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 129' ' ' GLN . . . . . 0.406 ' OE1' HG23 ' B' ' 126' ' ' ILE . 88.1 mt-30 -63.39 -35.04 79.1 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.683 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 130' ' ' LYS . . . . . 0.663 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 98.9 mttt -62.95 -41.63 99.57 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-N 112.833 -1.985 . . . . 0.0 110.835 174.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -64.3 -42.23 96.47 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 132' ' ' TYR . . . . . 0.841 ' CE2' HD11 ' B' ' 136' ' ' LEU . 91.6 t80 -60.13 -44.09 95.18 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 121.903 -0.498 . . . . 0.0 111.384 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 133' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' B' ' 137' ' ' GLU . 97.5 mt-10 -64.87 -36.55 84.7 Favored 'General case' 0 C--O 1.22 -0.453 0 C-N-CA 119.989 -0.684 . . . . 0.0 109.384 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 134' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' B' ' 130' ' ' LYS . 98.7 mttt -63.52 -39.8 95.36 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.604 177.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 49.6 tp -62.91 -41.4 99.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.349 0.595 . . . . 0.0 109.441 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 136' ' ' LEU . . . . . 0.841 HD11 ' CE2' ' B' ' 132' ' ' TYR . 88.8 mt -62.99 -41.47 99.59 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.426 177.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 137' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' B' ' 133' ' ' GLU . 97.1 mt-10 -65.06 -37.18 86.73 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 113.806 -1.543 . . . . 0.0 110.268 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.48 -43.75 96.38 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.995 177.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 67.3 m -60.94 -44.39 97.31 Favored 'General case' 0 C--N 1.346 0.449 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . 0.49 ' O ' ' N ' ' B' ' 144' ' ' THR . 88.4 mt -61.73 -40.33 94.7 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -177.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 92.6 m -61.78 -45.44 93.89 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.026 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -65.66 -42.81 90.95 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 94.3 mt -63.87 -43.41 97.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.574 178.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 144' ' ' THR . . . . . 0.49 ' N ' ' O ' ' B' ' 140' ' ' LEU . 95.3 m -61.59 -45.51 93.82 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . 0.441 ' O ' ' HB ' ' B' ' 148' ' ' THR . . . -64.52 -41.73 96.21 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 119.117 -1.033 . . . . 0.0 109.295 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 86.2 mt -64.99 -40.85 95.57 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 176.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 147' ' ' SER . . . . . 0.613 ' O ' ' N ' ' B' ' 149' ' ' PRO . 78.2 p -62.06 -41.86 98.6 Favored 'General case' 0 CA--C 1.477 -1.84 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -178.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 148' ' ' THR . . . . . 0.497 ' C ' ' O ' ' B' ' 147' ' ' SER . 40.5 m -26.51 85.36 0.03 OUTLIER Pre-proline 0 N--CA 1.478 0.947 0 O-C-N 123.958 0.786 . . . . 0.0 110.188 176.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 149' ' ' PRO . . . . . 0.613 ' N ' ' O ' ' B' ' 147' ' ' SER . 24.1 Cg_exo -60.52 145.18 99.23 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.051 1.834 . . . . 0.0 115.6 -177.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 9.9 tp -125.29 119.44 55.48 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.168 0 CA-C-N 114.036 -1.438 . . . . 0.0 108.197 174.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 59.5 t -148.89 94.2 4.1 Favored Pre-proline 0 C--N 1.307 -1.274 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.806 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.04 142.88 94.1 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 CA-C-N 119.909 1.003 . . . . 0.0 109.623 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 153' ' ' ILE . . . . . 0.617 ' CG2' HH12 ' A' ' 154' ' ' ARG . 43.8 mm -77.1 -66.89 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 154' ' ' ARG . . . . . 0.665 ' HD3' ' NH2' ' A' ' 154' ' ' ARG . 2.7 mpt_? -132.96 -158.84 0.92 Allowed 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 177.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -84.2 109.49 17.79 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 101.02 -17.34 56.32 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -177.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 89.3 mt -109.78 126.43 66.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.859 0.362 . . . . 0.0 111.282 -177.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 158' ' ' SER . . . . . 0.702 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 60.7 m -135.29 149.05 49.71 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.718 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -132.46 149.33 52.35 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 29.8 tp -144.23 78.75 13.38 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 161' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -71.82 149.89 54.78 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.725 2.283 . . . . 0.0 114.108 -177.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 91.6 mt -113.68 133.3 55.41 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 55.9 t -128.38 132.38 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 113.49 167.45 16.55 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.184 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 165' ' ' ASN . . . . . 0.634 ' O ' ' NH1' ' B' ' 170' ' ' ARG . 52.9 t30 -88.55 107.53 18.94 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -178.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 166' ' ' LEU . . . . . 0.553 HD21 ' CZ ' ' B' ' 171' ' ' PHE . 48.2 tp -64.78 105.35 0.98 Allowed 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -174.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 167' ' ' THR . . . . . 0.707 HG23 ' NE ' ' B' ' 170' ' ' ARG . 10.9 p -84.94 169.74 13.74 Favored 'General case' 0 C--N 1.348 0.502 0 CA-C-N 114.019 -1.446 . . . . 0.0 110.79 177.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.2 -37.87 84.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.704 176.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.3 -40.97 90.37 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-O 122.455 1.121 . . . . 0.0 111.894 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 170' ' ' ARG . . . . . 0.707 ' NE ' HG23 ' B' ' 167' ' ' THR . 87.7 mtm180 -61.83 -34.81 76.63 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 112.376 -2.193 . . . . 0.0 111.178 177.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 171' ' ' PHE . . . . . 0.553 ' CZ ' HD21 ' B' ' 166' ' ' LEU . 0.5 OUTLIER -53.95 -26.25 24.67 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -178.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 172' ' ' ASN . . . . . 0.541 ' O ' HG22 ' B' ' 175' ' ' VAL . 92.8 m-20 -62.86 -40.56 97.86 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.875 179.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 57.1 m -60.7 -41.07 94.44 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.098 0.475 . . . . 0.0 110.747 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 67.3 mt -63.92 -44.1 97.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -178.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 175' ' ' VAL . . . . . 0.541 HG22 ' O ' ' B' ' 172' ' ' ASN . 34.5 m -63.15 -40.22 88.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 176' ' ' CYS . . . . . 0.419 ' N ' HG23 ' B' ' 175' ' ' VAL . 99.1 m -61.88 -35.03 77.11 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.432 178.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 177' ' ' THR . . . . . 0.517 ' O ' HG13 ' B' ' 181' ' ' ILE . 25.1 m -61.74 -19.24 62.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.28 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 178' ' ' LEU . . . . . 0.621 ' CD2' HD21 ' B' ' 211' ' ' LEU . 89.4 mt -61.42 -39.01 89.19 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.328 -177.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 18.2 m -61.0 -43.81 98.35 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.259 177.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 180' ' ' ASN . . . . . 0.655 ' O ' ' OG ' ' B' ' 183' ' ' SER . 92.4 m-20 -62.13 -40.0 94.46 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.878 0.371 . . . . 0.0 110.481 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.517 HG13 ' O ' ' B' ' 177' ' ' THR . 72.2 mt -56.11 -35.0 40.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 O-C-N 122.157 -0.339 . . . . 0.0 110.902 -178.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 182' ' ' LEU . . . . . 0.533 HD21 HD21 ' B' ' 214' ' ' LEU . 84.6 mt -61.78 -41.52 97.83 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 119.799 -0.761 . . . . 0.0 109.11 177.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 183' ' ' SER . . . . . 0.655 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.3 p -62.89 -32.6 73.9 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 121.8 -0.562 . . . . 0.0 110.915 176.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 50.9 p -87.52 15.73 6.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.835 0.35 . . . . 0.0 111.831 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 79.5 p -59.35 -17.13 27.0 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.031 -177.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.02 -40.59 96.22 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.704 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 187' ' ' ASP . . . . . 0.702 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.2 m-20 -68.75 113.93 6.65 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.653 0.74 . . . . 0.0 110.622 -177.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.65 -42.36 99.57 Favored 'General case' 0 C--O 1.247 0.922 0 CA-C-N 114.772 -1.104 . . . . 0.0 113.118 -177.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -112.02 130.86 55.73 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 120.621 -0.431 . . . . 0.0 111.317 -178.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 190' ' ' LEU . . . . . . . . . . . . . 41.4 tp -123.13 117.64 25.86 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.901 178.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 83.9 mt -105.62 125.1 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 121.064 -0.254 . . . . 0.0 111.418 -178.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 49.7 mm -114.88 117.4 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 178.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 193' ' ' ASP . . . . . 0.615 ' CG ' ' HG ' ' B' ' 195' ' ' SER . 40.0 t0 -89.47 111.07 21.87 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.731 -176.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 194' ' ' LEU . . . . . . . . . . . . . 97.2 mt -92.24 -1.24 57.23 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.323 175.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 195' ' ' SER . . . . . 0.615 ' HG ' ' CG ' ' B' ' 193' ' ' ASP . 78.1 p -61.35 -37.16 82.34 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.698 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.42 -34.13 87.18 Favored Glycine 0 N--CA 1.439 -1.102 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 197' ' ' LEU . . . . . 0.974 HD23 ' N ' ' B' ' 198' ' ' ALA . 4.8 tt -78.19 132.71 37.71 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -176.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 198' ' ' ALA . . . . . 0.974 ' N ' HD23 ' B' ' 197' ' ' LEU . . . -64.5 -41.64 96.33 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.496 -178.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 199' ' ' GLN . . . . . 0.947 ' H ' ' CD2' ' B' ' 197' ' ' LEU . 58.9 tt0 -138.91 164.14 30.46 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 200' ' ' VAL . . . . . 0.465 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 50.2 t -121.36 132.51 70.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 O-C-N 120.688 -1.258 . . . . 0.0 109.433 176.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -90.46 149.42 22.23 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.926 -178.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.44 -32.45 70.22 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.295 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -64.6 -32.65 74.39 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.4 m -60.79 -44.32 96.98 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.274 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 205' ' ' ALA . . . . . 0.623 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -58.69 -29.56 66.73 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -177.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -65.44 -38.59 90.31 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.257 0.551 . . . . 0.0 109.672 176.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -66.89 -37.94 85.33 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.694 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.55 -43.46 98.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 120.528 -0.469 . . . . 0.0 109.808 -178.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 209' ' ' PHE . . . . . 0.623 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 65.3 m-85 -62.17 -43.02 99.75 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 114.195 -1.366 . . . . 0.0 112.767 177.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.42 -41.8 98.71 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.288 -0.965 . . . . 0.0 109.763 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 211' ' ' LEU . . . . . 0.621 HD21 ' CD2' ' B' ' 178' ' ' LEU . 39.7 mt -62.27 -42.46 99.36 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.418 -179.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 78.0 p -63.15 -36.06 82.36 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.291 -0.564 . . . . 0.0 112.11 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 213' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -66.89 -46.72 74.06 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.146 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 214' ' ' LEU . . . . . 0.533 HD21 HD21 ' B' ' 182' ' ' LEU . 52.0 tp -63.89 -43.17 96.83 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.765 0.793 . . . . 0.0 109.827 177.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 215' ' ' LEU . . . . . 0.417 ' HB3' ' O ' ' B' ' 220' ' ' THR . 88.9 mt -63.2 -43.76 97.25 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 113.485 -1.689 . . . . 0.0 111.599 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.33 -39.69 91.46 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.879 -176.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 87.1 mt -63.75 -42.05 97.9 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.389 0.614 . . . . 0.0 111.587 176.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 218' ' ' THR . . . . . . . . . . . . . 75.6 p -75.13 -16.41 60.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.106 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 80.85 64.65 1.78 Allowed Glycine 0 CA--C 1.528 0.848 0 N-CA-C 106.577 -2.609 . . . . 0.0 106.577 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 220' ' ' THR . . . . . 0.417 ' O ' ' HB3' ' B' ' 215' ' ' LEU . 98.1 m -142.46 103.23 4.22 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 175.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -61.92 139.36 58.39 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.92 -176.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 42.6 tp -116.3 121.4 41.88 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.231 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 3.2 mp -110.01 128.58 66.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.223 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 224' ' ' ILE . . . . . 0.61 ' CG2' HD11 ' B' ' 227' ' ' ILE . 50.7 mm -108.86 126.05 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.735 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 51.8 p -133.0 157.16 45.89 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.511 0.672 . . . . 0.0 112.714 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 89.16 18.04 54.44 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 113.894 -1.503 . . . . 0.0 110.981 -177.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 227' ' ' ILE . . . . . 0.667 HD12 HG23 ' B' ' 247' ' ' THR . 95.5 mt -82.54 125.69 39.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 121.908 -0.76 . . . . 0.0 111.586 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -65.86 140.31 97.17 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.604 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.78 -37.01 92.28 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 121.358 1.372 . . . . 0.0 112.446 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -64.39 -43.1 95.49 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 51.3 tp -61.62 -41.55 97.63 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.701 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.12 -37.07 86.13 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.756 0.312 . . . . 0.0 111.359 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 93.9 mtp -64.08 -41.17 97.42 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.442 -0.503 . . . . 0.0 109.659 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.79 -43.67 98.19 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 122.204 1.002 . . . . 0.0 109.202 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 37.3 mmt -63.76 -35.73 81.54 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.951 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -61.88 -40.52 95.68 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -178.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.31 -43.45 97.79 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.043 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 51.8 tp -61.68 -45.52 93.66 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 120.26 -0.576 . . . . 0.0 112.228 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 239' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' B' ' 240' ' ' ALA . 66.8 t0 -156.83 135.13 11.31 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 120.39 -0.524 . . . . 0.0 112.034 -179.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 240' ' ' ALA . . . . . 0.435 ' N ' ' OD1' ' B' ' 239' ' ' ASP . . . -62.59 -46.56 87.76 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 176.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 241' ' ' ASN . . . . . 0.514 ' O ' ' HB2' ' B' ' 244' ' ' SER . 92.5 m-20 -43.74 -18.96 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.421 -175.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 242' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -61.91 -45.88 91.77 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.236 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 243' ' ' SER . . . . . 0.41 ' O ' ' N ' ' B' ' 245' ' ' LEU . 77.7 p -57.95 -45.62 86.35 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 244' ' ' SER . . . . . 0.514 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 21.0 m -28.08 -38.47 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' B' ' 243' ' ' SER . 96.9 mt -87.73 138.54 31.38 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 121.521 -0.737 . . . . 0.0 110.489 178.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -66.75 134.93 53.18 Favored 'General case' 0 C--O 1.242 0.662 0 O-C-N 121.82 -0.55 . . . . 0.0 110.742 -174.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 247' ' ' THR . . . . . 0.667 HG23 HD12 ' B' ' 227' ' ' ILE . 97.3 m -124.6 126.81 46.4 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.919 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 248' ' ' TYR . . . . . 0.526 ' CG ' ' HB2' ' B' ' 254' ' ' ALA . 96.2 m-85 -111.6 143.14 42.97 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 177.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 249' ' ' SER . . . . . 0.553 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 77.9 p -62.97 -34.75 78.19 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.107 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 250' ' ' ASN . . . . . 0.553 ' OD1' ' O ' ' B' ' 249' ' ' SER . 99.3 m-20 -146.85 159.2 43.82 Favored 'General case' 0 N--CA 1.461 0.121 0 O-C-N 124.243 0.964 . . . . 0.0 112.033 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 79.7 t -64.02 -44.6 97.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.919 178.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 252' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.23 -46.01 92.16 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -178.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 253' ' ' ASP . . . . . 0.523 ' O ' HG22 ' B' ' 257' ' ' VAL . 94.4 m-20 -61.25 -43.75 98.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.821 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 254' ' ' ALA . . . . . 0.526 ' HB2' ' CG ' ' B' ' 248' ' ' TYR . . . -64.9 -40.24 94.78 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.133 178.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 255' ' ' VAL . . . . . 0.72 HG11 ' O ' ' A' ' 153' ' ' ILE . 55.4 t -65.12 -45.54 93.85 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.298 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.7 -47.0 85.54 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 120.286 -0.566 . . . . 0.0 111.335 -178.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 257' ' ' VAL . . . . . 0.523 HG22 ' O ' ' B' ' 253' ' ' ASP . 28.3 m -65.95 -40.0 86.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.758 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 258' ' ' LEU . . . . . 0.519 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 1.9 mt -33.34 -74.04 0.05 OUTLIER Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.566 -178.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 259' ' ' PRO . . . . . 0.541 ' O ' HG13 ' B' ' 260' ' ' ILE . 37.3 Cg_endo -61.93 141.23 88.79 Favored 'Trans proline' 0 N--CA 1.504 2.122 0 C-N-CA 121.605 1.537 . . . . 0.0 111.463 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 260' ' ' ILE . . . . . 0.541 HG13 ' O ' ' B' ' 259' ' ' PRO . 96.9 mt -159.22 -15.02 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-N 118.73 0.696 . . . . 0.0 112.311 177.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 C--O 1.216 -0.706 0 CA-C-O 117.885 -1.055 . . . . 0.0 111.553 -179.741 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.48 ' O ' ' OG ' ' A' ' 6' ' ' SER . . . -156.98 169.95 23.64 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 116.65 -1.643 . . . . 0.0 110.19 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.6 p -72.9 -18.81 61.37 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 124.902 1.376 . . . . 0.0 110.808 178.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -70.59 -67.02 0.53 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 114.444 -1.253 . . . . 0.0 112.189 174.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -66.71 -38.58 87.01 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.48 ' OG ' ' O ' ' A' ' 2' ' ' ALA . 64.1 m -58.97 -41.63 87.97 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 120.441 -0.503 . . . . 0.0 110.306 -177.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.68 ' CE2' HD12 ' A' ' 9' ' ' ILE . 41.1 t80 82.1 86.18 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 O-C-N 123.909 0.756 . . . . 0.0 111.301 176.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.48 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -60.86 -134.78 0.01 OUTLIER Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -177.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.68 HD12 ' CE2' ' A' ' 7' ' ' PHE . 57.2 mt 78.95 108.72 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.695 0 C-N-CA 122.583 0.353 . . . . 0.0 110.775 -178.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -63.31 -22.65 72.09 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 121.422 1.415 . . . . 0.0 112.134 -178.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.72 -37.83 95.29 Favored Glycine 0 C--O 1.245 0.817 0 C-N-CA 121.029 -0.605 . . . . 0.0 111.766 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.56 -39.07 91.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.359 0.6 . . . . 0.0 109.744 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 49.8 tp -62.95 -41.62 99.56 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -62.61 -39.56 94.17 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 56.2 t -60.74 -44.24 96.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 O-C-N 122.365 -0.21 . . . . 0.0 110.986 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 93.0 mt -62.62 -43.59 98.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.181 -177.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.428 ' NZ ' ' HA ' ' B' ' 6' ' ' SER . 98.9 mttt -62.4 -46.03 90.46 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 119.331 -0.948 . . . . 0.0 112.123 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.653 ' NZ ' HG12 ' B' ' 113' ' ' ILE . 98.6 mttt -60.65 -39.51 88.6 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 118.881 -1.128 . . . . 0.0 109.082 -175.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.8 -42.34 93.23 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.092 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 20' ' ' LEU . 89.3 mt -63.26 -40.97 98.89 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.105 0.479 . . . . 0.0 109.879 178.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.41 -38.86 92.78 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.576 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 53.7 m170 -58.16 -39.83 79.87 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 122.27 -0.268 . . . . 0.0 111.592 -178.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.0 p -114.69 130.23 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.545 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 35.6 ptt180 -72.04 109.32 5.77 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 122.245 1.021 . . . . 0.0 111.945 -177.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.5 p -140.21 142.9 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.555 ' O ' ' N ' ' A' ' 123' ' ' GLN . . . -98.18 93.12 1.33 Allowed Glycine 0 C--N 1.313 -0.709 0 C-N-CA 120.759 -0.734 . . . . 0.0 113.215 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 51.6 t -125.15 129.83 73.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 175.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.1 m -136.66 158.82 37.56 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.3 mt -120.21 129.59 75.32 Favored 'Isoleucine or valine' 0 C--O 1.243 0.732 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 177.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.436 ' HB ' ' OD1' ' A' ' 37' ' ' ASN . 16.5 p -106.39 166.92 10.19 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.503 178.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' A' ' 37' ' ' ASN . 45.0 t0 -131.83 104.14 14.3 Favored Pre-proline 0 C--N 1.32 -0.701 0 C-N-CA 120.491 -0.483 . . . . 0.0 110.813 178.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.52 ' CG ' HG23 ' A' ' 117' ' ' THR . 36.7 Cg_endo -63.93 -23.11 68.36 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.379 1.386 . . . . 0.0 111.605 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.12 -34.38 76.24 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.209 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 95.8 mt -87.4 165.03 15.88 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.861 177.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.722 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 43.2 tt0 -63.24 132.14 50.71 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -176.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.52 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 57.1 t0 62.32 21.19 12.35 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 177.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.436 ' OD1' ' HB ' ' A' ' 30' ' ' THR . 35.0 t-20 42.73 66.59 4.2 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.816 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.722 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 89.1 Cg_endo -70.67 156.18 61.47 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 C-N-CA 123.664 2.909 . . . . 0.0 111.993 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.3 mt -88.05 125.16 41.5 Favored 'Isoleucine or valine' 0 C--O 1.246 0.905 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.376 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.41 HG23 ' N ' ' A' ' 41' ' ' TYR . 27.2 m -105.65 -42.8 7.13 Favored 'Isoleucine or valine' 0 C--N 1.343 0.324 0 O-C-N 123.613 0.571 . . . . 0.0 111.998 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.41 ' N ' HG23 ' A' ' 40' ' ' VAL . 49.4 t80 -96.06 123.75 39.8 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.566 -178.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.1 p -142.67 139.83 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.338 177.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.573 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 57.6 p30 -97.39 165.12 12.17 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.474 ' OE1' ' HA ' ' A' ' 44' ' ' GLN . 13.2 mm100 -66.09 -38.03 87.26 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 177.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.88 -26.77 63.44 Favored Glycine 0 N--CA 1.453 -0.186 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.667 ' CD2' HD13 ' A' ' 57' ' ' ILE . 71.4 t80 -59.28 -47.58 84.84 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 -179.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.686 HG13 ' O ' ' A' ' 52' ' ' TYR . 69.5 t -59.38 -44.69 93.08 Favored 'Isoleucine or valine' 0 C--N 1.349 0.585 0 O-C-N 121.241 -0.912 . . . . 0.0 111.366 -173.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -63.73 -37.84 88.86 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.727 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 59.7 ttm -66.57 -43.82 83.93 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 175.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 36.4 p -91.87 -21.99 20.32 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.126 0.488 . . . . 0.0 111.315 -178.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . 77.83 19.56 75.21 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.686 ' O ' HG13 ' A' ' 47' ' ' VAL . 82.9 m-85 -112.58 139.31 48.27 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 122.868 0.467 . . . . 0.0 111.28 178.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -65.85 149.2 50.57 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.785 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.437 HG22 ' H ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -65.29 -32.32 73.92 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -178.207 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -66.36 -42.48 87.98 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 119.591 -0.843 . . . . 0.0 111.466 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -65.61 -45.1 84.44 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 119.886 -0.725 . . . . 0.0 109.427 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.667 HD13 ' CD2' ' A' ' 46' ' ' PHE . 97.0 mt -62.1 -46.7 95.87 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 C-N-CA 119.85 -0.74 . . . . 0.0 112.47 -174.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.2 mt -60.77 142.8 55.6 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.53 -3.08 87.33 Favored Glycine 0 N--CA 1.464 0.529 0 CA-C-O 119.234 -0.759 . . . . 0.0 112.877 177.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -136.19 152.08 50.4 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.275 1.537 . . . . 0.0 111.682 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.533 ' C ' ' H ' ' A' ' 63' ' ' ARG . 24.9 t-20 -80.27 151.89 29.33 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 121.194 0.521 . . . . 0.0 110.509 -178.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 85.6 m -64.56 14.15 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.342 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.533 ' H ' ' C ' ' A' ' 61' ' ' ASN . 36.3 ptt-85 -61.14 -40.78 95.12 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 122.073 -0.392 . . . . 0.0 111.354 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -55.12 -22.91 18.47 Favored 'General case' 0 CA--C 1.55 0.973 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -178.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.4 mt -66.04 -36.62 83.74 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.402 0.62 . . . . 0.0 112.636 176.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -61.95 137.87 58.3 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.061 -178.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.498 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -147.63 -147.73 4.6 Favored Glycine 0 CA--C 1.543 1.801 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.096 178.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.66 -41.2 98.94 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -177.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.445 ' O ' ' OE1' ' A' ' 93' ' ' GLN . 9.3 m-70 -76.84 -7.87 56.26 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.245 -177.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.498 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 27.4 m -64.02 129.38 39.81 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.22 -0.592 . . . . 0.0 109.71 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -86.47 111.9 42.57 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.809 -177.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.6 -31.38 91.59 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 121.97 1.78 . . . . 0.0 113.206 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.12 -40.11 95.48 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.111 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.443 ' OE1' ' HB ' ' A' ' 90' ' ' VAL . 78.8 mm-40 -65.31 -43.17 91.88 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.2 t -60.38 -43.69 94.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 114.189 -1.369 . . . . 0.0 107.74 -176.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -64.42 -38.06 89.71 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.646 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -63.49 -39.7 95.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.329 0.585 . . . . 0.0 110.625 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.92 -43.94 97.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.941 177.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -62.53 -42.95 99.86 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 113.925 -1.489 . . . . 0.0 108.287 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 99.3 m -61.24 -49.83 75.53 Favored 'General case' 0 C--O 1.247 0.947 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.8 -41.66 96.06 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 118.646 -0.692 . . . . 0.0 111.598 -169.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.0 mt -63.23 -39.29 94.2 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 118.702 0.683 . . . . 0.0 111.188 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 66.7 tp60 -64.87 -34.35 78.17 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 177.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -85.28 -3.54 58.86 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.599 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.2 tttt 48.57 37.59 9.5 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.679 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -120.64 143.89 37.39 Favored Pre-proline 0 CA--C 1.534 0.364 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -61.8 144.2 96.71 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 121.318 1.345 . . . . 0.0 113.307 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.5 p -139.39 141.39 35.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.805 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.972 HG23 ' OD1' ' A' ' 107' ' ' ASN . 97.4 m -125.64 121.82 34.63 Favored 'General case' 0 C--N 1.344 0.345 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 175.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.443 ' HB ' ' OE1' ' A' ' 74' ' ' GLU . 27.0 m -139.59 158.77 27.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 120.675 0.274 . . . . 0.0 111.274 178.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -104.7 129.25 52.91 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 176.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.426 HG23 ' O ' ' A' ' 92' ' ' ILE . 19.8 tt -138.55 130.46 37.57 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.142 0 CA-C-N 120.902 1.683 . . . . 0.0 112.207 178.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.445 ' OE1' ' O ' ' A' ' 69' ' ' HIS . 86.7 mt-30 -61.77 137.26 58.23 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.886 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -137.53 158.52 44.22 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.977 -178.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.432 ' CE1' ' HA3' ' A' ' 67' ' ' GLY . 93.9 m-85 -117.82 136.7 53.24 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -178.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.427 ' HG3' ' CE1' ' A' ' 102' ' ' PHE . 99.1 mttt -84.94 -173.52 4.77 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.175 0.512 . . . . 0.0 111.704 -178.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.42 -43.63 98.37 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.155 177.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 41.1 p-10 -83.81 6.12 22.53 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -178.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.17 -0.31 83.63 Favored Glycine 0 N--CA 1.465 0.609 0 C-N-CA 120.624 -0.798 . . . . 0.0 111.967 176.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 23.0 m -60.65 138.04 58.11 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.664 ' SD ' ' C ' ' A' ' 101' ' ' MET . 13.2 tmm? -104.09 129.03 51.76 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.878 0.37 . . . . 0.0 111.072 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.491 ' N ' ' SD ' ' A' ' 101' ' ' MET . 53.2 p90 -142.65 159.01 43.07 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 120.276 -0.57 . . . . 0.0 109.677 -178.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.832 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 23.6 m95 -90.38 144.29 25.95 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.55 HD21 ' HG2' ' A' ' 123' ' ' GLN . 54.9 t-20 -137.44 106.08 5.86 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -177.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.517 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 80.5 tt0 -72.22 134.34 45.58 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -177.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 40.5 tp -120.05 124.78 46.71 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.972 ' OD1' HG23 ' A' ' 89' ' ' THR . 97.8 m-20 -121.11 122.11 39.34 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 176.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 96.2 mt -119.52 129.12 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 O-C-N 123.43 0.457 . . . . 0.0 111.264 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -138.36 124.57 12.78 Favored Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.878 -0.147 . . . . 0.0 110.648 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -70.81 150.27 61.52 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 122.25 1.967 . . . . 0.0 112.54 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.569 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 67.4 mtt -121.59 153.8 37.58 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -127.48 93.96 3.86 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 177.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.442 ' CD1' HG22 ' B' ' 15' ' ' VAL . 96.2 mt -119.93 130.56 74.08 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.529 -177.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 50.01 37.54 14.32 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 118.746 0.703 . . . . 0.0 111.736 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 59.21 29.94 19.6 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.979 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -127.53 146.61 50.45 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.676 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 5.2 t -82.78 -175.38 5.76 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 121.279 -0.888 . . . . 0.0 109.471 -178.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.676 ' CD2' ' O ' ' A' ' 117' ' ' THR . 73.0 m-85 -168.83 156.18 7.43 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 171.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -129.14 146.31 51.1 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 174.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -135.63 136.88 50.12 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.366 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 177.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -111.25 128.48 8.71 Favored Glycine 0 CA--C 1.503 -0.683 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 178.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 96.5 mt -116.99 128.9 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.555 ' N ' ' O ' ' A' ' 26' ' ' GLY . 15.1 mp0 -120.14 116.91 26.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.101 0.477 . . . . 0.0 109.959 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -116.95 114.84 24.4 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.819 -178.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.411 ' OD1' ' OG1' ' A' ' 127' ' ' THR . 68.3 t0 -63.63 125.24 23.64 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -175.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.546 HG22 ' O ' ' A' ' 126' ' ' ILE . 2.7 mp -89.93 1.08 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 CA-C-N 113.887 -1.506 . . . . 0.0 110.457 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.411 ' OG1' ' OD1' ' A' ' 125' ' ' ASP . 18.4 m -60.46 -42.72 96.77 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.257 -0.902 . . . . 0.0 112.716 -177.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -60.07 -43.06 95.73 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -178.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -63.28 -39.62 95.1 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.705 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.832 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.7 mttt -62.49 -40.57 97.11 Favored 'General case' 0 CA--C 1.503 -0.854 0 C-N-CA 118.486 -1.286 . . . . 0.0 110.52 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.11 -37.3 84.6 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -178.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.837 ' CE2' HD11 ' A' ' 136' ' ' LEU . 90.5 t80 -61.49 -45.26 94.98 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.43 176.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.85 -38.92 92.87 Favored 'General case' 0 C--N 1.342 0.248 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.88 -40.51 95.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.84 0.352 . . . . 0.0 110.15 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 54.5 tp -60.97 -43.6 98.55 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.837 HD11 ' CE2' ' A' ' 132' ' ' TYR . 84.9 mt -62.62 -41.53 99.07 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.196 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.34 -40.62 97.81 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.915 -179.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -60.59 -41.84 95.52 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -177.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 63.3 m -61.33 -40.59 94.81 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.635 176.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 144' ' ' THR . 84.3 mt -63.53 -41.83 98.47 Favored 'General case' 0 C--O 1.221 -0.431 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 90.3 m -61.44 -45.97 92.05 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.295 -177.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.33 -40.14 93.3 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 95.9 mt -64.8 -43.51 96.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 113.781 -1.554 . . . . 0.0 111.281 176.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.504 ' N ' ' O ' ' A' ' 140' ' ' LEU . 90.4 m -62.24 -46.04 90.62 Favored 'General case' 0 C--N 1.344 0.361 0 C-N-CA 120.316 -0.554 . . . . 0.0 112.289 -178.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.06 -39.74 95.63 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 118.815 -1.154 . . . . 0.0 109.017 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.2 mt -63.3 -42.48 99.04 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.756 -0.657 . . . . 0.0 112.517 178.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.753 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.0 p -60.62 -39.95 90.12 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -177.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.495 ' C ' ' O ' ' A' ' 147' ' ' SER . 17.0 m -27.41 79.55 0.02 OUTLIER Pre-proline 0 N--CA 1.468 0.428 0 O-C-N 126.617 2.448 . . . . 0.0 106.733 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.753 ' N ' ' O ' ' A' ' 147' ' ' SER . 20.1 Cg_exo -62.89 145.17 94.48 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 121.007 1.138 . . . . 0.0 114.672 -174.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.584 ' O ' HG23 ' A' ' 151' ' ' VAL . 8.8 tp -120.57 135.45 60.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 103.124 -2.917 . . . . 0.0 103.124 175.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 150' ' ' ILE . 92.3 t -167.73 90.93 0.69 Allowed Pre-proline 0 CA--C 1.516 -0.355 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 178.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -61.39 137.34 69.47 Favored 'Trans proline' 0 C--N 1.3 -2.006 0 N-CA-C 109.465 -1.013 . . . . 0.0 109.465 -176.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.643 ' O ' ' HD2' ' A' ' 154' ' ' ARG . 45.6 mm -67.47 -44.43 86.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 119.746 -0.782 . . . . 0.0 111.069 179.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.643 ' HD2' ' O ' ' A' ' 153' ' ' ILE . 0.3 OUTLIER -159.12 -154.89 0.44 Allowed 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.082 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 63.0 t-20 -87.89 104.37 16.54 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 122.189 0.995 . . . . 0.0 111.897 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 89.91 8.61 66.96 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 114.243 -1.344 . . . . 0.0 111.022 -177.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.505 HG22 ' HB ' ' A' ' 153' ' ' ILE . 96.7 mt -124.09 125.71 71.18 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 CA-C-O 121.748 0.785 . . . . 0.0 109.477 174.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.656 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 57.8 m -132.82 151.47 52.01 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.276 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -138.96 141.96 38.4 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 121.546 -0.721 . . . . 0.0 111.244 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 25.9 tp -133.15 80.2 60.01 Favored Pre-proline 0 N--CA 1.471 0.581 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.141 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -69.65 149.18 67.24 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.778 2.319 . . . . 0.0 113.137 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 86.6 mt -116.99 126.13 52.44 Favored 'General case' 0 C--O 1.25 1.116 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.393 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 47.3 t -123.47 131.48 73.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 115.0 169.61 16.07 Favored Glycine 0 N--CA 1.479 1.537 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.93 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.779 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 54.2 t30 -84.96 113.14 21.19 Favored 'General case' 0 C--O 1.213 -0.835 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.52 HD21 ' CZ ' ' A' ' 171' ' ' PHE . 44.8 tp -73.66 103.48 4.26 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -177.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.67 HG23 ' HE ' ' A' ' 170' ' ' ARG . 9.8 p -86.82 167.34 14.47 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.557 178.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.22 -33.82 76.61 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.411 0.624 . . . . 0.0 111.6 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.1 -43.39 92.25 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.595 178.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.779 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 88.0 mtm180 -64.66 -31.22 72.35 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.134 0.974 . . . . 0.0 112.051 177.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.52 ' CZ ' HD21 ' A' ' 166' ' ' LEU . 0.5 OUTLIER -55.1 -29.38 57.5 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -178.564 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.578 ' O ' HG22 ' A' ' 175' ' ' VAL . 92.2 m-20 -61.12 -40.46 93.86 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 119.038 -1.065 . . . . 0.0 109.679 -177.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 52.6 m -59.71 -41.02 89.88 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.443 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 66.1 mt -63.35 -44.07 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.578 HG22 ' O ' ' A' ' 172' ' ' ASN . 26.8 m -62.57 -39.81 85.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . . . . . . . . . 98.5 m -62.86 -35.16 79.05 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.303 0.573 . . . . 0.0 110.416 178.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.492 ' O ' HG13 ' A' ' 181' ' ' ILE . 25.0 m -61.7 -19.44 62.38 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.201 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.683 ' CD2' HD21 ' A' ' 211' ' ' LEU . 87.8 mt -60.97 -41.43 96.36 Favored 'General case' 0 C--O 1.247 0.967 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 -177.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 19.2 m -59.63 -42.94 93.83 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 -179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.587 ' O ' ' OG ' ' A' ' 183' ' ' SER . 92.1 m-20 -61.43 -37.67 84.35 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 122.588 0.355 . . . . 0.0 110.983 178.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.516 HD12 ' HA ' ' A' ' 178' ' ' LEU . 67.6 mt -58.56 -37.71 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 O-C-N 121.685 -0.634 . . . . 0.0 109.476 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 85.0 mt -60.9 -40.34 92.71 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 119.418 -0.913 . . . . 0.0 108.833 -177.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.587 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 77.8 p -62.01 -33.86 75.13 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.528 176.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 59.3 p -89.37 23.36 2.56 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 120.752 0.31 . . . . 0.0 111.66 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 78.1 p -63.0 -20.54 65.39 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.775 -179.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.71 -37.56 82.1 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.793 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.656 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 98.7 m-20 -73.3 115.05 12.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.424 0.631 . . . . 0.0 110.902 -179.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.92 -42.56 99.84 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.045 -0.98 . . . . 0.0 113.03 -177.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -113.78 131.52 56.19 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.266 0.555 . . . . 0.0 110.779 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 38.9 tp -120.0 127.07 52.28 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 177.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 92.2 mt -114.27 127.15 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 118.658 0.663 . . . . 0.0 109.607 177.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.7 mm -112.23 126.71 69.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . 0.525 ' CG ' ' HG ' ' A' ' 195' ' ' SER . 39.0 t0 -94.66 118.27 31.45 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 122.046 0.927 . . . . 0.0 110.78 177.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 95.9 mt -98.56 -3.49 36.25 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.392 175.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.525 ' HG ' ' CG ' ' A' ' 193' ' ' ASP . 78.0 p -62.69 -33.7 75.62 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.629 0.604 . . . . 0.0 112.629 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.78 -43.63 98.98 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 108.491 -1.844 . . . . 0.0 108.491 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.936 HD23 ' N ' ' A' ' 198' ' ' ALA . 4.9 tt -70.0 129.15 38.68 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 113.104 -1.548 . . . . 0.0 108.584 -176.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.936 ' N ' HD23 ' A' ' 197' ' ' LEU . . . -60.24 -50.56 73.18 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.242 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.912 ' O ' ' CD2' ' A' ' 197' ' ' LEU . 58.4 tt0 -132.29 157.01 45.53 Favored 'General case' 0 C--O 1.204 -1.322 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -175.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.451 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 47.1 t -117.16 132.1 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 O-C-N 120.306 -1.496 . . . . 0.0 108.889 177.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -83.73 154.92 23.34 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.572 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -64.65 -39.2 93.27 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.123 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -58.26 -31.97 67.93 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 17.5 m -60.39 -41.86 94.69 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.563 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.497 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -57.22 -38.64 74.05 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -177.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -62.63 -37.01 84.61 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -64.76 -38.91 92.58 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.967 177.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 94.6 mt -63.47 -44.51 98.85 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.079 0 C-N-CA 119.598 -0.841 . . . . 0.0 108.982 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . 0.497 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 72.0 m-85 -61.53 -44.11 97.65 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.691 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.0 -41.87 98.53 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 119.347 -0.941 . . . . 0.0 109.363 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.683 HD21 ' CD2' ' A' ' 178' ' ' LEU . 38.8 mt -62.66 -42.08 99.42 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 78.1 p -61.99 -41.6 98.21 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 119.351 -0.939 . . . . 0.0 110.151 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -65.11 -45.36 85.44 Favored 'General case' 0 C--O 1.233 0.203 0 O-C-N 121.942 -0.474 . . . . 0.0 111.713 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 50.8 tp -62.36 -44.64 96.0 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 211' ' ' LEU . 85.8 mt -63.03 -40.54 98.04 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.705 -177.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.6 -44.26 96.48 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 90.5 mt -61.99 -39.81 93.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.09 0.472 . . . . 0.0 109.749 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 68.5 p -75.94 -10.96 59.85 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.308 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.63 37.39 14.0 Favored Glycine 0 C--O 1.219 -0.808 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.906 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 96.3 m -124.73 111.15 15.22 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 118.714 1.257 . . . . 0.0 111.309 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -62.31 138.44 58.43 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.548 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 48.0 tp -114.14 130.58 56.59 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 122.849 0.46 . . . . 0.0 109.874 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 3.3 mp -119.04 135.04 60.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.672 ' CG2' HD11 ' A' ' 227' ' ' ILE . 49.7 mm -115.14 132.24 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 38.5 p -133.57 166.8 21.74 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.863 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 78.09 19.61 74.49 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.684 -0.967 . . . . 0.0 110.684 178.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.672 HD11 ' CG2' ' A' ' 224' ' ' ILE . 97.4 mt -81.96 129.32 37.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 114.14 -1.03 . . . . 0.0 108.879 179.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 56.9 tttt -75.3 139.23 71.78 Favored Pre-proline 0 CA--C 1.533 0.31 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.58 -39.66 87.47 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 121.134 1.223 . . . . 0.0 112.526 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -62.83 -40.31 97.0 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-O 121.88 0.848 . . . . 0.0 110.262 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 49.0 tp -63.76 -42.05 97.89 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.543 176.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.31 -37.93 89.17 Favored 'General case' 0 N--CA 1.462 0.16 0 O-C-N 121.938 -0.476 . . . . 0.0 111.273 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 94.1 mtp -63.78 -41.15 98.0 Favored 'General case' 0 C--O 1.247 0.936 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -178.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.48 -38.86 92.76 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.594 177.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 32.4 mmt -65.68 -37.4 86.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.716 178.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -60.82 -41.67 96.17 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 121.558 -0.714 . . . . 0.0 109.371 -177.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.24 -41.55 97.07 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.527 0.68 . . . . 0.0 110.58 -179.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 54.3 tp -63.02 -41.67 99.61 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 177.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 240' ' ' ALA . 67.0 t0 -166.81 128.91 1.74 Allowed 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.417 -0.802 . . . . 0.0 112.656 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.402 ' N ' ' OD1' ' A' ' 239' ' ' ASP . . . -61.19 -27.88 68.74 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.636 -1.165 . . . . 0.0 110.853 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.415 ' O ' ' HB2' ' A' ' 244' ' ' SER . 88.2 m-20 -60.92 -28.96 69.31 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.537 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -55.98 -43.81 77.97 Favored 'General case' 0 C--N 1.316 -0.881 0 O-C-N 121.235 -0.916 . . . . 0.0 109.048 -176.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 88.4 p -63.48 -19.27 64.6 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.039 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . 0.415 ' HB2' ' O ' ' A' ' 241' ' ' ASN . 43.4 m -55.31 -38.4 68.62 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.259 178.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 96.8 mt -87.8 124.72 33.91 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 119.794 -0.762 . . . . 0.0 112.687 -176.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -49.19 134.62 17.73 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.903 -176.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.581 HG23 HD12 ' A' ' 227' ' ' ILE . 95.5 m -126.61 132.01 51.36 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 114.215 -1.357 . . . . 0.0 111.364 178.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' TYR . . . . . 0.505 ' CG ' ' HB2' ' A' ' 254' ' ' ALA . 96.0 m-85 -116.07 140.98 48.73 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.331 178.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . 0.448 ' O ' ' OD1' ' A' ' 250' ' ' ASN . 78.1 p -60.59 -41.94 95.73 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.448 ' OD1' ' O ' ' A' ' 249' ' ' SER . 99.2 m-20 -145.45 159.63 42.8 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.613 0.72 . . . . 0.0 111.069 -178.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . 0.403 ' O ' HG23 ' A' ' 255' ' ' VAL . 66.0 t -61.99 -44.72 99.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-N 114.632 -1.167 . . . . 0.0 112.085 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.31 -43.8 98.27 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . 0.464 ' O ' HG22 ' A' ' 257' ' ' VAL . 54.0 m-20 -64.13 -42.4 96.83 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.216 -178.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.505 ' HB2' ' CG ' ' A' ' 248' ' ' TYR . . . -64.96 -41.81 95.14 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.973 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . 0.661 HG13 HH11 ' B' ' 154' ' ' ARG . 73.3 t -63.08 -45.59 98.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.009 -178.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.93 -47.72 79.38 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.562 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.506 ' O ' ' C ' ' A' ' 258' ' ' LEU . 27.6 m -66.75 -41.67 88.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 120.138 -0.625 . . . . 0.0 112.403 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.506 ' C ' ' O ' ' A' ' 257' ' ' VAL . 1.3 mt -28.37 -72.93 0.05 OUTLIER Pre-proline 0 C--N 1.346 0.452 0 CA-C-O 119.562 -0.256 . . . . 0.0 111.248 -177.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' PRO . . . . . 0.475 ' CD ' ' CB ' ' A' ' 258' ' ' LEU . 45.4 Cg_endo -64.13 140.43 71.61 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.005 1.137 . . . . 0.0 112.073 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 259' ' ' PRO . 96.8 mt -152.74 -27.12 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 178.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 N--CA 1.473 0.68 0 CA-C-O 118.159 -0.924 . . . . 0.0 110.622 -177.017 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.493 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.83 158.94 29.25 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 118.728 -0.653 . . . . 0.0 109.933 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 80.7 p -58.88 -25.08 63.01 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 124.177 0.923 . . . . 0.0 110.908 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -68.88 -63.31 1.08 Allowed 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.521 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -67.18 -38.09 84.8 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.496 178.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.483 ' O ' ' HB3' ' B' ' 7' ' ' PHE . 66.3 m -59.69 -42.53 93.14 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 120.442 -0.503 . . . . 0.0 109.906 -177.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . 0.687 ' CE2' HD12 ' B' ' 9' ' ' ILE . 41.7 t80 83.08 88.19 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 O-C-N 123.904 0.753 . . . . 0.0 110.293 177.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . 0.496 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -62.42 -134.98 0.01 OUTLIER Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -178.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.687 HD12 ' CE2' ' B' ' 7' ' ' PHE . 56.4 mt 79.25 108.54 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.656 0 C-N-CA 122.546 0.338 . . . . 0.0 111.059 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -62.45 -24.25 75.41 Favored 'Trans proline' 0 N--CA 1.498 1.793 0 C-N-CA 121.428 1.419 . . . . 0.0 111.792 -178.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.92 -40.45 98.88 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 110.804 -0.918 . . . . 0.0 110.804 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -64.18 -38.94 92.87 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.742 0.782 . . . . 0.0 109.626 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 51.1 tp -62.25 -42.55 99.43 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 114.757 -1.11 . . . . 0.0 112.114 -177.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -64.54 -33.33 75.66 Favored 'General case' 0 CA--C 1.563 1.466 0 CA-C-O 121.628 0.727 . . . . 0.0 110.759 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . 0.442 HG22 ' CD1' ' A' ' 113' ' ' ILE . 74.1 t -61.9 -46.16 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-N 113.094 -1.867 . . . . 0.0 111.108 176.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 94.7 mt -63.76 -43.79 98.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.07 0.462 . . . . 0.0 110.255 -178.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . 0.47 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 98.9 mttt -63.42 -42.51 98.73 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.41 -41.07 98.72 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.065 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.67 -39.1 87.16 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.689 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' B' ' 20' ' ' LEU . 89.3 mt -64.07 -42.0 97.15 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.05 0.452 . . . . 0.0 110.234 175.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.95 -39.2 93.91 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.121 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 52.4 m170 -57.61 -40.14 78.47 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 121.192 -0.203 . . . . 0.0 111.365 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 10.6 p -114.28 130.27 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.551 ' O ' ' HG3' ' B' ' 24' ' ' ARG . 35.5 ptt180 -71.57 107.15 4.31 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 122.176 0.989 . . . . 0.0 112.392 -177.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.0 p -142.04 133.61 26.47 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.497 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' B' ' 123' ' ' GLN . . . -89.45 97.03 2.28 Favored Glycine 0 N--CA 1.434 -1.451 0 C-N-CA 119.441 -1.361 . . . . 0.0 113.326 -175.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 50.0 t -125.43 129.4 72.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 174.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 27.3 m -138.11 156.48 30.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.803 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.41 ' HB ' ' HB3' ' B' ' 41' ' ' TYR . 95.5 mt -119.43 127.87 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 122.579 1.18 . . . . 0.0 111.17 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.447 ' HB ' ' OD1' ' B' ' 37' ' ' ASN . 18.3 p -111.57 157.73 20.03 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 113.07 -1.877 . . . . 0.0 108.27 -176.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -125.38 104.4 28.5 Favored Pre-proline 0 C--O 1.24 0.569 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.12 -177.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' PRO . . . . . 0.432 ' CG ' HG23 ' B' ' 117' ' ' THR . 37.4 Cg_endo -64.76 -20.56 64.97 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 121.678 1.585 . . . . 0.0 111.564 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.37 -42.68 99.6 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 120.705 -0.398 . . . . 0.0 110.048 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 96.3 mt -74.97 -175.48 2.58 Favored 'General case' 0 N--CA 1.464 0.231 0 O-C-N 121.833 -0.542 . . . . 0.0 111.243 -179.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . 0.713 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 42.6 tt0 -78.9 130.93 36.16 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.46 ' O ' ' OD1' ' B' ' 36' ' ' ASP . 62.4 t0 56.37 36.26 27.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.476 -0.783 . . . . 0.0 110.661 177.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' ASN . . . . . 0.447 ' OD1' ' HB ' ' B' ' 30' ' ' THR . 23.1 t-20 31.89 68.68 0.83 Allowed Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.713 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 91.4 Cg_endo -72.08 155.69 56.68 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 C-N-CA 123.332 2.688 . . . . 0.0 111.569 179.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 96.3 mt -87.35 129.5 38.67 Favored 'Isoleucine or valine' 0 C--O 1.247 0.943 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.406 HG23 ' N ' ' B' ' 41' ' ' TYR . 26.8 m -109.32 -42.31 5.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 O-C-N 123.943 0.777 . . . . 0.0 112.478 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' TYR . . . . . 0.41 ' HB3' ' HB ' ' B' ' 29' ' ' ILE . 51.9 t80 -96.99 123.91 40.83 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 120.097 -0.641 . . . . 0.0 111.4 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 5.3 p -142.6 140.37 28.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.446 177.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . 0.607 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 57.5 p30 -100.72 160.98 13.92 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.162 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' GLN . . . . . 0.468 ' OE1' ' HA ' ' B' ' 44' ' ' GLN . 12.8 mm100 -62.98 -36.95 85.21 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.66 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.07 -27.04 64.27 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.681 ' CD2' HD13 ' B' ' 57' ' ' ILE . 65.9 t80 -60.37 -43.09 96.9 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 0.807 HG13 ' O ' ' B' ' 52' ' ' TYR . 76.9 t -61.07 -46.16 97.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.231 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -63.31 -43.73 97.0 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 119.896 -0.721 . . . . 0.0 110.317 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 59.7 ttm -63.41 -42.48 98.75 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 35.0 p -95.15 -16.55 22.49 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.609 -178.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' B' ' 47' ' ' VAL . . . 74.45 17.19 79.79 Favored Glycine 0 CA--C 1.53 0.974 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 178.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . 0.807 ' O ' HG13 ' B' ' 47' ' ' VAL . 83.8 m-85 -109.94 145.19 37.32 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 122.953 0.501 . . . . 0.0 110.328 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -75.24 148.34 39.55 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-O 121.254 0.549 . . . . 0.0 111.24 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . 0.428 HG22 ' H ' ' B' ' 54' ' ' THR . 0.2 OUTLIER -60.96 -37.21 81.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.866 -176.75 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.5 -39.75 95.27 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 120.113 -0.635 . . . . 0.0 111.993 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -72.1 -33.3 67.76 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 176.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.681 HD13 ' CD2' ' B' ' 46' ' ' PHE . 94.9 mt -68.02 -59.36 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 95.9 mt -53.14 134.69 38.61 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -175.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.4 -8.34 74.97 Favored Glycine 0 CA--C 1.538 1.498 0 CA-C-N 116.166 -0.47 . . . . 0.0 113.032 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -133.16 149.05 52.08 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -175.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' ASN . . . . . 0.548 ' C ' ' H ' ' B' ' 63' ' ' ARG . 24.8 t-20 -78.44 150.06 33.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.527 -1.215 . . . . 0.0 110.517 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' CYS . . . . . . . . . . . . . 82.5 m -63.42 9.23 0.06 Allowed 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . 0.548 ' H ' ' C ' ' B' ' 61' ' ' ASN . 34.8 ptt-85 -60.54 -32.93 71.96 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.516 -0.765 . . . . 0.0 112.42 -176.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -58.5 -30.61 67.17 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 86.6 mt -62.02 -41.26 97.89 Favored 'General case' 0 C--O 1.238 0.463 0 O-C-N 121.757 -0.59 . . . . 0.0 109.742 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -51.71 145.31 9.53 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.851 -175.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . 0.448 ' HA3' ' CE1' ' B' ' 95' ' ' TYR . . . -157.03 -153.9 6.85 Favored Glycine 0 CA--C 1.535 1.318 0 O-C-N 124.259 0.974 . . . . 0.0 111.774 177.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.26 -41.7 89.45 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -175.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -76.07 -9.84 58.94 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.139 -177.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' THR . . . . . 0.426 ' OG1' ' N ' ' B' ' 67' ' ' GLY . 26.2 m -61.89 134.03 56.17 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 120.258 -0.577 . . . . 0.0 109.517 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -90.45 112.16 51.37 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.518 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.62 -37.96 90.88 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 121.185 1.257 . . . . 0.0 111.856 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.97 -40.07 92.01 Favored 'General case' 0 CA--C 1.521 -0.171 0 C-N-CA 120.42 -0.512 . . . . 0.0 109.761 -175.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' GLU . . . . . 0.445 ' OE1' ' HB ' ' B' ' 90' ' ' VAL . 78.8 mm-40 -66.76 -38.81 87.35 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.001 177.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 70.1 t -62.43 -46.06 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -62.94 -37.46 87.13 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.667 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -62.12 -41.8 98.6 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 119.315 -0.954 . . . . 0.0 108.874 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 94.1 mt -63.49 -43.7 98.48 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 CA-C-O 120.81 0.338 . . . . 0.0 110.907 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 77.1 ttt180 -61.38 -43.21 99.25 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 88.4 m -61.75 -45.16 95.11 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.59 0.71 . . . . 0.0 110.171 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.36 -41.83 98.92 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -176.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 86.9 mt -62.7 -42.53 99.69 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.516 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 66.8 tp60 -62.78 -34.01 76.35 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -90.78 6.86 42.52 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.414 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 30.8 tttt 42.46 37.99 1.11 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.969 176.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -121.94 141.28 33.76 Favored Pre-proline 0 N--CA 1.467 0.42 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.222 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.1 141.38 88.45 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.075 1.183 . . . . 0.0 113.754 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.5 p -139.81 136.11 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.942 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' THR . . . . . 0.965 HG23 ' OD1' ' B' ' 107' ' ' ASN . 96.5 m -121.05 122.6 40.43 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.445 ' HB ' ' OE1' ' B' ' 74' ' ' GLU . 27.3 m -138.92 162.86 27.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.913 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -115.38 121.51 43.01 Favored 'General case' 0 N--CA 1.473 0.72 0 O-C-N 121.978 -0.451 . . . . 0.0 109.819 174.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 21.3 tt -129.83 132.69 65.66 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 O-C-N 124.191 0.932 . . . . 0.0 111.623 -174.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -69.78 143.33 53.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.97 178.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -133.2 177.31 7.77 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 121.718 0.77 . . . . 0.0 111.43 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' TYR . . . . . 0.448 ' CE1' ' HA3' ' B' ' 67' ' ' GLY . 96.5 m-85 -127.27 146.57 50.39 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.267 -1.333 . . . . 0.0 112.293 176.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . 0.416 ' HG3' ' CE1' ' B' ' 102' ' ' PHE . 98.7 mttt -101.11 -179.88 4.17 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.338 0.589 . . . . 0.0 110.584 177.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.87 -36.56 79.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.306 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 38.9 p-10 -87.09 -0.44 56.66 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.466 -0.771 . . . . 0.0 112.912 179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.65 3.25 64.6 Favored Glycine 0 N--CA 1.467 0.714 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.528 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 25.4 m -67.16 131.01 44.94 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . 0.597 ' SD ' ' N ' ' B' ' 102' ' ' PHE . 14.6 tmm? -90.83 141.86 28.38 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' PHE . . . . . 0.597 ' N ' ' SD ' ' B' ' 101' ' ' MET . 53.4 p90 -153.35 163.94 39.02 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 177.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' TRP . . . . . 0.853 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 23.3 m95 -96.16 140.8 30.33 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.825 0.821 . . . . 0.0 110.428 179.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . 0.515 HD21 ' HG2' ' B' ' 123' ' ' GLN . 63.2 t-20 -132.97 109.46 9.58 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 114.806 -1.088 . . . . 0.0 113.476 -177.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' B' ' 123' ' ' GLN . 81.0 tt0 -78.78 123.11 26.86 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.221 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 41.1 tp -112.27 126.56 55.37 Favored 'General case' 0 C--N 1.346 0.445 0 CA-C-O 120.873 0.368 . . . . 0.0 111.874 -177.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' ASN . . . . . 0.965 ' OD1' HG23 ' B' ' 89' ' ' THR . 97.8 m-20 -120.37 126.92 51.71 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 175.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 96.4 mt -121.9 133.15 69.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -143.53 123.3 7.61 Favored Pre-proline 0 CA--C 1.538 0.497 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 178.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -69.04 151.82 73.13 Favored 'Trans proline' 0 N--CA 1.501 1.941 0 C-N-CA 122.411 2.074 . . . . 0.0 112.471 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . 0.477 ' HB2' ' HB2' ' B' ' 118' ' ' TYR . 67.2 mtt -128.59 143.66 51.0 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -113.24 106.59 14.81 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 106.074 -1.825 . . . . 0.0 106.074 179.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . 0.653 HG12 ' NZ ' ' A' ' 18' ' ' LYS . 96.8 mt -133.15 127.06 54.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-N 118.474 0.579 . . . . 0.0 111.525 178.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 52.48 37.86 24.0 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.026 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 59.92 36.03 21.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.707 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -132.68 150.2 52.19 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 177.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' THR . . . . . 0.432 HG23 ' CG ' ' B' ' 32' ' ' PRO . 6.9 t -100.45 153.52 19.28 Favored 'General case' 0 C--O 1.217 -0.62 0 C-N-CA 120.555 -0.458 . . . . 0.0 109.908 -177.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' TYR . . . . . 0.477 ' HB2' ' HB2' ' B' ' 111' ' ' MET . 90.7 m-85 -148.43 146.37 28.4 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 121.071 -1.018 . . . . 0.0 111.182 -178.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -122.59 138.6 54.53 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 120.66 0.267 . . . . 0.0 111.198 -176.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.7 p -129.28 135.8 60.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -177.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -112.59 122.74 6.02 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 89.1 mt -111.71 127.31 68.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 123' ' ' GLN . . . . . 0.515 ' HG2' HD21 ' B' ' 104' ' ' ASN . 15.3 mp0 -118.61 122.96 43.83 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 178.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -119.92 123.6 43.97 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' B' ' 127' ' ' THR . 67.2 t0 -70.37 129.05 38.27 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.634 -178.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.562 ' O ' ' HG3' ' B' ' 130' ' ' LYS . 2.7 mp -102.61 15.55 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.837 0 CA-C-O 122.052 0.93 . . . . 0.0 109.278 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 127' ' ' THR . . . . . 0.479 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 19.5 m -63.13 -44.63 95.05 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 114.225 -1.352 . . . . 0.0 113.013 175.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 58.8 tptt -61.34 -46.1 91.64 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -178.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 129' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -63.69 -35.16 79.64 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.548 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 130' ' ' LYS . . . . . 0.853 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 98.7 mttt -63.73 -40.6 97.14 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 113.865 -1.516 . . . . 0.0 110.547 174.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.41 -41.38 96.66 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 132' ' ' TYR . . . . . 0.821 ' CE2' HD11 ' B' ' 136' ' ' LEU . 90.1 t80 -60.56 -44.16 96.46 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 121.693 -0.629 . . . . 0.0 111.066 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.0 -36.73 84.94 Favored 'General case' 0 C--N 1.333 -0.133 0 C-N-CA 120.328 -0.549 . . . . 0.0 109.548 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.2 -39.54 94.94 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.881 178.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 54.1 tp -62.59 -41.3 98.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.187 0.518 . . . . 0.0 109.741 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . 0.821 HD11 ' CE2' ' B' ' 132' ' ' TYR . 86.9 mt -62.9 -41.89 99.6 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.27 177.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 137' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.56 -36.78 84.79 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.466 -1.243 . . . . 0.0 110.432 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.05 -43.01 99.82 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 119.997 -0.681 . . . . 0.0 109.896 177.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 70.1 m -60.74 -44.38 96.75 Favored 'General case' 0 C--N 1.343 0.323 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . 0.443 ' O ' ' N ' ' B' ' 144' ' ' THR . 84.2 mt -61.04 -40.25 92.88 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -177.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 91.3 m -61.85 -45.46 93.71 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.91 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -66.33 -42.12 88.63 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 93.7 mt -63.67 -43.17 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.714 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 144' ' ' THR . . . . . 0.443 ' N ' ' O ' ' B' ' 140' ' ' LEU . 90.2 m -61.75 -45.24 94.77 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.56 -40.59 97.38 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 119.074 -1.051 . . . . 0.0 109.412 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 86.1 mt -64.49 -41.51 96.41 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 147' ' ' SER . . . . . 0.641 ' O ' ' N ' ' B' ' 149' ' ' PRO . 78.1 p -60.89 -42.77 98.65 Favored 'General case' 0 CA--C 1.48 -1.726 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . 0.494 ' C ' ' O ' ' B' ' 147' ' ' SER . 6.8 m -27.8 84.75 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.592 0 O-C-N 124.105 0.878 . . . . 0.0 110.158 177.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 149' ' ' PRO . . . . . 0.641 ' N ' ' O ' ' B' ' 147' ' ' SER . 23.0 Cg_exo -62.34 147.59 94.69 Favored 'Trans proline' 0 C--N 1.296 -2.213 0 C-N-CA 122.234 1.956 . . . . 0.0 115.641 -177.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 9.1 tp -127.74 120.17 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-N 114.004 -1.453 . . . . 0.0 107.867 174.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 63.8 t -150.71 92.95 3.82 Favored Pre-proline 0 C--N 1.314 -0.936 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.992 -178.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -60.77 137.16 71.06 Favored 'Trans proline' 0 N--CA 1.484 0.952 0 N-CA-C 109.175 -1.125 . . . . 0.0 109.175 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 153' ' ' ILE . . . . . 0.64 ' O ' ' HD2' ' B' ' 154' ' ' ARG . 45.2 mm -67.66 -43.9 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.17 178.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . 0.661 HH11 HG13 ' A' ' 255' ' ' VAL . 0.3 OUTLIER -158.82 -154.01 0.4 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -179.618 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 62.3 t-20 -86.89 108.49 18.8 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.69 -16.38 58.75 Favored Glycine 0 C--O 1.221 -0.713 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 157' ' ' ILE . . . . . 0.509 HG22 ' HB ' ' B' ' 153' ' ' ILE . 89.0 mt -110.13 125.59 67.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.326 0.584 . . . . 0.0 111.37 -176.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . 0.631 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 68.3 m -134.7 148.91 50.41 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.096 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -134.45 145.45 48.86 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.226 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 30.3 tp -138.45 79.25 30.56 Favored Pre-proline 0 C--O 1.234 0.283 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 161' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -70.54 146.99 56.87 Favored 'Trans proline' 0 N--CA 1.5 1.869 0 C-N-CA 122.831 2.354 . . . . 0.0 114.4 -178.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 87.0 mt -112.51 132.97 54.82 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 54.2 t -128.55 132.79 67.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 113.23 169.1 17.17 Favored Glycine 0 CA--C 1.535 1.304 0 C-N-CA 120.35 -0.929 . . . . 0.0 111.266 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 165' ' ' ASN . . . . . 0.688 ' O ' ' CZ ' ' B' ' 170' ' ' ARG . 61.9 t30 -89.62 107.02 18.85 Favored 'General case' 0 C--O 1.215 -0.752 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -177.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . 0.508 HD21 ' CZ ' ' B' ' 171' ' ' PHE . 46.7 tp -65.86 104.49 1.1 Allowed 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 -174.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 167' ' ' THR . . . . . 0.647 HG23 ' HE ' ' B' ' 170' ' ' ARG . 9.8 p -85.37 169.97 13.18 Favored 'General case' 0 C--N 1.346 0.456 0 CA-C-N 114.271 -1.331 . . . . 0.0 110.901 177.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.84 -37.39 84.38 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.718 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.34 -41.24 89.85 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-O 123.44 1.591 . . . . 0.0 111.508 -178.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 170' ' ' ARG . . . . . 0.688 ' CZ ' ' O ' ' B' ' 165' ' ' ASN . 88.3 mtm180 -62.58 -35.28 79.01 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 112.276 -2.238 . . . . 0.0 110.653 177.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 171' ' ' PHE . . . . . 0.508 ' CZ ' HD21 ' B' ' 166' ' ' LEU . 0.5 OUTLIER -54.9 -26.25 34.59 Favored 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -178.736 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 172' ' ' ASN . . . . . 0.531 ' O ' HG22 ' B' ' 175' ' ' VAL . 92.7 m-20 -62.88 -40.3 97.12 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.784 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 48.8 m -60.17 -41.77 93.57 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.051 0.453 . . . . 0.0 110.63 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 64.8 mt -63.43 -44.29 98.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 175' ' ' VAL . . . . . 0.531 HG22 ' O ' ' B' ' 172' ' ' ASN . 27.3 m -62.44 -39.81 85.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 176' ' ' CYS . . . . . . . . . . . . . 96.7 m -62.69 -35.58 80.14 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.344 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 177' ' ' THR . . . . . 0.527 ' O ' HG13 ' B' ' 181' ' ' ILE . 25.1 m -61.69 -19.42 62.34 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.499 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 178' ' ' LEU . . . . . 0.656 ' CD2' HD21 ' B' ' 211' ' ' LEU . 88.2 mt -61.23 -39.36 90.01 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -178.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 19.2 m -61.77 -44.03 97.69 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 120.74 0.305 . . . . 0.0 110.262 177.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 180' ' ' ASN . . . . . 0.587 ' O ' ' OG ' ' B' ' 183' ' ' SER . 92.6 m-20 -61.27 -40.22 93.29 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.853 0.358 . . . . 0.0 110.494 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.527 HG13 ' O ' ' B' ' 177' ' ' THR . 72.7 mt -57.47 -32.0 40.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 O-C-N 122.284 -0.26 . . . . 0.0 110.753 -178.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 182' ' ' LEU . . . . . . . . . . . . . 83.9 mt -62.38 -41.99 99.07 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.096 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . 0.587 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.4 p -63.28 -32.84 74.35 Favored 'General case' 0 C--N 1.334 -0.106 0 O-C-N 121.835 -0.54 . . . . 0.0 110.865 178.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 56.8 p -85.87 17.34 3.49 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.787 -177.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 78.8 p -61.5 -16.39 46.92 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.523 -176.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.17 -40.17 95.1 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 121.076 -0.25 . . . . 0.0 110.764 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 187' ' ' ASP . . . . . 0.631 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.6 m-20 -70.43 114.95 9.05 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.44 0.638 . . . . 0.0 110.635 -177.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -62.63 -42.6 99.68 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 114.922 -1.035 . . . . 0.0 113.112 -177.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -113.55 131.38 56.11 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.149 -177.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 190' ' ' LEU . . . . . . . . . . . . . 40.7 tp -123.29 119.37 29.93 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.089 177.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 84.5 mt -107.43 125.08 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 117.851 0.296 . . . . 0.0 110.89 -176.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 50.1 mm -113.7 118.83 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 193' ' ' ASP . . . . . 0.475 ' CG ' ' HG ' ' B' ' 195' ' ' SER . 41.5 t0 -90.29 112.17 23.62 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -176.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 194' ' ' LEU . . . . . . . . . . . . . 96.6 mt -94.71 -1.89 52.18 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 123.705 0.628 . . . . 0.0 109.782 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 195' ' ' SER . . . . . 0.475 ' HG ' ' CG ' ' B' ' 193' ' ' ASP . 77.9 p -60.83 -39.0 87.4 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.905 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.18 -35.19 90.47 Favored Glycine 0 N--CA 1.438 -1.205 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -178.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 197' ' ' LEU . . . . . 0.952 HD23 ' N ' ' B' ' 198' ' ' ALA . 5.3 tt -74.27 133.8 42.63 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 198' ' ' ALA . . . . . 0.952 ' N ' HD23 ' B' ' 197' ' ' LEU . . . -61.75 -47.38 85.44 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 120.012 -0.675 . . . . 0.0 111.322 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 199' ' ' GLN . . . . . 0.942 ' O ' ' CD2' ' B' ' 197' ' ' LEU . 59.2 tt0 -136.76 164.7 27.66 Favored 'General case' 0 C--O 1.209 -1.077 0 CA-C-O 122.083 0.944 . . . . 0.0 112.389 -177.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 200' ' ' VAL . . . . . 0.515 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 51.8 t -120.53 131.85 71.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 O-C-N 120.579 -1.326 . . . . 0.0 109.532 177.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -86.81 150.08 24.38 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.855 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.27 -33.17 74.1 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.253 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -63.7 -32.3 73.74 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.382 0.61 . . . . 0.0 109.481 177.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.2 m -60.81 -43.82 97.67 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.206 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 205' ' ' ALA . . . . . 0.633 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -58.26 -29.6 65.92 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -178.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -65.94 -38.35 88.39 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.431 0.634 . . . . 0.0 110.646 174.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -66.13 -38.46 88.21 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.477 178.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 95.0 mt -62.97 -45.51 98.69 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -178.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 209' ' ' PHE . . . . . 0.633 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 67.6 m-85 -61.47 -42.58 99.0 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.916 -176.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.82 -42.04 99.56 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 119.581 -0.847 . . . . 0.0 109.94 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . 0.656 HD21 ' CD2' ' B' ' 178' ' ' LEU . 38.3 mt -62.49 -42.52 99.55 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.173 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 78.1 p -63.46 -37.29 86.72 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.291 -0.564 . . . . 0.0 112.105 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 213' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -66.18 -46.64 76.63 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.214 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.404 ' O ' HG23 ' B' ' 218' ' ' THR . 53.3 tp -63.92 -42.57 97.35 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 121.895 0.855 . . . . 0.0 109.863 177.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 215' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' B' ' 211' ' ' LEU . 86.2 mt -62.53 -43.4 98.91 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 113.274 -1.785 . . . . 0.0 111.288 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.19 -39.77 93.83 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.749 0.309 . . . . 0.0 111.438 -177.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 92.4 mt -63.24 -41.97 99.14 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.443 0.64 . . . . 0.0 111.196 176.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 218' ' ' THR . . . . . 0.404 HG23 ' O ' ' B' ' 214' ' ' LEU . 68.3 p -74.75 -14.83 60.76 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.642 -178.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 78.14 65.46 1.87 Allowed Glycine 0 CA--C 1.528 0.885 0 N-CA-C 107.485 -2.246 . . . . 0.0 107.485 -177.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 220' ' ' THR . . . . . . . . . . . . . 95.3 m -144.08 105.31 4.24 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 175.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -62.15 140.96 58.4 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 120.371 -0.532 . . . . 0.0 110.922 -176.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 45.3 tp -117.18 121.83 42.32 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.645 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 3.5 mp -112.35 129.77 67.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.04 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 224' ' ' ILE . . . . . 0.643 ' CG2' HD11 ' B' ' 227' ' ' ILE . 50.1 mm -110.74 127.13 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 44.0 p -134.24 156.46 48.36 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 121.957 0.884 . . . . 0.0 112.495 -178.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 90.5 16.85 54.44 Favored Glycine 0 C--N 1.316 -0.564 0 CA-C-N 113.951 -1.477 . . . . 0.0 111.303 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 227' ' ' ILE . . . . . 0.643 HD11 ' CG2' ' B' ' 224' ' ' ILE . 95.5 mt -82.81 127.21 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 118.027 0.914 . . . . 0.0 111.284 -178.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 56.1 tttt -66.58 138.17 95.47 Favored Pre-proline 0 C--N 1.316 -0.868 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.525 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.9 -37.4 93.09 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 121.443 1.429 . . . . 0.0 112.616 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 46.8 tt0 -62.66 -44.12 97.07 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -179.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 48.3 tp -61.68 -41.64 97.84 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.267 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.06 -37.41 87.1 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.931 -0.307 . . . . 0.0 111.414 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 94.6 mtp -64.16 -40.06 95.34 Favored 'General case' 0 C--O 1.243 0.733 0 CA-C-O 121.248 0.547 . . . . 0.0 109.629 178.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.43 -42.74 98.69 Favored 'General case' 0 CA--C 1.554 1.114 0 CA-C-O 122.443 1.116 . . . . 0.0 109.539 178.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 33.0 mmt -63.81 -35.86 82.0 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.507 -1.224 . . . . 0.0 111.89 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -62.06 -40.33 95.44 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.006 -178.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.01 -43.66 98.14 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 120.512 -0.475 . . . . 0.0 109.825 177.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 55.1 tp -62.57 -44.57 96.0 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.625 -178.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 239' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' B' ' 240' ' ' ALA . 66.8 t0 -159.27 132.5 7.11 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.35 -0.54 . . . . 0.0 112.106 -178.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 240' ' ' ALA . . . . . 0.41 ' N ' ' OD1' ' B' ' 239' ' ' ASP . . . -61.07 -46.55 90.22 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 177.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 241' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' B' ' 244' ' ' SER . 92.1 m-20 -44.06 -20.14 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.689 -175.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 242' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -60.63 -44.99 95.71 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.141 -0.624 . . . . 0.0 110.298 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 243' ' ' SER . . . . . . . . . . . . . 78.1 p -57.93 -42.87 85.78 Favored 'General case' 0 C--N 1.34 0.175 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 178.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 244' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 20.0 m -34.61 -35.0 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -177.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 97.3 mt -88.36 132.51 34.4 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.702 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -58.28 135.41 57.13 Favored 'General case' 0 C--O 1.25 1.121 0 CA-C-O 121.906 0.86 . . . . 0.0 111.523 -178.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 247' ' ' THR . . . . . 0.604 HG23 HD12 ' B' ' 227' ' ' ILE . 98.1 m -127.13 128.09 45.63 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-N 114.525 -1.216 . . . . 0.0 112.004 178.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 248' ' ' TYR . . . . . 0.511 ' CG ' ' HB2' ' B' ' 254' ' ' ALA . 93.4 m-85 -112.46 143.78 43.02 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 249' ' ' SER . . . . . 0.565 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 78.2 p -62.57 -34.99 78.08 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.18 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 250' ' ' ASN . . . . . 0.565 ' OD1' ' O ' ' B' ' 249' ' ' SER . 99.0 m-20 -147.16 161.28 41.22 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 114.966 -1.015 . . . . 0.0 112.574 178.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 251' ' ' VAL . . . . . 0.406 ' O ' HG23 ' B' ' 255' ' ' VAL . 69.2 t -64.76 -44.93 96.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.788 178.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 252' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.04 -45.95 92.7 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . 0.477 ' O ' HG22 ' B' ' 257' ' ' VAL . 94.2 m-20 -61.23 -43.24 99.2 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.438 -0.801 . . . . 0.0 112.57 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 254' ' ' ALA . . . . . 0.511 ' HB2' ' CG ' ' B' ' 248' ' ' TYR . . . -65.73 -39.49 91.21 Favored 'General case' 0 CA--C 1.513 -0.477 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.062 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 255' ' ' VAL . . . . . 0.643 HG13 HH11 ' A' ' 154' ' ' ARG . 76.2 t -65.22 -45.76 92.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.875 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.548 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.0 -48.4 78.98 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 121.588 0.709 . . . . 0.0 111.263 -177.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 257' ' ' VAL . . . . . 0.477 HG22 ' O ' ' B' ' 253' ' ' ASP . 27.1 m -65.09 -40.83 90.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.959 -1.018 . . . . 0.0 111.464 -179.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 258' ' ' LEU . . . . . 0.482 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 1.3 mt -31.79 -72.3 0.07 OUTLIER Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.794 -178.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 259' ' ' PRO . . . . . 0.513 ' O ' HG13 ' B' ' 260' ' ' ILE . 39.8 Cg_endo -63.11 140.94 81.04 Favored 'Trans proline' 0 N--CA 1.504 2.103 0 C-N-CA 121.59 1.527 . . . . 0.0 111.351 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 260' ' ' ILE . . . . . 0.535 ' O ' HG22 ' B' ' 260' ' ' ILE . 96.7 mt -158.33 -15.4 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-N 118.591 0.632 . . . . 0.0 112.573 177.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 78.0 mtm . . . . . 0 N--CA 1.466 0.339 0 CA-C-O 118.207 -0.901 . . . . 0.0 111.825 179.675 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 900' ' ' FMN . . . . . 0.41 ' C9A' " O2'" ' A' ' 900' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 900' ' ' FMN . . . . . 0.405 ' H9 ' H1'1 ' B' ' 900' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.15 -175.16 4.59 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 88.5 p -85.11 -7.04 59.26 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.484 -0.76 . . . . 0.0 111.412 177.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -81.57 -63.45 1.39 Allowed 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 114.109 -1.405 . . . . 0.0 113.157 172.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -67.5 -38.79 84.84 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.557 ' O ' ' NZ ' ' B' ' 17' ' ' LYS . 66.9 m -59.44 -42.08 91.12 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.181 -177.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.522 ' CE2' HD12 ' A' ' 9' ' ' ILE . 46.9 t80 85.48 85.96 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 O-C-N 123.766 0.666 . . . . 0.0 111.03 177.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.646 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -58.78 -150.13 0.01 OUTLIER Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.455 -0.658 . . . . 0.0 111.455 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.646 ' HB ' ' O ' ' A' ' 8' ' ' GLY . 89.3 mt 91.4 111.85 0.02 OUTLIER Pre-proline 0 N--CA 1.471 0.598 0 C-N-CA 122.734 0.414 . . . . 0.0 110.775 -179.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.66 -22.03 64.77 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 121.431 1.421 . . . . 0.0 112.153 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.05 -38.68 96.36 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 120.953 -0.641 . . . . 0.0 111.917 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -65.09 -39.21 92.85 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.549 0.69 . . . . 0.0 109.968 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.6 tp -63.08 -41.5 99.42 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -63.21 -40.36 97.26 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.6 t -60.48 -44.18 95.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 O-C-N 122.242 -0.286 . . . . 0.0 110.953 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 92.9 mt -62.63 -43.74 98.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.646 -177.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.7 -45.89 90.68 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 119.411 -0.916 . . . . 0.0 112.09 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.467 ' NZ ' HG12 ' B' ' 113' ' ' ILE . 98.5 mttt -60.28 -39.26 86.22 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 118.578 -1.249 . . . . 0.0 109.074 -176.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.5 -40.93 93.14 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.242 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.8 mt -62.97 -40.71 98.55 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -63.26 -38.19 90.18 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.327 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 62.0 m170 -58.82 -39.38 81.02 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 122.2 -0.313 . . . . 0.0 111.271 -178.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.6 p -115.37 130.65 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.512 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 35.8 ptt180 -73.65 110.71 8.15 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 122.093 0.949 . . . . 0.0 111.961 -177.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.0 p -141.54 143.67 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.599 ' HA3' ' HB2' ' A' ' 123' ' ' GLN . . . -97.28 91.97 1.27 Allowed Glycine 0 C--N 1.313 -0.695 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.814 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 50.8 t -124.44 129.51 73.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 176.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.6 m -137.1 159.92 36.28 Favored 'Isoleucine or valine' 0 C--O 1.244 0.796 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.9 mt -119.88 131.29 72.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.667 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 177.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.7 p -108.11 165.88 11.15 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.555 ' C ' ' OD1' ' A' ' 37' ' ' ASN . 50.9 t0 -132.09 101.41 15.07 Favored Pre-proline 0 C--N 1.323 -0.544 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.194 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.546 ' CG ' HG23 ' A' ' 117' ' ' THR . 35.5 Cg_endo -63.53 -22.31 70.78 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.659 1.573 . . . . 0.0 111.746 -178.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.03 -36.01 82.14 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.231 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.5 mt -83.33 159.17 21.93 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.954 176.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.782 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 42.4 tt0 -58.53 135.67 57.37 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -177.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.535 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 59.8 t0 61.1 18.89 9.45 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 178.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.555 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 31.0 t-20 42.79 67.42 3.56 Favored Pre-proline 0 C--N 1.318 -0.787 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.748 -176.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.782 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 92.2 Cg_endo -71.13 156.3 59.81 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 123.985 3.123 . . . . 0.0 112.336 -178.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.2 mt -87.16 125.45 40.98 Favored 'Isoleucine or valine' 0 C--O 1.245 0.833 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.6 m -104.52 -44.26 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 O-C-N 123.659 0.6 . . . . 0.0 112.335 -179.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -96.35 124.68 40.44 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 120.304 -0.558 . . . . 0.0 111.838 -178.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.2 p -142.36 139.57 29.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 O-C-N 124.162 0.914 . . . . 0.0 109.333 176.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.598 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 56.6 p30 -97.04 167.56 10.99 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.461 ' OE1' ' HA ' ' A' ' 44' ' ' GLN . 14.1 mm100 -66.55 -39.08 88.37 Favored 'General case' 0 C--O 1.242 0.693 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 176.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.69 -27.16 63.54 Favored Glycine 0 N--CA 1.452 -0.241 0 N-CA-C 110.331 -1.107 . . . . 0.0 110.331 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.607 ' CD1' HD13 ' A' ' 57' ' ' ILE . 58.1 t80 -59.08 -48.28 82.16 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 105.571 -2.011 . . . . 0.0 105.571 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.586 HG13 ' O ' ' A' ' 52' ' ' TYR . 78.7 t -59.89 -44.62 94.71 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 O-C-N 121.092 -1.005 . . . . 0.0 111.708 -173.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -63.15 -38.24 90.38 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 120.496 -0.482 . . . . 0.0 112.035 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.453 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 60.2 ttm -66.85 -43.21 84.22 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 175.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 36.8 p -93.58 -21.32 19.49 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.993 0.425 . . . . 0.0 111.523 -177.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . 77.05 20.39 75.84 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.586 ' O ' HG13 ' A' ' 47' ' ' VAL . 85.4 m-85 -114.33 136.77 52.61 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.022 0.439 . . . . 0.0 111.137 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -63.57 147.63 50.94 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.703 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.439 HG22 ' H ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -64.22 -31.14 72.22 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.595 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -67.28 -42.24 84.16 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 119.615 -0.834 . . . . 0.0 111.499 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -66.55 -44.68 81.71 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.423 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.607 HD13 ' CD1' ' A' ' 46' ' ' PHE . 96.2 mt -62.03 -45.34 98.95 Favored 'Isoleucine or valine' 0 C--N 1.354 0.767 0 CA-C-O 118.046 -0.978 . . . . 0.0 111.348 -175.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.0 mt -64.37 141.22 58.85 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 -177.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 86.35 -0.06 86.93 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.615 178.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -137.16 152.45 49.95 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.502 1.651 . . . . 0.0 111.44 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.54 ' C ' ' H ' ' A' ' 63' ' ' ARG . 25.1 t-20 -81.88 152.25 26.93 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 121.245 0.545 . . . . 0.0 110.648 -178.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 83.4 m -64.16 15.36 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.34 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.54 ' H ' ' C ' ' A' ' 61' ' ' ASN . 35.8 ptt-85 -61.59 -42.19 98.5 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.255 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -55.21 -22.31 17.29 Favored 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -178.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 88.2 mt -66.39 -36.62 83.31 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 177.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -64.79 144.04 57.52 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.446 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.628 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -152.66 -147.98 4.74 Favored Glycine 0 CA--C 1.541 1.71 0 N-CA-C 111.649 -0.581 . . . . 0.0 111.649 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.16 -39.98 96.23 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -177.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -77.69 -6.97 55.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.672 0.272 . . . . 0.0 111.001 -178.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.628 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 27.9 m -64.0 128.8 37.41 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.126 -0.63 . . . . 0.0 109.729 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -85.5 109.87 25.11 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.242 -178.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 70' ' ' THR . 52.9 Cg_exo -57.09 -31.7 91.07 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 121.91 1.74 . . . . 0.0 113.063 178.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.08 -40.16 95.64 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.172 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.503 ' OE1' ' HB ' ' A' ' 90' ' ' VAL . 79.3 mm-40 -65.91 -44.0 86.49 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 67.4 t -59.92 -44.02 93.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 114.448 -1.251 . . . . 0.0 107.799 -175.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -63.99 -37.77 88.62 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.89 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -63.35 -39.53 94.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.339 0.59 . . . . 0.0 110.228 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 95.8 mt -63.89 -44.04 97.94 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 CA-C-N 114.946 -1.025 . . . . 0.0 112.0 178.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -62.96 -43.35 99.03 Favored 'General case' 0 C--O 1.251 1.141 0 CA-C-N 113.68 -1.6 . . . . 0.0 108.482 179.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 99.8 m -61.35 -50.08 74.35 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 119.729 -0.788 . . . . 0.0 108.962 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.89 -42.35 89.33 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 119.487 -0.292 . . . . 0.0 111.187 -173.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 89.2 mt -63.12 -39.79 95.7 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 119.09 0.859 . . . . 0.0 111.885 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 68.1 tp60 -63.24 -35.32 79.94 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 177.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -89.34 -2.91 58.61 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.694 -177.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 38.0 tttt 51.45 43.97 29.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.827 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -126.8 146.62 57.91 Favored Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 108' ' ' ILE . 24.2 Cg_exo -61.83 143.49 95.91 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.345 1.363 . . . . 0.0 112.822 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.7 142.3 30.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.862 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.917 HG23 ' OD1' ' A' ' 107' ' ' ASN . 96.6 m -126.41 122.22 34.7 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 175.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.503 ' HB ' ' OE1' ' A' ' 74' ' ' GLU . 29.3 m -139.05 159.47 29.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 121.106 -0.238 . . . . 0.0 111.308 178.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -103.61 133.99 47.7 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 105.021 -2.215 . . . . 0.0 105.021 176.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.5 HG23 ' O ' ' A' ' 92' ' ' ILE . 19.2 tt -142.4 125.23 14.14 Favored 'Isoleucine or valine' 0 C--N 1.374 1.635 0 CA-C-N 121.622 2.01 . . . . 0.0 112.341 176.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -58.87 136.55 57.86 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.377 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -136.07 159.96 40.09 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.161 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.4 ' CE1' ' HA3' ' A' ' 67' ' ' GLY . 93.8 m-85 -117.12 134.67 54.49 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -178.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.453 ' HE2' ' O ' ' A' ' 49' ' ' MET . 98.9 mttt -83.79 -174.3 5.2 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.086 0.469 . . . . 0.0 111.908 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.35 -43.13 99.54 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.102 178.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 40.9 p-10 -83.53 6.42 20.53 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -178.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.7 -1.38 87.04 Favored Glycine 0 N--CA 1.473 1.163 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.352 176.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.0 m -59.73 137.96 57.9 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.691 ' SD ' ' C ' ' A' ' 101' ' ' MET . 13.4 tmm? -105.47 129.03 53.85 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 120.959 0.409 . . . . 0.0 110.508 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.487 ' N ' ' SD ' ' A' ' 101' ' ' MET . 50.7 p90 -142.16 156.22 45.34 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.175 -176.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.724 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 20.8 m95 -88.24 142.2 27.94 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.477 HD21 ' HG2' ' A' ' 123' ' ' GLN . 54.3 t-20 -136.97 102.35 4.83 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -177.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.46 ' HB2' HD11 ' A' ' 126' ' ' ILE . 81.0 tt0 -67.75 136.77 54.75 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 -177.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 41.1 tp -121.5 122.57 40.03 Favored 'General case' 0 C--O 1.233 0.185 0 O-C-N 123.665 0.603 . . . . 0.0 112.593 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.917 ' OD1' HG23 ' A' ' 89' ' ' THR . 98.2 m-20 -118.85 123.32 44.42 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 116.724 -0.216 . . . . 0.0 110.64 177.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.432 ' O ' ' HA ' ' A' ' 87' ' ' PRO . 96.2 mt -120.03 128.77 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 O-C-N 123.468 0.48 . . . . 0.0 111.268 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -136.77 124.58 14.58 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 116.871 -0.15 . . . . 0.0 110.88 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -70.88 151.19 62.46 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.342 2.028 . . . . 0.0 112.499 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.587 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 67.2 mtt -124.03 153.13 41.78 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.983 -1.118 . . . . 0.0 107.983 179.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -129.09 95.59 4.1 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 176.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 96.5 mt -121.02 131.4 73.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.621 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 50.43 37.98 17.02 Favored 'General case' 0 CA--C 1.515 -0.398 0 O-C-N 121.567 -0.708 . . . . 0.0 111.441 176.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 58.7 30.51 20.05 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.707 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -126.81 147.9 49.99 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.814 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 5.2 t -84.85 -171.26 3.54 Favored 'General case' 0 C--O 1.214 -0.793 0 CA-C-O 118.618 -0.706 . . . . 0.0 109.323 -178.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.814 ' CD2' ' O ' ' A' ' 117' ' ' THR . 76.3 m-85 -174.96 154.95 1.93 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 175.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -130.71 146.2 52.12 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 174.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.7 134.86 56.14 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.461 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.439 ' HA3' ' H6 ' ' A' ' 900' ' ' FMN . . . -106.81 127.85 9.03 Favored Glycine 0 CA--C 1.502 -0.774 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 178.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.408 ' HB ' ' HB2' ' A' ' 107' ' ' ASN . 96.6 mt -116.58 128.16 74.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 177.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.599 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . 17.3 mp0 -118.72 112.87 20.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.072 0.463 . . . . 0.0 109.875 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -115.07 112.16 22.17 Favored 'General case' 0 C--O 1.248 0.974 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.881 -178.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 127' ' ' THR . 68.4 t0 -62.55 131.28 48.57 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -176.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.507 HG22 ' O ' ' A' ' 126' ' ' ILE . 3.3 mp -96.64 4.32 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 113.743 -1.571 . . . . 0.0 109.884 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.461 ' N ' ' OD1' ' A' ' 125' ' ' ASP . 25.6 m -60.37 -42.34 95.6 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 121.081 -1.012 . . . . 0.0 113.388 -178.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -59.63 -42.8 93.54 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -62.8 -39.73 95.16 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.702 177.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.724 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.8 mttt -62.34 -41.21 98.4 Favored 'General case' 0 CA--C 1.503 -0.834 0 C-N-CA 118.286 -1.366 . . . . 0.0 110.64 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -62.17 -37.59 85.81 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.659 ' CE2' HD11 ' A' ' 136' ' ' LEU . 87.5 t80 -61.48 -45.44 94.21 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.672 176.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.81 -38.61 91.56 Favored 'General case' 0 CA--C 1.522 -0.116 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.06 -40.83 97.1 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.068 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 54.8 tp -60.8 -43.84 97.62 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -177.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.659 HD11 ' CE2' ' A' ' 132' ' ' TYR . 85.2 mt -62.21 -41.34 98.29 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.382 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.09 -42.55 99.33 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 119.529 -0.868 . . . . 0.0 109.799 -178.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -60.68 -42.12 96.46 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -177.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 58.3 m -61.57 -41.12 96.95 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.642 176.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.51 ' O ' ' N ' ' A' ' 144' ' ' THR . 83.6 mt -63.5 -42.07 98.53 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 120.63 -0.428 . . . . 0.0 109.934 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 91.5 m -61.62 -45.4 94.23 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.152 -177.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -65.08 -40.21 94.31 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 95.2 mt -64.72 -43.39 96.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 114.115 -1.402 . . . . 0.0 111.313 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.51 ' N ' ' O ' ' A' ' 140' ' ' LEU . 99.4 m -62.65 -46.16 89.47 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 121.811 -0.556 . . . . 0.0 112.121 -177.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.454 ' O ' ' OG1' ' A' ' 148' ' ' THR . . . -63.31 -39.42 94.51 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 118.803 -1.159 . . . . 0.0 109.051 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 81.7 mt -63.38 -42.65 98.83 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.355 178.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.711 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.2 p -59.96 -39.65 86.34 Favored 'General case' 0 C--O 1.217 -0.644 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -178.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.49 ' C ' ' O ' ' A' ' 147' ' ' SER . 21.6 m -27.1 81.72 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.418 0 O-C-N 126.971 2.669 . . . . 0.0 106.133 -178.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.711 ' N ' ' O ' ' A' ' 147' ' ' SER . 21.1 Cg_exo -62.44 146.15 95.61 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 C-N-CA 121.427 1.418 . . . . 0.0 114.538 -175.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.574 ' O ' ' CG2' ' A' ' 151' ' ' VAL . 9.6 tp -124.52 136.58 60.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 102.843 -3.021 . . . . 0.0 102.843 178.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.574 ' CG2' ' O ' ' A' ' 150' ' ' ILE . 60.1 t -169.05 96.48 0.52 Allowed Pre-proline 0 N--CA 1.437 -1.083 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 178.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -64.8 133.28 35.68 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 109.785 -0.89 . . . . 0.0 109.785 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.665 ' O ' ' HD2' ' A' ' 154' ' ' ARG . 45.9 mm -69.19 -45.13 80.09 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.909 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.395 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.665 ' HD2' ' O ' ' A' ' 153' ' ' ILE . 1.1 tpt180 -156.15 -159.32 0.88 Allowed 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.422 ' ND2' ' HE3' ' B' ' 256' ' ' LYS . 58.9 t-20 -86.16 106.18 17.09 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.697 0.76 . . . . 0.0 111.289 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 88.8 10.06 67.52 Favored Glycine 0 N--CA 1.45 -0.386 0 CA-C-N 113.98 -1.463 . . . . 0.0 110.501 -177.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.449 HG12 ' HB2' ' A' ' 189' ' ' TYR . 96.6 mt -128.11 122.82 59.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 175.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.615 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 58.0 m -131.92 151.75 51.51 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.199 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -134.06 140.11 46.43 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.206 -0.597 . . . . 0.0 111.404 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 29.7 tp -131.18 76.49 76.27 Favored Pre-proline 0 N--CA 1.468 0.469 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.206 179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -68.89 149.11 72.02 Favored 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 122.791 2.327 . . . . 0.0 113.085 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 90.0 mt -117.38 128.63 55.22 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.179 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 45.8 t -123.48 131.56 72.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 115.58 167.55 15.18 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 120.89 -0.671 . . . . 0.0 111.92 178.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.888 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 60.0 t30 -84.19 115.64 22.53 Favored 'General case' 0 C--O 1.207 -1.151 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -178.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.512 HD21 ' CZ ' ' A' ' 171' ' ' PHE . 43.5 tp -75.76 105.57 6.87 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 -177.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.643 HG23 ' NE ' ' A' ' 170' ' ' ARG . 11.4 p -88.53 167.61 13.28 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.909 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.51 -34.19 77.68 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.983 0.42 . . . . 0.0 111.945 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.76 -42.11 91.3 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-O 121.805 0.812 . . . . 0.0 110.986 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.888 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 88.2 mtm180 -64.75 -34.26 77.91 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.791 177.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.512 ' CZ ' HD21 ' A' ' 166' ' ' LEU . 0.4 OUTLIER -55.07 -28.3 51.29 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 119.025 -0.512 . . . . 0.0 111.727 -177.084 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.711 ' O ' HG22 ' A' ' 175' ' ' VAL . 91.0 m-20 -60.35 -40.6 91.31 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 118.718 -1.193 . . . . 0.0 110.02 -177.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 50.3 m -59.25 -40.78 87.03 Favored 'General case' 0 C--N 1.315 -0.923 0 O-C-N 121.569 -0.707 . . . . 0.0 110.538 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 66.8 mt -62.9 -43.96 99.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.711 HG22 ' O ' ' A' ' 172' ' ' ASN . 23.0 m -62.32 -39.91 85.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -178.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . 0.438 ' N ' HG23 ' A' ' 175' ' ' VAL . 98.3 m -62.38 -34.61 77.04 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.274 178.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.582 ' O ' HG13 ' A' ' 181' ' ' ILE . 25.1 m -61.86 -19.71 62.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.905 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.786 ' CD2' HD21 ' A' ' 211' ' ' LEU . 91.3 mt -60.99 -41.18 95.98 Favored 'General case' 0 C--O 1.248 0.99 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -177.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 19.1 m -59.75 -43.58 94.21 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.576 ' O ' ' OG ' ' A' ' 183' ' ' SER . 92.0 m-20 -61.47 -35.4 77.52 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 122.775 0.43 . . . . 0.0 110.683 178.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.582 HG13 ' O ' ' A' ' 177' ' ' THR . 67.5 mt -60.32 -41.46 87.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.504 HD21 HD21 ' A' ' 214' ' ' LEU . 84.9 mt -60.3 -40.4 90.38 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 119.342 -0.943 . . . . 0.0 108.981 -176.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.576 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 78.1 p -61.45 -33.7 74.19 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.607 176.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 58.8 p -89.39 23.71 2.46 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.79 0.329 . . . . 0.0 111.446 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 78.1 p -64.48 -20.04 65.94 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.973 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -60.56 -37.43 81.23 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.921 -178.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.615 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 98.8 m-20 -73.57 114.98 12.43 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.383 0.611 . . . . 0.0 110.582 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -62.91 -42.62 99.85 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.123 -0.944 . . . . 0.0 113.027 -177.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . 0.449 ' HB2' HG12 ' A' ' 157' ' ' ILE . 98.5 m-85 -111.61 132.06 54.83 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.567 -0.453 . . . . 0.0 110.783 -177.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 40.0 tp -120.62 128.36 52.95 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 95.7 mt -116.94 127.32 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 118.35 0.523 . . . . 0.0 109.599 177.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.9 mm -112.84 127.05 70.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . 0.518 ' CG ' ' HG ' ' A' ' 195' ' ' SER . 40.0 t0 -94.23 118.02 30.96 Favored 'General case' 0 CA--C 1.552 1.053 0 O-C-N 121.796 -0.565 . . . . 0.0 110.824 177.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 194' ' ' LEU . 96.0 mt -96.51 -5.07 40.28 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.825 175.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.518 ' HG ' ' CG ' ' A' ' 193' ' ' ASP . 78.1 p -62.87 -33.81 76.06 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -62.28 -42.0 99.72 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 118.808 -1.663 . . . . 0.0 109.025 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.954 HD23 ' N ' ' A' ' 198' ' ' ALA . 4.7 tt -72.09 127.89 33.97 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 112.2 -2.0 . . . . 0.0 108.159 -177.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.954 ' N ' HD23 ' A' ' 197' ' ' LEU . . . -60.8 -47.21 87.38 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.956 0.408 . . . . 0.0 111.062 -178.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.908 ' O ' ' CD2' ' A' ' 197' ' ' LEU . 58.5 tt0 -133.63 155.93 48.79 Favored 'General case' 0 C--O 1.2 -1.547 0 CA-C-N 114.609 -1.178 . . . . 0.0 114.052 -174.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.433 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 46.9 t -117.97 132.51 67.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 O-C-N 120.17 -1.582 . . . . 0.0 108.707 178.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -90.44 155.46 18.91 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.642 -177.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -64.44 -39.34 93.63 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 120.254 -0.578 . . . . 0.0 109.915 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -57.81 -32.66 67.79 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-O 122.099 0.952 . . . . 0.0 108.944 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.9 m -61.14 -42.57 98.78 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.222 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.512 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -57.96 -39.42 78.1 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -177.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -62.26 -36.71 82.87 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -65.48 -39.11 91.56 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.113 177.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 93.5 mt -63.16 -44.2 99.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . 0.512 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 68.9 m-85 -61.82 -43.83 98.07 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.648 -178.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.64 -42.62 99.7 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 119.295 -0.962 . . . . 0.0 109.221 -178.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.786 HD21 ' CD2' ' A' ' 178' ' ' LEU . 37.7 mt -62.21 -41.87 98.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.644 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 78.4 p -61.44 -41.46 97.23 Favored 'General case' 0 CA--C 1.518 -0.265 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.266 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' HIS . . . . . 0.439 ' CE1' HD11 ' A' ' 217' ' ' LEU . 57.8 t-80 -64.97 -45.52 85.34 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 122.018 -0.427 . . . . 0.0 111.528 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.504 HD21 HD21 ' A' ' 182' ' ' LEU . 48.0 tp -62.12 -46.52 88.65 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 118.893 -1.123 . . . . 0.0 108.003 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 211' ' ' LEU . 90.2 mt -61.98 -40.43 95.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.588 -177.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.34 -43.47 96.4 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.179 -0.608 . . . . 0.0 109.442 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.439 HD11 ' CE1' ' A' ' 213' ' ' HIS . 84.6 mt -61.95 -39.96 93.91 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 69.2 p -76.43 -11.35 59.87 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.365 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 83.17 35.31 18.37 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-O 119.133 -0.815 . . . . 0.0 112.844 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 96.2 m -123.44 110.97 15.78 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 118.863 1.331 . . . . 0.0 111.713 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -61.63 138.46 58.31 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.81 178.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 50.0 tp -113.61 131.05 56.26 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 177.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 2.7 mp -118.37 135.14 59.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.561 ' CG2' HD11 ' A' ' 227' ' ' ILE . 50.1 mm -116.48 131.63 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -178.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 34.5 p -133.71 167.53 20.35 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 78.63 21.42 69.16 Favored Glycine 0 C--N 1.334 0.469 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.607 HD12 HG23 ' A' ' 247' ' ' THR . 97.6 mt -84.68 128.15 39.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 113.924 -1.138 . . . . 0.0 108.427 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 54.3 tttt -74.02 140.56 77.24 Favored Pre-proline 0 CA--C 1.535 0.377 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.32 -39.72 89.46 Favored 'Trans proline' 0 N--CA 1.496 1.658 0 C-N-CA 120.942 1.095 . . . . 0.0 112.489 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -64.78 -37.38 87.4 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.507 0.67 . . . . 0.0 110.28 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 52.7 tp -63.79 -42.31 97.76 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.468 177.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -65.17 -37.12 86.36 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.042 0.449 . . . . 0.0 110.873 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 94.1 mtp -63.29 -40.97 98.85 Favored 'General case' 0 C--O 1.248 0.985 0 C-N-CA 120.074 -0.65 . . . . 0.0 109.536 -178.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -64.02 -39.9 95.14 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.462 177.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 35.1 mmt -66.76 -36.73 83.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.554 177.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -60.84 -41.87 96.66 Favored 'General case' 0 CA--C 1.513 -0.479 0 O-C-N 121.432 -0.793 . . . . 0.0 109.479 -176.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.86 -39.88 90.8 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.506 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 59.0 tp -63.44 -41.05 98.65 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 240' ' ' ALA . 67.0 t0 -167.6 129.47 1.55 Allowed 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 121.487 0.661 . . . . 0.0 112.148 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.408 ' N ' ' OD1' ' A' ' 239' ' ' ASP . . . -61.04 -26.8 67.88 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.618 178.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.485 ' O ' ' HB2' ' A' ' 244' ' ' SER . 90.8 m-20 -61.24 -32.68 72.48 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.326 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -55.59 -44.38 76.89 Favored 'General case' 0 C--N 1.312 -1.065 0 O-C-N 121.214 -0.929 . . . . 0.0 109.089 -175.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 94.2 p -62.82 -20.04 64.66 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.937 178.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . 0.485 ' HB2' ' O ' ' A' ' 241' ' ' ASN . 49.7 m -56.4 -37.76 70.59 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 122.517 0.327 . . . . 0.0 111.854 177.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 92.5 mt -83.24 130.94 35.12 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 177.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -55.29 135.08 50.18 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-N 114.104 -1.407 . . . . 0.0 109.626 -177.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.607 HG23 HD12 ' A' ' 227' ' ' ILE . 98.0 m -126.79 132.14 51.1 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.836 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' TYR . . . . . 0.431 ' CG ' ' HB2' ' A' ' 254' ' ' ALA . 97.5 m-85 -118.09 140.54 49.61 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.401 178.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . 0.418 ' O ' ' OD1' ' A' ' 250' ' ' ASN . 78.1 p -61.39 -42.35 98.58 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -178.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.418 ' OD1' ' O ' ' A' ' 249' ' ' SER . 98.4 m-20 -144.03 160.5 40.75 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.72 0.772 . . . . 0.0 111.43 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 77.0 t -62.38 -44.74 99.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 114.641 -1.163 . . . . 0.0 112.044 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.73 -43.78 97.47 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.329 -0.549 . . . . 0.0 109.581 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . 0.551 ' O ' HG22 ' A' ' 257' ' ' VAL . 55.1 m-20 -63.43 -42.68 98.71 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.164 -178.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.431 ' HB2' ' CG ' ' A' ' 248' ' ' TYR . . . -64.92 -41.88 95.18 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.729 0.776 . . . . 0.0 109.942 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . . . . . . . . . 61.1 t -63.5 -45.89 96.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 114.225 -1.352 . . . . 0.0 111.304 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -63.89 -47.45 80.56 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.509 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 253' ' ' ASP . 33.4 m -66.89 -40.96 86.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 C-N-CA 119.908 -0.717 . . . . 0.0 112.481 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.483 ' C ' ' O ' ' A' ' 257' ' ' VAL . 0.9 OUTLIER -30.11 -73.42 0.05 OUTLIER Pre-proline 0 CA--C 1.533 0.293 0 O-C-N 123.166 0.291 . . . . 0.0 111.614 -176.847 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' PRO . . . . . 0.48 ' O ' HG13 ' A' ' 260' ' ' ILE . 43.6 Cg_endo -63.87 140.24 72.35 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 120.847 1.032 . . . . 0.0 111.857 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.48 HG13 ' O ' ' A' ' 259' ' ' PRO . 96.1 mt -152.91 -31.18 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 O-C-N 123.453 0.47 . . . . 0.0 112.16 178.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 77.3 mtm . . . . . 0 C--O 1.217 -0.617 0 CA-C-O 118.133 -0.937 . . . . 0.0 111.143 -177.213 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.521 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.62 175.32 11.65 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 100.0 p -72.09 -11.59 60.82 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.717 -0.219 . . . . 0.0 111.19 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -83.04 -60.94 2.0 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.063 0.458 . . . . 0.0 110.661 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -67.05 -39.16 86.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.253 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.537 ' O ' ' HB3' ' B' ' 7' ' ' PHE . 68.4 m -59.48 -43.28 93.33 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 120.249 -0.58 . . . . 0.0 109.6 -177.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . 0.537 ' HB3' ' O ' ' B' ' 6' ' ' SER . 48.3 t80 86.94 86.97 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.891 0.744 . . . . 0.0 110.71 177.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . 0.647 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -59.99 -149.72 0.01 OUTLIER Glycine 0 C--N 1.336 0.559 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.647 ' HB ' ' O ' ' B' ' 8' ' ' GLY . 88.5 mt 91.3 111.78 0.02 OUTLIER Pre-proline 0 N--CA 1.472 0.635 0 O-C-N 123.948 0.44 . . . . 0.0 110.761 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -63.86 -23.63 68.46 Favored 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 121.408 1.405 . . . . 0.0 111.788 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.58 -41.1 99.51 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -64.69 -39.33 93.47 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.843 0.83 . . . . 0.0 109.775 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 48.5 tp -61.76 -42.36 98.88 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 114.907 -1.042 . . . . 0.0 112.116 -177.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -65.15 -33.31 75.71 Favored 'General case' 0 CA--C 1.561 1.39 0 CA-C-O 121.681 0.753 . . . . 0.0 110.805 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 79.4 t -62.23 -46.46 96.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-N 112.927 -1.942 . . . . 0.0 110.912 177.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.94 -44.09 97.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 C-N-CA 120.31 -0.556 . . . . 0.0 110.674 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . 0.557 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 98.9 mttt -63.53 -41.99 98.46 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 113.643 0.979 . . . . 0.0 113.643 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.34 -41.21 98.87 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 119.028 -1.069 . . . . 0.0 110.254 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.61 -38.39 84.54 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.743 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 84.3 mt -63.77 -41.91 97.88 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.223 0.535 . . . . 0.0 110.255 175.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -62.87 -38.54 91.27 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.95 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 61.2 m170 -57.83 -39.86 78.67 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 121.19 -0.204 . . . . 0.0 111.156 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 14.1 p -115.28 130.74 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.523 ' O ' ' HG3' ' B' ' 24' ' ' ARG . 35.4 ptt180 -73.54 108.58 6.48 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 121.85 0.833 . . . . 0.0 112.316 -176.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.7 p -143.09 133.76 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.667 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.544 177.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . 0.541 ' HA3' ' HB2' ' B' ' 123' ' ' GLN . . . -86.78 96.21 2.13 Favored Glycine 0 N--CA 1.443 -0.869 0 C-N-CA 119.629 -1.272 . . . . 0.0 113.488 -176.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 47.0 t -125.58 128.81 72.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 175.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 29.5 m -138.8 157.29 29.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.587 179.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 96.5 mt -118.91 129.3 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 CA-C-O 121.676 0.751 . . . . 0.0 111.567 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.474 ' OG1' ' O ' ' B' ' 119' ' ' PHE . 9.9 p -111.85 154.49 25.07 Favored 'General case' 0 CA--C 1.502 -0.886 0 CA-C-N 113.073 -1.876 . . . . 0.0 108.819 -175.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.518 ' C ' ' OD1' ' B' ' 37' ' ' ASN . 51.0 t0 -122.77 102.3 38.55 Favored Pre-proline 0 C--O 1.237 0.415 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 -177.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' PRO . . . . . 0.455 ' CG ' HG23 ' B' ' 117' ' ' THR . 36.5 Cg_endo -64.52 -20.65 65.98 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 121.786 1.657 . . . . 0.0 111.27 -179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.19 -42.38 99.23 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 120.629 -0.429 . . . . 0.0 110.002 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 96.8 mt -73.15 179.79 3.68 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 121.778 -0.576 . . . . 0.0 111.097 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . 0.709 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 42.0 tt0 -75.58 132.88 40.96 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -178.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.488 ' O ' ' C ' ' B' ' 37' ' ' ASN . 66.0 t0 55.86 38.78 30.44 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.709 178.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' ASN . . . . . 0.518 ' OD1' ' C ' ' B' ' 31' ' ' ASP . 17.6 t-20 26.91 71.37 0.42 Allowed Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.709 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 92.6 Cg_endo -72.93 154.62 53.29 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 123.554 2.836 . . . . 0.0 111.944 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 95.9 mt -85.75 130.25 36.69 Favored 'Isoleucine or valine' 0 C--O 1.246 0.889 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 17.1 m -108.39 -44.06 6.5 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 O-C-N 123.884 0.74 . . . . 0.0 112.709 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -97.07 124.93 41.21 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 120.407 -0.517 . . . . 0.0 111.529 -178.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 6.5 p -142.34 140.53 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 O-C-N 124.195 0.934 . . . . 0.0 109.348 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . 0.636 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 55.4 p30 -101.18 162.62 12.76 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.144 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' GLN . . . . . 0.443 ' OE1' ' HA ' ' B' ' 44' ' ' GLN . 13.7 mm100 -62.86 -37.81 88.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.693 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.75 -27.53 64.24 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.054 -0.819 . . . . 0.0 111.054 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.656 ' CD1' HD13 ' B' ' 57' ' ' ILE . 53.3 t80 -60.36 -43.72 96.27 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 0.734 HG13 ' O ' ' B' ' 52' ' ' TYR . 77.6 t -61.78 -45.99 97.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.25 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -62.98 -44.31 96.39 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.394 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . 0.458 ' O ' ' HE2' ' B' ' 96' ' ' LYS . 60.2 ttm -63.48 -42.02 98.57 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 34.6 p -96.22 -16.1 21.63 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.931 -177.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' B' ' 47' ' ' VAL . . . 72.69 18.73 78.87 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.379 -1.089 . . . . 0.0 110.379 178.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . 0.734 ' O ' HG13 ' B' ' 47' ' ' VAL . 85.7 m-85 -111.28 144.03 41.11 Favored 'General case' 0 CA--C 1.513 -0.444 0 C-N-CA 122.893 0.477 . . . . 0.0 109.999 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -73.82 147.72 43.1 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-O 121.561 0.696 . . . . 0.0 111.228 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . 0.452 HG22 ' H ' ' B' ' 54' ' ' THR . 0.2 OUTLIER -61.42 -36.01 79.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.867 -177.779 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.48 -40.09 96.18 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 120.131 -0.628 . . . . 0.0 111.884 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -73.15 -33.69 65.64 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 176.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.656 HD13 ' CD1' ' B' ' 46' ' ' PHE . 97.2 mt -64.57 -53.95 36.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 118.204 -1.398 . . . . 0.0 109.475 177.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 88.6 mt -61.77 132.35 52.84 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.004 -170.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.55 -4.36 69.38 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 121.034 -0.603 . . . . 0.0 113.382 -177.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -133.22 149.25 52.02 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -177.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' ASN . . . . . 0.529 ' C ' ' H ' ' B' ' 63' ' ' ARG . 24.4 t-20 -78.86 151.79 31.62 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.565 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' CYS . . . . . . . . . . . . . 82.7 m -64.28 8.96 0.09 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.341 -178.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . 0.529 ' H ' ' C ' ' B' ' 61' ' ' ASN . 34.4 ptt-85 -59.4 -32.46 70.19 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.395 -177.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -60.95 -30.66 70.37 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 178.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 83.9 mt -61.66 -41.95 98.23 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 121.63 -0.669 . . . . 0.0 110.114 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -51.75 150.58 3.89 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.024 -177.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . 0.51 ' N ' ' OG1' ' B' ' 70' ' ' THR . . . -161.13 -153.94 7.21 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.33 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -58.98 -40.55 85.18 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -175.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -76.92 -9.43 58.68 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.307 -178.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' THR . . . . . 0.51 ' OG1' ' N ' ' B' ' 67' ' ' GLY . 26.9 m -61.19 133.81 56.35 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -90.5 110.1 38.65 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.485 -178.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.17 -38.15 87.71 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 120.979 1.12 . . . . 0.0 111.677 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.83 -40.42 92.75 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 120.459 -0.496 . . . . 0.0 109.8 -176.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' GLU . . . . . 0.504 ' OE1' ' HB ' ' B' ' 90' ' ' VAL . 79.0 mm-40 -67.23 -39.44 86.21 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.789 177.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 73.9 t -61.96 -45.95 97.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -63.29 -37.05 85.75 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.655 -178.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -62.33 -41.47 98.58 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 119.393 -0.923 . . . . 0.0 108.698 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 94.2 mt -63.28 -43.76 98.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-O 120.928 0.394 . . . . 0.0 110.427 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -62.31 -42.78 99.66 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 85.1 m -61.57 -45.4 94.29 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.027 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.28 -41.15 98.24 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 85.9 mt -62.98 -42.14 99.76 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -62.48 -36.63 83.1 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -91.64 7.4 41.72 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.5 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 32.3 tttt 43.1 45.79 4.74 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.414 -0.515 . . . . 0.0 112.195 175.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -128.15 143.72 49.01 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.274 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -62.31 140.51 83.19 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 120.933 1.089 . . . . 0.0 113.289 -178.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -140.82 137.16 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.361 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' THR . . . . . 0.926 HG23 ' OD1' ' B' ' 107' ' ' ASN . 95.7 m -121.47 123.81 42.94 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.504 ' HB ' ' OE1' ' B' ' 74' ' ' GLU . 26.9 m -138.27 163.13 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.955 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -114.62 120.42 40.09 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 174.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . 0.467 HD11 HG23 ' B' ' 70' ' ' THR . 20.9 tt -128.3 131.79 68.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.256 -176.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -71.44 143.46 50.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.419 177.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -132.92 -178.89 5.16 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-O 121.268 0.556 . . . . 0.0 111.176 -177.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -131.19 145.61 52.01 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 114.567 -1.197 . . . . 0.0 111.711 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . 0.458 ' HE2' ' O ' ' B' ' 49' ' ' MET . 98.6 mttt -103.01 177.09 4.93 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.317 0.58 . . . . 0.0 111.209 177.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.15 -35.43 75.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.716 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 38.4 p-10 -87.11 -1.78 58.14 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 119.168 0.895 . . . . 0.0 112.486 178.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.28 3.18 63.46 Favored Glycine 0 C--N 1.335 0.528 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.449 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 25.5 m -67.01 128.99 38.44 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . 0.603 ' SD ' ' N ' ' B' ' 102' ' ' PHE . 15.1 tmm? -87.75 142.23 27.98 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' PHE . . . . . 0.603 ' N ' ' SD ' ' B' ' 101' ' ' MET . 52.8 p90 -153.9 162.09 41.49 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' TRP . . . . . 0.757 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 20.9 m95 -95.16 138.68 32.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.404 0.621 . . . . 0.0 110.785 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . 0.477 HD21 ' HG2' ' B' ' 123' ' ' GLN . 62.8 t-20 -132.66 107.19 8.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.78 -1.1 . . . . 0.0 113.567 -177.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' GLU . . . . . 0.455 ' HB2' HD11 ' B' ' 126' ' ' ILE . 81.7 tt0 -76.14 123.7 26.25 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.276 -0.874 . . . . 0.0 109.413 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 39.0 tp -111.39 125.59 54.03 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.989 0.423 . . . . 0.0 112.012 -177.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' ASN . . . . . 0.926 ' OD1' HG23 ' B' ' 89' ' ' THR . 98.3 m-20 -119.08 128.6 54.48 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 96.5 mt -123.61 133.06 70.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -142.85 122.96 7.95 Favored Pre-proline 0 CA--C 1.539 0.545 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -69.89 152.29 68.61 Favored 'Trans proline' 0 N--CA 1.499 1.85 0 C-N-CA 122.381 2.054 . . . . 0.0 112.642 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . 0.478 ' HB2' ' HB2' ' B' ' 118' ' ' TYR . 67.3 mtt -130.22 141.85 50.61 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -113.34 108.43 17.23 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . 0.467 HG12 ' NZ ' ' A' ' 18' ' ' LYS . 96.7 mt -134.52 127.93 50.62 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 118.279 0.491 . . . . 0.0 112.04 177.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 52.49 38.33 25.25 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.93 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 60.09 37.07 21.21 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.441 -178.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -132.41 153.1 51.15 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' THR . . . . . 0.455 HG23 ' CG ' ' B' ' 32' ' ' PRO . 9.7 t -104.95 151.85 23.4 Favored 'General case' 0 C--O 1.214 -0.766 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -178.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' TYR . . . . . 0.478 ' HB2' ' HB2' ' B' ' 111' ' ' MET . 96.2 m-85 -149.29 147.03 27.88 Favored 'General case' 0 C--O 1.239 0.541 0 O-C-N 121.066 -1.021 . . . . 0.0 110.889 -177.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 119' ' ' PHE . . . . . 0.474 ' O ' ' OG1' ' B' ' 30' ' ' THR . 90.9 m-85 -123.03 139.25 54.28 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 123.523 0.514 . . . . 0.0 110.846 -176.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -128.0 133.63 66.83 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . 0.536 ' HA3' ' H6 ' ' B' ' 900' ' ' FMN . . . -107.03 122.1 6.79 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 122' ' ' ILE . . . . . 0.468 ' HB ' ' HB2' ' B' ' 107' ' ' ASN . 91.2 mt -111.33 127.22 68.62 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.44 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 123' ' ' GLN . . . . . 0.541 ' HB2' ' HA3' ' B' ' 26' ' ' GLY . 17.0 mp0 -117.97 118.96 33.39 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -118.09 121.16 39.87 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' B' ' 127' ' ' THR . 68.0 t0 -69.36 133.56 47.97 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.043 -0.981 . . . . 0.0 112.261 -178.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.492 ' O ' ' HG3' ' B' ' 130' ' ' LYS . 3.2 mp -107.24 17.89 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.77 0 CA-C-O 122.397 1.094 . . . . 0.0 108.918 177.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 127' ' ' THR . . . . . 0.552 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 97.0 m -63.76 -44.21 94.13 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 113.59 -1.641 . . . . 0.0 112.403 175.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 59.2 tptt -60.91 -45.66 93.74 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -178.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 129' ' ' GLN . . . . . 0.444 ' OE1' HG23 ' B' ' 126' ' ' ILE . 88.4 mt-30 -63.34 -35.17 79.5 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.687 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 130' ' ' LYS . . . . . 0.757 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 98.7 mttt -63.1 -41.41 99.38 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 113.253 -1.794 . . . . 0.0 110.691 174.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.67 -42.1 95.62 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 132' ' ' TYR . . . . . 0.667 ' CE2' HD11 ' B' ' 136' ' ' LEU . 87.9 t80 -59.92 -44.4 94.34 Favored 'General case' 0 C--N 1.329 -0.317 0 O-C-N 121.878 -0.514 . . . . 0.0 111.388 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' B' ' 137' ' ' GLU . 97.4 mt-10 -64.94 -36.53 84.68 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.724 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 134' ' ' LYS . . . . . 0.435 ' HG3' ' O ' ' B' ' 130' ' ' LYS . 98.8 mttt -63.11 -39.31 94.33 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.756 178.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 54.4 tp -62.78 -41.25 99.16 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.401 0.62 . . . . 0.0 109.83 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . 0.667 HD11 ' CE2' ' B' ' 132' ' ' TYR . 87.0 mt -63.34 -41.48 98.88 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.494 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 137' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' B' ' 133' ' ' GLU . 97.2 mt-10 -64.61 -37.98 89.43 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.511 -178.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.58 -43.68 96.26 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.824 176.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 61.4 m -60.96 -44.41 97.34 Favored 'General case' 0 C--N 1.344 0.352 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . 0.495 ' O ' ' N ' ' B' ' 144' ' ' THR . 84.5 mt -61.64 -40.36 94.6 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -177.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 99.3 m -61.9 -45.13 95.09 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.728 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -65.97 -42.33 90.0 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 93.9 mt -63.81 -43.2 97.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 114.515 -1.22 . . . . 0.0 110.493 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 144' ' ' THR . . . . . 0.495 ' N ' ' O ' ' B' ' 140' ' ' LEU . 99.8 m -61.7 -45.76 92.6 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -178.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.42 -40.5 97.35 Favored 'General case' 0 C--O 1.228 -0.071 0 C-N-CA 119.071 -1.052 . . . . 0.0 109.161 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 83.4 mt -64.38 -40.96 96.84 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 147' ' ' SER . . . . . 0.617 ' O ' ' N ' ' B' ' 149' ' ' PRO . 78.1 p -61.86 -41.44 97.85 Favored 'General case' 0 CA--C 1.483 -1.634 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -179.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . 0.504 ' C ' ' O ' ' B' ' 147' ' ' SER . 8.9 m -27.06 85.66 0.04 OUTLIER Pre-proline 0 N--CA 1.473 0.716 0 O-C-N 124.035 0.834 . . . . 0.0 109.999 177.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 149' ' ' PRO . . . . . 0.617 ' N ' ' O ' ' B' ' 147' ' ' SER . 24.3 Cg_exo -61.27 146.25 97.58 Favored 'Trans proline' 0 C--N 1.299 -2.036 0 C-N-CA 122.008 1.805 . . . . 0.0 115.211 -177.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 9.5 tp -127.91 123.36 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 174.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 29.9 t -152.78 96.71 2.93 Favored Pre-proline 0 C--N 1.304 -1.39 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.127 -178.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -63.43 132.34 35.45 Favored 'Trans proline' 0 N--CA 1.486 1.062 0 CA-C-N 119.626 0.902 . . . . 0.0 109.776 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 153' ' ' ILE . . . . . 0.663 ' O ' ' HD2' ' B' ' 154' ' ' ARG . 45.8 mm -68.97 -44.33 81.48 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.437 0 C-N-CA 119.738 -0.785 . . . . 0.0 110.88 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . 0.663 ' HD2' ' O ' ' B' ' 153' ' ' ILE . 1.0 OUTLIER -154.96 -157.18 0.73 Allowed 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 178.678 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -86.35 110.55 19.76 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.02 -20.36 50.89 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 -177.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 88.1 mt -108.6 123.89 64.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.76 0.314 . . . . 0.0 111.738 -176.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . 0.549 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 59.6 m -134.45 150.29 50.82 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.857 178.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -130.89 146.23 52.25 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 38.4 tp -139.61 74.58 33.28 Favored Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 161' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -69.43 148.09 66.44 Favored 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 122.754 2.303 . . . . 0.0 114.318 -177.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 92.9 mt -114.1 134.36 54.93 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 52.2 t -129.01 132.64 67.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 113.5 168.32 16.77 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 120.419 -0.896 . . . . 0.0 111.441 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 165' ' ' ASN . . . . . 0.705 ' O ' ' CZ ' ' B' ' 170' ' ' ARG . 56.2 t30 -89.09 107.79 19.24 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 -179.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . 0.518 HD21 ' CZ ' ' B' ' 171' ' ' PHE . 43.5 tp -66.34 104.34 1.2 Allowed 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -174.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 167' ' ' THR . . . . . 0.629 HG23 ' NE ' ' B' ' 170' ' ' ARG . 10.5 p -84.51 171.16 12.76 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 113.733 -1.576 . . . . 0.0 111.091 177.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -67.18 -38.46 85.42 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.766 177.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -66.55 -40.13 88.9 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-O 123.122 1.439 . . . . 0.0 111.773 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 170' ' ' ARG . . . . . 0.705 ' CZ ' ' O ' ' B' ' 165' ' ' ASN . 88.2 mtm180 -63.31 -36.83 85.0 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 112.241 -2.254 . . . . 0.0 111.109 178.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 171' ' ' PHE . . . . . 0.518 ' CZ ' HD21 ' B' ' 166' ' ' LEU . 0.4 OUTLIER -53.92 -25.16 19.01 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 113.607 0.965 . . . . 0.0 113.607 -178.472 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 172' ' ' ASN . . . . . 0.645 ' O ' HG22 ' B' ' 175' ' ' VAL . 90.1 m-20 -62.73 -40.2 96.47 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 119.909 -0.716 . . . . 0.0 110.872 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 49.3 m -60.41 -41.09 93.18 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.23 0.538 . . . . 0.0 110.802 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 66.5 mt -63.56 -43.95 98.45 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 175' ' ' VAL . . . . . 0.645 HG22 ' O ' ' B' ' 172' ' ' ASN . 23.8 m -62.6 -39.86 86.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 176' ' ' CYS . . . . . 0.438 ' N ' HG23 ' B' ' 175' ' ' VAL . 98.7 m -62.49 -35.09 78.25 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.241 177.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 177' ' ' THR . . . . . 0.613 ' O ' HG13 ' B' ' 181' ' ' ILE . 25.0 m -61.41 -19.81 62.35 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.243 -179.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 178' ' ' LEU . . . . . 0.755 ' CD2' HD21 ' B' ' 211' ' ' LEU . 93.3 mt -61.15 -39.6 90.71 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.397 -178.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 19.6 m -61.5 -44.22 97.46 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 176.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 180' ' ' ASN . . . . . 0.597 ' O ' ' OG ' ' B' ' 183' ' ' SER . 92.0 m-20 -61.52 -40.05 93.23 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.296 0.57 . . . . 0.0 110.29 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.613 HG13 ' O ' ' B' ' 177' ' ' THR . 70.4 mt -56.56 -35.94 46.38 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 O-C-N 121.978 -0.452 . . . . 0.0 110.582 -178.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 182' ' ' LEU . . . . . 0.473 HD21 HD21 ' B' ' 214' ' ' LEU . 84.1 mt -61.82 -41.79 98.22 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 119.839 -0.744 . . . . 0.0 109.187 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . 0.597 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.2 p -62.97 -33.08 74.63 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 121.897 -0.502 . . . . 0.0 110.779 177.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 54.3 p -85.88 16.15 4.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.823 0.344 . . . . 0.0 111.753 -177.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 78.5 p -60.64 -16.68 41.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.782 -176.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -61.5 -40.5 94.83 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.882 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 187' ' ' ASP . . . . . 0.549 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.8 m-20 -70.44 115.27 9.42 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.528 0.68 . . . . 0.0 110.401 -178.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.88 -42.29 99.71 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 114.895 -1.048 . . . . 0.0 113.305 -177.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -111.46 131.67 55.05 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.674 -0.411 . . . . 0.0 111.135 -177.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 190' ' ' LEU . . . . . . . . . . . . . 42.1 tp -123.8 118.81 28.01 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.056 177.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 84.8 mt -107.87 126.66 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.049 -177.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 50.0 mm -115.25 117.62 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 193' ' ' ASP . . . . . 0.565 ' CG ' ' HG ' ' B' ' 195' ' ' SER . 42.6 t0 -87.64 112.19 22.07 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.938 -177.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 194' ' ' LEU . . . . . . . . . . . . . 96.1 mt -92.5 -2.78 55.98 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 176.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 195' ' ' SER . . . . . 0.565 ' HG ' ' CG ' ' B' ' 193' ' ' ASP . 78.2 p -61.14 -38.27 85.8 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.819 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.74 -34.1 87.48 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -178.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 197' ' ' LEU . . . . . 0.984 ' CD2' ' H ' ' B' ' 199' ' ' GLN . 4.9 tt -77.2 132.73 38.9 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 198' ' ' ALA . . . . . 0.972 ' N ' HD23 ' B' ' 197' ' ' LEU . . . -63.78 -41.8 97.88 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 119.788 -0.765 . . . . 0.0 111.854 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 199' ' ' GLN . . . . . 0.984 ' H ' ' CD2' ' B' ' 197' ' ' LEU . 58.9 tt0 -138.08 163.43 31.65 Favored 'General case' 0 C--O 1.203 -1.345 0 CA-C-O 122.096 0.951 . . . . 0.0 113.008 -178.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 200' ' ' VAL . . . . . 0.466 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 50.3 t -121.46 132.77 69.9 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 O-C-N 120.229 -1.544 . . . . 0.0 109.349 178.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -94.06 148.65 21.96 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-O 121.918 0.866 . . . . 0.0 111.359 -177.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -59.9 -33.12 71.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.857 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -63.87 -33.58 76.01 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 178.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.4 m -61.09 -44.45 97.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.096 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 205' ' ' ALA . . . . . 0.641 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -57.95 -31.66 67.07 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.835 -178.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -65.43 -38.16 89.06 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.216 0.531 . . . . 0.0 109.884 176.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -66.32 -38.96 88.89 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.586 178.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.7 -43.13 97.95 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.589 0.709 . . . . 0.0 110.463 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 209' ' ' PHE . . . . . 0.641 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 65.3 m-85 -61.93 -43.34 99.04 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 113.828 -1.533 . . . . 0.0 112.384 178.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.92 -42.4 97.39 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 119.442 -0.903 . . . . 0.0 109.836 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . 0.755 HD21 ' CD2' ' B' ' 178' ' ' LEU . 37.7 mt -62.42 -42.49 99.48 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.078 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 78.2 p -62.8 -36.13 82.12 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.836 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 213' ' ' HIS . . . . . 0.407 ' CE1' HD11 ' B' ' 217' ' ' LEU . 58.7 t-80 -67.08 -46.68 73.53 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 115.296 -0.866 . . . . 0.0 112.261 178.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.473 HD21 HD21 ' B' ' 182' ' ' LEU . 51.1 tp -63.79 -43.21 97.01 Favored 'General case' 0 C--O 1.222 -0.357 0 CA-C-O 121.776 0.798 . . . . 0.0 109.487 178.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 215' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' B' ' 211' ' ' LEU . 90.9 mt -62.87 -43.89 97.59 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 113.607 -1.633 . . . . 0.0 111.253 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.55 -39.12 89.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.917 -177.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . 0.407 HD11 ' CE1' ' B' ' 213' ' ' HIS . 85.7 mt -63.02 -42.79 99.88 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.314 176.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 218' ' ' THR . . . . . 0.403 HG23 ' O ' ' B' ' 214' ' ' LEU . 66.7 p -74.24 -16.54 60.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.806 -178.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 80.45 61.21 2.23 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 107.307 -2.317 . . . . 0.0 107.307 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 220' ' ' THR . . . . . . . . . . . . . 94.9 m -141.3 106.84 5.06 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 174.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -63.57 140.2 58.85 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.416 -0.514 . . . . 0.0 110.689 -174.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 44.5 tp -116.03 120.89 40.56 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.557 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 3.0 mp -109.97 129.57 64.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.758 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 224' ' ' ILE . . . . . 0.489 ' CG2' HD11 ' B' ' 227' ' ' ILE . 50.8 mm -111.0 127.11 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 43.5 p -134.34 157.76 45.54 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.924 0.869 . . . . 0.0 112.688 -178.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 90.23 18.84 48.35 Favored Glycine 0 CA--C 1.5 -0.871 0 CA-C-N 113.815 -1.539 . . . . 0.0 111.182 -177.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 227' ' ' ILE . . . . . 0.614 HD12 HG23 ' B' ' 247' ' ' THR . 95.0 mt -85.29 125.44 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 CA-C-N 118.292 1.046 . . . . 0.0 111.556 -178.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 49.5 tttt -62.87 139.97 97.36 Favored Pre-proline 0 C--N 1.313 -0.98 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.08 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.1 -37.93 93.78 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 121.373 1.382 . . . . 0.0 112.799 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -64.7 -41.67 95.84 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -178.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 50.7 tp -61.61 -41.87 98.07 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.014 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.34 -36.65 84.82 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.742 0.306 . . . . 0.0 111.123 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 94.3 mtp -63.73 -40.98 98.07 Favored 'General case' 0 C--O 1.25 1.094 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.793 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.51 -44.4 96.47 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-O 122.291 1.043 . . . . 0.0 109.332 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 35.6 mmt -64.25 -35.64 81.48 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.634 -1.167 . . . . 0.0 111.716 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 36.9 t30 -61.39 -40.33 93.98 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 -177.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.06 -43.2 99.26 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.155 -0.618 . . . . 0.0 110.202 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 55.8 tp -61.58 -44.92 96.13 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 120.257 -0.577 . . . . 0.0 112.33 -178.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 239' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' B' ' 240' ' ' ALA . 66.8 t0 -158.09 134.69 9.65 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.355 -0.538 . . . . 0.0 112.141 -179.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 240' ' ' ALA . . . . . 0.421 ' N ' ' OD1' ' B' ' 239' ' ' ASP . . . -61.76 -46.69 88.49 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 176.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 241' ' ' ASN . . . . . 0.495 ' O ' ' HB2' ' B' ' 244' ' ' SER . 91.9 m-20 -43.21 -21.85 0.03 OUTLIER 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.361 -176.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 242' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -61.29 -45.36 94.8 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.523 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 243' ' ' SER . . . . . . . . . . . . . 77.4 p -58.18 -44.62 88.12 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 244' ' ' SER . . . . . 0.495 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 19.7 m -32.59 -37.82 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 94.9 mt -83.39 134.47 34.89 Favored 'General case' 0 CA--C 1.51 -0.572 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.27 175.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -63.61 136.56 57.61 Favored 'General case' 0 C--O 1.241 0.655 0 O-C-N 121.368 -0.833 . . . . 0.0 111.645 -176.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 247' ' ' THR . . . . . 0.614 HG23 HD12 ' B' ' 227' ' ' ILE . 98.3 m -125.43 127.54 46.7 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.537 -1.211 . . . . 0.0 112.083 178.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 248' ' ' TYR . . . . . 0.45 ' CG ' ' HB2' ' B' ' 254' ' ' ALA . 96.9 m-85 -112.44 143.42 43.6 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 249' ' ' SER . . . . . 0.599 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 78.3 p -62.85 -33.31 74.99 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.144 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 250' ' ' ASN . . . . . 0.599 ' OD1' ' O ' ' B' ' 249' ' ' SER . 98.9 m-20 -148.43 160.19 43.29 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.189 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 73.6 t -64.66 -44.55 96.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.077 177.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 252' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.96 -46.09 92.1 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . 0.574 ' O ' HG22 ' B' ' 257' ' ' VAL . 90.9 m-20 -60.67 -43.37 97.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.361 -0.836 . . . . 0.0 112.188 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 254' ' ' ALA . . . . . 0.45 ' HB2' ' CG ' ' B' ' 248' ' ' TYR . . . -65.42 -40.47 93.4 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 120.091 -0.644 . . . . 0.0 111.332 178.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 255' ' ' VAL . . . . . 0.404 ' O ' ' HD2' ' B' ' 259' ' ' PRO . 62.2 t -64.82 -45.52 94.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.656 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 256' ' ' LYS . . . . . 0.422 ' HE3' ' ND2' ' A' ' 155' ' ' ASN . 88.7 tttt -63.36 -48.65 77.06 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.485 -178.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 257' ' ' VAL . . . . . 0.574 HG22 ' O ' ' B' ' 253' ' ' ASP . 33.0 m -64.69 -41.13 91.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.623 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 258' ' ' LEU . . . . . 0.505 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 0.9 OUTLIER -33.09 -72.87 0.06 OUTLIER Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 120.775 -0.37 . . . . 0.0 111.947 -177.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 259' ' ' PRO . . . . . 0.595 ' O ' HG13 ' B' ' 260' ' ' ILE . 38.4 Cg_endo -62.54 141.78 87.64 Favored 'Trans proline' 0 N--CA 1.506 2.236 0 C-N-CA 121.855 1.703 . . . . 0.0 111.243 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 260' ' ' ILE . . . . . 0.595 HG13 ' O ' ' B' ' 259' ' ' PRO . 96.6 mt -160.61 -18.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 77.2 mtm . . . . . 0 C--O 1.219 -0.547 0 CA-C-O 117.919 -1.038 . . . . 0.0 111.786 -179.738 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 900' ' ' FMN . . . . . 0.439 ' H6 ' ' HA3' ' A' ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 900' ' ' FMN . . . . . 0.536 ' H6 ' ' HA3' ' B' ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.234 0 N-CA-C 109.054 -1.619 . . . . 0.0 109.054 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.54 165.47 35.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 119.173 -0.442 . . . . 0.0 110.111 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.9 p -70.9 -16.54 62.69 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-O 121.5 0.667 . . . . 0.0 111.356 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -72.1 -65.71 0.74 Allowed 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 114.275 -1.329 . . . . 0.0 112.151 174.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -67.07 -38.21 85.36 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.538 ' O ' ' NZ ' ' B' ' 17' ' ' LYS . 60.9 m -59.4 -42.45 91.76 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.152 -177.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.521 ' HB3' ' O ' ' A' ' 6' ' ' SER . 44.6 t80 84.6 84.04 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 O-C-N 123.69 0.618 . . . . 0.0 111.801 176.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.623 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -58.99 -141.72 0.01 OUTLIER Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 -177.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.623 ' HB ' ' O ' ' A' ' 8' ' ' GLY . 86.3 mt 84.64 109.92 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.626 0 C-N-CA 122.39 0.276 . . . . 0.0 110.682 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.27 -22.37 72.23 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.49 1.46 . . . . 0.0 111.994 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.41 -37.29 94.27 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.844 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.1 -39.9 93.79 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.51 0.671 . . . . 0.0 109.847 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 52.8 tp -63.23 -41.19 99.06 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.947 -0.569 . . . . 0.0 112.215 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -63.03 -41.33 99.49 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 60.1 t -60.36 -44.06 95.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 O-C-N 122.339 -0.226 . . . . 0.0 110.705 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 92.3 mt -62.58 -43.48 98.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.452 -177.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.43 ' NZ ' ' HA ' ' B' ' 6' ' ' SER . 98.9 mttt -62.53 -45.38 93.25 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 119.458 -0.897 . . . . 0.0 111.879 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.556 ' HZ1' HG12 ' B' ' 113' ' ' ILE . 98.4 mttt -60.44 -39.53 87.84 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 118.555 -1.258 . . . . 0.0 109.051 -176.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.85 -41.56 91.67 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.059 -0.656 . . . . 0.0 110.262 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.6 mt -63.07 -41.24 99.39 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.61 -38.79 92.45 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.383 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 62.6 m170 -58.69 -39.98 82.27 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 122.2 -0.312 . . . . 0.0 111.243 -178.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.9 p -114.61 129.3 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.496 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 34.6 ptt180 -71.11 108.71 4.77 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 122.098 0.951 . . . . 0.0 112.081 -177.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.0 p -140.07 142.59 31.49 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 178.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.416 ' HA3' ' HB2' ' A' ' 123' ' ' GLN . . . -97.84 93.48 1.4 Allowed Glycine 0 C--N 1.312 -0.783 0 C-N-CA 120.776 -0.726 . . . . 0.0 113.058 -179.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.9 t -124.41 130.0 73.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 175.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.3 m -136.34 159.22 38.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.6 mt -121.28 128.99 76.05 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 176.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.402 ' OG1' ' HB2' ' A' ' 119' ' ' PHE . 15.4 p -103.65 167.68 9.64 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.541 ' C ' ' OD1' ' A' ' 37' ' ' ASN . 45.6 t0 -133.37 101.23 13.45 Favored Pre-proline 0 C--N 1.32 -0.684 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.659 178.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.443 ' HG3' HG23 ' A' ' 117' ' ' THR . 34.8 Cg_endo -63.04 -22.58 73.66 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 121.411 1.407 . . . . 0.0 111.534 -179.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.4 -35.73 80.11 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.774 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 91.9 mt -85.85 161.0 19.29 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.656 177.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.744 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 43.1 tt0 -59.67 135.42 57.67 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -177.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.537 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 60.2 t0 60.65 22.37 12.23 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.877 178.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.541 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 22.5 t-20 40.9 67.82 2.72 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.877 -178.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.744 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 91.3 Cg_endo -71.23 156.88 58.47 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 C-N-CA 123.816 3.011 . . . . 0.0 112.493 -178.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.4 mt -90.08 125.34 42.98 Favored 'Isoleucine or valine' 0 C--O 1.245 0.862 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.441 HG23 ' N ' ' A' ' 41' ' ' TYR . 35.3 m -105.54 -43.57 7.63 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 O-C-N 123.585 0.553 . . . . 0.0 112.102 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.441 ' N ' HG23 ' A' ' 40' ' ' VAL . 46.8 t80 -95.28 124.58 39.39 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.736 -178.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.9 p -142.58 139.55 28.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.347 177.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.593 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 56.7 p30 -96.73 166.6 11.57 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.526 ' OE1' ' HA ' ' A' ' 44' ' ' GLN . 12.6 mm100 -67.19 -37.98 84.6 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-O 120.961 0.41 . . . . 0.0 111.855 177.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.03 -27.51 64.9 Favored Glycine 0 C--N 1.331 0.283 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.683 ' CD2' HD13 ' A' ' 57' ' ' ILE . 71.0 t80 -59.13 -48.43 81.64 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 -179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.669 HG13 ' O ' ' A' ' 52' ' ' TYR . 54.9 t -59.58 -44.9 94.26 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.585 0 O-C-N 121.297 -0.877 . . . . 0.0 111.442 -173.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -63.64 -37.61 87.98 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 120.415 -0.514 . . . . 0.0 112.027 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.408 ' O ' ' HE2' ' A' ' 96' ' ' LYS . 58.8 ttm -67.3 -43.59 81.35 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 175.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 39.8 p -90.06 -23.79 21.34 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.155 0.502 . . . . 0.0 111.634 -178.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.78 20.44 70.9 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 -179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.669 ' O ' HG13 ' A' ' 47' ' ' VAL . 90.4 m-85 -115.02 141.89 47.38 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.003 0.521 . . . . 0.0 111.539 178.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -65.96 149.52 50.1 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.848 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.441 HG22 ' H ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -65.7 -33.09 75.07 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -179.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.27 -43.71 85.67 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 119.535 -0.866 . . . . 0.0 111.286 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -64.76 -44.67 89.32 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 119.808 -0.757 . . . . 0.0 109.393 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.683 HD13 ' CD2' ' A' ' 46' ' ' PHE . 93.5 mt -61.81 -49.98 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 -174.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 84.1 mt -55.94 148.67 16.73 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 176.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.01 -4.54 61.53 Favored Glycine 0 CA--C 1.52 0.377 0 CA-C-O 119.379 -0.678 . . . . 0.0 113.305 177.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -136.98 149.37 47.48 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.041 1.42 . . . . 0.0 111.711 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.57 ' C ' ' H ' ' A' ' 63' ' ' ARG . 25.8 t-20 -80.89 152.09 28.29 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.189 0.519 . . . . 0.0 110.687 -178.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 82.0 m -62.2 15.12 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.291 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.57 ' H ' ' C ' ' A' ' 61' ' ' ASN . 34.4 ptt-85 -61.93 -41.6 98.14 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.979 -0.45 . . . . 0.0 111.376 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -56.17 -21.84 25.3 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 93.0 mt -67.25 -35.64 79.98 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.757 0.789 . . . . 0.0 113.063 177.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -63.05 142.87 58.22 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.157 -0.929 . . . . 0.0 112.225 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.499 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -152.8 -148.79 4.97 Favored Glycine 0 CA--C 1.54 1.638 0 C-N-CA 120.96 -0.638 . . . . 0.0 111.685 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.85 -40.69 98.23 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -177.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.452 ' O ' ' OE1' ' A' ' 93' ' ' GLN . 8.8 m-70 -76.5 -9.04 58.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.715 0.293 . . . . 0.0 111.101 -178.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.499 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 30.6 m -62.87 129.94 42.62 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 120.204 -0.598 . . . . 0.0 109.786 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -87.7 110.52 35.33 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.997 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -57.29 -32.16 92.92 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.993 1.795 . . . . 0.0 113.117 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.76 -39.6 94.67 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.979 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.49 ' OE1' ' HB ' ' A' ' 90' ' ' VAL . 79.4 mm-40 -65.09 -43.85 90.79 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 178.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.7 t -59.88 -43.94 93.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 114.273 -1.331 . . . . 0.0 107.817 -176.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.83 -37.8 88.73 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.724 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -63.26 -39.8 95.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.235 0.541 . . . . 0.0 110.295 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 95.1 mt -63.85 -44.07 98.02 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.996 178.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -62.83 -43.07 99.79 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 113.655 -1.611 . . . . 0.0 108.371 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 98.5 m -61.34 -48.76 79.82 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.57 -41.87 91.16 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.589 -172.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 90.6 mt -63.24 -40.08 96.43 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 118.831 0.741 . . . . 0.0 111.414 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 66.9 tp60 -64.49 -32.94 74.78 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -90.3 -2.36 58.0 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.533 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.2 tttt 49.35 39.17 15.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.955 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -121.89 144.06 40.08 Favored Pre-proline 0 CA--C 1.533 0.321 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.434 ' HB3' ' OD1' ' A' ' 109' ' ' ASP . 24.7 Cg_exo -61.46 143.32 97.33 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 121.402 1.402 . . . . 0.0 113.236 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.8 p -139.79 142.45 32.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.819 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.925 HG23 ' OD1' ' A' ' 107' ' ' ASN . 99.0 m -126.33 121.25 32.04 Favored 'General case' 0 C--N 1.344 0.336 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 175.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.49 ' HB ' ' OE1' ' A' ' 74' ' ' GLU . 29.9 m -138.85 158.72 30.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.323 177.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -102.87 133.58 47.72 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 105.498 -2.038 . . . . 0.0 105.498 176.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.424 HG23 ' O ' ' A' ' 92' ' ' ILE . 18.0 tt -140.41 129.97 27.36 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.213 0 CA-C-N 121.067 1.758 . . . . 0.0 112.438 177.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.452 ' OE1' ' O ' ' A' ' 69' ' ' HIS . 86.1 mt-30 -63.37 132.19 50.69 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.75 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -131.9 155.92 47.03 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.542 -178.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -114.84 134.52 55.07 Favored 'General case' 0 C--N 1.346 0.444 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.458 ' HG3' ' CE1' ' A' ' 102' ' ' PHE . 99.0 mttt -83.61 -174.18 5.14 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.139 0.495 . . . . 0.0 111.532 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -62.44 -41.52 98.79 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.041 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 40.9 p-10 -83.95 5.17 26.52 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 111.892 0.331 . . . . 0.0 111.892 -177.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.01 -1.77 85.12 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.004 176.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 25.0 m -60.39 137.46 58.14 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 106.576 -1.638 . . . . 0.0 106.576 178.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.66 ' SD ' ' C ' ' A' ' 101' ' ' MET . 14.7 tmm? -104.44 127.83 52.22 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.628 0.252 . . . . 0.0 110.711 178.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.458 ' CE1' ' HG3' ' A' ' 96' ' ' LYS . 52.6 p90 -140.7 157.01 46.06 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.244 -0.582 . . . . 0.0 109.803 -177.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.786 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 20.8 m95 -88.12 141.96 28.15 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.54 HD21 ' HG2' ' A' ' 123' ' ' GLN . 56.9 t-20 -137.38 102.92 4.93 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -177.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 80.8 tt0 -67.75 136.64 54.54 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -176.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 41.8 tp -121.74 124.22 43.71 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.925 ' OD1' HG23 ' A' ' 89' ' ' THR . 98.0 m-20 -122.43 124.49 43.76 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.671 177.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 87' ' ' PRO . 96.4 mt -120.57 129.28 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 O-C-N 123.436 0.46 . . . . 0.0 111.597 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.434 ' OD1' ' HB3' ' A' ' 87' ' ' PRO . 2.4 m-20 -137.81 121.6 11.68 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 110.581 -0.155 . . . . 0.0 110.581 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -69.6 150.86 69.75 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 122.432 2.088 . . . . 0.0 112.713 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.68 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 66.6 mtt -121.94 153.12 38.91 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -127.81 94.19 3.88 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 176.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.443 ' CD1' HG22 ' B' ' 15' ' ' VAL . 96.5 mt -119.05 130.97 73.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.876 -178.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 51.95 36.51 18.62 Favored 'General case' 0 CA--C 1.517 -0.292 0 O-C-N 121.406 -0.809 . . . . 0.0 111.468 176.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 59.42 30.31 19.98 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.758 -178.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -127.47 146.12 50.6 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 177.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.724 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 5.0 t -82.04 -173.2 4.36 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.578 -0.701 . . . . 0.0 109.77 -178.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.724 ' CD2' ' O ' ' A' ' 117' ' ' THR . 64.0 m-85 -171.11 157.44 5.16 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 173.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.402 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 97.6 m-85 -131.32 146.21 52.19 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 174.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.5 p -133.15 135.68 56.29 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 177.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.5 ' N ' HM73 ' A' ' 900' ' ' FMN . . . -109.17 127.41 8.51 Favored Glycine 0 CA--C 1.501 -0.795 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 178.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 96.2 mt -118.99 130.1 74.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.54 ' HG2' HD21 ' A' ' 104' ' ' ASN . 16.4 mp0 -120.39 117.74 28.53 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 123.563 0.539 . . . . 0.0 109.975 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -117.83 113.59 22.0 Favored 'General case' 0 C--O 1.248 0.995 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.032 -178.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 126' ' ' ILE . 68.1 t0 -64.02 132.41 50.51 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -174.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.52 HG22 ' O ' ' A' ' 126' ' ' ILE . 2.6 mp -97.5 2.58 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-N 113.765 -1.561 . . . . 0.0 110.398 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 19.3 m -60.61 -43.0 97.96 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.211 -0.931 . . . . 0.0 113.397 -178.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -59.76 -42.46 93.3 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -63.06 -39.05 93.59 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.723 177.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.786 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.7 mttt -62.41 -40.69 97.34 Favored 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 118.467 -1.293 . . . . 0.0 110.631 -178.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -62.53 -36.98 84.3 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -178.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.766 ' CE2' HD11 ' A' ' 136' ' ' LEU . 89.8 t80 -61.56 -45.96 91.93 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.597 176.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.62 -38.47 91.11 Favored 'General case' 0 C--O 1.225 -0.213 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.89 -40.91 97.07 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 51.5 tp -60.91 -43.6 98.33 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 -178.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.766 HD11 ' CE2' ' A' ' 132' ' ' TYR . 87.7 mt -62.7 -41.25 99.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.168 179.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.16 -41.1 99.19 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.766 -178.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -60.99 -41.84 97.27 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 -177.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 66.9 m -61.85 -41.0 97.29 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.661 176.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.424 ' O ' ' N ' ' A' ' 144' ' ' THR . 90.2 mt -63.15 -41.9 99.35 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 92.8 m -61.86 -45.46 93.7 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.151 -178.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -65.41 -41.07 93.99 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 94.9 mt -64.55 -43.47 96.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 113.968 -1.469 . . . . 0.0 111.383 177.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.424 ' N ' ' O ' ' A' ' 140' ' ' LEU . 99.1 m -62.25 -46.08 90.42 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 120.432 -0.507 . . . . 0.0 112.167 -178.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.402 ' O ' ' HB ' ' A' ' 148' ' ' THR . . . -62.02 -41.28 97.92 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 118.789 -1.164 . . . . 0.0 108.931 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.3 mt -63.88 -42.62 97.44 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 177.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.681 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.0 p -60.56 -37.28 80.75 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -178.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.454 ' C ' ' O ' ' A' ' 147' ' ' SER . 55.5 m -31.14 83.91 0.03 OUTLIER Pre-proline 0 C--N 1.344 0.359 0 O-C-N 126.79 2.556 . . . . 0.0 106.211 -178.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.681 ' N ' ' O ' ' A' ' 147' ' ' SER . 21.7 Cg_exo -62.74 145.31 94.91 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 120.849 1.033 . . . . 0.0 114.604 -175.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.651 ' O ' HG23 ' A' ' 151' ' ' VAL . 8.7 tp -121.78 136.94 57.04 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.933 0 N-CA-C 102.891 -3.003 . . . . 0.0 102.891 176.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 150' ' ' ILE . 60.1 t -170.23 94.74 0.48 Allowed Pre-proline 0 N--CA 1.445 -0.685 0 N-CA-C 105.992 -1.855 . . . . 0.0 105.992 177.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.421 ' HG3' ' HG3' ' B' ' 252' ' ' LYS . 46.2 Cg_endo -63.41 143.8 89.37 Favored 'Trans proline' 0 C--N 1.298 -2.092 0 N-CA-C 109.78 -0.892 . . . . 0.0 109.78 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.555 ' O ' HG11 ' B' ' 255' ' ' VAL . 44.2 mm -77.04 -60.27 2.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.03 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.68 ' NH2' ' HD3' ' B' ' 154' ' ' ARG . 1.6 mpt_? -140.41 -157.56 0.78 Allowed 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.0 t-20 -86.45 105.23 16.62 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.804 0.812 . . . . 0.0 111.5 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.11 8.55 66.6 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 114.032 -1.44 . . . . 0.0 110.615 -177.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 97.1 mt -123.93 125.57 71.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 175.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.716 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 58.5 m -132.3 151.47 51.82 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.222 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -139.34 142.84 37.6 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.575 -0.703 . . . . 0.0 111.08 177.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 16.8 tp -133.96 80.83 53.45 Favored Pre-proline 0 N--CA 1.469 0.517 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.355 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -69.25 149.89 70.7 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.788 2.325 . . . . 0.0 112.938 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 88.7 mt -119.0 128.09 54.07 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.502 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 47.7 t -124.17 131.27 73.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 116.78 169.62 15.22 Favored Glycine 0 N--CA 1.48 1.62 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.174 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.874 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 56.4 t30 -87.08 113.28 22.69 Favored 'General case' 0 C--O 1.221 -0.431 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -178.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.538 HD21 ' CZ ' ' A' ' 171' ' ' PHE . 46.7 tp -72.39 104.19 3.68 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -178.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.723 HG23 ' NE ' ' A' ' 170' ' ' ARG . 11.4 p -85.63 167.42 15.36 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.571 178.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.49 -34.85 79.24 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.937 0.398 . . . . 0.0 111.6 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.2 -41.97 94.01 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.757 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.874 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 88.0 mtm180 -64.08 -33.18 75.18 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 123.993 0.917 . . . . 0.0 112.368 178.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.538 ' CZ ' HD21 ' A' ' 166' ' ' LEU . 0.5 OUTLIER -53.68 -28.24 32.39 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 118.887 -0.578 . . . . 0.0 112.472 -178.766 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.592 ' O ' HG22 ' A' ' 175' ' ' VAL . 91.1 m-20 -61.0 -40.64 94.29 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 118.942 -1.103 . . . . 0.0 109.774 -178.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 54.7 m -59.47 -41.25 89.33 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.604 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 66.9 mt -63.69 -44.35 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.592 HG22 ' O ' ' A' ' 172' ' ' ASN . 33.5 m -62.79 -40.39 88.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . 0.429 ' N ' HG23 ' A' ' 175' ' ' VAL . 99.3 m -62.77 -34.7 77.79 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.304 0.573 . . . . 0.0 110.34 178.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.509 ' O ' HG13 ' A' ' 181' ' ' ILE . 24.6 m -62.11 -19.49 63.06 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.197 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.59 ' CD2' HD21 ' A' ' 211' ' ' LEU . 90.5 mt -60.93 -41.17 95.66 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -177.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 18.3 m -59.48 -42.96 93.3 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.628 ' O ' ' OG ' ' A' ' 183' ' ' SER . 91.0 m-20 -61.34 -36.63 80.72 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 122.668 0.387 . . . . 0.0 110.837 178.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.512 HD12 ' HA ' ' A' ' 178' ' ' LEU . 67.0 mt -59.02 -39.92 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 O-C-N 121.558 -0.714 . . . . 0.0 109.086 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.473 HD21 HD21 ' A' ' 214' ' ' LEU . 86.3 mt -60.71 -40.61 92.88 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -177.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.628 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 77.9 p -61.65 -33.49 74.05 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.501 176.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.417 ' OG1' ' HA ' ' A' ' 181' ' ' ILE . 66.1 p -89.69 23.37 2.69 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.69 -0.232 . . . . 0.0 111.581 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 78.3 p -63.46 -19.93 65.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.188 0.518 . . . . 0.0 110.752 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.49 -37.29 83.14 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.916 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.716 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 98.2 m-20 -74.18 112.93 10.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.563 0.696 . . . . 0.0 110.839 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -62.74 -42.42 99.66 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 114.967 -1.015 . . . . 0.0 113.063 -177.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -110.48 130.91 55.45 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.562 -178.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 39.2 tp -120.21 128.61 53.53 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 177.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 96.7 mt -116.1 127.53 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-N 118.59 0.632 . . . . 0.0 109.689 177.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.2 mm -113.36 126.93 70.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 178.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . 0.43 ' CG ' ' HG ' ' A' ' 195' ' ' SER . 41.3 t0 -94.67 117.89 30.84 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-O 121.379 0.609 . . . . 0.0 110.667 176.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 97.9 mt -98.59 -4.81 33.23 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.882 175.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.43 ' HG ' ' CG ' ' A' ' 193' ' ' ASP . 78.2 p -62.31 -33.31 74.42 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.81 -42.68 99.77 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 118.553 -1.784 . . . . 0.0 109.081 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.958 ' CD2' ' O ' ' A' ' 199' ' ' GLN . 5.0 tt -70.59 128.69 36.98 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 112.891 -1.655 . . . . 0.0 107.516 -174.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.897 ' N ' HD23 ' A' ' 197' ' ' LEU . . . -60.26 -45.3 93.77 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.745 -176.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.958 ' O ' ' CD2' ' A' ' 197' ' ' LEU . 58.8 tt0 -138.81 157.31 46.31 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-N 114.466 -1.243 . . . . 0.0 112.847 -174.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.482 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 47.4 t -118.23 131.71 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -87.66 156.01 19.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.543 -178.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -64.35 -38.89 92.65 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.211 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -58.68 -32.35 69.05 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -178.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.6 m -61.21 -42.32 98.38 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.481 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.476 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -57.52 -39.01 75.6 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -177.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -61.64 -37.11 82.79 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -65.54 -39.12 91.39 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.892 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 94.8 mt -63.18 -44.23 99.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -178.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . 0.476 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 71.8 m-85 -62.21 -43.58 98.5 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.743 -178.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.34 -42.04 99.07 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 119.316 -0.954 . . . . 0.0 109.231 -178.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.59 HD21 ' CD2' ' A' ' 178' ' ' LEU . 38.2 mt -62.08 -41.81 98.55 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 77.9 p -61.57 -41.14 96.96 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.07 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -64.49 -45.86 85.49 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.378 -179.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.473 HD21 HD21 ' A' ' 182' ' ' LEU . 48.6 tp -62.31 -46.14 90.06 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 119.1 -1.04 . . . . 0.0 108.492 178.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 211' ' ' LEU . 91.2 mt -62.2 -40.8 97.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.504 -177.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.27 -44.41 95.36 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.44 -178.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 87.5 mt -61.65 -39.68 92.23 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 69.8 p -75.77 -10.79 59.73 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.244 179.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.07 33.59 26.1 Favored Glycine 0 C--N 1.343 0.925 0 C-N-CA 120.501 -0.857 . . . . 0.0 113.205 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 97.3 m -119.36 113.27 20.56 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.073 1.436 . . . . 0.0 111.512 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -64.98 138.03 58.11 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.752 178.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 45.6 tp -113.8 130.82 56.41 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 3.0 mp -117.85 133.33 64.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.539 ' CG2' HD11 ' A' ' 227' ' ' ILE . 49.3 mm -115.48 131.81 66.73 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.416 HG22 ' HB2' ' A' ' 248' ' ' TYR . 44.4 p -133.72 166.13 23.34 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 120.531 -0.467 . . . . 0.0 111.997 -178.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 80.04 19.76 69.19 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.715 HD12 HG23 ' A' ' 247' ' ' THR . 97.1 mt -81.9 128.45 38.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 114.059 -1.07 . . . . 0.0 108.506 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 58.6 tttt -75.68 140.72 71.61 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.6 -39.22 89.63 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 121.069 1.179 . . . . 0.0 112.672 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 -64.36 -39.67 94.35 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.686 0.755 . . . . 0.0 110.188 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 52.0 tp -63.91 -42.44 97.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.937 -1.029 . . . . 0.0 112.688 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.84 -37.9 89.1 Favored 'General case' 0 N--CA 1.461 0.103 0 O-C-N 121.952 -0.468 . . . . 0.0 110.973 -179.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 94.2 mtp -63.61 -40.89 98.05 Favored 'General case' 0 C--O 1.248 1.026 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.468 -178.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.88 -38.62 91.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.437 177.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 35.0 mmt -65.59 -38.27 89.01 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.63 178.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -61.29 -41.82 97.61 Favored 'General case' 0 CA--C 1.515 -0.402 0 O-C-N 121.52 -0.738 . . . . 0.0 109.525 -177.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.16 -40.99 95.95 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.549 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 56.0 tp -63.52 -41.48 98.5 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 177.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -166.94 127.39 1.55 Allowed 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -60.45 -26.41 66.73 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.66 178.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.426 ' O ' ' HB2' ' A' ' 244' ' ' SER . 91.3 m-20 -61.39 -33.84 74.36 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.523 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -55.22 -44.27 75.25 Favored 'General case' 0 C--N 1.311 -1.088 0 O-C-N 121.551 -0.718 . . . . 0.0 109.422 -175.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 97.9 p -61.92 -20.12 63.44 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.865 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' A' ' 241' ' ' ASN . 40.6 m -56.03 -39.24 71.65 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.697 178.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 98.7 mt -84.03 122.82 29.31 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -43.38 135.42 3.52 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.895 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.715 HG23 HD12 ' A' ' 227' ' ' ILE . 97.9 m -127.25 132.53 50.36 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.243 -1.344 . . . . 0.0 110.844 177.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' TYR . . . . . 0.432 ' CB ' ' HB2' ' A' ' 254' ' ' ALA . 97.0 m-85 -118.01 139.83 50.63 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.29 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . 0.411 ' O ' ' OD1' ' A' ' 250' ' ' ASN . 78.3 p -61.16 -42.87 99.34 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 119.277 -0.969 . . . . 0.0 108.589 -178.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.411 ' OD1' ' O ' ' A' ' 249' ' ' SER . 99.0 m-20 -143.83 160.56 40.55 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.699 0.762 . . . . 0.0 111.434 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 54.9 t -63.09 -44.42 99.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.933 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.76 -44.96 96.08 Favored 'General case' 0 CA--C 1.513 -0.475 0 C-N-CA 120.215 -0.594 . . . . 0.0 109.668 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . 0.497 ' O ' HG22 ' A' ' 257' ' ' VAL . 54.5 m-20 -64.22 -41.36 97.06 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.361 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.432 ' HB2' ' CB ' ' A' ' 248' ' ' TYR . . . -64.83 -42.25 95.1 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.858 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . 0.478 HG13 HH11 ' B' ' 154' ' ' ARG . 68.3 t -64.03 -45.73 95.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-N 114.111 -1.404 . . . . 0.0 110.974 -178.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.62 -47.67 80.42 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.489 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.5 ' O ' ' C ' ' A' ' 258' ' ' LEU . 24.7 m -66.58 -40.45 86.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 120.118 -0.633 . . . . 0.0 112.206 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.5 ' C ' ' O ' ' A' ' 257' ' ' VAL . 0.9 OUTLIER -29.36 -74.9 0.04 OUTLIER Pre-proline 0 CA--C 1.533 0.313 0 CA-C-O 119.472 -0.299 . . . . 0.0 111.253 -177.106 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' PRO . . . . . 0.496 ' CD ' ' CB ' ' A' ' 258' ' ' LEU . 40.3 Cg_endo -62.84 139.61 75.33 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 C-N-CA 120.73 0.953 . . . . 0.0 111.884 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 259' ' ' PRO . 96.5 mt -151.36 -23.55 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 O-C-N 123.327 0.392 . . . . 0.0 111.97 178.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 78.4 mtm . . . . . 0 C--O 1.218 -0.566 0 CA-C-O 118.125 -0.94 . . . . 0.0 110.637 -177.545 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.451 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.51 157.36 35.3 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 78.5 p -59.86 -22.13 61.89 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 123.339 0.399 . . . . 0.0 110.948 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -70.83 -61.58 1.71 Allowed 'General case' 0 N--CA 1.426 -1.633 0 O-C-N 121.946 -0.472 . . . . 0.0 111.133 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -67.54 -37.97 83.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.349 -0.842 . . . . 0.0 112.114 178.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.527 ' O ' ' HB3' ' B' ' 7' ' ' PHE . 63.9 m -59.63 -42.87 93.7 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 120.048 -0.661 . . . . 0.0 110.009 -177.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . 0.527 ' HB3' ' O ' ' B' ' 6' ' ' SER . 44.8 t80 85.13 86.82 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 O-C-N 123.754 0.659 . . . . 0.0 110.431 177.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . 0.63 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -61.0 -140.72 0.01 OUTLIER Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 -178.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.63 ' HB ' ' O ' ' B' ' 8' ' ' GLY . 86.0 mt 83.62 109.81 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 122.438 0.295 . . . . 0.0 110.975 -178.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -62.3 -24.53 76.0 Favored 'Trans proline' 0 N--CA 1.499 1.852 0 C-N-CA 121.431 1.42 . . . . 0.0 111.714 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.62 -39.67 97.7 Favored Glycine 0 CA--C 1.53 0.998 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -64.33 -40.03 95.07 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.66 0.743 . . . . 0.0 109.693 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 52.3 tp -62.28 -42.27 99.2 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.026 -178.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -64.64 -33.34 75.72 Favored 'General case' 0 CA--C 1.56 1.333 0 CA-C-O 121.585 0.707 . . . . 0.0 110.614 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . 0.443 HG22 ' CD1' ' A' ' 113' ' ' ILE . 79.3 t -62.92 -46.24 96.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 113.136 -1.847 . . . . 0.0 111.08 177.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 95.5 mt -63.83 -43.96 98.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.422 -178.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . 0.538 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 98.9 mttt -63.45 -41.99 98.65 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.94 -40.91 99.09 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 118.983 -1.087 . . . . 0.0 110.177 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.92 -38.39 85.6 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.82 -178.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 86.0 mt -64.0 -42.15 97.25 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.098 0.475 . . . . 0.0 110.222 176.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.27 -39.15 93.8 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.16 -179.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -58.04 -40.0 79.79 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 121.106 -0.237 . . . . 0.0 111.102 -178.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 8.2 p -114.7 129.44 70.81 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.506 ' O ' ' HG3' ' B' ' 24' ' ' ARG . 34.5 ptt180 -70.94 106.65 3.72 Favored 'General case' 0 CA--C 1.527 0.079 0 CA-C-O 121.87 0.843 . . . . 0.0 112.527 -177.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.5 p -142.11 133.3 25.76 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.703 177.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . 0.453 ' O ' ' N ' ' B' ' 123' ' ' GLN . . . -88.45 97.79 2.35 Favored Glycine 0 N--CA 1.439 -1.135 0 C-N-CA 119.506 -1.33 . . . . 0.0 113.153 -176.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 45.9 t -125.3 129.08 73.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 174.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 27.5 m -138.11 155.96 30.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.821 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 94.8 mt -119.89 127.06 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 122.124 0.964 . . . . 0.0 111.181 179.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.405 HG22 HG12 ' B' ' 39' ' ' ILE . 23.7 p -106.71 157.99 17.3 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-N 112.654 -2.066 . . . . 0.0 108.628 -176.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.534 ' C ' ' OD1' ' B' ' 37' ' ' ASN . 46.1 t0 -126.78 101.36 26.77 Favored Pre-proline 0 C--O 1.239 0.515 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 -177.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.08 -20.7 67.81 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 121.714 1.609 . . . . 0.0 111.448 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.47 -43.29 99.12 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 120.575 -0.45 . . . . 0.0 109.865 178.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 91.8 mt -75.16 179.55 4.99 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.715 -0.616 . . . . 0.0 111.149 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . 0.666 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 42.5 tt0 -75.48 132.94 41.13 Favored 'General case' 0 C--N 1.342 0.245 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -178.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.5 ' O ' ' OD1' ' B' ' 36' ' ' ASP . 65.9 t0 56.21 37.11 28.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.757 178.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' ASN . . . . . 0.534 ' OD1' ' C ' ' B' ' 31' ' ' ASP . 13.2 t-20 30.11 70.48 0.59 Allowed Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.666 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 92.8 Cg_endo -72.82 156.26 52.99 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 123.401 2.734 . . . . 0.0 111.89 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.405 HG12 HG22 ' B' ' 30' ' ' THR . 96.1 mt -89.28 129.48 40.19 Favored 'Isoleucine or valine' 0 C--O 1.246 0.881 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.429 HG23 ' N ' ' B' ' 41' ' ' TYR . 35.1 m -108.63 -43.44 6.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 O-C-N 123.936 0.773 . . . . 0.0 112.585 179.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' TYR . . . . . 0.429 ' N ' HG23 ' B' ' 40' ' ' VAL . 49.1 t80 -96.05 124.86 40.23 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 120.191 -0.604 . . . . 0.0 111.45 -178.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 6.2 p -142.53 140.97 28.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.438 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . 0.63 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 56.4 p30 -101.32 160.98 13.95 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.111 178.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' GLN . . . . . 0.518 ' OE1' ' HA ' ' B' ' 44' ' ' GLN . 12.1 mm100 -63.0 -36.78 84.68 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.215 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.13 -27.75 65.51 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.686 ' CD2' HD13 ' B' ' 57' ' ' ILE . 66.8 t80 -60.32 -43.76 96.09 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.29 0.567 . . . . 0.0 109.601 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 0.738 HG13 ' O ' ' B' ' 52' ' ' TYR . 53.6 t -61.42 -46.4 96.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.336 -178.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -63.4 -44.25 95.2 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.21 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 59.0 ttm -63.34 -42.51 98.93 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 36.1 p -93.33 -18.62 22.22 Favored 'General case' 0 N--CA 1.463 0.207 0 C-N-CA 120.327 -0.549 . . . . 0.0 111.875 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' B' ' 47' ' ' VAL . . . 74.98 18.93 80.17 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 178.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . 0.738 ' O ' HG13 ' B' ' 47' ' ' VAL . 89.8 m-85 -112.59 146.04 39.29 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.149 0.58 . . . . 0.0 110.528 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -73.4 148.44 43.33 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.474 0.654 . . . . 0.0 111.316 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . 0.413 HG22 ' H ' ' B' ' 54' ' ' THR . 0.3 OUTLIER -61.82 -37.34 84.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.699 -177.565 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.81 -40.34 96.4 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.235 -0.586 . . . . 0.0 111.722 -178.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -71.62 -32.54 68.08 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 176.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.686 HD13 ' CD2' ' B' ' 46' ' ' PHE . 91.2 mt -66.63 -66.75 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 177.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . 0.25 97.0 mt -45.29 134.07 6.73 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.53 -9.95 73.4 Favored Glycine 0 CA--C 1.536 1.352 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.916 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -134.16 148.18 50.89 Favored 'General case' 0 C--N 1.342 0.263 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -174.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' ASN . . . . . 0.562 ' C ' ' H ' ' B' ' 63' ' ' ARG . 25.5 t-20 -79.39 151.18 31.09 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.446 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' CYS . . . . . . . . . . . . . 83.0 m -62.52 9.11 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.251 -178.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . 0.562 ' H ' ' C ' ' B' ' 61' ' ' ASN . 33.2 ptt-85 -59.89 -32.8 71.08 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.432 -177.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -60.14 -30.03 69.03 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 178.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 87.8 mt -62.2 -41.53 98.45 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 121.779 -0.575 . . . . 0.0 109.982 -178.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -51.28 149.28 4.09 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.914 -176.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . 0.403 ' N ' ' OG1' ' B' ' 70' ' ' THR . . . -159.84 -152.84 6.65 Favored Glycine 0 CA--C 1.537 1.426 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.944 177.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.73 -41.75 95.93 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 -175.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -74.94 -10.57 59.61 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.259 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' THR . . . . . 0.428 HG23 HD11 ' B' ' 92' ' ' ILE . 28.7 m -61.26 134.58 57.13 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 120.391 -0.524 . . . . 0.0 109.625 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 61.6 t0 -92.21 110.47 44.63 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.443 -178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.28 -38.35 88.52 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 121.023 1.149 . . . . 0.0 111.835 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.63 -39.73 89.32 Favored 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 120.451 -0.5 . . . . 0.0 109.697 -176.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' GLU . . . . . 0.486 ' OE1' ' HB ' ' B' ' 90' ' ' VAL . 79.1 mm-40 -66.52 -39.18 88.5 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.888 177.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 70.9 t -62.29 -45.58 98.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -63.12 -36.99 85.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.693 -177.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -62.43 -41.77 98.96 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 119.368 -0.933 . . . . 0.0 108.679 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 94.1 mt -63.47 -43.7 98.5 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-O 120.767 0.318 . . . . 0.0 110.508 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -61.96 -42.63 99.34 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 91.7 m -61.47 -45.14 95.51 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.966 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.82 -41.25 97.54 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -177.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 87.1 mt -62.98 -42.19 99.77 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.597 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 66.7 tp60 -62.85 -35.1 78.85 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . 0.429 ' O ' ' HG2' ' B' ' 86' ' ' GLU . 98.2 m-20 -92.1 6.35 46.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.594 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 30.2 tttt 42.99 40.19 2.1 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.414 -0.515 . . . . 0.0 111.823 175.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' B' ' 84' ' ' ASN . 54.6 mm-40 -122.46 141.59 35.23 Favored Pre-proline 0 N--CA 1.467 0.424 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.29 178.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' PRO . . . . . 0.452 ' HB3' ' OD1' ' B' ' 109' ' ' ASP . 25.6 Cg_exo -61.94 140.95 87.65 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.03 1.154 . . . . 0.0 113.716 -178.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.92 137.67 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.66 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' THR . . . . . 0.913 HG23 ' OD1' ' B' ' 107' ' ' ASN . 96.4 m -121.76 122.72 40.16 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.486 ' HB ' ' OE1' ' B' ' 74' ' ' GLU . 31.1 m -138.87 162.81 28.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.892 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -114.15 121.59 44.24 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 175.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . 0.428 HD11 HG23 ' B' ' 70' ' ' THR . 20.6 tt -127.47 131.46 70.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.07 -175.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -70.13 139.95 52.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.763 177.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -129.44 178.86 6.15 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.626 0.727 . . . . 0.0 111.385 -177.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -130.43 142.42 50.5 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 114.335 -1.302 . . . . 0.0 112.173 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . 0.455 ' HG3' ' CE1' ' B' ' 102' ' ' PHE . 98.7 mttt -100.47 177.68 4.96 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.129 0.49 . . . . 0.0 110.958 177.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.71 -35.09 75.44 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.777 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 38.7 p-10 -85.95 -1.64 57.51 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 118.872 0.76 . . . . 0.0 112.709 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.42 3.23 65.06 Favored Glycine 0 N--CA 1.47 0.96 0 C-N-CA 121.15 -0.547 . . . . 0.0 112.495 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 27.3 m -67.44 129.21 39.19 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.665 178.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . 0.514 ' SD ' ' C ' ' B' ' 101' ' ' MET . 16.9 tmm? -89.22 140.58 29.34 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' PHE . . . . . 0.481 ' N ' ' SD ' ' B' ' 101' ' ' MET . 52.8 p90 -151.66 161.89 41.92 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' TRP . . . . . 0.804 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 21.2 m95 -93.69 137.99 32.37 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.529 0.68 . . . . 0.0 110.813 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . 0.543 HD21 ' HG2' ' B' ' 123' ' ' GLN . 64.1 t-20 -133.0 106.97 7.97 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 114.74 -1.118 . . . . 0.0 113.461 -176.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' B' ' 123' ' ' GLN . 81.2 tt0 -75.09 125.04 28.09 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.75 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 40.0 tp -113.5 125.54 54.32 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 121.073 0.463 . . . . 0.0 112.072 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' ASN . . . . . 0.913 ' OD1' HG23 ' B' ' 89' ' ' THR . 98.0 m-20 -121.08 130.01 53.57 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.431 -0.804 . . . . 0.0 108.88 176.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 96.6 mt -123.8 132.81 70.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.699 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . 0.452 ' OD1' ' HB3' ' B' ' 87' ' ' PRO . 2.9 m-20 -142.77 120.18 7.07 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 178.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -67.97 152.05 77.26 Favored 'Trans proline' 0 N--CA 1.503 2.079 0 C-N-CA 122.632 2.221 . . . . 0.0 112.739 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . 0.574 ' HB2' ' HB2' ' B' ' 118' ' ' TYR . 66.9 mtt -128.4 144.33 51.12 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -114.88 106.95 14.77 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . 0.556 HG12 ' HZ1' ' A' ' 18' ' ' LYS . 96.8 mt -132.88 128.18 56.51 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-N 118.428 0.558 . . . . 0.0 111.77 178.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 53.51 36.68 23.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.946 179.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 61.32 35.85 17.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.628 -178.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -132.85 149.99 52.2 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 7.1 t -99.83 153.2 19.33 Favored 'General case' 0 C--O 1.214 -0.766 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -177.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' TYR . . . . . 0.574 ' HB2' ' HB2' ' B' ' 111' ' ' MET . 89.9 m-85 -148.29 148.9 30.96 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 121.189 -0.945 . . . . 0.0 111.349 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -124.96 139.68 53.6 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 120.881 0.372 . . . . 0.0 111.181 -177.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -128.54 133.95 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -176.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . 0.516 ' N ' HM73 ' B' ' 900' ' ' FMN . . . -108.54 123.78 7.16 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.186 -0.765 . . . . 0.0 111.186 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 95.2 mt -116.38 127.66 73.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 123' ' ' GLN . . . . . 0.543 ' HG2' HD21 ' B' ' 104' ' ' ASN . 16.4 mp0 -118.47 123.9 46.29 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -121.53 119.56 32.33 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' B' ' 126' ' ' ILE . 67.9 t0 -67.42 136.18 54.31 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.273 -0.876 . . . . 0.0 112.426 -178.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.506 ' O ' ' HG3' ' B' ' 130' ' ' LYS . 2.7 mp -109.78 15.07 8.26 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.937 0 CA-C-O 122.174 0.988 . . . . 0.0 109.132 178.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 127' ' ' THR . . . . . 0.453 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 97.6 m -63.05 -43.8 97.61 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 113.827 -1.533 . . . . 0.0 112.347 176.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 59.8 tptt -61.26 -45.92 92.53 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -177.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 129' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -63.51 -33.92 76.63 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.47 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 130' ' ' LYS . . . . . 0.804 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 98.8 mttt -63.53 -41.35 98.47 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 113.589 -1.641 . . . . 0.0 110.856 174.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -64.44 -41.48 96.54 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 132' ' ' TYR . . . . . 0.779 ' CE2' HD11 ' B' ' 136' ' ' LEU . 90.8 t80 -60.17 -44.96 94.61 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 121.801 -0.562 . . . . 0.0 111.358 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . 0.445 ' O ' ' HG3' ' B' ' 137' ' ' GLU . 97.4 mt-10 -64.58 -36.25 83.63 Favored 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 134' ' ' LYS . . . . . 0.435 ' HG3' ' O ' ' B' ' 130' ' ' LYS . 98.7 mttt -63.21 -39.81 95.7 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.68 177.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 52.8 tp -62.84 -41.57 99.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.332 0.587 . . . . 0.0 109.743 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . 0.779 HD11 ' CE2' ' B' ' 132' ' ' TYR . 89.9 mt -62.86 -41.85 99.53 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.269 177.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 137' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' B' ' 133' ' ' GLU . 97.3 mt-10 -65.16 -37.25 86.8 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.302 -1.317 . . . . 0.0 110.441 -178.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -63.22 -43.48 97.99 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.899 176.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 69.7 m -60.8 -44.14 97.25 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 89.7 mt -61.64 -40.32 94.46 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -176.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 94.5 m -62.11 -45.26 94.27 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.827 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -66.09 -42.8 88.83 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 92.5 mt -63.8 -43.24 97.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.688 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 144' ' ' THR . . . . . . . . . . . . . 99.6 m -61.68 -45.04 95.69 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 -178.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . 0.445 ' O ' ' HB ' ' B' ' 148' ' ' THR . . . -63.27 -41.72 99.06 Favored 'General case' 0 C--O 1.227 -0.093 0 C-N-CA 118.952 -1.099 . . . . 0.0 109.346 178.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 86.1 mt -64.83 -41.18 95.94 Favored 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 176.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 147' ' ' SER . . . . . 0.595 ' O ' ' N ' ' B' ' 149' ' ' PRO . 78.2 p -62.06 -41.34 98.04 Favored 'General case' 0 CA--C 1.479 -1.769 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . 0.482 ' C ' ' O ' ' B' ' 147' ' ' SER . 26.3 m -28.61 87.19 0.04 OUTLIER Pre-proline 0 N--CA 1.474 0.76 0 O-C-N 124.1 0.875 . . . . 0.0 109.874 176.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 149' ' ' PRO . . . . . 0.595 ' N ' ' O ' ' B' ' 147' ' ' SER . 23.8 Cg_exo -61.67 147.04 96.26 Favored 'Trans proline' 0 C--N 1.301 -1.95 0 C-N-CA 121.952 1.768 . . . . 0.0 114.942 -178.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 9.0 tp -127.73 121.98 57.89 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.533 0 CA-C-N 113.571 -1.65 . . . . 0.0 107.63 174.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 38.7 t -154.01 95.97 2.75 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.699 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -62.35 142.95 92.91 Favored 'Trans proline' 0 C--N 1.318 -1.046 0 N-CA-C 109.61 -0.958 . . . . 0.0 109.61 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 153' ' ' ILE . . . . . 0.487 ' O ' ' HD2' ' B' ' 154' ' ' ARG . 44.5 mm -77.21 -57.46 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.387 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . 0.68 ' HD3' ' NH2' ' A' ' 154' ' ' ARG . 1.2 tpt180 -141.53 -156.07 0.65 Allowed 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 61.0 t-20 -86.05 109.6 18.93 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.29 -16.72 59.59 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -178.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 86.7 mt -108.75 125.56 65.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-O 120.86 0.362 . . . . 0.0 110.994 -176.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . 0.68 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 61.5 m -134.45 149.28 50.73 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.132 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -135.4 147.34 48.99 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.157 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 17.1 tp -140.09 79.55 21.95 Favored Pre-proline 0 CA--C 1.531 0.228 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 161' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -70.05 147.96 62.14 Favored 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 122.839 2.359 . . . . 0.0 114.099 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 91.6 mt -115.29 133.87 55.64 Favored 'General case' 0 C--N 1.342 0.239 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 53.9 t -128.17 132.94 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 114.79 169.71 16.26 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.56 178.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 165' ' ' ASN . . . . . 0.723 ' O ' ' CZ ' ' B' ' 170' ' ' ARG . 60.9 t30 -91.62 107.11 18.97 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -178.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . 0.538 HD21 ' CZ ' ' B' ' 171' ' ' PHE . 47.7 tp -65.49 104.73 1.04 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 -174.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 167' ' ' THR . . . . . 0.696 HG23 ' NE ' ' B' ' 170' ' ' ARG . 11.2 p -83.88 169.92 14.6 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 114.103 -1.408 . . . . 0.0 110.797 177.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -66.32 -38.51 87.86 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.97 177.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.09 -40.0 90.45 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 123.427 1.584 . . . . 0.0 111.828 -178.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 170' ' ' ARG . . . . . 0.723 ' CZ ' ' O ' ' B' ' 165' ' ' ASN . 88.2 mtm180 -62.3 -36.24 81.51 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 111.914 -2.403 . . . . 0.0 111.05 178.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 171' ' ' PHE . . . . . 0.538 ' CZ ' HD21 ' B' ' 166' ' ' LEU . 0.5 OUTLIER -53.82 -25.16 18.12 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -179.439 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 172' ' ' ASN . . . . . 0.544 ' O ' HG22 ' B' ' 175' ' ' VAL . 91.4 m-20 -62.68 -40.23 96.43 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.845 178.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 49.2 m -60.46 -41.82 94.9 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.729 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 66.7 mt -63.92 -44.39 97.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 175' ' ' VAL . . . . . 0.544 HG22 ' O ' ' B' ' 172' ' ' ASN . 33.6 m -63.12 -40.59 89.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 176' ' ' CYS . . . . . 0.428 ' N ' HG23 ' B' ' 175' ' ' VAL . 97.1 m -62.58 -35.05 78.29 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.344 178.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 177' ' ' THR . . . . . 0.529 ' O ' HG13 ' B' ' 181' ' ' ILE . 25.3 m -61.9 -19.54 62.78 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.24 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 178' ' ' LEU . . . . . 0.566 ' CD2' HD21 ' B' ' 211' ' ' LEU . 91.1 mt -61.16 -39.51 90.38 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.278 -177.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 19.3 m -61.04 -43.95 98.11 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.185 177.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 180' ' ' ASN . . . . . 0.611 ' O ' ' OG ' ' B' ' 183' ' ' SER . 91.4 m-20 -61.45 -39.94 92.65 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.9 0.381 . . . . 0.0 110.416 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.529 HG13 ' O ' ' B' ' 177' ' ' THR . 71.8 mt -56.96 -34.44 44.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 O-C-N 122.221 -0.3 . . . . 0.0 110.626 -178.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 182' ' ' LEU . . . . . 0.476 HD21 HD21 ' B' ' 214' ' ' LEU . 85.3 mt -62.08 -41.59 98.34 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.11 178.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . 0.611 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.1 p -63.3 -32.96 74.51 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 121.853 -0.53 . . . . 0.0 110.827 177.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 64.8 p -86.16 17.29 3.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.679 -177.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 78.1 p -61.27 -16.68 47.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.654 -177.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -61.79 -39.82 93.04 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.756 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 187' ' ' ASP . . . . . 0.68 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.1 m-20 -72.11 113.35 9.05 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.504 0.669 . . . . 0.0 110.496 -177.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -62.8 -42.22 99.62 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 114.83 -1.077 . . . . 0.0 113.119 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -110.47 130.52 55.54 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.034 -177.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 190' ' ' LEU . . . . . 0.428 ' HA ' ' O ' ' B' ' 158' ' ' SER . 41.1 tp -123.46 119.33 29.69 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.139 178.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 87.2 mt -107.44 126.86 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 117.796 0.271 . . . . 0.0 111.15 -176.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 49.2 mm -116.29 117.31 55.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 193' ' ' ASP . . . . . 0.464 ' CG ' ' HG ' ' B' ' 195' ' ' SER . 43.3 t0 -88.38 111.33 21.63 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -177.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 194' ' ' LEU . . . . . . . . . . . . . 98.1 mt -93.98 -2.74 52.66 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 176.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 195' ' ' SER . . . . . 0.464 ' HG ' ' CG ' ' B' ' 193' ' ' ASP . 78.2 p -61.35 -37.32 82.89 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 120.94 -0.304 . . . . 0.0 110.872 -178.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.98 -34.01 87.49 Favored Glycine 0 N--CA 1.436 -1.312 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 197' ' ' LEU . . . . . 1.01 HD22 ' O ' ' B' ' 199' ' ' GLN . 5.2 tt -76.23 133.25 40.17 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -177.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 198' ' ' ALA . . . . . 0.915 ' N ' HD23 ' B' ' 197' ' ' LEU . . . -63.56 -41.26 98.42 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 119.979 -0.688 . . . . 0.0 111.935 -177.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 199' ' ' GLN . . . . . 1.01 ' O ' HD22 ' B' ' 197' ' ' LEU . 59.4 tt0 -140.96 164.23 30.82 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.446 0.641 . . . . 0.0 111.864 -179.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 200' ' ' VAL . . . . . 0.502 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 49.9 t -120.98 131.73 72.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 177.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -91.13 150.03 21.55 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.875 -177.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -60.5 -33.13 72.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.28 -178.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -63.77 -33.81 76.49 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.465 0.65 . . . . 0.0 109.388 178.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.5 m -60.79 -43.93 97.46 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.246 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 205' ' ' ALA . . . . . 0.64 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -58.26 -30.44 66.57 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 111.79 0.292 . . . . 0.0 111.79 -177.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -65.42 -38.27 89.42 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.307 0.575 . . . . 0.0 109.932 176.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -66.39 -39.11 88.86 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.694 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.82 -43.26 97.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 CA-C-O 121.688 0.756 . . . . 0.0 110.299 -178.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 209' ' ' PHE . . . . . 0.64 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 69.1 m-85 -61.95 -43.53 98.65 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 113.888 -1.505 . . . . 0.0 112.527 177.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.17 -41.77 99.28 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 119.584 -0.846 . . . . 0.0 110.046 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . 0.566 HD21 ' CD2' ' B' ' 178' ' ' LEU . 37.8 mt -62.3 -42.07 99.05 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.221 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 78.2 p -63.52 -35.58 80.94 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.893 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 213' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -66.78 -46.95 73.67 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.362 -0.836 . . . . 0.0 112.141 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.476 HD21 HD21 ' B' ' 182' ' ' LEU . 52.8 tp -63.89 -42.9 97.36 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 121.864 0.84 . . . . 0.0 110.032 177.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 215' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' B' ' 211' ' ' LEU . 92.6 mt -63.08 -43.42 98.58 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 113.389 -1.732 . . . . 0.0 111.701 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.18 -39.41 92.57 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.913 -177.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 90.0 mt -63.45 -42.3 98.64 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.322 0.582 . . . . 0.0 111.483 175.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 218' ' ' THR . . . . . . . . . . . . . 77.9 p -73.69 -15.92 61.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.716 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 78.91 63.88 2.02 Favored Glycine 0 CA--C 1.528 0.887 0 N-CA-C 107.051 -2.419 . . . . 0.0 107.051 -177.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 220' ' ' THR . . . . . . . . . . . . . 95.8 m -141.3 103.11 4.36 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 176.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -61.47 138.7 58.28 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.054 0.454 . . . . 0.0 110.952 -176.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 44.4 tp -115.67 121.85 43.79 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.679 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 3.2 mp -110.45 128.91 66.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.883 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 224' ' ' ILE . . . . . 0.477 ' CG2' HD11 ' B' ' 227' ' ' ILE . 49.6 mm -111.3 127.15 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 49.8 p -133.62 158.76 42.38 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.871 0.843 . . . . 0.0 112.709 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 89.47 16.4 57.07 Favored Glycine 0 CA--C 1.5 -0.896 0 CA-C-N 113.818 -1.537 . . . . 0.0 111.639 -177.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 227' ' ' ILE . . . . . 0.734 HD12 HG23 ' B' ' 247' ' ' THR . 95.5 mt -81.15 126.27 39.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 117.815 0.808 . . . . 0.0 111.498 -179.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 55.4 tttt -66.19 141.2 97.24 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.341 -178.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.45 -37.56 94.75 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 121.491 1.461 . . . . 0.0 112.614 179.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -63.94 -43.55 95.5 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -178.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 51.8 tp -62.05 -41.58 98.28 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.159 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.72 -37.01 85.76 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 120.749 0.309 . . . . 0.0 111.362 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 94.5 mtp -64.01 -40.89 97.35 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.805 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.7 -42.55 99.69 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-O 122.422 1.106 . . . . 0.0 109.467 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 35.2 mmt -63.98 -36.61 84.53 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 114.322 -1.308 . . . . 0.0 111.862 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 41.7 t30 -61.96 -40.46 95.64 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.002 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.28 -43.91 96.59 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 120.679 -0.409 . . . . 0.0 110.057 177.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.29 -44.42 96.55 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.71 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 239' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' B' ' 240' ' ' ALA . 67.0 t0 -159.1 133.08 7.57 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.324 -0.551 . . . . 0.0 112.104 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 240' ' ' ALA . . . . . 0.418 ' N ' ' OD1' ' B' ' 239' ' ' ASP . . . -62.51 -44.75 95.6 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 176.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 241' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' B' ' 244' ' ' SER . 92.1 m-20 -45.52 -22.61 0.16 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.594 -0.73 . . . . 0.0 112.046 -175.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 242' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -60.81 -45.43 94.46 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 119.888 -0.725 . . . . 0.0 110.39 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 243' ' ' SER . . . . . . . . . . . . . 77.5 p -57.89 -42.21 84.15 Favored 'General case' 0 C--O 1.225 -0.22 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 244' ' ' SER . . . . . 0.477 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 19.7 m -35.1 -34.46 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 -178.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 96.6 mt -87.74 134.2 33.71 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.015 -0.674 . . . . 0.0 110.567 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -58.85 135.53 57.55 Favored 'General case' 0 C--O 1.247 0.946 0 CA-C-O 121.427 0.632 . . . . 0.0 110.75 -177.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 247' ' ' THR . . . . . 0.734 HG23 HD12 ' B' ' 227' ' ' ILE . 95.8 m -125.91 127.51 46.12 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.722 177.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 248' ' ' TYR . . . . . 0.471 ' CB ' ' HB2' ' B' ' 254' ' ' ALA . 96.3 m-85 -113.8 142.56 45.91 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 249' ' ' SER . . . . . 0.604 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 78.4 p -63.12 -34.08 76.84 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.339 -178.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 250' ' ' ASN . . . . . 0.604 ' OD1' ' O ' ' B' ' 249' ' ' SER . 99.2 m-20 -147.94 159.55 43.75 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.199 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 58.0 t -64.23 -44.39 97.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.885 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 252' ' ' LYS . . . . . 0.421 ' HG3' ' HG3' ' A' ' 152' ' ' PRO . 88.7 tttt -60.94 -46.74 89.5 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -177.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . 0.5 ' O ' HG22 ' B' ' 257' ' ' VAL . 93.7 m-20 -61.74 -43.11 99.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.654 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 254' ' ' ALA . . . . . 0.471 ' HB2' ' CB ' ' B' ' 248' ' ' TYR . . . -64.87 -40.57 95.33 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.18 178.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 255' ' ' VAL . . . . . 0.555 HG11 ' O ' ' A' ' 153' ' ' ILE . 67.8 t -64.69 -45.72 94.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.506 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -63.26 -48.21 79.14 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.226 -178.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 257' ' ' VAL . . . . . 0.5 HG22 ' O ' ' B' ' 253' ' ' ASP . 22.6 m -65.2 -40.31 88.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.594 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 258' ' ' LEU . . . . . 0.515 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 0.9 OUTLIER -31.8 -73.96 0.05 OUTLIER Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 120.951 -0.3 . . . . 0.0 111.592 -178.359 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 259' ' ' PRO . . . . . 0.538 ' O ' HG13 ' B' ' 260' ' ' ILE . 35.5 Cg_endo -61.75 141.31 90.05 Favored 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 121.51 1.474 . . . . 0.0 111.196 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 260' ' ' ILE . . . . . 0.562 ' O ' HG22 ' B' ' 260' ' ' ILE . 96.8 mt -158.44 -12.57 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-N 118.591 0.632 . . . . 0.0 112.121 177.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 78.3 mtm . . . . . 0 C--O 1.219 -0.505 0 CA-C-O 117.99 -1.005 . . . . 0.0 111.583 179.921 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 900' ' ' FMN . . . . . 0.5 HM73 ' N ' ' A' ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 900' ' ' FMN . . . . . 0.516 HM73 ' N ' ' B' ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.427 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.76 179.25 8.68 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-O 121.57 0.7 . . . . 0.0 109.518 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 97.2 p -82.62 -2.18 53.11 Favored 'General case' 0 C--N 1.39 2.337 0 O-C-N 118.151 -2.843 . . . . 0.0 112.853 176.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -87.35 -64.15 1.19 Allowed 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.141 -1.391 . . . . 0.0 112.32 175.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -68.73 -39.23 80.49 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 178.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.497 ' O ' ' CB ' ' A' ' 7' ' ' PHE . 57.0 m -58.94 -42.13 89.04 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-N 116.314 -0.403 . . . . 0.0 109.923 -177.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.523 ' CE2' HD12 ' A' ' 9' ' ' ILE . 33.0 t80 86.38 87.59 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 O-C-N 123.816 0.697 . . . . 0.0 111.567 176.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.55 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -60.59 -143.21 0.01 OUTLIER Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.55 ' HB ' ' O ' ' A' ' 8' ' ' GLY . 65.3 mt 84.22 110.46 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.65 0 C-N-CA 122.881 0.472 . . . . 0.0 110.584 -178.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.94 -22.44 68.47 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 121.354 1.369 . . . . 0.0 112.18 -179.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.88 -37.29 94.44 Favored Glycine 0 C--O 1.247 0.921 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.07 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -65.04 -39.04 92.77 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.349 0.595 . . . . 0.0 109.745 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.8 tp -63.29 -41.95 99.02 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -179.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -62.32 -39.54 93.37 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 68.5 t -61.08 -43.97 97.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 O-C-N 122.02 -0.425 . . . . 0.0 111.066 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 95.4 mt -62.21 -43.28 97.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.213 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.4 ' NZ ' ' HA ' ' B' ' 6' ' ' SER . 98.7 mttt -62.96 -45.03 94.39 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 119.394 -0.923 . . . . 0.0 111.877 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.718 ' HZ1' HG12 ' B' ' 113' ' ' ILE . 98.5 mttt -61.05 -39.42 89.77 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 118.666 -1.214 . . . . 0.0 108.612 -175.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.35 -42.88 92.6 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 119.941 -0.703 . . . . 0.0 110.262 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' A' ' 20' ' ' LEU . 87.0 mt -63.1 -40.77 98.62 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -62.86 -38.9 92.7 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.491 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 57.5 m170 -58.88 -39.5 81.58 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 122.16 -0.337 . . . . 0.0 111.501 -178.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.3 p -114.82 130.36 69.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.462 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 31.6 ptt180 -72.9 110.15 6.99 Favored 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 121.939 0.876 . . . . 0.0 112.178 -177.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.5 p -140.96 143.3 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 N-CA-C 107.127 -1.435 . . . . 0.0 107.127 177.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' A' ' 123' ' ' GLN . . . -97.81 92.56 1.29 Allowed Glycine 0 C--N 1.312 -0.758 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.777 -178.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 52.0 t -124.79 129.98 73.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 175.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.8 m -136.92 159.24 37.01 Favored 'Isoleucine or valine' 0 C--O 1.244 0.782 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.5 mt -119.46 128.89 75.86 Favored 'Isoleucine or valine' 0 C--O 1.245 0.855 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 176.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.45 ' OG1' ' HB2' ' A' ' 119' ' ' PHE . 24.3 p -101.83 167.22 10.22 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 177.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.401 ' C ' ' OD1' ' A' ' 37' ' ' ASN . 53.1 t0 -133.82 101.86 12.64 Favored Pre-proline 0 C--O 1.222 -0.37 0 C-N-CA 120.314 -0.554 . . . . 0.0 109.872 178.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.57 -21.04 65.99 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 121.431 1.421 . . . . 0.0 111.501 -178.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.67 -29.72 70.85 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.316 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 91.4 mt -89.79 -178.87 5.61 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.865 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.645 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 42.1 tt0 -76.3 130.25 37.85 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -177.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.515 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 58.3 t0 63.11 22.04 13.2 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 177.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.401 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 29.7 t-20 42.3 68.03 2.99 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.996 -177.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.645 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 89.6 Cg_endo -71.36 157.17 57.38 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 124.085 3.19 . . . . 0.0 112.042 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 95.9 mt -89.84 123.61 42.12 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.5 m -103.95 -43.14 8.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.1 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -96.34 123.61 40.04 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.733 -178.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.5 p -142.87 140.29 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 O-C-N 124.356 1.035 . . . . 0.0 109.229 177.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.61 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 57.7 p30 -96.49 166.13 11.84 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.466 ' OE1' ' HA ' ' A' ' 44' ' ' GLN . 14.0 mm100 -66.15 -39.84 90.11 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 177.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.98 -25.44 61.87 Favored Glycine 0 C--O 1.237 0.294 0 N-CA-C 110.389 -1.085 . . . . 0.0 110.389 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.621 ' CD2' HD13 ' A' ' 57' ' ' ILE . 67.4 t80 -59.0 -47.51 84.93 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 105.863 -1.902 . . . . 0.0 105.863 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.722 HG13 ' O ' ' A' ' 52' ' ' TYR . 53.6 t -60.04 -44.38 94.7 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 O-C-N 121.161 -0.962 . . . . 0.0 111.498 -174.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -62.44 -37.56 86.35 Favored 'General case' 0 C--N 1.308 -1.222 0 C-N-CA 120.488 -0.485 . . . . 0.0 112.264 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 59.4 ttm -66.97 -43.64 82.55 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 176.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 34.8 p -93.48 -20.82 19.92 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.138 0.494 . . . . 0.0 111.287 -177.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . 77.82 19.44 75.47 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.722 ' O ' HG13 ' A' ' 47' ' ' VAL . 78.0 m-85 -111.79 138.79 47.9 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 122.579 0.351 . . . . 0.0 110.984 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -64.64 149.14 49.52 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.491 0.662 . . . . 0.0 109.495 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.448 HG22 ' H ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -65.85 -32.44 73.95 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.833 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.43 -42.34 83.33 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 119.381 -0.928 . . . . 0.0 111.382 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -64.65 -44.65 89.76 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.621 HD13 ' CD2' ' A' ' 46' ' ' PHE . 95.3 mt -63.76 -45.9 95.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 -174.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 83.8 mt -61.09 144.7 53.05 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.14 -5.99 73.83 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.353 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -134.49 151.28 51.03 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 119.222 1.511 . . . . 0.0 112.011 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.562 ' C ' ' H ' ' A' ' 63' ' ' ARG . 25.0 t-20 -81.45 152.2 27.5 Favored 'General case' 0 N--CA 1.453 -0.316 0 O-C-N 121.882 -0.511 . . . . 0.0 110.509 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 86.0 m -63.16 15.78 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.353 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.562 ' H ' ' C ' ' A' ' 61' ' ' ASN . 35.2 ptt-85 -61.12 -42.02 97.78 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 120.67 -0.412 . . . . 0.0 111.077 -179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -55.65 -21.74 19.45 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -178.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.6 mt -67.44 -35.48 79.32 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 122.241 1.02 . . . . 0.0 112.864 176.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -65.65 133.3 50.83 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.753 -176.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.524 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -143.69 -148.57 4.92 Favored Glycine 0 CA--C 1.543 1.832 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 -178.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.86 -41.11 99.25 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -177.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.444 ' O ' ' OE1' ' A' ' 93' ' ' GLN . 17.2 m-70 -75.93 -9.79 58.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.834 0.349 . . . . 0.0 110.852 -177.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.524 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 28.5 m -60.93 130.12 44.87 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.143 -0.623 . . . . 0.0 109.603 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -87.54 111.09 39.36 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.713 -178.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -57.55 -31.68 92.27 Favored 'Trans proline' 0 N--CA 1.496 1.635 0 C-N-CA 122.018 1.812 . . . . 0.0 112.99 179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.7 -40.26 96.34 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.509 -0.476 . . . . 0.0 110.951 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.424 ' OE1' ' HB ' ' A' ' 90' ' ' VAL . 79.2 mm-40 -65.6 -43.61 89.12 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.3 t -60.4 -43.13 93.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -63.67 -37.96 89.33 Favored 'General case' 0 CA--C 1.547 0.839 0 O-C-N 124.07 0.856 . . . . 0.0 112.007 178.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -63.31 -39.69 95.25 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.37 0.605 . . . . 0.0 110.544 178.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.1 mt -64.1 -43.79 97.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-N 114.873 -1.058 . . . . 0.0 112.367 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -62.65 -43.07 99.74 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 113.653 -1.612 . . . . 0.0 108.473 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 93.8 m -60.82 -49.11 78.8 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.25 -42.46 95.34 Favored 'General case' 0 C--N 1.363 1.189 0 O-C-N 123.754 0.659 . . . . 0.0 110.782 -171.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 87.4 mt -63.01 -40.94 99.26 Favored 'General case' 0 CA--C 1.514 -0.409 0 O-C-N 120.184 -1.573 . . . . 0.0 111.692 -178.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -63.42 -41.07 98.69 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -70.55 -23.35 62.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.197 177.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 49.5 tttt 63.34 46.53 4.38 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.614 -176.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -130.71 148.32 69.65 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -62.08 142.94 94.12 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 C-N-CA 121.441 1.427 . . . . 0.0 113.493 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.09 141.43 33.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.325 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.891 HG23 ' OD1' ' A' ' 107' ' ' ASN . 96.6 m -126.7 119.17 26.3 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 175.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.424 ' HB ' ' OE1' ' A' ' 74' ' ' GLU . 30.1 m -138.59 157.17 30.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 121.203 -0.199 . . . . 0.0 111.413 178.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -103.8 127.3 51.3 Favored 'General case' 0 C--O 1.244 0.808 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 177.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.421 HG23 ' O ' ' A' ' 92' ' ' ILE . 18.8 tt -135.74 131.45 50.45 Favored 'Isoleucine or valine' 0 C--N 1.372 1.567 0 CA-C-N 121.716 2.053 . . . . 0.0 112.606 177.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.444 ' OE1' ' O ' ' A' ' 69' ' ' HIS . 87.5 mt-30 -63.69 135.87 57.05 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.952 -179.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -137.97 162.25 34.56 Favored 'General case' 0 C--N 1.349 0.55 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.923 -177.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.492 ' CE1' ' HA3' ' A' ' 67' ' ' GLY . 92.3 m-85 -121.38 138.3 54.32 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 -178.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.488 ' HG3' ' CE1' ' A' ' 102' ' ' PHE . 99.2 mttt -86.71 -171.06 3.35 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.078 0.466 . . . . 0.0 111.525 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.69 -42.05 99.43 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.396 178.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 39.7 p-10 -85.49 7.61 22.23 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -177.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.48 -1.18 88.45 Favored Glycine 0 N--CA 1.471 0.983 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.146 177.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 23.4 m -60.06 137.63 58.05 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.678 ' SD ' ' C ' ' A' ' 101' ' ' MET . 14.1 tmm? -104.98 129.39 53.42 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-O 120.746 0.308 . . . . 0.0 111.231 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.488 ' CE1' ' HG3' ' A' ' 96' ' ' LYS . 53.5 p90 -141.12 158.97 43.19 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.927 -177.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.837 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 21.0 m95 -90.54 143.97 26.23 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.411 HD21 ' HG2' ' A' ' 123' ' ' GLN . 54.6 t-20 -138.46 103.54 4.91 Favored 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 -176.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -70.56 135.12 48.26 Favored 'General case' 0 N--CA 1.436 -1.15 0 O-C-N 120.974 -1.079 . . . . 0.0 108.16 -176.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 38.8 tp -120.16 123.61 43.73 Favored 'General case' 0 C--O 1.234 0.285 0 O-C-N 124.07 0.856 . . . . 0.0 112.662 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.891 ' OD1' HG23 ' A' ' 89' ' ' THR . 98.1 m-20 -119.55 123.0 42.87 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.96 177.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 96.4 mt -120.9 128.46 76.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 O-C-N 123.575 0.547 . . . . 0.0 111.496 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -137.33 126.81 15.32 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.819 -0.173 . . . . 0.0 111.003 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -70.73 151.45 63.57 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 122.162 1.908 . . . . 0.0 112.413 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.654 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 67.2 mtt -123.36 151.5 42.46 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 178.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -126.86 96.96 4.8 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 176.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.513 ' CD1' HG22 ' B' ' 15' ' ' VAL . 96.2 mt -121.02 131.56 72.7 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.035 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 50.27 37.46 15.1 Favored 'General case' 0 CA--C 1.515 -0.375 0 O-C-N 121.105 -0.997 . . . . 0.0 111.365 176.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 59.93 31.82 20.88 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 123.939 0.774 . . . . 0.0 110.994 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -128.71 147.95 50.8 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.705 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 3.6 t -84.3 -175.51 5.83 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-O 118.769 -0.634 . . . . 0.0 109.434 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.705 ' CD2' ' O ' ' A' ' 117' ' ' THR . 70.1 m-85 -169.1 156.04 6.94 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 173.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.45 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 86.0 m-85 -129.32 147.83 51.19 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 173.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.7 p -137.33 137.31 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 177.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -111.97 130.29 9.56 Favored Glycine 0 CA--C 1.504 -0.644 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 178.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 97.0 mt -117.65 129.54 73.93 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.536 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 177.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.595 ' N ' ' O ' ' A' ' 26' ' ' GLY . 17.9 mp0 -118.81 117.0 27.7 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.223 0.535 . . . . 0.0 109.833 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -117.99 114.97 23.96 Favored 'General case' 0 C--O 1.254 1.329 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.813 -178.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.412 ' OD1' ' OG1' ' A' ' 127' ' ' THR . 67.4 t0 -67.72 121.97 17.09 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -175.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.478 HG22 ' O ' ' A' ' 126' ' ' ILE . 3.6 mp -85.4 1.07 5.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 113.778 -1.556 . . . . 0.0 110.299 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.412 ' OG1' ' OD1' ' A' ' 125' ' ' ASP . 27.5 m -59.43 -42.58 92.21 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.186 -0.946 . . . . 0.0 112.937 -177.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -58.87 -42.31 89.13 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 -178.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -63.23 -39.47 94.7 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.445 177.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.837 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.8 mttt -62.41 -40.76 97.58 Favored 'General case' 0 C--O 1.214 -0.771 0 O-C-N 120.504 -1.372 . . . . 0.0 110.084 -178.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.72 -37.41 86.41 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.752 0.658 . . . . 0.0 109.49 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.735 ' CE2' HD11 ' A' ' 136' ' ' LEU . 88.2 t80 -61.45 -45.9 92.33 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.408 176.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.34 -38.45 91.07 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.67 -40.31 96.66 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 52.2 tp -60.97 -43.35 98.91 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -177.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.735 HD11 ' CE2' ' A' ' 132' ' ' TYR . 85.3 mt -62.8 -41.27 99.21 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.827 179.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.97 -41.87 98.5 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 119.668 -0.813 . . . . 0.0 109.691 -178.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -60.14 -43.06 96.0 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -177.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 54.7 m -61.61 -41.41 97.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.731 176.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.457 ' O ' ' N ' ' A' ' 144' ' ' THR . 85.8 mt -63.07 -41.69 99.5 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 121.933 -0.48 . . . . 0.0 109.963 178.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 78.6 m -61.61 -45.42 94.17 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.514 -177.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -65.13 -39.99 93.83 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 95.2 mt -64.59 -43.18 96.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 113.873 -1.512 . . . . 0.0 111.232 176.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.457 ' N ' ' O ' ' A' ' 140' ' ' LEU . 89.3 m -62.18 -46.07 90.59 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 120.37 -0.532 . . . . 0.0 112.285 -178.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.34 -40.62 96.98 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 118.851 -1.14 . . . . 0.0 109.064 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.7 mt -63.44 -42.63 98.66 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.491 178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.715 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.4 p -60.7 -36.42 78.75 Favored 'General case' 0 C--O 1.214 -0.803 0 C-N-CA 119.332 -0.947 . . . . 0.0 109.294 -177.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.438 ' C ' ' O ' ' A' ' 147' ' ' SER . 41.9 m -31.67 81.57 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.507 0 O-C-N 127.041 2.713 . . . . 0.0 105.823 -178.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.715 ' N ' ' O ' ' A' ' 147' ' ' SER . 19.4 Cg_exo -62.51 142.07 88.84 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 CA-C-O 123.088 1.203 . . . . 0.0 114.601 -174.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.562 ' O ' HG23 ' A' ' 151' ' ' VAL . 9.0 tp -115.91 136.3 53.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 102.603 -3.11 . . . . 0.0 102.603 175.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 150' ' ' ILE . 82.2 t -168.46 90.5 0.64 Allowed Pre-proline 0 CA--C 1.505 -0.771 0 N-CA-C 106.001 -1.851 . . . . 0.0 106.001 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.2 135.58 55.3 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 N-CA-C 109.678 -0.931 . . . . 0.0 109.678 -177.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.669 ' O ' ' HD2' ' A' ' 154' ' ' ARG . 44.5 mm -67.45 -44.76 86.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 C-N-CA 119.682 -0.807 . . . . 0.0 111.109 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.729 HH11 HG13 ' B' ' 255' ' ' VAL . 0.4 OUTLIER -157.31 -156.29 0.58 Allowed 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -179.864 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.411 ' ND2' ' HE3' ' B' ' 256' ' ' LYS . 61.4 t-20 -86.51 104.89 16.39 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.469 0.652 . . . . 0.0 111.619 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 88.56 7.96 71.22 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 114.121 -1.4 . . . . 0.0 110.245 -178.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.1 mt -123.52 123.71 67.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.792 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 174.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.609 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 69.4 m -132.38 152.57 51.4 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -137.51 143.4 41.66 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.492 177.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 16.3 tp -133.68 78.33 61.81 Favored Pre-proline 0 N--CA 1.465 0.295 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.328 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -69.2 150.19 71.33 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.68 2.253 . . . . 0.0 113.227 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 90.4 mt -118.48 125.99 51.07 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.064 -0.971 . . . . 0.0 111.12 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 51.4 t -122.95 131.57 73.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 178.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 117.29 168.63 14.72 Favored Glycine 0 N--CA 1.481 1.683 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.347 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.864 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 56.1 t30 -85.32 114.13 22.16 Favored 'General case' 0 C--O 1.201 -1.48 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -178.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.628 HD21 ' CZ ' ' A' ' 171' ' ' PHE . 48.2 tp -73.92 102.45 4.11 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -177.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.705 HG23 ' NE ' ' A' ' 170' ' ' ARG . 10.5 p -85.49 167.69 15.23 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.446 178.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.91 -34.93 79.27 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.955 0.407 . . . . 0.0 111.894 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.15 -46.66 86.15 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.499 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.864 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 87.6 mtm180 -61.6 -31.74 71.82 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.796 177.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.628 ' CZ ' HD21 ' A' ' 166' ' ' LEU . 0.4 OUTLIER -54.97 -28.28 50.41 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -177.53 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.637 ' O ' HG22 ' A' ' 175' ' ' VAL . 92.6 m-20 -60.8 -40.45 92.74 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 119.045 -1.062 . . . . 0.0 110.01 -178.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 58.7 m -59.42 -40.56 87.09 Favored 'General case' 0 C--N 1.322 -0.611 0 O-C-N 121.762 -0.586 . . . . 0.0 110.638 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 67.9 mt -63.66 -44.14 98.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.637 HG22 ' O ' ' A' ' 172' ' ' ASN . 35.2 m -62.29 -40.05 86.38 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . 0.415 ' N ' HG23 ' A' ' 175' ' ' VAL . 96.6 m -62.05 -35.24 78.02 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.318 179.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.519 ' O ' HG13 ' A' ' 181' ' ' ILE . 24.9 m -61.48 -19.84 62.48 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.283 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.606 ' CD2' HD21 ' A' ' 211' ' ' LEU . 87.6 mt -60.82 -40.82 94.16 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -177.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 18.5 m -59.48 -43.75 93.19 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.594 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.634 ' O ' ' OG ' ' A' ' 183' ' ' SER . 93.2 m-20 -61.1 -37.5 82.97 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.053 0.454 . . . . 0.0 111.059 178.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 177' ' ' THR . 66.8 mt -57.51 -39.01 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 O-C-N 121.401 -0.812 . . . . 0.0 109.165 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 87.3 mt -60.81 -40.47 92.82 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 119.439 -0.904 . . . . 0.0 108.625 -177.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.634 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 78.0 p -61.48 -34.0 74.72 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.727 176.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 53.0 p -90.45 23.58 2.93 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 122.226 -0.296 . . . . 0.0 111.514 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 78.2 p -63.04 -20.15 65.06 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.644 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.07 -36.2 79.0 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.865 -178.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.609 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 98.7 m-20 -72.55 114.0 10.2 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.568 0.699 . . . . 0.0 110.963 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -62.8 -42.48 99.73 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.919 -177.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -113.26 132.17 55.64 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.104 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 38.1 tp -120.6 128.93 53.5 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 96.4 mt -116.24 127.05 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 O-C-N 121.751 -0.593 . . . . 0.0 109.459 177.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.9 mm -113.08 126.35 70.48 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.484 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . 0.5 ' CG ' ' HG ' ' A' ' 195' ' ' SER . 40.2 t0 -95.25 120.34 35.32 Favored 'General case' 0 CA--C 1.551 1.017 0 O-C-N 121.662 -0.648 . . . . 0.0 110.48 178.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 194' ' ' LEU . 96.2 mt -101.01 -2.8 30.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.891 176.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.5 ' HG ' ' CG ' ' A' ' 193' ' ' ASP . 78.3 p -63.31 -32.32 73.71 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.85 -47.15 92.02 Favored Glycine 0 CA--C 1.54 1.61 0 N-CA-C 108.171 -1.972 . . . . 0.0 108.171 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.938 HD23 ' N ' ' A' ' 198' ' ' ALA . 4.9 tt -66.02 129.82 41.12 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 112.873 -1.664 . . . . 0.0 108.755 -177.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.938 ' N ' HD23 ' A' ' 197' ' ' LEU . . . -60.79 -50.98 71.26 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-O 121.417 0.627 . . . . 0.0 110.931 -179.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.889 ' O ' ' CD2' ' A' ' 197' ' ' LEU . 58.6 tt0 -132.76 156.78 46.46 Favored 'General case' 0 C--O 1.21 -1.017 0 CA-C-N 114.728 -1.124 . . . . 0.0 114.016 -174.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.483 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 46.1 t -117.83 130.69 72.32 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 O-C-N 120.424 -1.423 . . . . 0.0 108.425 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -83.76 155.86 22.84 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.237 -178.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -64.79 -39.48 93.67 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.988 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -57.24 -31.4 65.5 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 -178.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.8 m -61.42 -42.74 99.22 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.709 178.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.449 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -56.44 -39.06 72.47 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -177.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -61.26 -38.09 85.46 Favored 'General case' 0 N--CA 1.454 -0.227 0 O-C-N 121.776 -0.578 . . . . 0.0 110.087 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -64.57 -38.87 92.52 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.916 177.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.02 -44.88 99.9 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . 0.449 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 67.2 m-85 -61.04 -43.82 98.31 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.009 -177.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.97 -41.59 98.18 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 118.998 -1.081 . . . . 0.0 109.202 -178.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.606 HD21 ' CD2' ' A' ' 178' ' ' LEU . 38.8 mt -62.39 -42.18 99.23 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 78.0 p -61.04 -42.45 98.5 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 119.067 -1.053 . . . . 0.0 110.463 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' HIS . . . . . 0.483 ' CE1' HD11 ' A' ' 217' ' ' LEU . 58.5 t-80 -64.93 -45.72 84.64 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 122.034 -0.416 . . . . 0.0 111.728 -179.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 50.3 tp -62.41 -45.93 90.88 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 119.021 -1.071 . . . . 0.0 108.15 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 89.4 mt -62.84 -41.19 99.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.401 -177.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.03 -44.44 94.63 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.601 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.483 HD11 ' CE1' ' A' ' 213' ' ' HIS . 82.6 mt -61.93 -40.54 95.85 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 68.9 p -75.44 -11.72 60.1 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.241 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.96 40.17 9.6 Favored Glycine 0 C--O 1.217 -0.913 0 C-N-CA 120.617 -0.801 . . . . 0.0 113.863 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 99.9 m -125.99 115.03 19.26 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 119.104 1.452 . . . . 0.0 112.36 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -66.4 136.11 55.28 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.147 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 41.7 tp -111.97 128.69 56.24 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 2.8 mp -116.35 132.61 65.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.587 ' CG2' HD11 ' A' ' 227' ' ' ILE . 49.7 mm -114.35 131.39 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 39.7 p -133.38 165.75 24.12 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 120.766 -0.373 . . . . 0.0 111.583 -179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 79.35 20.35 69.62 Favored Glycine 0 C--O 1.224 -0.508 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 178.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.665 HD12 HG23 ' A' ' 247' ' ' THR . 97.3 mt -81.83 128.83 38.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 113.692 -1.254 . . . . 0.0 108.124 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 66.0 tttt -75.89 139.96 70.21 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.47 -38.23 89.79 Favored 'Trans proline' 0 N--CA 1.496 1.655 0 C-N-CA 121.108 1.205 . . . . 0.0 112.453 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -64.94 -39.23 93.19 Favored 'General case' 0 C--O 1.244 0.769 0 CA-C-O 121.29 0.566 . . . . 0.0 110.268 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 53.3 tp -63.57 -43.11 97.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.915 -1.039 . . . . 0.0 112.753 177.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.66 -37.66 88.19 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 121.96 -0.463 . . . . 0.0 111.175 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 93.7 mtp -63.2 -40.47 97.6 Favored 'General case' 0 C--O 1.251 1.16 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.704 -178.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -64.32 -39.29 93.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.758 176.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 30.1 mmt -65.45 -37.72 87.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.746 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -60.8 -41.02 94.81 Favored 'General case' 0 CA--C 1.513 -0.447 0 O-C-N 121.48 -0.763 . . . . 0.0 109.491 -176.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.71 -39.9 93.14 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.355 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 52.7 tp -63.18 -42.05 99.3 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 176.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -168.89 128.19 1.08 Allowed 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 121.404 0.621 . . . . 0.0 112.559 -179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -60.22 -28.02 67.67 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.821 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -61.16 -27.56 68.49 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.674 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -56.42 -43.73 79.66 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -176.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 96.6 p -63.2 -20.84 65.79 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 124.108 0.88 . . . . 0.0 111.298 178.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 41.7 m -55.25 -34.25 63.85 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 122.056 -0.403 . . . . 0.0 111.763 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 94.3 mt -89.76 121.6 32.07 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -46.1 134.77 8.12 Favored 'General case' 0 C--O 1.248 0.986 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.615 -177.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.665 HG23 HD12 ' A' ' 227' ' ' ILE . 97.8 m -126.48 132.8 51.35 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 114.605 -1.18 . . . . 0.0 110.968 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' TYR . . . . . 0.515 ' CG ' ' HB2' ' A' ' 254' ' ' ALA . 96.4 m-85 -117.51 139.49 50.86 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.788 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 78.3 p -60.68 -42.58 97.38 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -178.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -143.74 160.75 40.17 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.606 0.717 . . . . 0.0 111.651 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.02 -44.79 99.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 114.725 -1.125 . . . . 0.0 112.301 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.89 -44.67 96.78 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -178.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . 0.432 ' O ' HG22 ' A' ' 257' ' ' VAL . 55.6 m-20 -62.75 -44.38 96.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.599 -178.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.515 ' HB2' ' CG ' ' A' ' 248' ' ' TYR . . . -63.59 -42.45 98.28 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.975 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . 0.626 HG13 HH11 ' B' ' 154' ' ' ARG . 66.8 t -63.86 -45.41 97.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-N 114.051 -1.431 . . . . 0.0 110.798 -178.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.77 -47.09 82.36 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.846 179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.498 ' O ' ' C ' ' A' ' 258' ' ' LEU . 22.5 m -67.51 -41.09 85.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 O-C-N 121.453 -0.779 . . . . 0.0 112.034 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.498 ' C ' ' O ' ' A' ' 257' ' ' VAL . 1.1 mt -28.17 -74.84 0.04 OUTLIER Pre-proline 0 C--O 1.234 0.265 0 CA-C-O 119.518 -0.277 . . . . 0.0 111.542 -177.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' PRO . . . . . 0.485 ' CD ' ' CB ' ' A' ' 258' ' ' LEU . 39.9 Cg_endo -62.85 139.84 76.55 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 120.833 1.022 . . . . 0.0 111.934 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 259' ' ' PRO . 96.6 mt -151.8 -27.17 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 O-C-N 123.779 0.675 . . . . 0.0 111.981 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 C--O 1.216 -0.683 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.782 -177.262 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.58 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -165.18 170.26 15.11 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 84.2 p -66.82 -16.71 64.46 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -79.85 -64.21 1.24 Allowed 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.103 -177.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -66.4 -39.81 89.24 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.302 -0.863 . . . . 0.0 113.073 178.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.495 ' O ' ' CB ' ' B' ' 7' ' ' PHE . 58.9 m -59.25 -42.44 91.14 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 -178.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . 0.519 ' CE2' HD12 ' B' ' 9' ' ' ILE . 32.8 t80 87.01 90.96 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 O-C-N 123.742 0.651 . . . . 0.0 110.697 177.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . 0.549 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -63.27 -142.77 0.01 OUTLIER Glycine 0 C--N 1.339 0.727 0 N-CA-C 111.078 -0.809 . . . . 0.0 111.078 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.549 ' HB ' ' O ' ' B' ' 8' ' ' GLY . 64.7 mt 83.88 110.38 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 122.773 0.429 . . . . 0.0 110.784 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -63.15 -23.61 73.08 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 C-N-CA 121.249 1.299 . . . . 0.0 111.812 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.24 -38.81 96.82 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -64.99 -39.07 92.92 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.473 0.654 . . . . 0.0 109.551 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 49.8 tp -61.95 -43.0 99.74 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.507 -177.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -64.45 -31.78 73.14 Favored 'General case' 0 CA--C 1.559 1.317 0 CA-C-O 121.358 0.599 . . . . 0.0 110.614 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . 0.513 HG22 ' CD1' ' A' ' 113' ' ' ILE . 74.6 t -63.27 -46.19 96.31 Favored 'Isoleucine or valine' 0 C--O 1.249 1.053 0 CA-C-N 113.179 -1.828 . . . . 0.0 111.198 177.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.82 -43.69 97.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.795 -178.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . 0.406 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 98.9 mttt -63.31 -42.53 99.04 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.88 -40.54 97.83 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 118.991 -1.084 . . . . 0.0 109.964 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.87 -39.62 89.86 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 120.435 -0.506 . . . . 0.0 111.018 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 20' ' ' LEU . 87.6 mt -63.81 -41.93 97.78 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.276 0.56 . . . . 0.0 110.33 175.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -62.87 -39.01 93.12 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.798 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 56.4 m170 -58.2 -39.68 79.62 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 121.086 -0.246 . . . . 0.0 111.521 -178.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 13.6 p -114.71 130.11 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.482 ' O ' ' HG3' ' B' ' 24' ' ' ARG . 31.6 ptt180 -72.43 108.17 5.38 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.687 0.755 . . . . 0.0 112.582 -177.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.0 p -142.6 134.22 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.922 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.731 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . 0.569 ' O ' ' N ' ' B' ' 123' ' ' GLN . . . -88.25 96.99 2.25 Favored Glycine 0 C--N 1.31 -0.913 0 C-N-CA 119.655 -1.26 . . . . 0.0 113.43 -176.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 48.5 t -125.74 129.19 72.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 174.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 30.2 m -138.33 156.19 29.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.473 178.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 96.1 mt -118.0 124.71 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.247 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 25.9 p -102.31 159.34 15.49 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 113.146 -1.843 . . . . 0.0 108.603 -178.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -127.43 101.74 24.25 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.3 -18.58 60.98 Favored 'Trans proline' 0 N--CA 1.49 1.309 0 C-N-CA 121.683 1.589 . . . . 0.0 111.477 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.09 -39.9 94.03 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.576 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 93.8 mt -77.16 -164.71 0.48 Allowed 'General case' 0 N--CA 1.475 0.8 0 O-C-N 122.106 -0.371 . . . . 0.0 111.057 -178.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . 0.679 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 42.4 tt0 -87.56 129.87 34.95 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.45 ' O ' ' OD1' ' B' ' 36' ' ' ASP . 62.8 t0 57.47 35.42 25.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.751 177.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' ASN . . . . . 0.424 ' C ' ' O ' ' B' ' 36' ' ' ASP . 20.0 t-20 33.04 68.95 0.92 Allowed Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.679 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 89.3 Cg_endo -72.09 155.76 56.54 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 123.745 2.963 . . . . 0.0 111.865 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 95.6 mt -88.21 127.99 40.85 Favored 'Isoleucine or valine' 0 C--O 1.246 0.908 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 27.7 m -107.73 -43.03 6.31 Favored 'Isoleucine or valine' 0 C--N 1.343 0.3 0 O-C-N 123.892 0.745 . . . . 0.0 112.603 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -97.01 123.9 40.85 Favored 'General case' 0 C--O 1.242 0.681 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.366 -178.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 5.7 p -142.94 140.92 27.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 124.212 0.945 . . . . 0.0 109.293 177.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . 0.639 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 57.2 p30 -100.34 161.6 13.5 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.035 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' GLN . . . . . 0.442 ' OE1' ' HA ' ' B' ' 44' ' ' GLN . 13.8 mm100 -63.4 -38.02 89.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.569 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.37 -25.6 63.0 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 111.278 -0.729 . . . . 0.0 111.278 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.654 ' CE2' HD13 ' B' ' 57' ' ' ILE . 62.6 t80 -59.96 -43.86 94.79 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 0.872 HG13 ' O ' ' B' ' 52' ' ' TYR . 63.3 t -61.3 -45.69 98.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.153 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -62.87 -44.19 96.77 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.057 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 59.4 ttm -62.81 -42.83 99.88 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 34.5 p -95.62 -15.89 22.45 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.183 -0.607 . . . . 0.0 111.72 -178.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' B' ' 47' ' ' VAL . . . 73.46 19.22 79.64 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.336 -1.105 . . . . 0.0 110.336 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . 0.872 ' O ' HG13 ' B' ' 47' ' ' VAL . 78.4 m-85 -110.75 145.19 38.53 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 115.27 -0.465 . . . . 0.0 110.1 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -74.18 149.02 41.15 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 121.817 0.818 . . . . 0.0 110.874 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . 0.412 HG22 ' H ' ' B' ' 54' ' ' THR . 0.1 OUTLIER -61.99 -37.7 85.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.084 -177.398 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.03 -39.09 93.32 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 120.085 -0.646 . . . . 0.0 112.196 -178.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -72.59 -31.51 65.26 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.228 1.196 . . . . 0.0 114.228 177.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.654 HD13 ' CE2' ' B' ' 46' ' ' PHE . 92.1 mt -69.91 -61.73 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 97.0 mt -49.49 133.86 19.93 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 123.966 0.791 . . . . 0.0 109.984 -178.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.98 -10.19 72.21 Favored Glycine 0 CA--C 1.535 1.305 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.712 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -131.48 149.34 52.56 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -176.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' ASN . . . . . 0.577 ' OD1' " C2'" ' B' ' 900' ' ' FMN . 25.2 t-20 -79.62 151.49 30.56 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.693 -1.139 . . . . 0.0 110.619 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' CYS . . . . . . . . . . . . . 83.5 m -63.28 9.9 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.256 -178.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . 0.55 ' H ' ' C ' ' B' ' 61' ' ' ASN . 33.5 ptt-85 -60.06 -32.31 70.81 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.585 -177.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -60.5 -30.89 70.0 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 85.6 mt -62.21 -41.86 98.77 Favored 'General case' 0 C--O 1.238 0.462 0 O-C-N 121.601 -0.687 . . . . 0.0 109.758 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -50.12 143.81 7.79 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -177.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . 0.49 ' HA3' ' CE1' ' B' ' 95' ' ' TYR . . . -155.08 -152.86 6.3 Favored Glycine 0 C--N 1.353 1.473 0 CA-C-N 115.967 -0.561 . . . . 0.0 112.156 176.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.25 -42.43 95.27 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -175.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 17.8 m-70 -74.77 -9.92 59.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.069 -178.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' THR . . . . . 0.437 ' OG1' ' N ' ' B' ' 67' ' ' GLY . 27.4 m -60.64 133.5 56.16 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -90.55 110.92 44.56 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.39 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.64 -38.09 90.97 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 120.978 1.119 . . . . 0.0 111.63 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.16 -40.6 90.43 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -176.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' GLU . . . . . 0.42 ' OE1' ' HB ' ' B' ' 90' ' ' VAL . 79.5 mm-40 -67.0 -38.29 85.73 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.963 177.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 70.2 t -63.42 -44.76 99.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.091 0.472 . . . . 0.0 109.819 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -63.18 -37.3 86.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.7 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -62.44 -42.03 99.16 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 119.276 -0.97 . . . . 0.0 108.955 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 92.6 mt -63.51 -43.72 98.44 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 CA-C-O 120.894 0.378 . . . . 0.0 110.924 -178.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 77.7 ttt180 -61.37 -42.54 98.87 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 83.0 m -61.33 -44.93 96.37 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.884 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.99 -42.58 99.3 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -177.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.36 -42.49 99.44 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -62.91 -39.88 95.87 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -81.61 -4.02 54.98 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.803 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 36.7 tttt 50.08 48.52 21.88 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 121.825 -0.547 . . . . 0.0 111.649 177.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -132.93 144.58 53.44 Favored Pre-proline 0 N--CA 1.472 0.673 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.334 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.43 139.62 77.7 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 120.765 0.977 . . . . 0.0 114.045 -177.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -139.98 135.55 37.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.592 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' THR . . . . . 0.88 HG23 ' OD1' ' B' ' 107' ' ' ASN . 98.9 m -119.9 120.72 37.24 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.42 ' HB ' ' OE1' ' B' ' 74' ' ' GLU . 30.7 m -138.33 161.95 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.594 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -114.42 121.21 42.88 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 175.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . 0.403 HD11 HG23 ' B' ' 70' ' ' THR . 20.8 tt -128.43 132.65 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.798 -175.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.423 ' O ' ' ND2' ' B' ' 94' ' ' ASN . 85.7 mt-30 -71.21 141.67 50.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.076 178.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' ASN . . . . . 0.423 ' ND2' ' O ' ' B' ' 93' ' ' GLN . 8.9 m120 -134.92 179.95 5.99 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 121.247 0.546 . . . . 0.0 111.107 -177.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' TYR . . . . . 0.49 ' CE1' ' HA3' ' B' ' 67' ' ' GLY . 95.6 m-85 -130.23 149.68 51.81 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-N 114.524 -1.216 . . . . 0.0 111.855 177.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . 0.48 ' HG3' ' CE1' ' B' ' 102' ' ' PHE . 99.0 mttt -103.41 -177.07 3.26 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.269 0.557 . . . . 0.0 110.716 176.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.4 -35.07 76.48 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.647 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 36.6 p-10 -88.17 -0.33 56.96 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.271 -0.893 . . . . 0.0 113.042 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.38 3.73 66.83 Favored Glycine 0 N--CA 1.465 0.574 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.109 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 25.5 m -67.66 130.49 43.17 Favored 'General case' 0 N--CA 1.443 -0.801 0 O-C-N 122.159 -0.612 . . . . 0.0 109.39 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . 0.57 ' SD ' ' N ' ' B' ' 102' ' ' PHE . 15.8 tmm? -90.15 142.47 27.69 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' PHE . . . . . 0.57 ' N ' ' SD ' ' B' ' 101' ' ' MET . 53.9 p90 -152.72 163.72 39.15 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 177.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' TRP . . . . . 0.839 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 22.1 m95 -95.65 140.16 30.87 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.342 178.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . 0.403 HD21 ' HG2' ' B' ' 123' ' ' GLN . 62.6 t-20 -133.94 106.47 7.28 Favored 'General case' 0 C--O 1.217 -0.631 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -177.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -75.03 123.88 25.97 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 125.193 1.558 . . . . 0.0 109.262 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 38.9 tp -112.81 125.71 54.64 Favored 'General case' 0 N--CA 1.465 0.299 0 O-C-N 123.58 0.55 . . . . 0.0 111.608 -177.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' ASN . . . . . 0.88 ' OD1' HG23 ' B' ' 89' ' ' THR . 98.1 m-20 -118.96 127.7 53.72 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 176.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 96.5 mt -123.12 132.97 70.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -143.33 125.03 8.4 Favored Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -70.19 152.0 66.88 Favored 'Trans proline' 0 N--CA 1.5 1.878 0 C-N-CA 122.254 1.969 . . . . 0.0 112.624 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . 0.559 ' HB2' ' HB2' ' B' ' 118' ' ' TYR . 67.2 mtt -128.69 142.17 51.1 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -113.67 109.86 19.28 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . 0.718 HG12 ' HZ1' ' A' ' 18' ' ' LYS . 96.7 mt -136.11 127.92 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 O-C-N 121.352 -0.842 . . . . 0.0 111.709 178.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 52.49 37.33 22.6 Favored 'General case' 0 C--O 1.236 0.375 0 O-C-N 123.819 0.7 . . . . 0.0 109.63 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 61.71 35.74 16.78 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.519 0.676 . . . . 0.0 110.248 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -132.21 151.36 51.85 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 177.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 5.1 t -101.02 154.21 18.9 Favored 'General case' 0 C--O 1.215 -0.748 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' TYR . . . . . 0.559 ' HB2' ' HB2' ' B' ' 111' ' ' MET . 90.7 m-85 -149.16 145.32 27.11 Favored 'General case' 0 C--N 1.318 -0.791 0 O-C-N 121.09 -1.006 . . . . 0.0 111.152 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -120.02 139.25 52.79 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 120.812 0.339 . . . . 0.0 111.821 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -128.92 137.35 57.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -177.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -113.54 126.21 7.3 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 94.9 mt -114.29 127.92 71.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 123' ' ' GLN . . . . . 0.569 ' N ' ' O ' ' B' ' 26' ' ' GLY . 17.6 mp0 -117.87 123.42 45.83 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 178.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -121.56 124.19 43.77 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' B' ' 127' ' ' THR . 67.5 t0 -74.94 126.06 30.2 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.556 -177.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.561 ' O ' ' HG3' ' B' ' 130' ' ' LYS . 3.5 mp -98.98 18.85 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.424 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 127' ' ' THR . . . . . 0.539 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 98.1 m -64.55 -44.75 89.79 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 114.326 -1.306 . . . . 0.0 112.781 175.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -59.96 -45.19 93.44 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 -177.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 129' ' ' GLN . . . . . 0.449 ' OE1' HG23 ' B' ' 126' ' ' ILE . 88.5 mt-30 -63.6 -35.02 79.14 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.441 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 130' ' ' LYS . . . . . 0.839 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 99.0 mttt -63.27 -42.0 99.09 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-N 113.232 -1.803 . . . . 0.0 110.822 174.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.99 -41.69 97.44 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 132' ' ' TYR . . . . . 0.748 ' CE2' HD11 ' B' ' 136' ' ' LEU . 89.0 t80 -60.43 -45.3 94.13 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.948 -0.47 . . . . 0.0 111.341 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . 0.403 ' O ' ' HG3' ' B' ' 137' ' ' GLU . 97.3 mt-10 -64.23 -37.05 86.09 Favored 'General case' 0 C--O 1.218 -0.586 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.438 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 134' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' B' ' 130' ' ' LYS . 99.0 mttt -62.63 -39.71 94.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.89 177.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 53.2 tp -62.68 -41.12 98.92 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . 0.748 HD11 ' CE2' ' B' ' 132' ' ' TYR . 87.7 mt -62.83 -41.78 99.46 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 114.858 -1.064 . . . . 0.0 111.566 177.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 137' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' B' ' 133' ' ' GLU . 97.3 mt-10 -64.69 -36.93 85.87 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.484 -178.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -63.28 -44.07 96.15 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.873 177.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 63.2 m -61.04 -44.05 97.98 Favored 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . 0.431 ' O ' ' N ' ' B' ' 144' ' ' THR . 85.6 mt -61.98 -40.23 94.91 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -177.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 86.1 m -61.88 -45.52 93.39 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.173 179.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -65.66 -41.64 92.29 Favored 'General case' 0 CA--C 1.516 -0.35 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 93.0 mt -63.8 -43.12 97.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 114.458 -1.247 . . . . 0.0 110.559 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 144' ' ' THR . . . . . 0.431 ' N ' ' O ' ' B' ' 140' ' ' LEU . 89.0 m -61.69 -45.09 95.47 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -178.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . 0.413 ' O ' ' HB ' ' B' ' 148' ' ' THR . . . -63.8 -40.92 97.81 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 118.958 -1.097 . . . . 0.0 109.278 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 87.3 mt -64.53 -41.59 96.28 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 147' ' ' SER . . . . . 0.628 ' O ' ' N ' ' B' ' 149' ' ' PRO . 77.9 p -60.89 -42.1 97.34 Favored 'General case' 0 CA--C 1.481 -1.676 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 -178.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . 0.469 ' C ' ' O ' ' B' ' 147' ' ' SER . 23.2 m -29.42 84.91 0.03 OUTLIER Pre-proline 0 N--CA 1.482 1.169 0 O-C-N 123.959 0.787 . . . . 0.0 110.182 178.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 149' ' ' PRO . . . . . 0.628 ' N ' ' O ' ' B' ' 147' ' ' SER . 22.0 Cg_exo -61.46 148.24 93.46 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.865 1.71 . . . . 0.0 115.849 -176.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 150' ' ' ILE . . . . . 0.405 ' O ' HG23 ' B' ' 150' ' ' ILE . 9.6 tp -125.91 117.43 48.99 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.156 0 CA-C-N 114.273 -1.33 . . . . 0.0 107.805 173.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 40.1 t -146.99 92.94 4.85 Favored Pre-proline 0 C--N 1.314 -0.946 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.592 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -60.81 136.39 65.96 Favored 'Trans proline' 0 C--N 1.316 -1.154 0 CA-C-N 120.321 1.15 . . . . 0.0 109.219 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 153' ' ' ILE . . . . . 0.674 ' O ' ' HD2' ' B' ' 154' ' ' ARG . 44.6 mm -68.4 -44.35 83.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.956 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . 0.719 ' HD3' ' NH2' ' A' ' 154' ' ' ARG . 0.4 OUTLIER -156.56 -154.55 0.48 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.464 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 59.3 t-20 -87.02 108.03 18.68 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 121.024 0.44 . . . . 0.0 110.156 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.79 -17.31 58.47 Favored Glycine 0 CA--C 1.528 0.886 0 N-CA-C 110.516 -1.034 . . . . 0.0 110.516 -178.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 157' ' ' ILE . . . . . 0.46 HG22 ' HB ' ' B' ' 153' ' ' ILE . 85.3 mt -109.38 124.07 65.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.275 0.56 . . . . 0.0 111.002 -176.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . 0.542 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 74.5 m -134.74 149.75 50.49 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.738 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' B' ' 191' ' ' ILE . . . -132.25 147.27 52.4 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 18.0 tp -138.96 77.72 31.12 Favored Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 161' ' ' PRO . . . . . 0.429 ' HB3' ' HB3' ' B' ' 193' ' ' ASP . 90.1 Cg_endo -70.79 146.82 54.83 Favored 'Trans proline' 0 N--CA 1.498 1.76 0 C-N-CA 122.867 2.378 . . . . 0.0 114.095 -178.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 92.0 mt -113.03 133.85 54.79 Favored 'General case' 0 C--N 1.345 0.37 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 56.1 t -129.29 132.98 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 177.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 114.86 168.47 15.81 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.012 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 165' ' ' ASN . . . . . 0.768 ' O ' ' CZ ' ' B' ' 170' ' ' ARG . 61.4 t30 -90.03 106.65 18.62 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -177.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . 0.625 HD21 ' CZ ' ' B' ' 171' ' ' PHE . 42.3 tp -64.3 104.23 0.73 Allowed 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -174.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 167' ' ' THR . . . . . 0.692 HG23 ' NE ' ' B' ' 170' ' ' ARG . 9.6 p -85.73 168.6 14.2 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 113.806 -1.543 . . . . 0.0 111.094 177.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.05 -38.68 91.64 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.607 177.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -65.85 -41.68 91.38 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 122.402 1.096 . . . . 0.0 111.778 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 170' ' ' ARG . . . . . 0.768 ' CZ ' ' O ' ' B' ' 165' ' ' ASN . 87.8 mtm180 -61.53 -34.72 76.03 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 112.558 -2.11 . . . . 0.0 110.952 178.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 171' ' ' PHE . . . . . 0.625 ' CZ ' HD21 ' B' ' 166' ' ' LEU . 0.5 OUTLIER -54.89 -25.9 32.16 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -178.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 172' ' ' ASN . . . . . 0.599 ' O ' HG22 ' B' ' 175' ' ' VAL . 92.4 m-20 -62.74 -40.33 96.88 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.834 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 55.3 m -59.85 -41.41 91.36 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.013 0.435 . . . . 0.0 110.598 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 68.2 mt -63.87 -44.15 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 175' ' ' VAL . . . . . 0.599 HG22 ' O ' ' B' ' 172' ' ' ASN . 35.6 m -62.45 -40.01 86.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 176' ' ' CYS . . . . . 0.415 ' N ' HG23 ' B' ' 175' ' ' VAL . 98.1 m -61.95 -35.3 78.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.329 179.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 177' ' ' THR . . . . . 0.563 ' O ' HG13 ' B' ' 181' ' ' ILE . 25.0 m -61.84 -19.67 62.85 Favored 'General case' 0 C--O 1.22 -0.494 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.38 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 178' ' ' LEU . . . . . 0.57 ' CD2' HD21 ' B' ' 211' ' ' LEU . 89.6 mt -60.83 -39.24 88.29 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.238 -178.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 18.9 m -61.74 -44.29 97.21 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.547 177.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 180' ' ' ASN . . . . . 0.592 ' O ' ' OG ' ' B' ' 183' ' ' SER . 92.3 m-20 -61.74 -39.99 93.53 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.161 0.505 . . . . 0.0 110.537 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.563 HG13 ' O ' ' B' ' 177' ' ' THR . 73.0 mt -55.99 -33.48 35.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 O-C-N 122.143 -0.348 . . . . 0.0 110.465 -178.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 182' ' ' LEU . . . . . 0.4 ' HA ' HD23 ' B' ' 182' ' ' LEU . 86.7 mt -62.38 -41.74 98.87 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.163 178.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . 0.592 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.1 p -63.33 -32.89 74.43 Favored 'General case' 0 C--O 1.225 -0.221 0 O-C-N 121.905 -0.497 . . . . 0.0 110.768 177.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 45.9 p -86.96 17.04 4.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.907 0.384 . . . . 0.0 111.769 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 78.6 p -60.6 -16.51 38.98 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.966 -177.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.64 -40.3 94.41 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 122.075 -0.39 . . . . 0.0 110.811 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 187' ' ' ASP . . . . . 0.542 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.3 m-20 -68.52 114.41 6.9 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.576 0.703 . . . . 0.0 110.793 -178.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.88 -42.23 99.69 Favored 'General case' 0 C--O 1.25 1.109 0 CA-C-N 114.997 -1.001 . . . . 0.0 113.242 -178.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -113.0 131.77 55.63 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 120.711 -0.395 . . . . 0.0 111.386 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 190' ' ' LEU . . . . . . . . . . . . . 40.8 tp -123.97 118.96 28.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.372 177.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 191' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' B' ' 159' ' ' ALA . 85.6 mt -106.38 125.71 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 121.128 -0.229 . . . . 0.0 111.444 -178.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 48.7 mm -115.16 117.01 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 193' ' ' ASP . . . . . 0.527 ' CG ' ' HG ' ' B' ' 195' ' ' SER . 43.0 t0 -89.42 113.09 24.38 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -176.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 194' ' ' LEU . . . . . . . . . . . . . 96.2 mt -95.45 -1.1 51.55 Favored 'General case' 0 C--O 1.239 0.509 0 O-C-N 122.265 -0.272 . . . . 0.0 110.691 177.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 195' ' ' SER . . . . . 0.527 ' HG ' ' CG ' ' B' ' 193' ' ' ASP . 78.1 p -61.17 -36.7 80.54 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.0 -178.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.42 -37.37 94.0 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 197' ' ' LEU . . . . . 0.959 HD23 ' N ' ' B' ' 198' ' ' ALA . 5.2 tt -72.34 133.63 45.07 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.006 -0.738 . . . . 0.0 109.006 -178.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 198' ' ' ALA . . . . . 0.959 ' N ' HD23 ' B' ' 197' ' ' LEU . . . -61.81 -49.19 77.32 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 119.556 -0.858 . . . . 0.0 111.137 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 199' ' ' GLN . . . . . 0.901 ' O ' ' CD2' ' B' ' 197' ' ' LEU . 58.3 tt0 -134.5 164.55 27.22 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-O 121.783 0.802 . . . . 0.0 113.04 -178.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 200' ' ' VAL . . . . . 0.504 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 50.1 t -120.19 130.72 74.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 O-C-N 120.368 -1.458 . . . . 0.0 109.502 176.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -86.15 151.56 23.56 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.658 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -62.64 -33.12 74.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.439 -179.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -63.46 -31.93 73.23 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.6 m -60.92 -43.78 98.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.186 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 205' ' ' ALA . . . . . 0.641 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -58.73 -30.06 67.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 119.26 -0.4 . . . . 0.0 111.848 -178.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -64.61 -39.08 93.08 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 123.79 0.681 . . . . 0.0 110.191 175.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -66.33 -38.69 88.24 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.694 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 96.3 mt -63.14 -43.92 99.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -178.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 209' ' ' PHE . . . . . 0.641 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 64.0 m-85 -61.56 -43.57 98.62 Favored 'General case' 0 C--O 1.242 0.692 0 O-C-N 124.682 1.239 . . . . 0.0 111.856 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -62.9 -41.48 99.45 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 119.25 -0.98 . . . . 0.0 109.727 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . 0.57 HD21 ' CD2' ' B' ' 178' ' ' LEU . 37.8 mt -62.45 -42.43 99.46 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.189 -179.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 78.2 p -62.74 -37.58 87.14 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.283 -0.567 . . . . 0.0 112.141 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 213' ' ' HIS . . . . . 0.459 ' CE1' HD11 ' B' ' 217' ' ' LEU . 58.8 t-80 -66.31 -47.21 74.27 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.34 178.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . . . . . . . . . 53.4 tp -63.79 -43.44 96.32 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 121.616 0.722 . . . . 0.0 109.532 178.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 215' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' B' ' 211' ' ' LEU . 90.7 mt -63.09 -43.18 99.23 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 113.466 -1.697 . . . . 0.0 111.214 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.85 -39.46 94.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.727 -0.215 . . . . 0.0 110.933 -177.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . 0.459 HD11 ' CE1' ' B' ' 213' ' ' HIS . 85.7 mt -63.25 -42.46 99.18 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.203 0.525 . . . . 0.0 111.39 176.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 218' ' ' THR . . . . . . . . . . . . . 71.9 p -75.3 -14.15 60.48 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.683 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 77.79 72.66 1.13 Allowed Glycine 0 CA--C 1.528 0.877 0 N-CA-C 107.141 -2.384 . . . . 0.0 107.141 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 220' ' ' THR . . . . . . . . . . . . . 81.7 m -151.72 100.8 2.72 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 177.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -58.59 140.09 54.88 Favored 'General case' 0 C--N 1.321 -0.657 0 O-C-N 121.849 -0.532 . . . . 0.0 111.103 -177.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 42.0 tp -117.49 120.72 38.97 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.171 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 2.9 mp -109.92 128.91 65.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.166 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 224' ' ' ILE . . . . . 0.555 ' CG2' HD11 ' B' ' 227' ' ' ILE . 50.4 mm -110.68 127.47 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 O-C-N 123.572 0.545 . . . . 0.0 109.532 -179.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 43.7 p -134.42 157.57 46.11 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 90.78 16.17 55.17 Favored Glycine 0 N--CA 1.442 -0.967 0 CA-C-N 113.949 -1.478 . . . . 0.0 111.228 -177.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 227' ' ' ILE . . . . . 0.675 HD12 HG23 ' B' ' 247' ' ' THR . 95.9 mt -81.74 126.63 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 CA-C-N 117.889 0.845 . . . . 0.0 111.686 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 61.2 tttt -67.01 139.28 95.43 Favored Pre-proline 0 C--N 1.316 -0.854 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.521 -178.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.85 -37.04 92.78 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 121.354 1.37 . . . . 0.0 112.483 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -63.08 -43.48 98.4 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 53.1 tp -62.42 -41.98 99.1 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.679 -178.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -62.95 -36.99 85.29 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.892 0.377 . . . . 0.0 111.367 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 94.6 mtp -63.75 -41.15 98.06 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.758 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.3 -43.33 99.07 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 121.995 0.902 . . . . 0.0 109.366 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 30.2 mmt -64.33 -35.85 82.22 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 114.566 -1.197 . . . . 0.0 111.896 -178.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -61.08 -40.62 94.38 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.214 -0.448 . . . . 0.0 109.987 -178.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.77 -43.05 99.82 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.287 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 52.7 tp -62.68 -44.25 96.73 Favored 'General case' 0 CA--C 1.545 0.761 0 O-C-N 121.883 -0.51 . . . . 0.0 112.27 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 239' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' B' ' 240' ' ' ALA . 66.7 t0 -159.28 133.42 7.62 Favored 'General case' 0 CA--C 1.506 -0.714 0 C-N-CA 120.149 -0.62 . . . . 0.0 111.982 -178.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 240' ' ' ALA . . . . . 0.4 ' N ' ' OD1' ' B' ' 239' ' ' ASP . . . -60.98 -47.76 84.95 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 241' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' B' ' 244' ' ' SER . 90.2 m-20 -43.23 -19.37 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.475 -175.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 242' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -60.34 -45.03 94.9 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.172 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 243' ' ' SER . . . . . . . . . . . . . 78.1 p -58.77 -42.03 88.01 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 244' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 25.2 m -35.25 -32.53 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -177.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 98.9 mt -90.41 131.54 36.12 Favored 'General case' 0 CA--C 1.513 -0.452 0 O-C-N 121.1 -1.0 . . . . 0.0 110.061 178.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -59.47 134.89 57.42 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 121.421 0.629 . . . . 0.0 110.376 -176.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 247' ' ' THR . . . . . 0.675 HG23 HD12 ' B' ' 227' ' ' ILE . 97.3 m -125.62 127.99 47.19 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.484 -1.235 . . . . 0.0 111.861 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 248' ' ' TYR . . . . . 0.546 ' CG ' ' HB2' ' B' ' 254' ' ' ALA . 98.1 m-85 -113.3 144.15 43.22 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 249' ' ' SER . . . . . 0.563 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 78.6 p -64.57 -33.66 76.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.476 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 250' ' ' ASN . . . . . 0.563 ' OD1' ' O ' ' B' ' 249' ' ' SER . 99.0 m-20 -147.2 160.11 42.85 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.971 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 61.7 t -64.21 -44.69 97.49 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.254 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.293 177.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 252' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.24 -45.4 94.68 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -177.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . 0.444 ' O ' HG22 ' B' ' 257' ' ' VAL . 93.5 m-20 -61.51 -44.24 97.42 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.75 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 254' ' ' ALA . . . . . 0.546 ' HB2' ' CG ' ' B' ' 248' ' ' TYR . . . -65.44 -40.65 93.52 Favored 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.893 178.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 255' ' ' VAL . . . . . 0.729 HG13 HH11 ' A' ' 154' ' ' ARG . 74.2 t -64.66 -45.48 95.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.3 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 256' ' ' LYS . . . . . 0.411 ' HE3' ' ND2' ' A' ' 155' ' ' ASN . 88.6 tttt -63.04 -48.46 78.62 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 120.132 -0.627 . . . . 0.0 111.118 -178.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 257' ' ' VAL . . . . . 0.486 ' O ' ' C ' ' B' ' 258' ' ' LEU . 20.1 m -65.55 -40.79 89.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.662 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 258' ' ' LEU . . . . . 0.508 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 1.0 OUTLIER -31.58 -73.67 0.05 OUTLIER Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 119.499 -0.286 . . . . 0.0 111.664 -178.009 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 259' ' ' PRO . . . . . 0.508 ' CD ' ' CB ' ' B' ' 258' ' ' LEU . 36.6 Cg_endo -61.81 139.99 83.17 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 121.531 1.487 . . . . 0.0 111.575 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 260' ' ' ILE . . . . . 0.547 ' O ' HG22 ' B' ' 260' ' ' ILE . 96.6 mt -157.47 -14.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 118.665 0.666 . . . . 0.0 112.054 177.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 78.3 mtm . . . . . 0 C--O 1.214 -0.801 0 CA-C-O 117.761 -1.114 . . . . 0.0 111.573 -179.588 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 900' ' ' FMN . . . . . 0.552 " C2'" ' OD1' ' A' ' 61' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 900' ' ' FMN . . . . . 0.577 " C2'" ' OD1' ' B' ' 61' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 109.012 -1.635 . . . . 0.0 109.012 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.14 171.81 17.88 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 118.968 -0.539 . . . . 0.0 110.226 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.5 p -71.3 -14.89 62.36 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.332 0.653 . . . . 0.0 110.757 177.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -75.53 -66.3 0.79 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.615 175.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -67.28 -39.3 85.99 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.969 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.533 ' O ' ' HB3' ' A' ' 7' ' ' PHE . 63.1 m -59.44 -42.56 92.19 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.114 -176.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.533 ' HB3' ' O ' ' A' ' 6' ' ' SER . 44.3 t80 85.52 85.69 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 O-C-N 123.707 0.63 . . . . 0.0 112.495 177.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.664 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -62.21 -152.15 0.03 OUTLIER Glycine 0 CA--C 1.529 0.967 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -177.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.664 ' HB ' ' O ' ' A' ' 8' ' ' GLY . 66.9 mt 93.63 108.89 0.02 OUTLIER Pre-proline 0 N--CA 1.472 0.66 0 C-N-CA 122.371 0.269 . . . . 0.0 110.579 -178.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.48 -22.77 71.12 Favored 'Trans proline' 0 N--CA 1.496 1.657 0 C-N-CA 121.539 1.493 . . . . 0.0 112.181 -178.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.403 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -63.43 -38.3 96.15 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.112 -0.566 . . . . 0.0 111.726 179.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -65.52 -38.7 90.43 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.654 0.74 . . . . 0.0 109.706 178.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 52.5 tp -62.71 -41.39 99.12 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.85 -0.613 . . . . 0.0 112.412 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -64.25 -39.04 93.14 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 11' ' ' GLY . 55.5 t -60.51 -44.16 95.88 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 O-C-N 122.186 -0.321 . . . . 0.0 110.434 -178.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 92.4 mt -62.71 -43.64 98.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 C-N-CA 119.756 -0.777 . . . . 0.0 109.3 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.424 ' NZ ' ' HA ' ' B' ' 6' ' ' SER . 98.9 mttt -62.12 -45.37 93.76 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 119.365 -0.934 . . . . 0.0 112.221 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.712 ' HZ1' HG12 ' B' ' 113' ' ' ILE . 98.7 mttt -60.1 -40.21 88.84 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 118.672 -1.211 . . . . 0.0 109.124 -176.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.34 -42.68 96.21 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.09 -0.644 . . . . 0.0 110.157 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 20' ' ' LEU . 85.7 mt -62.95 -41.18 99.43 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.118 0.485 . . . . 0.0 109.926 178.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -63.49 -37.99 89.41 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.499 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 57.6 m170 -58.92 -39.8 82.63 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 122.179 -0.326 . . . . 0.0 111.254 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.2 p -113.82 130.44 67.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.498 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 34.6 ptt180 -72.51 110.25 6.76 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.99 0.9 . . . . 0.0 112.08 -177.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.3 p -140.98 143.14 28.83 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.164 178.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.472 ' O ' ' N ' ' A' ' 123' ' ' GLN . . . -97.91 91.76 1.2 Allowed Glycine 0 C--N 1.312 -0.768 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.76 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.4 t -124.84 130.25 73.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 175.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 28.4 m -137.17 159.99 36.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.6 mt -119.85 131.14 73.13 Favored 'Isoleucine or valine' 0 C--O 1.247 0.965 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 176.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.516 HG22 HG12 ' A' ' 39' ' ' ILE . 72.6 p -108.04 165.98 11.06 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.415 ' C ' ' OD1' ' A' ' 37' ' ' ASN . 56.1 t0 -130.8 103.29 15.94 Favored Pre-proline 0 C--N 1.319 -0.719 0 C-N-CA 121.087 -0.245 . . . . 0.0 110.538 178.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.436 ' HG3' HG23 ' A' ' 117' ' ' THR . 35.0 Cg_endo -62.69 -23.61 74.63 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 121.365 1.376 . . . . 0.0 111.701 -178.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.78 -36.38 83.68 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.729 -178.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.6 mt -83.74 156.12 22.73 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.641 177.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.754 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 43.0 tt0 -58.1 138.06 56.4 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -176.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.548 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 60.0 t0 59.29 20.47 8.64 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.767 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.415 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 46.5 t-20 40.29 68.58 2.2 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 115.432 -0.803 . . . . 0.0 111.072 -177.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.754 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 91.2 Cg_endo -70.69 155.31 63.11 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 124.06 3.173 . . . . 0.0 112.649 -178.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.516 HG12 HG22 ' A' ' 30' ' ' THR . 95.8 mt -87.68 123.85 40.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.429 HG23 ' N ' ' A' ' 41' ' ' TYR . 28.0 m -104.21 -43.41 8.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.883 -178.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.429 ' N ' HG23 ' A' ' 40' ' ' VAL . 43.5 t80 -94.84 124.31 38.81 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.552 -177.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.7 p -143.35 141.1 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 O-C-N 124.314 1.009 . . . . 0.0 109.345 177.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.676 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 56.8 p30 -98.45 166.76 11.21 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.512 ' OE1' ' HA ' ' A' ' 44' ' ' GLN . 13.5 mm100 -66.7 -39.04 87.9 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-O 120.887 0.375 . . . . 0.0 111.868 177.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.17 -25.98 63.04 Favored Glycine 0 C--N 1.332 0.346 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.676 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 62.9 t80 -59.22 -48.42 81.67 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 105.741 -1.948 . . . . 0.0 105.741 -178.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.57 HG13 ' O ' ' A' ' 52' ' ' TYR . 53.7 t -58.88 -44.9 91.72 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.542 0 O-C-N 121.274 -0.891 . . . . 0.0 111.074 -173.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -63.26 -37.71 88.31 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.768 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 59.7 ttm -67.17 -44.14 80.48 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 176.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 37.9 p -90.26 -23.2 21.27 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.146 0.498 . . . . 0.0 111.845 -178.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . 77.74 19.34 75.86 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.57 ' O ' HG13 ' A' ' 47' ' ' VAL . 77.4 m-85 -112.71 138.09 50.03 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.1 0.56 . . . . 0.0 111.606 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -63.75 148.2 49.78 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.535 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.421 HG22 ' H ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -65.54 -32.41 73.98 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -179.45 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.02 -43.43 87.66 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.434 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 74.8 mt-10 -64.73 -44.23 90.84 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.621 178.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.628 HD13 ' CD2' ' A' ' 46' ' ' PHE . 88.3 mt -61.49 -51.3 74.46 Favored 'Isoleucine or valine' 0 C--N 1.347 0.489 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -174.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 86.0 mt -56.83 146.03 27.62 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 177.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 84.17 -6.63 74.88 Favored Glycine 0 CA--C 1.524 0.612 0 CA-C-O 119.339 -0.7 . . . . 0.0 112.829 176.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -135.0 150.52 50.34 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 118.832 1.316 . . . . 0.0 111.882 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.559 ' C ' ' H ' ' A' ' 63' ' ' ARG . 24.9 t-20 -80.17 150.75 30.06 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.241 0.543 . . . . 0.0 110.771 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.406 ' HB3' HD12 ' A' ' 65' ' ' LEU . 76.8 m -63.14 15.86 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.502 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.559 ' H ' ' C ' ' A' ' 61' ' ' ASN . 35.8 ptt-85 -61.67 -41.36 97.44 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 120.778 -0.369 . . . . 0.0 111.262 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -56.41 -20.49 19.89 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 -178.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.406 HD12 ' HB3' ' A' ' 62' ' ' CYS . 87.8 mt -68.23 -34.3 75.99 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.546 0.689 . . . . 0.0 112.506 177.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -64.53 137.83 58.07 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.439 -0.8 . . . . 0.0 112.374 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.567 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -146.54 -147.06 4.49 Favored Glycine 0 CA--C 1.544 1.898 0 C-N-CA 120.825 -0.703 . . . . 0.0 111.892 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.01 -40.29 97.32 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -177.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.439 ' O ' ' OE1' ' A' ' 93' ' ' GLN . 12.6 m-70 -76.77 -7.85 56.19 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.035 -178.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.567 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 28.9 m -63.56 128.82 37.55 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.379 -0.528 . . . . 0.0 109.807 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -84.91 109.3 19.54 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.708 -178.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 70' ' ' THR . 51.5 Cg_exo -56.83 -32.97 93.56 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.042 1.828 . . . . 0.0 113.11 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.46 -39.54 94.0 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.207 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -64.88 -42.31 94.93 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 77.8 t -60.38 -43.65 94.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 114.242 -1.344 . . . . 0.0 107.679 -175.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -63.47 -37.72 88.4 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.928 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -63.77 -40.08 95.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.253 0.549 . . . . 0.0 110.443 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.75 -44.08 98.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-O 122.156 0.979 . . . . 0.0 111.99 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -63.25 -42.92 99.23 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 113.522 -1.672 . . . . 0.0 108.183 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 96.6 m -61.45 -49.92 74.88 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 120.061 -0.655 . . . . 0.0 109.776 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -58.66 -42.14 87.75 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-O 119.183 -0.437 . . . . 0.0 111.297 -174.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 84.2 mt -63.12 -39.52 94.93 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 119.386 0.994 . . . . 0.0 111.439 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -65.29 -33.22 75.47 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -88.75 -2.13 58.43 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.543 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.8 tttt 50.08 41.65 23.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.752 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -126.06 144.0 47.41 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.413 ' HA ' ' O ' ' A' ' 108' ' ' ILE . 24.6 Cg_exo -61.61 143.55 96.86 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 121.303 1.335 . . . . 0.0 113.595 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -139.51 141.62 34.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.721 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.722 HG23 ' OD1' ' A' ' 107' ' ' ASN . 91.2 m -125.47 122.42 36.6 Favored 'General case' 0 C--N 1.342 0.271 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 175.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 29.7 m -138.93 157.97 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.675 176.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -102.41 134.33 45.91 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 176.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.404 HG23 ' O ' ' A' ' 92' ' ' ILE . 18.7 tt -141.89 130.65 22.63 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.181 0 CA-C-N 120.5 1.5 . . . . 0.0 112.977 177.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.439 ' OE1' ' O ' ' A' ' 69' ' ' HIS . 86.0 mt-30 -64.75 132.7 50.32 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.871 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -134.09 156.19 48.7 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.46 -178.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -115.89 134.07 55.37 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -178.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.444 ' HG3' ' CE1' ' A' ' 102' ' ' PHE . 99.1 mttt -83.03 -173.66 4.84 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.166 0.508 . . . . 0.0 111.52 -178.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.52 -43.11 99.61 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.65 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 40.8 p-10 -82.65 5.54 20.79 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -178.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.39 -0.3 86.99 Favored Glycine 0 N--CA 1.466 0.641 0 C-N-CA 120.879 -0.676 . . . . 0.0 112.225 176.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 26.7 m -59.18 137.74 57.85 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.657 ' SD ' ' C ' ' A' ' 101' ' ' MET . 13.4 tmm? -102.36 127.89 49.17 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.724 0.297 . . . . 0.0 110.95 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.474 ' N ' ' SD ' ' A' ' 101' ' ' MET . 53.2 p90 -140.88 159.66 41.74 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.236 -0.586 . . . . 0.0 109.762 -177.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.888 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 26.1 m95 -92.55 141.12 28.85 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.528 HD21 ' HG2' ' A' ' 123' ' ' GLN . 53.9 t-20 -137.0 104.39 5.44 Favored 'General case' 0 C--O 1.226 -0.145 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -176.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 81.2 tt0 -69.25 137.38 53.08 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -177.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 44.1 tp -121.56 123.97 43.25 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.722 ' OD1' HG23 ' A' ' 89' ' ' THR . 98.3 m-20 -119.67 123.38 43.68 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.522 177.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.413 ' O ' ' HA ' ' A' ' 87' ' ' PRO . 96.2 mt -121.02 128.72 76.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 O-C-N 123.345 0.403 . . . . 0.0 111.225 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -140.61 122.96 9.68 Favored Pre-proline 0 CA--C 1.541 0.596 0 CA-C-O 119.912 -0.089 . . . . 0.0 110.785 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -70.71 150.28 62.16 Favored 'Trans proline' 0 N--CA 1.496 1.652 0 C-N-CA 122.593 2.195 . . . . 0.0 112.912 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.594 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 66.9 mtt -122.81 153.86 38.99 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 -179.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -125.0 98.8 5.84 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.596 1.089 . . . . 0.0 108.478 176.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.469 ' CD1' HG22 ' B' ' 15' ' ' VAL . 95.7 mt -121.24 131.19 73.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.875 -178.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 47.63 39.57 10.15 Favored 'General case' 0 CA--C 1.516 -0.349 0 O-C-N 121.599 -0.688 . . . . 0.0 111.613 177.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 59.31 30.64 20.4 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.906 -178.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -127.81 148.54 50.45 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.754 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 5.1 t -86.01 -172.4 4.06 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 121.506 -0.746 . . . . 0.0 109.68 -178.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.754 ' CD2' ' O ' ' A' ' 117' ' ' THR . 69.7 m-85 -171.03 157.32 5.18 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 174.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.463 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 97.2 m-85 -130.27 145.18 51.73 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 173.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -132.95 133.32 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.28 128.22 9.13 Favored Glycine 0 CA--C 1.504 -0.636 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 178.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 96.1 mt -118.09 129.6 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 178.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.528 ' HG2' HD21 ' A' ' 104' ' ' ASN . 16.3 mp0 -119.54 115.84 24.84 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.172 0.511 . . . . 0.0 109.756 179.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -117.72 115.22 24.59 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.13 -177.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 126' ' ' ILE . 68.0 t0 -64.14 129.76 41.26 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -174.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.494 HG22 ' O ' ' A' ' 126' ' ' ILE . 2.6 mp -95.14 2.05 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 113.576 -1.647 . . . . 0.0 110.02 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 20.1 m -60.79 -42.39 97.49 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -178.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -60.35 -42.07 94.95 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -177.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -62.94 -39.25 94.04 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.855 177.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.888 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.6 mttt -62.22 -40.71 97.04 Favored 'General case' 0 CA--C 1.5 -0.979 0 C-N-CA 118.397 -1.321 . . . . 0.0 110.643 -179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -62.32 -37.4 85.46 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 -178.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.661 ' CE2' HD11 ' A' ' 136' ' ' LEU . 89.4 t80 -61.75 -46.33 90.06 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.912 176.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.69 -38.9 92.56 Favored 'General case' 0 C--O 1.226 -0.168 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 130' ' ' LYS . 98.7 mttt -62.04 -40.45 95.77 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 53.1 tp -60.73 -43.53 97.78 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -177.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.661 HD11 ' CE2' ' A' ' 132' ' ' TYR . 86.5 mt -62.66 -41.36 99.02 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.495 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.27 -40.91 98.72 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 119.637 -0.825 . . . . 0.0 109.531 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -60.95 -41.45 96.34 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -177.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.1 m -61.99 -39.96 93.99 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.896 176.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.523 ' O ' ' N ' ' A' ' 144' ' ' THR . 87.7 mt -63.39 -42.03 98.78 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 178.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 99.6 m -61.85 -45.61 93.04 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.975 -177.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -64.54 -41.0 96.62 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 96.1 mt -64.7 -43.46 96.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 113.965 -1.47 . . . . 0.0 111.53 175.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.523 ' N ' ' O ' ' A' ' 140' ' ' LEU . 97.2 m -62.71 -46.07 89.82 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 120.283 -0.567 . . . . 0.0 112.358 -177.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.88 -39.84 95.7 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 118.813 -1.155 . . . . 0.0 109.138 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 87.6 mt -63.76 -42.48 97.8 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.644 178.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.679 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.1 p -60.19 -40.19 89.16 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -177.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.498 ' C ' ' O ' ' A' ' 147' ' ' SER . 93.5 m -26.64 83.57 0.03 OUTLIER Pre-proline 0 C--N 1.343 0.305 0 O-C-N 126.417 2.323 . . . . 0.0 106.814 -178.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.679 ' N ' ' O ' ' A' ' 147' ' ' SER . 22.0 Cg_exo -62.69 145.1 95.0 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 CA-C-O 122.428 0.928 . . . . 0.0 113.949 -175.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.64 ' O ' HG23 ' A' ' 151' ' ' VAL . 9.5 tp -120.25 135.98 58.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 102.378 -3.193 . . . . 0.0 102.378 175.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 150' ' ' ILE . 70.7 t -169.6 95.48 0.51 Allowed Pre-proline 0 N--CA 1.446 -0.64 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 176.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -61.83 135.71 57.51 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 N-CA-C 109.565 -0.975 . . . . 0.0 109.565 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.561 ' O ' ' HD2' ' A' ' 154' ' ' ARG . 46.1 mm -68.0 -44.28 84.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.104 179.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.571 ' NH2' ' HD3' ' B' ' 154' ' ' ARG . 0.3 OUTLIER -156.62 -157.65 0.72 Allowed 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -179.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 61.8 t-20 -86.94 105.88 17.41 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.871 0.843 . . . . 0.0 111.631 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 89.29 7.65 69.49 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 113.957 -1.474 . . . . 0.0 110.832 -177.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.474 HG12 ' HB2' ' A' ' 189' ' ' TYR . 96.2 mt -124.42 126.19 71.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 174.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.671 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 66.7 m -132.12 152.5 51.21 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 122.494 0.317 . . . . 0.0 110.36 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -137.91 142.02 40.62 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.612 -0.68 . . . . 0.0 111.338 177.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 15.9 tp -133.8 79.38 58.4 Favored Pre-proline 0 N--CA 1.472 0.662 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.525 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -69.65 150.76 69.32 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 122.782 2.322 . . . . 0.0 113.165 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 84.8 mt -116.63 125.51 51.9 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.61 178.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 43.2 t -122.16 130.97 74.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 115.74 169.48 15.67 Favored Glycine 0 N--CA 1.484 1.857 0 C-N-CA 120.959 -0.638 . . . . 0.0 112.061 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.864 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 53.9 t30 -86.51 113.23 22.26 Favored 'General case' 0 C--N 1.347 0.47 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.589 HD21 ' CZ ' ' A' ' 171' ' ' PHE . 46.7 tp -71.32 104.39 3.15 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 -177.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.751 HG23 ' NE ' ' A' ' 170' ' ' ARG . 10.4 p -86.46 166.98 15.08 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.414 178.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -66.01 -34.22 77.59 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.023 0.44 . . . . 0.0 111.551 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.55 -41.83 96.09 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.36 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.864 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 87.6 mtm180 -65.41 -33.98 77.22 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.328 1.051 . . . . 0.0 112.192 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.589 ' CZ ' HD21 ' A' ' 166' ' ' LEU . 0.4 OUTLIER -54.45 -27.94 40.85 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 118.946 -0.55 . . . . 0.0 112.239 -178.695 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.633 ' O ' HG22 ' A' ' 175' ' ' VAL . 91.6 m-20 -61.06 -40.37 93.41 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 119.652 1.114 . . . . 0.0 109.702 -178.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 41.4 m -59.77 -40.47 88.33 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.801 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 68.0 mt -63.21 -44.21 99.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.633 HG22 ' O ' ' A' ' 172' ' ' ASN . 27.1 m -62.82 -39.74 86.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . 0.426 ' N ' HG23 ' A' ' 175' ' ' VAL . 98.7 m -62.5 -34.6 77.19 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.313 0.578 . . . . 0.0 110.388 178.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.584 ' O ' HG13 ' A' ' 181' ' ' ILE . 24.9 m -62.63 -20.39 64.73 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.285 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.64 ' CD2' HD21 ' A' ' 211' ' ' LEU . 86.3 mt -61.17 -41.32 96.58 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -177.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 18.7 m -60.2 -43.27 96.06 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.62 ' O ' ' OG ' ' A' ' 183' ' ' SER . 93.2 m-20 -62.25 -37.26 84.74 Favored 'General case' 0 C--N 1.321 -0.674 0 C-N-CA 122.552 0.341 . . . . 0.0 110.963 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.584 HG13 ' O ' ' A' ' 177' ' ' THR . 69.6 mt -57.9 -37.63 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 O-C-N 121.536 -0.728 . . . . 0.0 109.473 -178.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.495 HD21 HD21 ' A' ' 214' ' ' LEU . 83.1 mt -61.1 -40.7 94.74 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -177.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.62 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 78.2 p -61.05 -33.0 72.61 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.228 176.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.467 ' OG1' ' HA ' ' A' ' 181' ' ' ILE . 22.6 p -89.09 23.18 2.5 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.592 0.234 . . . . 0.0 111.542 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 78.1 p -63.52 -20.84 65.95 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.216 0.531 . . . . 0.0 110.558 -178.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.64 -37.46 81.56 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.802 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.671 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 98.8 m-20 -74.1 113.48 11.34 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.388 0.613 . . . . 0.0 110.615 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -63.03 -42.17 99.71 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 114.999 -1.001 . . . . 0.0 112.91 -177.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . 0.474 ' HB2' HG12 ' A' ' 157' ' ' ILE . 98.2 m-85 -112.12 131.72 55.28 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.619 -178.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 39.4 tp -119.72 127.59 52.99 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 93.9 mt -114.72 126.63 72.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 O-C-N 121.637 -0.664 . . . . 0.0 110.027 177.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.8 mm -113.09 127.19 70.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . 0.562 ' OD2' ' OG ' ' A' ' 195' ' ' SER . 38.7 t0 -95.79 119.99 35.27 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 121.79 -0.569 . . . . 0.0 110.629 176.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 96.6 mt -97.17 -3.38 41.1 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.156 174.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.562 ' OG ' ' OD2' ' A' ' 193' ' ' ASP . 78.2 p -62.9 -33.26 74.94 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -62.02 -43.12 99.6 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 108.477 -1.849 . . . . 0.0 108.477 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 1.065 ' CD2' ' O ' ' A' ' 199' ' ' GLN . 5.2 tt -70.47 127.87 34.2 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 113.037 -1.582 . . . . 0.0 109.074 -176.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.889 ' N ' HD23 ' A' ' 197' ' ' LEU . . . -61.02 -48.69 80.62 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 119.764 -0.774 . . . . 0.0 110.772 -177.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 1.065 ' O ' ' CD2' ' A' ' 197' ' ' LEU . 58.3 tt0 -132.59 156.52 46.74 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 114.77 -1.105 . . . . 0.0 112.183 -174.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.449 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 45.7 t -118.14 133.25 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -91.25 153.98 19.6 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.571 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.8 -38.06 89.67 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.239 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -59.42 -31.74 69.55 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -178.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 19.1 m -60.91 -42.65 98.51 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.475 177.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.449 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -58.06 -38.24 75.94 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -177.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -61.32 -37.99 85.26 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -65.59 -38.51 89.69 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.961 177.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 94.9 mt -62.94 -43.98 99.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.027 -178.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . 0.449 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 71.0 m-85 -62.01 -42.68 99.42 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.635 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -61.96 -41.8 98.41 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.173 -178.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.64 HD21 ' CD2' ' A' ' 178' ' ' LEU . 39.8 mt -61.82 -42.23 98.77 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 78.0 p -61.72 -42.09 98.49 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 119.232 -0.987 . . . . 0.0 109.734 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -64.6 -46.25 83.49 Favored 'General case' 0 C--O 1.234 0.265 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.723 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.495 HD21 HD21 ' A' ' 182' ' ' LEU . 52.5 tp -62.39 -46.25 89.45 Favored 'General case' 0 C--N 1.344 0.354 0 C-N-CA 119.029 -1.068 . . . . 0.0 108.416 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 85.1 mt -61.72 -40.59 95.59 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.472 -177.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.25 -44.72 95.01 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 85.2 mt -61.65 -39.57 91.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.07 0.462 . . . . 0.0 109.822 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 67.0 p -75.53 -11.58 60.05 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.481 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.88 35.39 18.95 Favored Glycine 0 C--O 1.217 -0.939 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.935 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 95.2 m -121.86 113.83 20.19 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.227 1.514 . . . . 0.0 111.148 -178.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -65.78 137.24 57.11 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.206 177.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 43.5 tp -113.21 130.63 56.16 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 3.3 mp -117.41 133.74 63.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 122.857 0.463 . . . . 0.0 109.883 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.529 ' CG2' HD11 ' A' ' 227' ' ' ILE . 49.5 mm -114.93 132.22 64.81 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 43.9 p -134.08 166.63 22.29 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 120.392 -0.523 . . . . 0.0 112.058 -178.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 78.82 20.32 71.08 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 110.399 -1.08 . . . . 0.0 110.399 178.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.701 HD12 HG23 ' A' ' 247' ' ' THR . 97.3 mt -81.56 128.61 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 CA-C-N 114.042 -1.079 . . . . 0.0 108.818 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 63.5 tttt -76.04 140.26 69.92 Favored Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.06 -38.92 87.3 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 121.187 1.258 . . . . 0.0 112.324 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -64.7 -39.39 93.57 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-O 121.619 0.723 . . . . 0.0 110.083 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 48.7 tp -63.55 -42.6 98.38 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.987 -1.006 . . . . 0.0 113.104 176.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.86 -38.05 89.65 Favored 'General case' 0 CA--C 1.521 -0.141 0 O-C-N 121.916 -0.49 . . . . 0.0 111.101 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 94.1 mtp -63.84 -41.48 97.82 Favored 'General case' 0 C--O 1.251 1.135 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.561 -178.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -64.15 -40.02 95.25 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.484 177.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 33.4 mmt -65.68 -38.35 89.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.625 177.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -61.61 -41.55 97.62 Favored 'General case' 0 CA--C 1.516 -0.35 0 O-C-N 121.406 -0.808 . . . . 0.0 109.188 -177.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.43 -41.24 93.61 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.458 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 55.9 tp -63.76 -41.84 97.93 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.229 0.825 . . . . 0.0 113.229 177.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -165.51 126.24 1.88 Allowed 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.604 -0.685 . . . . 0.0 112.684 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -60.05 -26.57 66.23 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.951 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -61.78 -29.97 70.49 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.192 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -55.82 -44.73 78.16 Favored 'General case' 0 C--N 1.312 -1.023 0 O-C-N 121.484 -0.76 . . . . 0.0 109.352 -176.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 95.5 p -62.31 -20.07 63.95 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.23 178.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 19.1 m -55.22 -38.18 68.1 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.511 177.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 97.2 mt -86.3 123.84 31.99 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -178.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -48.37 135.21 14.11 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 114.7 -1.137 . . . . 0.0 109.707 -176.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.701 HG23 HD12 ' A' ' 227' ' ' ILE . 98.0 m -127.87 132.29 49.37 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 114.528 -1.215 . . . . 0.0 111.333 178.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' TYR . . . . . 0.456 ' CB ' ' HB2' ' A' ' 254' ' ' ALA . 97.6 m-85 -116.33 139.64 50.18 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.093 178.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 78.1 p -59.67 -43.07 94.14 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 119.152 -1.019 . . . . 0.0 108.304 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -142.68 159.63 41.86 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.726 0.774 . . . . 0.0 111.312 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 75.4 t -62.61 -45.0 99.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 CA-C-N 114.607 -1.179 . . . . 0.0 111.796 -179.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.92 -43.98 97.85 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.247 -0.581 . . . . 0.0 109.519 -178.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . 0.461 ' O ' HG22 ' A' ' 257' ' ' VAL . 54.6 m-20 -63.59 -41.95 98.3 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.973 -178.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.456 ' HB2' ' CB ' ' A' ' 248' ' ' TYR . . . -64.9 -41.7 95.38 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.037 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . 0.448 HG13 HH11 ' B' ' 154' ' ' ARG . 77.0 t -64.02 -45.56 96.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 114.021 -1.445 . . . . 0.0 110.925 -177.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.99 -47.15 81.49 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.763 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.515 ' O ' ' C ' ' A' ' 258' ' ' LEU . 28.6 m -66.34 -40.6 87.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 120.058 -0.657 . . . . 0.0 112.429 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.515 ' C ' ' O ' ' A' ' 257' ' ' VAL . 1.4 mt -28.36 -75.44 0.04 OUTLIER Pre-proline 0 C--N 1.344 0.355 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.318 -177.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' PRO . . . . . 0.507 ' CD ' ' CB ' ' A' ' 258' ' ' LEU . 42.0 Cg_endo -63.46 139.7 72.12 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 CA-C-N 119.561 0.879 . . . . 0.0 111.761 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 259' ' ' PRO . 96.7 mt -151.38 -26.57 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.694 177.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 78.1 mtm . . . . . 0 N--CA 1.472 0.663 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.562 -177.013 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.459 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.1 163.71 38.67 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 80.4 p -59.85 -20.82 59.32 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 123.37 0.419 . . . . 0.0 111.27 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -74.2 -63.63 1.19 Allowed 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.091 0.472 . . . . 0.0 111.303 -178.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -67.03 -38.85 86.63 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.877 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.545 ' O ' ' HB3' ' B' ' 7' ' ' PHE . 65.7 m -60.05 -43.14 95.58 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 119.979 -0.688 . . . . 0.0 109.928 -176.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . 0.545 ' HB3' ' O ' ' B' ' 6' ' ' SER . 46.2 t80 86.39 88.91 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 O-C-N 123.751 0.657 . . . . 0.0 110.745 177.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . 0.692 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -64.23 -151.73 0.07 OUTLIER Glycine 0 CA--C 1.53 0.99 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -179.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.692 ' HB ' ' O ' ' B' ' 8' ' ' GLY . 67.3 mt 92.98 108.81 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 122.387 0.275 . . . . 0.0 110.87 -178.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -62.53 -24.94 75.47 Favored 'Trans proline' 0 N--CA 1.5 1.855 0 C-N-CA 121.375 1.383 . . . . 0.0 111.847 -178.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.7 -40.5 98.13 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 110.689 -0.965 . . . . 0.0 110.689 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -64.89 -38.62 91.57 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.726 0.774 . . . . 0.0 109.506 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 52.4 tp -61.75 -42.53 99.09 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.848 -178.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -65.68 -32.81 74.58 Favored 'General case' 0 CA--C 1.562 1.442 0 CA-C-O 121.344 0.593 . . . . 0.0 110.534 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . 0.469 HG22 ' CD1' ' A' ' 113' ' ' ILE . 63.2 t -61.57 -46.28 96.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 113.097 -1.865 . . . . 0.0 110.664 177.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 92.9 mt -63.65 -43.91 98.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.259 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . 0.489 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 98.9 mttt -63.36 -41.61 98.84 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.98 -41.37 99.53 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 119.069 -1.053 . . . . 0.0 110.312 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.96 -38.8 89.91 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.656 -178.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.417 ' O ' ' O ' ' B' ' 23' ' ' VAL . 85.5 mt -64.31 -41.97 96.58 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.286 0.565 . . . . 0.0 110.295 175.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -63.15 -38.34 90.79 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.34 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 56.9 m170 -58.47 -39.64 80.49 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 121.236 -0.185 . . . . 0.0 111.087 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.417 ' O ' ' O ' ' B' ' 20' ' ' LEU . 10.0 p -113.96 130.54 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.504 ' O ' ' HG3' ' B' ' 24' ' ' ARG . 34.7 ptt180 -71.79 108.42 5.09 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 121.865 0.84 . . . . 0.0 112.446 -177.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 7.1 p -143.14 134.33 23.31 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.629 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.501 177.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . 0.508 ' O ' ' N ' ' B' ' 123' ' ' GLN . . . -89.59 95.76 2.13 Favored Glycine 0 N--CA 1.436 -1.332 0 C-N-CA 119.093 -1.527 . . . . 0.0 112.748 -175.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 45.9 t -124.86 129.42 73.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 174.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 27.2 m -138.6 157.25 30.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 120.708 -0.397 . . . . 0.0 110.722 178.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 95.9 mt -118.84 129.82 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 CA-C-O 122.377 1.084 . . . . 0.0 111.167 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.508 HG22 HG12 ' B' ' 39' ' ' ILE . 44.7 p -112.0 152.81 27.69 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 112.474 -2.148 . . . . 0.0 108.475 -175.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -121.87 103.6 39.9 Favored Pre-proline 0 C--O 1.239 0.506 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -177.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.78 -22.61 69.4 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 121.907 1.738 . . . . 0.0 111.519 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.6 -42.86 99.46 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 178.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 96.0 mt -75.41 171.08 14.87 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.507 -0.745 . . . . 0.0 111.121 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . 0.627 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 42.3 tt0 -69.85 133.56 47.51 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.962 0.727 . . . . 0.0 112.962 -176.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.522 ' O ' ' OD1' ' B' ' 36' ' ' ASP . 66.1 t0 56.59 35.51 26.18 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.701 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' ASN . . . . . 0.454 ' C ' ' O ' ' B' ' 36' ' ' ASP . 40.3 t-20 28.75 71.24 0.49 Allowed Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.627 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 91.8 Cg_endo -71.85 154.76 58.56 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 C-N-CA 123.736 2.957 . . . . 0.0 112.191 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.508 HG12 HG22 ' B' ' 30' ' ' THR . 95.6 mt -86.85 129.17 38.88 Favored 'Isoleucine or valine' 0 C--O 1.245 0.86 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.419 HG23 ' N ' ' B' ' 41' ' ' TYR . 29.8 m -109.04 -42.89 5.67 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 O-C-N 123.65 0.594 . . . . 0.0 112.373 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' TYR . . . . . 0.419 ' N ' HG23 ' B' ' 40' ' ' VAL . 46.2 t80 -95.61 124.76 39.78 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 119.85 -0.74 . . . . 0.0 111.183 -178.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 5.8 p -143.55 141.86 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 O-C-N 124.102 0.876 . . . . 0.0 109.545 177.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . 0.698 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 56.0 p30 -102.12 162.07 13.2 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.226 178.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' GLN . . . . . 0.505 ' OE1' ' HA ' ' B' ' 44' ' ' GLN . 12.9 mm100 -63.1 -37.89 88.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.303 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.48 -26.48 64.44 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.116 -0.794 . . . . 0.0 111.116 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.698 ' HB2' ' OD1' ' B' ' 43' ' ' ASN . 59.5 t80 -60.46 -43.3 97.02 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 0.688 HG13 ' O ' ' B' ' 52' ' ' TYR . 58.5 t -61.16 -46.33 96.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.032 -178.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -62.92 -44.23 96.64 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.341 -179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 59.7 ttm -63.22 -42.68 99.29 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 39.5 p -94.11 -17.29 22.95 Favored 'General case' 0 N--CA 1.462 0.137 0 C-N-CA 120.29 -0.564 . . . . 0.0 111.934 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' B' ' 47' ' ' VAL . . . 73.67 17.74 79.26 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 178.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . 0.688 ' O ' HG13 ' B' ' 47' ' ' VAL . 77.3 m-85 -110.39 142.89 41.46 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.231 0.612 . . . . 0.0 110.565 178.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -71.91 147.67 46.82 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 121.388 0.613 . . . . 0.0 111.289 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . 0.465 ' H ' HG22 ' B' ' 54' ' ' THR . 0.2 OUTLIER -62.62 -36.55 83.14 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.523 -176.702 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.2 -39.88 95.91 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.344 -178.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -72.72 -32.67 65.89 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 176.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.626 HD13 ' CD2' ' B' ' 46' ' ' PHE . 92.5 mt -64.96 -74.94 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 176.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 94.9 mt -36.42 132.82 0.56 Allowed 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.766 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.28 -13.56 66.59 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-N 115.874 -0.603 . . . . 0.0 113.252 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 69.1 mttm -132.72 149.07 52.33 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 117.572 0.686 . . . . 0.0 112.315 -173.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' ASN . . . . . 0.555 ' C ' ' H ' ' B' ' 63' ' ' ARG . 24.3 t-20 -78.6 149.73 32.89 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.437 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' CYS . . . . . 0.425 ' HB3' HD12 ' B' ' 65' ' ' LEU . 86.2 m -63.11 9.57 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.327 -178.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . 0.555 ' H ' ' C ' ' B' ' 61' ' ' ASN . 34.5 ptt-85 -59.41 -33.16 70.89 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 115.514 -0.766 . . . . 0.0 112.449 -177.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -59.73 -28.79 67.65 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . 0.425 HD12 ' HB3' ' B' ' 62' ' ' CYS . 83.4 mt -61.69 -41.98 98.32 Favored 'General case' 0 C--N 1.32 -0.7 0 O-C-N 121.938 -0.477 . . . . 0.0 109.751 -178.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -53.23 145.99 12.7 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.624 -176.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . 0.563 ' N ' ' OG1' ' B' ' 70' ' ' THR . . . -155.69 -153.22 6.48 Favored Glycine 0 CA--C 1.538 1.5 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.983 177.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -59.38 -41.47 89.45 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -176.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -75.44 -10.0 59.06 Favored 'General case' 0 C--N 1.315 -0.914 0 O-C-N 123.188 0.305 . . . . 0.0 111.171 -178.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' B' ' 67' ' ' GLY . 27.0 m -61.63 133.36 55.53 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 121.875 -0.516 . . . . 0.0 109.812 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -89.17 109.87 34.18 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.335 -178.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.16 -38.67 87.8 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 121.046 1.164 . . . . 0.0 111.811 -179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.13 -39.38 92.39 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 120.424 -0.511 . . . . 0.0 109.871 -175.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -66.57 -38.01 86.16 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.998 177.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 93.5 t -61.73 -45.53 98.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 -63.03 -37.3 86.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.697 -178.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -62.75 -41.84 99.4 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 119.254 -0.978 . . . . 0.0 108.707 179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.4 -43.73 98.62 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-O 120.781 0.324 . . . . 0.0 110.623 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 76.7 ttt180 -62.53 -42.47 99.55 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 99.5 m -61.45 -45.67 93.32 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.224 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.05 -40.82 97.05 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -177.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 81.4 mt -62.72 -42.34 99.61 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 67.1 tp60 -63.48 -34.6 78.12 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -91.96 8.12 38.98 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.413 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 31.0 tttt 42.81 43.03 3.26 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 120.442 -0.503 . . . . 0.0 111.356 175.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 -127.33 141.51 41.06 Favored Pre-proline 0 N--CA 1.469 0.508 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.556 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -62.09 141.01 87.13 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 120.806 1.004 . . . . 0.0 114.077 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.92 137.13 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' THR . . . . . 0.702 HG23 ' OD1' ' B' ' 107' ' ' ASN . 98.7 m -121.11 123.59 42.69 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.897 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 30.2 m -138.41 161.72 30.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.105 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -113.75 120.66 41.56 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 120.41 -0.516 . . . . 0.0 109.645 174.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . 0.454 HD11 HG23 ' B' ' 70' ' ' THR . 20.8 tt -127.79 132.21 69.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.317 -174.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -70.35 140.39 52.17 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.261 177.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -131.25 177.61 7.34 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 121.516 0.674 . . . . 0.0 110.911 -178.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -128.83 143.66 50.97 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 114.447 -1.251 . . . . 0.0 111.954 177.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . 0.435 ' HG3' ' CE1' ' B' ' 102' ' ' PHE . 98.6 mttt -100.09 179.25 4.55 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.283 0.563 . . . . 0.0 110.553 178.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.93 -36.64 79.86 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.843 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 38.5 p-10 -84.79 -1.74 56.75 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 121.426 -0.796 . . . . 0.0 112.912 177.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.06 5.59 65.81 Favored Glycine 0 N--CA 1.467 0.726 0 C-N-CA 121.114 -0.565 . . . . 0.0 112.685 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 29.1 m -68.06 129.95 41.48 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . 0.551 ' SD ' ' N ' ' B' ' 102' ' ' PHE . 15.3 tmm? -87.56 140.48 29.48 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' PHE . . . . . 0.551 ' N ' ' SD ' ' B' ' 101' ' ' MET . 53.7 p90 -151.72 163.01 40.07 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' TRP . . . . . 0.901 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 26.3 m95 -96.35 138.51 33.83 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.589 0.709 . . . . 0.0 110.72 178.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . 0.501 HD21 ' HG2' ' B' ' 123' ' ' GLN . 62.8 t-20 -133.55 109.6 9.35 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 114.669 -1.15 . . . . 0.0 113.467 -176.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' GLU . . . . . 0.401 ' O ' ' HA ' ' B' ' 123' ' ' GLN . 81.6 tt0 -79.16 125.56 29.59 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.768 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 40.0 tp -112.62 125.37 54.21 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -176.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' ASN . . . . . 0.702 ' OD1' HG23 ' B' ' 89' ' ' THR . 98.2 m-20 -118.57 128.59 54.71 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 176.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 96.5 mt -123.75 132.68 70.96 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.467 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -145.93 121.9 5.76 Favored Pre-proline 0 CA--C 1.542 0.665 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -69.23 152.14 72.04 Favored 'Trans proline' 0 N--CA 1.504 2.093 0 C-N-CA 122.893 2.395 . . . . 0.0 112.942 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . 0.483 ' HB2' ' HB2' ' B' ' 118' ' ' TYR . 67.0 mtt -129.99 143.26 50.7 Favored 'General case' 0 C--O 1.245 0.831 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 179.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -110.3 109.47 19.92 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 105.73 -1.952 . . . . 0.0 105.73 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . 0.712 HG12 ' HZ1' ' A' ' 18' ' ' LYS . 96.3 mt -132.46 128.01 57.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 177.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 50.61 38.53 19.13 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.999 178.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 61.46 37.07 16.88 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.51 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -134.21 151.26 51.22 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 177.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' THR . . . . . . . . . . . . . 6.9 t -102.47 154.41 19.12 Favored 'General case' 0 C--O 1.214 -0.785 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 -177.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' TYR . . . . . 0.483 ' HB2' ' HB2' ' B' ' 111' ' ' MET . 96.7 m-85 -148.76 147.85 29.3 Favored 'General case' 0 C--N 1.32 -0.689 0 O-C-N 120.828 -1.17 . . . . 0.0 111.445 -178.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 119' ' ' PHE . . . . . 0.453 ' HB2' ' OG1' ' B' ' 30' ' ' THR . 96.3 m-85 -123.2 137.42 54.89 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 123.318 0.387 . . . . 0.0 110.758 -177.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -127.26 132.02 69.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -177.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . 0.404 ' N ' HM73 ' B' ' 900' ' ' FMN . . . -107.39 124.09 7.48 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 111.256 -0.737 . . . . 0.0 111.256 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 122' ' ' ILE . . . . . 0.429 ' HB ' ' HB2' ' B' ' 107' ' ' ASN . 94.4 mt -114.94 127.6 72.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -178.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 123' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' B' ' 26' ' ' GLY . 16.1 mp0 -118.67 120.47 37.53 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -119.91 120.93 37.84 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' B' ' 127' ' ' THR . 68.0 t0 -67.31 134.79 52.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.331 -0.849 . . . . 0.0 112.704 -177.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.461 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 2.6 mp -108.4 14.48 8.21 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.856 0 CA-C-O 122.054 0.93 . . . . 0.0 108.858 178.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 127' ' ' THR . . . . . 0.49 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 98.5 m -62.72 -44.15 96.97 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 113.754 -1.566 . . . . 0.0 112.47 176.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -61.7 -45.66 93.01 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -177.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 129' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -62.84 -34.65 77.78 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.316 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 130' ' ' LYS . . . . . 0.901 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 98.7 mttt -63.06 -41.58 99.5 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-N 113.47 -1.696 . . . . 0.0 111.022 174.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.69 -42.31 98.01 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 132' ' ' TYR . . . . . 0.672 ' CE2' HD11 ' B' ' 136' ' ' LEU . 89.3 t80 -60.12 -45.44 93.0 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 121.733 -0.604 . . . . 0.0 111.494 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.87 -36.6 84.86 Favored 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 120.233 -0.587 . . . . 0.0 109.601 -179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 134' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' B' ' 130' ' ' LYS . 98.8 mttt -62.86 -39.15 93.52 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.66 177.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 54.7 tp -62.9 -41.58 99.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.163 0.506 . . . . 0.0 109.819 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . 0.672 HD11 ' CE2' ' B' ' 132' ' ' TYR . 90.3 mt -62.67 -42.11 99.44 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.253 177.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 137' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.39 -36.97 85.57 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.116 -1.402 . . . . 0.0 110.299 -178.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -63.11 -43.21 99.1 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.173 175.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 62.1 m -60.8 -43.93 97.49 Favored 'General case' 0 C--N 1.344 0.354 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . 0.516 ' O ' ' N ' ' B' ' 144' ' ' THR . 88.1 mt -61.1 -40.42 93.68 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -176.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 98.6 m -61.88 -45.25 94.57 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.84 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -65.49 -42.78 91.78 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 95.6 mt -63.96 -43.66 97.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.695 178.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 144' ' ' THR . . . . . 0.516 ' N ' ' O ' ' B' ' 140' ' ' LEU . 99.4 m -61.35 -45.69 93.34 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -177.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . 0.408 ' O ' ' HB ' ' B' ' 148' ' ' THR . . . -63.81 -40.81 97.51 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 119.041 -1.064 . . . . 0.0 109.581 179.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 90.0 mt -64.55 -40.64 95.95 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 177.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 147' ' ' SER . . . . . 0.587 ' O ' ' N ' ' B' ' 149' ' ' PRO . 77.4 p -61.36 -43.31 99.09 Favored 'General case' 0 CA--C 1.477 -1.831 0 C-N-CA 119.074 -1.05 . . . . 0.0 108.23 -178.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . 0.511 ' C ' ' O ' ' B' ' 147' ' ' SER . 43.0 m -24.48 85.66 0.04 OUTLIER Pre-proline 0 N--CA 1.478 0.929 0 O-C-N 124.051 0.844 . . . . 0.0 110.364 176.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 149' ' ' PRO . . . . . 0.587 ' N ' ' O ' ' B' ' 147' ' ' SER . 24.2 Cg_exo -61.67 147.53 95.12 Favored 'Trans proline' 0 C--N 1.299 -2.04 0 C-N-CA 120.898 1.065 . . . . 0.0 113.197 -177.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 8.8 tp -126.7 124.18 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 172.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 43.0 t -155.13 95.13 2.58 Favored Pre-proline 0 C--N 1.314 -0.963 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.103 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -60.46 136.48 67.89 Favored 'Trans proline' 0 N--CA 1.484 0.931 0 N-CA-C 109.438 -1.024 . . . . 0.0 109.438 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 153' ' ' ILE . . . . . 0.547 ' O ' ' HD2' ' B' ' 154' ' ' ARG . 45.6 mm -69.22 -43.44 81.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.09 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . 0.571 ' HD3' ' NH2' ' A' ' 154' ' ' ARG . 0.2 OUTLIER -155.9 -156.01 0.6 Allowed 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -86.62 110.58 19.93 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 97.54 -15.89 61.36 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.691 -0.964 . . . . 0.0 110.691 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 157' ' ' ILE . . . . . 0.442 HG12 ' HB2' ' B' ' 189' ' ' TYR . 87.9 mt -111.35 126.15 68.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 120.651 0.262 . . . . 0.0 110.666 -176.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . 0.659 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 71.4 m -134.22 150.45 51.05 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.13 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -133.6 147.2 51.48 Favored 'General case' 0 CA--C 1.519 -0.249 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.203 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 17.1 tp -140.65 78.31 21.3 Favored Pre-proline 0 CA--C 1.532 0.254 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 161' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -70.7 148.69 59.5 Favored 'Trans proline' 0 N--CA 1.499 1.848 0 C-N-CA 122.791 2.327 . . . . 0.0 114.302 -178.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 86.0 mt -112.24 134.97 53.47 Favored 'General case' 0 C--N 1.343 0.326 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 55.7 t -129.19 131.71 67.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 178.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 112.79 169.6 17.67 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 120.436 -0.888 . . . . 0.0 111.149 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 165' ' ' ASN . . . . . 0.737 ' O ' ' CZ ' ' B' ' 170' ' ' ARG . 60.2 t30 -91.25 107.36 19.15 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -177.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . 0.588 HD21 ' CZ ' ' B' ' 171' ' ' PHE . 47.7 tp -64.79 104.5 0.84 Allowed 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 113.98 1.104 . . . . 0.0 113.98 -173.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 167' ' ' THR . . . . . 0.696 HG23 ' NE ' ' B' ' 170' ' ' ARG . 10.5 p -84.0 169.79 14.62 Favored 'General case' 0 C--N 1.349 0.546 0 CA-C-N 114.117 -1.401 . . . . 0.0 110.925 176.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.57 -37.61 85.31 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.769 177.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.41 -40.08 89.36 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 123.176 1.465 . . . . 0.0 111.539 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 170' ' ' ARG . . . . . 0.737 ' CZ ' ' O ' ' B' ' 165' ' ' ASN . 88.0 mtm180 -62.19 -37.63 86.0 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 112.084 -2.325 . . . . 0.0 111.152 178.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 171' ' ' PHE . . . . . 0.588 ' CZ ' HD21 ' B' ' 166' ' ' LEU . 0.4 OUTLIER -53.81 -25.37 19.03 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -179.249 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 172' ' ' ASN . . . . . 0.588 ' O ' HG22 ' B' ' 175' ' ' VAL . 92.1 m-20 -62.57 -40.37 96.64 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.024 -0.671 . . . . 0.0 110.773 178.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 36.4 m -60.57 -41.13 93.97 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.974 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 67.5 mt -63.69 -44.09 98.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 175' ' ' VAL . . . . . 0.588 HG22 ' O ' ' B' ' 172' ' ' ASN . 28.8 m -62.96 -39.84 86.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 176' ' ' CYS . . . . . 0.429 ' N ' HG23 ' B' ' 175' ' ' VAL . 98.8 m -62.31 -35.54 79.38 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.494 178.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 177' ' ' THR . . . . . 0.607 ' O ' HG13 ' B' ' 181' ' ' ILE . 24.9 m -61.67 -20.81 63.83 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.502 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 178' ' ' LEU . . . . . 0.604 ' CD2' HD21 ' B' ' 211' ' ' LEU . 88.2 mt -61.29 -39.91 92.2 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.241 -177.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 19.0 m -61.07 -44.69 96.99 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.523 176.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 180' ' ' ASN . . . . . 0.582 ' O ' ' OG ' ' B' ' 183' ' ' SER . 92.7 m-20 -61.94 -40.65 96.27 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.846 0.355 . . . . 0.0 110.585 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.607 HG13 ' O ' ' B' ' 177' ' ' THR . 73.9 mt -56.31 -31.78 33.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 O-C-N 122.262 -0.274 . . . . 0.0 111.022 -177.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 182' ' ' LEU . . . . . 0.465 HD21 HD21 ' B' ' 214' ' ' LEU . 82.4 mt -62.29 -41.86 98.86 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.333 177.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . 0.582 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.2 p -62.45 -32.48 73.36 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 121.756 -0.59 . . . . 0.0 110.891 177.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 184' ' ' THR . . . . . 0.422 ' OG1' ' HA ' ' B' ' 181' ' ' ILE . 22.6 p -85.39 16.89 3.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.745 -178.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 78.5 p -61.29 -16.86 49.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.466 -176.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.0 -40.51 95.88 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 121.051 -0.259 . . . . 0.0 110.468 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 187' ' ' ASP . . . . . 0.659 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.6 m-20 -71.07 113.78 8.45 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.294 0.568 . . . . 0.0 110.378 -177.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -62.94 -42.27 99.75 Favored 'General case' 0 C--O 1.247 0.936 0 CA-C-N 114.904 -1.044 . . . . 0.0 113.149 -177.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 189' ' ' TYR . . . . . 0.442 ' HB2' HG12 ' B' ' 157' ' ' ILE . 98.2 m-85 -111.58 131.57 55.16 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.956 -178.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 190' ' ' LEU . . . . . . . . . . . . . 44.3 tp -123.61 119.03 28.66 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.176 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 84.6 mt -107.09 125.11 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-N 117.8 0.273 . . . . 0.0 111.303 -176.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 49.0 mm -115.63 118.4 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 193' ' ' ASP . . . . . 0.561 ' OD2' ' OG ' ' B' ' 195' ' ' SER . 40.6 t0 -91.19 113.29 25.52 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -176.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 194' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' B' ' 194' ' ' LEU . 96.3 mt -92.34 -2.23 56.52 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 123.325 0.391 . . . . 0.0 110.223 176.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 195' ' ' SER . . . . . 0.561 ' OG ' ' OD2' ' B' ' 193' ' ' ASP . 78.3 p -61.7 -37.69 85.09 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.704 -178.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.6 -34.37 88.24 Favored Glycine 0 N--CA 1.435 -1.375 0 C-N-CA 119.416 -1.373 . . . . 0.0 109.731 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 197' ' ' LEU . . . . . 1.093 ' CD2' ' O ' ' B' ' 199' ' ' GLN . 5.6 tt -76.78 132.97 39.53 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -177.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 198' ' ' ALA . . . . . 0.935 ' N ' HD23 ' B' ' 197' ' ' LEU . . . -64.48 -42.03 96.13 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 119.773 -0.771 . . . . 0.0 111.947 -178.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 199' ' ' GLN . . . . . 1.093 ' O ' ' CD2' ' B' ' 197' ' ' LEU . 59.0 tt0 -137.57 165.41 26.39 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.215 0.531 . . . . 0.0 111.425 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 200' ' ' VAL . . . . . 0.496 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 49.4 t -122.65 132.53 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -93.72 148.83 21.75 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.768 -177.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -60.99 -32.92 72.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.289 -178.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -63.91 -32.59 74.17 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.367 0.603 . . . . 0.0 109.482 177.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.3 m -60.71 -44.19 96.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.268 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 205' ' ' ALA . . . . . 0.617 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -59.45 -29.33 67.71 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 111.755 0.279 . . . . 0.0 111.755 -177.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -64.95 -38.98 92.76 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.878 175.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -66.86 -37.8 85.15 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.885 178.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.41 -43.17 98.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-O 122.009 0.909 . . . . 0.0 110.101 -178.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 209' ' ' PHE . . . . . 0.617 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 68.3 m-85 -62.28 -42.59 99.47 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 113.92 -1.491 . . . . 0.0 112.686 177.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.26 -41.58 99.06 Favored 'General case' 0 C--O 1.232 0.135 0 O-C-N 121.402 -0.811 . . . . 0.0 109.901 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . 0.604 HD21 ' CD2' ' B' ' 178' ' ' LEU . 38.8 mt -62.29 -42.21 99.16 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.317 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 78.0 p -63.84 -36.51 84.16 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.197 -0.601 . . . . 0.0 111.53 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 213' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -67.01 -47.29 71.91 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.176 178.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.465 HD21 HD21 ' B' ' 182' ' ' LEU . 54.2 tp -64.07 -42.6 96.93 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 121.956 0.884 . . . . 0.0 110.546 177.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 85.7 mt -62.83 -43.45 98.76 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 113.343 -1.753 . . . . 0.0 111.555 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.44 -40.04 93.0 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.921 -176.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 86.3 mt -63.39 -42.03 98.79 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 121.371 0.605 . . . . 0.0 111.374 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 218' ' ' THR . . . . . . . . . . . . . 69.9 p -73.88 -16.63 61.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.176 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 79.55 66.13 1.71 Allowed Glycine 0 CA--C 1.528 0.892 0 N-CA-C 106.831 -2.508 . . . . 0.0 106.831 -178.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 220' ' ' THR . . . . . . . . . . . . . 96.4 m -145.15 104.07 3.92 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 176.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -62.29 139.21 58.52 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 121.182 0.515 . . . . 0.0 110.954 -176.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 42.7 tp -115.87 121.84 43.56 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.532 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 3.5 mp -110.61 129.5 65.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.016 -178.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 224' ' ' ILE . . . . . 0.477 ' CG2' HD11 ' B' ' 227' ' ' ILE . 50.0 mm -111.11 126.99 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 50.5 p -133.97 157.97 44.69 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-O 122.077 0.942 . . . . 0.0 112.72 -178.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 89.1 17.86 55.0 Favored Glycine 0 CA--C 1.502 -0.77 0 CA-C-N 113.683 -1.598 . . . . 0.0 111.588 -177.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 227' ' ' ILE . . . . . 0.71 HD12 HG23 ' B' ' 247' ' ' THR . 96.1 mt -81.17 126.26 39.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 121.808 -0.819 . . . . 0.0 111.371 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 59.4 tttt -66.57 140.53 96.54 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.298 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.75 -37.24 91.98 Favored 'Trans proline' 0 N--CA 1.492 1.407 0 C-N-CA 121.518 1.479 . . . . 0.0 112.363 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -64.18 -42.27 96.77 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -178.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 50.9 tp -62.52 -41.73 99.04 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.751 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.24 -37.2 86.63 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.784 0.326 . . . . 0.0 111.224 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 94.6 mtp -64.31 -41.0 97.04 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.663 178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.78 -43.87 95.07 Favored 'General case' 0 CA--C 1.553 1.065 0 CA-C-O 122.632 1.206 . . . . 0.0 109.382 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 34.3 mmt -63.76 -36.29 83.4 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.167 -1.379 . . . . 0.0 111.894 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -63.32 -39.64 95.11 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.927 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -63.12 -44.45 95.59 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 56.1 tp -61.87 -44.72 96.25 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 120.358 -0.537 . . . . 0.0 112.027 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -157.14 132.59 9.18 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.972 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 240' ' ' ALA . . . . . . . . . . . . . . . -62.0 -45.34 94.05 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 177.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 241' ' ' ASN . . . . . 0.457 ' O ' ' HB2' ' B' ' 244' ' ' SER . 89.3 m-20 -45.45 -19.68 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.111 -175.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 242' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -61.7 -45.79 92.48 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.904 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 243' ' ' SER . . . . . . . . . . . . . 77.5 p -57.77 -44.14 85.98 Favored 'General case' 0 C--N 1.343 0.32 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 244' ' ' SER . . . . . 0.457 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 15.4 m -30.88 -36.14 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 95.3 mt -88.04 131.61 34.59 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.196 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -57.63 134.74 56.43 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 121.346 0.593 . . . . 0.0 110.918 -177.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 247' ' ' THR . . . . . 0.71 HG23 HD12 ' B' ' 227' ' ' ILE . 99.4 m -127.35 129.19 47.15 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.865 178.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 248' ' ' TYR . . . . . 0.491 ' CG ' ' HB2' ' B' ' 254' ' ' ALA . 96.5 m-85 -113.83 143.31 44.87 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 249' ' ' SER . . . . . 0.565 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 78.0 p -62.9 -34.32 77.17 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.275 -178.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 250' ' ' ASN . . . . . 0.565 ' OD1' ' O ' ' B' ' 249' ' ' SER . 99.0 m-20 -146.26 159.14 43.74 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.19 -0.913 . . . . 0.0 112.2 178.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 251' ' ' VAL . . . . . 0.434 ' O ' HG23 ' B' ' 255' ' ' VAL . 75.2 t -63.96 -44.83 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.889 178.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 252' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.05 -45.79 93.33 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . 0.467 ' O ' HG22 ' B' ' 257' ' ' VAL . 94.4 m-20 -61.09 -43.28 99.13 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.378 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 254' ' ' ALA . . . . . 0.491 ' HB2' ' CG ' ' B' ' 248' ' ' TYR . . . -65.7 -39.99 91.81 Favored 'General case' 0 CA--C 1.511 -0.556 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.319 178.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 255' ' ' VAL . . . . . 0.474 HG13 HH11 ' A' ' 154' ' ' ARG . 77.4 t -64.38 -45.88 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.584 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -63.17 -48.03 80.15 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.36 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 257' ' ' VAL . . . . . 0.493 ' O ' ' C ' ' B' ' 258' ' ' LEU . 26.5 m -64.66 -40.33 88.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.776 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 258' ' ' LEU . . . . . 0.519 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 1.3 mt -31.17 -74.97 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 120.873 -0.331 . . . . 0.0 111.597 -178.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 259' ' ' PRO . . . . . 0.519 ' CD ' ' CB ' ' B' ' 258' ' ' LEU . 36.7 Cg_endo -62.07 142.08 91.1 Favored 'Trans proline' 0 N--CA 1.501 1.928 0 C-N-CA 121.04 1.16 . . . . 0.0 110.983 -178.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 260' ' ' ILE . . . . . 0.528 ' O ' HG22 ' B' ' 260' ' ' ILE . 96.8 mt -158.84 -14.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 CA-C-N 118.72 0.691 . . . . 0.0 112.054 176.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 78.1 mtm . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 117.921 -1.037 . . . . 0.0 111.905 -179.637 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 900' ' ' FMN . . . . . 0.52 ' C9A' " O2'" ' A' ' 900' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 900' ' ' FMN . . . . . 0.506 ' C9A' " O2'" ' B' ' 900' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.041 -1.623 . . . . 0.0 109.041 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.81 168.49 24.27 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 116.429 -1.748 . . . . 0.0 110.18 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.2 p -70.68 -19.4 62.79 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 124.633 1.208 . . . . 0.0 110.814 178.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -70.61 -68.4 0.43 Allowed 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.531 -1.213 . . . . 0.0 112.39 175.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.22 -38.67 88.51 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.594 ' O ' ' NZ ' ' B' ' 17' ' ' LYS . 69.2 m -59.63 -41.09 89.65 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.22 -178.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.51 ' CE2' HD12 ' A' ' 9' ' ' ILE . 36.3 t80 83.49 89.8 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 O-C-N 123.765 0.666 . . . . 0.0 111.556 176.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.58 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -64.79 -141.18 0.02 OUTLIER Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 -177.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.58 ' HB ' ' O ' ' A' ' 8' ' ' GLY . 78.4 mt 83.53 110.74 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 122.584 0.354 . . . . 0.0 110.726 -178.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.79 -22.38 63.73 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 C-N-CA 121.485 1.456 . . . . 0.0 112.294 -178.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.23 -37.49 94.61 Favored Glycine 0 C--O 1.245 0.843 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.94 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -64.82 -39.37 93.47 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.366 0.603 . . . . 0.0 109.8 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.0 tp -63.57 -41.12 98.41 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -63.68 -40.8 97.71 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 65.5 t -60.26 -44.19 95.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 O-C-N 122.317 -0.239 . . . . 0.0 110.868 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 92.8 mt -62.49 -43.91 98.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -177.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.26 -45.84 91.47 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 119.441 -0.904 . . . . 0.0 111.987 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.524 ' NZ ' HG12 ' B' ' 113' ' ' ILE . 98.9 mttt -60.66 -39.34 88.0 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 118.756 -1.178 . . . . 0.0 108.871 -175.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.86 -41.79 92.22 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 119.905 -0.718 . . . . 0.0 110.137 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.5 mt -62.85 -40.93 98.97 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.57 -38.27 90.49 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.484 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 57.0 m170 -58.52 -39.84 81.26 Favored 'General case' 0 N--CA 1.47 0.525 0 O-C-N 122.328 -0.232 . . . . 0.0 111.422 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.5 p -113.98 129.09 70.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.54 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 35.4 ptt180 -72.03 107.71 4.88 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 122.094 0.95 . . . . 0.0 111.93 -176.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.6 p -139.22 144.44 29.2 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 178.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.471 ' HA3' ' HB2' ' A' ' 123' ' ' GLN . . . -98.87 93.73 1.35 Allowed Glycine 0 C--O 1.221 -0.706 0 C-N-CA 120.749 -0.738 . . . . 0.0 113.015 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 50.5 t -125.14 129.69 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 176.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.1 m -137.04 159.1 36.7 Favored 'Isoleucine or valine' 0 C--O 1.246 0.881 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.5 mt -120.25 129.37 75.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 176.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.432 HG22 HG12 ' A' ' 39' ' ' ILE . 26.9 p -103.11 169.03 8.8 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 177.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -133.77 101.98 12.65 Favored Pre-proline 0 C--N 1.321 -0.663 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.739 178.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.54 ' HG3' HG23 ' A' ' 117' ' ' THR . 35.2 Cg_endo -63.26 -22.37 72.32 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 C-N-CA 121.422 1.414 . . . . 0.0 111.408 -179.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.46 -33.9 74.54 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.155 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.1 mt -87.87 172.8 9.35 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.734 177.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.719 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 42.0 tt0 -68.86 132.11 46.23 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -176.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.509 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 56.7 t0 61.7 22.25 12.81 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.37 0.605 . . . . 0.0 112.564 177.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.401 ' OD1' ' HB ' ' A' ' 30' ' ' THR . 36.6 t-20 43.22 67.13 3.9 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.968 -178.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.719 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 95.4 Cg_endo -70.79 154.62 63.58 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 C-N-CA 123.79 2.993 . . . . 0.0 111.979 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.432 HG12 HG22 ' A' ' 30' ' ' THR . 96.5 mt -87.34 123.54 40.16 Favored 'Isoleucine or valine' 0 C--O 1.246 0.919 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.334 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.44 HG23 ' N ' ' A' ' 41' ' ' TYR . 30.0 m -103.99 -45.14 9.53 Favored 'Isoleucine or valine' 0 C--N 1.343 0.323 0 CA-C-N 116.033 -0.531 . . . . 0.0 112.204 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.44 ' N ' HG23 ' A' ' 40' ' ' VAL . 45.3 t80 -93.4 123.64 36.84 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 120.227 -0.589 . . . . 0.0 111.636 -178.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.1 p -142.28 140.12 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 O-C-N 124.237 0.96 . . . . 0.0 109.348 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.599 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 57.3 p30 -97.3 166.01 11.76 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.462 ' OE1' ' HA ' ' A' ' 44' ' ' GLN . 13.6 mm100 -66.41 -38.92 88.55 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 176.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.7 -26.48 62.62 Favored Glycine 0 C--N 1.33 0.201 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.644 ' CD2' HD13 ' A' ' 57' ' ' ILE . 66.7 t80 -58.86 -47.82 83.54 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.659 HG13 ' O ' ' A' ' 52' ' ' TYR . 78.5 t -59.97 -44.74 95.26 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.499 0 O-C-N 121.171 -0.956 . . . . 0.0 111.558 -173.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -63.2 -38.45 91.22 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.653 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 57.7 ttm -66.48 -44.07 83.68 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 175.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 41.5 p -90.11 -23.02 21.5 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.084 0.469 . . . . 0.0 111.416 -178.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . 78.05 18.97 75.83 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 -178.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.659 ' O ' HG13 ' A' ' 47' ' ' VAL . 70.4 m-85 -113.29 138.38 50.11 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 122.857 0.463 . . . . 0.0 111.28 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -63.18 148.25 48.6 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.808 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.433 HG22 ' H ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -65.97 -32.44 73.93 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -178.759 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.01 -42.03 85.66 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 119.706 -0.797 . . . . 0.0 111.483 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 74.1 mt-10 -64.69 -46.75 81.03 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.224 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.644 HD13 ' CD2' ' A' ' 46' ' ' PHE . 97.7 mt -60.41 -50.49 80.11 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.539 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -175.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 86.9 mt -55.84 145.3 24.99 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.25 -4.37 81.36 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.024 176.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -136.31 152.79 51.06 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.181 1.491 . . . . 0.0 111.846 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.562 ' C ' ' H ' ' A' ' 63' ' ' ARG . 25.8 t-20 -81.19 150.8 28.5 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 121.232 0.539 . . . . 0.0 110.453 -178.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 80.1 m -63.11 15.21 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.365 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.562 ' H ' ' C ' ' A' ' 61' ' ' ASN . 34.5 ptt-85 -61.55 -41.63 97.66 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 122.09 -0.382 . . . . 0.0 111.31 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -55.28 -22.1 17.17 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 113.938 1.088 . . . . 0.0 113.938 -177.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 93.4 mt -65.89 -37.1 85.25 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.538 0.685 . . . . 0.0 112.639 177.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -62.17 138.1 58.36 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.211 -0.904 . . . . 0.0 112.121 -178.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.529 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -147.2 -148.07 4.68 Favored Glycine 0 CA--C 1.542 1.762 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.089 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.14 -40.4 97.49 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -76.61 -9.22 58.51 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.608 0.242 . . . . 0.0 111.008 -177.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.529 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 30.0 m -64.36 128.54 36.24 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.142 -0.623 . . . . 0.0 109.59 -179.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -86.43 112.39 45.96 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.039 -178.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -57.48 -30.6 88.81 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 121.974 1.782 . . . . 0.0 113.09 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.75 -39.98 95.6 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.054 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -65.8 -43.61 88.18 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 177.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 55.9 t -60.2 -44.02 94.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 114.2 -1.364 . . . . 0.0 107.476 -176.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -64.63 -37.59 88.11 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.7 179.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -63.33 -40.03 96.18 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.391 0.615 . . . . 0.0 110.784 179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.8 mt -63.84 -44.1 98.03 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 CA-C-N 114.857 -1.065 . . . . 0.0 112.055 178.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -61.83 -42.72 99.38 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 113.91 -1.495 . . . . 0.0 108.333 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 92.3 m -60.13 -49.94 75.67 Favored 'General case' 0 C--O 1.246 0.896 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.32 -40.45 94.25 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 120.341 -0.544 . . . . 0.0 111.228 -170.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 84.8 mt -62.99 -40.33 97.43 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-N 118.723 0.692 . . . . 0.0 111.511 -179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -64.09 -40.39 96.12 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -72.06 -22.26 61.4 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.475 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.9 tttt 61.22 43.8 10.56 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.452 -176.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -126.7 149.09 67.37 Favored Pre-proline 0 N--CA 1.467 0.397 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -61.81 143.44 95.97 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 121.316 1.344 . . . . 0.0 113.368 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.04 141.72 33.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.809 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.877 HG23 ' OD1' ' A' ' 107' ' ' ASN . 96.6 m -126.31 122.18 34.73 Favored 'General case' 0 C--N 1.343 0.315 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 175.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 27.7 m -139.55 158.08 27.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.202 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -104.51 130.06 52.48 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 175.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.443 HG23 ' O ' ' A' ' 92' ' ' ILE . 18.2 tt -139.89 128.01 25.88 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.087 0 CA-C-N 120.958 1.708 . . . . 0.0 112.369 178.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -60.71 136.66 58.13 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 114.495 -1.229 . . . . 0.0 109.899 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -137.06 159.69 41.14 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.671 -179.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -118.65 136.67 53.78 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.513 ' HG3' ' CE1' ' A' ' 102' ' ' PHE . 99.2 mttt -87.03 -172.92 4.2 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.036 0.446 . . . . 0.0 111.621 -177.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.31 -43.85 97.88 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.384 178.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 41.1 p-10 -82.23 5.1 21.01 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -178.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 87.61 0.0 84.53 Favored Glycine 0 N--CA 1.467 0.758 0 C-N-CA 120.825 -0.703 . . . . 0.0 111.911 176.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 18.2 m -61.15 138.66 58.21 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 178.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.689 ' SD ' ' C ' ' A' ' 101' ' ' MET . 13.6 tmm? -104.66 129.85 52.77 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.88 0.372 . . . . 0.0 110.891 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.513 ' CE1' ' HG3' ' A' ' 96' ' ' LYS . 54.3 p90 -141.76 158.91 43.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.666 -177.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.804 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 25.0 m95 -90.34 143.54 26.67 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.485 HD21 ' HG2' ' A' ' 123' ' ' GLN . 59.4 t-20 -138.2 101.7 4.47 Favored 'General case' 0 N--CA 1.462 0.162 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 -177.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 80.4 tt0 -66.91 136.18 54.98 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -176.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 38.3 tp -120.35 123.74 43.84 Favored 'General case' 0 C--O 1.233 0.185 0 O-C-N 123.739 0.649 . . . . 0.0 112.424 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.877 ' OD1' HG23 ' A' ' 89' ' ' THR . 98.5 m-20 -121.38 122.67 40.33 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.598 177.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 95.5 mt -120.04 128.23 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 O-C-N 123.523 0.514 . . . . 0.0 111.215 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -136.33 122.99 14.04 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 116.942 -0.117 . . . . 0.0 110.716 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -71.78 150.81 56.63 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.281 1.988 . . . . 0.0 112.602 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.486 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 66.7 mtt -124.17 154.62 39.82 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -128.0 94.41 3.92 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 176.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.483 ' CD1' HG22 ' B' ' 15' ' ' VAL . 96.4 mt -119.69 130.84 73.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.563 -178.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 50.15 37.61 15.04 Favored 'General case' 0 CA--C 1.518 -0.252 0 O-C-N 121.661 -0.649 . . . . 0.0 111.476 176.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 58.77 29.3 18.52 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.884 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -125.89 147.56 49.44 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.751 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 8.4 t -83.79 -173.38 4.68 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.431 -0.793 . . . . 0.0 109.517 -178.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.751 ' CD2' ' O ' ' A' ' 117' ' ' THR . 83.5 m-85 -171.02 154.06 4.0 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 173.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -128.87 145.15 51.29 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 174.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.5 p -134.41 135.17 54.31 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 177.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.466 ' N ' HM73 ' A' ' 900' ' ' FMN . . . -107.91 129.32 9.56 Favored Glycine 0 CA--C 1.505 -0.565 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 178.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.47 ' HB ' ' HB2' ' A' ' 107' ' ' ASN . 96.9 mt -117.77 128.82 74.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.485 ' HG2' HD21 ' A' ' 104' ' ' ASN . 17.4 mp0 -119.13 116.63 26.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.145 0.498 . . . . 0.0 109.929 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -116.09 113.38 23.07 Favored 'General case' 0 C--O 1.244 0.807 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.112 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' A' ' 126' ' ' ILE . 68.2 t0 -63.8 128.74 37.16 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 114.217 1.191 . . . . 0.0 114.217 -176.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.545 HG22 ' O ' ' A' ' 126' ' ' ILE . 2.7 mp -96.29 3.88 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 113.951 -1.477 . . . . 0.0 110.398 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 30.5 m -60.05 -42.64 94.9 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.335 -0.853 . . . . 0.0 113.234 -178.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -59.87 -42.32 93.46 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -63.69 -40.13 96.05 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.521 177.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.804 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.5 mttt -62.92 -41.42 99.46 Favored 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 118.393 -1.323 . . . . 0.0 110.359 -178.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -61.68 -36.69 81.58 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 -179.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.752 ' CE2' HD11 ' A' ' 136' ' ' LEU . 85.8 t80 -61.82 -44.74 96.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.369 176.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.74 -38.74 92.0 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.97 -40.91 97.2 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 54.8 tp -61.26 -43.85 98.2 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.752 HD11 ' CE2' ' A' ' 132' ' ' TYR . 86.6 mt -62.54 -41.06 98.64 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.242 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.91 -41.02 97.44 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.915 -179.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -60.82 -42.17 97.17 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -178.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 58.3 m -61.54 -41.55 97.52 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.677 177.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.464 ' O ' ' N ' ' A' ' 144' ' ' THR . 86.9 mt -64.08 -41.88 97.15 Favored 'General case' 0 C--O 1.224 -0.274 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 91.8 m -61.22 -46.03 92.11 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.38 -177.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -64.79 -40.24 94.91 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 95.7 mt -64.47 -43.49 96.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 113.939 -1.482 . . . . 0.0 111.219 177.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.464 ' N ' ' O ' ' A' ' 140' ' ' LEU . 92.7 m -62.71 -45.95 90.39 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.773 -0.579 . . . . 0.0 112.332 -178.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.4 -40.16 96.46 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 118.853 -1.139 . . . . 0.0 108.991 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 85.2 mt -63.5 -42.57 98.5 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.472 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.746 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.1 p -60.87 -38.78 86.75 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 -178.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.491 ' C ' ' O ' ' A' ' 147' ' ' SER . 31.9 m -27.22 79.85 0.02 OUTLIER Pre-proline 0 N--CA 1.467 0.415 0 O-C-N 126.531 2.394 . . . . 0.0 106.591 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.746 ' N ' ' O ' ' A' ' 147' ' ' SER . 20.9 Cg_exo -62.53 144.46 94.56 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 120.947 1.098 . . . . 0.0 114.666 -173.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.566 ' O ' HG23 ' A' ' 151' ' ' VAL . 9.5 tp -121.44 135.2 62.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 102.928 -2.99 . . . . 0.0 102.928 176.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 150' ' ' ILE . 99.6 t -167.55 91.81 0.69 Allowed Pre-proline 0 CA--C 1.513 -0.46 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 178.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -61.49 136.26 62.26 Favored 'Trans proline' 0 C--N 1.3 -2.011 0 N-CA-C 109.323 -1.068 . . . . 0.0 109.323 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.587 ' O ' ' HD2' ' A' ' 154' ' ' ARG . 45.5 mm -67.83 -44.34 85.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 119.932 -0.707 . . . . 0.0 110.795 179.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.587 ' HD2' ' O ' ' A' ' 153' ' ' ILE . 0.2 OUTLIER -156.89 -156.39 0.61 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.437 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.468 ' ND2' ' HE3' ' B' ' 256' ' ' LYS . 63.7 t-20 -87.51 105.14 17.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 122.08 0.943 . . . . 0.0 112.008 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 88.98 9.19 68.12 Favored Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 114.188 -1.369 . . . . 0.0 110.758 -177.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.0 mt -126.19 125.36 67.62 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 CA-C-O 121.546 0.689 . . . . 0.0 109.231 174.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.566 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 42.5 m -133.26 152.22 51.93 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.061 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -137.67 141.95 41.13 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.753 -0.592 . . . . 0.0 111.286 177.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 18.0 tp -133.93 78.33 60.33 Favored Pre-proline 0 N--CA 1.47 0.564 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.243 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -70.21 151.63 66.57 Favored 'Trans proline' 0 N--CA 1.496 1.661 0 C-N-CA 122.82 2.347 . . . . 0.0 113.096 -179.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 88.3 mt -117.47 128.76 55.31 Favored 'General case' 0 C--O 1.25 1.089 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.388 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 49.3 t -123.82 130.9 73.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 115.05 170.08 16.22 Favored Glycine 0 N--CA 1.479 1.539 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.042 178.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.939 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 55.9 t30 -85.05 115.29 22.78 Favored 'General case' 0 C--O 1.213 -0.841 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -178.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.506 HD21 ' CZ ' ' A' ' 171' ' ' PHE . 41.8 tp -73.67 105.34 4.95 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 115.052 1.501 . . . . 0.0 115.052 -177.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.656 HG23 ' NE ' ' A' ' 170' ' ' ARG . 16.6 p -87.55 165.87 15.16 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.01 178.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -66.72 -33.51 75.8 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.506 0.669 . . . . 0.0 111.455 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.7 -41.36 92.43 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.686 178.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.939 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 87.6 mtm180 -64.71 -33.16 75.31 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 124.173 0.989 . . . . 0.0 112.233 176.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.506 ' CZ ' HD21 ' A' ' 166' ' ' LEU . 0.6 OUTLIER -54.33 -28.76 44.87 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.11 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.569 ' O ' HG22 ' A' ' 175' ' ' VAL . 92.6 m-20 -60.53 -41.19 93.94 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 119.003 -1.079 . . . . 0.0 109.857 -178.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 67.3 m -59.57 -41.15 89.54 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.692 -178.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 66.6 mt -63.33 -44.05 98.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 172' ' ' ASN . 30.5 m -62.72 -39.67 85.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . 0.403 ' N ' HG23 ' A' ' 175' ' ' VAL . 98.8 m -61.8 -34.5 76.02 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.262 0.553 . . . . 0.0 110.294 178.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.548 ' O ' HG13 ' A' ' 181' ' ' ILE . 25.3 m -62.22 -20.4 64.17 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.131 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.693 ' CD2' HD21 ' A' ' 211' ' ' LEU . 89.9 mt -61.12 -41.54 96.9 Favored 'General case' 0 C--O 1.246 0.887 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -178.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 16.9 m -58.87 -43.34 90.84 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.532 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.593 ' O ' ' OG ' ' A' ' 183' ' ' SER . 92.2 m-20 -61.98 -37.98 86.85 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 122.558 0.343 . . . . 0.0 110.954 178.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.553 HD12 HD23 ' A' ' 178' ' ' LEU . 70.3 mt -58.62 -37.9 68.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.438 HD21 HD21 ' A' ' 214' ' ' LEU . 86.0 mt -60.65 -40.82 93.42 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.015 -177.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.593 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 78.1 p -61.98 -33.32 74.09 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.486 176.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.475 ' OG1' ' HA ' ' A' ' 181' ' ' ILE . 19.2 p -89.67 24.69 2.25 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.561 0.219 . . . . 0.0 111.267 -178.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 78.0 p -63.62 -20.29 65.55 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.198 0.523 . . . . 0.0 110.746 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.17 -37.19 79.42 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.825 -178.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.566 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 99.0 m-20 -74.88 113.88 12.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.457 0.646 . . . . 0.0 110.972 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.83 -42.44 99.73 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 115.056 -0.975 . . . . 0.0 112.885 -177.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -112.03 131.02 55.67 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.202 0.525 . . . . 0.0 110.912 -178.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 38.6 tp -120.25 128.89 53.76 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 177.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 96.2 mt -117.05 126.59 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 CA-C-N 118.587 0.63 . . . . 0.0 109.582 177.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.6 mm -112.66 126.43 70.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . 0.545 ' CG ' ' HG ' ' A' ' 195' ' ' SER . 39.5 t0 -94.82 118.57 31.98 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-O 121.949 0.881 . . . . 0.0 110.46 177.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 95.7 mt -96.93 -3.79 41.17 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.257 175.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.545 ' HG ' ' CG ' ' A' ' 193' ' ' ASP . 78.2 p -61.72 -32.72 72.96 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.82 -42.51 99.75 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 108.766 -1.734 . . . . 0.0 108.766 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.937 ' CD2' ' O ' ' A' ' 199' ' ' GLN . 5.1 tt -72.57 128.59 36.03 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 112.975 -1.612 . . . . 0.0 108.862 -176.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.919 ' N ' HD23 ' A' ' 197' ' ' LEU . . . -60.94 -49.01 79.17 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.203 -178.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.937 ' O ' ' CD2' ' A' ' 197' ' ' LEU . 57.7 tt0 -132.79 155.53 48.76 Favored 'General case' 0 C--O 1.206 -1.219 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -175.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.426 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 53.1 t -117.13 132.43 66.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 O-C-N 120.133 -1.605 . . . . 0.0 108.875 178.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -86.16 156.16 20.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.662 -178.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.3 -38.5 90.43 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.181 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -58.37 -31.7 67.88 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -178.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 17.6 m -60.86 -42.48 97.95 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.659 177.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.523 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -57.05 -38.74 73.67 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -177.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -62.12 -37.39 84.95 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -178.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -64.94 -39.42 93.48 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.103 177.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.29 -44.64 99.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 C-N-CA 119.525 -0.87 . . . . 0.0 108.941 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . 0.523 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 69.1 m-85 -61.65 -43.56 98.63 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.413 -178.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.0 -42.35 99.06 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 119.313 -0.955 . . . . 0.0 109.103 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.693 HD21 ' CD2' ' A' ' 178' ' ' LEU . 40.1 mt -61.65 -42.27 98.67 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 78.1 p -61.89 -41.66 98.15 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 119.351 -0.939 . . . . 0.0 110.116 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' HIS . . . . . 0.445 ' CE1' HD11 ' A' ' 217' ' ' LEU . 55.7 t-80 -64.06 -45.91 86.69 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.787 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.438 HD21 HD21 ' A' ' 182' ' ' LEU . 53.9 tp -62.12 -46.14 90.37 Favored 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 178.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 211' ' ' LEU . 84.2 mt -62.56 -40.56 97.22 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.627 -176.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -61.59 -43.1 99.49 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -178.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.445 HD11 ' CE1' ' A' ' 213' ' ' HIS . 85.9 mt -61.8 -39.63 92.4 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 74.8 p -76.68 -11.59 59.87 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.242 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 81.26 38.63 14.45 Favored Glycine 0 C--O 1.217 -0.909 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.329 -178.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 94.7 m -123.95 112.85 17.71 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 119.024 1.412 . . . . 0.0 111.658 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -63.07 136.63 57.91 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.2 178.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 44.2 tp -114.43 130.63 56.72 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 178.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 3.4 mp -118.21 135.36 58.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 C-N-CA 122.867 0.467 . . . . 0.0 109.849 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.579 ' CG2' HD11 ' A' ' 227' ' ' ILE . 49.0 mm -114.85 131.74 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 43.8 p -132.89 167.35 20.38 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 120.854 -0.338 . . . . 0.0 111.876 -178.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 77.31 20.47 74.98 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.584 HD12 HG23 ' A' ' 247' ' ' THR . 97.5 mt -81.79 128.6 38.58 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 114.043 -1.078 . . . . 0.0 108.77 178.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 66.9 tttt -75.43 140.82 72.59 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.09 -39.28 86.34 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 121.138 1.225 . . . . 0.0 112.496 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -64.04 -39.31 93.8 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-O 121.829 0.823 . . . . 0.0 110.318 -178.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 49.6 tp -64.18 -42.23 96.77 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.845 -1.071 . . . . 0.0 112.721 177.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.74 -37.27 87.01 Favored 'General case' 0 CA--C 1.521 -0.154 0 O-C-N 121.753 -0.592 . . . . 0.0 111.198 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 94.5 mtp -63.7 -41.35 98.13 Favored 'General case' 0 C--O 1.247 0.959 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -178.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -63.7 -40.33 96.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.668 177.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 37.7 mmt -65.33 -37.13 86.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.823 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 38.2 t30 -60.51 -41.54 94.57 Favored 'General case' 0 CA--C 1.515 -0.385 0 O-C-N 121.544 -0.723 . . . . 0.0 109.408 -177.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.59 -40.74 92.88 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.238 0.542 . . . . 0.0 110.505 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 52.2 tp -62.89 -40.96 99.15 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 177.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 240' ' ' ALA . 67.1 t0 -169.53 130.26 1.07 Allowed 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.5 -0.75 . . . . 0.0 112.486 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.416 ' N ' ' OD1' ' A' ' 239' ' ' ASP . . . -60.93 -26.89 67.82 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.811 178.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.496 ' O ' ' HB2' ' A' ' 244' ' ' SER . 87.6 m-20 -60.68 -30.42 69.91 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.691 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -55.83 -43.34 76.91 Favored 'General case' 0 C--N 1.311 -1.086 0 O-C-N 121.399 -0.813 . . . . 0.0 109.056 -176.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 94.7 p -63.15 -19.12 64.18 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.043 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . 0.496 ' HB2' ' O ' ' A' ' 241' ' ' ASN . 70.9 m -54.94 -37.04 65.93 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.405 177.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 95.0 mt -89.19 119.26 29.52 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 119.732 -0.787 . . . . 0.0 112.93 -177.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -42.65 135.55 2.82 Favored 'General case' 0 C--O 1.244 0.773 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.68 -178.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.584 HG23 HD12 ' A' ' 227' ' ' ILE . 97.7 m -126.52 132.72 51.32 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.198 -1.364 . . . . 0.0 111.043 178.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' TYR . . . . . 0.453 ' CB ' ' HB2' ' A' ' 254' ' ' ALA . 96.5 m-85 -117.54 141.18 48.66 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.978 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . 0.467 ' O ' ' OD1' ' A' ' 250' ' ' ASN . 77.3 p -62.2 -41.03 97.98 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -178.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . 0.467 ' OD1' ' O ' ' A' ' 249' ' ' SER . 98.9 m-20 -146.15 160.58 41.75 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.63 0.729 . . . . 0.0 111.155 -178.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 70.2 t -62.8 -45.13 99.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.142 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.04 -44.51 97.29 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.327 -0.549 . . . . 0.0 109.633 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . 0.461 ' O ' HG22 ' A' ' 257' ' ' VAL . 55.2 m-20 -63.74 -42.32 97.89 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.343 -178.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.453 ' HB2' ' CB ' ' A' ' 248' ' ' TYR . . . -65.19 -41.93 94.08 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 119.807 -0.757 . . . . 0.0 109.829 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . 0.433 HG13 HH11 ' B' ' 154' ' ' ARG . 57.3 t -63.73 -45.61 96.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.927 -178.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.81 -47.83 79.28 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.513 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.487 ' O ' ' C ' ' A' ' 258' ' ' LEU . 21.7 m -66.36 -40.11 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 120.048 -0.661 . . . . 0.0 112.314 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.487 ' C ' ' O ' ' A' ' 257' ' ' VAL . 1.0 OUTLIER -30.18 -73.41 0.05 OUTLIER Pre-proline 0 C--N 1.345 0.41 0 C-N-CA 121.041 -0.264 . . . . 0.0 111.347 -176.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' A' ' 258' ' ' LEU . 41.0 Cg_endo -63.6 139.85 72.05 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 120.891 1.061 . . . . 0.0 112.117 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 259' ' ' PRO . 96.7 mt -152.12 -28.23 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-N 116.154 -0.476 . . . . 0.0 112.248 178.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.658 -177.151 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.558 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.7 159.58 40.81 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 118.974 -0.536 . . . . 0.0 109.994 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 79.7 p -59.59 -21.49 60.43 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 122.101 0.953 . . . . 0.0 110.877 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -73.66 -64.95 0.89 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.042 -177.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -66.39 -38.67 88.04 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.931 177.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.492 ' O ' ' HB3' ' B' ' 7' ' ' PHE . 68.5 m -59.87 -41.7 92.11 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 120.425 -0.51 . . . . 0.0 109.904 -178.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . 0.492 ' HB3' ' O ' ' B' ' 6' ' ' SER . 37.7 t80 84.54 92.98 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 O-C-N 123.844 0.715 . . . . 0.0 110.268 177.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . 0.588 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -67.06 -140.75 0.05 OUTLIER Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 -178.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.588 ' HB ' ' O ' ' B' ' 8' ' ' GLY . 75.9 mt 82.98 110.81 0.03 OUTLIER Pre-proline 0 N--CA 1.473 0.69 0 C-N-CA 122.519 0.328 . . . . 0.0 111.045 -178.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.14 -23.65 66.65 Favored 'Trans proline' 0 N--CA 1.499 1.806 0 C-N-CA 121.369 1.379 . . . . 0.0 111.936 -178.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.08 -39.7 97.96 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 -179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -64.53 -39.7 94.26 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.587 0.708 . . . . 0.0 109.652 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 50.7 tp -61.71 -42.66 99.25 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.21 -177.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -65.3 -33.59 76.35 Favored 'General case' 0 CA--C 1.562 1.418 0 CA-C-O 121.514 0.673 . . . . 0.0 110.523 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . 0.483 HG22 ' CD1' ' A' ' 113' ' ' ILE . 76.0 t -62.83 -45.75 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 113.135 -1.848 . . . . 0.0 111.086 177.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 95.0 mt -64.11 -43.79 97.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.177 -178.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . 0.594 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 98.9 mttt -63.41 -42.13 98.74 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.38 -41.13 98.78 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.973 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.45 -38.81 85.32 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.522 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.406 ' O ' ' O ' ' B' ' 23' ' ' VAL . 83.4 mt -63.61 -42.34 98.21 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.154 0.502 . . . . 0.0 110.152 175.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -62.84 -38.61 91.45 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.128 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 55.9 m170 -57.79 -39.91 78.65 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 121.153 -0.219 . . . . 0.0 111.38 -178.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . 0.406 ' O ' ' O ' ' B' ' 20' ' ' LEU . 10.6 p -114.19 129.36 70.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.541 ' O ' ' HG3' ' B' ' 24' ' ' ARG . 35.1 ptt180 -71.84 105.9 3.97 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 121.971 0.891 . . . . 0.0 112.421 -176.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.0 p -141.77 134.45 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.471 178.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . 0.496 ' O ' ' N ' ' B' ' 123' ' ' GLN . . . -89.33 98.22 2.42 Favored Glycine 0 N--CA 1.438 -1.178 0 C-N-CA 119.525 -1.321 . . . . 0.0 113.054 -175.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 48.6 t -126.03 129.01 72.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 174.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 26.9 m -138.82 156.59 28.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.857 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 96.0 mt -119.81 125.04 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 122.753 1.263 . . . . 0.0 111.595 179.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.445 HG22 HG12 ' B' ' 39' ' ' ILE . 37.4 p -104.17 159.45 15.68 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 113.266 -1.788 . . . . 0.0 108.844 -178.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -126.59 103.26 25.1 Favored Pre-proline 0 C--O 1.238 0.462 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' PRO . . . . . 0.45 ' HG3' HG23 ' B' ' 117' ' ' THR . 36.8 Cg_endo -64.58 -19.59 65.01 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 121.88 1.72 . . . . 0.0 111.355 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.59 -41.63 97.71 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.677 -0.409 . . . . 0.0 109.922 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 94.9 mt -77.08 -172.7 2.47 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.823 -0.548 . . . . 0.0 111.209 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . 0.727 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 42.0 tt0 -79.69 130.94 35.79 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -178.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.446 ' O ' ' C ' ' B' ' 37' ' ' ASN . 61.9 t0 55.21 39.61 31.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.672 177.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' ASN . . . . . 0.446 ' C ' ' O ' ' B' ' 36' ' ' ASP . 23.1 t-20 29.8 69.73 0.61 Allowed Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.727 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 92.8 Cg_endo -72.08 153.91 57.42 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 123.449 2.766 . . . . 0.0 111.696 178.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.445 HG12 HG22 ' B' ' 30' ' ' THR . 96.3 mt -86.58 128.33 39.62 Favored 'Isoleucine or valine' 0 C--O 1.246 0.901 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.424 HG23 ' N ' ' B' ' 41' ' ' TYR . 30.1 m -108.15 -44.77 6.94 Favored 'Isoleucine or valine' 0 C--N 1.341 0.214 0 O-C-N 123.933 0.77 . . . . 0.0 112.631 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' TYR . . . . . 0.424 ' N ' HG23 ' B' ' 40' ' ' VAL . 47.6 t80 -94.38 123.77 37.99 Favored 'General case' 0 C--O 1.234 0.27 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.27 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 6.3 p -142.14 140.91 29.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 O-C-N 124.033 0.833 . . . . 0.0 109.414 178.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . 0.63 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 56.8 p30 -101.21 161.4 13.64 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.128 178.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' GLN . . . . . 0.457 ' OE1' ' HA ' ' B' ' 44' ' ' GLN . 13.1 mm100 -63.11 -37.77 88.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.624 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.89 -26.69 63.35 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.657 ' CD2' HD13 ' B' ' 57' ' ' ILE . 61.9 t80 -60.19 -43.54 95.82 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 0.812 HG13 ' O ' ' B' ' 52' ' ' TYR . 75.3 t -61.46 -45.95 97.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.276 -179.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -62.96 -44.69 95.35 Favored 'General case' 0 C--N 1.323 -0.543 0 C-N-CA 119.921 -0.712 . . . . 0.0 110.251 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 57.9 ttm -63.11 -42.55 99.59 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 40.9 p -93.53 -17.28 23.56 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 120.122 -0.631 . . . . 0.0 111.776 -177.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' B' ' 47' ' ' VAL . . . 73.44 17.71 79.08 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . 0.812 ' O ' HG13 ' B' ' 47' ' ' VAL . 70.0 m-85 -111.12 146.01 37.58 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 122.944 0.497 . . . . 0.0 110.349 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -74.4 147.16 42.33 Favored 'General case' 0 C--O 1.241 0.64 0 CA-C-O 121.45 0.643 . . . . 0.0 111.302 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.36 -38.65 84.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.05 -177.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.23 -39.17 93.86 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 120.103 -0.639 . . . . 0.0 111.81 -178.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -72.3 -31.66 65.9 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 176.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.657 HD13 ' CD2' ' B' ' 46' ' ' PHE . 91.8 mt -68.61 -71.67 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 176.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 96.8 mt -37.25 133.3 0.69 Allowed 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.813 178.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.1 -11.01 71.31 Favored Glycine 0 CA--C 1.537 1.418 0 CA-C-N 116.059 -0.519 . . . . 0.0 113.001 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -133.9 150.19 51.33 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -174.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' ASN . . . . . 0.568 ' C ' ' H ' ' B' ' 63' ' ' ARG . 25.9 t-20 -79.53 149.41 31.45 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.41 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' CYS . . . . . . . . . . . . . 81.8 m -62.74 10.08 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.372 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . 0.568 ' H ' ' C ' ' B' ' 61' ' ' ASN . 33.3 ptt-85 -60.61 -33.54 72.91 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.323 -177.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -58.92 -29.88 67.41 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 178.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 87.3 mt -62.2 -41.31 98.25 Favored 'General case' 0 C--O 1.238 0.466 0 O-C-N 121.573 -0.705 . . . . 0.0 109.686 -178.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -51.82 146.25 8.44 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.857 -176.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . -156.71 -153.29 6.58 Favored Glycine 0 CA--C 1.534 1.242 0 O-C-N 123.886 0.741 . . . . 0.0 111.831 177.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.31 -41.21 93.0 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -176.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -75.95 -11.1 59.9 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.945 -178.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' THR . . . . . 0.43 HG23 HD11 ' B' ' 92' ' ' ILE . 28.5 m -62.02 133.7 55.68 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 120.229 -0.589 . . . . 0.0 109.427 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -91.02 112.61 54.6 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.639 -179.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.38 -37.56 89.17 Favored 'Trans proline' 0 N--CA 1.489 1.219 0 C-N-CA 121.074 1.183 . . . . 0.0 111.734 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.99 -40.51 89.41 Favored 'General case' 0 CA--C 1.52 -0.186 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.793 -176.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -66.84 -39.39 87.6 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.078 177.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 75.2 t -61.82 -46.43 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -63.15 -36.99 85.45 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.76 -178.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -62.27 -42.11 99.05 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 119.371 -0.932 . . . . 0.0 109.0 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 95.5 mt -63.57 -43.44 98.25 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 CA-C-O 120.751 0.31 . . . . 0.0 110.841 -178.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -61.16 -42.39 98.47 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 76.5 m -61.15 -45.06 96.21 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.352 0.596 . . . . 0.0 110.017 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.12 -40.34 97.32 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 113.777 1.029 . . . . 0.0 113.777 -177.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 81.8 mt -62.65 -42.81 99.81 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.034 -0.666 . . . . 0.0 109.38 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 67.6 tp60 -63.21 -38.95 93.19 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -81.99 -4.36 56.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.166 -0.925 . . . . 0.0 110.92 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 45.7 tttt 50.33 43.72 26.62 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.537 -0.465 . . . . 0.0 111.548 176.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -127.95 146.42 59.03 Favored Pre-proline 0 N--CA 1.466 0.349 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.421 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -62.41 140.41 82.11 Favored 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 120.973 1.115 . . . . 0.0 113.893 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.58 135.9 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.725 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' THR . . . . . 0.87 HG23 ' OD1' ' B' ' 107' ' ' ASN . 93.7 m -121.01 123.45 42.44 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . . . . . . . . . 29.4 m -138.64 162.74 28.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.76 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -115.91 119.8 37.12 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.931 -0.48 . . . . 0.0 109.78 174.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . 0.43 HD11 HG23 ' B' ' 70' ' ' THR . 20.6 tt -127.99 132.44 68.64 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.807 -174.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -70.98 144.42 50.5 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.899 177.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' ASN . . . . . 0.407 HD22 ' HA ' ' B' ' 94' ' ' ASN . 8.0 m120 -133.62 -179.41 5.51 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-O 121.435 0.636 . . . . 0.0 111.489 -178.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -131.46 145.95 52.02 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.146 177.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . 0.501 ' HG3' ' CE2' ' B' ' 102' ' ' PHE . 98.8 mttt -103.45 -180.0 4.11 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.402 0.62 . . . . 0.0 110.658 178.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.46 -35.9 76.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.502 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 38.4 p-10 -86.82 -1.44 57.78 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.42 -0.8 . . . . 0.0 112.928 178.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.89 3.7 63.85 Favored Glycine 0 N--CA 1.466 0.695 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.464 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 21.7 m -68.48 129.41 39.84 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.274 -0.57 . . . . 0.0 109.478 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . 0.594 ' SD ' ' N ' ' B' ' 102' ' ' PHE . 15.0 tmm? -88.3 143.44 27.02 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' PHE . . . . . 0.594 ' N ' ' SD ' ' B' ' 101' ' ' MET . 54.4 p90 -153.28 163.5 39.79 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 178.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' TRP . . . . . 0.826 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 25.3 m95 -95.71 139.72 31.55 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.614 0.721 . . . . 0.0 110.468 178.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . 0.476 HD21 ' HG2' ' B' ' 123' ' ' GLN . 64.8 t-20 -133.66 105.85 7.06 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-N 114.804 -1.089 . . . . 0.0 113.783 -177.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' GLU . . . . . 0.469 ' HB2' HD11 ' B' ' 126' ' ' ILE . 81.1 tt0 -73.87 124.24 25.75 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.999 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 37.3 tp -112.04 125.42 54.07 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-O 120.936 0.398 . . . . 0.0 111.631 -177.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' ASN . . . . . 0.87 ' OD1' HG23 ' B' ' 89' ' ' THR . 98.3 m-20 -120.15 127.87 52.89 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 176.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 95.8 mt -122.66 132.59 70.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -141.79 121.55 8.2 Favored Pre-proline 0 CA--C 1.537 0.453 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -70.32 151.88 66.11 Favored 'Trans proline' 0 N--CA 1.501 1.924 0 C-N-CA 122.434 2.09 . . . . 0.0 112.505 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 66.6 mtt -130.87 143.12 50.5 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -112.12 107.4 16.31 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 178.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . 0.524 HG12 ' NZ ' ' A' ' 18' ' ' LYS . 96.8 mt -133.32 127.54 54.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-N 118.521 0.6 . . . . 0.0 111.596 177.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 52.54 38.18 25.0 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.88 178.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 58.86 37.04 24.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.53 -178.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -132.82 150.68 52.13 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' THR . . . . . 0.45 HG23 ' HG3' ' B' ' 32' ' ' PRO . 9.4 t -101.4 152.46 20.7 Favored 'General case' 0 C--O 1.217 -0.628 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -177.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -147.39 146.48 29.63 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 120.791 -1.193 . . . . 0.0 111.189 -178.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -123.07 137.75 54.85 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.765 -177.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -128.86 133.36 66.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 -177.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . 0.472 ' N ' HM73 ' B' ' 900' ' ' FMN . . . -108.57 123.17 6.9 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 122' ' ' ILE . . . . . 0.517 ' HB ' ' HB2' ' B' ' 107' ' ' ASN . 92.4 mt -112.33 127.43 69.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 123' ' ' GLN . . . . . 0.496 ' N ' ' O ' ' B' ' 26' ' ' GLY . 17.5 mp0 -117.93 123.58 46.16 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 178.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -120.13 121.16 38.19 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' B' ' 127' ' ' THR . 68.2 t0 -69.39 131.72 45.25 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.588 -179.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.519 HG22 ' O ' ' B' ' 126' ' ' ILE . 2.7 mp -107.51 17.82 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.807 0 CA-C-O 122.097 0.951 . . . . 0.0 109.095 178.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 127' ' ' THR . . . . . 0.447 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 99.3 m -63.85 -44.04 94.32 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.24 -1.345 . . . . 0.0 112.501 175.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 59.9 tptt -60.88 -46.15 91.76 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 129' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -63.21 -36.19 82.81 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 115.146 -0.933 . . . . 0.0 111.499 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 130' ' ' LYS . . . . . 0.826 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 98.5 mttt -63.57 -41.42 98.39 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-N 113.779 -1.555 . . . . 0.0 110.511 175.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.99 -41.46 97.51 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 132' ' ' TYR . . . . . 0.76 ' CE2' HD11 ' B' ' 136' ' ' LEU . 86.2 t80 -59.78 -44.11 94.07 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 121.663 -0.648 . . . . 0.0 111.156 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' B' ' 137' ' ' GLU . 97.6 mt-10 -64.61 -36.96 85.93 Favored 'General case' 0 C--O 1.224 -0.254 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.563 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 134' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' B' ' 130' ' ' LYS . 99.0 mttt -62.94 -39.57 95.01 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.676 178.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 54.5 tp -63.01 -41.56 99.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.32 0.581 . . . . 0.0 109.811 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . 0.76 HD11 ' CE2' ' B' ' 132' ' ' TYR . 89.2 mt -63.01 -41.28 99.53 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.404 177.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 137' ' ' GLU . . . . . 0.408 ' HG3' ' O ' ' B' ' 133' ' ' GLU . 97.2 mt-10 -64.37 -36.54 84.47 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.357 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.77 -43.47 96.31 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.915 176.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 62.3 m -60.87 -45.76 93.29 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 88.5 mt -60.87 -40.33 92.53 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 99.7 m -61.86 -45.44 93.79 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.97 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -66.3 -42.1 88.8 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 94.9 mt -63.11 -43.62 99.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.642 178.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 144' ' ' THR . . . . . . . . . . . . . 93.4 m -61.78 -45.66 92.93 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.25 -41.31 99.04 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 119.021 -1.072 . . . . 0.0 109.369 178.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 87.5 mt -64.58 -41.12 96.47 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 177.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 147' ' ' SER . . . . . 0.64 ' O ' ' N ' ' B' ' 149' ' ' PRO . 78.2 p -61.76 -40.84 96.56 Favored 'General case' 0 CA--C 1.479 -1.779 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . 0.486 ' C ' ' O ' ' B' ' 147' ' ' SER . 20.6 m -27.92 84.24 0.03 OUTLIER Pre-proline 0 N--CA 1.472 0.657 0 O-C-N 124.128 0.892 . . . . 0.0 110.143 177.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 149' ' ' PRO . . . . . 0.64 ' N ' ' O ' ' B' ' 147' ' ' SER . 22.8 Cg_exo -61.69 147.13 96.04 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 C-N-CA 122.044 1.829 . . . . 0.0 115.802 -176.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 9.6 tp -128.47 121.24 54.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-N 114.258 -1.337 . . . . 0.0 107.771 174.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 58.1 t -151.68 92.83 3.59 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.946 -178.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -60.59 136.05 64.6 Favored 'Trans proline' 0 C--N 1.32 -0.932 0 N-CA-C 109.029 -1.181 . . . . 0.0 109.029 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 153' ' ' ILE . . . . . 0.586 ' O ' ' HD2' ' B' ' 154' ' ' ARG . 45.0 mm -67.74 -43.72 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.876 178.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . 0.586 ' HD2' ' O ' ' B' ' 153' ' ' ILE . 0.2 OUTLIER -156.7 -155.5 0.54 Allowed 'General case' 0 C--N 1.347 0.469 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -179.718 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 62.9 t-20 -86.86 108.27 18.69 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.57 -17.42 57.64 Favored Glycine 0 C--N 1.34 0.803 0 N-CA-C 110.069 -1.213 . . . . 0.0 110.069 -179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 85.6 mt -110.25 125.64 67.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.144 0.497 . . . . 0.0 111.348 -176.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . 0.521 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 47.4 m -135.1 149.6 50.07 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.87 179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -132.96 145.89 51.29 Favored 'General case' 0 CA--C 1.519 -0.217 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.29 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 18.0 tp -139.44 77.76 28.47 Favored Pre-proline 0 CA--C 1.531 0.227 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 161' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -71.56 150.23 56.96 Favored 'Trans proline' 0 N--CA 1.499 1.849 0 C-N-CA 122.835 2.357 . . . . 0.0 114.362 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 92.6 mt -113.83 134.93 54.49 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 55.9 t -128.46 132.93 67.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 112.8 170.61 17.97 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.198 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 165' ' ' ASN . . . . . 0.743 ' O ' ' NH1' ' B' ' 170' ' ' ARG . 61.1 t30 -90.52 107.29 19.07 Favored 'General case' 0 C--O 1.216 -0.673 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -178.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . 0.528 HD21 ' CZ ' ' B' ' 171' ' ' PHE . 40.3 tp -63.92 106.16 0.97 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -174.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 167' ' ' THR . . . . . 0.594 HG23 ' NH2' ' B' ' 170' ' ' ARG . 34.5 p -86.79 169.45 12.59 Favored 'General case' 0 C--N 1.353 0.729 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.285 177.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -67.61 -37.33 82.38 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.928 176.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.91 -39.55 90.69 Favored 'General case' 0 CA--C 1.548 0.887 0 CA-C-O 123.345 1.545 . . . . 0.0 111.486 -179.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 170' ' ' ARG . . . . . 0.743 ' NH1' ' O ' ' B' ' 165' ' ' ASN . 87.9 mtm180 -63.25 -36.36 83.42 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 112.408 -2.178 . . . . 0.0 110.842 177.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 171' ' ' PHE . . . . . 0.528 ' CZ ' HD21 ' B' ' 166' ' ' LEU . 0.5 OUTLIER -53.76 -25.29 18.18 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 114.233 1.197 . . . . 0.0 114.233 -179.009 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 172' ' ' ASN . . . . . 0.514 ' O ' HG22 ' B' ' 175' ' ' VAL . 93.4 m-20 -62.95 -40.57 98.09 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.01 178.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 57.2 m -60.49 -41.72 94.85 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.776 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 66.4 mt -63.52 -44.45 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -178.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 175' ' ' VAL . . . . . 0.514 HG22 ' O ' ' B' ' 172' ' ' ASN . 30.5 m -62.59 -39.92 86.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 -179.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 176' ' ' CYS . . . . . 0.404 ' N ' HG23 ' B' ' 175' ' ' VAL . 97.2 m -61.53 -34.82 76.19 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.226 178.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 177' ' ' THR . . . . . 0.585 ' O ' HG13 ' B' ' 181' ' ' ILE . 25.0 m -62.27 -20.4 64.23 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.25 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 178' ' ' LEU . . . . . 0.685 ' CD2' HD21 ' B' ' 211' ' ' LEU . 91.5 mt -61.27 -38.93 88.54 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.269 -178.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 18.3 m -61.95 -44.09 97.49 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 176.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 180' ' ' ASN . . . . . 0.564 ' O ' ' OG ' ' B' ' 183' ' ' SER . 93.3 m-20 -61.8 -40.89 96.78 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.956 0.408 . . . . 0.0 110.554 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.585 HG13 ' O ' ' B' ' 177' ' ' THR . 75.0 mt -57.35 -31.64 38.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.776 -177.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 182' ' ' LEU . . . . . 0.436 HD21 HD21 ' B' ' 214' ' ' LEU . 84.5 mt -62.85 -41.68 99.45 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 119.693 -0.803 . . . . 0.0 109.202 177.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . 0.564 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.2 p -63.54 -32.8 74.37 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 121.845 -0.534 . . . . 0.0 110.817 177.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 184' ' ' THR . . . . . 0.455 ' OG1' ' HA ' ' B' ' 181' ' ' ILE . 17.4 p -86.2 17.94 3.39 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.367 -176.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 80.3 p -61.12 -15.61 35.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.665 -177.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.45 -40.21 95.86 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 121.029 -0.268 . . . . 0.0 110.729 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 187' ' ' ASP . . . . . 0.521 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.4 m-20 -71.42 114.14 9.18 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.433 0.635 . . . . 0.0 110.831 -177.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.38 -42.43 99.41 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 114.803 -1.09 . . . . 0.0 113.09 -178.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -111.82 130.97 55.64 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 120.523 -0.471 . . . . 0.0 111.221 -178.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 190' ' ' LEU . . . . . . . . . . . . . 41.9 tp -124.1 118.24 26.47 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.926 177.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 87.0 mt -106.93 125.91 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-N 117.759 0.254 . . . . 0.0 111.216 -177.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 49.8 mm -115.41 118.54 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 193' ' ' ASP . . . . . 0.522 ' CG ' ' HG ' ' B' ' 195' ' ' SER . 41.7 t0 -90.47 111.67 23.02 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -176.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 194' ' ' LEU . . . . . . . . . . . . . 96.2 mt -92.45 -1.61 56.87 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 123.624 0.577 . . . . 0.0 109.627 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 195' ' ' SER . . . . . 0.522 ' HG ' ' CG ' ' B' ' 193' ' ' ASP . 77.8 p -60.88 -36.81 80.17 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.794 -178.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.46 -34.72 89.36 Favored Glycine 0 N--CA 1.439 -1.105 0 N-CA-C 109.919 -1.273 . . . . 0.0 109.919 -178.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 197' ' ' LEU . . . . . 0.979 ' CD2' ' O ' ' B' ' 199' ' ' GLN . 5.4 tt -77.22 134.01 38.73 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 198' ' ' ALA . . . . . 0.959 ' N ' HD23 ' B' ' 197' ' ' LEU . . . -63.75 -44.96 91.92 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 119.954 -0.698 . . . . 0.0 111.572 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 199' ' ' GLN . . . . . 0.979 ' O ' ' CD2' ' B' ' 197' ' ' LEU . 58.4 tt0 -136.83 163.25 31.07 Favored 'General case' 0 C--O 1.212 -0.921 0 CA-C-O 122.202 1.001 . . . . 0.0 112.602 -177.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 200' ' ' VAL . . . . . 0.463 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 55.8 t -120.65 132.17 70.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 O-C-N 120.382 -1.449 . . . . 0.0 109.583 177.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -89.7 150.24 22.41 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.79 -178.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -61.38 -33.24 73.33 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.325 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -63.15 -32.99 74.51 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.435 0.636 . . . . 0.0 109.357 177.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.7 m -60.65 -44.24 96.65 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.291 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 205' ' ' ALA . . . . . 0.676 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -58.15 -29.64 65.73 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -178.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -65.63 -38.77 90.34 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.502 0.668 . . . . 0.0 110.519 174.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -66.2 -39.0 89.33 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.752 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 95.4 mt -62.86 -45.72 98.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -178.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 209' ' ' PHE . . . . . 0.676 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 66.1 m-85 -61.22 -42.22 98.21 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.781 -176.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.0 -42.07 99.75 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.61 -0.836 . . . . 0.0 109.607 178.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . 0.685 HD21 ' CD2' ' B' ' 178' ' ' LEU . 39.4 mt -62.18 -42.3 99.14 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.106 -178.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 78.2 p -63.97 -35.74 81.68 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.385 -0.526 . . . . 0.0 112.0 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 213' ' ' HIS . . . . . 0.427 ' CE1' HD11 ' B' ' 217' ' ' LEU . 56.3 t-80 -66.92 -46.87 73.48 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.324 -0.853 . . . . 0.0 112.106 177.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.436 HD21 HD21 ' B' ' 182' ' ' LEU . 56.5 tp -63.96 -43.08 96.87 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.598 0.713 . . . . 0.0 109.88 177.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 215' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' B' ' 211' ' ' LEU . 84.9 mt -63.07 -44.46 95.74 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 113.544 -1.662 . . . . 0.0 111.368 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -61.69 -39.08 90.19 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.258 -177.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . 0.427 HD11 ' CE1' ' B' ' 213' ' ' HIS . 86.2 mt -62.86 -41.62 99.44 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.309 0.576 . . . . 0.0 111.023 176.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 218' ' ' THR . . . . . 0.404 HG23 ' O ' ' B' ' 214' ' ' LEU . 67.3 p -76.06 -16.26 59.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.641 -178.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 78.81 68.13 1.53 Allowed Glycine 0 CA--C 1.528 0.864 0 N-CA-C 107.573 -2.211 . . . . 0.0 107.573 -177.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 220' ' ' THR . . . . . . . . . . . . . 81.0 m -146.51 105.84 3.91 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 176.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -63.16 139.93 58.82 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.879 -175.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 40.6 tp -118.13 122.18 42.42 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.414 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 3.6 mp -112.25 129.19 68.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.249 -178.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 224' ' ' ILE . . . . . 0.539 ' CG2' HD11 ' B' ' 227' ' ' ILE . 49.5 mm -109.51 126.17 66.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 50.4 p -133.29 156.08 48.23 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.697 0.761 . . . . 0.0 112.559 -177.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 91.0 16.27 54.57 Favored Glycine 0 CA--C 1.504 -0.598 0 CA-C-N 114.018 -1.446 . . . . 0.0 111.319 -177.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 227' ' ' ILE . . . . . 0.592 HD12 HG23 ' B' ' 247' ' ' THR . 96.1 mt -81.48 126.48 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 118.046 0.923 . . . . 0.0 111.27 -178.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 64.3 tttt -66.24 140.23 96.74 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.392 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.71 -36.78 91.09 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.378 1.385 . . . . 0.0 112.554 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -64.0 -43.88 94.35 Favored 'General case' 0 C--O 1.243 0.718 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -178.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 50.1 tp -61.64 -41.8 98.01 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.526 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.82 -37.1 86.12 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.881 -0.328 . . . . 0.0 111.314 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 94.7 mtp -63.83 -41.06 97.93 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.276 -0.57 . . . . 0.0 109.777 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.11 -43.71 97.68 Favored 'General case' 0 CA--C 1.553 1.082 0 CA-C-O 122.305 1.05 . . . . 0.0 109.589 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 37.9 mmt -63.96 -35.21 79.95 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.878 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -61.71 -39.99 93.45 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.989 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.7 -43.24 99.3 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 177.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 51.4 tp -61.83 -43.79 98.14 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 120.377 -0.529 . . . . 0.0 111.636 -178.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 239' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' B' ' 240' ' ' ALA . 66.8 t0 -162.23 135.01 5.88 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.96 -178.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 240' ' ' ALA . . . . . 0.439 ' N ' ' OD1' ' B' ' 239' ' ' ASP . . . -62.09 -44.3 96.95 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 177.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 241' ' ' ASN . . . . . 0.626 ' O ' ' HB2' ' B' ' 244' ' ' SER . 89.3 m-20 -45.83 -20.2 0.08 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.289 -174.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 242' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -61.24 -45.66 93.62 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 120.083 -0.647 . . . . 0.0 110.402 178.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 243' ' ' SER . . . . . . . . . . . . . 77.7 p -55.96 -43.46 77.52 Favored 'General case' 0 C--O 1.225 -0.191 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 244' ' ' SER . . . . . 0.626 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 70.9 m -34.07 -33.22 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 -177.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 97.1 mt -89.96 132.56 35.27 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.667 178.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -58.69 136.78 57.77 Favored 'General case' 0 C--O 1.251 1.176 0 CA-C-O 121.833 0.825 . . . . 0.0 111.261 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 247' ' ' THR . . . . . 0.592 HG23 HD12 ' B' ' 227' ' ' ILE . 97.4 m -125.97 128.01 46.84 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.703 -1.135 . . . . 0.0 111.74 178.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 248' ' ' TYR . . . . . 0.49 ' CG ' ' HB2' ' B' ' 254' ' ' ALA . 95.9 m-85 -113.64 143.46 44.54 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 249' ' ' SER . . . . . 0.564 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 78.1 p -63.11 -35.8 81.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.855 0.36 . . . . 0.0 111.295 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 250' ' ' ASN . . . . . 0.564 ' OD1' ' O ' ' B' ' 249' ' ' SER . 98.6 m-20 -146.67 162.08 39.21 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.321 178.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 73.0 t -65.0 -44.74 95.99 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.175 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.924 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 252' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.38 -46.04 91.84 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -177.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . 0.476 ' O ' HG22 ' B' ' 257' ' ' VAL . 94.7 m-20 -61.43 -43.21 99.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.763 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 254' ' ' ALA . . . . . 0.49 ' HB2' ' CG ' ' B' ' 248' ' ' TYR . . . -65.3 -40.35 93.71 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.468 0.652 . . . . 0.0 111.08 178.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 255' ' ' VAL . . . . . . . . . . . . . 53.6 t -65.39 -45.35 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.277 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 256' ' ' LYS . . . . . 0.468 ' HE3' ' ND2' ' A' ' 155' ' ' ASN . 88.5 tttt -63.37 -48.33 78.39 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.113 -178.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 257' ' ' VAL . . . . . 0.476 HG22 ' O ' ' B' ' 253' ' ' ASP . 21.1 m -65.14 -40.22 88.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.519 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 258' ' ' LEU . . . . . 0.492 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 1.0 OUTLIER -31.9 -73.33 0.05 OUTLIER Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.826 -178.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 259' ' ' PRO . . . . . 0.543 ' O ' HG13 ' B' ' 260' ' ' ILE . 37.5 Cg_endo -62.25 141.47 87.98 Favored 'Trans proline' 0 N--CA 1.504 2.092 0 C-N-CA 121.572 1.515 . . . . 0.0 111.498 -178.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 260' ' ' ILE . . . . . 0.543 HG13 ' O ' ' B' ' 259' ' ' PRO . 96.9 mt -159.35 -16.48 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 118.587 0.63 . . . . 0.0 112.411 177.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 C--O 1.22 -0.453 0 CA-C-O 118.083 -0.96 . . . . 0.0 111.73 179.856 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 900' ' ' FMN . . . . . 0.466 HM73 ' N ' ' A' ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 900' ' ' FMN . . . . . 0.472 HM73 ' N ' ' B' ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.221 -1.551 . . . . 0.0 109.221 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.36 174.84 13.82 Favored 'General case' 0 CA--C 1.483 -1.624 0 CA-C-O 123.219 1.485 . . . . 0.0 109.746 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 93.9 p -80.12 -3.81 50.31 Favored 'General case' 0 CA--C 1.572 1.795 0 O-C-N 117.817 -3.052 . . . . 0.0 112.766 177.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -85.29 -64.64 1.12 Allowed 'General case' 0 C--N 1.267 -3.017 0 O-C-N 127.09 2.744 . . . . 0.0 112.304 174.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -70.06 -38.82 75.88 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.089 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.508 ' O ' ' NZ ' ' B' ' 17' ' ' LYS . 65.6 m -59.15 -41.76 89.07 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.862 -177.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.502 ' HB3' ' O ' ' A' ' 6' ' ' SER . 36.2 t80 85.14 87.33 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.364 0.602 . . . . 0.0 111.771 176.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.578 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -60.5 -142.76 0.01 OUTLIER Glycine 0 C--N 1.337 0.628 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.578 ' HB ' ' O ' ' A' ' 8' ' ' GLY . 78.0 mt 84.96 111.76 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.629 0 O-C-N 124.075 0.515 . . . . 0.0 110.655 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.68 -22.25 64.46 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.195 1.263 . . . . 0.0 112.219 -178.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.41 -38.54 95.94 Favored Glycine 0 N--CA 1.465 0.578 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.228 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -64.86 -39.17 93.14 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 51.9 tp -63.06 -41.66 99.51 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -63.29 -40.31 97.0 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 57.6 t -60.76 -44.04 96.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 O-C-N 122.014 -0.429 . . . . 0.0 111.025 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 92.9 mt -62.32 -43.49 98.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 119.508 -0.877 . . . . 0.0 109.12 -177.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.441 ' NZ ' ' HA ' ' B' ' 6' ' ' SER . 98.8 mttt -62.54 -46.22 89.36 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 119.331 -0.948 . . . . 0.0 112.036 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.579 ' NZ ' HG12 ' B' ' 113' ' ' ILE . 98.6 mttt -60.23 -39.46 86.74 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 118.72 -1.192 . . . . 0.0 108.83 -176.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.35 -42.14 90.86 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 120.034 -0.666 . . . . 0.0 110.156 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.0 mt -62.99 -40.93 99.24 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -63.08 -38.85 92.83 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.949 -0.568 . . . . 0.0 112.525 179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 54.4 m170 -58.44 -40.06 81.53 Favored 'General case' 0 N--CA 1.468 0.454 0 O-C-N 122.168 -0.332 . . . . 0.0 111.48 -178.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.0 p -114.85 130.52 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.478 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 33.3 ptt180 -72.09 111.63 7.48 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 122.126 0.965 . . . . 0.0 112.207 -177.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.6 p -141.31 143.1 28.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.571 ' O ' ' N ' ' A' ' 123' ' ' GLN . . . -97.81 90.65 1.09 Allowed Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.767 -178.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 54.4 t -124.38 129.81 73.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 176.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 27.3 m -137.38 159.77 35.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.6 mt -120.09 129.92 74.91 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.64 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 176.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.433 ' OG1' ' HB2' ' A' ' 119' ' ' PHE . 17.5 p -106.16 166.08 10.77 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 179.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.427 ' C ' ' OD1' ' A' ' 37' ' ' ASN . 44.3 t0 -132.78 101.7 13.98 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.534 ' CG ' HG23 ' A' ' 117' ' ' THR . 37.6 Cg_endo -64.64 -21.2 65.56 Favored 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 121.576 1.517 . . . . 0.0 111.572 -178.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.54 -33.61 75.28 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.648 -0.705 . . . . 0.0 112.399 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 88.9 mt -86.83 172.22 10.27 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.272 178.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.657 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 42.2 tt0 -67.58 133.06 48.74 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -178.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.567 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 62.8 t0 61.44 20.85 11.53 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 177.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.427 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 40.4 t-20 43.1 68.68 2.74 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.727 -177.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.657 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 88.1 Cg_endo -71.4 155.63 59.73 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 123.9 3.067 . . . . 0.0 112.39 -178.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.3 mt -87.91 124.35 41.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 O-C-N 124.047 0.842 . . . . 0.0 108.977 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.409 HG23 ' N ' ' A' ' 41' ' ' TYR . 27.6 m -105.18 -42.43 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 O-C-N 123.609 0.568 . . . . 0.0 112.332 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.409 ' N ' HG23 ' A' ' 40' ' ' VAL . 46.7 t80 -97.13 123.2 40.82 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 120.289 -0.564 . . . . 0.0 111.968 -178.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.6 p -142.56 139.73 28.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.918 177.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.684 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 55.7 p30 -95.78 165.96 12.04 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 178.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.47 ' OE1' ' HA ' ' A' ' 44' ' ' GLN . 14.0 mm100 -66.63 -39.82 88.45 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 177.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.57 -25.0 62.63 Favored Glycine 0 C--O 1.236 0.247 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.684 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 64.5 t80 -59.39 -48.48 81.47 Favored 'General case' 0 CA--C 1.51 -0.575 0 N-CA-C 105.221 -2.14 . . . . 0.0 105.221 -179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.569 HG13 ' O ' ' A' ' 52' ' ' TYR . 54.4 t -58.78 -44.7 90.83 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.554 0 O-C-N 121.088 -1.008 . . . . 0.0 111.623 -174.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -63.15 -35.81 81.52 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 120.441 -0.504 . . . . 0.0 112.278 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 60.9 ttm -68.08 -42.66 80.07 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 177.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 43.6 p -95.58 -20.59 18.86 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.358 0.599 . . . . 0.0 111.255 -177.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . 77.94 19.41 75.25 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.569 ' O ' HG13 ' A' ' 47' ' ' VAL . 75.0 m-85 -112.37 137.74 50.09 Favored 'General case' 0 C--O 1.222 -0.366 0 C-N-CA 122.569 0.348 . . . . 0.0 110.881 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -63.22 147.94 49.54 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.829 179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.446 HG22 ' H ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -65.2 -33.79 76.84 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.61 -43.15 85.54 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.959 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 76.2 mt-10 -64.23 -45.12 89.6 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.354 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.575 HD13 ' CE2' ' A' ' 46' ' ' PHE . 96.1 mt -62.85 -48.37 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 -175.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.2 mt -57.49 144.99 34.72 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.03 -2.96 82.51 Favored Glycine 0 C--O 1.237 0.329 0 C-N-CA 121.062 -0.589 . . . . 0.0 113.534 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -134.78 151.47 50.99 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.916 1.358 . . . . 0.0 112.308 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.574 ' C ' ' H ' ' A' ' 63' ' ' ARG . 25.5 t-20 -81.57 149.38 28.66 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.343 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 71.4 m -61.96 16.15 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.515 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.574 ' H ' ' C ' ' A' ' 61' ' ' ASN . 36.5 ptt-85 -61.35 -41.52 97.19 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.973 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -55.91 -20.31 15.37 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.5 mt -68.77 -35.94 77.7 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.951 0.881 . . . . 0.0 112.064 177.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -64.92 136.85 57.3 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.877 -176.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.567 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -147.28 -149.09 4.89 Favored Glycine 0 CA--C 1.537 1.415 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -178.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.83 -40.03 96.14 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -177.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -76.32 -9.58 58.74 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.952 0.406 . . . . 0.0 111.003 -178.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.567 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 27.0 m -61.4 129.65 42.24 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 120.058 -0.657 . . . . 0.0 109.567 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -86.49 112.1 44.02 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.791 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -57.45 -31.12 90.44 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 121.966 1.777 . . . . 0.0 113.283 179.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.49 -40.67 96.1 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 120.499 -0.481 . . . . 0.0 110.815 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.422 ' OE1' ' HB ' ' A' ' 90' ' ' VAL . 79.2 mm-40 -65.53 -45.03 85.02 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.4 t -59.09 -43.62 89.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -177.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -63.87 -37.74 88.52 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.042 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -63.47 -39.79 95.39 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.497 0.665 . . . . 0.0 110.128 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 95.8 mt -64.22 -44.04 97.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.96 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -62.66 -43.19 99.44 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 113.771 -1.558 . . . . 0.0 108.231 -179.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 99.3 m -61.16 -48.54 81.13 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.37 -41.34 96.94 Favored 'General case' 0 C--N 1.361 1.081 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.186 -172.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 90.2 mt -63.05 -40.08 96.65 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 120.632 -1.293 . . . . 0.0 111.582 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -63.03 -40.78 98.77 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -70.11 -25.19 63.39 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.457 177.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 51.5 tttt 65.23 42.81 3.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 114.87 -1.059 . . . . 0.0 110.413 -176.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -125.96 148.57 63.26 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -61.64 143.82 96.99 Favored 'Trans proline' 0 N--CA 1.497 1.694 0 C-N-CA 121.334 1.356 . . . . 0.0 112.928 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.93 141.34 31.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.457 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.945 HG23 ' OD1' ' A' ' 107' ' ' ASN . 99.6 m -128.1 120.33 27.17 Favored 'General case' 0 C--N 1.345 0.386 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 176.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.422 ' HB ' ' OE1' ' A' ' 74' ' ' GLU . 29.0 m -138.82 158.31 29.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.82 -0.173 . . . . 0.0 111.453 178.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -102.96 128.75 49.65 Favored 'General case' 0 C--O 1.247 0.931 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 177.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.459 HG23 ' O ' ' A' ' 92' ' ' ILE . 18.3 tt -137.55 129.45 41.0 Favored 'Isoleucine or valine' 0 C--N 1.378 1.837 0 CA-C-N 121.917 2.144 . . . . 0.0 112.363 177.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -61.5 134.29 56.69 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.107 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -135.43 159.82 40.38 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.102 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.455 ' CE1' ' HA3' ' A' ' 67' ' ' GLY . 93.0 m-85 -118.46 137.22 53.32 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.49 ' HG3' ' CE1' ' A' ' 102' ' ' PHE . 99.2 mttt -85.97 -171.77 3.75 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.394 0.616 . . . . 0.0 111.754 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -62.99 -42.08 99.75 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.295 179.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 41.1 p-10 -84.8 8.12 18.39 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -178.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.84 -3.41 87.17 Favored Glycine 0 N--CA 1.473 1.108 0 C-N-CA 120.571 -0.824 . . . . 0.0 111.916 177.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.7 m -59.3 137.89 57.82 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 106.255 -1.758 . . . . 0.0 106.255 178.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.687 ' SD ' ' C ' ' A' ' 101' ' ' MET . 13.4 tmm? -107.01 129.29 54.82 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 122.184 -0.323 . . . . 0.0 111.032 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.49 ' CE1' ' HG3' ' A' ' 96' ' ' LYS . 52.9 p90 -140.61 158.62 43.71 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.404 -177.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.842 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 22.8 m95 -89.03 144.87 25.85 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.554 HD21 ' HG2' ' A' ' 123' ' ' GLN . 56.4 t-20 -139.0 102.06 4.44 Favored 'General case' 0 C--O 1.245 0.862 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -176.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 80.8 tt0 -67.27 136.43 54.91 Favored 'General case' 0 CA--C 1.507 -0.69 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -177.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 40.2 tp -121.43 123.76 42.85 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -179.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.945 ' OD1' HG23 ' A' ' 89' ' ' THR . 98.1 m-20 -120.58 122.64 41.01 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 123.237 0.336 . . . . 0.0 110.742 177.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 96.3 mt -120.71 128.33 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 O-C-N 123.536 0.523 . . . . 0.0 111.505 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -138.24 125.14 13.26 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.17 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -71.56 152.12 59.36 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.399 2.066 . . . . 0.0 112.313 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.63 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 66.6 mtt -124.47 152.73 42.99 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 179.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -127.41 96.19 4.49 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 177.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.496 ' CD1' HG22 ' B' ' 15' ' ' VAL . 96.4 mt -120.34 131.28 73.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.184 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 51.13 38.33 20.6 Favored 'General case' 0 CA--C 1.511 -0.538 0 O-C-N 121.355 -0.84 . . . . 0.0 111.51 175.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 59.39 31.49 21.13 Favored 'General case' 0 C--N 1.322 -0.608 0 O-C-N 123.777 0.673 . . . . 0.0 111.049 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -129.55 148.73 51.48 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.76 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 7.4 t -86.58 -173.33 4.45 Favored 'General case' 0 C--O 1.209 -1.034 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -178.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.76 ' CD2' ' O ' ' A' ' 117' ' ' THR . 77.2 m-85 -170.5 155.71 5.16 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 175.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.433 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 83.7 m-85 -129.44 146.38 51.3 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 175.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -136.43 135.54 49.27 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 177.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.498 ' N ' HM73 ' A' ' 900' ' ' FMN . . . -111.12 130.28 9.69 Favored Glycine 0 CA--C 1.5 -0.89 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 178.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 96.2 mt -119.01 129.69 74.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 177.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.571 ' N ' ' O ' ' A' ' 26' ' ' GLY . 15.7 mp0 -119.67 115.27 23.59 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -116.46 113.07 22.32 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.647 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.464 ' OD1' ' N ' ' A' ' 126' ' ' ILE . 68.3 t0 -63.75 131.15 46.97 Favored 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -176.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.465 HG22 ' O ' ' A' ' 126' ' ' ILE . 2.6 mp -96.01 4.29 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 113.53 -1.668 . . . . 0.0 110.136 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 29.5 m -60.92 -42.45 98.14 Favored 'General case' 0 C--N 1.364 1.237 0 O-C-N 120.595 -1.316 . . . . 0.0 113.528 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -59.49 -43.06 93.41 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -63.0 -40.07 96.66 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.792 177.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.842 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.6 mttt -62.95 -40.81 98.79 Favored 'General case' 0 CA--C 1.504 -0.814 0 C-N-CA 118.277 -1.369 . . . . 0.0 110.187 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -61.43 -38.52 87.47 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.013 -178.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.763 ' CE2' HD11 ' A' ' 136' ' ' LEU . 86.6 t80 -61.76 -45.85 92.11 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.307 176.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.82 -38.29 90.53 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -62.44 -40.21 95.85 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.391 -0.524 . . . . 0.0 109.74 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 52.9 tp -61.05 -43.59 98.65 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -178.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.763 HD11 ' CE2' ' A' ' 132' ' ' TYR . 85.7 mt -62.72 -41.24 99.05 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.002 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -62.93 -41.5 99.49 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 119.337 -0.945 . . . . 0.0 109.672 -178.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -60.14 -42.24 94.42 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -177.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 55.4 m -61.68 -41.36 97.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.851 176.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 144' ' ' THR . 84.6 mt -63.23 -41.41 99.11 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 178.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 88.3 m -61.54 -45.63 93.34 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.102 -177.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -65.19 -40.52 94.34 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 94.5 mt -64.7 -43.17 96.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 113.9 -1.5 . . . . 0.0 111.331 176.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.502 ' N ' ' O ' ' A' ' 140' ' ' LEU . 96.4 m -62.11 -46.01 90.96 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 120.372 -0.531 . . . . 0.0 112.371 -178.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.47 ' O ' ' OG1' ' A' ' 148' ' ' THR . . . -62.93 -39.77 95.6 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 118.95 -1.1 . . . . 0.0 109.451 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.4 mt -63.32 -42.71 99.0 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.719 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.0 p -59.6 -40.22 86.78 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 -177.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.47 ' OG1' ' O ' ' A' ' 145' ' ' ALA . 12.6 m -26.72 80.64 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.524 0 O-C-N 127.54 3.025 . . . . 0.0 106.195 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.719 ' N ' ' O ' ' A' ' 147' ' ' SER . 19.3 Cg_exo -62.19 143.66 94.65 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 121.08 1.187 . . . . 0.0 113.651 -175.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.677 ' O ' HG23 ' A' ' 151' ' ' VAL . 8.9 tp -118.69 136.07 57.07 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 102.655 -3.091 . . . . 0.0 102.655 175.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.677 HG23 ' O ' ' A' ' 150' ' ' ILE . 89.1 t -169.25 92.59 0.55 Allowed Pre-proline 0 CA--C 1.508 -0.673 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 178.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -61.89 136.47 61.79 Favored 'Trans proline' 0 N--CA 1.487 1.105 0 CA-C-N 119.598 0.892 . . . . 0.0 110.086 -177.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.692 ' O ' ' HD2' ' A' ' 154' ' ' ARG . 45.4 mm -67.34 -45.25 86.29 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.526 0 C-N-CA 119.952 -0.699 . . . . 0.0 110.381 178.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.692 ' HD2' ' O ' ' A' ' 153' ' ' ILE . 0.7 OUTLIER -157.71 -156.4 0.58 Allowed 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.422 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 63.1 t-20 -86.93 104.78 16.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.48 0.657 . . . . 0.0 110.971 -178.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.21 7.97 67.08 Favored Glycine 0 C--O 1.224 -0.494 0 CA-C-N 114.077 -1.42 . . . . 0.0 110.015 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.6 mt -123.92 123.66 67.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 175.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.7 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 57.6 m -132.74 151.69 51.92 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -139.84 142.44 36.6 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.333 0.587 . . . . 0.0 111.309 178.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 20.7 tp -131.34 81.19 66.01 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.322 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -69.29 150.01 70.56 Favored 'Trans proline' 0 N--CA 1.499 1.829 0 C-N-CA 122.712 2.274 . . . . 0.0 113.117 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 90.6 mt -119.62 126.72 51.85 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.792 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 55.4 t -124.11 131.6 72.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 117.68 167.8 14.34 Favored Glycine 0 N--CA 1.476 1.326 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.241 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.903 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 56.2 t30 -85.11 115.02 22.67 Favored 'General case' 0 C--O 1.204 -1.305 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.57 HD21 ' CZ ' ' A' ' 171' ' ' PHE . 47.8 tp -75.12 103.42 5.29 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -177.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.734 HG23 ' NE ' ' A' ' 170' ' ' ARG . 10.7 p -85.29 167.95 15.15 Favored 'General case' 0 C--O 1.226 -0.14 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.637 178.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -65.75 -33.59 76.21 Favored 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.33 -45.17 89.04 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.149 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.903 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 87.4 mtm180 -63.27 -33.37 75.36 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.219 -0.9 . . . . 0.0 112.267 178.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.57 ' CZ ' HD21 ' A' ' 166' ' ' LEU . 0.4 OUTLIER -54.5 -28.2 43.36 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 119.086 -0.483 . . . . 0.0 111.897 -177.586 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.634 ' O ' HG22 ' A' ' 175' ' ' VAL . 91.5 m-20 -60.97 -39.81 90.99 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 118.866 -1.134 . . . . 0.0 109.842 -177.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 66.9 m -59.4 -40.92 88.14 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 121.787 -0.571 . . . . 0.0 110.484 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 67.0 mt -63.63 -44.01 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 172' ' ' ASN . 33.7 m -62.53 -40.89 89.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 -178.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . 0.432 ' N ' HG23 ' A' ' 175' ' ' VAL . 96.5 m -62.33 -34.53 76.81 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.312 178.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.569 ' O ' HG13 ' A' ' 181' ' ' ILE . 25.4 m -61.91 -19.59 62.85 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.931 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.636 ' CD2' HD21 ' A' ' 211' ' ' LEU . 84.9 mt -60.87 -41.58 96.23 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -177.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 19.5 m -59.53 -43.43 93.48 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.622 ' O ' ' OG ' ' A' ' 183' ' ' SER . 92.5 m-20 -61.85 -37.24 83.75 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-O 121.016 0.436 . . . . 0.0 110.719 178.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.569 HG13 ' O ' ' A' ' 177' ' ' THR . 66.0 mt -58.21 -38.68 69.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 O-C-N 121.296 -0.877 . . . . 0.0 109.437 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.52 HD21 HD21 ' A' ' 214' ' ' LEU . 87.0 mt -60.89 -40.6 93.67 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -177.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.622 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 77.1 p -61.53 -34.02 74.83 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.526 177.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 49.4 p -89.26 25.17 1.96 Allowed 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.634 0.254 . . . . 0.0 111.304 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 78.5 p -63.6 -21.51 66.4 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.846 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -59.76 -36.96 77.71 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.14 -178.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.7 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 98.8 m-20 -72.03 112.97 8.57 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.593 0.711 . . . . 0.0 110.853 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.88 -42.78 99.89 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 114.959 -1.018 . . . . 0.0 112.802 -177.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -113.37 131.61 55.92 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.802 -178.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 38.3 tp -121.08 128.49 52.65 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 96.1 mt -116.39 127.14 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 177.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.3 mm -112.68 126.98 70.14 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.413 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . 0.497 ' CG ' ' HG ' ' A' ' 195' ' ' SER . 40.1 t0 -95.13 119.56 33.84 Favored 'General case' 0 CA--C 1.56 1.352 0 CA-C-O 119.638 -0.22 . . . . 0.0 110.913 178.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 95.8 mt -99.64 -4.03 31.82 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 125.022 1.451 . . . . 0.0 111.06 176.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.497 ' HG ' ' CG ' ' A' ' 193' ' ' ASP . 78.4 p -63.12 -32.24 73.57 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -62.08 -44.38 97.84 Favored Glycine 0 CA--C 1.544 1.851 0 N-CA-C 108.103 -1.999 . . . . 0.0 108.103 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 1.068 ' CD2' ' O ' ' A' ' 199' ' ' GLN . 6.7 tt -67.37 128.76 37.62 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 112.536 -1.832 . . . . 0.0 109.284 -178.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.772 ' N ' HD23 ' A' ' 197' ' ' LEU . . . -60.53 -50.38 73.79 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-O 121.402 0.62 . . . . 0.0 110.476 -178.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 1.068 ' O ' ' CD2' ' A' ' 197' ' ' LEU . 59.1 tt0 -133.55 156.5 47.7 Favored 'General case' 0 C--O 1.209 -1.034 0 CA-C-N 114.445 -1.252 . . . . 0.0 114.328 -175.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.487 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 44.9 t -116.07 131.08 69.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 O-C-N 120.321 -1.487 . . . . 0.0 108.619 178.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -84.21 155.74 22.36 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.759 -179.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.59 -39.47 93.79 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 120.052 -0.659 . . . . 0.0 110.045 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -57.16 -31.98 65.95 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.3 m -61.52 -42.38 98.72 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.546 178.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.454 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -56.39 -39.7 73.39 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -177.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -61.19 -37.41 82.84 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.634 -0.427 . . . . 0.0 109.882 -178.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -65.0 -38.96 92.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.835 177.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.92 -44.63 99.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 C-N-CA 119.469 -0.893 . . . . 0.0 108.734 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . 0.454 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 68.9 m-85 -62.35 -43.59 98.46 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.001 -177.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.13 -42.01 98.81 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 118.882 -1.127 . . . . 0.0 109.181 -178.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.636 HD21 ' CD2' ' A' ' 178' ' ' LEU . 41.1 mt -62.11 -41.66 98.44 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 78.3 p -61.28 -42.19 98.22 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 118.936 -1.106 . . . . 0.0 110.351 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' HIS . . . . . 0.455 ' CE1' HD11 ' A' ' 217' ' ' LEU . 59.0 t-80 -63.42 -46.02 88.28 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.76 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.52 HD21 HD21 ' A' ' 182' ' ' LEU . 52.8 tp -62.49 -46.76 87.0 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 88.4 mt -62.02 -40.53 95.99 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.902 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.46 -44.5 95.8 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.292 -178.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.455 HD11 ' CE1' ' A' ' 213' ' ' HIS . 84.0 mt -61.76 -40.18 94.23 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 75.2 p -75.81 -11.66 60.02 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.239 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 83.1 37.05 13.21 Favored Glycine 0 C--N 1.343 0.939 0 C-N-CA 120.723 -0.751 . . . . 0.0 114.027 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 99.8 m -123.2 114.68 20.6 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.046 1.423 . . . . 0.0 112.022 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -65.65 138.08 57.76 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.268 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 42.9 tp -112.37 130.01 56.11 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 3.2 mp -117.61 132.56 67.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.617 ' CG2' HD11 ' A' ' 227' ' ' ILE . 49.4 mm -115.33 131.43 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 42.6 p -134.01 167.67 20.2 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 78.15 19.14 75.28 Favored Glycine 0 C--O 1.223 -0.537 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.617 HD11 ' CG2' ' A' ' 224' ' ' ILE . 97.4 mt -81.53 128.35 38.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 113.611 -1.294 . . . . 0.0 108.112 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -74.01 140.2 76.97 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.29 -38.92 88.7 Favored 'Trans proline' 0 N--CA 1.497 1.723 0 C-N-CA 120.99 1.127 . . . . 0.0 112.627 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -64.83 -38.7 91.86 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 121.351 0.596 . . . . 0.0 109.948 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 51.2 tp -63.64 -42.76 98.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.832 177.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.48 -37.99 89.46 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 120.442 -0.503 . . . . 0.0 110.73 -178.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 94.1 mtp -63.31 -40.4 97.23 Favored 'General case' 0 C--O 1.247 0.923 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.834 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -64.04 -39.38 93.96 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.755 177.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 33.1 mmt -65.94 -36.63 83.88 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.623 178.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -61.11 -41.48 96.76 Favored 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 121.367 -0.833 . . . . 0.0 109.413 -176.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.71 -40.68 93.14 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.618 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 54.5 tp -63.61 -41.55 98.3 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 176.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -168.18 124.63 1.05 Allowed 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.254 0.55 . . . . 0.0 112.454 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.66 -27.1 66.09 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.54 -1.209 . . . . 0.0 110.764 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -62.49 -26.42 68.52 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.789 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -56.23 -44.21 79.38 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -176.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 99.4 p -61.78 -20.59 63.75 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 123.766 0.666 . . . . 0.0 111.283 179.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 50.1 m -57.11 -33.77 67.68 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 94.7 mt -87.79 121.79 30.65 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 119.458 -0.897 . . . . 0.0 113.261 179.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -46.03 135.84 7.12 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.712 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.544 HG23 HD12 ' A' ' 227' ' ' ILE . 97.8 m -127.46 132.92 49.95 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.673 179.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' TYR . . . . . 0.457 ' CG ' ' HB2' ' A' ' 254' ' ' ALA . 95.1 m-85 -118.13 139.18 51.63 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.12 178.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 78.0 p -60.47 -41.76 94.83 Favored 'General case' 0 CA--C 1.504 -0.792 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -178.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -144.46 160.78 40.52 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.824 0.821 . . . . 0.0 111.604 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 72.3 t -63.23 -44.43 99.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 CA-C-N 114.586 -1.188 . . . . 0.0 112.25 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.57 -44.54 96.08 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.036 -0.665 . . . . 0.0 109.466 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . 0.569 ' O ' HG22 ' A' ' 257' ' ' VAL . 55.6 m-20 -63.83 -42.51 97.62 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.487 -178.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.457 ' HB2' ' CG ' ' A' ' 248' ' ' TYR . . . -63.88 -42.8 97.41 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 122.035 0.921 . . . . 0.0 109.791 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . 0.456 HG13 HH11 ' B' ' 154' ' ' ARG . 66.3 t -63.6 -45.71 96.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.157 -1.383 . . . . 0.0 111.143 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.84 -47.66 79.88 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 120.355 -0.538 . . . . 0.0 111.267 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 253' ' ' ASP . 33.3 m -66.48 -40.54 86.73 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 O-C-N 121.373 -0.829 . . . . 0.0 112.285 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.506 ' C ' ' O ' ' A' ' 257' ' ' VAL . 1.7 mt -28.64 -75.48 0.04 OUTLIER Pre-proline 0 N--CA 1.467 0.375 0 O-C-N 123.17 0.294 . . . . 0.0 111.607 -177.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' PRO . . . . . 0.494 ' CD ' ' CB ' ' A' ' 258' ' ' LEU . 42.7 Cg_endo -63.25 139.3 71.25 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 120.754 0.969 . . . . 0.0 111.943 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 259' ' ' PRO . 96.7 mt -151.74 -27.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 O-C-N 124.049 0.843 . . . . 0.0 111.962 178.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 78.0 mtm . . . . . 0 N--CA 1.475 0.789 0 CA-C-O 118.094 -0.955 . . . . 0.0 110.754 -177.425 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.49 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.13 165.32 36.33 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 79.4 p -66.96 -13.59 61.98 Favored 'General case' 0 CA--C 1.568 1.669 0 O-C-N 121.724 -0.61 . . . . 0.0 112.398 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -80.04 -63.25 1.45 Allowed 'General case' 0 C--N 1.311 -1.108 0 O-C-N 124.532 1.145 . . . . 0.0 109.379 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -67.05 -39.19 86.87 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.445 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.502 ' O ' ' HB3' ' B' ' 7' ' ' PHE . 66.6 m -59.68 -42.08 92.12 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 120.147 -0.621 . . . . 0.0 109.782 -177.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . 0.502 ' HB3' ' O ' ' B' ' 6' ' ' SER . 36.8 t80 85.85 90.96 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.573 177.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . 0.583 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -63.58 -141.85 0.02 OUTLIER Glycine 0 C--N 1.34 0.754 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.583 ' HB ' ' O ' ' B' ' 8' ' ' GLY . 78.5 mt 84.49 111.86 0.03 OUTLIER Pre-proline 0 CA--C 1.545 0.776 0 O-C-N 124.086 0.521 . . . . 0.0 110.796 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.79 -24.31 68.56 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 121.109 1.206 . . . . 0.0 111.783 -178.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.71 -40.43 98.76 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.604 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -64.87 -39.44 93.55 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.557 0.694 . . . . 0.0 109.234 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 50.3 tp -62.05 -42.28 99.02 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.454 -177.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -65.14 -31.15 72.19 Favored 'General case' 0 CA--C 1.562 1.439 0 CA-C-O 121.643 0.735 . . . . 0.0 110.805 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . 0.496 HG22 ' CD1' ' A' ' 113' ' ' ILE . 78.3 t -63.81 -46.27 94.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 113.119 -1.855 . . . . 0.0 111.276 177.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 95.0 mt -64.24 -43.71 97.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.761 -178.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . 0.508 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 98.9 mttt -63.35 -42.64 98.93 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.03 -40.91 99.15 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 119.105 -1.038 . . . . 0.0 109.726 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.32 -39.16 86.04 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.816 -178.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 84.2 mt -64.12 -42.02 97.0 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.383 0.611 . . . . 0.0 110.278 175.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -63.07 -39.08 93.65 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.831 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 53.0 m170 -57.63 -40.16 78.58 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 119.547 -0.263 . . . . 0.0 111.488 -178.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 14.8 p -114.93 130.26 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.494 ' O ' ' HG3' ' B' ' 24' ' ' ARG . 33.2 ptt180 -71.7 109.97 5.95 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.888 0.851 . . . . 0.0 112.343 -177.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.2 p -143.19 133.53 22.16 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.8 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.514 177.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . 0.568 ' O ' ' N ' ' B' ' 123' ' ' GLN . . . -87.25 95.32 2.06 Favored Glycine 0 C--N 1.31 -0.87 0 C-N-CA 119.354 -1.403 . . . . 0.0 113.538 -177.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 49.7 t -125.54 129.11 72.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 106.634 -1.617 . . . . 0.0 106.634 174.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 27.6 m -139.01 156.49 27.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.58 0.229 . . . . 0.0 110.478 178.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 96.1 mt -117.98 126.88 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.61 177.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' B' ' 119' ' ' PHE . 24.1 p -106.65 157.42 17.71 Favored 'General case' 0 CA--C 1.505 -0.786 0 O-C-N 126.003 2.064 . . . . 0.0 108.688 -178.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -124.76 102.47 32.06 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' PRO . . . . . 0.464 ' CG ' HG23 ' B' ' 117' ' ' THR . 37.9 Cg_endo -65.54 -18.3 59.07 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 121.697 1.598 . . . . 0.0 111.473 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.24 -40.26 96.93 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.741 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 90.4 mt -76.47 -170.47 1.52 Allowed 'General case' 0 CA--C 1.544 0.727 0 O-C-N 121.823 -0.548 . . . . 0.0 111.234 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . 0.653 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 42.4 tt0 -82.04 131.25 35.24 Favored 'General case' 0 C--N 1.342 0.26 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.502 ' O ' ' OD1' ' B' ' 36' ' ' ASP . 66.3 t0 56.22 35.27 25.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.063 177.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' ASN . . . . . 0.444 ' C ' ' O ' ' B' ' 36' ' ' ASP . 28.3 t-20 33.3 70.34 0.81 Allowed Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.653 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 89.2 Cg_endo -72.66 154.19 54.47 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 123.434 2.756 . . . . 0.0 111.994 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 96.1 mt -86.47 128.81 39.17 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.401 HG23 ' N ' ' B' ' 41' ' ' TYR . 29.3 m -109.15 -42.82 5.6 Favored 'Isoleucine or valine' 0 C--N 1.341 0.231 0 O-C-N 123.681 0.613 . . . . 0.0 112.446 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' TYR . . . . . 0.401 ' N ' HG23 ' B' ' 40' ' ' VAL . 49.5 t80 -97.44 123.57 41.34 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.654 -178.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 5.8 p -142.65 140.65 28.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.017 177.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . 0.721 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 57.4 p30 -99.98 160.73 14.09 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.289 179.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' GLN . . . . . 0.472 ' OE1' ' HA ' ' B' ' 44' ' ' GLN . 13.4 mm100 -62.94 -38.27 90.4 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.418 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.57 -25.63 63.48 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.721 ' HB2' ' OD1' ' B' ' 43' ' ' ASN . 60.5 t80 -60.03 -43.66 95.15 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 0.746 HG13 ' O ' ' B' ' 52' ' ' TYR . 53.7 t -61.07 -46.33 96.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.066 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -63.36 -43.55 97.36 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.226 -0.59 . . . . 0.0 110.244 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 60.8 ttm -63.06 -41.92 99.56 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 41.5 p -96.75 -16.11 21.03 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.729 -178.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' B' ' 47' ' ' VAL . . . 73.08 19.69 79.7 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 178.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . 0.746 ' O ' HG13 ' B' ' 47' ' ' VAL . 74.8 m-85 -111.25 145.1 39.34 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -73.78 147.48 43.41 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.897 0.856 . . . . 0.0 111.061 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . 0.411 ' H ' HG22 ' B' ' 54' ' ' THR . 0.2 OUTLIER -61.79 -37.57 84.87 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.198 -177.43 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.04 -39.52 94.26 Favored 'General case' 0 C--N 1.314 -0.936 0 O-C-N 124.075 0.859 . . . . 0.0 111.322 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -72.86 -32.42 65.42 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 177.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.613 HD13 ' CE2' ' B' ' 46' ' ' PHE . 93.1 mt -67.32 -69.55 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 178.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 95.6 mt -39.36 132.36 1.48 Allowed 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.368 178.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.85 -7.45 76.88 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.516 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -132.4 149.1 52.41 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 -176.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' ASN . . . . . 0.54 ' C ' ' H ' ' B' ' 63' ' ' ARG . 25.5 t-20 -79.17 150.07 31.8 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 114.572 -1.195 . . . . 0.0 110.843 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' CYS . . . . . . . . . . . . . 71.7 m -62.94 9.22 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.76 -0.654 . . . . 0.0 112.674 -178.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . 0.54 ' H ' ' C ' ' B' ' 61' ' ' ASN . 34.6 ptt-85 -59.4 -31.2 69.03 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.495 -178.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -61.54 -31.25 71.27 Favored 'General case' 0 C--O 1.239 0.531 0 O-C-N 121.878 -0.514 . . . . 0.0 111.922 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 92.4 mt -61.24 -44.28 97.51 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -178.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -46.59 144.11 2.38 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.424 0.631 . . . . 0.0 109.938 -179.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . 0.555 ' N ' ' OG1' ' B' ' 70' ' ' THR . . . -155.39 -152.98 6.36 Favored Glycine 0 CA--C 1.543 1.817 0 CA-C-N 115.28 -0.873 . . . . 0.0 112.656 176.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -60.97 -40.99 95.51 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.447 -0.376 . . . . 0.0 111.172 -175.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -75.6 -9.93 59.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.175 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' THR . . . . . 0.555 ' OG1' ' N ' ' B' ' 67' ' ' GLY . 25.0 m -60.66 133.52 56.18 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -90.55 111.72 49.1 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.453 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.39 -38.38 89.27 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 121.099 1.199 . . . . 0.0 111.882 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.99 -40.9 90.77 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 120.473 -0.491 . . . . 0.0 109.821 -176.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' GLU . . . . . 0.429 ' OE1' ' HB ' ' B' ' 90' ' ' VAL . 79.2 mm-40 -66.78 -39.35 87.78 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.835 178.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 71.0 t -62.59 -45.66 98.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -62.85 -37.28 86.23 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.748 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -62.48 -42.06 99.23 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.938 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 95.2 mt -63.33 -43.79 98.77 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 CA-C-O 120.86 0.362 . . . . 0.0 110.735 -178.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -61.58 -42.67 99.18 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 87.2 m -60.93 -46.58 90.12 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.79 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.86 -41.72 96.44 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 -178.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 87.8 mt -62.13 -42.29 99.09 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -62.56 -39.89 95.09 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -80.2 -4.2 52.15 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.105 178.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 37.5 tttt 50.67 44.77 27.52 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.222 -0.591 . . . . 0.0 112.134 178.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -128.88 145.43 56.39 Favored Pre-proline 0 N--CA 1.467 0.383 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.15 140.1 81.87 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 120.905 1.07 . . . . 0.0 113.642 -178.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -140.12 136.59 37.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.909 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' THR . . . . . 0.941 HG23 ' OD1' ' B' ' 107' ' ' ASN . 97.4 m -122.24 122.68 39.69 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 178.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.429 ' HB ' ' OE1' ' B' ' 74' ' ' GLU . 30.7 m -139.4 162.82 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.854 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -113.63 120.82 42.23 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 176.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 20.6 tt -128.43 131.79 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.68 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -70.46 141.6 52.03 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.857 178.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -133.75 -179.75 5.73 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.261 0.553 . . . . 0.0 111.174 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' TYR . . . . . 0.461 ' CE1' ' HA3' ' B' ' 67' ' ' GLY . 96.3 m-85 -131.11 148.25 52.71 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.485 178.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . 0.495 ' HG3' ' CE1' ' B' ' 102' ' ' PHE . 98.7 mttt -104.35 -179.08 3.84 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.052 0.453 . . . . 0.0 110.693 177.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.72 -35.52 76.54 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.493 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 37.0 p-10 -87.37 -0.33 56.61 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 119.053 0.842 . . . . 0.0 112.954 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 93.02 3.23 65.8 Favored Glycine 0 N--CA 1.465 0.601 0 C-N-CA 121.152 -0.546 . . . . 0.0 111.892 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 24.7 m -68.16 129.56 40.3 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . 0.569 ' SD ' ' N ' ' B' ' 102' ' ' PHE . 15.2 tmm? -90.46 142.99 27.18 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' PHE . . . . . 0.569 ' N ' ' SD ' ' B' ' 101' ' ' MET . 53.9 p90 -153.6 163.62 39.67 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' TRP . . . . . 0.851 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 23.6 m95 -95.25 140.19 30.5 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.018 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . 0.53 HD21 ' HG2' ' B' ' 123' ' ' GLN . 62.8 t-20 -133.71 105.63 6.93 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 -176.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' GLU . . . . . 0.414 ' O ' ' HA ' ' B' ' 123' ' ' GLN . 81.4 tt0 -73.02 126.84 30.91 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.635 1.209 . . . . 0.0 109.02 179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 39.4 tp -114.18 125.91 54.47 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' ASN . . . . . 0.941 ' OD1' HG23 ' B' ' 89' ' ' THR . 98.0 m-20 -119.92 127.86 53.08 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 176.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 96.2 mt -123.69 132.83 70.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -144.51 123.12 6.86 Favored Pre-proline 0 CA--C 1.538 0.483 0 O-C-N 123.482 0.488 . . . . 0.0 109.931 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -70.74 152.71 64.45 Favored 'Trans proline' 0 N--CA 1.5 1.891 0 C-N-CA 122.366 2.044 . . . . 0.0 112.618 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . 0.489 ' HB2' ' HB2' ' B' ' 118' ' ' TYR . 66.4 mtt -129.18 144.09 51.09 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -113.58 111.21 21.5 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . 0.579 HG12 ' NZ ' ' A' ' 18' ' ' LYS . 96.8 mt -137.92 127.72 35.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 O-C-N 121.534 -0.729 . . . . 0.0 111.81 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 52.25 38.33 24.43 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 123.997 0.811 . . . . 0.0 109.626 178.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 61.54 36.15 17.08 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.538 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -133.8 151.66 51.64 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' THR . . . . . 0.464 HG23 ' CG ' ' B' ' 32' ' ' PRO . 8.8 t -102.76 154.08 19.52 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.262 -178.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' TYR . . . . . 0.489 ' HB2' ' HB2' ' B' ' 111' ' ' MET . 96.8 m-85 -148.12 145.34 28.34 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 121.529 -0.732 . . . . 0.0 110.917 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 119' ' ' PHE . . . . . 0.431 ' O ' ' OG1' ' B' ' 30' ' ' THR . 86.4 m-85 -118.12 138.91 51.95 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.384 0.427 . . . . 0.0 111.347 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.5 p -128.22 136.15 60.87 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -178.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . 0.516 ' N ' HM73 ' B' ' 900' ' ' FMN . . . -112.2 127.88 8.27 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 122' ' ' ILE . . . . . 0.412 ' HB ' ' HB2' ' B' ' 107' ' ' ASN . 95.4 mt -117.63 128.62 74.82 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 123' ' ' GLN . . . . . 0.568 ' N ' ' O ' ' B' ' 26' ' ' GLY . 15.3 mp0 -119.12 121.54 40.02 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -120.31 121.18 38.07 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' B' ' 126' ' ' ILE . 68.3 t0 -69.12 134.16 48.97 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.083 -177.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.495 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 2.5 mp -107.3 17.16 6.73 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.493 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 127' ' ' THR . . . . . 0.461 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 98.2 m -63.36 -45.23 92.15 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 114.138 -1.392 . . . . 0.0 112.647 175.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 59.7 tptt -60.53 -45.6 93.27 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 129' ' ' GLN . . . . . 0.438 ' OE1' HG23 ' B' ' 126' ' ' ILE . 88.5 mt-30 -62.53 -36.57 83.04 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.484 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 130' ' ' LYS . . . . . 0.851 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 98.9 mttt -62.64 -41.7 99.19 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 112.737 -2.028 . . . . 0.0 111.115 174.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.5 -42.08 96.06 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 132' ' ' TYR . . . . . 0.762 ' CE2' HD11 ' B' ' 136' ' ' LEU . 88.1 t80 -60.76 -44.95 96.08 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.972 -0.455 . . . . 0.0 111.785 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . 0.43 ' O ' ' HG3' ' B' ' 137' ' ' GLU . 97.3 mt-10 -63.8 -36.49 84.06 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 119.932 -0.707 . . . . 0.0 109.367 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 134' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' B' ' 130' ' ' LYS . 98.9 mttt -62.41 -39.62 93.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.801 177.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 53.8 tp -62.28 -41.76 98.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.75 0.786 . . . . 0.0 109.451 179.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . 0.762 HD11 ' CE2' ' B' ' 132' ' ' TYR . 87.6 mt -63.02 -41.82 99.65 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.921 177.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 137' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' B' ' 133' ' ' GLU . 97.3 mt-10 -65.27 -36.45 84.13 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.508 -1.678 . . . . 0.0 110.276 -178.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -63.83 -43.79 95.16 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.106 -0.638 . . . . 0.0 109.649 177.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 68.2 m -61.14 -44.1 97.85 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . 0.468 ' O ' ' N ' ' B' ' 144' ' ' THR . 86.1 mt -61.74 -40.06 93.77 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -177.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 97.2 m -61.32 -45.58 93.85 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.059 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -66.39 -42.39 87.95 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 93.1 mt -63.52 -43.19 98.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 114.517 -1.219 . . . . 0.0 110.598 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 144' ' ' THR . . . . . 0.468 ' N ' ' O ' ' B' ' 140' ' ' LEU . 92.1 m -61.31 -45.12 95.76 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.13 -40.8 96.95 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 119.299 -0.96 . . . . 0.0 109.332 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 87.1 mt -64.55 -41.17 96.5 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.754 0.649 . . . . 0.0 112.754 177.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 147' ' ' SER . . . . . 0.626 ' O ' ' N ' ' B' ' 149' ' ' PRO . 78.4 p -61.91 -40.91 97.08 Favored 'General case' 0 CA--C 1.476 -1.895 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 -178.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . 0.491 ' C ' ' O ' ' B' ' 147' ' ' SER . 7.3 m -28.9 85.16 0.03 OUTLIER Pre-proline 0 C--N 1.353 0.738 0 O-C-N 123.745 0.653 . . . . 0.0 110.351 176.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 149' ' ' PRO . . . . . 0.626 ' N ' ' O ' ' B' ' 147' ' ' SER . 23.4 Cg_exo -61.89 146.71 96.29 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 C-N-CA 122.393 2.062 . . . . 0.0 115.57 -176.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 9.0 tp -126.67 119.81 54.47 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.21 0 CA-C-N 114.658 -1.155 . . . . 0.0 108.036 174.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 59.3 t -151.26 93.41 3.61 Favored Pre-proline 0 C--N 1.295 -1.764 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.809 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -60.23 137.35 74.4 Favored 'Trans proline' 0 N--CA 1.489 1.238 0 CA-C-N 119.852 0.983 . . . . 0.0 109.569 -178.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 153' ' ' ILE . . . . . 0.721 ' O ' ' HD2' ' B' ' 154' ' ' ARG . 45.2 mm -68.7 -43.55 82.98 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.516 0 C-N-CA 120.37 -0.532 . . . . 0.0 110.579 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . 0.721 ' HD2' ' O ' ' B' ' 153' ' ' ILE . 0.7 OUTLIER -157.16 -154.61 0.47 Allowed 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.449 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 62.0 t-20 -87.32 107.99 18.76 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.1 -18.39 55.73 Favored Glycine 0 CA--C 1.534 1.23 0 N-CA-C 110.432 -1.067 . . . . 0.0 110.432 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 157' ' ' ILE . . . . . 0.429 HG22 ' HB ' ' B' ' 153' ' ' ILE . 85.1 mt -108.04 124.45 64.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.287 0.565 . . . . 0.0 111.16 -177.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . 0.655 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 69.1 m -135.0 148.72 50.04 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.517 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -134.62 146.92 50.03 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 24.4 tp -137.61 80.73 31.29 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 161' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -70.63 147.73 57.9 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.666 2.244 . . . . 0.0 114.077 -178.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 90.5 mt -114.55 133.85 55.48 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 109.074 -0.714 . . . . 0.0 109.074 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 54.6 t -130.51 132.73 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 177.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 114.3 168.61 16.25 Favored Glycine 0 N--CA 1.471 0.984 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.512 178.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 165' ' ' ASN . . . . . 0.813 ' O ' ' CZ ' ' B' ' 170' ' ' ARG . 60.5 t30 -89.92 107.16 18.95 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -178.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . 0.588 HD21 ' CZ ' ' B' ' 171' ' ' PHE . 42.1 tp -65.02 104.73 0.91 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -174.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 167' ' ' THR . . . . . 0.7 HG23 ' NE ' ' B' ' 170' ' ' ARG . 10.0 p -85.38 169.57 13.57 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 113.828 -1.533 . . . . 0.0 110.83 177.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.57 -37.52 85.1 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.307 177.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.63 -39.9 88.49 Favored 'General case' 0 CA--C 1.553 1.09 0 CA-C-O 121.682 0.753 . . . . 0.0 111.798 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 170' ' ' ARG . . . . . 0.813 ' CZ ' ' O ' ' B' ' 165' ' ' ASN . 87.9 mtm180 -63.67 -36.04 82.51 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 113.193 -1.821 . . . . 0.0 110.475 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 171' ' ' PHE . . . . . 0.588 ' CZ ' HD21 ' B' ' 166' ' ' LEU . 0.4 OUTLIER -54.1 -25.55 22.52 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -178.194 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 172' ' ' ASN . . . . . 0.557 ' O ' HG22 ' B' ' 175' ' ' VAL . 92.9 m-20 -62.48 -40.53 96.96 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.672 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 59.7 m -60.12 -41.76 93.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.27 0.557 . . . . 0.0 110.51 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 67.4 mt -63.9 -44.21 97.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -179.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 175' ' ' VAL . . . . . 0.557 HG22 ' O ' ' B' ' 172' ' ' ASN . 29.8 m -62.61 -40.81 89.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -178.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 176' ' ' CYS . . . . . 0.433 ' N ' HG23 ' B' ' 175' ' ' VAL . 98.2 m -62.26 -35.44 78.97 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.291 178.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 177' ' ' THR . . . . . 0.596 ' O ' HG13 ' B' ' 181' ' ' ILE . 25.3 m -61.3 -19.45 61.78 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 178' ' ' LEU . . . . . 0.595 ' CD2' HD21 ' B' ' 211' ' ' LEU . 87.4 mt -60.97 -39.47 89.69 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.479 -178.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 18.2 m -62.03 -44.44 96.7 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.414 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 180' ' ' ASN . . . . . 0.574 ' O ' ' OG ' ' B' ' 183' ' ' SER . 92.1 m-20 -61.97 -40.3 95.12 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.121 0.486 . . . . 0.0 110.435 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.596 HG13 ' O ' ' B' ' 177' ' ' THR . 73.3 mt -56.35 -32.37 35.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 O-C-N 122.074 -0.391 . . . . 0.0 110.74 -178.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 182' ' ' LEU . . . . . 0.521 HD21 HD21 ' B' ' 214' ' ' LEU . 86.4 mt -62.66 -41.5 99.1 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 178.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . 0.574 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.7 p -63.98 -32.91 74.61 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 122.129 -0.357 . . . . 0.0 110.593 177.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 44.6 p -85.88 17.96 3.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.766 0.317 . . . . 0.0 111.684 -178.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 78.6 p -60.59 -16.44 38.07 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.274 -177.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.82 -40.86 96.76 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.966 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 187' ' ' ASP . . . . . 0.655 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.3 m-20 -67.98 113.32 5.58 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.699 0.761 . . . . 0.0 110.776 -178.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.8 -42.39 99.69 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 114.697 -1.138 . . . . 0.0 113.102 -178.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -113.29 130.98 56.11 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.212 -178.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 190' ' ' LEU . . . . . 0.409 ' HA ' ' O ' ' B' ' 158' ' ' SER . 40.5 tp -123.72 118.16 26.59 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.908 178.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 84.2 mt -106.15 125.95 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-O 120.812 0.339 . . . . 0.0 111.303 -178.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 49.7 mm -114.51 117.58 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 193' ' ' ASP . . . . . 0.425 ' OD2' ' OG ' ' B' ' 195' ' ' SER . 41.9 t0 -88.43 114.62 25.23 Favored 'General case' 0 C--O 1.246 0.873 0 CA-C-O 121.65 0.738 . . . . 0.0 111.352 -177.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 194' ' ' LEU . . . . . . . . . . . . . 96.2 mt -97.1 -1.34 45.44 Favored 'General case' 0 C--N 1.356 0.858 0 O-C-N 120.39 -1.444 . . . . 0.0 110.067 176.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 195' ' ' SER . . . . . 0.425 ' OG ' ' OD2' ' B' ' 193' ' ' ASP . 78.4 p -61.19 -36.24 79.33 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 121.169 -0.213 . . . . 0.0 110.803 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.87 -35.42 91.29 Favored Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 197' ' ' LEU . . . . . 1.107 ' CD2' ' O ' ' B' ' 199' ' ' GLN . 7.0 tt -74.75 132.61 41.76 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 121.847 -0.796 . . . . 0.0 109.589 -178.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 198' ' ' ALA . . . . . 0.775 ' N ' HD23 ' B' ' 197' ' ' LEU . . . -61.33 -48.9 79.23 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 119.309 -0.957 . . . . 0.0 110.143 -178.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 199' ' ' GLN . . . . . 1.107 ' O ' ' CD2' ' B' ' 197' ' ' LEU . 57.1 tt0 -135.06 164.62 27.24 Favored 'General case' 0 C--O 1.21 -1.02 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -178.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 200' ' ' VAL . . . . . 0.54 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 48.3 t -119.44 130.95 73.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 119.506 -1.996 . . . . 0.0 109.403 177.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -87.26 150.84 23.62 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.122 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -61.49 -32.61 72.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.59 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -64.11 -32.78 74.48 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.2 m -60.89 -43.36 98.61 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.573 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 205' ' ' ALA . . . . . 0.687 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -58.63 -29.53 66.59 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 119.212 -0.423 . . . . 0.0 111.792 -178.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -65.75 -38.74 89.93 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 123.649 0.593 . . . . 0.0 109.68 176.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -66.57 -38.04 86.23 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.752 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 93.5 mt -63.68 -44.36 98.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 -178.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 209' ' ' PHE . . . . . 0.687 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 66.9 m-85 -61.35 -43.56 98.66 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.618 179.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.39 -41.54 98.78 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 119.102 -1.039 . . . . 0.0 109.532 179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . 0.595 HD21 ' CD2' ' B' ' 178' ' ' LEU . 39.9 mt -62.23 -41.94 98.86 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.316 -178.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 78.3 p -63.3 -35.78 81.51 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 121.686 -0.634 . . . . 0.0 112.159 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 213' ' ' HIS . . . . . 0.43 ' CE1' HD11 ' B' ' 217' ' ' LEU . 58.8 t-80 -67.18 -46.83 72.77 Favored 'General case' 0 C--O 1.243 0.722 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.839 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.521 HD21 HD21 ' B' ' 182' ' ' LEU . 54.1 tp -64.23 -43.06 96.13 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 122.069 0.938 . . . . 0.0 109.406 178.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 215' ' ' LEU . . . . . . . . . . . . . 88.1 mt -63.09 -43.74 97.66 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 113.617 -1.629 . . . . 0.0 111.379 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.12 -39.32 92.15 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.005 -177.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . 0.43 HD11 ' CE1' ' B' ' 213' ' ' HIS . 85.4 mt -63.7 -42.69 97.95 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.238 0.542 . . . . 0.0 111.51 176.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 218' ' ' THR . . . . . . . . . . . . . 75.9 p -74.11 -16.03 61.03 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.911 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 79.29 72.56 1.18 Allowed Glycine 0 CA--C 1.528 0.862 0 N-CA-C 106.517 -2.633 . . . . 0.0 106.517 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 220' ' ' THR . . . . . . . . . . . . . 93.2 m -151.85 98.2 2.44 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.586 1.328 . . . . 0.0 114.586 177.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -56.13 139.76 46.29 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.204 -177.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 43.1 tp -116.64 120.58 39.1 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.184 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 3.5 mp -109.13 129.23 64.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.241 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 224' ' ' ILE . . . . . 0.568 ' CG2' HD11 ' B' ' 227' ' ' ILE . 49.7 mm -111.7 126.94 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.57 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 44.5 p -134.78 157.77 45.88 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 91.07 17.55 50.57 Favored Glycine 0 CA--C 1.498 -1.027 0 CA-C-N 113.949 -1.478 . . . . 0.0 110.534 -177.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 227' ' ' ILE . . . . . 0.568 HD11 ' CG2' ' B' ' 224' ' ' ILE . 95.7 mt -83.59 125.77 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 O-C-N 121.363 -1.08 . . . . 0.0 111.355 -179.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 56.2 tttt -63.93 139.67 97.7 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.368 -178.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.77 -37.17 92.1 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 121.297 1.331 . . . . 0.0 112.539 178.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -63.83 -43.32 96.54 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 52.0 tp -61.87 -41.78 98.27 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.913 -178.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.03 -36.51 84.24 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.801 0.334 . . . . 0.0 111.139 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 94.5 mtp -64.47 -40.64 96.07 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.78 -43.93 97.51 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 122.107 0.956 . . . . 0.0 109.004 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 33.5 mmt -63.82 -34.96 79.09 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.989 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -61.81 -40.21 94.44 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.774 -178.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.27 -43.85 96.79 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.156 178.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 52.5 tp -62.92 -44.75 95.24 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 120.137 -0.625 . . . . 0.0 112.039 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -156.51 132.32 9.62 Favored 'General case' 0 CA--C 1.511 -0.526 0 C-N-CA 120.551 -0.46 . . . . 0.0 112.001 -179.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 240' ' ' ALA . . . . . 0.4 ' O ' ' N ' ' B' ' 242' ' ' PHE . . . -61.93 -47.94 82.66 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 176.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 241' ' ' ASN . . . . . 0.448 ' O ' ' HB2' ' B' ' 244' ' ' SER . 92.7 m-20 -42.69 -18.28 0.01 OUTLIER 'General case' 0 C--O 1.217 -0.615 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.556 -176.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 242' ' ' PHE . . . . . 0.4 ' N ' ' O ' ' B' ' 240' ' ' ALA . 89.1 t80 -60.81 -44.58 96.69 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 119.801 -0.759 . . . . 0.0 109.906 178.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 243' ' ' SER . . . . . . . . . . . . . 78.4 p -58.85 -42.42 89.31 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 -178.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 244' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 20.5 m -33.84 -33.04 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 99.1 mt -91.69 130.37 37.5 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 121.458 -0.776 . . . . 0.0 111.889 177.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -57.59 134.76 56.42 Favored 'General case' 0 CA--C 1.502 -0.881 0 O-C-N 121.317 -0.864 . . . . 0.0 111.726 -175.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 247' ' ' THR . . . . . 0.566 HG23 HD12 ' B' ' 227' ' ' ILE . 96.3 m -125.25 127.66 47.08 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.151 -0.931 . . . . 0.0 111.917 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 248' ' ' TYR . . . . . 0.49 ' CG ' ' HB2' ' B' ' 254' ' ' ALA . 97.6 m-85 -112.98 144.26 42.86 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 177.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 249' ' ' SER . . . . . 0.595 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 79.4 p -64.23 -33.46 75.86 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.218 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 250' ' ' ASN . . . . . 0.595 ' OD1' ' O ' ' B' ' 249' ' ' SER . 98.8 m-20 -147.94 159.61 43.69 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 124.509 1.13 . . . . 0.0 111.937 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 77.7 t -64.34 -44.15 97.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.443 -0.798 . . . . 0.0 112.293 178.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 252' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -60.78 -46.15 91.61 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -177.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . 0.594 ' O ' HG22 ' B' ' 257' ' ' VAL . 94.3 m-20 -61.37 -43.05 99.53 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.924 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 254' ' ' ALA . . . . . 0.49 ' HB2' ' CG ' ' B' ' 248' ' ' TYR . . . -65.85 -40.25 91.54 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 120.185 -0.606 . . . . 0.0 110.913 178.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 255' ' ' VAL . . . . . 0.617 HG13 HH11 ' A' ' 154' ' ' ARG . 67.3 t -65.14 -45.71 93.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 C-N-CA 120.525 -0.47 . . . . 0.0 111.043 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.56 -48.55 78.98 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 120.204 -0.598 . . . . 0.0 111.614 -178.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 257' ' ' VAL . . . . . 0.594 HG22 ' O ' ' B' ' 253' ' ' ASP . 32.6 m -65.22 -40.63 89.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 114.678 -1.146 . . . . 0.0 111.302 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 258' ' ' LEU . . . . . 0.523 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 1.6 mt -32.25 -73.76 0.05 OUTLIER Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.589 -177.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 259' ' ' PRO . . . . . 0.523 ' CD ' ' CB ' ' B' ' 258' ' ' LEU . 36.3 Cg_endo -61.76 140.76 87.62 Favored 'Trans proline' 0 N--CA 1.505 2.155 0 C-N-CA 121.49 1.46 . . . . 0.0 111.133 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 260' ' ' ILE . . . . . 0.56 ' O ' HG22 ' B' ' 260' ' ' ILE . 96.7 mt -159.11 -13.82 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 O-C-N 121.33 -0.856 . . . . 0.0 112.204 177.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 C--O 1.216 -0.71 0 CA-C-O 117.792 -1.099 . . . . 0.0 111.353 -179.381 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 900' ' ' FMN . . . . . 0.498 HM73 ' N ' ' A' ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 900' ' ' FMN . . . . . 0.516 HM73 ' N ' ' B' ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.026 -1.629 . . . . 0.0 109.026 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.413 ' O ' ' OG ' ' A' ' 6' ' ' SER . . . -152.2 165.07 35.99 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.373 0.606 . . . . 0.0 110.201 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 80.8 p -70.53 -18.28 62.94 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.084 -1.01 . . . . 0.0 112.112 177.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -71.75 -65.07 0.81 Allowed 'General case' 0 CA--C 1.549 0.923 0 CA-C-N 114.18 -1.373 . . . . 0.0 112.574 174.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -68.1 -37.77 81.55 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.99 0.424 . . . . 0.0 112.089 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.518 ' O ' ' HB3' ' A' ' 7' ' ' PHE . 70.9 m -59.44 -42.17 91.31 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -177.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.518 ' HB3' ' O ' ' A' ' 6' ' ' SER . 42.5 t80 83.95 86.93 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.134 0.493 . . . . 0.0 111.865 176.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.603 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -62.49 -142.92 0.01 OUTLIER Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 -178.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.603 ' HB ' ' O ' ' A' ' 8' ' ' GLY . 74.5 mt 85.64 110.27 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 122.701 0.4 . . . . 0.0 110.538 -178.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -63.7 -22.35 69.82 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 121.389 1.393 . . . . 0.0 112.175 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.417 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -63.83 -38.22 95.82 Favored Glycine 0 N--CA 1.467 0.706 0 C-N-CA 121.138 -0.553 . . . . 0.0 111.919 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -65.18 -39.27 92.66 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 121.41 0.624 . . . . 0.0 109.614 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.2 tp -63.44 -41.15 98.67 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -63.73 -40.31 96.44 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 11' ' ' GLY . 56.3 t -60.31 -44.36 95.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 O-C-N 122.199 -0.313 . . . . 0.0 110.892 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 92.2 mt -62.78 -43.61 98.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.407 -178.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.27 -46.04 90.58 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 119.491 -0.883 . . . . 0.0 112.119 -179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.503 ' HZ1' HG12 ' B' ' 113' ' ' ILE . 98.4 mttt -60.39 -39.86 88.83 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 118.51 -1.276 . . . . 0.0 109.187 -176.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.84 -42.1 92.83 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.286 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 20' ' ' LEU . 87.8 mt -62.83 -40.95 99.0 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 178.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -63.92 -37.65 88.19 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.505 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 60.0 m170 -58.55 -40.15 82.2 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 122.221 -0.299 . . . . 0.0 111.417 -178.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.3 p -114.4 130.01 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.517 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 36.2 ptt180 -71.85 110.46 6.38 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-O 122.016 0.912 . . . . 0.0 112.229 -177.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.9 p -141.31 144.13 26.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 123' ' ' GLN . . . -97.55 90.99 1.14 Allowed Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.786 -178.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 51.4 t -124.23 129.26 74.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 176.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.7 m -137.49 159.78 34.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.7 mt -121.71 130.36 74.67 Favored 'Isoleucine or valine' 0 C--O 1.245 0.868 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 177.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.4 p -106.35 167.85 9.55 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.448 ' C ' ' OD1' ' A' ' 37' ' ' ASN . 44.0 t0 -134.5 102.42 11.62 Favored Pre-proline 0 C--N 1.32 -0.716 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.389 179.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.478 ' HG3' HG23 ' A' ' 117' ' ' THR . 36.4 Cg_endo -63.17 -23.08 73.07 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 121.453 1.436 . . . . 0.0 111.503 -178.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.97 -35.88 81.63 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.66 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.413 ' HB2' ' HD2' ' A' ' 38' ' ' PRO . 95.2 mt -84.31 157.35 21.54 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.498 177.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.71 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 43.3 tt0 -58.37 136.01 57.33 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -176.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.566 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 62.4 t0 60.29 22.8 12.25 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 179.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.448 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 42.4 t-20 38.16 70.06 1.35 Allowed Pre-proline 0 CA--C 1.543 0.69 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.244 -176.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.71 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 92.7 Cg_endo -71.13 156.3 59.8 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 123.948 3.099 . . . . 0.0 112.121 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.6 mt -88.1 125.22 41.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.439 HG23 ' N ' ' A' ' 41' ' ' TYR . 33.9 m -104.8 -42.59 7.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.025 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.439 ' N ' HG23 ' A' ' 40' ' ' VAL . 48.9 t80 -97.68 123.76 41.73 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 120.228 -0.589 . . . . 0.0 111.809 -177.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.9 p -143.06 140.85 26.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 124.303 1.002 . . . . 0.0 109.215 177.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.599 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 57.3 p30 -98.41 166.99 11.11 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.517 ' OE1' ' HA ' ' A' ' 44' ' ' GLN . 13.2 mm100 -66.4 -38.81 88.33 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 120.988 0.423 . . . . 0.0 111.933 177.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.27 -26.86 64.47 Favored Glycine 0 C--N 1.332 0.313 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.659 ' CD2' HD13 ' A' ' 57' ' ' ILE . 66.3 t80 -59.03 -48.43 81.63 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.603 HG13 ' O ' ' A' ' 52' ' ' TYR . 61.3 t -59.41 -45.09 93.82 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.556 0 O-C-N 121.312 -0.868 . . . . 0.0 111.573 -174.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -63.64 -37.73 88.44 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 120.412 -0.515 . . . . 0.0 112.383 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 60.4 ttm -66.65 -43.01 85.76 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 114.258 1.206 . . . . 0.0 114.258 176.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 34.9 p -93.75 -20.4 20.15 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.272 0.558 . . . . 0.0 111.453 -177.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.28 21.6 72.75 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.603 ' O ' HG13 ' A' ' 47' ' ' VAL . 81.1 m-85 -115.9 138.21 51.38 Favored 'General case' 0 C--O 1.221 -0.435 0 C-N-CA 122.909 0.484 . . . . 0.0 111.213 179.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -63.65 148.24 49.51 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.662 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.451 HG22 ' H ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -65.57 -32.36 73.9 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -66.21 -45.01 82.25 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 119.351 -0.94 . . . . 0.0 111.359 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -63.47 -45.44 90.8 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 119.939 -0.704 . . . . 0.0 109.749 178.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.659 HD13 ' CD2' ' A' ' 46' ' ' PHE . 90.6 mt -62.1 -48.99 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -175.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 79.0 mt -57.11 146.04 29.01 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 176.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 82.96 -3.91 82.27 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.875 -0.679 . . . . 0.0 113.121 177.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -137.47 151.7 48.75 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.879 1.34 . . . . 0.0 111.9 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.556 ' C ' ' H ' ' A' ' 63' ' ' ARG . 25.6 t-20 -81.23 151.92 27.91 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.701 -178.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 83.6 m -63.67 16.44 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.276 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.556 ' H ' ' C ' ' A' ' 61' ' ' ASN . 36.4 ptt-85 -62.47 -40.81 97.85 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 122.054 -0.404 . . . . 0.0 111.282 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -56.03 -21.53 22.12 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 84.0 mt -68.22 -35.24 77.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 122.003 0.906 . . . . 0.0 113.011 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -65.12 143.05 58.14 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.904 -1.044 . . . . 0.0 112.238 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.534 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -154.2 -147.57 4.7 Favored Glycine 0 CA--C 1.538 1.484 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 -177.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -63.21 -41.1 99.1 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -177.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.446 ' O ' ' OE1' ' A' ' 93' ' ' GLN . 10.8 m-70 -77.1 -8.56 57.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.955 0.407 . . . . 0.0 111.086 -177.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.534 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 26.6 m -63.04 130.28 44.01 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.657 -178.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -85.4 109.55 22.4 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.8 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 70' ' ' THR . 50.9 Cg_exo -56.92 -32.08 91.44 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.023 1.815 . . . . 0.0 113.19 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.59 -39.64 94.1 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.975 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.485 ' OE1' ' HB ' ' A' ' 90' ' ' VAL . 78.9 mm-40 -65.84 -43.54 88.21 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.8 t -59.45 -43.83 91.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -176.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -63.88 -37.97 89.35 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.027 178.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -63.63 -39.67 94.95 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.243 0.544 . . . . 0.0 110.156 178.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.77 -44.47 98.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.154 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -63.01 -42.71 99.9 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 113.831 -1.531 . . . . 0.0 108.36 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 96.4 m -61.64 -48.85 78.99 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.04 -41.69 92.83 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 120.819 -0.352 . . . . 0.0 111.185 -172.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 83.0 mt -63.0 -39.55 95.11 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.025 -1.047 . . . . 0.0 111.319 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -64.17 -32.59 74.22 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 177.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -90.22 0.59 57.13 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.302 -178.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.2 tttt 45.46 35.94 2.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.55 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -119.13 143.8 34.79 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -61.39 143.39 97.66 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.62 1.546 . . . . 0.0 113.674 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -140.12 143.25 30.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.697 -177.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.897 HG23 ' OD1' ' A' ' 107' ' ' ASN . 99.9 m -128.46 120.59 27.14 Favored 'General case' 0 C--N 1.345 0.394 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 176.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.485 ' HB ' ' OE1' ' A' ' 74' ' ' GLU . 27.8 m -138.75 157.61 29.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.73 -0.214 . . . . 0.0 111.461 177.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -101.93 133.76 46.21 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 177.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.428 HG23 ' O ' ' A' ' 92' ' ' ILE . 19.0 tt -141.18 131.9 27.06 Favored 'Isoleucine or valine' 0 C--N 1.378 1.833 0 CA-C-N 121.61 2.005 . . . . 0.0 112.417 176.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.446 ' OE1' ' O ' ' A' ' 69' ' ' HIS . 85.7 mt-30 -64.6 133.74 52.9 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.884 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -134.85 158.57 43.87 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.8 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -116.5 134.7 54.54 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -178.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.514 ' HG3' ' CE1' ' A' ' 102' ' ' PHE . 99.1 mttt -83.7 -171.76 3.77 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.184 0.516 . . . . 0.0 111.76 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.46 -43.48 98.71 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.941 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.41 ' CG ' ' HG1' ' A' ' 100' ' ' THR . 42.5 p-10 -84.31 7.17 20.22 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.08 -0.4 87.5 Favored Glycine 0 N--CA 1.471 0.97 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.185 176.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.41 ' HG1' ' CG ' ' A' ' 98' ' ' ASP . 23.5 m -58.93 139.15 56.99 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 178.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.622 ' SD ' ' C ' ' A' ' 101' ' ' MET . 13.8 tmm? -105.06 127.28 52.81 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.593 0.235 . . . . 0.0 110.506 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.514 ' CE1' ' HG3' ' A' ' 96' ' ' LYS . 52.7 p90 -141.68 156.12 45.65 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.958 -177.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.721 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 24.4 m95 -88.66 143.98 26.58 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.547 HD21 ' HG2' ' A' ' 123' ' ' GLN . 56.4 t-20 -138.1 100.82 4.25 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -177.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.408 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 80.6 tt0 -66.32 136.57 56.0 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -177.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 40.3 tp -122.23 122.94 40.31 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.897 ' OD1' HG23 ' A' ' 89' ' ' THR . 97.8 m-20 -118.67 122.61 42.93 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 120.953 -0.299 . . . . 0.0 110.71 177.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 96.4 mt -120.31 128.64 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 O-C-N 123.535 0.522 . . . . 0.0 111.635 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -139.85 123.03 10.42 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-N 116.714 -0.221 . . . . 0.0 110.933 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -70.98 152.13 62.75 Favored 'Trans proline' 0 N--CA 1.497 1.712 0 C-N-CA 122.451 2.101 . . . . 0.0 112.368 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.661 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 66.8 mtt -122.82 154.32 38.38 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -128.74 94.12 3.78 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 176.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.462 ' CD1' HG22 ' B' ' 15' ' ' VAL . 96.1 mt -118.51 130.78 72.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.19 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 52.5 38.51 25.76 Favored 'General case' 0 CA--C 1.512 -0.501 0 O-C-N 121.414 -0.804 . . . . 0.0 111.774 176.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 58.27 30.22 19.18 Favored 'General case' 0 C--N 1.323 -0.576 0 O-C-N 123.844 0.715 . . . . 0.0 110.833 -178.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 61.3 mtpt -128.2 149.09 50.6 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.173 -0.676 . . . . 0.0 109.173 177.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.756 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 5.2 t -86.1 -172.25 3.98 Favored 'General case' 0 C--O 1.218 -0.58 0 CA-C-N 118.538 0.608 . . . . 0.0 109.514 -177.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.756 ' CD2' ' O ' ' A' ' 117' ' ' THR . 65.1 m-85 -171.69 156.26 4.26 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 175.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -131.34 146.49 52.31 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 174.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -134.94 135.18 53.17 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.483 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 177.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.464 ' HA3' ' H6 ' ' A' ' 900' ' ' FMN . . . -108.75 129.2 9.42 Favored Glycine 0 CA--C 1.499 -0.908 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 178.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 96.6 mt -118.41 129.57 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.547 ' HG2' HD21 ' A' ' 104' ' ' ASN . 13.9 mp0 -121.05 113.3 19.85 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 123.641 0.588 . . . . 0.0 109.609 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -113.57 112.79 24.12 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.959 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -62.39 128.22 35.01 Favored 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -175.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.478 HG22 ' O ' ' A' ' 126' ' ' ILE . 3.0 mt -93.53 2.29 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 113.511 -1.677 . . . . 0.0 110.199 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 20.1 m -60.56 -42.38 96.49 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.979 -1.076 . . . . 0.0 113.671 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.4 tptt -59.96 -42.34 93.87 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -178.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -63.01 -39.56 95.12 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.927 177.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.721 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.7 mttt -62.85 -40.79 98.54 Favored 'General case' 0 CA--C 1.502 -0.877 0 C-N-CA 118.292 -1.363 . . . . 0.0 110.621 -178.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -61.69 -37.93 85.92 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -178.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.672 ' CE2' HD11 ' A' ' 136' ' ' LEU . 90.7 t80 -61.67 -45.96 91.76 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.668 175.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.23 -38.93 92.81 Favored 'General case' 0 N--CA 1.462 0.152 0 C-N-CA 120.167 -0.613 . . . . 0.0 109.539 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.07 -40.21 95.02 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 52.7 tp -60.65 -43.86 97.1 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -176.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.672 HD11 ' CE2' ' A' ' 132' ' ' TYR . 84.9 mt -62.26 -40.87 97.63 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.948 -0.389 . . . . 0.0 109.948 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -61.84 -41.73 98.16 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 119.398 -0.921 . . . . 0.0 109.852 -178.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -60.81 -41.96 96.7 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -177.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.0 m -61.94 -41.14 97.63 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.877 176.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.454 ' O ' ' N ' ' A' ' 144' ' ' THR . 87.9 mt -63.49 -41.8 98.56 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.431 -0.508 . . . . 0.0 109.884 178.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 79.9 m -61.72 -45.59 93.3 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.271 -177.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -65.3 -39.67 92.83 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 94.7 mt -64.44 -43.57 96.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 113.991 -1.458 . . . . 0.0 111.365 176.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.454 ' N ' ' O ' ' A' ' 140' ' ' LEU . 99.3 m -62.49 -46.3 89.11 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 120.396 -0.522 . . . . 0.0 112.25 -178.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.45 -40.07 95.43 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 118.875 -1.13 . . . . 0.0 109.117 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 90.1 mt -63.61 -42.8 98.19 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.689 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.1 p -60.57 -37.17 80.43 Favored 'General case' 0 C--O 1.218 -0.564 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -178.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.453 ' C ' ' O ' ' A' ' 147' ' ' SER . 27.5 m -30.06 82.82 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.41 0 O-C-N 127.003 2.689 . . . . 0.0 106.123 -176.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.689 ' N ' ' O ' ' A' ' 147' ' ' SER . 21.8 Cg_exo -62.29 144.62 95.56 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 CA-C-O 122.749 1.062 . . . . 0.0 114.432 -174.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.649 ' O ' HG23 ' A' ' 151' ' ' VAL . 8.9 tp -121.26 135.33 61.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 102.575 -3.12 . . . . 0.0 102.575 176.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 150' ' ' ILE . 65.5 t -169.74 94.35 0.51 Allowed Pre-proline 0 CA--C 1.507 -0.703 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 176.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -62.56 137.71 65.94 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 N-CA-C 109.843 -0.868 . . . . 0.0 109.843 -178.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.659 ' O ' ' HD2' ' A' ' 154' ' ' ARG . 45.5 mm -68.28 -44.57 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 119.991 -0.683 . . . . 0.0 110.151 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.659 ' HD2' ' O ' ' A' ' 153' ' ' ILE . 0.7 OUTLIER -156.76 -157.55 0.7 Allowed 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.875 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -86.74 104.91 16.57 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.559 0.695 . . . . 0.0 111.521 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 90.65 8.65 65.39 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 114.069 -1.423 . . . . 0.0 110.063 -177.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.463 HG12 ' HB2' ' A' ' 189' ' ' TYR . 96.5 mt -125.96 124.17 65.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 175.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.651 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 42.2 m -131.95 152.14 51.28 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -137.52 140.66 41.24 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.494 177.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 19.9 tp -131.21 78.49 72.49 Favored Pre-proline 0 N--CA 1.469 0.512 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.358 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -69.83 150.57 67.98 Favored 'Trans proline' 0 N--CA 1.498 1.757 0 C-N-CA 122.719 2.279 . . . . 0.0 113.033 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 92.3 mt -119.36 126.27 51.01 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 115.012 -0.995 . . . . 0.0 111.241 178.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 49.0 t -122.37 130.74 74.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 117.24 169.12 14.88 Favored Glycine 0 N--CA 1.48 1.619 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.3 178.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.876 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 53.6 t30 -86.19 114.7 23.23 Favored 'General case' 0 C--O 1.214 -0.803 0 CA-C-N 116.972 0.386 . . . . 0.0 110.109 -178.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.588 HD21 ' CZ ' ' A' ' 171' ' ' PHE . 47.1 tp -74.31 105.29 5.41 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 -177.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.65 HG23 ' NE ' ' A' ' 170' ' ' ARG . 11.4 p -87.8 167.41 13.83 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.146 0.498 . . . . 0.0 110.489 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.88 -33.96 77.26 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.92 0.39 . . . . 0.0 111.862 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.58 -42.72 95.42 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.484 178.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.876 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 87.3 mtm180 -64.93 -33.65 76.52 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 124.169 0.988 . . . . 0.0 112.884 178.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.588 ' CZ ' HD21 ' A' ' 166' ' ' LEU . 0.4 OUTLIER -54.73 -28.32 47.29 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 118.913 -0.565 . . . . 0.0 112.39 -178.128 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.634 ' O ' HG22 ' A' ' 175' ' ' VAL . 90.2 m-20 -61.07 -40.69 94.64 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 118.892 -1.123 . . . . 0.0 109.939 -178.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 70.2 m -59.15 -41.41 88.25 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.71 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 67.3 mt -63.67 -44.01 98.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 172' ' ' ASN . 33.9 m -62.56 -40.63 89.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . 0.436 ' N ' HG23 ' A' ' 175' ' ' VAL . 97.7 m -62.27 -34.2 76.1 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.131 0.491 . . . . 0.0 110.435 177.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.501 ' O ' HG13 ' A' ' 181' ' ' ILE . 25.1 m -61.96 -19.74 63.09 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.026 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.624 ' CD2' HD21 ' A' ' 211' ' ' LEU . 85.6 mt -61.04 -40.89 95.32 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -177.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 18.9 m -59.11 -43.28 91.88 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.586 ' O ' ' OG ' ' A' ' 183' ' ' SER . 90.8 m-20 -61.92 -37.6 85.29 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-O 120.773 0.32 . . . . 0.0 110.829 178.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 177' ' ' THR . 70.3 mt -56.77 -37.17 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 121.515 -0.741 . . . . 0.0 109.765 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.509 HD21 HD21 ' A' ' 214' ' ' LEU . 85.9 mt -61.28 -40.74 95.26 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -177.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.586 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 78.1 p -62.22 -35.38 78.71 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.406 177.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 39.2 p -88.63 25.11 1.8 Allowed 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.65 0.262 . . . . 0.0 111.456 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 78.1 p -65.36 -20.01 66.2 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.732 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.37 -37.46 80.8 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.986 -178.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.651 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 99.0 m-20 -72.73 114.26 10.68 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.489 0.662 . . . . 0.0 110.924 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.13 -42.05 99.42 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.926 -177.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . 0.463 ' HB2' HG12 ' A' ' 157' ' ' ILE . 97.1 m-85 -112.02 131.23 55.54 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.873 -178.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 38.0 tp -121.14 128.37 52.46 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 96.7 mt -117.33 128.4 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.9 mm -114.22 128.33 71.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . 0.524 ' CG ' ' HG ' ' A' ' 195' ' ' SER . 40.1 t0 -96.09 119.54 34.77 Favored 'General case' 0 CA--C 1.552 1.037 0 O-C-N 121.873 -0.517 . . . . 0.0 110.474 177.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 99.0 mt -98.38 -4.56 34.55 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.593 175.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.524 ' HG ' ' CG ' ' A' ' 193' ' ' ASP . 78.1 p -62.35 -33.46 74.76 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -62.42 -44.09 98.12 Favored Glycine 0 CA--C 1.534 1.243 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.938 HD23 ' N ' ' A' ' 198' ' ' ALA . 4.8 tt -68.96 128.51 36.96 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 112.788 -1.706 . . . . 0.0 108.495 -177.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.938 ' N ' HD23 ' A' ' 197' ' ' LEU . . . -59.68 -48.96 79.62 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-O 121.196 0.522 . . . . 0.0 110.703 -177.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.906 ' O ' ' CD2' ' A' ' 197' ' ' LEU . 57.9 tt0 -136.22 158.51 44.23 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 114.444 -1.253 . . . . 0.0 113.506 -173.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.47 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 46.9 t -118.72 132.28 69.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -89.53 156.79 18.39 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.296 -178.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.27 -39.94 94.97 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.104 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -57.59 -32.62 67.37 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.9 m -61.64 -42.24 98.62 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.609 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.448 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -57.5 -39.03 75.59 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -176.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -61.06 -36.35 79.38 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -64.81 -39.08 93.01 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.998 177.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 95.3 mt -63.29 -44.49 99.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -178.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . 0.448 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 75.1 m-85 -62.32 -43.36 98.99 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.6 -177.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.52 -41.93 99.18 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 119.07 -1.052 . . . . 0.0 109.105 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.624 HD21 ' CD2' ' A' ' 178' ' ' LEU . 38.3 mt -62.25 -41.5 98.5 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 78.2 p -61.36 -42.25 98.39 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.084 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' HIS . . . . . 0.502 ' CE1' HD11 ' A' ' 217' ' ' LEU . 57.7 t-80 -64.55 -45.66 86.14 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 120.626 -0.43 . . . . 0.0 111.372 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.509 HD21 HD21 ' A' ' 182' ' ' LEU . 47.8 tp -62.5 -45.76 91.51 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 118.909 -1.116 . . . . 0.0 108.379 179.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 211' ' ' LEU . 90.4 mt -62.74 -40.76 98.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.141 -177.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.62 -44.54 96.22 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.174 -0.61 . . . . 0.0 109.751 -178.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.502 HD11 ' CE1' ' A' ' 213' ' ' HIS . 84.5 mt -61.91 -39.88 93.54 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 66.8 p -74.95 -11.65 60.17 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.508 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.32 36.32 17.84 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 120.6 -0.809 . . . . 0.0 113.715 -178.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 97.0 m -123.21 117.29 24.98 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 119.174 1.487 . . . . 0.0 111.708 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -68.21 137.2 54.62 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.42 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 43.6 tp -111.81 130.86 55.67 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 2.8 mp -117.83 134.29 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.616 ' CG2' HD11 ' A' ' 227' ' ' ILE . 49.5 mm -115.67 131.31 68.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -178.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 44.2 p -134.3 165.57 24.81 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 120.666 -0.414 . . . . 0.0 111.916 -177.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 78.66 21.78 68.31 Favored Glycine 0 N--CA 1.464 0.528 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.677 HD12 HG23 ' A' ' 247' ' ' THR . 97.7 mt -83.83 128.22 39.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 113.87 -1.165 . . . . 0.0 108.291 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -77.4 141.07 65.44 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.33 -39.77 85.63 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 120.984 1.122 . . . . 0.0 112.629 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -63.04 -39.71 95.56 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.356 0.598 . . . . 0.0 110.16 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 52.4 tp -63.67 -42.64 98.02 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.904 177.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.45 -37.8 88.79 Favored 'General case' 0 CA--C 1.522 -0.109 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.991 -178.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 94.0 mtp -63.22 -41.3 99.11 Favored 'General case' 0 C--O 1.248 0.989 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.917 -178.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.96 -38.45 91.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.519 176.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 31.9 mmt -65.79 -37.61 86.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.576 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 39.3 t30 -61.11 -42.33 98.32 Favored 'General case' 0 CA--C 1.516 -0.33 0 O-C-N 121.55 -0.719 . . . . 0.0 109.401 -176.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.66 -41.59 95.34 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.524 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 54.5 tp -63.3 -41.5 98.96 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 177.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -167.58 124.26 1.14 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.299 0.571 . . . . 0.0 112.507 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.36 -26.6 65.21 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.55 -1.205 . . . . 0.0 110.625 178.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -62.37 -28.93 70.11 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.729 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -56.69 -44.51 81.56 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -176.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 95.2 p -60.93 -20.07 61.63 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 123.8 0.688 . . . . 0.0 111.15 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 31.1 m -55.79 -40.21 72.35 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 97.1 mt -81.4 122.44 27.49 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -43.1 133.51 3.83 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.028 177.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.677 HG23 HD12 ' A' ' 227' ' ' ILE . 93.8 m -127.48 133.83 49.86 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.89 177.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' TYR . . . . . 0.407 ' CG ' ' HB2' ' A' ' 254' ' ' ALA . 97.7 m-85 -119.02 139.65 51.35 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.173 179.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 78.0 p -61.86 -42.63 99.29 Favored 'General case' 0 CA--C 1.505 -0.774 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -178.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -141.83 158.73 43.44 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.776 0.798 . . . . 0.0 111.641 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 63.3 t -62.39 -44.69 99.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-N 114.668 -1.151 . . . . 0.0 112.22 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.82 -44.18 97.25 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.207 -0.597 . . . . 0.0 109.434 -178.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . 0.573 ' O ' HG22 ' A' ' 257' ' ' VAL . 55.3 m-20 -63.87 -41.02 97.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.375 -178.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.407 ' HB2' ' CG ' ' A' ' 248' ' ' TYR . . . -64.2 -44.64 91.34 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.895 0.855 . . . . 0.0 109.832 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . 0.427 ' O ' ' HD2' ' A' ' 259' ' ' PRO . 76.6 t -63.18 -45.84 97.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 113.944 -1.48 . . . . 0.0 110.912 -178.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.33 -46.55 86.1 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.141 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.573 HG22 ' O ' ' A' ' 253' ' ' ASP . 32.1 m -68.11 -40.72 83.43 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 O-C-N 121.489 -0.757 . . . . 0.0 111.923 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.498 ' C ' ' O ' ' A' ' 257' ' ' VAL . 1.5 mt -29.49 -74.46 0.04 OUTLIER Pre-proline 0 C--O 1.234 0.237 0 C-N-CA 121.047 -0.261 . . . . 0.0 111.538 -177.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' PRO . . . . . 0.491 ' O ' HG13 ' A' ' 260' ' ' ILE . 43.6 Cg_endo -63.57 140.34 74.79 Favored 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 120.778 0.986 . . . . 0.0 111.96 -179.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.491 HG13 ' O ' ' A' ' 259' ' ' PRO . 96.6 mt -153.15 -29.5 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 123.914 0.759 . . . . 0.0 111.883 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 78.0 mtm . . . . . 0 N--CA 1.474 0.751 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.567 -176.831 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.434 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.11 155.45 34.05 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 81.0 p -57.98 -27.58 63.59 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.784 176.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -65.54 -63.58 1.06 Allowed 'General case' 0 N--CA 1.437 -1.114 0 CA-C-O 121.004 0.43 . . . . 0.0 111.7 178.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -66.72 -38.06 85.94 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.323 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.523 ' O ' ' HB3' ' B' ' 7' ' ' PHE . 69.4 m -59.8 -42.53 93.63 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.877 -177.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . 0.523 ' HB3' ' O ' ' B' ' 6' ' ' SER . 43.7 t80 84.83 90.85 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.387 177.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . 0.606 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -65.45 -142.6 0.04 OUTLIER Glycine 0 C--N 1.339 0.703 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.606 ' HB ' ' O ' ' B' ' 8' ' ' GLY . 74.1 mt 85.33 110.49 0.03 OUTLIER Pre-proline 0 CA--C 1.545 0.774 0 C-N-CA 122.634 0.374 . . . . 0.0 110.88 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -62.9 -24.42 74.24 Favored 'Trans proline' 0 N--CA 1.498 1.791 0 C-N-CA 121.314 1.343 . . . . 0.0 111.864 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.14 -40.75 98.98 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 111.072 -0.811 . . . . 0.0 111.072 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -64.21 -39.84 94.82 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.676 0.75 . . . . 0.0 109.292 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 49.2 tp -61.9 -42.38 99.01 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.419 -177.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -65.24 -32.82 74.68 Favored 'General case' 0 CA--C 1.562 1.413 0 CA-C-O 121.489 0.661 . . . . 0.0 110.624 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . 0.462 HG22 ' CD1' ' A' ' 113' ' ' ILE . 72.7 t -62.24 -46.48 96.34 Favored 'Isoleucine or valine' 0 C--O 1.244 0.774 0 CA-C-N 113.189 -1.823 . . . . 0.0 110.851 177.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 93.1 mt -64.08 -43.76 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.069 -178.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . 0.45 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 99.0 mttt -63.46 -42.07 98.63 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.52 -41.43 98.5 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 118.838 -1.145 . . . . 0.0 110.142 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.52 -39.01 86.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.891 -178.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' B' ' 20' ' ' LEU . 87.9 mt -63.9 -42.25 97.48 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.369 0.604 . . . . 0.0 110.345 175.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -63.15 -38.47 91.28 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.019 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 57.7 m170 -57.43 -40.27 78.0 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 119.54 -0.267 . . . . 0.0 111.467 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 10.0 p -114.45 129.72 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.534 ' O ' ' HG3' ' B' ' 24' ' ' ARG . 36.0 ptt180 -71.43 108.59 4.93 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.736 0.779 . . . . 0.0 112.538 -177.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.9 p -143.11 134.16 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.857 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.602 177.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . 0.445 ' HA3' ' HB2' ' B' ' 123' ' ' GLN . . . -86.5 95.89 2.09 Favored Glycine 0 C--N 1.313 -0.742 0 C-N-CA 119.555 -1.307 . . . . 0.0 113.393 -177.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 47.0 t -125.34 128.62 72.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 174.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 34.6 m -139.09 157.23 28.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.48 178.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 96.1 mt -120.54 128.58 76.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 O-C-N 123.721 0.638 . . . . 0.0 111.787 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 23.2 p -108.69 157.24 18.72 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-N 112.819 -1.991 . . . . 0.0 108.602 -176.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.435 ' C ' ' OD1' ' B' ' 37' ' ' ASN . 43.3 t0 -125.46 102.97 29.2 Favored Pre-proline 0 CA--C 1.531 0.222 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -178.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 117' ' ' THR . 37.0 Cg_endo -64.14 -22.12 67.51 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 121.694 1.596 . . . . 0.0 111.431 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.84 -45.69 93.52 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.229 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 98.7 mt -70.64 176.88 3.82 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.786 -0.571 . . . . 0.0 111.404 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . 0.549 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 42.1 tt0 -78.23 131.37 37.1 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -175.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.516 ' O ' ' OD1' ' B' ' 36' ' ' ASP . 66.7 t0 58.2 36.91 26.12 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.582 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' ASN . . . . . 0.467 ' C ' ' O ' ' B' ' 36' ' ' ASP . 32.7 t-20 28.09 73.1 0.41 Allowed Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.549 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 91.9 Cg_endo -72.98 155.33 52.94 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 123.578 2.852 . . . . 0.0 111.732 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 96.3 mt -86.54 130.02 37.39 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.412 HG23 ' N ' ' B' ' 41' ' ' TYR . 34.5 m -109.39 -42.12 5.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 O-C-N 123.708 0.63 . . . . 0.0 112.378 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' TYR . . . . . 0.412 ' N ' HG23 ' B' ' 40' ' ' VAL . 51.2 t80 -98.73 124.1 43.36 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 120.297 -0.561 . . . . 0.0 111.485 -178.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 5.1 p -143.08 142.13 26.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 O-C-N 124.046 0.841 . . . . 0.0 109.279 177.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . 0.642 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 57.0 p30 -102.64 162.08 13.21 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.212 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' GLN . . . . . 0.506 ' OE1' ' HA ' ' B' ' 44' ' ' GLN . 12.7 mm100 -62.8 -37.42 86.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.373 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.41 -27.43 65.69 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.677 ' CE2' HD13 ' B' ' 57' ' ' ILE . 62.4 t80 -59.91 -43.52 94.83 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 0.752 HG13 ' O ' ' B' ' 52' ' ' TYR . 66.1 t -61.71 -46.61 96.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.218 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -63.67 -44.36 93.97 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.013 -0.675 . . . . 0.0 110.439 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 60.6 ttm -62.86 -41.99 99.59 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 32.2 p -96.04 -14.86 22.62 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 120.35 -0.54 . . . . 0.0 112.017 -177.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.54 19.96 79.27 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 177.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . 0.752 ' O ' HG13 ' B' ' 47' ' ' VAL . 81.9 m-85 -112.99 144.94 41.71 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 122.897 0.479 . . . . 0.0 110.128 178.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -73.62 148.58 42.74 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-O 121.884 0.85 . . . . 0.0 111.013 179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . 0.431 ' H ' HG22 ' B' ' 54' ' ' THR . 0.1 OUTLIER -63.15 -35.63 80.94 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.127 -177.466 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.41 -40.79 96.46 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.568 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -72.43 -32.73 66.56 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 177.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.677 HD13 ' CE2' ' B' ' 46' ' ' PHE . 93.5 mt -66.1 -73.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' B' ' 57' ' ' ILE . 94.6 mt -35.27 132.51 0.38 Allowed 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.362 174.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.85 -9.16 73.43 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.831 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -136.71 149.14 47.73 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -174.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' ASN . . . . . 0.514 ' C ' ' H ' ' B' ' 63' ' ' ARG . 25.9 t-20 -78.72 152.09 31.75 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.889 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' CYS . . . . . . . . . . . . . 82.8 m -64.53 8.67 0.1 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.342 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . 0.514 ' H ' ' C ' ' B' ' 61' ' ' ASN . 34.6 ptt-85 -58.85 -30.95 68.08 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.487 -178.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -61.55 -30.78 70.86 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 81.0 mt -61.76 -42.77 99.41 Favored 'General case' 0 C--O 1.24 0.589 0 O-C-N 122.005 -0.435 . . . . 0.0 109.87 -178.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -49.99 148.93 2.96 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 123.7 0.625 . . . . 0.0 109.846 -177.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . 0.48 ' N ' ' OG1' ' B' ' 70' ' ' THR . . . -160.57 -151.36 6.18 Favored Glycine 0 CA--C 1.54 1.656 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.339 175.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.4 -41.88 94.8 Favored 'General case' 0 N--CA 1.472 0.642 0 O-C-N 122.659 -0.318 . . . . 0.0 111.738 -175.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -75.81 -9.56 58.7 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 123.169 0.293 . . . . 0.0 111.406 -178.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' THR . . . . . 0.48 ' OG1' ' N ' ' B' ' 67' ' ' GLY . 24.5 m -61.35 135.79 57.82 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -91.08 109.28 34.25 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.283 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.96 -38.69 86.51 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 120.884 1.056 . . . . 0.0 111.888 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.52 -40.38 91.23 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 120.527 -0.469 . . . . 0.0 109.798 -176.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' GLU . . . . . 0.477 ' OE1' ' HB ' ' B' ' 90' ' ' VAL . 78.8 mm-40 -66.87 -38.6 86.63 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.667 177.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 85.3 t -61.74 -46.01 97.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -62.91 -37.34 86.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.738 -178.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -62.57 -41.96 99.26 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 119.359 -0.936 . . . . 0.0 108.672 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.47 -43.79 98.54 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.492 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.859 -178.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -62.48 -43.01 99.86 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 83.6 m -61.11 -45.29 95.3 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.965 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.53 -40.98 96.64 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 -177.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 80.2 mt -63.18 -41.79 99.27 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -62.22 -35.42 78.86 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . 0.424 ' O ' ' C ' ' B' ' 85' ' ' LYS . 98.5 m-20 -91.16 10.25 27.79 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.604 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' B' ' 84' ' ' ASN . 30.7 tttt 38.08 37.82 0.17 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 120.509 -0.477 . . . . 0.0 112.037 176.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -120.66 140.69 30.94 Favored Pre-proline 0 N--CA 1.469 0.487 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.96 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' PRO . . . . . 0.401 ' HB3' ' OD2' ' B' ' 109' ' ' ASP . 27.0 Cg_exo -61.63 140.29 85.75 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 121.006 1.137 . . . . 0.0 114.011 -177.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -140.94 137.44 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -177.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' THR . . . . . 0.877 HG23 ' OD1' ' B' ' 107' ' ' ASN . 97.0 m -121.65 122.78 40.37 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.477 ' HB ' ' OE1' ' B' ' 74' ' ' GLU . 28.2 m -139.04 163.2 27.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.859 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -114.71 122.4 46.31 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.189 0.519 . . . . 0.0 109.638 175.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . 0.472 HD11 HG23 ' B' ' 70' ' ' THR . 20.5 tt -128.9 132.58 67.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 114.999 -1.0 . . . . 0.0 112.038 -175.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.439 ' O ' ' ND2' ' B' ' 94' ' ' ASN . 84.0 mt-30 -71.9 144.01 49.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.613 177.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' ASN . . . . . 0.439 ' ND2' ' O ' ' B' ' 93' ' ' GLN . 8.2 m120 -135.48 -178.69 5.23 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.353 0.596 . . . . 0.0 110.989 -176.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -132.42 145.12 50.97 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 114.634 -1.167 . . . . 0.0 111.829 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . 0.507 ' HG3' ' CE1' ' B' ' 102' ' ' PHE . 98.7 mttt -102.47 179.59 4.26 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.0 0.429 . . . . 0.0 110.917 178.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -59.82 -35.49 74.84 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.17 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 38.4 p-10 -88.08 -0.67 57.33 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 119.0 0.818 . . . . 0.0 112.738 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.47 5.89 64.77 Favored Glycine 0 N--CA 1.465 0.607 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.209 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 25.7 m -67.68 129.63 40.49 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.508 177.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . 0.571 ' SD ' ' N ' ' B' ' 102' ' ' PHE . 14.9 tmm? -87.98 141.82 28.27 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' PHE . . . . . 0.571 ' N ' ' SD ' ' B' ' 101' ' ' MET . 53.2 p90 -154.81 162.08 41.24 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' TRP . . . . . 0.743 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 24.7 m95 -96.36 138.76 33.47 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.324 -0.551 . . . . 0.0 111.093 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . 0.51 HD21 ' HG2' ' B' ' 123' ' ' GLN . 64.0 t-20 -132.55 106.37 7.79 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 114.737 -1.119 . . . . 0.0 113.807 -177.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -75.49 123.92 26.28 Favored 'General case' 0 C--N 1.315 -0.91 0 O-C-N 124.286 0.992 . . . . 0.0 109.346 -179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 37.9 tp -111.61 126.02 54.56 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.075 0.464 . . . . 0.0 111.989 -177.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' ASN . . . . . 0.877 ' OD1' HG23 ' B' ' 89' ' ' THR . 97.6 m-20 -118.79 127.91 53.97 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 176.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 96.7 mt -123.79 133.11 70.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . 0.401 ' OD2' ' HB3' ' B' ' 87' ' ' PRO . 1.2 m-20 -146.6 120.9 5.23 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 178.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -69.48 153.34 70.35 Favored 'Trans proline' 0 N--CA 1.504 2.096 0 C-N-CA 122.581 2.187 . . . . 0.0 112.629 -178.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . 0.536 ' HB2' ' HB2' ' B' ' 118' ' ' TYR . 66.5 mtt -128.74 144.02 51.07 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 178.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -113.49 108.68 17.51 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 178.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . 0.503 HG12 ' HZ1' ' A' ' 18' ' ' LYS . 96.7 mt -134.6 128.3 50.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 O-C-N 121.64 -0.663 . . . . 0.0 111.736 177.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 52.89 38.66 27.46 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 123.974 0.796 . . . . 0.0 109.695 178.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 60.55 35.94 20.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.53 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -134.55 152.03 51.5 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' THR . . . . . 0.424 HG23 ' HG3' ' B' ' 32' ' ' PRO . 9.5 t -102.62 152.92 20.62 Favored 'General case' 0 C--O 1.214 -0.812 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.298 -177.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' TYR . . . . . 0.536 ' HB2' ' HB2' ' B' ' 111' ' ' MET . 95.2 m-85 -147.46 147.17 29.92 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 121.349 -0.844 . . . . 0.0 111.465 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -122.89 139.2 54.29 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 120.975 0.416 . . . . 0.0 111.57 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -128.85 134.33 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -176.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . 0.509 ' HA3' ' H6 ' ' B' ' 900' ' ' FMN . . . -109.87 125.14 7.45 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 122' ' ' ILE . . . . . 0.431 ' HB ' ' HB2' ' B' ' 107' ' ' ASN . 95.5 mt -114.84 127.75 72.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 123' ' ' GLN . . . . . 0.51 ' HG2' HD21 ' B' ' 104' ' ' ASN . 13.8 mp0 -119.8 118.5 30.99 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -116.75 120.28 38.07 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' B' ' 126' ' ' ILE . 68.0 t0 -67.65 133.8 49.99 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.225 -0.898 . . . . 0.0 112.465 -178.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.478 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 3.3 mt -107.49 16.16 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.626 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 127' ' ' THR . . . . . 0.439 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 97.8 m -63.45 -44.08 95.54 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 114.254 -1.339 . . . . 0.0 112.672 176.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 59.7 tptt -61.38 -45.79 92.87 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -177.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 129' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -62.75 -35.42 79.73 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.474 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 130' ' ' LYS . . . . . 0.743 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 98.8 mttt -63.13 -41.4 99.31 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 112.91 -1.95 . . . . 0.0 111.073 175.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.41 -41.89 96.38 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 132' ' ' TYR . . . . . 0.66 ' CE2' HD11 ' B' ' 136' ' ' LEU . 90.9 t80 -60.83 -44.76 96.51 Favored 'General case' 0 N--CA 1.454 -0.245 0 O-C-N 121.941 -0.474 . . . . 0.0 111.644 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.28 -36.56 84.49 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 119.966 -0.693 . . . . 0.0 109.75 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 134' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' B' ' 130' ' ' LYS . 98.9 mttt -63.29 -38.92 93.03 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.846 177.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 52.7 tp -62.55 -41.44 98.89 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.46 0.647 . . . . 0.0 109.385 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . 0.66 HD11 ' CE2' ' B' ' 132' ' ' TYR . 85.2 mt -63.03 -41.58 99.56 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.405 178.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 137' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.95 -37.74 88.52 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 113.89 -1.505 . . . . 0.0 110.237 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -63.19 -43.66 97.58 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 120.029 -0.668 . . . . 0.0 109.952 176.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 53.4 m -61.04 -44.63 97.12 Favored 'General case' 0 C--N 1.346 0.43 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 88.3 mt -61.55 -40.44 94.69 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -177.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 81.8 m -61.6 -45.37 94.38 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.961 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -66.16 -41.49 90.3 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 92.5 mt -63.69 -43.56 98.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.63 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 144' ' ' THR . . . . . . . . . . . . . 99.1 m -61.55 -45.18 95.24 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -178.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.12 -40.7 96.75 Favored 'General case' 0 C--O 1.227 -0.121 0 C-N-CA 119.192 -1.003 . . . . 0.0 109.331 179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 91.5 mt -64.18 -41.39 97.14 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 147' ' ' SER . . . . . 0.61 ' O ' ' N ' ' B' ' 149' ' ' PRO . 78.1 p -62.78 -42.25 99.62 Favored 'General case' 0 CA--C 1.477 -1.854 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . 0.508 ' C ' ' O ' ' B' ' 147' ' ' SER . 12.3 m -25.52 85.33 0.03 OUTLIER Pre-proline 0 N--CA 1.475 0.793 0 O-C-N 124.12 0.887 . . . . 0.0 110.165 176.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 149' ' ' PRO . . . . . 0.61 ' N ' ' O ' ' B' ' 147' ' ' SER . 23.8 Cg_exo -60.83 146.48 97.42 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.112 1.874 . . . . 0.0 115.897 -177.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 9.7 tp -128.36 119.33 50.24 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.148 0 CA-C-N 114.015 -1.448 . . . . 0.0 108.029 174.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 41.6 t -153.02 93.34 3.19 Favored Pre-proline 0 C--N 1.308 -1.197 0 C-N-CA 120.301 -0.56 . . . . 0.0 110.931 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -60.18 137.27 74.18 Favored 'Trans proline' 0 N--CA 1.488 1.181 0 CA-C-N 119.728 0.939 . . . . 0.0 109.727 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 153' ' ' ILE . . . . . 0.694 ' O ' ' HD2' ' B' ' 154' ' ' ARG . 44.5 mm -68.41 -43.3 84.18 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.499 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.351 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . 0.694 ' HD2' ' O ' ' B' ' 153' ' ' ILE . 0.8 OUTLIER -155.96 -155.92 0.59 Allowed 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.683 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 61.8 t-20 -86.84 109.73 19.49 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.87 -18.71 56.46 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -177.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 157' ' ' ILE . . . . . 0.43 HG22 ' HB ' ' B' ' 153' ' ' ILE . 88.0 mt -108.91 125.69 65.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.098 0.475 . . . . 0.0 111.036 -176.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . 0.647 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 57.9 m -134.96 149.77 50.27 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.933 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -132.91 146.96 52.26 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 24.3 tp -139.5 77.07 29.51 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 161' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -70.83 147.54 56.21 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.689 2.259 . . . . 0.0 114.083 -178.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 95.1 mt -113.97 133.99 55.13 Favored 'General case' 0 C--N 1.343 0.306 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 54.7 t -128.79 132.13 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 115.03 169.43 15.99 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 120.508 -0.854 . . . . 0.0 111.276 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 165' ' ' ASN . . . . . 0.688 ' O ' ' CZ ' ' B' ' 170' ' ' ARG . 59.2 t30 -91.5 106.55 18.57 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -177.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . 0.597 HD21 ' CZ ' ' B' ' 171' ' ' PHE . 47.5 tp -65.25 104.83 0.99 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -174.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 167' ' ' THR . . . . . 0.608 HG23 ' NE ' ' B' ' 170' ' ' ARG . 10.7 p -84.76 171.24 12.47 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 114.088 -1.414 . . . . 0.0 110.904 176.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -66.77 -37.69 85.1 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.671 177.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.51 -40.92 89.45 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-O 122.456 1.122 . . . . 0.0 111.962 -178.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 170' ' ' ARG . . . . . 0.688 ' CZ ' ' O ' ' B' ' 165' ' ' ASN . 87.6 mtm180 -62.07 -36.54 81.99 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 112.367 -2.197 . . . . 0.0 111.405 178.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 171' ' ' PHE . . . . . 0.597 ' CZ ' HD21 ' B' ' 166' ' ' LEU . 0.3 OUTLIER -54.08 -26.25 26.04 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -178.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 172' ' ' ASN . . . . . 0.569 ' O ' HG22 ' B' ' 175' ' ' VAL . 90.3 m-20 -62.58 -40.2 96.11 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.967 178.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 67.9 m -60.46 -41.7 94.69 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.095 0.474 . . . . 0.0 110.708 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 67.8 mt -64.17 -44.12 97.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 175' ' ' VAL . . . . . 0.569 HG22 ' O ' ' B' ' 172' ' ' ASN . 34.0 m -62.9 -40.59 89.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 176' ' ' CYS . . . . . 0.438 ' N ' HG23 ' B' ' 175' ' ' VAL . 99.5 m -62.27 -34.71 77.08 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.415 177.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 177' ' ' THR . . . . . 0.535 ' O ' HG13 ' B' ' 181' ' ' ILE . 25.2 m -61.53 -19.82 62.54 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-O 121.001 0.429 . . . . 0.0 110.213 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 178' ' ' LEU . . . . . 0.608 ' CD2' HD21 ' B' ' 211' ' ' LEU . 86.8 mt -61.1 -39.02 88.38 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.255 -178.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 19.2 m -60.94 -44.31 97.43 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.357 177.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 180' ' ' ASN . . . . . 0.563 ' O ' ' OG ' ' B' ' 183' ' ' SER . 91.2 m-20 -62.16 -40.38 95.79 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.682 0.277 . . . . 0.0 110.538 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.535 HG13 ' O ' ' B' ' 177' ' ' THR . 76.3 mt -55.45 -31.77 28.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.729 -177.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 182' ' ' LEU . . . . . 0.474 HD21 HD21 ' B' ' 214' ' ' LEU . 84.4 mt -62.42 -42.27 99.32 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.249 178.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . 0.563 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.0 p -63.53 -33.81 76.4 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 121.876 -0.515 . . . . 0.0 110.999 178.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 33.1 p -85.23 15.77 4.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.866 0.365 . . . . 0.0 111.899 -177.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 78.7 p -59.83 -16.42 28.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.977 -177.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.38 -40.59 94.89 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.946 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 187' ' ' ASP . . . . . 0.647 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.5 m-20 -69.97 114.37 8.07 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.535 0.684 . . . . 0.0 110.711 -178.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.9 -41.99 99.63 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-N 114.9 -1.046 . . . . 0.0 113.161 -177.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 189' ' ' TYR . . . . . 0.429 ' HB2' HG12 ' B' ' 157' ' ' ILE . 96.9 m-85 -111.45 130.7 55.63 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.197 -178.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 190' ' ' LEU . . . . . . . . . . . . . 40.5 tp -124.26 118.65 27.28 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.002 -0.545 . . . . 0.0 112.059 177.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 88.3 mt -107.81 127.71 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 120.613 0.244 . . . . 0.0 111.552 -177.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 49.2 mm -116.68 119.13 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 193' ' ' ASP . . . . . 0.525 ' CG ' ' HG ' ' B' ' 195' ' ' SER . 40.8 t0 -89.89 111.64 22.75 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 120.919 0.39 . . . . 0.0 111.739 -177.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 194' ' ' LEU . . . . . . . . . . . . . 98.4 mt -92.14 -2.42 56.59 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.32 175.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 195' ' ' SER . . . . . 0.525 ' HG ' ' CG ' ' B' ' 193' ' ' ASP . 78.3 p -61.25 -37.34 82.75 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 121.047 -0.261 . . . . 0.0 110.865 -179.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -62.18 -33.89 87.36 Favored Glycine 0 N--CA 1.438 -1.195 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 197' ' ' LEU . . . . . 1.012 HD23 ' N ' ' B' ' 198' ' ' ALA . 4.7 tt -77.97 133.32 38.05 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 121.962 -0.728 . . . . 0.0 109.323 -176.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 198' ' ' ALA . . . . . 1.012 ' N ' HD23 ' B' ' 197' ' ' LEU . . . -64.55 -42.23 95.82 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.361 -176.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 199' ' ' GLN . . . . . 0.943 ' H ' ' CD2' ' B' ' 197' ' ' LEU . 58.8 tt0 -140.48 165.02 28.57 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 121.623 0.725 . . . . 0.0 112.648 -178.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 200' ' ' VAL . . . . . 0.472 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 51.0 t -120.93 132.91 69.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 O-C-N 121.037 -1.04 . . . . 0.0 109.526 177.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -93.8 148.95 21.65 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.151 0.5 . . . . 0.0 110.822 -177.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -58.07 -33.71 69.34 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.308 -179.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -64.93 -33.39 75.91 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.4 m -61.19 -44.59 97.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.555 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 205' ' ' ALA . . . . . 0.656 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -57.71 -29.42 64.69 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.666 -177.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -65.66 -37.46 86.58 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.312 0.577 . . . . 0.0 109.603 176.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -66.12 -38.69 88.82 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.586 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.83 -43.3 97.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.079 -178.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 209' ' ' PHE . . . . . 0.656 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 73.6 m-85 -62.47 -43.14 99.54 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 114.16 -1.382 . . . . 0.0 112.733 177.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.4 -41.64 98.75 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 119.379 -0.929 . . . . 0.0 109.701 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . 0.608 HD21 ' CD2' ' B' ' 178' ' ' LEU . 39.4 mt -62.44 -42.29 99.35 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.314 -179.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 78.3 p -62.33 -36.57 82.59 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.908 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 213' ' ' HIS . . . . . 0.485 ' CE1' HD11 ' B' ' 217' ' ' LEU . 58.1 t-80 -67.26 -46.77 72.67 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.012 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.474 HD21 HD21 ' B' ' 182' ' ' LEU . 51.0 tp -63.97 -43.35 96.02 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.81 0.815 . . . . 0.0 109.83 177.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 215' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' B' ' 211' ' ' LEU . 91.8 mt -62.95 -43.97 97.35 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 113.502 -1.681 . . . . 0.0 111.588 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.83 -39.5 92.01 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.82 -177.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . 0.485 HD11 ' CE1' ' B' ' 213' ' ' HIS . 85.6 mt -63.56 -42.02 98.39 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.362 0.601 . . . . 0.0 111.652 176.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 218' ' ' THR . . . . . 0.412 HG23 ' O ' ' B' ' 214' ' ' LEU . 74.2 p -74.17 -17.21 60.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.987 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 81.08 66.42 1.62 Allowed Glycine 0 CA--C 1.527 0.784 0 N-CA-C 106.696 -2.562 . . . . 0.0 106.696 -178.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 220' ' ' THR . . . . . . . . . . . . . 94.2 m -147.11 104.56 3.69 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 114.652 1.352 . . . . 0.0 114.652 176.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -61.92 140.45 58.3 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.667 -0.413 . . . . 0.0 111.022 -175.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 44.8 tp -116.69 121.79 42.65 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.37 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 3.0 mp -110.26 128.83 66.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.916 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 224' ' ' ILE . . . . . 0.534 ' CG2' HD11 ' B' ' 227' ' ' ILE . 50.7 mm -109.39 126.58 66.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.552 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 49.4 p -133.44 157.62 45.12 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 90.1 16.95 55.03 Favored Glycine 0 CA--C 1.499 -0.918 0 CA-C-N 113.898 -1.501 . . . . 0.0 111.117 -177.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 227' ' ' ILE . . . . . 0.733 HD12 HG23 ' B' ' 247' ' ' THR . 94.8 mt -81.72 125.64 39.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 O-C-N 121.942 -0.74 . . . . 0.0 111.851 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 65.9 tttt -66.73 141.68 97.04 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.406 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.11 -37.47 94.05 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 121.364 1.376 . . . . 0.0 112.609 178.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -64.04 -43.03 96.8 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -177.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 51.3 tp -61.89 -41.34 97.78 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.527 -179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.15 -36.83 85.31 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.504 -179.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 94.7 mtp -64.08 -40.83 97.11 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.73 -42.84 97.83 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 122.195 0.997 . . . . 0.0 109.238 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 32.4 mmt -63.89 -35.92 82.22 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.782 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -61.66 -40.39 94.78 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -178.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.67 -44.43 93.79 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.07 178.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 51.0 tp -62.45 -45.41 93.17 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 120.317 -0.553 . . . . 0.0 111.924 -178.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -156.68 131.78 9.12 Favored 'General case' 0 CA--C 1.511 -0.555 0 C-N-CA 120.301 -0.559 . . . . 0.0 111.956 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 240' ' ' ALA . . . . . . . . . . . . . . . -62.13 -47.28 85.25 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 176.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 241' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' B' ' 244' ' ' SER . 93.7 m-20 -42.52 -19.16 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.484 -176.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 242' ' ' PHE . . . . . . . . . . . . . 91.8 t80 -62.6 -44.82 95.33 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.138 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 243' ' ' SER . . . . . . . . . . . . . 78.0 p -57.63 -44.02 85.24 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 244' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 19.8 m -29.81 -40.61 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 96.4 mt -84.25 141.67 30.81 Favored 'General case' 0 C--N 1.313 -1.013 0 O-C-N 121.561 -0.712 . . . . 0.0 110.993 178.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -69.06 133.55 48.23 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 120.923 0.392 . . . . 0.0 110.285 -174.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 247' ' ' THR . . . . . 0.733 HG23 HD12 ' B' ' 227' ' ' ILE . 97.8 m -124.1 125.86 45.22 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.861 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 248' ' ' TYR . . . . . 0.482 ' CG ' ' HB2' ' B' ' 254' ' ' ALA . 96.9 m-85 -111.71 142.85 43.52 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 249' ' ' SER . . . . . 0.571 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 78.4 p -62.86 -33.04 74.43 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.058 -179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 250' ' ' ASN . . . . . 0.571 ' OD1' ' O ' ' B' ' 249' ' ' SER . 99.3 m-20 -147.31 157.75 43.71 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 115.122 -0.945 . . . . 0.0 112.004 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 69.3 t -64.9 -44.75 96.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.312 -0.858 . . . . 0.0 112.263 178.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 252' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.74 -46.06 91.89 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -178.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . 0.547 ' O ' HG22 ' B' ' 257' ' ' VAL . 70.3 m-20 -60.94 -42.88 99.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.651 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 254' ' ' ALA . . . . . 0.482 ' HB2' ' CG ' ' B' ' 248' ' ' TYR . . . -65.57 -41.14 93.26 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.15 178.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 255' ' ' VAL . . . . . 0.444 ' O ' ' HD2' ' B' ' 259' ' ' PRO . 76.2 t -65.02 -45.36 94.78 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.067 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.07 -47.96 80.68 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 119.968 -0.693 . . . . 0.0 111.491 -178.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 257' ' ' VAL . . . . . 0.547 HG22 ' O ' ' B' ' 253' ' ' ASP . 27.2 m -65.46 -40.58 88.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.577 179.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 258' ' ' LEU . . . . . 0.507 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 1.3 mt -32.74 -73.29 0.06 OUTLIER Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 120.902 -0.319 . . . . 0.0 111.507 -177.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 259' ' ' PRO . . . . . 0.57 ' O ' HG13 ' B' ' 260' ' ' ILE . 37.1 Cg_endo -61.84 141.36 89.78 Favored 'Trans proline' 0 N--CA 1.504 2.103 0 C-N-CA 121.459 1.439 . . . . 0.0 111.308 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 260' ' ' ILE . . . . . 0.57 HG13 ' O ' ' B' ' 259' ' ' PRO . 96.7 mt -159.54 -16.43 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 CA-C-N 118.692 0.678 . . . . 0.0 112.3 177.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 78.3 mtm . . . . . 0 C--O 1.216 -0.703 0 CA-C-O 117.785 -1.102 . . . . 0.0 111.434 -178.848 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 900' ' ' FMN . . . . . 0.464 ' H6 ' ' HA3' ' A' ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 900' ' ' FMN . . . . . 0.509 ' H6 ' ' HA3' ' B' ' 121' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.16 172.39 18.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.144 0.497 . . . . 0.0 110.272 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 85.4 p -73.27 -10.23 59.54 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.6 -0.688 . . . . 0.0 111.17 177.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -83.33 -62.97 1.45 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 114.713 -1.131 . . . . 0.0 112.434 176.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -69.33 -39.71 78.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.782 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.611 ' O ' ' NZ ' ' B' ' 17' ' ' LYS . 57.8 m -59.62 -41.66 90.92 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -177.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.505 ' CE2' HD12 ' A' ' 9' ' ' ILE . 32.2 t80 83.18 89.64 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.179 0.514 . . . . 0.0 112.213 177.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.538 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -63.49 -140.27 0.01 OUTLIER Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 -177.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.538 ' HB ' ' O ' ' A' ' 8' ' ' GLY . 67.7 mt 82.11 108.34 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 122.686 0.394 . . . . 0.0 110.523 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.93 -21.75 68.69 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.466 1.444 . . . . 0.0 112.141 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.2 -38.39 95.86 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 121.08 -0.581 . . . . 0.0 111.896 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -65.05 -39.64 93.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.512 0.672 . . . . 0.0 109.486 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 52.9 tp -62.81 -41.41 99.29 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -62.21 -40.68 96.92 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 75.0 t -60.12 -44.36 94.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 O-C-N 122.146 -0.346 . . . . 0.0 110.91 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 91.9 mt -62.51 -43.65 98.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.468 -178.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.51 -46.52 88.05 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 119.269 -0.973 . . . . 0.0 112.306 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.585 ' NZ ' HG12 ' B' ' 113' ' ' ILE . 98.4 mttt -59.3 -39.77 84.05 Favored 'General case' 0 CA--C 1.519 -0.229 0 C-N-CA 118.608 -1.237 . . . . 0.0 109.02 -176.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.34 -41.89 90.22 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.306 -178.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 20' ' ' LEU . 85.4 mt -62.93 -40.91 99.07 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 178.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -63.43 -38.2 90.22 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 57.9 m170 -58.62 -39.86 81.68 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 122.339 -0.226 . . . . 0.0 111.329 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 23' ' ' VAL . 12.6 p -113.88 129.95 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.505 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 34.8 ptt180 -72.36 108.27 5.38 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-O 122.072 0.939 . . . . 0.0 112.161 -177.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.0 p -140.47 142.96 30.06 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 123' ' ' GLN . . . -97.45 92.77 1.34 Allowed Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.674 -178.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 53.3 t -125.44 130.17 72.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.6 m -137.4 159.54 35.35 Favored 'Isoleucine or valine' 0 C--O 1.239 0.522 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.6 mt -121.12 129.76 75.35 Favored 'Isoleucine or valine' 0 C--O 1.247 0.952 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 177.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.441 HG22 HG12 ' A' ' 39' ' ' ILE . 19.6 p -106.32 168.47 9.13 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.518 ' C ' ' OD1' ' A' ' 37' ' ' ASN . 62.7 t0 -133.88 102.85 12.14 Favored Pre-proline 0 C--N 1.318 -0.781 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.117 178.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.549 ' HG3' HG23 ' A' ' 117' ' ' THR . 36.9 Cg_endo -63.83 -22.88 69.07 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 121.495 1.463 . . . . 0.0 111.647 -178.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.02 -35.19 79.4 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.955 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.4 mt -86.39 159.81 19.25 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.375 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.835 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 42.9 tt0 -57.43 134.35 55.98 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -176.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.514 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 56.8 t0 59.76 23.49 12.39 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 178.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.518 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 39.8 t-20 38.82 65.89 2.97 Favored Pre-proline 0 CA--C 1.542 0.65 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.129 -178.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.835 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 91.3 Cg_endo -68.55 155.18 69.85 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 124.007 3.138 . . . . 0.0 112.129 -178.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.441 HG12 HG22 ' A' ' 30' ' ' THR . 96.4 mt -86.53 125.0 40.77 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.0 m -104.66 -41.78 6.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 116.136 -0.483 . . . . 0.0 112.086 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -96.07 123.57 39.73 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.859 -178.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.5 p -142.62 139.53 28.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 O-C-N 124.295 0.997 . . . . 0.0 109.133 177.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.616 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 58.0 p30 -98.3 167.01 11.12 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.506 ' OE1' ' HA ' ' A' ' 44' ' ' GLN . 14.4 mm100 -66.43 -39.41 88.89 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 178.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.19 -26.14 63.31 Favored Glycine 0 C--N 1.33 0.208 0 N-CA-C 110.312 -1.115 . . . . 0.0 110.312 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.616 ' HB2' ' OD1' ' A' ' 43' ' ' ASN . 60.5 t80 -59.18 -49.3 78.39 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 -179.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.6 HG13 ' O ' ' A' ' 52' ' ' TYR . 53.5 t -58.45 -44.9 89.88 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 O-C-N 121.423 -0.798 . . . . 0.0 111.464 -174.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -62.99 -37.16 86.07 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 120.511 -0.476 . . . . 0.0 112.116 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 59.6 ttm -68.65 -43.62 75.89 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 177.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 35.4 p -90.48 -23.2 21.04 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.34 0.59 . . . . 0.0 111.48 -178.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . 78.01 21.08 71.8 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 -179.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.6 ' O ' HG13 ' A' ' 47' ' ' VAL . 70.3 m-85 -114.46 138.87 50.04 Favored 'General case' 0 C--O 1.221 -0.42 0 C-N-CA 122.936 0.494 . . . . 0.0 111.162 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -64.21 150.14 46.45 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.646 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.432 HG22 ' H ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -65.78 -33.55 76.12 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -179.283 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.26 -44.19 84.35 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.659 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -64.62 -45.49 86.65 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.585 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.598 HD13 ' CD2' ' A' ' 46' ' ' PHE . 92.0 mt -61.58 -50.26 81.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 -174.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 80.6 mt -57.26 145.48 31.72 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 176.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.3 -6.68 78.89 Favored Glycine 0 N--CA 1.46 0.235 0 C-N-CA 120.84 -0.695 . . . . 0.0 113.208 177.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -135.6 152.73 51.54 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.685 1.243 . . . . 0.0 111.903 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.562 ' C ' ' H ' ' A' ' 63' ' ' ARG . 25.2 t-20 -81.36 152.44 27.5 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.474 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 80.3 m -63.2 16.3 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.444 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.562 ' H ' ' C ' ' A' ' 61' ' ' ASN . 35.4 ptt-85 -61.88 -41.62 98.08 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 120.773 -0.371 . . . . 0.0 111.16 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -55.44 -20.55 12.78 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -178.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.7 mt -71.23 -32.17 68.45 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.611 0.719 . . . . 0.0 112.505 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -65.95 141.41 58.22 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.178 -178.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.59 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -151.08 -148.5 4.81 Favored Glycine 0 CA--C 1.539 1.553 0 N-CA-C 111.193 -0.763 . . . . 0.0 111.193 -178.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -62.79 -39.57 94.64 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -177.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -77.83 -8.72 58.42 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.902 0.382 . . . . 0.0 111.114 -178.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.59 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 28.6 m -62.27 128.69 37.26 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.177 -0.609 . . . . 0.0 109.55 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -85.89 111.06 35.17 Favored Pre-proline 0 CA--C 1.535 0.403 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.859 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -57.44 -31.87 92.5 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 121.959 1.773 . . . . 0.0 113.247 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.42 -40.1 95.11 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.951 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.434 ' OE1' ' HB ' ' A' ' 90' ' ' VAL . 78.9 mm-40 -65.5 -43.99 88.39 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 71.9 t -59.3 -43.86 90.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -176.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -64.35 -37.54 87.87 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.472 -0.785 . . . . 0.0 112.144 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -63.28 -39.89 95.85 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.304 0.573 . . . . 0.0 110.068 178.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 93.6 mt -64.01 -44.16 97.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.933 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -62.61 -43.13 99.58 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 113.633 -1.622 . . . . 0.0 108.229 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 97.0 m -61.55 -49.44 76.65 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.4 -42.57 92.03 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.381 -172.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 89.3 mt -62.77 -39.98 95.88 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 121.473 -0.767 . . . . 0.0 111.177 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 66.9 tp60 -65.07 -31.44 72.66 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 177.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -89.62 -1.33 57.99 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.22 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 46.7 tttt 47.32 39.45 8.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.529 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -122.48 143.9 40.82 Favored Pre-proline 0 CA--C 1.532 0.287 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' A' ' 108' ' ' ILE . 24.8 Cg_exo -61.63 144.37 97.45 Favored 'Trans proline' 0 N--CA 1.497 1.698 0 C-N-CA 121.559 1.506 . . . . 0.0 113.569 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -139.09 142.41 33.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.366 -0.833 . . . . 0.0 110.563 -178.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.913 HG23 ' OD1' ' A' ' 107' ' ' ASN . 97.7 m -127.57 118.21 23.5 Favored 'General case' 0 C--N 1.345 0.377 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 176.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.434 ' HB ' ' OE1' ' A' ' 74' ' ' GLU . 28.3 m -138.47 157.49 30.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.675 -0.238 . . . . 0.0 111.496 178.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -100.67 133.52 45.0 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 176.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.456 HG23 ' O ' ' A' ' 92' ' ' ILE . 17.1 tt -141.28 128.21 20.88 Favored 'Isoleucine or valine' 0 C--N 1.377 1.777 0 CA-C-N 121.374 1.897 . . . . 0.0 112.711 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -62.61 135.69 57.51 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.254 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -138.16 161.36 37.0 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.699 -179.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -118.14 136.23 53.74 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.474 ' HG3' ' CE1' ' A' ' 102' ' ' PHE . 99.2 mttt -85.77 -171.45 3.6 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.239 0.543 . . . . 0.0 111.921 -179.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -62.51 -44.09 97.21 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.919 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 42.9 p-10 -83.42 7.36 17.05 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.84 -1.1 89.09 Favored Glycine 0 N--CA 1.471 0.99 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.258 176.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.8 m -58.31 137.89 56.83 Favored 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.679 ' SD ' ' C ' ' A' ' 101' ' ' MET . 12.5 tmm? -104.97 129.78 53.31 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.556 0.217 . . . . 0.0 110.443 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.548 ' N ' ' SD ' ' A' ' 101' ' ' MET . 53.4 p90 -142.33 158.43 43.72 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.007 -177.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.915 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 23.3 m95 -89.8 141.26 28.8 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.555 HD21 ' HG2' ' A' ' 123' ' ' GLN . 54.3 t-20 -136.58 105.0 5.74 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -176.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 80.8 tt0 -70.18 135.99 49.63 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 -177.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 41.6 tp -120.9 122.77 40.95 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.913 ' OD1' HG23 ' A' ' 89' ' ' THR . 98.1 m-20 -120.31 121.65 39.09 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.773 177.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.439 ' O ' ' HA ' ' A' ' 87' ' ' PRO . 96.2 mt -119.68 128.57 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 O-C-N 123.493 0.496 . . . . 0.0 111.421 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -136.31 125.76 15.84 Favored Pre-proline 0 CA--C 1.541 0.617 0 O-C-N 123.079 0.237 . . . . 0.0 110.903 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -71.31 151.75 60.46 Favored 'Trans proline' 0 N--CA 1.497 1.724 0 C-N-CA 122.666 2.244 . . . . 0.0 112.363 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.671 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 67.0 mtt -123.89 153.17 41.51 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -128.48 91.14 3.18 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.549 ' CD1' HG22 ' B' ' 15' ' ' VAL . 96.2 mt -117.34 131.37 70.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.429 -178.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 49.38 39.07 15.45 Favored 'General case' 0 CA--C 1.512 -0.499 0 O-C-N 121.496 -0.752 . . . . 0.0 111.68 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 58.7 30.42 19.93 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.954 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -127.59 146.35 50.56 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.785 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 7.7 t -85.38 -170.41 3.11 Favored 'General case' 0 C--O 1.214 -0.772 0 O-C-N 121.687 -0.633 . . . . 0.0 109.334 -178.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.785 ' CD2' ' O ' ' A' ' 117' ' ' THR . 66.0 m-85 -174.0 155.38 2.51 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 177.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -131.11 145.57 52.03 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 174.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -134.33 134.1 55.04 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.506 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -107.8 127.08 8.56 Favored Glycine 0 CA--C 1.501 -0.832 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 96.8 mt -116.6 128.93 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.555 ' HG2' HD21 ' A' ' 104' ' ' ASN . 17.7 mp0 -119.08 115.64 24.71 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.579 0.549 . . . . 0.0 109.63 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -117.64 111.78 19.64 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.838 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.453 ' OD1' ' N ' ' A' ' 126' ' ' ILE . 67.9 t0 -62.88 131.77 49.87 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -175.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.511 HG22 ' O ' ' A' ' 126' ' ' ILE . 2.9 mp -95.48 3.56 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 113.542 -1.663 . . . . 0.0 109.637 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 20.0 m -60.04 -42.98 95.58 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.007 -1.058 . . . . 0.0 113.62 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -60.57 -41.69 95.11 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -177.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -63.51 -39.79 95.36 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.003 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.915 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.6 mttt -62.81 -41.06 99.14 Favored 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 118.157 -1.417 . . . . 0.0 110.535 -178.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.1 -37.66 83.54 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.653 -178.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.774 ' CE2' HD11 ' A' ' 136' ' ' LEU . 89.7 t80 -61.77 -45.3 94.51 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.543 176.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.73 -38.69 91.85 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.02 -40.93 97.37 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 52.8 tp -60.64 -43.36 97.66 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -177.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.774 HD11 ' CE2' ' A' ' 132' ' ' TYR . 83.6 mt -62.28 -40.91 97.82 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.094 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -63.56 -41.83 98.39 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 119.355 -0.938 . . . . 0.0 109.837 -178.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -60.27 -41.55 93.5 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 -177.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 48.8 m -61.66 -41.09 97.06 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.071 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 144' ' ' THR . 84.4 mt -63.69 -41.72 98.11 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.449 -0.5 . . . . 0.0 109.758 177.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 96.9 m -61.39 -46.0 92.01 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.268 -177.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -65.21 -40.48 94.19 Favored 'General case' 0 C--O 1.239 0.549 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 95.5 mt -64.78 -43.47 96.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 113.967 -1.469 . . . . 0.0 111.523 176.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.515 ' N ' ' O ' ' A' ' 140' ' ' LEU . 92.1 m -62.53 -46.48 88.18 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -178.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.477 ' O ' ' OG1' ' A' ' 148' ' ' THR . . . -62.58 -40.57 97.29 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 118.875 -1.13 . . . . 0.0 109.251 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 85.3 mt -63.8 -42.73 97.64 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.675 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.1 p -60.93 -37.67 83.12 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -178.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.477 ' OG1' ' O ' ' A' ' 145' ' ' ALA . 18.8 m -29.09 83.73 0.03 OUTLIER Pre-proline 0 C--N 1.347 0.492 0 O-C-N 126.592 2.432 . . . . 0.0 106.613 -178.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.675 ' N ' ' O ' ' A' ' 147' ' ' SER . 22.4 Cg_exo -61.94 144.04 96.07 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 CA-C-O 122.753 1.064 . . . . 0.0 113.906 -174.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.639 ' O ' HG23 ' A' ' 151' ' ' VAL . 9.3 tp -120.49 135.1 61.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 102.057 -3.312 . . . . 0.0 102.057 175.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 150' ' ' ILE . 95.4 t -167.89 95.11 0.62 Allowed Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 177.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -64.12 143.69 84.96 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 N-CA-C 109.822 -0.876 . . . . 0.0 109.822 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.59 ' O ' HG11 ' B' ' 255' ' ' VAL . 43.4 mm -75.84 -68.61 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.225 -0.59 . . . . 0.0 109.463 178.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.725 ' NH2' ' HD3' ' B' ' 154' ' ' ARG . 4.8 mpt_? -132.02 -160.34 1.04 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 63.3 t-20 -83.63 104.57 13.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.799 0.809 . . . . 0.0 111.415 -178.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 93.16 9.2 60.84 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 113.991 -1.458 . . . . 0.0 110.115 -177.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.6 mt -126.1 123.48 63.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 175.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.682 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 74.5 m -133.16 151.72 51.96 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -138.15 141.03 40.12 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 120.303 -0.559 . . . . 0.0 111.625 177.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 21.7 tp -130.51 80.48 70.13 Favored Pre-proline 0 N--CA 1.47 0.571 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.454 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -70.34 152.47 66.31 Favored 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 122.758 2.305 . . . . 0.0 113.229 -178.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 90.1 mt -120.88 126.39 49.92 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.175 178.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 48.4 t -123.28 131.2 73.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 117.41 169.32 14.89 Favored Glycine 0 N--CA 1.477 1.423 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.238 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.78 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 57.1 t30 -85.25 115.28 22.93 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 117.16 0.48 . . . . 0.0 110.07 -179.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.595 HD21 ' CZ ' ' A' ' 171' ' ' PHE . 47.1 tp -73.7 104.05 4.48 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -177.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.736 HG23 ' NE ' ' A' ' 170' ' ' ARG . 10.6 p -85.92 166.85 15.63 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.588 179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.85 -34.16 77.51 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.166 0.507 . . . . 0.0 111.779 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.45 -42.44 95.95 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.102 178.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.78 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 87.5 mtm180 -65.37 -33.75 76.7 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 124.316 1.047 . . . . 0.0 112.462 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.595 ' CZ ' HD21 ' A' ' 166' ' ' LEU . 0.5 OUTLIER -54.21 -28.49 41.25 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-O 118.986 -0.531 . . . . 0.0 112.381 -178.778 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.604 ' O ' HG22 ' A' ' 175' ' ' VAL . 91.2 m-20 -60.55 -40.71 92.57 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 118.975 -1.09 . . . . 0.0 109.7 -178.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 52.0 m -59.22 -41.31 88.34 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 121.685 -0.635 . . . . 0.0 110.777 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 66.2 mt -63.25 -44.08 99.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 172' ' ' ASN . 35.4 m -62.08 -40.35 87.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . 0.418 ' N ' HG23 ' A' ' 175' ' ' VAL . 98.3 m -62.21 -33.97 75.59 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.396 178.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.523 ' O ' HG13 ' A' ' 181' ' ' ILE . 25.3 m -62.45 -19.85 63.93 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.135 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.708 ' CD2' HD21 ' A' ' 211' ' ' LEU . 86.2 mt -61.1 -41.87 97.47 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 -177.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 18.4 m -59.27 -43.28 92.51 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.61 ' O ' ' OG ' ' A' ' 183' ' ' SER . 93.1 m-20 -61.78 -37.68 85.22 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 120.759 0.314 . . . . 0.0 110.661 178.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.523 HG13 ' O ' ' A' ' 177' ' ' THR . 68.7 mt -57.15 -37.18 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 O-C-N 121.384 -0.822 . . . . 0.0 109.918 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.527 HD21 HD21 ' A' ' 214' ' ' LEU . 85.9 mt -61.16 -40.69 94.81 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -177.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.61 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 78.0 p -61.62 -33.15 73.42 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.464 177.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.442 ' OG1' ' HA ' ' A' ' 181' ' ' ILE . 21.9 p -89.88 23.32 2.79 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.672 0.272 . . . . 0.0 111.433 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 78.1 p -63.41 -21.49 66.32 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.63 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.29 -37.2 79.77 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.953 -179.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.682 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 98.6 m-20 -72.58 113.21 9.36 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.53 0.681 . . . . 0.0 110.706 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.95 -42.09 99.71 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.914 -177.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -112.88 130.89 55.94 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.862 -178.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 38.5 tp -120.82 128.81 53.2 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 96.5 mt -117.08 127.54 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 178.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.8 mm -113.17 127.4 70.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . 0.488 ' CG ' ' HG ' ' A' ' 195' ' ' SER . 40.5 t0 -95.15 117.99 31.18 Favored 'General case' 0 CA--C 1.549 0.93 0 O-C-N 121.871 -0.518 . . . . 0.0 110.538 177.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . . . . . . . . . 96.1 mt -97.38 -4.93 37.48 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.661 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.488 ' HG ' ' CG ' ' A' ' 193' ' ' ASP . 78.1 p -62.99 -32.51 73.88 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.63 -44.39 98.01 Favored Glycine 0 CA--C 1.533 1.17 0 N-CA-C 108.332 -1.907 . . . . 0.0 108.332 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.975 ' CD2' ' O ' ' A' ' 199' ' ' GLN . 4.7 tt -68.34 127.76 34.12 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 112.871 -1.664 . . . . 0.0 109.289 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.934 ' N ' HD23 ' A' ' 197' ' ' LEU . . . -59.4 -50.08 75.35 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 120.179 -0.608 . . . . 0.0 110.562 -178.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.975 ' O ' ' CD2' ' A' ' 197' ' ' LEU . 58.1 tt0 -132.82 157.89 43.88 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 114.757 -1.11 . . . . 0.0 113.443 -175.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.475 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 44.1 t -117.69 132.71 66.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -88.56 155.45 19.63 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.642 -178.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.4 -39.49 93.95 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 120.135 -0.626 . . . . 0.0 109.987 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -57.85 -31.48 66.71 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -178.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.5 m -61.18 -42.3 98.32 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.413 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.495 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -57.65 -37.85 74.06 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -177.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -60.83 -37.79 83.22 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 120.516 -0.473 . . . . 0.0 109.749 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -66.02 -38.58 88.79 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.108 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 94.6 mt -63.11 -44.54 99.54 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -178.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . 0.495 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 73.3 m-85 -62.18 -43.38 98.96 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.427 -178.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -62.06 -41.95 98.68 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 119.125 -1.03 . . . . 0.0 109.072 -178.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.708 HD21 ' CD2' ' A' ' 178' ' ' LEU . 39.4 mt -62.34 -41.78 98.85 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 78.2 p -61.74 -43.15 99.41 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 118.993 -1.083 . . . . 0.0 110.14 -179.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' HIS . . . . . 0.443 ' CE1' HD11 ' A' ' 217' ' ' LEU . 58.6 t-80 -64.14 -45.28 89.22 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.602 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.527 HD21 HD21 ' A' ' 182' ' ' LEU . 49.8 tp -62.19 -45.93 91.2 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 118.843 -1.143 . . . . 0.0 108.247 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 211' ' ' LEU . 88.0 mt -62.15 -41.03 97.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.423 -178.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -60.84 -44.78 96.52 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -177.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.443 HD11 ' CE1' ' A' ' 213' ' ' HIS . 85.3 mt -61.4 -40.04 92.93 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 67.4 p -75.55 -12.11 60.16 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.596 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.62 37.63 13.61 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 120.626 -0.797 . . . . 0.0 113.57 -178.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 91.9 m -123.92 114.64 20.09 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 119.02 1.41 . . . . 0.0 111.544 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -66.15 138.11 57.49 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.83 178.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 42.1 tp -114.02 130.11 56.57 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 4.0 mp -116.29 134.41 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 122.886 0.475 . . . . 0.0 109.741 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.576 ' CG2' HD11 ' A' ' 227' ' ' ILE . 49.0 mm -116.53 131.57 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -178.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 37.8 p -133.81 165.41 25.05 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -177.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 78.35 22.64 67.26 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.722 HD12 HG23 ' A' ' 247' ' ' THR . 97.8 mt -83.96 128.55 38.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 CA-C-N 113.947 -1.127 . . . . 0.0 108.439 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 43.1 tttt -76.31 138.39 67.94 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.25 -39.5 86.32 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 121.044 1.162 . . . . 0.0 112.595 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -63.55 -40.0 95.88 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-O 121.416 0.627 . . . . 0.0 109.967 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 48.8 tp -63.66 -42.6 98.07 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.88 177.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.27 -37.42 87.41 Favored 'General case' 0 C--O 1.227 -0.12 0 C-N-CA 120.596 -0.441 . . . . 0.0 110.89 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 94.2 mtp -63.03 -41.13 99.45 Favored 'General case' 0 C--O 1.247 0.953 0 C-N-CA 120.004 -0.679 . . . . 0.0 109.742 -178.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.38 -38.4 91.0 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.523 177.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 30.2 mmt -65.88 -37.5 86.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.688 178.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -61.18 -41.86 97.55 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.616 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -60.66 -40.65 92.84 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.573 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 55.6 tp -63.72 -41.03 98.15 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 177.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -169.19 125.95 0.93 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.369 0.604 . . . . 0.0 112.404 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.58 -27.36 66.2 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.572 -1.194 . . . . 0.0 110.893 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -61.45 -28.87 69.58 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.288 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -55.73 -44.48 77.58 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 -177.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 96.8 p -61.43 -21.03 63.75 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 123.779 0.674 . . . . 0.0 111.287 178.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 40.6 m -55.04 -38.76 68.39 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 122.313 -0.242 . . . . 0.0 111.617 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 96.3 mt -84.19 120.36 26.11 Favored 'General case' 0 C--O 1.225 -0.206 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -44.63 134.73 5.27 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.047 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.722 HG23 HD12 ' A' ' 227' ' ' ILE . 96.8 m -128.61 133.83 48.41 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.905 178.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' TYR . . . . . 0.456 ' CB ' ' HB2' ' A' ' 254' ' ' ALA . 97.4 m-85 -117.7 140.05 50.19 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 114.953 -1.022 . . . . 0.0 110.959 179.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 78.0 p -60.23 -43.89 95.66 Favored 'General case' 0 CA--C 1.506 -0.737 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -178.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -142.27 161.36 38.22 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 121.725 0.774 . . . . 0.0 111.79 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 77.4 t -62.46 -45.0 99.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-N 114.614 -1.175 . . . . 0.0 112.053 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -60.48 -44.31 96.04 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.193 -0.603 . . . . 0.0 109.561 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . 0.401 ' O ' HG22 ' A' ' 257' ' ' VAL . 54.3 m-20 -62.99 -43.72 98.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.668 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.456 ' HB2' ' CB ' ' A' ' 248' ' ' TYR . . . -63.76 -43.25 96.98 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.94 0.876 . . . . 0.0 109.767 -179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . 0.557 HG13 HH11 ' B' ' 154' ' ' ARG . 56.9 t -63.37 -45.77 97.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 114.003 -1.453 . . . . 0.0 111.129 -177.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.46 -46.95 83.9 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 120.649 -0.421 . . . . 0.0 111.301 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.494 ' O ' ' C ' ' A' ' 258' ' ' LEU . 21.2 m -66.45 -41.1 88.11 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 O-C-N 121.539 -0.726 . . . . 0.0 112.005 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.494 ' C ' ' O ' ' A' ' 257' ' ' VAL . 1.9 mt -29.85 -72.85 0.05 OUTLIER Pre-proline 0 N--CA 1.466 0.328 0 CA-C-O 119.497 -0.287 . . . . 0.0 111.51 -177.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' PRO . . . . . 0.492 ' O ' HG13 ' A' ' 260' ' ' ILE . 44.7 Cg_endo -64.12 139.28 65.94 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 CA-C-N 119.635 0.905 . . . . 0.0 111.764 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.492 HG13 ' O ' ' A' ' 259' ' ' PRO . 96.5 mt -153.74 -25.03 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 O-C-N 123.638 0.586 . . . . 0.0 111.764 178.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 N--CA 1.475 0.811 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.68 -177.66 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.424 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.26 162.5 33.67 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 79.5 p -59.61 -21.8 60.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.779 177.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -74.67 -62.02 1.68 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 120.948 0.404 . . . . 0.0 111.361 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -66.72 -39.98 88.23 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.092 179.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.503 ' O ' ' HB3' ' B' ' 7' ' ' PHE . 61.0 m -60.33 -42.59 95.95 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 119.98 -0.688 . . . . 0.0 109.833 -177.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . 0.51 ' CE2' HD12 ' B' ' 9' ' ' ILE . 36.7 t80 84.79 92.86 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.339 177.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . 0.559 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -65.46 -139.87 0.03 OUTLIER Glycine 0 C--N 1.338 0.678 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.559 ' HB ' ' O ' ' B' ' 8' ' ' GLY . 68.0 mt 81.61 108.35 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 122.567 0.347 . . . . 0.0 110.912 -178.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -62.94 -24.23 74.13 Favored 'Trans proline' 0 N--CA 1.499 1.814 0 C-N-CA 121.338 1.359 . . . . 0.0 111.711 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.95 -40.64 98.69 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -64.67 -39.35 93.53 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.763 0.792 . . . . 0.0 109.131 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 54.1 tp -62.41 -42.24 99.29 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.476 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -63.91 -32.39 73.91 Favored 'General case' 0 CA--C 1.562 1.431 0 CA-C-O 121.535 0.683 . . . . 0.0 110.525 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . 0.549 HG22 ' CD1' ' A' ' 113' ' ' ILE . 70.0 t -62.83 -46.22 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 113.237 -1.801 . . . . 0.0 111.007 176.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 93.3 mt -64.16 -43.96 97.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.007 -178.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . 0.611 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 99.0 mttt -63.55 -41.8 98.42 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -179.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.22 -41.22 99.09 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 119.01 -1.076 . . . . 0.0 109.973 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.37 -38.73 84.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.966 -178.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 86.0 mt -63.91 -41.97 97.55 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 121.359 0.6 . . . . 0.0 110.263 175.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -63.07 -38.73 92.35 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.192 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 56.5 m170 -57.83 -39.85 78.65 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 119.557 -0.259 . . . . 0.0 111.323 -178.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 12.3 p -114.04 129.94 69.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.526 ' O ' ' HG3' ' B' ' 24' ' ' ARG . 35.0 ptt180 -72.0 106.21 4.19 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.711 0.767 . . . . 0.0 112.447 -177.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.403 ' O ' HG13 ' B' ' 25' ' ' VAL . 6.6 p -142.01 133.68 26.69 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.86 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.816 177.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . 0.498 ' O ' ' N ' ' B' ' 123' ' ' GLN . . . -87.31 97.53 2.28 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 119.422 -1.37 . . . . 0.0 113.202 -176.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 49.4 t -126.41 129.07 71.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 174.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 30.0 m -138.44 156.23 29.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 121.014 -0.274 . . . . 0.0 110.429 178.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 95.8 mt -119.01 127.41 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.237 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.437 HG22 HG12 ' B' ' 39' ' ' ILE . 33.2 p -107.54 158.13 17.47 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-N 113.002 -1.908 . . . . 0.0 108.694 -177.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . 0.49 ' C ' ' OD1' ' B' ' 37' ' ' ASN . 64.1 t0 -125.18 103.07 30.09 Favored Pre-proline 0 C--O 1.236 0.381 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -178.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' PRO . . . . . 0.491 ' HG3' HG23 ' B' ' 117' ' ' THR . 37.1 Cg_endo -64.39 -21.76 66.37 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.723 1.616 . . . . 0.0 111.496 -178.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.02 -45.39 93.79 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.539 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 90.9 mt -71.23 179.45 2.85 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.913 -0.492 . . . . 0.0 111.676 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . 0.699 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 41.4 tt0 -77.13 129.67 36.31 Favored 'General case' 0 C--N 1.344 0.327 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -174.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.47 ' O ' ' C ' ' B' ' 37' ' ' ASN . 65.2 t0 58.01 38.14 26.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.461 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' ASN . . . . . 0.49 ' OD1' ' C ' ' B' ' 31' ' ' ASP . 24.3 t-20 27.69 69.73 0.49 Allowed Pre-proline 0 C--N 1.327 -0.413 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.699 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 92.1 Cg_endo -70.72 153.39 64.56 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 123.676 2.917 . . . . 0.0 111.635 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.437 HG12 HG22 ' B' ' 30' ' ' THR . 96.0 mt -84.46 129.93 36.84 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 18.0 m -109.55 -41.61 4.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 O-C-N 123.592 0.557 . . . . 0.0 112.339 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -96.81 123.62 40.56 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 120.198 -0.601 . . . . 0.0 111.506 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 5.8 p -142.38 140.61 28.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.222 177.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . 0.651 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 56.7 p30 -102.13 162.1 13.17 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.177 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' GLN . . . . . 0.489 ' OE1' ' HA ' ' B' ' 44' ' ' GLN . 13.8 mm100 -62.55 -38.12 88.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.379 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.35 -26.71 64.48 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.651 ' HB2' ' OD1' ' B' ' 43' ' ' ASN . 58.0 t80 -60.04 -43.61 95.23 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 0.738 HG13 ' O ' ' B' ' 52' ' ' TYR . 53.3 t -61.63 -46.4 96.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.091 -178.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -63.09 -45.02 94.05 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.021 -0.672 . . . . 0.0 110.262 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 60.3 ttm -62.75 -42.6 99.75 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 34.3 p -93.77 -17.63 22.93 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.968 -178.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' B' ' 47' ' ' VAL . . . 73.59 19.83 79.75 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 178.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . 0.738 ' O ' HG13 ' B' ' 47' ' ' VAL . 70.8 m-85 -112.08 145.64 39.38 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.244 -0.478 . . . . 0.0 110.172 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -74.39 148.96 40.73 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.684 0.754 . . . . 0.0 111.173 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.05 -38.15 87.65 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.698 -177.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.83 -39.94 95.89 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 120.238 -0.585 . . . . 0.0 111.854 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -73.76 -32.89 64.04 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.613 HD13 ' CD2' ' B' ' 46' ' ' PHE . 93.4 mt -66.2 -72.12 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 95.6 mt -37.19 131.82 0.79 Allowed 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.71 175.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.28 -12.22 66.77 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.957 -179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -133.98 149.92 51.24 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.358 0.599 . . . . 0.0 112.595 -174.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' ASN . . . . . 0.509 ' C ' ' H ' ' B' ' 63' ' ' ARG . 25.9 t-20 -77.66 153.31 33.23 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 114.602 -1.181 . . . . 0.0 110.8 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' CYS . . . . . . . . . . . . . 84.6 m -64.91 9.12 0.1 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.524 -178.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . 0.509 ' H ' ' C ' ' B' ' 61' ' ' ASN . 33.5 ptt-85 -58.72 -32.04 68.83 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.719 -178.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -60.33 -31.06 69.94 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.524 0.564 . . . . 0.0 112.524 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 85.4 mt -61.82 -42.53 99.14 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -178.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -50.0 146.01 5.16 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 123.624 0.577 . . . . 0.0 109.764 -178.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . 0.546 ' N ' ' OG1' ' B' ' 70' ' ' THR . . . -156.19 -152.24 6.19 Favored Glycine 0 CA--C 1.54 1.656 0 CA-C-N 115.1 -0.955 . . . . 0.0 112.773 175.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -60.19 -40.76 91.17 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.576 -0.312 . . . . 0.0 111.64 -175.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -76.36 -9.27 58.52 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 123.092 0.245 . . . . 0.0 111.434 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' THR . . . . . 0.546 ' OG1' ' N ' ' B' ' 67' ' ' GLY . 26.5 m -61.25 134.3 56.84 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -91.78 110.84 46.33 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.162 -178.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.43 -39.02 89.5 Favored 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 121.035 1.157 . . . . 0.0 111.917 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.74 -41.12 90.23 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 120.508 -0.477 . . . . 0.0 109.871 -176.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' GLU . . . . . 0.443 ' OE1' ' HB ' ' B' ' 90' ' ' VAL . 79.0 mm-40 -66.36 -38.96 88.78 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.752 177.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 85.9 t -61.88 -46.26 96.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 178.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -63.21 -36.84 84.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.751 -178.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -62.24 -42.12 99.03 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 119.168 -1.013 . . . . 0.0 108.642 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 95.0 mt -63.53 -43.49 98.33 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 CA-C-O 120.751 0.31 . . . . 0.0 110.574 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -62.1 -42.54 99.32 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 94.9 m -61.65 -45.79 92.52 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.137 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.49 -41.49 97.34 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 -177.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 86.0 mt -62.95 -42.57 99.86 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -178.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 66.8 tp60 -62.84 -33.86 76.12 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -91.39 8.28 36.99 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.498 179.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 37.9 tttt 40.05 41.6 0.95 Allowed 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.403 -0.519 . . . . 0.0 111.946 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -124.45 140.91 36.27 Favored Pre-proline 0 N--CA 1.47 0.57 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.171 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -61.99 141.11 88.07 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 120.99 1.127 . . . . 0.0 113.827 -178.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -139.78 136.14 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.325 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' THR . . . . . 0.902 HG23 ' OD1' ' B' ' 107' ' ' ASN . 92.6 m -120.12 121.26 38.42 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.831 178.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.443 ' HB ' ' OE1' ' B' ' 74' ' ' GLU . 29.2 m -139.09 162.99 27.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.978 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -113.49 119.58 38.06 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 121.153 0.502 . . . . 0.0 109.694 175.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 20.8 tt -126.42 131.99 70.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 114.855 -1.066 . . . . 0.0 112.144 -175.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.488 ' O ' ' ND2' ' B' ' 94' ' ' ASN . 85.5 mt-30 -72.56 145.57 47.32 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.194 177.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' B' ' 93' ' ' GLN . 8.7 m120 -138.54 -179.67 5.94 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 121.359 0.6 . . . . 0.0 110.61 -177.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -129.62 148.26 51.5 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.525 177.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . 0.468 ' HG3' ' CE1' ' B' ' 102' ' ' PHE . 98.8 mttt -104.71 -179.08 3.84 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.02 0.438 . . . . 0.0 110.59 178.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.31 -36.25 77.48 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.211 -179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 37.6 p-10 -87.45 -1.29 57.82 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.931 0.787 . . . . 0.0 112.832 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.99 5.07 64.45 Favored Glycine 0 N--CA 1.466 0.69 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.249 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 26.5 m -67.32 128.38 36.18 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.305 177.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . 0.663 ' SD ' ' N ' ' B' ' 102' ' ' PHE . 13.9 tmm? -87.5 143.5 27.19 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' PHE . . . . . 0.663 ' N ' ' SD ' ' B' ' 101' ' ' MET . 53.2 p90 -154.86 163.86 39.66 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' TRP . . . . . 0.934 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 24.5 m95 -96.72 137.4 35.86 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.944 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . 0.507 HD21 ' HG2' ' B' ' 123' ' ' GLN . 62.7 t-20 -132.17 110.84 10.95 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 114.904 -1.043 . . . . 0.0 113.686 -176.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -80.4 124.52 28.96 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 123.842 0.713 . . . . 0.0 109.185 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 39.8 tp -111.25 125.29 53.66 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.002 0.429 . . . . 0.0 111.824 -177.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' ASN . . . . . 0.902 ' OD1' HG23 ' B' ' 89' ' ' THR . 97.9 m-20 -120.05 126.73 51.51 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 176.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 96.4 mt -122.79 133.33 69.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -143.23 123.39 7.85 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -70.0 151.92 67.88 Favored 'Trans proline' 0 N--CA 1.504 2.119 0 C-N-CA 122.657 2.238 . . . . 0.0 112.582 -179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . 0.506 ' HB2' ' HB2' ' B' ' 118' ' ' TYR . 67.1 mtt -128.28 143.76 51.06 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -113.79 107.28 15.52 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 177.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . 0.585 HG12 ' NZ ' ' A' ' 18' ' ' LYS . 96.6 mt -134.62 127.77 50.06 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 O-C-N 121.811 -0.556 . . . . 0.0 112.071 178.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 51.15 38.5 21.14 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 123.834 0.709 . . . . 0.0 109.814 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 61.21 35.42 18.36 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.526 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -132.58 149.07 52.37 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' THR . . . . . 0.491 HG23 ' HG3' ' B' ' 32' ' ' PRO . 10.0 t -101.64 153.62 19.6 Favored 'General case' 0 C--O 1.214 -0.775 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 -178.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' TYR . . . . . 0.506 ' HB2' ' HB2' ' B' ' 111' ' ' MET . 96.9 m-85 -148.13 147.55 29.61 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 121.317 -0.864 . . . . 0.0 111.497 -178.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -122.27 137.93 54.67 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 123.626 0.579 . . . . 0.0 110.9 -177.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -127.32 133.99 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -177.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -108.94 122.87 6.72 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 94.6 mt -113.52 127.45 70.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -179.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 123' ' ' GLN . . . . . 0.507 ' HG2' HD21 ' B' ' 104' ' ' ASN . 17.8 mp0 -118.45 121.6 40.71 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -121.42 119.34 31.8 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' B' ' 126' ' ' ILE . 67.9 t0 -68.31 135.54 52.05 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.57 -177.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.528 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 2.8 mp -107.41 17.72 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.512 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 127' ' ' THR . . . . . 0.5 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 97.5 m -63.95 -44.15 93.68 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 114.439 -1.255 . . . . 0.0 112.687 177.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -62.18 -45.85 91.55 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -177.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 129' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -62.58 -35.1 78.42 Favored 'General case' 0 CA--C 1.549 0.936 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.43 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 130' ' ' LYS . . . . . 0.934 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 98.6 mttt -63.64 -41.33 98.25 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-N 112.817 -1.992 . . . . 0.0 110.728 175.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -64.71 -41.64 95.85 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 132' ' ' TYR . . . . . 0.766 ' CE2' HD11 ' B' ' 136' ' ' LEU . 90.0 t80 -60.47 -44.57 95.75 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.831 -0.543 . . . . 0.0 111.566 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . 0.411 ' O ' ' HG3' ' B' ' 137' ' ' GLU . 97.0 mt-10 -64.47 -36.35 83.9 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.55 -179.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 134' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.27 -39.16 93.82 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.833 177.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.76 -41.24 99.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.565 0.698 . . . . 0.0 109.378 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . 0.766 HD11 ' CE2' ' B' ' 132' ' ' TYR . 84.5 mt -63.0 -41.67 99.65 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.453 178.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 137' ' ' GLU . . . . . 0.411 ' HG3' ' O ' ' B' ' 133' ' ' GLU . 97.1 mt-10 -65.28 -37.51 87.41 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 113.523 -1.672 . . . . 0.0 110.229 -178.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -63.43 -43.36 97.66 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.055 176.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 65.6 m -60.64 -44.57 96.23 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' B' ' 144' ' ' THR . 86.1 mt -61.5 -40.13 93.5 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -177.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 95.4 m -61.67 -45.65 93.09 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.994 178.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -66.38 -42.6 87.69 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 93.8 mt -63.58 -43.5 98.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 114.438 -1.256 . . . . 0.0 110.591 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 144' ' ' THR . . . . . 0.417 ' N ' ' O ' ' B' ' 140' ' ' LEU . 91.0 m -61.76 -45.07 95.47 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -178.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.65 -41.08 96.36 Favored 'General case' 0 C--O 1.226 -0.149 0 C-N-CA 119.161 -1.016 . . . . 0.0 109.435 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 87.4 mt -64.87 -41.18 95.86 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 176.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 147' ' ' SER . . . . . 0.575 ' O ' ' N ' ' B' ' 149' ' ' PRO . 78.3 p -62.44 -41.82 99.01 Favored 'General case' 0 CA--C 1.478 -1.79 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 -179.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . 0.488 ' C ' ' O ' ' B' ' 147' ' ' SER . 7.1 m -26.1 86.45 0.04 OUTLIER Pre-proline 0 N--CA 1.482 1.148 0 O-C-N 124.196 0.935 . . . . 0.0 110.425 176.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 149' ' ' PRO . . . . . 0.575 ' N ' ' O ' ' B' ' 147' ' ' SER . 24.1 Cg_exo -60.8 145.96 98.16 Favored 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 121.613 1.542 . . . . 0.0 115.342 -176.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 9.4 tp -127.68 119.83 52.78 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.828 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 172.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 61.0 t -150.25 94.88 3.65 Favored Pre-proline 0 C--N 1.303 -1.418 0 CA-C-N 115.949 -0.568 . . . . 0.0 111.064 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -62.28 143.03 93.43 Favored 'Trans proline' 0 N--CA 1.485 0.983 0 N-CA-C 109.512 -0.995 . . . . 0.0 109.512 -179.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 153' ' ' ILE . . . . . 0.564 HG21 HH12 ' A' ' 154' ' ' ARG . 44.1 mm -76.19 -66.52 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . 0.725 ' HD3' ' NH2' ' A' ' 154' ' ' ARG . 4.4 mpt_? -132.06 -157.92 0.85 Allowed 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 62.5 t-20 -83.98 110.39 18.39 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.06 -18.23 55.98 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -178.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 86.4 mt -108.34 124.61 64.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.993 0.425 . . . . 0.0 111.068 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . 0.625 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 67.0 m -135.98 149.65 48.94 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.74 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -133.83 145.67 49.94 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 22.7 tp -137.28 80.22 34.64 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 161' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -72.19 149.63 52.12 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.623 2.215 . . . . 0.0 114.048 -177.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 92.1 mt -115.29 134.52 55.05 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 55.5 t -129.98 132.66 65.4 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 113.98 169.59 16.79 Favored Glycine 0 N--CA 1.47 0.911 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.48 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 165' ' ' ASN . . . . . 0.683 ' O ' ' CZ ' ' B' ' 170' ' ' ARG . 62.9 t30 -89.97 107.39 19.09 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.221 0.822 . . . . 0.0 113.221 -177.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . 0.613 HD21 ' CZ ' ' B' ' 171' ' ' PHE . 44.0 tp -64.55 104.49 0.8 Allowed 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -175.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 167' ' ' THR . . . . . 0.685 HG23 ' NE ' ' B' ' 170' ' ' ARG . 10.5 p -84.19 169.74 14.49 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-N 114.116 -1.402 . . . . 0.0 110.894 177.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -66.92 -37.42 84.29 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.637 177.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.86 -40.39 87.85 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-O 122.119 0.961 . . . . 0.0 111.554 -178.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 170' ' ' ARG . . . . . 0.685 ' NE ' HG23 ' B' ' 167' ' ' THR . 88.0 mtm180 -62.48 -35.98 81.04 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 112.762 -2.017 . . . . 0.0 111.248 178.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 171' ' ' PHE . . . . . 0.613 ' CZ ' HD21 ' B' ' 166' ' ' LEU . 0.5 OUTLIER -54.82 -25.64 29.78 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -178.686 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 172' ' ' ASN . . . . . 0.534 ' O ' HG22 ' B' ' 175' ' ' VAL . 91.9 m-20 -62.67 -40.26 96.52 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.804 178.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 49.2 m -60.52 -41.48 94.46 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.145 0.498 . . . . 0.0 110.801 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 65.9 mt -63.86 -44.03 97.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -178.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 175' ' ' VAL . . . . . 0.534 HG22 ' O ' ' B' ' 172' ' ' ASN . 33.3 m -62.54 -40.21 87.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 176' ' ' CYS . . . . . 0.418 ' N ' HG23 ' B' ' 175' ' ' VAL . 99.9 m -62.02 -35.23 77.94 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.381 178.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 177' ' ' THR . . . . . 0.556 ' O ' HG13 ' B' ' 181' ' ' ILE . 24.7 m -61.32 -20.27 62.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.938 0.399 . . . . 0.0 110.184 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 178' ' ' LEU . . . . . 0.672 ' CD2' HD21 ' B' ' 211' ' ' LEU . 87.8 mt -61.1 -39.47 90.08 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.281 -177.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 19.0 m -61.85 -44.4 96.91 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.322 177.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 180' ' ' ASN . . . . . 0.575 ' O ' ' OG ' ' B' ' 183' ' ' SER . 92.9 m-20 -61.88 -40.73 96.4 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.802 0.334 . . . . 0.0 110.411 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.556 HG13 ' O ' ' B' ' 177' ' ' THR . 75.1 mt -55.69 -31.2 28.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 C-N-CA 120.916 -0.314 . . . . 0.0 110.897 -178.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 182' ' ' LEU . . . . . 0.514 HD21 HD21 ' B' ' 214' ' ' LEU . 85.1 mt -62.8 -42.08 99.56 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 119.982 -0.687 . . . . 0.0 109.328 177.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . 0.575 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.2 p -62.91 -32.85 74.22 Favored 'General case' 0 N--CA 1.455 -0.183 0 O-C-N 122.004 -0.435 . . . . 0.0 110.89 177.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 184' ' ' THR . . . . . 0.427 ' OG1' ' HA ' ' B' ' 181' ' ' ILE . 21.0 p -85.49 16.09 4.05 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.77 0.319 . . . . 0.0 111.775 -178.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 79.2 p -59.68 -17.52 34.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.034 -177.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.78 -40.52 95.49 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.683 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 187' ' ' ASP . . . . . 0.625 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.2 m-20 -69.31 113.34 6.55 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.519 0.676 . . . . 0.0 110.632 -178.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -62.7 -41.96 99.39 Favored 'General case' 0 C--O 1.243 0.738 0 CA-C-N 114.807 -1.088 . . . . 0.0 113.154 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -112.49 130.45 55.99 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.2 -178.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 190' ' ' LEU . . . . . . . . . . . . . 41.1 tp -124.07 118.73 27.61 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.025 177.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 86.6 mt -107.12 126.82 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-O 120.608 0.242 . . . . 0.0 111.416 -177.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 49.2 mm -115.66 117.53 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 193' ' ' ASP . . . . . 0.503 ' CG ' ' HG ' ' B' ' 195' ' ' SER . 41.2 t0 -88.49 109.74 20.29 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.04 0.448 . . . . 0.0 112.11 -177.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 194' ' ' LEU . . . . . . . . . . . . . 96.3 mt -90.34 -3.53 57.68 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.517 176.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 195' ' ' SER . . . . . 0.503 ' HG ' ' CG ' ' B' ' 193' ' ' ASP . 78.1 p -61.46 -36.68 81.12 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 120.998 -0.281 . . . . 0.0 110.896 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.04 -33.24 83.26 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 197' ' ' LEU . . . . . 1.01 HD23 ' N ' ' B' ' 198' ' ' ALA . 4.8 tt -78.38 132.83 37.53 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 122.163 -0.61 . . . . 0.0 109.489 -177.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 198' ' ' ALA . . . . . 1.01 ' N ' HD23 ' B' ' 197' ' ' LEU . . . -63.15 -44.21 96.15 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 119.454 -0.899 . . . . 0.0 110.765 -177.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 199' ' ' GLN . . . . . 0.972 ' O ' ' CD2' ' B' ' 197' ' ' LEU . 58.0 tt0 -137.58 165.99 25.0 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.778 0.799 . . . . 0.0 112.947 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 200' ' ' VAL . . . . . 0.524 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 47.3 t -121.46 132.07 71.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 O-C-N 120.716 -1.24 . . . . 0.0 109.384 177.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -91.09 149.26 21.89 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.15 0.5 . . . . 0.0 110.979 -178.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.22 -32.92 71.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.414 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -64.79 -32.26 73.87 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.4 m -60.3 -44.33 95.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.572 178.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 205' ' ' ALA . . . . . 0.706 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -58.51 -28.31 65.3 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -65.42 -38.68 90.64 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.224 0.535 . . . . 0.0 109.874 176.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -67.52 -38.08 83.74 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.934 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 96.3 mt -63.61 -43.42 98.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.208 0.527 . . . . 0.0 109.866 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 209' ' ' PHE . . . . . 0.706 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 71.7 m-85 -62.19 -42.99 99.8 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.275 -1.33 . . . . 0.0 112.859 177.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -63.52 -41.35 98.5 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 119.492 -0.883 . . . . 0.0 109.545 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . 0.672 HD21 ' CD2' ' B' ' 178' ' ' LEU . 40.2 mt -62.54 -42.37 99.49 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.33 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 78.2 p -63.14 -36.66 84.36 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.224 -0.59 . . . . 0.0 111.873 -179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 213' ' ' HIS . . . . . 0.414 ' CE1' HD11 ' B' ' 217' ' ' LEU . 58.8 t-80 -67.58 -46.36 72.89 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 115.362 -0.836 . . . . 0.0 112.204 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.514 HD21 HD21 ' B' ' 182' ' ' LEU . 52.8 tp -63.77 -42.73 97.74 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.963 0.887 . . . . 0.0 109.994 177.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 215' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' B' ' 211' ' ' LEU . 89.6 mt -62.94 -44.06 97.1 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 113.454 -1.703 . . . . 0.0 111.708 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.33 -39.47 93.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.743 -176.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . 0.414 HD11 ' CE1' ' B' ' 213' ' ' HIS . 86.1 mt -63.79 -42.11 97.79 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.349 0.595 . . . . 0.0 111.434 176.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 218' ' ' THR . . . . . 0.425 HG23 ' O ' ' B' ' 214' ' ' LEU . 68.6 p -74.42 -17.58 60.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.063 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 80.61 69.42 1.4 Allowed Glycine 0 CA--C 1.528 0.87 0 N-CA-C 106.424 -2.67 . . . . 0.0 106.424 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 220' ' ' THR . . . . . . . . . . . . . 96.7 m -149.02 101.4 3.16 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 177.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -59.59 140.08 56.64 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.907 0.384 . . . . 0.0 111.055 -176.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 42.7 tp -117.54 121.62 41.46 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.313 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 4.3 mp -109.09 128.72 64.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.155 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 224' ' ' ILE . . . . . 0.525 ' CG2' HD11 ' B' ' 227' ' ' ILE . 49.8 mm -109.86 127.3 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.573 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 43.3 p -133.16 158.15 43.54 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.574 0.702 . . . . 0.0 112.684 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 88.44 19.98 50.2 Favored Glycine 0 CA--C 1.499 -0.943 0 CA-C-N 113.762 -1.563 . . . . 0.0 111.175 -178.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 227' ' ' ILE . . . . . 0.768 HD12 HG23 ' B' ' 247' ' ' THR . 95.9 mt -83.84 125.69 40.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 O-C-N 122.12 -0.635 . . . . 0.0 111.464 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 37.4 tttt -65.51 138.67 96.95 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.494 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.2 -37.02 94.56 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 121.424 1.416 . . . . 0.0 112.538 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -64.16 -43.34 95.46 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 50.5 tp -61.92 -41.61 98.13 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.826 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.13 -36.19 83.23 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.735 0.302 . . . . 0.0 111.286 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 94.7 mtp -64.15 -40.53 96.34 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.26 -42.41 99.15 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 122.085 0.945 . . . . 0.0 109.219 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 30.4 mmt -64.06 -35.42 80.66 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 114.625 -1.171 . . . . 0.0 112.102 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -62.26 -40.24 95.55 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.276 -0.42 . . . . 0.0 109.891 -177.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.07 -44.11 96.69 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.09 178.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 54.3 tp -62.08 -44.95 95.56 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 120.383 -0.527 . . . . 0.0 112.303 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 239' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -158.88 133.82 8.26 Favored 'General case' 0 CA--C 1.51 -0.577 0 C-N-CA 120.352 -0.539 . . . . 0.0 111.888 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 240' ' ' ALA . . . . . . . . . . . . . . . -62.61 -47.43 83.79 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 177.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 241' ' ' ASN . . . . . 0.465 ' O ' ' HB2' ' B' ' 244' ' ' SER . 90.2 m-20 -41.65 -19.71 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.477 -176.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 242' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -61.9 -44.87 95.89 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 119.87 -0.732 . . . . 0.0 109.816 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 243' ' ' SER . . . . . 0.432 ' O ' ' N ' ' B' ' 245' ' ' LEU . 78.1 p -57.87 -44.68 86.79 Favored 'General case' 0 C--N 1.345 0.377 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 244' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 18.0 m -29.43 -36.36 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . 0.432 ' N ' ' O ' ' B' ' 243' ' ' SER . 96.4 mt -89.18 133.37 34.44 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.369 -178.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -61.48 134.48 56.92 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-O 121.155 0.502 . . . . 0.0 110.474 -176.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 247' ' ' THR . . . . . 0.768 HG23 HD12 ' B' ' 227' ' ' ILE . 95.0 m -126.34 128.52 47.21 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.047 -0.978 . . . . 0.0 111.923 178.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 248' ' ' TYR . . . . . 0.477 ' CG ' ' HB2' ' B' ' 254' ' ' ALA . 97.5 m-85 -112.89 144.96 41.57 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 249' ' ' SER . . . . . 0.59 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 78.2 p -63.76 -33.54 75.89 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.818 -178.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 250' ' ' ASN . . . . . 0.59 ' OD1' ' O ' ' B' ' 249' ' ' SER . 99.3 m-20 -148.45 160.36 43.13 Favored 'General case' 0 C--O 1.231 0.086 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.049 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 79.2 t -64.63 -44.21 96.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.046 178.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 252' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -61.29 -46.11 91.7 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -178.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . 0.438 ' O ' HG13 ' B' ' 257' ' ' VAL . 92.9 m-20 -61.07 -43.75 98.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.835 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 254' ' ' ALA . . . . . 0.477 ' HB2' ' CG ' ' B' ' 248' ' ' TYR . . . -65.77 -40.5 92.06 Favored 'General case' 0 CA--C 1.512 -0.499 0 C-N-CA 120.069 -0.652 . . . . 0.0 111.299 178.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 255' ' ' VAL . . . . . 0.603 HG13 HH11 ' A' ' 154' ' ' ARG . 56.9 t -64.72 -45.75 94.27 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.07 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -63.01 -47.72 81.9 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 119.906 -0.718 . . . . 0.0 111.487 -178.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 257' ' ' VAL . . . . . 0.441 ' O ' ' C ' ' B' ' 258' ' ' LEU . 18.8 m -64.73 -40.41 88.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.533 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 258' ' ' LEU . . . . . 0.485 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 1.7 mt -33.79 -71.33 0.1 Allowed Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.479 -177.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 259' ' ' PRO . . . . . 0.569 ' O ' HG13 ' B' ' 260' ' ' ILE . 37.6 Cg_endo -62.39 139.91 79.49 Favored 'Trans proline' 0 N--CA 1.501 1.965 0 C-N-CA 121.418 1.412 . . . . 0.0 111.193 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 260' ' ' ILE . . . . . 0.569 HG13 ' O ' ' B' ' 259' ' ' PRO . 96.6 mt -159.62 -13.48 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 CA-C-N 118.713 0.688 . . . . 0.0 112.361 176.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 C--O 1.216 -0.686 0 CA-C-O 117.859 -1.067 . . . . 0.0 111.436 -179.983 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 900' ' ' FMN . . . . . 0.466 ' C9A' " O2'" ' A' ' 900' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 900' ' ' FMN . . . . . 0.45 ' C9A' " O2'" ' B' ' 900' ' ' FMN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.13 170.76 20.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.144 0.497 . . . . 0.0 110.196 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 80.1 p -72.66 -14.71 61.65 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.36 -0.837 . . . . 0.0 111.788 177.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -76.32 -66.59 0.78 Allowed 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 114.326 -1.306 . . . . 0.0 112.966 174.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -66.94 -39.64 87.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.908 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.539 ' O ' ' NZ ' ' B' ' 17' ' ' LYS . 49.8 m -59.25 -41.37 88.63 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -177.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.567 ' CE2' HD12 ' A' ' 9' ' ' ILE . 36.1 t80 84.37 88.23 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.127 0.489 . . . . 0.0 112.034 177.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.47 ' O ' ' HB ' ' A' ' 9' ' ' ILE . . . -62.19 -137.74 0.01 OUTLIER Glycine 0 CA--C 1.523 0.573 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 -177.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.567 HD12 ' CE2' ' A' ' 7' ' ' PHE . 55.8 mt 79.02 109.81 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 122.679 0.392 . . . . 0.0 110.637 -178.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.59 -22.06 70.43 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 121.438 1.425 . . . . 0.0 112.138 -178.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.464 ' O ' HG23 ' A' ' 15' ' ' VAL . . . -63.28 -37.46 94.9 Favored Glycine 0 N--CA 1.468 0.83 0 C-N-CA 121.045 -0.598 . . . . 0.0 111.862 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -66.14 -39.31 89.75 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.514 0.673 . . . . 0.0 109.519 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.1 tp -63.33 -41.46 98.89 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -63.65 -39.9 95.49 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 11' ' ' GLY . 67.9 t -60.03 -44.19 94.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 O-C-N 122.174 -0.329 . . . . 0.0 110.938 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 93.0 mt -62.49 -43.57 98.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 119.589 -0.844 . . . . 0.0 109.321 -178.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.444 ' NZ ' ' HA ' ' B' ' 6' ' ' SER . 98.9 mttt -62.28 -46.19 89.88 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 119.361 -0.936 . . . . 0.0 112.022 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.661 ' HZ1' HG12 ' B' ' 113' ' ' ILE . 98.4 mttt -60.46 -39.54 87.96 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 118.642 -1.223 . . . . 0.0 109.079 -176.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.58 -42.2 91.94 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.144 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.2 mt -62.95 -40.15 96.8 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 177.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.19 -39.39 94.51 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.479 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 60.7 m170 -59.29 -39.42 82.92 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 122.226 -0.297 . . . . 0.0 111.606 -178.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.8 p -113.76 130.64 67.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.49 ' O ' ' HG3' ' A' ' 24' ' ' ARG . 34.6 ptt180 -73.41 109.99 7.35 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-O 122.062 0.934 . . . . 0.0 112.187 -177.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.9 p -141.29 143.75 27.37 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.579 ' O ' ' N ' ' A' ' 123' ' ' GLN . . . -98.91 91.2 1.07 Allowed Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.908 -178.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 52.6 t -124.55 130.45 73.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 175.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.8 m -136.62 159.73 37.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.4 mt -120.43 129.55 75.43 Favored 'Isoleucine or valine' 0 C--O 1.244 0.797 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.467 HG22 HG12 ' A' ' 39' ' ' ILE . 22.4 p -106.56 167.48 9.82 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.425 ' C ' ' OD1' ' A' ' 37' ' ' ASN . 58.6 t0 -133.15 104.13 12.6 Favored Pre-proline 0 C--N 1.321 -0.66 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.251 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.697 ' HG3' HG23 ' A' ' 117' ' ' THR . 36.0 Cg_endo -63.4 -24.59 71.15 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.414 1.409 . . . . 0.0 111.501 -178.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.95 -35.75 81.17 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.17 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 96.4 mt -84.13 157.47 21.69 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.849 178.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.709 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 43.4 tt0 -57.46 134.59 56.2 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 113.361 0.875 . . . . 0.0 113.361 -176.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.526 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 59.2 t0 60.54 23.67 13.36 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.425 ' OD1' ' C ' ' A' ' 31' ' ' ASP . 40.6 t-20 39.23 69.2 1.73 Allowed Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 115.139 -0.937 . . . . 0.0 111.181 -176.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.709 ' HD3' ' O ' ' A' ' 35' ' ' GLU . 93.3 Cg_endo -70.19 155.31 64.83 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 C-N-CA 123.95 3.1 . . . . 0.0 112.123 -178.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.467 HG12 HG22 ' A' ' 30' ' ' THR . 96.0 mt -88.95 122.07 39.83 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.466 HG23 ' N ' ' A' ' 41' ' ' TYR . 30.3 m -102.01 -45.97 11.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.243 -178.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.466 ' N ' HG23 ' A' ' 40' ' ' VAL . 48.9 t80 -93.72 124.36 37.67 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 120.185 -0.606 . . . . 0.0 111.949 -178.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.7 p -143.09 140.27 27.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.226 0.953 . . . . 0.0 109.217 176.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.614 ' OD1' ' HB2' ' A' ' 46' ' ' PHE . 56.9 p30 -96.49 166.43 11.69 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.474 ' OE1' ' HA ' ' A' ' 44' ' ' GLN . 14.9 mm100 -66.55 -39.82 88.72 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 177.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -59.89 -24.25 60.12 Favored Glycine 0 N--CA 1.453 -0.209 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.631 ' CD2' HD13 ' A' ' 57' ' ' ILE . 65.5 t80 -59.61 -47.86 83.92 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 105.627 -1.99 . . . . 0.0 105.627 -179.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.579 HG13 ' O ' ' A' ' 52' ' ' TYR . 71.4 t -58.96 -44.54 91.24 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.646 0 O-C-N 121.301 -0.875 . . . . 0.0 111.745 -174.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -63.25 -37.29 86.68 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 120.399 -0.52 . . . . 0.0 112.301 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 59.2 ttm -66.79 -43.38 84.1 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 176.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 36.3 p -93.51 -21.18 19.62 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.346 0.593 . . . . 0.0 111.541 -177.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . 76.44 20.46 76.88 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -179.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.579 ' O ' HG13 ' A' ' 47' ' ' VAL . 82.1 m-85 -113.25 137.08 52.01 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 122.783 0.433 . . . . 0.0 111.12 178.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -62.62 146.99 50.65 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.558 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.426 HG22 ' H ' ' A' ' 54' ' ' THR . 0.1 OUTLIER -64.84 -32.9 74.82 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -179.485 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -66.69 -43.1 85.31 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.516 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 76.5 mt-10 -64.67 -45.65 85.77 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.073 -0.651 . . . . 0.0 109.252 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.631 HD13 ' CD2' ' A' ' 46' ' ' PHE . 89.1 mt -61.26 -49.84 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 N-CA-C 113.74 1.015 . . . . 0.0 113.74 -175.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.1 mt -55.53 148.27 16.02 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 176.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 81.28 -3.44 77.38 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.873 -0.679 . . . . 0.0 113.062 177.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -137.15 151.41 48.78 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 118.705 1.252 . . . . 0.0 112.037 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.575 ' C ' ' H ' ' A' ' 63' ' ' ARG . 25.1 t-20 -81.77 151.71 27.31 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.553 -178.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 79.2 m -62.09 15.39 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.373 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.575 ' H ' ' C ' ' A' ' 61' ' ' ASN . 35.2 ptt-85 -62.21 -41.41 98.34 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.139 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -56.04 -21.99 24.81 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -178.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.2 mt -67.33 -35.73 80.0 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 122.066 0.936 . . . . 0.0 112.916 177.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -63.21 146.38 53.51 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.847 -1.069 . . . . 0.0 112.263 -178.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.496 ' N ' ' OG1' ' A' ' 70' ' ' THR . . . -156.54 -150.93 5.8 Favored Glycine 0 CA--C 1.538 1.519 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -177.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.75 -41.29 99.14 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -178.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.432 ' O ' ' OE1' ' A' ' 93' ' ' GLN . 11.1 m-70 -76.21 -9.08 58.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.847 0.356 . . . . 0.0 110.916 -178.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.496 ' OG1' ' N ' ' A' ' 67' ' ' GLY . 32.9 m -62.62 128.69 37.14 Favored 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.595 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -84.75 110.99 31.8 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.825 -179.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -57.29 -31.09 89.88 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 121.997 1.798 . . . . 0.0 113.207 178.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.5 -39.31 93.54 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.888 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.571 ' OE1' ' HB ' ' A' ' 90' ' ' VAL . 79.1 mm-40 -65.45 -44.43 87.28 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.0 t -59.31 -44.1 91.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -176.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -63.97 -38.19 90.17 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.004 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -63.68 -39.6 94.73 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.403 0.621 . . . . 0.0 110.24 178.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 94.1 mt -63.71 -44.12 98.27 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.053 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -62.88 -42.52 99.8 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 113.814 -1.539 . . . . 0.0 108.309 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 97.6 m -61.24 -49.37 77.37 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -59.65 -42.46 92.87 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.189 -172.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 91.5 mt -63.45 -39.56 94.79 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.007 -1.058 . . . . 0.0 111.492 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -64.06 -33.16 75.12 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -89.08 -2.63 58.64 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.381 -178.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.2 tttt 49.22 40.78 18.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.59 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -122.69 144.26 42.11 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_exo -61.32 142.88 97.37 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 121.473 1.448 . . . . 0.0 113.543 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -139.75 141.63 34.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.589 -178.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.93 HG23 ' OD1' ' A' ' 107' ' ' ASN . 98.8 m -128.12 120.05 26.57 Favored 'General case' 0 C--N 1.344 0.332 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 175.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.571 ' HB ' ' OE1' ' A' ' 74' ' ' GLU . 28.4 m -138.85 158.7 30.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.465 178.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -101.76 132.39 47.51 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 177.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.453 HG23 ' O ' ' A' ' 92' ' ' ILE . 19.2 tt -139.99 129.44 28.29 Favored 'Isoleucine or valine' 0 C--N 1.377 1.789 0 CA-C-N 121.557 1.98 . . . . 0.0 112.527 176.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.432 ' OE1' ' O ' ' A' ' 69' ' ' HIS . 86.1 mt-30 -62.98 133.45 54.63 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.55 -1.205 . . . . 0.0 109.948 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -134.48 158.33 44.19 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.758 -178.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.428 ' CE1' ' HA3' ' A' ' 67' ' ' GLY . 92.7 m-85 -116.16 135.13 54.2 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -179.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.438 ' HG3' ' CE1' ' A' ' 102' ' ' PHE . 99.2 mttt -83.69 -172.51 4.19 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.161 0.505 . . . . 0.0 111.618 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.05 -42.26 99.66 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.158 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 41.0 p-10 -83.31 5.84 21.84 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.51 -0.65 88.39 Favored Glycine 0 N--CA 1.47 0.925 0 O-C-N 121.547 -0.721 . . . . 0.0 112.126 176.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.1 m -59.83 138.32 57.83 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.649 ' SD ' ' C ' ' A' ' 101' ' ' MET . 14.9 tmm? -104.45 128.75 52.42 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.561 0.22 . . . . 0.0 110.782 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.438 ' CE1' ' HG3' ' A' ' 96' ' ' LYS . 52.7 p90 -141.44 158.55 43.72 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.888 -176.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.638 ' CD1' ' NZ ' ' A' ' 130' ' ' LYS . 20.7 m95 -90.81 141.29 28.96 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.571 HD21 ' HG2' ' A' ' 123' ' ' GLN . 53.1 t-20 -136.41 106.8 6.44 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -177.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.443 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 80.5 tt0 -72.37 134.9 45.7 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 -177.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 43.9 tp -120.78 123.07 41.76 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASN . . . . . 0.93 ' OD1' HG23 ' A' ' 89' ' ' THR . 98.0 m-20 -118.68 123.86 45.96 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 120.911 -0.316 . . . . 0.0 110.866 177.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 96.3 mt -120.21 128.45 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 O-C-N 123.525 0.516 . . . . 0.0 111.57 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -137.96 123.09 12.35 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 116.764 -0.198 . . . . 0.0 110.925 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -70.26 150.85 65.76 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 122.454 2.103 . . . . 0.0 112.578 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . 0.634 ' HB2' ' HB2' ' A' ' 118' ' ' TYR . 66.3 mtt -122.67 152.63 40.34 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -127.23 91.51 3.33 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 107.894 -1.151 . . . . 0.0 107.894 177.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.411 ' CD1' HG22 ' B' ' 15' ' ' VAL . 96.7 mt -117.81 130.57 72.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 115.586 -0.734 . . . . 0.0 112.275 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 53.31 36.56 23.13 Favored 'General case' 0 CA--C 1.513 -0.472 0 O-C-N 121.461 -0.774 . . . . 0.0 111.648 176.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 59.21 30.62 20.41 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 123.853 0.721 . . . . 0.0 110.813 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -127.52 149.55 50.08 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.782 ' O ' ' CD2' ' A' ' 118' ' ' TYR . 9.9 t -85.79 -173.11 4.45 Favored 'General case' 0 C--O 1.219 -0.504 0 O-C-N 121.687 -0.633 . . . . 0.0 109.489 -178.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.782 ' CD2' ' O ' ' A' ' 117' ' ' THR . 69.0 m-85 -171.9 155.71 3.92 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 174.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -131.51 146.34 52.18 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 174.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -133.87 135.1 55.57 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 177.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.496 ' HA3' ' H6 ' ' A' ' 900' ' ' FMN . . . -106.9 127.27 8.78 Favored Glycine 0 CA--C 1.502 -0.765 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 177.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 96.3 mt -117.89 129.27 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 178.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.579 ' N ' ' O ' ' A' ' 26' ' ' GLY . 15.9 mp0 -120.18 115.74 24.24 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 123.69 0.619 . . . . 0.0 109.793 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -115.35 113.14 23.4 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.817 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.401 ' OD1' ' C ' ' A' ' 125' ' ' ASP . 68.4 t0 -65.77 123.23 19.2 Favored 'General case' 0 CA--C 1.549 0.932 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -175.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.519 HG22 ' O ' ' A' ' 126' ' ' ILE . 3.0 mp -87.0 2.89 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 113.666 -1.606 . . . . 0.0 110.194 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 31.6 m -60.13 -42.47 94.88 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.042 -1.036 . . . . 0.0 113.393 -178.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -59.66 -42.6 93.2 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -178.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -62.38 -39.19 92.36 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.855 176.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.638 ' NZ ' ' CD1' ' A' ' 103' ' ' TRP . 98.8 mttt -62.53 -40.71 97.64 Favored 'General case' 0 CA--C 1.502 -0.876 0 C-N-CA 118.31 -1.356 . . . . 0.0 110.494 -178.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.53 -37.27 85.44 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.357 -0.537 . . . . 0.0 109.657 -178.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.836 ' CE2' HD11 ' A' ' 136' ' ' LEU . 90.6 t80 -61.74 -45.7 92.8 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.244 176.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.33 -39.44 93.91 Favored 'General case' 0 C--O 1.226 -0.179 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -61.48 -41.23 96.95 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 50.6 tp -61.09 -43.76 98.39 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 -177.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.836 HD11 ' CE2' ' A' ' 132' ' ' TYR . 88.5 mt -62.22 -41.08 98.06 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.882 178.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -62.76 -41.36 99.18 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 119.453 -0.899 . . . . 0.0 109.762 -178.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -60.99 -42.01 97.58 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -177.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 53.7 m -61.67 -41.34 97.41 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.71 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 144' ' ' THR . 87.5 mt -63.39 -41.89 98.78 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.458 -0.497 . . . . 0.0 109.785 178.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 87.3 m -61.65 -45.33 94.49 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.381 -177.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -65.05 -41.3 95.27 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 96.4 mt -64.45 -43.6 96.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.005 -1.452 . . . . 0.0 111.235 175.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.518 ' N ' ' O ' ' A' ' 140' ' ' LEU . 95.6 m -62.29 -46.32 89.28 Favored 'General case' 0 C--N 1.345 0.411 0 C-N-CA 120.364 -0.534 . . . . 0.0 112.185 -178.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.22 -41.21 99.08 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 118.882 -1.127 . . . . 0.0 109.15 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.6 mt -63.93 -42.67 97.3 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 178.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.702 ' O ' ' N ' ' A' ' 149' ' ' PRO . 78.2 p -59.6 -38.38 81.1 Favored 'General case' 0 C--O 1.218 -0.598 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -178.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.465 ' C ' ' O ' ' A' ' 147' ' ' SER . 86.1 m -28.97 82.37 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.32 0 O-C-N 126.944 2.653 . . . . 0.0 106.101 -178.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.702 ' N ' ' O ' ' A' ' 147' ' ' SER . 23.2 Cg_exo -61.85 145.0 97.32 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 CA-C-O 122.788 1.078 . . . . 0.0 114.301 -174.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.595 ' O ' HG23 ' A' ' 151' ' ' VAL . 9.5 tp -120.44 136.49 57.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 102.502 -3.147 . . . . 0.0 102.502 176.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 150' ' ' ILE . 96.3 t -167.9 93.83 0.64 Allowed Pre-proline 0 CA--C 1.506 -0.725 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 178.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -63.82 143.71 86.74 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 N-CA-C 109.901 -0.846 . . . . 0.0 109.901 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.72 ' O ' HG11 ' B' ' 255' ' ' VAL . 44.3 mm -77.03 -68.71 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.659 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ARG . . . . . 0.665 ' NH2' ' HD3' ' B' ' 154' ' ' ARG . 3.1 mpt_? -132.99 -161.41 1.14 Allowed 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -83.34 104.99 13.93 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.849 0.833 . . . . 0.0 111.291 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 92.8 10.06 60.49 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 113.904 -1.498 . . . . 0.0 110.2 -177.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.5 mt -126.98 125.67 66.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.735 ' OG ' ' OD2' ' A' ' 187' ' ' ASP . 58.7 m -132.25 152.46 51.34 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -138.37 142.28 39.64 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.481 177.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 27.4 tp -135.45 80.58 45.03 Favored Pre-proline 0 N--CA 1.468 0.454 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.386 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -70.98 151.54 62.22 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.638 2.225 . . . . 0.0 113.005 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 88.6 mt -117.65 126.79 53.14 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.184 177.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 47.7 t -122.95 130.13 74.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 116.57 167.49 14.69 Favored Glycine 0 N--CA 1.479 1.558 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.179 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.841 ' O ' ' NH1' ' A' ' 170' ' ' ARG . 57.6 t30 -84.16 115.83 22.61 Favored 'General case' 0 C--O 1.222 -0.358 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -178.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.56 HD21 ' CZ ' ' A' ' 171' ' ' PHE . 45.3 tp -74.28 104.83 5.19 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 -177.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.738 HG23 ' NE ' ' A' ' 170' ' ' ARG . 10.8 p -87.04 166.74 14.81 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.269 0.557 . . . . 0.0 110.485 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.97 -33.75 76.54 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.086 0.47 . . . . 0.0 111.773 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.12 -43.76 90.94 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.519 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . 0.841 ' NH1' ' O ' ' A' ' 165' ' ' ASN . 87.1 mtm180 -64.99 -29.38 70.3 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 178.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.56 ' CZ ' HD21 ' A' ' 166' ' ' LEU . 0.5 OUTLIER -54.6 -28.98 50.28 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.524 0.565 . . . . 0.0 112.524 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.604 ' O ' HG22 ' A' ' 175' ' ' VAL . 92.1 m-20 -60.89 -41.12 95.43 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 119.102 -1.039 . . . . 0.0 109.679 -177.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 60.0 m -59.45 -40.81 88.03 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.687 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 67.6 mt -63.25 -44.13 99.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.604 HG22 ' O ' ' A' ' 172' ' ' ASN . 34.5 m -63.0 -39.95 87.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' CYS . . . . . 0.414 ' N ' HG23 ' A' ' 175' ' ' VAL . 98.1 m -62.08 -34.66 76.71 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.431 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.5 ' O ' HG13 ' A' ' 181' ' ' ILE . 25.0 m -61.92 -19.27 62.52 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.097 179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.653 ' CD2' HD21 ' A' ' 211' ' ' LEU . 88.2 mt -61.0 -41.02 95.72 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -177.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 17.4 m -58.97 -43.2 91.31 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ASN . . . . . 0.674 ' O ' ' OG ' ' A' ' 183' ' ' SER . 93.1 m-20 -61.76 -35.98 79.69 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 122.507 0.323 . . . . 0.0 110.748 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.504 HD12 ' HA ' ' A' ' 178' ' ' LEU . 65.2 mt -58.99 -40.54 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 121.441 -0.787 . . . . 0.0 109.538 -178.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.548 HD21 HD21 ' A' ' 214' ' ' LEU . 85.6 mt -60.53 -40.18 90.59 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -177.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.674 ' OG ' ' O ' ' A' ' 180' ' ' ASN . 78.2 p -61.09 -33.5 73.44 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.419 175.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.407 ' OG1' ' HA ' ' A' ' 181' ' ' ILE . 60.0 p -91.71 23.59 3.51 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.7 0.286 . . . . 0.0 111.402 -179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 77.8 p -63.49 -20.86 65.95 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.674 -178.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.76 -37.65 82.58 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.929 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.735 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 98.5 m-20 -71.38 113.75 8.74 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.617 0.722 . . . . 0.0 110.928 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -62.95 -42.73 99.91 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.029 -0.987 . . . . 0.0 112.86 -177.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -112.06 131.36 55.48 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.981 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 39.5 tp -120.01 127.94 53.07 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 177.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 96.2 mt -115.73 125.94 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 49.6 mm -112.62 126.57 70.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 178.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' ASP . . . . . 0.507 ' OD2' ' OG ' ' A' ' 195' ' ' SER . 38.7 t0 -95.58 118.09 31.64 Favored 'General case' 0 CA--C 1.551 1.007 0 O-C-N 121.88 -0.512 . . . . 0.0 110.443 177.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 194' ' ' LEU . 96.9 mt -97.67 -3.35 39.47 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.848 175.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.507 ' OG ' ' OD2' ' A' ' 193' ' ' ASP . 78.0 p -62.24 -33.42 74.55 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.86 -44.68 97.52 Favored Glycine 0 CA--C 1.535 1.288 0 N-CA-C 108.39 -1.884 . . . . 0.0 108.39 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.943 HD23 ' N ' ' A' ' 198' ' ' ALA . 4.7 tt -69.22 128.03 35.17 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 112.792 -1.704 . . . . 0.0 108.902 -177.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.943 ' N ' HD23 ' A' ' 197' ' ' LEU . . . -60.8 -47.0 88.3 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-O 121.253 0.549 . . . . 0.0 110.48 -177.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.915 ' O ' ' CD2' ' A' ' 197' ' ' LEU . 58.4 tt0 -135.83 156.86 48.14 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-N 114.623 -1.171 . . . . 0.0 113.851 -173.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.453 ' N ' ' HG2' ' A' ' 199' ' ' GLN . 45.3 t -118.73 132.03 69.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 O-C-N 120.924 -1.11 . . . . 0.0 108.298 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -86.95 156.01 19.97 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.582 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.11 -39.06 93.22 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 120.144 -0.623 . . . . 0.0 109.975 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -57.45 -31.98 66.46 Favored 'General case' 0 N--CA 1.465 0.279 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -178.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.4 m -61.32 -42.08 98.07 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.445 178.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.433 ' O ' ' CD2' ' A' ' 209' ' ' PHE . . . -58.32 -38.42 77.07 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -176.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -61.81 -37.14 83.3 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -178.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -65.92 -38.18 88.02 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.979 177.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 94.7 mt -62.84 -44.35 99.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -178.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . 0.433 ' CD2' ' O ' ' A' ' 205' ' ' ALA . 68.4 m-85 -62.74 -43.06 99.78 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.491 -177.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.27 -42.09 99.04 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 118.961 -1.096 . . . . 0.0 109.168 -178.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.653 HD21 ' CD2' ' A' ' 178' ' ' LEU . 39.8 mt -62.17 -41.87 98.72 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 78.2 p -61.52 -42.36 98.7 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 119.117 -1.033 . . . . 0.0 110.26 -179.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -63.92 -45.43 89.3 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.755 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.548 HD21 HD21 ' A' ' 182' ' ' LEU . 47.8 tp -62.45 -45.87 91.1 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 118.995 -1.082 . . . . 0.0 108.18 178.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 87.7 mt -62.67 -40.36 96.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.366 -177.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.42 -44.97 95.23 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.116 -0.634 . . . . 0.0 109.507 -177.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 86.2 mt -61.68 -40.29 94.46 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 82.6 p -75.38 -11.41 60.04 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.501 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.88 35.14 19.75 Favored Glycine 0 C--N 1.341 0.832 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.697 -178.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 96.7 m -120.47 113.84 20.9 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 119.051 1.426 . . . . 0.0 111.772 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -66.57 136.5 55.71 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.574 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 45.0 tp -112.63 129.44 56.38 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . . . . . . . . . 3.0 mp -116.3 134.58 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.671 ' CG2' HD11 ' A' ' 227' ' ' ILE . 49.8 mm -115.41 130.74 69.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 44.8 p -133.49 165.04 25.8 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.881 -177.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . 78.53 20.46 71.57 Favored Glycine 0 C--O 1.225 -0.462 0 N-CA-C 110.676 -0.969 . . . . 0.0 110.676 178.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.671 HD11 ' CG2' ' A' ' 224' ' ' ILE . 98.1 mt -82.32 128.04 39.09 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 113.767 -1.217 . . . . 0.0 108.248 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -75.67 140.44 71.42 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.09 -39.62 84.92 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 121.018 1.145 . . . . 0.0 112.483 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -63.72 -38.93 92.95 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.418 0.628 . . . . 0.0 110.198 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 52.9 tp -64.23 -42.24 96.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.791 177.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.84 -37.69 88.46 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 120.545 -0.462 . . . . 0.0 111.09 -178.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' MET . . . . . . . . . . . . . 94.0 mtp -63.33 -41.06 98.86 Favored 'General case' 0 C--O 1.249 1.041 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.82 -178.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.87 -38.89 92.78 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.468 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' MET . . . . . . . . . . . . . 36.4 mmt -66.21 -37.63 86.03 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.514 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -61.18 -42.74 99.12 Favored 'General case' 0 CA--C 1.514 -0.405 0 O-C-N 121.58 -0.7 . . . . 0.0 109.617 -176.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -60.18 -40.09 88.76 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.713 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' LEU . . . . . . . . . . . . . 56.7 tp -63.3 -41.09 98.93 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -168.15 127.55 1.24 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.33 0.586 . . . . 0.0 112.532 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -59.47 -26.59 65.37 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.801 178.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.412 ' O ' ' HB2' ' A' ' 244' ' ' SER . 89.4 m-20 -62.67 -29.41 70.62 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.534 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -55.92 -45.64 78.67 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -175.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 98.4 p -60.99 -21.02 63.14 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 123.918 0.761 . . . . 0.0 111.44 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 241' ' ' ASN . 43.1 m -54.39 -40.47 68.22 Favored 'General case' 0 C--N 1.32 -0.713 0 O-C-N 122.342 -0.224 . . . . 0.0 111.553 178.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 95.0 mt -83.18 119.68 24.84 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.403 ' HA ' ' HD3' ' A' ' 246' ' ' LYS . 74.4 mmtt -41.52 134.64 2.3 Favored 'General case' 0 C--O 1.243 0.724 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.103 178.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.637 HG23 HD12 ' A' ' 227' ' ' ILE . 98.1 m -127.75 134.44 49.52 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.43 -1.259 . . . . 0.0 110.936 177.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' TYR . . . . . 0.493 ' CB ' ' HB2' ' A' ' 254' ' ' ALA . 97.2 m-85 -118.41 139.59 51.16 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.851 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' SER . . . . . . . . . . . . . 78.0 p -61.38 -42.74 99.21 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -143.73 159.57 42.26 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.685 0.755 . . . . 0.0 111.599 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 75.9 t -62.53 -44.76 99.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 114.711 -1.132 . . . . 0.0 111.953 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.84 -44.28 97.16 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . 0.512 ' O ' HG22 ' A' ' 257' ' ' VAL . 55.4 m-20 -64.14 -42.03 96.95 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.455 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.493 ' HB2' ' CB ' ' A' ' 248' ' ' TYR . . . -64.65 -42.47 95.4 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.868 0.842 . . . . 0.0 109.829 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' VAL . . . . . 0.422 HG13 HH11 ' B' ' 154' ' ' ARG . 54.8 t -63.41 -46.04 96.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 113.946 -1.479 . . . . 0.0 111.173 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.7 -46.21 86.52 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 120.589 -0.445 . . . . 0.0 111.459 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.512 HG22 ' O ' ' A' ' 253' ' ' ASP . 32.9 m -66.71 -40.81 86.96 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.134 0 O-C-N 121.468 -0.77 . . . . 0.0 112.073 179.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.495 ' C ' ' O ' ' A' ' 257' ' ' VAL . 2.1 mt -29.48 -75.47 0.04 OUTLIER Pre-proline 0 C--O 1.234 0.262 0 O-C-N 123.099 0.25 . . . . 0.0 111.522 -177.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' PRO . . . . . 0.492 ' CD ' ' CB ' ' A' ' 258' ' ' LEU . 42.5 Cg_endo -63.33 139.96 74.34 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 120.789 0.992 . . . . 0.0 111.825 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 259' ' ' PRO . 96.7 mt -151.85 -27.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 O-C-N 123.953 0.783 . . . . 0.0 111.973 178.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' MET . . . . . . . . . . . . . 78.1 mtm . . . . . 0 N--CA 1.473 0.708 0 CA-C-O 118.058 -0.972 . . . . 0.0 110.736 -177.174 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.475 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.91 161.14 22.79 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 79.2 p -59.87 -21.7 61.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.871 177.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -74.21 -64.05 1.1 Allowed 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.969 0.414 . . . . 0.0 111.123 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -65.63 -39.43 91.45 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.281 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.504 ' O ' ' HB3' ' B' ' 7' ' ' PHE . 49.5 m -59.97 -41.88 92.94 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.094 -0.642 . . . . 0.0 109.792 -177.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . 0.561 ' CE2' HD12 ' B' ' 9' ' ' ILE . 37.8 t80 85.48 92.22 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.352 177.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' GLY . . . . . 0.49 ' O ' ' HB ' ' B' ' 9' ' ' ILE . . . -65.02 -137.18 0.02 OUTLIER Glycine 0 C--N 1.338 0.687 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -178.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' ILE . . . . . 0.561 HD12 ' CE2' ' B' ' 7' ' ' PHE . 55.3 mt 78.62 109.48 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 122.613 0.365 . . . . 0.0 111.162 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -62.24 -23.87 75.68 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 121.304 1.336 . . . . 0.0 111.806 -178.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.3 -40.29 98.4 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -64.5 -39.81 94.48 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.733 0.778 . . . . 0.0 109.267 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 52.7 tp -61.88 -42.55 99.2 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.439 -177.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -65.12 -32.17 73.74 Favored 'General case' 0 CA--C 1.561 1.37 0 CA-C-O 121.479 0.657 . . . . 0.0 110.705 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . 0.411 HG22 ' CD1' ' A' ' 113' ' ' ILE . 75.4 t -62.6 -46.03 97.37 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 CA-C-N 113.101 -1.863 . . . . 0.0 110.926 177.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 92.6 mt -64.04 -43.81 97.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.871 -178.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . 0.539 ' NZ ' ' O ' ' A' ' 6' ' ' SER . 98.9 mttt -63.3 -42.44 99.04 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -179.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -63.21 -41.23 99.12 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 118.998 -1.081 . . . . 0.0 110.026 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.19 -38.85 84.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.867 -178.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' B' ' 20' ' ' LEU . 89.0 mt -64.31 -41.7 96.7 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-O 121.289 0.566 . . . . 0.0 110.122 174.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.29 -39.89 94.46 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.021 -179.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' HIS . . . . . . . . . . . . . 59.4 m170 -58.46 -39.58 80.31 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 121.121 -0.231 . . . . 0.0 111.601 -178.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' VAL . . . . . . . . . . . . . 13.3 p -113.97 130.42 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.5 ' O ' ' HG3' ' B' ' 24' ' ' ARG . 34.6 ptt180 -73.15 108.04 5.82 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-O 121.726 0.774 . . . . 0.0 112.577 -177.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . . . . . . . . . 6.6 p -143.3 133.8 22.21 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.885 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.687 177.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' B' ' 123' ' ' GLN . . . -88.43 95.88 2.14 Favored Glycine 0 C--N 1.315 -0.626 0 C-N-CA 119.364 -1.398 . . . . 0.0 113.403 -176.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 47.7 t -125.23 129.54 73.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 174.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 31.8 m -137.97 157.29 32.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.53 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 95.8 mt -119.27 127.42 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.666 178.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.457 HG22 HG12 ' B' ' 39' ' ' ILE . 31.3 p -109.01 157.04 19.05 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-N 112.795 -2.002 . . . . 0.0 108.567 -177.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -124.86 104.26 30.31 Favored Pre-proline 0 C--O 1.235 0.294 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' PRO . . . . . 0.622 ' HG3' HG23 ' B' ' 117' ' ' THR . 37.0 Cg_endo -64.54 -22.51 65.08 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 121.639 1.559 . . . . 0.0 111.59 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -62.13 -43.76 98.13 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.423 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 99.4 mt -73.02 174.67 7.55 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.951 -0.468 . . . . 0.0 111.378 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . 0.606 ' O ' ' HD3' ' B' ' 38' ' ' PRO . 42.7 tt0 -73.16 131.25 41.8 Favored 'General case' 0 C--N 1.345 0.381 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -176.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.476 ' O ' ' OD1' ' B' ' 36' ' ' ASP . 66.0 t0 57.54 38.19 27.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.625 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' ASN . . . . . 0.465 ' C ' ' O ' ' B' ' 36' ' ' ASP . 29.7 t-20 28.63 71.86 0.47 Allowed Pre-proline 0 CA--C 1.535 0.368 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -178.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.606 ' HD3' ' O ' ' B' ' 35' ' ' GLU . 92.1 Cg_endo -71.77 154.18 59.0 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 123.551 2.834 . . . . 0.0 111.84 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.457 HG12 HG22 ' B' ' 30' ' ' THR . 95.6 mt -87.5 127.91 40.44 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.453 HG23 ' N ' ' B' ' 41' ' ' TYR . 26.7 m -108.03 -45.44 7.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 O-C-N 123.777 0.673 . . . . 0.0 112.437 -178.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' TYR . . . . . 0.453 ' N ' HG23 ' B' ' 40' ' ' VAL . 51.6 t80 -94.73 124.51 38.81 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.552 -178.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 6.0 p -142.97 140.96 27.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.311 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' ASN . . . . . 0.647 ' OD1' ' HB2' ' B' ' 46' ' ' PHE . 57.2 p30 -100.34 161.46 13.59 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.086 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' GLN . . . . . 0.446 ' OE1' ' HA ' ' B' ' 44' ' ' GLN . 14.4 mm100 -63.16 -37.98 89.37 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.502 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' GLY . . . . . . . . . . . . . . . -60.17 -25.01 61.72 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.291 -0.723 . . . . 0.0 111.291 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' PHE . . . . . 0.647 ' HB2' ' OD1' ' B' ' 43' ' ' ASN . 61.3 t80 -60.33 -43.3 96.54 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' VAL . . . . . 0.71 HG13 ' O ' ' B' ' 52' ' ' TYR . 69.4 t -61.16 -46.35 96.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.252 -178.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -62.67 -44.22 96.81 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.213 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' MET . . . . . . . . . . . . . 59.3 ttm -62.98 -42.06 99.73 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' THR . . . . . . . . . . . . . 33.8 p -96.11 -16.1 21.75 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 120.231 -0.588 . . . . 0.0 111.969 -178.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' B' ' 47' ' ' VAL . . . 73.08 18.3 79.11 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 178.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' TYR . . . . . 0.71 ' O ' HG13 ' B' ' 47' ' ' VAL . 82.6 m-85 -110.62 143.17 41.46 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.294 -0.453 . . . . 0.0 110.038 178.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -71.79 146.9 47.75 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-O 121.904 0.859 . . . . 0.0 110.994 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . 0.418 ' H ' HG22 ' B' ' 54' ' ' THR . 0.1 OUTLIER -61.63 -36.8 81.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.065 -177.349 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.37 -39.59 94.18 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 120.197 -0.601 . . . . 0.0 112.015 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -72.51 -32.04 65.83 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 177.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.645 HD13 ' CE2' ' B' ' 46' ' ' PHE . 95.8 mt -66.68 -71.29 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 178.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 94.2 mt -36.61 130.97 0.71 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.38 175.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.24 -8.23 69.54 Favored Glycine 0 CA--C 1.534 1.248 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.617 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -136.08 149.14 48.6 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -174.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' ASN . . . . . 0.521 ' OD1' " H3'" ' B' ' 900' ' ' FMN . 25.7 t-20 -79.55 151.6 30.6 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.798 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' CYS . . . . . . . . . . . . . 78.3 m -62.83 7.91 0.07 Allowed 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.375 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' ARG . . . . . 0.515 ' H ' ' C ' ' B' ' 61' ' ' ASN . 33.5 ptt-85 -58.79 -31.89 68.82 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.54 -0.755 . . . . 0.0 112.497 -178.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -60.93 -31.2 70.74 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 178.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' LEU . . . . . . . . . . . . . 81.5 mt -61.94 -42.36 99.02 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -177.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -48.02 151.67 0.92 Allowed 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.155 0.503 . . . . 0.0 109.888 -178.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . 0.406 ' N ' ' OG1' ' B' ' 70' ' ' THR . . . -162.26 -152.93 6.92 Favored Glycine 0 CA--C 1.54 1.649 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.184 175.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.87 -42.23 97.5 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 122.634 -0.333 . . . . 0.0 111.823 -175.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -74.93 -9.98 59.05 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.161 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' THR . . . . . 0.406 ' OG1' ' N ' ' B' ' 67' ' ' GLY . 31.5 m -61.29 134.72 57.27 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -90.94 110.26 40.74 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.25 -178.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.84 -38.14 85.47 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 120.965 1.11 . . . . 0.0 111.828 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.38 -40.03 89.4 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 120.568 -0.453 . . . . 0.0 109.787 -176.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' GLU . . . . . 0.567 ' OE1' ' HB ' ' B' ' 90' ' ' VAL . 79.2 mm-40 -66.16 -39.65 89.95 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.889 177.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' VAL . . . . . . . . . . . . . 72.1 t -61.92 -46.24 96.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -62.88 -37.45 86.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.885 -178.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -62.84 -41.53 99.38 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 119.312 -0.955 . . . . 0.0 108.79 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' ILE . . . . . . . . . . . . . 95.0 mt -63.34 -43.73 98.72 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.488 0 CA-C-O 120.761 0.315 . . . . 0.0 110.714 -178.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -62.27 -42.44 99.34 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . . . . . . . . . 81.7 m -60.81 -45.75 93.19 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.994 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' ALA . . . . . . . . . . . . . . . -61.5 -41.81 97.84 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -177.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 87.9 mt -63.57 -41.79 98.36 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' GLN . . . . . . . . . . . . . 67.4 tp60 -62.21 -35.33 78.57 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -91.61 8.41 36.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.682 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . . . . . . . . . 26.9 tttt 41.51 42.29 1.89 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.3 -0.56 . . . . 0.0 112.045 176.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -124.31 141.3 37.1 Favored Pre-proline 0 N--CA 1.471 0.58 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.096 178.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -61.73 140.12 84.29 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 120.875 1.05 . . . . 0.0 114.029 -178.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.87 135.9 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -177.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' THR . . . . . 0.909 HG23 ' OD1' ' B' ' 107' ' ' ASN . 96.2 m -121.85 122.06 38.58 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' VAL . . . . . 0.567 ' HB ' ' OE1' ' B' ' 74' ' ' GLU . 26.9 m -139.31 163.28 26.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.753 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -113.6 121.47 44.27 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.131 0.491 . . . . 0.0 109.881 175.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 21.2 tt -127.87 131.47 69.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.034 -175.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -71.94 142.05 49.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.938 177.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -132.9 -178.47 4.97 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.407 0.623 . . . . 0.0 111.04 -176.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' TYR . . . . . 0.405 ' CE1' ' HA3' ' B' ' 67' ' ' GLY . 96.2 m-85 -132.2 146.03 51.74 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.813 178.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . 0.42 ' HG3' ' CE1' ' B' ' 102' ' ' PHE . 98.8 mttt -102.93 179.29 4.32 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.056 0.455 . . . . 0.0 110.702 177.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -60.53 -35.16 75.31 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.243 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 37.0 p-10 -86.49 -1.95 58.04 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.038 0.836 . . . . 0.0 112.785 177.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.59 4.62 65.62 Favored Glycine 0 N--CA 1.465 0.612 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.165 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 25.8 m -67.65 128.98 38.46 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 120.125 -0.63 . . . . 0.0 109.331 178.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . 0.531 ' SD ' ' N ' ' B' ' 102' ' ' PHE . 16.8 tmm? -87.25 143.37 27.31 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' PHE . . . . . 0.531 ' N ' ' SD ' ' B' ' 101' ' ' MET . 52.1 p90 -154.74 163.86 39.64 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' TRP . . . . . 0.663 ' CD1' ' NZ ' ' B' ' 130' ' ' LYS . 22.0 m95 -97.51 137.57 36.26 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.276 -0.57 . . . . 0.0 111.086 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . 0.546 HD21 ' HG2' ' B' ' 123' ' ' GLN . 63.8 t-20 -131.9 113.4 13.4 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 114.707 -1.133 . . . . 0.0 113.957 -177.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -83.51 121.41 27.17 Favored 'General case' 0 C--N 1.318 -0.788 0 O-C-N 124.441 1.088 . . . . 0.0 109.015 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 41.2 tp -109.52 125.66 52.73 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.066 0.46 . . . . 0.0 111.95 -177.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' ASN . . . . . 0.909 ' OD1' HG23 ' B' ' 89' ' ' THR . 98.2 m-20 -118.34 129.6 55.53 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 176.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 96.7 mt -124.07 132.75 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -144.37 121.3 6.43 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -69.27 152.18 71.85 Favored 'Trans proline' 0 N--CA 1.503 2.043 0 C-N-CA 122.424 2.083 . . . . 0.0 112.576 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . 0.49 ' HB2' ' HB2' ' B' ' 118' ' ' TYR . 66.1 mtt -128.75 142.26 51.06 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -112.51 105.27 13.45 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . 0.661 HG12 ' HZ1' ' A' ' 18' ' ' LYS . 96.8 mt -132.9 127.93 56.1 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 O-C-N 121.697 -0.627 . . . . 0.0 111.695 177.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 53.94 37.19 26.13 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 123.913 0.758 . . . . 0.0 109.713 178.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 60.58 36.28 19.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.266 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -132.63 153.23 51.27 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 177.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' THR . . . . . 0.622 HG23 ' HG3' ' B' ' 32' ' ' PRO . 11.3 t -103.23 152.31 21.64 Favored 'General case' 0 C--O 1.213 -0.82 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.16 -178.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' TYR . . . . . 0.49 ' HB2' ' HB2' ' B' ' 111' ' ' MET . 96.5 m-85 -148.04 146.95 29.09 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 121.222 -0.924 . . . . 0.0 111.278 -179.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -123.54 138.98 54.45 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 120.971 0.415 . . . . 0.0 111.512 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 2.6 p -128.01 133.67 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -176.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . 0.518 ' HA3' ' H6 ' ' B' ' 900' ' ' FMN . . . -107.93 121.98 6.58 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 122' ' ' ILE . . . . . . . . . . . . . 91.9 mt -113.36 127.14 70.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 123' ' ' GLN . . . . . 0.546 ' HG2' HD21 ' B' ' 104' ' ' ASN . 15.8 mp0 -118.55 122.58 42.99 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 124' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -119.68 121.21 38.74 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' B' ' 127' ' ' THR . 68.3 t0 -72.23 128.04 34.41 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.604 -177.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.5 HG22 ' O ' ' B' ' 126' ' ' ILE . 2.9 mp -100.93 17.42 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.58 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 127' ' ' THR . . . . . 0.491 ' N ' ' OD1' ' B' ' 125' ' ' ASP . 98.1 m -62.57 -44.14 97.07 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 114.197 -1.365 . . . . 0.0 112.846 176.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 128' ' ' LYS . . . . . . . . . . . . . 59.9 tptt -61.67 -45.05 95.65 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -177.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 129' ' ' GLN . . . . . 0.406 ' OE1' HG23 ' B' ' 126' ' ' ILE . 88.1 mt-30 -63.39 -35.04 79.1 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.683 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 130' ' ' LYS . . . . . 0.663 ' NZ ' ' CD1' ' B' ' 103' ' ' TRP . 98.9 mttt -62.95 -41.63 99.57 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-N 112.833 -1.985 . . . . 0.0 110.835 174.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -64.3 -42.23 96.47 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 132' ' ' TYR . . . . . 0.841 ' CE2' HD11 ' B' ' 136' ' ' LEU . 91.6 t80 -60.13 -44.09 95.18 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 121.903 -0.498 . . . . 0.0 111.384 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 133' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' B' ' 137' ' ' GLU . 97.5 mt-10 -64.87 -36.55 84.7 Favored 'General case' 0 C--O 1.22 -0.453 0 C-N-CA 119.989 -0.684 . . . . 0.0 109.384 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 134' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' B' ' 130' ' ' LYS . 98.7 mttt -63.52 -39.8 95.36 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.604 177.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 135' ' ' LEU . . . . . . . . . . . . . 49.6 tp -62.91 -41.4 99.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.349 0.595 . . . . 0.0 109.441 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . 0.841 HD11 ' CE2' ' B' ' 132' ' ' TYR . 88.8 mt -62.99 -41.47 99.59 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.426 177.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 137' ' ' GLU . . . . . 0.464 ' HG3' ' O ' ' B' ' 133' ' ' GLU . 97.1 mt-10 -65.06 -37.18 86.73 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 113.806 -1.543 . . . . 0.0 110.268 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 138' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.48 -43.75 96.38 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.995 177.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 67.3 m -60.94 -44.39 97.31 Favored 'General case' 0 C--N 1.346 0.449 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . 0.49 ' O ' ' N ' ' B' ' 144' ' ' THR . 88.4 mt -61.73 -40.33 94.7 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -177.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 141' ' ' THR . . . . . . . . . . . . . 92.6 m -61.78 -45.44 93.89 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.026 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 142' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -65.66 -42.81 90.95 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 94.3 mt -63.87 -43.41 97.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.574 178.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 144' ' ' THR . . . . . 0.49 ' N ' ' O ' ' B' ' 140' ' ' LEU . 95.3 m -61.59 -45.51 93.82 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -178.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . 0.441 ' O ' ' HB ' ' B' ' 148' ' ' THR . . . -64.52 -41.73 96.21 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 119.117 -1.033 . . . . 0.0 109.295 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 146' ' ' LEU . . . . . . . . . . . . . 86.2 mt -64.99 -40.85 95.57 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 176.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 147' ' ' SER . . . . . 0.613 ' O ' ' N ' ' B' ' 149' ' ' PRO . 78.2 p -62.06 -41.86 98.6 Favored 'General case' 0 CA--C 1.477 -1.84 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -178.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . 0.497 ' C ' ' O ' ' B' ' 147' ' ' SER . 40.5 m -26.51 85.36 0.03 OUTLIER Pre-proline 0 N--CA 1.478 0.947 0 O-C-N 123.958 0.786 . . . . 0.0 110.188 176.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 149' ' ' PRO . . . . . 0.613 ' N ' ' O ' ' B' ' 147' ' ' SER . 24.1 Cg_exo -60.52 145.18 99.23 Favored 'Trans proline' 0 N--CA 1.496 1.644 0 C-N-CA 122.051 1.834 . . . . 0.0 115.6 -177.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 150' ' ' ILE . . . . . . . . . . . . . 9.9 tp -125.29 119.44 55.48 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.168 0 CA-C-N 114.036 -1.438 . . . . 0.0 108.197 174.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 151' ' ' VAL . . . . . . . . . . . . . 59.5 t -148.89 94.2 4.1 Favored Pre-proline 0 C--N 1.307 -1.274 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.806 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 152' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -62.04 142.88 94.1 Favored 'Trans proline' 0 C--N 1.317 -1.086 0 CA-C-N 119.909 1.003 . . . . 0.0 109.623 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 153' ' ' ILE . . . . . 0.617 ' CG2' HH12 ' A' ' 154' ' ' ARG . 43.8 mm -77.1 -66.89 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . 0.665 ' HD3' ' NH2' ' A' ' 154' ' ' ARG . 2.7 mpt_? -132.96 -158.84 0.92 Allowed 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 177.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 155' ' ' ASN . . . . . . . . . . . . . 61.5 t-20 -84.2 109.49 17.79 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . 101.02 -17.34 56.32 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -177.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 157' ' ' ILE . . . . . . . . . . . . . 89.3 mt -109.78 126.43 66.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.859 0.362 . . . . 0.0 111.282 -177.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . 0.702 ' OG ' ' OD2' ' B' ' 187' ' ' ASP . 60.7 m -135.29 149.05 49.71 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.718 178.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 159' ' ' ALA . . . . . . . . . . . . . . . -132.46 149.33 52.35 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 160' ' ' LEU . . . . . . . . . . . . . 29.8 tp -144.23 78.75 13.38 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 161' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -71.82 149.89 54.78 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 122.725 2.283 . . . . 0.0 114.108 -177.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 162' ' ' LEU . . . . . . . . . . . . . 91.6 mt -113.68 133.3 55.41 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 163' ' ' VAL . . . . . . . . . . . . . 55.9 t -128.38 132.38 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 164' ' ' GLY . . . . . . . . . . . . . . . 113.49 167.45 16.55 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.184 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 165' ' ' ASN . . . . . 0.634 ' O ' ' NH1' ' B' ' 170' ' ' ARG . 52.9 t30 -88.55 107.53 18.94 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -178.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 166' ' ' LEU . . . . . 0.553 HD21 ' CZ ' ' B' ' 171' ' ' PHE . 48.2 tp -64.78 105.35 0.98 Allowed 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -174.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 167' ' ' THR . . . . . 0.707 HG23 ' NE ' ' B' ' 170' ' ' ARG . 10.9 p -84.94 169.74 13.74 Favored 'General case' 0 C--N 1.348 0.502 0 CA-C-N 114.019 -1.446 . . . . 0.0 110.79 177.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 168' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.2 -37.87 84.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.704 176.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.3 -40.97 90.37 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-O 122.455 1.121 . . . . 0.0 111.894 -178.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 170' ' ' ARG . . . . . 0.707 ' NE ' HG23 ' B' ' 167' ' ' THR . 87.7 mtm180 -61.83 -34.81 76.63 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 112.376 -2.193 . . . . 0.0 111.178 177.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 171' ' ' PHE . . . . . 0.553 ' CZ ' HD21 ' B' ' 166' ' ' LEU . 0.5 OUTLIER -53.95 -26.25 24.67 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -178.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 172' ' ' ASN . . . . . 0.541 ' O ' HG22 ' B' ' 175' ' ' VAL . 92.8 m-20 -62.86 -40.56 97.86 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.127 -0.629 . . . . 0.0 110.875 179.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 173' ' ' SER . . . . . . . . . . . . . 57.1 m -60.7 -41.07 94.44 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.098 0.475 . . . . 0.0 110.747 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 174' ' ' ILE . . . . . . . . . . . . . 67.3 mt -63.92 -44.1 97.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -178.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 175' ' ' VAL . . . . . 0.541 HG22 ' O ' ' B' ' 172' ' ' ASN . 34.5 m -63.15 -40.22 88.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 176' ' ' CYS . . . . . 0.419 ' N ' HG23 ' B' ' 175' ' ' VAL . 99.1 m -61.88 -35.03 77.11 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.432 178.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 177' ' ' THR . . . . . 0.517 ' O ' HG13 ' B' ' 181' ' ' ILE . 25.1 m -61.74 -19.24 62.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.28 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 178' ' ' LEU . . . . . 0.621 ' CD2' HD21 ' B' ' 211' ' ' LEU . 89.4 mt -61.42 -39.01 89.19 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.328 -177.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 179' ' ' THR . . . . . . . . . . . . . 18.2 m -61.0 -43.81 98.35 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.259 177.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 180' ' ' ASN . . . . . 0.655 ' O ' ' OG ' ' B' ' 183' ' ' SER . 92.4 m-20 -62.13 -40.0 94.46 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.878 0.371 . . . . 0.0 110.481 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.517 HG13 ' O ' ' B' ' 177' ' ' THR . 72.2 mt -56.11 -35.0 40.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 O-C-N 122.157 -0.339 . . . . 0.0 110.902 -178.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 182' ' ' LEU . . . . . 0.533 HD21 HD21 ' B' ' 214' ' ' LEU . 84.6 mt -61.78 -41.52 97.83 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 119.799 -0.761 . . . . 0.0 109.11 177.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 183' ' ' SER . . . . . 0.655 ' OG ' ' O ' ' B' ' 180' ' ' ASN . 78.3 p -62.89 -32.6 73.9 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 121.8 -0.562 . . . . 0.0 110.915 176.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 184' ' ' THR . . . . . . . . . . . . . 50.9 p -87.52 15.73 6.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.835 0.35 . . . . 0.0 111.831 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 185' ' ' SER . . . . . . . . . . . . . 79.5 p -59.35 -17.13 27.0 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.031 -177.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 186' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -62.02 -40.59 96.22 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.704 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 187' ' ' ASP . . . . . 0.702 ' OD2' ' OG ' ' B' ' 158' ' ' SER . 98.2 m-20 -68.75 113.93 6.65 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.653 0.74 . . . . 0.0 110.622 -177.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 188' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.65 -42.36 99.57 Favored 'General case' 0 C--O 1.247 0.922 0 CA-C-N 114.772 -1.104 . . . . 0.0 113.118 -177.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 189' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -112.02 130.86 55.73 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 120.621 -0.431 . . . . 0.0 111.317 -178.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 190' ' ' LEU . . . . . . . . . . . . . 41.4 tp -123.13 117.64 25.86 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.901 178.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 191' ' ' ILE . . . . . . . . . . . . . 83.9 mt -105.62 125.1 60.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 121.064 -0.254 . . . . 0.0 111.418 -178.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 192' ' ' ILE . . . . . . . . . . . . . 49.7 mm -114.88 117.4 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 178.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 193' ' ' ASP . . . . . 0.615 ' CG ' ' HG ' ' B' ' 195' ' ' SER . 40.0 t0 -89.47 111.07 21.87 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.731 -176.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 194' ' ' LEU . . . . . . . . . . . . . 97.2 mt -92.24 -1.24 57.23 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.323 175.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 195' ' ' SER . . . . . 0.615 ' HG ' ' CG ' ' B' ' 193' ' ' ASP . 78.1 p -61.35 -37.16 82.34 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.698 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 196' ' ' GLY . . . . . . . . . . . . . . . -61.42 -34.13 87.18 Favored Glycine 0 N--CA 1.439 -1.102 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 197' ' ' LEU . . . . . 0.974 HD23 ' N ' ' B' ' 198' ' ' ALA . 4.8 tt -78.19 132.71 37.71 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 -176.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 198' ' ' ALA . . . . . 0.974 ' N ' HD23 ' B' ' 197' ' ' LEU . . . -64.5 -41.64 96.33 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.496 -178.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 199' ' ' GLN . . . . . 0.947 ' H ' ' CD2' ' B' ' 197' ' ' LEU . 58.9 tt0 -138.91 164.14 30.46 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -179.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 200' ' ' VAL . . . . . 0.465 ' N ' ' HG2' ' B' ' 199' ' ' GLN . 50.2 t -121.36 132.51 70.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 O-C-N 120.688 -1.258 . . . . 0.0 109.433 176.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 201' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -90.46 149.42 22.23 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.926 -178.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 202' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.44 -32.45 70.22 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.295 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 203' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -64.6 -32.65 74.39 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 204' ' ' THR . . . . . . . . . . . . . 19.4 m -60.79 -44.32 96.98 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.274 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 205' ' ' ALA . . . . . 0.623 ' O ' ' CD2' ' B' ' 209' ' ' PHE . . . -58.69 -29.56 66.73 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 111.705 0.261 . . . . 0.0 111.705 -177.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 206' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -65.44 -38.59 90.31 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.257 0.551 . . . . 0.0 109.672 176.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 207' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -66.89 -37.94 85.33 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.694 178.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 208' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.55 -43.46 98.29 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 120.528 -0.469 . . . . 0.0 109.808 -178.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 209' ' ' PHE . . . . . 0.623 ' CD2' ' O ' ' B' ' 205' ' ' ALA . 65.3 m-85 -62.17 -43.02 99.75 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 114.195 -1.366 . . . . 0.0 112.767 177.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.42 -41.8 98.71 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 119.288 -0.965 . . . . 0.0 109.763 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . 0.621 HD21 ' CD2' ' B' ' 178' ' ' LEU . 39.7 mt -62.27 -42.46 99.36 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.418 -179.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 78.0 p -63.15 -36.06 82.36 Favored 'General case' 0 C--N 1.32 -0.709 0 C-N-CA 120.291 -0.564 . . . . 0.0 112.11 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 213' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 -66.89 -46.72 74.06 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.146 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 214' ' ' LEU . . . . . 0.533 HD21 HD21 ' B' ' 182' ' ' LEU . 52.0 tp -63.89 -43.17 96.83 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.765 0.793 . . . . 0.0 109.827 177.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 215' ' ' LEU . . . . . 0.417 ' HB3' ' O ' ' B' ' 220' ' ' THR . 88.9 mt -63.2 -43.76 97.25 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 113.485 -1.689 . . . . 0.0 111.599 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 216' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.33 -39.69 91.46 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.879 -176.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 217' ' ' LEU . . . . . . . . . . . . . 87.1 mt -63.75 -42.05 97.9 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.389 0.614 . . . . 0.0 111.587 176.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 218' ' ' THR . . . . . . . . . . . . . 75.6 p -75.13 -16.41 60.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.106 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 219' ' ' GLY . . . . . . . . . . . . . . . 80.85 64.65 1.78 Allowed Glycine 0 CA--C 1.528 0.848 0 N-CA-C 106.577 -2.609 . . . . 0.0 106.577 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 220' ' ' THR . . . . . 0.417 ' O ' ' HB3' ' B' ' 215' ' ' LEU . 98.1 m -142.46 103.23 4.22 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 175.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 221' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -61.92 139.36 58.39 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.92 -176.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 222' ' ' LEU . . . . . . . . . . . . . 42.6 tp -116.3 121.4 41.88 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.231 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 223' ' ' ILE . . . . . . . . . . . . . 3.2 mp -110.01 128.58 66.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.223 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 224' ' ' ILE . . . . . 0.61 ' CG2' HD11 ' B' ' 227' ' ' ILE . 50.7 mm -108.86 126.05 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.735 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 225' ' ' THR . . . . . . . . . . . . . 51.8 p -133.0 157.16 45.89 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.511 0.672 . . . . 0.0 112.714 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 226' ' ' GLY . . . . . . . . . . . . . . . 89.16 18.04 54.44 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 113.894 -1.503 . . . . 0.0 110.981 -177.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 227' ' ' ILE . . . . . 0.667 HD12 HG23 ' B' ' 247' ' ' THR . 95.5 mt -82.54 125.69 39.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 121.908 -0.76 . . . . 0.0 111.586 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 228' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -65.86 140.31 97.17 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.604 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 229' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.78 -37.01 92.28 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 121.358 1.372 . . . . 0.0 112.446 178.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 230' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -64.39 -43.1 95.49 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 231' ' ' LEU . . . . . . . . . . . . . 51.3 tp -61.62 -41.55 97.63 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.701 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.12 -37.07 86.13 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 120.756 0.312 . . . . 0.0 111.359 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 233' ' ' MET . . . . . . . . . . . . . 93.9 mtp -64.08 -41.17 97.42 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.442 -0.503 . . . . 0.0 109.659 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 234' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.79 -43.67 98.19 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-O 122.204 1.002 . . . . 0.0 109.202 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 235' ' ' MET . . . . . . . . . . . . . 37.3 mmt -63.76 -35.73 81.54 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.951 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 236' ' ' ASN . . . . . . . . . . . . . 40.1 t30 -61.88 -40.52 95.68 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -178.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 237' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.31 -43.45 97.79 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.043 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 238' ' ' LEU . . . . . . . . . . . . . 51.8 tp -61.68 -45.52 93.66 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 120.26 -0.576 . . . . 0.0 112.228 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 239' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' B' ' 240' ' ' ALA . 66.8 t0 -156.83 135.13 11.31 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 120.39 -0.524 . . . . 0.0 112.034 -179.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 240' ' ' ALA . . . . . 0.435 ' N ' ' OD1' ' B' ' 239' ' ' ASP . . . -62.59 -46.56 87.76 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 176.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 241' ' ' ASN . . . . . 0.514 ' O ' ' HB2' ' B' ' 244' ' ' SER . 92.5 m-20 -43.74 -18.96 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.421 -175.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 242' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -61.91 -45.88 91.77 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.236 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 243' ' ' SER . . . . . 0.41 ' O ' ' N ' ' B' ' 245' ' ' LEU . 77.7 p -57.95 -45.62 86.35 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 244' ' ' SER . . . . . 0.514 ' HB2' ' O ' ' B' ' 241' ' ' ASN . 21.0 m -28.08 -38.47 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' B' ' 243' ' ' SER . 96.9 mt -87.73 138.54 31.38 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 121.521 -0.737 . . . . 0.0 110.489 178.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 246' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -66.75 134.93 53.18 Favored 'General case' 0 C--O 1.242 0.662 0 O-C-N 121.82 -0.55 . . . . 0.0 110.742 -174.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 247' ' ' THR . . . . . 0.667 HG23 HD12 ' B' ' 227' ' ' ILE . 97.3 m -124.6 126.81 46.4 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.919 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 248' ' ' TYR . . . . . 0.526 ' CG ' ' HB2' ' B' ' 254' ' ' ALA . 96.2 m-85 -111.6 143.14 42.97 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 177.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 249' ' ' SER . . . . . 0.553 ' O ' ' OD1' ' B' ' 250' ' ' ASN . 77.9 p -62.97 -34.75 78.19 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.107 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 250' ' ' ASN . . . . . 0.553 ' OD1' ' O ' ' B' ' 249' ' ' SER . 99.3 m-20 -146.85 159.2 43.82 Favored 'General case' 0 N--CA 1.461 0.121 0 O-C-N 124.243 0.964 . . . . 0.0 112.033 179.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 79.7 t -64.02 -44.6 97.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.919 178.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 252' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.23 -46.01 92.16 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -178.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 253' ' ' ASP . . . . . 0.523 ' O ' HG22 ' B' ' 257' ' ' VAL . 94.4 m-20 -61.25 -43.75 98.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.328 -0.851 . . . . 0.0 112.821 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 254' ' ' ALA . . . . . 0.526 ' HB2' ' CG ' ' B' ' 248' ' ' TYR . . . -64.9 -40.24 94.78 Favored 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.133 178.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 255' ' ' VAL . . . . . 0.72 HG11 ' O ' ' A' ' 153' ' ' ILE . 55.4 t -65.12 -45.54 93.85 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.298 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.7 -47.0 85.54 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 120.286 -0.566 . . . . 0.0 111.335 -178.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 257' ' ' VAL . . . . . 0.523 HG22 ' O ' ' B' ' 253' ' ' ASP . 28.3 m -65.95 -40.0 86.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 114.679 -1.146 . . . . 0.0 111.758 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 258' ' ' LEU . . . . . 0.519 ' CB ' ' CD ' ' B' ' 259' ' ' PRO . 1.9 mt -33.34 -74.04 0.05 OUTLIER Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.566 -178.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 259' ' ' PRO . . . . . 0.541 ' O ' HG13 ' B' ' 260' ' ' ILE . 37.3 Cg_endo -61.93 141.23 88.79 Favored 'Trans proline' 0 N--CA 1.504 2.122 0 C-N-CA 121.605 1.537 . . . . 0.0 111.463 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 260' ' ' ILE . . . . . 0.541 HG13 ' O ' ' B' ' 259' ' ' PRO . 96.9 mt -159.22 -15.02 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-N 118.73 0.696 . . . . 0.0 112.311 177.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 261' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 C--O 1.216 -0.706 0 CA-C-O 117.885 -1.055 . . . . 0.0 111.553 -179.741 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 900' ' ' FMN . . . . . 0.543 " H3'" ' OD1' ' A' ' 61' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 900' ' ' FMN . . . . . 0.521 " H3'" ' OD1' ' B' ' 61' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_